Regulation	O
of	O
Saccharomyces	O
cerevisiae	O
kinetochores	O
by	O
the	O
type	B-Gene_or_gene_product
1	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
Glc7p	B-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
protein	B-X
phosphorylation	B-X
in	B-X
regulation	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
kinetochores	B-X
.	B-X
By	B-X
use	B-X
of	B-X
phosphatase	B-X
inhibitors	B-X
and	B-X
a	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
mutant	B-X
(	B-X
glc7-10	B-X
)	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
microtubule	B-X
binding	B-X
activity	B-X
,	B-X
but	B-X
not	B-X
the	B-X
centromeric	B-X
DNA-binding	B-X
activity	B-X
,	B-X
of	B-X
the	B-X
kinetochore	B-X
complex	B-X
is	B-X
regulated	B-X
by	B-X
a	B-X
balance	B-X
between	B-X
a	B-X
protein	B-X
kinase	B-X
and	B-X
the	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP1	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
GLC7	B-X
gene	B-X
.	B-X
glc7-10	B-X
mutant	B-X
cells	B-X
exhibit	B-X
low	B-X
kinetochore-microtubule	B-X
binding	B-X
activity	B-X
in	B-X
vitro	B-X
and	B-X
a	B-X
high	B-X
frequency	B-X
of	B-X
chromosome	B-X
loss	B-X
in	B-X
vivo	B-X
.	B-X
Specifically	B-X
,	B-X
the	B-X
Ndc10p	B-X
component	B-X
of	B-X
the	B-X
centromere	B-X
DNA-binding	B-X
CBF3	B-X
complex	B-X
is	B-X
altered	B-X
by	B-X
the	B-X
glc7-10	B-X
mutation	B-X
;	B-X
Ndc10p	B-X
is	B-X
hyperphosphorylated	B-X
in	B-X
glc7-10	B-X
extracts	B-X
.	B-X
Furthermore	B-X
,	B-X
addition	B-X
of	B-X
recombinant	B-X
Ndc10p	B-X
reconstitutes	B-X
the	B-X
microtubule-binding	B-X
activity	B-X
of	B-X
a	B-X
glc7-10	B-X
extract	B-X
to	B-X
wild-type	B-X
levels	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
glc7-10-induced	B-X
mitotic	B-X
arrest	B-X
is	B-X
abolished	B-X
in	B-X
spindle	B-X
checkpoint	B-X
mutants	B-X
,	B-X
suggesting	B-X
that	B-X
defects	B-X
in	B-X
kinetochore-microtubule	B-X
interactions	B-X
caused	B-X
by	B-X
hyperphosphorylation	B-X
of	B-X
kinetochore	B-X
proteins	B-X
activate	B-X
the	B-X
spindle	B-X
checkpoint	B-X
.	B-X

We	O
have	O
investigated	O
the	O
role	O
of	O
protein	O
phosphorylation	O
in	O
regulation	O
of	O
Saccharomyces	O
cerevisiae	O
kinetochores	O
.	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
protein	B-X
phosphorylation	B-X
in	B-X
regulation	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
kinetochores	B-X
.	B-X
By	B-X
use	B-X
of	B-X
phosphatase	B-X
inhibitors	B-X
and	B-X
a	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
mutant	B-X
(	B-X
glc7-10	B-X
)	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
microtubule	B-X
binding	B-X
activity	B-X
,	B-X
but	B-X
not	B-X
the	B-X
centromeric	B-X
DNA-binding	B-X
activity	B-X
,	B-X
of	B-X
the	B-X
kinetochore	B-X
complex	B-X
is	B-X
regulated	B-X
by	B-X
a	B-X
balance	B-X
between	B-X
a	B-X
protein	B-X
kinase	B-X
and	B-X
the	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP1	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
GLC7	B-X
gene	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
glc7-10-induced	B-X
mitotic	B-X
arrest	B-X
is	B-X
abolished	B-X
in	B-X
spindle	B-X
checkpoint	B-X
mutants	B-X
,	B-X
suggesting	B-X
that	B-X
defects	B-X
in	B-X
kinetochore-microtubule	B-X
interactions	B-X
caused	B-X
by	B-X
hyperphosphorylation	B-X
of	B-X
kinetochore	B-X
proteins	B-X
activate	B-X
the	B-X
spindle	B-X
checkpoint	B-X
.	B-X
To	B-X
elucidate	B-X
the	B-X
underlying	B-X
mechanisms	B-X
,	B-X
we	B-X
developed	B-X
an	B-X
assay	B-X
to	B-X
assemble	B-X
kinetochores	B-X
de	B-X
novo	B-X
using	B-X
centromeric	B-X
DNA	B-X
and	B-X
budding	B-X
yeast	B-X
extracts	B-X
.	B-X
Assembly	B-X
is	B-X
enhanced	B-X
by	B-X
mitotic	B-X
phosphorylation	B-X
of	B-X
the	B-X
Dsn1	B-X
kinetochore	B-X
protein	B-X
and	B-X
generates	B-X
kinetochores	B-X
capable	B-X
of	B-X
binding	B-X
microtubules	B-X
.	B-X
We	B-X
used	B-X
this	B-X
assay	B-X
to	B-X
investigate	B-X
why	B-X
kinetochores	B-X
recruit	B-X
the	B-X
microtubule-binding	B-X
Ndc80	B-X
complex	B-X
via	B-X
two	B-X
receptors	B-X
:	B-X
the	B-X
Mis12	B-X
complex	B-X
and	B-X
CENP-T	B-X
.	B-X
Although	B-X
the	B-X
CENP-T	B-X
pathway	B-X
is	B-X
non-essential	B-X
in	B-X
yeast	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
it	B-X
becomes	B-X
essential	B-X
for	B-X
viability	B-X
and	B-X
Ndc80c	B-X
recruitment	B-X
when	B-X
the	B-X
Mis12	B-X
pathway	B-X
is	B-X
crippled	B-X
by	B-X
defects	B-X
in	B-X
Dsn1	B-X
phosphorylation	B-X
.	B-X
Assembling	B-X
kinetochores	B-X
de	B-X
novo	B-X
in	B-X
yeast	B-X
extracts	B-X
provides	B-X
a	B-X
powerful	B-X
and	B-X
genetically	B-X
tractable	B-X
method	B-X
to	B-X
elucidate	B-X
critical	B-X
regulatory	B-X
events	B-X
in	B-X
the	B-X
future	B-X
.	B-X

By	O
use	O
of	O
phosphatase	O
inhibitors	O
and	O
a	O
type	B-Gene_or_gene_product
1	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
mutant	O
(	O
glc7	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
)	O
,	O
we	O
show	O
that	O
the	O
microtubule	O
binding	O
activity	O
,	O
but	O
not	O
the	O
centromeric	O
DNA	O
-	O
binding	O
activity	O
,	O
of	O
the	O
kinetochore	O
complex	O
is	O
regulated	O
by	O
a	O
balance	O
between	O
a	O
protein	O
kinase	O
and	O
the	O
type	B-Gene_or_gene_product
1	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
(	O
PP1	B-Gene_or_gene_product
)	O
encoded	O
by	O
the	O
GLC7	O
gene	O
.	O

glc7	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
mutant	O
cells	O
exhibit	O
low	O
kinetochore	O
-	O
microtubule	O
binding	O
activity	O
in	O
vitro	O
and	O
a	O
high	O
frequency	O
of	O
chromosome	O
loss	O
in	O
vivo	O
.	O

Specifically	O
,	O
the	O
Ndc10p	B-Gene_or_gene_product
component	O
of	O
the	O
centromere	O
DNA	O
-	O
binding	O
CBF3	O
complex	O
is	O
altered	O
by	O
the	O
glc7	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
mutation	O
;	O
Ndc10p	B-Gene_or_gene_product
is	O
hyperphosphorylated	O
in	O
glc7	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
extracts	O
.	O
<EOS>	B-X
By	B-X
use	B-X
of	B-X
phosphatase	B-X
inhibitors	B-X
and	B-X
a	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
mutant	B-X
(	B-X
glc7-10	B-X
)	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
microtubule	B-X
binding	B-X
activity	B-X
,	B-X
but	B-X
not	B-X
the	B-X
centromeric	B-X
DNA-binding	B-X
activity	B-X
,	B-X
of	B-X
the	B-X
kinetochore	B-X
complex	B-X
is	B-X
regulated	B-X
by	B-X
a	B-X
balance	B-X
between	B-X
a	B-X
protein	B-X
kinase	B-X
and	B-X
the	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP1	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
GLC7	B-X
gene	B-X
.	B-X
glc7-10	B-X
mutant	B-X
cells	B-X
exhibit	B-X
low	B-X
kinetochore-microtubule	B-X
binding	B-X
activity	B-X
in	B-X
vitro	B-X
and	B-X
a	B-X
high	B-X
frequency	B-X
of	B-X
chromosome	B-X
loss	B-X
in	B-X
vivo	B-X
.	B-X
Specifically	B-X
,	B-X
the	B-X
Ndc10p	B-X
component	B-X
of	B-X
the	B-X
centromere	B-X
DNA-binding	B-X
CBF3	B-X
complex	B-X
is	B-X
altered	B-X
by	B-X
the	B-X
glc7-10	B-X
mutation	B-X
;	B-X
Ndc10p	B-X
is	B-X
hyperphosphorylated	B-X
in	B-X
glc7-10	B-X
extracts	B-X
.	B-X
Furthermore	B-X
,	B-X
addition	B-X
of	B-X
recombinant	B-X
Ndc10p	B-X
reconstitutes	B-X
the	B-X
microtubule-binding	B-X
activity	B-X
of	B-X
a	B-X
glc7-10	B-X
extract	B-X
to	B-X
wild-type	B-X
levels	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
glc7-10-induced	B-X
mitotic	B-X
arrest	B-X
is	B-X
abolished	B-X
in	B-X
spindle	B-X
checkpoint	B-X
mutants	B-X
,	B-X
suggesting	B-X
that	B-X
defects	B-X
in	B-X
kinetochore-microtubule	B-X
interactions	B-X
caused	B-X
by	B-X
hyperphosphorylation	B-X
of	B-X
kinetochore	B-X
proteins	B-X
activate	B-X
the	B-X
spindle	B-X
checkpoint	B-X
.	B-X

Furthermore	O
,	O
addition	O
of	O
recombinant	O
Ndc10p	B-Gene_or_gene_product
reconstitutes	O
the	O
microtubule	O
-	O
binding	O
activity	O
of	O
a	O
glc7	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
extract	O
to	O
wild	O
-	O
type	O
levels	O
.	O
<EOS>	B-X
By	B-X
use	B-X
of	B-X
phosphatase	B-X
inhibitors	B-X
and	B-X
a	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
mutant	B-X
(	B-X
glc7-10	B-X
)	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
microtubule	B-X
binding	B-X
activity	B-X
,	B-X
but	B-X
not	B-X
the	B-X
centromeric	B-X
DNA-binding	B-X
activity	B-X
,	B-X
of	B-X
the	B-X
kinetochore	B-X
complex	B-X
is	B-X
regulated	B-X
by	B-X
a	B-X
balance	B-X
between	B-X
a	B-X
protein	B-X
kinase	B-X
and	B-X
the	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP1	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
GLC7	B-X
gene	B-X
.	B-X
glc7-10	B-X
mutant	B-X
cells	B-X
exhibit	B-X
low	B-X
kinetochore-microtubule	B-X
binding	B-X
activity	B-X
in	B-X
vitro	B-X
and	B-X
a	B-X
high	B-X
frequency	B-X
of	B-X
chromosome	B-X
loss	B-X
in	B-X
vivo	B-X
.	B-X
Specifically	B-X
,	B-X
the	B-X
Ndc10p	B-X
component	B-X
of	B-X
the	B-X
centromere	B-X
DNA-binding	B-X
CBF3	B-X
complex	B-X
is	B-X
altered	B-X
by	B-X
the	B-X
glc7-10	B-X
mutation	B-X
;	B-X
Ndc10p	B-X
is	B-X
hyperphosphorylated	B-X
in	B-X
glc7-10	B-X
extracts	B-X
.	B-X
Furthermore	B-X
,	B-X
addition	B-X
of	B-X
recombinant	B-X
Ndc10p	B-X
reconstitutes	B-X
the	B-X
microtubule-binding	B-X
activity	B-X
of	B-X
a	B-X
glc7-10	B-X
extract	B-X
to	B-X
wild-type	B-X
levels	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
glc7-10-induced	B-X
mitotic	B-X
arrest	B-X
is	B-X
abolished	B-X
in	B-X
spindle	B-X
checkpoint	B-X
mutants	B-X
,	B-X
suggesting	B-X
that	B-X
defects	B-X
in	B-X
kinetochore-microtubule	B-X
interactions	B-X
caused	B-X
by	B-X
hyperphosphorylation	B-X
of	B-X
kinetochore	B-X
proteins	B-X
activate	B-X
the	B-X
spindle	B-X
checkpoint	B-X
.	B-X

Finally	O
,	O
the	O
glc7	B-Gene_or_gene_product
-	I-Gene_or_gene_product
10	I-Gene_or_gene_product
-	O
induced	O
mitotic	O
arrest	O
is	O
abolished	O
in	O
spindle	O
checkpoint	O
mutants	O
,	O
suggesting	O
that	O
defects	O
in	O
kinetochore	O
-	O
microtubule	O
interactions	O
caused	O
by	O
hyperphosphorylation	O
of	O
kinetochore	O
proteins	O
activate	O
the	O
spindle	O
checkpoint	O
.	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
protein	B-X
phosphorylation	B-X
in	B-X
regulation	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
kinetochores	B-X
.	B-X
By	B-X
use	B-X
of	B-X
phosphatase	B-X
inhibitors	B-X
and	B-X
a	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
mutant	B-X
(	B-X
glc7-10	B-X
)	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
microtubule	B-X
binding	B-X
activity	B-X
,	B-X
but	B-X
not	B-X
the	B-X
centromeric	B-X
DNA-binding	B-X
activity	B-X
,	B-X
of	B-X
the	B-X
kinetochore	B-X
complex	B-X
is	B-X
regulated	B-X
by	B-X
a	B-X
balance	B-X
between	B-X
a	B-X
protein	B-X
kinase	B-X
and	B-X
the	B-X
type	B-X
1	B-X
protein	B-X
phosphatase	B-X
(	B-X
PP1	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
GLC7	B-X
gene	B-X
.	B-X
glc7-10	B-X
mutant	B-X
cells	B-X
exhibit	B-X
low	B-X
kinetochore-microtubule	B-X
binding	B-X
activity	B-X
in	B-X
vitro	B-X
and	B-X
a	B-X
high	B-X
frequency	B-X
of	B-X
chromosome	B-X
loss	B-X
in	B-X
vivo	B-X
.	B-X
Specifically	B-X
,	B-X
the	B-X
Ndc10p	B-X
component	B-X
of	B-X
the	B-X
centromere	B-X
DNA-binding	B-X
CBF3	B-X
complex	B-X
is	B-X
altered	B-X
by	B-X
the	B-X
glc7-10	B-X
mutation	B-X
;	B-X
Ndc10p	B-X
is	B-X
hyperphosphorylated	B-X
in	B-X
glc7-10	B-X
extracts	B-X
.	B-X
Furthermore	B-X
,	B-X
addition	B-X
of	B-X
recombinant	B-X
Ndc10p	B-X
reconstitutes	B-X
the	B-X
microtubule-binding	B-X
activity	B-X
of	B-X
a	B-X
glc7-10	B-X
extract	B-X
to	B-X
wild-type	B-X
levels	B-X
.	B-X
Finally	B-X
,	B-X
the	B-X
glc7-10-induced	B-X
mitotic	B-X
arrest	B-X
is	B-X
abolished	B-X
in	B-X
spindle	B-X
checkpoint	B-X
mutants	B-X
,	B-X
suggesting	B-X
that	B-X
defects	B-X
in	B-X
kinetochore-microtubule	B-X
interactions	B-X
caused	B-X
by	B-X
hyperphosphorylation	B-X
of	B-X
kinetochore	B-X
proteins	B-X
activate	B-X
the	B-X
spindle	B-X
checkpoint	B-X
.	B-X

Human	O
placental	O
Na	B-Gene_or_gene_product
+	I-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
multivitamin	I-Gene_or_gene_product
transporter	I-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
the	B-X
human	B-X
Na+-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
which	B-X
transports	B-X
the	B-X
water-soluble	B-X
vitamins	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
,	B-X
from	B-X
a	B-X
placental	B-X
choriocarcinoma	B-X
cell	B-X
line	B-X
(	B-X
JAR	B-X
)	B-X
.	B-X
When	B-X
expressed	B-X
in	B-X
HRPE	B-X
cells	B-X
,	B-X
the	B-X
cDNA-induced	B-X
transport	B-X
process	B-X
is	B-X
obligatorily	B-X
dependent	B-X
on	B-X
Na+	B-X
and	B-X
accepts	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
as	B-X
substrates	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
the	B-X
cDNA-specific	B-X
uptake	B-X
rate	B-X
of	B-X
pantothenate	B-X
or	B-X
biotin	B-X
and	B-X
Na+	B-X
concentration	B-X
is	B-X
sigmoidal	B-X
with	B-X
a	B-X
Na+	B-X
:	B-X
vitamin	B-X
stoichiometry	B-X
of	B-X
2:1	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
,	B-X
induces	B-X
inward	B-X
currents	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
in	B-X
a	B-X
Na+-	B-X
,	B-X
concentration-	B-X
,	B-X
and	B-X
potential-dependent	B-X
manner	B-X
.	B-X

Cloning	O
,	O
functional	O
expression	O
,	O
gene	O
structure	O
,	O
and	O
chromosomal	O
localization	O
.	O
<EOS>	B-X
Gene	B-X
mapping	B-X
studies	B-X
have	B-X
placed	B-X
CD69	B-X
on	B-X
distal	B-X
mouse	B-X
chromosome	B-X
6	B-X
and	B-X
human	B-X
chromosome	B-X
12p13	B-X
,	B-X
close	B-X
to	B-X
,	B-X
if	B-X
not	B-X
in	B-X
,	B-X
the	B-X
NK	B-X
gene	B-X
complex	B-X
.	B-X
The	B-X
structure	B-X
,	B-X
chromosomal	B-X
localization	B-X
,	B-X
expression	B-X
and	B-X
function	B-X
of	B-X
CD69	B-X
suggest	B-X
that	B-X
it	B-X
is	B-X
likely	B-X
a	B-X
pleiotropic	B-X
immune	B-X
regulator	B-X
,	B-X
potentially	B-X
important	B-X
not	B-X
only	B-X
in	B-X
NK	B-X
cell	B-X
function	B-X
but	B-X
also	B-X
in	B-X
the	B-X
activation	B-X
and	B-X
differentiation	B-X
of	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
hematopoietic	B-X
cells	B-X
.	B-X
The	B-X
gene	B-X
contains	B-X
22	B-X
exons	B-X
spanning	B-X
approximately	B-X
85	B-X
kb	B-X
.	B-X
The	B-X
gene	B-X
is	B-X
localized	B-X
to	B-X
chromosome	B-X
7	B-X
at	B-X
p13-p14	B-X
by	B-X
fluorescence	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
With	B-X
the	B-X
TATA-	B-X
and	B-X
CAAT-less	B-X
5'-flanking	B-X
region	B-X
(	B-X
wild	B-X
type	B-X
,	B-X
-3276/+212	B-X
)	B-X
of	B-X
the	B-X
OGDH	B-X
gene-luciferase	B-X
reporter	B-X
vector	B-X
construct	B-X
and	B-X
its	B-X
nested	B-X
deletion	B-X
or	B-X
linker-scanning	B-X
mutant	B-X
constructs	B-X
the	B-X
transient	B-X
reporter	B-X
expression	B-X
assays	B-X
in	B-X
BHK-21	B-X
cells	B-X
reveal	B-X
the	B-X
existence	B-X
of	B-X
two	B-X
10-bp	B-X
cis-acting	B-X
elements	B-X
(	B-X
-53/-44	B-X
and	B-X
-33/-24	B-X
)	B-X
and	B-X
two	B-X
trans-acting	B-X
elements	B-X
(	B-X
-536/-496	B-X
and	B-X
-93/-84	B-X
)	B-X
.	B-X

We	O
have	O
cloned	O
the	O
human	O
Na	B-Gene_or_gene_product
+	I-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
multivitamin	I-Gene_or_gene_product
transporter	I-Gene_or_gene_product
(	O
SMVT	B-Gene_or_gene_product
)	O
,	O
which	O
transports	O
the	O
water	O
-	O
soluble	O
vitamins	O
pantothenate	O
,	O
biotin	O
,	O
and	O
lipoate	O
,	O
from	O
a	O
placental	O
choriocarcinoma	O
cell	O
line	O
(	O
JAR	O
)	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
the	B-X
human	B-X
Na+-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
which	B-X
transports	B-X
the	B-X
water-soluble	B-X
vitamins	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
,	B-X
from	B-X
a	B-X
placental	B-X
choriocarcinoma	B-X
cell	B-X
line	B-X
(	B-X
JAR	B-X
)	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
exhibits	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
homology	B-X
(	B-X
84	B-X
%	B-X
identity	B-X
and	B-X
89	B-X
%	B-X
similarity	B-X
)	B-X
to	B-X
the	B-X
rat	B-X
counterpart	B-X
.	B-X
When	B-X
expressed	B-X
in	B-X
HRPE	B-X
cells	B-X
,	B-X
the	B-X
cDNA-induced	B-X
transport	B-X
process	B-X
is	B-X
obligatorily	B-X
dependent	B-X
on	B-X
Na+	B-X
and	B-X
accepts	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
as	B-X
substrates	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
the	B-X
cDNA-specific	B-X
uptake	B-X
rate	B-X
of	B-X
pantothenate	B-X
or	B-X
biotin	B-X
and	B-X
Na+	B-X
concentration	B-X
is	B-X
sigmoidal	B-X
with	B-X
a	B-X
Na+	B-X
:	B-X
vitamin	B-X
stoichiometry	B-X
of	B-X
2:1	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
,	B-X
induces	B-X
inward	B-X
currents	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
in	B-X
a	B-X
Na+-	B-X
,	B-X
concentration-	B-X
,	B-X
and	B-X
potential-dependent	B-X
manner	B-X
.	B-X
We	B-X
also	B-X
report	B-X
here	B-X
on	B-X
the	B-X
structural	B-X
organization	B-X
and	B-X
chromosomal	B-X
localization	B-X
of	B-X
the	B-X
human	B-X
SMVT	B-X
gene	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
approximately	B-X
14	B-X
kilobase	B-X
pairs	B-X
in	B-X
length	B-X
and	B-X
consists	B-X
of	B-X
17	B-X
exons	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
located	B-X
on	B-X
chromosome	B-X
2p23	B-X
as	B-X
evidenced	B-X
by	B-X
somatic	B-X
cell	B-X
hybrid	B-X
analysis	B-X
and	B-X
fluorescence	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X

The	O
cDNA	O
codes	O
for	O
a	O
protein	O
of	O
635	O
amino	O
acids	O
with	O
12	O
transmembrane	O
domains	O
and	O
4	O
putative	O
sites	O
for	O
N	O
-	O
linked	O
glycosylation	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
the	B-X
human	B-X
Na+-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
which	B-X
transports	B-X
the	B-X
water-soluble	B-X
vitamins	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
,	B-X
from	B-X
a	B-X
placental	B-X
choriocarcinoma	B-X
cell	B-X
line	B-X
(	B-X
JAR	B-X
)	B-X
.	B-X
The	B-X
cDNA	B-X
codes	B-X
for	B-X
a	B-X
protein	B-X
of	B-X
635	B-X
amino	B-X
acids	B-X
with	B-X
12	B-X
transmembrane	B-X
domains	B-X
and	B-X
4	B-X
putative	B-X
sites	B-X
for	B-X
N-linked	B-X
glycosylation	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
exhibits	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
homology	B-X
(	B-X
84	B-X
%	B-X
identity	B-X
and	B-X
89	B-X
%	B-X
similarity	B-X
)	B-X
to	B-X
the	B-X
rat	B-X
counterpart	B-X
.	B-X
When	B-X
expressed	B-X
in	B-X
HRPE	B-X
cells	B-X
,	B-X
the	B-X
cDNA-induced	B-X
transport	B-X
process	B-X
is	B-X
obligatorily	B-X
dependent	B-X
on	B-X
Na+	B-X
and	B-X
accepts	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
as	B-X
substrates	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
the	B-X
cDNA-specific	B-X
uptake	B-X
rate	B-X
of	B-X
pantothenate	B-X
or	B-X
biotin	B-X
and	B-X
Na+	B-X
concentration	B-X
is	B-X
sigmoidal	B-X
with	B-X
a	B-X
Na+	B-X
:	B-X
vitamin	B-X
stoichiometry	B-X
of	B-X
2:1	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
,	B-X
induces	B-X
inward	B-X
currents	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
in	B-X
a	B-X
Na+-	B-X
,	B-X
concentration-	B-X
,	B-X
and	B-X
potential-dependent	B-X
manner	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
approximately	B-X
14	B-X
kilobase	B-X
pairs	B-X
in	B-X
length	B-X
and	B-X
consists	B-X
of	B-X
17	B-X
exons	B-X
.	B-X

The	O
human	O
SMVT	B-Gene_or_gene_product
exhibits	O
a	O
high	O
degree	O
of	O
homology	O
(	O
84	O
%	O
identity	O
and	O
89	O
%	O
similarity	O
)	O
to	O
the	O
rat	O
counterpart	O
.	O

When	O
expressed	O
in	O
HRPE	O
cells	O
,	O
the	O
cDNA	O
-	O
induced	O
transport	O
process	O
is	O
obligatorily	O
dependent	O
on	O
Na	O
+	O
and	O
accepts	O
pantothenate	O
,	O
biotin	O
,	O
and	O
lipoate	O
as	O
substrates	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
the	B-X
human	B-X
Na+-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
which	B-X
transports	B-X
the	B-X
water-soluble	B-X
vitamins	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
,	B-X
from	B-X
a	B-X
placental	B-X
choriocarcinoma	B-X
cell	B-X
line	B-X
(	B-X
JAR	B-X
)	B-X
.	B-X
The	B-X
cDNA	B-X
codes	B-X
for	B-X
a	B-X
protein	B-X
of	B-X
635	B-X
amino	B-X
acids	B-X
with	B-X
12	B-X
transmembrane	B-X
domains	B-X
and	B-X
4	B-X
putative	B-X
sites	B-X
for	B-X
N-linked	B-X
glycosylation	B-X
.	B-X
When	B-X
expressed	B-X
in	B-X
HRPE	B-X
cells	B-X
,	B-X
the	B-X
cDNA-induced	B-X
transport	B-X
process	B-X
is	B-X
obligatorily	B-X
dependent	B-X
on	B-X
Na+	B-X
and	B-X
accepts	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
as	B-X
substrates	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
the	B-X
cDNA-specific	B-X
uptake	B-X
rate	B-X
of	B-X
pantothenate	B-X
or	B-X
biotin	B-X
and	B-X
Na+	B-X
concentration	B-X
is	B-X
sigmoidal	B-X
with	B-X
a	B-X
Na+	B-X
:	B-X
vitamin	B-X
stoichiometry	B-X
of	B-X
2:1	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
,	B-X
induces	B-X
inward	B-X
currents	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
in	B-X
a	B-X
Na+-	B-X
,	B-X
concentration-	B-X
,	B-X
and	B-X
potential-dependent	B-X
manner	B-X
.	B-X

The	O
relationship	O
between	O
the	O
cDNA	O
-	O
specific	O
uptake	O
rate	O
of	O
pantothenate	O
or	O
biotin	O
and	O
Na	O
+	O
concentration	O
is	O
sigmoidal	O
with	O
a	O
Na	O
+	O
:	O
vitamin	O
stoichiometry	O
of	O
2	O
:	O
1	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
the	B-X
human	B-X
Na+-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
which	B-X
transports	B-X
the	B-X
water-soluble	B-X
vitamins	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
,	B-X
from	B-X
a	B-X
placental	B-X
choriocarcinoma	B-X
cell	B-X
line	B-X
(	B-X
JAR	B-X
)	B-X
.	B-X
The	B-X
cDNA	B-X
codes	B-X
for	B-X
a	B-X
protein	B-X
of	B-X
635	B-X
amino	B-X
acids	B-X
with	B-X
12	B-X
transmembrane	B-X
domains	B-X
and	B-X
4	B-X
putative	B-X
sites	B-X
for	B-X
N-linked	B-X
glycosylation	B-X
.	B-X
When	B-X
expressed	B-X
in	B-X
HRPE	B-X
cells	B-X
,	B-X
the	B-X
cDNA-induced	B-X
transport	B-X
process	B-X
is	B-X
obligatorily	B-X
dependent	B-X
on	B-X
Na+	B-X
and	B-X
accepts	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
as	B-X
substrates	B-X
.	B-X
The	B-X
relationship	B-X
between	B-X
the	B-X
cDNA-specific	B-X
uptake	B-X
rate	B-X
of	B-X
pantothenate	B-X
or	B-X
biotin	B-X
and	B-X
Na+	B-X
concentration	B-X
is	B-X
sigmoidal	B-X
with	B-X
a	B-X
Na+	B-X
:	B-X
vitamin	B-X
stoichiometry	B-X
of	B-X
2:1	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
,	B-X
induces	B-X
inward	B-X
currents	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
in	B-X
a	B-X
Na+-	B-X
,	B-X
concentration-	B-X
,	B-X
and	B-X
potential-dependent	B-X
manner	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
approximately	B-X
14	B-X
kilobase	B-X
pairs	B-X
in	B-X
length	B-X
and	B-X
consists	B-X
of	B-X
17	B-X
exons	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
located	B-X
on	B-X
chromosome	B-X
2p23	B-X
as	B-X
evidenced	B-X
by	B-X
somatic	B-X
cell	B-X
hybrid	B-X
analysis	B-X
and	B-X
fluorescence	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X

The	O
human	O
SMVT	B-Gene_or_gene_product
,	O
when	O
expressed	O
in	O
Xenopus	O
laevis	O
oocytes	O
,	O
induces	O
inward	O
currents	O
in	O
the	O
presence	O
of	O
pantothenate	O
,	O
biotin	O
,	O
and	O
lipoate	O
in	O
a	O
Na	O
+	O
-	O
,	O
concentration	O
-	O
,	O
and	O
potential	O
-	O
dependent	O
manner	O
.	O

We	O
also	O
report	O
here	O
on	O
the	O
structural	O
organization	O
and	O
chromosomal	O
localization	O
of	O
the	O
human	O
SMVT	B-Gene_or_gene_product
gene	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
the	B-X
human	B-X
Na+-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
which	B-X
transports	B-X
the	B-X
water-soluble	B-X
vitamins	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
,	B-X
from	B-X
a	B-X
placental	B-X
choriocarcinoma	B-X
cell	B-X
line	B-X
(	B-X
JAR	B-X
)	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
exhibits	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
homology	B-X
(	B-X
84	B-X
%	B-X
identity	B-X
and	B-X
89	B-X
%	B-X
similarity	B-X
)	B-X
to	B-X
the	B-X
rat	B-X
counterpart	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
,	B-X
induces	B-X
inward	B-X
currents	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
in	B-X
a	B-X
Na+-	B-X
,	B-X
concentration-	B-X
,	B-X
and	B-X
potential-dependent	B-X
manner	B-X
.	B-X
We	B-X
also	B-X
report	B-X
here	B-X
on	B-X
the	B-X
structural	B-X
organization	B-X
and	B-X
chromosomal	B-X
localization	B-X
of	B-X
the	B-X
human	B-X
SMVT	B-X
gene	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
approximately	B-X
14	B-X
kilobase	B-X
pairs	B-X
in	B-X
length	B-X
and	B-X
consists	B-X
of	B-X
17	B-X
exons	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
located	B-X
on	B-X
chromosome	B-X
2p23	B-X
as	B-X
evidenced	B-X
by	B-X
somatic	B-X
cell	B-X
hybrid	B-X
analysis	B-X
and	B-X
fluorescence	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X

The	O
SMVT	B-Gene_or_gene_product
gene	O
is	O
approximately	O
14	O
kilobase	O
pairs	O
in	O
length	O
and	O
consists	O
of	O
17	O
exons	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
the	B-X
human	B-X
Na+-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
which	B-X
transports	B-X
the	B-X
water-soluble	B-X
vitamins	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
,	B-X
from	B-X
a	B-X
placental	B-X
choriocarcinoma	B-X
cell	B-X
line	B-X
(	B-X
JAR	B-X
)	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
exhibits	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
homology	B-X
(	B-X
84	B-X
%	B-X
identity	B-X
and	B-X
89	B-X
%	B-X
similarity	B-X
)	B-X
to	B-X
the	B-X
rat	B-X
counterpart	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
,	B-X
induces	B-X
inward	B-X
currents	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
in	B-X
a	B-X
Na+-	B-X
,	B-X
concentration-	B-X
,	B-X
and	B-X
potential-dependent	B-X
manner	B-X
.	B-X
We	B-X
also	B-X
report	B-X
here	B-X
on	B-X
the	B-X
structural	B-X
organization	B-X
and	B-X
chromosomal	B-X
localization	B-X
of	B-X
the	B-X
human	B-X
SMVT	B-X
gene	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
approximately	B-X
14	B-X
kilobase	B-X
pairs	B-X
in	B-X
length	B-X
and	B-X
consists	B-X
of	B-X
17	B-X
exons	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
located	B-X
on	B-X
chromosome	B-X
2p23	B-X
as	B-X
evidenced	B-X
by	B-X
somatic	B-X
cell	B-X
hybrid	B-X
analysis	B-X
and	B-X
fluorescence	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X

The	O
SMVT	B-Gene_or_gene_product
gene	O
is	O
located	O
on	O
chromosome	O
2p23	O
as	O
evidenced	O
by	O
somatic	O
cell	O
hybrid	O
analysis	O
and	O
fluorescence	O
in	O
situ	O
hybridization	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
the	B-X
human	B-X
Na+-dependent	B-X
multivitamin	B-X
transporter	B-X
(	B-X
SMVT	B-X
)	B-X
,	B-X
which	B-X
transports	B-X
the	B-X
water-soluble	B-X
vitamins	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
,	B-X
from	B-X
a	B-X
placental	B-X
choriocarcinoma	B-X
cell	B-X
line	B-X
(	B-X
JAR	B-X
)	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
exhibits	B-X
a	B-X
high	B-X
degree	B-X
of	B-X
homology	B-X
(	B-X
84	B-X
%	B-X
identity	B-X
and	B-X
89	B-X
%	B-X
similarity	B-X
)	B-X
to	B-X
the	B-X
rat	B-X
counterpart	B-X
.	B-X
When	B-X
expressed	B-X
in	B-X
HRPE	B-X
cells	B-X
,	B-X
the	B-X
cDNA-induced	B-X
transport	B-X
process	B-X
is	B-X
obligatorily	B-X
dependent	B-X
on	B-X
Na+	B-X
and	B-X
accepts	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
as	B-X
substrates	B-X
.	B-X
The	B-X
human	B-X
SMVT	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Xenopus	B-X
laevis	B-X
oocytes	B-X
,	B-X
induces	B-X
inward	B-X
currents	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
pantothenate	B-X
,	B-X
biotin	B-X
,	B-X
and	B-X
lipoate	B-X
in	B-X
a	B-X
Na+-	B-X
,	B-X
concentration-	B-X
,	B-X
and	B-X
potential-dependent	B-X
manner	B-X
.	B-X
We	B-X
also	B-X
report	B-X
here	B-X
on	B-X
the	B-X
structural	B-X
organization	B-X
and	B-X
chromosomal	B-X
localization	B-X
of	B-X
the	B-X
human	B-X
SMVT	B-X
gene	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
approximately	B-X
14	B-X
kilobase	B-X
pairs	B-X
in	B-X
length	B-X
and	B-X
consists	B-X
of	B-X
17	B-X
exons	B-X
.	B-X
The	B-X
SMVT	B-X
gene	B-X
is	B-X
located	B-X
on	B-X
chromosome	B-X
2p23	B-X
as	B-X
evidenced	B-X
by	B-X
somatic	B-X
cell	B-X
hybrid	B-X
analysis	B-X
and	B-X
fluorescence	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X

Aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
,	O
a	O
key	O
enzyme	O
in	O
the	O
oxidative	O
deamination	O
of	O
norepinephrine	O
in	O
rats	O
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

The	O
sympathoneural	O
neurotransmitter	O
norepinephrine	O
(	O
NE	O
)	O
is	O
deaminated	O
to	O
3	O
,	O
4	O
-	O
dihydroxymandelaldehyde	O
(	O
DHMAL	O
)	O
and	O
subsequently	O
converted	O
to	O
either	O
3	O
,	O
4	O
-	O
dihydroxymandelic	O
acid	O
(	O
DHMA	O
)	O
or	O
3	O
,	O
4	O
-	O
dihydroxyphenylglycol	O
(	O
DHPG	O
)	O
.	O
<EOS>	B-X
The	B-X
presence	B-X
of	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
was	B-X
studied	B-X
in	B-X
32	B-X
samples	B-X
and	B-X
10	B-X
different	B-X
cultivars	B-X
of	B-X
natural	B-X
table	B-X
olives	B-X
,	B-X
using	B-X
an	B-X
accurate	B-X
method	B-X
to	B-X
avoid	B-X
wrong	B-X
quantification	B-X
.	B-X
High	B-X
levels	B-X
of	B-X
DHPG	B-X
(	B-X
up	B-X
to	B-X
368	B-X
mg/kg	B-X
of	B-X
dry	B-X
weight	B-X
)	B-X
were	B-X
found	B-X
in	B-X
the	B-X
pulp	B-X
of	B-X
natural	B-X
black	B-X
olives	B-X
independent	B-X
of	B-X
cultivar	B-X
and	B-X
processing	B-X
method	B-X
,	B-X
similar	B-X
to	B-X
its	B-X
concentration	B-X
in	B-X
the	B-X
brine	B-X
in	B-X
almost	B-X
all	B-X
of	B-X
the	B-X
samples	B-X
.	B-X
The	B-X
presented	B-X
data	B-X
for	B-X
this	B-X
antioxidant	B-X
indicate	B-X
that	B-X
natural	B-X
table	B-X
olives	B-X
are	B-X
a	B-X
rich	B-X
source	B-X
of	B-X
DHPG	B-X
and	B-X
hydroxytyrosol	B-X
,	B-X
compounds	B-X
with	B-X
interesting	B-X
nutritional	B-X
and	B-X
antioxidant	B-X
properties	B-X
.	B-X
Hydroxytyrosol	B-X
(	B-X
HT	B-X
)	B-X
and	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
are	B-X
two	B-X
phenolic	B-X
antioxidants	B-X
naturally	B-X
found	B-X
in	B-X
olive	B-X
fruit	B-X
with	B-X
anti-inflammatory	B-X
properties	B-X
.	B-X
This	B-X
study	B-X
explored	B-X
the	B-X
interaction	B-X
of	B-X
pectin	B-X
with	B-X
HT	B-X
and	B-X
DHPG	B-X
via	B-X
their	B-X
encapsulation	B-X
into	B-X
pectinate	B-X
beads	B-X
.	B-X
The	B-X
entrapment	B-X
efficiency	B-X
,	B-X
swelling	B-X
properties	B-X
,	B-X
and	B-X
in	B-X
vitro	B-X
release	B-X
of	B-X
HT	B-X
and	B-X
DHPG	B-X
of	B-X
the	B-X
beads	B-X
were	B-X
studied	B-X
.	B-X
The	B-X
results	B-X
show	B-X
that	B-X
the	B-X
beads	B-X
can	B-X
entrap	B-X
the	B-X
water	B-X
soluble	B-X
compounds	B-X
HT	B-X
and	B-X
DHPG	B-X
in	B-X
sufficient	B-X
amounts	B-X
to	B-X
reach	B-X
the	B-X
colon	B-X
.	B-X
The	B-X
beads	B-X
consisted	B-X
of	B-X
an	B-X
important	B-X
amount	B-X
of	B-X
pectin-bound	B-X
HT	B-X
or	B-X
DHPG	B-X
after	B-X
two	B-X
hours	B-X
at	B-X
gastric	B-X
pH	B-X
.	B-X
This	B-X
study	B-X
highlights	B-X
the	B-X
potential	B-X
use	B-X
of	B-X
HT-and	B-X
DHPG-loaded	B-X
pectinate	B-X
gel	B-X
beads	B-X
for	B-X
the	B-X
colon-targeted	B-X
delivery	B-X
of	B-X
these	B-X
bioactive	B-X
compounds	B-X
to	B-X
help	B-X
prevent	B-X
or	B-X
relieve	B-X
chronic	B-X
inflammatory	B-X
bowel	B-X
disease	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
relative	O
importance	O
of	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
versus	O
aldehyde	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
in	O
the	O
formation	O
of	O
DHPG	O
from	O
DHMAL	O
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
A	B-X
significant	B-X
decrease	B-X
in	B-X
DHPG	B-X
,	B-X
however	B-X
,	B-X
was	B-X
obtained	B-X
only	B-X
with	B-X
an	B-X
extremely	B-X
high	B-X
dose	B-X
(	B-X
9	B-X
mg/kg/day	B-X
)	B-X
of	B-X
the	B-X
nonselective	B-X
inhibitor	B-X
AL	B-X
1576	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

The	O
in	O
vitro	O
incubation	O
of	O
NE	O
with	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
in	O
the	O
presence	O
of	O
monoamine	B-Gene_or_gene_product
oxidase	I-Gene_or_gene_product
(	O
MAO	B-Gene_or_gene_product
)	O
resulted	O
in	O
the	O
formation	O
of	O
DHPG	O
,	O
which	O
was	O
confirmed	O
by	O
mass	O
spectrometry	O
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
There	B-X
was	B-X
no	B-X
correlation	B-X
between	B-X
the	B-X
selectivity	B-X
of	B-X
inhibitors	B-X
and	B-X
effects	B-X
on	B-X
NE	B-X
metabolite	B-X
levels	B-X
.	B-X
A	B-X
significant	B-X
decrease	B-X
in	B-X
DHPG	B-X
,	B-X
however	B-X
,	B-X
was	B-X
obtained	B-X
only	B-X
with	B-X
an	B-X
extremely	B-X
high	B-X
dose	B-X
(	B-X
9	B-X
mg/kg/day	B-X
)	B-X
of	B-X
the	B-X
nonselective	B-X
inhibitor	B-X
AL	B-X
1576	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

Although	O
aldehyde	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
also	O
generated	O
DHPG	O
,	O
its	O
activity	O
was	O
much	O
lower	O
than	O
that	O
of	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
A	B-X
significant	B-X
decrease	B-X
in	B-X
DHPG	B-X
,	B-X
however	B-X
,	B-X
was	B-X
obtained	B-X
only	B-X
with	B-X
an	B-X
extremely	B-X
high	B-X
dose	B-X
(	B-X
9	B-X
mg/kg/day	B-X
)	B-X
of	B-X
the	B-X
nonselective	B-X
inhibitor	B-X
AL	B-X
1576	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

With	O
northern	O
blotting	O
,	O
the	O
expression	O
of	O
both	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
and	O
aldehyde	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
was	O
detected	O
in	O
rat	O
superior	O
cervical	O
ganglia	O
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

However	O
,	O
with	O
western	O
blotting	O
,	O
only	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
was	O
immunologically	O
detectable	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

Treatment	O
of	O
rats	O
with	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
inhibitors	O
for	O
3	O
days	O
increased	O
the	O
plasma	O
level	O
of	O
DHMA	O
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
There	B-X
was	B-X
no	B-X
correlation	B-X
between	B-X
the	B-X
selectivity	B-X
of	B-X
inhibitors	B-X
and	B-X
effects	B-X
on	B-X
NE	B-X
metabolite	B-X
levels	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

There	O
was	O
no	O
correlation	O
between	O
the	O
selectivity	O
of	O
inhibitors	O
and	O
effects	O
on	O
NE	O
metabolite	O
levels	O
.	O
<EOS>	B-X
This	B-X
study	B-X
investigated	B-X
the	B-X
effects	B-X
of	B-X
acute	B-X
and	B-X
chronic	B-X
(	B-X
one	B-X
daily	B-X
i.p	B-X
.	B-X
MAO-A	B-X
and	B-X
MAO-B	B-X
activities	B-X
and	B-X
levels	B-X
of	B-X
brain	B-X
monoamines	B-X
(	B-X
serotonin	B-X
(	B-X
5-HT	B-X
)	B-X
,	B-X
dopamine	B-X
(	B-X
DA	B-X
)	B-X
and	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
)	B-X
and	B-X
their	B-X
deaminated	B-X
metabolites	B-X
were	B-X
subsequently	B-X
measured	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
phenelzine	B-X
displayed	B-X
weak	B-X
anxiolytic-like	B-X
effects	B-X
as	B-X
it	B-X
increased	B-X
risk	B-X
assessment	B-X
responses	B-X
when	B-X
mice	B-X
were	B-X
constrained	B-X
in	B-X
one	B-X
part	B-X
of	B-X
the	B-X
apparatus	B-X
facing	B-X
the	B-X
rat	B-X
which	B-X
remained	B-X
at	B-X
a	B-X
constant	B-X
distance	B-X
.	B-X
These	B-X
behavioral	B-X
changes	B-X
were	B-X
associated	B-X
with	B-X
a	B-X
dramatic	B-X
increase	B-X
in	B-X
5-HT	B-X
levels	B-X
,	B-X
in	B-X
particular	B-X
after	B-X
chronic	B-X
treatment	B-X
,	B-X
while	B-X
levels	B-X
of	B-X
DA	B-X
and	B-X
NE	B-X
increased	B-X
only	B-X
slightly	B-X
.	B-X
Importantly	B-X
,	B-X
no	B-X
significant	B-X
differences	B-X
in	B-X
DA	B-X
and	B-X
NE	B-X
levels	B-X
between	B-X
acute	B-X
and	B-X
chronic	B-X
regimens	B-X
were	B-X
observed	B-X
.	B-X
Levels	B-X
of	B-X
deaminated	B-X
metabolites	B-X
of	B-X
monoamines	B-X
were	B-X
markedly	B-X
decreased	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
the	B-X
effects	B-X
of	B-X
phenelzine	B-X
may	B-X
be	B-X
due	B-X
mainly	B-X
to	B-X
its	B-X
effects	B-X
on	B-X
the	B-X
5-HT	B-X
system	B-X
and	B-X
presumably	B-X
related	B-X
to	B-X
the	B-X
full	B-X
inhibition	B-X
of	B-X
MAO-A	B-X
and/or	B-X
MAO-B	B-X
.	B-X

A	O
significant	O
decrease	O
in	O
DHPG	O
,	O
however	O
,	O
was	O
obtained	O
only	O
with	O
an	O
extremely	O
high	O
dose	O
(	O
9	O
mg	O
/	O
kg	O
/	O
day	O
)	O
of	O
the	O
nonselective	O
inhibitor	O
AL	O
1576	O
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
There	B-X
was	B-X
no	B-X
correlation	B-X
between	B-X
the	B-X
selectivity	B-X
of	B-X
inhibitors	B-X
and	B-X
effects	B-X
on	B-X
NE	B-X
metabolite	B-X
levels	B-X
.	B-X
A	B-X
significant	B-X
decrease	B-X
in	B-X
DHPG	B-X
,	B-X
however	B-X
,	B-X
was	B-X
obtained	B-X
only	B-X
with	B-X
an	B-X
extremely	B-X
high	B-X
dose	B-X
(	B-X
9	B-X
mg/kg/day	B-X
)	B-X
of	B-X
the	B-X
nonselective	B-X
inhibitor	B-X
AL	B-X
1576	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

The	O
present	O
study	O
confirmed	O
that	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
generates	O
DHPG	O
from	O
NE	O
in	O
the	O
presence	O
of	O
MAO	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
There	B-X
was	B-X
no	B-X
correlation	B-X
between	B-X
the	B-X
selectivity	B-X
of	B-X
inhibitors	B-X
and	B-X
effects	B-X
on	B-X
NE	B-X
metabolite	B-X
levels	B-X
.	B-X
A	B-X
significant	B-X
decrease	B-X
in	B-X
DHPG	B-X
,	B-X
however	B-X
,	B-X
was	B-X
obtained	B-X
only	B-X
with	B-X
an	B-X
extremely	B-X
high	B-X
dose	B-X
(	B-X
9	B-X
mg/kg/day	B-X
)	B-X
of	B-X
the	B-X
nonselective	B-X
inhibitor	B-X
AL	B-X
1576	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

In	O
rat	O
sympathetic	O
neurons	O
,	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
appears	O
to	O
be	O
more	O
important	O
than	O
aldehyde	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
for	O
the	O
formation	O
of	O
DHPG	O
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
A	B-X
significant	B-X
decrease	B-X
in	B-X
DHPG	B-X
,	B-X
however	B-X
,	B-X
was	B-X
obtained	B-X
only	B-X
with	B-X
an	B-X
extremely	B-X
high	B-X
dose	B-X
(	B-X
9	B-X
mg/kg/day	B-X
)	B-X
of	B-X
the	B-X
nonselective	B-X
inhibitor	B-X
AL	B-X
1576	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

However	O
,	O
when	O
aldose	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
is	O
inhibited	O
,	O
it	O
appears	O
that	O
aldehyde	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
can	O
compensate	O
for	O
the	O
conversion	O
of	O
DHMAL	O
to	O
DHPG	O
,	O
indicating	O
redundancy	O
in	O
the	O
reduction	O
pathway	O
.	O
<EOS>	B-X
The	B-X
sympathoneural	B-X
neurotransmitter	B-X
norepinephrine	B-X
(	B-X
NE	B-X
)	B-X
is	B-X
deaminated	B-X
to	B-X
3,4-dihydroxymandelaldehyde	B-X
(	B-X
DHMAL	B-X
)	B-X
and	B-X
subsequently	B-X
converted	B-X
to	B-X
either	B-X
3,4-dihydroxymandelic	B-X
acid	B-X
(	B-X
DHMA	B-X
)	B-X
or	B-X
3,4-dihydroxyphenylglycol	B-X
(	B-X
DHPG	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
relative	B-X
importance	B-X
of	B-X
aldose	B-X
reductase	B-X
versus	B-X
aldehyde	B-X
reductase	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
from	B-X
DHMAL	B-X
.	B-X
The	B-X
in	B-X
vitro	B-X
incubation	B-X
of	B-X
NE	B-X
with	B-X
aldose	B-X
reductase	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
monoamine	B-X
oxidase	B-X
(	B-X
MAO	B-X
)	B-X
resulted	B-X
in	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
mass	B-X
spectrometry	B-X
.	B-X
Although	B-X
aldehyde	B-X
reductase	B-X
also	B-X
generated	B-X
DHPG	B-X
,	B-X
its	B-X
activity	B-X
was	B-X
much	B-X
lower	B-X
than	B-X
that	B-X
of	B-X
aldose	B-X
reductase	B-X
.	B-X
With	B-X
northern	B-X
blotting	B-X
,	B-X
the	B-X
expression	B-X
of	B-X
both	B-X
aldose	B-X
reductase	B-X
and	B-X
aldehyde	B-X
reductase	B-X
was	B-X
detected	B-X
in	B-X
rat	B-X
superior	B-X
cervical	B-X
ganglia	B-X
.	B-X
However	B-X
,	B-X
with	B-X
western	B-X
blotting	B-X
,	B-X
only	B-X
aldose	B-X
reductase	B-X
was	B-X
immunologically	B-X
detectable	B-X
.	B-X
Treatment	B-X
of	B-X
rats	B-X
with	B-X
aldose	B-X
reductase	B-X
inhibitors	B-X
for	B-X
3	B-X
days	B-X
increased	B-X
the	B-X
plasma	B-X
level	B-X
of	B-X
DHMA	B-X
.	B-X
A	B-X
significant	B-X
decrease	B-X
in	B-X
DHPG	B-X
,	B-X
however	B-X
,	B-X
was	B-X
obtained	B-X
only	B-X
with	B-X
an	B-X
extremely	B-X
high	B-X
dose	B-X
(	B-X
9	B-X
mg/kg/day	B-X
)	B-X
of	B-X
the	B-X
nonselective	B-X
inhibitor	B-X
AL	B-X
1576	B-X
.	B-X
The	B-X
present	B-X
study	B-X
confirmed	B-X
that	B-X
aldose	B-X
reductase	B-X
generates	B-X
DHPG	B-X
from	B-X
NE	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
MAO	B-X
.	B-X
In	B-X
rat	B-X
sympathetic	B-X
neurons	B-X
,	B-X
aldose	B-X
reductase	B-X
appears	B-X
to	B-X
be	B-X
more	B-X
important	B-X
than	B-X
aldehyde	B-X
reductase	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
DHPG	B-X
.	B-X
However	B-X
,	B-X
when	B-X
aldose	B-X
reductase	B-X
is	B-X
inhibited	B-X
,	B-X
it	B-X
appears	B-X
that	B-X
aldehyde	B-X
reductase	B-X
can	B-X
compensate	B-X
for	B-X
the	B-X
conversion	B-X
of	B-X
DHMAL	B-X
to	B-X
DHPG	B-X
,	B-X
indicating	B-X
redundancy	B-X
in	B-X
the	B-X
reduction	B-X
pathway	B-X
.	B-X

Phosphorylation	O
of	O
deoxycytidine	O
analog	O
monophosphates	O
by	O
UMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CMP	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
:	O
molecular	O
characterization	O
of	O
the	O
human	O
enzyme	O
.	O
<EOS>	B-X
Phosphorylation	B-X
of	B-X
deoxycytidine	B-X
analogs	B-X
by	B-X
cellular	B-X
enzymes	B-X
is	B-X
a	B-X
prerequisite	B-X
for	B-X
the	B-X
activity	B-X
of	B-X
these	B-X
compounds	B-X
.	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
kinetic	B-X
parameters	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
1-beta-D-arabinofuranosylcytosine	B-X
(	B-X
araC	B-X
)	B-X
and	B-X
2	B-X
'	B-X
,	B-X
2'-difluorodeoxycytidine	B-X
(	B-X
dFdC	B-X
)	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
catalyzed	B-X
by	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
.	B-X
We	B-X
cloned	B-X
the	B-X
cDNA	B-X
of	B-X
this	B-X
enzyme	B-X
to	B-X
enable	B-X
characterization	B-X
of	B-X
the	B-X
recombinant	B-X
protein	B-X
,	B-X
determine	B-X
its	B-X
expression	B-X
in	B-X
different	B-X
tissues	B-X
,	B-X
and	B-X
determine	B-X
the	B-X
chromosome	B-X
location	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
We	B-X
showed	B-X
that	B-X
the	B-X
recombinant	B-X
UMP-CMP	B-X
kinase	B-X
phosphorylated	B-X
CMP	B-X
,	B-X
dCMP	B-X
,	B-X
and	B-X
UMP	B-X
with	B-X
highest	B-X
efficiency	B-X
and	B-X
dUMP	B-X
,	B-X
AMP	B-X
,	B-X
and	B-X
dAMP	B-X
with	B-X
lower	B-X
efficiency	B-X
.	B-X
The	B-X
monophosphates	B-X
of	B-X
araC	B-X
and	B-X
dFdC	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
phosphorylated	B-X
with	B-X
similar	B-X
efficiency	B-X
as	B-X
dCMP	B-X
and	B-X
CMP	B-X
.	B-X
We	B-X
further	B-X
showed	B-X
,	B-X
in	B-X
a	B-X
combined	B-X
enzymatic	B-X
assay	B-X
,	B-X
that	B-X
human	B-X
deoxycytidine	B-X
kinase	B-X
and	B-X
UMP-CMP	B-X
kinase	B-X
together	B-X
phosphorylated	B-X
araC	B-X
,	B-X
dFdC	B-X
,	B-X
and	B-X
2',3'-dideoxycytidine	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
mRNA	B-X
was	B-X
ubiquitously	B-X
present	B-X
in	B-X
human	B-X
tissues	B-X
as	B-X
a	B-X
3.9-kb	B-X
transcript	B-X
with	B-X
highest	B-X
levels	B-X
in	B-X
pancreas	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
liver	B-X
.	B-X
The	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
gene	B-X
was	B-X
localized	B-X
to	B-X
chromosome	B-X
1p34.1-1p33	B-X
by	B-X
radiation	B-X
hybrid	B-X
analysis	B-X
.	B-X
We	B-X
further	B-X
expressed	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
as	B-X
a	B-X
fusion	B-X
protein	B-X
to	B-X
the	B-X
green	B-X
fluorescent	B-X
protein	B-X
in	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
,	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
fusion	B-X
protein	B-X
was	B-X
located	B-X
in	B-X
the	B-X
cytosol	B-X
and	B-X
nucleus	B-X
.	B-X

Phosphorylation	O
of	O
deoxycytidine	O
analogs	O
by	O
cellular	O
enzymes	O
is	O
a	O
prerequisite	O
for	O
the	O
activity	O
of	O
these	O
compounds	O
.	O
<EOS>	B-X
Phosphorylation	B-X
of	B-X
deoxycytidine	B-X
analogs	B-X
by	B-X
cellular	B-X
enzymes	B-X
is	B-X
a	B-X
prerequisite	B-X
for	B-X
the	B-X
activity	B-X
of	B-X
these	B-X
compounds	B-X
.	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
kinetic	B-X
parameters	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
1-beta-D-arabinofuranosylcytosine	B-X
(	B-X
araC	B-X
)	B-X
and	B-X
2	B-X
'	B-X
,	B-X
2'-difluorodeoxycytidine	B-X
(	B-X
dFdC	B-X
)	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
catalyzed	B-X
by	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
.	B-X
We	B-X
further	B-X
showed	B-X
,	B-X
in	B-X
a	B-X
combined	B-X
enzymatic	B-X
assay	B-X
,	B-X
that	B-X
human	B-X
deoxycytidine	B-X
kinase	B-X
and	B-X
UMP-CMP	B-X
kinase	B-X
together	B-X
phosphorylated	B-X
araC	B-X
,	B-X
dFdC	B-X
,	B-X
and	B-X
2',3'-dideoxycytidine	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
.	B-X

We	O
have	O
investigated	O
the	O
kinetic	O
parameters	O
for	O
the	O
phosphorylation	O
of	O
1	O
-	O
beta	O
-	O
D	O
-	O
arabinofuranosylcytosine	O
(	O
araC	O
)	O
and	O
2	O
'	O
,	O
2	O
'	O
-	O
difluorodeoxycytidine	O
(	O
dFdC	O
)	O
to	O
their	O
diphosphate	O
forms	O
catalyzed	O
by	O
human	O
UMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CMP	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
kinetic	B-X
parameters	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
1-beta-D-arabinofuranosylcytosine	B-X
(	B-X
araC	B-X
)	B-X
and	B-X
2	B-X
'	B-X
,	B-X
2'-difluorodeoxycytidine	B-X
(	B-X
dFdC	B-X
)	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
catalyzed	B-X
by	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
.	B-X
We	B-X
showed	B-X
that	B-X
the	B-X
recombinant	B-X
UMP-CMP	B-X
kinase	B-X
phosphorylated	B-X
CMP	B-X
,	B-X
dCMP	B-X
,	B-X
and	B-X
UMP	B-X
with	B-X
highest	B-X
efficiency	B-X
and	B-X
dUMP	B-X
,	B-X
AMP	B-X
,	B-X
and	B-X
dAMP	B-X
with	B-X
lower	B-X
efficiency	B-X
.	B-X
The	B-X
monophosphates	B-X
of	B-X
araC	B-X
and	B-X
dFdC	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
phosphorylated	B-X
with	B-X
similar	B-X
efficiency	B-X
as	B-X
dCMP	B-X
and	B-X
CMP	B-X
.	B-X
We	B-X
further	B-X
showed	B-X
,	B-X
in	B-X
a	B-X
combined	B-X
enzymatic	B-X
assay	B-X
,	B-X
that	B-X
human	B-X
deoxycytidine	B-X
kinase	B-X
and	B-X
UMP-CMP	B-X
kinase	B-X
together	B-X
phosphorylated	B-X
araC	B-X
,	B-X
dFdC	B-X
,	B-X
and	B-X
2',3'-dideoxycytidine	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
mRNA	B-X
was	B-X
ubiquitously	B-X
present	B-X
in	B-X
human	B-X
tissues	B-X
as	B-X
a	B-X
3.9-kb	B-X
transcript	B-X
with	B-X
highest	B-X
levels	B-X
in	B-X
pancreas	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
liver	B-X
.	B-X
The	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
gene	B-X
was	B-X
localized	B-X
to	B-X
chromosome	B-X
1p34.1-1p33	B-X
by	B-X
radiation	B-X
hybrid	B-X
analysis	B-X
.	B-X
We	B-X
further	B-X
expressed	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
as	B-X
a	B-X
fusion	B-X
protein	B-X
to	B-X
the	B-X
green	B-X
fluorescent	B-X
protein	B-X
in	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
,	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
fusion	B-X
protein	B-X
was	B-X
located	B-X
in	B-X
the	B-X
cytosol	B-X
and	B-X
nucleus	B-X
.	B-X

We	O
cloned	O
the	O
cDNA	O
of	O
this	O
enzyme	O
to	O
enable	O
characterization	O
of	O
the	O
recombinant	O
protein	O
,	O
determine	O
its	O
expression	O
in	O
different	O
tissues	O
,	O
and	O
determine	O
the	O
chromosome	O
location	O
of	O
the	O
gene	O
.	O
<EOS>	B-X
Activation	B-X
induced	B-X
cytidine	B-X
deaminase	B-X
is	B-X
an	B-X
enzyme	B-X
crucial	B-X
to	B-X
somatic	B-X
hypermutation	B-X
and	B-X
gene	B-X
conversion	B-X
,	B-X
processes	B-X
that	B-X
are	B-X
essential	B-X
for	B-X
the	B-X
diversification	B-X
of	B-X
Ig	B-X
V	B-X
genes	B-X
.	B-X
The	B-X
bovine	B-X
Ig	B-X
repertoire	B-X
appears	B-X
to	B-X
be	B-X
diversified	B-X
by	B-X
mechanisms	B-X
that	B-X
are	B-X
significantly	B-X
different	B-X
to	B-X
those	B-X
that	B-X
operate	B-X
in	B-X
humans	B-X
and	B-X
mice	B-X
.	B-X
This	B-X
study	B-X
set	B-X
out	B-X
to	B-X
test	B-X
the	B-X
hypothesis	B-X
that	B-X
differences	B-X
in	B-X
the	B-X
organization	B-X
,	B-X
coding	B-X
sequence	B-X
,	B-X
expression	B-X
or	B-X
genomic	B-X
location	B-X
of	B-X
the	B-X
bovine	B-X
AICDA	B-X
gene	B-X
enables	B-X
the	B-X
encoded	B-X
enzyme	B-X
to	B-X
catalyse	B-X
the	B-X
unusual	B-X
Ig	B-X
diversification	B-X
mechanism	B-X
seen	B-X
in	B-X
cattle	B-X
as	B-X
well	B-X
as	B-X
conventional	B-X
antigen-driven	B-X
mutation	B-X
.	B-X
AICDA	B-X
expression	B-X
was	B-X
detected	B-X
in	B-X
lymphoid	B-X
tissues	B-X
from	B-X
neonatal	B-X
and	B-X
older	B-X
cattle	B-X
,	B-X
but	B-X
AICDA	B-X
cDNA	B-X
could	B-X
not	B-X
be	B-X
detected	B-X
in	B-X
muscle	B-X
tissue	B-X
.	B-X
The	B-X
pattern	B-X
of	B-X
gene	B-X
expression	B-X
did	B-X
not	B-X
therefore	B-X
differ	B-X
from	B-X
that	B-X
in	B-X
other	B-X
vertebrates	B-X
.	B-X
The	B-X
AICDA	B-X
cDNA	B-X
was	B-X
cloned	B-X
and	B-X
expressed	B-X
successfully	B-X
in	B-X
Escherichia	B-X
coli	B-X
generating	B-X
a	B-X
phenotype	B-X
consistent	B-X
with	B-X
the	B-X
mutating	B-X
action	B-X
of	B-X
this	B-X
deaminase	B-X
.	B-X
Using	B-X
a	B-X
whole	B-X
genome	B-X
radiation	B-X
hybrid	B-X
panel	B-X
,	B-X
bovine	B-X
AICDA	B-X
was	B-X
mapped	B-X
to	B-X
a	B-X
region	B-X
of	B-X
bovine	B-X
chromosome	B-X
5	B-X
syntenic	B-X
with	B-X
the	B-X
location	B-X
of	B-X
human	B-X
AICDA	B-X
on	B-X
chromosome	B-X
12	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
the	B-X
unusual	B-X
nature	B-X
of	B-X
Ig	B-X
diversification	B-X
in	B-X
cattle	B-X
is	B-X
unlikely	B-X
to	B-X
be	B-X
attributable	B-X
to	B-X
the	B-X
structure	B-X
,	B-X
sequence	B-X
,	B-X
activity	B-X
or	B-X
genomic	B-X
location	B-X
of	B-X
bovine	B-X
AICDA	B-X
.	B-X

We	O
showed	O
that	O
the	O
recombinant	O
UMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CMP	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
phosphorylated	O
CMP	O
,	O
dCMP	O
,	O
and	O
UMP	O
with	O
highest	O
efficiency	O
and	O
dUMP	O
,	O
AMP	O
,	O
and	O
dAMP	O
with	O
lower	O
efficiency	O
.	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
kinetic	B-X
parameters	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
1-beta-D-arabinofuranosylcytosine	B-X
(	B-X
araC	B-X
)	B-X
and	B-X
2	B-X
'	B-X
,	B-X
2'-difluorodeoxycytidine	B-X
(	B-X
dFdC	B-X
)	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
catalyzed	B-X
by	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
.	B-X
We	B-X
cloned	B-X
the	B-X
cDNA	B-X
of	B-X
this	B-X
enzyme	B-X
to	B-X
enable	B-X
characterization	B-X
of	B-X
the	B-X
recombinant	B-X
protein	B-X
,	B-X
determine	B-X
its	B-X
expression	B-X
in	B-X
different	B-X
tissues	B-X
,	B-X
and	B-X
determine	B-X
the	B-X
chromosome	B-X
location	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
We	B-X
showed	B-X
that	B-X
the	B-X
recombinant	B-X
UMP-CMP	B-X
kinase	B-X
phosphorylated	B-X
CMP	B-X
,	B-X
dCMP	B-X
,	B-X
and	B-X
UMP	B-X
with	B-X
highest	B-X
efficiency	B-X
and	B-X
dUMP	B-X
,	B-X
AMP	B-X
,	B-X
and	B-X
dAMP	B-X
with	B-X
lower	B-X
efficiency	B-X
.	B-X
The	B-X
monophosphates	B-X
of	B-X
araC	B-X
and	B-X
dFdC	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
phosphorylated	B-X
with	B-X
similar	B-X
efficiency	B-X
as	B-X
dCMP	B-X
and	B-X
CMP	B-X
.	B-X
We	B-X
further	B-X
showed	B-X
,	B-X
in	B-X
a	B-X
combined	B-X
enzymatic	B-X
assay	B-X
,	B-X
that	B-X
human	B-X
deoxycytidine	B-X
kinase	B-X
and	B-X
UMP-CMP	B-X
kinase	B-X
together	B-X
phosphorylated	B-X
araC	B-X
,	B-X
dFdC	B-X
,	B-X
and	B-X
2',3'-dideoxycytidine	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
mRNA	B-X
was	B-X
ubiquitously	B-X
present	B-X
in	B-X
human	B-X
tissues	B-X
as	B-X
a	B-X
3.9-kb	B-X
transcript	B-X
with	B-X
highest	B-X
levels	B-X
in	B-X
pancreas	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
liver	B-X
.	B-X
The	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
gene	B-X
was	B-X
localized	B-X
to	B-X
chromosome	B-X
1p34.1-1p33	B-X
by	B-X
radiation	B-X
hybrid	B-X
analysis	B-X
.	B-X
We	B-X
further	B-X
expressed	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
as	B-X
a	B-X
fusion	B-X
protein	B-X
to	B-X
the	B-X
green	B-X
fluorescent	B-X
protein	B-X
in	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
,	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
fusion	B-X
protein	B-X
was	B-X
located	B-X
in	B-X
the	B-X
cytosol	B-X
and	B-X
nucleus	B-X
.	B-X

The	O
monophosphates	O
of	O
araC	O
and	O
dFdC	O
were	O
shown	O
to	O
be	O
phosphorylated	O
with	O
similar	O
efficiency	O
as	O
dCMP	O
and	O
CMP	O
.	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
kinetic	B-X
parameters	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
1-beta-D-arabinofuranosylcytosine	B-X
(	B-X
araC	B-X
)	B-X
and	B-X
2	B-X
'	B-X
,	B-X
2'-difluorodeoxycytidine	B-X
(	B-X
dFdC	B-X
)	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
catalyzed	B-X
by	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
.	B-X
We	B-X
showed	B-X
that	B-X
the	B-X
recombinant	B-X
UMP-CMP	B-X
kinase	B-X
phosphorylated	B-X
CMP	B-X
,	B-X
dCMP	B-X
,	B-X
and	B-X
UMP	B-X
with	B-X
highest	B-X
efficiency	B-X
and	B-X
dUMP	B-X
,	B-X
AMP	B-X
,	B-X
and	B-X
dAMP	B-X
with	B-X
lower	B-X
efficiency	B-X
.	B-X
The	B-X
monophosphates	B-X
of	B-X
araC	B-X
and	B-X
dFdC	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
phosphorylated	B-X
with	B-X
similar	B-X
efficiency	B-X
as	B-X
dCMP	B-X
and	B-X
CMP	B-X
.	B-X
We	B-X
further	B-X
showed	B-X
,	B-X
in	B-X
a	B-X
combined	B-X
enzymatic	B-X
assay	B-X
,	B-X
that	B-X
human	B-X
deoxycytidine	B-X
kinase	B-X
and	B-X
UMP-CMP	B-X
kinase	B-X
together	B-X
phosphorylated	B-X
araC	B-X
,	B-X
dFdC	B-X
,	B-X
and	B-X
2',3'-dideoxycytidine	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
mRNA	B-X
was	B-X
ubiquitously	B-X
present	B-X
in	B-X
human	B-X
tissues	B-X
as	B-X
a	B-X
3.9-kb	B-X
transcript	B-X
with	B-X
highest	B-X
levels	B-X
in	B-X
pancreas	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
liver	B-X
.	B-X
The	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
gene	B-X
was	B-X
localized	B-X
to	B-X
chromosome	B-X
1p34.1-1p33	B-X
by	B-X
radiation	B-X
hybrid	B-X
analysis	B-X
.	B-X
We	B-X
further	B-X
expressed	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
as	B-X
a	B-X
fusion	B-X
protein	B-X
to	B-X
the	B-X
green	B-X
fluorescent	B-X
protein	B-X
in	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
,	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
fusion	B-X
protein	B-X
was	B-X
located	B-X
in	B-X
the	B-X
cytosol	B-X
and	B-X
nucleus	B-X
.	B-X

We	O
further	O
showed	O
,	O
in	O
a	O
combined	O
enzymatic	O
assay	O
,	O
that	O
human	O
deoxycytidine	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
and	O
UMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CMP	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
together	O
phosphorylated	O
araC	O
,	O
dFdC	O
,	O
and	O
2	O
'	O
,	O
3	O
'	O
-	O
dideoxycytidine	O
to	O
their	O
diphosphate	O
forms	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
the	O
UMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CMP	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
mRNA	O
was	O
ubiquitously	O
present	O
in	O
human	O
tissues	O
as	O
a	O
3	O
.	O
9	O
-	O
kb	O
transcript	O
with	O
highest	O
levels	O
in	O
pancreas	O
,	O
skeletal	O
muscle	O
,	O
and	O
liver	O
.	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
kinetic	B-X
parameters	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
1-beta-D-arabinofuranosylcytosine	B-X
(	B-X
araC	B-X
)	B-X
and	B-X
2	B-X
'	B-X
,	B-X
2'-difluorodeoxycytidine	B-X
(	B-X
dFdC	B-X
)	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
catalyzed	B-X
by	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
.	B-X
We	B-X
cloned	B-X
the	B-X
cDNA	B-X
of	B-X
this	B-X
enzyme	B-X
to	B-X
enable	B-X
characterization	B-X
of	B-X
the	B-X
recombinant	B-X
protein	B-X
,	B-X
determine	B-X
its	B-X
expression	B-X
in	B-X
different	B-X
tissues	B-X
,	B-X
and	B-X
determine	B-X
the	B-X
chromosome	B-X
location	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
We	B-X
showed	B-X
that	B-X
the	B-X
recombinant	B-X
UMP-CMP	B-X
kinase	B-X
phosphorylated	B-X
CMP	B-X
,	B-X
dCMP	B-X
,	B-X
and	B-X
UMP	B-X
with	B-X
highest	B-X
efficiency	B-X
and	B-X
dUMP	B-X
,	B-X
AMP	B-X
,	B-X
and	B-X
dAMP	B-X
with	B-X
lower	B-X
efficiency	B-X
.	B-X
The	B-X
monophosphates	B-X
of	B-X
araC	B-X
and	B-X
dFdC	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
phosphorylated	B-X
with	B-X
similar	B-X
efficiency	B-X
as	B-X
dCMP	B-X
and	B-X
CMP	B-X
.	B-X
We	B-X
further	B-X
showed	B-X
,	B-X
in	B-X
a	B-X
combined	B-X
enzymatic	B-X
assay	B-X
,	B-X
that	B-X
human	B-X
deoxycytidine	B-X
kinase	B-X
and	B-X
UMP-CMP	B-X
kinase	B-X
together	B-X
phosphorylated	B-X
araC	B-X
,	B-X
dFdC	B-X
,	B-X
and	B-X
2',3'-dideoxycytidine	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
mRNA	B-X
was	B-X
ubiquitously	B-X
present	B-X
in	B-X
human	B-X
tissues	B-X
as	B-X
a	B-X
3.9-kb	B-X
transcript	B-X
with	B-X
highest	B-X
levels	B-X
in	B-X
pancreas	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
liver	B-X
.	B-X
The	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
gene	B-X
was	B-X
localized	B-X
to	B-X
chromosome	B-X
1p34.1-1p33	B-X
by	B-X
radiation	B-X
hybrid	B-X
analysis	B-X
.	B-X
We	B-X
further	B-X
expressed	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
as	B-X
a	B-X
fusion	B-X
protein	B-X
to	B-X
the	B-X
green	B-X
fluorescent	B-X
protein	B-X
in	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
,	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
fusion	B-X
protein	B-X
was	B-X
located	B-X
in	B-X
the	B-X
cytosol	B-X
and	B-X
nucleus	B-X
.	B-X

The	O
human	O
UMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CMP	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
gene	O
was	O
localized	O
to	O
chromosome	O
1p34	O
.	O
1	O
-	O
1p33	O
by	O
radiation	O
hybrid	O
analysis	O
.	O
<EOS>	B-X
We	B-X
have	B-X
investigated	B-X
the	B-X
kinetic	B-X
parameters	B-X
for	B-X
the	B-X
phosphorylation	B-X
of	B-X
1-beta-D-arabinofuranosylcytosine	B-X
(	B-X
araC	B-X
)	B-X
and	B-X
2	B-X
'	B-X
,	B-X
2'-difluorodeoxycytidine	B-X
(	B-X
dFdC	B-X
)	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
catalyzed	B-X
by	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
.	B-X
We	B-X
cloned	B-X
the	B-X
cDNA	B-X
of	B-X
this	B-X
enzyme	B-X
to	B-X
enable	B-X
characterization	B-X
of	B-X
the	B-X
recombinant	B-X
protein	B-X
,	B-X
determine	B-X
its	B-X
expression	B-X
in	B-X
different	B-X
tissues	B-X
,	B-X
and	B-X
determine	B-X
the	B-X
chromosome	B-X
location	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
We	B-X
showed	B-X
that	B-X
the	B-X
recombinant	B-X
UMP-CMP	B-X
kinase	B-X
phosphorylated	B-X
CMP	B-X
,	B-X
dCMP	B-X
,	B-X
and	B-X
UMP	B-X
with	B-X
highest	B-X
efficiency	B-X
and	B-X
dUMP	B-X
,	B-X
AMP	B-X
,	B-X
and	B-X
dAMP	B-X
with	B-X
lower	B-X
efficiency	B-X
.	B-X
The	B-X
monophosphates	B-X
of	B-X
araC	B-X
and	B-X
dFdC	B-X
were	B-X
shown	B-X
to	B-X
be	B-X
phosphorylated	B-X
with	B-X
similar	B-X
efficiency	B-X
as	B-X
dCMP	B-X
and	B-X
CMP	B-X
.	B-X
We	B-X
further	B-X
showed	B-X
,	B-X
in	B-X
a	B-X
combined	B-X
enzymatic	B-X
assay	B-X
,	B-X
that	B-X
human	B-X
deoxycytidine	B-X
kinase	B-X
and	B-X
UMP-CMP	B-X
kinase	B-X
together	B-X
phosphorylated	B-X
araC	B-X
,	B-X
dFdC	B-X
,	B-X
and	B-X
2',3'-dideoxycytidine	B-X
to	B-X
their	B-X
diphosphate	B-X
forms	B-X
.	B-X
Northern	B-X
blot	B-X
analysis	B-X
showed	B-X
that	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
mRNA	B-X
was	B-X
ubiquitously	B-X
present	B-X
in	B-X
human	B-X
tissues	B-X
as	B-X
a	B-X
3.9-kb	B-X
transcript	B-X
with	B-X
highest	B-X
levels	B-X
in	B-X
pancreas	B-X
,	B-X
skeletal	B-X
muscle	B-X
,	B-X
and	B-X
liver	B-X
.	B-X
The	B-X
human	B-X
UMP-CMP	B-X
kinase	B-X
gene	B-X
was	B-X
localized	B-X
to	B-X
chromosome	B-X
1p34.1-1p33	B-X
by	B-X
radiation	B-X
hybrid	B-X
analysis	B-X
.	B-X
We	B-X
further	B-X
expressed	B-X
the	B-X
UMP-CMP	B-X
kinase	B-X
as	B-X
a	B-X
fusion	B-X
protein	B-X
to	B-X
the	B-X
green	B-X
fluorescent	B-X
protein	B-X
in	B-X
Chinese	B-X
hamster	B-X
ovary	B-X
cells	B-X
,	B-X
and	B-X
showed	B-X
that	B-X
the	B-X
fusion	B-X
protein	B-X
was	B-X
located	B-X
in	B-X
the	B-X
cytosol	B-X
and	B-X
nucleus	B-X
.	B-X

We	O
further	O
expressed	O
the	O
UMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
CMP	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
as	O
a	O
fusion	O
protein	O
to	O
the	O
green	B-Gene_or_gene_product
fluorescent	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
in	O
Chinese	O
hamster	O
ovary	O
cells	O
,	O
and	O
showed	O
that	O
the	O
fusion	O
protein	O
was	O
located	O
in	O
the	O
cytosol	O
and	O
nucleus	O
.	O

Hsl7	B-Gene_or_gene_product
localizes	O
to	O
a	O
septin	B-Gene_or_gene_product
ring	O
and	O
serves	O
as	O
an	O
adapter	O
in	O
a	O
regulatory	O
pathway	O
that	O
relieves	O
tyrosine	O
phosphorylation	O
of	O
Cdc28	B-Gene_or_gene_product
protein	O
kinase	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

Successful	O
mitosis	O
requires	O
faithful	O
DNA	O
replication	O
,	O
spindle	O
assembly	O
,	O
chromosome	O
segregation	O
,	O
and	O
cell	O
division	O
.	O
<EOS>	B-X
Successful	B-X
mitosis	B-X
requires	B-X
faithful	B-X
DNA	B-X
replication	B-X
,	B-X
spindle	B-X
assembly	B-X
,	B-X
chromosome	B-X
segregation	B-X
,	B-X
and	B-X
cell	B-X
division	B-X
.	B-X
In	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
-to-M	B-X
transition	B-X
requires	B-X
activation	B-X
of	B-X
Clb-bound	B-X
forms	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
,	B-X
Cdc28	B-X
.	B-X
Using	B-X
both	B-X
indirect	B-X
immunofluorescence	B-X
with	B-X
anti-Hsl7	B-X
antibodies	B-X
and	B-X
a	B-X
fusion	B-X
of	B-X
Hsl7	B-X
to	B-X
green	B-X
fluorescent	B-X
protein	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Hsl7	B-X
also	B-X
localizes	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
,	B-X
congruent	B-X
with	B-X
the	B-X
septin	B-X
ring	B-X
that	B-X
faces	B-X
the	B-X
daughter	B-X
cell	B-X
.	B-X
Both	B-X
Swe1	B-X
and	B-X
a	B-X
segment	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
Hsl1	B-X
(	B-X
which	B-X
has	B-X
no	B-X
sequence	B-X
counterpart	B-X
in	B-X
two	B-X
Hsl1-related	B-X
protein	B-X
kinases	B-X
,	B-X
Gin4	B-X
and	B-X
Kcc4	B-X
)	B-X
were	B-X
identified	B-X
as	B-X
gene	B-X
products	B-X
that	B-X
interact	B-X
with	B-X
Hsl7	B-X
in	B-X
a	B-X
two-hybrid	B-X
screen	B-X
of	B-X
a	B-X
random	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
library	B-X
.	B-X
Hsl7	B-X
plus	B-X
Swe1	B-X
and	B-X
Hsl7	B-X
plus	B-X
Hsl1	B-X
can	B-X
be	B-X
coimmunoprecipitated	B-X
from	B-X
extracts	B-X
of	B-X
cells	B-X
overexpressing	B-X
these	B-X
proteins	B-X
,	B-X
confirming	B-X
that	B-X
Hsl7	B-X
physically	B-X
associates	B-X
with	B-X
both	B-X
partners	B-X
.	B-X
Phosphorylation	B-X
and	B-X
ubiquitinylation	B-X
of	B-X
Swe1	B-X
,	B-X
preludes	B-X
to	B-X
its	B-X
destruction	B-X
,	B-X
are	B-X
severely	B-X
reduced	B-X
in	B-X
cells	B-X
lacking	B-X
either	B-X
Hsl1	B-X
or	B-X
Hsl7	B-X
(	B-X
or	B-X
both	B-X
)	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
Thus	B-X
,	B-X
Hsl1	B-X
and	B-X
Hsl7	B-X
promote	B-X
proper	B-X
timing	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
by	B-X
coupling	B-X
septin	B-X
ring	B-X
assembly	B-X
to	B-X
alleviation	B-X
of	B-X
Swe1-dependent	B-X
inhibition	B-X
of	B-X
Cdc28	B-X
.	B-X

In	O
the	O
budding	O
yeast	O
Saccharomyces	O
cerevisiae	O
,	O
the	O
G	O
(	O
2	O
)	O
-	O
to	O
-	O
M	O
transition	O
requires	O
activation	O
of	O
Clb	O
-	O
bound	O
forms	O
of	O
the	O
protein	O
kinase	O
,	O
Cdc28	B-Gene_or_gene_product
.	O

These	O
complexes	O
are	O
held	O
in	O
an	O
inactive	O
state	O
via	O
phosphorylation	O
of	O
Tyr19	O
in	O
the	O
ATP	O
-	O
binding	O
loop	O
of	O
Cdc28	B-Gene_or_gene_product
by	O
the	O
Swe1	B-Gene_or_gene_product
protein	O
kinase	O
.	O

The	O
HSL1	B-Gene_or_gene_product
and	O
HSL7	B-Gene_or_gene_product
gene	O
products	O
act	O
as	O
negative	O
regulators	O
of	O
Swe1	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
-to-M	B-X
transition	B-X
requires	B-X
activation	B-X
of	B-X
Clb-bound	B-X
forms	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
,	B-X
Cdc28	B-X
.	B-X
These	B-X
complexes	B-X
are	B-X
held	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
via	B-X
phosphorylation	B-X
of	B-X
Tyr19	B-X
in	B-X
the	B-X
ATP-binding	B-X
loop	B-X
of	B-X
Cdc28	B-X
by	B-X
the	B-X
Swe1	B-X
protein	B-X
kinase	B-X
.	B-X
The	B-X
HSL1	B-X
and	B-X
HSL7	B-X
gene	B-X
products	B-X
act	B-X
as	B-X
negative	B-X
regulators	B-X
of	B-X
Swe1	B-X
.	B-X
Both	B-X
Swe1	B-X
and	B-X
a	B-X
segment	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
Hsl1	B-X
(	B-X
which	B-X
has	B-X
no	B-X
sequence	B-X
counterpart	B-X
in	B-X
two	B-X
Hsl1-related	B-X
protein	B-X
kinases	B-X
,	B-X
Gin4	B-X
and	B-X
Kcc4	B-X
)	B-X
were	B-X
identified	B-X
as	B-X
gene	B-X
products	B-X
that	B-X
interact	B-X
with	B-X
Hsl7	B-X
in	B-X
a	B-X
two-hybrid	B-X
screen	B-X
of	B-X
a	B-X
random	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
library	B-X
.	B-X
Hsl7	B-X
plus	B-X
Swe1	B-X
and	B-X
Hsl7	B-X
plus	B-X
Hsl1	B-X
can	B-X
be	B-X
coimmunoprecipitated	B-X
from	B-X
extracts	B-X
of	B-X
cells	B-X
overexpressing	B-X
these	B-X
proteins	B-X
,	B-X
confirming	B-X
that	B-X
Hsl7	B-X
physically	B-X
associates	B-X
with	B-X
both	B-X
partners	B-X
.	B-X
Phosphorylation	B-X
and	B-X
ubiquitinylation	B-X
of	B-X
Swe1	B-X
,	B-X
preludes	B-X
to	B-X
its	B-X
destruction	B-X
,	B-X
are	B-X
severely	B-X
reduced	B-X
in	B-X
cells	B-X
lacking	B-X
either	B-X
Hsl1	B-X
or	B-X
Hsl7	B-X
(	B-X
or	B-X
both	B-X
)	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
Hsl7	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
presents	B-X
its	B-X
cargo	B-X
of	B-X
bound	B-X
Swe1	B-X
,	B-X
allowing	B-X
phosphorylation	B-X
by	B-X
Hsl1	B-X
.	B-X
Thus	B-X
,	B-X
Hsl1	B-X
and	B-X
Hsl7	B-X
promote	B-X
proper	B-X
timing	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
by	B-X
coupling	B-X
septin	B-X
ring	B-X
assembly	B-X
to	B-X
alleviation	B-X
of	B-X
Swe1-dependent	B-X
inhibition	B-X
of	B-X
Cdc28	B-X
.	B-X

Hsl1	B-Gene_or_gene_product
is	O
a	O
large	O
(	O
1	O
,	O
518	O
-	O
residue	O
)	O
protein	O
kinase	O
with	O
an	O
N	O
-	O
terminal	O
catalytic	O
domain	O
and	O
a	O
very	O
long	O
C	O
-	O
terminal	O
extension	O
.	O

Hsl1	B-Gene_or_gene_product
localizes	O
to	O
the	O
incipient	O
site	O
of	O
cytokinesis	O
in	O
the	O
bud	O
neck	O
in	O
a	O
septin	B-Gene_or_gene_product
-	O
dependent	O
manner	O
;	O
however	O
,	O
the	O
function	O
of	O
Hsl7	B-Gene_or_gene_product
was	O
not	O
previously	O
known	O
.	O

Using	O
both	O
indirect	O
immunofluorescence	O
with	O
anti	O
-	O
Hsl7	B-Gene_or_gene_product
antibodies	O
and	O
a	O
fusion	O
of	O
Hsl7	B-Gene_or_gene_product
to	O
green	O
fluorescent	O
protein	O
,	O
we	O
found	O
that	O
Hsl7	B-Gene_or_gene_product
also	O
localizes	O
to	O
the	O
bud	O
neck	O
,	O
congruent	O
with	O
the	O
septin	B-Gene_or_gene_product
ring	O
that	O
faces	O
the	O
daughter	O
cell	O
.	O

Both	O
Swe1	B-Gene_or_gene_product
and	O
a	O
segment	O
of	O
the	O
C	O
terminus	O
of	O
Hsl1	B-Gene_or_gene_product
(	O
which	O
has	O
no	O
sequence	O
counterpart	O
in	O
two	O
Hsl1	B-Gene_or_gene_product
-	O
related	O
protein	O
kinases	O
,	O
Gin4	B-Gene_or_gene_product
and	O
Kcc4	B-Gene_or_gene_product
)	O
were	O
identified	O
as	O
gene	O
products	O
that	O
interact	O
with	O
Hsl7	B-Gene_or_gene_product
in	O
a	O
two	O
-	O
hybrid	O
screen	O
of	O
a	O
random	O
S	O
.	O
cerevisiae	O
cDNA	O
library	O
.	O

Hsl7	B-Gene_or_gene_product
plus	O
Swe1	B-Gene_or_gene_product
and	O
Hsl7	B-Gene_or_gene_product
plus	O
Hsl1	B-Gene_or_gene_product
can	O
be	O
coimmunoprecipitated	O
from	O
extracts	O
of	O
cells	O
overexpressing	O
these	O
proteins	O
,	O
confirming	O
that	O
Hsl7	B-Gene_or_gene_product
physically	O
associates	O
with	O
both	O
partners	O
.	O
<EOS>	B-X
These	B-X
complexes	B-X
are	B-X
held	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
via	B-X
phosphorylation	B-X
of	B-X
Tyr19	B-X
in	B-X
the	B-X
ATP-binding	B-X
loop	B-X
of	B-X
Cdc28	B-X
by	B-X
the	B-X
Swe1	B-X
protein	B-X
kinase	B-X
.	B-X
The	B-X
HSL1	B-X
and	B-X
HSL7	B-X
gene	B-X
products	B-X
act	B-X
as	B-X
negative	B-X
regulators	B-X
of	B-X
Swe1	B-X
.	B-X
Hsl1	B-X
is	B-X
a	B-X
large	B-X
(	B-X
1,518-residue	B-X
)	B-X
protein	B-X
kinase	B-X
with	B-X
an	B-X
N-terminal	B-X
catalytic	B-X
domain	B-X
and	B-X
a	B-X
very	B-X
long	B-X
C-terminal	B-X
extension	B-X
.	B-X
Hsl1	B-X
localizes	B-X
to	B-X
the	B-X
incipient	B-X
site	B-X
of	B-X
cytokinesis	B-X
in	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
a	B-X
septin-dependent	B-X
manner	B-X
;	B-X
however	B-X
,	B-X
the	B-X
function	B-X
of	B-X
Hsl7	B-X
was	B-X
not	B-X
previously	B-X
known	B-X
.	B-X
Using	B-X
both	B-X
indirect	B-X
immunofluorescence	B-X
with	B-X
anti-Hsl7	B-X
antibodies	B-X
and	B-X
a	B-X
fusion	B-X
of	B-X
Hsl7	B-X
to	B-X
green	B-X
fluorescent	B-X
protein	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Hsl7	B-X
also	B-X
localizes	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
,	B-X
congruent	B-X
with	B-X
the	B-X
septin	B-X
ring	B-X
that	B-X
faces	B-X
the	B-X
daughter	B-X
cell	B-X
.	B-X
Both	B-X
Swe1	B-X
and	B-X
a	B-X
segment	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
Hsl1	B-X
(	B-X
which	B-X
has	B-X
no	B-X
sequence	B-X
counterpart	B-X
in	B-X
two	B-X
Hsl1-related	B-X
protein	B-X
kinases	B-X
,	B-X
Gin4	B-X
and	B-X
Kcc4	B-X
)	B-X
were	B-X
identified	B-X
as	B-X
gene	B-X
products	B-X
that	B-X
interact	B-X
with	B-X
Hsl7	B-X
in	B-X
a	B-X
two-hybrid	B-X
screen	B-X
of	B-X
a	B-X
random	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
library	B-X
.	B-X
Hsl7	B-X
plus	B-X
Swe1	B-X
and	B-X
Hsl7	B-X
plus	B-X
Hsl1	B-X
can	B-X
be	B-X
coimmunoprecipitated	B-X
from	B-X
extracts	B-X
of	B-X
cells	B-X
overexpressing	B-X
these	B-X
proteins	B-X
,	B-X
confirming	B-X
that	B-X
Hsl7	B-X
physically	B-X
associates	B-X
with	B-X
both	B-X
partners	B-X
.	B-X
Also	B-X
consistent	B-X
with	B-X
the	B-X
two-hybrid	B-X
results	B-X
,	B-X
Hsl7	B-X
coimmunoprecipitates	B-X
with	B-X
full-length	B-X
Hsl1	B-X
less	B-X
efficiently	B-X
than	B-X
with	B-X
a	B-X
C-terminal	B-X
fragment	B-X
of	B-X
Hsl1	B-X
.	B-X
Moreover	B-X
,	B-X
Hsl7	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
an	B-X
hsl1Delta	B-X
mutant	B-X
,	B-X
whereas	B-X
Hsl1	B-X
is	B-X
localized	B-X
normally	B-X
in	B-X
an	B-X
hsl7Delta	B-X
mutant	B-X
.	B-X
Phosphorylation	B-X
and	B-X
ubiquitinylation	B-X
of	B-X
Swe1	B-X
,	B-X
preludes	B-X
to	B-X
its	B-X
destruction	B-X
,	B-X
are	B-X
severely	B-X
reduced	B-X
in	B-X
cells	B-X
lacking	B-X
either	B-X
Hsl1	B-X
or	B-X
Hsl7	B-X
(	B-X
or	B-X
both	B-X
)	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
data	B-X
suggest	B-X
that	B-X
formation	B-X
of	B-X
the	B-X
septin	B-X
rings	B-X
provides	B-X
sites	B-X
for	B-X
docking	B-X
Hsl1	B-X
,	B-X
exposing	B-X
its	B-X
C	B-X
terminus	B-X
and	B-X
thereby	B-X
permitting	B-X
recruitment	B-X
of	B-X
Hsl7	B-X
.	B-X
Hsl7	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
presents	B-X
its	B-X
cargo	B-X
of	B-X
bound	B-X
Swe1	B-X
,	B-X
allowing	B-X
phosphorylation	B-X
by	B-X
Hsl1	B-X
.	B-X
Thus	B-X
,	B-X
Hsl1	B-X
and	B-X
Hsl7	B-X
promote	B-X
proper	B-X
timing	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
by	B-X
coupling	B-X
septin	B-X
ring	B-X
assembly	B-X
to	B-X
alleviation	B-X
of	B-X
Swe1-dependent	B-X
inhibition	B-X
of	B-X
Cdc28	B-X
.	B-X
Furthermore	B-X
,	B-X
like	B-X
septins	B-X
and	B-X
Hsl1	B-X
,	B-X
homologs	B-X
of	B-X
Hsl7	B-X
are	B-X
found	B-X
in	B-X
fission	B-X
yeast	B-X
,	B-X
flies	B-X
,	B-X
worms	B-X
,	B-X
and	B-X
humans	B-X
,	B-X
suggesting	B-X
that	B-X
its	B-X
function	B-X
in	B-X
this	B-X
control	B-X
mechanism	B-X
may	B-X
be	B-X
conserved	B-X
in	B-X
all	B-X
eukaryotes	B-X
.	B-X

Also	O
consistent	O
with	O
the	O
two	O
-	O
hybrid	O
results	O
,	O
Hsl7	B-Gene_or_gene_product
coimmunoprecipitates	O
with	O
full	O
-	O
length	O
Hsl1	B-Gene_or_gene_product
less	O
efficiently	O
than	O
with	O
a	O
C	O
-	O
terminal	O
fragment	O
of	O
Hsl1	B-Gene_or_gene_product
.	O

Moreover	O
,	O
Hsl7	B-Gene_or_gene_product
does	O
not	O
localize	O
to	O
the	O
bud	O
neck	O
in	O
an	O
hsl1Delta	B-Gene_or_gene_product
mutant	O
,	O
whereas	O
Hsl1	B-Gene_or_gene_product
is	O
localized	O
normally	O
in	O
an	O
hsl7Delta	B-Gene_or_gene_product
mutant	O
.	O
<EOS>	B-X
Many	B-X
environmental	B-X
stresses	B-X
temporarily	B-X
disrupt	B-X
bud	B-X
formation	B-X
,	B-X
and	B-X
in	B-X
such	B-X
circumstances	B-X
,	B-X
the	B-X
morphogenesis	B-X
checkpoint	B-X
halts	B-X
nuclear	B-X
division	B-X
until	B-X
bud	B-X
formation	B-X
can	B-X
resume	B-X
.	B-X
Swe1	B-X
is	B-X
localized	B-X
to	B-X
the	B-X
septin	B-X
cytoskeleton	B-X
at	B-X
the	B-X
bud	B-X
neck	B-X
by	B-X
the	B-X
Swe1-binding	B-X
protein	B-X
Hsl7	B-X
.	B-X
Although	B-X
septins	B-X
form	B-X
a	B-X
ring	B-X
at	B-X
the	B-X
presumptive	B-X
bud	B-X
site	B-X
before	B-X
bud	B-X
emergence	B-X
,	B-X
Hsl7	B-X
is	B-X
not	B-X
recruited	B-X
to	B-X
the	B-X
septins	B-X
until	B-X
after	B-X
bud	B-X
emergence	B-X
,	B-X
suggesting	B-X
that	B-X
septins	B-X
and/or	B-X
Hsl7	B-X
respond	B-X
to	B-X
a	B-X
``	B-X
bud	B-X
sensor	B-X
.	B-X
''	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
recruitment	B-X
of	B-X
Hsl7	B-X
to	B-X
the	B-X
septin	B-X
ring	B-X
depends	B-X
on	B-X
a	B-X
combination	B-X
of	B-X
two	B-X
septin-binding	B-X
kinases	B-X
:	B-X
Hsl1	B-X
and	B-X
Elm1	B-X
.	B-X
We	B-X
elucidate	B-X
which	B-X
domains	B-X
of	B-X
these	B-X
kinases	B-X
are	B-X
needed	B-X
and	B-X
show	B-X
that	B-X
artificial	B-X
targeting	B-X
of	B-X
those	B-X
domains	B-X
suffices	B-X
to	B-X
recruit	B-X
Hsl7	B-X
to	B-X
septin	B-X
rings	B-X
even	B-X
in	B-X
unbudded	B-X
cells	B-X
.	B-X
Moreover	B-X
,	B-X
recruitment	B-X
of	B-X
Elm1	B-X
is	B-X
responsive	B-X
to	B-X
bud	B-X
emergence	B-X
.	B-X
Our	B-X
findings	B-X
suggest	B-X
that	B-X
Elm1	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
sensing	B-X
bud	B-X
emergence	B-X
.	B-X

Phosphorylation	O
and	O
ubiquitinylation	O
of	O
Swe1	B-Gene_or_gene_product
,	O
preludes	O
to	O
its	O
destruction	O
,	O
are	O
severely	O
reduced	O
in	O
cells	O
lacking	O
either	O
Hsl1	B-Gene_or_gene_product
or	O
Hsl7	B-Gene_or_gene_product
(	O
or	O
both	O
)	O
,	O
as	O
judged	O
by	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O
<EOS>	B-X
These	B-X
complexes	B-X
are	B-X
held	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
via	B-X
phosphorylation	B-X
of	B-X
Tyr19	B-X
in	B-X
the	B-X
ATP-binding	B-X
loop	B-X
of	B-X
Cdc28	B-X
by	B-X
the	B-X
Swe1	B-X
protein	B-X
kinase	B-X
.	B-X
The	B-X
HSL1	B-X
and	B-X
HSL7	B-X
gene	B-X
products	B-X
act	B-X
as	B-X
negative	B-X
regulators	B-X
of	B-X
Swe1	B-X
.	B-X
Hsl1	B-X
is	B-X
a	B-X
large	B-X
(	B-X
1,518-residue	B-X
)	B-X
protein	B-X
kinase	B-X
with	B-X
an	B-X
N-terminal	B-X
catalytic	B-X
domain	B-X
and	B-X
a	B-X
very	B-X
long	B-X
C-terminal	B-X
extension	B-X
.	B-X
Hsl1	B-X
localizes	B-X
to	B-X
the	B-X
incipient	B-X
site	B-X
of	B-X
cytokinesis	B-X
in	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
a	B-X
septin-dependent	B-X
manner	B-X
;	B-X
however	B-X
,	B-X
the	B-X
function	B-X
of	B-X
Hsl7	B-X
was	B-X
not	B-X
previously	B-X
known	B-X
.	B-X
Using	B-X
both	B-X
indirect	B-X
immunofluorescence	B-X
with	B-X
anti-Hsl7	B-X
antibodies	B-X
and	B-X
a	B-X
fusion	B-X
of	B-X
Hsl7	B-X
to	B-X
green	B-X
fluorescent	B-X
protein	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Hsl7	B-X
also	B-X
localizes	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
,	B-X
congruent	B-X
with	B-X
the	B-X
septin	B-X
ring	B-X
that	B-X
faces	B-X
the	B-X
daughter	B-X
cell	B-X
.	B-X
Both	B-X
Swe1	B-X
and	B-X
a	B-X
segment	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
Hsl1	B-X
(	B-X
which	B-X
has	B-X
no	B-X
sequence	B-X
counterpart	B-X
in	B-X
two	B-X
Hsl1-related	B-X
protein	B-X
kinases	B-X
,	B-X
Gin4	B-X
and	B-X
Kcc4	B-X
)	B-X
were	B-X
identified	B-X
as	B-X
gene	B-X
products	B-X
that	B-X
interact	B-X
with	B-X
Hsl7	B-X
in	B-X
a	B-X
two-hybrid	B-X
screen	B-X
of	B-X
a	B-X
random	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
library	B-X
.	B-X
Hsl7	B-X
plus	B-X
Swe1	B-X
and	B-X
Hsl7	B-X
plus	B-X
Hsl1	B-X
can	B-X
be	B-X
coimmunoprecipitated	B-X
from	B-X
extracts	B-X
of	B-X
cells	B-X
overexpressing	B-X
these	B-X
proteins	B-X
,	B-X
confirming	B-X
that	B-X
Hsl7	B-X
physically	B-X
associates	B-X
with	B-X
both	B-X
partners	B-X
.	B-X
Also	B-X
consistent	B-X
with	B-X
the	B-X
two-hybrid	B-X
results	B-X
,	B-X
Hsl7	B-X
coimmunoprecipitates	B-X
with	B-X
full-length	B-X
Hsl1	B-X
less	B-X
efficiently	B-X
than	B-X
with	B-X
a	B-X
C-terminal	B-X
fragment	B-X
of	B-X
Hsl1	B-X
.	B-X
Moreover	B-X
,	B-X
Hsl7	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
an	B-X
hsl1Delta	B-X
mutant	B-X
,	B-X
whereas	B-X
Hsl1	B-X
is	B-X
localized	B-X
normally	B-X
in	B-X
an	B-X
hsl7Delta	B-X
mutant	B-X
.	B-X
Phosphorylation	B-X
and	B-X
ubiquitinylation	B-X
of	B-X
Swe1	B-X
,	B-X
preludes	B-X
to	B-X
its	B-X
destruction	B-X
,	B-X
are	B-X
severely	B-X
reduced	B-X
in	B-X
cells	B-X
lacking	B-X
either	B-X
Hsl1	B-X
or	B-X
Hsl7	B-X
(	B-X
or	B-X
both	B-X
)	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
data	B-X
suggest	B-X
that	B-X
formation	B-X
of	B-X
the	B-X
septin	B-X
rings	B-X
provides	B-X
sites	B-X
for	B-X
docking	B-X
Hsl1	B-X
,	B-X
exposing	B-X
its	B-X
C	B-X
terminus	B-X
and	B-X
thereby	B-X
permitting	B-X
recruitment	B-X
of	B-X
Hsl7	B-X
.	B-X
Hsl7	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
presents	B-X
its	B-X
cargo	B-X
of	B-X
bound	B-X
Swe1	B-X
,	B-X
allowing	B-X
phosphorylation	B-X
by	B-X
Hsl1	B-X
.	B-X
Thus	B-X
,	B-X
Hsl1	B-X
and	B-X
Hsl7	B-X
promote	B-X
proper	B-X
timing	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
by	B-X
coupling	B-X
septin	B-X
ring	B-X
assembly	B-X
to	B-X
alleviation	B-X
of	B-X
Swe1-dependent	B-X
inhibition	B-X
of	B-X
Cdc28	B-X
.	B-X
Furthermore	B-X
,	B-X
like	B-X
septins	B-X
and	B-X
Hsl1	B-X
,	B-X
homologs	B-X
of	B-X
Hsl7	B-X
are	B-X
found	B-X
in	B-X
fission	B-X
yeast	B-X
,	B-X
flies	B-X
,	B-X
worms	B-X
,	B-X
and	B-X
humans	B-X
,	B-X
suggesting	B-X
that	B-X
its	B-X
function	B-X
in	B-X
this	B-X
control	B-X
mechanism	B-X
may	B-X
be	B-X
conserved	B-X
in	B-X
all	B-X
eukaryotes	B-X
.	B-X

Collectively	O
,	O
these	O
data	O
suggest	O
that	O
formation	O
of	O
the	O
septin	B-Gene_or_gene_product
rings	O
provides	O
sites	O
for	O
docking	O
Hsl1	B-Gene_or_gene_product
,	O
exposing	O
its	O
C	O
terminus	O
and	O
thereby	O
permitting	O
recruitment	O
of	O
Hsl7	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
-to-M	B-X
transition	B-X
requires	B-X
activation	B-X
of	B-X
Clb-bound	B-X
forms	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
,	B-X
Cdc28	B-X
.	B-X
These	B-X
complexes	B-X
are	B-X
held	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
via	B-X
phosphorylation	B-X
of	B-X
Tyr19	B-X
in	B-X
the	B-X
ATP-binding	B-X
loop	B-X
of	B-X
Cdc28	B-X
by	B-X
the	B-X
Swe1	B-X
protein	B-X
kinase	B-X
.	B-X
Hsl1	B-X
is	B-X
a	B-X
large	B-X
(	B-X
1,518-residue	B-X
)	B-X
protein	B-X
kinase	B-X
with	B-X
an	B-X
N-terminal	B-X
catalytic	B-X
domain	B-X
and	B-X
a	B-X
very	B-X
long	B-X
C-terminal	B-X
extension	B-X
.	B-X
Hsl1	B-X
localizes	B-X
to	B-X
the	B-X
incipient	B-X
site	B-X
of	B-X
cytokinesis	B-X
in	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
a	B-X
septin-dependent	B-X
manner	B-X
;	B-X
however	B-X
,	B-X
the	B-X
function	B-X
of	B-X
Hsl7	B-X
was	B-X
not	B-X
previously	B-X
known	B-X
.	B-X
Using	B-X
both	B-X
indirect	B-X
immunofluorescence	B-X
with	B-X
anti-Hsl7	B-X
antibodies	B-X
and	B-X
a	B-X
fusion	B-X
of	B-X
Hsl7	B-X
to	B-X
green	B-X
fluorescent	B-X
protein	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Hsl7	B-X
also	B-X
localizes	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
,	B-X
congruent	B-X
with	B-X
the	B-X
septin	B-X
ring	B-X
that	B-X
faces	B-X
the	B-X
daughter	B-X
cell	B-X
.	B-X
Both	B-X
Swe1	B-X
and	B-X
a	B-X
segment	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
Hsl1	B-X
(	B-X
which	B-X
has	B-X
no	B-X
sequence	B-X
counterpart	B-X
in	B-X
two	B-X
Hsl1-related	B-X
protein	B-X
kinases	B-X
,	B-X
Gin4	B-X
and	B-X
Kcc4	B-X
)	B-X
were	B-X
identified	B-X
as	B-X
gene	B-X
products	B-X
that	B-X
interact	B-X
with	B-X
Hsl7	B-X
in	B-X
a	B-X
two-hybrid	B-X
screen	B-X
of	B-X
a	B-X
random	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
library	B-X
.	B-X
Hsl7	B-X
plus	B-X
Swe1	B-X
and	B-X
Hsl7	B-X
plus	B-X
Hsl1	B-X
can	B-X
be	B-X
coimmunoprecipitated	B-X
from	B-X
extracts	B-X
of	B-X
cells	B-X
overexpressing	B-X
these	B-X
proteins	B-X
,	B-X
confirming	B-X
that	B-X
Hsl7	B-X
physically	B-X
associates	B-X
with	B-X
both	B-X
partners	B-X
.	B-X
Also	B-X
consistent	B-X
with	B-X
the	B-X
two-hybrid	B-X
results	B-X
,	B-X
Hsl7	B-X
coimmunoprecipitates	B-X
with	B-X
full-length	B-X
Hsl1	B-X
less	B-X
efficiently	B-X
than	B-X
with	B-X
a	B-X
C-terminal	B-X
fragment	B-X
of	B-X
Hsl1	B-X
.	B-X
Moreover	B-X
,	B-X
Hsl7	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
an	B-X
hsl1Delta	B-X
mutant	B-X
,	B-X
whereas	B-X
Hsl1	B-X
is	B-X
localized	B-X
normally	B-X
in	B-X
an	B-X
hsl7Delta	B-X
mutant	B-X
.	B-X
Phosphorylation	B-X
and	B-X
ubiquitinylation	B-X
of	B-X
Swe1	B-X
,	B-X
preludes	B-X
to	B-X
its	B-X
destruction	B-X
,	B-X
are	B-X
severely	B-X
reduced	B-X
in	B-X
cells	B-X
lacking	B-X
either	B-X
Hsl1	B-X
or	B-X
Hsl7	B-X
(	B-X
or	B-X
both	B-X
)	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
data	B-X
suggest	B-X
that	B-X
formation	B-X
of	B-X
the	B-X
septin	B-X
rings	B-X
provides	B-X
sites	B-X
for	B-X
docking	B-X
Hsl1	B-X
,	B-X
exposing	B-X
its	B-X
C	B-X
terminus	B-X
and	B-X
thereby	B-X
permitting	B-X
recruitment	B-X
of	B-X
Hsl7	B-X
.	B-X
Hsl7	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
presents	B-X
its	B-X
cargo	B-X
of	B-X
bound	B-X
Swe1	B-X
,	B-X
allowing	B-X
phosphorylation	B-X
by	B-X
Hsl1	B-X
.	B-X
Thus	B-X
,	B-X
Hsl1	B-X
and	B-X
Hsl7	B-X
promote	B-X
proper	B-X
timing	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
by	B-X
coupling	B-X
septin	B-X
ring	B-X
assembly	B-X
to	B-X
alleviation	B-X
of	B-X
Swe1-dependent	B-X
inhibition	B-X
of	B-X
Cdc28	B-X
.	B-X
Furthermore	B-X
,	B-X
like	B-X
septins	B-X
and	B-X
Hsl1	B-X
,	B-X
homologs	B-X
of	B-X
Hsl7	B-X
are	B-X
found	B-X
in	B-X
fission	B-X
yeast	B-X
,	B-X
flies	B-X
,	B-X
worms	B-X
,	B-X
and	B-X
humans	B-X
,	B-X
suggesting	B-X
that	B-X
its	B-X
function	B-X
in	B-X
this	B-X
control	B-X
mechanism	B-X
may	B-X
be	B-X
conserved	B-X
in	B-X
all	B-X
eukaryotes	B-X
.	B-X

Hsl7	B-Gene_or_gene_product
,	O
in	O
turn	O
,	O
presents	O
its	O
cargo	O
of	O
bound	O
Swe1	B-Gene_or_gene_product
,	O
allowing	O
phosphorylation	O
by	O
Hsl1	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
-to-M	B-X
transition	B-X
requires	B-X
activation	B-X
of	B-X
Clb-bound	B-X
forms	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
,	B-X
Cdc28	B-X
.	B-X
These	B-X
complexes	B-X
are	B-X
held	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
via	B-X
phosphorylation	B-X
of	B-X
Tyr19	B-X
in	B-X
the	B-X
ATP-binding	B-X
loop	B-X
of	B-X
Cdc28	B-X
by	B-X
the	B-X
Swe1	B-X
protein	B-X
kinase	B-X
.	B-X
The	B-X
HSL1	B-X
and	B-X
HSL7	B-X
gene	B-X
products	B-X
act	B-X
as	B-X
negative	B-X
regulators	B-X
of	B-X
Swe1	B-X
.	B-X
Hsl1	B-X
is	B-X
a	B-X
large	B-X
(	B-X
1,518-residue	B-X
)	B-X
protein	B-X
kinase	B-X
with	B-X
an	B-X
N-terminal	B-X
catalytic	B-X
domain	B-X
and	B-X
a	B-X
very	B-X
long	B-X
C-terminal	B-X
extension	B-X
.	B-X
Hsl1	B-X
localizes	B-X
to	B-X
the	B-X
incipient	B-X
site	B-X
of	B-X
cytokinesis	B-X
in	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
a	B-X
septin-dependent	B-X
manner	B-X
;	B-X
however	B-X
,	B-X
the	B-X
function	B-X
of	B-X
Hsl7	B-X
was	B-X
not	B-X
previously	B-X
known	B-X
.	B-X
Using	B-X
both	B-X
indirect	B-X
immunofluorescence	B-X
with	B-X
anti-Hsl7	B-X
antibodies	B-X
and	B-X
a	B-X
fusion	B-X
of	B-X
Hsl7	B-X
to	B-X
green	B-X
fluorescent	B-X
protein	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Hsl7	B-X
also	B-X
localizes	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
,	B-X
congruent	B-X
with	B-X
the	B-X
septin	B-X
ring	B-X
that	B-X
faces	B-X
the	B-X
daughter	B-X
cell	B-X
.	B-X
Both	B-X
Swe1	B-X
and	B-X
a	B-X
segment	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
Hsl1	B-X
(	B-X
which	B-X
has	B-X
no	B-X
sequence	B-X
counterpart	B-X
in	B-X
two	B-X
Hsl1-related	B-X
protein	B-X
kinases	B-X
,	B-X
Gin4	B-X
and	B-X
Kcc4	B-X
)	B-X
were	B-X
identified	B-X
as	B-X
gene	B-X
products	B-X
that	B-X
interact	B-X
with	B-X
Hsl7	B-X
in	B-X
a	B-X
two-hybrid	B-X
screen	B-X
of	B-X
a	B-X
random	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
library	B-X
.	B-X
Hsl7	B-X
plus	B-X
Swe1	B-X
and	B-X
Hsl7	B-X
plus	B-X
Hsl1	B-X
can	B-X
be	B-X
coimmunoprecipitated	B-X
from	B-X
extracts	B-X
of	B-X
cells	B-X
overexpressing	B-X
these	B-X
proteins	B-X
,	B-X
confirming	B-X
that	B-X
Hsl7	B-X
physically	B-X
associates	B-X
with	B-X
both	B-X
partners	B-X
.	B-X
Also	B-X
consistent	B-X
with	B-X
the	B-X
two-hybrid	B-X
results	B-X
,	B-X
Hsl7	B-X
coimmunoprecipitates	B-X
with	B-X
full-length	B-X
Hsl1	B-X
less	B-X
efficiently	B-X
than	B-X
with	B-X
a	B-X
C-terminal	B-X
fragment	B-X
of	B-X
Hsl1	B-X
.	B-X
Moreover	B-X
,	B-X
Hsl7	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
an	B-X
hsl1Delta	B-X
mutant	B-X
,	B-X
whereas	B-X
Hsl1	B-X
is	B-X
localized	B-X
normally	B-X
in	B-X
an	B-X
hsl7Delta	B-X
mutant	B-X
.	B-X
Phosphorylation	B-X
and	B-X
ubiquitinylation	B-X
of	B-X
Swe1	B-X
,	B-X
preludes	B-X
to	B-X
its	B-X
destruction	B-X
,	B-X
are	B-X
severely	B-X
reduced	B-X
in	B-X
cells	B-X
lacking	B-X
either	B-X
Hsl1	B-X
or	B-X
Hsl7	B-X
(	B-X
or	B-X
both	B-X
)	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
data	B-X
suggest	B-X
that	B-X
formation	B-X
of	B-X
the	B-X
septin	B-X
rings	B-X
provides	B-X
sites	B-X
for	B-X
docking	B-X
Hsl1	B-X
,	B-X
exposing	B-X
its	B-X
C	B-X
terminus	B-X
and	B-X
thereby	B-X
permitting	B-X
recruitment	B-X
of	B-X
Hsl7	B-X
.	B-X
Hsl7	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
presents	B-X
its	B-X
cargo	B-X
of	B-X
bound	B-X
Swe1	B-X
,	B-X
allowing	B-X
phosphorylation	B-X
by	B-X
Hsl1	B-X
.	B-X
Thus	B-X
,	B-X
Hsl1	B-X
and	B-X
Hsl7	B-X
promote	B-X
proper	B-X
timing	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
by	B-X
coupling	B-X
septin	B-X
ring	B-X
assembly	B-X
to	B-X
alleviation	B-X
of	B-X
Swe1-dependent	B-X
inhibition	B-X
of	B-X
Cdc28	B-X
.	B-X
Furthermore	B-X
,	B-X
like	B-X
septins	B-X
and	B-X
Hsl1	B-X
,	B-X
homologs	B-X
of	B-X
Hsl7	B-X
are	B-X
found	B-X
in	B-X
fission	B-X
yeast	B-X
,	B-X
flies	B-X
,	B-X
worms	B-X
,	B-X
and	B-X
humans	B-X
,	B-X
suggesting	B-X
that	B-X
its	B-X
function	B-X
in	B-X
this	B-X
control	B-X
mechanism	B-X
may	B-X
be	B-X
conserved	B-X
in	B-X
all	B-X
eukaryotes	B-X
.	B-X

Thus	O
,	O
Hsl1	B-Gene_or_gene_product
and	O
Hsl7	B-Gene_or_gene_product
promote	O
proper	O
timing	O
of	O
cell	O
cycle	O
progression	O
by	O
coupling	O
septin	B-Gene_or_gene_product
ring	O
assembly	O
to	O
alleviation	O
of	O
Swe1	B-Gene_or_gene_product
-	O
dependent	O
inhibition	O
of	O
Cdc28	B-Gene_or_gene_product
.	O
<EOS>	B-X
Successful	B-X
mitosis	B-X
requires	B-X
faithful	B-X
DNA	B-X
replication	B-X
,	B-X
spindle	B-X
assembly	B-X
,	B-X
chromosome	B-X
segregation	B-X
,	B-X
and	B-X
cell	B-X
division	B-X
.	B-X
In	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
-to-M	B-X
transition	B-X
requires	B-X
activation	B-X
of	B-X
Clb-bound	B-X
forms	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
,	B-X
Cdc28	B-X
.	B-X
These	B-X
complexes	B-X
are	B-X
held	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
via	B-X
phosphorylation	B-X
of	B-X
Tyr19	B-X
in	B-X
the	B-X
ATP-binding	B-X
loop	B-X
of	B-X
Cdc28	B-X
by	B-X
the	B-X
Swe1	B-X
protein	B-X
kinase	B-X
.	B-X
The	B-X
HSL1	B-X
and	B-X
HSL7	B-X
gene	B-X
products	B-X
act	B-X
as	B-X
negative	B-X
regulators	B-X
of	B-X
Swe1	B-X
.	B-X
Hsl1	B-X
is	B-X
a	B-X
large	B-X
(	B-X
1,518-residue	B-X
)	B-X
protein	B-X
kinase	B-X
with	B-X
an	B-X
N-terminal	B-X
catalytic	B-X
domain	B-X
and	B-X
a	B-X
very	B-X
long	B-X
C-terminal	B-X
extension	B-X
.	B-X
Hsl1	B-X
localizes	B-X
to	B-X
the	B-X
incipient	B-X
site	B-X
of	B-X
cytokinesis	B-X
in	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
a	B-X
septin-dependent	B-X
manner	B-X
;	B-X
however	B-X
,	B-X
the	B-X
function	B-X
of	B-X
Hsl7	B-X
was	B-X
not	B-X
previously	B-X
known	B-X
.	B-X
Using	B-X
both	B-X
indirect	B-X
immunofluorescence	B-X
with	B-X
anti-Hsl7	B-X
antibodies	B-X
and	B-X
a	B-X
fusion	B-X
of	B-X
Hsl7	B-X
to	B-X
green	B-X
fluorescent	B-X
protein	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Hsl7	B-X
also	B-X
localizes	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
,	B-X
congruent	B-X
with	B-X
the	B-X
septin	B-X
ring	B-X
that	B-X
faces	B-X
the	B-X
daughter	B-X
cell	B-X
.	B-X
Both	B-X
Swe1	B-X
and	B-X
a	B-X
segment	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
Hsl1	B-X
(	B-X
which	B-X
has	B-X
no	B-X
sequence	B-X
counterpart	B-X
in	B-X
two	B-X
Hsl1-related	B-X
protein	B-X
kinases	B-X
,	B-X
Gin4	B-X
and	B-X
Kcc4	B-X
)	B-X
were	B-X
identified	B-X
as	B-X
gene	B-X
products	B-X
that	B-X
interact	B-X
with	B-X
Hsl7	B-X
in	B-X
a	B-X
two-hybrid	B-X
screen	B-X
of	B-X
a	B-X
random	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
library	B-X
.	B-X
Hsl7	B-X
plus	B-X
Swe1	B-X
and	B-X
Hsl7	B-X
plus	B-X
Hsl1	B-X
can	B-X
be	B-X
coimmunoprecipitated	B-X
from	B-X
extracts	B-X
of	B-X
cells	B-X
overexpressing	B-X
these	B-X
proteins	B-X
,	B-X
confirming	B-X
that	B-X
Hsl7	B-X
physically	B-X
associates	B-X
with	B-X
both	B-X
partners	B-X
.	B-X
Also	B-X
consistent	B-X
with	B-X
the	B-X
two-hybrid	B-X
results	B-X
,	B-X
Hsl7	B-X
coimmunoprecipitates	B-X
with	B-X
full-length	B-X
Hsl1	B-X
less	B-X
efficiently	B-X
than	B-X
with	B-X
a	B-X
C-terminal	B-X
fragment	B-X
of	B-X
Hsl1	B-X
.	B-X
Moreover	B-X
,	B-X
Hsl7	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
an	B-X
hsl1Delta	B-X
mutant	B-X
,	B-X
whereas	B-X
Hsl1	B-X
is	B-X
localized	B-X
normally	B-X
in	B-X
an	B-X
hsl7Delta	B-X
mutant	B-X
.	B-X
Phosphorylation	B-X
and	B-X
ubiquitinylation	B-X
of	B-X
Swe1	B-X
,	B-X
preludes	B-X
to	B-X
its	B-X
destruction	B-X
,	B-X
are	B-X
severely	B-X
reduced	B-X
in	B-X
cells	B-X
lacking	B-X
either	B-X
Hsl1	B-X
or	B-X
Hsl7	B-X
(	B-X
or	B-X
both	B-X
)	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
data	B-X
suggest	B-X
that	B-X
formation	B-X
of	B-X
the	B-X
septin	B-X
rings	B-X
provides	B-X
sites	B-X
for	B-X
docking	B-X
Hsl1	B-X
,	B-X
exposing	B-X
its	B-X
C	B-X
terminus	B-X
and	B-X
thereby	B-X
permitting	B-X
recruitment	B-X
of	B-X
Hsl7	B-X
.	B-X
Hsl7	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
presents	B-X
its	B-X
cargo	B-X
of	B-X
bound	B-X
Swe1	B-X
,	B-X
allowing	B-X
phosphorylation	B-X
by	B-X
Hsl1	B-X
.	B-X
Thus	B-X
,	B-X
Hsl1	B-X
and	B-X
Hsl7	B-X
promote	B-X
proper	B-X
timing	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
by	B-X
coupling	B-X
septin	B-X
ring	B-X
assembly	B-X
to	B-X
alleviation	B-X
of	B-X
Swe1-dependent	B-X
inhibition	B-X
of	B-X
Cdc28	B-X
.	B-X
Furthermore	B-X
,	B-X
like	B-X
septins	B-X
and	B-X
Hsl1	B-X
,	B-X
homologs	B-X
of	B-X
Hsl7	B-X
are	B-X
found	B-X
in	B-X
fission	B-X
yeast	B-X
,	B-X
flies	B-X
,	B-X
worms	B-X
,	B-X
and	B-X
humans	B-X
,	B-X
suggesting	B-X
that	B-X
its	B-X
function	B-X
in	B-X
this	B-X
control	B-X
mechanism	B-X
may	B-X
be	B-X
conserved	B-X
in	B-X
all	B-X
eukaryotes	B-X
.	B-X

Furthermore	O
,	O
like	O
septins	B-Gene_or_gene_product
and	O
Hsl1	B-Gene_or_gene_product
,	O
homologs	O
of	O
Hsl7	B-Gene_or_gene_product
are	O
found	O
in	O
fission	O
yeast	O
,	O
flies	O
,	O
worms	O
,	O
and	O
humans	O
,	O
suggesting	O
that	O
its	O
function	O
in	O
this	O
control	O
mechanism	O
may	O
be	O
conserved	O
in	O
all	O
eukaryotes	O
.	O
<EOS>	B-X
In	B-X
the	B-X
budding	B-X
yeast	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
-to-M	B-X
transition	B-X
requires	B-X
activation	B-X
of	B-X
Clb-bound	B-X
forms	B-X
of	B-X
the	B-X
protein	B-X
kinase	B-X
,	B-X
Cdc28	B-X
.	B-X
Hsl1	B-X
is	B-X
a	B-X
large	B-X
(	B-X
1,518-residue	B-X
)	B-X
protein	B-X
kinase	B-X
with	B-X
an	B-X
N-terminal	B-X
catalytic	B-X
domain	B-X
and	B-X
a	B-X
very	B-X
long	B-X
C-terminal	B-X
extension	B-X
.	B-X
Hsl1	B-X
localizes	B-X
to	B-X
the	B-X
incipient	B-X
site	B-X
of	B-X
cytokinesis	B-X
in	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
a	B-X
septin-dependent	B-X
manner	B-X
;	B-X
however	B-X
,	B-X
the	B-X
function	B-X
of	B-X
Hsl7	B-X
was	B-X
not	B-X
previously	B-X
known	B-X
.	B-X
Using	B-X
both	B-X
indirect	B-X
immunofluorescence	B-X
with	B-X
anti-Hsl7	B-X
antibodies	B-X
and	B-X
a	B-X
fusion	B-X
of	B-X
Hsl7	B-X
to	B-X
green	B-X
fluorescent	B-X
protein	B-X
,	B-X
we	B-X
found	B-X
that	B-X
Hsl7	B-X
also	B-X
localizes	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
,	B-X
congruent	B-X
with	B-X
the	B-X
septin	B-X
ring	B-X
that	B-X
faces	B-X
the	B-X
daughter	B-X
cell	B-X
.	B-X
Both	B-X
Swe1	B-X
and	B-X
a	B-X
segment	B-X
of	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
Hsl1	B-X
(	B-X
which	B-X
has	B-X
no	B-X
sequence	B-X
counterpart	B-X
in	B-X
two	B-X
Hsl1-related	B-X
protein	B-X
kinases	B-X
,	B-X
Gin4	B-X
and	B-X
Kcc4	B-X
)	B-X
were	B-X
identified	B-X
as	B-X
gene	B-X
products	B-X
that	B-X
interact	B-X
with	B-X
Hsl7	B-X
in	B-X
a	B-X
two-hybrid	B-X
screen	B-X
of	B-X
a	B-X
random	B-X
S.	B-X
cerevisiae	B-X
cDNA	B-X
library	B-X
.	B-X
Hsl7	B-X
plus	B-X
Swe1	B-X
and	B-X
Hsl7	B-X
plus	B-X
Hsl1	B-X
can	B-X
be	B-X
coimmunoprecipitated	B-X
from	B-X
extracts	B-X
of	B-X
cells	B-X
overexpressing	B-X
these	B-X
proteins	B-X
,	B-X
confirming	B-X
that	B-X
Hsl7	B-X
physically	B-X
associates	B-X
with	B-X
both	B-X
partners	B-X
.	B-X
Also	B-X
consistent	B-X
with	B-X
the	B-X
two-hybrid	B-X
results	B-X
,	B-X
Hsl7	B-X
coimmunoprecipitates	B-X
with	B-X
full-length	B-X
Hsl1	B-X
less	B-X
efficiently	B-X
than	B-X
with	B-X
a	B-X
C-terminal	B-X
fragment	B-X
of	B-X
Hsl1	B-X
.	B-X
Moreover	B-X
,	B-X
Hsl7	B-X
does	B-X
not	B-X
localize	B-X
to	B-X
the	B-X
bud	B-X
neck	B-X
in	B-X
an	B-X
hsl1Delta	B-X
mutant	B-X
,	B-X
whereas	B-X
Hsl1	B-X
is	B-X
localized	B-X
normally	B-X
in	B-X
an	B-X
hsl7Delta	B-X
mutant	B-X
.	B-X
Phosphorylation	B-X
and	B-X
ubiquitinylation	B-X
of	B-X
Swe1	B-X
,	B-X
preludes	B-X
to	B-X
its	B-X
destruction	B-X
,	B-X
are	B-X
severely	B-X
reduced	B-X
in	B-X
cells	B-X
lacking	B-X
either	B-X
Hsl1	B-X
or	B-X
Hsl7	B-X
(	B-X
or	B-X
both	B-X
)	B-X
,	B-X
as	B-X
judged	B-X
by	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
data	B-X
suggest	B-X
that	B-X
formation	B-X
of	B-X
the	B-X
septin	B-X
rings	B-X
provides	B-X
sites	B-X
for	B-X
docking	B-X
Hsl1	B-X
,	B-X
exposing	B-X
its	B-X
C	B-X
terminus	B-X
and	B-X
thereby	B-X
permitting	B-X
recruitment	B-X
of	B-X
Hsl7	B-X
.	B-X
Hsl7	B-X
,	B-X
in	B-X
turn	B-X
,	B-X
presents	B-X
its	B-X
cargo	B-X
of	B-X
bound	B-X
Swe1	B-X
,	B-X
allowing	B-X
phosphorylation	B-X
by	B-X
Hsl1	B-X
.	B-X
Thus	B-X
,	B-X
Hsl1	B-X
and	B-X
Hsl7	B-X
promote	B-X
proper	B-X
timing	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
by	B-X
coupling	B-X
septin	B-X
ring	B-X
assembly	B-X
to	B-X
alleviation	B-X
of	B-X
Swe1-dependent	B-X
inhibition	B-X
of	B-X
Cdc28	B-X
.	B-X
Furthermore	B-X
,	B-X
like	B-X
septins	B-X
and	B-X
Hsl1	B-X
,	B-X
homologs	B-X
of	B-X
Hsl7	B-X
are	B-X
found	B-X
in	B-X
fission	B-X
yeast	B-X
,	B-X
flies	B-X
,	B-X
worms	B-X
,	B-X
and	B-X
humans	B-X
,	B-X
suggesting	B-X
that	B-X
its	B-X
function	B-X
in	B-X
this	B-X
control	B-X
mechanism	B-X
may	B-X
be	B-X
conserved	B-X
in	B-X
all	B-X
eukaryotes	B-X
.	B-X

New	O
insights	O
into	O
the	O
regulation	O
of	O
protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
C	I-Gene_or_gene_product
and	O
novel	O
phorbol	O
ester	O
receptors	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
,	B-X
a	B-X
family	B-X
of	B-X
related	B-X
serine-threonine	B-X
kinases	B-X
,	B-X
is	B-X
a	B-X
key	B-X
player	B-X
in	B-X
the	B-X
cellular	B-X
responses	B-X
mediated	B-X
by	B-X
the	B-X
second	B-X
messenger	B-X
diacylglycerol	B-X
(	B-X
DAG	B-X
)	B-X
and	B-X
the	B-X
phorbol	B-X
ester	B-X
tumor	B-X
promoters	B-X
.	B-X
The	B-X
traditional	B-X
view	B-X
of	B-X
PKCs	B-X
as	B-X
DAG/phospholipid-regulated	B-X
proteins	B-X
has	B-X
expanded	B-X
in	B-X
the	B-X
last	B-X
few	B-X
years	B-X
by	B-X
three	B-X
seminal	B-X
discoveries	B-X
.	B-X
First	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
maturation	B-X
is	B-X
controlled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
transphosphorylation	B-X
mechanisms	B-X
,	B-X
which	B-X
includes	B-X
phosphorylation	B-X
of	B-X
PKC	B-X
isozymes	B-X
by	B-X
phosphoinositide-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
PDKs	B-X
)	B-X
and	B-X
tyrosine	B-X
kinases	B-X
.	B-X
Second	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
localization	B-X
are	B-X
regulated	B-X
by	B-X
direct	B-X
interaction	B-X
with	B-X
different	B-X
types	B-X
of	B-X
interacting	B-X
proteins	B-X
.	B-X
Protein-protein	B-X
interactions	B-X
are	B-X
now	B-X
recognized	B-X
as	B-X
important	B-X
mechanisms	B-X
that	B-X
target	B-X
individual	B-X
PKCs	B-X
to	B-X
different	B-X
intracellular	B-X
compartments	B-X
and	B-X
confer	B-X
selectivity	B-X
by	B-X
associating	B-X
individual	B-X
isozymes	B-X
with	B-X
specific	B-X
substrates	B-X
.	B-X
Last	B-X
,	B-X
the	B-X
discovery	B-X
of	B-X
novel	B-X
phorbol	B-X
ester	B-X
receptors	B-X
lacking	B-X
kinase	B-X
activity	B-X
allows	B-X
us	B-X
to	B-X
speculate	B-X
that	B-X
some	B-X
of	B-X
the	B-X
biological	B-X
responses	B-X
elicited	B-X
by	B-X
phorbol	B-X
esters	B-X
or	B-X
by	B-X
activation	B-X
of	B-X
receptors	B-X
coupled	B-X
to	B-X
elevation	B-X
in	B-X
DAG	B-X
levels	B-X
could	B-X
be	B-X
mediated	B-X
by	B-X
PKC-independent	B-X
pathways	B-X
.	B-X

Protein	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
C	I-Gene_or_gene_product
(	O
PKC	B-Gene_or_gene_product
)	O
,	O
a	O
family	O
of	O
related	O
serine	O
-	O
threonine	O
kinases	O
,	O
is	O
a	O
key	O
player	O
in	O
the	O
cellular	O
responses	O
mediated	O
by	O
the	O
second	O
messenger	O
diacylglycerol	O
(	O
DAG	O
)	O
and	O
the	O
phorbol	O
ester	O
tumor	O
promoters	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
,	B-X
a	B-X
family	B-X
of	B-X
related	B-X
serine-threonine	B-X
kinases	B-X
,	B-X
is	B-X
a	B-X
key	B-X
player	B-X
in	B-X
the	B-X
cellular	B-X
responses	B-X
mediated	B-X
by	B-X
the	B-X
second	B-X
messenger	B-X
diacylglycerol	B-X
(	B-X
DAG	B-X
)	B-X
and	B-X
the	B-X
phorbol	B-X
ester	B-X
tumor	B-X
promoters	B-X
.	B-X
The	B-X
traditional	B-X
view	B-X
of	B-X
PKCs	B-X
as	B-X
DAG/phospholipid-regulated	B-X
proteins	B-X
has	B-X
expanded	B-X
in	B-X
the	B-X
last	B-X
few	B-X
years	B-X
by	B-X
three	B-X
seminal	B-X
discoveries	B-X
.	B-X
First	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
maturation	B-X
is	B-X
controlled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
transphosphorylation	B-X
mechanisms	B-X
,	B-X
which	B-X
includes	B-X
phosphorylation	B-X
of	B-X
PKC	B-X
isozymes	B-X
by	B-X
phosphoinositide-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
PDKs	B-X
)	B-X
and	B-X
tyrosine	B-X
kinases	B-X
.	B-X
Second	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
localization	B-X
are	B-X
regulated	B-X
by	B-X
direct	B-X
interaction	B-X
with	B-X
different	B-X
types	B-X
of	B-X
interacting	B-X
proteins	B-X
.	B-X
Protein-protein	B-X
interactions	B-X
are	B-X
now	B-X
recognized	B-X
as	B-X
important	B-X
mechanisms	B-X
that	B-X
target	B-X
individual	B-X
PKCs	B-X
to	B-X
different	B-X
intracellular	B-X
compartments	B-X
and	B-X
confer	B-X
selectivity	B-X
by	B-X
associating	B-X
individual	B-X
isozymes	B-X
with	B-X
specific	B-X
substrates	B-X
.	B-X
Last	B-X
,	B-X
the	B-X
discovery	B-X
of	B-X
novel	B-X
phorbol	B-X
ester	B-X
receptors	B-X
lacking	B-X
kinase	B-X
activity	B-X
allows	B-X
us	B-X
to	B-X
speculate	B-X
that	B-X
some	B-X
of	B-X
the	B-X
biological	B-X
responses	B-X
elicited	B-X
by	B-X
phorbol	B-X
esters	B-X
or	B-X
by	B-X
activation	B-X
of	B-X
receptors	B-X
coupled	B-X
to	B-X
elevation	B-X
in	B-X
DAG	B-X
levels	B-X
could	B-X
be	B-X
mediated	B-X
by	B-X
PKC-independent	B-X
pathways	B-X
.	B-X

The	O
traditional	O
view	O
of	O
PKCs	B-Gene_or_gene_product
as	O
DAG	O
/	O
phospholipid	O
-	O
regulated	O
proteins	O
has	O
expanded	O
in	O
the	O
last	O
few	O
years	O
by	O
three	O
seminal	O
discoveries	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
,	B-X
a	B-X
family	B-X
of	B-X
related	B-X
serine-threonine	B-X
kinases	B-X
,	B-X
is	B-X
a	B-X
key	B-X
player	B-X
in	B-X
the	B-X
cellular	B-X
responses	B-X
mediated	B-X
by	B-X
the	B-X
second	B-X
messenger	B-X
diacylglycerol	B-X
(	B-X
DAG	B-X
)	B-X
and	B-X
the	B-X
phorbol	B-X
ester	B-X
tumor	B-X
promoters	B-X
.	B-X
The	B-X
traditional	B-X
view	B-X
of	B-X
PKCs	B-X
as	B-X
DAG/phospholipid-regulated	B-X
proteins	B-X
has	B-X
expanded	B-X
in	B-X
the	B-X
last	B-X
few	B-X
years	B-X
by	B-X
three	B-X
seminal	B-X
discoveries	B-X
.	B-X
Second	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
localization	B-X
are	B-X
regulated	B-X
by	B-X
direct	B-X
interaction	B-X
with	B-X
different	B-X
types	B-X
of	B-X
interacting	B-X
proteins	B-X
.	B-X
Protein-protein	B-X
interactions	B-X
are	B-X
now	B-X
recognized	B-X
as	B-X
important	B-X
mechanisms	B-X
that	B-X
target	B-X
individual	B-X
PKCs	B-X
to	B-X
different	B-X
intracellular	B-X
compartments	B-X
and	B-X
confer	B-X
selectivity	B-X
by	B-X
associating	B-X
individual	B-X
isozymes	B-X
with	B-X
specific	B-X
substrates	B-X
.	B-X
Last	B-X
,	B-X
the	B-X
discovery	B-X
of	B-X
novel	B-X
phorbol	B-X
ester	B-X
receptors	B-X
lacking	B-X
kinase	B-X
activity	B-X
allows	B-X
us	B-X
to	B-X
speculate	B-X
that	B-X
some	B-X
of	B-X
the	B-X
biological	B-X
responses	B-X
elicited	B-X
by	B-X
phorbol	B-X
esters	B-X
or	B-X
by	B-X
activation	B-X
of	B-X
receptors	B-X
coupled	B-X
to	B-X
elevation	B-X
in	B-X
DAG	B-X
levels	B-X
could	B-X
be	B-X
mediated	B-X
by	B-X
PKC-independent	B-X
pathways	B-X
.	B-X

First	O
,	O
PKC	B-Gene_or_gene_product
activity	O
and	O
maturation	O
is	O
controlled	O
by	O
autophosphorylation	O
and	O
transphosphorylation	O
mechanisms	O
,	O
which	O
includes	O
phosphorylation	O
of	O
PKC	B-Gene_or_gene_product
isozymes	O
by	O
phosphoinositide	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
PDKs	B-Gene_or_gene_product
)	O
and	O
tyrosine	O
kinases	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
,	B-X
a	B-X
family	B-X
of	B-X
related	B-X
serine-threonine	B-X
kinases	B-X
,	B-X
is	B-X
a	B-X
key	B-X
player	B-X
in	B-X
the	B-X
cellular	B-X
responses	B-X
mediated	B-X
by	B-X
the	B-X
second	B-X
messenger	B-X
diacylglycerol	B-X
(	B-X
DAG	B-X
)	B-X
and	B-X
the	B-X
phorbol	B-X
ester	B-X
tumor	B-X
promoters	B-X
.	B-X
The	B-X
traditional	B-X
view	B-X
of	B-X
PKCs	B-X
as	B-X
DAG/phospholipid-regulated	B-X
proteins	B-X
has	B-X
expanded	B-X
in	B-X
the	B-X
last	B-X
few	B-X
years	B-X
by	B-X
three	B-X
seminal	B-X
discoveries	B-X
.	B-X
First	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
maturation	B-X
is	B-X
controlled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
transphosphorylation	B-X
mechanisms	B-X
,	B-X
which	B-X
includes	B-X
phosphorylation	B-X
of	B-X
PKC	B-X
isozymes	B-X
by	B-X
phosphoinositide-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
PDKs	B-X
)	B-X
and	B-X
tyrosine	B-X
kinases	B-X
.	B-X
Second	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
localization	B-X
are	B-X
regulated	B-X
by	B-X
direct	B-X
interaction	B-X
with	B-X
different	B-X
types	B-X
of	B-X
interacting	B-X
proteins	B-X
.	B-X
Protein-protein	B-X
interactions	B-X
are	B-X
now	B-X
recognized	B-X
as	B-X
important	B-X
mechanisms	B-X
that	B-X
target	B-X
individual	B-X
PKCs	B-X
to	B-X
different	B-X
intracellular	B-X
compartments	B-X
and	B-X
confer	B-X
selectivity	B-X
by	B-X
associating	B-X
individual	B-X
isozymes	B-X
with	B-X
specific	B-X
substrates	B-X
.	B-X
Last	B-X
,	B-X
the	B-X
discovery	B-X
of	B-X
novel	B-X
phorbol	B-X
ester	B-X
receptors	B-X
lacking	B-X
kinase	B-X
activity	B-X
allows	B-X
us	B-X
to	B-X
speculate	B-X
that	B-X
some	B-X
of	B-X
the	B-X
biological	B-X
responses	B-X
elicited	B-X
by	B-X
phorbol	B-X
esters	B-X
or	B-X
by	B-X
activation	B-X
of	B-X
receptors	B-X
coupled	B-X
to	B-X
elevation	B-X
in	B-X
DAG	B-X
levels	B-X
could	B-X
be	B-X
mediated	B-X
by	B-X
PKC-independent	B-X
pathways	B-X
.	B-X

Second	O
,	O
PKC	B-Gene_or_gene_product
activity	O
and	O
localization	O
are	O
regulated	O
by	O
direct	O
interaction	O
with	O
different	O
types	O
of	O
interacting	O
proteins	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
,	B-X
a	B-X
family	B-X
of	B-X
related	B-X
serine-threonine	B-X
kinases	B-X
,	B-X
is	B-X
a	B-X
key	B-X
player	B-X
in	B-X
the	B-X
cellular	B-X
responses	B-X
mediated	B-X
by	B-X
the	B-X
second	B-X
messenger	B-X
diacylglycerol	B-X
(	B-X
DAG	B-X
)	B-X
and	B-X
the	B-X
phorbol	B-X
ester	B-X
tumor	B-X
promoters	B-X
.	B-X
The	B-X
traditional	B-X
view	B-X
of	B-X
PKCs	B-X
as	B-X
DAG/phospholipid-regulated	B-X
proteins	B-X
has	B-X
expanded	B-X
in	B-X
the	B-X
last	B-X
few	B-X
years	B-X
by	B-X
three	B-X
seminal	B-X
discoveries	B-X
.	B-X
First	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
maturation	B-X
is	B-X
controlled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
transphosphorylation	B-X
mechanisms	B-X
,	B-X
which	B-X
includes	B-X
phosphorylation	B-X
of	B-X
PKC	B-X
isozymes	B-X
by	B-X
phosphoinositide-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
PDKs	B-X
)	B-X
and	B-X
tyrosine	B-X
kinases	B-X
.	B-X
Second	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
localization	B-X
are	B-X
regulated	B-X
by	B-X
direct	B-X
interaction	B-X
with	B-X
different	B-X
types	B-X
of	B-X
interacting	B-X
proteins	B-X
.	B-X
Protein-protein	B-X
interactions	B-X
are	B-X
now	B-X
recognized	B-X
as	B-X
important	B-X
mechanisms	B-X
that	B-X
target	B-X
individual	B-X
PKCs	B-X
to	B-X
different	B-X
intracellular	B-X
compartments	B-X
and	B-X
confer	B-X
selectivity	B-X
by	B-X
associating	B-X
individual	B-X
isozymes	B-X
with	B-X
specific	B-X
substrates	B-X
.	B-X
Last	B-X
,	B-X
the	B-X
discovery	B-X
of	B-X
novel	B-X
phorbol	B-X
ester	B-X
receptors	B-X
lacking	B-X
kinase	B-X
activity	B-X
allows	B-X
us	B-X
to	B-X
speculate	B-X
that	B-X
some	B-X
of	B-X
the	B-X
biological	B-X
responses	B-X
elicited	B-X
by	B-X
phorbol	B-X
esters	B-X
or	B-X
by	B-X
activation	B-X
of	B-X
receptors	B-X
coupled	B-X
to	B-X
elevation	B-X
in	B-X
DAG	B-X
levels	B-X
could	B-X
be	B-X
mediated	B-X
by	B-X
PKC-independent	B-X
pathways	B-X
.	B-X

Protein	O
-	O
protein	O
interactions	O
are	O
now	O
recognized	O
as	O
important	O
mechanisms	O
that	O
target	O
individual	O
PKCs	B-Gene_or_gene_product
to	O
different	O
intracellular	O
compartments	O
and	O
confer	O
selectivity	O
by	O
associating	O
individual	O
isozymes	O
with	O
specific	O
substrates	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
,	B-X
a	B-X
family	B-X
of	B-X
related	B-X
serine-threonine	B-X
kinases	B-X
,	B-X
is	B-X
a	B-X
key	B-X
player	B-X
in	B-X
the	B-X
cellular	B-X
responses	B-X
mediated	B-X
by	B-X
the	B-X
second	B-X
messenger	B-X
diacylglycerol	B-X
(	B-X
DAG	B-X
)	B-X
and	B-X
the	B-X
phorbol	B-X
ester	B-X
tumor	B-X
promoters	B-X
.	B-X
The	B-X
traditional	B-X
view	B-X
of	B-X
PKCs	B-X
as	B-X
DAG/phospholipid-regulated	B-X
proteins	B-X
has	B-X
expanded	B-X
in	B-X
the	B-X
last	B-X
few	B-X
years	B-X
by	B-X
three	B-X
seminal	B-X
discoveries	B-X
.	B-X
First	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
maturation	B-X
is	B-X
controlled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
transphosphorylation	B-X
mechanisms	B-X
,	B-X
which	B-X
includes	B-X
phosphorylation	B-X
of	B-X
PKC	B-X
isozymes	B-X
by	B-X
phosphoinositide-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
PDKs	B-X
)	B-X
and	B-X
tyrosine	B-X
kinases	B-X
.	B-X
Second	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
localization	B-X
are	B-X
regulated	B-X
by	B-X
direct	B-X
interaction	B-X
with	B-X
different	B-X
types	B-X
of	B-X
interacting	B-X
proteins	B-X
.	B-X
Protein-protein	B-X
interactions	B-X
are	B-X
now	B-X
recognized	B-X
as	B-X
important	B-X
mechanisms	B-X
that	B-X
target	B-X
individual	B-X
PKCs	B-X
to	B-X
different	B-X
intracellular	B-X
compartments	B-X
and	B-X
confer	B-X
selectivity	B-X
by	B-X
associating	B-X
individual	B-X
isozymes	B-X
with	B-X
specific	B-X
substrates	B-X
.	B-X

Last	O
,	O
the	O
discovery	O
of	O
novel	O
phorbol	O
ester	O
receptors	O
lacking	O
kinase	O
activity	O
allows	O
us	O
to	O
speculate	O
that	O
some	O
of	O
the	O
biological	O
responses	O
elicited	O
by	O
phorbol	O
esters	O
or	O
by	O
activation	O
of	O
receptors	O
coupled	O
to	O
elevation	O
in	O
DAG	O
levels	O
could	O
be	O
mediated	O
by	O
PKC	B-Gene_or_gene_product
-	O
independent	O
pathways	O
.	O
<EOS>	B-X
Protein	B-X
kinase	B-X
C	B-X
(	B-X
PKC	B-X
)	B-X
,	B-X
a	B-X
family	B-X
of	B-X
related	B-X
serine-threonine	B-X
kinases	B-X
,	B-X
is	B-X
a	B-X
key	B-X
player	B-X
in	B-X
the	B-X
cellular	B-X
responses	B-X
mediated	B-X
by	B-X
the	B-X
second	B-X
messenger	B-X
diacylglycerol	B-X
(	B-X
DAG	B-X
)	B-X
and	B-X
the	B-X
phorbol	B-X
ester	B-X
tumor	B-X
promoters	B-X
.	B-X
The	B-X
traditional	B-X
view	B-X
of	B-X
PKCs	B-X
as	B-X
DAG/phospholipid-regulated	B-X
proteins	B-X
has	B-X
expanded	B-X
in	B-X
the	B-X
last	B-X
few	B-X
years	B-X
by	B-X
three	B-X
seminal	B-X
discoveries	B-X
.	B-X
First	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
maturation	B-X
is	B-X
controlled	B-X
by	B-X
autophosphorylation	B-X
and	B-X
transphosphorylation	B-X
mechanisms	B-X
,	B-X
which	B-X
includes	B-X
phosphorylation	B-X
of	B-X
PKC	B-X
isozymes	B-X
by	B-X
phosphoinositide-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
PDKs	B-X
)	B-X
and	B-X
tyrosine	B-X
kinases	B-X
.	B-X
Second	B-X
,	B-X
PKC	B-X
activity	B-X
and	B-X
localization	B-X
are	B-X
regulated	B-X
by	B-X
direct	B-X
interaction	B-X
with	B-X
different	B-X
types	B-X
of	B-X
interacting	B-X
proteins	B-X
.	B-X
Protein-protein	B-X
interactions	B-X
are	B-X
now	B-X
recognized	B-X
as	B-X
important	B-X
mechanisms	B-X
that	B-X
target	B-X
individual	B-X
PKCs	B-X
to	B-X
different	B-X
intracellular	B-X
compartments	B-X
and	B-X
confer	B-X
selectivity	B-X
by	B-X
associating	B-X
individual	B-X
isozymes	B-X
with	B-X
specific	B-X
substrates	B-X
.	B-X
Last	B-X
,	B-X
the	B-X
discovery	B-X
of	B-X
novel	B-X
phorbol	B-X
ester	B-X
receptors	B-X
lacking	B-X
kinase	B-X
activity	B-X
allows	B-X
us	B-X
to	B-X
speculate	B-X
that	B-X
some	B-X
of	B-X
the	B-X
biological	B-X
responses	B-X
elicited	B-X
by	B-X
phorbol	B-X
esters	B-X
or	B-X
by	B-X
activation	B-X
of	B-X
receptors	B-X
coupled	B-X
to	B-X
elevation	B-X
in	B-X
DAG	B-X
levels	B-X
could	B-X
be	B-X
mediated	B-X
by	B-X
PKC-independent	B-X
pathways	B-X
.	B-X

Differential	O
roles	O
of	O
TLR2	B-Gene_or_gene_product
and	O
TLR4	B-Gene_or_gene_product
in	O
recognition	O
of	O
gram	O
-	O
negative	O
and	O
gram	O
-	O
positive	O
bacterial	O
cell	O
wall	O
components	O
.	O
<EOS>	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2	B-X
and	B-X
TLR4	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
recognition	B-X
of	B-X
various	B-X
bacterial	B-X
cell	B-X
wall	B-X
components	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
To	B-X
investigate	B-X
in	B-X
vivo	B-X
roles	B-X
of	B-X
TLR2	B-X
,	B-X
we	B-X
generated	B-X
TLR2-deficient	B-X
mice	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
LPS	B-X
unresponsiveness	B-X
in	B-X
TLR4-deficient	B-X
mice	B-X
,	B-X
TLR2-deficient	B-X
mice	B-X
responded	B-X
to	B-X
LPS	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
wild-type	B-X
mice	B-X
.	B-X
TLR2-deficient	B-X
macrophages	B-X
were	B-X
hyporesponsive	B-X
to	B-X
several	B-X
Gram-positive	B-X
bacterial	B-X
cell	B-X
walls	B-X
as	B-X
well	B-X
as	B-X
Staphylococcus	B-X
aureus	B-X
peptidoglycan	B-X
.	B-X
TLR4-deficient	B-X
macrophages	B-X
lacked	B-X
the	B-X
response	B-X
to	B-X
Gram-positive	B-X
lipoteichoic	B-X
acids	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
TLR2	B-X
and	B-X
TLR4	B-X
recognize	B-X
different	B-X
bacterial	B-X
cell	B-X
wall	B-X
components	B-X
in	B-X
vivo	B-X
and	B-X
TLR2	B-X
plays	B-X
a	B-X
major	B-X
role	B-X
in	B-X
Gram-positive	B-X
bacterial	B-X
recognition	B-X
.	B-X

Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
TLR	I-Gene_or_gene_product
)	I-Gene_or_gene_product
2	I-Gene_or_gene_product
and	O
TLR4	B-Gene_or_gene_product
are	O
implicated	O
in	O
the	O
recognition	O
of	O
various	O
bacterial	O
cell	O
wall	O
components	O
,	O
such	O
as	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O
<EOS>	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2	B-X
and	B-X
TLR4	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
recognition	B-X
of	B-X
various	B-X
bacterial	B-X
cell	B-X
wall	B-X
components	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
To	B-X
investigate	B-X
in	B-X
vivo	B-X
roles	B-X
of	B-X
TLR2	B-X
,	B-X
we	B-X
generated	B-X
TLR2-deficient	B-X
mice	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
LPS	B-X
unresponsiveness	B-X
in	B-X
TLR4-deficient	B-X
mice	B-X
,	B-X
TLR2-deficient	B-X
mice	B-X
responded	B-X
to	B-X
LPS	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
wild-type	B-X
mice	B-X
.	B-X
TLR2-deficient	B-X
macrophages	B-X
were	B-X
hyporesponsive	B-X
to	B-X
several	B-X
Gram-positive	B-X
bacterial	B-X
cell	B-X
walls	B-X
as	B-X
well	B-X
as	B-X
Staphylococcus	B-X
aureus	B-X
peptidoglycan	B-X
.	B-X
TLR4-deficient	B-X
macrophages	B-X
lacked	B-X
the	B-X
response	B-X
to	B-X
Gram-positive	B-X
lipoteichoic	B-X
acids	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
TLR2	B-X
and	B-X
TLR4	B-X
recognize	B-X
different	B-X
bacterial	B-X
cell	B-X
wall	B-X
components	B-X
in	B-X
vivo	B-X
and	B-X
TLR2	B-X
plays	B-X
a	B-X
major	B-X
role	B-X
in	B-X
Gram-positive	B-X
bacterial	B-X
recognition	B-X
.	B-X

To	O
investigate	O
in	O
vivo	O
roles	O
of	O
TLR2	B-Gene_or_gene_product
,	O
we	O
generated	O
TLR2	B-Gene_or_gene_product
-	O
deficient	O
mice	O
.	O
<EOS>	B-X
Emerging	B-X
evidences	B-X
have	B-X
indicated	B-X
that	B-X
leukocytic	B-X
toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
played	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
development	B-X
of	B-X
diabetic	B-X
cardiomyopathy	B-X
.	B-X
Our	B-X
study	B-X
aimed	B-X
to	B-X
investigate	B-X
whether	B-X
TLR2	B-X
knockout	B-X
(	B-X
KO	B-X
)	B-X
exerted	B-X
a	B-X
cardioprotective	B-X
effect	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
establishment	B-X
of	B-X
diabetes	B-X
model	B-X
was	B-X
set	B-X
up	B-X
in	B-X
mice	B-X
via	B-X
intraperitoneal	B-X
injection	B-X
of	B-X
streptozotocin	B-X
(	B-X
STZ	B-X
)	B-X
.	B-X
Results	B-X
demonstrated	B-X
that	B-X
blocking	B-X
of	B-X
TLR2	B-X
significantly	B-X
suppressed	B-X
the	B-X
enhanced	B-X
left	B-X
ventricular	B-X
end-diastolic	B-X
dimension	B-X
(	B-X
LVEDD	B-X
)	B-X
,	B-X
left	B-X
ventricular	B-X
end	B-X
systolic	B-X
diameter	B-X
(	B-X
LVESD	B-X
)	B-X
and	B-X
the	B-X
reduced	B-X
the	B-X
heart	B-X
rate	B-X
in	B-X
diabetic	B-X
cardiomyopathy	B-X
mice	B-X
.	B-X
The	B-X
decreased	B-X
resting	B-X
cell	B-X
length	B-X
,	B-X
PS	B-X
,	B-X
TPS	B-X
and	B-X
+	B-X
dL/dt	B-X
while	B-X
increased	B-X
TR90	B-X
and	B-X
-	B-X
dL/dt	B-X
caused	B-X
by	B-X
diabetic	B-X
cardiomyopathy	B-X
were	B-X
remarkably	B-X
inhibited	B-X
by	B-X
TLR2	B-X
KO	B-X
.	B-X

In	O
contrast	O
to	O
LPS	O
unresponsiveness	O
in	O
TLR4	B-Gene_or_gene_product
-	O
deficient	O
mice	O
,	O
TLR2	B-Gene_or_gene_product
-	O
deficient	O
mice	O
responded	O
to	O
LPS	O
to	O
the	O
same	O
extent	O
as	O
wild	O
-	O
type	O
mice	O
.	O

TLR2	B-Gene_or_gene_product
-	O
deficient	O
macrophages	O
were	O
hyporesponsive	O
to	O
several	O
Gram	O
-	O
positive	O
bacterial	O
cell	O
walls	O
as	O
well	O
as	O
Staphylococcus	O
aureus	O
peptidoglycan	O
.	O
<EOS>	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2	B-X
and	B-X
TLR4	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
recognition	B-X
of	B-X
various	B-X
bacterial	B-X
cell	B-X
wall	B-X
components	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
To	B-X
investigate	B-X
in	B-X
vivo	B-X
roles	B-X
of	B-X
TLR2	B-X
,	B-X
we	B-X
generated	B-X
TLR2-deficient	B-X
mice	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
LPS	B-X
unresponsiveness	B-X
in	B-X
TLR4-deficient	B-X
mice	B-X
,	B-X
TLR2-deficient	B-X
mice	B-X
responded	B-X
to	B-X
LPS	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
wild-type	B-X
mice	B-X
.	B-X
TLR2-deficient	B-X
macrophages	B-X
were	B-X
hyporesponsive	B-X
to	B-X
several	B-X
Gram-positive	B-X
bacterial	B-X
cell	B-X
walls	B-X
as	B-X
well	B-X
as	B-X
Staphylococcus	B-X
aureus	B-X
peptidoglycan	B-X
.	B-X
TLR4-deficient	B-X
macrophages	B-X
lacked	B-X
the	B-X
response	B-X
to	B-X
Gram-positive	B-X
lipoteichoic	B-X
acids	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
TLR2	B-X
and	B-X
TLR4	B-X
recognize	B-X
different	B-X
bacterial	B-X
cell	B-X
wall	B-X
components	B-X
in	B-X
vivo	B-X
and	B-X
TLR2	B-X
plays	B-X
a	B-X
major	B-X
role	B-X
in	B-X
Gram-positive	B-X
bacterial	B-X
recognition	B-X
.	B-X

TLR4	B-Gene_or_gene_product
-	O
deficient	O
macrophages	O
lacked	O
the	O
response	O
to	O
Gram	O
-	O
positive	O
lipoteichoic	O
acids	O
.	O
<EOS>	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2	B-X
and	B-X
TLR4	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
recognition	B-X
of	B-X
various	B-X
bacterial	B-X
cell	B-X
wall	B-X
components	B-X
,	B-X
such	B-X
as	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
To	B-X
investigate	B-X
in	B-X
vivo	B-X
roles	B-X
of	B-X
TLR2	B-X
,	B-X
we	B-X
generated	B-X
TLR2-deficient	B-X
mice	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
LPS	B-X
unresponsiveness	B-X
in	B-X
TLR4-deficient	B-X
mice	B-X
,	B-X
TLR2-deficient	B-X
mice	B-X
responded	B-X
to	B-X
LPS	B-X
to	B-X
the	B-X
same	B-X
extent	B-X
as	B-X
wild-type	B-X
mice	B-X
.	B-X
TLR2-deficient	B-X
macrophages	B-X
were	B-X
hyporesponsive	B-X
to	B-X
several	B-X
Gram-positive	B-X
bacterial	B-X
cell	B-X
walls	B-X
as	B-X
well	B-X
as	B-X
Staphylococcus	B-X
aureus	B-X
peptidoglycan	B-X
.	B-X
TLR4-deficient	B-X
macrophages	B-X
lacked	B-X
the	B-X
response	B-X
to	B-X
Gram-positive	B-X
lipoteichoic	B-X
acids	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
TLR2	B-X
and	B-X
TLR4	B-X
recognize	B-X
different	B-X
bacterial	B-X
cell	B-X
wall	B-X
components	B-X
in	B-X
vivo	B-X
and	B-X
TLR2	B-X
plays	B-X
a	B-X
major	B-X
role	B-X
in	B-X
Gram-positive	B-X
bacterial	B-X
recognition	B-X
.	B-X

These	O
results	O
demonstrate	O
that	O
TLR2	B-Gene_or_gene_product
and	O
TLR4	B-Gene_or_gene_product
recognize	O
different	O
bacterial	O
cell	O
wall	O
components	O
in	O
vivo	O
and	O
TLR2	B-Gene_or_gene_product
plays	O
a	O
major	O
role	O
in	O
Gram	O
-	O
positive	O
bacterial	O
recognition	O
.	O

Identification	O
of	O
a	O
central	O
phosphorylation	O
site	O
in	O
p21	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
regulating	O
autoinhibition	O
and	O
kinase	O
activity	O
.	O
<EOS>	B-X
p21-activated	B-X
kinases	B-X
(	B-X
Pak	B-X
)	B-X
/Ste20	B-X
kinases	B-X
are	B-X
regulated	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
by	B-X
the	B-X
small	B-X
GTP-binding	B-X
proteins	B-X
Rac	B-X
and	B-X
Cdc42	B-X
and	B-X
lipids	B-X
,	B-X
such	B-X
as	B-X
sphingosine	B-X
,	B-X
which	B-X
stimulate	B-X
autophosphorylation	B-X
and	B-X
phosphorylation	B-X
of	B-X
exogenous	B-X
substrates	B-X
.	B-X
We	B-X
investigated	B-X
Pak	B-X
kinase	B-X
activation	B-X
in	B-X
more	B-X
detail	B-X
to	B-X
gain	B-X
insight	B-X
into	B-X
the	B-X
interplay	B-X
between	B-X
the	B-X
GTPase/sphingosine	B-X
binding	B-X
,	B-X
an	B-X
intramolecular	B-X
inhibitory	B-X
interaction	B-X
,	B-X
and	B-X
autophosphorylation	B-X
.	B-X
We	B-X
present	B-X
biochemical	B-X
evidence	B-X
that	B-X
an	B-X
autoinhibitory	B-X
domain	B-X
(	B-X
ID	B-X
)	B-X
contained	B-X
within	B-X
amino	B-X
acid	B-X
residues	B-X
67-150	B-X
of	B-X
Pak1	B-X
interacts	B-X
with	B-X
the	B-X
carboxyl-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
GTPase-dependent	B-X
fashion	B-X
.	B-X
Cdc42-	B-X
and	B-X
sphingosine-stimulated	B-X
Pak1	B-X
activity	B-X
can	B-X
be	B-X
inhibited	B-X
in	B-X
trans	B-X
by	B-X
recombinant	B-X
ID	B-X
peptide	B-X
,	B-X
indicating	B-X
similarities	B-X
in	B-X
their	B-X
mode	B-X
of	B-X
activation	B-X
.	B-X
We	B-X
identified	B-X
phospho-acceptor	B-X
site	B-X
threonine	B-X
423	B-X
in	B-X
the	B-X
kinase	B-X
activation	B-X
loop	B-X
as	B-X
a	B-X
critical	B-X
determinant	B-X
for	B-X
the	B-X
sensitivity	B-X
to	B-X
autoinhibition	B-X
and	B-X
enzymatic	B-X
activity	B-X
.	B-X
Phosphorylation	B-X
studies	B-X
suggested	B-X
that	B-X
the	B-X
stimulatory	B-X
effect	B-X
of	B-X
both	B-X
GTPase	B-X
and	B-X
sphingosine	B-X
results	B-X
in	B-X
exposure	B-X
of	B-X
the	B-X
activation	B-X
loop	B-X
,	B-X
making	B-X
it	B-X
accessible	B-X
for	B-X
intermolecular	B-X
phosphorylation	B-X
.	B-X

p21	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
Pak	B-Gene_or_gene_product
)	O
/	O
Ste20	B-Gene_or_gene_product
kinases	O
are	O
regulated	O
in	O
vitro	O
and	O
in	O
vivo	O
by	O
the	O
small	O
GTP	O
-	O
binding	O
proteins	O
Rac	B-Gene_or_gene_product
and	O
Cdc42	B-Gene_or_gene_product
and	O
lipids	O
,	O
such	O
as	O
sphingosine	O
,	O
which	O
stimulate	O
autophosphorylation	O
and	O
phosphorylation	O
of	O
exogenous	O
substrates	O
.	O
<EOS>	B-X
p21-activated	B-X
kinases	B-X
(	B-X
Pak	B-X
)	B-X
/Ste20	B-X
kinases	B-X
are	B-X
regulated	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
by	B-X
the	B-X
small	B-X
GTP-binding	B-X
proteins	B-X
Rac	B-X
and	B-X
Cdc42	B-X
and	B-X
lipids	B-X
,	B-X
such	B-X
as	B-X
sphingosine	B-X
,	B-X
which	B-X
stimulate	B-X
autophosphorylation	B-X
and	B-X
phosphorylation	B-X
of	B-X
exogenous	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
of	B-X
Pak	B-X
activation	B-X
by	B-X
these	B-X
agents	B-X
remains	B-X
unclear	B-X
.	B-X
We	B-X
investigated	B-X
Pak	B-X
kinase	B-X
activation	B-X
in	B-X
more	B-X
detail	B-X
to	B-X
gain	B-X
insight	B-X
into	B-X
the	B-X
interplay	B-X
between	B-X
the	B-X
GTPase/sphingosine	B-X
binding	B-X
,	B-X
an	B-X
intramolecular	B-X
inhibitory	B-X
interaction	B-X
,	B-X
and	B-X
autophosphorylation	B-X
.	B-X
We	B-X
present	B-X
biochemical	B-X
evidence	B-X
that	B-X
an	B-X
autoinhibitory	B-X
domain	B-X
(	B-X
ID	B-X
)	B-X
contained	B-X
within	B-X
amino	B-X
acid	B-X
residues	B-X
67-150	B-X
of	B-X
Pak1	B-X
interacts	B-X
with	B-X
the	B-X
carboxyl-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
GTPase-dependent	B-X
fashion	B-X
.	B-X
Cdc42-	B-X
and	B-X
sphingosine-stimulated	B-X
Pak1	B-X
activity	B-X
can	B-X
be	B-X
inhibited	B-X
in	B-X
trans	B-X
by	B-X
recombinant	B-X
ID	B-X
peptide	B-X
,	B-X
indicating	B-X
similarities	B-X
in	B-X
their	B-X
mode	B-X
of	B-X
activation	B-X
.	B-X
However	B-X
,	B-X
Pak1	B-X
,	B-X
which	B-X
was	B-X
autophosphorylated	B-X
in	B-X
response	B-X
to	B-X
either	B-X
GTPase	B-X
or	B-X
sphingosine	B-X
,	B-X
is	B-X
highly	B-X
active	B-X
and	B-X
is	B-X
insensitive	B-X
to	B-X
inhibition	B-X
by	B-X
the	B-X
ID	B-X
peptide	B-X
.	B-X
Phosphorylation	B-X
studies	B-X
suggested	B-X
that	B-X
the	B-X
stimulatory	B-X
effect	B-X
of	B-X
both	B-X
GTPase	B-X
and	B-X
sphingosine	B-X
results	B-X
in	B-X
exposure	B-X
of	B-X
the	B-X
activation	B-X
loop	B-X
,	B-X
making	B-X
it	B-X
accessible	B-X
for	B-X
intermolecular	B-X
phosphorylation	B-X
.	B-X

The	O
mechanism	O
of	O
Pak	B-Gene_or_gene_product
activation	O
by	O
these	O
agents	O
remains	O
unclear	O
.	O
<EOS>	B-X
Purification	B-X
and	B-X
characterization	B-X
of	B-X
hypoglycemic	B-X
peptides	B-X
from	B-X
traditional	B-X
Chinese	B-X
soy-fermented	B-X
Bevirimat	B-X
(	B-X
BVM	B-X
)	B-X
,	B-X
the	B-X
first-in-class	B-X
maturation	B-X
inhibitor	B-X
drug	B-X
,	B-X
targets	B-X
the	B-X
6HB	B-X
and	B-X
impedes	B-X
proteolytic	B-X
cleavage	B-X
,	B-X
yet	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
its	B-X
activity	B-X
,	B-X
and	B-X
relatedly	B-X
,	B-X
the	B-X
escape	B-X
mechanisms	B-X
of	B-X
mutant	B-X
viruses	B-X
,	B-X
remain	B-X
unclear	B-X
.	B-X
We	B-X
identified	B-X
two	B-X
primary	B-X
escape	B-X
mechanisms	B-X
,	B-X
and	B-X
both	B-X
lead	B-X
to	B-X
loss	B-X
of	B-X
symmetry	B-X
,	B-X
thereby	B-X
facilitating	B-X
helix	B-X
uncoiling	B-X
to	B-X
aid	B-X
access	B-X
of	B-X
protease	B-X
.	B-X
Mutational	B-X
inactivation	B-X
of	B-X
NF2	B-X
is	B-X
found	B-X
in	B-X
40-60	B-X
%	B-X
of	B-X
sporadic	B-X
meningiomas	B-X
,	B-X
but	B-X
the	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
malignant	B-X
changes	B-X
of	B-X
meningioma	B-X
cells	B-X
remain	B-X
unclear	B-X
.	B-X
Because	B-X
group	B-X
I	B-X
p21-activated	B-X
kinases	B-X
(	B-X
Paks	B-X
)	B-X
bind	B-X
to	B-X
and	B-X
are	B-X
inhibited	B-X
by	B-X
the	B-X
NF2-encoded	B-X
protein	B-X
Merlin	B-X
,	B-X
we	B-X
assessed	B-X
the	B-X
signaling	B-X
and	B-X
anti-tumor	B-X
effects	B-X
of	B-X
three	B-X
group-I	B-X
specific	B-X
Pak	B-X
inhibitors	B-X
-	B-X
Frax597	B-X
,	B-X
716	B-X
and	B-X
1036	B-X
-	B-X
in	B-X
NF2-/-	B-X
meningiomas	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
an	B-X
orthotopic	B-X
mouse	B-X
model	B-X
.	B-X
We	B-X
found	B-X
that	B-X
these	B-X
Pak	B-X
inhibitors	B-X
suppressed	B-X
the	B-X
proliferation	B-X
and	B-X
motility	B-X
of	B-X
both	B-X
benign	B-X
(	B-X
Ben-Men1	B-X
)	B-X
and	B-X
malignant	B-X
(	B-X
KT21-MG1	B-X
)	B-X
meningiomas	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
found	B-X
a	B-X
strong	B-X
reduction	B-X
in	B-X
phosphorylation	B-X
of	B-X
Mek	B-X
and	B-X
S6	B-X
,	B-X
and	B-X
decreased	B-X
cyclin	B-X
D1	B-X
expression	B-X
in	B-X
both	B-X
cell	B-X
lines	B-X
after	B-X
treatment	B-X
with	B-X
Pak	B-X
inhibitors	B-X
.	B-X
Using	B-X
intracranial	B-X
xenografts	B-X
of	B-X
luciferase-expressing	B-X
KT21-MG1	B-X
cells	B-X
,	B-X
we	B-X
found	B-X
that	B-X
treated	B-X
mice	B-X
showed	B-X
significant	B-X
tumor	B-X
suppression	B-X
for	B-X
all	B-X
three	B-X
Pak	B-X
inhibitors	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
results	B-X
suggest	B-X
that	B-X
Pak	B-X
inhibitors	B-X
might	B-X
be	B-X
useful	B-X
agents	B-X
in	B-X
treating	B-X
NF2-deficient	B-X
meningiomas	B-X
.	B-X

We	O
investigated	O
Pak	B-Gene_or_gene_product
kinase	O
activation	O
in	O
more	O
detail	O
to	O
gain	O
insight	O
into	O
the	O
interplay	O
between	O
the	O
GTPase	O
/	O
sphingosine	O
binding	O
,	O
an	O
intramolecular	O
inhibitory	O
interaction	O
,	O
and	O
autophosphorylation	O
.	O
<EOS>	B-X
p21-activated	B-X
kinases	B-X
(	B-X
Pak	B-X
)	B-X
/Ste20	B-X
kinases	B-X
are	B-X
regulated	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
by	B-X
the	B-X
small	B-X
GTP-binding	B-X
proteins	B-X
Rac	B-X
and	B-X
Cdc42	B-X
and	B-X
lipids	B-X
,	B-X
such	B-X
as	B-X
sphingosine	B-X
,	B-X
which	B-X
stimulate	B-X
autophosphorylation	B-X
and	B-X
phosphorylation	B-X
of	B-X
exogenous	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
of	B-X
Pak	B-X
activation	B-X
by	B-X
these	B-X
agents	B-X
remains	B-X
unclear	B-X
.	B-X
We	B-X
investigated	B-X
Pak	B-X
kinase	B-X
activation	B-X
in	B-X
more	B-X
detail	B-X
to	B-X
gain	B-X
insight	B-X
into	B-X
the	B-X
interplay	B-X
between	B-X
the	B-X
GTPase/sphingosine	B-X
binding	B-X
,	B-X
an	B-X
intramolecular	B-X
inhibitory	B-X
interaction	B-X
,	B-X
and	B-X
autophosphorylation	B-X
.	B-X
We	B-X
present	B-X
biochemical	B-X
evidence	B-X
that	B-X
an	B-X
autoinhibitory	B-X
domain	B-X
(	B-X
ID	B-X
)	B-X
contained	B-X
within	B-X
amino	B-X
acid	B-X
residues	B-X
67-150	B-X
of	B-X
Pak1	B-X
interacts	B-X
with	B-X
the	B-X
carboxyl-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
GTPase-dependent	B-X
fashion	B-X
.	B-X
Cdc42-	B-X
and	B-X
sphingosine-stimulated	B-X
Pak1	B-X
activity	B-X
can	B-X
be	B-X
inhibited	B-X
in	B-X
trans	B-X
by	B-X
recombinant	B-X
ID	B-X
peptide	B-X
,	B-X
indicating	B-X
similarities	B-X
in	B-X
their	B-X
mode	B-X
of	B-X
activation	B-X
.	B-X
However	B-X
,	B-X
Pak1	B-X
,	B-X
which	B-X
was	B-X
autophosphorylated	B-X
in	B-X
response	B-X
to	B-X
either	B-X
GTPase	B-X
or	B-X
sphingosine	B-X
,	B-X
is	B-X
highly	B-X
active	B-X
and	B-X
is	B-X
insensitive	B-X
to	B-X
inhibition	B-X
by	B-X
the	B-X
ID	B-X
peptide	B-X
.	B-X
We	B-X
identified	B-X
phospho-acceptor	B-X
site	B-X
threonine	B-X
423	B-X
in	B-X
the	B-X
kinase	B-X
activation	B-X
loop	B-X
as	B-X
a	B-X
critical	B-X
determinant	B-X
for	B-X
the	B-X
sensitivity	B-X
to	B-X
autoinhibition	B-X
and	B-X
enzymatic	B-X
activity	B-X
.	B-X
Phosphorylation	B-X
studies	B-X
suggested	B-X
that	B-X
the	B-X
stimulatory	B-X
effect	B-X
of	B-X
both	B-X
GTPase	B-X
and	B-X
sphingosine	B-X
results	B-X
in	B-X
exposure	B-X
of	B-X
the	B-X
activation	B-X
loop	B-X
,	B-X
making	B-X
it	B-X
accessible	B-X
for	B-X
intermolecular	B-X
phosphorylation	B-X
.	B-X

We	O
present	O
biochemical	O
evidence	O
that	O
an	O
autoinhibitory	O
domain	O
(	O
ID	O
)	O
contained	O
within	O
amino	O
acid	O
residues	O
67	O
-	O
150	O
of	O
Pak1	B-Gene_or_gene_product
interacts	O
with	O
the	O
carboxyl	O
-	O
terminal	O
kinase	O
domain	O
and	O
that	O
this	O
interaction	O
is	O
regulated	O
in	O
a	O
GTPase	O
-	O
dependent	O
fashion	O
.	O

Cdc42	B-Gene_or_gene_product
-	O
and	O
sphingosine	O
-	O
stimulated	O
Pak1	B-Gene_or_gene_product
activity	O
can	O
be	O
inhibited	O
in	O
trans	O
by	O
recombinant	O
ID	O
peptide	O
,	O
indicating	O
similarities	O
in	O
their	O
mode	O
of	O
activation	O
.	O
<EOS>	B-X
p21-activated	B-X
kinases	B-X
(	B-X
Pak	B-X
)	B-X
/Ste20	B-X
kinases	B-X
are	B-X
regulated	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
by	B-X
the	B-X
small	B-X
GTP-binding	B-X
proteins	B-X
Rac	B-X
and	B-X
Cdc42	B-X
and	B-X
lipids	B-X
,	B-X
such	B-X
as	B-X
sphingosine	B-X
,	B-X
which	B-X
stimulate	B-X
autophosphorylation	B-X
and	B-X
phosphorylation	B-X
of	B-X
exogenous	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
of	B-X
Pak	B-X
activation	B-X
by	B-X
these	B-X
agents	B-X
remains	B-X
unclear	B-X
.	B-X
We	B-X
investigated	B-X
Pak	B-X
kinase	B-X
activation	B-X
in	B-X
more	B-X
detail	B-X
to	B-X
gain	B-X
insight	B-X
into	B-X
the	B-X
interplay	B-X
between	B-X
the	B-X
GTPase/sphingosine	B-X
binding	B-X
,	B-X
an	B-X
intramolecular	B-X
inhibitory	B-X
interaction	B-X
,	B-X
and	B-X
autophosphorylation	B-X
.	B-X
We	B-X
present	B-X
biochemical	B-X
evidence	B-X
that	B-X
an	B-X
autoinhibitory	B-X
domain	B-X
(	B-X
ID	B-X
)	B-X
contained	B-X
within	B-X
amino	B-X
acid	B-X
residues	B-X
67-150	B-X
of	B-X
Pak1	B-X
interacts	B-X
with	B-X
the	B-X
carboxyl-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
GTPase-dependent	B-X
fashion	B-X
.	B-X
Cdc42-	B-X
and	B-X
sphingosine-stimulated	B-X
Pak1	B-X
activity	B-X
can	B-X
be	B-X
inhibited	B-X
in	B-X
trans	B-X
by	B-X
recombinant	B-X
ID	B-X
peptide	B-X
,	B-X
indicating	B-X
similarities	B-X
in	B-X
their	B-X
mode	B-X
of	B-X
activation	B-X
.	B-X
However	B-X
,	B-X
Pak1	B-X
,	B-X
which	B-X
was	B-X
autophosphorylated	B-X
in	B-X
response	B-X
to	B-X
either	B-X
GTPase	B-X
or	B-X
sphingosine	B-X
,	B-X
is	B-X
highly	B-X
active	B-X
and	B-X
is	B-X
insensitive	B-X
to	B-X
inhibition	B-X
by	B-X
the	B-X
ID	B-X
peptide	B-X
.	B-X
We	B-X
identified	B-X
phospho-acceptor	B-X
site	B-X
threonine	B-X
423	B-X
in	B-X
the	B-X
kinase	B-X
activation	B-X
loop	B-X
as	B-X
a	B-X
critical	B-X
determinant	B-X
for	B-X
the	B-X
sensitivity	B-X
to	B-X
autoinhibition	B-X
and	B-X
enzymatic	B-X
activity	B-X
.	B-X
Phosphorylation	B-X
studies	B-X
suggested	B-X
that	B-X
the	B-X
stimulatory	B-X
effect	B-X
of	B-X
both	B-X
GTPase	B-X
and	B-X
sphingosine	B-X
results	B-X
in	B-X
exposure	B-X
of	B-X
the	B-X
activation	B-X
loop	B-X
,	B-X
making	B-X
it	B-X
accessible	B-X
for	B-X
intermolecular	B-X
phosphorylation	B-X
.	B-X

However	O
,	O
Pak1	B-Gene_or_gene_product
,	O
which	O
was	O
autophosphorylated	O
in	O
response	O
to	O
either	O
GTPase	O
or	O
sphingosine	O
,	O
is	O
highly	O
active	O
and	O
is	O
insensitive	O
to	O
inhibition	O
by	O
the	O
ID	O
peptide	O
.	O
<EOS>	B-X
To	B-X
expand	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
via	B-X
which	B-X
NCAM	B-X
influences	B-X
differentiation	B-X
of	B-X
neurons	B-X
,	B-X
we	B-X
used	B-X
a	B-X
yeast	B-X
two-hybrid	B-X
screening	B-X
to	B-X
search	B-X
for	B-X
new	B-X
binding	B-X
partners	B-X
of	B-X
NCAM	B-X
and	B-X
identified	B-X
p21-activated	B-X
kinase	B-X
1	B-X
(	B-X
Pak1	B-X
)	B-X
.	B-X
We	B-X
show	B-X
that	B-X
NCAM	B-X
interacts	B-X
with	B-X
Pak1	B-X
in	B-X
growth	B-X
cones	B-X
of	B-X
neurons	B-X
.	B-X
The	B-X
autophosphorylation	B-X
and	B-X
activity	B-X
of	B-X
Pak1	B-X
were	B-X
enhanced	B-X
when	B-X
isolated	B-X
growth	B-X
cones	B-X
were	B-X
incubated	B-X
with	B-X
NCAM	B-X
function	B-X
triggering	B-X
antibodies	B-X
,	B-X
which	B-X
mimic	B-X
the	B-X
interaction	B-X
between	B-X
NCAM	B-X
and	B-X
its	B-X
extracellular	B-X
ligands	B-X
.	B-X
The	B-X
association	B-X
of	B-X
Pak1	B-X
with	B-X
cell	B-X
membranes	B-X
,	B-X
the	B-X
efficiency	B-X
of	B-X
Pak1	B-X
binding	B-X
to	B-X
its	B-X
activators	B-X
,	B-X
and	B-X
Pak1	B-X
activity	B-X
were	B-X
inhibited	B-X
in	B-X
brains	B-X
of	B-X
NCAM-deficient	B-X
mice	B-X
.	B-X
NCAM-dependent	B-X
Pak1	B-X
activation	B-X
was	B-X
abolished	B-X
after	B-X
lipid	B-X
raft	B-X
disruption	B-X
,	B-X
suggesting	B-X
that	B-X
NCAM	B-X
promotes	B-X
Pak1	B-X
activation	B-X
in	B-X
the	B-X
lipid	B-X
raft	B-X
environment	B-X
.	B-X
Phosphorylation	B-X
of	B-X
the	B-X
downstream	B-X
Pak1	B-X
effectors	B-X
LIMK1	B-X
and	B-X
cofilin	B-X
was	B-X
reduced	B-X
in	B-X
growth	B-X
cones	B-X
from	B-X
NCAM-deficient	B-X
neurons	B-X
,	B-X
which	B-X
was	B-X
accompanied	B-X
by	B-X
decreased	B-X
levels	B-X
of	B-X
filamentous	B-X
actin	B-X
and	B-X
inhibited	B-X
filopodium	B-X
mobility	B-X
in	B-X
the	B-X
growth	B-X
cones	B-X
.	B-X
Dominant-negative	B-X
Pak1	B-X
inhibited	B-X
and	B-X
constitutively	B-X
active	B-X
Pak1	B-X
enhanced	B-X
the	B-X
ability	B-X
of	B-X
neurons	B-X
to	B-X
increase	B-X
neurite	B-X
outgrowth	B-X
in	B-X
response	B-X
to	B-X
the	B-X
extracellular	B-X
ligands	B-X
of	B-X
NCAM	B-X
.	B-X
Our	B-X
combined	B-X
observations	B-X
thus	B-X
indicate	B-X
that	B-X
NCAM	B-X
activates	B-X
Pak1	B-X
to	B-X
drive	B-X
actin	B-X
polymerization	B-X
to	B-X
promote	B-X
neuronal	B-X
differentiation	B-X
.	B-X

We	O
identified	O
phospho	O
-	O
acceptor	O
site	O
threonine	O
423	O
in	O
the	O
kinase	O
activation	O
loop	O
as	O
a	O
critical	O
determinant	O
for	O
the	O
sensitivity	O
to	O
autoinhibition	O
and	O
enzymatic	O
activity	O
.	O
<EOS>	B-X
p21-activated	B-X
kinases	B-X
(	B-X
Pak	B-X
)	B-X
/Ste20	B-X
kinases	B-X
are	B-X
regulated	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
by	B-X
the	B-X
small	B-X
GTP-binding	B-X
proteins	B-X
Rac	B-X
and	B-X
Cdc42	B-X
and	B-X
lipids	B-X
,	B-X
such	B-X
as	B-X
sphingosine	B-X
,	B-X
which	B-X
stimulate	B-X
autophosphorylation	B-X
and	B-X
phosphorylation	B-X
of	B-X
exogenous	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
of	B-X
Pak	B-X
activation	B-X
by	B-X
these	B-X
agents	B-X
remains	B-X
unclear	B-X
.	B-X
We	B-X
investigated	B-X
Pak	B-X
kinase	B-X
activation	B-X
in	B-X
more	B-X
detail	B-X
to	B-X
gain	B-X
insight	B-X
into	B-X
the	B-X
interplay	B-X
between	B-X
the	B-X
GTPase/sphingosine	B-X
binding	B-X
,	B-X
an	B-X
intramolecular	B-X
inhibitory	B-X
interaction	B-X
,	B-X
and	B-X
autophosphorylation	B-X
.	B-X
We	B-X
present	B-X
biochemical	B-X
evidence	B-X
that	B-X
an	B-X
autoinhibitory	B-X
domain	B-X
(	B-X
ID	B-X
)	B-X
contained	B-X
within	B-X
amino	B-X
acid	B-X
residues	B-X
67-150	B-X
of	B-X
Pak1	B-X
interacts	B-X
with	B-X
the	B-X
carboxyl-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
GTPase-dependent	B-X
fashion	B-X
.	B-X
Cdc42-	B-X
and	B-X
sphingosine-stimulated	B-X
Pak1	B-X
activity	B-X
can	B-X
be	B-X
inhibited	B-X
in	B-X
trans	B-X
by	B-X
recombinant	B-X
ID	B-X
peptide	B-X
,	B-X
indicating	B-X
similarities	B-X
in	B-X
their	B-X
mode	B-X
of	B-X
activation	B-X
.	B-X
However	B-X
,	B-X
Pak1	B-X
,	B-X
which	B-X
was	B-X
autophosphorylated	B-X
in	B-X
response	B-X
to	B-X
either	B-X
GTPase	B-X
or	B-X
sphingosine	B-X
,	B-X
is	B-X
highly	B-X
active	B-X
and	B-X
is	B-X
insensitive	B-X
to	B-X
inhibition	B-X
by	B-X
the	B-X
ID	B-X
peptide	B-X
.	B-X
We	B-X
identified	B-X
phospho-acceptor	B-X
site	B-X
threonine	B-X
423	B-X
in	B-X
the	B-X
kinase	B-X
activation	B-X
loop	B-X
as	B-X
a	B-X
critical	B-X
determinant	B-X
for	B-X
the	B-X
sensitivity	B-X
to	B-X
autoinhibition	B-X
and	B-X
enzymatic	B-X
activity	B-X
.	B-X
Phosphorylation	B-X
studies	B-X
suggested	B-X
that	B-X
the	B-X
stimulatory	B-X
effect	B-X
of	B-X
both	B-X
GTPase	B-X
and	B-X
sphingosine	B-X
results	B-X
in	B-X
exposure	B-X
of	B-X
the	B-X
activation	B-X
loop	B-X
,	B-X
making	B-X
it	B-X
accessible	B-X
for	B-X
intermolecular	B-X
phosphorylation	B-X
.	B-X

Phosphorylation	O
studies	O
suggested	O
that	O
the	O
stimulatory	O
effect	O
of	O
both	O
GTPase	O
and	O
sphingosine	O
results	O
in	O
exposure	O
of	O
the	O
activation	O
loop	O
,	O
making	O
it	O
accessible	O
for	O
intermolecular	O
phosphorylation	O
.	O
<EOS>	B-X
p21-activated	B-X
kinases	B-X
(	B-X
Pak	B-X
)	B-X
/Ste20	B-X
kinases	B-X
are	B-X
regulated	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
by	B-X
the	B-X
small	B-X
GTP-binding	B-X
proteins	B-X
Rac	B-X
and	B-X
Cdc42	B-X
and	B-X
lipids	B-X
,	B-X
such	B-X
as	B-X
sphingosine	B-X
,	B-X
which	B-X
stimulate	B-X
autophosphorylation	B-X
and	B-X
phosphorylation	B-X
of	B-X
exogenous	B-X
substrates	B-X
.	B-X
The	B-X
mechanism	B-X
of	B-X
Pak	B-X
activation	B-X
by	B-X
these	B-X
agents	B-X
remains	B-X
unclear	B-X
.	B-X
We	B-X
investigated	B-X
Pak	B-X
kinase	B-X
activation	B-X
in	B-X
more	B-X
detail	B-X
to	B-X
gain	B-X
insight	B-X
into	B-X
the	B-X
interplay	B-X
between	B-X
the	B-X
GTPase/sphingosine	B-X
binding	B-X
,	B-X
an	B-X
intramolecular	B-X
inhibitory	B-X
interaction	B-X
,	B-X
and	B-X
autophosphorylation	B-X
.	B-X
We	B-X
present	B-X
biochemical	B-X
evidence	B-X
that	B-X
an	B-X
autoinhibitory	B-X
domain	B-X
(	B-X
ID	B-X
)	B-X
contained	B-X
within	B-X
amino	B-X
acid	B-X
residues	B-X
67-150	B-X
of	B-X
Pak1	B-X
interacts	B-X
with	B-X
the	B-X
carboxyl-terminal	B-X
kinase	B-X
domain	B-X
and	B-X
that	B-X
this	B-X
interaction	B-X
is	B-X
regulated	B-X
in	B-X
a	B-X
GTPase-dependent	B-X
fashion	B-X
.	B-X
Cdc42-	B-X
and	B-X
sphingosine-stimulated	B-X
Pak1	B-X
activity	B-X
can	B-X
be	B-X
inhibited	B-X
in	B-X
trans	B-X
by	B-X
recombinant	B-X
ID	B-X
peptide	B-X
,	B-X
indicating	B-X
similarities	B-X
in	B-X
their	B-X
mode	B-X
of	B-X
activation	B-X
.	B-X
However	B-X
,	B-X
Pak1	B-X
,	B-X
which	B-X
was	B-X
autophosphorylated	B-X
in	B-X
response	B-X
to	B-X
either	B-X
GTPase	B-X
or	B-X
sphingosine	B-X
,	B-X
is	B-X
highly	B-X
active	B-X
and	B-X
is	B-X
insensitive	B-X
to	B-X
inhibition	B-X
by	B-X
the	B-X
ID	B-X
peptide	B-X
.	B-X
We	B-X
identified	B-X
phospho-acceptor	B-X
site	B-X
threonine	B-X
423	B-X
in	B-X
the	B-X
kinase	B-X
activation	B-X
loop	B-X
as	B-X
a	B-X
critical	B-X
determinant	B-X
for	B-X
the	B-X
sensitivity	B-X
to	B-X
autoinhibition	B-X
and	B-X
enzymatic	B-X
activity	B-X
.	B-X
Phosphorylation	B-X
studies	B-X
suggested	B-X
that	B-X
the	B-X
stimulatory	B-X
effect	B-X
of	B-X
both	B-X
GTPase	B-X
and	B-X
sphingosine	B-X
results	B-X
in	B-X
exposure	B-X
of	B-X
the	B-X
activation	B-X
loop	B-X
,	B-X
making	B-X
it	B-X
accessible	B-X
for	B-X
intermolecular	B-X
phosphorylation	B-X
.	B-X

Loss	O
of	O
imprinting	O
and	O
elevated	O
expression	O
of	O
wild	O
-	O
type	O
p73	B-Gene_or_gene_product
in	O
human	O
gastric	O
adenocarcinoma	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
gene	B-X
located	B-X
at	B-X
1p36.3	B-X
encodes	B-X
for	B-X
a	B-X
protein	B-X
with	B-X
significant	B-X
similarity	B-X
to	B-X
p53	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
penetrance	B-X
of	B-X
p73	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
expression	B-X
,	B-X
allelotype	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
p73	B-X
in	B-X
five	B-X
cell	B-X
lines	B-X
and	B-X
75	B-X
tissues	B-X
.	B-X
Although	B-X
extremely	B-X
low	B-X
levels	B-X
of	B-X
p73	B-X
expression	B-X
were	B-X
observed	B-X
in	B-X
all	B-X
noncancerous	B-X
gastric	B-X
tissues	B-X
and	B-X
four	B-X
of	B-X
five	B-X
cell	B-X
lines	B-X
,	B-X
a	B-X
significant	B-X
elevation	B-X
of	B-X
p73	B-X
was	B-X
detected	B-X
in	B-X
37	B-X
of	B-X
39	B-X
(	B-X
94.9	B-X
%	B-X
)	B-X
carcinoma	B-X
tissues	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
tumor-specific	B-X
increase	B-X
of	B-X
p73	B-X
was	B-X
identified	B-X
in	B-X
14	B-X
of	B-X
16	B-X
(	B-X
87.5	B-X
%	B-X
)	B-X
matched	B-X
sets	B-X
.	B-X
Allelotyping	B-X
analysis	B-X
using	B-X
a	B-X
StyI	B-X
or	B-X
BanI	B-X
polymorphism	B-X
revealed	B-X
that	B-X
5	B-X
of	B-X
21	B-X
(	B-X
23.8	B-X
%	B-X
)	B-X
informative	B-X
carcinomas	B-X
,	B-X
but	B-X
none	B-X
of	B-X
19	B-X
noncancerous	B-X
cases	B-X
,	B-X
express	B-X
p73	B-X
biallelically	B-X
,	B-X
suggesting	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
a	B-X
silent	B-X
allele	B-X
in	B-X
a	B-X
subset	B-X
of	B-X
cancers	B-X
.	B-X
Whereas	B-X
the	B-X
transcription	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
was	B-X
markedly	B-X
induced	B-X
by	B-X
serum	B-X
starvation	B-X
or	B-X
clump	B-X
formation	B-X
of	B-X
the	B-X
cells	B-X
,	B-X
treatment	B-X
with	B-X
5-aza-2'deoxycytidine	B-X
activated	B-X
a	B-X
silent	B-X
allele	B-X
with	B-X
a	B-X
subsequent	B-X
up-regulation	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
,	B-X
supporting	B-X
the	B-X
genomic	B-X
imprinting	B-X
and	B-X
autoregulation	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
Allelic	B-X
deletion	B-X
or	B-X
mutation	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
not	B-X
found	B-X
,	B-X
and	B-X
no	B-X
association	B-X
of	B-X
p73	B-X
expression	B-X
with	B-X
the	B-X
mutational	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
expression	B-X
of	B-X
p21Waf1	B-X
was	B-X
recognized	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
argues	B-X
that	B-X
p73	B-X
is	B-X
not	B-X
a	B-X
target	B-X
of	B-X
genetic	B-X
alteration	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
and	B-X
suggests	B-X
that	B-X
overexpression	B-X
of	B-X
p73	B-X
might	B-X
be	B-X
triggered	B-X
by	B-X
physiological	B-X
stresses	B-X
accompanied	B-X
with	B-X
outgrowth	B-X
of	B-X
tumors	B-X
,	B-X
such	B-X
as	B-X
hypoxia	B-X
or	B-X
nutrient	B-X
deprivation	B-X
.	B-X

The	O
p73	B-Gene_or_gene_product
gene	O
located	O
at	O
1p36	O
.	O
3	O
encodes	O
for	O
a	O
protein	O
with	O
significant	O
similarity	O
to	O
p53	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
p73	B-X
gene	B-X
located	B-X
at	B-X
1p36.3	B-X
encodes	B-X
for	B-X
a	B-X
protein	B-X
with	B-X
significant	B-X
similarity	B-X
to	B-X
p53	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
penetrance	B-X
of	B-X
p73	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
expression	B-X
,	B-X
allelotype	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
p73	B-X
in	B-X
five	B-X
cell	B-X
lines	B-X
and	B-X
75	B-X
tissues	B-X
.	B-X
Although	B-X
extremely	B-X
low	B-X
levels	B-X
of	B-X
p73	B-X
expression	B-X
were	B-X
observed	B-X
in	B-X
all	B-X
noncancerous	B-X
gastric	B-X
tissues	B-X
and	B-X
four	B-X
of	B-X
five	B-X
cell	B-X
lines	B-X
,	B-X
a	B-X
significant	B-X
elevation	B-X
of	B-X
p73	B-X
was	B-X
detected	B-X
in	B-X
37	B-X
of	B-X
39	B-X
(	B-X
94.9	B-X
%	B-X
)	B-X
carcinoma	B-X
tissues	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
tumor-specific	B-X
increase	B-X
of	B-X
p73	B-X
was	B-X
identified	B-X
in	B-X
14	B-X
of	B-X
16	B-X
(	B-X
87.5	B-X
%	B-X
)	B-X
matched	B-X
sets	B-X
.	B-X
Allelotyping	B-X
analysis	B-X
using	B-X
a	B-X
StyI	B-X
or	B-X
BanI	B-X
polymorphism	B-X
revealed	B-X
that	B-X
5	B-X
of	B-X
21	B-X
(	B-X
23.8	B-X
%	B-X
)	B-X
informative	B-X
carcinomas	B-X
,	B-X
but	B-X
none	B-X
of	B-X
19	B-X
noncancerous	B-X
cases	B-X
,	B-X
express	B-X
p73	B-X
biallelically	B-X
,	B-X
suggesting	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
a	B-X
silent	B-X
allele	B-X
in	B-X
a	B-X
subset	B-X
of	B-X
cancers	B-X
.	B-X
Whereas	B-X
the	B-X
transcription	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
was	B-X
markedly	B-X
induced	B-X
by	B-X
serum	B-X
starvation	B-X
or	B-X
clump	B-X
formation	B-X
of	B-X
the	B-X
cells	B-X
,	B-X
treatment	B-X
with	B-X
5-aza-2'deoxycytidine	B-X
activated	B-X
a	B-X
silent	B-X
allele	B-X
with	B-X
a	B-X
subsequent	B-X
up-regulation	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
,	B-X
supporting	B-X
the	B-X
genomic	B-X
imprinting	B-X
and	B-X
autoregulation	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
Allelic	B-X
deletion	B-X
or	B-X
mutation	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
not	B-X
found	B-X
,	B-X
and	B-X
no	B-X
association	B-X
of	B-X
p73	B-X
expression	B-X
with	B-X
the	B-X
mutational	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
expression	B-X
of	B-X
p21Waf1	B-X
was	B-X
recognized	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
argues	B-X
that	B-X
p73	B-X
is	B-X
not	B-X
a	B-X
target	B-X
of	B-X
genetic	B-X
alteration	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
and	B-X
suggests	B-X
that	B-X
overexpression	B-X
of	B-X
p73	B-X
might	B-X
be	B-X
triggered	B-X
by	B-X
physiological	B-X
stresses	B-X
accompanied	B-X
with	B-X
outgrowth	B-X
of	B-X
tumors	B-X
,	B-X
such	B-X
as	B-X
hypoxia	B-X
or	B-X
nutrient	B-X
deprivation	B-X
.	B-X

To	O
investigate	O
the	O
penetrance	O
of	O
p73	B-Gene_or_gene_product
in	O
gastric	O
carcinogenesis	O
,	O
we	O
analyzed	O
the	O
expression	O
,	O
allelotype	O
,	O
and	O
mutation	O
of	O
p73	B-Gene_or_gene_product
in	O
five	O
cell	O
lines	O
and	O
75	O
tissues	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
gene	B-X
located	B-X
at	B-X
1p36.3	B-X
encodes	B-X
for	B-X
a	B-X
protein	B-X
with	B-X
significant	B-X
similarity	B-X
to	B-X
p53	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
penetrance	B-X
of	B-X
p73	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
expression	B-X
,	B-X
allelotype	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
p73	B-X
in	B-X
five	B-X
cell	B-X
lines	B-X
and	B-X
75	B-X
tissues	B-X
.	B-X
Although	B-X
extremely	B-X
low	B-X
levels	B-X
of	B-X
p73	B-X
expression	B-X
were	B-X
observed	B-X
in	B-X
all	B-X
noncancerous	B-X
gastric	B-X
tissues	B-X
and	B-X
four	B-X
of	B-X
five	B-X
cell	B-X
lines	B-X
,	B-X
a	B-X
significant	B-X
elevation	B-X
of	B-X
p73	B-X
was	B-X
detected	B-X
in	B-X
37	B-X
of	B-X
39	B-X
(	B-X
94.9	B-X
%	B-X
)	B-X
carcinoma	B-X
tissues	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
tumor-specific	B-X
increase	B-X
of	B-X
p73	B-X
was	B-X
identified	B-X
in	B-X
14	B-X
of	B-X
16	B-X
(	B-X
87.5	B-X
%	B-X
)	B-X
matched	B-X
sets	B-X
.	B-X
Allelotyping	B-X
analysis	B-X
using	B-X
a	B-X
StyI	B-X
or	B-X
BanI	B-X
polymorphism	B-X
revealed	B-X
that	B-X
5	B-X
of	B-X
21	B-X
(	B-X
23.8	B-X
%	B-X
)	B-X
informative	B-X
carcinomas	B-X
,	B-X
but	B-X
none	B-X
of	B-X
19	B-X
noncancerous	B-X
cases	B-X
,	B-X
express	B-X
p73	B-X
biallelically	B-X
,	B-X
suggesting	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
a	B-X
silent	B-X
allele	B-X
in	B-X
a	B-X
subset	B-X
of	B-X
cancers	B-X
.	B-X
Whereas	B-X
the	B-X
transcription	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
was	B-X
markedly	B-X
induced	B-X
by	B-X
serum	B-X
starvation	B-X
or	B-X
clump	B-X
formation	B-X
of	B-X
the	B-X
cells	B-X
,	B-X
treatment	B-X
with	B-X
5-aza-2'deoxycytidine	B-X
activated	B-X
a	B-X
silent	B-X
allele	B-X
with	B-X
a	B-X
subsequent	B-X
up-regulation	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
,	B-X
supporting	B-X
the	B-X
genomic	B-X
imprinting	B-X
and	B-X
autoregulation	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
Allelic	B-X
deletion	B-X
or	B-X
mutation	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
not	B-X
found	B-X
,	B-X
and	B-X
no	B-X
association	B-X
of	B-X
p73	B-X
expression	B-X
with	B-X
the	B-X
mutational	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
expression	B-X
of	B-X
p21Waf1	B-X
was	B-X
recognized	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
argues	B-X
that	B-X
p73	B-X
is	B-X
not	B-X
a	B-X
target	B-X
of	B-X
genetic	B-X
alteration	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
and	B-X
suggests	B-X
that	B-X
overexpression	B-X
of	B-X
p73	B-X
might	B-X
be	B-X
triggered	B-X
by	B-X
physiological	B-X
stresses	B-X
accompanied	B-X
with	B-X
outgrowth	B-X
of	B-X
tumors	B-X
,	B-X
such	B-X
as	B-X
hypoxia	B-X
or	B-X
nutrient	B-X
deprivation	B-X
.	B-X

Although	O
extremely	O
low	O
levels	O
of	O
p73	B-Gene_or_gene_product
expression	O
were	O
observed	O
in	O
all	O
noncancerous	O
gastric	O
tissues	O
and	O
four	O
of	O
five	O
cell	O
lines	O
,	O
a	O
significant	O
elevation	O
of	O
p73	B-Gene_or_gene_product
was	O
detected	O
in	O
37	O
of	O
39	O
(	O
94	O
.	O
9	O
%	O
)	O
carcinoma	O
tissues	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
gene	B-X
located	B-X
at	B-X
1p36.3	B-X
encodes	B-X
for	B-X
a	B-X
protein	B-X
with	B-X
significant	B-X
similarity	B-X
to	B-X
p53	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
penetrance	B-X
of	B-X
p73	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
expression	B-X
,	B-X
allelotype	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
p73	B-X
in	B-X
five	B-X
cell	B-X
lines	B-X
and	B-X
75	B-X
tissues	B-X
.	B-X
Although	B-X
extremely	B-X
low	B-X
levels	B-X
of	B-X
p73	B-X
expression	B-X
were	B-X
observed	B-X
in	B-X
all	B-X
noncancerous	B-X
gastric	B-X
tissues	B-X
and	B-X
four	B-X
of	B-X
five	B-X
cell	B-X
lines	B-X
,	B-X
a	B-X
significant	B-X
elevation	B-X
of	B-X
p73	B-X
was	B-X
detected	B-X
in	B-X
37	B-X
of	B-X
39	B-X
(	B-X
94.9	B-X
%	B-X
)	B-X
carcinoma	B-X
tissues	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
tumor-specific	B-X
increase	B-X
of	B-X
p73	B-X
was	B-X
identified	B-X
in	B-X
14	B-X
of	B-X
16	B-X
(	B-X
87.5	B-X
%	B-X
)	B-X
matched	B-X
sets	B-X
.	B-X
Allelotyping	B-X
analysis	B-X
using	B-X
a	B-X
StyI	B-X
or	B-X
BanI	B-X
polymorphism	B-X
revealed	B-X
that	B-X
5	B-X
of	B-X
21	B-X
(	B-X
23.8	B-X
%	B-X
)	B-X
informative	B-X
carcinomas	B-X
,	B-X
but	B-X
none	B-X
of	B-X
19	B-X
noncancerous	B-X
cases	B-X
,	B-X
express	B-X
p73	B-X
biallelically	B-X
,	B-X
suggesting	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
a	B-X
silent	B-X
allele	B-X
in	B-X
a	B-X
subset	B-X
of	B-X
cancers	B-X
.	B-X
Whereas	B-X
the	B-X
transcription	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
was	B-X
markedly	B-X
induced	B-X
by	B-X
serum	B-X
starvation	B-X
or	B-X
clump	B-X
formation	B-X
of	B-X
the	B-X
cells	B-X
,	B-X
treatment	B-X
with	B-X
5-aza-2'deoxycytidine	B-X
activated	B-X
a	B-X
silent	B-X
allele	B-X
with	B-X
a	B-X
subsequent	B-X
up-regulation	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
,	B-X
supporting	B-X
the	B-X
genomic	B-X
imprinting	B-X
and	B-X
autoregulation	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
Allelic	B-X
deletion	B-X
or	B-X
mutation	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
not	B-X
found	B-X
,	B-X
and	B-X
no	B-X
association	B-X
of	B-X
p73	B-X
expression	B-X
with	B-X
the	B-X
mutational	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
expression	B-X
of	B-X
p21Waf1	B-X
was	B-X
recognized	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
argues	B-X
that	B-X
p73	B-X
is	B-X
not	B-X
a	B-X
target	B-X
of	B-X
genetic	B-X
alteration	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
and	B-X
suggests	B-X
that	B-X
overexpression	B-X
of	B-X
p73	B-X
might	B-X
be	B-X
triggered	B-X
by	B-X
physiological	B-X
stresses	B-X
accompanied	B-X
with	B-X
outgrowth	B-X
of	B-X
tumors	B-X
,	B-X
such	B-X
as	B-X
hypoxia	B-X
or	B-X
nutrient	B-X
deprivation	B-X
.	B-X

Furthermore	O
,	O
a	O
tumor	O
-	O
specific	O
increase	O
of	O
p73	B-Gene_or_gene_product
was	O
identified	O
in	O
14	O
of	O
16	O
(	O
87	O
.	O
5	O
%	O
)	O
matched	O
sets	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
gene	B-X
located	B-X
at	B-X
1p36.3	B-X
encodes	B-X
for	B-X
a	B-X
protein	B-X
with	B-X
significant	B-X
similarity	B-X
to	B-X
p53	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
penetrance	B-X
of	B-X
p73	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
expression	B-X
,	B-X
allelotype	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
p73	B-X
in	B-X
five	B-X
cell	B-X
lines	B-X
and	B-X
75	B-X
tissues	B-X
.	B-X
Although	B-X
extremely	B-X
low	B-X
levels	B-X
of	B-X
p73	B-X
expression	B-X
were	B-X
observed	B-X
in	B-X
all	B-X
noncancerous	B-X
gastric	B-X
tissues	B-X
and	B-X
four	B-X
of	B-X
five	B-X
cell	B-X
lines	B-X
,	B-X
a	B-X
significant	B-X
elevation	B-X
of	B-X
p73	B-X
was	B-X
detected	B-X
in	B-X
37	B-X
of	B-X
39	B-X
(	B-X
94.9	B-X
%	B-X
)	B-X
carcinoma	B-X
tissues	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
tumor-specific	B-X
increase	B-X
of	B-X
p73	B-X
was	B-X
identified	B-X
in	B-X
14	B-X
of	B-X
16	B-X
(	B-X
87.5	B-X
%	B-X
)	B-X
matched	B-X
sets	B-X
.	B-X
Allelotyping	B-X
analysis	B-X
using	B-X
a	B-X
StyI	B-X
or	B-X
BanI	B-X
polymorphism	B-X
revealed	B-X
that	B-X
5	B-X
of	B-X
21	B-X
(	B-X
23.8	B-X
%	B-X
)	B-X
informative	B-X
carcinomas	B-X
,	B-X
but	B-X
none	B-X
of	B-X
19	B-X
noncancerous	B-X
cases	B-X
,	B-X
express	B-X
p73	B-X
biallelically	B-X
,	B-X
suggesting	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
a	B-X
silent	B-X
allele	B-X
in	B-X
a	B-X
subset	B-X
of	B-X
cancers	B-X
.	B-X
Whereas	B-X
the	B-X
transcription	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
was	B-X
markedly	B-X
induced	B-X
by	B-X
serum	B-X
starvation	B-X
or	B-X
clump	B-X
formation	B-X
of	B-X
the	B-X
cells	B-X
,	B-X
treatment	B-X
with	B-X
5-aza-2'deoxycytidine	B-X
activated	B-X
a	B-X
silent	B-X
allele	B-X
with	B-X
a	B-X
subsequent	B-X
up-regulation	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
,	B-X
supporting	B-X
the	B-X
genomic	B-X
imprinting	B-X
and	B-X
autoregulation	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
Allelic	B-X
deletion	B-X
or	B-X
mutation	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
not	B-X
found	B-X
,	B-X
and	B-X
no	B-X
association	B-X
of	B-X
p73	B-X
expression	B-X
with	B-X
the	B-X
mutational	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
expression	B-X
of	B-X
p21Waf1	B-X
was	B-X
recognized	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
argues	B-X
that	B-X
p73	B-X
is	B-X
not	B-X
a	B-X
target	B-X
of	B-X
genetic	B-X
alteration	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
and	B-X
suggests	B-X
that	B-X
overexpression	B-X
of	B-X
p73	B-X
might	B-X
be	B-X
triggered	B-X
by	B-X
physiological	B-X
stresses	B-X
accompanied	B-X
with	B-X
outgrowth	B-X
of	B-X
tumors	B-X
,	B-X
such	B-X
as	B-X
hypoxia	B-X
or	B-X
nutrient	B-X
deprivation	B-X
.	B-X

Allelotyping	O
analysis	O
using	O
a	O
StyI	O
or	O
BanI	O
polymorphism	O
revealed	O
that	O
5	O
of	O
21	O
(	O
23	O
.	O
8	O
%	O
)	O
informative	O
carcinomas	O
,	O
but	O
none	O
of	O
19	O
noncancerous	O
cases	O
,	O
express	O
p73	B-Gene_or_gene_product
biallelically	O
,	O
suggesting	O
the	O
transcriptional	O
activation	O
of	O
a	O
silent	O
allele	O
in	O
a	O
subset	O
of	O
cancers	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
gene	B-X
located	B-X
at	B-X
1p36.3	B-X
encodes	B-X
for	B-X
a	B-X
protein	B-X
with	B-X
significant	B-X
similarity	B-X
to	B-X
p53	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
penetrance	B-X
of	B-X
p73	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
expression	B-X
,	B-X
allelotype	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
p73	B-X
in	B-X
five	B-X
cell	B-X
lines	B-X
and	B-X
75	B-X
tissues	B-X
.	B-X
Although	B-X
extremely	B-X
low	B-X
levels	B-X
of	B-X
p73	B-X
expression	B-X
were	B-X
observed	B-X
in	B-X
all	B-X
noncancerous	B-X
gastric	B-X
tissues	B-X
and	B-X
four	B-X
of	B-X
five	B-X
cell	B-X
lines	B-X
,	B-X
a	B-X
significant	B-X
elevation	B-X
of	B-X
p73	B-X
was	B-X
detected	B-X
in	B-X
37	B-X
of	B-X
39	B-X
(	B-X
94.9	B-X
%	B-X
)	B-X
carcinoma	B-X
tissues	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
tumor-specific	B-X
increase	B-X
of	B-X
p73	B-X
was	B-X
identified	B-X
in	B-X
14	B-X
of	B-X
16	B-X
(	B-X
87.5	B-X
%	B-X
)	B-X
matched	B-X
sets	B-X
.	B-X
Allelotyping	B-X
analysis	B-X
using	B-X
a	B-X
StyI	B-X
or	B-X
BanI	B-X
polymorphism	B-X
revealed	B-X
that	B-X
5	B-X
of	B-X
21	B-X
(	B-X
23.8	B-X
%	B-X
)	B-X
informative	B-X
carcinomas	B-X
,	B-X
but	B-X
none	B-X
of	B-X
19	B-X
noncancerous	B-X
cases	B-X
,	B-X
express	B-X
p73	B-X
biallelically	B-X
,	B-X
suggesting	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
a	B-X
silent	B-X
allele	B-X
in	B-X
a	B-X
subset	B-X
of	B-X
cancers	B-X
.	B-X
Whereas	B-X
the	B-X
transcription	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
was	B-X
markedly	B-X
induced	B-X
by	B-X
serum	B-X
starvation	B-X
or	B-X
clump	B-X
formation	B-X
of	B-X
the	B-X
cells	B-X
,	B-X
treatment	B-X
with	B-X
5-aza-2'deoxycytidine	B-X
activated	B-X
a	B-X
silent	B-X
allele	B-X
with	B-X
a	B-X
subsequent	B-X
up-regulation	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
,	B-X
supporting	B-X
the	B-X
genomic	B-X
imprinting	B-X
and	B-X
autoregulation	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
Allelic	B-X
deletion	B-X
or	B-X
mutation	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
not	B-X
found	B-X
,	B-X
and	B-X
no	B-X
association	B-X
of	B-X
p73	B-X
expression	B-X
with	B-X
the	B-X
mutational	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
expression	B-X
of	B-X
p21Waf1	B-X
was	B-X
recognized	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
argues	B-X
that	B-X
p73	B-X
is	B-X
not	B-X
a	B-X
target	B-X
of	B-X
genetic	B-X
alteration	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
and	B-X
suggests	B-X
that	B-X
overexpression	B-X
of	B-X
p73	B-X
might	B-X
be	B-X
triggered	B-X
by	B-X
physiological	B-X
stresses	B-X
accompanied	B-X
with	B-X
outgrowth	B-X
of	B-X
tumors	B-X
,	B-X
such	B-X
as	B-X
hypoxia	B-X
or	B-X
nutrient	B-X
deprivation	B-X
.	B-X

Whereas	O
the	O
transcription	O
of	O
an	O
active	O
allele	O
was	O
markedly	O
induced	O
by	O
serum	O
starvation	O
or	O
clump	O
formation	O
of	O
the	O
cells	O
,	O
treatment	O
with	O
5	O
-	O
aza	O
-	O
2	O
'	O
deoxycytidine	O
activated	O
a	O
silent	O
allele	O
with	O
a	O
subsequent	O
up	O
-	O
regulation	O
of	O
an	O
active	O
allele	O
,	O
supporting	O
the	O
genomic	O
imprinting	O
and	O
autoregulation	O
of	O
the	O
gene	O
.	O
<EOS>	B-X
The	B-X
p73	B-X
gene	B-X
located	B-X
at	B-X
1p36.3	B-X
encodes	B-X
for	B-X
a	B-X
protein	B-X
with	B-X
significant	B-X
similarity	B-X
to	B-X
p53	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
penetrance	B-X
of	B-X
p73	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
,	B-X
we	B-X
analyzed	B-X
the	B-X
expression	B-X
,	B-X
allelotype	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
p73	B-X
in	B-X
five	B-X
cell	B-X
lines	B-X
and	B-X
75	B-X
tissues	B-X
.	B-X
Furthermore	B-X
,	B-X
a	B-X
tumor-specific	B-X
increase	B-X
of	B-X
p73	B-X
was	B-X
identified	B-X
in	B-X
14	B-X
of	B-X
16	B-X
(	B-X
87.5	B-X
%	B-X
)	B-X
matched	B-X
sets	B-X
.	B-X
Allelotyping	B-X
analysis	B-X
using	B-X
a	B-X
StyI	B-X
or	B-X
BanI	B-X
polymorphism	B-X
revealed	B-X
that	B-X
5	B-X
of	B-X
21	B-X
(	B-X
23.8	B-X
%	B-X
)	B-X
informative	B-X
carcinomas	B-X
,	B-X
but	B-X
none	B-X
of	B-X
19	B-X
noncancerous	B-X
cases	B-X
,	B-X
express	B-X
p73	B-X
biallelically	B-X
,	B-X
suggesting	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
a	B-X
silent	B-X
allele	B-X
in	B-X
a	B-X
subset	B-X
of	B-X
cancers	B-X
.	B-X
Whereas	B-X
the	B-X
transcription	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
was	B-X
markedly	B-X
induced	B-X
by	B-X
serum	B-X
starvation	B-X
or	B-X
clump	B-X
formation	B-X
of	B-X
the	B-X
cells	B-X
,	B-X
treatment	B-X
with	B-X
5-aza-2'deoxycytidine	B-X
activated	B-X
a	B-X
silent	B-X
allele	B-X
with	B-X
a	B-X
subsequent	B-X
up-regulation	B-X
of	B-X
an	B-X
active	B-X
allele	B-X
,	B-X
supporting	B-X
the	B-X
genomic	B-X
imprinting	B-X
and	B-X
autoregulation	B-X
of	B-X
the	B-X
gene	B-X
.	B-X
Allelic	B-X
deletion	B-X
or	B-X
mutation	B-X
of	B-X
the	B-X
gene	B-X
was	B-X
not	B-X
found	B-X
,	B-X
and	B-X
no	B-X
association	B-X
of	B-X
p73	B-X
expression	B-X
with	B-X
the	B-X
mutational	B-X
status	B-X
of	B-X
p53	B-X
or	B-X
expression	B-X
of	B-X
p21Waf1	B-X
was	B-X
recognized	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
this	B-X
study	B-X
argues	B-X
that	B-X
p73	B-X
is	B-X
not	B-X
a	B-X
target	B-X
of	B-X
genetic	B-X
alteration	B-X
in	B-X
gastric	B-X
carcinogenesis	B-X
and	B-X
suggests	B-X
that	B-X
overexpression	B-X
of	B-X
p73	B-X
might	B-X
be	B-X
triggered	B-X
by	B-X
physiological	B-X
stresses	B-X
accompanied	B-X
with	B-X
outgrowth	B-X
of	B-X
tumors	B-X
,	B-X
such	B-X
as	B-X
hypoxia	B-X
or	B-X
nutrient	B-X
deprivation	B-X
.	B-X

Allelic	O
deletion	O
or	O
mutation	O
of	O
the	O
gene	O
was	O
not	O
found	O
,	O
and	O
no	O
association	O
of	O
p73	B-Gene_or_gene_product
expression	O
with	O
the	O
mutational	O
status	O
of	O
p53	B-Gene_or_gene_product
or	O
expression	O
of	O
p21Waf1	B-Gene_or_gene_product
was	O
recognized	O
.	O
<EOS>	B-X
BRCA1	B-X
and	B-X
BRCA2	B-X
screening	B-X
in	B-X
women	B-X
at	B-X
high-risk	B-X
of	B-X
breast	B-X
cancer	B-X
results	B-X
in	B-X
the	B-X
identification	B-X
of	B-X
both	B-X
unambiguously	B-X
defined	B-X
deleterious	B-X
mutations	B-X
and	B-X
sequence	B-X
variants	B-X
of	B-X
unknown	B-X
clinical	B-X
significance	B-X
(	B-X
VUS	B-X
)	B-X
.	B-X
We	B-X
identified	B-X
470	B-X
unique	B-X
sequence	B-X
variants	B-X
,	B-X
of	B-X
which	B-X
113	B-X
were	B-X
deleterious	B-X
mutations	B-X
.	B-X
Deleterious	B-X
mutations	B-X
occurred	B-X
three	B-X
times	B-X
more	B-X
often	B-X
in	B-X
women	B-X
with	B-X
CBC	B-X
(	B-X
15.3	B-X
%	B-X
)	B-X
than	B-X
in	B-X
women	B-X
with	B-X
UBC	B-X
(	B-X
5.2	B-X
%	B-X
)	B-X
,	B-X
whereas	B-X
combined	B-X
,	B-X
VUS	B-X
were	B-X
observed	B-X
in	B-X
similar	B-X
frequencies	B-X
in	B-X
women	B-X
with	B-X
CBC	B-X
and	B-X
UBC	B-X
.	B-X
A	B-X
set	B-X
of	B-X
yeast	B-X
strains	B-X
based	B-X
on	B-X
Saccharomyces	B-X
cerevisiae	B-X
S288C	B-X
in	B-X
which	B-X
commonly	B-X
used	B-X
selectable	B-X
marker	B-X
genes	B-X
are	B-X
deleted	B-X
by	B-X
design	B-X
based	B-X
on	B-X
the	B-X
yeast	B-X
genome	B-X
sequence	B-X
has	B-X
been	B-X
constructed	B-X
and	B-X
analysed	B-X
.	B-X
These	B-X
strains	B-X
minimize	B-X
or	B-X
eliminate	B-X
the	B-X
homology	B-X
to	B-X
the	B-X
corresponding	B-X
marker	B-X
genes	B-X
in	B-X
commonly	B-X
used	B-X
vectors	B-X
without	B-X
significantly	B-X
affecting	B-X
adjacent	B-X
gene	B-X
expression	B-X
.	B-X
Because	B-X
the	B-X
homology	B-X
between	B-X
commonly	B-X
used	B-X
auxotrophic	B-X
marker	B-X
gene	B-X
segments	B-X
and	B-X
genomic	B-X
sequences	B-X
has	B-X
been	B-X
largely	B-X
or	B-X
completely	B-X
abolished	B-X
,	B-X
these	B-X
strains	B-X
will	B-X
also	B-X
reduce	B-X
plasmid	B-X
integration	B-X
events	B-X
which	B-X
can	B-X
interfere	B-X
with	B-X
a	B-X
wide	B-X
variety	B-X
of	B-X
molecular	B-X
genetic	B-X
applications	B-X
.	B-X
We	B-X
also	B-X
report	B-X
the	B-X
construction	B-X
of	B-X
new	B-X
members	B-X
of	B-X
the	B-X
pRS400	B-X
series	B-X
of	B-X
vectors	B-X
,	B-X
containing	B-X
the	B-X
kanMX	B-X
,	B-X
ADE2	B-X
and	B-X
MET15	B-X
genes	B-X
.	B-X

Taken	O
together	O
,	O
this	O
study	O
argues	O
that	O
p73	B-Gene_or_gene_product
is	O
not	O
a	O
target	O
of	O
genetic	O
alteration	O
in	O
gastric	O
carcinogenesis	O
and	O
suggests	O
that	O
overexpression	O
of	O
p73	B-Gene_or_gene_product
might	O
be	O
triggered	O
by	O
physiological	O
stresses	O
accompanied	O
with	O
outgrowth	O
of	O
tumors	O
,	O
such	O
as	O
hypoxia	O
or	O
nutrient	O
deprivation	O
.	O
<EOS>	B-X
Many	B-X
processes	B-X
are	B-X
involved	B-X
in	B-X
sleep	B-X
regulation	B-X
,	B-X
including	B-X
the	B-X
ingestion	B-X
of	B-X
nutrients	B-X
,	B-X
suggesting	B-X
a	B-X
link	B-X
between	B-X
diet	B-X
and	B-X
sleep	B-X
.	B-X
Aside	B-X
from	B-X
studies	B-X
investigating	B-X
the	B-X
effects	B-X
of	B-X
tryptophan	B-X
,	B-X
previous	B-X
research	B-X
on	B-X
sleep	B-X
and	B-X
diet	B-X
has	B-X
primarily	B-X
focused	B-X
on	B-X
the	B-X
effects	B-X
of	B-X
sleep	B-X
deprivation	B-X
or	B-X
sleep	B-X
restriction	B-X
on	B-X
diet	B-X
.	B-X
Four	B-X
themes	B-X
emerged	B-X
:	B-X
tryptophan	B-X
consumption	B-X
and	B-X
tryptophan	B-X
depletion	B-X
,	B-X
dietary	B-X
supplements	B-X
,	B-X
food	B-X
items	B-X
,	B-X
and	B-X
macronutrients	B-X
.	B-X
High	B-X
carbohydrate	B-X
diets	B-X
,	B-X
and	B-X
foods	B-X
containing	B-X
tryptophan	B-X
,	B-X
melatonin	B-X
,	B-X
and	B-X
phytonutrients	B-X
(	B-X
e.g.	B-X
,	B-X
cherries	B-X
)	B-X
,	B-X
were	B-X
linked	B-X
to	B-X
improved	B-X
sleep	B-X
outcomes	B-X
.	B-X

Activity	O
of	O
the	O
human	O
cytochrome	B-Gene_or_gene_product
c1	I-Gene_or_gene_product
promoter	O
is	O
modulated	O
by	O
E2F	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
human	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
is	B-X
strongly	B-X
activated	B-X
in	B-X
transfected	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
expressing	B-X
exogenous	B-X
human	B-X
E2F1	B-X
.	B-X
Transfection-deletion	B-X
experiments	B-X
,	B-X
DNase	B-X
I	B-X
protection	B-X
by	B-X
E2F1	B-X
and	B-X
gel	B-X
mobility-shift	B-X
experiments	B-X
locate	B-X
E2F1	B-X
activation	B-X
sites	B-X
to	B-X
two	B-X
regions	B-X
on	B-X
either	B-X
side	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Deletion	B-X
of	B-X
either	B-X
region	B-X
prevents	B-X
E2F1	B-X
activation	B-X
in	B-X
transfected	B-X
SL2	B-X
cells	B-X
,	B-X
suggesting	B-X
a	B-X
co-operative	B-X
interaction	B-X
between	B-X
them	B-X
.	B-X
E2F6	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
that	B-X
lacks	B-X
transactivation	B-X
domains	B-X
but	B-X
contains	B-X
specific	B-X
suppressor	B-X
domains	B-X
,	B-X
inhibits	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
activity	B-X
when	B-X
co-transfected	B-X
into	B-X
HeLa	B-X
cells	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
E2F	B-X
proteins	B-X
modulate	B-X
the	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
However	B-X
,	B-X
E2F	B-X
is	B-X
not	B-X
a	B-X
general	B-X
regulator	B-X
of	B-X
oxidative	B-X
phosphorylation	B-X
genes	B-X
since	B-X
three	B-X
additional	B-X
nuclear-encoded	B-X
mitochondrial	B-X
genes	B-X
were	B-X
unaffected	B-X
by	B-X
E2F1	B-X
or	B-X
E2F6	B-X
.	B-X

The	O
human	O
cytochrome	B-Gene_or_gene_product
c	I-Gene_or_gene_product
(	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	I-Gene_or_gene_product
promoter	O
is	O
strongly	O
activated	O
in	O
transfected	O
Drosophila	O
SL2	O
cells	O
expressing	O
exogenous	O
human	O
E2F1	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
human	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
is	B-X
strongly	B-X
activated	B-X
in	B-X
transfected	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
expressing	B-X
exogenous	B-X
human	B-X
E2F1	B-X
.	B-X
Transfection-deletion	B-X
experiments	B-X
,	B-X
DNase	B-X
I	B-X
protection	B-X
by	B-X
E2F1	B-X
and	B-X
gel	B-X
mobility-shift	B-X
experiments	B-X
locate	B-X
E2F1	B-X
activation	B-X
sites	B-X
to	B-X
two	B-X
regions	B-X
on	B-X
either	B-X
side	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Deletion	B-X
of	B-X
either	B-X
region	B-X
prevents	B-X
E2F1	B-X
activation	B-X
in	B-X
transfected	B-X
SL2	B-X
cells	B-X
,	B-X
suggesting	B-X
a	B-X
co-operative	B-X
interaction	B-X
between	B-X
them	B-X
.	B-X
E2F6	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
that	B-X
lacks	B-X
transactivation	B-X
domains	B-X
but	B-X
contains	B-X
specific	B-X
suppressor	B-X
domains	B-X
,	B-X
inhibits	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
activity	B-X
when	B-X
co-transfected	B-X
into	B-X
HeLa	B-X
cells	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
E2F	B-X
proteins	B-X
modulate	B-X
the	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
However	B-X
,	B-X
E2F	B-X
is	B-X
not	B-X
a	B-X
general	B-X
regulator	B-X
of	B-X
oxidative	B-X
phosphorylation	B-X
genes	B-X
since	B-X
three	B-X
additional	B-X
nuclear-encoded	B-X
mitochondrial	B-X
genes	B-X
were	B-X
unaffected	B-X
by	B-X
E2F1	B-X
or	B-X
E2F6	B-X
.	B-X

Transfection	O
-	O
deletion	O
experiments	O
,	O
DNase	B-Gene_or_gene_product
I	I-Gene_or_gene_product
protection	O
by	O
E2F1	B-Gene_or_gene_product
and	O
gel	O
mobility	O
-	O
shift	O
experiments	O
locate	O
E2F1	B-Gene_or_gene_product
activation	O
sites	O
to	O
two	O
regions	O
on	O
either	O
side	O
of	O
the	O
transcription	O
start	O
site	O
.	O
<EOS>	B-X
The	B-X
human	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
is	B-X
strongly	B-X
activated	B-X
in	B-X
transfected	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
expressing	B-X
exogenous	B-X
human	B-X
E2F1	B-X
.	B-X
Transfection-deletion	B-X
experiments	B-X
,	B-X
DNase	B-X
I	B-X
protection	B-X
by	B-X
E2F1	B-X
and	B-X
gel	B-X
mobility-shift	B-X
experiments	B-X
locate	B-X
E2F1	B-X
activation	B-X
sites	B-X
to	B-X
two	B-X
regions	B-X
on	B-X
either	B-X
side	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Deletion	B-X
of	B-X
either	B-X
region	B-X
prevents	B-X
E2F1	B-X
activation	B-X
in	B-X
transfected	B-X
SL2	B-X
cells	B-X
,	B-X
suggesting	B-X
a	B-X
co-operative	B-X
interaction	B-X
between	B-X
them	B-X
.	B-X
E2F6	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
that	B-X
lacks	B-X
transactivation	B-X
domains	B-X
but	B-X
contains	B-X
specific	B-X
suppressor	B-X
domains	B-X
,	B-X
inhibits	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
activity	B-X
when	B-X
co-transfected	B-X
into	B-X
HeLa	B-X
cells	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
E2F	B-X
proteins	B-X
modulate	B-X
the	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
However	B-X
,	B-X
E2F	B-X
is	B-X
not	B-X
a	B-X
general	B-X
regulator	B-X
of	B-X
oxidative	B-X
phosphorylation	B-X
genes	B-X
since	B-X
three	B-X
additional	B-X
nuclear-encoded	B-X
mitochondrial	B-X
genes	B-X
were	B-X
unaffected	B-X
by	B-X
E2F1	B-X
or	B-X
E2F6	B-X
.	B-X

Deletion	O
of	O
either	O
region	O
prevents	O
E2F1	B-Gene_or_gene_product
activation	O
in	O
transfected	O
SL2	O
cells	O
,	O
suggesting	O
a	O
co	O
-	O
operative	O
interaction	O
between	O
them	O
.	O
<EOS>	B-X
The	B-X
human	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
is	B-X
strongly	B-X
activated	B-X
in	B-X
transfected	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
expressing	B-X
exogenous	B-X
human	B-X
E2F1	B-X
.	B-X
Transfection-deletion	B-X
experiments	B-X
,	B-X
DNase	B-X
I	B-X
protection	B-X
by	B-X
E2F1	B-X
and	B-X
gel	B-X
mobility-shift	B-X
experiments	B-X
locate	B-X
E2F1	B-X
activation	B-X
sites	B-X
to	B-X
two	B-X
regions	B-X
on	B-X
either	B-X
side	B-X
of	B-X
the	B-X
transcription	B-X
start	B-X
site	B-X
.	B-X
Deletion	B-X
of	B-X
either	B-X
region	B-X
prevents	B-X
E2F1	B-X
activation	B-X
in	B-X
transfected	B-X
SL2	B-X
cells	B-X
,	B-X
suggesting	B-X
a	B-X
co-operative	B-X
interaction	B-X
between	B-X
them	B-X
.	B-X
E2F6	B-X
,	B-X
a	B-X
member	B-X
of	B-X
the	B-X
E2F	B-X
family	B-X
that	B-X
lacks	B-X
transactivation	B-X
domains	B-X
but	B-X
contains	B-X
specific	B-X
suppressor	B-X
domains	B-X
,	B-X
inhibits	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
activity	B-X
when	B-X
co-transfected	B-X
into	B-X
HeLa	B-X
cells	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
E2F	B-X
proteins	B-X
modulate	B-X
the	B-X
cytochrome	B-X
c	B-X
(	B-X
1	B-X
)	B-X
promoter	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
However	B-X
,	B-X
E2F	B-X
is	B-X
not	B-X
a	B-X
general	B-X
regulator	B-X
of	B-X
oxidative	B-X
phosphorylation	B-X
genes	B-X
since	B-X
three	B-X
additional	B-X
nuclear-encoded	B-X
mitochondrial	B-X
genes	B-X
were	B-X
unaffected	B-X
by	B-X
E2F1	B-X
or	B-X
E2F6	B-X
.	B-X

E2F6	B-Gene_or_gene_product
,	O
a	O
member	O
of	O
the	O
E2F	B-Gene_or_gene_product
family	O
that	O
lacks	O
transactivation	O
domains	O
but	O
contains	O
specific	O
suppressor	O
domains	O
,	O
inhibits	O
cytochrome	B-Gene_or_gene_product
c	I-Gene_or_gene_product
(	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	I-Gene_or_gene_product
promoter	O
activity	O
when	O
co	O
-	O
transfected	O
into	O
HeLa	O
cells	O
,	O
indicating	O
that	O
the	O
E2F	B-Gene_or_gene_product
proteins	O
modulate	O
the	O
cytochrome	B-Gene_or_gene_product
c	I-Gene_or_gene_product
(	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	I-Gene_or_gene_product
promoter	O
in	O
mammalian	O
cells	O
.	O

However	O
,	O
E2F	B-Gene_or_gene_product
is	O
not	O
a	O
general	O
regulator	O
of	O
oxidative	O
phosphorylation	O
genes	O
since	O
three	O
additional	O
nuclear	O
-	O
encoded	O
mitochondrial	O
genes	O
were	O
unaffected	O
by	O
E2F1	B-Gene_or_gene_product
or	O
E2F6	B-Gene_or_gene_product
.	O
<EOS>	B-X
RB	B-X
forms	B-X
complexes	B-X
with	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
and	B-X
downregulates	B-X
numerous	B-X
genes	B-X
.	B-X
Among	B-X
the	B-X
RB-E2F	B-X
target	B-X
genes	B-X
,	B-X
a	B-X
large	B-X
number	B-X
code	B-X
for	B-X
key	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
Their	B-X
transcriptional	B-X
repression	B-X
by	B-X
the	B-X
RB-E2F	B-X
complex	B-X
is	B-X
released	B-X
through	B-X
phosphorylation	B-X
of	B-X
RB	B-X
,	B-X
leading	B-X
to	B-X
expression	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
High	B-X
levels	B-X
of	B-X
p21	B-X
then	B-X
result	B-X
in	B-X
RB-E2F	B-X
complex	B-X
formation	B-X
and	B-X
downregulation	B-X
of	B-X
a	B-X
large	B-X
number	B-X
of	B-X
cell	B-X
cycle	B-X
genes	B-X
.	B-X
The	B-X
reduced	B-X
expression	B-X
of	B-X
the	B-X
many	B-X
regulators	B-X
leads	B-X
to	B-X
cell	B-X
cycle	B-X
arrest	B-X
.	B-X
Examination	B-X
of	B-X
the	B-X
p53-p21-RB	B-X
targets	B-X
and	B-X
genes	B-X
controlled	B-X
by	B-X
the	B-X
related	B-X
p53-p21-DREAM	B-X
signaling	B-X
pathway	B-X
reveals	B-X
that	B-X
there	B-X
is	B-X
a	B-X
large	B-X
overlap	B-X
of	B-X
the	B-X
two	B-X
groups	B-X
.	B-X
Mechanistically	B-X
this	B-X
can	B-X
be	B-X
explained	B-X
by	B-X
replacing	B-X
RB-E2F	B-X
complexes	B-X
with	B-X
the	B-X
DREAM	B-X
transcriptional	B-X
repressor	B-X
complex	B-X
at	B-X
E2F	B-X
sites	B-X
in	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
RB-E2F	B-X
,	B-X
DREAM	B-X
can	B-X
downregulate	B-X
genes	B-X
also	B-X
through	B-X
CHR	B-X
transcription	B-X
factor	B-X
binding	B-X
sites	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
distinct	B-X
gene	B-X
set	B-X
controlled	B-X
by	B-X
p53-p21-DREAM	B-X
signaling	B-X
independent	B-X
of	B-X
RB-E2F	B-X
.	B-X
Furthermore	B-X
,	B-X
RB	B-X
has	B-X
non-canonical	B-X
functions	B-X
without	B-X
binding	B-X
to	B-X
E2F	B-X
and	B-X
DNA	B-X
.	B-X

Nuclear	O
-	O
specific	O
degradation	O
of	O
Far1	B-Gene_or_gene_product
is	O
controlled	O
by	O
the	O
localization	O
of	O
the	O
F	O
-	O
box	O
protein	O
Cdc4	B-Gene_or_gene_product
.	O

Far1	B-Gene_or_gene_product
is	O
a	O
bifunctional	O
protein	O
that	O
is	O
required	O
to	O
arrest	O
the	O
cell	O
cycle	O
and	O
establish	O
cell	O
polarity	O
during	O
yeast	O
mating	O
.	O
<EOS>	B-X
Far1	B-X
is	B-X
a	B-X
bifunctional	B-X
protein	B-X
that	B-X
is	B-X
required	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
establish	B-X
cell	B-X
polarity	B-X
during	B-X
yeast	B-X
mating	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SCF	B-X
(	B-X
Cdc4	B-X
)	B-X
ubiquitylates	B-X
Far1	B-X
in	B-X
the	B-X
nucleus	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
targets	B-X
the	B-X
multi-ubiquitylated	B-X
protein	B-X
to	B-X
26S	B-X
proteasomes	B-X
most	B-X
likely	B-X
located	B-X
at	B-X
the	B-X
nuclear	B-X
envelope	B-X
.	B-X
In	B-X
response	B-X
to	B-X
mating	B-X
pheromones	B-X
,	B-X
a	B-X
fraction	B-X
of	B-X
Far1	B-X
was	B-X
stabilized	B-X
after	B-X
its	B-X
export	B-X
into	B-X
the	B-X
cytoplasm	B-X
by	B-X
Ste21/Msn5	B-X
.	B-X
Preventing	B-X
nuclear	B-X
export	B-X
destabilized	B-X
Far1	B-X
,	B-X
while	B-X
conversely	B-X
cytoplasmic	B-X
Far1	B-X
was	B-X
stabilized	B-X
,	B-X
although	B-X
the	B-X
protein	B-X
was	B-X
efficiently	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdc28-Cln-dependent	B-X
manner	B-X
.	B-X
The	B-X
core	B-X
SCF	B-X
subunits	B-X
Cdc53	B-X
,	B-X
Hrt1	B-X
and	B-X
Skp1	B-X
were	B-X
distributed	B-X
in	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
cytoplasm	B-X
,	B-X
whereas	B-X
the	B-X
F-box	B-X
protein	B-X
Cdc4	B-X
was	B-X
exclusively	B-X
nuclear	B-X
.	B-X
A	B-X
cytoplasmic	B-X
form	B-X
of	B-X
Cdc4	B-X
was	B-X
unable	B-X
to	B-X
complement	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
cdc4-1	B-X
cells	B-X
,	B-X
but	B-X
it	B-X
was	B-X
sufficient	B-X
to	B-X
degrade	B-X
Far1	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Our	B-X
results	B-X
illustrate	B-X
the	B-X
importance	B-X
of	B-X
subcellular	B-X
localization	B-X
of	B-X
F-box	B-X
proteins	B-X
,	B-X
and	B-X
provide	B-X
an	B-X
example	B-X
of	B-X
how	B-X
an	B-X
extracellular	B-X
signal	B-X
regulates	B-X
protein	B-X
stability	B-X
at	B-X
the	B-X
level	B-X
of	B-X
substrate	B-X
localization	B-X
.	B-X

Here	O
we	O
show	O
that	O
SCF	O
(	O
Cdc4	O
)	O
ubiquitylates	O
Far1	B-Gene_or_gene_product
in	O
the	O
nucleus	O
,	O
which	O
in	O
turn	O
targets	O
the	O
multi	O
-	O
ubiquitylated	O
protein	O
to	O
26S	O
proteasomes	O
most	O
likely	O
located	O
at	O
the	O
nuclear	O
envelope	O
.	O
<EOS>	B-X
Far1	B-X
is	B-X
a	B-X
bifunctional	B-X
protein	B-X
that	B-X
is	B-X
required	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
establish	B-X
cell	B-X
polarity	B-X
during	B-X
yeast	B-X
mating	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SCF	B-X
(	B-X
Cdc4	B-X
)	B-X
ubiquitylates	B-X
Far1	B-X
in	B-X
the	B-X
nucleus	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
targets	B-X
the	B-X
multi-ubiquitylated	B-X
protein	B-X
to	B-X
26S	B-X
proteasomes	B-X
most	B-X
likely	B-X
located	B-X
at	B-X
the	B-X
nuclear	B-X
envelope	B-X
.	B-X
In	B-X
response	B-X
to	B-X
mating	B-X
pheromones	B-X
,	B-X
a	B-X
fraction	B-X
of	B-X
Far1	B-X
was	B-X
stabilized	B-X
after	B-X
its	B-X
export	B-X
into	B-X
the	B-X
cytoplasm	B-X
by	B-X
Ste21/Msn5	B-X
.	B-X
Preventing	B-X
nuclear	B-X
export	B-X
destabilized	B-X
Far1	B-X
,	B-X
while	B-X
conversely	B-X
cytoplasmic	B-X
Far1	B-X
was	B-X
stabilized	B-X
,	B-X
although	B-X
the	B-X
protein	B-X
was	B-X
efficiently	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdc28-Cln-dependent	B-X
manner	B-X
.	B-X
The	B-X
core	B-X
SCF	B-X
subunits	B-X
Cdc53	B-X
,	B-X
Hrt1	B-X
and	B-X
Skp1	B-X
were	B-X
distributed	B-X
in	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
cytoplasm	B-X
,	B-X
whereas	B-X
the	B-X
F-box	B-X
protein	B-X
Cdc4	B-X
was	B-X
exclusively	B-X
nuclear	B-X
.	B-X
A	B-X
cytoplasmic	B-X
form	B-X
of	B-X
Cdc4	B-X
was	B-X
unable	B-X
to	B-X
complement	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
cdc4-1	B-X
cells	B-X
,	B-X
but	B-X
it	B-X
was	B-X
sufficient	B-X
to	B-X
degrade	B-X
Far1	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Our	B-X
results	B-X
illustrate	B-X
the	B-X
importance	B-X
of	B-X
subcellular	B-X
localization	B-X
of	B-X
F-box	B-X
proteins	B-X
,	B-X
and	B-X
provide	B-X
an	B-X
example	B-X
of	B-X
how	B-X
an	B-X
extracellular	B-X
signal	B-X
regulates	B-X
protein	B-X
stability	B-X
at	B-X
the	B-X
level	B-X
of	B-X
substrate	B-X
localization	B-X
.	B-X

In	O
response	O
to	O
mating	O
pheromones	O
,	O
a	O
fraction	O
of	O
Far1	B-Gene_or_gene_product
was	O
stabilized	O
after	O
its	O
export	O
into	O
the	O
cytoplasm	O
by	O
Ste21	B-Gene_or_gene_product
/	O
Msn5	B-Gene_or_gene_product
.	O
<EOS>	B-X
Far1	B-X
is	B-X
a	B-X
bifunctional	B-X
protein	B-X
that	B-X
is	B-X
required	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
establish	B-X
cell	B-X
polarity	B-X
during	B-X
yeast	B-X
mating	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SCF	B-X
(	B-X
Cdc4	B-X
)	B-X
ubiquitylates	B-X
Far1	B-X
in	B-X
the	B-X
nucleus	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
targets	B-X
the	B-X
multi-ubiquitylated	B-X
protein	B-X
to	B-X
26S	B-X
proteasomes	B-X
most	B-X
likely	B-X
located	B-X
at	B-X
the	B-X
nuclear	B-X
envelope	B-X
.	B-X
In	B-X
response	B-X
to	B-X
mating	B-X
pheromones	B-X
,	B-X
a	B-X
fraction	B-X
of	B-X
Far1	B-X
was	B-X
stabilized	B-X
after	B-X
its	B-X
export	B-X
into	B-X
the	B-X
cytoplasm	B-X
by	B-X
Ste21/Msn5	B-X
.	B-X
Preventing	B-X
nuclear	B-X
export	B-X
destabilized	B-X
Far1	B-X
,	B-X
while	B-X
conversely	B-X
cytoplasmic	B-X
Far1	B-X
was	B-X
stabilized	B-X
,	B-X
although	B-X
the	B-X
protein	B-X
was	B-X
efficiently	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdc28-Cln-dependent	B-X
manner	B-X
.	B-X
The	B-X
core	B-X
SCF	B-X
subunits	B-X
Cdc53	B-X
,	B-X
Hrt1	B-X
and	B-X
Skp1	B-X
were	B-X
distributed	B-X
in	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
cytoplasm	B-X
,	B-X
whereas	B-X
the	B-X
F-box	B-X
protein	B-X
Cdc4	B-X
was	B-X
exclusively	B-X
nuclear	B-X
.	B-X
A	B-X
cytoplasmic	B-X
form	B-X
of	B-X
Cdc4	B-X
was	B-X
unable	B-X
to	B-X
complement	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
cdc4-1	B-X
cells	B-X
,	B-X
but	B-X
it	B-X
was	B-X
sufficient	B-X
to	B-X
degrade	B-X
Far1	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X

Preventing	O
nuclear	O
export	O
destabilized	O
Far1	B-Gene_or_gene_product
,	O
while	O
conversely	O
cytoplasmic	O
Far1	B-Gene_or_gene_product
was	O
stabilized	O
,	O
although	O
the	O
protein	O
was	O
efficiently	O
phosphorylated	O
in	O
a	O
Cdc28	O
-	O
Cln	O
-	O
dependent	O
manner	O
.	O

The	O
core	O
SCF	O
subunits	O
Cdc53	B-Gene_or_gene_product
,	O
Hrt1	B-Gene_or_gene_product
and	O
Skp1	B-Gene_or_gene_product
were	O
distributed	O
in	O
the	O
nucleus	O
and	O
the	O
cytoplasm	O
,	O
whereas	O
the	O
F	O
-	O
box	O
protein	O
Cdc4	B-Gene_or_gene_product
was	O
exclusively	O
nuclear	O
.	O

A	O
cytoplasmic	O
form	O
of	O
Cdc4	B-Gene_or_gene_product
was	O
unable	O
to	O
complement	O
the	O
growth	O
defect	O
of	O
cdc4	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
cells	O
,	O
but	O
it	O
was	O
sufficient	O
to	O
degrade	O
Far1	B-Gene_or_gene_product
in	O
the	O
cytoplasm	O
.	O
<EOS>	B-X
Far1	B-X
is	B-X
a	B-X
bifunctional	B-X
protein	B-X
that	B-X
is	B-X
required	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
establish	B-X
cell	B-X
polarity	B-X
during	B-X
yeast	B-X
mating	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SCF	B-X
(	B-X
Cdc4	B-X
)	B-X
ubiquitylates	B-X
Far1	B-X
in	B-X
the	B-X
nucleus	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
targets	B-X
the	B-X
multi-ubiquitylated	B-X
protein	B-X
to	B-X
26S	B-X
proteasomes	B-X
most	B-X
likely	B-X
located	B-X
at	B-X
the	B-X
nuclear	B-X
envelope	B-X
.	B-X
In	B-X
response	B-X
to	B-X
mating	B-X
pheromones	B-X
,	B-X
a	B-X
fraction	B-X
of	B-X
Far1	B-X
was	B-X
stabilized	B-X
after	B-X
its	B-X
export	B-X
into	B-X
the	B-X
cytoplasm	B-X
by	B-X
Ste21/Msn5	B-X
.	B-X
Preventing	B-X
nuclear	B-X
export	B-X
destabilized	B-X
Far1	B-X
,	B-X
while	B-X
conversely	B-X
cytoplasmic	B-X
Far1	B-X
was	B-X
stabilized	B-X
,	B-X
although	B-X
the	B-X
protein	B-X
was	B-X
efficiently	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdc28-Cln-dependent	B-X
manner	B-X
.	B-X
The	B-X
core	B-X
SCF	B-X
subunits	B-X
Cdc53	B-X
,	B-X
Hrt1	B-X
and	B-X
Skp1	B-X
were	B-X
distributed	B-X
in	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
cytoplasm	B-X
,	B-X
whereas	B-X
the	B-X
F-box	B-X
protein	B-X
Cdc4	B-X
was	B-X
exclusively	B-X
nuclear	B-X
.	B-X
A	B-X
cytoplasmic	B-X
form	B-X
of	B-X
Cdc4	B-X
was	B-X
unable	B-X
to	B-X
complement	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
cdc4-1	B-X
cells	B-X
,	B-X
but	B-X
it	B-X
was	B-X
sufficient	B-X
to	B-X
degrade	B-X
Far1	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X

Our	O
results	O
illustrate	O
the	O
importance	O
of	O
subcellular	O
localization	O
of	O
F	O
-	O
box	O
proteins	O
,	O
and	O
provide	O
an	O
example	O
of	O
how	O
an	O
extracellular	O
signal	O
regulates	O
protein	O
stability	O
at	O
the	O
level	O
of	O
substrate	O
localization	O
.	O
<EOS>	B-X
Far1	B-X
is	B-X
a	B-X
bifunctional	B-X
protein	B-X
that	B-X
is	B-X
required	B-X
to	B-X
arrest	B-X
the	B-X
cell	B-X
cycle	B-X
and	B-X
establish	B-X
cell	B-X
polarity	B-X
during	B-X
yeast	B-X
mating	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SCF	B-X
(	B-X
Cdc4	B-X
)	B-X
ubiquitylates	B-X
Far1	B-X
in	B-X
the	B-X
nucleus	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
targets	B-X
the	B-X
multi-ubiquitylated	B-X
protein	B-X
to	B-X
26S	B-X
proteasomes	B-X
most	B-X
likely	B-X
located	B-X
at	B-X
the	B-X
nuclear	B-X
envelope	B-X
.	B-X
In	B-X
response	B-X
to	B-X
mating	B-X
pheromones	B-X
,	B-X
a	B-X
fraction	B-X
of	B-X
Far1	B-X
was	B-X
stabilized	B-X
after	B-X
its	B-X
export	B-X
into	B-X
the	B-X
cytoplasm	B-X
by	B-X
Ste21/Msn5	B-X
.	B-X
Preventing	B-X
nuclear	B-X
export	B-X
destabilized	B-X
Far1	B-X
,	B-X
while	B-X
conversely	B-X
cytoplasmic	B-X
Far1	B-X
was	B-X
stabilized	B-X
,	B-X
although	B-X
the	B-X
protein	B-X
was	B-X
efficiently	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdc28-Cln-dependent	B-X
manner	B-X
.	B-X
The	B-X
core	B-X
SCF	B-X
subunits	B-X
Cdc53	B-X
,	B-X
Hrt1	B-X
and	B-X
Skp1	B-X
were	B-X
distributed	B-X
in	B-X
the	B-X
nucleus	B-X
and	B-X
the	B-X
cytoplasm	B-X
,	B-X
whereas	B-X
the	B-X
F-box	B-X
protein	B-X
Cdc4	B-X
was	B-X
exclusively	B-X
nuclear	B-X
.	B-X
A	B-X
cytoplasmic	B-X
form	B-X
of	B-X
Cdc4	B-X
was	B-X
unable	B-X
to	B-X
complement	B-X
the	B-X
growth	B-X
defect	B-X
of	B-X
cdc4-1	B-X
cells	B-X
,	B-X
but	B-X
it	B-X
was	B-X
sufficient	B-X
to	B-X
degrade	B-X
Far1	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
Our	B-X
results	B-X
illustrate	B-X
the	B-X
importance	B-X
of	B-X
subcellular	B-X
localization	B-X
of	B-X
F-box	B-X
proteins	B-X
,	B-X
and	B-X
provide	B-X
an	B-X
example	B-X
of	B-X
how	B-X
an	B-X
extracellular	B-X
signal	B-X
regulates	B-X
protein	B-X
stability	B-X
at	B-X
the	B-X
level	B-X
of	B-X
substrate	B-X
localization	B-X
.	B-X

Evidence	O
for	O
an	O
accessory	O
protein	O
function	O
for	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
in	O
anti	O
-	O
bacterial	O
responses	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
family	B-X
are	B-X
components	B-X
of	B-X
the	B-X
mammalian	B-X
anti-microbial	B-X
response	B-X
,	B-X
signaling	B-X
with	B-X
a	B-X
domain	B-X
closely	B-X
related	B-X
to	B-X
that	B-X
of	B-X
IL-1	B-X
receptors	B-X
.	B-X
In	B-X
this	B-X
report	B-X
the	B-X
expression	B-X
and	B-X
function	B-X
of	B-X
TLR1	B-X
,	B-X
a	B-X
TLR	B-X
of	B-X
unknown	B-X
function	B-X
,	B-X
are	B-X
examined	B-X
.	B-X
TLR1	B-X
is	B-X
expressed	B-X
by	B-X
monocytes	B-X
,	B-X
as	B-X
demonstrated	B-X
using	B-X
a	B-X
novel	B-X
mAb	B-X
.	B-X
TLR1	B-X
transfection	B-X
of	B-X
HeLa	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
neither	B-X
TLR1	B-X
nor	B-X
TLR2	B-X
,	B-X
was	B-X
not	B-X
sufficient	B-X
to	B-X
confer	B-X
responsiveness	B-X
to	B-X
several	B-X
microbial	B-X
extracts	B-X
.	B-X
However	B-X
,	B-X
cotransfection	B-X
of	B-X
TLR1	B-X
and	B-X
TLR2	B-X
resulted	B-X
in	B-X
enhanced	B-X
signaling	B-X
by	B-X
HeLa	B-X
cells	B-X
to	B-X
soluble	B-X
factors	B-X
released	B-X
from	B-X
Neisseria	B-X
meningitidis	B-X
relative	B-X
to	B-X
the	B-X
response	B-X
with	B-X
either	B-X
TLR	B-X
alone	B-X
.	B-X
The	B-X
N.	B-X
meningitidis	B-X
factors	B-X
recognized	B-X
by	B-X
TLR1/TLR2	B-X
were	B-X
not	B-X
released	B-X
by	B-X
N.	B-X
meningitidis	B-X
mutant	B-X
in	B-X
the	B-X
LpxA	B-X
gene	B-X
.	B-X
Although	B-X
LpxA	B-X
is	B-X
required	B-X
for	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
because	B-X
cooperation	B-X
between	B-X
TLR1	B-X
and	B-X
TLR2	B-X
was	B-X
not	B-X
seen	B-X
with	B-X
all	B-X
LPS	B-X
preparations	B-X
,	B-X
the	B-X
microbial	B-X
component	B-X
(	B-X
s	B-X
)	B-X
TLR1/2	B-X
recognizes	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
a	B-X
complex	B-X
of	B-X
LPS	B-X
and	B-X
other	B-X
molecules	B-X
or	B-X
a	B-X
compound	B-X
metabolically	B-X
and	B-X
chemically	B-X
related	B-X
to	B-X
LPS	B-X
.	B-X
The	B-X
functional	B-X
IL-1R	B-X
consists	B-X
of	B-X
a	B-X
heterodimer	B-X
;	B-X
this	B-X
report	B-X
suggests	B-X
a	B-X
similar	B-X
mechanism	B-X
for	B-X
TLR1	B-X
and	B-X
TLR2	B-X
,	B-X
for	B-X
certain	B-X
agonists	B-X
.	B-X
These	B-X
data	B-X
further	B-X
suggest	B-X
that	B-X
mammalian	B-X
responsiveness	B-X
to	B-X
some	B-X
bacterial	B-X
products	B-X
may	B-X
be	B-X
mediated	B-X
by	B-X
combinations	B-X
of	B-X
TLRs	B-X
,	B-X
suggesting	B-X
a	B-X
mechanism	B-X
for	B-X
diversifying	B-X
the	B-X
repertoire	B-X
of	B-X
Toll-mediated	B-X
responses	B-X
.	B-X

Members	O
of	O
the	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
TLR	B-Gene_or_gene_product
)	O
family	O
are	O
components	O
of	O
the	O
mammalian	O
anti	O
-	O
microbial	O
response	O
,	O
signaling	O
with	O
a	O
domain	O
closely	O
related	O
to	O
that	O
of	O
IL	O
-	O
1	O
receptors	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
family	B-X
are	B-X
components	B-X
of	B-X
the	B-X
mammalian	B-X
anti-microbial	B-X
response	B-X
,	B-X
signaling	B-X
with	B-X
a	B-X
domain	B-X
closely	B-X
related	B-X
to	B-X
that	B-X
of	B-X
IL-1	B-X
receptors	B-X
.	B-X
In	B-X
this	B-X
report	B-X
the	B-X
expression	B-X
and	B-X
function	B-X
of	B-X
TLR1	B-X
,	B-X
a	B-X
TLR	B-X
of	B-X
unknown	B-X
function	B-X
,	B-X
are	B-X
examined	B-X
.	B-X
TLR1	B-X
is	B-X
expressed	B-X
by	B-X
monocytes	B-X
,	B-X
as	B-X
demonstrated	B-X
using	B-X
a	B-X
novel	B-X
mAb	B-X
.	B-X
Monocytes	B-X
also	B-X
express	B-X
TLR2	B-X
.	B-X
TLR1	B-X
transfection	B-X
of	B-X
HeLa	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
neither	B-X
TLR1	B-X
nor	B-X
TLR2	B-X
,	B-X
was	B-X
not	B-X
sufficient	B-X
to	B-X
confer	B-X
responsiveness	B-X
to	B-X
several	B-X
microbial	B-X
extracts	B-X
.	B-X
However	B-X
,	B-X
cotransfection	B-X
of	B-X
TLR1	B-X
and	B-X
TLR2	B-X
resulted	B-X
in	B-X
enhanced	B-X
signaling	B-X
by	B-X
HeLa	B-X
cells	B-X
to	B-X
soluble	B-X
factors	B-X
released	B-X
from	B-X
Neisseria	B-X
meningitidis	B-X
relative	B-X
to	B-X
the	B-X
response	B-X
with	B-X
either	B-X
TLR	B-X
alone	B-X
.	B-X
The	B-X
N.	B-X
meningitidis	B-X
factors	B-X
recognized	B-X
by	B-X
TLR1/TLR2	B-X
were	B-X
not	B-X
released	B-X
by	B-X
N.	B-X
meningitidis	B-X
mutant	B-X
in	B-X
the	B-X
LpxA	B-X
gene	B-X
.	B-X
Although	B-X
LpxA	B-X
is	B-X
required	B-X
for	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
because	B-X
cooperation	B-X
between	B-X
TLR1	B-X
and	B-X
TLR2	B-X
was	B-X
not	B-X
seen	B-X
with	B-X
all	B-X
LPS	B-X
preparations	B-X
,	B-X
the	B-X
microbial	B-X
component	B-X
(	B-X
s	B-X
)	B-X
TLR1/2	B-X
recognizes	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
a	B-X
complex	B-X
of	B-X
LPS	B-X
and	B-X
other	B-X
molecules	B-X
or	B-X
a	B-X
compound	B-X
metabolically	B-X
and	B-X
chemically	B-X
related	B-X
to	B-X
LPS	B-X
.	B-X
The	B-X
functional	B-X
IL-1R	B-X
consists	B-X
of	B-X
a	B-X
heterodimer	B-X
;	B-X
this	B-X
report	B-X
suggests	B-X
a	B-X
similar	B-X
mechanism	B-X
for	B-X
TLR1	B-X
and	B-X
TLR2	B-X
,	B-X
for	B-X
certain	B-X
agonists	B-X
.	B-X
These	B-X
data	B-X
further	B-X
suggest	B-X
that	B-X
mammalian	B-X
responsiveness	B-X
to	B-X
some	B-X
bacterial	B-X
products	B-X
may	B-X
be	B-X
mediated	B-X
by	B-X
combinations	B-X
of	B-X
TLRs	B-X
,	B-X
suggesting	B-X
a	B-X
mechanism	B-X
for	B-X
diversifying	B-X
the	B-X
repertoire	B-X
of	B-X
Toll-mediated	B-X
responses	B-X
.	B-X

In	O
this	O
report	O
the	O
expression	O
and	O
function	O
of	O
TLR1	B-Gene_or_gene_product
,	O
a	O
TLR	B-Gene_or_gene_product
of	O
unknown	O
function	O
,	O
are	O
examined	O
.	O
<EOS>	B-X
The	B-X
parasite	B-X
Leishmania	B-X
major	B-X
counteractively	B-X
modulates	B-X
TLR2	B-X
and	B-X
TLR9	B-X
expression	B-X
and	B-X
their	B-X
functions	B-X
.	B-X
Although	B-X
TLR1	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
,	B-X
and	B-X
TLR7	B-X
are	B-X
also	B-X
implicated	B-X
in	B-X
Leishmania	B-X
infection	B-X
,	B-X
whether	B-X
their	B-X
expression	B-X
was	B-X
altered	B-X
in	B-X
TLR2	B-X
or	B-X
TLR9	B-X
deficiency	B-X
remained	B-X
unknown	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
examined	B-X
TLR1	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
TLR7	B-X
expression	B-X
in	B-X
L.	B-X
major	B-X
infection	B-X
in	B-X
TLR2-deficient	B-X
or	B-X
TLR9-deficient	B-X
macrophages	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
TLR9-deficiency	B-X
reduced	B-X
TLR1	B-X
,	B-X
TLR2	B-X
and	B-X
TLR3	B-X
but	B-X
not	B-X
TLR7	B-X
expression	B-X
in	B-X
the	B-X
macrophages	B-X
treated	B-X
with	B-X
live	B-X
or	B-X
killed	B-X
L.	B-X
major	B-X
promastigotes	B-X
.	B-X
TLR2-deficiency	B-X
had	B-X
little	B-X
effects	B-X
by	B-X
comparison	B-X
.	B-X
TLR9-deficient	B-X
macrophages	B-X
had	B-X
reduced	B-X
CD40	B-X
expression	B-X
and	B-X
less	B-X
IL-12	B-X
and	B-X
TNF-	B-X
expression	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
TLR9	B-X
modulates	B-X
TLR1	B-X
,	B-X
TLR2	B-X
and	B-X
TLR3	B-X
,	B-X
but	B-X
not	B-X
TLR7	B-X
,	B-X
expression	B-X
in	B-X
L.	B-X
major-infected	B-X
macrophages	B-X
.	B-X

TLR1	B-Gene_or_gene_product
is	O
expressed	O
by	O
monocytes	O
,	O
as	O
demonstrated	O
using	O
a	O
novel	O
mAb	O
.	O
<EOS>	B-X
In	B-X
this	B-X
report	B-X
the	B-X
expression	B-X
and	B-X
function	B-X
of	B-X
TLR1	B-X
,	B-X
a	B-X
TLR	B-X
of	B-X
unknown	B-X
function	B-X
,	B-X
are	B-X
examined	B-X
.	B-X
TLR1	B-X
is	B-X
expressed	B-X
by	B-X
monocytes	B-X
,	B-X
as	B-X
demonstrated	B-X
using	B-X
a	B-X
novel	B-X
mAb	B-X
.	B-X
TLR1	B-X
transfection	B-X
of	B-X
HeLa	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
neither	B-X
TLR1	B-X
nor	B-X
TLR2	B-X
,	B-X
was	B-X
not	B-X
sufficient	B-X
to	B-X
confer	B-X
responsiveness	B-X
to	B-X
several	B-X
microbial	B-X
extracts	B-X
.	B-X
However	B-X
,	B-X
cotransfection	B-X
of	B-X
TLR1	B-X
and	B-X
TLR2	B-X
resulted	B-X
in	B-X
enhanced	B-X
signaling	B-X
by	B-X
HeLa	B-X
cells	B-X
to	B-X
soluble	B-X
factors	B-X
released	B-X
from	B-X
Neisseria	B-X
meningitidis	B-X
relative	B-X
to	B-X
the	B-X
response	B-X
with	B-X
either	B-X
TLR	B-X
alone	B-X
.	B-X
The	B-X
N.	B-X
meningitidis	B-X
factors	B-X
recognized	B-X
by	B-X
TLR1/TLR2	B-X
were	B-X
not	B-X
released	B-X
by	B-X
N.	B-X
meningitidis	B-X
mutant	B-X
in	B-X
the	B-X
LpxA	B-X
gene	B-X
.	B-X
Although	B-X
LpxA	B-X
is	B-X
required	B-X
for	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
because	B-X
cooperation	B-X
between	B-X
TLR1	B-X
and	B-X
TLR2	B-X
was	B-X
not	B-X
seen	B-X
with	B-X
all	B-X
LPS	B-X
preparations	B-X
,	B-X
the	B-X
microbial	B-X
component	B-X
(	B-X
s	B-X
)	B-X
TLR1/2	B-X
recognizes	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
a	B-X
complex	B-X
of	B-X
LPS	B-X
and	B-X
other	B-X
molecules	B-X
or	B-X
a	B-X
compound	B-X
metabolically	B-X
and	B-X
chemically	B-X
related	B-X
to	B-X
LPS	B-X
.	B-X
The	B-X
functional	B-X
IL-1R	B-X
consists	B-X
of	B-X
a	B-X
heterodimer	B-X
;	B-X
this	B-X
report	B-X
suggests	B-X
a	B-X
similar	B-X
mechanism	B-X
for	B-X
TLR1	B-X
and	B-X
TLR2	B-X
,	B-X
for	B-X
certain	B-X
agonists	B-X
.	B-X

Monocytes	O
also	O
express	O
TLR2	B-Gene_or_gene_product
.	O
<EOS>	B-X
PMAr	B-X
cells	B-X
retained	B-X
a	B-X
high	B-X
phagocytic	B-X
capacity	B-X
for	B-X
latex	B-X
beads	B-X
,	B-X
and	B-X
expressed	B-X
a	B-X
cytokine	B-X
profile	B-X
that	B-X
resembled	B-X
MDM	B-X
in	B-X
response	B-X
to	B-X
TLR	B-X
ligands	B-X
,	B-X
in	B-X
particular	B-X
with	B-X
marked	B-X
TLR2	B-X
responses	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
a	B-X
modified	B-X
PMA	B-X
differentiation	B-X
protocol	B-X
can	B-X
enhance	B-X
macrophage	B-X
differentiation	B-X
of	B-X
THP-1	B-X
cells	B-X
and	B-X
identify	B-X
increased	B-X
numbers	B-X
of	B-X
mitochondria	B-X
and	B-X
lysosomes	B-X
,	B-X
resistance	B-X
to	B-X
apoptosis	B-X
and	B-X
the	B-X
potency	B-X
of	B-X
TLR2	B-X
responses	B-X
as	B-X
important	B-X
discriminators	B-X
of	B-X
the	B-X
level	B-X
of	B-X
macrophage	B-X
differentiation	B-X
for	B-X
transformed	B-X
cells	B-X
.	B-X
In	B-X
atopic	B-X
dermatitis	B-X
(	B-X
AD	B-X
)	B-X
,	B-X
monocytes	B-X
,	B-X
which	B-X
accumulate	B-X
in	B-X
the	B-X
inflamed	B-X
skin	B-X
,	B-X
are	B-X
characterized	B-X
by	B-X
a	B-X
significantly	B-X
impaired	B-X
Toll-like	B-X
receptors	B-X
(	B-X
TLR	B-X
)	B-X
expression	B-X
and	B-X
TLR2-mediated	B-X
cytokine	B-X
secretion	B-X
.	B-X
However	B-X
,	B-X
data	B-X
on	B-X
expression	B-X
of	B-X
TLR	B-X
on	B-X
monocytes	B-X
of	B-X
peripheral	B-X
blood	B-X
(	B-X
PB	B-X
)	B-X
in	B-X
AD	B-X
are	B-X
not	B-X
available	B-X
.	B-X

TLR1	B-Gene_or_gene_product
transfection	O
of	O
HeLa	O
cells	O
,	O
which	O
express	O
neither	O
TLR1	B-Gene_or_gene_product
nor	O
TLR2	B-Gene_or_gene_product
,	O
was	O
not	O
sufficient	O
to	O
confer	O
responsiveness	O
to	O
several	O
microbial	O
extracts	O
.	O
<EOS>	B-X
It	B-X
has	B-X
been	B-X
demonstrated	B-X
that	B-X
curli	B-X
and	B-X
-amyloid	B-X
are	B-X
recognized	B-X
by	B-X
the	B-X
immune	B-X
system	B-X
via	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
2/TLR1	B-X
complex	B-X
.	B-X
We	B-X
used	B-X
HeLa	B-X
57A	B-X
cells	B-X
,	B-X
a	B-X
human	B-X
cervical	B-X
cancer	B-X
cell	B-X
line	B-X
containing	B-X
a	B-X
luciferase	B-X
reporter	B-X
gene	B-X
under	B-X
the	B-X
control	B-X
of	B-X
an	B-X
NF-B	B-X
promoter	B-X
.	B-X
When	B-X
HeLa	B-X
57A	B-X
cells	B-X
were	B-X
transiently	B-X
transfected	B-X
with	B-X
combinations	B-X
of	B-X
human	B-X
expression	B-X
vectors	B-X
containing	B-X
genes	B-X
for	B-X
TLR2	B-X
,	B-X
TLR1	B-X
,	B-X
and	B-X
CD14	B-X
,	B-X
membrane-bound	B-X
CD14	B-X
enhanced	B-X
NF-B	B-X
activation	B-X
through	B-X
the	B-X
TLR2/TLR1	B-X
complex	B-X
stimulated	B-X
with	B-X
curli	B-X
fibers	B-X
or	B-X
recombinant	B-X
CsgA	B-X
,	B-X
the	B-X
curli	B-X
major	B-X
subunit	B-X
.	B-X
Similarly	B-X
,	B-X
soluble	B-X
CD14	B-X
augmented	B-X
the	B-X
TLR2/TLR1	B-X
response	B-X
to	B-X
curli	B-X
fibers	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
membrane-bound	B-X
CD14	B-X
.	B-X
We	B-X
further	B-X
revealed	B-X
that	B-X
IL-6	B-X
and	B-X
nitric	B-X
oxide	B-X
production	B-X
were	B-X
significantly	B-X
higher	B-X
by	B-X
wild-type	B-X
(	B-X
C57BL/6	B-X
)	B-X
bone	B-X
marrow-derived	B-X
macrophages	B-X
compared	B-X
with	B-X
TLR2-deficient	B-X
or	B-X
CD14-deficient	B-X
bone	B-X
marrow-derived	B-X
macrophages	B-X
when	B-X
stimulated	B-X
with	B-X
curli	B-X
fibers	B-X
,	B-X
recombinant	B-X
CsgA	B-X
,	B-X
or	B-X
synthetic	B-X
CsgA	B-X
peptide	B-X
,	B-X
CsgA-R4-5	B-X
.	B-X
Binding	B-X
assays	B-X
demonstrated	B-X
that	B-X
recombinant	B-X
TLR2	B-X
,	B-X
TLR1	B-X
,	B-X
and	B-X
CD14	B-X
bound	B-X
purified	B-X
curli	B-X
fibers	B-X
.	B-X
Activation	B-X
of	B-X
the	B-X
TLR2/TLR1/CD14	B-X
trimolecular	B-X
complex	B-X
by	B-X
amyloids	B-X
provides	B-X
novel	B-X
insights	B-X
for	B-X
innate	B-X
immunity	B-X
with	B-X
implications	B-X
for	B-X
amyloid-associated	B-X
diseases	B-X
.	B-X

However	O
,	O
cotransfection	O
of	O
TLR1	B-Gene_or_gene_product
and	O
TLR2	B-Gene_or_gene_product
resulted	O
in	O
enhanced	O
signaling	O
by	O
HeLa	O
cells	O
to	O
soluble	O
factors	O
released	O
from	O
Neisseria	O
meningitidis	O
relative	O
to	O
the	O
response	O
with	O
either	O
TLR	B-Gene_or_gene_product
alone	O
.	O

This	O
phenomenon	O
was	O
also	O
seen	O
with	O
high	O
concentrations	O
of	O
some	O
preparations	O
of	O
LPS	O
.	O
<EOS>	B-X
Monocytes	B-X
also	B-X
express	B-X
TLR2	B-X
.	B-X
This	B-X
phenomenon	B-X
was	B-X
also	B-X
seen	B-X
with	B-X
high	B-X
concentrations	B-X
of	B-X
some	B-X
preparations	B-X
of	B-X
LPS	B-X
.	B-X
Although	B-X
LpxA	B-X
is	B-X
required	B-X
for	B-X
LPS	B-X
biosynthesis	B-X
,	B-X
because	B-X
cooperation	B-X
between	B-X
TLR1	B-X
and	B-X
TLR2	B-X
was	B-X
not	B-X
seen	B-X
with	B-X
all	B-X
LPS	B-X
preparations	B-X
,	B-X
the	B-X
microbial	B-X
component	B-X
(	B-X
s	B-X
)	B-X
TLR1/2	B-X
recognizes	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
a	B-X
complex	B-X
of	B-X
LPS	B-X
and	B-X
other	B-X
molecules	B-X
or	B-X
a	B-X
compound	B-X
metabolically	B-X
and	B-X
chemically	B-X
related	B-X
to	B-X
LPS	B-X
.	B-X
Bacterial	B-X
endotoxin	B-X
,	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
,	B-X
is	B-X
a	B-X
causative	B-X
agent	B-X
of	B-X
Gram-negative	B-X
septic	B-X
shock	B-X
.	B-X
However	B-X
,	B-X
if	B-X
preadministered	B-X
at	B-X
a	B-X
low	B-X
dose	B-X
,	B-X
LPS	B-X
makes	B-X
mice	B-X
resistant	B-X
to	B-X
subsequent	B-X
endotoxin	B-X
challenge	B-X
,	B-X
the	B-X
phenomenon	B-X
known	B-X
as	B-X
LPS	B-X
tolerance	B-X
.	B-X
Here	B-X
we	B-X
demonstrated	B-X
that	B-X
the	B-X
pharmaceutical	B-X
preparation	B-X
of	B-X
Gram-positive	B-X
Streptococcus	B-X
pyogenes	B-X
,	B-X
OK-432	B-X
,	B-X
also	B-X
induced	B-X
a	B-X
state	B-X
analogous	B-X
to	B-X
LPS	B-X
tolerance	B-X
if	B-X
administered	B-X
6-48	B-X
h	B-X
prior	B-X
to	B-X
LPS	B-X
challenge	B-X
.	B-X
The	B-X
preadministration	B-X
of	B-X
OK-432	B-X
increased	B-X
the	B-X
lethal	B-X
dose	B-X
of	B-X
LPS	B-X
threefold	B-X
in	B-X
BDF1	B-X
mice	B-X
,	B-X
and	B-X
this	B-X
was	B-X
accompanied	B-X
by	B-X
reduced	B-X
gene	B-X
expression	B-X
of	B-X
IL-6	B-X
,	B-X
IFN-gamma	B-X
,	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
,	B-X
and	B-X
IL-10	B-X
in	B-X
spleen	B-X
and	B-X
peritoneal	B-X
cells	B-X
.	B-X
Serum	B-X
concentrations	B-X
of	B-X
IL-6	B-X
and	B-X
IFN-gamma	B-X
were	B-X
also	B-X
suppressed	B-X
by	B-X
the	B-X
preadministration	B-X
of	B-X
OK-432	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
the	B-X
LPS	B-X
tolerance	B-X
,	B-X
the	B-X
levels	B-X
of	B-X
TNF-alpha	B-X
mRNA	B-X
were	B-X
not	B-X
suppressed	B-X
in	B-X
OK-432-administered	B-X
mice	B-X
,	B-X
and	B-X
their	B-X
peritoneal	B-X
cells	B-X
produced	B-X
high	B-X
levels	B-X
of	B-X
TNF-alpha	B-X
and	B-X
soluble	B-X
TNF	B-X
receptor	B-X
p75	B-X
in	B-X
response	B-X
to	B-X
LPS	B-X
in	B-X
vitro	B-X
.	B-X
Peritoneal	B-X
cells	B-X
from	B-X
OK-432	B-X
but	B-X
not	B-X
LPS-administered	B-X
mice	B-X
were	B-X
hyporesponsive	B-X
to	B-X
IFN-gamma	B-X
in	B-X
terms	B-X
of	B-X
nitric	B-X
oxide	B-X
synthesis	B-X
,	B-X
and	B-X
this	B-X
hyporesponsiveness	B-X
to	B-X
IFN-gamma	B-X
was	B-X
abrogated	B-X
by	B-X
anti-IL-10	B-X
antibodies	B-X
.	B-X
Likewise	B-X
,	B-X
peritoneal	B-X
cells	B-X
from	B-X
both	B-X
OK-432-	B-X
and	B-X
LPS-administered	B-X
mice	B-X
were	B-X
hyporesponsive	B-X
to	B-X
LPS	B-X
,	B-X
serum	B-X
,	B-X
TNF-alpha	B-X
,	B-X
IFN-gamma	B-X
,	B-X
and	B-X
PMA	B-X
in	B-X
terms	B-X
of	B-X
IL-6	B-X
production	B-X
.	B-X
Anti-IL-10	B-X
antibodies	B-X
increased	B-X
IL-6	B-X
production	B-X
eightfold	B-X
in	B-X
cells	B-X
from	B-X
OK-432-administered	B-X
mice	B-X
,	B-X
but	B-X
marginally	B-X
in	B-X
cells	B-X
from	B-X
LPS-administered	B-X
mice	B-X
.	B-X

The	O
N	O
.	O
meningitidis	O
factors	O
recognized	O
by	O
TLR1	B-Gene_or_gene_product
/	O
TLR2	B-Gene_or_gene_product
were	O
not	O
released	O
by	O
N	O
.	O
meningitidis	O
mutant	O
in	O
the	O
LpxA	B-Gene_or_gene_product
gene	O
.	O

Although	O
LpxA	B-Gene_or_gene_product
is	O
required	O
for	O
LPS	O
biosynthesis	O
,	O
because	O
cooperation	O
between	O
TLR1	B-Gene_or_gene_product
and	O
TLR2	B-Gene_or_gene_product
was	O
not	O
seen	O
with	O
all	O
LPS	O
preparations	O
,	O
the	O
microbial	O
component	O
(	O
s	O
)	O
TLR1	B-Gene_or_gene_product
/	O
2	B-Gene_or_gene_product
recognizes	O
is	O
likely	O
to	O
be	O
a	O
complex	O
of	O
LPS	O
and	O
other	O
molecules	O
or	O
a	O
compound	O
metabolically	O
and	O
chemically	O
related	O
to	O
LPS	O
.	O
<EOS>	B-X
As	B-X
excessive	B-X
inflammatory	B-X
cytokines	B-X
released	B-X
by	B-X
macrophages	B-X
are	B-X
a	B-X
critical	B-X
cause	B-X
of	B-X
liver	B-X
injury	B-X
,	B-X
we	B-X
aimed	B-X
to	B-X
find	B-X
novel	B-X
compounds	B-X
that	B-X
could	B-X
inhibit	B-X
macrophage	B-X
expression	B-X
of	B-X
inflammatory	B-X
cytokines	B-X
and	B-X
alleviate	B-X
liver	B-X
injury	B-X
.	B-X
Homeostasis	B-X
dysfunction	B-X
in	B-X
M1/M2	B-X
macrophage	B-X
polarization	B-X
causes	B-X
pathological	B-X
conditions	B-X
and	B-X
inflammation	B-X
.	B-X
Decreased	B-X
neuroinflammation	B-X
can	B-X
be	B-X
obtained	B-X
by	B-X
using	B-X
natural	B-X
compounds	B-X
,	B-X
including	B-X
flavonoids	B-X
,	B-X
which	B-X
are	B-X
known	B-X
to	B-X
ameliorate	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
found	B-X
that	B-X
quercetin	B-X
effectively	B-X
inhibited	B-X
the	B-X
expression	B-X
of	B-X
lipocalin-2	B-X
in	B-X
both	B-X
macrophages	B-X
and	B-X
microglial	B-X
cells	B-X
stimulated	B-X
by	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
The	B-X
production	B-X
of	B-X
nitric	B-X
oxide	B-X
(	B-X
NO	B-X
)	B-X
and	B-X
expression	B-X
levels	B-X
of	B-X
the	B-X
pro-inflammatory	B-X
cytokines	B-X
,	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
(	B-X
iNOS	B-X
)	B-X
and	B-X
cyclooxygenase	B-X
(	B-X
COX	B-X
)	B-X
-2	B-X
,	B-X
were	B-X
also	B-X
attenuated	B-X
by	B-X
quercetin	B-X
treatment	B-X
.	B-X
The	B-X
M1	B-X
polarization-associated	B-X
chemokines	B-X
,	B-X
C-C	B-X
motif	B-X
chemokine	B-X
ligand	B-X
(	B-X
CCL	B-X
)	B-X
-2	B-X
and	B-X
C-X-C	B-X
motif	B-X
chemokine	B-X
ligand	B-X
(	B-X
CXCL	B-X
)	B-X
-10	B-X
,	B-X
were	B-X
also	B-X
effectively	B-X
reduced	B-X
by	B-X
the	B-X
quercetin	B-X
treatment	B-X
.	B-X
The	B-X
microglial	B-X
phagocytic	B-X
ability	B-X
induced	B-X
by	B-X
the	B-X
LPS	B-X
was	B-X
also	B-X
effectively	B-X
reduced	B-X
by	B-X
the	B-X
quercetin	B-X
treatment	B-X
.	B-X
Importantly	B-X
,	B-X
the	B-X
quercetin	B-X
increased	B-X
the	B-X
expression	B-X
levels	B-X
of	B-X
the	B-X
M2	B-X
marker	B-X
,	B-X
IL-10	B-X
,	B-X
and	B-X
the	B-X
endogenous	B-X
antioxidants	B-X
,	B-X
heme	B-X
oxygenase	B-X
(	B-X
HO	B-X
)	B-X
-1	B-X
,	B-X
glutamate-cysteine	B-X
ligase	B-X
catalytic	B-X
subunit	B-X
(	B-X
GCLC	B-X
)	B-X
,	B-X
glutamate-cysteine	B-X
ligase	B-X
modifier	B-X
subunit	B-X
(	B-X
GCLM	B-X
)	B-X
,	B-X
and	B-X
NAD	B-X
(	B-X
P	B-X
)	B-X
H	B-X
quinone	B-X
oxidoreductase-1	B-X
(	B-X
NQO1	B-X
)	B-X
.	B-X
The	B-X
enhancement	B-X
of	B-X
the	B-X
M2	B-X
markers	B-X
and	B-X
endogenous	B-X
antioxidants	B-X
by	B-X
quercetin	B-X
was	B-X
activated	B-X
by	B-X
the	B-X
AMP-activated	B-X
protein	B-X
kinase	B-X
(	B-X
AMPK	B-X
)	B-X
and	B-X
Akt	B-X
signaling	B-X
pathways	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
quercetin	B-X
enhanced	B-X
the	B-X
M2	B-X
macrophage	B-X
polarization	B-X
and	B-X
endogenous	B-X
antioxidant	B-X
expression	B-X
in	B-X
both	B-X
macrophages	B-X
and	B-X
microglia	B-X
.	B-X
Our	B-X
findings	B-X
provide	B-X
valuable	B-X
information	B-X
that	B-X
quercetin	B-X
may	B-X
act	B-X
as	B-X
a	B-X
potential	B-X
drug	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
diseases	B-X
related	B-X
to	B-X
inflammatory	B-X
disorders	B-X
in	B-X
the	B-X
central	B-X
nervous	B-X
system	B-X
.	B-X

The	O
functional	O
IL	O
-	O
1R	O
consists	O
of	O
a	O
heterodimer	O
;	O
this	O
report	O
suggests	O
a	O
similar	O
mechanism	O
for	O
TLR1	B-Gene_or_gene_product
and	O
TLR2	B-Gene_or_gene_product
,	O
for	O
certain	O
agonists	O
.	O
<EOS>	B-X
IL-33	B-X
,	B-X
a	B-X
new	B-X
member	B-X
of	B-X
the	B-X
IL-1F	B-X
,	B-X
is	B-X
widely	B-X
expressed	B-X
throughout	B-X
the	B-X
body	B-X
and	B-X
can	B-X
be	B-X
up-regulated	B-X
by	B-X
stimulation	B-X
with	B-X
proinflammatory	B-X
factors	B-X
.	B-X
It	B-X
has	B-X
been	B-X
identified	B-X
as	B-X
a	B-X
functional	B-X
ligand	B-X
for	B-X
the	B-X
plasma	B-X
membrane	B-X
receptor	B-X
complex	B-X
that	B-X
is	B-X
a	B-X
heterodimer	B-X
consisting	B-X
of	B-X
membrane-bound	B-X
ST2L	B-X
,	B-X
which	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
IL-1R	B-X
family	B-X
,	B-X
and	B-X
IL-1RAcP	B-X
.	B-X
IL-33	B-X
is	B-X
crucial	B-X
for	B-X
the	B-X
induction	B-X
of	B-X
Th2	B-X
immune	B-X
responses	B-X
.	B-X
Recently	B-X
,	B-X
many	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
IL-33	B-X
may	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
and	B-X
progression	B-X
of	B-X
fibrotic	B-X
diseases	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
the	B-X
biologic	B-X
characteristics	B-X
of	B-X
IL-33	B-X
and	B-X
the	B-X
role	B-X
of	B-X
the	B-X
IL-33/ST2	B-X
signaling	B-X
pathway	B-X
in	B-X
various	B-X
fibrotic	B-X
diseases	B-X
will	B-X
be	B-X
discussed	B-X
.	B-X

These	O
data	O
further	O
suggest	O
that	O
mammalian	O
responsiveness	O
to	O
some	O
bacterial	O
products	O
may	O
be	O
mediated	O
by	O
combinations	O
of	O
TLRs	B-Gene_or_gene_product
,	O
suggesting	O
a	O
mechanism	O
for	O
diversifying	O
the	O
repertoire	O
of	O
Toll	B-Gene_or_gene_product
-	O
mediated	O
responses	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
family	B-X
are	B-X
components	B-X
of	B-X
the	B-X
mammalian	B-X
anti-microbial	B-X
response	B-X
,	B-X
signaling	B-X
with	B-X
a	B-X
domain	B-X
closely	B-X
related	B-X
to	B-X
that	B-X
of	B-X
IL-1	B-X
receptors	B-X
.	B-X
TLR1	B-X
transfection	B-X
of	B-X
HeLa	B-X
cells	B-X
,	B-X
which	B-X
express	B-X
neither	B-X
TLR1	B-X
nor	B-X
TLR2	B-X
,	B-X
was	B-X
not	B-X
sufficient	B-X
to	B-X
confer	B-X
responsiveness	B-X
to	B-X
several	B-X
microbial	B-X
extracts	B-X
.	B-X
The	B-X
functional	B-X
IL-1R	B-X
consists	B-X
of	B-X
a	B-X
heterodimer	B-X
;	B-X
this	B-X
report	B-X
suggests	B-X
a	B-X
similar	B-X
mechanism	B-X
for	B-X
TLR1	B-X
and	B-X
TLR2	B-X
,	B-X
for	B-X
certain	B-X
agonists	B-X
.	B-X
These	B-X
data	B-X
further	B-X
suggest	B-X
that	B-X
mammalian	B-X
responsiveness	B-X
to	B-X
some	B-X
bacterial	B-X
products	B-X
may	B-X
be	B-X
mediated	B-X
by	B-X
combinations	B-X
of	B-X
TLRs	B-X
,	B-X
suggesting	B-X
a	B-X
mechanism	B-X
for	B-X
diversifying	B-X
the	B-X
repertoire	B-X
of	B-X
Toll-mediated	B-X
responses	B-X
.	B-X

PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
M	I-Gene_or_gene_product
transfers	O
the	O
first	O
mannose	O
to	O
glycosylphosphatidylinositol	O
on	O
the	O
lumenal	O
side	O
of	O
the	O
ER	O
.	O
<EOS>	B-X
In	B-X
particular	B-X
,	B-X
mammalian	B-X
and	B-X
protozoan	B-X
mannosyltransferases	B-X
needed	B-X
for	B-X
addition	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
(	B-X
GPI-MT-I	B-X
)	B-X
have	B-X
different	B-X
substrate	B-X
specificities	B-X
and	B-X
are	B-X
targets	B-X
of	B-X
species-	B-X
specific	B-X
inhibitors	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
a	B-X
human	B-X
cell	B-X
line	B-X
defective	B-X
in	B-X
GPI-MT-I	B-X
and	B-X
the	B-X
gene	B-X
responsible	B-X
,	B-X
PIG-M.	B-X
PIG-M	B-X
encodes	B-X
a	B-X
new	B-X
type	B-X
of	B-X
mannosyltransferase	B-X
of	B-X
423	B-X
amino	B-X
acids	B-X
,	B-X
bearing	B-X
multiple	B-X
transmembrane	B-X
domains	B-X
.	B-X
PIG-M	B-X
has	B-X
a	B-X
functionally	B-X
important	B-X
DXD	B-X
motif	B-X
,	B-X
a	B-X
characteristic	B-X
of	B-X
many	B-X
glycosyltransferases	B-X
,	B-X
within	B-X
a	B-X
domain	B-X
facing	B-X
the	B-X
lumen	B-X
of	B-X
the	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
,	B-X
indicating	B-X
that	B-X
transfer	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
to	B-X
GPI	B-X
occurs	B-X
on	B-X
the	B-X
lumenal	B-X
side	B-X
of	B-X
the	B-X
ER	B-X
membrane	B-X
.	B-X

Glycosylphosphatidylinositol	O
(	O
GPI	O
)	O
acts	O
as	O
a	O
membrane	O
anchor	O
of	O
many	O
cell	O
surface	O
proteins	O
.	O
<EOS>	B-X
Glycosyl-phosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
is	B-X
a	B-X
complex	B-X
glycolipid	B-X
structure	B-X
that	B-X
acts	B-X
as	B-X
a	B-X
membrane	B-X
anchor	B-X
for	B-X
many	B-X
cell-surface	B-X
proteins	B-X
of	B-X
eukaryotes	B-X
.	B-X
GPI-anchored	B-X
proteins	B-X
are	B-X
particularly	B-X
abundant	B-X
in	B-X
protozoa	B-X
such	B-X
as	B-X
Trypanosoma	B-X
brucei	B-X
,	B-X
Leishmania	B-X
major	B-X
,	B-X
Plasmodium	B-X
falciparum	B-X
and	B-X
Toxoplasma	B-X
gondii	B-X
,	B-X
and	B-X
represent	B-X
the	B-X
major	B-X
carbohydrate	B-X
modification	B-X
of	B-X
many	B-X
cell-surface	B-X
parasite	B-X
proteins	B-X
.	B-X
Although	B-X
the	B-X
GPI	B-X
core	B-X
glycan	B-X
is	B-X
conserved	B-X
in	B-X
all	B-X
organisms	B-X
,	B-X
many	B-X
differences	B-X
in	B-X
additional	B-X
modifications	B-X
to	B-X
GPI	B-X
structures	B-X
and	B-X
biosynthetic	B-X
pathways	B-X
have	B-X
been	B-X
reported	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
characteristics	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
are	B-X
currently	B-X
being	B-X
explored	B-X
for	B-X
the	B-X
development	B-X
of	B-X
parasite-specific	B-X
inhibitors	B-X
.	B-X
In	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
studies	B-X
using	B-X
sugars	B-X
and	B-X
substrate	B-X
analogues	B-X
as	B-X
well	B-X
as	B-X
natural	B-X
compounds	B-X
have	B-X
shown	B-X
that	B-X
it	B-X
is	B-X
possible	B-X
to	B-X
interfere	B-X
with	B-X
GPI	B-X
biosynthesis	B-X
at	B-X
different	B-X
steps	B-X
in	B-X
a	B-X
species-specific	B-X
manner	B-X
.	B-X
Here	B-X
we	B-X
review	B-X
the	B-X
recent	B-X
and	B-X
promising	B-X
progress	B-X
in	B-X
the	B-X
field	B-X
of	B-X
GPI	B-X
inhibition	B-X
.	B-X

Its	O
structure	O
and	O
biosynthetic	O
pathway	O
are	O
generally	O
conserved	O
among	O
eukaryotic	O
organisms	O
,	O
with	O
a	O
number	O
of	O
differences	O
.	O
<EOS>	B-X
The	B-X
monoxenic	B-X
organisms	B-X
revealed	B-X
conserved	B-X
housekeeping	B-X
functions	B-X
when	B-X
compared	B-X
to	B-X
other	B-X
trypanosomatids	B-X
,	B-X
especially	B-X
compared	B-X
with	B-X
Leishmania	B-X
major	B-X
.	B-X
However	B-X
,	B-X
major	B-X
differences	B-X
were	B-X
found	B-X
in	B-X
ORFs	B-X
corresponding	B-X
to	B-X
the	B-X
cytoskeleton	B-X
,	B-X
the	B-X
kinetoplast	B-X
,	B-X
and	B-X
the	B-X
paraflagellar	B-X
structure	B-X
.	B-X
The	B-X
monoxenic	B-X
organisms	B-X
also	B-X
contain	B-X
a	B-X
large	B-X
number	B-X
of	B-X
genes	B-X
for	B-X
cytosolic	B-X
calpain-like	B-X
and	B-X
surface	B-X
gp63	B-X
metalloproteases	B-X
and	B-X
a	B-X
reduced	B-X
number	B-X
of	B-X
compartmentalized	B-X
cysteine	B-X
proteases	B-X
in	B-X
comparison	B-X
to	B-X
other	B-X
TriTryp	B-X
organisms	B-X
,	B-X
reflecting	B-X
adaptations	B-X
to	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
symbiont	B-X
.	B-X
The	B-X
assembled	B-X
bacterial	B-X
endosymbiont	B-X
sequences	B-X
exhibit	B-X
a	B-X
high	B-X
A+T	B-X
content	B-X
with	B-X
a	B-X
total	B-X
of	B-X
787	B-X
and	B-X
769	B-X
ORFs	B-X
for	B-X
the	B-X
Angomonas	B-X
deanei	B-X
and	B-X
Strigomonas	B-X
culicis	B-X
endosymbionts	B-X
,	B-X
respectively	B-X
,	B-X
and	B-X
indicate	B-X
that	B-X
these	B-X
organisms	B-X
hold	B-X
a	B-X
common	B-X
ancestor	B-X
related	B-X
to	B-X
the	B-X
Alcaligenaceae	B-X
family	B-X
.	B-X
Importantly	B-X
,	B-X
both	B-X
symbionts	B-X
contain	B-X
enzymes	B-X
that	B-X
complement	B-X
essential	B-X
host	B-X
cell	B-X
biosynthetic	B-X
pathways	B-X
,	B-X
such	B-X
as	B-X
those	B-X
for	B-X
amino	B-X
acid	B-X
,	B-X
lipid	B-X
and	B-X
purine/pyrimidine	B-X
metabolism	B-X
.	B-X
These	B-X
findings	B-X
increase	B-X
our	B-X
understanding	B-X
of	B-X
the	B-X
intricate	B-X
symbiotic	B-X
relationship	B-X
between	B-X
the	B-X
bacterium	B-X
and	B-X
the	B-X
trypanosomatid	B-X
host	B-X
and	B-X
provide	B-X
clues	B-X
to	B-X
better	B-X
understand	B-X
eukaryotic	B-X
cell	B-X
evolution	B-X
.	B-X

In	O
particular	O
,	O
mammalian	O
and	O
protozoan	O
mannosyltransferases	B-Gene_or_gene_product
needed	O
for	O
addition	O
of	O
the	O
first	O
mannose	O
(	O
GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
)	O
have	O
different	O
substrate	O
specificities	O
and	O
are	O
targets	O
of	O
species	O
-	O
specific	O
inhibitors	O
of	O
GPI	O
biosynthesis	O
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
acts	B-X
as	B-X
a	B-X
membrane	B-X
anchor	B-X
of	B-X
many	B-X
cell	B-X
surface	B-X
proteins	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
mammalian	B-X
and	B-X
protozoan	B-X
mannosyltransferases	B-X
needed	B-X
for	B-X
addition	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
(	B-X
GPI-MT-I	B-X
)	B-X
have	B-X
different	B-X
substrate	B-X
specificities	B-X
and	B-X
are	B-X
targets	B-X
of	B-X
species-	B-X
specific	B-X
inhibitors	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
.	B-X
GPI-MT-I	B-X
,	B-X
however	B-X
,	B-X
has	B-X
not	B-X
been	B-X
molecularly	B-X
characterized	B-X
.	B-X
Characterization	B-X
of	B-X
GPI-MT-I	B-X
would	B-X
also	B-X
help	B-X
to	B-X
clarify	B-X
the	B-X
topology	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
a	B-X
human	B-X
cell	B-X
line	B-X
defective	B-X
in	B-X
GPI-MT-I	B-X
and	B-X
the	B-X
gene	B-X
responsible	B-X
,	B-X
PIG-M.	B-X
PIG-M	B-X
encodes	B-X
a	B-X
new	B-X
type	B-X
of	B-X
mannosyltransferase	B-X
of	B-X
423	B-X
amino	B-X
acids	B-X
,	B-X
bearing	B-X
multiple	B-X
transmembrane	B-X
domains	B-X
.	B-X
PIG-M	B-X
has	B-X
a	B-X
functionally	B-X
important	B-X
DXD	B-X
motif	B-X
,	B-X
a	B-X
characteristic	B-X
of	B-X
many	B-X
glycosyltransferases	B-X
,	B-X
within	B-X
a	B-X
domain	B-X
facing	B-X
the	B-X
lumen	B-X
of	B-X
the	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
,	B-X
indicating	B-X
that	B-X
transfer	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
to	B-X
GPI	B-X
occurs	B-X
on	B-X
the	B-X
lumenal	B-X
side	B-X
of	B-X
the	B-X
ER	B-X
membrane	B-X
.	B-X

GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
,	O
however	O
,	O
has	O
not	O
been	O
molecularly	O
characterized	O
.	O
<EOS>	B-X
Paroxysmal	B-X
nocturnal	B-X
hemoglobinuria	B-X
(	B-X
PNH	B-X
)	B-X
is	B-X
a	B-X
rare	B-X
hematopoietic	B-X
stem	B-X
cell	B-X
disorder	B-X
characterized	B-X
by	B-X
a	B-X
somatic	B-X
mutation	B-X
in	B-X
the	B-X
PIGA	B-X
gene	B-X
,	B-X
leading	B-X
to	B-X
a	B-X
deficiency	B-X
of	B-X
proteins	B-X
linked	B-X
to	B-X
the	B-X
cell	B-X
membrane	B-X
via	B-X
glycophosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
anchors	B-X
.	B-X
While	B-X
flow	B-X
cytometry	B-X
is	B-X
the	B-X
method	B-X
of	B-X
choice	B-X
for	B-X
identifying	B-X
cells	B-X
deficient	B-X
in	B-X
GPI-linked	B-X
proteins	B-X
and	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
necessary	B-X
for	B-X
the	B-X
diagnosis	B-X
of	B-X
PNH	B-X
,	B-X
to	B-X
date	B-X
there	B-X
has	B-X
not	B-X
been	B-X
an	B-X
attempt	B-X
to	B-X
standardize	B-X
the	B-X
methodology	B-X
used	B-X
to	B-X
identify	B-X
these	B-X
cells	B-X
.	B-X
In	B-X
patients	B-X
with	B-X
acute	B-X
myocardial	B-X
infarction	B-X
(	B-X
AMI	B-X
)	B-X
,	B-X
glycoprotein	B-X
IIb/IIIa	B-X
inhibitors	B-X
(	B-X
GPI	B-X
)	B-X
reduce	B-X
thrombus	B-X
burden	B-X
and	B-X
improve	B-X
myocardial	B-X
perfusion	B-X
.	B-X
However	B-X
,	B-X
as	B-X
higher	B-X
local	B-X
concentrations	B-X
of	B-X
GPI	B-X
are	B-X
associated	B-X
with	B-X
enhanced	B-X
platelet	B-X
inhibition	B-X
,	B-X
intralesional	B-X
(	B-X
IL	B-X
)	B-X
GPI	B-X
administration	B-X
may	B-X
be	B-X
particularly	B-X
effective	B-X
in	B-X
cases	B-X
of	B-X
HTB	B-X
.	B-X
Modest-sized	B-X
randomized	B-X
trials	B-X
comparing	B-X
IL	B-X
and	B-X
IC	B-X
GPI	B-X
delivery	B-X
have	B-X
reported	B-X
conflicting	B-X
outcomes	B-X
.	B-X
Some	B-X
trials	B-X
have	B-X
demonstrated	B-X
improved	B-X
coronary	B-X
flow	B-X
and	B-X
myocardial	B-X
perfusion	B-X
with	B-X
reduced	B-X
major	B-X
adverse	B-X
cardiac	B-X
events	B-X
with	B-X
IL	B-X
compared	B-X
with	B-X
IC	B-X
GPI	B-X
administration	B-X
,	B-X
whereas	B-X
others	B-X
have	B-X
shown	B-X
no	B-X
significant	B-X
benefits	B-X
.	B-X
Furthermore	B-X
,	B-X
although	B-X
no	B-X
direct	B-X
comparison	B-X
has	B-X
been	B-X
made	B-X
between	B-X
IL	B-X
delivery	B-X
using	B-X
an	B-X
aspiration	B-X
catheter	B-X
,	B-X
microcatheter	B-X
or	B-X
a	B-X
dedicated	B-X
balloon-based	B-X
``	B-X
weeping	B-X
''	B-X
infusion-catheter	B-X
,	B-X
improved	B-X
outcomes	B-X
have	B-X
been	B-X
most	B-X
consistent	B-X
following	B-X
GPI	B-X
administration	B-X
at	B-X
the	B-X
site	B-X
of	B-X
the	B-X
lesion	B-X
and	B-X
thrombus	B-X
with	B-X
the	B-X
dedicated	B-X
infusion	B-X
catheter	B-X
.	B-X
This	B-X
review	B-X
provides	B-X
an	B-X
update	B-X
on	B-X
the	B-X
role	B-X
and	B-X
outcomes	B-X
of	B-X
IL	B-X
GPI	B-X
administration	B-X
in	B-X
patients	B-X
with	B-X
AMI	B-X
and	B-X
HTB	B-X
.	B-X

Characterization	O
of	O
GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
would	O
also	O
help	O
to	O
clarify	O
the	O
topology	O
of	O
GPI	O
biosynthesis	O
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
acts	B-X
as	B-X
a	B-X
membrane	B-X
anchor	B-X
of	B-X
many	B-X
cell	B-X
surface	B-X
proteins	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
mammalian	B-X
and	B-X
protozoan	B-X
mannosyltransferases	B-X
needed	B-X
for	B-X
addition	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
(	B-X
GPI-MT-I	B-X
)	B-X
have	B-X
different	B-X
substrate	B-X
specificities	B-X
and	B-X
are	B-X
targets	B-X
of	B-X
species-	B-X
specific	B-X
inhibitors	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
.	B-X
GPI-MT-I	B-X
,	B-X
however	B-X
,	B-X
has	B-X
not	B-X
been	B-X
molecularly	B-X
characterized	B-X
.	B-X
Characterization	B-X
of	B-X
GPI-MT-I	B-X
would	B-X
also	B-X
help	B-X
to	B-X
clarify	B-X
the	B-X
topology	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
a	B-X
human	B-X
cell	B-X
line	B-X
defective	B-X
in	B-X
GPI-MT-I	B-X
and	B-X
the	B-X
gene	B-X
responsible	B-X
,	B-X
PIG-M.	B-X
PIG-M	B-X
encodes	B-X
a	B-X
new	B-X
type	B-X
of	B-X
mannosyltransferase	B-X
of	B-X
423	B-X
amino	B-X
acids	B-X
,	B-X
bearing	B-X
multiple	B-X
transmembrane	B-X
domains	B-X
.	B-X
PIG-M	B-X
has	B-X
a	B-X
functionally	B-X
important	B-X
DXD	B-X
motif	B-X
,	B-X
a	B-X
characteristic	B-X
of	B-X
many	B-X
glycosyltransferases	B-X
,	B-X
within	B-X
a	B-X
domain	B-X
facing	B-X
the	B-X
lumen	B-X
of	B-X
the	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
,	B-X
indicating	B-X
that	B-X
transfer	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
to	B-X
GPI	B-X
occurs	B-X
on	B-X
the	B-X
lumenal	B-X
side	B-X
of	B-X
the	B-X
ER	B-X
membrane	B-X
.	B-X

Here	O
,	O
we	O
report	O
a	O
human	O
cell	O
line	O
defective	O
in	O
GPI	B-Gene_or_gene_product
-	I-Gene_or_gene_product
MT	I-Gene_or_gene_product
-	I-Gene_or_gene_product
I	I-Gene_or_gene_product
and	O
the	O
gene	O
responsible	O
,	O
PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
M	I-Gene_or_gene_product
.	O
<EOS>	B-X
Glycosylphosphatidylinositol	B-X
(	B-X
GPI	B-X
)	B-X
acts	B-X
as	B-X
a	B-X
membrane	B-X
anchor	B-X
of	B-X
many	B-X
cell	B-X
surface	B-X
proteins	B-X
.	B-X
Its	B-X
structure	B-X
and	B-X
biosynthetic	B-X
pathway	B-X
are	B-X
generally	B-X
conserved	B-X
among	B-X
eukaryotic	B-X
organisms	B-X
,	B-X
with	B-X
a	B-X
number	B-X
of	B-X
differences	B-X
.	B-X
In	B-X
particular	B-X
,	B-X
mammalian	B-X
and	B-X
protozoan	B-X
mannosyltransferases	B-X
needed	B-X
for	B-X
addition	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
(	B-X
GPI-MT-I	B-X
)	B-X
have	B-X
different	B-X
substrate	B-X
specificities	B-X
and	B-X
are	B-X
targets	B-X
of	B-X
species-	B-X
specific	B-X
inhibitors	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
.	B-X
GPI-MT-I	B-X
,	B-X
however	B-X
,	B-X
has	B-X
not	B-X
been	B-X
molecularly	B-X
characterized	B-X
.	B-X
Characterization	B-X
of	B-X
GPI-MT-I	B-X
would	B-X
also	B-X
help	B-X
to	B-X
clarify	B-X
the	B-X
topology	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
a	B-X
human	B-X
cell	B-X
line	B-X
defective	B-X
in	B-X
GPI-MT-I	B-X
and	B-X
the	B-X
gene	B-X
responsible	B-X
,	B-X
PIG-M.	B-X
PIG-M	B-X
encodes	B-X
a	B-X
new	B-X
type	B-X
of	B-X
mannosyltransferase	B-X
of	B-X
423	B-X
amino	B-X
acids	B-X
,	B-X
bearing	B-X
multiple	B-X
transmembrane	B-X
domains	B-X
.	B-X
PIG-M	B-X
has	B-X
a	B-X
functionally	B-X
important	B-X
DXD	B-X
motif	B-X
,	B-X
a	B-X
characteristic	B-X
of	B-X
many	B-X
glycosyltransferases	B-X
,	B-X
within	B-X
a	B-X
domain	B-X
facing	B-X
the	B-X
lumen	B-X
of	B-X
the	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
,	B-X
indicating	B-X
that	B-X
transfer	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
to	B-X
GPI	B-X
occurs	B-X
on	B-X
the	B-X
lumenal	B-X
side	B-X
of	B-X
the	B-X
ER	B-X
membrane	B-X
.	B-X

PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
M	I-Gene_or_gene_product
encodes	O
a	O
new	O
type	O
of	O
mannosyltransferase	B-Gene_or_gene_product
of	O
423	O
amino	O
acids	O
,	O
bearing	O
multiple	O
transmembrane	O
domains	O
.	O
<EOS>	B-X
In	B-X
particular	B-X
,	B-X
mammalian	B-X
and	B-X
protozoan	B-X
mannosyltransferases	B-X
needed	B-X
for	B-X
addition	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
(	B-X
GPI-MT-I	B-X
)	B-X
have	B-X
different	B-X
substrate	B-X
specificities	B-X
and	B-X
are	B-X
targets	B-X
of	B-X
species-	B-X
specific	B-X
inhibitors	B-X
of	B-X
GPI	B-X
biosynthesis	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
a	B-X
human	B-X
cell	B-X
line	B-X
defective	B-X
in	B-X
GPI-MT-I	B-X
and	B-X
the	B-X
gene	B-X
responsible	B-X
,	B-X
PIG-M.	B-X
PIG-M	B-X
encodes	B-X
a	B-X
new	B-X
type	B-X
of	B-X
mannosyltransferase	B-X
of	B-X
423	B-X
amino	B-X
acids	B-X
,	B-X
bearing	B-X
multiple	B-X
transmembrane	B-X
domains	B-X
.	B-X
PIG-M	B-X
has	B-X
a	B-X
functionally	B-X
important	B-X
DXD	B-X
motif	B-X
,	B-X
a	B-X
characteristic	B-X
of	B-X
many	B-X
glycosyltransferases	B-X
,	B-X
within	B-X
a	B-X
domain	B-X
facing	B-X
the	B-X
lumen	B-X
of	B-X
the	B-X
endoplasmic	B-X
reticulum	B-X
(	B-X
ER	B-X
)	B-X
,	B-X
indicating	B-X
that	B-X
transfer	B-X
of	B-X
the	B-X
first	B-X
mannose	B-X
to	B-X
GPI	B-X
occurs	B-X
on	B-X
the	B-X
lumenal	B-X
side	B-X
of	B-X
the	B-X
ER	B-X
membrane	B-X
.	B-X

PIG	B-Gene_or_gene_product
-	I-Gene_or_gene_product
M	I-Gene_or_gene_product
has	O
a	O
functionally	O
important	O
DXD	O
motif	O
,	O
a	O
characteristic	O
of	O
many	O
glycosyltransferases	B-Gene_or_gene_product
,	O
within	O
a	O
domain	O
facing	O
the	O
lumen	O
of	O
the	O
endoplasmic	O
reticulum	O
(	O
ER	O
)	O
,	O
indicating	O
that	O
transfer	O
of	O
the	O
first	O
mannose	O
to	O
GPI	O
occurs	O
on	O
the	O
lumenal	O
side	O
of	O
the	O
ER	O
membrane	O
.	O

Human	O
neuron	O
-	O
committed	O
teratocarcinoma	O
NT2	O
cell	O
line	O
has	O
abnormal	O
ND10	O
structures	O
and	O
is	O
poorly	O
infected	O
by	O
herpes	O
simplex	O
virus	O
type	O
1	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

Herpes	O
simplex	O
virus	O
type	O
1	O
(	O
HSV	O
-	O
1	O
)	O
immediate	B-Gene_or_gene_product
-	I-Gene_or_gene_product
early	I-Gene_or_gene_product
regulatory	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
ICP0	I-Gene_or_gene_product
stimulates	O
the	O
initiation	O
of	O
lytic	O
infection	O
and	O
reactivation	O
from	O
quiescence	O
in	O
human	O
fibroblast	O
cells	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

These	O
functions	O
correlate	O
with	O
its	O
ability	O
to	O
localize	O
to	O
and	O
disrupt	O
centromeres	O
and	O
specific	O
subnuclear	O
structures	O
known	O
as	O
ND10	O
,	O
PML	O
nuclear	O
bodies	O
,	O
or	O
promyelocytic	O
oncogenic	O
domains	O
.	O
<EOS>	B-X
We	B-X
follow	B-X
with	B-X
an	B-X
outline	B-X
of	B-X
the	B-X
structure	B-X
and	B-X
subcellular	B-X
location	B-X
of	B-X
SETDB1	B-X
,	B-X
as	B-X
well	B-X
as	B-X
potential	B-X
mechanisms	B-X
for	B-X
regulation	B-X
of	B-X
its	B-X
nuclear	B-X
transport	B-X
.	B-X
Subsequently	B-X
,	B-X
we	B-X
introduce	B-X
SETDB1	B-X
's	B-X
various	B-X
functions	B-X
,	B-X
including	B-X
its	B-X
roles	B-X
in	B-X
promyelocytic	B-X
leukemia	B-X
nuclear	B-X
body	B-X
(	B-X
PML-NB	B-X
)	B-X
formation	B-X
,	B-X
the	B-X
methylation	B-X
and	B-X
activation	B-X
of	B-X
Akt	B-X
,	B-X
the	B-X
silencing	B-X
of	B-X
the	B-X
androgen	B-X
receptor	B-X
(	B-X
AR	B-X
)	B-X
gene	B-X
,	B-X
retroelement	B-X
silencing	B-X
,	B-X
the	B-X
inhibition	B-X
of	B-X
tumor	B-X
suppressor	B-X
p53	B-X
,	B-X
and	B-X
its	B-X
role	B-X
in	B-X
promoting	B-X
intestinal	B-X
differentiation	B-X
and	B-X
survival	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
provide	B-X
a	B-X
detailed	B-X
review	B-X
of	B-X
the	B-X
oncogenic	B-X
effects	B-X
of	B-X
SETDB1	B-X
overexpression	B-X
in	B-X
breast	B-X
cancer	B-X
,	B-X
non-small	B-X
cell	B-X
lung	B-X
cancer	B-X
,	B-X
prostate	B-X
cancer	B-X
,	B-X
colorectal	B-X
cancer	B-X
,	B-X
acute	B-X
myeloid	B-X
leukemia	B-X
,	B-X
glioma	B-X
,	B-X
melanoma	B-X
,	B-X
pancreatic	B-X
ductal	B-X
adenocarcinoma	B-X
,	B-X
liver	B-X
cancer	B-X
,	B-X
nasopharyngeal	B-X
carcinoma	B-X
,	B-X
gastric	B-X
carcinoma	B-X
,	B-X
and	B-X
endometrial	B-X
cancer	B-X
.	B-X
SETDB1	B-X
has	B-X
a	B-X
central	B-X
role	B-X
in	B-X
normal	B-X
physiology	B-X
and	B-X
nervous	B-X
system	B-X
development	B-X
,	B-X
having	B-X
been	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cell	B-X
cycle	B-X
progression	B-X
,	B-X
inactivation	B-X
of	B-X
the	B-X
X	B-X
chromosome	B-X
,	B-X
immune	B-X
cells	B-X
function	B-X
,	B-X
expression	B-X
of	B-X
retroelements	B-X
and	B-X
formation	B-X
of	B-X
promyelocytic	B-X
leukemia	B-X
(	B-X
PML	B-X
)	B-X
nuclear	B-X
bodies	B-X
(	B-X
NB	B-X
)	B-X
.	B-X
SETDB1	B-X
has	B-X
been	B-X
frequently	B-X
deregulated	B-X
in	B-X
carcinogenesis	B-X
,	B-X
being	B-X
implicated	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
gliomas	B-X
,	B-X
melanomas	B-X
,	B-X
as	B-X
well	B-X
as	B-X
in	B-X
lung	B-X
,	B-X
breast	B-X
,	B-X
gastrointestinal	B-X
and	B-X
ovarian	B-X
tumors	B-X
,	B-X
where	B-X
it	B-X
mainly	B-X
exerts	B-X
an	B-X
oncogenic	B-X
role	B-X
.	B-X

Since	O
the	O
natural	O
site	O
of	O
herpesvirus	O
latency	O
is	O
in	O
neurons	O
,	O
we	O
investigated	O
the	O
status	O
of	O
ND10	O
and	O
centromeres	O
in	O
uninfected	O
and	O
infected	O
human	O
cells	O
with	O
neuronal	O
characteristics	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

We	O
found	O
that	O
NT2	O
cells	O
,	O
a	O
neuronally	O
committed	O
human	O
teratocarcinoma	O
cell	O
line	O
,	O
have	O
abnormal	O
ND10	O
characterized	O
by	O
low	O
expression	O
of	O
the	O
major	O
ND10	O
component	O
PML	B-Gene_or_gene_product
and	O
no	O
detectable	O
expression	O
of	O
another	O
major	O
ND10	O
antigen	O
,	O
Sp100	B-Gene_or_gene_product
.	O

In	O
addition	O
,	O
PML	B-Gene_or_gene_product
is	O
less	O
extensively	O
modified	O
by	O
the	O
ubiquitin	B-Gene_or_gene_product
-	O
like	O
protein	O
SUMO	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
in	O
NT2	O
cells	O
compared	O
to	O
fibroblasts	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

After	O
treatment	O
with	O
retinoic	O
acid	O
,	O
NT2	O
cells	O
differentiate	O
into	O
neuron	O
-	O
like	O
hNT	O
cells	O
which	O
express	O
very	O
high	O
levels	O
of	O
both	O
PML	B-Gene_or_gene_product
and	O
Sp100	B-Gene_or_gene_product
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

Infection	O
of	O
both	O
NT2	O
and	O
hNT	O
cells	O
by	O
HSV	O
-	O
1	O
was	O
poor	O
compared	O
to	O
human	O
fibroblasts	O
,	O
and	O
after	O
low	O
-	O
multiplicity	O
infection	O
yields	O
of	O
virus	O
were	O
reduced	O
by	O
2	O
to	O
3	O
orders	O
of	O
magnitude	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

ICP0	B-Gene_or_gene_product
-	O
deficient	O
mutants	O
were	O
also	O
disabled	O
in	O
the	O
neuron	O
-	O
related	O
cell	O
lines	O
,	O
and	O
cells	O
quiescently	O
infected	O
with	O
an	O
ICP0	B-Gene_or_gene_product
-	O
null	O
virus	O
could	O
be	O
established	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

These	O
results	O
correlated	O
with	O
less	O
-	O
efficient	O
disruption	O
of	O
ND10	O
and	O
centromeres	O
induced	O
by	O
ICP0	B-Gene_or_gene_product
in	O
NT2	O
and	O
hNT	O
cells	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

Furthermore	O
,	O
the	O
ability	O
of	O
ICP0	B-Gene_or_gene_product
to	O
activate	O
gene	O
expression	O
in	O
transfection	O
assays	O
in	O
NT2	O
cells	O
was	O
poor	O
compared	O
to	O
Vero	O
cells	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

These	O
results	O
suggest	O
that	O
a	O
contributory	O
factor	O
in	O
the	O
reduced	O
HSV	O
-	O
1	O
replication	O
in	O
the	O
neuron	O
-	O
related	O
cells	O
is	O
inefficient	O
ICP0	B-Gene_or_gene_product
function	O
;	O
it	O
is	O
possible	O
that	O
this	O
is	O
pertinent	O
to	O
the	O
establishment	O
of	O
latent	O
infection	O
in	O
neurons	O
in	O
vivo	O
.	O
<EOS>	B-X
Herpes	B-X
simplex	B-X
virus	B-X
type	B-X
1	B-X
(	B-X
HSV-1	B-X
)	B-X
immediate-early	B-X
regulatory	B-X
protein	B-X
ICP0	B-X
stimulates	B-X
the	B-X
initiation	B-X
of	B-X
lytic	B-X
infection	B-X
and	B-X
reactivation	B-X
from	B-X
quiescence	B-X
in	B-X
human	B-X
fibroblast	B-X
cells	B-X
.	B-X
These	B-X
functions	B-X
correlate	B-X
with	B-X
its	B-X
ability	B-X
to	B-X
localize	B-X
to	B-X
and	B-X
disrupt	B-X
centromeres	B-X
and	B-X
specific	B-X
subnuclear	B-X
structures	B-X
known	B-X
as	B-X
ND10	B-X
,	B-X
PML	B-X
nuclear	B-X
bodies	B-X
,	B-X
or	B-X
promyelocytic	B-X
oncogenic	B-X
domains	B-X
.	B-X
Since	B-X
the	B-X
natural	B-X
site	B-X
of	B-X
herpesvirus	B-X
latency	B-X
is	B-X
in	B-X
neurons	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
status	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
in	B-X
uninfected	B-X
and	B-X
infected	B-X
human	B-X
cells	B-X
with	B-X
neuronal	B-X
characteristics	B-X
.	B-X
We	B-X
found	B-X
that	B-X
NT2	B-X
cells	B-X
,	B-X
a	B-X
neuronally	B-X
committed	B-X
human	B-X
teratocarcinoma	B-X
cell	B-X
line	B-X
,	B-X
have	B-X
abnormal	B-X
ND10	B-X
characterized	B-X
by	B-X
low	B-X
expression	B-X
of	B-X
the	B-X
major	B-X
ND10	B-X
component	B-X
PML	B-X
and	B-X
no	B-X
detectable	B-X
expression	B-X
of	B-X
another	B-X
major	B-X
ND10	B-X
antigen	B-X
,	B-X
Sp100	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
PML	B-X
is	B-X
less	B-X
extensively	B-X
modified	B-X
by	B-X
the	B-X
ubiquitin-like	B-X
protein	B-X
SUMO-1	B-X
in	B-X
NT2	B-X
cells	B-X
compared	B-X
to	B-X
fibroblasts	B-X
.	B-X
After	B-X
treatment	B-X
with	B-X
retinoic	B-X
acid	B-X
,	B-X
NT2	B-X
cells	B-X
differentiate	B-X
into	B-X
neuron-like	B-X
hNT	B-X
cells	B-X
which	B-X
express	B-X
very	B-X
high	B-X
levels	B-X
of	B-X
both	B-X
PML	B-X
and	B-X
Sp100	B-X
.	B-X
Infection	B-X
of	B-X
both	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
by	B-X
HSV-1	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
human	B-X
fibroblasts	B-X
,	B-X
and	B-X
after	B-X
low-multiplicity	B-X
infection	B-X
yields	B-X
of	B-X
virus	B-X
were	B-X
reduced	B-X
by	B-X
2	B-X
to	B-X
3	B-X
orders	B-X
of	B-X
magnitude	B-X
.	B-X
ICP0-deficient	B-X
mutants	B-X
were	B-X
also	B-X
disabled	B-X
in	B-X
the	B-X
neuron-related	B-X
cell	B-X
lines	B-X
,	B-X
and	B-X
cells	B-X
quiescently	B-X
infected	B-X
with	B-X
an	B-X
ICP0-null	B-X
virus	B-X
could	B-X
be	B-X
established	B-X
.	B-X
These	B-X
results	B-X
correlated	B-X
with	B-X
less-efficient	B-X
disruption	B-X
of	B-X
ND10	B-X
and	B-X
centromeres	B-X
induced	B-X
by	B-X
ICP0	B-X
in	B-X
NT2	B-X
and	B-X
hNT	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
ICP0	B-X
to	B-X
activate	B-X
gene	B-X
expression	B-X
in	B-X
transfection	B-X
assays	B-X
in	B-X
NT2	B-X
cells	B-X
was	B-X
poor	B-X
compared	B-X
to	B-X
Vero	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
a	B-X
contributory	B-X
factor	B-X
in	B-X
the	B-X
reduced	B-X
HSV-1	B-X
replication	B-X
in	B-X
the	B-X
neuron-related	B-X
cells	B-X
is	B-X
inefficient	B-X
ICP0	B-X
function	B-X
;	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
this	B-X
is	B-X
pertinent	B-X
to	B-X
the	B-X
establishment	B-X
of	B-X
latent	B-X
infection	B-X
in	B-X
neurons	B-X
in	B-X
vivo	B-X
.	B-X

The	O
SV40	B-Gene_or_gene_product
small	I-Gene_or_gene_product
t	I-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
prevents	O
mammary	O
gland	O
differentiation	O
and	O
induces	O
breast	O
cancer	O
formation	O
in	O
transgenic	O
mice	O
;	O
truncated	O
large	B-Gene_or_gene_product
T	I-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
molecules	O
harboring	O
the	O
intact	O
p53	B-Gene_or_gene_product
and	O
pRb	B-Gene_or_gene_product
binding	O
region	O
do	O
not	O
have	O
this	O
effect	O
.	O
<EOS>	B-X
We	B-X
report	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
that	B-X
the	B-X
SV40	B-X
small	B-X
t-antigen	B-X
inhibits	B-X
mammary	B-X
gland	B-X
differentiation	B-X
during	B-X
mid-pregnancy	B-X
and	B-X
that	B-X
about	B-X
10	B-X
%	B-X
of	B-X
multiparous	B-X
WAP-SVt	B-X
transgenic	B-X
animals	B-X
develop	B-X
breast	B-X
tumors	B-X
with	B-X
latencies	B-X
ranging	B-X
from	B-X
10-17	B-X
months	B-X
.	B-X
Cyclin	B-X
D1	B-X
is	B-X
deregulated	B-X
and	B-X
over	B-X
expressed	B-X
in	B-X
the	B-X
small	B-X
t-antigen	B-X
positive	B-X
mammary	B-X
gland	B-X
epithelial	B-X
cells	B-X
(	B-X
ME-cells	B-X
)	B-X
and	B-X
in	B-X
the	B-X
breast	B-X
tumor	B-X
cells	B-X
.	B-X
SV40	B-X
small	B-X
t-antigen	B-X
immortalized	B-X
ME-cells	B-X
(	B-X
t-ME-cells	B-X
)	B-X
exhibit	B-X
a	B-X
strong	B-X
intranuclear	B-X
cyclin	B-X
D1	B-X
staining	B-X
,	B-X
also	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
external	B-X
growth	B-X
factors	B-X
and	B-X
the	B-X
cells	B-X
continue	B-X
to	B-X
divide	B-X
for	B-X
several	B-X
days	B-X
without	B-X
serum	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
expression	B-X
rate	B-X
of	B-X
cyclin	B-X
E	B-X
and	B-X
p21	B-X
(	B-X
Waf1	B-X
)	B-X
but	B-X
not	B-X
of	B-X
p53	B-X
is	B-X
increased	B-X
.	B-X
WAP-SVT	B-X
transgenic	B-X
animals	B-X
exhibit	B-X
an	B-X
almost	B-X
regular	B-X
mammary	B-X
gland	B-X
development	B-X
until	B-X
late	B-X
pregnancy	B-X
but	B-X
the	B-X
majority	B-X
of	B-X
the	B-X
ME-cells	B-X
are	B-X
eliminated	B-X
by	B-X
apoptosis	B-X
during	B-X
the	B-X
early	B-X
lactation	B-X
period	B-X
.	B-X
Tumor	B-X
formation	B-X
is	B-X
delayed	B-X
and	B-X
less	B-X
efficient	B-X
than	B-X
in	B-X
T/t-antigen	B-X
positive	B-X
animals	B-X
.	B-X
Sequestration	B-X
of	B-X
p53	B-X
and	B-X
pRb	B-X
by	B-X
the	B-X
N-terminal	B-X
truncated	B-X
T-antigen	B-X
molecules	B-X
(	B-X
T1-antigen	B-X
and	B-X
T2-antigen	B-X
)	B-X
does	B-X
not	B-X
affect	B-X
mammary	B-X
gland	B-X
differentiation	B-X
and	B-X
the	B-X
transgenic	B-X
animals	B-X
(	B-X
WAP-SVBst-Bam	B-X
)	B-X
do	B-X
not	B-X
develop	B-X
breast	B-X
tumors	B-X
.	B-X

We	O
report	O
here	O
for	O
the	O
first	O
time	O
,	O
that	O
the	O
SV40	B-Gene_or_gene_product
small	I-Gene_or_gene_product
t	I-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
inhibits	O
mammary	O
gland	O
differentiation	O
during	O
mid	O
-	O
pregnancy	O
and	O
that	O
about	O
10	O
%	O
of	O
multiparous	O
WAP	B-Gene_or_gene_product
-	O
SVt	B-Gene_or_gene_product
transgenic	O
animals	O
develop	O
breast	O
tumors	O
with	O
latencies	O
ranging	O
from	O
10	O
-	O
17	O
months	O
.	O
<EOS>	B-X
We	B-X
report	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
that	B-X
the	B-X
SV40	B-X
small	B-X
t-antigen	B-X
inhibits	B-X
mammary	B-X
gland	B-X
differentiation	B-X
during	B-X
mid-pregnancy	B-X
and	B-X
that	B-X
about	B-X
10	B-X
%	B-X
of	B-X
multiparous	B-X
WAP-SVt	B-X
transgenic	B-X
animals	B-X
develop	B-X
breast	B-X
tumors	B-X
with	B-X
latencies	B-X
ranging	B-X
from	B-X
10-17	B-X
months	B-X
.	B-X
Cyclin	B-X
D1	B-X
is	B-X
deregulated	B-X
and	B-X
over	B-X
expressed	B-X
in	B-X
the	B-X
small	B-X
t-antigen	B-X
positive	B-X
mammary	B-X
gland	B-X
epithelial	B-X
cells	B-X
(	B-X
ME-cells	B-X
)	B-X
and	B-X
in	B-X
the	B-X
breast	B-X
tumor	B-X
cells	B-X
.	B-X
SV40	B-X
small	B-X
t-antigen	B-X
immortalized	B-X
ME-cells	B-X
(	B-X
t-ME-cells	B-X
)	B-X
exhibit	B-X
a	B-X
strong	B-X
intranuclear	B-X
cyclin	B-X
D1	B-X
staining	B-X
,	B-X
also	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
external	B-X
growth	B-X
factors	B-X
and	B-X
the	B-X
cells	B-X
continue	B-X
to	B-X
divide	B-X
for	B-X
several	B-X
days	B-X
without	B-X
serum	B-X
.	B-X
WAP-SVT	B-X
transgenic	B-X
animals	B-X
exhibit	B-X
an	B-X
almost	B-X
regular	B-X
mammary	B-X
gland	B-X
development	B-X
until	B-X
late	B-X
pregnancy	B-X
but	B-X
the	B-X
majority	B-X
of	B-X
the	B-X
ME-cells	B-X
are	B-X
eliminated	B-X
by	B-X
apoptosis	B-X
during	B-X
the	B-X
early	B-X
lactation	B-X
period	B-X
.	B-X
Tumor	B-X
formation	B-X
is	B-X
delayed	B-X
and	B-X
less	B-X
efficient	B-X
than	B-X
in	B-X
T/t-antigen	B-X
positive	B-X
animals	B-X
.	B-X
Sequestration	B-X
of	B-X
p53	B-X
and	B-X
pRb	B-X
by	B-X
the	B-X
N-terminal	B-X
truncated	B-X
T-antigen	B-X
molecules	B-X
(	B-X
T1-antigen	B-X
and	B-X
T2-antigen	B-X
)	B-X
does	B-X
not	B-X
affect	B-X
mammary	B-X
gland	B-X
differentiation	B-X
and	B-X
the	B-X
transgenic	B-X
animals	B-X
(	B-X
WAP-SVBst-Bam	B-X
)	B-X
do	B-X
not	B-X
develop	B-X
breast	B-X
tumors	B-X
.	B-X

Cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
is	O
deregulated	O
and	O
over	O
expressed	O
in	O
the	O
small	B-Gene_or_gene_product
t	I-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
positive	O
mammary	O
gland	O
epithelial	O
cells	O
(	O
ME	O
-	O
cells	O
)	O
and	O
in	O
the	O
breast	O
tumor	O
cells	O
.	O
<EOS>	B-X
We	B-X
report	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
that	B-X
the	B-X
SV40	B-X
small	B-X
t-antigen	B-X
inhibits	B-X
mammary	B-X
gland	B-X
differentiation	B-X
during	B-X
mid-pregnancy	B-X
and	B-X
that	B-X
about	B-X
10	B-X
%	B-X
of	B-X
multiparous	B-X
WAP-SVt	B-X
transgenic	B-X
animals	B-X
develop	B-X
breast	B-X
tumors	B-X
with	B-X
latencies	B-X
ranging	B-X
from	B-X
10-17	B-X
months	B-X
.	B-X
Cyclin	B-X
D1	B-X
is	B-X
deregulated	B-X
and	B-X
over	B-X
expressed	B-X
in	B-X
the	B-X
small	B-X
t-antigen	B-X
positive	B-X
mammary	B-X
gland	B-X
epithelial	B-X
cells	B-X
(	B-X
ME-cells	B-X
)	B-X
and	B-X
in	B-X
the	B-X
breast	B-X
tumor	B-X
cells	B-X
.	B-X
SV40	B-X
small	B-X
t-antigen	B-X
immortalized	B-X
ME-cells	B-X
(	B-X
t-ME-cells	B-X
)	B-X
exhibit	B-X
a	B-X
strong	B-X
intranuclear	B-X
cyclin	B-X
D1	B-X
staining	B-X
,	B-X
also	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
external	B-X
growth	B-X
factors	B-X
and	B-X
the	B-X
cells	B-X
continue	B-X
to	B-X
divide	B-X
for	B-X
several	B-X
days	B-X
without	B-X
serum	B-X
.	B-X
WAP-SVT	B-X
transgenic	B-X
animals	B-X
exhibit	B-X
an	B-X
almost	B-X
regular	B-X
mammary	B-X
gland	B-X
development	B-X
until	B-X
late	B-X
pregnancy	B-X
but	B-X
the	B-X
majority	B-X
of	B-X
the	B-X
ME-cells	B-X
are	B-X
eliminated	B-X
by	B-X
apoptosis	B-X
during	B-X
the	B-X
early	B-X
lactation	B-X
period	B-X
.	B-X
Tumor	B-X
formation	B-X
is	B-X
delayed	B-X
and	B-X
less	B-X
efficient	B-X
than	B-X
in	B-X
T/t-antigen	B-X
positive	B-X
animals	B-X
.	B-X
Sequestration	B-X
of	B-X
p53	B-X
and	B-X
pRb	B-X
by	B-X
the	B-X
N-terminal	B-X
truncated	B-X
T-antigen	B-X
molecules	B-X
(	B-X
T1-antigen	B-X
and	B-X
T2-antigen	B-X
)	B-X
does	B-X
not	B-X
affect	B-X
mammary	B-X
gland	B-X
differentiation	B-X
and	B-X
the	B-X
transgenic	B-X
animals	B-X
(	B-X
WAP-SVBst-Bam	B-X
)	B-X
do	B-X
not	B-X
develop	B-X
breast	B-X
tumors	B-X
.	B-X

SV40	B-Gene_or_gene_product
small	I-Gene_or_gene_product
t	I-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
immortalized	O
ME	O
-	O
cells	O
(	O
t	O
-	O
ME	O
-	O
cells	O
)	O
exhibit	O
a	O
strong	O
intranuclear	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
staining	O
,	O
also	O
in	O
the	O
absence	O
of	O
external	O
growth	O
factors	O
and	O
the	O
cells	O
continue	O
to	O
divide	O
for	O
several	O
days	O
without	O
serum	O
.	O

In	O
addition	O
,	O
the	O
expression	O
rate	O
of	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
and	O
p21	B-Gene_or_gene_product
(	O
Waf1	B-Gene_or_gene_product
)	O
but	O
not	O
of	O
p53	B-Gene_or_gene_product
is	O
increased	O
.	O
<EOS>	B-X
The	B-X
apoptosis	B-X
rate	B-X
of	B-X
cardiomyocytes	B-X
increased	B-X
to	B-X
approximately	B-X
40	B-X
%	B-X
under	B-X
24	B-X
hours	B-X
of	B-X
hypoxia	B-X
as	B-X
evaluated	B-X
by	B-X
the	B-X
TUNEL	B-X
method	B-X
.	B-X
The	B-X
cyclin	B-X
A	B-X
protein	B-X
level	B-X
assessed	B-X
by	B-X
immunoblot	B-X
analysis	B-X
accumulated	B-X
in	B-X
a	B-X
time-dependent	B-X
manner	B-X
in	B-X
cardiomyocytes	B-X
,	B-X
but	B-X
there	B-X
was	B-X
no	B-X
increase	B-X
in	B-X
nonmyocytes	B-X
.	B-X
Hypoxia	B-X
increased	B-X
the	B-X
activity	B-X
of	B-X
cyclin	B-X
A-associated	B-X
kinase	B-X
but	B-X
not	B-X
the	B-X
activity	B-X
of	B-X
cyclin	B-X
E-associated	B-X
kinase	B-X
,	B-X
and	B-X
the	B-X
apoptosis	B-X
was	B-X
inhibited	B-X
by	B-X
infection	B-X
of	B-X
dominant-negative	B-X
cdk2	B-X
adenovirus	B-X
,	B-X
suggesting	B-X
that	B-X
cyclin	B-X
A	B-X
and	B-X
its	B-X
associated	B-X
kinase	B-X
play	B-X
significant	B-X
roles	B-X
in	B-X
the	B-X
apoptosis	B-X
of	B-X
cardiomyocytes	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
cyclin	B-X
A-mediated	B-X
apoptosis	B-X
,	B-X
we	B-X
infected	B-X
cultured	B-X
cells	B-X
with	B-X
cyclin	B-X
A	B-X
adenovirus	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
cells	B-X
in	B-X
the	B-X
hypoxic	B-X
condition	B-X
showed	B-X
an	B-X
increase	B-X
in	B-X
caspase-3	B-X
activity	B-X
and	B-X
a	B-X
subsequent	B-X
decrease	B-X
in	B-X
p21	B-X
(	B-X
cip1/waf1	B-X
)	B-X
protein	B-X
,	B-X
which	B-X
is	B-X
partly	B-X
cleaved	B-X
by	B-X
caspase-3	B-X
.	B-X
These	B-X
findings	B-X
confirm	B-X
that	B-X
cyclin	B-X
A-associated	B-X
kinase	B-X
mediates	B-X
hypoxia-induced	B-X
apoptosis	B-X
in	B-X
cardiomyocytes	B-X
,	B-X
and	B-X
they	B-X
also	B-X
suggest	B-X
that	B-X
additional	B-X
elements	B-X
of	B-X
the	B-X
cell-cycle-dependent	B-X
machinery	B-X
participate	B-X
in	B-X
this	B-X
mechanism	B-X
.	B-X

Coimmunoprecipitation	O
experiments	O
revealed	O
that	O
p21	B-Gene_or_gene_product
(	O
Waf1	B-Gene_or_gene_product
)	O
is	O
mainly	O
associated	O
with	O
the	O
cyclin	O
D	O
/	O
CDK4	O
but	O
not	O
with	O
the	O
cyclin	O
E	O
/	O
CDK2	O
complex	O
.	O

WAP	O
-	O
SVT	O
transgenic	O
animals	O
exhibit	O
an	O
almost	O
regular	O
mammary	O
gland	O
development	O
until	O
late	O
pregnancy	O
but	O
the	O
majority	O
of	O
the	O
ME	O
-	O
cells	O
are	O
eliminated	O
by	O
apoptosis	O
during	O
the	O
early	O
lactation	O
period	O
.	O
<EOS>	B-X
We	B-X
report	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
,	B-X
that	B-X
the	B-X
SV40	B-X
small	B-X
t-antigen	B-X
inhibits	B-X
mammary	B-X
gland	B-X
differentiation	B-X
during	B-X
mid-pregnancy	B-X
and	B-X
that	B-X
about	B-X
10	B-X
%	B-X
of	B-X
multiparous	B-X
WAP-SVt	B-X
transgenic	B-X
animals	B-X
develop	B-X
breast	B-X
tumors	B-X
with	B-X
latencies	B-X
ranging	B-X
from	B-X
10-17	B-X
months	B-X
.	B-X
Cyclin	B-X
D1	B-X
is	B-X
deregulated	B-X
and	B-X
over	B-X
expressed	B-X
in	B-X
the	B-X
small	B-X
t-antigen	B-X
positive	B-X
mammary	B-X
gland	B-X
epithelial	B-X
cells	B-X
(	B-X
ME-cells	B-X
)	B-X
and	B-X
in	B-X
the	B-X
breast	B-X
tumor	B-X
cells	B-X
.	B-X
SV40	B-X
small	B-X
t-antigen	B-X
immortalized	B-X
ME-cells	B-X
(	B-X
t-ME-cells	B-X
)	B-X
exhibit	B-X
a	B-X
strong	B-X
intranuclear	B-X
cyclin	B-X
D1	B-X
staining	B-X
,	B-X
also	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
external	B-X
growth	B-X
factors	B-X
and	B-X
the	B-X
cells	B-X
continue	B-X
to	B-X
divide	B-X
for	B-X
several	B-X
days	B-X
without	B-X
serum	B-X
.	B-X
WAP-SVT	B-X
transgenic	B-X
animals	B-X
exhibit	B-X
an	B-X
almost	B-X
regular	B-X
mammary	B-X
gland	B-X
development	B-X
until	B-X
late	B-X
pregnancy	B-X
but	B-X
the	B-X
majority	B-X
of	B-X
the	B-X
ME-cells	B-X
are	B-X
eliminated	B-X
by	B-X
apoptosis	B-X
during	B-X
the	B-X
early	B-X
lactation	B-X
period	B-X
.	B-X
Tumor	B-X
formation	B-X
is	B-X
delayed	B-X
and	B-X
less	B-X
efficient	B-X
than	B-X
in	B-X
T/t-antigen	B-X
positive	B-X
animals	B-X
.	B-X
Sequestration	B-X
of	B-X
p53	B-X
and	B-X
pRb	B-X
by	B-X
the	B-X
N-terminal	B-X
truncated	B-X
T-antigen	B-X
molecules	B-X
(	B-X
T1-antigen	B-X
and	B-X
T2-antigen	B-X
)	B-X
does	B-X
not	B-X
affect	B-X
mammary	B-X
gland	B-X
differentiation	B-X
and	B-X
the	B-X
transgenic	B-X
animals	B-X
(	B-X
WAP-SVBst-Bam	B-X
)	B-X
do	B-X
not	B-X
develop	B-X
breast	B-X
tumors	B-X
.	B-X

Tumor	O
formation	O
is	O
delayed	O
and	O
less	O
efficient	O
than	O
in	O
T	B-Gene_or_gene_product
/	O
t	B-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
positive	O
animals	O
.	O

Sequestration	O
of	O
p53	B-Gene_or_gene_product
and	O
pRb	B-Gene_or_gene_product
by	O
the	O
N	O
-	O
terminal	O
truncated	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
molecules	O
(	O
T1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
and	O
T2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
)	O
does	O
not	O
affect	O
mammary	O
gland	O
differentiation	O
and	O
the	O
transgenic	O
animals	O
(	O
WAP	B-Gene_or_gene_product
-	O
SVBst	B-Gene_or_gene_product
-	O
Bam	B-Gene_or_gene_product
)	O
do	O
not	O
develop	O
breast	O
tumors	O
.	O

TAK1	B-Gene_or_gene_product
is	O
a	O
ubiquitin	B-Gene_or_gene_product
-	O
dependent	O
kinase	O
of	O
MKK	B-Gene_or_gene_product
and	O
IKK	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
and	B-X
Jun	B-X
amino-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
pro-inflammatory	B-X
mediators	B-X
such	B-X
as	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
and	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
TRIKA1	B-X
is	B-X
a	B-X
dimeric	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
complex	B-X
composed	B-X
of	B-X
Ubc13	B-X
and	B-X
Uev1A	B-X
(	B-X
or	B-X
the	B-X
functionally	B-X
equivalent	B-X
Mms2	B-X
)	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
purification	B-X
and	B-X
identification	B-X
of	B-X
TRIKA2	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
TAK1	B-X
,	B-X
TAB1	B-X
and	B-X
TAB2	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
complex	B-X
previously	B-X
implicated	B-X
in	B-X
IKK	B-X
activation	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
TRAF6	B-X
is	B-X
conjugated	B-X
by	B-X
the	B-X
K63	B-X
polyubiquitin	B-X
chains	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
ubiquitination	B-X
has	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
in	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
of	B-X
IKK	B-X
and	B-X
JNK	B-X
.	B-X

TRAF6	B-Gene_or_gene_product
is	O
a	O
signal	O
transducer	O
that	O
activates	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
and	O
Jun	B-Gene_or_gene_product
amino	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
JNK	B-Gene_or_gene_product
)	O
in	O
response	O
to	O
pro	O
-	O
inflammatory	O
mediators	O
such	O
as	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
and	O
lipopolysaccharides	O
(	O
LPS	O
)	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
and	B-X
Jun	B-X
amino-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
pro-inflammatory	B-X
mediators	B-X
such	B-X
as	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
and	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
TRIKA1	B-X
is	B-X
a	B-X
dimeric	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
complex	B-X
composed	B-X
of	B-X
Ubc13	B-X
and	B-X
Uev1A	B-X
(	B-X
or	B-X
the	B-X
functionally	B-X
equivalent	B-X
Mms2	B-X
)	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
purification	B-X
and	B-X
identification	B-X
of	B-X
TRIKA2	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
TAK1	B-X
,	B-X
TAB1	B-X
and	B-X
TAB2	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
complex	B-X
previously	B-X
implicated	B-X
in	B-X
IKK	B-X
activation	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
TRAF6	B-X
is	B-X
conjugated	B-X
by	B-X
the	B-X
K63	B-X
polyubiquitin	B-X
chains	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
ubiquitination	B-X
has	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
in	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
of	B-X
IKK	B-X
and	B-X
JNK	B-X
.	B-X

IKK	O
activation	O
by	O
TRAF6	B-Gene_or_gene_product
requires	O
two	O
intermediary	O
factors	O
,	O
TRAF6	B-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
IKK	I-Gene_or_gene_product
activator	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
TRIKA1	B-Gene_or_gene_product
)	O
and	O
TRIKA2	B-Gene_or_gene_product
(	O
ref	O
.	O
5	O
)	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
and	B-X
Jun	B-X
amino-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
pro-inflammatory	B-X
mediators	B-X
such	B-X
as	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
and	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
5	B-X
)	B-X
.	B-X
TRIKA1	B-X
is	B-X
a	B-X
dimeric	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
complex	B-X
composed	B-X
of	B-X
Ubc13	B-X
and	B-X
Uev1A	B-X
(	B-X
or	B-X
the	B-X
functionally	B-X
equivalent	B-X
Mms2	B-X
)	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
purification	B-X
and	B-X
identification	B-X
of	B-X
TRIKA2	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
TAK1	B-X
,	B-X
TAB1	B-X
and	B-X
TAB2	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
complex	B-X
previously	B-X
implicated	B-X
in	B-X
IKK	B-X
activation	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
TRAF6	B-X
is	B-X
conjugated	B-X
by	B-X
the	B-X
K63	B-X
polyubiquitin	B-X
chains	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
ubiquitination	B-X
has	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
in	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
of	B-X
IKK	B-X
and	B-X
JNK	B-X
.	B-X

TRIKA1	O
is	O
a	O
dimeric	O
ubiquitin	B-Gene_or_gene_product
-	O
conjugating	O
enzyme	O
complex	O
composed	O
of	O
Ubc13	B-Gene_or_gene_product
and	O
Uev1A	B-Gene_or_gene_product
(	O
or	O
the	O
functionally	O
equivalent	O
Mms2	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
TRIKA1	B-X
is	B-X
a	B-X
dimeric	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
complex	B-X
composed	B-X
of	B-X
Ubc13	B-X
and	B-X
Uev1A	B-X
(	B-X
or	B-X
the	B-X
functionally	B-X
equivalent	B-X
Mms2	B-X
)	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
purification	B-X
and	B-X
identification	B-X
of	B-X
TRIKA2	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
TAK1	B-X
,	B-X
TAB1	B-X
and	B-X
TAB2	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
complex	B-X
previously	B-X
implicated	B-X
in	B-X
IKK	B-X
activation	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
TRAF6	B-X
is	B-X
conjugated	B-X
by	B-X
the	B-X
K63	B-X
polyubiquitin	B-X
chains	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
ubiquitination	B-X
has	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
in	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
of	B-X
IKK	B-X
and	B-X
JNK	B-X
.	B-X

This	O
Ubc	O
complex	O
,	O
together	O
with	O
TRAF6	B-Gene_or_gene_product
,	O
catalyses	O
the	O
formation	O
of	O
a	O
Lys	O
63	O
(	O
K63	O
)	O
-	O
linked	O
polyubiquitin	B-Gene_or_gene_product
chain	O
that	O
mediates	O
IKK	O
activation	O
through	O
a	O
unique	O
proteasome	O
-	O
independent	O
mechanism	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
and	B-X
Jun	B-X
amino-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
pro-inflammatory	B-X
mediators	B-X
such	B-X
as	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
and	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
TRIKA1	B-X
is	B-X
a	B-X
dimeric	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
complex	B-X
composed	B-X
of	B-X
Ubc13	B-X
and	B-X
Uev1A	B-X
(	B-X
or	B-X
the	B-X
functionally	B-X
equivalent	B-X
Mms2	B-X
)	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
purification	B-X
and	B-X
identification	B-X
of	B-X
TRIKA2	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
TAK1	B-X
,	B-X
TAB1	B-X
and	B-X
TAB2	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
complex	B-X
previously	B-X
implicated	B-X
in	B-X
IKK	B-X
activation	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
TRAF6	B-X
is	B-X
conjugated	B-X
by	B-X
the	B-X
K63	B-X
polyubiquitin	B-X
chains	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
ubiquitination	B-X
has	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
in	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
of	B-X
IKK	B-X
and	B-X
JNK	B-X
.	B-X

Here	O
we	O
report	O
the	O
purification	O
and	O
identification	O
of	O
TRIKA2	O
,	O
which	O
is	O
composed	O
of	O
TAK1	B-Gene_or_gene_product
,	O
TAB1	B-Gene_or_gene_product
and	O
TAB2	B-Gene_or_gene_product
,	O
a	O
protein	O
kinase	O
complex	O
previously	O
implicated	O
in	O
IKK	O
activation	O
through	O
an	O
unknown	O
mechanism	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
and	B-X
Jun	B-X
amino-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
pro-inflammatory	B-X
mediators	B-X
such	B-X
as	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
and	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
TRIKA1	B-X
is	B-X
a	B-X
dimeric	B-X
ubiquitin-conjugating	B-X
enzyme	B-X
complex	B-X
composed	B-X
of	B-X
Ubc13	B-X
and	B-X
Uev1A	B-X
(	B-X
or	B-X
the	B-X
functionally	B-X
equivalent	B-X
Mms2	B-X
)	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
purification	B-X
and	B-X
identification	B-X
of	B-X
TRIKA2	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
TAK1	B-X
,	B-X
TAB1	B-X
and	B-X
TAB2	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
complex	B-X
previously	B-X
implicated	B-X
in	B-X
IKK	B-X
activation	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
ubiquitination	B-X
has	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
in	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
of	B-X
IKK	B-X
and	B-X
JNK	B-X
.	B-X

We	O
find	O
that	O
the	O
TAK1	B-Gene_or_gene_product
kinase	O
complex	O
phosphorylates	O
and	O
activates	O
IKK	O
in	O
a	O
manner	O
that	O
depends	O
on	O
TRAF6	B-Gene_or_gene_product
and	O
Ubc13	O
-	O
Uev1A	O
.	O

Moreover	O
,	O
the	O
activity	O
of	O
TAK1	B-Gene_or_gene_product
to	O
phosphorylate	O
MKK6	B-Gene_or_gene_product
,	O
which	O
activates	O
the	O
JNK	B-Gene_or_gene_product
-	O
p38	B-Gene_or_gene_product
kinase	O
pathway	O
,	O
is	O
directly	O
regulated	O
by	O
K63	O
-	O
linked	O
polyubiquitination	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
and	B-X
Jun	B-X
amino-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
pro-inflammatory	B-X
mediators	B-X
such	B-X
as	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
and	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
purification	B-X
and	B-X
identification	B-X
of	B-X
TRIKA2	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
TAK1	B-X
,	B-X
TAB1	B-X
and	B-X
TAB2	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
complex	B-X
previously	B-X
implicated	B-X
in	B-X
IKK	B-X
activation	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
TRAF6	B-X
is	B-X
conjugated	B-X
by	B-X
the	B-X
K63	B-X
polyubiquitin	B-X
chains	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
ubiquitination	B-X
has	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
in	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
of	B-X
IKK	B-X
and	B-X
JNK	B-X
.	B-X

We	O
also	O
provide	O
evidence	O
that	O
TRAF6	B-Gene_or_gene_product
is	O
conjugated	O
by	O
the	O
K63	O
polyubiquitin	B-Gene_or_gene_product
chains	O
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
and	B-X
Jun	B-X
amino-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
pro-inflammatory	B-X
mediators	B-X
such	B-X
as	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
and	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
We	B-X
also	B-X
provide	B-X
evidence	B-X
that	B-X
TRAF6	B-X
is	B-X
conjugated	B-X
by	B-X
the	B-X
K63	B-X
polyubiquitin	B-X
chains	B-X
.	B-X

These	O
results	O
indicate	O
that	O
ubiquitination	O
has	O
an	O
important	O
regulatory	O
role	O
in	O
stress	O
response	O
pathways	O
,	O
including	O
those	O
of	O
IKK	O
and	O
JNK	B-Gene_or_gene_product
.	O
<EOS>	B-X
TRAF6	B-X
is	B-X
a	B-X
signal	B-X
transducer	B-X
that	B-X
activates	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
and	B-X
Jun	B-X
amino-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
in	B-X
response	B-X
to	B-X
pro-inflammatory	B-X
mediators	B-X
such	B-X
as	B-X
interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
and	B-X
lipopolysaccharides	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
IKK	B-X
activation	B-X
by	B-X
TRAF6	B-X
requires	B-X
two	B-X
intermediary	B-X
factors	B-X
,	B-X
TRAF6-regulated	B-X
IKK	B-X
activator	B-X
1	B-X
(	B-X
TRIKA1	B-X
)	B-X
and	B-X
TRIKA2	B-X
(	B-X
ref	B-X
.	B-X
This	B-X
Ubc	B-X
complex	B-X
,	B-X
together	B-X
with	B-X
TRAF6	B-X
,	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
Lys	B-X
63	B-X
(	B-X
K63	B-X
)	B-X
-linked	B-X
polyubiquitin	B-X
chain	B-X
that	B-X
mediates	B-X
IKK	B-X
activation	B-X
through	B-X
a	B-X
unique	B-X
proteasome-independent	B-X
mechanism	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
the	B-X
purification	B-X
and	B-X
identification	B-X
of	B-X
TRIKA2	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
TAK1	B-X
,	B-X
TAB1	B-X
and	B-X
TAB2	B-X
,	B-X
a	B-X
protein	B-X
kinase	B-X
complex	B-X
previously	B-X
implicated	B-X
in	B-X
IKK	B-X
activation	B-X
through	B-X
an	B-X
unknown	B-X
mechanism	B-X
.	B-X
We	B-X
find	B-X
that	B-X
the	B-X
TAK1	B-X
kinase	B-X
complex	B-X
phosphorylates	B-X
and	B-X
activates	B-X
IKK	B-X
in	B-X
a	B-X
manner	B-X
that	B-X
depends	B-X
on	B-X
TRAF6	B-X
and	B-X
Ubc13-Uev1A	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
TAK1	B-X
to	B-X
phosphorylate	B-X
MKK6	B-X
,	B-X
which	B-X
activates	B-X
the	B-X
JNK-p38	B-X
kinase	B-X
pathway	B-X
,	B-X
is	B-X
directly	B-X
regulated	B-X
by	B-X
K63-linked	B-X
polyubiquitination	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
ubiquitination	B-X
has	B-X
an	B-X
important	B-X
regulatory	B-X
role	B-X
in	B-X
stress	B-X
response	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
of	B-X
IKK	B-X
and	B-X
JNK	B-X
.	B-X

Rb	B-Gene_or_gene_product
targets	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
methylation	O
and	O
HP1	B-Gene_or_gene_product
to	O
promoters	O
.	O
<EOS>	B-X
In	B-X
eukaryotic	B-X
cells	B-X
the	B-X
histone	B-X
methylase	B-X
SUV39H1	B-X
and	B-X
the	B-X
methyl-lysine	B-X
binding	B-X
protein	B-X
HP1	B-X
functionally	B-X
interact	B-X
to	B-X
repress	B-X
transcription	B-X
at	B-X
heterochromatic	B-X
sites	B-X
.	B-X
Lysine	B-X
9	B-X
of	B-X
histone	B-X
H3	B-X
is	B-X
methylated	B-X
by	B-X
SUV39H1	B-X
(	B-X
ref	B-X
.	B-X
2	B-X
)	B-X
,	B-X
creating	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
the	B-X
chromo	B-X
domain	B-X
of	B-X
HP1	B-X
(	B-X
refs	B-X
3	B-X
,	B-X
4	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
are	B-X
both	B-X
involved	B-X
in	B-X
the	B-X
repressive	B-X
functions	B-X
of	B-X
the	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
protein	B-X
.	B-X
Rb	B-X
associates	B-X
with	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
in	B-X
vivo	B-X
by	B-X
means	B-X
of	B-X
its	B-X
pocket	B-X
domain	B-X
.	B-X
SUV39H1	B-X
cooperates	B-X
with	B-X
Rb	B-X
to	B-X
repress	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
,	B-X
and	B-X
in	B-X
fibroblasts	B-X
that	B-X
are	B-X
disrupted	B-X
for	B-X
SUV39	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
cyclin	B-X
E	B-X
and	B-X
cyclin	B-X
A2	B-X
genes	B-X
are	B-X
specifically	B-X
elevated	B-X
.	B-X
Chromatin	B-X
immunoprecipitations	B-X
show	B-X
that	B-X
Rb	B-X
is	B-X
necessary	B-X
to	B-X
direct	B-X
methylation	B-X
of	B-X
histone	B-X
H3	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
for	B-X
binding	B-X
of	B-X
HP1	B-X
to	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
SUV39H1-HP1	B-X
complex	B-X
is	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
heterochromatic	B-X
silencing	B-X
but	B-X
also	B-X
has	B-X
a	B-X
role	B-X
in	B-X
repression	B-X
of	B-X
euchromatic	B-X
genes	B-X
by	B-X
Rb	B-X
and	B-X
perhaps	B-X
other	B-X
co-repressor	B-X
proteins	B-X
.	B-X

In	O
eukaryotic	O
cells	O
the	O
histone	B-Gene_or_gene_product
methylase	O
SUV39H1	B-Gene_or_gene_product
and	O
the	O
methyl	O
-	O
lysine	O
binding	O
protein	O
HP1	B-Gene_or_gene_product
functionally	O
interact	O
to	O
repress	O
transcription	O
at	O
heterochromatic	O
sites	O
.	O
<EOS>	B-X
In	B-X
eukaryotic	B-X
cells	B-X
the	B-X
histone	B-X
methylase	B-X
SUV39H1	B-X
and	B-X
the	B-X
methyl-lysine	B-X
binding	B-X
protein	B-X
HP1	B-X
functionally	B-X
interact	B-X
to	B-X
repress	B-X
transcription	B-X
at	B-X
heterochromatic	B-X
sites	B-X
.	B-X
Lysine	B-X
9	B-X
of	B-X
histone	B-X
H3	B-X
is	B-X
methylated	B-X
by	B-X
SUV39H1	B-X
(	B-X
ref	B-X
.	B-X
2	B-X
)	B-X
,	B-X
creating	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
the	B-X
chromo	B-X
domain	B-X
of	B-X
HP1	B-X
(	B-X
refs	B-X
3	B-X
,	B-X
4	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
are	B-X
both	B-X
involved	B-X
in	B-X
the	B-X
repressive	B-X
functions	B-X
of	B-X
the	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
protein	B-X
.	B-X
Rb	B-X
associates	B-X
with	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
in	B-X
vivo	B-X
by	B-X
means	B-X
of	B-X
its	B-X
pocket	B-X
domain	B-X
.	B-X
SUV39H1	B-X
cooperates	B-X
with	B-X
Rb	B-X
to	B-X
repress	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
,	B-X
and	B-X
in	B-X
fibroblasts	B-X
that	B-X
are	B-X
disrupted	B-X
for	B-X
SUV39	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
cyclin	B-X
E	B-X
and	B-X
cyclin	B-X
A2	B-X
genes	B-X
are	B-X
specifically	B-X
elevated	B-X
.	B-X
Chromatin	B-X
immunoprecipitations	B-X
show	B-X
that	B-X
Rb	B-X
is	B-X
necessary	B-X
to	B-X
direct	B-X
methylation	B-X
of	B-X
histone	B-X
H3	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
for	B-X
binding	B-X
of	B-X
HP1	B-X
to	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
SUV39H1-HP1	B-X
complex	B-X
is	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
heterochromatic	B-X
silencing	B-X
but	B-X
also	B-X
has	B-X
a	B-X
role	B-X
in	B-X
repression	B-X
of	B-X
euchromatic	B-X
genes	B-X
by	B-X
Rb	B-X
and	B-X
perhaps	B-X
other	B-X
co-repressor	B-X
proteins	B-X
.	B-X

Lysine	O
9	O
of	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
is	O
methylated	O
by	O
SUV39H1	B-Gene_or_gene_product
(	O
ref	O
.	O
2	O
)	O
,	O
creating	O
a	O
binding	O
site	O
for	O
the	O
chromo	O
domain	O
of	O
HP1	B-Gene_or_gene_product
(	O
refs	O
3	O
,	O
4	O
)	O
.	O
<EOS>	B-X
In	B-X
eukaryotic	B-X
cells	B-X
the	B-X
histone	B-X
methylase	B-X
SUV39H1	B-X
and	B-X
the	B-X
methyl-lysine	B-X
binding	B-X
protein	B-X
HP1	B-X
functionally	B-X
interact	B-X
to	B-X
repress	B-X
transcription	B-X
at	B-X
heterochromatic	B-X
sites	B-X
.	B-X
Lysine	B-X
9	B-X
of	B-X
histone	B-X
H3	B-X
is	B-X
methylated	B-X
by	B-X
SUV39H1	B-X
(	B-X
ref	B-X
.	B-X
2	B-X
)	B-X
,	B-X
creating	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
the	B-X
chromo	B-X
domain	B-X
of	B-X
HP1	B-X
(	B-X
refs	B-X
3	B-X
,	B-X
4	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
are	B-X
both	B-X
involved	B-X
in	B-X
the	B-X
repressive	B-X
functions	B-X
of	B-X
the	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
protein	B-X
.	B-X
Rb	B-X
associates	B-X
with	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
in	B-X
vivo	B-X
by	B-X
means	B-X
of	B-X
its	B-X
pocket	B-X
domain	B-X
.	B-X
SUV39H1	B-X
cooperates	B-X
with	B-X
Rb	B-X
to	B-X
repress	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
,	B-X
and	B-X
in	B-X
fibroblasts	B-X
that	B-X
are	B-X
disrupted	B-X
for	B-X
SUV39	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
cyclin	B-X
E	B-X
and	B-X
cyclin	B-X
A2	B-X
genes	B-X
are	B-X
specifically	B-X
elevated	B-X
.	B-X
Chromatin	B-X
immunoprecipitations	B-X
show	B-X
that	B-X
Rb	B-X
is	B-X
necessary	B-X
to	B-X
direct	B-X
methylation	B-X
of	B-X
histone	B-X
H3	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
for	B-X
binding	B-X
of	B-X
HP1	B-X
to	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
SUV39H1-HP1	B-X
complex	B-X
is	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
heterochromatic	B-X
silencing	B-X
but	B-X
also	B-X
has	B-X
a	B-X
role	B-X
in	B-X
repression	B-X
of	B-X
euchromatic	B-X
genes	B-X
by	B-X
Rb	B-X
and	B-X
perhaps	B-X
other	B-X
co-repressor	B-X
proteins	B-X
.	B-X

Here	O
we	O
show	O
that	O
SUV39H1	B-Gene_or_gene_product
and	O
HP1	B-Gene_or_gene_product
are	O
both	O
involved	O
in	O
the	O
repressive	O
functions	O
of	O
the	O
retinoblastoma	B-Gene_or_gene_product
(	O
Rb	B-Gene_or_gene_product
)	O
protein	O
.	O
<EOS>	B-X
In	B-X
eukaryotic	B-X
cells	B-X
the	B-X
histone	B-X
methylase	B-X
SUV39H1	B-X
and	B-X
the	B-X
methyl-lysine	B-X
binding	B-X
protein	B-X
HP1	B-X
functionally	B-X
interact	B-X
to	B-X
repress	B-X
transcription	B-X
at	B-X
heterochromatic	B-X
sites	B-X
.	B-X
Lysine	B-X
9	B-X
of	B-X
histone	B-X
H3	B-X
is	B-X
methylated	B-X
by	B-X
SUV39H1	B-X
(	B-X
ref	B-X
.	B-X
2	B-X
)	B-X
,	B-X
creating	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
the	B-X
chromo	B-X
domain	B-X
of	B-X
HP1	B-X
(	B-X
refs	B-X
3	B-X
,	B-X
4	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
are	B-X
both	B-X
involved	B-X
in	B-X
the	B-X
repressive	B-X
functions	B-X
of	B-X
the	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
protein	B-X
.	B-X
Rb	B-X
associates	B-X
with	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
in	B-X
vivo	B-X
by	B-X
means	B-X
of	B-X
its	B-X
pocket	B-X
domain	B-X
.	B-X
SUV39H1	B-X
cooperates	B-X
with	B-X
Rb	B-X
to	B-X
repress	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
,	B-X
and	B-X
in	B-X
fibroblasts	B-X
that	B-X
are	B-X
disrupted	B-X
for	B-X
SUV39	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
cyclin	B-X
E	B-X
and	B-X
cyclin	B-X
A2	B-X
genes	B-X
are	B-X
specifically	B-X
elevated	B-X
.	B-X
Chromatin	B-X
immunoprecipitations	B-X
show	B-X
that	B-X
Rb	B-X
is	B-X
necessary	B-X
to	B-X
direct	B-X
methylation	B-X
of	B-X
histone	B-X
H3	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
for	B-X
binding	B-X
of	B-X
HP1	B-X
to	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
SUV39H1-HP1	B-X
complex	B-X
is	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
heterochromatic	B-X
silencing	B-X
but	B-X
also	B-X
has	B-X
a	B-X
role	B-X
in	B-X
repression	B-X
of	B-X
euchromatic	B-X
genes	B-X
by	B-X
Rb	B-X
and	B-X
perhaps	B-X
other	B-X
co-repressor	B-X
proteins	B-X
.	B-X

Rb	B-Gene_or_gene_product
associates	O
with	O
SUV39H1	B-Gene_or_gene_product
and	O
HP1	B-Gene_or_gene_product
in	O
vivo	O
by	O
means	O
of	O
its	O
pocket	O
domain	O
.	O
<EOS>	B-X
In	B-X
eukaryotic	B-X
cells	B-X
the	B-X
histone	B-X
methylase	B-X
SUV39H1	B-X
and	B-X
the	B-X
methyl-lysine	B-X
binding	B-X
protein	B-X
HP1	B-X
functionally	B-X
interact	B-X
to	B-X
repress	B-X
transcription	B-X
at	B-X
heterochromatic	B-X
sites	B-X
.	B-X
Lysine	B-X
9	B-X
of	B-X
histone	B-X
H3	B-X
is	B-X
methylated	B-X
by	B-X
SUV39H1	B-X
(	B-X
ref	B-X
.	B-X
2	B-X
)	B-X
,	B-X
creating	B-X
a	B-X
binding	B-X
site	B-X
for	B-X
the	B-X
chromo	B-X
domain	B-X
of	B-X
HP1	B-X
(	B-X
refs	B-X
3	B-X
,	B-X
4	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
are	B-X
both	B-X
involved	B-X
in	B-X
the	B-X
repressive	B-X
functions	B-X
of	B-X
the	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
protein	B-X
.	B-X
Rb	B-X
associates	B-X
with	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
in	B-X
vivo	B-X
by	B-X
means	B-X
of	B-X
its	B-X
pocket	B-X
domain	B-X
.	B-X
SUV39H1	B-X
cooperates	B-X
with	B-X
Rb	B-X
to	B-X
repress	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
,	B-X
and	B-X
in	B-X
fibroblasts	B-X
that	B-X
are	B-X
disrupted	B-X
for	B-X
SUV39	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
cyclin	B-X
E	B-X
and	B-X
cyclin	B-X
A2	B-X
genes	B-X
are	B-X
specifically	B-X
elevated	B-X
.	B-X
Chromatin	B-X
immunoprecipitations	B-X
show	B-X
that	B-X
Rb	B-X
is	B-X
necessary	B-X
to	B-X
direct	B-X
methylation	B-X
of	B-X
histone	B-X
H3	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
for	B-X
binding	B-X
of	B-X
HP1	B-X
to	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
SUV39H1-HP1	B-X
complex	B-X
is	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
heterochromatic	B-X
silencing	B-X
but	B-X
also	B-X
has	B-X
a	B-X
role	B-X
in	B-X
repression	B-X
of	B-X
euchromatic	B-X
genes	B-X
by	B-X
Rb	B-X
and	B-X
perhaps	B-X
other	B-X
co-repressor	B-X
proteins	B-X
.	B-X

SUV39H1	B-Gene_or_gene_product
cooperates	O
with	O
Rb	B-Gene_or_gene_product
to	O
repress	O
the	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
promoter	O
,	O
and	O
in	O
fibroblasts	O
that	O
are	O
disrupted	O
for	O
SUV39	B-Gene_or_gene_product
,	O
the	O
activity	O
of	O
the	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
and	O
cyclin	B-Gene_or_gene_product
A2	I-Gene_or_gene_product
genes	O
are	O
specifically	O
elevated	O
.	O
<EOS>	B-X
In	B-X
eukaryotic	B-X
cells	B-X
the	B-X
histone	B-X
methylase	B-X
SUV39H1	B-X
and	B-X
the	B-X
methyl-lysine	B-X
binding	B-X
protein	B-X
HP1	B-X
functionally	B-X
interact	B-X
to	B-X
repress	B-X
transcription	B-X
at	B-X
heterochromatic	B-X
sites	B-X
.	B-X
Lysine	B-X
9	B-X
of	B-X
histone	B-X
H3	B-X
is	B-X
methylated	B-X
by	B-X
SUV39H1	B-X
(	B-X
ref	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
are	B-X
both	B-X
involved	B-X
in	B-X
the	B-X
repressive	B-X
functions	B-X
of	B-X
the	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
protein	B-X
.	B-X
Rb	B-X
associates	B-X
with	B-X
SUV39H1	B-X
and	B-X
HP1	B-X
in	B-X
vivo	B-X
by	B-X
means	B-X
of	B-X
its	B-X
pocket	B-X
domain	B-X
.	B-X
SUV39H1	B-X
cooperates	B-X
with	B-X
Rb	B-X
to	B-X
repress	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
,	B-X
and	B-X
in	B-X
fibroblasts	B-X
that	B-X
are	B-X
disrupted	B-X
for	B-X
SUV39	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
cyclin	B-X
E	B-X
and	B-X
cyclin	B-X
A2	B-X
genes	B-X
are	B-X
specifically	B-X
elevated	B-X
.	B-X
Chromatin	B-X
immunoprecipitations	B-X
show	B-X
that	B-X
Rb	B-X
is	B-X
necessary	B-X
to	B-X
direct	B-X
methylation	B-X
of	B-X
histone	B-X
H3	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
for	B-X
binding	B-X
of	B-X
HP1	B-X
to	B-X
the	B-X
cyclin	B-X
E	B-X
promoter	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
SUV39H1-HP1	B-X
complex	B-X
is	B-X
not	B-X
only	B-X
involved	B-X
in	B-X
heterochromatic	B-X
silencing	B-X
but	B-X
also	B-X
has	B-X
a	B-X
role	B-X
in	B-X
repression	B-X
of	B-X
euchromatic	B-X
genes	B-X
by	B-X
Rb	B-X
and	B-X
perhaps	B-X
other	B-X
co-repressor	B-X
proteins	B-X
.	B-X

Chromatin	O
immunoprecipitations	O
show	O
that	O
Rb	B-Gene_or_gene_product
is	O
necessary	O
to	O
direct	O
methylation	O
of	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
,	O
and	O
is	O
necessary	O
for	O
binding	O
of	O
HP1	B-Gene_or_gene_product
to	O
the	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
promoter	O
.	O

These	O
results	O
indicate	O
that	O
the	O
SUV39H1	O
-	O
HP1	O
complex	O
is	O
not	O
only	O
involved	O
in	O
heterochromatic	O
silencing	O
but	O
also	O
has	O
a	O
role	O
in	O
repression	O
of	O
euchromatic	O
genes	O
by	O
Rb	B-Gene_or_gene_product
and	O
perhaps	O
other	O
co	O
-	O
repressor	O
proteins	O
.	O
<EOS>	B-X
Cytosine	B-X
methylation	B-X
and	B-X
posttranslational	B-X
modifications	B-X
of	B-X
the	B-X
amino	B-X
termini	B-X
of	B-X
the	B-X
core	B-X
histones	B-X
in	B-X
the	B-X
nucleosome	B-X
provide	B-X
epigenetic	B-X
codes	B-X
for	B-X
genome	B-X
regulation	B-X
.	B-X
In	B-X
the	B-X
nucleus	B-X
,	B-X
not	B-X
only	B-X
is	B-X
the	B-X
DNA	B-X
methylated	B-X
,	B-X
but	B-X
the	B-X
methylated	B-X
DNA	B-X
is	B-X
also	B-X
interpreted	B-X
by	B-X
methyl-CpG	B-X
binding	B-X
domain	B-X
(	B-X
MBD	B-X
)	B-X
proteins	B-X
.	B-X
MBD1	B-X
possesses	B-X
an	B-X
MBD	B-X
involved	B-X
in	B-X
mediating	B-X
DNA	B-X
methylation-dependent	B-X
transcriptional	B-X
repression	B-X
.	B-X
The	B-X
MBD	B-X
of	B-X
MBD1	B-X
binds	B-X
a	B-X
symmetrically	B-X
methylated	B-X
CpG	B-X
sequence	B-X
,	B-X
but	B-X
the	B-X
precise	B-X
roles	B-X
of	B-X
this	B-X
domain	B-X
have	B-X
not	B-X
been	B-X
investigated	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
little	B-X
is	B-X
understood	B-X
about	B-X
the	B-X
state	B-X
of	B-X
histone	B-X
modifications	B-X
within	B-X
MBD1-containing	B-X
heterochromatin	B-X
on	B-X
methylated	B-X
gene	B-X
promoters	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
histone	B-X
H3	B-X
methylase	B-X
Suv39h1	B-X
and	B-X
the	B-X
methyl	B-X
lysine-binding	B-X
protein	B-X
HP1	B-X
directly	B-X
interact	B-X
with	B-X
MBD	B-X
of	B-X
MBD1	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
cells	B-X
.	B-X
Suv39h1	B-X
was	B-X
found	B-X
to	B-X
enhance	B-X
MBD1-mediated	B-X
transcriptional	B-X
repression	B-X
via	B-X
MBD	B-X
but	B-X
not	B-X
via	B-X
the	B-X
C-terminal	B-X
transcriptional	B-X
repression	B-X
domain	B-X
of	B-X
MBD1	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
MBD1	B-X
may	B-X
tether	B-X
the	B-X
Suv39h1-HP1	B-X
complex	B-X
to	B-X
methylated	B-X
DNA	B-X
regions	B-X
,	B-X
suggesting	B-X
the	B-X
presence	B-X
of	B-X
a	B-X
pathway	B-X
from	B-X
DNA	B-X
methylation	B-X
to	B-X
the	B-X
modifications	B-X
of	B-X
histones	B-X
for	B-X
epigenetic	B-X
gene	B-X
regulation	B-X
.	B-X

p70S6	B-Gene_or_gene_product
kinase	O
signals	O
cell	O
survival	O
as	O
well	O
as	O
growth	O
,	O
inactivating	O
the	O
pro	O
-	O
apoptotic	O
molecule	O
BAD	B-Gene_or_gene_product
.	O
<EOS>	B-X
Cytokines	B-X
often	B-X
deliver	B-X
simultaneous	B-X
,	B-X
yet	B-X
distinct	B-X
,	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
survival	B-X
signals	B-X
.	B-X
The	B-X
70-kDa	B-X
ribosomal	B-X
protein	B-X
S6	B-X
kinase	B-X
(	B-X
p70S6K	B-X
)	B-X
is	B-X
known	B-X
to	B-X
regulate	B-X
cell	B-X
growth	B-X
by	B-X
inducing	B-X
protein	B-X
synthesis	B-X
components	B-X
.	B-X
We	B-X
purified	B-X
membrane-based	B-X
p70S6K	B-X
as	B-X
a	B-X
kinase	B-X
responsible	B-X
for	B-X
site-specific	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
,	B-X
which	B-X
inactivates	B-X
this	B-X
proapoptotic	B-X
molecule	B-X
.	B-X
Rapamycin	B-X
inhibited	B-X
mitochondrial-based	B-X
p70S6K	B-X
,	B-X
which	B-X
prevented	B-X
phosphorylation	B-X
of	B-X
Ser-136	B-X
on	B-X
BAD	B-X
and	B-X
blocked	B-X
cell	B-X
survival	B-X
induced	B-X
by	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
IGF-1	B-X
)	B-X
.	B-X
Moreover	B-X
,	B-X
IGF-1-induced	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
Ser-136	B-X
was	B-X
abolished	B-X
in	B-X
p70S6K-deficient	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
p70S6K	B-X
is	B-X
itself	B-X
a	B-X
dual	B-X
pathway	B-X
kinase	B-X
,	B-X
signaling	B-X
cell	B-X
survival	B-X
as	B-X
well	B-X
as	B-X
growth	B-X
through	B-X
differential	B-X
substrates	B-X
which	B-X
include	B-X
mitochondrial	B-X
BAD	B-X
and	B-X
the	B-X
ribosomal	B-X
subunit	B-X
S6	B-X
,	B-X
respectively	B-X
.	B-X

Cytokines	O
often	O
deliver	O
simultaneous	O
,	O
yet	O
distinct	O
,	O
cell	O
growth	O
and	O
cell	O
survival	O
signals	O
.	O
<EOS>	B-X
Cytokines	B-X
often	B-X
deliver	B-X
simultaneous	B-X
,	B-X
yet	B-X
distinct	B-X
,	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
survival	B-X
signals	B-X
.	B-X
The	B-X
70-kDa	B-X
ribosomal	B-X
protein	B-X
S6	B-X
kinase	B-X
(	B-X
p70S6K	B-X
)	B-X
is	B-X
known	B-X
to	B-X
regulate	B-X
cell	B-X
growth	B-X
by	B-X
inducing	B-X
protein	B-X
synthesis	B-X
components	B-X
.	B-X
Rapamycin	B-X
inhibited	B-X
mitochondrial-based	B-X
p70S6K	B-X
,	B-X
which	B-X
prevented	B-X
phosphorylation	B-X
of	B-X
Ser-136	B-X
on	B-X
BAD	B-X
and	B-X
blocked	B-X
cell	B-X
survival	B-X
induced	B-X
by	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
IGF-1	B-X
)	B-X
.	B-X
Moreover	B-X
,	B-X
IGF-1-induced	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
Ser-136	B-X
was	B-X
abolished	B-X
in	B-X
p70S6K-deficient	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
p70S6K	B-X
is	B-X
itself	B-X
a	B-X
dual	B-X
pathway	B-X
kinase	B-X
,	B-X
signaling	B-X
cell	B-X
survival	B-X
as	B-X
well	B-X
as	B-X
growth	B-X
through	B-X
differential	B-X
substrates	B-X
which	B-X
include	B-X
mitochondrial	B-X
BAD	B-X
and	B-X
the	B-X
ribosomal	B-X
subunit	B-X
S6	B-X
,	B-X
respectively	B-X
.	B-X

The	O
70	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kDa	I-Gene_or_gene_product
ribosomal	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
S6	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
p70S6K	B-Gene_or_gene_product
)	O
is	O
known	O
to	O
regulate	O
cell	O
growth	O
by	O
inducing	O
protein	O
synthesis	O
components	O
.	O
<EOS>	B-X
Cytokines	B-X
often	B-X
deliver	B-X
simultaneous	B-X
,	B-X
yet	B-X
distinct	B-X
,	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
survival	B-X
signals	B-X
.	B-X
The	B-X
70-kDa	B-X
ribosomal	B-X
protein	B-X
S6	B-X
kinase	B-X
(	B-X
p70S6K	B-X
)	B-X
is	B-X
known	B-X
to	B-X
regulate	B-X
cell	B-X
growth	B-X
by	B-X
inducing	B-X
protein	B-X
synthesis	B-X
components	B-X
.	B-X
We	B-X
purified	B-X
membrane-based	B-X
p70S6K	B-X
as	B-X
a	B-X
kinase	B-X
responsible	B-X
for	B-X
site-specific	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
,	B-X
which	B-X
inactivates	B-X
this	B-X
proapoptotic	B-X
molecule	B-X
.	B-X
Rapamycin	B-X
inhibited	B-X
mitochondrial-based	B-X
p70S6K	B-X
,	B-X
which	B-X
prevented	B-X
phosphorylation	B-X
of	B-X
Ser-136	B-X
on	B-X
BAD	B-X
and	B-X
blocked	B-X
cell	B-X
survival	B-X
induced	B-X
by	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
IGF-1	B-X
)	B-X
.	B-X
Moreover	B-X
,	B-X
IGF-1-induced	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
Ser-136	B-X
was	B-X
abolished	B-X
in	B-X
p70S6K-deficient	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
p70S6K	B-X
is	B-X
itself	B-X
a	B-X
dual	B-X
pathway	B-X
kinase	B-X
,	B-X
signaling	B-X
cell	B-X
survival	B-X
as	B-X
well	B-X
as	B-X
growth	B-X
through	B-X
differential	B-X
substrates	B-X
which	B-X
include	B-X
mitochondrial	B-X
BAD	B-X
and	B-X
the	B-X
ribosomal	B-X
subunit	B-X
S6	B-X
,	B-X
respectively	B-X
.	B-X

We	O
purified	O
membrane	O
-	O
based	O
p70S6K	B-Gene_or_gene_product
as	O
a	O
kinase	O
responsible	O
for	O
site	O
-	O
specific	O
phosphorylation	O
of	O
BAD	B-Gene_or_gene_product
,	O
which	O
inactivates	O
this	O
proapoptotic	O
molecule	O
.	O
<EOS>	B-X
The	B-X
70-kDa	B-X
ribosomal	B-X
protein	B-X
S6	B-X
kinase	B-X
(	B-X
p70S6K	B-X
)	B-X
is	B-X
known	B-X
to	B-X
regulate	B-X
cell	B-X
growth	B-X
by	B-X
inducing	B-X
protein	B-X
synthesis	B-X
components	B-X
.	B-X
We	B-X
purified	B-X
membrane-based	B-X
p70S6K	B-X
as	B-X
a	B-X
kinase	B-X
responsible	B-X
for	B-X
site-specific	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
,	B-X
which	B-X
inactivates	B-X
this	B-X
proapoptotic	B-X
molecule	B-X
.	B-X
Rapamycin	B-X
inhibited	B-X
mitochondrial-based	B-X
p70S6K	B-X
,	B-X
which	B-X
prevented	B-X
phosphorylation	B-X
of	B-X
Ser-136	B-X
on	B-X
BAD	B-X
and	B-X
blocked	B-X
cell	B-X
survival	B-X
induced	B-X
by	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
IGF-1	B-X
)	B-X
.	B-X
Moreover	B-X
,	B-X
IGF-1-induced	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
Ser-136	B-X
was	B-X
abolished	B-X
in	B-X
p70S6K-deficient	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
p70S6K	B-X
is	B-X
itself	B-X
a	B-X
dual	B-X
pathway	B-X
kinase	B-X
,	B-X
signaling	B-X
cell	B-X
survival	B-X
as	B-X
well	B-X
as	B-X
growth	B-X
through	B-X
differential	B-X
substrates	B-X
which	B-X
include	B-X
mitochondrial	B-X
BAD	B-X
and	B-X
the	B-X
ribosomal	B-X
subunit	B-X
S6	B-X
,	B-X
respectively	B-X
.	B-X

Rapamycin	O
inhibited	O
mitochondrial	O
-	O
based	O
p70S6K	B-Gene_or_gene_product
,	O
which	O
prevented	O
phosphorylation	O
of	O
Ser	O
-	O
136	O
on	O
BAD	B-Gene_or_gene_product
and	O
blocked	O
cell	O
survival	O
induced	O
by	O
insulin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
IGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
Cytokines	B-X
often	B-X
deliver	B-X
simultaneous	B-X
,	B-X
yet	B-X
distinct	B-X
,	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
survival	B-X
signals	B-X
.	B-X
The	B-X
70-kDa	B-X
ribosomal	B-X
protein	B-X
S6	B-X
kinase	B-X
(	B-X
p70S6K	B-X
)	B-X
is	B-X
known	B-X
to	B-X
regulate	B-X
cell	B-X
growth	B-X
by	B-X
inducing	B-X
protein	B-X
synthesis	B-X
components	B-X
.	B-X
We	B-X
purified	B-X
membrane-based	B-X
p70S6K	B-X
as	B-X
a	B-X
kinase	B-X
responsible	B-X
for	B-X
site-specific	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
,	B-X
which	B-X
inactivates	B-X
this	B-X
proapoptotic	B-X
molecule	B-X
.	B-X
Rapamycin	B-X
inhibited	B-X
mitochondrial-based	B-X
p70S6K	B-X
,	B-X
which	B-X
prevented	B-X
phosphorylation	B-X
of	B-X
Ser-136	B-X
on	B-X
BAD	B-X
and	B-X
blocked	B-X
cell	B-X
survival	B-X
induced	B-X
by	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
IGF-1	B-X
)	B-X
.	B-X
Moreover	B-X
,	B-X
IGF-1-induced	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
Ser-136	B-X
was	B-X
abolished	B-X
in	B-X
p70S6K-deficient	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
p70S6K	B-X
is	B-X
itself	B-X
a	B-X
dual	B-X
pathway	B-X
kinase	B-X
,	B-X
signaling	B-X
cell	B-X
survival	B-X
as	B-X
well	B-X
as	B-X
growth	B-X
through	B-X
differential	B-X
substrates	B-X
which	B-X
include	B-X
mitochondrial	B-X
BAD	B-X
and	B-X
the	B-X
ribosomal	B-X
subunit	B-X
S6	B-X
,	B-X
respectively	B-X
.	B-X

Moreover	O
,	O
IGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
induced	O
phosphorylation	O
of	O
BAD	B-Gene_or_gene_product
Ser	O
-	O
136	O
was	O
abolished	O
in	O
p70S6K	B-Gene_or_gene_product
-	O
deficient	O
cells	O
.	O
<EOS>	B-X
The	B-X
70-kDa	B-X
ribosomal	B-X
protein	B-X
S6	B-X
kinase	B-X
(	B-X
p70S6K	B-X
)	B-X
is	B-X
known	B-X
to	B-X
regulate	B-X
cell	B-X
growth	B-X
by	B-X
inducing	B-X
protein	B-X
synthesis	B-X
components	B-X
.	B-X
We	B-X
purified	B-X
membrane-based	B-X
p70S6K	B-X
as	B-X
a	B-X
kinase	B-X
responsible	B-X
for	B-X
site-specific	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
,	B-X
which	B-X
inactivates	B-X
this	B-X
proapoptotic	B-X
molecule	B-X
.	B-X
Rapamycin	B-X
inhibited	B-X
mitochondrial-based	B-X
p70S6K	B-X
,	B-X
which	B-X
prevented	B-X
phosphorylation	B-X
of	B-X
Ser-136	B-X
on	B-X
BAD	B-X
and	B-X
blocked	B-X
cell	B-X
survival	B-X
induced	B-X
by	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
IGF-1	B-X
)	B-X
.	B-X
Moreover	B-X
,	B-X
IGF-1-induced	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
Ser-136	B-X
was	B-X
abolished	B-X
in	B-X
p70S6K-deficient	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
p70S6K	B-X
is	B-X
itself	B-X
a	B-X
dual	B-X
pathway	B-X
kinase	B-X
,	B-X
signaling	B-X
cell	B-X
survival	B-X
as	B-X
well	B-X
as	B-X
growth	B-X
through	B-X
differential	B-X
substrates	B-X
which	B-X
include	B-X
mitochondrial	B-X
BAD	B-X
and	B-X
the	B-X
ribosomal	B-X
subunit	B-X
S6	B-X
,	B-X
respectively	B-X
.	B-X

Thus	O
,	O
p70S6K	B-Gene_or_gene_product
is	O
itself	O
a	O
dual	O
pathway	O
kinase	O
,	O
signaling	O
cell	O
survival	O
as	O
well	O
as	O
growth	O
through	O
differential	O
substrates	O
which	O
include	O
mitochondrial	O
BAD	B-Gene_or_gene_product
and	O
the	O
ribosomal	O
subunit	O
S6	B-Gene_or_gene_product
,	O
respectively	O
.	O
<EOS>	B-X
Cytokines	B-X
often	B-X
deliver	B-X
simultaneous	B-X
,	B-X
yet	B-X
distinct	B-X
,	B-X
cell	B-X
growth	B-X
and	B-X
cell	B-X
survival	B-X
signals	B-X
.	B-X
The	B-X
70-kDa	B-X
ribosomal	B-X
protein	B-X
S6	B-X
kinase	B-X
(	B-X
p70S6K	B-X
)	B-X
is	B-X
known	B-X
to	B-X
regulate	B-X
cell	B-X
growth	B-X
by	B-X
inducing	B-X
protein	B-X
synthesis	B-X
components	B-X
.	B-X
We	B-X
purified	B-X
membrane-based	B-X
p70S6K	B-X
as	B-X
a	B-X
kinase	B-X
responsible	B-X
for	B-X
site-specific	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
,	B-X
which	B-X
inactivates	B-X
this	B-X
proapoptotic	B-X
molecule	B-X
.	B-X
Rapamycin	B-X
inhibited	B-X
mitochondrial-based	B-X
p70S6K	B-X
,	B-X
which	B-X
prevented	B-X
phosphorylation	B-X
of	B-X
Ser-136	B-X
on	B-X
BAD	B-X
and	B-X
blocked	B-X
cell	B-X
survival	B-X
induced	B-X
by	B-X
insulin-like	B-X
growth	B-X
factor	B-X
1	B-X
(	B-X
IGF-1	B-X
)	B-X
.	B-X
Moreover	B-X
,	B-X
IGF-1-induced	B-X
phosphorylation	B-X
of	B-X
BAD	B-X
Ser-136	B-X
was	B-X
abolished	B-X
in	B-X
p70S6K-deficient	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
p70S6K	B-X
is	B-X
itself	B-X
a	B-X
dual	B-X
pathway	B-X
kinase	B-X
,	B-X
signaling	B-X
cell	B-X
survival	B-X
as	B-X
well	B-X
as	B-X
growth	B-X
through	B-X
differential	B-X
substrates	B-X
which	B-X
include	B-X
mitochondrial	B-X
BAD	B-X
and	B-X
the	B-X
ribosomal	B-X
subunit	B-X
S6	B-X
,	B-X
respectively	B-X
.	B-X

Polyamine	O
depletion	O
induces	O
rapid	O
NF	O
-	O
kappa	O
B	O
activation	O
in	O
IEC	O
-	O
6	O
cells	O
.	O
<EOS>	B-X
The	B-X
proliferation	B-X
of	B-X
the	B-X
rat	B-X
intestinal	B-X
mucosal	B-X
IEC-6	B-X
cell	B-X
line	B-X
requires	B-X
polyamines	B-X
,	B-X
whose	B-X
synthesis	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
enzyme	B-X
ornithine	B-X
decarboxylase	B-X
(	B-X
ODC	B-X
)	B-X
.	B-X
ODC	B-X
inhibition	B-X
leads	B-X
to	B-X
polyamine	B-X
depletion	B-X
,	B-X
as	B-X
well	B-X
as	B-X
inhibition	B-X
of	B-X
both	B-X
cell	B-X
proliferation	B-X
and	B-X
apoptosis	B-X
by	B-X
regulating	B-X
gene	B-X
expression	B-X
.	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

The	O
proliferation	O
of	O
the	O
rat	O
intestinal	O
mucosal	O
IEC	O
-	O
6	O
cell	O
line	O
requires	O
polyamines	O
,	O
whose	O
synthesis	O
is	O
catalyzed	O
by	O
the	O
enzyme	O
ornithine	B-Gene_or_gene_product
decarboxylase	I-Gene_or_gene_product
(	O
ODC	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
The	B-X
proliferation	B-X
of	B-X
the	B-X
rat	B-X
intestinal	B-X
mucosal	B-X
IEC-6	B-X
cell	B-X
line	B-X
requires	B-X
polyamines	B-X
,	B-X
whose	B-X
synthesis	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
enzyme	B-X
ornithine	B-X
decarboxylase	B-X
(	B-X
ODC	B-X
)	B-X
.	B-X
ODC	B-X
inhibition	B-X
leads	B-X
to	B-X
polyamine	B-X
depletion	B-X
,	B-X
as	B-X
well	B-X
as	B-X
inhibition	B-X
of	B-X
both	B-X
cell	B-X
proliferation	B-X
and	B-X
apoptosis	B-X
by	B-X
regulating	B-X
gene	B-X
expression	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

ODC	B-Gene_or_gene_product
inhibition	O
leads	O
to	O
polyamine	O
depletion	O
,	O
as	O
well	O
as	O
inhibition	O
of	O
both	O
cell	O
proliferation	O
and	O
apoptosis	O
by	O
regulating	O
gene	O
expression	O
.	O
<EOS>	B-X
The	B-X
proliferation	B-X
of	B-X
the	B-X
rat	B-X
intestinal	B-X
mucosal	B-X
IEC-6	B-X
cell	B-X
line	B-X
requires	B-X
polyamines	B-X
,	B-X
whose	B-X
synthesis	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
enzyme	B-X
ornithine	B-X
decarboxylase	B-X
(	B-X
ODC	B-X
)	B-X
.	B-X
ODC	B-X
inhibition	B-X
leads	B-X
to	B-X
polyamine	B-X
depletion	B-X
,	B-X
as	B-X
well	B-X
as	B-X
inhibition	B-X
of	B-X
both	B-X
cell	B-X
proliferation	B-X
and	B-X
apoptosis	B-X
by	B-X
regulating	B-X
gene	B-X
expression	B-X
.	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

The	O
NF	O
-	O
kappa	O
B	O
transcription	O
factor	O
regulates	O
genes	O
involved	O
in	O
apoptotic	O
,	O
immune	O
,	O
and	O
inflammatory	O
responses	O
.	O
<EOS>	B-X
The	B-X
transcription	B-X
factor	B-X
Stat3	B-X
is	B-X
essential	B-X
for	B-X
timely	B-X
initiation	B-X
of	B-X
post-lactational	B-X
regression	B-X
and	B-X
orchestrates	B-X
the	B-X
processes	B-X
of	B-X
cell	B-X
death	B-X
and	B-X
tissue	B-X
remodelling	B-X
that	B-X
occur	B-X
during	B-X
the	B-X
first	B-X
6	B-X
days	B-X
of	B-X
involution	B-X
in	B-X
the	B-X
mouse	B-X
.	B-X
This	B-X
raises	B-X
two	B-X
interesting	B-X
questions	B-X
:	B-X
1	B-X
)	B-X
do	B-X
the	B-X
high	B-X
levels	B-X
of	B-X
active	B-X
Stat3	B-X
present	B-X
in	B-X
the	B-X
mammary	B-X
epithelium	B-X
during	B-X
involution	B-X
promote	B-X
tumor	B-X
spread	B-X
and	B-X
2	B-X
)	B-X
how	B-X
do	B-X
tumor	B-X
cells	B-X
escape	B-X
the	B-X
pro-apoptotic	B-X
effects	B-X
of	B-X
Stat3	B-X
?	B-X
In	B-X
order	B-X
to	B-X
address	B-X
these	B-X
questions	B-X
,	B-X
it	B-X
is	B-X
essential	B-X
to	B-X
understand	B-X
the	B-X
role	B-X
of	B-X
Stat3	B-X
in	B-X
involution	B-X
and	B-X
the	B-X
mechanisms	B-X
by	B-X
which	B-X
Stat3	B-X
regulates	B-X
both	B-X
cell	B-X
death	B-X
and	B-X
tissue	B-X
remodelling	B-X
.	B-X
Firstly	B-X
,	B-X
post-lactational	B-X
regression	B-X
is	B-X
associated	B-X
with	B-X
an	B-X
acute	B-X
phase	B-X
and	B-X
inflammatory	B-X
response	B-X
in	B-X
addition	B-X
to	B-X
cell	B-X
death	B-X
and	B-X
secondly	B-X
,	B-X
Stat3	B-X
alone	B-X
is	B-X
insufficient	B-X
to	B-X
induce	B-X
involution	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
the	B-X
NF-kappaB	B-X
regulatory	B-X
kinase	B-X
IKKbeta	B-X
.	B-X
Both	B-X
Stat3	B-X
and	B-X
NF-kappaB	B-X
have	B-X
been	B-X
shown	B-X
to	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
inflammatory	B-X
signalling	B-X
and	B-X
the	B-X
acute	B-X
phase	B-X
response	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
a	B-X
role	B-X
for	B-X
the	B-X
innate	B-X
immune	B-X
response	B-X
in	B-X
mammary	B-X
epithelial	B-X
cell	B-X
fate	B-X
during	B-X
involution	B-X
and	B-X
highlight	B-X
potential	B-X
roles	B-X
for	B-X
this	B-X
response	B-X
in	B-X
tissue	B-X
remodelling-associated	B-X
breast	B-X
cancer	B-X
metastasis	B-X
.	B-X

In	O
the	O
present	O
study	O
we	O
tested	O
the	O
hypothesis	O
that	O
NF	O
-	O
kappa	O
B	O
is	O
activated	O
following	O
ODC	B-Gene_or_gene_product
inhibition	O
.	O
<EOS>	B-X
The	B-X
proliferation	B-X
of	B-X
the	B-X
rat	B-X
intestinal	B-X
mucosal	B-X
IEC-6	B-X
cell	B-X
line	B-X
requires	B-X
polyamines	B-X
,	B-X
whose	B-X
synthesis	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
enzyme	B-X
ornithine	B-X
decarboxylase	B-X
(	B-X
ODC	B-X
)	B-X
.	B-X
ODC	B-X
inhibition	B-X
leads	B-X
to	B-X
polyamine	B-X
depletion	B-X
,	B-X
as	B-X
well	B-X
as	B-X
inhibition	B-X
of	B-X
both	B-X
cell	B-X
proliferation	B-X
and	B-X
apoptosis	B-X
by	B-X
regulating	B-X
gene	B-X
expression	B-X
.	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

We	O
found	O
that	O
the	O
inhibition	O
of	O
ODC	B-Gene_or_gene_product
by	O
alpha	O
-	O
difluoromethylornithine	O
(	O
DFMO	O
)	O
resulted	O
in	O
a	O
approximately	O
50	O
%	O
decrease	O
in	O
intracellular	O
putrescine	O
levels	O
within	O
1	O
h	O
.	O

NF	O
-	O
kappa	O
B	O
is	O
activated	O
by	O
DFMO	O
through	O
the	O
degradation	O
of	O
the	O
inhibitory	O
protein	O
I	B-Gene_or_gene_product
kappa	I-Gene_or_gene_product
B	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
that	O
sequesters	O
NF	O
-	O
kappa	O
B	O
in	O
the	O
cytoplasm	O
.	O
<EOS>	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

The	O
DFMO	O
-	O
induced	O
NF	O
-	O
kappa	O
B	O
complexes	O
contain	O
the	O
p65	B-Gene_or_gene_product
and	O
p50	B-Gene_or_gene_product
members	O
of	O
the	O
Rel	B-Gene_or_gene_product
protein	O
family	O
.	O
<EOS>	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

DFMO	O
-	O
induced	O
NF	O
-	O
kappa	O
B	O
activation	O
was	O
accompanied	O
by	O
the	O
translocation	O
of	O
p65	B-Gene_or_gene_product
from	O
the	O
cytoplasm	O
into	O
the	O
nucleus	O
.	O
<EOS>	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

DFMO	O
selectively	O
inhibited	O
a	O
gene	O
reporter	O
construct	O
dependent	O
on	O
the	O
kappa	O
B	O
site	O
present	O
in	O
the	O
HLA	B-Gene_or_gene_product
-	I-Gene_or_gene_product
B7	I-Gene_or_gene_product
gene	O
.	O
<EOS>	B-X
ODC	B-X
inhibition	B-X
leads	B-X
to	B-X
polyamine	B-X
depletion	B-X
,	B-X
as	B-X
well	B-X
as	B-X
inhibition	B-X
of	B-X
both	B-X
cell	B-X
proliferation	B-X
and	B-X
apoptosis	B-X
by	B-X
regulating	B-X
gene	B-X
expression	B-X
.	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

In	O
contrast	O
,	O
DFMO	O
had	O
no	O
effect	O
on	O
a	O
gene	O
reporter	O
construct	O
dependent	O
on	O
the	O
kappa	O
B	O
site	O
present	O
in	O
the	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
8	I-Gene_or_gene_product
gene	O
.	O
<EOS>	B-X
ODC	B-X
inhibition	B-X
leads	B-X
to	B-X
polyamine	B-X
depletion	B-X
,	B-X
as	B-X
well	B-X
as	B-X
inhibition	B-X
of	B-X
both	B-X
cell	B-X
proliferation	B-X
and	B-X
apoptosis	B-X
by	B-X
regulating	B-X
gene	B-X
expression	B-X
.	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

Thus	O
,	O
we	O
report	O
that	O
ODC	B-Gene_or_gene_product
inhibition	O
activates	O
the	O
NF	O
-	O
kappa	O
B	O
transcription	O
factor	O
,	O
which	O
may	O
mediate	O
the	O
altered	O
physiological	O
state	O
of	O
intestinal	O
cells	O
that	O
occurs	O
following	O
polyamine	O
depletion	O
.	O
<EOS>	B-X
The	B-X
proliferation	B-X
of	B-X
the	B-X
rat	B-X
intestinal	B-X
mucosal	B-X
IEC-6	B-X
cell	B-X
line	B-X
requires	B-X
polyamines	B-X
,	B-X
whose	B-X
synthesis	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
enzyme	B-X
ornithine	B-X
decarboxylase	B-X
(	B-X
ODC	B-X
)	B-X
.	B-X
ODC	B-X
inhibition	B-X
leads	B-X
to	B-X
polyamine	B-X
depletion	B-X
,	B-X
as	B-X
well	B-X
as	B-X
inhibition	B-X
of	B-X
both	B-X
cell	B-X
proliferation	B-X
and	B-X
apoptosis	B-X
by	B-X
regulating	B-X
gene	B-X
expression	B-X
.	B-X
The	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
regulates	B-X
genes	B-X
involved	B-X
in	B-X
apoptotic	B-X
,	B-X
immune	B-X
,	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
tested	B-X
the	B-X
hypothesis	B-X
that	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
following	B-X
ODC	B-X
inhibition	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
inhibition	B-X
of	B-X
ODC	B-X
by	B-X
alpha-difluoromethylornithine	B-X
(	B-X
DFMO	B-X
)	B-X
resulted	B-X
in	B-X
a	B-X
approximately	B-X
50	B-X
%	B-X
decrease	B-X
in	B-X
intracellular	B-X
putrescine	B-X
levels	B-X
within	B-X
1	B-X
h.	B-X
NF-kappa	B-X
B	B-X
is	B-X
activated	B-X
by	B-X
DFMO	B-X
through	B-X
the	B-X
degradation	B-X
of	B-X
the	B-X
inhibitory	B-X
protein	B-X
I	B-X
kappa	B-X
B	B-X
alpha	B-X
that	B-X
sequesters	B-X
NF-kappa	B-X
B	B-X
in	B-X
the	B-X
cytoplasm	B-X
.	B-X
The	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
complexes	B-X
contain	B-X
the	B-X
p65	B-X
and	B-X
p50	B-X
members	B-X
of	B-X
the	B-X
Rel	B-X
protein	B-X
family	B-X
.	B-X
DFMO-induced	B-X
NF-kappa	B-X
B	B-X
activation	B-X
was	B-X
accompanied	B-X
by	B-X
the	B-X
translocation	B-X
of	B-X
p65	B-X
from	B-X
the	B-X
cytoplasm	B-X
into	B-X
the	B-X
nucleus	B-X
.	B-X
DFMO	B-X
selectively	B-X
inhibited	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
HLA-B7	B-X
gene	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
DFMO	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
a	B-X
gene	B-X
reporter	B-X
construct	B-X
dependent	B-X
on	B-X
the	B-X
kappa	B-X
B	B-X
site	B-X
present	B-X
in	B-X
the	B-X
interleukin-8	B-X
gene	B-X
.	B-X
Thus	B-X
,	B-X
we	B-X
report	B-X
that	B-X
ODC	B-X
inhibition	B-X
activates	B-X
the	B-X
NF-kappa	B-X
B	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
may	B-X
mediate	B-X
the	B-X
altered	B-X
physiological	B-X
state	B-X
of	B-X
intestinal	B-X
cells	B-X
that	B-X
occurs	B-X
following	B-X
polyamine	B-X
depletion	B-X
.	B-X

Nucleocytoplasmic	O
shuttling	O
of	O
p130	B-Gene_or_gene_product
/	O
RBL2	B-Gene_or_gene_product
:	O
novel	O
regulatory	O
mechanism	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma-related	B-X
pocket	B-X
proteins	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
transformation	B-X
.	B-X
p130	B-X
was	B-X
observed	B-X
to	B-X
shuttle	B-X
between	B-X
the	B-X
nucleus	B-X
and	B-X
cytoplasm	B-X
in	B-X
a	B-X
heterokaryon	B-X
fusion	B-X
assay	B-X
,	B-X
suggesting	B-X
the	B-X
presence	B-X
of	B-X
nuclear	B-X
and	B-X
cytoplasmic	B-X
localization	B-X
signals	B-X
.	B-X
Two	B-X
independent	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLS	B-X
)	B-X
that	B-X
could	B-X
target	B-X
reporter	B-X
proteins	B-X
to	B-X
the	B-X
nucleus	B-X
in	B-X
transient	B-X
transfection	B-X
and	B-X
microinjection	B-X
experiments	B-X
were	B-X
identified	B-X
in	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
p130	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
,	B-X
the	B-X
intact	B-X
pocket	B-X
domain	B-X
of	B-X
p130	B-X
itself	B-X
was	B-X
sufficient	B-X
for	B-X
nuclear	B-X
translocation	B-X
.	B-X
Moreover	B-X
,	B-X
an	B-X
additional	B-X
functional	B-X
NLS	B-X
was	B-X
mapped	B-X
within	B-X
the	B-X
unique	B-X
Loop	B-X
region	B-X
of	B-X
p130	B-X
.	B-X
Removal	B-X
of	B-X
the	B-X
entire	B-X
N	B-X
terminus	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
ability	B-X
of	B-X
p130	B-X
to	B-X
interact	B-X
with	B-X
E2F	B-X
and	B-X
to	B-X
induce	B-X
growth	B-X
arrest	B-X
.	B-X

The	O
retinoblastoma	O
-	O
related	O
pocket	O
proteins	O
pRb	B-Gene_or_gene_product
,	O
p107	B-Gene_or_gene_product
,	O
and	O
p130	B-Gene_or_gene_product
are	O
implicated	O
in	O
the	O
control	O
of	O
cell	O
proliferation	O
,	O
differentiation	O
,	O
and	O
transformation	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma-related	B-X
pocket	B-X
proteins	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
transformation	B-X
.	B-X
The	B-X
function	B-X
of	B-X
pocket	B-X
proteins	B-X
is	B-X
in	B-X
part	B-X
mediated	B-X
by	B-X
their	B-X
ability	B-X
to	B-X
inhibit	B-X
specific	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
The	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2Fs	B-X
is	B-X
controlled	B-X
by	B-X
alteration	B-X
of	B-X
their	B-X
nucleocytoplasmic	B-X
localization	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
p130	B-X
was	B-X
observed	B-X
to	B-X
shuttle	B-X
between	B-X
the	B-X
nucleus	B-X
and	B-X
cytoplasm	B-X
in	B-X
a	B-X
heterokaryon	B-X
fusion	B-X
assay	B-X
,	B-X
suggesting	B-X
the	B-X
presence	B-X
of	B-X
nuclear	B-X
and	B-X
cytoplasmic	B-X
localization	B-X
signals	B-X
.	B-X
Two	B-X
independent	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLS	B-X
)	B-X
that	B-X
could	B-X
target	B-X
reporter	B-X
proteins	B-X
to	B-X
the	B-X
nucleus	B-X
in	B-X
transient	B-X
transfection	B-X
and	B-X
microinjection	B-X
experiments	B-X
were	B-X
identified	B-X
in	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
p130	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
,	B-X
the	B-X
intact	B-X
pocket	B-X
domain	B-X
of	B-X
p130	B-X
itself	B-X
was	B-X
sufficient	B-X
for	B-X
nuclear	B-X
translocation	B-X
.	B-X
Moreover	B-X
,	B-X
an	B-X
additional	B-X
functional	B-X
NLS	B-X
was	B-X
mapped	B-X
within	B-X
the	B-X
unique	B-X
Loop	B-X
region	B-X
of	B-X
p130	B-X
.	B-X
Removal	B-X
of	B-X
the	B-X
entire	B-X
N	B-X
terminus	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
ability	B-X
of	B-X
p130	B-X
to	B-X
interact	B-X
with	B-X
E2F	B-X
and	B-X
to	B-X
induce	B-X
growth	B-X
arrest	B-X
.	B-X
A	B-X
model	B-X
suggesting	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
pRb	B-X
family	B-X
members	B-X
can	B-X
be	B-X
regulated	B-X
by	B-X
intracellular	B-X
trafficking	B-X
of	B-X
the	B-X
proteins	B-X
is	B-X
proposed	B-X
.	B-X

The	O
function	O
of	O
pocket	O
proteins	O
is	O
in	O
part	O
mediated	O
by	O
their	O
ability	O
to	O
inhibit	O
specific	O
E2F	B-Gene_or_gene_product
transcription	O
factors	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma-related	B-X
pocket	B-X
proteins	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
transformation	B-X
.	B-X
The	B-X
function	B-X
of	B-X
pocket	B-X
proteins	B-X
is	B-X
in	B-X
part	B-X
mediated	B-X
by	B-X
their	B-X
ability	B-X
to	B-X
inhibit	B-X
specific	B-X
E2F	B-X
transcription	B-X
factors	B-X
.	B-X
The	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2Fs	B-X
is	B-X
controlled	B-X
by	B-X
alteration	B-X
of	B-X
their	B-X
nucleocytoplasmic	B-X
localization	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Two	B-X
independent	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLS	B-X
)	B-X
that	B-X
could	B-X
target	B-X
reporter	B-X
proteins	B-X
to	B-X
the	B-X
nucleus	B-X
in	B-X
transient	B-X
transfection	B-X
and	B-X
microinjection	B-X
experiments	B-X
were	B-X
identified	B-X
in	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
p130	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
,	B-X
the	B-X
intact	B-X
pocket	B-X
domain	B-X
of	B-X
p130	B-X
itself	B-X
was	B-X
sufficient	B-X
for	B-X
nuclear	B-X
translocation	B-X
.	B-X
Moreover	B-X
,	B-X
an	B-X
additional	B-X
functional	B-X
NLS	B-X
was	B-X
mapped	B-X
within	B-X
the	B-X
unique	B-X
Loop	B-X
region	B-X
of	B-X
p130	B-X
.	B-X
Removal	B-X
of	B-X
the	B-X
entire	B-X
N	B-X
terminus	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
ability	B-X
of	B-X
p130	B-X
to	B-X
interact	B-X
with	B-X
E2F	B-X
and	B-X
to	B-X
induce	B-X
growth	B-X
arrest	B-X
.	B-X
A	B-X
model	B-X
suggesting	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
pRb	B-X
family	B-X
members	B-X
can	B-X
be	B-X
regulated	B-X
by	B-X
intracellular	B-X
trafficking	B-X
of	B-X
the	B-X
proteins	B-X
is	B-X
proposed	B-X
.	B-X

The	O
transcriptional	O
activity	O
of	O
E2Fs	B-Gene_or_gene_product
is	O
controlled	O
by	O
alteration	O
of	O
their	O
nucleocytoplasmic	O
localization	O
during	O
the	O
cell	O
cycle	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma-related	B-X
pocket	B-X
proteins	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
transformation	B-X
.	B-X
The	B-X
transcriptional	B-X
activity	B-X
of	B-X
E2Fs	B-X
is	B-X
controlled	B-X
by	B-X
alteration	B-X
of	B-X
their	B-X
nucleocytoplasmic	B-X
localization	B-X
during	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
p130	B-X
was	B-X
observed	B-X
to	B-X
shuttle	B-X
between	B-X
the	B-X
nucleus	B-X
and	B-X
cytoplasm	B-X
in	B-X
a	B-X
heterokaryon	B-X
fusion	B-X
assay	B-X
,	B-X
suggesting	B-X
the	B-X
presence	B-X
of	B-X
nuclear	B-X
and	B-X
cytoplasmic	B-X
localization	B-X
signals	B-X
.	B-X
Two	B-X
independent	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLS	B-X
)	B-X
that	B-X
could	B-X
target	B-X
reporter	B-X
proteins	B-X
to	B-X
the	B-X
nucleus	B-X
in	B-X
transient	B-X
transfection	B-X
and	B-X
microinjection	B-X
experiments	B-X
were	B-X
identified	B-X
in	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
p130	B-X
.	B-X
An	B-X
N-terminal	B-X
domain	B-X
that	B-X
conferred	B-X
cytoplasmic	B-X
localization	B-X
was	B-X
identified	B-X
.	B-X
A	B-X
model	B-X
suggesting	B-X
that	B-X
the	B-X
activity	B-X
of	B-X
pRb	B-X
family	B-X
members	B-X
can	B-X
be	B-X
regulated	B-X
by	B-X
intracellular	B-X
trafficking	B-X
of	B-X
the	B-X
proteins	B-X
is	B-X
proposed	B-X
.	B-X

p130	B-Gene_or_gene_product
was	O
observed	O
to	O
shuttle	O
between	O
the	O
nucleus	O
and	O
cytoplasm	O
in	O
a	O
heterokaryon	O
fusion	O
assay	O
,	O
suggesting	O
the	O
presence	O
of	O
nuclear	O
and	O
cytoplasmic	O
localization	O
signals	O
.	O

Two	O
independent	O
nuclear	O
localization	O
signals	O
(	O
NLS	O
)	O
that	O
could	O
target	O
reporter	O
proteins	O
to	O
the	O
nucleus	O
in	O
transient	O
transfection	O
and	O
microinjection	O
experiments	O
were	O
identified	O
in	O
the	O
C	O
terminus	O
of	O
p130	B-Gene_or_gene_product
.	O

In	O
addition	O
to	O
the	O
C	O
-	O
terminal	O
NLS	O
,	O
the	O
intact	O
pocket	O
domain	O
of	O
p130	B-Gene_or_gene_product
itself	O
was	O
sufficient	O
for	O
nuclear	O
translocation	O
.	O

Moreover	O
,	O
an	O
additional	O
functional	O
NLS	O
was	O
mapped	O
within	O
the	O
unique	O
Loop	O
region	O
of	O
p130	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
retinoblastoma-related	B-X
pocket	B-X
proteins	B-X
pRb	B-X
,	B-X
p107	B-X
,	B-X
and	B-X
p130	B-X
are	B-X
implicated	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
proliferation	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
transformation	B-X
.	B-X
p130	B-X
was	B-X
observed	B-X
to	B-X
shuttle	B-X
between	B-X
the	B-X
nucleus	B-X
and	B-X
cytoplasm	B-X
in	B-X
a	B-X
heterokaryon	B-X
fusion	B-X
assay	B-X
,	B-X
suggesting	B-X
the	B-X
presence	B-X
of	B-X
nuclear	B-X
and	B-X
cytoplasmic	B-X
localization	B-X
signals	B-X
.	B-X
Two	B-X
independent	B-X
nuclear	B-X
localization	B-X
signals	B-X
(	B-X
NLS	B-X
)	B-X
that	B-X
could	B-X
target	B-X
reporter	B-X
proteins	B-X
to	B-X
the	B-X
nucleus	B-X
in	B-X
transient	B-X
transfection	B-X
and	B-X
microinjection	B-X
experiments	B-X
were	B-X
identified	B-X
in	B-X
the	B-X
C	B-X
terminus	B-X
of	B-X
p130	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
C-terminal	B-X
NLS	B-X
,	B-X
the	B-X
intact	B-X
pocket	B-X
domain	B-X
of	B-X
p130	B-X
itself	B-X
was	B-X
sufficient	B-X
for	B-X
nuclear	B-X
translocation	B-X
.	B-X
Moreover	B-X
,	B-X
an	B-X
additional	B-X
functional	B-X
NLS	B-X
was	B-X
mapped	B-X
within	B-X
the	B-X
unique	B-X
Loop	B-X
region	B-X
of	B-X
p130	B-X
.	B-X
Removal	B-X
of	B-X
the	B-X
entire	B-X
N	B-X
terminus	B-X
did	B-X
not	B-X
affect	B-X
the	B-X
ability	B-X
of	B-X
p130	B-X
to	B-X
interact	B-X
with	B-X
E2F	B-X
and	B-X
to	B-X
induce	B-X
growth	B-X
arrest	B-X
.	B-X

An	O
N	O
-	O
terminal	O
domain	O
that	O
conferred	O
cytoplasmic	O
localization	O
was	O
identified	O
.	O

Removal	O
of	O
the	O
entire	O
N	O
terminus	O
did	O
not	O
affect	O
the	O
ability	O
of	O
p130	B-Gene_or_gene_product
to	O
interact	O
with	O
E2F	B-Gene_or_gene_product
and	O
to	O
induce	O
growth	O
arrest	O
.	O
<EOS>	B-X
GPH	B-X
members	B-X
belong	B-X
to	B-X
the	B-X
cystine-knot	B-X
growth	B-X
factor	B-X
superfamily	B-X
,	B-X
and	B-X
their	B-X
receptors	B-X
(	B-X
GPHR	B-X
)	B-X
,	B-X
possessing	B-X
unusually	B-X
large	B-X
N-terminal	B-X
ectodomains	B-X
,	B-X
belong	B-X
to	B-X
the	B-X
G-protein	B-X
coupled	B-X
receptor	B-X
Family	B-X
A.	B-X
GPHR	B-X
ectodomains	B-X
can	B-X
be	B-X
divided	B-X
into	B-X
two	B-X
subdomains	B-X
:	B-X
a	B-X
high-affinity	B-X
hormone	B-X
binding	B-X
subdomain	B-X
primarily	B-X
centered	B-X
on	B-X
the	B-X
N-terminus	B-X
,	B-X
and	B-X
a	B-X
second	B-X
subdomain	B-X
that	B-X
is	B-X
located	B-X
on	B-X
the	B-X
C-terminal	B-X
region	B-X
of	B-X
the	B-X
ectodomain	B-X
that	B-X
is	B-X
involved	B-X
in	B-X
signal	B-X
specificity	B-X
.	B-X
Initially	B-X
,	B-X
the	B-X
FSH	B-X
structure	B-X
was	B-X
determined	B-X
in	B-X
partially	B-X
glycosylated	B-X
free	B-X
form	B-X
in	B-X
2001	B-X
,	B-X
followed	B-X
by	B-X
a	B-X
structure	B-X
of	B-X
FSH	B-X
bound	B-X
to	B-X
a	B-X
truncated	B-X
FSHR	B-X
ectodomain	B-X
in	B-X
2005	B-X
,	B-X
and	B-X
the	B-X
structure	B-X
of	B-X
FSH	B-X
bound	B-X
to	B-X
the	B-X
entire	B-X
ectodomain	B-X
in	B-X
2012	B-X
.	B-X
First	B-X
,	B-X
binding	B-X
of	B-X
FSH	B-X
to	B-X
the	B-X
FSHR	B-X
high-affinity	B-X
hormone-binding	B-X
subdomain	B-X
induces	B-X
a	B-X
conformational	B-X
change	B-X
in	B-X
the	B-X
hormone	B-X
to	B-X
form	B-X
a	B-X
binding	B-X
pocket	B-X
that	B-X
is	B-X
specific	B-X
for	B-X
a	B-X
sulfated-tyrosine	B-X
found	B-X
as	B-X
sTyr	B-X
335	B-X
in	B-X
FSHR	B-X
.	B-X
The	B-X
canonical	B-X
members	B-X
of	B-X
the	B-X
Jagged/Serrate	B-X
and	B-X
Delta	B-X
families	B-X
of	B-X
transmembrane	B-X
ligands	B-X
have	B-X
an	B-X
extracellular	B-X
,	B-X
amino-terminal	B-X
C2	B-X
domain	B-X
that	B-X
binds	B-X
to	B-X
phospholipids	B-X
and	B-X
is	B-X
required	B-X
for	B-X
optimal	B-X
activation	B-X
of	B-X
the	B-X
Notch	B-X
receptor	B-X
.	B-X
We	B-X
found	B-X
in	B-X
reporter	B-X
cell	B-X
assays	B-X
that	B-X
mutations	B-X
affecting	B-X
an	B-X
N-glycosylation	B-X
site	B-X
reduced	B-X
the	B-X
ligand	B-X
's	B-X
ability	B-X
to	B-X
activate	B-X
Notch	B-X
.	B-X
This	B-X
N-glycosylation	B-X
site	B-X
located	B-X
in	B-X
the	B-X
C2	B-X
domain	B-X
is	B-X
conserved	B-X
in	B-X
the	B-X
Jagged/Serrate	B-X
family	B-X
but	B-X
is	B-X
lacking	B-X
in	B-X
the	B-X
Delta	B-X
family	B-X
.	B-X
Site-specific	B-X
glycan	B-X
analysis	B-X
of	B-X
the	B-X
JAG1	B-X
amino	B-X
terminus	B-X
demonstrated	B-X
that	B-X
occupancy	B-X
of	B-X
this	B-X
site	B-X
by	B-X
either	B-X
a	B-X
complex-type	B-X
or	B-X
high-mannose	B-X
N-glycan	B-X
was	B-X
required	B-X
for	B-X
full	B-X
Notch	B-X
activation	B-X
in	B-X
reporter	B-X
cell	B-X
assays	B-X
.	B-X
Similarly	B-X
to	B-X
JAG1	B-X
variants	B-X
with	B-X
defects	B-X
in	B-X
Notch	B-X
binding	B-X
,	B-X
N-glycan	B-X
removal	B-X
,	B-X
either	B-X
by	B-X
mutagenesis	B-X
of	B-X
the	B-X
glycosylation	B-X
site	B-X
or	B-X
by	B-X
endoglycosidase	B-X
treatment	B-X
,	B-X
reduced	B-X
receptor	B-X
activation	B-X
.	B-X
The	B-X
N-glycan	B-X
variants	B-X
also	B-X
reduced	B-X
receptor	B-X
activation	B-X
in	B-X
a	B-X
Notch	B-X
signaling-dependent	B-X
vascular	B-X
smooth	B-X
muscle	B-X
cell	B-X
differentiation	B-X
assay	B-X
.	B-X
Loss	B-X
of	B-X
the	B-X
C2	B-X
N-glycan	B-X
reduced	B-X
JAG1	B-X
binding	B-X
to	B-X
liposomes	B-X
to	B-X
a	B-X
similar	B-X
extent	B-X
as	B-X
the	B-X
loss	B-X
of	B-X
the	B-X
entire	B-X
C2	B-X
domain	B-X
.	B-X
Molecular	B-X
dynamics	B-X
simulations	B-X
suggested	B-X
that	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
N-glycan	B-X
limits	B-X
the	B-X
orientation	B-X
of	B-X
JAG1	B-X
relative	B-X
to	B-X
the	B-X
membrane	B-X
,	B-X
thus	B-X
facilitating	B-X
Notch	B-X
binding	B-X
.	B-X
These	B-X
data	B-X
are	B-X
consistent	B-X
with	B-X
a	B-X
critical	B-X
role	B-X
for	B-X
the	B-X
N-glycan	B-X
in	B-X
promoting	B-X
a	B-X
lipid-binding	B-X
conformation	B-X
that	B-X
is	B-X
required	B-X
to	B-X
orient	B-X
Jagged	B-X
at	B-X
the	B-X
cell	B-X
membrane	B-X
for	B-X
full	B-X
Notch	B-X
activation	B-X
.	B-X

A	O
model	O
suggesting	O
that	O
the	O
activity	O
of	O
pRb	B-Gene_or_gene_product
family	O
members	O
can	O
be	O
regulated	O
by	O
intracellular	O
trafficking	O
of	O
the	O
proteins	O
is	O
proposed	O
.	O

S	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Cdk	I-Gene_or_gene_product
-	O
dependent	O
phosphorylation	O
of	O
Sld2	B-Gene_or_gene_product
essential	O
for	O
chromosomal	O
DNA	O
replication	O
in	O
budding	O
yeast	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
in	B-X
eukaryotic	B-X
cells	B-X
work	B-X
as	B-X
a	B-X
key	B-X
enzyme	B-X
at	B-X
various	B-X
points	B-X
in	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
At	B-X
the	B-X
onset	B-X
of	B-X
S	B-X
phase	B-X
,	B-X
active	B-X
S-phase	B-X
Cdks	B-X
(	B-X
S-Cdks	B-X
)	B-X
are	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
Although	B-X
several	B-X
replication	B-X
proteins	B-X
are	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdk-dependent	B-X
manner	B-X
,	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
phosphorylation	B-X
of	B-X
these	B-X
proteins	B-X
on	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
have	B-X
not	B-X
been	B-X
elucidated	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Sld2	B-X
(	B-X
ref	B-X
.	B-X
5	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
replication	B-X
proteins	B-X
of	B-X
budding	B-X
yeast	B-X
(	B-X
Saccharomyces	B-X
cerevisiae	B-X
)	B-X
,	B-X
is	B-X
phosphorylated	B-X
in	B-X
S	B-X
phase	B-X
in	B-X
an	B-X
S-Cdk-dependent	B-X
manner	B-X
,	B-X
and	B-X
mutant	B-X
Sld2	B-X
lacking	B-X
all	B-X
the	B-X
preferred	B-X
Cdk	B-X
phosphorylation	B-X
sites	B-X
(	B-X
All-A	B-X
)	B-X
is	B-X
defective	B-X
in	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
complex	B-X
that	B-X
contains	B-X
,	B-X
at	B-X
least	B-X
,	B-X
Sld2	B-X
and	B-X
Dpb11	B-X
(	B-X
ref	B-X
.	B-X
6	B-X
)	B-X
(	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
)	B-X
is	B-X
formed	B-X
predominantly	B-X
in	B-X
S	B-X
phase	B-X
;	B-X
the	B-X
All-A	B-X
protein	B-X
is	B-X
defective	B-X
in	B-X
this	B-X
complex	B-X
formation	B-X
.	B-X
Because	B-X
this	B-X
complex	B-X
is	B-X
suggested	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
,	B-X
it	B-X
seems	B-X
likely	B-X
that	B-X
S-Cdk	B-X
positively	B-X
regulates	B-X
formation	B-X
of	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
and	B-X
,	B-X
consequently	B-X
,	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X

Cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
Cdks	B-Gene_or_gene_product
)	O
in	O
eukaryotic	O
cells	O
work	O
as	O
a	O
key	O
enzyme	O
at	O
various	O
points	O
in	O
the	O
cell	O
cycle	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
in	B-X
eukaryotic	B-X
cells	B-X
work	B-X
as	B-X
a	B-X
key	B-X
enzyme	B-X
at	B-X
various	B-X
points	B-X
in	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
At	B-X
the	B-X
onset	B-X
of	B-X
S	B-X
phase	B-X
,	B-X
active	B-X
S-phase	B-X
Cdks	B-X
(	B-X
S-Cdks	B-X
)	B-X
are	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
Although	B-X
several	B-X
replication	B-X
proteins	B-X
are	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdk-dependent	B-X
manner	B-X
,	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
phosphorylation	B-X
of	B-X
these	B-X
proteins	B-X
on	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
have	B-X
not	B-X
been	B-X
elucidated	B-X
.	B-X
5	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
replication	B-X
proteins	B-X
of	B-X
budding	B-X
yeast	B-X
(	B-X
Saccharomyces	B-X
cerevisiae	B-X
)	B-X
,	B-X
is	B-X
phosphorylated	B-X
in	B-X
S	B-X
phase	B-X
in	B-X
an	B-X
S-Cdk-dependent	B-X
manner	B-X
,	B-X
and	B-X
mutant	B-X
Sld2	B-X
lacking	B-X
all	B-X
the	B-X
preferred	B-X
Cdk	B-X
phosphorylation	B-X
sites	B-X
(	B-X
All-A	B-X
)	B-X
is	B-X
defective	B-X
in	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
6	B-X
)	B-X
(	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
)	B-X
is	B-X
formed	B-X
predominantly	B-X
in	B-X
S	B-X
phase	B-X
;	B-X
the	B-X
All-A	B-X
protein	B-X
is	B-X
defective	B-X
in	B-X
this	B-X
complex	B-X
formation	B-X
.	B-X

At	O
the	O
onset	O
of	O
S	O
phase	O
,	O
active	O
S	O
-	O
phase	O
Cdks	B-Gene_or_gene_product
(	O
S	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Cdks	I-Gene_or_gene_product
)	O
are	O
essential	O
for	O
chromosomal	O
DNA	O
replication	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
in	B-X
eukaryotic	B-X
cells	B-X
work	B-X
as	B-X
a	B-X
key	B-X
enzyme	B-X
at	B-X
various	B-X
points	B-X
in	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
At	B-X
the	B-X
onset	B-X
of	B-X
S	B-X
phase	B-X
,	B-X
active	B-X
S-phase	B-X
Cdks	B-X
(	B-X
S-Cdks	B-X
)	B-X
are	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
Although	B-X
several	B-X
replication	B-X
proteins	B-X
are	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdk-dependent	B-X
manner	B-X
,	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
phosphorylation	B-X
of	B-X
these	B-X
proteins	B-X
on	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
have	B-X
not	B-X
been	B-X
elucidated	B-X
.	B-X
5	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
replication	B-X
proteins	B-X
of	B-X
budding	B-X
yeast	B-X
(	B-X
Saccharomyces	B-X
cerevisiae	B-X
)	B-X
,	B-X
is	B-X
phosphorylated	B-X
in	B-X
S	B-X
phase	B-X
in	B-X
an	B-X
S-Cdk-dependent	B-X
manner	B-X
,	B-X
and	B-X
mutant	B-X
Sld2	B-X
lacking	B-X
all	B-X
the	B-X
preferred	B-X
Cdk	B-X
phosphorylation	B-X
sites	B-X
(	B-X
All-A	B-X
)	B-X
is	B-X
defective	B-X
in	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
6	B-X
)	B-X
(	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
)	B-X
is	B-X
formed	B-X
predominantly	B-X
in	B-X
S	B-X
phase	B-X
;	B-X
the	B-X
All-A	B-X
protein	B-X
is	B-X
defective	B-X
in	B-X
this	B-X
complex	B-X
formation	B-X
.	B-X
Because	B-X
this	B-X
complex	B-X
is	B-X
suggested	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
,	B-X
it	B-X
seems	B-X
likely	B-X
that	B-X
S-Cdk	B-X
positively	B-X
regulates	B-X
formation	B-X
of	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
and	B-X
,	B-X
consequently	B-X
,	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X

Although	O
several	O
replication	O
proteins	O
are	O
phosphorylated	O
in	O
a	O
Cdk	B-Gene_or_gene_product
-	O
dependent	O
manner	O
,	O
the	O
biological	O
effects	O
of	O
phosphorylation	O
of	O
these	O
proteins	O
on	O
the	O
activation	O
of	O
DNA	O
replication	O
have	O
not	O
been	O
elucidated	O
.	O

Here	O
we	O
show	O
that	O
Sld2	B-Gene_or_gene_product
(	O
ref	O
.	O
4	O
)	O
(	O
also	O
known	O
as	O
Drc1	B-Gene_or_gene_product
;	O
ref	O
.	O
5	O
)	O
,	O
one	O
of	O
the	O
replication	O
proteins	O
of	O
budding	O
yeast	O
(	O
Saccharomyces	O
cerevisiae	O
)	O
,	O
is	O
phosphorylated	O
in	O
S	O
phase	O
in	O
an	O
S	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Cdk	I-Gene_or_gene_product
-	O
dependent	O
manner	O
,	O
and	O
mutant	O
Sld2	B-Gene_or_gene_product
lacking	O
all	O
the	O
preferred	O
Cdk	B-Gene_or_gene_product
phosphorylation	O
sites	O
(	O
All	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
)	O
is	O
defective	O
in	O
chromosomal	O
DNA	O
replication	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
in	B-X
eukaryotic	B-X
cells	B-X
work	B-X
as	B-X
a	B-X
key	B-X
enzyme	B-X
at	B-X
various	B-X
points	B-X
in	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
At	B-X
the	B-X
onset	B-X
of	B-X
S	B-X
phase	B-X
,	B-X
active	B-X
S-phase	B-X
Cdks	B-X
(	B-X
S-Cdks	B-X
)	B-X
are	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
Although	B-X
several	B-X
replication	B-X
proteins	B-X
are	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdk-dependent	B-X
manner	B-X
,	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
phosphorylation	B-X
of	B-X
these	B-X
proteins	B-X
on	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
have	B-X
not	B-X
been	B-X
elucidated	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Sld2	B-X
(	B-X
ref	B-X
.	B-X
4	B-X
)	B-X
(	B-X
also	B-X
known	B-X
as	B-X
Drc1	B-X
;	B-X
ref	B-X
.	B-X
5	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
replication	B-X
proteins	B-X
of	B-X
budding	B-X
yeast	B-X
(	B-X
Saccharomyces	B-X
cerevisiae	B-X
)	B-X
,	B-X
is	B-X
phosphorylated	B-X
in	B-X
S	B-X
phase	B-X
in	B-X
an	B-X
S-Cdk-dependent	B-X
manner	B-X
,	B-X
and	B-X
mutant	B-X
Sld2	B-X
lacking	B-X
all	B-X
the	B-X
preferred	B-X
Cdk	B-X
phosphorylation	B-X
sites	B-X
(	B-X
All-A	B-X
)	B-X
is	B-X
defective	B-X
in	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
complex	B-X
that	B-X
contains	B-X
,	B-X
at	B-X
least	B-X
,	B-X
Sld2	B-X
and	B-X
Dpb11	B-X
(	B-X
ref	B-X
.	B-X
6	B-X
)	B-X
(	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
)	B-X
is	B-X
formed	B-X
predominantly	B-X
in	B-X
S	B-X
phase	B-X
;	B-X
the	B-X
All-A	B-X
protein	B-X
is	B-X
defective	B-X
in	B-X
this	B-X
complex	B-X
formation	B-X
.	B-X
Because	B-X
this	B-X
complex	B-X
is	B-X
suggested	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
,	B-X
it	B-X
seems	B-X
likely	B-X
that	B-X
S-Cdk	B-X
positively	B-X
regulates	B-X
formation	B-X
of	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
and	B-X
,	B-X
consequently	B-X
,	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X

Moreover	O
,	O
the	O
complex	O
that	O
contains	O
,	O
at	O
least	O
,	O
Sld2	B-Gene_or_gene_product
and	O
Dpb11	B-Gene_or_gene_product
(	O
ref	O
.	O
6	O
)	O
(	O
the	O
Sld2	O
-	O
Dpb11	O
complex	O
)	O
is	O
formed	O
predominantly	O
in	O
S	O
phase	O
;	O
the	O
All	B-Gene_or_gene_product
-	I-Gene_or_gene_product
A	I-Gene_or_gene_product
protein	O
is	O
defective	O
in	O
this	O
complex	O
formation	O
.	O

Because	O
this	O
complex	O
is	O
suggested	O
to	O
be	O
essential	O
for	O
chromosomal	O
DNA	O
replication	O
,	O
it	O
seems	O
likely	O
that	O
S	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Cdk	I-Gene_or_gene_product
positively	O
regulates	O
formation	O
of	O
the	O
Sld2	O
-	O
Dpb11	O
complex	O
and	O
,	O
consequently	O
,	O
chromosomal	O
DNA	O
replication	O
.	O
<EOS>	B-X
Cyclin-dependent	B-X
protein	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
in	B-X
eukaryotic	B-X
cells	B-X
work	B-X
as	B-X
a	B-X
key	B-X
enzyme	B-X
at	B-X
various	B-X
points	B-X
in	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
At	B-X
the	B-X
onset	B-X
of	B-X
S	B-X
phase	B-X
,	B-X
active	B-X
S-phase	B-X
Cdks	B-X
(	B-X
S-Cdks	B-X
)	B-X
are	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
Although	B-X
several	B-X
replication	B-X
proteins	B-X
are	B-X
phosphorylated	B-X
in	B-X
a	B-X
Cdk-dependent	B-X
manner	B-X
,	B-X
the	B-X
biological	B-X
effects	B-X
of	B-X
phosphorylation	B-X
of	B-X
these	B-X
proteins	B-X
on	B-X
the	B-X
activation	B-X
of	B-X
DNA	B-X
replication	B-X
have	B-X
not	B-X
been	B-X
elucidated	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Sld2	B-X
(	B-X
ref	B-X
.	B-X
5	B-X
)	B-X
,	B-X
one	B-X
of	B-X
the	B-X
replication	B-X
proteins	B-X
of	B-X
budding	B-X
yeast	B-X
(	B-X
Saccharomyces	B-X
cerevisiae	B-X
)	B-X
,	B-X
is	B-X
phosphorylated	B-X
in	B-X
S	B-X
phase	B-X
in	B-X
an	B-X
S-Cdk-dependent	B-X
manner	B-X
,	B-X
and	B-X
mutant	B-X
Sld2	B-X
lacking	B-X
all	B-X
the	B-X
preferred	B-X
Cdk	B-X
phosphorylation	B-X
sites	B-X
(	B-X
All-A	B-X
)	B-X
is	B-X
defective	B-X
in	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
complex	B-X
that	B-X
contains	B-X
,	B-X
at	B-X
least	B-X
,	B-X
Sld2	B-X
and	B-X
Dpb11	B-X
(	B-X
ref	B-X
.	B-X
6	B-X
)	B-X
(	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
)	B-X
is	B-X
formed	B-X
predominantly	B-X
in	B-X
S	B-X
phase	B-X
;	B-X
the	B-X
All-A	B-X
protein	B-X
is	B-X
defective	B-X
in	B-X
this	B-X
complex	B-X
formation	B-X
.	B-X
Because	B-X
this	B-X
complex	B-X
is	B-X
suggested	B-X
to	B-X
be	B-X
essential	B-X
for	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
,	B-X
it	B-X
seems	B-X
likely	B-X
that	B-X
S-Cdk	B-X
positively	B-X
regulates	B-X
formation	B-X
of	B-X
the	B-X
Sld2-Dpb11	B-X
complex	B-X
and	B-X
,	B-X
consequently	B-X
,	B-X
chromosomal	B-X
DNA	B-X
replication	B-X
.	B-X

Steps	O
in	O
assembly	O
of	O
silent	O
chromatin	O
in	O
yeast	O
:	O
Sir3	B-Gene_or_gene_product
-	O
independent	O
binding	O
of	O
a	O
Sir2	O
/	O
Sir4	O
complex	O
to	O
silencers	O
and	O
role	O
for	O
Sir2	B-Gene_or_gene_product
-	O
dependent	O
deacetylation	O
.	O
<EOS>	B-X
Transcriptional	B-X
silencing	B-X
at	B-X
the	B-X
budding	B-X
yeast	B-X
silent	B-X
mating	B-X
type	B-X
(	B-X
HM	B-X
)	B-X
loci	B-X
and	B-X
telomeric	B-X
DNA	B-X
regions	B-X
requires	B-X
Sir2	B-X
,	B-X
a	B-X
conserved	B-X
NAD-dependent	B-X
histone	B-X
deacetylase	B-X
,	B-X
Sir3	B-X
,	B-X
Sir4	B-X
,	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
,	B-X
and	B-X
several	B-X
DNA-binding	B-X
proteins	B-X
.	B-X
Silencing	B-X
at	B-X
the	B-X
yeast	B-X
ribosomal	B-X
DNA	B-X
(	B-X
rDNA	B-X
)	B-X
repeats	B-X
requires	B-X
a	B-X
complex	B-X
containing	B-X
Sir2	B-X
,	B-X
Net1	B-X
,	B-X
and	B-X
Cdc14	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
native	B-X
Sir2/Sir4	B-X
complex	B-X
is	B-X
composed	B-X
solely	B-X
of	B-X
Sir2	B-X
and	B-X
Sir4	B-X
and	B-X
that	B-X
native	B-X
Sir3	B-X
is	B-X
not	B-X
associated	B-X
with	B-X
other	B-X
proteins	B-X
.	B-X
We	B-X
further	B-X
show	B-X
that	B-X
the	B-X
initial	B-X
binding	B-X
of	B-X
the	B-X
Sir2/Sir4	B-X
complex	B-X
to	B-X
DNA	B-X
sites	B-X
that	B-X
nucleate	B-X
silencing	B-X
,	B-X
accompanied	B-X
by	B-X
partial	B-X
Sir2-dependent	B-X
histone	B-X
deacetylation	B-X
,	B-X
occurs	B-X
independently	B-X
of	B-X
Sir3	B-X
and	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
the	B-X
first	B-X
step	B-X
in	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
at	B-X
the	B-X
HM	B-X
loci	B-X
and	B-X
telomeres	B-X
.	B-X
The	B-X
enzymatic	B-X
activity	B-X
of	B-X
Sir2	B-X
is	B-X
not	B-X
required	B-X
for	B-X
this	B-X
initial	B-X
binding	B-X
,	B-X
but	B-X
is	B-X
required	B-X
for	B-X
the	B-X
association	B-X
of	B-X
silencing	B-X
proteins	B-X
with	B-X
regions	B-X
distal	B-X
from	B-X
nucleation	B-X
sites	B-X
.	B-X
At	B-X
the	B-X
rDNA	B-X
repeats	B-X
,	B-X
we	B-X
show	B-X
that	B-X
histone	B-X
H3	B-X
and	B-X
H4	B-X
tails	B-X
are	B-X
required	B-X
for	B-X
silencing	B-X
and	B-X
rDNA-associated	B-X
H4	B-X
is	B-X
hypoacetylated	B-X
in	B-X
a	B-X
Sir2-dependent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
the	B-X
binding	B-X
of	B-X
Sir2	B-X
to	B-X
rDNA	B-X
is	B-X
independent	B-X
of	B-X
its	B-X
histone	B-X
deacetylase	B-X
activity	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
support	B-X
a	B-X
stepwise	B-X
model	B-X
for	B-X
the	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
domains	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X

Transcriptional	O
silencing	O
at	O
the	O
budding	O
yeast	O
silent	O
mating	O
type	O
(	O
HM	O
)	O
loci	O
and	O
telomeric	O
DNA	O
regions	O
requires	O
Sir2	B-Gene_or_gene_product
,	O
a	O
conserved	O
NAD	O
-	O
dependent	O
histone	B-Gene_or_gene_product
deacetylase	I-Gene_or_gene_product
,	O
Sir3	B-Gene_or_gene_product
,	O
Sir4	B-Gene_or_gene_product
,	O
histones	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
and	O
H4	B-Gene_or_gene_product
,	O
and	O
several	O
DNA	O
-	O
binding	O
proteins	O
.	O
<EOS>	B-X
Transcriptional	B-X
silencing	B-X
at	B-X
the	B-X
budding	B-X
yeast	B-X
silent	B-X
mating	B-X
type	B-X
(	B-X
HM	B-X
)	B-X
loci	B-X
and	B-X
telomeric	B-X
DNA	B-X
regions	B-X
requires	B-X
Sir2	B-X
,	B-X
a	B-X
conserved	B-X
NAD-dependent	B-X
histone	B-X
deacetylase	B-X
,	B-X
Sir3	B-X
,	B-X
Sir4	B-X
,	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
,	B-X
and	B-X
several	B-X
DNA-binding	B-X
proteins	B-X
.	B-X
Silencing	B-X
at	B-X
the	B-X
yeast	B-X
ribosomal	B-X
DNA	B-X
(	B-X
rDNA	B-X
)	B-X
repeats	B-X
requires	B-X
a	B-X
complex	B-X
containing	B-X
Sir2	B-X
,	B-X
Net1	B-X
,	B-X
and	B-X
Cdc14	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
native	B-X
Sir2/Sir4	B-X
complex	B-X
is	B-X
composed	B-X
solely	B-X
of	B-X
Sir2	B-X
and	B-X
Sir4	B-X
and	B-X
that	B-X
native	B-X
Sir3	B-X
is	B-X
not	B-X
associated	B-X
with	B-X
other	B-X
proteins	B-X
.	B-X
We	B-X
further	B-X
show	B-X
that	B-X
the	B-X
initial	B-X
binding	B-X
of	B-X
the	B-X
Sir2/Sir4	B-X
complex	B-X
to	B-X
DNA	B-X
sites	B-X
that	B-X
nucleate	B-X
silencing	B-X
,	B-X
accompanied	B-X
by	B-X
partial	B-X
Sir2-dependent	B-X
histone	B-X
deacetylation	B-X
,	B-X
occurs	B-X
independently	B-X
of	B-X
Sir3	B-X
and	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
the	B-X
first	B-X
step	B-X
in	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
at	B-X
the	B-X
HM	B-X
loci	B-X
and	B-X
telomeres	B-X
.	B-X
The	B-X
enzymatic	B-X
activity	B-X
of	B-X
Sir2	B-X
is	B-X
not	B-X
required	B-X
for	B-X
this	B-X
initial	B-X
binding	B-X
,	B-X
but	B-X
is	B-X
required	B-X
for	B-X
the	B-X
association	B-X
of	B-X
silencing	B-X
proteins	B-X
with	B-X
regions	B-X
distal	B-X
from	B-X
nucleation	B-X
sites	B-X
.	B-X
At	B-X
the	B-X
rDNA	B-X
repeats	B-X
,	B-X
we	B-X
show	B-X
that	B-X
histone	B-X
H3	B-X
and	B-X
H4	B-X
tails	B-X
are	B-X
required	B-X
for	B-X
silencing	B-X
and	B-X
rDNA-associated	B-X
H4	B-X
is	B-X
hypoacetylated	B-X
in	B-X
a	B-X
Sir2-dependent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
the	B-X
binding	B-X
of	B-X
Sir2	B-X
to	B-X
rDNA	B-X
is	B-X
independent	B-X
of	B-X
its	B-X
histone	B-X
deacetylase	B-X
activity	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
support	B-X
a	B-X
stepwise	B-X
model	B-X
for	B-X
the	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
domains	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X

Silencing	O
at	O
the	O
yeast	O
ribosomal	O
DNA	O
(	O
rDNA	O
)	O
repeats	O
requires	O
a	O
complex	O
containing	O
Sir2	B-Gene_or_gene_product
,	O
Net1	B-Gene_or_gene_product
,	O
and	O
Cdc14	B-Gene_or_gene_product
.	O
<EOS>	B-X
Nucleolar	B-X
rDNA	B-X
is	B-X
tightly	B-X
associated	B-X
with	B-X
silent	B-X
heterochromatin	B-X
,	B-X
which	B-X
is	B-X
important	B-X
for	B-X
rDNA	B-X
stability	B-X
,	B-X
nucleolar	B-X
integration	B-X
,	B-X
and	B-X
cellular	B-X
senescence	B-X
.	B-X
Two	B-X
pathways	B-X
have	B-X
been	B-X
described	B-X
that	B-X
lead	B-X
to	B-X
rDNA	B-X
silencing	B-X
in	B-X
yeast	B-X
:	B-X
1	B-X
)	B-X
the	B-X
RENT	B-X
(	B-X
regulator	B-X
of	B-X
nucleolar	B-X
silencing	B-X
and	B-X
telophase	B-X
exit	B-X
)	B-X
complex	B-X
,	B-X
which	B-X
is	B-X
composed	B-X
of	B-X
Net1	B-X
,	B-X
Sir2	B-X
,	B-X
and	B-X
Cdc14	B-X
and	B-X
is	B-X
required	B-X
for	B-X
Sir2-dependent	B-X
rDNA	B-X
silencing	B-X
;	B-X
and	B-X
2	B-X
)	B-X
the	B-X
Sir2-independent	B-X
silencing	B-X
mechanism	B-X
,	B-X
which	B-X
involves	B-X
the	B-X
Tof2	B-X
and	B-X
Tof2-copurified	B-X
complex	B-X
,	B-X
made	B-X
up	B-X
of	B-X
Lrs4	B-X
and	B-X
Csm1	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
present	B-X
evidence	B-X
that	B-X
changes	B-X
in	B-X
histone	B-X
H3	B-X
lysine	B-X
methylation	B-X
levels	B-X
distinctly	B-X
regulate	B-X
rDNA	B-X
silencing	B-X
by	B-X
recruiting	B-X
different	B-X
silencing	B-X
proteins	B-X
to	B-X
rDNA	B-X
,	B-X
thereby	B-X
contributing	B-X
to	B-X
rDNA	B-X
silencing	B-X
and	B-X
nucleolar	B-X
organization	B-X
in	B-X
yeast	B-X
.	B-X
Transcriptional	B-X
silencing	B-X
at	B-X
the	B-X
budding	B-X
yeast	B-X
silent	B-X
mating	B-X
type	B-X
(	B-X
HM	B-X
)	B-X
loci	B-X
and	B-X
telomeric	B-X
DNA	B-X
regions	B-X
requires	B-X
Sir2	B-X
,	B-X
a	B-X
conserved	B-X
NAD-dependent	B-X
histone	B-X
deacetylase	B-X
,	B-X
Sir3	B-X
,	B-X
Sir4	B-X
,	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
,	B-X
and	B-X
several	B-X
DNA-binding	B-X
proteins	B-X
.	B-X
Silencing	B-X
at	B-X
the	B-X
yeast	B-X
ribosomal	B-X
DNA	B-X
(	B-X
rDNA	B-X
)	B-X
repeats	B-X
requires	B-X
a	B-X
complex	B-X
containing	B-X
Sir2	B-X
,	B-X
Net1	B-X
,	B-X
and	B-X
Cdc14	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
native	B-X
Sir2/Sir4	B-X
complex	B-X
is	B-X
composed	B-X
solely	B-X
of	B-X
Sir2	B-X
and	B-X
Sir4	B-X
and	B-X
that	B-X
native	B-X
Sir3	B-X
is	B-X
not	B-X
associated	B-X
with	B-X
other	B-X
proteins	B-X
.	B-X
We	B-X
further	B-X
show	B-X
that	B-X
the	B-X
initial	B-X
binding	B-X
of	B-X
the	B-X
Sir2/Sir4	B-X
complex	B-X
to	B-X
DNA	B-X
sites	B-X
that	B-X
nucleate	B-X
silencing	B-X
,	B-X
accompanied	B-X
by	B-X
partial	B-X
Sir2-dependent	B-X
histone	B-X
deacetylation	B-X
,	B-X
occurs	B-X
independently	B-X
of	B-X
Sir3	B-X
and	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
the	B-X
first	B-X
step	B-X
in	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
at	B-X
the	B-X
HM	B-X
loci	B-X
and	B-X
telomeres	B-X
.	B-X
The	B-X
enzymatic	B-X
activity	B-X
of	B-X
Sir2	B-X
is	B-X
not	B-X
required	B-X
for	B-X
this	B-X
initial	B-X
binding	B-X
,	B-X
but	B-X
is	B-X
required	B-X
for	B-X
the	B-X
association	B-X
of	B-X
silencing	B-X
proteins	B-X
with	B-X
regions	B-X
distal	B-X
from	B-X
nucleation	B-X
sites	B-X
.	B-X
At	B-X
the	B-X
rDNA	B-X
repeats	B-X
,	B-X
we	B-X
show	B-X
that	B-X
histone	B-X
H3	B-X
and	B-X
H4	B-X
tails	B-X
are	B-X
required	B-X
for	B-X
silencing	B-X
and	B-X
rDNA-associated	B-X
H4	B-X
is	B-X
hypoacetylated	B-X
in	B-X
a	B-X
Sir2-dependent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
the	B-X
binding	B-X
of	B-X
Sir2	B-X
to	B-X
rDNA	B-X
is	B-X
independent	B-X
of	B-X
its	B-X
histone	B-X
deacetylase	B-X
activity	B-X
.	B-X

Here	O
we	O
show	O
that	O
the	O
native	O
Sir2	O
/	O
Sir4	O
complex	O
is	O
composed	O
solely	O
of	O
Sir2	B-Gene_or_gene_product
and	O
Sir4	B-Gene_or_gene_product
and	O
that	O
native	O
Sir3	B-Gene_or_gene_product
is	O
not	O
associated	O
with	O
other	O
proteins	O
.	O

We	O
further	O
show	O
that	O
the	O
initial	O
binding	O
of	O
the	O
Sir2	O
/	O
Sir4	O
complex	O
to	O
DNA	O
sites	O
that	O
nucleate	O
silencing	O
,	O
accompanied	O
by	O
partial	O
Sir2	B-Gene_or_gene_product
-	O
dependent	O
histone	B-Gene_or_gene_product
deacetylation	O
,	O
occurs	O
independently	O
of	O
Sir3	B-Gene_or_gene_product
and	O
is	O
likely	O
to	O
be	O
the	O
first	O
step	O
in	O
assembly	O
of	O
silent	O
chromatin	O
at	O
the	O
HM	O
loci	O
and	O
telomeres	O
.	O
<EOS>	B-X
Transcriptional	B-X
silencing	B-X
at	B-X
the	B-X
budding	B-X
yeast	B-X
silent	B-X
mating	B-X
type	B-X
(	B-X
HM	B-X
)	B-X
loci	B-X
and	B-X
telomeric	B-X
DNA	B-X
regions	B-X
requires	B-X
Sir2	B-X
,	B-X
a	B-X
conserved	B-X
NAD-dependent	B-X
histone	B-X
deacetylase	B-X
,	B-X
Sir3	B-X
,	B-X
Sir4	B-X
,	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
,	B-X
and	B-X
several	B-X
DNA-binding	B-X
proteins	B-X
.	B-X
Silencing	B-X
at	B-X
the	B-X
yeast	B-X
ribosomal	B-X
DNA	B-X
(	B-X
rDNA	B-X
)	B-X
repeats	B-X
requires	B-X
a	B-X
complex	B-X
containing	B-X
Sir2	B-X
,	B-X
Net1	B-X
,	B-X
and	B-X
Cdc14	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
the	B-X
native	B-X
Sir2/Sir4	B-X
complex	B-X
is	B-X
composed	B-X
solely	B-X
of	B-X
Sir2	B-X
and	B-X
Sir4	B-X
and	B-X
that	B-X
native	B-X
Sir3	B-X
is	B-X
not	B-X
associated	B-X
with	B-X
other	B-X
proteins	B-X
.	B-X
We	B-X
further	B-X
show	B-X
that	B-X
the	B-X
initial	B-X
binding	B-X
of	B-X
the	B-X
Sir2/Sir4	B-X
complex	B-X
to	B-X
DNA	B-X
sites	B-X
that	B-X
nucleate	B-X
silencing	B-X
,	B-X
accompanied	B-X
by	B-X
partial	B-X
Sir2-dependent	B-X
histone	B-X
deacetylation	B-X
,	B-X
occurs	B-X
independently	B-X
of	B-X
Sir3	B-X
and	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
the	B-X
first	B-X
step	B-X
in	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
at	B-X
the	B-X
HM	B-X
loci	B-X
and	B-X
telomeres	B-X
.	B-X
The	B-X
enzymatic	B-X
activity	B-X
of	B-X
Sir2	B-X
is	B-X
not	B-X
required	B-X
for	B-X
this	B-X
initial	B-X
binding	B-X
,	B-X
but	B-X
is	B-X
required	B-X
for	B-X
the	B-X
association	B-X
of	B-X
silencing	B-X
proteins	B-X
with	B-X
regions	B-X
distal	B-X
from	B-X
nucleation	B-X
sites	B-X
.	B-X
At	B-X
the	B-X
rDNA	B-X
repeats	B-X
,	B-X
we	B-X
show	B-X
that	B-X
histone	B-X
H3	B-X
and	B-X
H4	B-X
tails	B-X
are	B-X
required	B-X
for	B-X
silencing	B-X
and	B-X
rDNA-associated	B-X
H4	B-X
is	B-X
hypoacetylated	B-X
in	B-X
a	B-X
Sir2-dependent	B-X
manner	B-X
.	B-X
However	B-X
,	B-X
the	B-X
binding	B-X
of	B-X
Sir2	B-X
to	B-X
rDNA	B-X
is	B-X
independent	B-X
of	B-X
its	B-X
histone	B-X
deacetylase	B-X
activity	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
support	B-X
a	B-X
stepwise	B-X
model	B-X
for	B-X
the	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
domains	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X

The	O
enzymatic	O
activity	O
of	O
Sir2	B-Gene_or_gene_product
is	O
not	O
required	O
for	O
this	O
initial	O
binding	O
,	O
but	O
is	O
required	O
for	O
the	O
association	O
of	O
silencing	O
proteins	O
with	O
regions	O
distal	O
from	O
nucleation	O
sites	O
.	O
<EOS>	B-X
Sirtuins	B-X
have	B-X
received	B-X
considerable	B-X
attention	B-X
since	B-X
the	B-X
discovery	B-X
that	B-X
silent	B-X
information	B-X
regulator	B-X
2	B-X
(	B-X
Sir2	B-X
)	B-X
extends	B-X
the	B-X
lifespan	B-X
of	B-X
yeast	B-X
.	B-X
Sir2	B-X
,	B-X
a	B-X
nicotinamide	B-X
adenine	B-X
dinucleotide-	B-X
(	B-X
NAD-	B-X
)	B-X
dependent	B-X
histone	B-X
deacetylase	B-X
,	B-X
serves	B-X
as	B-X
both	B-X
a	B-X
transcriptional	B-X
effector	B-X
and	B-X
energy	B-X
sensor	B-X
.	B-X
In	B-X
mammals	B-X
,	B-X
the	B-X
sirtuin	B-X
(	B-X
SIRT	B-X
)	B-X
family	B-X
consists	B-X
of	B-X
seven	B-X
proteins	B-X
(	B-X
SIRT1-SIRT7	B-X
)	B-X
.	B-X
These	B-X
vary	B-X
in	B-X
tissue	B-X
specificity	B-X
,	B-X
subcellular	B-X
localization	B-X
,	B-X
and	B-X
enzymatic	B-X
activity	B-X
and	B-X
targets	B-X
.	B-X

At	O
the	O
rDNA	O
repeats	O
,	O
we	O
show	O
that	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
and	O
H4	B-Gene_or_gene_product
tails	O
are	O
required	O
for	O
silencing	O
and	O
rDNA	O
-	O
associated	O
H4	B-Gene_or_gene_product
is	O
hypoacetylated	O
in	O
a	O
Sir2	B-Gene_or_gene_product
-	O
dependent	O
manner	O
.	O

However	O
,	O
the	O
binding	O
of	O
Sir2	B-Gene_or_gene_product
to	O
rDNA	O
is	O
independent	O
of	O
its	O
histone	B-Gene_or_gene_product
deacetylase	I-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
Histone	B-X
deacetylase	B-X
Sir2	B-X
negatively	B-X
regulates	B-X
initiation	B-X
of	B-X
the	B-X
multicopy	B-X
(	B-X
150	B-X
)	B-X
rDNA	B-X
origins	B-X
,	B-X
while	B-X
Rpd3	B-X
histone	B-X
deacetylase	B-X
negatively	B-X
regulates	B-X
firing	B-X
of	B-X
single-copy	B-X
origins	B-X
.	B-X
However	B-X
,	B-X
Rpd3	B-X
's	B-X
effect	B-X
on	B-X
single-copy	B-X
origins	B-X
might	B-X
derive	B-X
indirectly	B-X
from	B-X
a	B-X
positive	B-X
function	B-X
for	B-X
Rpd3	B-X
in	B-X
rDNA	B-X
origin	B-X
firing	B-X
shifting	B-X
the	B-X
competitive	B-X
balance	B-X
.	B-X
Our	B-X
quantitative	B-X
experiments	B-X
support	B-X
the	B-X
idea	B-X
that	B-X
origins	B-X
compete	B-X
for	B-X
limiting	B-X
factors	B-X
;	B-X
however	B-X
,	B-X
our	B-X
results	B-X
show	B-X
that	B-X
Rpd3	B-X
's	B-X
effect	B-X
on	B-X
single-copy	B-X
origin	B-X
is	B-X
independent	B-X
of	B-X
rDNA	B-X
copy-number	B-X
and	B-X
of	B-X
Sir2	B-X
's	B-X
effects	B-X
on	B-X
rDNA	B-X
origin	B-X
firing	B-X
.	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
responsible	B-X
for	B-X
settling	B-X
and	B-X
maintaining	B-X
such	B-X
interactions	B-X
remain	B-X
poorly	B-X
understood	B-X
.	B-X
This	B-X
clustering	B-X
is	B-X
functionally	B-X
linked	B-X
to	B-X
the	B-X
formation	B-X
of	B-X
heterochromatin	B-X
in	B-X
subtelomeric	B-X
regions	B-X
through	B-X
the	B-X
recruitment	B-X
of	B-X
the	B-X
silencing	B-X
SIR	B-X
complex	B-X
composed	B-X
of	B-X
Sir2/3/4	B-X
.	B-X

Together	O
,	O
these	O
results	O
support	O
a	O
stepwise	O
model	O
for	O
the	O
assembly	O
of	O
silent	O
chromatin	O
domains	O
in	O
Saccharomyces	O
cerevisiae	O
.	O
<EOS>	B-X
Transcriptional	B-X
silencing	B-X
at	B-X
the	B-X
budding	B-X
yeast	B-X
silent	B-X
mating	B-X
type	B-X
(	B-X
HM	B-X
)	B-X
loci	B-X
and	B-X
telomeric	B-X
DNA	B-X
regions	B-X
requires	B-X
Sir2	B-X
,	B-X
a	B-X
conserved	B-X
NAD-dependent	B-X
histone	B-X
deacetylase	B-X
,	B-X
Sir3	B-X
,	B-X
Sir4	B-X
,	B-X
histones	B-X
H3	B-X
and	B-X
H4	B-X
,	B-X
and	B-X
several	B-X
DNA-binding	B-X
proteins	B-X
.	B-X
We	B-X
further	B-X
show	B-X
that	B-X
the	B-X
initial	B-X
binding	B-X
of	B-X
the	B-X
Sir2/Sir4	B-X
complex	B-X
to	B-X
DNA	B-X
sites	B-X
that	B-X
nucleate	B-X
silencing	B-X
,	B-X
accompanied	B-X
by	B-X
partial	B-X
Sir2-dependent	B-X
histone	B-X
deacetylation	B-X
,	B-X
occurs	B-X
independently	B-X
of	B-X
Sir3	B-X
and	B-X
is	B-X
likely	B-X
to	B-X
be	B-X
the	B-X
first	B-X
step	B-X
in	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
at	B-X
the	B-X
HM	B-X
loci	B-X
and	B-X
telomeres	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
support	B-X
a	B-X
stepwise	B-X
model	B-X
for	B-X
the	B-X
assembly	B-X
of	B-X
silent	B-X
chromatin	B-X
domains	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X

Role	O
of	O
glycogen	B-Gene_or_gene_product
synthase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
in	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
and	O
apoptosis	O
in	O
hepatocytes	O
.	O
<EOS>	B-X
Nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
prevents	B-X
hepatocytes	B-X
from	B-X
undergoing	B-X
apoptosis	B-X
during	B-X
development	B-X
and	B-X
liver	B-X
regeneration	B-X
.	B-X
Mice	B-X
with	B-X
inactivated	B-X
glycogen	B-X
synthase	B-X
kinase	B-X
(	B-X
GSK	B-X
)	B-X
-3beta	B-X
die	B-X
from	B-X
hepatocyte	B-X
apoptosis	B-X
during	B-X
development	B-X
due	B-X
to	B-X
a	B-X
defect	B-X
in	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
Hoeflich	B-X
KP	B-X
,	B-X
Luo	B-X
J	B-X
,	B-X
Rubie	B-X
EA	B-X
,	B-X
Tsao	B-X
MS	B-X
,	B-X
Jin	B-X
O	B-X
,	B-X
and	B-X
Woodgett	B-X
JR	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
role	B-X
of	B-X
GSK-3	B-X
in	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
in	B-X
primary	B-X
hepatocytes	B-X
.	B-X
LiCl	B-X
,	B-X
an	B-X
established	B-X
inhibitor	B-X
of	B-X
GSK-3	B-X
,	B-X
sensitized	B-X
primary	B-X
rat	B-X
hepatocytes	B-X
toward	B-X
TNF-alpha-mediated	B-X
apoptosis	B-X
resulting	B-X
in	B-X
90	B-X
%	B-X
cell	B-X
death	B-X
after	B-X
24	B-X
h.	B-X
This	B-X
was	B-X
accompanied	B-X
by	B-X
increased	B-X
caspase	B-X
8-like	B-X
and	B-X
3-like	B-X
activities	B-X
,	B-X
nuclear	B-X
fragmentation	B-X
and	B-X
DNA	B-X
laddering	B-X
.	B-X
LiCl	B-X
treatment	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
IkappaB-alpha	B-X
degradation	B-X
,	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
activity	B-X
,	B-X
NF-kappaB	B-X
binding	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
nuclear	B-X
import	B-X
and	B-X
export	B-X
,	B-X
but	B-X
decreased	B-X
transcription	B-X
of	B-X
the	B-X
NF-kappaB-dependent	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
gene	B-X
and	B-X
a	B-X
NF-kappaB-driven	B-X
reporter	B-X
gene	B-X
.	B-X
The	B-X
p65	B-X
sequence	B-X
revealed	B-X
four	B-X
potential	B-X
GSK-3	B-X
phosphorylation	B-X
sites	B-X
within	B-X
its	B-X
COOH-terminal	B-X
transactivation	B-X
domains	B-X
and	B-X
recombinant	B-X
GSK-3beta	B-X
phosphorylated	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
-p65	B-X
(	B-X
354-551	B-X
)	B-X
,	B-X
but	B-X
not	B-X
GST-p65	B-X
(	B-X
1-305	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
GSK-3	B-X
protects	B-X
hepatocytes	B-X
from	B-X
TNF-alpha-induced	B-X
apoptosis	B-X
through	B-X
p65	B-X
phosphorylation	B-X
and	B-X
upregulation	B-X
of	B-X
NF-kappaB	B-X
transactivation	B-X
.	B-X

Nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
prevents	O
hepatocytes	O
from	O
undergoing	O
apoptosis	O
during	O
development	O
and	O
liver	O
regeneration	O
.	O
<EOS>	B-X
Nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
prevents	B-X
hepatocytes	B-X
from	B-X
undergoing	B-X
apoptosis	B-X
during	B-X
development	B-X
and	B-X
liver	B-X
regeneration	B-X
.	B-X
Mice	B-X
with	B-X
inactivated	B-X
glycogen	B-X
synthase	B-X
kinase	B-X
(	B-X
GSK	B-X
)	B-X
-3beta	B-X
die	B-X
from	B-X
hepatocyte	B-X
apoptosis	B-X
during	B-X
development	B-X
due	B-X
to	B-X
a	B-X
defect	B-X
in	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
Hoeflich	B-X
KP	B-X
,	B-X
Luo	B-X
J	B-X
,	B-X
Rubie	B-X
EA	B-X
,	B-X
Tsao	B-X
MS	B-X
,	B-X
Jin	B-X
O	B-X
,	B-X
and	B-X
Woodgett	B-X
JR	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
role	B-X
of	B-X
GSK-3	B-X
in	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
in	B-X
primary	B-X
hepatocytes	B-X
.	B-X
LiCl	B-X
,	B-X
an	B-X
established	B-X
inhibitor	B-X
of	B-X
GSK-3	B-X
,	B-X
sensitized	B-X
primary	B-X
rat	B-X
hepatocytes	B-X
toward	B-X
TNF-alpha-mediated	B-X
apoptosis	B-X
resulting	B-X
in	B-X
90	B-X
%	B-X
cell	B-X
death	B-X
after	B-X
24	B-X
h.	B-X
This	B-X
was	B-X
accompanied	B-X
by	B-X
increased	B-X
caspase	B-X
8-like	B-X
and	B-X
3-like	B-X
activities	B-X
,	B-X
nuclear	B-X
fragmentation	B-X
and	B-X
DNA	B-X
laddering	B-X
.	B-X
LiCl	B-X
treatment	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
IkappaB-alpha	B-X
degradation	B-X
,	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
activity	B-X
,	B-X
NF-kappaB	B-X
binding	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
nuclear	B-X
import	B-X
and	B-X
export	B-X
,	B-X
but	B-X
decreased	B-X
transcription	B-X
of	B-X
the	B-X
NF-kappaB-dependent	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
gene	B-X
and	B-X
a	B-X
NF-kappaB-driven	B-X
reporter	B-X
gene	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
GSK-3	B-X
protects	B-X
hepatocytes	B-X
from	B-X
TNF-alpha-induced	B-X
apoptosis	B-X
through	B-X
p65	B-X
phosphorylation	B-X
and	B-X
upregulation	B-X
of	B-X
NF-kappaB	B-X
transactivation	B-X
.	B-X

Mice	O
with	O
inactivated	O
glycogen	B-Gene_or_gene_product
synthase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	I-Gene_or_gene_product
GSK	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
die	O
from	O
hepatocyte	O
apoptosis	O
during	O
development	O
due	O
to	O
a	O
defect	O
in	O
NF	O
-	O
kappaB	O
activation	O
(	O
Hoeflich	O
KP	O
,	O
Luo	O
J	O
,	O
Rubie	O
EA	O
,	O
Tsao	O
MS	O
,	O
Jin	O
O	O
,	O
and	O
Woodgett	O
JR	O
.	O
Nature	O
406	O
:	O
86	O
-	O
90	O
,	O
2000	O
)	O
.	O

In	O
this	O
study	O
,	O
we	O
determined	O
the	O
role	O
of	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
in	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
induced	O
NF	O
-	O
kappaB	O
activation	O
and	O
cell	O
death	O
in	O
primary	O
hepatocytes	O
.	O
<EOS>	B-X
Nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
prevents	B-X
hepatocytes	B-X
from	B-X
undergoing	B-X
apoptosis	B-X
during	B-X
development	B-X
and	B-X
liver	B-X
regeneration	B-X
.	B-X
Mice	B-X
with	B-X
inactivated	B-X
glycogen	B-X
synthase	B-X
kinase	B-X
(	B-X
GSK	B-X
)	B-X
-3beta	B-X
die	B-X
from	B-X
hepatocyte	B-X
apoptosis	B-X
during	B-X
development	B-X
due	B-X
to	B-X
a	B-X
defect	B-X
in	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
Hoeflich	B-X
KP	B-X
,	B-X
Luo	B-X
J	B-X
,	B-X
Rubie	B-X
EA	B-X
,	B-X
Tsao	B-X
MS	B-X
,	B-X
Jin	B-X
O	B-X
,	B-X
and	B-X
Woodgett	B-X
JR	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
role	B-X
of	B-X
GSK-3	B-X
in	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
in	B-X
primary	B-X
hepatocytes	B-X
.	B-X
LiCl	B-X
,	B-X
an	B-X
established	B-X
inhibitor	B-X
of	B-X
GSK-3	B-X
,	B-X
sensitized	B-X
primary	B-X
rat	B-X
hepatocytes	B-X
toward	B-X
TNF-alpha-mediated	B-X
apoptosis	B-X
resulting	B-X
in	B-X
90	B-X
%	B-X
cell	B-X
death	B-X
after	B-X
24	B-X
h.	B-X
This	B-X
was	B-X
accompanied	B-X
by	B-X
increased	B-X
caspase	B-X
8-like	B-X
and	B-X
3-like	B-X
activities	B-X
,	B-X
nuclear	B-X
fragmentation	B-X
and	B-X
DNA	B-X
laddering	B-X
.	B-X
LiCl	B-X
treatment	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
IkappaB-alpha	B-X
degradation	B-X
,	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
activity	B-X
,	B-X
NF-kappaB	B-X
binding	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
nuclear	B-X
import	B-X
and	B-X
export	B-X
,	B-X
but	B-X
decreased	B-X
transcription	B-X
of	B-X
the	B-X
NF-kappaB-dependent	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
gene	B-X
and	B-X
a	B-X
NF-kappaB-driven	B-X
reporter	B-X
gene	B-X
.	B-X
The	B-X
p65	B-X
sequence	B-X
revealed	B-X
four	B-X
potential	B-X
GSK-3	B-X
phosphorylation	B-X
sites	B-X
within	B-X
its	B-X
COOH-terminal	B-X
transactivation	B-X
domains	B-X
and	B-X
recombinant	B-X
GSK-3beta	B-X
phosphorylated	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
-p65	B-X
(	B-X
354-551	B-X
)	B-X
,	B-X
but	B-X
not	B-X
GST-p65	B-X
(	B-X
1-305	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
GSK-3	B-X
protects	B-X
hepatocytes	B-X
from	B-X
TNF-alpha-induced	B-X
apoptosis	B-X
through	B-X
p65	B-X
phosphorylation	B-X
and	B-X
upregulation	B-X
of	B-X
NF-kappaB	B-X
transactivation	B-X
.	B-X

LiCl	O
,	O
an	O
established	O
inhibitor	O
of	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
,	O
sensitized	O
primary	O
rat	O
hepatocytes	O
toward	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
mediated	O
apoptosis	O
resulting	O
in	O
90	O
%	O
cell	O
death	O
after	O
24	O
h	O
.	O
<EOS>	B-X
Nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
prevents	B-X
hepatocytes	B-X
from	B-X
undergoing	B-X
apoptosis	B-X
during	B-X
development	B-X
and	B-X
liver	B-X
regeneration	B-X
.	B-X
Mice	B-X
with	B-X
inactivated	B-X
glycogen	B-X
synthase	B-X
kinase	B-X
(	B-X
GSK	B-X
)	B-X
-3beta	B-X
die	B-X
from	B-X
hepatocyte	B-X
apoptosis	B-X
during	B-X
development	B-X
due	B-X
to	B-X
a	B-X
defect	B-X
in	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
Hoeflich	B-X
KP	B-X
,	B-X
Luo	B-X
J	B-X
,	B-X
Rubie	B-X
EA	B-X
,	B-X
Tsao	B-X
MS	B-X
,	B-X
Jin	B-X
O	B-X
,	B-X
and	B-X
Woodgett	B-X
JR	B-X
.	B-X
Nature	B-X
406	B-X
:	B-X
86-90	B-X
,	B-X
2000	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
role	B-X
of	B-X
GSK-3	B-X
in	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
in	B-X
primary	B-X
hepatocytes	B-X
.	B-X
LiCl	B-X
,	B-X
an	B-X
established	B-X
inhibitor	B-X
of	B-X
GSK-3	B-X
,	B-X
sensitized	B-X
primary	B-X
rat	B-X
hepatocytes	B-X
toward	B-X
TNF-alpha-mediated	B-X
apoptosis	B-X
resulting	B-X
in	B-X
90	B-X
%	B-X
cell	B-X
death	B-X
after	B-X
24	B-X
h.	B-X
This	B-X
was	B-X
accompanied	B-X
by	B-X
increased	B-X
caspase	B-X
8-like	B-X
and	B-X
3-like	B-X
activities	B-X
,	B-X
nuclear	B-X
fragmentation	B-X
and	B-X
DNA	B-X
laddering	B-X
.	B-X
LiCl	B-X
treatment	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
IkappaB-alpha	B-X
degradation	B-X
,	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
activity	B-X
,	B-X
NF-kappaB	B-X
binding	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
nuclear	B-X
import	B-X
and	B-X
export	B-X
,	B-X
but	B-X
decreased	B-X
transcription	B-X
of	B-X
the	B-X
NF-kappaB-dependent	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
gene	B-X
and	B-X
a	B-X
NF-kappaB-driven	B-X
reporter	B-X
gene	B-X
.	B-X
The	B-X
p65	B-X
sequence	B-X
revealed	B-X
four	B-X
potential	B-X
GSK-3	B-X
phosphorylation	B-X
sites	B-X
within	B-X
its	B-X
COOH-terminal	B-X
transactivation	B-X
domains	B-X
and	B-X
recombinant	B-X
GSK-3beta	B-X
phosphorylated	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
-p65	B-X
(	B-X
354-551	B-X
)	B-X
,	B-X
but	B-X
not	B-X
GST-p65	B-X
(	B-X
1-305	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
GSK-3	B-X
protects	B-X
hepatocytes	B-X
from	B-X
TNF-alpha-induced	B-X
apoptosis	B-X
through	B-X
p65	B-X
phosphorylation	B-X
and	B-X
upregulation	B-X
of	B-X
NF-kappaB	B-X
transactivation	B-X
.	B-X

This	O
was	O
accompanied	O
by	O
increased	O
caspase	B-Gene_or_gene_product
8	I-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
and	O
3	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
activities	O
,	O
nuclear	O
fragmentation	O
and	O
DNA	O
laddering	O
.	O
<EOS>	B-X
Mice	B-X
with	B-X
inactivated	B-X
glycogen	B-X
synthase	B-X
kinase	B-X
(	B-X
GSK	B-X
)	B-X
-3beta	B-X
die	B-X
from	B-X
hepatocyte	B-X
apoptosis	B-X
during	B-X
development	B-X
due	B-X
to	B-X
a	B-X
defect	B-X
in	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
Hoeflich	B-X
KP	B-X
,	B-X
Luo	B-X
J	B-X
,	B-X
Rubie	B-X
EA	B-X
,	B-X
Tsao	B-X
MS	B-X
,	B-X
Jin	B-X
O	B-X
,	B-X
and	B-X
Woodgett	B-X
JR	B-X
.	B-X
Nature	B-X
406	B-X
:	B-X
86-90	B-X
,	B-X
2000	B-X
)	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
role	B-X
of	B-X
GSK-3	B-X
in	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
in	B-X
primary	B-X
hepatocytes	B-X
.	B-X
LiCl	B-X
,	B-X
an	B-X
established	B-X
inhibitor	B-X
of	B-X
GSK-3	B-X
,	B-X
sensitized	B-X
primary	B-X
rat	B-X
hepatocytes	B-X
toward	B-X
TNF-alpha-mediated	B-X
apoptosis	B-X
resulting	B-X
in	B-X
90	B-X
%	B-X
cell	B-X
death	B-X
after	B-X
24	B-X
h.	B-X
This	B-X
was	B-X
accompanied	B-X
by	B-X
increased	B-X
caspase	B-X
8-like	B-X
and	B-X
3-like	B-X
activities	B-X
,	B-X
nuclear	B-X
fragmentation	B-X
and	B-X
DNA	B-X
laddering	B-X
.	B-X
LiCl	B-X
treatment	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
IkappaB-alpha	B-X
degradation	B-X
,	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
activity	B-X
,	B-X
NF-kappaB	B-X
binding	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
nuclear	B-X
import	B-X
and	B-X
export	B-X
,	B-X
but	B-X
decreased	B-X
transcription	B-X
of	B-X
the	B-X
NF-kappaB-dependent	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
gene	B-X
and	B-X
a	B-X
NF-kappaB-driven	B-X
reporter	B-X
gene	B-X
.	B-X
The	B-X
p65	B-X
sequence	B-X
revealed	B-X
four	B-X
potential	B-X
GSK-3	B-X
phosphorylation	B-X
sites	B-X
within	B-X
its	B-X
COOH-terminal	B-X
transactivation	B-X
domains	B-X
and	B-X
recombinant	B-X
GSK-3beta	B-X
phosphorylated	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
-p65	B-X
(	B-X
354-551	B-X
)	B-X
,	B-X
but	B-X
not	B-X
GST-p65	B-X
(	B-X
1-305	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
GSK-3	B-X
protects	B-X
hepatocytes	B-X
from	B-X
TNF-alpha-induced	B-X
apoptosis	B-X
through	B-X
p65	B-X
phosphorylation	B-X
and	B-X
upregulation	B-X
of	B-X
NF-kappaB	B-X
transactivation	B-X
.	B-X

LiCl	O
treatment	O
had	O
no	O
effect	O
on	O
IkappaB	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
degradation	O
,	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
activity	O
,	O
NF	O
-	O
kappaB	O
binding	O
activity	O
,	O
and	O
p65	B-Gene_or_gene_product
nuclear	O
import	O
and	O
export	O
,	O
but	O
decreased	O
transcription	O
of	O
the	O
NF	O
-	O
kappaB	O
-	O
dependent	O
inducible	O
nitric	B-Gene_or_gene_product
oxide	I-Gene_or_gene_product
synthase	I-Gene_or_gene_product
gene	O
and	O
a	O
NF	O
-	O
kappaB	O
-	O
driven	O
reporter	O
gene	O
.	O

The	O
p65	B-Gene_or_gene_product
sequence	O
revealed	O
four	O
potential	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
phosphorylation	O
sites	O
within	O
its	O
COOH	O
-	O
terminal	O
transactivation	O
domains	O
and	O
recombinant	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3beta	I-Gene_or_gene_product
phosphorylated	O
glutathione	B-Gene_or_gene_product
S	I-Gene_or_gene_product
-	I-Gene_or_gene_product
transferase	I-Gene_or_gene_product
(	O
GST	B-Gene_or_gene_product
)	O
-	O
p65	B-Gene_or_gene_product
(	O
354	O
-	O
551	O
)	O
,	O
but	O
not	O
GST	B-Gene_or_gene_product
-	O
p65	B-Gene_or_gene_product
(	O
1	O
-	O
305	O
)	O
in	O
vitro	O
.	O

These	O
results	O
indicate	O
that	O
GSK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
protects	O
hepatocytes	O
from	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
-	O
induced	O
apoptosis	O
through	O
p65	B-Gene_or_gene_product
phosphorylation	O
and	O
upregulation	O
of	O
NF	O
-	O
kappaB	O
transactivation	O
.	O
<EOS>	B-X
Nuclear	B-X
factor-kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
prevents	B-X
hepatocytes	B-X
from	B-X
undergoing	B-X
apoptosis	B-X
during	B-X
development	B-X
and	B-X
liver	B-X
regeneration	B-X
.	B-X
Mice	B-X
with	B-X
inactivated	B-X
glycogen	B-X
synthase	B-X
kinase	B-X
(	B-X
GSK	B-X
)	B-X
-3beta	B-X
die	B-X
from	B-X
hepatocyte	B-X
apoptosis	B-X
during	B-X
development	B-X
due	B-X
to	B-X
a	B-X
defect	B-X
in	B-X
NF-kappaB	B-X
activation	B-X
(	B-X
Hoeflich	B-X
KP	B-X
,	B-X
Luo	B-X
J	B-X
,	B-X
Rubie	B-X
EA	B-X
,	B-X
Tsao	B-X
MS	B-X
,	B-X
Jin	B-X
O	B-X
,	B-X
and	B-X
Woodgett	B-X
JR	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
determined	B-X
the	B-X
role	B-X
of	B-X
GSK-3	B-X
in	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
and	B-X
cell	B-X
death	B-X
in	B-X
primary	B-X
hepatocytes	B-X
.	B-X
LiCl	B-X
,	B-X
an	B-X
established	B-X
inhibitor	B-X
of	B-X
GSK-3	B-X
,	B-X
sensitized	B-X
primary	B-X
rat	B-X
hepatocytes	B-X
toward	B-X
TNF-alpha-mediated	B-X
apoptosis	B-X
resulting	B-X
in	B-X
90	B-X
%	B-X
cell	B-X
death	B-X
after	B-X
24	B-X
h.	B-X
This	B-X
was	B-X
accompanied	B-X
by	B-X
increased	B-X
caspase	B-X
8-like	B-X
and	B-X
3-like	B-X
activities	B-X
,	B-X
nuclear	B-X
fragmentation	B-X
and	B-X
DNA	B-X
laddering	B-X
.	B-X
LiCl	B-X
treatment	B-X
had	B-X
no	B-X
effect	B-X
on	B-X
IkappaB-alpha	B-X
degradation	B-X
,	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
activity	B-X
,	B-X
NF-kappaB	B-X
binding	B-X
activity	B-X
,	B-X
and	B-X
p65	B-X
nuclear	B-X
import	B-X
and	B-X
export	B-X
,	B-X
but	B-X
decreased	B-X
transcription	B-X
of	B-X
the	B-X
NF-kappaB-dependent	B-X
inducible	B-X
nitric	B-X
oxide	B-X
synthase	B-X
gene	B-X
and	B-X
a	B-X
NF-kappaB-driven	B-X
reporter	B-X
gene	B-X
.	B-X
The	B-X
p65	B-X
sequence	B-X
revealed	B-X
four	B-X
potential	B-X
GSK-3	B-X
phosphorylation	B-X
sites	B-X
within	B-X
its	B-X
COOH-terminal	B-X
transactivation	B-X
domains	B-X
and	B-X
recombinant	B-X
GSK-3beta	B-X
phosphorylated	B-X
glutathione	B-X
S-transferase	B-X
(	B-X
GST	B-X
)	B-X
-p65	B-X
(	B-X
354-551	B-X
)	B-X
,	B-X
but	B-X
not	B-X
GST-p65	B-X
(	B-X
1-305	B-X
)	B-X
in	B-X
vitro	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
GSK-3	B-X
protects	B-X
hepatocytes	B-X
from	B-X
TNF-alpha-induced	B-X
apoptosis	B-X
through	B-X
p65	B-X
phosphorylation	B-X
and	B-X
upregulation	B-X
of	B-X
NF-kappaB	B-X
transactivation	B-X
.	B-X

An	O
E2F	B-Gene_or_gene_product
-	O
binding	O
site	O
mediates	O
the	O
activation	O
of	O
the	O
proliferative	O
isoform	O
of	O
6	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphofructo	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
/	O
fructose	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	I-Gene_or_gene_product
6	I-Gene_or_gene_product
-	I-Gene_or_gene_product
bisphosphatase	I-Gene_or_gene_product
by	O
phosphatidylinositol	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
E2F	B-X
is	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
the	B-X
glycolytic	B-X
enzyme	B-X
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase	B-X
(	B-X
6PF2K/Fru-2,6-BPase	B-X
)	B-X
during	B-X
cell	B-X
division	B-X
.	B-X
We	B-X
identified	B-X
and	B-X
monitored	B-X
the	B-X
E2F-pocket	B-X
protein	B-X
complexes	B-X
that	B-X
bind	B-X
to	B-X
the	B-X
E2F	B-X
site	B-X
of	B-X
the	B-X
F-type	B-X
promoter	B-X
during	B-X
cell-cycle	B-X
entry	B-X
,	B-X
and	B-X
we	B-X
analysed	B-X
their	B-X
contribution	B-X
to	B-X
the	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI	B-X
3-kinase	B-X
)	B-X
-mediated	B-X
regulation	B-X
of	B-X
the	B-X
promoter	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
predominant	B-X
E2F	B-X
complex	B-X
bound	B-X
to	B-X
the	B-X
F-type	B-X
promoter	B-X
in	B-X
unstimulated/quiescent	B-X
cells	B-X
contains	B-X
E2F4	B-X
,	B-X
DP1	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
In	B-X
serum-stimulated	B-X
(	B-X
S-phase	B-X
)	B-X
cells	B-X
,	B-X
the	B-X
composition	B-X
of	B-X
the	B-X
complex	B-X
switched	B-X
to	B-X
E2F1/4	B-X
,	B-X
DP1	B-X
and	B-X
p107	B-X
,	B-X
together	B-X
with	B-X
cyclin	B-X
A	B-X
and	B-X
cyclin-dependent	B-X
kinase	B-X
2	B-X
.	B-X
Treatment	B-X
with	B-X
the	B-X
PI	B-X
3-kinase	B-X
specific	B-X
inhibitor	B-X
LY	B-X
294002	B-X
prevented	B-X
the	B-X
formation	B-X
of	B-X
the	B-X
S-phase	B-X
complex	B-X
,	B-X
suggesting	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
PI	B-X
3-kinase	B-X
pathway	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
this	B-X
complex	B-X
.	B-X
Further	B-X
supporting	B-X
this	B-X
idea	B-X
,	B-X
we	B-X
obtained	B-X
results	B-X
showing	B-X
that	B-X
treatment	B-X
of	B-X
cycling	B-X
NIH	B-X
3T3	B-X
cells	B-X
with	B-X
either	B-X
wortmannin	B-X
or	B-X
LY	B-X
294002	B-X
induces	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
transcriptionally	B-X
repressive	B-X
p130-E2F4-DP1	B-X
complex	B-X
.	B-X
Using	B-X
the	B-X
Rat-1	B-X
ER-E2F1	B-X
cell	B-X
line	B-X
where	B-X
E2F1	B-X
activity	B-X
can	B-X
be	B-X
conditionally	B-X
induced	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
E2F	B-X
activity	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
in	B-X
vivo	B-X
transcriptional	B-X
regulation	B-X
of	B-X
the	B-X
F-type	B-X
6PF2K/Fru-2	B-X
,	B-X
6-BPase	B-X
gene	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
show	B-X
that	B-X
the	B-X
F-type	B-X
6PF2K/Fru-2	B-X
,	B-X
6-BPase	B-X
is	B-X
a	B-X
genuine	B-X
E2F-regulated	B-X
gene	B-X
,	B-X
and	B-X
that	B-X
its	B-X
regulation	B-X
by	B-X
the	B-X
PI	B-X
3-kinase	B-X
pathway	B-X
is	B-X
at	B-X
least	B-X
partially	B-X
mediated	B-X
through	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
.	B-X

In	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
E2F	B-Gene_or_gene_product
is	O
implicated	O
in	O
the	O
regulation	O
of	O
the	O
glycolytic	O
enzyme	O
6	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphofructo	I-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
/	O
fructose	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	I-Gene_or_gene_product
6	I-Gene_or_gene_product
-	I-Gene_or_gene_product
bisphosphatase	I-Gene_or_gene_product
(	O
6PF2K	B-Gene_or_gene_product
/	O
Fru	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	I-Gene_or_gene_product
6	I-Gene_or_gene_product
-	I-Gene_or_gene_product
BPase	I-Gene_or_gene_product
)	O
during	O
cell	O
division	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
E2F	B-X
is	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
the	B-X
glycolytic	B-X
enzyme	B-X
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase	B-X
(	B-X
6PF2K/Fru-2,6-BPase	B-X
)	B-X
during	B-X
cell	B-X
division	B-X
.	B-X
The	B-X
expression	B-X
of	B-X
this	B-X
enzyme	B-X
is	B-X
induced	B-X
during	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
We	B-X
identified	B-X
and	B-X
monitored	B-X
the	B-X
E2F-pocket	B-X
protein	B-X
complexes	B-X
that	B-X
bind	B-X
to	B-X
the	B-X
E2F	B-X
site	B-X
of	B-X
the	B-X
F-type	B-X
promoter	B-X
during	B-X
cell-cycle	B-X
entry	B-X
,	B-X
and	B-X
we	B-X
analysed	B-X
their	B-X
contribution	B-X
to	B-X
the	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI	B-X
3-kinase	B-X
)	B-X
-mediated	B-X
regulation	B-X
of	B-X
the	B-X
promoter	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
predominant	B-X
E2F	B-X
complex	B-X
bound	B-X
to	B-X
the	B-X
F-type	B-X
promoter	B-X
in	B-X
unstimulated/quiescent	B-X
cells	B-X
contains	B-X
E2F4	B-X
,	B-X
DP1	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
In	B-X
serum-stimulated	B-X
(	B-X
S-phase	B-X
)	B-X
cells	B-X
,	B-X
the	B-X
composition	B-X
of	B-X
the	B-X
complex	B-X
switched	B-X
to	B-X
E2F1/4	B-X
,	B-X
DP1	B-X
and	B-X
p107	B-X
,	B-X
together	B-X
with	B-X
cyclin	B-X
A	B-X
and	B-X
cyclin-dependent	B-X
kinase	B-X
2	B-X
.	B-X
Treatment	B-X
with	B-X
the	B-X
PI	B-X
3-kinase	B-X
specific	B-X
inhibitor	B-X
LY	B-X
294002	B-X
prevented	B-X
the	B-X
formation	B-X
of	B-X
the	B-X
S-phase	B-X
complex	B-X
,	B-X
suggesting	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
PI	B-X
3-kinase	B-X
pathway	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
this	B-X
complex	B-X
.	B-X
Further	B-X
supporting	B-X
this	B-X
idea	B-X
,	B-X
we	B-X
obtained	B-X
results	B-X
showing	B-X
that	B-X
treatment	B-X
of	B-X
cycling	B-X
NIH	B-X
3T3	B-X
cells	B-X
with	B-X
either	B-X
wortmannin	B-X
or	B-X
LY	B-X
294002	B-X
induces	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
transcriptionally	B-X
repressive	B-X
p130-E2F4-DP1	B-X
complex	B-X
.	B-X
Using	B-X
the	B-X
Rat-1	B-X
ER-E2F1	B-X
cell	B-X
line	B-X
where	B-X
E2F1	B-X
activity	B-X
can	B-X
be	B-X
conditionally	B-X
induced	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
E2F	B-X
activity	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
in	B-X
vivo	B-X
transcriptional	B-X
regulation	B-X
of	B-X
the	B-X
F-type	B-X
6PF2K/Fru-2	B-X
,	B-X
6-BPase	B-X
gene	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
show	B-X
that	B-X
the	B-X
F-type	B-X
6PF2K/Fru-2	B-X
,	B-X
6-BPase	B-X
is	B-X
a	B-X
genuine	B-X
E2F-regulated	B-X
gene	B-X
,	B-X
and	B-X
that	B-X
its	B-X
regulation	B-X
by	B-X
the	B-X
PI	B-X
3-kinase	B-X
pathway	B-X
is	B-X
at	B-X
least	B-X
partially	B-X
mediated	B-X
through	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
.	B-X

The	O
expression	O
of	O
this	O
enzyme	O
is	O
induced	O
during	O
the	O
G	O
(	O
1	O
)	O
/	O
S	O
transition	O
of	O
the	O
cell	O
cycle	O
.	O

We	O
identified	O
and	O
monitored	O
the	O
E2F	O
-	O
pocket	O
protein	O
complexes	O
that	O
bind	O
to	O
the	O
E2F	B-Gene_or_gene_product
site	O
of	O
the	O
F	O
-	O
type	O
promoter	O
during	O
cell	O
-	O
cycle	O
entry	O
,	O
and	O
we	O
analysed	O
their	O
contribution	O
to	O
the	O
phosphatidylinositol	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
)	O
-	O
mediated	O
regulation	O
of	O
the	O
promoter	O
.	O

We	O
found	O
that	O
the	O
predominant	O
E2F	O
complex	O
bound	O
to	O
the	O
F	O
-	O
type	O
promoter	O
in	O
unstimulated	O
/	O
quiescent	O
cells	O
contains	O
E2F4	B-Gene_or_gene_product
,	O
DP1	B-Gene_or_gene_product
and	O
p130	B-Gene_or_gene_product
proteins	O
.	O

In	O
serum	O
-	O
stimulated	O
(	O
S	O
-	O
phase	O
)	O
cells	O
,	O
the	O
composition	O
of	O
the	O
complex	O
switched	O
to	O
E2F1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
4	I-Gene_or_gene_product
,	O
DP1	B-Gene_or_gene_product
and	O
p107	B-Gene_or_gene_product
,	O
together	O
with	O
cyclin	B-Gene_or_gene_product
A	I-Gene_or_gene_product
and	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
E2F	B-X
is	B-X
implicated	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
the	B-X
glycolytic	B-X
enzyme	B-X
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase	B-X
(	B-X
6PF2K/Fru-2,6-BPase	B-X
)	B-X
during	B-X
cell	B-X
division	B-X
.	B-X
We	B-X
identified	B-X
and	B-X
monitored	B-X
the	B-X
E2F-pocket	B-X
protein	B-X
complexes	B-X
that	B-X
bind	B-X
to	B-X
the	B-X
E2F	B-X
site	B-X
of	B-X
the	B-X
F-type	B-X
promoter	B-X
during	B-X
cell-cycle	B-X
entry	B-X
,	B-X
and	B-X
we	B-X
analysed	B-X
their	B-X
contribution	B-X
to	B-X
the	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI	B-X
3-kinase	B-X
)	B-X
-mediated	B-X
regulation	B-X
of	B-X
the	B-X
promoter	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
predominant	B-X
E2F	B-X
complex	B-X
bound	B-X
to	B-X
the	B-X
F-type	B-X
promoter	B-X
in	B-X
unstimulated/quiescent	B-X
cells	B-X
contains	B-X
E2F4	B-X
,	B-X
DP1	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
In	B-X
serum-stimulated	B-X
(	B-X
S-phase	B-X
)	B-X
cells	B-X
,	B-X
the	B-X
composition	B-X
of	B-X
the	B-X
complex	B-X
switched	B-X
to	B-X
E2F1/4	B-X
,	B-X
DP1	B-X
and	B-X
p107	B-X
,	B-X
together	B-X
with	B-X
cyclin	B-X
A	B-X
and	B-X
cyclin-dependent	B-X
kinase	B-X
2	B-X
.	B-X
Treatment	B-X
with	B-X
the	B-X
PI	B-X
3-kinase	B-X
specific	B-X
inhibitor	B-X
LY	B-X
294002	B-X
prevented	B-X
the	B-X
formation	B-X
of	B-X
the	B-X
S-phase	B-X
complex	B-X
,	B-X
suggesting	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
PI	B-X
3-kinase	B-X
pathway	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
this	B-X
complex	B-X
.	B-X
Further	B-X
supporting	B-X
this	B-X
idea	B-X
,	B-X
we	B-X
obtained	B-X
results	B-X
showing	B-X
that	B-X
treatment	B-X
of	B-X
cycling	B-X
NIH	B-X
3T3	B-X
cells	B-X
with	B-X
either	B-X
wortmannin	B-X
or	B-X
LY	B-X
294002	B-X
induces	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
transcriptionally	B-X
repressive	B-X
p130-E2F4-DP1	B-X
complex	B-X
.	B-X
Using	B-X
the	B-X
Rat-1	B-X
ER-E2F1	B-X
cell	B-X
line	B-X
where	B-X
E2F1	B-X
activity	B-X
can	B-X
be	B-X
conditionally	B-X
induced	B-X
,	B-X
we	B-X
demonstrated	B-X
that	B-X
E2F	B-X
activity	B-X
is	B-X
involved	B-X
in	B-X
the	B-X
in	B-X
vivo	B-X
transcriptional	B-X
regulation	B-X
of	B-X
the	B-X
F-type	B-X
6PF2K/Fru-2	B-X
,	B-X
6-BPase	B-X
gene	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
show	B-X
that	B-X
the	B-X
F-type	B-X
6PF2K/Fru-2	B-X
,	B-X
6-BPase	B-X
is	B-X
a	B-X
genuine	B-X
E2F-regulated	B-X
gene	B-X
,	B-X
and	B-X
that	B-X
its	B-X
regulation	B-X
by	B-X
the	B-X
PI	B-X
3-kinase	B-X
pathway	B-X
is	B-X
at	B-X
least	B-X
partially	B-X
mediated	B-X
through	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
.	B-X

Treatment	O
with	O
the	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
specific	O
inhibitor	O
LY	O
294002	O
prevented	O
the	O
formation	O
of	O
the	O
S	O
-	O
phase	O
complex	O
,	O
suggesting	O
that	O
activation	O
of	O
the	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
pathway	O
is	O
essential	O
for	O
the	O
formation	O
of	O
this	O
complex	O
.	O

Further	O
supporting	O
this	O
idea	O
,	O
we	O
obtained	O
results	O
showing	O
that	O
treatment	O
of	O
cycling	O
NIH	O
3T3	O
cells	O
with	O
either	O
wortmannin	O
or	O
LY	O
294002	O
induces	O
the	O
accumulation	O
of	O
the	O
transcriptionally	O
repressive	O
p130	O
-	O
E2F4	O
-	O
DP1	O
complex	O
.	O
<EOS>	B-X
We	B-X
identified	B-X
and	B-X
monitored	B-X
the	B-X
E2F-pocket	B-X
protein	B-X
complexes	B-X
that	B-X
bind	B-X
to	B-X
the	B-X
E2F	B-X
site	B-X
of	B-X
the	B-X
F-type	B-X
promoter	B-X
during	B-X
cell-cycle	B-X
entry	B-X
,	B-X
and	B-X
we	B-X
analysed	B-X
their	B-X
contribution	B-X
to	B-X
the	B-X
phosphatidylinositol	B-X
3-kinase	B-X
(	B-X
PI	B-X
3-kinase	B-X
)	B-X
-mediated	B-X
regulation	B-X
of	B-X
the	B-X
promoter	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
predominant	B-X
E2F	B-X
complex	B-X
bound	B-X
to	B-X
the	B-X
F-type	B-X
promoter	B-X
in	B-X
unstimulated/quiescent	B-X
cells	B-X
contains	B-X
E2F4	B-X
,	B-X
DP1	B-X
and	B-X
p130	B-X
proteins	B-X
.	B-X
In	B-X
serum-stimulated	B-X
(	B-X
S-phase	B-X
)	B-X
cells	B-X
,	B-X
the	B-X
composition	B-X
of	B-X
the	B-X
complex	B-X
switched	B-X
to	B-X
E2F1/4	B-X
,	B-X
DP1	B-X
and	B-X
p107	B-X
,	B-X
together	B-X
with	B-X
cyclin	B-X
A	B-X
and	B-X
cyclin-dependent	B-X
kinase	B-X
2	B-X
.	B-X
Treatment	B-X
with	B-X
the	B-X
PI	B-X
3-kinase	B-X
specific	B-X
inhibitor	B-X
LY	B-X
294002	B-X
prevented	B-X
the	B-X
formation	B-X
of	B-X
the	B-X
S-phase	B-X
complex	B-X
,	B-X
suggesting	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
PI	B-X
3-kinase	B-X
pathway	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
formation	B-X
of	B-X
this	B-X
complex	B-X
.	B-X
Further	B-X
supporting	B-X
this	B-X
idea	B-X
,	B-X
we	B-X
obtained	B-X
results	B-X
showing	B-X
that	B-X
treatment	B-X
of	B-X
cycling	B-X
NIH	B-X
3T3	B-X
cells	B-X
with	B-X
either	B-X
wortmannin	B-X
or	B-X
LY	B-X
294002	B-X
induces	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
transcriptionally	B-X
repressive	B-X
p130-E2F4-DP1	B-X
complex	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
show	B-X
that	B-X
the	B-X
F-type	B-X
6PF2K/Fru-2	B-X
,	B-X
6-BPase	B-X
is	B-X
a	B-X
genuine	B-X
E2F-regulated	B-X
gene	B-X
,	B-X
and	B-X
that	B-X
its	B-X
regulation	B-X
by	B-X
the	B-X
PI	B-X
3-kinase	B-X
pathway	B-X
is	B-X
at	B-X
least	B-X
partially	B-X
mediated	B-X
through	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
.	B-X

Using	O
the	O
Rat	O
-	O
1	O
ER	B-Gene_or_gene_product
-	I-Gene_or_gene_product
E2F1	I-Gene_or_gene_product
cell	O
line	O
where	O
E2F1	B-Gene_or_gene_product
activity	O
can	O
be	O
conditionally	O
induced	O
,	O
we	O
demonstrated	O
that	O
E2F	B-Gene_or_gene_product
activity	O
is	O
involved	O
in	O
the	O
in	O
vivo	O
transcriptional	O
regulation	O
of	O
the	O
F	O
-	O
type	O
6PF2K	B-Gene_or_gene_product
/	O
Fru	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	I-Gene_or_gene_product
6	I-Gene_or_gene_product
-	I-Gene_or_gene_product
BPase	I-Gene_or_gene_product
gene	O
.	O

Taken	O
together	O
,	O
our	O
results	O
show	O
that	O
the	O
F	O
-	O
type	O
6PF2K	B-Gene_or_gene_product
/	O
Fru	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	I-Gene_or_gene_product
6	I-Gene_or_gene_product
-	I-Gene_or_gene_product
BPase	I-Gene_or_gene_product
is	O
a	O
genuine	O
E2F	B-Gene_or_gene_product
-	O
regulated	O
gene	O
,	O
and	O
that	O
its	O
regulation	O
by	O
the	O
PI	B-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
pathway	O
is	O
at	O
least	O
partially	O
mediated	O
through	O
the	O
E2F	B-Gene_or_gene_product
transcription	O
factor	O
.	O

Two	O
TOR	B-Gene_or_gene_product
complexes	O
,	O
only	O
one	O
of	O
which	O
is	O
rapamycin	O
sensitive	O
,	O
have	O
distinct	O
roles	O
in	O
cell	O
growth	O
control	O
.	O
<EOS>	B-X
The	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
TOR	B-X
)	B-X
proteins	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
TOR1	B-X
and	B-X
TOR2	B-X
,	B-X
redundantly	B-X
regulate	B-X
growth	B-X
in	B-X
a	B-X
rapamycin-sensitive	B-X
manner	B-X
.	B-X
TOR2	B-X
additionally	B-X
regulates	B-X
polarization	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
in	B-X
a	B-X
rapamycin-insensitive	B-X
manner	B-X
.	B-X
We	B-X
describe	B-X
two	B-X
functionally	B-X
distinct	B-X
TOR	B-X
complexes	B-X
.	B-X
TOR	B-X
Complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
contains	B-X
TOR1	B-X
or	B-X
TOR2	B-X
,	B-X
KOG1	B-X
(	B-X
YHR186c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
TORC2	B-X
contains	B-X
TOR2	B-X
,	B-X
AVO1	B-X
(	B-X
YOL078w	B-X
)	B-X
,	B-X
AVO2	B-X
(	B-X
YMR068w	B-X
)	B-X
,	B-X
AVO3	B-X
(	B-X
YER093c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
FKBP-rapamycin	B-X
binds	B-X
TORC1	B-X
,	B-X
and	B-X
TORC1	B-X
disruption	B-X
mimics	B-X
rapamycin	B-X
treatment	B-X
,	B-X
suggesting	B-X
that	B-X
TORC1	B-X
mediates	B-X
the	B-X
rapamycin-sensitive	B-X
,	B-X
TOR-shared	B-X
pathway	B-X
.	B-X
FKBP-rapamycin	B-X
fails	B-X
to	B-X
bind	B-X
TORC2	B-X
,	B-X
and	B-X
TORC2	B-X
disruption	B-X
causes	B-X
an	B-X
actin	B-X
defect	B-X
,	B-X
suggesting	B-X
that	B-X
TORC2	B-X
mediates	B-X
the	B-X
rapamycin-insensitive	B-X
,	B-X
TOR2-unique	B-X
pathway	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
distinct	B-X
TOR	B-X
complexes	B-X
account	B-X
for	B-X
the	B-X
diversity	B-X
,	B-X
specificity	B-X
,	B-X
and	B-X
selective	B-X
rapamycin	B-X
inhibition	B-X
of	B-X
TOR	B-X
signaling	B-X
.	B-X
TORC1	B-X
and	B-X
possibly	B-X
TORC2	B-X
are	B-X
conserved	B-X
from	B-X
yeast	B-X
to	B-X
man	B-X
.	B-X

The	O
target	B-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
(	O
TOR	B-Gene_or_gene_product
)	O
proteins	O
in	O
Saccharomyces	O
cerevisiae	O
,	O
TOR1	B-Gene_or_gene_product
and	O
TOR2	B-Gene_or_gene_product
,	O
redundantly	O
regulate	O
growth	O
in	O
a	O
rapamycin	O
-	O
sensitive	O
manner	O
.	O

TOR2	B-Gene_or_gene_product
additionally	O
regulates	O
polarization	O
of	O
the	O
actin	B-Gene_or_gene_product
cytoskeleton	O
in	O
a	O
rapamycin	O
-	O
insensitive	O
manner	O
.	O

We	O
describe	O
two	O
functionally	O
distinct	O
TOR	B-Gene_or_gene_product
complexes	O
.	O
<EOS>	B-X
In	B-X
humans	B-X
,	B-X
22	B-X
autosomal	B-X
genes	B-X
encode	B-X
for	B-X
a	B-X
redundant	B-X
set	B-X
of	B-X
subunits	B-X
allowing	B-X
the	B-X
composition	B-X
of	B-X
diverse	B-X
V-ATPase	B-X
complexes	B-X
with	B-X
specific	B-X
properties	B-X
and	B-X
expression	B-X
.	B-X
Here	B-X
we	B-X
describe	B-X
26	B-X
patients	B-X
harbouring	B-X
20	B-X
distinct	B-X
pathogenic	B-X
de	B-X
novo	B-X
missense	B-X
ATP6V1A	B-X
variants	B-X
,	B-X
mainly	B-X
clustering	B-X
within	B-X
the	B-X
ATP	B-X
synthase	B-X
/	B-X
family-nucleotide-binding	B-X
domain	B-X
.	B-X
Fibroblasts	B-X
of	B-X
two	B-X
patients	B-X
with	B-X
developmental	B-X
epileptic	B-X
encephalopathies	B-X
showed	B-X
decreased	B-X
LAMP1	B-X
expression	B-X
,	B-X
Lysotracker	B-X
staining	B-X
and	B-X
increased	B-X
organelle	B-X
pH	B-X
,	B-X
consistent	B-X
with	B-X
lysosomal	B-X
impairment	B-X
and	B-X
loss	B-X
of	B-X
V-ATPase	B-X
function	B-X
.	B-X
Fibroblasts	B-X
of	B-X
two	B-X
patients	B-X
with	B-X
milder	B-X
disease	B-X
,	B-X
exhibited	B-X
a	B-X
different	B-X
phenotype	B-X
with	B-X
increased	B-X
Lysotracker	B-X
staining	B-X
,	B-X
decreased	B-X
organelle	B-X
pH	B-X
and	B-X
no	B-X
significant	B-X
modification	B-X
in	B-X
LAMP1	B-X
expression	B-X
.	B-X
Transmission	B-X
electron	B-X
microscopy	B-X
of	B-X
fibroblasts	B-X
of	B-X
four	B-X
patients	B-X
with	B-X
variable	B-X
severity	B-X
and	B-X
of	B-X
induced	B-X
pluripotent	B-X
stem	B-X
cell-derived	B-X
neurons	B-X
from	B-X
two	B-X
patients	B-X
with	B-X
developmental	B-X
epileptic	B-X
encephalopathies	B-X
showed	B-X
electron-dense	B-X
inclusions	B-X
,	B-X
lipid	B-X
droplets	B-X
,	B-X
osmiophilic	B-X
material	B-X
and	B-X
lamellated	B-X
membrane	B-X
structures	B-X
resembling	B-X
phospholipids	B-X
.	B-X

TOR	O
Complex	O
1	O
(	O
TORC1	O
)	O
contains	O
TOR1	B-Gene_or_gene_product
or	O
TOR2	B-Gene_or_gene_product
,	O
KOG1	B-Gene_or_gene_product
(	O
YHR186c	B-Gene_or_gene_product
)	O
,	O
and	O
LST8	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
TOR	B-X
)	B-X
proteins	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
TOR1	B-X
and	B-X
TOR2	B-X
,	B-X
redundantly	B-X
regulate	B-X
growth	B-X
in	B-X
a	B-X
rapamycin-sensitive	B-X
manner	B-X
.	B-X
TOR2	B-X
additionally	B-X
regulates	B-X
polarization	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
in	B-X
a	B-X
rapamycin-insensitive	B-X
manner	B-X
.	B-X
We	B-X
describe	B-X
two	B-X
functionally	B-X
distinct	B-X
TOR	B-X
complexes	B-X
.	B-X
TOR	B-X
Complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
contains	B-X
TOR1	B-X
or	B-X
TOR2	B-X
,	B-X
KOG1	B-X
(	B-X
YHR186c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
TORC2	B-X
contains	B-X
TOR2	B-X
,	B-X
AVO1	B-X
(	B-X
YOL078w	B-X
)	B-X
,	B-X
AVO2	B-X
(	B-X
YMR068w	B-X
)	B-X
,	B-X
AVO3	B-X
(	B-X
YER093c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
FKBP-rapamycin	B-X
binds	B-X
TORC1	B-X
,	B-X
and	B-X
TORC1	B-X
disruption	B-X
mimics	B-X
rapamycin	B-X
treatment	B-X
,	B-X
suggesting	B-X
that	B-X
TORC1	B-X
mediates	B-X
the	B-X
rapamycin-sensitive	B-X
,	B-X
TOR-shared	B-X
pathway	B-X
.	B-X
FKBP-rapamycin	B-X
fails	B-X
to	B-X
bind	B-X
TORC2	B-X
,	B-X
and	B-X
TORC2	B-X
disruption	B-X
causes	B-X
an	B-X
actin	B-X
defect	B-X
,	B-X
suggesting	B-X
that	B-X
TORC2	B-X
mediates	B-X
the	B-X
rapamycin-insensitive	B-X
,	B-X
TOR2-unique	B-X
pathway	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
distinct	B-X
TOR	B-X
complexes	B-X
account	B-X
for	B-X
the	B-X
diversity	B-X
,	B-X
specificity	B-X
,	B-X
and	B-X
selective	B-X
rapamycin	B-X
inhibition	B-X
of	B-X
TOR	B-X
signaling	B-X
.	B-X
TORC1	B-X
and	B-X
possibly	B-X
TORC2	B-X
are	B-X
conserved	B-X
from	B-X
yeast	B-X
to	B-X
man	B-X
.	B-X

TORC2	O
contains	O
TOR2	B-Gene_or_gene_product
,	O
AVO1	B-Gene_or_gene_product
(	O
YOL078w	B-Gene_or_gene_product
)	O
,	O
AVO2	B-Gene_or_gene_product
(	O
YMR068w	B-Gene_or_gene_product
)	O
,	O
AVO3	B-Gene_or_gene_product
(	O
YER093c	B-Gene_or_gene_product
)	O
,	O
and	O
LST8	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
TOR	B-X
)	B-X
proteins	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
TOR1	B-X
and	B-X
TOR2	B-X
,	B-X
redundantly	B-X
regulate	B-X
growth	B-X
in	B-X
a	B-X
rapamycin-sensitive	B-X
manner	B-X
.	B-X
TOR2	B-X
additionally	B-X
regulates	B-X
polarization	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
in	B-X
a	B-X
rapamycin-insensitive	B-X
manner	B-X
.	B-X
TOR	B-X
Complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
contains	B-X
TOR1	B-X
or	B-X
TOR2	B-X
,	B-X
KOG1	B-X
(	B-X
YHR186c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
TORC2	B-X
contains	B-X
TOR2	B-X
,	B-X
AVO1	B-X
(	B-X
YOL078w	B-X
)	B-X
,	B-X
AVO2	B-X
(	B-X
YMR068w	B-X
)	B-X
,	B-X
AVO3	B-X
(	B-X
YER093c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
FKBP-rapamycin	B-X
fails	B-X
to	B-X
bind	B-X
TORC2	B-X
,	B-X
and	B-X
TORC2	B-X
disruption	B-X
causes	B-X
an	B-X
actin	B-X
defect	B-X
,	B-X
suggesting	B-X
that	B-X
TORC2	B-X
mediates	B-X
the	B-X
rapamycin-insensitive	B-X
,	B-X
TOR2-unique	B-X
pathway	B-X
.	B-X
TORC1	B-X
and	B-X
possibly	B-X
TORC2	B-X
are	B-X
conserved	B-X
from	B-X
yeast	B-X
to	B-X
man	B-X
.	B-X

FKBP	O
-	O
rapamycin	O
binds	O
TORC1	O
,	O
and	O
TORC1	O
disruption	O
mimics	O
rapamycin	O
treatment	O
,	O
suggesting	O
that	O
TORC1	O
mediates	O
the	O
rapamycin	O
-	O
sensitive	O
,	O
TOR	B-Gene_or_gene_product
-	O
shared	O
pathway	O
.	O
<EOS>	B-X
The	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
TOR	B-X
)	B-X
proteins	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
TOR1	B-X
and	B-X
TOR2	B-X
,	B-X
redundantly	B-X
regulate	B-X
growth	B-X
in	B-X
a	B-X
rapamycin-sensitive	B-X
manner	B-X
.	B-X
TOR2	B-X
additionally	B-X
regulates	B-X
polarization	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
in	B-X
a	B-X
rapamycin-insensitive	B-X
manner	B-X
.	B-X
We	B-X
describe	B-X
two	B-X
functionally	B-X
distinct	B-X
TOR	B-X
complexes	B-X
.	B-X
TOR	B-X
Complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
contains	B-X
TOR1	B-X
or	B-X
TOR2	B-X
,	B-X
KOG1	B-X
(	B-X
YHR186c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
TORC2	B-X
contains	B-X
TOR2	B-X
,	B-X
AVO1	B-X
(	B-X
YOL078w	B-X
)	B-X
,	B-X
AVO2	B-X
(	B-X
YMR068w	B-X
)	B-X
,	B-X
AVO3	B-X
(	B-X
YER093c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
FKBP-rapamycin	B-X
binds	B-X
TORC1	B-X
,	B-X
and	B-X
TORC1	B-X
disruption	B-X
mimics	B-X
rapamycin	B-X
treatment	B-X
,	B-X
suggesting	B-X
that	B-X
TORC1	B-X
mediates	B-X
the	B-X
rapamycin-sensitive	B-X
,	B-X
TOR-shared	B-X
pathway	B-X
.	B-X
FKBP-rapamycin	B-X
fails	B-X
to	B-X
bind	B-X
TORC2	B-X
,	B-X
and	B-X
TORC2	B-X
disruption	B-X
causes	B-X
an	B-X
actin	B-X
defect	B-X
,	B-X
suggesting	B-X
that	B-X
TORC2	B-X
mediates	B-X
the	B-X
rapamycin-insensitive	B-X
,	B-X
TOR2-unique	B-X
pathway	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
distinct	B-X
TOR	B-X
complexes	B-X
account	B-X
for	B-X
the	B-X
diversity	B-X
,	B-X
specificity	B-X
,	B-X
and	B-X
selective	B-X
rapamycin	B-X
inhibition	B-X
of	B-X
TOR	B-X
signaling	B-X
.	B-X
TORC1	B-X
and	B-X
possibly	B-X
TORC2	B-X
are	B-X
conserved	B-X
from	B-X
yeast	B-X
to	B-X
man	B-X
.	B-X

FKBP	O
-	O
rapamycin	O
fails	O
to	O
bind	O
TORC2	O
,	O
and	O
TORC2	O
disruption	O
causes	O
an	O
actin	B-Gene_or_gene_product
defect	O
,	O
suggesting	O
that	O
TORC2	O
mediates	O
the	O
rapamycin	O
-	O
insensitive	O
,	O
TOR2	B-Gene_or_gene_product
-	O
unique	O
pathway	O
.	O
<EOS>	B-X
The	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
TOR	B-X
)	B-X
proteins	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
TOR1	B-X
and	B-X
TOR2	B-X
,	B-X
redundantly	B-X
regulate	B-X
growth	B-X
in	B-X
a	B-X
rapamycin-sensitive	B-X
manner	B-X
.	B-X
TOR2	B-X
additionally	B-X
regulates	B-X
polarization	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
in	B-X
a	B-X
rapamycin-insensitive	B-X
manner	B-X
.	B-X
TOR	B-X
Complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
contains	B-X
TOR1	B-X
or	B-X
TOR2	B-X
,	B-X
KOG1	B-X
(	B-X
YHR186c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
TORC2	B-X
contains	B-X
TOR2	B-X
,	B-X
AVO1	B-X
(	B-X
YOL078w	B-X
)	B-X
,	B-X
AVO2	B-X
(	B-X
YMR068w	B-X
)	B-X
,	B-X
AVO3	B-X
(	B-X
YER093c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
FKBP-rapamycin	B-X
binds	B-X
TORC1	B-X
,	B-X
and	B-X
TORC1	B-X
disruption	B-X
mimics	B-X
rapamycin	B-X
treatment	B-X
,	B-X
suggesting	B-X
that	B-X
TORC1	B-X
mediates	B-X
the	B-X
rapamycin-sensitive	B-X
,	B-X
TOR-shared	B-X
pathway	B-X
.	B-X
FKBP-rapamycin	B-X
fails	B-X
to	B-X
bind	B-X
TORC2	B-X
,	B-X
and	B-X
TORC2	B-X
disruption	B-X
causes	B-X
an	B-X
actin	B-X
defect	B-X
,	B-X
suggesting	B-X
that	B-X
TORC2	B-X
mediates	B-X
the	B-X
rapamycin-insensitive	B-X
,	B-X
TOR2-unique	B-X
pathway	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
distinct	B-X
TOR	B-X
complexes	B-X
account	B-X
for	B-X
the	B-X
diversity	B-X
,	B-X
specificity	B-X
,	B-X
and	B-X
selective	B-X
rapamycin	B-X
inhibition	B-X
of	B-X
TOR	B-X
signaling	B-X
.	B-X
TORC1	B-X
and	B-X
possibly	B-X
TORC2	B-X
are	B-X
conserved	B-X
from	B-X
yeast	B-X
to	B-X
man	B-X
.	B-X

Thus	O
,	O
the	O
distinct	O
TOR	B-Gene_or_gene_product
complexes	O
account	O
for	O
the	O
diversity	O
,	O
specificity	O
,	O
and	O
selective	O
rapamycin	O
inhibition	O
of	O
TOR	B-Gene_or_gene_product
signaling	O
.	O
<EOS>	B-X
The	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
TOR	B-X
)	B-X
proteins	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
TOR1	B-X
and	B-X
TOR2	B-X
,	B-X
redundantly	B-X
regulate	B-X
growth	B-X
in	B-X
a	B-X
rapamycin-sensitive	B-X
manner	B-X
.	B-X
TOR2	B-X
additionally	B-X
regulates	B-X
polarization	B-X
of	B-X
the	B-X
actin	B-X
cytoskeleton	B-X
in	B-X
a	B-X
rapamycin-insensitive	B-X
manner	B-X
.	B-X
We	B-X
describe	B-X
two	B-X
functionally	B-X
distinct	B-X
TOR	B-X
complexes	B-X
.	B-X
TOR	B-X
Complex	B-X
1	B-X
(	B-X
TORC1	B-X
)	B-X
contains	B-X
TOR1	B-X
or	B-X
TOR2	B-X
,	B-X
KOG1	B-X
(	B-X
YHR186c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
TORC2	B-X
contains	B-X
TOR2	B-X
,	B-X
AVO1	B-X
(	B-X
YOL078w	B-X
)	B-X
,	B-X
AVO2	B-X
(	B-X
YMR068w	B-X
)	B-X
,	B-X
AVO3	B-X
(	B-X
YER093c	B-X
)	B-X
,	B-X
and	B-X
LST8	B-X
.	B-X
FKBP-rapamycin	B-X
binds	B-X
TORC1	B-X
,	B-X
and	B-X
TORC1	B-X
disruption	B-X
mimics	B-X
rapamycin	B-X
treatment	B-X
,	B-X
suggesting	B-X
that	B-X
TORC1	B-X
mediates	B-X
the	B-X
rapamycin-sensitive	B-X
,	B-X
TOR-shared	B-X
pathway	B-X
.	B-X
FKBP-rapamycin	B-X
fails	B-X
to	B-X
bind	B-X
TORC2	B-X
,	B-X
and	B-X
TORC2	B-X
disruption	B-X
causes	B-X
an	B-X
actin	B-X
defect	B-X
,	B-X
suggesting	B-X
that	B-X
TORC2	B-X
mediates	B-X
the	B-X
rapamycin-insensitive	B-X
,	B-X
TOR2-unique	B-X
pathway	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
distinct	B-X
TOR	B-X
complexes	B-X
account	B-X
for	B-X
the	B-X
diversity	B-X
,	B-X
specificity	B-X
,	B-X
and	B-X
selective	B-X
rapamycin	B-X
inhibition	B-X
of	B-X
TOR	B-X
signaling	B-X
.	B-X
TORC1	B-X
and	B-X
possibly	B-X
TORC2	B-X
are	B-X
conserved	B-X
from	B-X
yeast	B-X
to	B-X
man	B-X
.	B-X

TORC1	O
and	O
possibly	O
TORC2	O
are	O
conserved	O
from	O
yeast	O
to	O
man	O
.	O

Summary	O
and	O
comparison	O
of	O
the	O
signaling	O
mechanisms	O
of	O
the	O
Toll	B-Gene_or_gene_product
/	I-Gene_or_gene_product
interleukin	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
family	O
.	O
<EOS>	B-X
The	B-X
Toll/interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
receptor	B-X
(	B-X
TIR	B-X
)	B-X
family	B-X
comprises	B-X
two	B-X
groups	B-X
of	B-X
transmembrane	B-X
proteins	B-X
,	B-X
which	B-X
share	B-X
functional	B-X
and	B-X
structural	B-X
properties	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
TLRs	B-X
can	B-X
form	B-X
dimeric	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
two	B-X
different	B-X
TLRs	B-X
or	B-X
homodimers	B-X
in	B-X
the	B-X
case	B-X
of	B-X
TLR4	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
A	B-X
hallmark	B-X
of	B-X
the	B-X
TIR	B-X
family	B-X
is	B-X
the	B-X
cytoplasmic	B-X
TIR	B-X
domain	B-X
that	B-X
is	B-X
indispensable	B-X
for	B-X
signal	B-X
transduction	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X
Subsequently	B-X
,	B-X
several	B-X
central	B-X
signaling	B-X
pathways	B-X
are	B-X
activated	B-X
in	B-X
parallel	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
NFkappaB	B-X
being	B-X
the	B-X
most	B-X
prominent	B-X
event	B-X
of	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X
Subtle	B-X
differences	B-X
in	B-X
TLR	B-X
signaling	B-X
pathways	B-X
are	B-X
now	B-X
becoming	B-X
apparent	B-X
,	B-X
which	B-X
reveal	B-X
how	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
decides	B-X
at	B-X
a	B-X
very	B-X
early	B-X
stage	B-X
the	B-X
direction	B-X
in	B-X
which	B-X
the	B-X
adaptive	B-X
immune	B-X
response	B-X
will	B-X
develop	B-X
.	B-X

The	O
Toll	B-Gene_or_gene_product
/	I-Gene_or_gene_product
interleukin	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	I-Gene_or_gene_product
IL	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
TIR	B-Gene_or_gene_product
)	O
family	O
comprises	O
two	O
groups	O
of	O
transmembrane	O
proteins	O
,	O
which	O
share	O
functional	O
and	O
structural	O
properties	O
.	O
<EOS>	B-X
The	B-X
Toll/interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
receptor	B-X
(	B-X
TIR	B-X
)	B-X
family	B-X
comprises	B-X
two	B-X
groups	B-X
of	B-X
transmembrane	B-X
proteins	B-X
,	B-X
which	B-X
share	B-X
functional	B-X
and	B-X
structural	B-X
properties	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
TLRs	B-X
can	B-X
form	B-X
dimeric	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
two	B-X
different	B-X
TLRs	B-X
or	B-X
homodimers	B-X
in	B-X
the	B-X
case	B-X
of	B-X
TLR4	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
A	B-X
hallmark	B-X
of	B-X
the	B-X
TIR	B-X
family	B-X
is	B-X
the	B-X
cytoplasmic	B-X
TIR	B-X
domain	B-X
that	B-X
is	B-X
indispensable	B-X
for	B-X
signal	B-X
transduction	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X

The	O
members	O
of	O
the	O
IL	O
-	O
1	O
receptor	O
(	O
IL	O
-	O
1R	O
)	O
subfamily	O
are	O
characterized	O
by	O
three	O
extracellular	O
immunoglobulin	B-Gene_or_gene_product
(	O
Ig	B-Gene_or_gene_product
)	O
-	O
like	O
domains	O
.	O
<EOS>	B-X
The	B-X
Toll/interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
receptor	B-X
(	B-X
TIR	B-X
)	B-X
family	B-X
comprises	B-X
two	B-X
groups	B-X
of	B-X
transmembrane	B-X
proteins	B-X
,	B-X
which	B-X
share	B-X
functional	B-X
and	B-X
structural	B-X
properties	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
TLRs	B-X
possess	B-X
leucine-rich	B-X
repeats	B-X
in	B-X
their	B-X
extracellular	B-X
part	B-X
.	B-X
TLRs	B-X
can	B-X
form	B-X
dimeric	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
two	B-X
different	B-X
TLRs	B-X
or	B-X
homodimers	B-X
in	B-X
the	B-X
case	B-X
of	B-X
TLR4	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X

They	O
form	O
heterodimeric	O
signaling	O
receptor	O
complexes	O
consisting	O
of	O
receptor	O
and	O
accessory	O
proteins	O
.	O
<EOS>	B-X
The	B-X
Toll/interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
receptor	B-X
(	B-X
TIR	B-X
)	B-X
family	B-X
comprises	B-X
two	B-X
groups	B-X
of	B-X
transmembrane	B-X
proteins	B-X
,	B-X
which	B-X
share	B-X
functional	B-X
and	B-X
structural	B-X
properties	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
TLRs	B-X
can	B-X
form	B-X
dimeric	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
two	B-X
different	B-X
TLRs	B-X
or	B-X
homodimers	B-X
in	B-X
the	B-X
case	B-X
of	B-X
TLR4	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X
Subsequently	B-X
,	B-X
several	B-X
central	B-X
signaling	B-X
pathways	B-X
are	B-X
activated	B-X
in	B-X
parallel	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
NFkappaB	B-X
being	B-X
the	B-X
most	B-X
prominent	B-X
event	B-X
of	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X
Subtle	B-X
differences	B-X
in	B-X
TLR	B-X
signaling	B-X
pathways	B-X
are	B-X
now	B-X
becoming	B-X
apparent	B-X
,	B-X
which	B-X
reveal	B-X
how	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
decides	B-X
at	B-X
a	B-X
very	B-X
early	B-X
stage	B-X
the	B-X
direction	B-X
in	B-X
which	B-X
the	B-X
adaptive	B-X
immune	B-X
response	B-X
will	B-X
develop	B-X
.	B-X

The	O
members	O
of	O
the	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
TLR	B-Gene_or_gene_product
)	O
subfamily	O
recognize	O
alarm	O
signals	O
that	O
can	O
be	O
derived	O
either	O
from	O
pathogens	O
or	O
the	O
host	O
itself	O
.	O
<EOS>	B-X
Enteric	B-X
pathogens	B-X
such	B-X
as	B-X
Salmonella	B-X
enterica	B-X
cause	B-X
significant	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
S.	B-X
enterica	B-X
serovars	B-X
are	B-X
a	B-X
diverse	B-X
group	B-X
of	B-X
pathogens	B-X
that	B-X
have	B-X
evolved	B-X
to	B-X
survive	B-X
in	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
environments	B-X
and	B-X
across	B-X
multiple	B-X
hosts	B-X
.	B-X
S.	B-X
enterica	B-X
serovars	B-X
such	B-X
as	B-X
S.	B-X
Typhi	B-X
,	B-X
S.	B-X
Dublin	B-X
,	B-X
and	B-X
S.	B-X
Gallinarum	B-X
have	B-X
a	B-X
restricted	B-X
host	B-X
range	B-X
,	B-X
in	B-X
which	B-X
they	B-X
are	B-X
typically	B-X
associated	B-X
with	B-X
one	B-X
or	B-X
a	B-X
few	B-X
host	B-X
species	B-X
,	B-X
while	B-X
S.	B-X
Enteritidis	B-X
and	B-X
S.	B-X
Typhimurium	B-X
have	B-X
broad	B-X
host	B-X
ranges	B-X
.	B-X
This	B-X
review	B-X
examines	B-X
how	B-X
S.	B-X
enterica	B-X
has	B-X
evolved	B-X
through	B-X
adaptation	B-X
to	B-X
different	B-X
host	B-X
environments	B-X
,	B-X
especially	B-X
as	B-X
related	B-X
to	B-X
the	B-X
chicken	B-X
host	B-X
,	B-X
and	B-X
continues	B-X
to	B-X
be	B-X
an	B-X
important	B-X
human	B-X
pathogen	B-X
.	B-X
Several	B-X
factors	B-X
impact	B-X
host	B-X
range	B-X
,	B-X
and	B-X
these	B-X
include	B-X
the	B-X
acquisition	B-X
of	B-X
genes	B-X
via	B-X
horizontal	B-X
gene	B-X
transfer	B-X
with	B-X
plasmids	B-X
,	B-X
transposons	B-X
,	B-X
and	B-X
phages	B-X
,	B-X
which	B-X
can	B-X
potentially	B-X
expand	B-X
host	B-X
range	B-X
,	B-X
and	B-X
the	B-X
loss	B-X
of	B-X
genes	B-X
or	B-X
their	B-X
function	B-X
,	B-X
which	B-X
would	B-X
reduce	B-X
the	B-X
range	B-X
of	B-X
hosts	B-X
that	B-X
the	B-X
organism	B-X
can	B-X
infect	B-X
.	B-X
S.	B-X
Gallinarum	B-X
,	B-X
with	B-X
a	B-X
limited	B-X
host	B-X
range	B-X
,	B-X
has	B-X
a	B-X
large	B-X
number	B-X
of	B-X
pseudogenes	B-X
in	B-X
its	B-X
genome	B-X
compared	B-X
to	B-X
broader-host-range	B-X
serovars	B-X
.	B-X
The	B-X
ability	B-X
to	B-X
colonize	B-X
different	B-X
hosts	B-X
also	B-X
involves	B-X
interactions	B-X
with	B-X
the	B-X
host	B-X
's	B-X
immune	B-X
system	B-X
and	B-X
commensal	B-X
organisms	B-X
that	B-X
are	B-X
present	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
factors	B-X
that	B-X
impact	B-X
the	B-X
ability	B-X
of	B-X
Salmonella	B-X
to	B-X
colonize	B-X
a	B-X
particular	B-X
host	B-X
species	B-X
,	B-X
such	B-X
as	B-X
chickens	B-X
,	B-X
are	B-X
complex	B-X
and	B-X
multifactorial	B-X
,	B-X
involving	B-X
the	B-X
host	B-X
,	B-X
the	B-X
pathogen	B-X
,	B-X
and	B-X
extrinsic	B-X
pressures	B-X
.	B-X
It	B-X
is	B-X
the	B-X
interplay	B-X
of	B-X
these	B-X
factors	B-X
which	B-X
leads	B-X
to	B-X
the	B-X
differences	B-X
in	B-X
host	B-X
ranges	B-X
that	B-X
we	B-X
observe	B-X
today	B-X
.	B-X

TLRs	B-Gene_or_gene_product
possess	O
leucine	O
-	O
rich	O
repeats	O
in	O
their	O
extracellular	O
part	O
.	O
<EOS>	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
TLRs	B-X
possess	B-X
leucine-rich	B-X
repeats	B-X
in	B-X
their	B-X
extracellular	B-X
part	B-X
.	B-X
TLRs	B-X
can	B-X
form	B-X
dimeric	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
two	B-X
different	B-X
TLRs	B-X
or	B-X
homodimers	B-X
in	B-X
the	B-X
case	B-X
of	B-X
TLR4	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X

TLRs	B-Gene_or_gene_product
can	O
form	O
dimeric	O
receptor	O
complexes	O
consisting	O
of	O
two	O
different	O
TLRs	B-Gene_or_gene_product
or	O
homodimers	O
in	O
the	O
case	O
of	O
TLR4	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Toll/interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
receptor	B-X
(	B-X
TIR	B-X
)	B-X
family	B-X
comprises	B-X
two	B-X
groups	B-X
of	B-X
transmembrane	B-X
proteins	B-X
,	B-X
which	B-X
share	B-X
functional	B-X
and	B-X
structural	B-X
properties	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
TLRs	B-X
possess	B-X
leucine-rich	B-X
repeats	B-X
in	B-X
their	B-X
extracellular	B-X
part	B-X
.	B-X
TLRs	B-X
can	B-X
form	B-X
dimeric	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
two	B-X
different	B-X
TLRs	B-X
or	B-X
homodimers	B-X
in	B-X
the	B-X
case	B-X
of	B-X
TLR4	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X

The	O
TLR4	B-Gene_or_gene_product
receptor	O
complex	O
requires	O
supportive	O
molecules	O
for	O
optimal	O
response	O
to	O
its	O
ligand	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O
<EOS>	B-X
The	B-X
Toll/interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
receptor	B-X
(	B-X
TIR	B-X
)	B-X
family	B-X
comprises	B-X
two	B-X
groups	B-X
of	B-X
transmembrane	B-X
proteins	B-X
,	B-X
which	B-X
share	B-X
functional	B-X
and	B-X
structural	B-X
properties	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
TLRs	B-X
can	B-X
form	B-X
dimeric	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
two	B-X
different	B-X
TLRs	B-X
or	B-X
homodimers	B-X
in	B-X
the	B-X
case	B-X
of	B-X
TLR4	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X
Subsequently	B-X
,	B-X
several	B-X
central	B-X
signaling	B-X
pathways	B-X
are	B-X
activated	B-X
in	B-X
parallel	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
NFkappaB	B-X
being	B-X
the	B-X
most	B-X
prominent	B-X
event	B-X
of	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X
Subtle	B-X
differences	B-X
in	B-X
TLR	B-X
signaling	B-X
pathways	B-X
are	B-X
now	B-X
becoming	B-X
apparent	B-X
,	B-X
which	B-X
reveal	B-X
how	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
decides	B-X
at	B-X
a	B-X
very	B-X
early	B-X
stage	B-X
the	B-X
direction	B-X
in	B-X
which	B-X
the	B-X
adaptive	B-X
immune	B-X
response	B-X
will	B-X
develop	B-X
.	B-X
The	B-X
creation	B-X
of	B-X
pathogen-specific	B-X
mediator	B-X
environments	B-X
by	B-X
dendritic	B-X
cells	B-X
defines	B-X
whether	B-X
a	B-X
cellular	B-X
or	B-X
humoral	B-X
response	B-X
will	B-X
be	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
the	B-X
pathogen	B-X
.	B-X

A	O
hallmark	O
of	O
the	O
TIR	B-Gene_or_gene_product
family	O
is	O
the	O
cytoplasmic	O
TIR	B-Gene_or_gene_product
domain	O
that	O
is	O
indispensable	O
for	O
signal	O
transduction	O
.	O
<EOS>	B-X
The	B-X
Toll/interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
receptor	B-X
(	B-X
TIR	B-X
)	B-X
family	B-X
comprises	B-X
two	B-X
groups	B-X
of	B-X
transmembrane	B-X
proteins	B-X
,	B-X
which	B-X
share	B-X
functional	B-X
and	B-X
structural	B-X
properties	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
A	B-X
hallmark	B-X
of	B-X
the	B-X
TIR	B-X
family	B-X
is	B-X
the	B-X
cytoplasmic	B-X
TIR	B-X
domain	B-X
that	B-X
is	B-X
indispensable	B-X
for	B-X
signal	B-X
transduction	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X
Subsequently	B-X
,	B-X
several	B-X
central	B-X
signaling	B-X
pathways	B-X
are	B-X
activated	B-X
in	B-X
parallel	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
NFkappaB	B-X
being	B-X
the	B-X
most	B-X
prominent	B-X
event	B-X
of	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X
Subtle	B-X
differences	B-X
in	B-X
TLR	B-X
signaling	B-X
pathways	B-X
are	B-X
now	B-X
becoming	B-X
apparent	B-X
,	B-X
which	B-X
reveal	B-X
how	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
decides	B-X
at	B-X
a	B-X
very	B-X
early	B-X
stage	B-X
the	B-X
direction	B-X
in	B-X
which	B-X
the	B-X
adaptive	B-X
immune	B-X
response	B-X
will	B-X
develop	B-X
.	B-X

The	O
TIR	B-Gene_or_gene_product
domain	O
serves	O
as	O
a	O
scaffold	O
for	O
a	O
series	O
of	O
protein	O
-	O
protein	O
interactions	O
which	O
result	O
in	O
the	O
activation	O
of	O
a	O
unique	O
signaling	O
module	O
consisting	O
of	O
MyD88	B-Gene_or_gene_product
,	O
interleukin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
IRAK	B-Gene_or_gene_product
)	O
family	O
members	O
and	O
Tollip	B-Gene_or_gene_product
,	O
which	O
is	O
used	O
exclusively	O
by	O
TIR	B-Gene_or_gene_product
family	O
members	O
.	O
<EOS>	B-X
The	B-X
Toll/interleukin-1	B-X
(	B-X
IL-1	B-X
)	B-X
receptor	B-X
(	B-X
TIR	B-X
)	B-X
family	B-X
comprises	B-X
two	B-X
groups	B-X
of	B-X
transmembrane	B-X
proteins	B-X
,	B-X
which	B-X
share	B-X
functional	B-X
and	B-X
structural	B-X
properties	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
TLRs	B-X
can	B-X
form	B-X
dimeric	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
two	B-X
different	B-X
TLRs	B-X
or	B-X
homodimers	B-X
in	B-X
the	B-X
case	B-X
of	B-X
TLR4	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
A	B-X
hallmark	B-X
of	B-X
the	B-X
TIR	B-X
family	B-X
is	B-X
the	B-X
cytoplasmic	B-X
TIR	B-X
domain	B-X
that	B-X
is	B-X
indispensable	B-X
for	B-X
signal	B-X
transduction	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X
Subsequently	B-X
,	B-X
several	B-X
central	B-X
signaling	B-X
pathways	B-X
are	B-X
activated	B-X
in	B-X
parallel	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
NFkappaB	B-X
being	B-X
the	B-X
most	B-X
prominent	B-X
event	B-X
of	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X
Subtle	B-X
differences	B-X
in	B-X
TLR	B-X
signaling	B-X
pathways	B-X
are	B-X
now	B-X
becoming	B-X
apparent	B-X
,	B-X
which	B-X
reveal	B-X
how	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
decides	B-X
at	B-X
a	B-X
very	B-X
early	B-X
stage	B-X
the	B-X
direction	B-X
in	B-X
which	B-X
the	B-X
adaptive	B-X
immune	B-X
response	B-X
will	B-X
develop	B-X
.	B-X

Subsequently	O
,	O
several	O
central	O
signaling	O
pathways	O
are	O
activated	O
in	O
parallel	O
,	O
the	O
activation	O
of	O
NFkappaB	O
being	O
the	O
most	O
prominent	O
event	O
of	O
the	O
inflammatory	O
response	O
.	O
<EOS>	B-X
They	B-X
form	B-X
heterodimeric	B-X
signaling	B-X
receptor	B-X
complexes	B-X
consisting	B-X
of	B-X
receptor	B-X
and	B-X
accessory	B-X
proteins	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
The	B-X
TIR	B-X
domain	B-X
serves	B-X
as	B-X
a	B-X
scaffold	B-X
for	B-X
a	B-X
series	B-X
of	B-X
protein-protein	B-X
interactions	B-X
which	B-X
result	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
unique	B-X
signaling	B-X
module	B-X
consisting	B-X
of	B-X
MyD88	B-X
,	B-X
interleukin-1	B-X
receptor	B-X
associated	B-X
kinase	B-X
(	B-X
IRAK	B-X
)	B-X
family	B-X
members	B-X
and	B-X
Tollip	B-X
,	B-X
which	B-X
is	B-X
used	B-X
exclusively	B-X
by	B-X
TIR	B-X
family	B-X
members	B-X
.	B-X
Subsequently	B-X
,	B-X
several	B-X
central	B-X
signaling	B-X
pathways	B-X
are	B-X
activated	B-X
in	B-X
parallel	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
NFkappaB	B-X
being	B-X
the	B-X
most	B-X
prominent	B-X
event	B-X
of	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X
Subtle	B-X
differences	B-X
in	B-X
TLR	B-X
signaling	B-X
pathways	B-X
are	B-X
now	B-X
becoming	B-X
apparent	B-X
,	B-X
which	B-X
reveal	B-X
how	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
decides	B-X
at	B-X
a	B-X
very	B-X
early	B-X
stage	B-X
the	B-X
direction	B-X
in	B-X
which	B-X
the	B-X
adaptive	B-X
immune	B-X
response	B-X
will	B-X
develop	B-X
.	B-X
The	B-X
creation	B-X
of	B-X
pathogen-specific	B-X
mediator	B-X
environments	B-X
by	B-X
dendritic	B-X
cells	B-X
defines	B-X
whether	B-X
a	B-X
cellular	B-X
or	B-X
humoral	B-X
response	B-X
will	B-X
be	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
the	B-X
pathogen	B-X
.	B-X

Recent	O
developments	O
indicate	O
that	O
in	O
addition	O
to	O
the	O
common	O
signaling	O
module	O
MyD88	O
/	O
IRAK	O
/	O
Tollip	O
,	O
other	O
molecules	O
can	O
modulate	O
signaling	O
by	O
TLRs	B-Gene_or_gene_product
,	O
especially	O
of	O
TLR4	B-Gene_or_gene_product
,	O
resulting	O
in	O
differential	O
biological	O
answers	O
to	O
distinct	O
pathogenic	O
structures	O
.	O

Subtle	O
differences	O
in	O
TLR	B-Gene_or_gene_product
signaling	O
pathways	O
are	O
now	O
becoming	O
apparent	O
,	O
which	O
reveal	O
how	O
the	O
innate	O
immune	O
system	O
decides	O
at	O
a	O
very	O
early	O
stage	O
the	O
direction	O
in	O
which	O
the	O
adaptive	O
immune	O
response	O
will	O
develop	O
.	O

The	O
creation	O
of	O
pathogen	O
-	O
specific	O
mediator	O
environments	O
by	O
dendritic	O
cells	O
defines	O
whether	O
a	O
cellular	O
or	O
humoral	O
response	O
will	O
be	O
activated	O
in	O
response	O
to	O
the	O
pathogen	O
.	O
<EOS>	B-X
The	B-X
members	B-X
of	B-X
the	B-X
IL-1	B-X
receptor	B-X
(	B-X
IL-1R	B-X
)	B-X
subfamily	B-X
are	B-X
characterized	B-X
by	B-X
three	B-X
extracellular	B-X
immunoglobulin	B-X
(	B-X
Ig	B-X
)	B-X
-like	B-X
domains	B-X
.	B-X
The	B-X
members	B-X
of	B-X
the	B-X
Toll-like	B-X
receptor	B-X
(	B-X
TLR	B-X
)	B-X
subfamily	B-X
recognize	B-X
alarm	B-X
signals	B-X
that	B-X
can	B-X
be	B-X
derived	B-X
either	B-X
from	B-X
pathogens	B-X
or	B-X
the	B-X
host	B-X
itself	B-X
.	B-X
TLRs	B-X
possess	B-X
leucine-rich	B-X
repeats	B-X
in	B-X
their	B-X
extracellular	B-X
part	B-X
.	B-X
The	B-X
TLR4	B-X
receptor	B-X
complex	B-X
requires	B-X
supportive	B-X
molecules	B-X
for	B-X
optimal	B-X
response	B-X
to	B-X
its	B-X
ligand	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
.	B-X
Subsequently	B-X
,	B-X
several	B-X
central	B-X
signaling	B-X
pathways	B-X
are	B-X
activated	B-X
in	B-X
parallel	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
NFkappaB	B-X
being	B-X
the	B-X
most	B-X
prominent	B-X
event	B-X
of	B-X
the	B-X
inflammatory	B-X
response	B-X
.	B-X
Recent	B-X
developments	B-X
indicate	B-X
that	B-X
in	B-X
addition	B-X
to	B-X
the	B-X
common	B-X
signaling	B-X
module	B-X
MyD88/IRAK/Tollip	B-X
,	B-X
other	B-X
molecules	B-X
can	B-X
modulate	B-X
signaling	B-X
by	B-X
TLRs	B-X
,	B-X
especially	B-X
of	B-X
TLR4	B-X
,	B-X
resulting	B-X
in	B-X
differential	B-X
biological	B-X
answers	B-X
to	B-X
distinct	B-X
pathogenic	B-X
structures	B-X
.	B-X
Subtle	B-X
differences	B-X
in	B-X
TLR	B-X
signaling	B-X
pathways	B-X
are	B-X
now	B-X
becoming	B-X
apparent	B-X
,	B-X
which	B-X
reveal	B-X
how	B-X
the	B-X
innate	B-X
immune	B-X
system	B-X
decides	B-X
at	B-X
a	B-X
very	B-X
early	B-X
stage	B-X
the	B-X
direction	B-X
in	B-X
which	B-X
the	B-X
adaptive	B-X
immune	B-X
response	B-X
will	B-X
develop	B-X
.	B-X
The	B-X
creation	B-X
of	B-X
pathogen-specific	B-X
mediator	B-X
environments	B-X
by	B-X
dendritic	B-X
cells	B-X
defines	B-X
whether	B-X
a	B-X
cellular	B-X
or	B-X
humoral	B-X
response	B-X
will	B-X
be	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
the	B-X
pathogen	B-X
.	B-X

Cloning	O
and	O
expression	O
of	O
the	O
human	O
N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglutamate	I-Gene_or_gene_product
synthase	I-Gene_or_gene_product
gene	O
.	O

N	B-Gene_or_gene_product
-	I-Gene_or_gene_product
acetylglutamate	I-Gene_or_gene_product
synthase	I-Gene_or_gene_product
(	O
NAGS	B-Gene_or_gene_product
,	O
E	B-Gene_or_gene_product
.	I-Gene_or_gene_product
C	I-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	I-Gene_or_gene_product
3	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
is	O
a	O
mitochondrial	O
enzyme	O
catalyzing	O
the	O
formation	O
of	O
N	O
-	O
acetylglutamate	O
(	O
NAG	O
)	O
,	O
an	O
essential	O
allosteric	O
activator	O
of	O
carbamylphosphate	B-Gene_or_gene_product
synthase	I-Gene_or_gene_product
I	I-Gene_or_gene_product
(	O
CPSI	B-Gene_or_gene_product
)	O
,	O
the	O
first	O
enzyme	O
of	O
the	O
urea	O
cycle	O
.	O

Patients	O
with	O
NAGS	B-Gene_or_gene_product
deficiency	O
develop	O
hyperammonemia	O
because	O
CPSI	B-Gene_or_gene_product
is	O
inactive	O
without	O
NAG	O
.	O
<EOS>	B-X
N-acetylglutamate	B-X
synthase	B-X
(	B-X
NAGS	B-X
,	B-X
E.C	B-X
.	B-X
2.3.1.1	B-X
)	B-X
is	B-X
a	B-X
mitochondrial	B-X
enzyme	B-X
catalyzing	B-X
the	B-X
formation	B-X
of	B-X
N-acetylglutamate	B-X
(	B-X
NAG	B-X
)	B-X
,	B-X
an	B-X
essential	B-X
allosteric	B-X
activator	B-X
of	B-X
carbamylphosphate	B-X
synthase	B-X
I	B-X
(	B-X
CPSI	B-X
)	B-X
,	B-X
the	B-X
first	B-X
enzyme	B-X
of	B-X
the	B-X
urea	B-X
cycle	B-X
.	B-X
Patients	B-X
with	B-X
NAGS	B-X
deficiency	B-X
develop	B-X
hyperammonemia	B-X
because	B-X
CPSI	B-X
is	B-X
inactive	B-X
without	B-X
NAG	B-X
.	B-X
The	B-X
human	B-X
NAGS	B-X
cDNA	B-X
was	B-X
isolated	B-X
from	B-X
a	B-X
liver	B-X
library	B-X
based	B-X
on	B-X
its	B-X
similarity	B-X
to	B-X
mouse	B-X
NAGS	B-X
.	B-X
The	B-X
deduced	B-X
amino	B-X
acid	B-X
sequence	B-X
contains	B-X
an	B-X
N-terminal	B-X
putative	B-X
mitochondrial	B-X
targeting	B-X
signal	B-X
of	B-X
49	B-X
amino	B-X
acids	B-X
(	B-X
63	B-X
%	B-X
identity	B-X
with	B-X
mouse	B-X
NAGS	B-X
)	B-X
followed	B-X
by	B-X
a	B-X
``	B-X
variable	B-X
domain	B-X
''	B-X
of	B-X
45	B-X
amino	B-X
acids	B-X
(	B-X
35	B-X
%	B-X
identity	B-X
)	B-X
and	B-X
a	B-X
``	B-X
conserved	B-X
domain	B-X
''	B-X
of	B-X
440	B-X
amino	B-X
acids	B-X
(	B-X
92	B-X
%	B-X
identity	B-X
)	B-X
.	B-X
A	B-X
cDNA	B-X
sequence	B-X
containing	B-X
the	B-X
``	B-X
conserved	B-X
domain	B-X
''	B-X
complements	B-X
an	B-X
NAGS-deficient	B-X
Escherichia	B-X
coli	B-X
strain	B-X
and	B-X
the	B-X
recombinant	B-X
protein	B-X
has	B-X
arginine-responsive	B-X
NAGS	B-X
catalytic	B-X
activity	B-X
.	B-X
The	B-X
NAGS	B-X
gene	B-X
is	B-X
expressed	B-X
in	B-X
the	B-X
liver	B-X
and	B-X
small	B-X
intestine	B-X
;	B-X
the	B-X
intestinal	B-X
transcript	B-X
is	B-X
smaller	B-X
in	B-X
size	B-X
than	B-X
liver	B-X
transcript	B-X
.	B-X

The	O
human	O
NAGS	B-Gene_or_gene_product
cDNA	O
was	O
isolated	O
from	O
a	O
liver	O
library	O
based	O
on	O
its	O
similarity	O
to	O
mouse	O
NAGS	B-Gene_or_gene_product
.	O
<EOS>	B-X
N-acetylglutamate	B-X
synthase	B-X
(	B-X
NAGS	B-X
,	B-X
E.C	B-X
.	B-X
Patients	B-X
with	B-X
NAGS	B-X
deficiency	B-X
develop	B-X
hyperammonemia	B-X
because	B-X
CPSI	B-X
is	B-X
inactive	B-X
without	B-X
NAG	B-X
.	B-X
The	B-X
human	B-X
NAGS	B-X
cDNA	B-X
was	B-X
isolated	B-X
from	B-X
a	B-X
liver	B-X
library	B-X
based	B-X
on	B-X
its	B-X
similarity	B-X
to	B-X
mouse	B-X
NAGS	B-X
.	B-X
The	B-X
deduced	B-X
amino	B-X
acid	B-X
sequence	B-X
contains	B-X
an	B-X
N-terminal	B-X
putative	B-X
mitochondrial	B-X
targeting	B-X
signal	B-X
of	B-X
49	B-X
amino	B-X
acids	B-X
(	B-X
63	B-X
%	B-X
identity	B-X
with	B-X
mouse	B-X
NAGS	B-X
)	B-X
followed	B-X
by	B-X
a	B-X
``	B-X
variable	B-X
domain	B-X
''	B-X
of	B-X
45	B-X
amino	B-X
acids	B-X
(	B-X
35	B-X
%	B-X
identity	B-X
)	B-X
and	B-X
a	B-X
``	B-X
conserved	B-X
domain	B-X
''	B-X
of	B-X
440	B-X
amino	B-X
acids	B-X
(	B-X
92	B-X
%	B-X
identity	B-X
)	B-X
.	B-X
A	B-X
cDNA	B-X
sequence	B-X
containing	B-X
the	B-X
``	B-X
conserved	B-X
domain	B-X
''	B-X
complements	B-X
an	B-X
NAGS-deficient	B-X
Escherichia	B-X
coli	B-X
strain	B-X
and	B-X
the	B-X
recombinant	B-X
protein	B-X
has	B-X
arginine-responsive	B-X
NAGS	B-X
catalytic	B-X
activity	B-X
.	B-X
The	B-X
NAGS	B-X
gene	B-X
is	B-X
expressed	B-X
in	B-X
the	B-X
liver	B-X
and	B-X
small	B-X
intestine	B-X
;	B-X
the	B-X
intestinal	B-X
transcript	B-X
is	B-X
smaller	B-X
in	B-X
size	B-X
than	B-X
liver	B-X
transcript	B-X
.	B-X

The	O
deduced	O
amino	O
acid	O
sequence	O
contains	O
an	O
N	O
-	O
terminal	O
putative	O
mitochondrial	O
targeting	O
signal	O
of	O
49	O
amino	O
acids	O
(	O
63	O
%	O
identity	O
with	O
mouse	O
NAGS	B-Gene_or_gene_product
)	O
followed	O
by	O
a	O
"	O
variable	O
domain	O
"	O
of	O
45	O
amino	O
acids	O
(	O
35	O
%	O
identity	O
)	O
and	O
a	O
"	O
conserved	O
domain	O
"	O
of	O
440	O
amino	O
acids	O
(	O
92	O
%	O
identity	O
)	O
.	O

A	O
cDNA	O
sequence	O
containing	O
the	O
"	O
conserved	O
domain	O
"	O
complements	O
an	O
NAGS	B-Gene_or_gene_product
-	O
deficient	O
Escherichia	O
coli	O
strain	O
and	O
the	O
recombinant	O
protein	O
has	O
arginine	O
-	O
responsive	O
NAGS	B-Gene_or_gene_product
catalytic	O
activity	O
.	O
<EOS>	B-X
N-acetylglutamate	B-X
synthase	B-X
(	B-X
NAGS	B-X
,	B-X
E.C	B-X
.	B-X
Patients	B-X
with	B-X
NAGS	B-X
deficiency	B-X
develop	B-X
hyperammonemia	B-X
because	B-X
CPSI	B-X
is	B-X
inactive	B-X
without	B-X
NAG	B-X
.	B-X
The	B-X
human	B-X
NAGS	B-X
cDNA	B-X
was	B-X
isolated	B-X
from	B-X
a	B-X
liver	B-X
library	B-X
based	B-X
on	B-X
its	B-X
similarity	B-X
to	B-X
mouse	B-X
NAGS	B-X
.	B-X
The	B-X
deduced	B-X
amino	B-X
acid	B-X
sequence	B-X
contains	B-X
an	B-X
N-terminal	B-X
putative	B-X
mitochondrial	B-X
targeting	B-X
signal	B-X
of	B-X
49	B-X
amino	B-X
acids	B-X
(	B-X
63	B-X
%	B-X
identity	B-X
with	B-X
mouse	B-X
NAGS	B-X
)	B-X
followed	B-X
by	B-X
a	B-X
``	B-X
variable	B-X
domain	B-X
''	B-X
of	B-X
45	B-X
amino	B-X
acids	B-X
(	B-X
35	B-X
%	B-X
identity	B-X
)	B-X
and	B-X
a	B-X
``	B-X
conserved	B-X
domain	B-X
''	B-X
of	B-X
440	B-X
amino	B-X
acids	B-X
(	B-X
92	B-X
%	B-X
identity	B-X
)	B-X
.	B-X
A	B-X
cDNA	B-X
sequence	B-X
containing	B-X
the	B-X
``	B-X
conserved	B-X
domain	B-X
''	B-X
complements	B-X
an	B-X
NAGS-deficient	B-X
Escherichia	B-X
coli	B-X
strain	B-X
and	B-X
the	B-X
recombinant	B-X
protein	B-X
has	B-X
arginine-responsive	B-X
NAGS	B-X
catalytic	B-X
activity	B-X
.	B-X
The	B-X
NAGS	B-X
gene	B-X
is	B-X
expressed	B-X
in	B-X
the	B-X
liver	B-X
and	B-X
small	B-X
intestine	B-X
;	B-X
the	B-X
intestinal	B-X
transcript	B-X
is	B-X
smaller	B-X
in	B-X
size	B-X
than	B-X
liver	B-X
transcript	B-X
.	B-X

The	O
NAGS	B-Gene_or_gene_product
gene	O
is	O
expressed	O
in	O
the	O
liver	O
and	O
small	O
intestine	O
;	O
the	O
intestinal	O
transcript	O
is	O
smaller	O
in	O
size	O
than	O
liver	O
transcript	O
.	O
<EOS>	B-X
NAG	B-X
synthase	B-X
(	B-X
NAGS	B-X
;	B-X
EC	B-X
2.3.1.1	B-X
)	B-X
catalyses	B-X
the	B-X
formation	B-X
of	B-X
NAG	B-X
from	B-X
glutamate	B-X
and	B-X
acetyl-CoA	B-X
in	B-X
liver	B-X
and	B-X
intestinal	B-X
mitochondria	B-X
.	B-X
This	B-X
enzyme	B-X
is	B-X
supposed	B-X
to	B-X
regulate	B-X
ureagenesis	B-X
by	B-X
producing	B-X
variable	B-X
amounts	B-X
of	B-X
NAG	B-X
,	B-X
thus	B-X
modulating	B-X
CPSI	B-X
activity	B-X
.	B-X
Moreover	B-X
,	B-X
inherited	B-X
deficiencies	B-X
in	B-X
NAGS	B-X
have	B-X
been	B-X
associated	B-X
with	B-X
hyperammonaemia	B-X
,	B-X
probably	B-X
due	B-X
to	B-X
the	B-X
loss	B-X
of	B-X
CPSI	B-X
activity	B-X
.	B-X
Although	B-X
the	B-X
existence	B-X
of	B-X
the	B-X
NAGS	B-X
protein	B-X
in	B-X
mammals	B-X
has	B-X
been	B-X
known	B-X
for	B-X
decades	B-X
,	B-X
the	B-X
gene	B-X
has	B-X
remained	B-X
elusive	B-X
.	B-X
We	B-X
identified	B-X
the	B-X
mouse	B-X
(	B-X
Mus	B-X
musculus	B-X
)	B-X
and	B-X
human	B-X
NAGS	B-X
genes	B-X
using	B-X
their	B-X
similarity	B-X
to	B-X
the	B-X
respective	B-X
Neurospora	B-X
crassa	B-X
gene	B-X
.	B-X
NAGS	B-X
was	B-X
cloned	B-X
from	B-X
a	B-X
mouse	B-X
liver	B-X
cDNA	B-X
library	B-X
and	B-X
was	B-X
found	B-X
to	B-X
encode	B-X
a	B-X
2.3	B-X
kb	B-X
message	B-X
,	B-X
highly	B-X
expressed	B-X
in	B-X
liver	B-X
and	B-X
small	B-X
intestine	B-X
with	B-X
lower	B-X
expression	B-X
levels	B-X
in	B-X
kidney	B-X
,	B-X
spleen	B-X
and	B-X
testis	B-X
.	B-X
The	B-X
cDNA	B-X
sequence	B-X
complements	B-X
an	B-X
argA	B-X
(	B-X
NAGS	B-X
)	B-X
-deficient	B-X
Escherichia	B-X
coli	B-X
strain	B-X
,	B-X
reversing	B-X
its	B-X
arginine	B-X
auxotrophy	B-X
.	B-X
His-tagged	B-X
versions	B-X
of	B-X
the	B-X
pre-protein	B-X
and	B-X
two	B-X
putative	B-X
mature	B-X
proteins	B-X
were	B-X
each	B-X
overexpressed	B-X
in	B-X
E.	B-X
coli	B-X
,	B-X
and	B-X
purified	B-X
to	B-X
apparent	B-X
homogeneity	B-X
by	B-X
using	B-X
a	B-X
nickel-affinity	B-X
column	B-X
.	B-X
The	B-X
pre-protein	B-X
and	B-X
the	B-X
two	B-X
putative	B-X
mature	B-X
proteins	B-X
catalysed	B-X
the	B-X
NAGS	B-X
reaction	B-X
but	B-X
one	B-X
of	B-X
the	B-X
putative	B-X
mature	B-X
enzymes	B-X
had	B-X
significantly	B-X
higher	B-X
activity	B-X
than	B-X
the	B-X
pre-protein	B-X
.	B-X
The	B-X
addition	B-X
of	B-X
l-arginine	B-X
increased	B-X
the	B-X
catalytic	B-X
activity	B-X
of	B-X
the	B-X
purified	B-X
recombinant	B-X
NAGS	B-X
enzymes	B-X
by	B-X
approx	B-X
.	B-X

Osmium	O
(	O
VI	O
)	O
complexes	O
of	O
the	O
3	O
'	O
,	O
5	O
'	O
-	O
dinucleoside	O
monophosphates	O
,	O
ApU	O
and	O
UpA	O
.	O
<EOS>	B-X
The	B-X
dinucleoside	B-X
monophosphates	B-X
,	B-X
ApU	B-X
and	B-X
UpA	B-X
,	B-X
react	B-X
with	B-X
potassium	B-X
osmate	B-X
(	B-X
VI	B-X
)	B-X
and	B-X
2,2'-bipyridyl	B-X
to	B-X
form	B-X
the	B-X
corresponding	B-X
oxo-osmium	B-X
(	B-X
VI	B-X
)	B-X
bipyridyl	B-X
sugar	B-X
ester	B-X
in	B-X
which	B-X
the	B-X
osmate	B-X
group	B-X
is	B-X
bonded	B-X
to	B-X
the	B-X
terminal	B-X
2',3'-glycol	B-X
.	B-X
Osmium	B-X
(	B-X
VIII	B-X
)	B-X
tetroxide	B-X
and	B-X
2,2'-bipyridyl	B-X
react	B-X
with	B-X
the	B-X
dinucleosides	B-X
to	B-X
form	B-X
the	B-X
corresponding	B-X
oxo-osmium	B-X
(	B-X
VI	B-X
)	B-X
bipyridyl	B-X
heterocyclic	B-X
esters	B-X
which	B-X
result	B-X
from	B-X
addition	B-X
of	B-X
the	B-X
tetroxide	B-X
to	B-X
the	B-X
5,6-double	B-X
bond	B-X
of	B-X
the	B-X
uracil	B-X
residue	B-X
.	B-X

The	O
dinucleoside	O
monophosphates	O
,	O
ApU	O
and	O
UpA	O
,	O
react	O
with	O
potassium	O
osmate	O
(	O
VI	O
)	O
and	O
2	O
,	O
2	O
'	O
-	O
bipyridyl	O
to	O
form	O
the	O
corresponding	O
oxo	O
-	O
osmium	O
(	O
VI	O
)	O
bipyridyl	O
sugar	O
ester	O
in	O
which	O
the	O
osmate	O
group	O
is	O
bonded	O
to	O
the	O
terminal	O
2	O
'	O
,	O
3	O
'	O
-	O
glycol	O
.	O

Osmium	O
(	O
VIII	O
)	O
tetroxide	O
and	O
2	O
,	O
2	O
'	O
-	O
bipyridyl	O
react	O
with	O
the	O
dinucleosides	O
to	O
form	O
the	O
corresponding	O
oxo	O
-	O
osmium	O
(	O
VI	O
)	O
bipyridyl	O
heterocyclic	O
esters	O
which	O
result	O
from	O
addition	O
of	O
the	O
tetroxide	O
to	O
the	O
5	O
,	O
6	O
-	O
double	O
bond	O
of	O
the	O
uracil	O
residue	O
.	O

Although	O
capable	O
of	O
transesterification	O
reactions	O
,	O
these	O
heterocyclic	O
esters	O
are	O
exceptionally	O
stable	O
toward	O
exchange	O
reactions	O
in	O
solution	O
.	O
<EOS>	B-X
Osmium	B-X
(	B-X
VIII	B-X
)	B-X
tetroxide	B-X
and	B-X
2,2'-bipyridyl	B-X
react	B-X
with	B-X
the	B-X
dinucleosides	B-X
to	B-X
form	B-X
the	B-X
corresponding	B-X
oxo-osmium	B-X
(	B-X
VI	B-X
)	B-X
bipyridyl	B-X
heterocyclic	B-X
esters	B-X
which	B-X
result	B-X
from	B-X
addition	B-X
of	B-X
the	B-X
tetroxide	B-X
to	B-X
the	B-X
5,6-double	B-X
bond	B-X
of	B-X
the	B-X
uracil	B-X
residue	B-X
.	B-X
Although	B-X
capable	B-X
of	B-X
transesterification	B-X
reactions	B-X
,	B-X
these	B-X
heterocyclic	B-X
esters	B-X
are	B-X
exceptionally	B-X
stable	B-X
toward	B-X
exchange	B-X
reactions	B-X
in	B-X
solution	B-X
.	B-X
No	B-X
apparent	B-X
exchange	B-X
was	B-X
observed	B-X
after	B-X
1	B-X
month	B-X
.	B-X

No	O
apparent	O
exchange	O
was	O
observed	O
after	O
1	O
month	O
.	O
<EOS>	B-X
The	B-X
programmed	B-X
death-ligand	B-X
1	B-X
checkpoint	B-X
inhibitor	B-X
,	B-X
atezolizumab	B-X
is	B-X
a	B-X
monoclonal	B-X
antibody	B-X
that	B-X
is	B-X
indicated	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
several	B-X
cancers	B-X
.	B-X
The	B-X
objective	B-X
of	B-X
the	B-X
studies	B-X
reported	B-X
in	B-X
this	B-X
paper	B-X
was	B-X
to	B-X
evaluate	B-X
the	B-X
stability	B-X
of	B-X
atezolizumab	B-X
diluted	B-X
to	B-X
2.4	B-X
mg/mL	B-X
and	B-X
9.6	B-X
mg/mL	B-X
(	B-X
Study	B-X
1	B-X
)	B-X
,	B-X
and	B-X
16.8	B-X
mg/mL	B-X
(	B-X
Study	B-X
2	B-X
)	B-X
in	B-X
intravenous	B-X
bags	B-X
containing	B-X
normal	B-X
saline	B-X
and	B-X
stored	B-X
for	B-X
up	B-X
to	B-X
12	B-X
months	B-X
.	B-X
Atezolizumab	B-X
was	B-X
withdrawn	B-X
from	B-X
commercial	B-X
vials	B-X
(	B-X
1,200	B-X
mg/20	B-X
mL	B-X
or	B-X
840	B-X
mg/14	B-X
mL	B-X
)	B-X
under	B-X
aseptic	B-X
conditions	B-X
and	B-X
added	B-X
to	B-X
infusion	B-X
bags	B-X
containing	B-X
normal	B-X
saline	B-X
with	B-X
target	B-X
concentrations	B-X
of	B-X
2.4	B-X
mg/mL	B-X
,	B-X
9.6	B-X
mg/mL	B-X
,	B-X
and	B-X
16.8	B-X
mg/mL	B-X
.	B-X
Bags	B-X
were	B-X
stored	B-X
at	B-X
30C	B-X
for	B-X
24	B-X
hours	B-X
with	B-X
exposure	B-X
to	B-X
ambient	B-X
light	B-X
,	B-X
then	B-X
at	B-X
2C	B-X
to	B-X
8C	B-X
for	B-X
up	B-X
to	B-X
12	B-X
months	B-X
protected	B-X
from	B-X
light	B-X
.	B-X
10-mL	B-X
samples	B-X
were	B-X
withdrawn	B-X
at	B-X
selected	B-X
time	B-X
points	B-X
and	B-X
evaluated	B-X
by	B-X
analytical	B-X
assays	B-X
for	B-X
color	B-X
,	B-X
opalescence	B-X
,	B-X
and	B-X
clarity	B-X
;	B-X
visible	B-X
and	B-X
subvisible	B-X
particulates	B-X
;	B-X
pH	B-X
;	B-X
protein	B-X
concentration	B-X
by	B-X
ultraviolet	B-X
spectrophotometric	B-X
analysis	B-X
;	B-X
size-exclusion	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
;	B-X
ion-exchange	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
;	B-X
non-reduced	B-X
capillary	B-X
electrophoresis-sodium	B-X
dodecyl	B-X
sulfate	B-X
;	B-X
and	B-X
potency	B-X
assays	B-X
.	B-X
No	B-X
substantial	B-X
changes	B-X
in	B-X
atezolizumab	B-X
product	B-X
quality	B-X
were	B-X
apparent	B-X
by	B-X
any	B-X
measure	B-X
related	B-X
to	B-X
any	B-X
analytical	B-X
assay	B-X
in	B-X
either	B-X
study	B-X
after	B-X
3	B-X
months	B-X
of	B-X
storage	B-X
at	B-X
2C	B-X
to	B-X
8C	B-X
.	B-X
No	B-X
new	B-X
peaks	B-X
were	B-X
observed	B-X
on	B-X
size-exclusion	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
,	B-X
ion-exchange	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
,	B-X
or	B-X
non-reduced	B-X
capillary	B-X
Funding	B-X
Acknowledgment	B-X
This	B-X
study	B-X
was	B-X
funded	B-X
by	B-X
Genentech	B-X
,	B-X
Inc.	B-X
,	B-X
South	B-X
San	B-X
Francisco	B-X
,	B-X
California	B-X
.	B-X
electrophoresis-sodium	B-X
dodecyl	B-X
sulfate	B-X
profiles	B-X
of	B-X
diluted	B-X
atezolizumab	B-X
after	B-X
the	B-X
extended	B-X
storage	B-X
of	B-X
12	B-X
months	B-X
at	B-X
2C	B-X
to	B-X
8C	B-X
.	B-X
In	B-X
Study	B-X
1	B-X
,	B-X
a	B-X
decreasing	B-X
trend	B-X
in	B-X
ion-exchange	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
main	B-X
peak	B-X
area	B-X
was	B-X
detected	B-X
in	B-X
samples	B-X
from	B-X
polyvinylchloride	B-X
bags	B-X
containing	B-X
2.4	B-X
mg/mL	B-X
atezolizumab	B-X
;	B-X
and	B-X
substantial	B-X
changes	B-X
were	B-X
observed	B-X
at	B-X
12	B-X
months	B-X
in	B-X
samples	B-X
from	B-X
polyvinylchloride	B-X
bags	B-X
containing	B-X
2.4	B-X
mg/mL	B-X
and	B-X
9.6	B-X
mg/mL	B-X
atezolizumab	B-X
.	B-X
In	B-X
Study	B-X
2	B-X
,	B-X
decreasing	B-X
trends	B-X
in	B-X
main	B-X
peak	B-X
areas	B-X
were	B-X
detected	B-X
by	B-X
size-exclusion	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
analyses	B-X
,	B-X
ion-exchange	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
analyses	B-X
,	B-X
and	B-X
nonreduced	B-X
capillary	B-X
electrophoresis-sodium	B-X
dodecyl	B-X
sulfate	B-X
analyses	B-X
of	B-X
samples	B-X
stored	B-X
in	B-X
polyvinylchloride	B-X
bags	B-X
,	B-X
where	B-X
substantial	B-X
changes	B-X
were	B-X
observed	B-X
in	B-X
size	B-X
exclusion	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
main	B-X
peak	B-X
area	B-X
at	B-X
12	B-X
months	B-X
and	B-X
in	B-X
ion-exchange	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
main	B-X
peak	B-X
areas	B-X
at	B-X
the	B-X
6-month	B-X
and	B-X
subsequent	B-X
time	B-X
points	B-X
.	B-X
Decreasing	B-X
trends	B-X
in	B-X
main	B-X
peak	B-X
areas	B-X
were	B-X
detected	B-X
by	B-X
ion-exchange	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
analyses	B-X
and	B-X
non-reduced	B-X
capillary	B-X
electrophoresis-sodium	B-X
dodecyl	B-X
sulfate	B-X
analyses	B-X
of	B-X
samples	B-X
taken	B-X
from	B-X
polyolefin	B-X
bags	B-X
,	B-X
where	B-X
substantial	B-X
changes	B-X
were	B-X
observed	B-X
in	B-X
ion-exchange	B-X
high-performance	B-X
liquid	B-X
chromatography	B-X
main	B-X
peak	B-X
areas	B-X
at	B-X
6	B-X
and	B-X
12	B-X
months	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
atezolizumab	B-X
diluted	B-X
to	B-X
2.4	B-X
mg/mL	B-X
to	B-X
16.8	B-X
mg/mL	B-X
in	B-X
0.9	B-X
%	B-X
sodium	B-X
chloride	B-X
remains	B-X
physicochemically	B-X
stable	B-X
when	B-X
stored	B-X
for	B-X
24	B-X
hours	B-X
at	B-X
30C	B-X
,	B-X
followed	B-X
by	B-X
3	B-X
months	B-X
at	B-X
2C	B-X
to	B-X
8C	B-X
in	B-X
polyvinylchloride	B-X
and	B-X
polyolefin	B-X
infusion	B-X
bags	B-X
.	B-X

This	O
reaction	O
thus	O
seems	O
promising	O
for	O
single	O
-	O
site	O
osmium	O
labeling	O
in	O
polynucleotides	O
.	O
<EOS>	B-X
The	B-X
dinucleoside	B-X
monophosphates	B-X
,	B-X
ApU	B-X
and	B-X
UpA	B-X
,	B-X
react	B-X
with	B-X
potassium	B-X
osmate	B-X
(	B-X
VI	B-X
)	B-X
and	B-X
2,2'-bipyridyl	B-X
to	B-X
form	B-X
the	B-X
corresponding	B-X
oxo-osmium	B-X
(	B-X
VI	B-X
)	B-X
bipyridyl	B-X
sugar	B-X
ester	B-X
in	B-X
which	B-X
the	B-X
osmate	B-X
group	B-X
is	B-X
bonded	B-X
to	B-X
the	B-X
terminal	B-X
2',3'-glycol	B-X
.	B-X
Osmium	B-X
(	B-X
VIII	B-X
)	B-X
tetroxide	B-X
and	B-X
2,2'-bipyridyl	B-X
react	B-X
with	B-X
the	B-X
dinucleosides	B-X
to	B-X
form	B-X
the	B-X
corresponding	B-X
oxo-osmium	B-X
(	B-X
VI	B-X
)	B-X
bipyridyl	B-X
heterocyclic	B-X
esters	B-X
which	B-X
result	B-X
from	B-X
addition	B-X
of	B-X
the	B-X
tetroxide	B-X
to	B-X
the	B-X
5,6-double	B-X
bond	B-X
of	B-X
the	B-X
uracil	B-X
residue	B-X
.	B-X
Although	B-X
capable	B-X
of	B-X
transesterification	B-X
reactions	B-X
,	B-X
these	B-X
heterocyclic	B-X
esters	B-X
are	B-X
exceptionally	B-X
stable	B-X
toward	B-X
exchange	B-X
reactions	B-X
in	B-X
solution	B-X
.	B-X
This	B-X
reaction	B-X
thus	B-X
seems	B-X
promising	B-X
for	B-X
single-site	B-X
osmium	B-X
labeling	B-X
in	B-X
polynucleotides	B-X
.	B-X

Transcriptional	O
activation	O
of	O
the	O
NF	O
-	O
kappaB	O
p65	B-Gene_or_gene_product
subunit	I-Gene_or_gene_product
by	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
and	I-Gene_or_gene_product
stress	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
MSK1	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
key	B-X
regulators	B-X
of	B-X
transcription	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
NF-kappaB	B-X
activity	B-X
has	B-X
long	B-X
been	B-X
thought	B-X
to	B-X
be	B-X
regulated	B-X
mainly	B-X
by	B-X
IkappaB	B-X
family	B-X
members	B-X
,	B-X
which	B-X
keep	B-X
the	B-X
transcription	B-X
factor	B-X
complex	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
in	B-X
the	B-X
cytoplasm	B-X
by	B-X
masking	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
.	B-X
Nowadays	B-X
,	B-X
the	B-X
importance	B-X
of	B-X
additional	B-X
mechanisms	B-X
controlling	B-X
the	B-X
nuclear	B-X
transcription	B-X
potential	B-X
of	B-X
NF-kappaB	B-X
is	B-X
generally	B-X
accepted	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
inhibitors	B-X
SB203580	B-X
and	B-X
PD98059	B-X
or	B-X
U0126	B-X
,	B-X
as	B-X
well	B-X
as	B-X
a	B-X
potent	B-X
mitogen-	B-X
and	B-X
stress-	B-X
activated	B-X
protein	B-X
kinase-1	B-X
(	B-X
MSK1	B-X
)	B-X
inhibitor	B-X
H89	B-X
,	B-X
counteract	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-mediated	B-X
stimulation	B-X
of	B-X
p65	B-X
transactivation	B-X
capacity	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
p65	B-X
revealed	B-X
Ser276	B-X
as	B-X
a	B-X
target	B-X
for	B-X
phosphorylation	B-X
and	B-X
transactivation	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
Moreover	B-X
,	B-X
we	B-X
identified	B-X
MSK1	B-X
as	B-X
a	B-X
nuclear	B-X
kinase	B-X
for	B-X
p65	B-X
,	B-X
since	B-X
MSK1	B-X
associates	B-X
with	B-X
p65	B-X
in	B-X
a	B-X
stimulus-dependent	B-X
way	B-X
and	B-X
phosphorylates	B-X
p65	B-X
at	B-X
Ser276	B-X
.	B-X
This	B-X
effect	B-X
represents	B-X
,	B-X
together	B-X
with	B-X
phosphorylation	B-X
of	B-X
nucleosome	B-X
components	B-X
such	B-X
as	B-X
histone	B-X
H3	B-X
,	B-X
an	B-X
essential	B-X
step	B-X
leading	B-X
to	B-X
selective	B-X
transcriptional	B-X
activation	B-X
of	B-X
NF-kappaB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

Nuclear	O
factor	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
is	O
one	O
of	O
the	O
key	O
regulators	O
of	O
transcription	O
of	O
a	O
variety	O
of	O
genes	O
involved	O
in	O
immune	O
and	O
inflammatory	O
responses	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
key	B-X
regulators	B-X
of	B-X
transcription	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
Therefore	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
effect	B-X
of	B-X
statins	B-X
on	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
signaling	B-X
in	B-X
human	B-X
endothelial	B-X
cells	B-X
(	B-X
EC	B-X
)	B-X
.	B-X
ECs	B-X
were	B-X
pre-incubated	B-X
for	B-X
16	B-X
h	B-X
with	B-X
cerivastatin	B-X
(	B-X
10	B-X
(	B-X
-9	B-X
)	B-X
to	B-X
10	B-X
(	B-X
-7	B-X
)	B-X
M	B-X
)	B-X
or	B-X
vehicle	B-X
in	B-X
the	B-X
presence	B-X
or	B-X
absence	B-X
of	B-X
mevalonate	B-X
,	B-X
followed	B-X
by	B-X
stimulation	B-X
with	B-X
20	B-X
ng/ml	B-X
TNF-alpha	B-X
.	B-X
Statin-treatment	B-X
prevented	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
binding	B-X
activity	B-X
,	B-X
nuclear	B-X
translocation	B-X
of	B-X
the	B-X
NF-kappaB	B-X
p65	B-X
subunit	B-X
,	B-X
as	B-X
well	B-X
as	B-X
NF-kappaB	B-X
controlled	B-X
tissue	B-X
factor	B-X
(	B-X
TF	B-X
)	B-X
gene	B-X
transcription	B-X
in	B-X
cultured	B-X
EC	B-X
.	B-X
IkappaBalpha	B-X
phosphorylation	B-X
and	B-X
IkappaBalpha	B-X
degradation	B-X
,	B-X
however	B-X
,	B-X
still	B-X
occurred	B-X
in	B-X
statin-treated	B-X
cells	B-X
.	B-X
TNF-alpha	B-X
also	B-X
activated	B-X
phosphatidylinositol	B-X
(	B-X
PI	B-X
)	B-X
3-kinase	B-X
,	B-X
as	B-X
reflected	B-X
by	B-X
phosphorylation	B-X
of	B-X
Akt	B-X
.	B-X
Statin	B-X
treatment	B-X
of	B-X
cells	B-X
abrogated	B-X
TNF-alpha-induced	B-X
Akt	B-X
phosphorylation	B-X
and	B-X
p65	B-X
nuclear	B-X
translocation	B-X
.	B-X
As	B-X
observed	B-X
with	B-X
statins	B-X
,	B-X
inhibition	B-X
of	B-X
PI3-kinase	B-X
activity	B-X
by	B-X
Ly294002	B-X
also	B-X
blocked	B-X
TNF-alpha-induced	B-X
p65	B-X
translocation	B-X
,	B-X
but	B-X
did	B-X
not	B-X
prevent	B-X
IkappaBalpha	B-X
phosphorylation	B-X
nor	B-X
IkappaBalpha	B-X
degradation	B-X
.	B-X
These	B-X
studies	B-X
demonstrate	B-X
that	B-X
TNF-alpha-induced	B-X
NF-kappaB	B-X
activation	B-X
is	B-X
abrogated	B-X
by	B-X
statin	B-X
treatment	B-X
in	B-X
HUVEC	B-X
independently	B-X
of	B-X
the	B-X
classical	B-X
IKK-pathway	B-X
but	B-X
via	B-X
inhibition	B-X
of	B-X
PI3-kinase/Akt	B-X
signaling	B-X
.	B-X

NF	O
-	O
kappaB	O
activity	O
has	O
long	O
been	O
thought	O
to	O
be	O
regulated	O
mainly	O
by	O
IkappaB	B-Gene_or_gene_product
family	O
members	O
,	O
which	O
keep	O
the	O
transcription	O
factor	O
complex	O
in	O
an	O
inactive	O
form	O
in	O
the	O
cytoplasm	O
by	O
masking	O
the	O
nuclear	O
localization	O
signal	O
.	O

Nowadays	O
,	O
the	O
importance	O
of	O
additional	O
mechanisms	O
controlling	O
the	O
nuclear	O
transcription	O
potential	O
of	O
NF	O
-	O
kappaB	O
is	O
generally	O
accepted	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
key	B-X
regulators	B-X
of	B-X
transcription	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
NF-kappaB	B-X
activity	B-X
has	B-X
long	B-X
been	B-X
thought	B-X
to	B-X
be	B-X
regulated	B-X
mainly	B-X
by	B-X
IkappaB	B-X
family	B-X
members	B-X
,	B-X
which	B-X
keep	B-X
the	B-X
transcription	B-X
factor	B-X
complex	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
in	B-X
the	B-X
cytoplasm	B-X
by	B-X
masking	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
.	B-X
Nowadays	B-X
,	B-X
the	B-X
importance	B-X
of	B-X
additional	B-X
mechanisms	B-X
controlling	B-X
the	B-X
nuclear	B-X
transcription	B-X
potential	B-X
of	B-X
NF-kappaB	B-X
is	B-X
generally	B-X
accepted	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
inhibitors	B-X
SB203580	B-X
and	B-X
PD98059	B-X
or	B-X
U0126	B-X
,	B-X
as	B-X
well	B-X
as	B-X
a	B-X
potent	B-X
mitogen-	B-X
and	B-X
stress-	B-X
activated	B-X
protein	B-X
kinase-1	B-X
(	B-X
MSK1	B-X
)	B-X
inhibitor	B-X
H89	B-X
,	B-X
counteract	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-mediated	B-X
stimulation	B-X
of	B-X
p65	B-X
transactivation	B-X
capacity	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
p65	B-X
revealed	B-X
Ser276	B-X
as	B-X
a	B-X
target	B-X
for	B-X
phosphorylation	B-X
and	B-X
transactivation	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
Moreover	B-X
,	B-X
we	B-X
identified	B-X
MSK1	B-X
as	B-X
a	B-X
nuclear	B-X
kinase	B-X
for	B-X
p65	B-X
,	B-X
since	B-X
MSK1	B-X
associates	B-X
with	B-X
p65	B-X
in	B-X
a	B-X
stimulus-dependent	B-X
way	B-X
and	B-X
phosphorylates	B-X
p65	B-X
at	B-X
Ser276	B-X
.	B-X
This	B-X
effect	B-X
represents	B-X
,	B-X
together	B-X
with	B-X
phosphorylation	B-X
of	B-X
nucleosome	B-X
components	B-X
such	B-X
as	B-X
histone	B-X
H3	B-X
,	B-X
an	B-X
essential	B-X
step	B-X
leading	B-X
to	B-X
selective	B-X
transcriptional	B-X
activation	B-X
of	B-X
NF-kappaB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

We	O
show	O
that	O
the	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
inhibitors	O
SB203580	O
and	O
PD98059	O
or	O
U0126	O
,	O
as	O
well	O
as	O
a	O
potent	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
and	I-Gene_or_gene_product
stress	I-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
MSK1	B-Gene_or_gene_product
)	O
inhibitor	O
H89	O
,	O
counteract	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
TNF	B-Gene_or_gene_product
)	O
-	O
mediated	O
stimulation	O
of	O
p65	B-Gene_or_gene_product
transactivation	O
capacity	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
key	B-X
regulators	B-X
of	B-X
transcription	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
NF-kappaB	B-X
activity	B-X
has	B-X
long	B-X
been	B-X
thought	B-X
to	B-X
be	B-X
regulated	B-X
mainly	B-X
by	B-X
IkappaB	B-X
family	B-X
members	B-X
,	B-X
which	B-X
keep	B-X
the	B-X
transcription	B-X
factor	B-X
complex	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
in	B-X
the	B-X
cytoplasm	B-X
by	B-X
masking	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
.	B-X
Nowadays	B-X
,	B-X
the	B-X
importance	B-X
of	B-X
additional	B-X
mechanisms	B-X
controlling	B-X
the	B-X
nuclear	B-X
transcription	B-X
potential	B-X
of	B-X
NF-kappaB	B-X
is	B-X
generally	B-X
accepted	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
inhibitors	B-X
SB203580	B-X
and	B-X
PD98059	B-X
or	B-X
U0126	B-X
,	B-X
as	B-X
well	B-X
as	B-X
a	B-X
potent	B-X
mitogen-	B-X
and	B-X
stress-	B-X
activated	B-X
protein	B-X
kinase-1	B-X
(	B-X
MSK1	B-X
)	B-X
inhibitor	B-X
H89	B-X
,	B-X
counteract	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-mediated	B-X
stimulation	B-X
of	B-X
p65	B-X
transactivation	B-X
capacity	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
p65	B-X
revealed	B-X
Ser276	B-X
as	B-X
a	B-X
target	B-X
for	B-X
phosphorylation	B-X
and	B-X
transactivation	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
Moreover	B-X
,	B-X
we	B-X
identified	B-X
MSK1	B-X
as	B-X
a	B-X
nuclear	B-X
kinase	B-X
for	B-X
p65	B-X
,	B-X
since	B-X
MSK1	B-X
associates	B-X
with	B-X
p65	B-X
in	B-X
a	B-X
stimulus-dependent	B-X
way	B-X
and	B-X
phosphorylates	B-X
p65	B-X
at	B-X
Ser276	B-X
.	B-X

Mutational	O
analysis	O
of	O
p65	B-Gene_or_gene_product
revealed	O
Ser276	O
as	O
a	O
target	O
for	O
phosphorylation	O
and	O
transactivation	O
in	O
response	O
to	O
TNF	B-Gene_or_gene_product
.	O

Moreover	O
,	O
we	O
identified	O
MSK1	B-Gene_or_gene_product
as	O
a	O
nuclear	O
kinase	O
for	O
p65	B-Gene_or_gene_product
,	O
since	O
MSK1	B-Gene_or_gene_product
associates	O
with	O
p65	B-Gene_or_gene_product
in	O
a	O
stimulus	O
-	O
dependent	O
way	O
and	O
phosphorylates	O
p65	B-Gene_or_gene_product
at	O
Ser276	O
.	O

This	O
effect	O
represents	O
,	O
together	O
with	O
phosphorylation	O
of	O
nucleosome	O
components	O
such	O
as	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
,	O
an	O
essential	O
step	O
leading	O
to	O
selective	O
transcriptional	O
activation	O
of	O
NF	O
-	O
kappaB	O
-	O
dependent	O
gene	O
expression	O
.	O
<EOS>	B-X
Nuclear	B-X
factor	B-X
kappaB	B-X
(	B-X
NF-kappaB	B-X
)	B-X
is	B-X
one	B-X
of	B-X
the	B-X
key	B-X
regulators	B-X
of	B-X
transcription	B-X
of	B-X
a	B-X
variety	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
immune	B-X
and	B-X
inflammatory	B-X
responses	B-X
.	B-X
NF-kappaB	B-X
activity	B-X
has	B-X
long	B-X
been	B-X
thought	B-X
to	B-X
be	B-X
regulated	B-X
mainly	B-X
by	B-X
IkappaB	B-X
family	B-X
members	B-X
,	B-X
which	B-X
keep	B-X
the	B-X
transcription	B-X
factor	B-X
complex	B-X
in	B-X
an	B-X
inactive	B-X
form	B-X
in	B-X
the	B-X
cytoplasm	B-X
by	B-X
masking	B-X
the	B-X
nuclear	B-X
localization	B-X
signal	B-X
.	B-X
Nowadays	B-X
,	B-X
the	B-X
importance	B-X
of	B-X
additional	B-X
mechanisms	B-X
controlling	B-X
the	B-X
nuclear	B-X
transcription	B-X
potential	B-X
of	B-X
NF-kappaB	B-X
is	B-X
generally	B-X
accepted	B-X
.	B-X
We	B-X
show	B-X
that	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
inhibitors	B-X
SB203580	B-X
and	B-X
PD98059	B-X
or	B-X
U0126	B-X
,	B-X
as	B-X
well	B-X
as	B-X
a	B-X
potent	B-X
mitogen-	B-X
and	B-X
stress-	B-X
activated	B-X
protein	B-X
kinase-1	B-X
(	B-X
MSK1	B-X
)	B-X
inhibitor	B-X
H89	B-X
,	B-X
counteract	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-mediated	B-X
stimulation	B-X
of	B-X
p65	B-X
transactivation	B-X
capacity	B-X
.	B-X
Mutational	B-X
analysis	B-X
of	B-X
p65	B-X
revealed	B-X
Ser276	B-X
as	B-X
a	B-X
target	B-X
for	B-X
phosphorylation	B-X
and	B-X
transactivation	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
Moreover	B-X
,	B-X
we	B-X
identified	B-X
MSK1	B-X
as	B-X
a	B-X
nuclear	B-X
kinase	B-X
for	B-X
p65	B-X
,	B-X
since	B-X
MSK1	B-X
associates	B-X
with	B-X
p65	B-X
in	B-X
a	B-X
stimulus-dependent	B-X
way	B-X
and	B-X
phosphorylates	B-X
p65	B-X
at	B-X
Ser276	B-X
.	B-X
This	B-X
effect	B-X
represents	B-X
,	B-X
together	B-X
with	B-X
phosphorylation	B-X
of	B-X
nucleosome	B-X
components	B-X
such	B-X
as	B-X
histone	B-X
H3	B-X
,	B-X
an	B-X
essential	B-X
step	B-X
leading	B-X
to	B-X
selective	B-X
transcriptional	B-X
activation	B-X
of	B-X
NF-kappaB-dependent	B-X
gene	B-X
expression	B-X
.	B-X

Human	O
claspin	B-Gene_or_gene_product
is	O
required	O
for	O
replication	O
checkpoint	O
control	O
.	O
<EOS>	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Claspin	B-Gene_or_gene_product
is	O
a	O
newly	O
identified	O
protein	O
that	O
regulates	O
Chk1	B-Gene_or_gene_product
activation	O
in	O
Xenopus	O
.	O
<EOS>	B-X
Claspin	B-X
is	B-X
a	B-X
newly	B-X
identified	B-X
protein	B-X
that	B-X
regulates	B-X
Chk1	B-X
activation	B-X
in	B-X
Xenopus	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
human	B-X
Claspin	B-X
is	B-X
a	B-X
cell	B-X
cycle	B-X
regulated	B-X
protein	B-X
that	B-X
peaks	B-X
at	B-X
S/G2	B-X
phase	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Given	B-X
that	B-X
both	B-X
the	B-X
ATR	B-X
and	B-X
Rad9-Rad1-Hus1	B-X
complexes	B-X
are	B-X
involved	B-X
in	B-X
Chk1	B-X
activation	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
Claspin	B-X
works	B-X
as	B-X
an	B-X
adaptor	B-X
molecule	B-X
bringing	B-X
these	B-X
molecules	B-X
together	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
augments	B-X
the	B-X
premature	B-X
chromatin	B-X
condensation	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
,	B-X
inhibits	B-X
the	B-X
UV-induced	B-X
reduction	B-X
of	B-X
DNA	B-X
synthesis	B-X
,	B-X
and	B-X
decreases	B-X
cell	B-X
survival	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

In	O
the	O
present	O
study	O
we	O
investigated	O
the	O
role	O
of	O
human	O
Claspin	B-Gene_or_gene_product
in	O
the	O
DNA	O
damage	O
/	O
replication	O
checkpoint	O
in	O
mammalian	O
cells	O
.	O
<EOS>	B-X
Claspin	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
DNA	B-X
replication	B-X
stress	B-X
and	B-X
damage	B-X
responses	B-X
and	B-X
is	B-X
an	B-X
essential	B-X
regulator	B-X
for	B-X
the	B-X
S-phase	B-X
checkpoint	B-X
.	B-X
CLSPN	B-X
is	B-X
an	B-X
oncogenic	B-X
gene	B-X
that	B-X
contributes	B-X
to	B-X
tumor	B-X
proliferation	B-X
in	B-X
several	B-X
human	B-X
solid	B-X
tumors	B-X
.	B-X
The	B-X
present	B-X
study	B-X
aimed	B-X
to	B-X
elucidate	B-X
the	B-X
role	B-X
of	B-X
claspin	B-X
and	B-X
its	B-X
relationship	B-X
with	B-X
DTX	B-X
resistance	B-X
in	B-X
PCa	B-X
.	B-X
Claspin-positive	B-X
cases	B-X
were	B-X
associated	B-X
with	B-X
higher	B-X
Gleason	B-X
score	B-X
,	B-X
venous	B-X
invasion	B-X
,	B-X
and	B-X
perineural	B-X
invasion	B-X
.	B-X
Claspin	B-X
knockdown	B-X
by	B-X
siRNA	B-X
decreased	B-X
cell	B-X
proliferation	B-X
,	B-X
upregulated	B-X
DTX	B-X
sensitivity	B-X
,	B-X
and	B-X
suppressed	B-X
the	B-X
expression	B-X
of	B-X
Akt	B-X
,	B-X
Erk1/2	B-X
,	B-X
and	B-X
CHK1	B-X
phosphorylation	B-X
in	B-X
DU145	B-X
and	B-X
PC3	B-X
cell	B-X
lines	B-X
.	B-X
Furthermore	B-X
,	B-X
claspin	B-X
expression	B-X
was	B-X
much	B-X
more	B-X
upregulated	B-X
in	B-X
DTX-resistant	B-X
DU145	B-X
(	B-X
DU145-DR	B-X
)	B-X
than	B-X
in	B-X
parental	B-X
DU145	B-X
cells	B-X
.	B-X
Claspin	B-X
knockdown	B-X
significantly	B-X
upregulated	B-X
the	B-X
sensitivity	B-X
to	B-X
DTX	B-X
in	B-X
DU145-DR	B-X
cells	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
claspin	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
PCa	B-X
tumor	B-X
progression	B-X
and	B-X
DTX	B-X
resistance	B-X
.	B-X

We	O
observed	O
that	O
human	O
Claspin	B-Gene_or_gene_product
is	O
a	O
cell	O
cycle	O
regulated	O
protein	O
that	O
peaks	O
at	O
S	O
/	O
G2	O
phase	O
.	O
<EOS>	B-X
Claspin	B-X
is	B-X
a	B-X
newly	B-X
identified	B-X
protein	B-X
that	B-X
regulates	B-X
Chk1	B-X
activation	B-X
in	B-X
Xenopus	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
human	B-X
Claspin	B-X
is	B-X
a	B-X
cell	B-X
cycle	B-X
regulated	B-X
protein	B-X
that	B-X
peaks	B-X
at	B-X
S/G2	B-X
phase	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Given	B-X
that	B-X
both	B-X
the	B-X
ATR	B-X
and	B-X
Rad9-Rad1-Hus1	B-X
complexes	B-X
are	B-X
involved	B-X
in	B-X
Chk1	B-X
activation	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
Claspin	B-X
works	B-X
as	B-X
an	B-X
adaptor	B-X
molecule	B-X
bringing	B-X
these	B-X
molecules	B-X
together	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
augments	B-X
the	B-X
premature	B-X
chromatin	B-X
condensation	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
,	B-X
inhibits	B-X
the	B-X
UV-induced	B-X
reduction	B-X
of	B-X
DNA	B-X
synthesis	B-X
,	B-X
and	B-X
decreases	B-X
cell	B-X
survival	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Claspin	B-Gene_or_gene_product
localizes	O
in	O
the	O
nuclei	O
,	O
but	O
it	O
only	O
associates	O
with	O
Chk1	B-Gene_or_gene_product
following	O
replication	O
stress	O
or	O
other	O
types	O
of	O
DNA	O
damage	O
.	O
<EOS>	B-X
Drinking	B-X
alcohol	B-X
increases	B-X
the	B-X
risk	B-X
of	B-X
several	B-X
cancer	B-X
types	B-X
,	B-X
including	B-X
cancers	B-X
of	B-X
the	B-X
upper	B-X
aerodigestive	B-X
tract	B-X
,	B-X
liver	B-X
,	B-X
colorectum	B-X
,	B-X
and	B-X
breast	B-X
.	B-X
Ethanol	B-X
's	B-X
metabolite	B-X
acetaldehyde	B-X
can	B-X
cause	B-X
DNA	B-X
damage	B-X
and	B-X
block	B-X
DNA	B-X
synthesis	B-X
and	B-X
repair	B-X
,	B-X
whilst	B-X
both	B-X
ethanol	B-X
and	B-X
acetaldehyde	B-X
can	B-X
disrupt	B-X
DNA	B-X
methylation	B-X
.	B-X
Ethanol	B-X
can	B-X
also	B-X
induce	B-X
inflammation	B-X
and	B-X
oxidative	B-X
stress	B-X
leading	B-X
to	B-X
lipid	B-X
peroxidation	B-X
and	B-X
further	B-X
DNA	B-X
damage	B-X
.	B-X
SMAD4	B-X
,	B-X
which	B-X
serves	B-X
as	B-X
the	B-X
central	B-X
mediator	B-X
of	B-X
TGF-	B-X
signaling	B-X
,	B-X
is	B-X
specifically	B-X
inactivated	B-X
in	B-X
over	B-X
half	B-X
of	B-X
pancreatic	B-X
duct	B-X
adenocarcinoma	B-X
,	B-X
and	B-X
varying	B-X
degrees	B-X
in	B-X
many	B-X
other	B-X
types	B-X
of	B-X
cancers	B-X
.	B-X
In	B-X
other	B-X
cases	B-X
,	B-X
such	B-X
as	B-X
skin	B-X
cancer	B-X
,	B-X
loss	B-X
of	B-X
SMAD4	B-X
plays	B-X
an	B-X
important	B-X
initiating	B-X
role	B-X
by	B-X
disrupting	B-X
DNA	B-X
damage	B-X
response	B-X
and	B-X
repair	B-X
mechanisms	B-X
and	B-X
enhance	B-X
genomic	B-X
instability	B-X
,	B-X
suggesting	B-X
its	B-X
distinct	B-X
roles	B-X
in	B-X
different	B-X
types	B-X
of	B-X
tumors	B-X
.	B-X
This	B-X
review	B-X
lists	B-X
SMAD4	B-X
mutations	B-X
in	B-X
various	B-X
types	B-X
of	B-X
cancer	B-X
and	B-X
summarizes	B-X
recent	B-X
advances	B-X
on	B-X
SMAD4	B-X
with	B-X
focuses	B-X
on	B-X
the	B-X
function	B-X
,	B-X
signaling	B-X
pathway	B-X
,	B-X
and	B-X
the	B-X
possibility	B-X
of	B-X
SMAD4	B-X
as	B-X
a	B-X
prognostic	B-X
indicator	B-X
.	B-X

In	O
addition	O
,	O
Claspin	B-Gene_or_gene_product
is	O
phosphorylated	O
in	O
response	O
to	O
replication	O
stress	O
,	O
and	O
this	O
phosphorylation	O
appears	O
to	O
be	O
required	O
for	O
its	O
association	O
with	O
Chk1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Claspin	B-X
is	B-X
a	B-X
newly	B-X
identified	B-X
protein	B-X
that	B-X
regulates	B-X
Chk1	B-X
activation	B-X
in	B-X
Xenopus	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
human	B-X
Claspin	B-X
is	B-X
a	B-X
cell	B-X
cycle	B-X
regulated	B-X
protein	B-X
that	B-X
peaks	B-X
at	B-X
S/G2	B-X
phase	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Given	B-X
that	B-X
both	B-X
the	B-X
ATR	B-X
and	B-X
Rad9-Rad1-Hus1	B-X
complexes	B-X
are	B-X
involved	B-X
in	B-X
Chk1	B-X
activation	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
Claspin	B-X
works	B-X
as	B-X
an	B-X
adaptor	B-X
molecule	B-X
bringing	B-X
these	B-X
molecules	B-X
together	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
augments	B-X
the	B-X
premature	B-X
chromatin	B-X
condensation	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
,	B-X
inhibits	B-X
the	B-X
UV-induced	B-X
reduction	B-X
of	B-X
DNA	B-X
synthesis	B-X
,	B-X
and	B-X
decreases	B-X
cell	B-X
survival	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Moreover	O
,	O
Claspin	B-Gene_or_gene_product
interacts	O
with	O
the	O
checkpoint	O
proteins	O
ATR	B-Gene_or_gene_product
and	O
Rad9	B-Gene_or_gene_product
.	O
<EOS>	B-X
Claspin	B-X
is	B-X
a	B-X
newly	B-X
identified	B-X
protein	B-X
that	B-X
regulates	B-X
Chk1	B-X
activation	B-X
in	B-X
Xenopus	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
human	B-X
Claspin	B-X
is	B-X
a	B-X
cell	B-X
cycle	B-X
regulated	B-X
protein	B-X
that	B-X
peaks	B-X
at	B-X
S/G2	B-X
phase	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Given	B-X
that	B-X
both	B-X
the	B-X
ATR	B-X
and	B-X
Rad9-Rad1-Hus1	B-X
complexes	B-X
are	B-X
involved	B-X
in	B-X
Chk1	B-X
activation	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
Claspin	B-X
works	B-X
as	B-X
an	B-X
adaptor	B-X
molecule	B-X
bringing	B-X
these	B-X
molecules	B-X
together	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
augments	B-X
the	B-X
premature	B-X
chromatin	B-X
condensation	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
,	B-X
inhibits	B-X
the	B-X
UV-induced	B-X
reduction	B-X
of	B-X
DNA	B-X
synthesis	B-X
,	B-X
and	B-X
decreases	B-X
cell	B-X
survival	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Given	O
that	O
both	O
the	O
ATR	B-Gene_or_gene_product
and	O
Rad9	O
-	O
Rad1	O
-	O
Hus1	O
complexes	O
are	O
involved	O
in	O
Chk1	B-Gene_or_gene_product
activation	O
,	O
it	O
is	O
possible	O
that	O
Claspin	B-Gene_or_gene_product
works	O
as	O
an	O
adaptor	O
molecule	O
bringing	O
these	O
molecules	O
together	O
.	O
<EOS>	B-X
Claspin	B-X
is	B-X
a	B-X
newly	B-X
identified	B-X
protein	B-X
that	B-X
regulates	B-X
Chk1	B-X
activation	B-X
in	B-X
Xenopus	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
human	B-X
Claspin	B-X
is	B-X
a	B-X
cell	B-X
cycle	B-X
regulated	B-X
protein	B-X
that	B-X
peaks	B-X
at	B-X
S/G2	B-X
phase	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Given	B-X
that	B-X
both	B-X
the	B-X
ATR	B-X
and	B-X
Rad9-Rad1-Hus1	B-X
complexes	B-X
are	B-X
involved	B-X
in	B-X
Chk1	B-X
activation	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
Claspin	B-X
works	B-X
as	B-X
an	B-X
adaptor	B-X
molecule	B-X
bringing	B-X
these	B-X
molecules	B-X
together	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
augments	B-X
the	B-X
premature	B-X
chromatin	B-X
condensation	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
,	B-X
inhibits	B-X
the	B-X
UV-induced	B-X
reduction	B-X
of	B-X
DNA	B-X
synthesis	B-X
,	B-X
and	B-X
decreases	B-X
cell	B-X
survival	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Using	O
small	O
interfering	O
RNA	O
technology	O
,	O
we	O
have	O
shown	O
that	O
down	O
-	O
regulation	O
of	O
Claspin	B-Gene_or_gene_product
expression	O
inhibits	O
Chk1	B-Gene_or_gene_product
activation	O
in	O
response	O
to	O
replication	O
stress	O
.	O
<EOS>	B-X
Claspin	B-X
is	B-X
a	B-X
newly	B-X
identified	B-X
protein	B-X
that	B-X
regulates	B-X
Chk1	B-X
activation	B-X
in	B-X
Xenopus	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
human	B-X
Claspin	B-X
is	B-X
a	B-X
cell	B-X
cycle	B-X
regulated	B-X
protein	B-X
that	B-X
peaks	B-X
at	B-X
S/G2	B-X
phase	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Given	B-X
that	B-X
both	B-X
the	B-X
ATR	B-X
and	B-X
Rad9-Rad1-Hus1	B-X
complexes	B-X
are	B-X
involved	B-X
in	B-X
Chk1	B-X
activation	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
Claspin	B-X
works	B-X
as	B-X
an	B-X
adaptor	B-X
molecule	B-X
bringing	B-X
these	B-X
molecules	B-X
together	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
augments	B-X
the	B-X
premature	B-X
chromatin	B-X
condensation	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
,	B-X
inhibits	B-X
the	B-X
UV-induced	B-X
reduction	B-X
of	B-X
DNA	B-X
synthesis	B-X
,	B-X
and	B-X
decreases	B-X
cell	B-X
survival	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

More	O
importantly	O
,	O
down	O
-	O
regulation	O
of	O
Claspin	B-Gene_or_gene_product
augments	O
the	O
premature	O
chromatin	O
condensation	O
induced	O
by	O
hydroxyurea	O
,	O
inhibits	O
the	O
UV	O
-	O
induced	O
reduction	O
of	O
DNA	O
synthesis	O
,	O
and	O
decreases	O
cell	O
survival	O
.	O
<EOS>	B-X
Claspin	B-X
is	B-X
a	B-X
newly	B-X
identified	B-X
protein	B-X
that	B-X
regulates	B-X
Chk1	B-X
activation	B-X
in	B-X
Xenopus	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
human	B-X
Claspin	B-X
is	B-X
a	B-X
cell	B-X
cycle	B-X
regulated	B-X
protein	B-X
that	B-X
peaks	B-X
at	B-X
S/G2	B-X
phase	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Given	B-X
that	B-X
both	B-X
the	B-X
ATR	B-X
and	B-X
Rad9-Rad1-Hus1	B-X
complexes	B-X
are	B-X
involved	B-X
in	B-X
Chk1	B-X
activation	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
Claspin	B-X
works	B-X
as	B-X
an	B-X
adaptor	B-X
molecule	B-X
bringing	B-X
these	B-X
molecules	B-X
together	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
augments	B-X
the	B-X
premature	B-X
chromatin	B-X
condensation	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
,	B-X
inhibits	B-X
the	B-X
UV-induced	B-X
reduction	B-X
of	B-X
DNA	B-X
synthesis	B-X
,	B-X
and	B-X
decreases	B-X
cell	B-X
survival	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Taken	O
together	O
,	O
these	O
data	O
imply	O
a	O
potentially	O
critical	O
role	O
for	O
Claspin	B-Gene_or_gene_product
in	O
replication	O
checkpoint	O
control	O
in	O
mammalian	O
cells	O
.	O
<EOS>	B-X
Claspin	B-X
is	B-X
a	B-X
newly	B-X
identified	B-X
protein	B-X
that	B-X
regulates	B-X
Chk1	B-X
activation	B-X
in	B-X
Xenopus	B-X
.	B-X
In	B-X
the	B-X
present	B-X
study	B-X
we	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
human	B-X
Claspin	B-X
in	B-X
the	B-X
DNA	B-X
damage/replication	B-X
checkpoint	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
We	B-X
observed	B-X
that	B-X
human	B-X
Claspin	B-X
is	B-X
a	B-X
cell	B-X
cycle	B-X
regulated	B-X
protein	B-X
that	B-X
peaks	B-X
at	B-X
S/G2	B-X
phase	B-X
.	B-X
Claspin	B-X
localizes	B-X
in	B-X
the	B-X
nuclei	B-X
,	B-X
but	B-X
it	B-X
only	B-X
associates	B-X
with	B-X
Chk1	B-X
following	B-X
replication	B-X
stress	B-X
or	B-X
other	B-X
types	B-X
of	B-X
DNA	B-X
damage	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
Claspin	B-X
is	B-X
phosphorylated	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
,	B-X
and	B-X
this	B-X
phosphorylation	B-X
appears	B-X
to	B-X
be	B-X
required	B-X
for	B-X
its	B-X
association	B-X
with	B-X
Chk1	B-X
.	B-X
Moreover	B-X
,	B-X
Claspin	B-X
interacts	B-X
with	B-X
the	B-X
checkpoint	B-X
proteins	B-X
ATR	B-X
and	B-X
Rad9	B-X
.	B-X
Given	B-X
that	B-X
both	B-X
the	B-X
ATR	B-X
and	B-X
Rad9-Rad1-Hus1	B-X
complexes	B-X
are	B-X
involved	B-X
in	B-X
Chk1	B-X
activation	B-X
,	B-X
it	B-X
is	B-X
possible	B-X
that	B-X
Claspin	B-X
works	B-X
as	B-X
an	B-X
adaptor	B-X
molecule	B-X
bringing	B-X
these	B-X
molecules	B-X
together	B-X
.	B-X
Using	B-X
small	B-X
interfering	B-X
RNA	B-X
technology	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
expression	B-X
inhibits	B-X
Chk1	B-X
activation	B-X
in	B-X
response	B-X
to	B-X
replication	B-X
stress	B-X
.	B-X
More	B-X
importantly	B-X
,	B-X
down-regulation	B-X
of	B-X
Claspin	B-X
augments	B-X
the	B-X
premature	B-X
chromatin	B-X
condensation	B-X
induced	B-X
by	B-X
hydroxyurea	B-X
,	B-X
inhibits	B-X
the	B-X
UV-induced	B-X
reduction	B-X
of	B-X
DNA	B-X
synthesis	B-X
,	B-X
and	B-X
decreases	B-X
cell	B-X
survival	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
these	B-X
data	B-X
imply	B-X
a	B-X
potentially	B-X
critical	B-X
role	B-X
for	B-X
Claspin	B-X
in	B-X
replication	B-X
checkpoint	B-X
control	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

Cbl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
b	I-Gene_or_gene_product
negatively	O
regulates	O
B	B-Gene_or_gene_product
cell	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
signaling	O
in	O
mature	O
B	O
cells	O
through	O
ubiquitination	O
of	O
the	O
tyrosine	O
kinase	O
Syk	B-Gene_or_gene_product
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
Cbl	B-X
family	B-X
of	B-X
molecular	B-X
adaptors	B-X
play	B-X
key	B-X
roles	B-X
in	B-X
regulating	B-X
tyrosine	B-X
kinase-dependent	B-X
signaling	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cellular	B-X
systems	B-X
.	B-X
Here	B-X
we	B-X
provide	B-X
evidence	B-X
that	B-X
in	B-X
B	B-X
cells	B-X
Cbl-b	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
B	B-X
cell	B-X
antigen	B-X
receptor	B-X
(	B-X
BCR	B-X
)	B-X
signaling	B-X
during	B-X
the	B-X
normal	B-X
course	B-X
of	B-X
a	B-X
response	B-X
.	B-X
In	B-X
B	B-X
cells	B-X
from	B-X
Cbl-b-deficient	B-X
mice	B-X
cross-linking	B-X
the	B-X
BCRs	B-X
resulted	B-X
in	B-X
sustained	B-X
phosphorylation	B-X
of	B-X
Igalpha	B-X
,	B-X
Syk	B-X
,	B-X
and	B-X
phospholipase	B-X
C	B-X
(	B-X
PLC	B-X
)	B-X
-gamma2	B-X
,	B-X
leading	B-X
to	B-X
prolonged	B-X
Ca2+	B-X
mobilization	B-X
,	B-X
and	B-X
increases	B-X
in	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
and	B-X
c-Jun	B-X
NH2-terminal	B-X
protein	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
phosphorylation	B-X
and	B-X
surface	B-X
expression	B-X
of	B-X
the	B-X
activation	B-X
marker	B-X
,	B-X
CD69	B-X
.	B-X
Image	B-X
analysis	B-X
following	B-X
BCR	B-X
cross-linking	B-X
showed	B-X
sustained	B-X
polarization	B-X
of	B-X
the	B-X
BCRs	B-X
into	B-X
large	B-X
signaling-active	B-X
caps	B-X
associated	B-X
with	B-X
phosphorylated	B-X
Syk	B-X
in	B-X
Cbl-b-deficient	B-X
B	B-X
cells	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
BCRs	B-X
in	B-X
Cbl-b-expressing	B-X
B	B-X
cells	B-X
that	B-X
rapidly	B-X
proceeded	B-X
to	B-X
form	B-X
small	B-X
,	B-X
condensed	B-X
,	B-X
signaling	B-X
inactive	B-X
caps	B-X
.	B-X
Significantly	B-X
,	B-X
prolonged	B-X
phosphorylation	B-X
of	B-X
Syk	B-X
correlated	B-X
with	B-X
reduced	B-X
ubiquitination	B-X
of	B-X
Syk	B-X
indicating	B-X
that	B-X
Cbl-b	B-X
negatively	B-X
regulates	B-X
BCR	B-X
signaling	B-X
by	B-X
targeting	B-X
Syk	B-X
for	B-X
ubiquitination	B-X
.	B-X

Members	O
of	O
the	O
Cbl	B-Gene_or_gene_product
family	O
of	O
molecular	O
adaptors	O
play	O
key	O
roles	O
in	O
regulating	O
tyrosine	O
kinase	O
-	O
dependent	O
signaling	O
in	O
a	O
variety	O
of	O
cellular	O
systems	O
.	O

Here	O
we	O
provide	O
evidence	O
that	O
in	O
B	O
cells	O
Cbl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
b	I-Gene_or_gene_product
functions	O
as	O
a	O
negative	O
regulator	O
of	O
B	B-Gene_or_gene_product
cell	I-Gene_or_gene_product
antigen	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
(	O
BCR	B-Gene_or_gene_product
)	O
signaling	O
during	O
the	O
normal	O
course	O
of	O
a	O
response	O
.	O

In	O
B	O
cells	O
from	O
Cbl	B-Gene_or_gene_product
-	O
b	O
-	O
deficient	O
mice	O
cross	O
-	O
linking	O
the	O
BCRs	B-Gene_or_gene_product
resulted	O
in	O
sustained	O
phosphorylation	O
of	O
Igalpha	B-Gene_or_gene_product
,	O
Syk	B-Gene_or_gene_product
,	O
and	O
phospholipase	B-Gene_or_gene_product
C	I-Gene_or_gene_product
(	I-Gene_or_gene_product
PLC	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
gamma2	I-Gene_or_gene_product
,	O
leading	O
to	O
prolonged	O
Ca2	O
+	O
mobilization	O
,	O
and	O
increases	O
in	O
extracellular	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
ERK	B-Gene_or_gene_product
)	O
and	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
NH2	I-Gene_or_gene_product
-	I-Gene_or_gene_product
terminal	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
JNK	B-Gene_or_gene_product
)	O
phosphorylation	O
and	O
surface	O
expression	O
of	O
the	O
activation	O
marker	O
,	O
CD69	B-Gene_or_gene_product
.	O

Image	O
analysis	O
following	O
BCR	B-Gene_or_gene_product
cross	O
-	O
linking	O
showed	O
sustained	O
polarization	O
of	O
the	O
BCRs	B-Gene_or_gene_product
into	O
large	O
signaling	O
-	O
active	O
caps	O
associated	O
with	O
phosphorylated	O
Syk	B-Gene_or_gene_product
in	O
Cbl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
b	I-Gene_or_gene_product
-	O
deficient	O
B	O
cells	O
in	O
contrast	O
to	O
the	O
BCRs	B-Gene_or_gene_product
in	O
Cbl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
b	I-Gene_or_gene_product
-	O
expressing	O
B	O
cells	O
that	O
rapidly	O
proceeded	O
to	O
form	O
small	O
,	O
condensed	O
,	O
signaling	O
inactive	O
caps	O
.	O

Significantly	O
,	O
prolonged	O
phosphorylation	O
of	O
Syk	B-Gene_or_gene_product
correlated	O
with	O
reduced	O
ubiquitination	O
of	O
Syk	B-Gene_or_gene_product
indicating	O
that	O
Cbl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
b	I-Gene_or_gene_product
negatively	O
regulates	O
BCR	B-Gene_or_gene_product
signaling	O
by	O
targeting	O
Syk	B-Gene_or_gene_product
for	O
ubiquitination	O
.	O
<EOS>	B-X
Members	B-X
of	B-X
the	B-X
Cbl	B-X
family	B-X
of	B-X
molecular	B-X
adaptors	B-X
play	B-X
key	B-X
roles	B-X
in	B-X
regulating	B-X
tyrosine	B-X
kinase-dependent	B-X
signaling	B-X
in	B-X
a	B-X
variety	B-X
of	B-X
cellular	B-X
systems	B-X
.	B-X
Here	B-X
we	B-X
provide	B-X
evidence	B-X
that	B-X
in	B-X
B	B-X
cells	B-X
Cbl-b	B-X
functions	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
B	B-X
cell	B-X
antigen	B-X
receptor	B-X
(	B-X
BCR	B-X
)	B-X
signaling	B-X
during	B-X
the	B-X
normal	B-X
course	B-X
of	B-X
a	B-X
response	B-X
.	B-X
In	B-X
B	B-X
cells	B-X
from	B-X
Cbl-b-deficient	B-X
mice	B-X
cross-linking	B-X
the	B-X
BCRs	B-X
resulted	B-X
in	B-X
sustained	B-X
phosphorylation	B-X
of	B-X
Igalpha	B-X
,	B-X
Syk	B-X
,	B-X
and	B-X
phospholipase	B-X
C	B-X
(	B-X
PLC	B-X
)	B-X
-gamma2	B-X
,	B-X
leading	B-X
to	B-X
prolonged	B-X
Ca2+	B-X
mobilization	B-X
,	B-X
and	B-X
increases	B-X
in	B-X
extracellular	B-X
signal-regulated	B-X
kinase	B-X
(	B-X
ERK	B-X
)	B-X
and	B-X
c-Jun	B-X
NH2-terminal	B-X
protein	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
phosphorylation	B-X
and	B-X
surface	B-X
expression	B-X
of	B-X
the	B-X
activation	B-X
marker	B-X
,	B-X
CD69	B-X
.	B-X
Image	B-X
analysis	B-X
following	B-X
BCR	B-X
cross-linking	B-X
showed	B-X
sustained	B-X
polarization	B-X
of	B-X
the	B-X
BCRs	B-X
into	B-X
large	B-X
signaling-active	B-X
caps	B-X
associated	B-X
with	B-X
phosphorylated	B-X
Syk	B-X
in	B-X
Cbl-b-deficient	B-X
B	B-X
cells	B-X
in	B-X
contrast	B-X
to	B-X
the	B-X
BCRs	B-X
in	B-X
Cbl-b-expressing	B-X
B	B-X
cells	B-X
that	B-X
rapidly	B-X
proceeded	B-X
to	B-X
form	B-X
small	B-X
,	B-X
condensed	B-X
,	B-X
signaling	B-X
inactive	B-X
caps	B-X
.	B-X
Significantly	B-X
,	B-X
prolonged	B-X
phosphorylation	B-X
of	B-X
Syk	B-X
correlated	B-X
with	B-X
reduced	B-X
ubiquitination	B-X
of	B-X
Syk	B-X
indicating	B-X
that	B-X
Cbl-b	B-X
negatively	B-X
regulates	B-X
BCR	B-X
signaling	B-X
by	B-X
targeting	B-X
Syk	B-X
for	B-X
ubiquitination	B-X
.	B-X

Proteolytic	O
signaling	O
by	O
TNFalpha	B-Gene_or_gene_product
:	O
caspase	B-Gene_or_gene_product
activation	O
and	O
IkappaB	B-Gene_or_gene_product
degradation	O
.	O
<EOS>	B-X
The	B-X
complex	B-X
promotes	B-X
activation	B-X
of	B-X
downstream	B-X
caspase	B-X
cascade	B-X
and	B-X
induces	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
According	B-X
to	B-X
their	B-X
structures	B-X
and	B-X
functions	B-X
,	B-X
apoptosis	B-X
related	B-X
caspases	B-X
can	B-X
be	B-X
divided	B-X
into	B-X
upstream	B-X
and	B-X
downstream	B-X
caspases	B-X
.	B-X
In	B-X
general	B-X
,	B-X
upstream	B-X
caspases	B-X
cleave	B-X
and	B-X
activate	B-X
downstream	B-X
caspases	B-X
by	B-X
proteolysis	B-X
of	B-X
the	B-X
Asp-X	B-X
site	B-X
.	B-X
Activated	B-X
caspases	B-X
then	B-X
cleaved	B-X
target	B-X
substrates	B-X
.	B-X
To	B-X
date	B-X
,	B-X
more	B-X
than	B-X
70	B-X
proteins	B-X
have	B-X
been	B-X
identified	B-X
to	B-X
be	B-X
substrates	B-X
of	B-X
caspases	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Activation	B-X
of	B-X
NF-kappaB	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
phosphorylates	B-X
IkappaBalpha	B-X
at	B-X
the	B-X
residues	B-X
32	B-X
and	B-X
36	B-X
followed	B-X
by	B-X
polyubiquitination	B-X
at	B-X
lysine	B-X
21	B-X
and	B-X
22	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
the	B-X
molecules	B-X
by	B-X
26S	B-X
proteasome	B-X
.	B-X
There	B-X
is	B-X
extensive	B-X
crosstalk	B-X
between	B-X
the	B-X
apoptotic	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathways	B-X
that	B-X
emanate	B-X
from	B-X
TNF-R1	B-X
.	B-X
On	B-X
the	B-X
one	B-X
hand	B-X
,	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
can	B-X
inactivate	B-X
caspases	B-X
;	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
activated	B-X
caspases	B-X
can	B-X
inhibit	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
.	B-X

Following	O
binding	O
its	O
death	B-Gene_or_gene_product
receptor	I-Gene_or_gene_product
on	O
the	O
plasma	O
membrane	O
,	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
TNF	B-Gene_or_gene_product
)	O
induces	O
the	O
receptor	O
trimerization	O
and	O
recruits	O
a	O
number	O
of	O
death	O
domain	O
-	O
containing	O
molecules	O
to	O
form	O
the	O
receptor	O
complex	O
.	O
<EOS>	B-X
Following	B-X
binding	B-X
its	B-X
death	B-X
receptor	B-X
on	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
induces	B-X
the	B-X
receptor	B-X
trimerization	B-X
and	B-X
recruits	B-X
a	B-X
number	B-X
of	B-X
death	B-X
domain-containing	B-X
molecules	B-X
to	B-X
form	B-X
the	B-X
receptor	B-X
complex	B-X
.	B-X
The	B-X
complex	B-X
promotes	B-X
activation	B-X
of	B-X
downstream	B-X
caspase	B-X
cascade	B-X
and	B-X
induces	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
Caspases	B-X
can	B-X
alter	B-X
the	B-X
function	B-X
of	B-X
their	B-X
target	B-X
proteins	B-X
by	B-X
destroying	B-X
structural	B-X
components	B-X
of	B-X
the	B-X
cytoskeleton	B-X
and	B-X
nuclear	B-X
scaffold	B-X
or	B-X
by	B-X
removing	B-X
their	B-X
regulatory	B-X
domains	B-X
.	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
phosphorylates	B-X
IkappaBalpha	B-X
at	B-X
the	B-X
residues	B-X
32	B-X
and	B-X
36	B-X
followed	B-X
by	B-X
polyubiquitination	B-X
at	B-X
lysine	B-X
21	B-X
and	B-X
22	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
the	B-X
molecules	B-X
by	B-X
26S	B-X
proteasome	B-X
.	B-X
There	B-X
is	B-X
extensive	B-X
crosstalk	B-X
between	B-X
the	B-X
apoptotic	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathways	B-X
that	B-X
emanate	B-X
from	B-X
TNF-R1	B-X
.	B-X

The	O
complex	O
promotes	O
activation	O
of	O
downstream	O
caspase	B-Gene_or_gene_product
cascade	O
and	O
induces	O
degradation	O
of	O
IkappaBalpha	B-Gene_or_gene_product
.	O
<EOS>	B-X
With	B-X
regard	B-X
to	B-X
TNFalpha	B-X
,	B-X
the	B-X
NF-kappaB-mediated	B-X
inhibition	B-X
of	B-X
PCD	B-X
seems	B-X
to	B-X
involve	B-X
an	B-X
attenuation	B-X
of	B-X
the	B-X
c-Jun-N-terminal	B-X
kinase	B-X
(	B-X
JNK	B-X
)	B-X
cascade	B-X
mediated	B-X
through	B-X
the	B-X
induction	B-X
of	B-X
select	B-X
downstream	B-X
targets	B-X
such	B-X
as	B-X
the	B-X
caspase	B-X
inhibitor	B-X
XIAP	B-X
,	B-X
the	B-X
zinc-finger	B-X
protein	B-X
A20	B-X
,	B-X
and	B-X
the	B-X
inhibitor	B-X
of	B-X
the	B-X
MKK7/JNKK2	B-X
kinase	B-X
,	B-X
Gadd45beta/Myd118	B-X
.	B-X
The	B-X
antioxidant	B-X
activity	B-X
of	B-X
NF-kappaB	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
depend	B-X
upon	B-X
upregulation	B-X
of	B-X
both	B-X
Ferritin	B-X
heavy	B-X
chain	B-X
(	B-X
FHC	B-X
)	B-X
--	B-X
a	B-X
component	B-X
of	B-X
Ferritin	B-X
,	B-X
the	B-X
primary	B-X
iron-storage	B-X
protein	B-X
complex	B-X
found	B-X
in	B-X
cells	B-X
--	B-X
and	B-X
of	B-X
the	B-X
mitochondrial	B-X
enzyme	B-X
Mn++	B-X
superoxide	B-X
dismutase	B-X
(	B-X
Mn-SOD	B-X
)	B-X
.	B-X
Following	B-X
binding	B-X
its	B-X
death	B-X
receptor	B-X
on	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
induces	B-X
the	B-X
receptor	B-X
trimerization	B-X
and	B-X
recruits	B-X
a	B-X
number	B-X
of	B-X
death	B-X
domain-containing	B-X
molecules	B-X
to	B-X
form	B-X
the	B-X
receptor	B-X
complex	B-X
.	B-X
The	B-X
complex	B-X
promotes	B-X
activation	B-X
of	B-X
downstream	B-X
caspase	B-X
cascade	B-X
and	B-X
induces	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
According	B-X
to	B-X
their	B-X
structures	B-X
and	B-X
functions	B-X
,	B-X
apoptosis	B-X
related	B-X
caspases	B-X
can	B-X
be	B-X
divided	B-X
into	B-X
upstream	B-X
and	B-X
downstream	B-X
caspases	B-X
.	B-X
In	B-X
general	B-X
,	B-X
upstream	B-X
caspases	B-X
cleave	B-X
and	B-X
activate	B-X
downstream	B-X
caspases	B-X
by	B-X
proteolysis	B-X
of	B-X
the	B-X
Asp-X	B-X
site	B-X
.	B-X
Activated	B-X
caspases	B-X
then	B-X
cleaved	B-X
target	B-X
substrates	B-X
.	B-X
To	B-X
date	B-X
,	B-X
more	B-X
than	B-X
70	B-X
proteins	B-X
have	B-X
been	B-X
identified	B-X
to	B-X
be	B-X
substrates	B-X
of	B-X
caspases	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Activation	B-X
of	B-X
NF-kappaB	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
phosphorylates	B-X
IkappaBalpha	B-X
at	B-X
the	B-X
residues	B-X
32	B-X
and	B-X
36	B-X
followed	B-X
by	B-X
polyubiquitination	B-X
at	B-X
lysine	B-X
21	B-X
and	B-X
22	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
the	B-X
molecules	B-X
by	B-X
26S	B-X
proteasome	B-X
.	B-X
On	B-X
the	B-X
one	B-X
hand	B-X
,	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
can	B-X
inactivate	B-X
caspases	B-X
;	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
activated	B-X
caspases	B-X
can	B-X
inhibit	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
.	B-X

Caspases	B-Gene_or_gene_product
are	O
activated	O
using	O
mechanisms	O
of	O
oligomeration	O
and	O
'	O
self	O
-	O
controlled	O
proteolysis	O
'	O
.	O
<EOS>	B-X
Caspases	B-X
are	B-X
activated	B-X
using	B-X
mechanisms	B-X
of	B-X
oligomeration	B-X
and	B-X
'self-controlled	B-X
proteolysis	B-X
'	B-X
.	B-X
In	B-X
general	B-X
,	B-X
upstream	B-X
caspases	B-X
cleave	B-X
and	B-X
activate	B-X
downstream	B-X
caspases	B-X
by	B-X
proteolysis	B-X
of	B-X
the	B-X
Asp-X	B-X
site	B-X
.	B-X
Caspases	B-X
can	B-X
alter	B-X
the	B-X
function	B-X
of	B-X
their	B-X
target	B-X
proteins	B-X
by	B-X
destroying	B-X
structural	B-X
components	B-X
of	B-X
the	B-X
cytoskeleton	B-X
and	B-X
nuclear	B-X
scaffold	B-X
or	B-X
by	B-X
removing	B-X
their	B-X
regulatory	B-X
domains	B-X
.	B-X
On	B-X
the	B-X
one	B-X
hand	B-X
,	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
can	B-X
inactivate	B-X
caspases	B-X
;	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
activated	B-X
caspases	B-X
can	B-X
inhibit	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Both	B-X
processes	B-X
involve	B-X
in	B-X
proteolysis	B-X
.	B-X

According	O
to	O
their	O
structures	O
and	O
functions	O
,	O
apoptosis	O
related	O
caspases	B-Gene_or_gene_product
can	O
be	O
divided	O
into	O
upstream	O
and	O
downstream	O
caspases	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
complex	B-X
promotes	B-X
activation	B-X
of	B-X
downstream	B-X
caspase	B-X
cascade	B-X
and	B-X
induces	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
According	B-X
to	B-X
their	B-X
structures	B-X
and	B-X
functions	B-X
,	B-X
apoptosis	B-X
related	B-X
caspases	B-X
can	B-X
be	B-X
divided	B-X
into	B-X
upstream	B-X
and	B-X
downstream	B-X
caspases	B-X
.	B-X
In	B-X
general	B-X
,	B-X
upstream	B-X
caspases	B-X
cleave	B-X
and	B-X
activate	B-X
downstream	B-X
caspases	B-X
by	B-X
proteolysis	B-X
of	B-X
the	B-X
Asp-X	B-X
site	B-X
.	B-X
Activated	B-X
caspases	B-X
then	B-X
cleaved	B-X
target	B-X
substrates	B-X
.	B-X
To	B-X
date	B-X
,	B-X
more	B-X
than	B-X
70	B-X
proteins	B-X
have	B-X
been	B-X
identified	B-X
to	B-X
be	B-X
substrates	B-X
of	B-X
caspases	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
one	B-X
hand	B-X
,	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
can	B-X
inactivate	B-X
caspases	B-X
;	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
activated	B-X
caspases	B-X
can	B-X
inhibit	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
.	B-X

In	O
general	O
,	O
upstream	O
caspases	B-Gene_or_gene_product
cleave	O
and	O
activate	O
downstream	O
caspases	B-Gene_or_gene_product
by	O
proteolysis	O
of	O
the	O
Asp	O
-	O
X	O
site	O
.	O
<EOS>	B-X
The	B-X
complex	B-X
promotes	B-X
activation	B-X
of	B-X
downstream	B-X
caspase	B-X
cascade	B-X
and	B-X
induces	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
Caspases	B-X
are	B-X
activated	B-X
using	B-X
mechanisms	B-X
of	B-X
oligomeration	B-X
and	B-X
'self-controlled	B-X
proteolysis	B-X
'	B-X
.	B-X
According	B-X
to	B-X
their	B-X
structures	B-X
and	B-X
functions	B-X
,	B-X
apoptosis	B-X
related	B-X
caspases	B-X
can	B-X
be	B-X
divided	B-X
into	B-X
upstream	B-X
and	B-X
downstream	B-X
caspases	B-X
.	B-X
In	B-X
general	B-X
,	B-X
upstream	B-X
caspases	B-X
cleave	B-X
and	B-X
activate	B-X
downstream	B-X
caspases	B-X
by	B-X
proteolysis	B-X
of	B-X
the	B-X
Asp-X	B-X
site	B-X
.	B-X
Activated	B-X
caspases	B-X
then	B-X
cleaved	B-X
target	B-X
substrates	B-X
.	B-X
To	B-X
date	B-X
,	B-X
more	B-X
than	B-X
70	B-X
proteins	B-X
have	B-X
been	B-X
identified	B-X
to	B-X
be	B-X
substrates	B-X
of	B-X
caspases	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
On	B-X
the	B-X
one	B-X
hand	B-X
,	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
can	B-X
inactivate	B-X
caspases	B-X
;	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
activated	B-X
caspases	B-X
can	B-X
inhibit	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
.	B-X
Both	B-X
processes	B-X
involve	B-X
in	B-X
proteolysis	B-X
.	B-X

Activated	O
caspases	B-Gene_or_gene_product
then	O
cleaved	O
target	O
substrates	O
.	O
<EOS>	B-X
The	B-X
pyroptosis	B-X
execution	B-X
protein	B-X
GSDMD	B-X
is	B-X
cleaved	B-X
by	B-X
inflammasome-activated	B-X
caspase-1	B-X
and	B-X
LPS-activated	B-X
caspase-11/4/5	B-X
.	B-X
How	B-X
the	B-X
caspases	B-X
recognize	B-X
GSDMD	B-X
and	B-X
its	B-X
connection	B-X
with	B-X
caspase	B-X
activation	B-X
are	B-X
unknown	B-X
.	B-X
Our	B-X
study	B-X
reveals	B-X
an	B-X
unprecedented	B-X
substrate-targeting	B-X
mechanism	B-X
for	B-X
caspases	B-X
.	B-X
The	B-X
hydrophobic	B-X
interface	B-X
suggests	B-X
an	B-X
additional	B-X
space	B-X
for	B-X
developing	B-X
inhibitors	B-X
specific	B-X
for	B-X
pyroptotic	B-X
caspases	B-X
.	B-X

To	O
date	O
,	O
more	O
than	O
70	O
proteins	O
have	O
been	O
identified	O
to	O
be	O
substrates	O
of	O
caspases	B-Gene_or_gene_product
in	O
mammalian	O
cells	O
.	O
<EOS>	B-X
According	B-X
to	B-X
their	B-X
structures	B-X
and	B-X
functions	B-X
,	B-X
apoptosis	B-X
related	B-X
caspases	B-X
can	B-X
be	B-X
divided	B-X
into	B-X
upstream	B-X
and	B-X
downstream	B-X
caspases	B-X
.	B-X
In	B-X
general	B-X
,	B-X
upstream	B-X
caspases	B-X
cleave	B-X
and	B-X
activate	B-X
downstream	B-X
caspases	B-X
by	B-X
proteolysis	B-X
of	B-X
the	B-X
Asp-X	B-X
site	B-X
.	B-X
Activated	B-X
caspases	B-X
then	B-X
cleaved	B-X
target	B-X
substrates	B-X
.	B-X
To	B-X
date	B-X
,	B-X
more	B-X
than	B-X
70	B-X
proteins	B-X
have	B-X
been	B-X
identified	B-X
to	B-X
be	B-X
substrates	B-X
of	B-X
caspases	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Caspases	B-X
can	B-X
alter	B-X
the	B-X
function	B-X
of	B-X
their	B-X
target	B-X
proteins	B-X
by	B-X
destroying	B-X
structural	B-X
components	B-X
of	B-X
the	B-X
cytoskeleton	B-X
and	B-X
nuclear	B-X
scaffold	B-X
or	B-X
by	B-X
removing	B-X
their	B-X
regulatory	B-X
domains	B-X
.	B-X
On	B-X
the	B-X
one	B-X
hand	B-X
,	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
can	B-X
inactivate	B-X
caspases	B-X
;	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
activated	B-X
caspases	B-X
can	B-X
inhibit	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
.	B-X

Caspases	B-Gene_or_gene_product
can	O
alter	O
the	O
function	O
of	O
their	O
target	O
proteins	O
by	O
destroying	O
structural	O
components	O
of	O
the	O
cytoskeleton	O
and	O
nuclear	O
scaffold	O
or	O
by	O
removing	O
their	O
regulatory	O
domains	O
.	O
<EOS>	B-X
Gasdermin	B-X
proteins	B-X
form	B-X
large	B-X
membrane	B-X
pores	B-X
in	B-X
human	B-X
cells	B-X
that	B-X
release	B-X
immune	B-X
cytokines	B-X
and	B-X
induce	B-X
lytic	B-X
cell	B-X
death	B-X
.	B-X
Autophagy	B-X
is	B-X
a	B-X
common	B-X
name	B-X
for	B-X
a	B-X
number	B-X
of	B-X
catabolic	B-X
processes	B-X
,	B-X
which	B-X
keep	B-X
the	B-X
cellular	B-X
homeostasis	B-X
by	B-X
removing	B-X
damaged	B-X
and	B-X
dysfunctional	B-X
intracellular	B-X
components	B-X
.	B-X
A	B-X
central	B-X
axis	B-X
of	B-X
autophagy	B-X
is	B-X
formed	B-X
along	B-X
the	B-X
interactions	B-X
of	B-X
autophagy	B-X
modifiers	B-X
(	B-X
Atg8-family	B-X
proteins	B-X
)	B-X
with	B-X
a	B-X
variety	B-X
of	B-X
their	B-X
cellular	B-X
counter	B-X
partners	B-X
.	B-X
Besides	B-X
autophagy	B-X
,	B-X
Atg8-proteins	B-X
participate	B-X
in	B-X
many	B-X
other	B-X
pathways	B-X
,	B-X
among	B-X
which	B-X
membrane	B-X
trafficking	B-X
and	B-X
neuronal	B-X
signaling	B-X
are	B-X
the	B-X
most	B-X
known	B-X
.	B-X
Despite	B-X
the	B-X
fact	B-X
that	B-X
autophagy	B-X
modifiers	B-X
are	B-X
well-studied	B-X
,	B-X
as	B-X
the	B-X
small	B-X
globular	B-X
proteins	B-X
show	B-X
similarity	B-X
to	B-X
ubiquitin	B-X
on	B-X
a	B-X
structural	B-X
level	B-X
,	B-X
the	B-X
mechanism	B-X
of	B-X
their	B-X
interactions	B-X
are	B-X
still	B-X
not	B-X
completely	B-X
understood	B-X
.	B-X
A	B-X
thorough	B-X
analysis	B-X
and	B-X
classification	B-X
of	B-X
all	B-X
known	B-X
mechanisms	B-X
of	B-X
Atg8-protein	B-X
interactions	B-X
could	B-X
shed	B-X
light	B-X
on	B-X
their	B-X
functioning	B-X
and	B-X
connect	B-X
the	B-X
pathways	B-X
involving	B-X
Atg8-proteins	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
we	B-X
present	B-X
our	B-X
views	B-X
of	B-X
the	B-X
key	B-X
features	B-X
of	B-X
the	B-X
Atg8-proteins	B-X
and	B-X
describe	B-X
the	B-X
basic	B-X
principles	B-X
of	B-X
their	B-X
recognition	B-X
and	B-X
binding	B-X
by	B-X
interaction	B-X
partners	B-X
.	B-X
We	B-X
discuss	B-X
affinity	B-X
and	B-X
selectivity	B-X
of	B-X
their	B-X
interactions	B-X
as	B-X
well	B-X
as	B-X
provide	B-X
perspectives	B-X
for	B-X
discovery	B-X
of	B-X
new	B-X
Atg8-interacting	B-X
proteins	B-X
and	B-X
therapeutic	B-X
approaches	B-X
to	B-X
tackle	B-X
major	B-X
human	B-X
diseases	B-X
.	B-X

Activation	O
of	O
NF	O
-	O
kappaB	O
is	O
dependent	O
on	O
the	O
degradation	O
of	O
IkappaBalpha	B-Gene_or_gene_product
.	O
<EOS>	B-X
This	B-X
leads	B-X
to	B-X
increased	B-X
interaction	B-X
between	B-X
IB	B-X
and	B-X
-calpain	B-X
protease	B-X
and	B-X
subsequent	B-X
-calpain-mediated	B-X
IB	B-X
degradation	B-X
and	B-X
NF-B	B-X
activation-dependent	B-X
transcriptional	B-X
upregulation	B-X
of	B-X
PD-L1	B-X
expression	B-X
.	B-X
Nuclear	B-X
factor	B-X
B	B-X
(	B-X
NF-B	B-X
)	B-X
is	B-X
a	B-X
transcription	B-X
factor	B-X
that	B-X
is	B-X
activated	B-X
by	B-X
all	B-X
pathogen-associated	B-X
stimuli	B-X
and	B-X
can	B-X
reprogram	B-X
the	B-X
epigenome	B-X
by	B-X
activating	B-X
latent	B-X
enhancers	B-X
.	B-X
However	B-X
,	B-X
we	B-X
show	B-X
that	B-X
NF-B	B-X
does	B-X
so	B-X
only	B-X
in	B-X
response	B-X
to	B-X
a	B-X
subset	B-X
of	B-X
stimuli	B-X
.	B-X
This	B-X
stimulus	B-X
specificity	B-X
depends	B-X
on	B-X
the	B-X
temporal	B-X
dynamics	B-X
of	B-X
NF-B	B-X
activity	B-X
,	B-X
in	B-X
particular	B-X
whether	B-X
it	B-X
is	B-X
oscillatory	B-X
or	B-X
non-oscillatory	B-X
.	B-X
Non-oscillatory	B-X
NF-B	B-X
opens	B-X
chromatin	B-X
by	B-X
sustained	B-X
disruption	B-X
of	B-X
nucleosomal	B-X
histone-DNA	B-X
interactions	B-X
,	B-X
enabling	B-X
activation	B-X
of	B-X
latent	B-X
enhancers	B-X
that	B-X
modulate	B-X
expression	B-X
of	B-X
immune	B-X
response	B-X
genes	B-X
.	B-X

IkappaB	O
kinase	O
(	O
IKK	O
)	O
phosphorylates	O
IkappaBalpha	B-Gene_or_gene_product
at	O
the	O
residues	O
32	O
and	O
36	O
followed	O
by	O
polyubiquitination	O
at	O
lysine	O
21	O
and	O
22	O
and	O
subsequent	O
degradation	O
of	O
the	O
molecules	O
by	O
26S	O
proteasome	O
.	O
<EOS>	B-X
Following	B-X
binding	B-X
its	B-X
death	B-X
receptor	B-X
on	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
induces	B-X
the	B-X
receptor	B-X
trimerization	B-X
and	B-X
recruits	B-X
a	B-X
number	B-X
of	B-X
death	B-X
domain-containing	B-X
molecules	B-X
to	B-X
form	B-X
the	B-X
receptor	B-X
complex	B-X
.	B-X
The	B-X
complex	B-X
promotes	B-X
activation	B-X
of	B-X
downstream	B-X
caspase	B-X
cascade	B-X
and	B-X
induces	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
Activation	B-X
of	B-X
NF-kappaB	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
phosphorylates	B-X
IkappaBalpha	B-X
at	B-X
the	B-X
residues	B-X
32	B-X
and	B-X
36	B-X
followed	B-X
by	B-X
polyubiquitination	B-X
at	B-X
lysine	B-X
21	B-X
and	B-X
22	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
the	B-X
molecules	B-X
by	B-X
26S	B-X
proteasome	B-X
.	B-X

There	O
is	O
extensive	O
crosstalk	O
between	O
the	O
apoptotic	O
and	O
NF	O
-	O
kappaB	O
signaling	O
pathways	O
that	O
emanate	O
from	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
R1	I-Gene_or_gene_product
.	O
<EOS>	B-X
Following	B-X
binding	B-X
its	B-X
death	B-X
receptor	B-X
on	B-X
the	B-X
plasma	B-X
membrane	B-X
,	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
induces	B-X
the	B-X
receptor	B-X
trimerization	B-X
and	B-X
recruits	B-X
a	B-X
number	B-X
of	B-X
death	B-X
domain-containing	B-X
molecules	B-X
to	B-X
form	B-X
the	B-X
receptor	B-X
complex	B-X
.	B-X
The	B-X
complex	B-X
promotes	B-X
activation	B-X
of	B-X
downstream	B-X
caspase	B-X
cascade	B-X
and	B-X
induces	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
Activation	B-X
of	B-X
NF-kappaB	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
degradation	B-X
of	B-X
IkappaBalpha	B-X
.	B-X
IkappaB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
phosphorylates	B-X
IkappaBalpha	B-X
at	B-X
the	B-X
residues	B-X
32	B-X
and	B-X
36	B-X
followed	B-X
by	B-X
polyubiquitination	B-X
at	B-X
lysine	B-X
21	B-X
and	B-X
22	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
the	B-X
molecules	B-X
by	B-X
26S	B-X
proteasome	B-X
.	B-X
There	B-X
is	B-X
extensive	B-X
crosstalk	B-X
between	B-X
the	B-X
apoptotic	B-X
and	B-X
NF-kappaB	B-X
signaling	B-X
pathways	B-X
that	B-X
emanate	B-X
from	B-X
TNF-R1	B-X
.	B-X
On	B-X
the	B-X
one	B-X
hand	B-X
,	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
can	B-X
inactivate	B-X
caspases	B-X
;	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
activated	B-X
caspases	B-X
can	B-X
inhibit	B-X
the	B-X
activation	B-X
of	B-X
NF-kappaB	B-X
.	B-X
This	B-X
crosstalk	B-X
may	B-X
be	B-X
important	B-X
for	B-X
maintaining	B-X
the	B-X
balance	B-X
between	B-X
the	B-X
two	B-X
pathways	B-X
and	B-X
for	B-X
determining	B-X
whether	B-X
a	B-X
cell	B-X
should	B-X
live	B-X
or	B-X
die	B-X
.	B-X

On	O
the	O
one	O
hand	O
,	O
activation	O
of	O
NF	O
-	O
kappaB	O
can	O
inactivate	O
caspases	B-Gene_or_gene_product
;	O
on	O
the	O
other	O
hand	O
,	O
activated	O
caspases	B-Gene_or_gene_product
can	O
inhibit	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
.	O
<EOS>	B-X
A	B-X
number	B-X
of	B-X
pulmonary	B-X
diseases	B-X
have	B-X
been	B-X
linked	B-X
to	B-X
the	B-X
activation	B-X
of	B-X
NF-B	B-X
and	B-X
the	B-X
NLRP3	B-X
inflammasome	B-X
.	B-X
Coomassie	B-X
brilliant	B-X
blue	B-X
G-250	B-X
(	B-X
CBBG	B-X
)	B-X
is	B-X
proved	B-X
to	B-X
be	B-X
a	B-X
safe	B-X
highly	B-X
selective	B-X
P27R	B-X
antagonist	B-X
with	B-X
promising	B-X
consequent	B-X
inactivation	B-X
of	B-X
NLRP3	B-X
inflammasome	B-X
.	B-X
It	B-X
also	B-X
exhibited	B-X
anti-inflammatory	B-X
potential	B-X
as	B-X
revealed	B-X
by	B-X
the	B-X
determination	B-X
of	B-X
TNF-	B-X
,	B-X
IL-1	B-X
,	B-X
IL-18	B-X
,	B-X
MCP-1	B-X
in	B-X
the	B-X
lung	B-X
tissue	B-X
.	B-X
The	B-X
lung	B-X
protective	B-X
effects	B-X
of	B-X
CBBG	B-X
might	B-X
be	B-X
attributed	B-X
on	B-X
the	B-X
one	B-X
hand	B-X
to	B-X
the	B-X
inhibition	B-X
of	B-X
NLRP3	B-X
inflammasome	B-X
and	B-X
on	B-X
the	B-X
other	B-X
hand	B-X
to	B-X
the	B-X
inactivation	B-X
of	B-X
NF-B	B-X
.	B-X
Decreased	B-X
levels	B-X
of	B-X
phospho-p65	B-X
and	B-X
its	B-X
DNA-binding	B-X
activity	B-X
as	B-X
well	B-X
as	B-X
the	B-X
analysis	B-X
of	B-X
TLR4	B-X
confirmed	B-X
NF-B	B-X
inactivation	B-X
.	B-X
Caspase-1	B-X
activity	B-X
is	B-X
suppressed	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
inhibiting	B-X
NLRP3	B-X
inflammasome	B-X
assembly	B-X
.	B-X

Both	O
processes	O
involve	O
in	O
proteolysis	O
.	O
<EOS>	B-X
Biochemical	B-X
processes	B-X
involved	B-X
in	B-X
complex	B-X
diseases	B-X
,	B-X
such	B-X
as	B-X
neurodegenerative	B-X
diseases	B-X
,	B-X
diabetes	B-X
and	B-X
cancer	B-X
,	B-X
can	B-X
be	B-X
identified	B-X
by	B-X
combining	B-X
proteomics	B-X
analysis	B-X
and	B-X
bioinformatics	B-X
tools	B-X
.	B-X
Eventually	B-X
,	B-X
terminomics	B-X
is	B-X
unveiling	B-X
new	B-X
functions	B-X
for	B-X
cleaved	B-X
proteoforms	B-X
,	B-X
by	B-X
analyzing	B-X
the	B-X
effect	B-X
of	B-X
proteolysis	B-X
globally	B-X
.	B-X
Interactomics	B-X
is	B-X
shedding	B-X
new	B-X
light	B-X
on	B-X
protein	B-X
complexes	B-X
truly	B-X
involved	B-X
in	B-X
biochemical	B-X
pathways	B-X
and	B-X
how	B-X
their	B-X
alteration	B-X
can	B-X
lead	B-X
to	B-X
dysfunctionality	B-X
(	B-X
in	B-X
disease	B-X
pathogenesis	B-X
,	B-X
for	B-X
example	B-X
)	B-X
.	B-X
Terminomics	B-X
is	B-X
revealing	B-X
the	B-X
function	B-X
of	B-X
new	B-X
discovered	B-X
proteoforms	B-X
and	B-X
attributing	B-X
a	B-X
novel	B-X
role	B-X
to	B-X
proteolysis	B-X
.	B-X

This	O
crosstalk	O
may	O
be	O
important	O
for	O
maintaining	O
the	O
balance	O
between	O
the	O
two	O
pathways	O
and	O
for	O
determining	O
whether	O
a	O
cell	O
should	O
live	O
or	O
die	O
.	O
<EOS>	B-X
The	B-X
quality	B-X
of	B-X
life	B-X
of	B-X
women	B-X
with	B-X
deep	B-X
infiltrating	B-X
endometriosis	B-X
(	B-X
DIE	B-X
)	B-X
is	B-X
impaired	B-X
and	B-X
may	B-X
improve	B-X
with	B-X
combined	B-X
oral	B-X
contraceptives	B-X
(	B-X
COCs	B-X
)	B-X
.	B-X
There	B-X
is	B-X
considerable	B-X
controversy	B-X
over	B-X
whether	B-X
to	B-X
allow	B-X
the	B-X
simulator	B-X
to	B-X
die	B-X
during	B-X
a	B-X
session	B-X
when	B-X
death	B-X
is	B-X
not	B-X
a	B-X
predefined	B-X
learning	B-X
objective	B-X
.	B-X
Some	B-X
educators	B-X
never	B-X
allow	B-X
the	B-X
simulator	B-X
to	B-X
die	B-X
unless	B-X
death	B-X
is	B-X
the	B-X
objective	B-X
of	B-X
the	B-X
scenario	B-X
,	B-X
and	B-X
others	B-X
allow	B-X
the	B-X
simulator	B-X
to	B-X
die	B-X
unexpectedly	B-X
during	B-X
any	B-X
scenario	B-X
.	B-X
We	B-X
do	B-X
not	B-X
know	B-X
whether	B-X
such	B-X
a	B-X
fatal	B-X
event	B-X
may	B-X
affect	B-X
a	B-X
student	B-X
's	B-X
learning	B-X
process	B-X
and	B-X
emotions	B-X
,	B-X
and	B-X
no	B-X
randomized	B-X
trials	B-X
have	B-X
been	B-X
conducted	B-X
to	B-X
determine	B-X
the	B-X
impact	B-X
of	B-X
simulated	B-X
death	B-X
.	B-X

The	O
roles	O
of	O
APC	B-Gene_or_gene_product
and	O
Axin	B-Gene_or_gene_product
derived	O
from	O
experimental	O
and	O
theoretical	O
analysis	O
of	O
the	O
Wnt	B-Gene_or_gene_product
pathway	O
.	O
<EOS>	B-X
Wnt	B-X
signaling	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
both	B-X
oncogenesis	B-X
and	B-X
development	B-X
.	B-X
Activation	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
results	B-X
in	B-X
stabilization	B-X
of	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
beta-catenin	B-X
.	B-X
Although	B-X
the	B-X
key	B-X
molecules	B-X
required	B-X
for	B-X
transducing	B-X
a	B-X
Wnt	B-X
signal	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
a	B-X
quantitative	B-X
understanding	B-X
of	B-X
this	B-X
pathway	B-X
has	B-X
been	B-X
lacking	B-X
.	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
for	B-X
the	B-X
canonical	B-X
Wnt	B-X
pathway	B-X
that	B-X
describes	B-X
the	B-X
interactions	B-X
among	B-X
the	B-X
core	B-X
components	B-X
:	B-X
Wnt	B-X
,	B-X
Frizzled	B-X
,	B-X
Dishevelled	B-X
,	B-X
GSK3beta	B-X
,	B-X
APC	B-X
,	B-X
axin	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
TCF	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X
We	B-X
predict	B-X
several	B-X
unusual	B-X
features	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
,	B-X
some	B-X
of	B-X
which	B-X
we	B-X
tested	B-X
experimentally	B-X
.	B-X
An	B-X
insight	B-X
from	B-X
our	B-X
model	B-X
,	B-X
which	B-X
we	B-X
confirmed	B-X
experimentally	B-X
,	B-X
is	B-X
that	B-X
the	B-X
two	B-X
scaffold	B-X
proteins	B-X
axin	B-X
and	B-X
APC	B-X
promote	B-X
the	B-X
formation	B-X
of	B-X
degradation	B-X
complexes	B-X
in	B-X
very	B-X
different	B-X
ways	B-X
.	B-X
We	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
importance	B-X
of	B-X
axin	B-X
degradation	B-X
in	B-X
amplifying	B-X
and	B-X
sharpening	B-X
the	B-X
Wnt	B-X
signal	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
the	B-X
dependence	B-X
of	B-X
axin	B-X
degradation	B-X
on	B-X
APC	B-X
is	B-X
an	B-X
essential	B-X
part	B-X
of	B-X
an	B-X
unappreciated	B-X
regulatory	B-X
loop	B-X
that	B-X
prevents	B-X
the	B-X
accumulation	B-X
of	B-X
beta-catenin	B-X
at	B-X
decreased	B-X
APC	B-X
concentrations	B-X
.	B-X
By	B-X
applying	B-X
control	B-X
analysis	B-X
to	B-X
our	B-X
mathematical	B-X
model	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
modular	B-X
design	B-X
,	B-X
sensitivity	B-X
,	B-X
and	B-X
robustness	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
and	B-X
derive	B-X
an	B-X
explicit	B-X
expression	B-X
for	B-X
tumor	B-X
suppression	B-X
and	B-X
oncogenicity	B-X
.	B-X

Wnt	B-Gene_or_gene_product
signaling	O
plays	O
an	O
important	O
role	O
in	O
both	O
oncogenesis	O
and	O
development	O
.	O
<EOS>	B-X
Ubiquitination	B-X
,	B-X
an	B-X
important	B-X
type	B-X
of	B-X
protein	B-X
posttranslational	B-X
modification	B-X
(	B-X
PTM	B-X
)	B-X
,	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
controlling	B-X
substrate	B-X
degradation	B-X
and	B-X
subsequently	B-X
mediates	B-X
the	B-X
``	B-X
quantity	B-X
''	B-X
and	B-X
``	B-X
quality	B-X
''	B-X
of	B-X
various	B-X
proteins	B-X
,	B-X
serving	B-X
to	B-X
ensure	B-X
cell	B-X
homeostasis	B-X
and	B-X
guarantee	B-X
life	B-X
activities	B-X
.	B-X
With	B-X
regard	B-X
to	B-X
tumor	B-X
metabolism	B-X
,	B-X
the	B-X
ubiquitination	B-X
of	B-X
some	B-X
key	B-X
proteins	B-X
such	B-X
as	B-X
RagA	B-X
,	B-X
mTOR	B-X
,	B-X
PTEN	B-X
,	B-X
AKT	B-X
,	B-X
c-Myc	B-X
and	B-X
P53	B-X
significantly	B-X
regulates	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
mTORC1	B-X
,	B-X
AMPK	B-X
and	B-X
PTEN-AKT	B-X
signaling	B-X
pathways	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
ubiquitination	B-X
in	B-X
the	B-X
TLR	B-X
,	B-X
RLR	B-X
and	B-X
STING-dependent	B-X
signaling	B-X
pathways	B-X
also	B-X
modulates	B-X
the	B-X
TME	B-X
.	B-X
Moreover	B-X
,	B-X
the	B-X
ubiquitination	B-X
of	B-X
core	B-X
stem	B-X
cell	B-X
regulator	B-X
triplets	B-X
(	B-X
Nanog	B-X
,	B-X
Oct4	B-X
and	B-X
Sox2	B-X
)	B-X
and	B-X
members	B-X
of	B-X
the	B-X
Wnt	B-X
and	B-X
Hippo-YAP	B-X
signaling	B-X
pathways	B-X
participates	B-X
in	B-X
the	B-X
maintenance	B-X
of	B-X
CSC	B-X
stemness	B-X
.	B-X

Activation	O
of	O
the	O
Wnt	B-Gene_or_gene_product
pathway	O
results	O
in	O
stabilization	O
of	O
the	O
transcriptional	O
coactivator	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Wnt/-catenin	B-X
signaling	B-X
pathway	B-X
is	B-X
crucial	B-X
to	B-X
regulate	B-X
cell	B-X
proliferation	B-X
and	B-X
polarity	B-X
,	B-X
cell	B-X
determination	B-X
,	B-X
and	B-X
tissue	B-X
homeostasis	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
Wnt/-catenin	B-X
signaling	B-X
is	B-X
based	B-X
on	B-X
the	B-X
interaction	B-X
between	B-X
Wnt	B-X
glycoproteins	B-X
and	B-X
seven	B-X
transmembrane	B-X
receptors-Frizzled	B-X
(	B-X
Fzd	B-X
)	B-X
.	B-X
This	B-X
binding	B-X
promotes	B-X
recruitment	B-X
of	B-X
the	B-X
scaffolding	B-X
protein	B-X
Disheveled	B-X
(	B-X
Dvl	B-X
)	B-X
,	B-X
which	B-X
results	B-X
in	B-X
the	B-X
phosphorylation	B-X
of	B-X
the	B-X
co-receptor	B-X
LRP5/6	B-X
.	B-X
The	B-X
resultant	B-X
molecular	B-X
complex	B-X
Wnt-Fzd-LRP5/6-Dvl	B-X
forms	B-X
a	B-X
structural	B-X
region	B-X
for	B-X
Axin	B-X
interaction	B-X
that	B-X
disrupts	B-X
Axin-mediated	B-X
phosphorylation/degradation	B-X
of	B-X
the	B-X
transcriptional	B-X
co-activator	B-X
-catenin	B-X
,	B-X
thereby	B-X
allowing	B-X
it	B-X
to	B-X
stabilize	B-X
and	B-X
accumulate	B-X
in	B-X
the	B-X
nucleus	B-X
where	B-X
it	B-X
activates	B-X
the	B-X
expression	B-X
of	B-X
Wnt-dependent	B-X
genes	B-X
.	B-X
Due	B-X
to	B-X
the	B-X
prominent	B-X
physiological	B-X
function	B-X
,	B-X
the	B-X
Wnt/-catenin	B-X
signaling	B-X
must	B-X
be	B-X
strictly	B-X
controlled	B-X
because	B-X
its	B-X
dysregulation	B-X
,	B-X
which	B-X
is	B-X
caused	B-X
by	B-X
different	B-X
stimuli	B-X
,	B-X
may	B-X
lead	B-X
to	B-X
alterations	B-X
in	B-X
cell	B-X
proliferation	B-X
,	B-X
apoptosis	B-X
,	B-X
and	B-X
inflammation-associated	B-X
cancer	B-X
.	B-X

Recent	O
studies	O
have	O
demonstrated	O
that	O
axin	B-Gene_or_gene_product
,	O
which	O
coordinates	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
degradation	O
,	O
is	O
itself	O
degraded	O
.	O
<EOS>	B-X
Activation	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
results	B-X
in	B-X
stabilization	B-X
of	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
beta-catenin	B-X
.	B-X
Recent	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
axin	B-X
,	B-X
which	B-X
coordinates	B-X
beta-catenin	B-X
degradation	B-X
,	B-X
is	B-X
itself	B-X
degraded	B-X
.	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
for	B-X
the	B-X
canonical	B-X
Wnt	B-X
pathway	B-X
that	B-X
describes	B-X
the	B-X
interactions	B-X
among	B-X
the	B-X
core	B-X
components	B-X
:	B-X
Wnt	B-X
,	B-X
Frizzled	B-X
,	B-X
Dishevelled	B-X
,	B-X
GSK3beta	B-X
,	B-X
APC	B-X
,	B-X
axin	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
TCF	B-X
.	B-X
Using	B-X
a	B-X
system	B-X
of	B-X
differential	B-X
equations	B-X
,	B-X
the	B-X
model	B-X
incorporates	B-X
the	B-X
kinetics	B-X
of	B-X
protein-protein	B-X
interactions	B-X
,	B-X
protein	B-X
synthesis/degradation	B-X
,	B-X
and	B-X
phosphorylation/dephosphorylation	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X
An	B-X
insight	B-X
from	B-X
our	B-X
model	B-X
,	B-X
which	B-X
we	B-X
confirmed	B-X
experimentally	B-X
,	B-X
is	B-X
that	B-X
the	B-X
two	B-X
scaffold	B-X
proteins	B-X
axin	B-X
and	B-X
APC	B-X
promote	B-X
the	B-X
formation	B-X
of	B-X
degradation	B-X
complexes	B-X
in	B-X
very	B-X
different	B-X
ways	B-X
.	B-X
We	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
importance	B-X
of	B-X
axin	B-X
degradation	B-X
in	B-X
amplifying	B-X
and	B-X
sharpening	B-X
the	B-X
Wnt	B-X
signal	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
the	B-X
dependence	B-X
of	B-X
axin	B-X
degradation	B-X
on	B-X
APC	B-X
is	B-X
an	B-X
essential	B-X
part	B-X
of	B-X
an	B-X
unappreciated	B-X
regulatory	B-X
loop	B-X
that	B-X
prevents	B-X
the	B-X
accumulation	B-X
of	B-X
beta-catenin	B-X
at	B-X
decreased	B-X
APC	B-X
concentrations	B-X
.	B-X

Although	O
the	O
key	O
molecules	O
required	O
for	O
transducing	O
a	O
Wnt	B-Gene_or_gene_product
signal	O
have	O
been	O
identified	O
,	O
a	O
quantitative	O
understanding	O
of	O
this	O
pathway	O
has	O
been	O
lacking	O
.	O
<EOS>	B-X
Wnt/-catenin	B-X
signaling	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
both	B-X
ontogenesis	B-X
and	B-X
development	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
a	B-X
Wnt	B-X
stimulus	B-X
,	B-X
-catenin	B-X
is	B-X
degraded	B-X
by	B-X
a	B-X
multiprotein	B-X
``	B-X
destruction	B-X
complex	B-X
''	B-X
that	B-X
includes	B-X
Axin	B-X
,	B-X
APC	B-X
,	B-X
GSK3B	B-X
,	B-X
and	B-X
FBXW11	B-X
.	B-X
Although	B-X
the	B-X
key	B-X
molecules	B-X
required	B-X
for	B-X
transducing	B-X
Wnt	B-X
signals	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
a	B-X
quantitative	B-X
understanding	B-X
of	B-X
this	B-X
pathway	B-X
has	B-X
been	B-X
lacking	B-X
.	B-X
Similar	B-X
amounts	B-X
of	B-X
destruction	B-X
complex-constituting	B-X
proteins	B-X
and	B-X
-catenin	B-X
interacted	B-X
,	B-X
and	B-X
the	B-X
number	B-X
of	B-X
destruction	B-X
complexes	B-X
was	B-X
calculated	B-X
to	B-X
be	B-X
about	B-X
1468	B-X
molecules/cell	B-X
.	B-X
Interestingly	B-X
,	B-X
APC	B-X
had	B-X
the	B-X
minimum	B-X
expression	B-X
level	B-X
among	B-X
the	B-X
destruction	B-X
complex	B-X
components	B-X
at	B-X
about	B-X
2233	B-X
molecules/cell	B-X
,	B-X
and	B-X
this	B-X
number	B-X
approximately	B-X
corresponded	B-X
to	B-X
the	B-X
calculated	B-X
number	B-X
of	B-X
destruction	B-X
complexes	B-X
.	B-X

We	O
have	O
developed	O
a	O
mathematical	O
model	O
for	O
the	O
canonical	O
Wnt	B-Gene_or_gene_product
pathway	O
that	O
describes	O
the	O
interactions	O
among	O
the	O
core	O
components	O
:	O
Wnt	B-Gene_or_gene_product
,	O
Frizzled	B-Gene_or_gene_product
,	O
Dishevelled	B-Gene_or_gene_product
,	O
GSK3beta	B-Gene_or_gene_product
,	O
APC	B-Gene_or_gene_product
,	O
axin	B-Gene_or_gene_product
,	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
,	O
and	O
TCF	B-Gene_or_gene_product
.	O
<EOS>	B-X
Wnt	B-X
signaling	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
both	B-X
oncogenesis	B-X
and	B-X
development	B-X
.	B-X
Activation	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
results	B-X
in	B-X
stabilization	B-X
of	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
beta-catenin	B-X
.	B-X
Recent	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
axin	B-X
,	B-X
which	B-X
coordinates	B-X
beta-catenin	B-X
degradation	B-X
,	B-X
is	B-X
itself	B-X
degraded	B-X
.	B-X
Although	B-X
the	B-X
key	B-X
molecules	B-X
required	B-X
for	B-X
transducing	B-X
a	B-X
Wnt	B-X
signal	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
a	B-X
quantitative	B-X
understanding	B-X
of	B-X
this	B-X
pathway	B-X
has	B-X
been	B-X
lacking	B-X
.	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
for	B-X
the	B-X
canonical	B-X
Wnt	B-X
pathway	B-X
that	B-X
describes	B-X
the	B-X
interactions	B-X
among	B-X
the	B-X
core	B-X
components	B-X
:	B-X
Wnt	B-X
,	B-X
Frizzled	B-X
,	B-X
Dishevelled	B-X
,	B-X
GSK3beta	B-X
,	B-X
APC	B-X
,	B-X
axin	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
TCF	B-X
.	B-X
Using	B-X
a	B-X
system	B-X
of	B-X
differential	B-X
equations	B-X
,	B-X
the	B-X
model	B-X
incorporates	B-X
the	B-X
kinetics	B-X
of	B-X
protein-protein	B-X
interactions	B-X
,	B-X
protein	B-X
synthesis/degradation	B-X
,	B-X
and	B-X
phosphorylation/dephosphorylation	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X
We	B-X
predict	B-X
several	B-X
unusual	B-X
features	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
,	B-X
some	B-X
of	B-X
which	B-X
we	B-X
tested	B-X
experimentally	B-X
.	B-X
An	B-X
insight	B-X
from	B-X
our	B-X
model	B-X
,	B-X
which	B-X
we	B-X
confirmed	B-X
experimentally	B-X
,	B-X
is	B-X
that	B-X
the	B-X
two	B-X
scaffold	B-X
proteins	B-X
axin	B-X
and	B-X
APC	B-X
promote	B-X
the	B-X
formation	B-X
of	B-X
degradation	B-X
complexes	B-X
in	B-X
very	B-X
different	B-X
ways	B-X
.	B-X
We	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
importance	B-X
of	B-X
axin	B-X
degradation	B-X
in	B-X
amplifying	B-X
and	B-X
sharpening	B-X
the	B-X
Wnt	B-X
signal	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
the	B-X
dependence	B-X
of	B-X
axin	B-X
degradation	B-X
on	B-X
APC	B-X
is	B-X
an	B-X
essential	B-X
part	B-X
of	B-X
an	B-X
unappreciated	B-X
regulatory	B-X
loop	B-X
that	B-X
prevents	B-X
the	B-X
accumulation	B-X
of	B-X
beta-catenin	B-X
at	B-X
decreased	B-X
APC	B-X
concentrations	B-X
.	B-X
By	B-X
applying	B-X
control	B-X
analysis	B-X
to	B-X
our	B-X
mathematical	B-X
model	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
modular	B-X
design	B-X
,	B-X
sensitivity	B-X
,	B-X
and	B-X
robustness	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
and	B-X
derive	B-X
an	B-X
explicit	B-X
expression	B-X
for	B-X
tumor	B-X
suppression	B-X
and	B-X
oncogenicity	B-X
.	B-X

Using	O
a	O
system	O
of	O
differential	O
equations	O
,	O
the	O
model	O
incorporates	O
the	O
kinetics	O
of	O
protein	O
-	O
protein	O
interactions	O
,	O
protein	O
synthesis	O
/	O
degradation	O
,	O
and	O
phosphorylation	O
/	O
dephosphorylation	O
.	O
<EOS>	B-X
Recent	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
axin	B-X
,	B-X
which	B-X
coordinates	B-X
beta-catenin	B-X
degradation	B-X
,	B-X
is	B-X
itself	B-X
degraded	B-X
.	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
for	B-X
the	B-X
canonical	B-X
Wnt	B-X
pathway	B-X
that	B-X
describes	B-X
the	B-X
interactions	B-X
among	B-X
the	B-X
core	B-X
components	B-X
:	B-X
Wnt	B-X
,	B-X
Frizzled	B-X
,	B-X
Dishevelled	B-X
,	B-X
GSK3beta	B-X
,	B-X
APC	B-X
,	B-X
axin	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
TCF	B-X
.	B-X
Using	B-X
a	B-X
system	B-X
of	B-X
differential	B-X
equations	B-X
,	B-X
the	B-X
model	B-X
incorporates	B-X
the	B-X
kinetics	B-X
of	B-X
protein-protein	B-X
interactions	B-X
,	B-X
protein	B-X
synthesis/degradation	B-X
,	B-X
and	B-X
phosphorylation/dephosphorylation	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X
An	B-X
insight	B-X
from	B-X
our	B-X
model	B-X
,	B-X
which	B-X
we	B-X
confirmed	B-X
experimentally	B-X
,	B-X
is	B-X
that	B-X
the	B-X
two	B-X
scaffold	B-X
proteins	B-X
axin	B-X
and	B-X
APC	B-X
promote	B-X
the	B-X
formation	B-X
of	B-X
degradation	B-X
complexes	B-X
in	B-X
very	B-X
different	B-X
ways	B-X
.	B-X
We	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
importance	B-X
of	B-X
axin	B-X
degradation	B-X
in	B-X
amplifying	B-X
and	B-X
sharpening	B-X
the	B-X
Wnt	B-X
signal	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
the	B-X
dependence	B-X
of	B-X
axin	B-X
degradation	B-X
on	B-X
APC	B-X
is	B-X
an	B-X
essential	B-X
part	B-X
of	B-X
an	B-X
unappreciated	B-X
regulatory	B-X
loop	B-X
that	B-X
prevents	B-X
the	B-X
accumulation	B-X
of	B-X
beta-catenin	B-X
at	B-X
decreased	B-X
APC	B-X
concentrations	B-X
.	B-X
By	B-X
applying	B-X
control	B-X
analysis	B-X
to	B-X
our	B-X
mathematical	B-X
model	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
modular	B-X
design	B-X
,	B-X
sensitivity	B-X
,	B-X
and	B-X
robustness	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
and	B-X
derive	B-X
an	B-X
explicit	B-X
expression	B-X
for	B-X
tumor	B-X
suppression	B-X
and	B-X
oncogenicity	B-X
.	B-X

We	O
initially	O
defined	O
a	O
reference	O
state	O
of	O
kinetic	O
,	O
thermodynamic	O
,	O
and	O
flux	O
data	O
from	O
experiments	O
using	O
Xenopus	O
extracts	O
.	O
<EOS>	B-X
Using	B-X
a	B-X
system	B-X
of	B-X
differential	B-X
equations	B-X
,	B-X
the	B-X
model	B-X
incorporates	B-X
the	B-X
kinetics	B-X
of	B-X
protein-protein	B-X
interactions	B-X
,	B-X
protein	B-X
synthesis/degradation	B-X
,	B-X
and	B-X
phosphorylation/dephosphorylation	B-X
.	B-X
We	B-X
initially	B-X
defined	B-X
a	B-X
reference	B-X
state	B-X
of	B-X
kinetic	B-X
,	B-X
thermodynamic	B-X
,	B-X
and	B-X
flux	B-X
data	B-X
from	B-X
experiments	B-X
using	B-X
Xenopus	B-X
extracts	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X

Predictions	O
based	O
on	O
the	O
analysis	O
of	O
the	O
reference	O
state	O
were	O
used	O
iteratively	O
to	O
develop	O
a	O
more	O
refined	O
model	O
from	O
which	O
we	O
analyzed	O
the	O
effects	O
of	O
prolonged	O
and	O
transient	O
Wnt	B-Gene_or_gene_product
stimulation	O
on	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
axin	B-Gene_or_gene_product
turnover	O
.	O

We	O
predict	O
several	O
unusual	O
features	O
of	O
the	O
Wnt	B-Gene_or_gene_product
pathway	O
,	O
some	O
of	O
which	O
we	O
tested	O
experimentally	O
.	O
<EOS>	B-X
Wnt	B-X
signaling	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
both	B-X
oncogenesis	B-X
and	B-X
development	B-X
.	B-X
Activation	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
results	B-X
in	B-X
stabilization	B-X
of	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
beta-catenin	B-X
.	B-X
Although	B-X
the	B-X
key	B-X
molecules	B-X
required	B-X
for	B-X
transducing	B-X
a	B-X
Wnt	B-X
signal	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
a	B-X
quantitative	B-X
understanding	B-X
of	B-X
this	B-X
pathway	B-X
has	B-X
been	B-X
lacking	B-X
.	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
for	B-X
the	B-X
canonical	B-X
Wnt	B-X
pathway	B-X
that	B-X
describes	B-X
the	B-X
interactions	B-X
among	B-X
the	B-X
core	B-X
components	B-X
:	B-X
Wnt	B-X
,	B-X
Frizzled	B-X
,	B-X
Dishevelled	B-X
,	B-X
GSK3beta	B-X
,	B-X
APC	B-X
,	B-X
axin	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
TCF	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X
We	B-X
predict	B-X
several	B-X
unusual	B-X
features	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
,	B-X
some	B-X
of	B-X
which	B-X
we	B-X
tested	B-X
experimentally	B-X
.	B-X
An	B-X
insight	B-X
from	B-X
our	B-X
model	B-X
,	B-X
which	B-X
we	B-X
confirmed	B-X
experimentally	B-X
,	B-X
is	B-X
that	B-X
the	B-X
two	B-X
scaffold	B-X
proteins	B-X
axin	B-X
and	B-X
APC	B-X
promote	B-X
the	B-X
formation	B-X
of	B-X
degradation	B-X
complexes	B-X
in	B-X
very	B-X
different	B-X
ways	B-X
.	B-X
We	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
importance	B-X
of	B-X
axin	B-X
degradation	B-X
in	B-X
amplifying	B-X
and	B-X
sharpening	B-X
the	B-X
Wnt	B-X
signal	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
the	B-X
dependence	B-X
of	B-X
axin	B-X
degradation	B-X
on	B-X
APC	B-X
is	B-X
an	B-X
essential	B-X
part	B-X
of	B-X
an	B-X
unappreciated	B-X
regulatory	B-X
loop	B-X
that	B-X
prevents	B-X
the	B-X
accumulation	B-X
of	B-X
beta-catenin	B-X
at	B-X
decreased	B-X
APC	B-X
concentrations	B-X
.	B-X
By	B-X
applying	B-X
control	B-X
analysis	B-X
to	B-X
our	B-X
mathematical	B-X
model	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
modular	B-X
design	B-X
,	B-X
sensitivity	B-X
,	B-X
and	B-X
robustness	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
and	B-X
derive	B-X
an	B-X
explicit	B-X
expression	B-X
for	B-X
tumor	B-X
suppression	B-X
and	B-X
oncogenicity	B-X
.	B-X

An	O
insight	O
from	O
our	O
model	O
,	O
which	O
we	O
confirmed	O
experimentally	O
,	O
is	O
that	O
the	O
two	O
scaffold	O
proteins	O
axin	B-Gene_or_gene_product
and	O
APC	B-Gene_or_gene_product
promote	O
the	O
formation	O
of	O
degradation	O
complexes	O
in	O
very	O
different	O
ways	O
.	O
<EOS>	B-X
Recent	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
axin	B-X
,	B-X
which	B-X
coordinates	B-X
beta-catenin	B-X
degradation	B-X
,	B-X
is	B-X
itself	B-X
degraded	B-X
.	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
for	B-X
the	B-X
canonical	B-X
Wnt	B-X
pathway	B-X
that	B-X
describes	B-X
the	B-X
interactions	B-X
among	B-X
the	B-X
core	B-X
components	B-X
:	B-X
Wnt	B-X
,	B-X
Frizzled	B-X
,	B-X
Dishevelled	B-X
,	B-X
GSK3beta	B-X
,	B-X
APC	B-X
,	B-X
axin	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
TCF	B-X
.	B-X
Using	B-X
a	B-X
system	B-X
of	B-X
differential	B-X
equations	B-X
,	B-X
the	B-X
model	B-X
incorporates	B-X
the	B-X
kinetics	B-X
of	B-X
protein-protein	B-X
interactions	B-X
,	B-X
protein	B-X
synthesis/degradation	B-X
,	B-X
and	B-X
phosphorylation/dephosphorylation	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X
We	B-X
predict	B-X
several	B-X
unusual	B-X
features	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
,	B-X
some	B-X
of	B-X
which	B-X
we	B-X
tested	B-X
experimentally	B-X
.	B-X
An	B-X
insight	B-X
from	B-X
our	B-X
model	B-X
,	B-X
which	B-X
we	B-X
confirmed	B-X
experimentally	B-X
,	B-X
is	B-X
that	B-X
the	B-X
two	B-X
scaffold	B-X
proteins	B-X
axin	B-X
and	B-X
APC	B-X
promote	B-X
the	B-X
formation	B-X
of	B-X
degradation	B-X
complexes	B-X
in	B-X
very	B-X
different	B-X
ways	B-X
.	B-X
We	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
importance	B-X
of	B-X
axin	B-X
degradation	B-X
in	B-X
amplifying	B-X
and	B-X
sharpening	B-X
the	B-X
Wnt	B-X
signal	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
the	B-X
dependence	B-X
of	B-X
axin	B-X
degradation	B-X
on	B-X
APC	B-X
is	B-X
an	B-X
essential	B-X
part	B-X
of	B-X
an	B-X
unappreciated	B-X
regulatory	B-X
loop	B-X
that	B-X
prevents	B-X
the	B-X
accumulation	B-X
of	B-X
beta-catenin	B-X
at	B-X
decreased	B-X
APC	B-X
concentrations	B-X
.	B-X
By	B-X
applying	B-X
control	B-X
analysis	B-X
to	B-X
our	B-X
mathematical	B-X
model	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
modular	B-X
design	B-X
,	B-X
sensitivity	B-X
,	B-X
and	B-X
robustness	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
and	B-X
derive	B-X
an	B-X
explicit	B-X
expression	B-X
for	B-X
tumor	B-X
suppression	B-X
and	B-X
oncogenicity	B-X
.	B-X

We	O
can	O
also	O
explain	O
the	O
importance	O
of	O
axin	B-Gene_or_gene_product
degradation	O
in	O
amplifying	O
and	O
sharpening	O
the	O
Wnt	B-Gene_or_gene_product
signal	O
,	O
and	O
we	O
show	O
that	O
the	O
dependence	O
of	O
axin	B-Gene_or_gene_product
degradation	O
on	O
APC	B-Gene_or_gene_product
is	O
an	O
essential	O
part	O
of	O
an	O
unappreciated	O
regulatory	O
loop	O
that	O
prevents	O
the	O
accumulation	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
at	O
decreased	O
APC	B-Gene_or_gene_product
concentrations	O
.	O
<EOS>	B-X
Wnt	B-X
signaling	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
both	B-X
oncogenesis	B-X
and	B-X
development	B-X
.	B-X
Activation	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
results	B-X
in	B-X
stabilization	B-X
of	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
beta-catenin	B-X
.	B-X
Recent	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
axin	B-X
,	B-X
which	B-X
coordinates	B-X
beta-catenin	B-X
degradation	B-X
,	B-X
is	B-X
itself	B-X
degraded	B-X
.	B-X
Although	B-X
the	B-X
key	B-X
molecules	B-X
required	B-X
for	B-X
transducing	B-X
a	B-X
Wnt	B-X
signal	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
a	B-X
quantitative	B-X
understanding	B-X
of	B-X
this	B-X
pathway	B-X
has	B-X
been	B-X
lacking	B-X
.	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
for	B-X
the	B-X
canonical	B-X
Wnt	B-X
pathway	B-X
that	B-X
describes	B-X
the	B-X
interactions	B-X
among	B-X
the	B-X
core	B-X
components	B-X
:	B-X
Wnt	B-X
,	B-X
Frizzled	B-X
,	B-X
Dishevelled	B-X
,	B-X
GSK3beta	B-X
,	B-X
APC	B-X
,	B-X
axin	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
TCF	B-X
.	B-X
Using	B-X
a	B-X
system	B-X
of	B-X
differential	B-X
equations	B-X
,	B-X
the	B-X
model	B-X
incorporates	B-X
the	B-X
kinetics	B-X
of	B-X
protein-protein	B-X
interactions	B-X
,	B-X
protein	B-X
synthesis/degradation	B-X
,	B-X
and	B-X
phosphorylation/dephosphorylation	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X
We	B-X
predict	B-X
several	B-X
unusual	B-X
features	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
,	B-X
some	B-X
of	B-X
which	B-X
we	B-X
tested	B-X
experimentally	B-X
.	B-X
An	B-X
insight	B-X
from	B-X
our	B-X
model	B-X
,	B-X
which	B-X
we	B-X
confirmed	B-X
experimentally	B-X
,	B-X
is	B-X
that	B-X
the	B-X
two	B-X
scaffold	B-X
proteins	B-X
axin	B-X
and	B-X
APC	B-X
promote	B-X
the	B-X
formation	B-X
of	B-X
degradation	B-X
complexes	B-X
in	B-X
very	B-X
different	B-X
ways	B-X
.	B-X
We	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
importance	B-X
of	B-X
axin	B-X
degradation	B-X
in	B-X
amplifying	B-X
and	B-X
sharpening	B-X
the	B-X
Wnt	B-X
signal	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
the	B-X
dependence	B-X
of	B-X
axin	B-X
degradation	B-X
on	B-X
APC	B-X
is	B-X
an	B-X
essential	B-X
part	B-X
of	B-X
an	B-X
unappreciated	B-X
regulatory	B-X
loop	B-X
that	B-X
prevents	B-X
the	B-X
accumulation	B-X
of	B-X
beta-catenin	B-X
at	B-X
decreased	B-X
APC	B-X
concentrations	B-X
.	B-X
By	B-X
applying	B-X
control	B-X
analysis	B-X
to	B-X
our	B-X
mathematical	B-X
model	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
modular	B-X
design	B-X
,	B-X
sensitivity	B-X
,	B-X
and	B-X
robustness	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
and	B-X
derive	B-X
an	B-X
explicit	B-X
expression	B-X
for	B-X
tumor	B-X
suppression	B-X
and	B-X
oncogenicity	B-X
.	B-X

By	O
applying	O
control	O
analysis	O
to	O
our	O
mathematical	O
model	O
,	O
we	O
demonstrate	O
the	O
modular	O
design	O
,	O
sensitivity	O
,	O
and	O
robustness	O
of	O
the	O
Wnt	B-Gene_or_gene_product
pathway	O
and	O
derive	O
an	O
explicit	O
expression	O
for	O
tumor	O
suppression	O
and	O
oncogenicity	O
.	O
<EOS>	B-X
Wnt	B-X
signaling	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
both	B-X
oncogenesis	B-X
and	B-X
development	B-X
.	B-X
Activation	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
results	B-X
in	B-X
stabilization	B-X
of	B-X
the	B-X
transcriptional	B-X
coactivator	B-X
beta-catenin	B-X
.	B-X
Recent	B-X
studies	B-X
have	B-X
demonstrated	B-X
that	B-X
axin	B-X
,	B-X
which	B-X
coordinates	B-X
beta-catenin	B-X
degradation	B-X
,	B-X
is	B-X
itself	B-X
degraded	B-X
.	B-X
Although	B-X
the	B-X
key	B-X
molecules	B-X
required	B-X
for	B-X
transducing	B-X
a	B-X
Wnt	B-X
signal	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
a	B-X
quantitative	B-X
understanding	B-X
of	B-X
this	B-X
pathway	B-X
has	B-X
been	B-X
lacking	B-X
.	B-X
We	B-X
have	B-X
developed	B-X
a	B-X
mathematical	B-X
model	B-X
for	B-X
the	B-X
canonical	B-X
Wnt	B-X
pathway	B-X
that	B-X
describes	B-X
the	B-X
interactions	B-X
among	B-X
the	B-X
core	B-X
components	B-X
:	B-X
Wnt	B-X
,	B-X
Frizzled	B-X
,	B-X
Dishevelled	B-X
,	B-X
GSK3beta	B-X
,	B-X
APC	B-X
,	B-X
axin	B-X
,	B-X
beta-catenin	B-X
,	B-X
and	B-X
TCF	B-X
.	B-X
Using	B-X
a	B-X
system	B-X
of	B-X
differential	B-X
equations	B-X
,	B-X
the	B-X
model	B-X
incorporates	B-X
the	B-X
kinetics	B-X
of	B-X
protein-protein	B-X
interactions	B-X
,	B-X
protein	B-X
synthesis/degradation	B-X
,	B-X
and	B-X
phosphorylation/dephosphorylation	B-X
.	B-X
Predictions	B-X
based	B-X
on	B-X
the	B-X
analysis	B-X
of	B-X
the	B-X
reference	B-X
state	B-X
were	B-X
used	B-X
iteratively	B-X
to	B-X
develop	B-X
a	B-X
more	B-X
refined	B-X
model	B-X
from	B-X
which	B-X
we	B-X
analyzed	B-X
the	B-X
effects	B-X
of	B-X
prolonged	B-X
and	B-X
transient	B-X
Wnt	B-X
stimulation	B-X
on	B-X
beta-catenin	B-X
and	B-X
axin	B-X
turnover	B-X
.	B-X
We	B-X
predict	B-X
several	B-X
unusual	B-X
features	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
,	B-X
some	B-X
of	B-X
which	B-X
we	B-X
tested	B-X
experimentally	B-X
.	B-X
An	B-X
insight	B-X
from	B-X
our	B-X
model	B-X
,	B-X
which	B-X
we	B-X
confirmed	B-X
experimentally	B-X
,	B-X
is	B-X
that	B-X
the	B-X
two	B-X
scaffold	B-X
proteins	B-X
axin	B-X
and	B-X
APC	B-X
promote	B-X
the	B-X
formation	B-X
of	B-X
degradation	B-X
complexes	B-X
in	B-X
very	B-X
different	B-X
ways	B-X
.	B-X
We	B-X
can	B-X
also	B-X
explain	B-X
the	B-X
importance	B-X
of	B-X
axin	B-X
degradation	B-X
in	B-X
amplifying	B-X
and	B-X
sharpening	B-X
the	B-X
Wnt	B-X
signal	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
the	B-X
dependence	B-X
of	B-X
axin	B-X
degradation	B-X
on	B-X
APC	B-X
is	B-X
an	B-X
essential	B-X
part	B-X
of	B-X
an	B-X
unappreciated	B-X
regulatory	B-X
loop	B-X
that	B-X
prevents	B-X
the	B-X
accumulation	B-X
of	B-X
beta-catenin	B-X
at	B-X
decreased	B-X
APC	B-X
concentrations	B-X
.	B-X
By	B-X
applying	B-X
control	B-X
analysis	B-X
to	B-X
our	B-X
mathematical	B-X
model	B-X
,	B-X
we	B-X
demonstrate	B-X
the	B-X
modular	B-X
design	B-X
,	B-X
sensitivity	B-X
,	B-X
and	B-X
robustness	B-X
of	B-X
the	B-X
Wnt	B-X
pathway	B-X
and	B-X
derive	B-X
an	B-X
explicit	B-X
expression	B-X
for	B-X
tumor	B-X
suppression	B-X
and	B-X
oncogenicity	B-X
.	B-X

Characterizing	O
the	O
role	O
of	O
MDM2	B-Gene_or_gene_product
in	O
diethylnitrosamine	O
induced	O
acute	O
liver	O
damage	O
and	O
development	O
of	O
pre	O
-	O
neoplastic	O
lesions	O
.	O
<EOS>	B-X
Pre-neoplastic	B-X
lesions	B-X
in	B-X
rodent	B-X
liver	B-X
often	B-X
express	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
and	B-X
lack	B-X
a	B-X
p53	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X

Pre	O
-	O
neoplastic	O
lesions	O
in	O
rodent	O
liver	O
often	O
express	O
high	O
levels	O
of	O
MDM2	B-Gene_or_gene_product
and	O
lack	O
a	O
p53	B-Gene_or_gene_product
response	O
to	O
DNA	O
damage	O
.	O

The	O
question	O
we	O
posed	O
was	O
whether	O
there	O
is	O
a	O
liver	O
-	O
specific	O
regulation	O
of	O
the	O
p53	B-Gene_or_gene_product
/	O
MDM2	B-Gene_or_gene_product
feedback	O
loop	O
and	O
if	O
it	O
can	O
be	O
related	O
to	O
the	O
development	O
of	O
pre	O
-	O
neoplastic	O
lesions	O
,	O
referred	O
to	O
as	O
enzyme	O
altered	O
foci	O
(	O
EAF	O
)	O
in	O
rats	O
.	O

Acute	O
responses	O
of	O
p53	B-Gene_or_gene_product
and	O
MDM2	B-Gene_or_gene_product
to	O
diethylnitrosamine	O
(	O
DEN	O
)	O
were	O
characterized	O
by	O
employing	O
immunohistochemistry	O
,	O
western	O
blotting	O
,	O
RT	O
-	O
PCR	O
and	O
in	O
situ	O
hybridization	O
.	O
<EOS>	B-X
Pre-neoplastic	B-X
lesions	B-X
in	B-X
rodent	B-X
liver	B-X
often	B-X
express	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
and	B-X
lack	B-X
a	B-X
p53	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X

A	O
single	O
dose	O
of	O
DEN	O
induced	O
a	O
centrilobular	O
p53	B-Gene_or_gene_product
response	O
that	O
peaked	O
at	O
24	O
h	O
.	O
<EOS>	B-X
Pre-neoplastic	B-X
lesions	B-X
in	B-X
rodent	B-X
liver	B-X
often	B-X
express	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
and	B-X
lack	B-X
a	B-X
p53	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
It	B-X
was	B-X
terminated	B-X
at	B-X
24	B-X
h	B-X
and	B-X
there	B-X
were	B-X
no	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X
The	B-X
data	B-X
support	B-X
the	B-X
hypothesis	B-X
that	B-X
EAF	B-X
hepatocytes	B-X
are	B-X
initiated	B-X
via	B-X
epigenetic	B-X
mechanisms	B-X
.	B-X

It	O
was	O
associated	O
with	O
transcriptional	O
activation	O
of	O
MDM2	B-Gene_or_gene_product
and	O
signs	O
of	O
apoptosis	O
.	O
<EOS>	B-X
Increased	B-X
mitochondrial	B-X
fission	B-X
by	B-X
forced	B-X
expression	B-X
of	B-X
DNM1L	B-X
or	B-X
knockdown	B-X
of	B-X
MFN1	B-X
promoted	B-X
the	B-X
survival	B-X
of	B-X
HCC	B-X
cells	B-X
both	B-X
in	B-X
vitro	B-X
and	B-X
in	B-X
vivo	B-X
mainly	B-X
by	B-X
facilitating	B-X
autophagy	B-X
and	B-X
inhibiting	B-X
mitochondria-dependent	B-X
apoptosis	B-X
.	B-X
We	B-X
further	B-X
demonstrated	B-X
that	B-X
the	B-X
survival-promoting	B-X
role	B-X
of	B-X
increased	B-X
mitochondrial	B-X
fission	B-X
was	B-X
mediated	B-X
via	B-X
elevated	B-X
ROS	B-X
production	B-X
and	B-X
subsequent	B-X
activation	B-X
of	B-X
AKT	B-X
,	B-X
which	B-X
facilitated	B-X
MDM2-mediated	B-X
TP53	B-X
degradation	B-X
,	B-X
and	B-X
NFKBIA-	B-X
and	B-X
IKK-mediated	B-X
transcriptional	B-X
activity	B-X
of	B-X
NFKB	B-X
in	B-X
HCC	B-X
cells	B-X
.	B-X
In	B-X
silico	B-X
studies	B-X
of	B-X
a	B-X
library	B-X
of	B-X
diarylpentanoids	B-X
led	B-X
us	B-X
to	B-X
the	B-X
identification	B-X
of	B-X
potential	B-X
new	B-X
MDM2/X	B-X
ligands	B-X
.	B-X
The	B-X
effect	B-X
on	B-X
p53-MDM2/X	B-X
interactions	B-X
was	B-X
evaluated	B-X
through	B-X
yeast-based	B-X
assays	B-X
for	B-X
compounds	B-X
showing	B-X
potent	B-X
antiproliferative	B-X
activity	B-X
in	B-X
HCT116	B-X
cells	B-X
and	B-X
low	B-X
toxicity	B-X
in	B-X
normal	B-X
cells	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
identification	B-X
of	B-X
a	B-X
potential	B-X
dual	B-X
inhibitor	B-X
.	B-X
The	B-X
antiproliferative	B-X
effect	B-X
of	B-X
this	B-X
compound	B-X
was	B-X
associated	B-X
with	B-X
induction	B-X
of	B-X
cell	B-X
cycle	B-X
arrest	B-X
,	B-X
apoptosis	B-X
,	B-X
PARP	B-X
cleavage	B-X
and	B-X
increased	B-X
p53	B-X
and	B-X
its	B-X
transcriptional	B-X
targets	B-X
,	B-X
p21	B-X
and	B-X
PUMA	B-X
,	B-X
in	B-X
HCT116	B-X
cells	B-X
.	B-X
Docking	B-X
poses	B-X
and	B-X
residues	B-X
involved	B-X
in	B-X
the	B-X
inhibition	B-X
of	B-X
p53-MDM2/X	B-X
interactions	B-X
were	B-X
predicted	B-X
by	B-X
docking	B-X
studies	B-X
.	B-X

However	O
,	O
in	O
midzonal	O
hepatocytes	O
,	O
which	O
constitutively	O
expressed	O
high	O
levels	O
of	O
cytoplasmic	O
MDM2	B-Gene_or_gene_product
,	O
there	O
was	O
a	O
rapid	O
-	O
onset	O
but	O
transient	O
p53	B-Gene_or_gene_product
response	O
.	O
<EOS>	B-X
Pre-neoplastic	B-X
lesions	B-X
in	B-X
rodent	B-X
liver	B-X
often	B-X
express	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
and	B-X
lack	B-X
a	B-X
p53	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X
The	B-X
data	B-X
support	B-X
the	B-X
hypothesis	B-X
that	B-X
EAF	B-X
hepatocytes	B-X
are	B-X
initiated	B-X
via	B-X
epigenetic	B-X
mechanisms	B-X
.	B-X

It	O
was	O
terminated	O
at	O
24	O
h	O
and	O
there	O
were	O
no	O
signs	O
of	O
apoptosis	O
.	O
<EOS>	B-X
Acute	B-X
lung	B-X
injury	B-X
caused	B-X
by	B-X
renal	B-X
ischemia-reperfusion	B-X
is	B-X
one	B-X
of	B-X
the	B-X
leading	B-X
causes	B-X
of	B-X
acute	B-X
kidney	B-X
injury-related	B-X
death	B-X
.	B-X
Interstitial	B-X
cells	B-X
of	B-X
Cajal	B-X
(	B-X
ICCs	B-X
)	B-X
function	B-X
as	B-X
pacemaker	B-X
cells	B-X
in	B-X
the	B-X
gastrointestinal	B-X
tract	B-X
.	B-X
Acute	B-X
thoracic	B-X
trauma	B-X
is	B-X
a	B-X
common	B-X
and	B-X
lethal	B-X
cause	B-X
of	B-X
death	B-X
due	B-X
to	B-X
physical	B-X
trauma	B-X
caused	B-X
by	B-X
traffic	B-X
accidents	B-X
.	B-X
This	B-X
study	B-X
aimed	B-X
to	B-X
explore	B-X
the	B-X
distribution	B-X
of	B-X
esophageal	B-X
ICCs	B-X
and	B-X
distribution	B-X
changes	B-X
observed	B-X
after	B-X
acute	B-X
thoracic	B-X
trauma	B-X
.	B-X
Thirty	B-X
rabbits	B-X
were	B-X
randomly	B-X
divided	B-X
into	B-X
a	B-X
control	B-X
group	B-X
and	B-X
two	B-X
study	B-X
groups	B-X
.	B-X
The	B-X
control	B-X
group	B-X
animals	B-X
underwent	B-X
an	B-X
esophagectomy	B-X
.	B-X
All	B-X
animals	B-X
in	B-X
the	B-X
study	B-X
groups	B-X
underwent	B-X
right	B-X
chest	B-X
puncture	B-X
using	B-X
the	B-X
Hopkinson	B-X
bar	B-X
technique	B-X
.	B-X
The	B-X
study	B-X
groups	B-X
were	B-X
subjected	B-X
to	B-X
esophagectomy	B-X
24	B-X
and	B-X
72	B-X
h	B-X
after	B-X
chest	B-X
puncture	B-X
.	B-X
Distribution	B-X
,	B-X
morphology	B-X
,	B-X
and	B-X
density	B-X
of	B-X
esophageal	B-X
ICCs	B-X
were	B-X
detected	B-X
using	B-X
transmission	B-X
electron	B-X
microscopy	B-X
,	B-X
toluidine	B-X
blue	B-X
staining	B-X
,	B-X
and	B-X
immunohistochemistry	B-X
.	B-X
Apoptosis	B-X
of	B-X
esophageal	B-X
ICCs	B-X
was	B-X
evaluated	B-X
using	B-X
the	B-X
terminal	B-X
deoxynucleotidyl	B-X
transferase	B-X
(	B-X
TdT	B-X
)	B-X
dUTP	B-X
Nick-End	B-X
Labeling	B-X
assay	B-X
.	B-X
Western	B-X
blotting	B-X
and	B-X
reverse	B-X
transcription	B-X
polymerase	B-X
chain	B-X
reaction	B-X
were	B-X
used	B-X
to	B-X
detect	B-X
changes	B-X
in	B-X
the	B-X
SCF/c-kit	B-X
signaling	B-X
pathway	B-X
.	B-X
Esophageal	B-X
ICCs	B-X
distribution	B-X
and	B-X
SCF/c-kit	B-X
signal	B-X
pathway	B-X
decreased	B-X
from	B-X
the	B-X
upper	B-X
part	B-X
to	B-X
the	B-X
lower	B-X
part	B-X
in	B-X
both	B-X
physiological	B-X
state	B-X
and	B-X
after	B-X
thoracic	B-X
trauma	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
death	B-X
of	B-X
ICCs	B-X
increased	B-X
from	B-X
the	B-X
upper	B-X
part	B-X
to	B-X
the	B-X
lower	B-X
part	B-X
,	B-X
both	B-X
in	B-X
physiological	B-X
and	B-X
injured	B-X
state	B-X
(	B-X
P	B-X
<	B-X
0.05	B-X
)	B-X
.	B-X
After	B-X
thoracic	B-X
trauma	B-X
,	B-X
increased	B-X
ICCs	B-X
and	B-X
decreased	B-X
death	B-X
of	B-X
ICCs	B-X
in	B-X
all	B-X
parts	B-X
of	B-X
the	B-X
esophagus	B-X
(	B-X
P	B-X
<	B-X
0.05	B-X
)	B-X
were	B-X
observed	B-X
.	B-X
The	B-X
observed	B-X
distribution	B-X
and	B-X
changes	B-X
in	B-X
esophageal	B-X
ICCs	B-X
would	B-X
have	B-X
an	B-X
impact	B-X
on	B-X
motility	B-X
and	B-X
motility	B-X
disorders	B-X
of	B-X
the	B-X
esophagus	B-X
.	B-X

The	O
rapidly	O
declining	O
p53	B-Gene_or_gene_product
levels	O
in	O
midzonal	O
areas	O
was	O
preceded	O
by	O
a	O
transient	O
peak	O
in	O
MDM2	B-Gene_or_gene_product
mRNA	O
levels	O
at	O
6	O
h	O
.	O
<EOS>	B-X
Pre-neoplastic	B-X
lesions	B-X
in	B-X
rodent	B-X
liver	B-X
often	B-X
express	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
and	B-X
lack	B-X
a	B-X
p53	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
It	B-X
was	B-X
terminated	B-X
at	B-X
24	B-X
h	B-X
and	B-X
there	B-X
were	B-X
no	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X
The	B-X
data	B-X
support	B-X
the	B-X
hypothesis	B-X
that	B-X
EAF	B-X
hepatocytes	B-X
are	B-X
initiated	B-X
via	B-X
epigenetic	B-X
mechanisms	B-X
.	B-X

Rats	O
pre	O
-	O
treated	O
with	O
repeated	O
low	O
or	O
high	O
weekly	O
doses	O
of	O
DEN	O
exhibited	O
EAF	O
and	O
these	O
lesions	O
expressed	O
high	O
levels	O
of	O
cytoplasmic	O
MDM2	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
pharmacological	B-X
effects	B-X
of	B-X
(	B-X
-	B-X
)	B-X
-deprenyl	B-X
is	B-X
multi-fold	B-X
in	B-X
its	B-X
nature	B-X
(	B-X
dopamine	B-X
sparing	B-X
activity	B-X
,	B-X
neuroprotective	B-X
and	B-X
neuronal	B-X
rescue	B-X
effects	B-X
)	B-X
,	B-X
which	B-X
can	B-X
not	B-X
be	B-X
explained	B-X
solely	B-X
by	B-X
the	B-X
irreversible	B-X
MAO-B	B-X
inhibitory	B-X
action	B-X
of	B-X
the	B-X
substance	B-X
.	B-X
Deprenyl	B-X
slightly	B-X
inhibits	B-X
the	B-X
re-uptake	B-X
of	B-X
noradrenaline	B-X
and	B-X
dopamine	B-X
,	B-X
but	B-X
methylamphetamine	B-X
,	B-X
the	B-X
metabolite	B-X
of	B-X
the	B-X
inhibitor	B-X
,	B-X
by	B-X
one	B-X
order	B-X
of	B-X
magnitude	B-X
is	B-X
more	B-X
potent	B-X
in	B-X
this	B-X
respect	B-X
,	B-X
than	B-X
the	B-X
parent	B-X
compound	B-X
.	B-X
Neither	B-X
the	B-X
metabolite	B-X
nor	B-X
(	B-X
-	B-X
)	B-X
-deprenyl	B-X
acts	B-X
on	B-X
the	B-X
uptake	B-X
of	B-X
serotonin	B-X
.	B-X
The	B-X
in	B-X
vivo	B-X
pharmacokinetic	B-X
studies	B-X
with	B-X
(	B-X
-	B-X
)	B-X
-deprenyl	B-X
,	B-X
using	B-X
the	B-X
double	B-X
labelled	B-X
radioisotope	B-X
technique	B-X
(	B-X
1.5	B-X
mg/kg	B-X
;	B-X
orally	B-X
)	B-X
in	B-X
rats	B-X
revealed	B-X
that	B-X
the	B-X
molar	B-X
concentration	B-X
of	B-X
methylamphetamine	B-X
can	B-X
reach	B-X
the	B-X
level	B-X
suitable	B-X
to	B-X
induce	B-X
a	B-X
significant	B-X
inhibition	B-X
of	B-X
amine	B-X
uptake	B-X
.	B-X
Deprenyl	B-X
,	B-X
but	B-X
especially	B-X
methylamphetamine	B-X
pre-treatment	B-X
can	B-X
prevent	B-X
the	B-X
noradrenaline	B-X
release	B-X
induced	B-X
by	B-X
the	B-X
noradrenergic	B-X
neurotoxin	B-X
DSP-4	B-X
.	B-X
The	B-X
uptake	B-X
inhibitory	B-X
effect	B-X
of	B-X
(	B-X
-	B-X
)	B-X
-deprenyl	B-X
and	B-X
the	B-X
metabolites	B-X
is	B-X
reversible	B-X
.	B-X
After	B-X
repeated	B-X
administration	B-X
of	B-X
(	B-X
-	B-X
)	B-X
-deprenyl	B-X
(	B-X
1.5	B-X
mg/kg	B-X
daily	B-X
,	B-X
for	B-X
8	B-X
days	B-X
)	B-X
sustained	B-X
concentration	B-X
of	B-X
its	B-X
metabolites	B-X
was	B-X
detected	B-X
,	B-X
compared	B-X
to	B-X
that	B-X
of	B-X
the	B-X
acute	B-X
studies	B-X
.	B-X
This	B-X
can	B-X
at	B-X
least	B-X
partly	B-X
explain	B-X
why	B-X
(	B-X
-	B-X
)	B-X
deprenyl	B-X
should	B-X
be	B-X
administered	B-X
daily	B-X
to	B-X
evoke	B-X
therapeutic	B-X
effects	B-X
in	B-X
Parkinson	B-X
's	B-X
disease	B-X
.	B-X
Administration	B-X
of	B-X
(	B-X
-	B-X
)	B-X
-deprenyl	B-X
in	B-X
a	B-X
low	B-X
dose	B-X
,	B-X
following	B-X
the	B-X
toxic	B-X
insult	B-X
,	B-X
can	B-X
rescue	B-X
the	B-X
damaged	B-X
neurones	B-X
.	B-X
The	B-X
(	B-X
+/-	B-X
)	B-X
-desmethyl-deprenyl	B-X
almost	B-X
lacks	B-X
the	B-X
property	B-X
to	B-X
inhibit	B-X
apoptosis	B-X
.	B-X
For	B-X
neuroprotection	B-X
and	B-X
neuronal	B-X
rescue	B-X
an	B-X
optimal	B-X
dose	B-X
of	B-X
(	B-X
-	B-X
)	B-X
-deprenyl	B-X
should	B-X
be	B-X
administered	B-X
,	B-X
because	B-X
to	B-X
reach	B-X
a	B-X
well	B-X
balanced	B-X
concentration	B-X
of	B-X
the	B-X
metabolites	B-X
in	B-X
tissues	B-X
is	B-X
critical	B-X
.	B-X

Using	O
MDM2	B-Gene_or_gene_product
as	O
a	O
marker	O
for	O
EAF	O
gave	O
similar	O
results	O
as	O
using	O
glutathione	B-Gene_or_gene_product
transferase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
P	I-Gene_or_gene_product
(	O
GST	B-Gene_or_gene_product
-	I-Gene_or_gene_product
P	I-Gene_or_gene_product
)	O
as	O
a	O
marker	O
.	O

Furthermore	O
,	O
small	O
EAF	O
,	O
elicited	O
by	O
low	O
doses	O
of	O
DEN	O
,	O
were	O
preferentially	O
localized	O
to	O
midzonal	O
areas	O
.	O
<EOS>	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X
The	B-X
data	B-X
support	B-X
the	B-X
hypothesis	B-X
that	B-X
EAF	B-X
hepatocytes	B-X
are	B-X
initiated	B-X
via	B-X
epigenetic	B-X
mechanisms	B-X
.	B-X

It	O
is	O
concluded	O
that	O
in	O
centrilobular	O
areas	O
DEN	O
-	O
induced	O
alterations	O
in	O
p53	B-Gene_or_gene_product
/	O
MDM2	B-Gene_or_gene_product
levels	O
are	O
compatible	O
with	O
a	O
previously	O
described	O
feedback	O
loop	O
.	O
<EOS>	B-X
Pre-neoplastic	B-X
lesions	B-X
in	B-X
rodent	B-X
liver	B-X
often	B-X
express	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
and	B-X
lack	B-X
a	B-X
p53	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X

An	O
attenuated	O
p53	B-Gene_or_gene_product
response	O
in	O
midzonal	O
hepatocytes	O
can	O
be	O
related	O
to	O
a	O
high	O
constitutive	O
expression	O
of	O
MDM2	B-Gene_or_gene_product
in	O
these	O
cells	O
.	O
<EOS>	B-X
Pre-neoplastic	B-X
lesions	B-X
in	B-X
rodent	B-X
liver	B-X
often	B-X
express	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
and	B-X
lack	B-X
a	B-X
p53	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X
The	B-X
data	B-X
support	B-X
the	B-X
hypothesis	B-X
that	B-X
EAF	B-X
hepatocytes	B-X
are	B-X
initiated	B-X
via	B-X
epigenetic	B-X
mechanisms	B-X
.	B-X

The	O
localization	O
of	O
small	O
EAF	O
to	O
midzonal	O
areas	O
,	O
and	O
the	O
fact	O
that	O
EAF	O
cells	O
expressed	O
high	O
levels	O
of	O
MDM2	B-Gene_or_gene_product
,	O
indicates	O
that	O
MDM2	B-Gene_or_gene_product
expression	O
is	O
a	O
factor	O
governing	O
initiation	O
and	O
early	O
development	O
of	O
EAF	O
.	O
<EOS>	B-X
Pre-neoplastic	B-X
lesions	B-X
in	B-X
rodent	B-X
liver	B-X
often	B-X
express	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
and	B-X
lack	B-X
a	B-X
p53	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
Acute	B-X
responses	B-X
of	B-X
p53	B-X
and	B-X
MDM2	B-X
to	B-X
diethylnitrosamine	B-X
(	B-X
DEN	B-X
)	B-X
were	B-X
characterized	B-X
by	B-X
employing	B-X
immunohistochemistry	B-X
,	B-X
western	B-X
blotting	B-X
,	B-X
RT-PCR	B-X
and	B-X
in	B-X
situ	B-X
hybridization	B-X
.	B-X
A	B-X
single	B-X
dose	B-X
of	B-X
DEN	B-X
induced	B-X
a	B-X
centrilobular	B-X
p53	B-X
response	B-X
that	B-X
peaked	B-X
at	B-X
24	B-X
h.	B-X
It	B-X
was	B-X
associated	B-X
with	B-X
transcriptional	B-X
activation	B-X
of	B-X
MDM2	B-X
and	B-X
signs	B-X
of	B-X
apoptosis	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
It	B-X
is	B-X
concluded	B-X
that	B-X
in	B-X
centrilobular	B-X
areas	B-X
DEN-induced	B-X
alterations	B-X
in	B-X
p53/MDM2	B-X
levels	B-X
are	B-X
compatible	B-X
with	B-X
a	B-X
previously	B-X
described	B-X
feedback	B-X
loop	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X
The	B-X
data	B-X
support	B-X
the	B-X
hypothesis	B-X
that	B-X
EAF	B-X
hepatocytes	B-X
are	B-X
initiated	B-X
via	B-X
epigenetic	B-X
mechanisms	B-X
.	B-X

The	O
data	O
support	O
the	O
hypothesis	O
that	O
EAF	O
hepatocytes	O
are	O
initiated	O
via	O
epigenetic	O
mechanisms	O
.	O
<EOS>	B-X
The	B-X
question	B-X
we	B-X
posed	B-X
was	B-X
whether	B-X
there	B-X
is	B-X
a	B-X
liver-specific	B-X
regulation	B-X
of	B-X
the	B-X
p53/MDM2	B-X
feedback	B-X
loop	B-X
and	B-X
if	B-X
it	B-X
can	B-X
be	B-X
related	B-X
to	B-X
the	B-X
development	B-X
of	B-X
pre-neoplastic	B-X
lesions	B-X
,	B-X
referred	B-X
to	B-X
as	B-X
enzyme	B-X
altered	B-X
foci	B-X
(	B-X
EAF	B-X
)	B-X
in	B-X
rats	B-X
.	B-X
However	B-X
,	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
,	B-X
which	B-X
constitutively	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
,	B-X
there	B-X
was	B-X
a	B-X
rapid-onset	B-X
but	B-X
transient	B-X
p53	B-X
response	B-X
.	B-X
The	B-X
rapidly	B-X
declining	B-X
p53	B-X
levels	B-X
in	B-X
midzonal	B-X
areas	B-X
was	B-X
preceded	B-X
by	B-X
a	B-X
transient	B-X
peak	B-X
in	B-X
MDM2	B-X
mRNA	B-X
levels	B-X
at	B-X
6	B-X
h.	B-X
Rats	B-X
pre-treated	B-X
with	B-X
repeated	B-X
low	B-X
or	B-X
high	B-X
weekly	B-X
doses	B-X
of	B-X
DEN	B-X
exhibited	B-X
EAF	B-X
and	B-X
these	B-X
lesions	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
cytoplasmic	B-X
MDM2	B-X
.	B-X
Using	B-X
MDM2	B-X
as	B-X
a	B-X
marker	B-X
for	B-X
EAF	B-X
gave	B-X
similar	B-X
results	B-X
as	B-X
using	B-X
glutathione	B-X
transferase-P	B-X
(	B-X
GST-P	B-X
)	B-X
as	B-X
a	B-X
marker	B-X
.	B-X
Furthermore	B-X
,	B-X
small	B-X
EAF	B-X
,	B-X
elicited	B-X
by	B-X
low	B-X
doses	B-X
of	B-X
DEN	B-X
,	B-X
were	B-X
preferentially	B-X
localized	B-X
to	B-X
midzonal	B-X
areas	B-X
.	B-X
An	B-X
attenuated	B-X
p53	B-X
response	B-X
in	B-X
midzonal	B-X
hepatocytes	B-X
can	B-X
be	B-X
related	B-X
to	B-X
a	B-X
high	B-X
constitutive	B-X
expression	B-X
of	B-X
MDM2	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
The	B-X
localization	B-X
of	B-X
small	B-X
EAF	B-X
to	B-X
midzonal	B-X
areas	B-X
,	B-X
and	B-X
the	B-X
fact	B-X
that	B-X
EAF	B-X
cells	B-X
expressed	B-X
high	B-X
levels	B-X
of	B-X
MDM2	B-X
,	B-X
indicates	B-X
that	B-X
MDM2	B-X
expression	B-X
is	B-X
a	B-X
factor	B-X
governing	B-X
initiation	B-X
and	B-X
early	B-X
development	B-X
of	B-X
EAF	B-X
.	B-X
The	B-X
data	B-X
support	B-X
the	B-X
hypothesis	B-X
that	B-X
EAF	B-X
hepatocytes	B-X
are	B-X
initiated	B-X
via	B-X
epigenetic	B-X
mechanisms	B-X
.	B-X

Reciprocal	O
regulation	O
between	O
Slt2	B-Gene_or_gene_product
MAPK	B-Gene_or_gene_product
and	O
isoforms	O
of	O
Msg5	B-Gene_or_gene_product
dual	B-Gene_or_gene_product
-	I-Gene_or_gene_product
specificity	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
phosphatase	I-Gene_or_gene_product
modulates	O
the	O
yeast	O
cell	O
integrity	O
pathway	O
.	O
<EOS>	B-X
Dual-specificity	B-X
protein	B-X
phosphatases	B-X
(	B-X
DSPs	B-X
)	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
negative	B-X
regulation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPKs	B-X
)	B-X
by	B-X
dephosphorylating	B-X
both	B-X
threonine-	B-X
and	B-X
tyrosine-conserved	B-X
residues	B-X
located	B-X
at	B-X
the	B-X
activation	B-X
loop	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Msg5	B-X
DSP	B-X
activity	B-X
is	B-X
essential	B-X
for	B-X
maintaining	B-X
a	B-X
low	B-X
level	B-X
of	B-X
signaling	B-X
through	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
role	B-X
of	B-X
this	B-X
phosphatase	B-X
on	B-X
cell	B-X
wall	B-X
physiology	B-X
,	B-X
cells	B-X
lacking	B-X
Msg5	B-X
displayed	B-X
an	B-X
increased	B-X
sensitivity	B-X
to	B-X
the	B-X
cell	B-X
wall-interfering	B-X
compound	B-X
Congo	B-X
Red	B-X
.	B-X
We	B-X
have	B-X
observed	B-X
that	B-X
the	B-X
N-terminal	B-X
non-catalytic	B-X
region	B-X
of	B-X
this	B-X
phosphatase	B-X
was	B-X
responsible	B-X
for	B-X
binding	B-X
to	B-X
the	B-X
kinase	B-X
domain	B-X
of	B-X
Slt2	B-X
,	B-X
the	B-X
MAPK	B-X
that	B-X
operates	B-X
in	B-X
this	B-X
pathway	B-X
.	B-X
In	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
experiments	B-X
revealed	B-X
that	B-X
both	B-X
proteins	B-X
act	B-X
on	B-X
each	B-X
other	B-X
.	B-X
Msg5	B-X
bound	B-X
and	B-X
dephosphorylated	B-X
activated	B-X
Slt2	B-X
.	B-X
Reciprocally	B-X
,	B-X
Slt2	B-X
phosphorylated	B-X
Msg5	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
alternative	B-X
use	B-X
of	B-X
translation	B-X
initiation	B-X
sites	B-X
at	B-X
MSG5	B-X
resulted	B-X
in	B-X
two	B-X
protein	B-X
forms	B-X
that	B-X
are	B-X
functional	B-X
on	B-X
Slt2	B-X
and	B-X
became	B-X
equally	B-X
phosphorylated	B-X
following	B-X
activation	B-X
of	B-X
this	B-X
MAPK	B-X
.	B-X
Under	B-X
activating	B-X
conditions	B-X
,	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
affinity	B-X
between	B-X
Msg5	B-X
and	B-X
Slt2	B-X
was	B-X
observed	B-X
,	B-X
leading	B-X
us	B-X
to	B-X
suggest	B-X
that	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
Slt2	B-X
controls	B-X
the	B-X
action	B-X
of	B-X
Msg5	B-X
was	B-X
via	B-X
the	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
the	B-X
existence	B-X
of	B-X
posttranscriptional	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DSPs	B-X
in	B-X
yeast	B-X
and	B-X
provide	B-X
new	B-X
insights	B-X
into	B-X
the	B-X
negative	B-X
control	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X

Dual	B-Gene_or_gene_product
-	I-Gene_or_gene_product
specificity	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
phosphatases	I-Gene_or_gene_product
(	O
DSPs	B-Gene_or_gene_product
)	O
are	O
involved	O
in	O
the	O
negative	O
regulation	O
of	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
MAPKs	B-Gene_or_gene_product
)	O
by	O
dephosphorylating	O
both	O
threonine	O
-	O
and	O
tyrosine	O
-	O
conserved	O
residues	O
located	O
at	O
the	O
activation	O
loop	O
.	O
<EOS>	B-X
Dual-specificity	B-X
protein	B-X
phosphatases	B-X
(	B-X
DSPs	B-X
)	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
negative	B-X
regulation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPKs	B-X
)	B-X
by	B-X
dephosphorylating	B-X
both	B-X
threonine-	B-X
and	B-X
tyrosine-conserved	B-X
residues	B-X
located	B-X
at	B-X
the	B-X
activation	B-X
loop	B-X
.	B-X
In	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
experiments	B-X
revealed	B-X
that	B-X
both	B-X
proteins	B-X
act	B-X
on	B-X
each	B-X
other	B-X
.	B-X
Msg5	B-X
bound	B-X
and	B-X
dephosphorylated	B-X
activated	B-X
Slt2	B-X
.	B-X
Reciprocally	B-X
,	B-X
Slt2	B-X
phosphorylated	B-X
Msg5	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
alternative	B-X
use	B-X
of	B-X
translation	B-X
initiation	B-X
sites	B-X
at	B-X
MSG5	B-X
resulted	B-X
in	B-X
two	B-X
protein	B-X
forms	B-X
that	B-X
are	B-X
functional	B-X
on	B-X
Slt2	B-X
and	B-X
became	B-X
equally	B-X
phosphorylated	B-X
following	B-X
activation	B-X
of	B-X
this	B-X
MAPK	B-X
.	B-X
Under	B-X
activating	B-X
conditions	B-X
,	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
affinity	B-X
between	B-X
Msg5	B-X
and	B-X
Slt2	B-X
was	B-X
observed	B-X
,	B-X
leading	B-X
us	B-X
to	B-X
suggest	B-X
that	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
Slt2	B-X
controls	B-X
the	B-X
action	B-X
of	B-X
Msg5	B-X
was	B-X
via	B-X
the	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
the	B-X
existence	B-X
of	B-X
posttranscriptional	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DSPs	B-X
in	B-X
yeast	B-X
and	B-X
provide	B-X
new	B-X
insights	B-X
into	B-X
the	B-X
negative	B-X
control	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X

Here	O
we	O
show	O
that	O
Msg5	B-Gene_or_gene_product
DSP	B-Gene_or_gene_product
activity	O
is	O
essential	O
for	O
maintaining	O
a	O
low	O
level	O
of	O
signaling	O
through	O
the	O
cell	O
integrity	O
pathway	O
in	O
Saccharomyces	O
cerevisiae	O
.	O
<EOS>	B-X
Dual-specificity	B-X
protein	B-X
phosphatases	B-X
(	B-X
DSPs	B-X
)	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
negative	B-X
regulation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPKs	B-X
)	B-X
by	B-X
dephosphorylating	B-X
both	B-X
threonine-	B-X
and	B-X
tyrosine-conserved	B-X
residues	B-X
located	B-X
at	B-X
the	B-X
activation	B-X
loop	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Msg5	B-X
DSP	B-X
activity	B-X
is	B-X
essential	B-X
for	B-X
maintaining	B-X
a	B-X
low	B-X
level	B-X
of	B-X
signaling	B-X
through	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
role	B-X
of	B-X
this	B-X
phosphatase	B-X
on	B-X
cell	B-X
wall	B-X
physiology	B-X
,	B-X
cells	B-X
lacking	B-X
Msg5	B-X
displayed	B-X
an	B-X
increased	B-X
sensitivity	B-X
to	B-X
the	B-X
cell	B-X
wall-interfering	B-X
compound	B-X
Congo	B-X
Red	B-X
.	B-X
We	B-X
have	B-X
observed	B-X
that	B-X
the	B-X
N-terminal	B-X
non-catalytic	B-X
region	B-X
of	B-X
this	B-X
phosphatase	B-X
was	B-X
responsible	B-X
for	B-X
binding	B-X
to	B-X
the	B-X
kinase	B-X
domain	B-X
of	B-X
Slt2	B-X
,	B-X
the	B-X
MAPK	B-X
that	B-X
operates	B-X
in	B-X
this	B-X
pathway	B-X
.	B-X
Msg5	B-X
bound	B-X
and	B-X
dephosphorylated	B-X
activated	B-X
Slt2	B-X
.	B-X
Reciprocally	B-X
,	B-X
Slt2	B-X
phosphorylated	B-X
Msg5	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
alternative	B-X
use	B-X
of	B-X
translation	B-X
initiation	B-X
sites	B-X
at	B-X
MSG5	B-X
resulted	B-X
in	B-X
two	B-X
protein	B-X
forms	B-X
that	B-X
are	B-X
functional	B-X
on	B-X
Slt2	B-X
and	B-X
became	B-X
equally	B-X
phosphorylated	B-X
following	B-X
activation	B-X
of	B-X
this	B-X
MAPK	B-X
.	B-X
Under	B-X
activating	B-X
conditions	B-X
,	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
affinity	B-X
between	B-X
Msg5	B-X
and	B-X
Slt2	B-X
was	B-X
observed	B-X
,	B-X
leading	B-X
us	B-X
to	B-X
suggest	B-X
that	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
Slt2	B-X
controls	B-X
the	B-X
action	B-X
of	B-X
Msg5	B-X
was	B-X
via	B-X
the	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
the	B-X
existence	B-X
of	B-X
posttranscriptional	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DSPs	B-X
in	B-X
yeast	B-X
and	B-X
provide	B-X
new	B-X
insights	B-X
into	B-X
the	B-X
negative	B-X
control	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X

Consistent	O
with	O
a	O
role	O
of	O
this	O
phosphatase	O
on	O
cell	O
wall	O
physiology	O
,	O
cells	O
lacking	O
Msg5	B-Gene_or_gene_product
displayed	O
an	O
increased	O
sensitivity	O
to	O
the	O
cell	O
wall	O
-	O
interfering	O
compound	O
Congo	O
Red	O
.	O

We	O
have	O
observed	O
that	O
the	O
N	O
-	O
terminal	O
non	O
-	O
catalytic	O
region	O
of	O
this	O
phosphatase	O
was	O
responsible	O
for	O
binding	O
to	O
the	O
kinase	O
domain	O
of	O
Slt2	B-Gene_or_gene_product
,	O
the	O
MAPK	B-Gene_or_gene_product
that	O
operates	O
in	O
this	O
pathway	O
.	O

In	O
vivo	O
and	O
in	O
vitro	O
experiments	O
revealed	O
that	O
both	O
proteins	O
act	O
on	O
each	O
other	O
.	O
<EOS>	B-X
Pulpitis	B-X
is	B-X
a	B-X
commonly	B-X
seen	B-X
oral	B-X
inflammation	B-X
condition	B-X
in	B-X
clinical	B-X
practice	B-X
,	B-X
it	B-X
can	B-X
cause	B-X
much	B-X
pain	B-X
for	B-X
the	B-X
patient	B-X
and	B-X
may	B-X
induce	B-X
infections	B-X
in	B-X
other	B-X
systems	B-X
.	B-X
In	B-X
this	B-X
work	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
the	B-X
expression	B-X
of	B-X
miR-155	B-X
was	B-X
associated	B-X
with	B-X
dental	B-X
pulpal	B-X
inflammation	B-X
both	B-X
in	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
.	B-X
Steroid	B-X
hormones	B-X
control	B-X
many	B-X
physiological	B-X
processes	B-X
by	B-X
activating	B-X
specific	B-X
receptors	B-X
that	B-X
act	B-X
as	B-X
transcription	B-X
factors	B-X
.	B-X
In	B-X
vivo	B-X
,	B-X
each	B-X
of	B-X
these	B-X
receptors	B-X
has	B-X
a	B-X
specific	B-X
set	B-X
of	B-X
target	B-X
genes	B-X
,	B-X
but	B-X
in	B-X
vitro	B-X
the	B-X
glucocorticoid	B-X
,	B-X
progesterone	B-X
,	B-X
mineralocorticoid	B-X
and	B-X
androgen	B-X
receptors	B-X
(	B-X
class	B-X
I	B-X
receptors	B-X
)	B-X
all	B-X
recognise	B-X
response	B-X
elements	B-X
which	B-X
are	B-X
organised	B-X
as	B-X
inverted	B-X
repeats	B-X
of	B-X
5'-TGTTCT-3'-like	B-X
sequences	B-X
with	B-X
a	B-X
three	B-X
nucleotide	B-X
spacer	B-X
.	B-X
This	B-X
poses	B-X
the	B-X
question	B-X
how	B-X
the	B-X
in	B-X
vivo	B-X
specificity	B-X
of	B-X
the	B-X
different	B-X
steroid	B-X
responses	B-X
is	B-X
mediated	B-X
.	B-X
Swapping	B-X
experiments	B-X
between	B-X
the	B-X
DNA-binding	B-X
domains	B-X
of	B-X
the	B-X
androgen	B-X
and	B-X
glucocorticoid	B-X
receptor	B-X
revealed	B-X
that	B-X
it	B-X
is	B-X
not	B-X
the	B-X
first	B-X
zinc	B-X
finger	B-X
,	B-X
but	B-X
rather	B-X
the	B-X
second	B-X
zinc	B-X
finger	B-X
and	B-X
part	B-X
of	B-X
the	B-X
hinge	B-X
region	B-X
which	B-X
contribute	B-X
to	B-X
this	B-X
specificity	B-X
.	B-X
We	B-X
could	B-X
subsequently	B-X
demonstrate	B-X
that	B-X
the	B-X
AR	B-X
binds	B-X
direct	B-X
repeats	B-X
of	B-X
5'-TGTTCT-3'-like	B-X
sequences	B-X
in	B-X
gel	B-X
retardation	B-X
assays	B-X
as	B-X
well	B-X
as	B-X
in	B-X
transfection	B-X
experiments	B-X
.	B-X
It	B-X
will	B-X
be	B-X
exciting	B-X
to	B-X
learn	B-X
how	B-X
such	B-X
DNA	B-X
elements	B-X
will	B-X
affect	B-X
the	B-X
properties	B-X
of	B-X
the	B-X
receptor	B-X
dimer	B-X
with	B-X
respect	B-X
to	B-X
ligand	B-X
binding	B-X
,	B-X
interactions	B-X
between	B-X
the	B-X
aminoterminal	B-X
domain	B-X
and	B-X
the	B-X
ligand-binding	B-X
domain	B-X
,	B-X
the	B-X
recruitement	B-X
of	B-X
co-activators	B-X
and	B-X
cooperativity	B-X
with	B-X
other	B-X
transcription	B-X
factors	B-X
.	B-X

Msg5	B-Gene_or_gene_product
bound	O
and	O
dephosphorylated	O
activated	O
Slt2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Dual-specificity	B-X
protein	B-X
phosphatases	B-X
(	B-X
DSPs	B-X
)	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
negative	B-X
regulation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPKs	B-X
)	B-X
by	B-X
dephosphorylating	B-X
both	B-X
threonine-	B-X
and	B-X
tyrosine-conserved	B-X
residues	B-X
located	B-X
at	B-X
the	B-X
activation	B-X
loop	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Msg5	B-X
DSP	B-X
activity	B-X
is	B-X
essential	B-X
for	B-X
maintaining	B-X
a	B-X
low	B-X
level	B-X
of	B-X
signaling	B-X
through	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
role	B-X
of	B-X
this	B-X
phosphatase	B-X
on	B-X
cell	B-X
wall	B-X
physiology	B-X
,	B-X
cells	B-X
lacking	B-X
Msg5	B-X
displayed	B-X
an	B-X
increased	B-X
sensitivity	B-X
to	B-X
the	B-X
cell	B-X
wall-interfering	B-X
compound	B-X
Congo	B-X
Red	B-X
.	B-X
We	B-X
have	B-X
observed	B-X
that	B-X
the	B-X
N-terminal	B-X
non-catalytic	B-X
region	B-X
of	B-X
this	B-X
phosphatase	B-X
was	B-X
responsible	B-X
for	B-X
binding	B-X
to	B-X
the	B-X
kinase	B-X
domain	B-X
of	B-X
Slt2	B-X
,	B-X
the	B-X
MAPK	B-X
that	B-X
operates	B-X
in	B-X
this	B-X
pathway	B-X
.	B-X
Msg5	B-X
bound	B-X
and	B-X
dephosphorylated	B-X
activated	B-X
Slt2	B-X
.	B-X
Reciprocally	B-X
,	B-X
Slt2	B-X
phosphorylated	B-X
Msg5	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
alternative	B-X
use	B-X
of	B-X
translation	B-X
initiation	B-X
sites	B-X
at	B-X
MSG5	B-X
resulted	B-X
in	B-X
two	B-X
protein	B-X
forms	B-X
that	B-X
are	B-X
functional	B-X
on	B-X
Slt2	B-X
and	B-X
became	B-X
equally	B-X
phosphorylated	B-X
following	B-X
activation	B-X
of	B-X
this	B-X
MAPK	B-X
.	B-X
Under	B-X
activating	B-X
conditions	B-X
,	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
affinity	B-X
between	B-X
Msg5	B-X
and	B-X
Slt2	B-X
was	B-X
observed	B-X
,	B-X
leading	B-X
us	B-X
to	B-X
suggest	B-X
that	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
Slt2	B-X
controls	B-X
the	B-X
action	B-X
of	B-X
Msg5	B-X
was	B-X
via	B-X
the	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
.	B-X

Reciprocally	O
,	O
Slt2	B-Gene_or_gene_product
phosphorylated	O
Msg5	B-Gene_or_gene_product
as	O
a	O
consequence	O
of	O
the	O
activation	O
of	O
the	O
cell	O
integrity	O
pathway	O
.	O
<EOS>	B-X
Dual-specificity	B-X
protein	B-X
phosphatases	B-X
(	B-X
DSPs	B-X
)	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
negative	B-X
regulation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPKs	B-X
)	B-X
by	B-X
dephosphorylating	B-X
both	B-X
threonine-	B-X
and	B-X
tyrosine-conserved	B-X
residues	B-X
located	B-X
at	B-X
the	B-X
activation	B-X
loop	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Msg5	B-X
DSP	B-X
activity	B-X
is	B-X
essential	B-X
for	B-X
maintaining	B-X
a	B-X
low	B-X
level	B-X
of	B-X
signaling	B-X
through	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
role	B-X
of	B-X
this	B-X
phosphatase	B-X
on	B-X
cell	B-X
wall	B-X
physiology	B-X
,	B-X
cells	B-X
lacking	B-X
Msg5	B-X
displayed	B-X
an	B-X
increased	B-X
sensitivity	B-X
to	B-X
the	B-X
cell	B-X
wall-interfering	B-X
compound	B-X
Congo	B-X
Red	B-X
.	B-X
We	B-X
have	B-X
observed	B-X
that	B-X
the	B-X
N-terminal	B-X
non-catalytic	B-X
region	B-X
of	B-X
this	B-X
phosphatase	B-X
was	B-X
responsible	B-X
for	B-X
binding	B-X
to	B-X
the	B-X
kinase	B-X
domain	B-X
of	B-X
Slt2	B-X
,	B-X
the	B-X
MAPK	B-X
that	B-X
operates	B-X
in	B-X
this	B-X
pathway	B-X
.	B-X
Msg5	B-X
bound	B-X
and	B-X
dephosphorylated	B-X
activated	B-X
Slt2	B-X
.	B-X
Reciprocally	B-X
,	B-X
Slt2	B-X
phosphorylated	B-X
Msg5	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
alternative	B-X
use	B-X
of	B-X
translation	B-X
initiation	B-X
sites	B-X
at	B-X
MSG5	B-X
resulted	B-X
in	B-X
two	B-X
protein	B-X
forms	B-X
that	B-X
are	B-X
functional	B-X
on	B-X
Slt2	B-X
and	B-X
became	B-X
equally	B-X
phosphorylated	B-X
following	B-X
activation	B-X
of	B-X
this	B-X
MAPK	B-X
.	B-X
Under	B-X
activating	B-X
conditions	B-X
,	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
affinity	B-X
between	B-X
Msg5	B-X
and	B-X
Slt2	B-X
was	B-X
observed	B-X
,	B-X
leading	B-X
us	B-X
to	B-X
suggest	B-X
that	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
Slt2	B-X
controls	B-X
the	B-X
action	B-X
of	B-X
Msg5	B-X
was	B-X
via	B-X
the	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
the	B-X
existence	B-X
of	B-X
posttranscriptional	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DSPs	B-X
in	B-X
yeast	B-X
and	B-X
provide	B-X
new	B-X
insights	B-X
into	B-X
the	B-X
negative	B-X
control	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X

In	O
addition	O
,	O
alternative	O
use	O
of	O
translation	O
initiation	O
sites	O
at	O
MSG5	B-Gene_or_gene_product
resulted	O
in	O
two	O
protein	O
forms	O
that	O
are	O
functional	O
on	O
Slt2	B-Gene_or_gene_product
and	O
became	O
equally	O
phosphorylated	O
following	O
activation	O
of	O
this	O
MAPK	B-Gene_or_gene_product
.	O
<EOS>	B-X
Dual-specificity	B-X
protein	B-X
phosphatases	B-X
(	B-X
DSPs	B-X
)	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
negative	B-X
regulation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPKs	B-X
)	B-X
by	B-X
dephosphorylating	B-X
both	B-X
threonine-	B-X
and	B-X
tyrosine-conserved	B-X
residues	B-X
located	B-X
at	B-X
the	B-X
activation	B-X
loop	B-X
.	B-X
We	B-X
have	B-X
observed	B-X
that	B-X
the	B-X
N-terminal	B-X
non-catalytic	B-X
region	B-X
of	B-X
this	B-X
phosphatase	B-X
was	B-X
responsible	B-X
for	B-X
binding	B-X
to	B-X
the	B-X
kinase	B-X
domain	B-X
of	B-X
Slt2	B-X
,	B-X
the	B-X
MAPK	B-X
that	B-X
operates	B-X
in	B-X
this	B-X
pathway	B-X
.	B-X
In	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
experiments	B-X
revealed	B-X
that	B-X
both	B-X
proteins	B-X
act	B-X
on	B-X
each	B-X
other	B-X
.	B-X
Msg5	B-X
bound	B-X
and	B-X
dephosphorylated	B-X
activated	B-X
Slt2	B-X
.	B-X
Reciprocally	B-X
,	B-X
Slt2	B-X
phosphorylated	B-X
Msg5	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
alternative	B-X
use	B-X
of	B-X
translation	B-X
initiation	B-X
sites	B-X
at	B-X
MSG5	B-X
resulted	B-X
in	B-X
two	B-X
protein	B-X
forms	B-X
that	B-X
are	B-X
functional	B-X
on	B-X
Slt2	B-X
and	B-X
became	B-X
equally	B-X
phosphorylated	B-X
following	B-X
activation	B-X
of	B-X
this	B-X
MAPK	B-X
.	B-X
Under	B-X
activating	B-X
conditions	B-X
,	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
affinity	B-X
between	B-X
Msg5	B-X
and	B-X
Slt2	B-X
was	B-X
observed	B-X
,	B-X
leading	B-X
us	B-X
to	B-X
suggest	B-X
that	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
Slt2	B-X
controls	B-X
the	B-X
action	B-X
of	B-X
Msg5	B-X
was	B-X
via	B-X
the	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
.	B-X

Under	O
activating	O
conditions	O
,	O
a	O
decrease	O
in	O
the	O
affinity	O
between	O
Msg5	B-Gene_or_gene_product
and	O
Slt2	B-Gene_or_gene_product
was	O
observed	O
,	O
leading	O
us	O
to	O
suggest	O
that	O
the	O
mechanism	O
by	O
which	O
Slt2	B-Gene_or_gene_product
controls	O
the	O
action	O
of	O
Msg5	B-Gene_or_gene_product
was	O
via	O
the	O
modulation	O
of	O
protein	O
-	O
protein	O
interactions	O
.	O
<EOS>	B-X
Dual-specificity	B-X
protein	B-X
phosphatases	B-X
(	B-X
DSPs	B-X
)	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
negative	B-X
regulation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPKs	B-X
)	B-X
by	B-X
dephosphorylating	B-X
both	B-X
threonine-	B-X
and	B-X
tyrosine-conserved	B-X
residues	B-X
located	B-X
at	B-X
the	B-X
activation	B-X
loop	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Msg5	B-X
DSP	B-X
activity	B-X
is	B-X
essential	B-X
for	B-X
maintaining	B-X
a	B-X
low	B-X
level	B-X
of	B-X
signaling	B-X
through	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
role	B-X
of	B-X
this	B-X
phosphatase	B-X
on	B-X
cell	B-X
wall	B-X
physiology	B-X
,	B-X
cells	B-X
lacking	B-X
Msg5	B-X
displayed	B-X
an	B-X
increased	B-X
sensitivity	B-X
to	B-X
the	B-X
cell	B-X
wall-interfering	B-X
compound	B-X
Congo	B-X
Red	B-X
.	B-X
We	B-X
have	B-X
observed	B-X
that	B-X
the	B-X
N-terminal	B-X
non-catalytic	B-X
region	B-X
of	B-X
this	B-X
phosphatase	B-X
was	B-X
responsible	B-X
for	B-X
binding	B-X
to	B-X
the	B-X
kinase	B-X
domain	B-X
of	B-X
Slt2	B-X
,	B-X
the	B-X
MAPK	B-X
that	B-X
operates	B-X
in	B-X
this	B-X
pathway	B-X
.	B-X
In	B-X
vivo	B-X
and	B-X
in	B-X
vitro	B-X
experiments	B-X
revealed	B-X
that	B-X
both	B-X
proteins	B-X
act	B-X
on	B-X
each	B-X
other	B-X
.	B-X
Msg5	B-X
bound	B-X
and	B-X
dephosphorylated	B-X
activated	B-X
Slt2	B-X
.	B-X
Reciprocally	B-X
,	B-X
Slt2	B-X
phosphorylated	B-X
Msg5	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
alternative	B-X
use	B-X
of	B-X
translation	B-X
initiation	B-X
sites	B-X
at	B-X
MSG5	B-X
resulted	B-X
in	B-X
two	B-X
protein	B-X
forms	B-X
that	B-X
are	B-X
functional	B-X
on	B-X
Slt2	B-X
and	B-X
became	B-X
equally	B-X
phosphorylated	B-X
following	B-X
activation	B-X
of	B-X
this	B-X
MAPK	B-X
.	B-X
Under	B-X
activating	B-X
conditions	B-X
,	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
affinity	B-X
between	B-X
Msg5	B-X
and	B-X
Slt2	B-X
was	B-X
observed	B-X
,	B-X
leading	B-X
us	B-X
to	B-X
suggest	B-X
that	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
Slt2	B-X
controls	B-X
the	B-X
action	B-X
of	B-X
Msg5	B-X
was	B-X
via	B-X
the	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
the	B-X
existence	B-X
of	B-X
posttranscriptional	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DSPs	B-X
in	B-X
yeast	B-X
and	B-X
provide	B-X
new	B-X
insights	B-X
into	B-X
the	B-X
negative	B-X
control	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X

Our	O
results	O
indicate	O
the	O
existence	O
of	O
posttranscriptional	O
mechanisms	O
of	O
regulation	O
of	O
DSPs	B-Gene_or_gene_product
in	O
yeast	O
and	O
provide	O
new	O
insights	O
into	O
the	O
negative	O
control	O
of	O
the	O
cell	O
integrity	O
pathway	O
.	O
<EOS>	B-X
Dual-specificity	B-X
protein	B-X
phosphatases	B-X
(	B-X
DSPs	B-X
)	B-X
are	B-X
involved	B-X
in	B-X
the	B-X
negative	B-X
regulation	B-X
of	B-X
mitogen-activated	B-X
protein	B-X
kinases	B-X
(	B-X
MAPKs	B-X
)	B-X
by	B-X
dephosphorylating	B-X
both	B-X
threonine-	B-X
and	B-X
tyrosine-conserved	B-X
residues	B-X
located	B-X
at	B-X
the	B-X
activation	B-X
loop	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Msg5	B-X
DSP	B-X
activity	B-X
is	B-X
essential	B-X
for	B-X
maintaining	B-X
a	B-X
low	B-X
level	B-X
of	B-X
signaling	B-X
through	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
in	B-X
Saccharomyces	B-X
cerevisiae	B-X
.	B-X
Consistent	B-X
with	B-X
a	B-X
role	B-X
of	B-X
this	B-X
phosphatase	B-X
on	B-X
cell	B-X
wall	B-X
physiology	B-X
,	B-X
cells	B-X
lacking	B-X
Msg5	B-X
displayed	B-X
an	B-X
increased	B-X
sensitivity	B-X
to	B-X
the	B-X
cell	B-X
wall-interfering	B-X
compound	B-X
Congo	B-X
Red	B-X
.	B-X
We	B-X
have	B-X
observed	B-X
that	B-X
the	B-X
N-terminal	B-X
non-catalytic	B-X
region	B-X
of	B-X
this	B-X
phosphatase	B-X
was	B-X
responsible	B-X
for	B-X
binding	B-X
to	B-X
the	B-X
kinase	B-X
domain	B-X
of	B-X
Slt2	B-X
,	B-X
the	B-X
MAPK	B-X
that	B-X
operates	B-X
in	B-X
this	B-X
pathway	B-X
.	B-X
Reciprocally	B-X
,	B-X
Slt2	B-X
phosphorylated	B-X
Msg5	B-X
as	B-X
a	B-X
consequence	B-X
of	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X
Under	B-X
activating	B-X
conditions	B-X
,	B-X
a	B-X
decrease	B-X
in	B-X
the	B-X
affinity	B-X
between	B-X
Msg5	B-X
and	B-X
Slt2	B-X
was	B-X
observed	B-X
,	B-X
leading	B-X
us	B-X
to	B-X
suggest	B-X
that	B-X
the	B-X
mechanism	B-X
by	B-X
which	B-X
Slt2	B-X
controls	B-X
the	B-X
action	B-X
of	B-X
Msg5	B-X
was	B-X
via	B-X
the	B-X
modulation	B-X
of	B-X
protein-protein	B-X
interactions	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
the	B-X
existence	B-X
of	B-X
posttranscriptional	B-X
mechanisms	B-X
of	B-X
regulation	B-X
of	B-X
DSPs	B-X
in	B-X
yeast	B-X
and	B-X
provide	B-X
new	B-X
insights	B-X
into	B-X
the	B-X
negative	B-X
control	B-X
of	B-X
the	B-X
cell	B-X
integrity	B-X
pathway	B-X
.	B-X

Role	O
of	O
vav1	B-Gene_or_gene_product
-	O
and	O
src	B-Gene_or_gene_product
-	O
related	O
tyrosine	O
kinases	O
in	O
macrophage	O
activation	O
by	O
CpG	O
DNA	O
.	O
<EOS>	B-X
Macrophage	B-X
activation	B-X
by	B-X
CpG	B-X
DNA	B-X
requires	B-X
toll-like	B-X
receptor	B-X
9	B-X
and	B-X
the	B-X
adaptor	B-X
protein	B-X
MyD88	B-X
.	B-X
Gram-negative	B-X
bacterial	B-X
lipopolysaccharide	B-X
also	B-X
activates	B-X
macrophages	B-X
via	B-X
a	B-X
toll-like	B-X
receptor	B-X
pathway	B-X
(	B-X
TLR-4	B-X
)	B-X
,	B-X
but	B-X
we	B-X
and	B-X
others	B-X
have	B-X
reported	B-X
that	B-X
lipopolysaccharide	B-X
also	B-X
stimulates	B-X
tyrosine	B-X
phosphorylation	B-X
in	B-X
macrophages	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
exposure	B-X
of	B-X
RAW	B-X
264.7	B-X
murine	B-X
macrophages	B-X
to	B-X
CpG	B-X
DNA	B-X
(	B-X
but	B-X
not	B-X
non-CpG	B-X
DNA	B-X
)	B-X
provoked	B-X
the	B-X
rapid	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
.	B-X
PP1	B-X
,	B-X
a	B-X
selective	B-X
inhibitor	B-X
of	B-X
src-related	B-X
tyrosine	B-X
kinases	B-X
,	B-X
blocked	B-X
both	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
and	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
macrophage	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
any	B-X
of	B-X
three	B-X
dominant	B-X
interfering	B-X
mutants	B-X
of	B-X
vav1	B-X
(	B-X
a	B-X
truncated	B-X
protein	B-X
,	B-X
vavC	B-X
;	B-X
a	B-X
form	B-X
containing	B-X
a	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
regulatory	B-X
tyrosine	B-X
residue	B-X
,	B-X
vavYF174	B-X
;	B-X
and	B-X
a	B-X
form	B-X
with	B-X
an	B-X
in-frame	B-X
deletion	B-X
of	B-X
six	B-X
amino	B-X
acids	B-X
required	B-X
for	B-X
the	B-X
guanidine	B-X
nucleotide	B-X
exchange	B-X
factor	B-X
(	B-X
GEF	B-X
)	B-X
activity	B-X
of	B-X
vav1	B-X
for	B-X
rac	B-X
family	B-X
GTPases	B-X
,	B-X
vavGEFmt	B-X
)	B-X
consistently	B-X
inhibited	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
in	B-X
RAW-TT10	B-X
macrophages	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
NF-kappaB	B-X
activity	B-X
(	B-X
but	B-X
not	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
activation	B-X
)	B-X
was	B-X
inhibited	B-X
by	B-X
preincubation	B-X
with	B-X
PP1	B-X
or	B-X
by	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
vavC	B-X
mutant	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
by	B-X
a	B-X
src-related	B-X
tyrosine	B-X
kinase	B-X
or	B-X
kinases	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
macrophage	B-X
response	B-X
to	B-X
CpG	B-X
DNA	B-X
.	B-X

Macrophage	O
activation	O
by	O
CpG	O
DNA	O
requires	O
toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
9	I-Gene_or_gene_product
and	O
the	O
adaptor	O
protein	O
MyD88	B-Gene_or_gene_product
.	O
<EOS>	B-X
Macrophage	B-X
activation	B-X
by	B-X
CpG	B-X
DNA	B-X
requires	B-X
toll-like	B-X
receptor	B-X
9	B-X
and	B-X
the	B-X
adaptor	B-X
protein	B-X
MyD88	B-X
.	B-X
Gram-negative	B-X
bacterial	B-X
lipopolysaccharide	B-X
also	B-X
activates	B-X
macrophages	B-X
via	B-X
a	B-X
toll-like	B-X
receptor	B-X
pathway	B-X
(	B-X
TLR-4	B-X
)	B-X
,	B-X
but	B-X
we	B-X
and	B-X
others	B-X
have	B-X
reported	B-X
that	B-X
lipopolysaccharide	B-X
also	B-X
stimulates	B-X
tyrosine	B-X
phosphorylation	B-X
in	B-X
macrophages	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
exposure	B-X
of	B-X
RAW	B-X
264.7	B-X
murine	B-X
macrophages	B-X
to	B-X
CpG	B-X
DNA	B-X
(	B-X
but	B-X
not	B-X
non-CpG	B-X
DNA	B-X
)	B-X
provoked	B-X
the	B-X
rapid	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
.	B-X
PP1	B-X
,	B-X
a	B-X
selective	B-X
inhibitor	B-X
of	B-X
src-related	B-X
tyrosine	B-X
kinases	B-X
,	B-X
blocked	B-X
both	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
and	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
macrophage	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
any	B-X
of	B-X
three	B-X
dominant	B-X
interfering	B-X
mutants	B-X
of	B-X
vav1	B-X
(	B-X
a	B-X
truncated	B-X
protein	B-X
,	B-X
vavC	B-X
;	B-X
a	B-X
form	B-X
containing	B-X
a	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
regulatory	B-X
tyrosine	B-X
residue	B-X
,	B-X
vavYF174	B-X
;	B-X
and	B-X
a	B-X
form	B-X
with	B-X
an	B-X
in-frame	B-X
deletion	B-X
of	B-X
six	B-X
amino	B-X
acids	B-X
required	B-X
for	B-X
the	B-X
guanidine	B-X
nucleotide	B-X
exchange	B-X
factor	B-X
(	B-X
GEF	B-X
)	B-X
activity	B-X
of	B-X
vav1	B-X
for	B-X
rac	B-X
family	B-X
GTPases	B-X
,	B-X
vavGEFmt	B-X
)	B-X
consistently	B-X
inhibited	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
in	B-X
RAW-TT10	B-X
macrophages	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
NF-kappaB	B-X
activity	B-X
(	B-X
but	B-X
not	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
activation	B-X
)	B-X
was	B-X
inhibited	B-X
by	B-X
preincubation	B-X
with	B-X
PP1	B-X
or	B-X
by	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
vavC	B-X
mutant	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
by	B-X
a	B-X
src-related	B-X
tyrosine	B-X
kinase	B-X
or	B-X
kinases	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
macrophage	B-X
response	B-X
to	B-X
CpG	B-X
DNA	B-X
.	B-X

Gram	O
-	O
negative	O
bacterial	O
lipopolysaccharide	O
also	O
activates	O
macrophages	O
via	O
a	O
toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
pathway	O
(	O
TLR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
)	O
,	O
but	O
we	O
and	O
others	O
have	O
reported	O
that	O
lipopolysaccharide	O
also	O
stimulates	O
tyrosine	O
phosphorylation	O
in	O
macrophages	O
.	O

Herein	O
we	O
report	O
that	O
exposure	O
of	O
RAW	O
264	O
.	O
7	O
murine	O
macrophages	O
to	O
CpG	O
DNA	O
(	O
but	O
not	O
non	O
-	O
CpG	O
DNA	O
)	O
provoked	O
the	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
vav1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Macrophage	B-X
activation	B-X
by	B-X
CpG	B-X
DNA	B-X
requires	B-X
toll-like	B-X
receptor	B-X
9	B-X
and	B-X
the	B-X
adaptor	B-X
protein	B-X
MyD88	B-X
.	B-X
Gram-negative	B-X
bacterial	B-X
lipopolysaccharide	B-X
also	B-X
activates	B-X
macrophages	B-X
via	B-X
a	B-X
toll-like	B-X
receptor	B-X
pathway	B-X
(	B-X
TLR-4	B-X
)	B-X
,	B-X
but	B-X
we	B-X
and	B-X
others	B-X
have	B-X
reported	B-X
that	B-X
lipopolysaccharide	B-X
also	B-X
stimulates	B-X
tyrosine	B-X
phosphorylation	B-X
in	B-X
macrophages	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
exposure	B-X
of	B-X
RAW	B-X
264.7	B-X
murine	B-X
macrophages	B-X
to	B-X
CpG	B-X
DNA	B-X
(	B-X
but	B-X
not	B-X
non-CpG	B-X
DNA	B-X
)	B-X
provoked	B-X
the	B-X
rapid	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
.	B-X
PP1	B-X
,	B-X
a	B-X
selective	B-X
inhibitor	B-X
of	B-X
src-related	B-X
tyrosine	B-X
kinases	B-X
,	B-X
blocked	B-X
both	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
and	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
macrophage	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
any	B-X
of	B-X
three	B-X
dominant	B-X
interfering	B-X
mutants	B-X
of	B-X
vav1	B-X
(	B-X
a	B-X
truncated	B-X
protein	B-X
,	B-X
vavC	B-X
;	B-X
a	B-X
form	B-X
containing	B-X
a	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
regulatory	B-X
tyrosine	B-X
residue	B-X
,	B-X
vavYF174	B-X
;	B-X
and	B-X
a	B-X
form	B-X
with	B-X
an	B-X
in-frame	B-X
deletion	B-X
of	B-X
six	B-X
amino	B-X
acids	B-X
required	B-X
for	B-X
the	B-X
guanidine	B-X
nucleotide	B-X
exchange	B-X
factor	B-X
(	B-X
GEF	B-X
)	B-X
activity	B-X
of	B-X
vav1	B-X
for	B-X
rac	B-X
family	B-X
GTPases	B-X
,	B-X
vavGEFmt	B-X
)	B-X
consistently	B-X
inhibited	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
in	B-X
RAW-TT10	B-X
macrophages	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
NF-kappaB	B-X
activity	B-X
(	B-X
but	B-X
not	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
activation	B-X
)	B-X
was	B-X
inhibited	B-X
by	B-X
preincubation	B-X
with	B-X
PP1	B-X
or	B-X
by	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
vavC	B-X
mutant	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
by	B-X
a	B-X
src-related	B-X
tyrosine	B-X
kinase	B-X
or	B-X
kinases	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
macrophage	B-X
response	B-X
to	B-X
CpG	B-X
DNA	B-X
.	B-X

PP1	B-Gene_or_gene_product
,	O
a	O
selective	O
inhibitor	O
of	O
src	B-Gene_or_gene_product
-	O
related	O
tyrosine	O
kinases	O
,	O
blocked	O
both	O
the	O
CpG	O
DNA	O
-	O
mediated	O
tyrosine	O
phosphorylation	O
of	O
vav1	B-Gene_or_gene_product
and	O
the	O
CpG	O
DNA	O
-	O
mediated	O
up	O
-	O
regulation	O
of	O
macrophage	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
secretion	O
and	O
inducible	O
nitric	B-Gene_or_gene_product
-	I-Gene_or_gene_product
oxide	I-Gene_or_gene_product
synthase	I-Gene_or_gene_product
protein	O
accumulation	O
.	O
<EOS>	B-X
Macrophage	B-X
activation	B-X
by	B-X
CpG	B-X
DNA	B-X
requires	B-X
toll-like	B-X
receptor	B-X
9	B-X
and	B-X
the	B-X
adaptor	B-X
protein	B-X
MyD88	B-X
.	B-X
Gram-negative	B-X
bacterial	B-X
lipopolysaccharide	B-X
also	B-X
activates	B-X
macrophages	B-X
via	B-X
a	B-X
toll-like	B-X
receptor	B-X
pathway	B-X
(	B-X
TLR-4	B-X
)	B-X
,	B-X
but	B-X
we	B-X
and	B-X
others	B-X
have	B-X
reported	B-X
that	B-X
lipopolysaccharide	B-X
also	B-X
stimulates	B-X
tyrosine	B-X
phosphorylation	B-X
in	B-X
macrophages	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
exposure	B-X
of	B-X
RAW	B-X
264.7	B-X
murine	B-X
macrophages	B-X
to	B-X
CpG	B-X
DNA	B-X
(	B-X
but	B-X
not	B-X
non-CpG	B-X
DNA	B-X
)	B-X
provoked	B-X
the	B-X
rapid	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
.	B-X
PP1	B-X
,	B-X
a	B-X
selective	B-X
inhibitor	B-X
of	B-X
src-related	B-X
tyrosine	B-X
kinases	B-X
,	B-X
blocked	B-X
both	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
and	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
macrophage	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
any	B-X
of	B-X
three	B-X
dominant	B-X
interfering	B-X
mutants	B-X
of	B-X
vav1	B-X
(	B-X
a	B-X
truncated	B-X
protein	B-X
,	B-X
vavC	B-X
;	B-X
a	B-X
form	B-X
containing	B-X
a	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
regulatory	B-X
tyrosine	B-X
residue	B-X
,	B-X
vavYF174	B-X
;	B-X
and	B-X
a	B-X
form	B-X
with	B-X
an	B-X
in-frame	B-X
deletion	B-X
of	B-X
six	B-X
amino	B-X
acids	B-X
required	B-X
for	B-X
the	B-X
guanidine	B-X
nucleotide	B-X
exchange	B-X
factor	B-X
(	B-X
GEF	B-X
)	B-X
activity	B-X
of	B-X
vav1	B-X
for	B-X
rac	B-X
family	B-X
GTPases	B-X
,	B-X
vavGEFmt	B-X
)	B-X
consistently	B-X
inhibited	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
in	B-X
RAW-TT10	B-X
macrophages	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
NF-kappaB	B-X
activity	B-X
(	B-X
but	B-X
not	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
activation	B-X
)	B-X
was	B-X
inhibited	B-X
by	B-X
preincubation	B-X
with	B-X
PP1	B-X
or	B-X
by	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
vavC	B-X
mutant	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
by	B-X
a	B-X
src-related	B-X
tyrosine	B-X
kinase	B-X
or	B-X
kinases	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
macrophage	B-X
response	B-X
to	B-X
CpG	B-X
DNA	B-X
.	B-X

Furthermore	O
,	O
we	O
found	O
that	O
the	O
inducible	O
expression	O
of	O
any	O
of	O
three	O
dominant	O
interfering	O
mutants	O
of	O
vav1	B-Gene_or_gene_product
(	O
a	O
truncated	O
protein	O
,	O
vavC	B-Gene_or_gene_product
;	O
a	O
form	O
containing	O
a	O
point	O
mutation	O
in	O
the	O
regulatory	O
tyrosine	O
residue	O
,	O
vavYF174	B-Gene_or_gene_product
;	O
and	O
a	O
form	O
with	O
an	O
in	O
-	O
frame	O
deletion	O
of	O
six	O
amino	O
acids	O
required	O
for	O
the	O
guanidine	B-Gene_or_gene_product
nucleotide	I-Gene_or_gene_product
exchange	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
GEF	B-Gene_or_gene_product
)	O
activity	O
of	O
vav1	B-Gene_or_gene_product
for	O
rac	B-Gene_or_gene_product
family	O
GTPases	O
,	O
vavGEFmt	B-Gene_or_gene_product
)	O
consistently	O
inhibited	O
CpG	O
DNA	O
-	O
mediated	O
up	O
-	O
regulation	O
of	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
secretion	O
and	O
inducible	O
nitric	B-Gene_or_gene_product
-	I-Gene_or_gene_product
oxide	I-Gene_or_gene_product
synthase	I-Gene_or_gene_product
protein	O
accumulation	O
in	O
RAW	O
-	O
TT10	O
macrophages	O
.	O
<EOS>	B-X
Macrophage	B-X
activation	B-X
by	B-X
CpG	B-X
DNA	B-X
requires	B-X
toll-like	B-X
receptor	B-X
9	B-X
and	B-X
the	B-X
adaptor	B-X
protein	B-X
MyD88	B-X
.	B-X
Gram-negative	B-X
bacterial	B-X
lipopolysaccharide	B-X
also	B-X
activates	B-X
macrophages	B-X
via	B-X
a	B-X
toll-like	B-X
receptor	B-X
pathway	B-X
(	B-X
TLR-4	B-X
)	B-X
,	B-X
but	B-X
we	B-X
and	B-X
others	B-X
have	B-X
reported	B-X
that	B-X
lipopolysaccharide	B-X
also	B-X
stimulates	B-X
tyrosine	B-X
phosphorylation	B-X
in	B-X
macrophages	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
exposure	B-X
of	B-X
RAW	B-X
264.7	B-X
murine	B-X
macrophages	B-X
to	B-X
CpG	B-X
DNA	B-X
(	B-X
but	B-X
not	B-X
non-CpG	B-X
DNA	B-X
)	B-X
provoked	B-X
the	B-X
rapid	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
.	B-X
PP1	B-X
,	B-X
a	B-X
selective	B-X
inhibitor	B-X
of	B-X
src-related	B-X
tyrosine	B-X
kinases	B-X
,	B-X
blocked	B-X
both	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
and	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
macrophage	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
any	B-X
of	B-X
three	B-X
dominant	B-X
interfering	B-X
mutants	B-X
of	B-X
vav1	B-X
(	B-X
a	B-X
truncated	B-X
protein	B-X
,	B-X
vavC	B-X
;	B-X
a	B-X
form	B-X
containing	B-X
a	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
regulatory	B-X
tyrosine	B-X
residue	B-X
,	B-X
vavYF174	B-X
;	B-X
and	B-X
a	B-X
form	B-X
with	B-X
an	B-X
in-frame	B-X
deletion	B-X
of	B-X
six	B-X
amino	B-X
acids	B-X
required	B-X
for	B-X
the	B-X
guanidine	B-X
nucleotide	B-X
exchange	B-X
factor	B-X
(	B-X
GEF	B-X
)	B-X
activity	B-X
of	B-X
vav1	B-X
for	B-X
rac	B-X
family	B-X
GTPases	B-X
,	B-X
vavGEFmt	B-X
)	B-X
consistently	B-X
inhibited	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
in	B-X
RAW-TT10	B-X
macrophages	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
NF-kappaB	B-X
activity	B-X
(	B-X
but	B-X
not	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
activation	B-X
)	B-X
was	B-X
inhibited	B-X
by	B-X
preincubation	B-X
with	B-X
PP1	B-X
or	B-X
by	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
vavC	B-X
mutant	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
by	B-X
a	B-X
src-related	B-X
tyrosine	B-X
kinase	B-X
or	B-X
kinases	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
macrophage	B-X
response	B-X
to	B-X
CpG	B-X
DNA	B-X
.	B-X

Finally	O
,	O
we	O
determined	O
that	O
CpG	O
DNA	O
-	O
mediated	O
up	O
-	O
regulation	O
of	O
NF	O
-	O
kappaB	O
activity	O
(	O
but	O
not	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
activation	O
)	O
was	O
inhibited	O
by	O
preincubation	O
with	O
PP1	B-Gene_or_gene_product
or	O
by	O
expression	O
of	O
the	O
truncated	O
vavC	B-Gene_or_gene_product
mutant	O
.	O
<EOS>	B-X
Macrophage	B-X
activation	B-X
by	B-X
CpG	B-X
DNA	B-X
requires	B-X
toll-like	B-X
receptor	B-X
9	B-X
and	B-X
the	B-X
adaptor	B-X
protein	B-X
MyD88	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
exposure	B-X
of	B-X
RAW	B-X
264.7	B-X
murine	B-X
macrophages	B-X
to	B-X
CpG	B-X
DNA	B-X
(	B-X
but	B-X
not	B-X
non-CpG	B-X
DNA	B-X
)	B-X
provoked	B-X
the	B-X
rapid	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
.	B-X
PP1	B-X
,	B-X
a	B-X
selective	B-X
inhibitor	B-X
of	B-X
src-related	B-X
tyrosine	B-X
kinases	B-X
,	B-X
blocked	B-X
both	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
and	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
macrophage	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
any	B-X
of	B-X
three	B-X
dominant	B-X
interfering	B-X
mutants	B-X
of	B-X
vav1	B-X
(	B-X
a	B-X
truncated	B-X
protein	B-X
,	B-X
vavC	B-X
;	B-X
a	B-X
form	B-X
containing	B-X
a	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
regulatory	B-X
tyrosine	B-X
residue	B-X
,	B-X
vavYF174	B-X
;	B-X
and	B-X
a	B-X
form	B-X
with	B-X
an	B-X
in-frame	B-X
deletion	B-X
of	B-X
six	B-X
amino	B-X
acids	B-X
required	B-X
for	B-X
the	B-X
guanidine	B-X
nucleotide	B-X
exchange	B-X
factor	B-X
(	B-X
GEF	B-X
)	B-X
activity	B-X
of	B-X
vav1	B-X
for	B-X
rac	B-X
family	B-X
GTPases	B-X
,	B-X
vavGEFmt	B-X
)	B-X
consistently	B-X
inhibited	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
in	B-X
RAW-TT10	B-X
macrophages	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
NF-kappaB	B-X
activity	B-X
(	B-X
but	B-X
not	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
activation	B-X
)	B-X
was	B-X
inhibited	B-X
by	B-X
preincubation	B-X
with	B-X
PP1	B-X
or	B-X
by	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
vavC	B-X
mutant	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
by	B-X
a	B-X
src-related	B-X
tyrosine	B-X
kinase	B-X
or	B-X
kinases	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
macrophage	B-X
response	B-X
to	B-X
CpG	B-X
DNA	B-X
.	B-X

Taken	O
together	O
,	O
our	O
results	O
indicate	O
that	O
the	O
tyrosine	O
phosphorylation	O
of	O
vav1	B-Gene_or_gene_product
by	O
a	O
src	B-Gene_or_gene_product
-	O
related	O
tyrosine	O
kinase	O
or	O
kinases	O
plays	O
an	O
important	O
role	O
in	O
the	O
macrophage	O
response	O
to	O
CpG	O
DNA	O
.	O
<EOS>	B-X
Macrophage	B-X
activation	B-X
by	B-X
CpG	B-X
DNA	B-X
requires	B-X
toll-like	B-X
receptor	B-X
9	B-X
and	B-X
the	B-X
adaptor	B-X
protein	B-X
MyD88	B-X
.	B-X
Gram-negative	B-X
bacterial	B-X
lipopolysaccharide	B-X
also	B-X
activates	B-X
macrophages	B-X
via	B-X
a	B-X
toll-like	B-X
receptor	B-X
pathway	B-X
(	B-X
TLR-4	B-X
)	B-X
,	B-X
but	B-X
we	B-X
and	B-X
others	B-X
have	B-X
reported	B-X
that	B-X
lipopolysaccharide	B-X
also	B-X
stimulates	B-X
tyrosine	B-X
phosphorylation	B-X
in	B-X
macrophages	B-X
.	B-X
Herein	B-X
we	B-X
report	B-X
that	B-X
exposure	B-X
of	B-X
RAW	B-X
264.7	B-X
murine	B-X
macrophages	B-X
to	B-X
CpG	B-X
DNA	B-X
(	B-X
but	B-X
not	B-X
non-CpG	B-X
DNA	B-X
)	B-X
provoked	B-X
the	B-X
rapid	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
.	B-X
PP1	B-X
,	B-X
a	B-X
selective	B-X
inhibitor	B-X
of	B-X
src-related	B-X
tyrosine	B-X
kinases	B-X
,	B-X
blocked	B-X
both	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
and	B-X
the	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
macrophage	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
found	B-X
that	B-X
the	B-X
inducible	B-X
expression	B-X
of	B-X
any	B-X
of	B-X
three	B-X
dominant	B-X
interfering	B-X
mutants	B-X
of	B-X
vav1	B-X
(	B-X
a	B-X
truncated	B-X
protein	B-X
,	B-X
vavC	B-X
;	B-X
a	B-X
form	B-X
containing	B-X
a	B-X
point	B-X
mutation	B-X
in	B-X
the	B-X
regulatory	B-X
tyrosine	B-X
residue	B-X
,	B-X
vavYF174	B-X
;	B-X
and	B-X
a	B-X
form	B-X
with	B-X
an	B-X
in-frame	B-X
deletion	B-X
of	B-X
six	B-X
amino	B-X
acids	B-X
required	B-X
for	B-X
the	B-X
guanidine	B-X
nucleotide	B-X
exchange	B-X
factor	B-X
(	B-X
GEF	B-X
)	B-X
activity	B-X
of	B-X
vav1	B-X
for	B-X
rac	B-X
family	B-X
GTPases	B-X
,	B-X
vavGEFmt	B-X
)	B-X
consistently	B-X
inhibited	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
tumor	B-X
necrosis	B-X
factor	B-X
secretion	B-X
and	B-X
inducible	B-X
nitric-oxide	B-X
synthase	B-X
protein	B-X
accumulation	B-X
in	B-X
RAW-TT10	B-X
macrophages	B-X
.	B-X
Finally	B-X
,	B-X
we	B-X
determined	B-X
that	B-X
CpG	B-X
DNA-mediated	B-X
up-regulation	B-X
of	B-X
NF-kappaB	B-X
activity	B-X
(	B-X
but	B-X
not	B-X
mitogen-activated	B-X
protein	B-X
kinase	B-X
activation	B-X
)	B-X
was	B-X
inhibited	B-X
by	B-X
preincubation	B-X
with	B-X
PP1	B-X
or	B-X
by	B-X
expression	B-X
of	B-X
the	B-X
truncated	B-X
vavC	B-X
mutant	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
the	B-X
tyrosine	B-X
phosphorylation	B-X
of	B-X
vav1	B-X
by	B-X
a	B-X
src-related	B-X
tyrosine	B-X
kinase	B-X
or	B-X
kinases	B-X
plays	B-X
an	B-X
important	B-X
role	B-X
in	B-X
the	B-X
macrophage	B-X
response	B-X
to	B-X
CpG	B-X
DNA	B-X
.	B-X

E2F	B-Gene_or_gene_product
-	O
dependent	O
histone	B-Gene_or_gene_product
acetylation	O
and	O
recruitment	O
of	O
the	O
Tip60	O
acetyltransferase	O
complex	O
to	O
chromatin	O
in	O
late	O
G1	O
.	O
<EOS>	B-X
E2F	B-X
proteins	B-X
can	B-X
either	B-X
activate	B-X
or	B-X
repress	B-X
transcription	B-X
.	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Histones	B-X
H3	B-X
and	B-X
H4	B-X
simultaneously	B-X
become	B-X
hyperacetylated	B-X
,	B-X
but	B-X
it	B-X
remains	B-X
unclear	B-X
whether	B-X
this	B-X
is	B-X
a	B-X
prerequisite	B-X
or	B-X
a	B-X
consequence	B-X
of	B-X
E2F	B-X
binding	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
activating	B-X
E2F	B-X
species	B-X
are	B-X
required	B-X
for	B-X
hyperacetylation	B-X
of	B-X
target	B-X
chromatin	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
Moreover	B-X
,	B-X
E2F-dependent	B-X
recruitment	B-X
of	B-X
Tip60	B-X
to	B-X
chromatin	B-X
occurred	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
following	B-X
serum	B-X
stimulation	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

E2F	B-Gene_or_gene_product
proteins	O
can	O
either	O
activate	O
or	O
repress	O
transcription	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
protein	B-X
RB	B-X
and	B-X
the	B-X
transcription	B-X
factor	B-X
p53	B-X
are	B-X
central	B-X
tumor	B-X
suppressors	B-X
.	B-X
They	B-X
are	B-X
often	B-X
found	B-X
inactivated	B-X
in	B-X
various	B-X
tumor	B-X
types	B-X
.	B-X
Both	B-X
proteins	B-X
play	B-X
central	B-X
roles	B-X
in	B-X
regulating	B-X
the	B-X
cell	B-X
division	B-X
cycle	B-X
.	B-X
RB	B-X
forms	B-X
complexes	B-X
with	B-X
the	B-X
E2F	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
and	B-X
downregulates	B-X
numerous	B-X
genes	B-X
.	B-X
Among	B-X
the	B-X
RB-E2F	B-X
target	B-X
genes	B-X
,	B-X
a	B-X
large	B-X
number	B-X
code	B-X
for	B-X
key	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
Their	B-X
transcriptional	B-X
repression	B-X
by	B-X
the	B-X
RB-E2F	B-X
complex	B-X
is	B-X
released	B-X
through	B-X
phosphorylation	B-X
of	B-X
RB	B-X
,	B-X
leading	B-X
to	B-X
expression	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
regulators	B-X
.	B-X
The	B-X
release	B-X
from	B-X
repression	B-X
can	B-X
be	B-X
prevented	B-X
by	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
inhibitor	B-X
p21/CDKN1A	B-X
.	B-X
The	B-X
CDKN1A	B-X
gene	B-X
is	B-X
transcriptionally	B-X
activated	B-X
by	B-X
p53	B-X
.	B-X
High	B-X
levels	B-X
of	B-X
p21	B-X
then	B-X
result	B-X
in	B-X
RB-E2F	B-X
complex	B-X
formation	B-X
and	B-X
downregulation	B-X
of	B-X
a	B-X
large	B-X
number	B-X
of	B-X
cell	B-X
cycle	B-X
genes	B-X
.	B-X
Thus	B-X
,	B-X
p53-dependent	B-X
transcriptional	B-X
repression	B-X
is	B-X
indirect	B-X
.	B-X
Mechanistically	B-X
this	B-X
can	B-X
be	B-X
explained	B-X
by	B-X
replacing	B-X
RB-E2F	B-X
complexes	B-X
with	B-X
the	B-X
DREAM	B-X
transcriptional	B-X
repressor	B-X
complex	B-X
at	B-X
E2F	B-X
sites	B-X
in	B-X
target	B-X
promoters	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
RB-E2F	B-X
,	B-X
DREAM	B-X
can	B-X
downregulate	B-X
genes	B-X
also	B-X
through	B-X
CHR	B-X
transcription	B-X
factor	B-X
binding	B-X
sites	B-X
.	B-X
This	B-X
results	B-X
in	B-X
a	B-X
distinct	B-X
gene	B-X
set	B-X
controlled	B-X
by	B-X
p53-p21-DREAM	B-X
signaling	B-X
independent	B-X
of	B-X
RB-E2F	B-X
.	B-X
Furthermore	B-X
,	B-X
RB	B-X
has	B-X
non-canonical	B-X
functions	B-X
without	B-X
binding	B-X
to	B-X
E2F	B-X
and	B-X
DNA	B-X
.	B-X

Following	O
mitogenic	O
stimulation	O
,	O
repressive	O
E2F4	O
-	O
p130	O
-	O
histone	O
deacetylase	O
complexes	O
dissociate	O
from	O
,	O
while	O
activating	O
species	O
(	O
E2F1	B-Gene_or_gene_product
,	O
-	B-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
and	O
-	B-Gene_or_gene_product
3	I-Gene_or_gene_product
)	O
associate	O
with	O
,	O
target	O
promoters	O
.	O
<EOS>	B-X
E2F	B-X
proteins	B-X
can	B-X
either	B-X
activate	B-X
or	B-X
repress	B-X
transcription	B-X
.	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Histones	B-X
H3	B-X
and	B-X
H4	B-X
simultaneously	B-X
become	B-X
hyperacetylated	B-X
,	B-X
but	B-X
it	B-X
remains	B-X
unclear	B-X
whether	B-X
this	B-X
is	B-X
a	B-X
prerequisite	B-X
or	B-X
a	B-X
consequence	B-X
of	B-X
E2F	B-X
binding	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
activating	B-X
E2F	B-X
species	B-X
are	B-X
required	B-X
for	B-X
hyperacetylation	B-X
of	B-X
target	B-X
chromatin	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
Moreover	B-X
,	B-X
E2F-dependent	B-X
recruitment	B-X
of	B-X
Tip60	B-X
to	B-X
chromatin	B-X
occurred	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
following	B-X
serum	B-X
stimulation	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

Histones	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
and	O
H4	B-Gene_or_gene_product
simultaneously	O
become	O
hyperacetylated	O
,	O
but	O
it	O
remains	O
unclear	O
whether	O
this	O
is	O
a	O
prerequisite	O
or	O
a	O
consequence	O
of	O
E2F	B-Gene_or_gene_product
binding	O
.	O
<EOS>	B-X
Subsequently	B-X
,	B-X
CDK2-cyclin	B-X
E	B-X
catalyzes	B-X
the	B-X
hyperphosphorylation	B-X
of	B-X
Rb	B-X
that	B-X
promotes	B-X
the	B-X
release	B-X
and	B-X
activation	B-X
of	B-X
the	B-X
E2F	B-X
transcription	B-X
factor	B-X
,	B-X
which	B-X
in	B-X
turn	B-X
lead	B-X
to	B-X
the	B-X
biosynthesis	B-X
of	B-X
dozens	B-X
of	B-X
proteins	B-X
required	B-X
for	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
In	B-X
recent	B-X
years	B-X
it	B-X
has	B-X
become	B-X
evident	B-X
that	B-X
p53-dependent	B-X
repression	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
p53-p21-DREAM-E2F/CHR	B-X
pathway	B-X
(	B-X
p53-DREAM	B-X
pathway	B-X
)	B-X
.	B-X
DREAM	B-X
is	B-X
a	B-X
transcriptional	B-X
repressor	B-X
that	B-X
binds	B-X
to	B-X
E2F	B-X
or	B-X
CHR	B-X
promoter	B-X
sites	B-X
.	B-X
Gene	B-X
regulation	B-X
and	B-X
deregulation	B-X
by	B-X
DREAM	B-X
shares	B-X
many	B-X
mechanistic	B-X
characteristics	B-X
with	B-X
the	B-X
retinoblastoma	B-X
pRB	B-X
tumor	B-X
suppressor	B-X
that	B-X
acts	B-X
through	B-X
E2F	B-X
elements	B-X
.	B-X
However	B-X
,	B-X
because	B-X
of	B-X
its	B-X
binding	B-X
to	B-X
E2F	B-X
and	B-X
CHR	B-X
elements	B-X
,	B-X
DREAM	B-X
regulates	B-X
a	B-X
larger	B-X
set	B-X
of	B-X
target	B-X
genes	B-X
leading	B-X
to	B-X
regulatory	B-X
functions	B-X
distinct	B-X
from	B-X
pRB/E2F	B-X
.	B-X

Here	O
,	O
we	O
show	O
that	O
activating	O
E2F	B-Gene_or_gene_product
species	O
are	O
required	O
for	O
hyperacetylation	O
of	O
target	O
chromatin	O
in	O
human	O
cells	O
.	O
<EOS>	B-X
E2F	B-X
proteins	B-X
can	B-X
either	B-X
activate	B-X
or	B-X
repress	B-X
transcription	B-X
.	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Histones	B-X
H3	B-X
and	B-X
H4	B-X
simultaneously	B-X
become	B-X
hyperacetylated	B-X
,	B-X
but	B-X
it	B-X
remains	B-X
unclear	B-X
whether	B-X
this	B-X
is	B-X
a	B-X
prerequisite	B-X
or	B-X
a	B-X
consequence	B-X
of	B-X
E2F	B-X
binding	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
activating	B-X
E2F	B-X
species	B-X
are	B-X
required	B-X
for	B-X
hyperacetylation	B-X
of	B-X
target	B-X
chromatin	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
Moreover	B-X
,	B-X
E2F-dependent	B-X
recruitment	B-X
of	B-X
Tip60	B-X
to	B-X
chromatin	B-X
occurred	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
following	B-X
serum	B-X
stimulation	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

Overexpression	O
of	O
a	O
dominant	O
-	O
negative	O
(	O
DN	O
)	O
E2F1	B-Gene_or_gene_product
mutant	O
in	O
serum	O
-	O
stimulated	O
T98G	O
cells	O
blocked	O
all	O
E2F	B-Gene_or_gene_product
binding	O
,	O
H4	B-Gene_or_gene_product
acetylation	O
,	O
and	O
,	O
albeit	O
partially	O
,	O
H3	B-Gene_or_gene_product
acetylation	O
.	O
<EOS>	B-X
E2F	B-X
proteins	B-X
can	B-X
either	B-X
activate	B-X
or	B-X
repress	B-X
transcription	B-X
.	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Histones	B-X
H3	B-X
and	B-X
H4	B-X
simultaneously	B-X
become	B-X
hyperacetylated	B-X
,	B-X
but	B-X
it	B-X
remains	B-X
unclear	B-X
whether	B-X
this	B-X
is	B-X
a	B-X
prerequisite	B-X
or	B-X
a	B-X
consequence	B-X
of	B-X
E2F	B-X
binding	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
activating	B-X
E2F	B-X
species	B-X
are	B-X
required	B-X
for	B-X
hyperacetylation	B-X
of	B-X
target	B-X
chromatin	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
Moreover	B-X
,	B-X
E2F-dependent	B-X
recruitment	B-X
of	B-X
Tip60	B-X
to	B-X
chromatin	B-X
occurred	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
following	B-X
serum	B-X
stimulation	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

Target	O
gene	O
activation	O
and	O
S	O
-	O
phase	O
entry	O
were	O
also	O
blocked	O
by	O
DN	O
E2F1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

Conversely	O
,	O
ectopic	O
activation	O
of	O
E2F1	B-Gene_or_gene_product
rapidly	O
induced	O
H3	B-Gene_or_gene_product
and	O
H4	B-Gene_or_gene_product
acetylation	O
,	O
demonstrating	O
a	O
direct	O
role	O
for	O
E2F	B-Gene_or_gene_product
in	O
these	O
events	O
.	O
<EOS>	B-X
E2F	B-X
proteins	B-X
can	B-X
either	B-X
activate	B-X
or	B-X
repress	B-X
transcription	B-X
.	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Histones	B-X
H3	B-X
and	B-X
H4	B-X
simultaneously	B-X
become	B-X
hyperacetylated	B-X
,	B-X
but	B-X
it	B-X
remains	B-X
unclear	B-X
whether	B-X
this	B-X
is	B-X
a	B-X
prerequisite	B-X
or	B-X
a	B-X
consequence	B-X
of	B-X
E2F	B-X
binding	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
activating	B-X
E2F	B-X
species	B-X
are	B-X
required	B-X
for	B-X
hyperacetylation	B-X
of	B-X
target	B-X
chromatin	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
Moreover	B-X
,	B-X
E2F-dependent	B-X
recruitment	B-X
of	B-X
Tip60	B-X
to	B-X
chromatin	B-X
occurred	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
following	B-X
serum	B-X
stimulation	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

E2F1	B-Gene_or_gene_product
was	O
previously	O
shown	O
to	O
bind	O
the	O
histone	B-Gene_or_gene_product
acetyltransferases	I-Gene_or_gene_product
(	O
HATs	B-Gene_or_gene_product
)	O
p300	B-Gene_or_gene_product
/	O
CBP	B-Gene_or_gene_product
and	O
PCAF	B-Gene_or_gene_product
/	O
GCN5	B-Gene_or_gene_product
.	O
<EOS>	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Histones	B-X
H3	B-X
and	B-X
H4	B-X
simultaneously	B-X
become	B-X
hyperacetylated	B-X
,	B-X
but	B-X
it	B-X
remains	B-X
unclear	B-X
whether	B-X
this	B-X
is	B-X
a	B-X
prerequisite	B-X
or	B-X
a	B-X
consequence	B-X
of	B-X
E2F	B-X
binding	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X

In	O
our	O
hands	O
,	O
ectopically	O
expressed	O
E2F1	B-Gene_or_gene_product
also	O
bound	O
the	O
unrelated	O
HAT	B-Gene_or_gene_product
Tip60	B-Gene_or_gene_product
and	O
induced	O
recruitment	O
of	O
five	O
subunits	O
of	O
the	O
Tip60	O
complex	O
(	O
Tip60	B-Gene_or_gene_product
,	O
TRRAP	B-Gene_or_gene_product
,	O
p400	B-Gene_or_gene_product
,	O
Tip48	B-Gene_or_gene_product
,	O
and	O
Tip49	B-Gene_or_gene_product
)	O
to	O
target	O
promoters	O
in	O
vivo	O
.	O
<EOS>	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
activating	B-X
E2F	B-X
species	B-X
are	B-X
required	B-X
for	B-X
hyperacetylation	B-X
of	B-X
target	B-X
chromatin	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
Moreover	B-X
,	B-X
E2F-dependent	B-X
recruitment	B-X
of	B-X
Tip60	B-X
to	B-X
chromatin	B-X
occurred	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
following	B-X
serum	B-X
stimulation	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

Moreover	O
,	O
E2F	B-Gene_or_gene_product
-	O
dependent	O
recruitment	O
of	O
Tip60	B-Gene_or_gene_product
to	O
chromatin	O
occurred	O
in	O
late	O
G	O
(	O
1	O
)	O
following	O
serum	O
stimulation	O
.	O
<EOS>	B-X
E2F	B-X
proteins	B-X
can	B-X
either	B-X
activate	B-X
or	B-X
repress	B-X
transcription	B-X
.	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Histones	B-X
H3	B-X
and	B-X
H4	B-X
simultaneously	B-X
become	B-X
hyperacetylated	B-X
,	B-X
but	B-X
it	B-X
remains	B-X
unclear	B-X
whether	B-X
this	B-X
is	B-X
a	B-X
prerequisite	B-X
or	B-X
a	B-X
consequence	B-X
of	B-X
E2F	B-X
binding	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
activating	B-X
E2F	B-X
species	B-X
are	B-X
required	B-X
for	B-X
hyperacetylation	B-X
of	B-X
target	B-X
chromatin	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
Moreover	B-X
,	B-X
E2F-dependent	B-X
recruitment	B-X
of	B-X
Tip60	B-X
to	B-X
chromatin	B-X
occurred	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
following	B-X
serum	B-X
stimulation	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

We	O
speculate	O
that	O
the	O
activities	O
of	O
multiple	O
HAT	O
complexes	O
account	O
for	O
E2F	B-Gene_or_gene_product
-	O
dependent	O
acetylation	O
,	O
transcription	O
,	O
and	O
S	O
-	O
phase	O
entry	O
.	O
<EOS>	B-X
E2F	B-X
proteins	B-X
can	B-X
either	B-X
activate	B-X
or	B-X
repress	B-X
transcription	B-X
.	B-X
Following	B-X
mitogenic	B-X
stimulation	B-X
,	B-X
repressive	B-X
E2F4-p130-histone	B-X
deacetylase	B-X
complexes	B-X
dissociate	B-X
from	B-X
,	B-X
while	B-X
activating	B-X
species	B-X
(	B-X
E2F1	B-X
,	B-X
-2	B-X
,	B-X
and	B-X
-3	B-X
)	B-X
associate	B-X
with	B-X
,	B-X
target	B-X
promoters	B-X
.	B-X
Histones	B-X
H3	B-X
and	B-X
H4	B-X
simultaneously	B-X
become	B-X
hyperacetylated	B-X
,	B-X
but	B-X
it	B-X
remains	B-X
unclear	B-X
whether	B-X
this	B-X
is	B-X
a	B-X
prerequisite	B-X
or	B-X
a	B-X
consequence	B-X
of	B-X
E2F	B-X
binding	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
activating	B-X
E2F	B-X
species	B-X
are	B-X
required	B-X
for	B-X
hyperacetylation	B-X
of	B-X
target	B-X
chromatin	B-X
in	B-X
human	B-X
cells	B-X
.	B-X
Overexpression	B-X
of	B-X
a	B-X
dominant-negative	B-X
(	B-X
DN	B-X
)	B-X
E2F1	B-X
mutant	B-X
in	B-X
serum-stimulated	B-X
T98G	B-X
cells	B-X
blocked	B-X
all	B-X
E2F	B-X
binding	B-X
,	B-X
H4	B-X
acetylation	B-X
,	B-X
and	B-X
,	B-X
albeit	B-X
partially	B-X
,	B-X
H3	B-X
acetylation	B-X
.	B-X
Target	B-X
gene	B-X
activation	B-X
and	B-X
S-phase	B-X
entry	B-X
were	B-X
also	B-X
blocked	B-X
by	B-X
DN	B-X
E2F1	B-X
.	B-X
Conversely	B-X
,	B-X
ectopic	B-X
activation	B-X
of	B-X
E2F1	B-X
rapidly	B-X
induced	B-X
H3	B-X
and	B-X
H4	B-X
acetylation	B-X
,	B-X
demonstrating	B-X
a	B-X
direct	B-X
role	B-X
for	B-X
E2F	B-X
in	B-X
these	B-X
events	B-X
.	B-X
E2F1	B-X
was	B-X
previously	B-X
shown	B-X
to	B-X
bind	B-X
the	B-X
histone	B-X
acetyltransferases	B-X
(	B-X
HATs	B-X
)	B-X
p300/CBP	B-X
and	B-X
PCAF/GCN5	B-X
.	B-X
In	B-X
our	B-X
hands	B-X
,	B-X
ectopically	B-X
expressed	B-X
E2F1	B-X
also	B-X
bound	B-X
the	B-X
unrelated	B-X
HAT	B-X
Tip60	B-X
and	B-X
induced	B-X
recruitment	B-X
of	B-X
five	B-X
subunits	B-X
of	B-X
the	B-X
Tip60	B-X
complex	B-X
(	B-X
Tip60	B-X
,	B-X
TRRAP	B-X
,	B-X
p400	B-X
,	B-X
Tip48	B-X
,	B-X
and	B-X
Tip49	B-X
)	B-X
to	B-X
target	B-X
promoters	B-X
in	B-X
vivo	B-X
.	B-X
Moreover	B-X
,	B-X
E2F-dependent	B-X
recruitment	B-X
of	B-X
Tip60	B-X
to	B-X
chromatin	B-X
occurred	B-X
in	B-X
late	B-X
G	B-X
(	B-X
1	B-X
)	B-X
following	B-X
serum	B-X
stimulation	B-X
.	B-X
We	B-X
speculate	B-X
that	B-X
the	B-X
activities	B-X
of	B-X
multiple	B-X
HAT	B-X
complexes	B-X
account	B-X
for	B-X
E2F-dependent	B-X
acetylation	B-X
,	B-X
transcription	B-X
,	B-X
and	B-X
S-phase	B-X
entry	B-X
.	B-X

E2F1	B-Gene_or_gene_product
uses	O
the	O
ATM	B-Gene_or_gene_product
signaling	O
pathway	O
to	O
induce	O
p53	B-Gene_or_gene_product
and	O
Chk2	B-Gene_or_gene_product
phosphorylation	O
and	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
by	B-X
several	B-X
DNA	B-X
damage-inducible	B-X
kinases	B-X
,	B-X
such	B-X
as	B-X
ATM	B-X
,	B-X
and	B-X
is	B-X
a	B-X
key	B-X
effector	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
promoting	B-X
cell	B-X
cycle	B-X
arrest	B-X
or	B-X
apoptosis	B-X
.	B-X
Deregulation	B-X
of	B-X
the	B-X
Rb-E2F1	B-X
pathway	B-X
also	B-X
results	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
the	B-X
promotion	B-X
of	B-X
apoptosis	B-X
,	B-X
and	B-X
this	B-X
contributes	B-X
to	B-X
the	B-X
suppression	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
novel	B-X
connection	B-X
between	B-X
E2F1	B-X
and	B-X
the	B-X
ATM	B-X
DNA	B-X
damage	B-X
response	B-X
pathway	B-X
.	B-X
In	B-X
primary	B-X
human	B-X
fibroblasts	B-X
lacking	B-X
functional	B-X
ATM	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
E2F1	B-X
to	B-X
induce	B-X
the	B-X
phosphorylation	B-X
of	B-X
p53	B-X
and	B-X
apoptosis	B-X
is	B-X
impaired	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
ATM	B-X
status	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
transcriptional	B-X
activation	B-X
of	B-X
target	B-X
genes	B-X
or	B-X
the	B-X
stimulation	B-X
of	B-X
DNA	B-X
synthesis	B-X
by	B-X
E2F1	B-X
.	B-X
Cells	B-X
containing	B-X
mutant	B-X
Nijmegen	B-X
breakage	B-X
syndrome	B-X
protein	B-X
(	B-X
NBS1	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Mre11-Rad50	B-X
DNA	B-X
repair	B-X
complex	B-X
,	B-X
also	B-X
have	B-X
attenuated	B-X
p53	B-X
phosphorylation	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
E2F1	B-X
expression	B-X
.	B-X
Moreover	B-X
,	B-X
E2F1	B-X
induces	B-X
ATM-	B-X
and	B-X
NBS1-dependent	B-X
phosphorylation	B-X
of	B-X
the	B-X
checkpoint	B-X
kinase	B-X
Chk2	B-X
at	B-X
Thr68	B-X
,	B-X
a	B-X
phosphorylation	B-X
site	B-X
that	B-X
stimulates	B-X
Chk2	B-X
activity	B-X
.	B-X
Delayed	B-X
gammaH2AX	B-X
phosphorylation	B-X
and	B-X
absence	B-X
of	B-X
ATM	B-X
autophosphorylation	B-X
at	B-X
Ser1981	B-X
suggest	B-X
that	B-X
E2F1	B-X
stimulates	B-X
ATM	B-X
through	B-X
a	B-X
unique	B-X
mechanism	B-X
that	B-X
is	B-X
distinct	B-X
from	B-X
agents	B-X
that	B-X
cause	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
.	B-X
These	B-X
findings	B-X
identify	B-X
new	B-X
roles	B-X
for	B-X
several	B-X
DNA	B-X
damage	B-X
response	B-X
factors	B-X
by	B-X
demonstrating	B-X
that	B-X
they	B-X
also	B-X
participate	B-X
in	B-X
the	B-X
oncogenic	B-X
stress	B-X
signaling	B-X
pathway	B-X
between	B-X
E2F1	B-X
and	B-X
p53	B-X
.	B-X

The	O
p53	B-Gene_or_gene_product
tumor	O
suppressor	O
protein	O
is	O
phosphorylated	O
and	O
activated	O
by	O
several	O
DNA	O
damage	O
-	O
inducible	O
kinases	O
,	O
such	O
as	O
ATM	B-Gene_or_gene_product
,	O
and	O
is	O
a	O
key	O
effector	O
of	O
the	O
DNA	O
damage	O
response	O
by	O
promoting	O
cell	O
cycle	O
arrest	O
or	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
process	B-X
of	B-X
programmed	B-X
cell	B-X
death	B-X
,	B-X
or	B-X
apoptosis	B-X
,	B-X
is	B-X
generally	B-X
characterized	B-X
by	B-X
distinct	B-X
morphological	B-X
characteristics	B-X
and	B-X
energy-dependent	B-X
biochemical	B-X
mechanisms	B-X
.	B-X
Apoptosis	B-X
is	B-X
considered	B-X
a	B-X
vital	B-X
component	B-X
of	B-X
various	B-X
processes	B-X
including	B-X
normal	B-X
cell	B-X
turnover	B-X
,	B-X
proper	B-X
development	B-X
and	B-X
functioning	B-X
of	B-X
the	B-X
immune	B-X
system	B-X
,	B-X
hormone-dependent	B-X
atrophy	B-X
,	B-X
embryonic	B-X
development	B-X
and	B-X
chemical-induced	B-X
cell	B-X
death	B-X
.	B-X
Inappropriate	B-X
apoptosis	B-X
(	B-X
either	B-X
too	B-X
little	B-X
or	B-X
too	B-X
much	B-X
)	B-X
is	B-X
a	B-X
factor	B-X
in	B-X
many	B-X
human	B-X
conditions	B-X
including	B-X
neurodegenerative	B-X
diseases	B-X
,	B-X
ischemic	B-X
damage	B-X
,	B-X
autoimmune	B-X
disorders	B-X
and	B-X
many	B-X
types	B-X
of	B-X
cancer	B-X
.	B-X
The	B-X
ability	B-X
to	B-X
modulate	B-X
the	B-X
life	B-X
or	B-X
death	B-X
of	B-X
a	B-X
cell	B-X
is	B-X
recognized	B-X
for	B-X
its	B-X
immense	B-X
therapeutic	B-X
potential	B-X
.	B-X
Therefore	B-X
,	B-X
research	B-X
continues	B-X
to	B-X
focus	B-X
on	B-X
the	B-X
elucidation	B-X
and	B-X
analysis	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
machinery	B-X
and	B-X
signaling	B-X
pathways	B-X
that	B-X
control	B-X
cell	B-X
cycle	B-X
arrest	B-X
and	B-X
apoptosis	B-X
.	B-X
To	B-X
that	B-X
end	B-X
,	B-X
the	B-X
field	B-X
of	B-X
apoptosis	B-X
research	B-X
has	B-X
been	B-X
moving	B-X
forward	B-X
at	B-X
an	B-X
alarmingly	B-X
rapid	B-X
rate	B-X
.	B-X
Although	B-X
many	B-X
of	B-X
the	B-X
key	B-X
apoptotic	B-X
proteins	B-X
have	B-X
been	B-X
identified	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
action	B-X
or	B-X
inaction	B-X
of	B-X
these	B-X
proteins	B-X
remain	B-X
to	B-X
be	B-X
elucidated	B-X
.	B-X
The	B-X
goal	B-X
of	B-X
this	B-X
review	B-X
is	B-X
to	B-X
provide	B-X
a	B-X
general	B-X
overview	B-X
of	B-X
current	B-X
knowledge	B-X
on	B-X
the	B-X
process	B-X
of	B-X
apoptosis	B-X
including	B-X
morphology	B-X
,	B-X
biochemistry	B-X
,	B-X
the	B-X
role	B-X
of	B-X
apoptosis	B-X
in	B-X
health	B-X
and	B-X
disease	B-X
,	B-X
detection	B-X
methods	B-X
,	B-X
as	B-X
well	B-X
as	B-X
a	B-X
discussion	B-X
of	B-X
potential	B-X
alternative	B-X
forms	B-X
of	B-X
apoptosis	B-X
.	B-X

Deregulation	O
of	O
the	O
Rb	B-Gene_or_gene_product
-	O
E2F1	B-Gene_or_gene_product
pathway	O
also	O
results	O
in	O
the	O
activation	O
of	O
p53	B-Gene_or_gene_product
and	O
the	O
promotion	O
of	O
apoptosis	O
,	O
and	O
this	O
contributes	O
to	O
the	O
suppression	O
of	O
tumor	O
development	O
.	O

Here	O
,	O
we	O
describe	O
a	O
novel	O
connection	O
between	O
E2F1	B-Gene_or_gene_product
and	O
the	O
ATM	B-Gene_or_gene_product
DNA	O
damage	O
response	O
pathway	O
.	O
<EOS>	B-X
The	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
by	B-X
several	B-X
DNA	B-X
damage-inducible	B-X
kinases	B-X
,	B-X
such	B-X
as	B-X
ATM	B-X
,	B-X
and	B-X
is	B-X
a	B-X
key	B-X
effector	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
promoting	B-X
cell	B-X
cycle	B-X
arrest	B-X
or	B-X
apoptosis	B-X
.	B-X
Deregulation	B-X
of	B-X
the	B-X
Rb-E2F1	B-X
pathway	B-X
also	B-X
results	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
the	B-X
promotion	B-X
of	B-X
apoptosis	B-X
,	B-X
and	B-X
this	B-X
contributes	B-X
to	B-X
the	B-X
suppression	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
novel	B-X
connection	B-X
between	B-X
E2F1	B-X
and	B-X
the	B-X
ATM	B-X
DNA	B-X
damage	B-X
response	B-X
pathway	B-X
.	B-X
In	B-X
primary	B-X
human	B-X
fibroblasts	B-X
lacking	B-X
functional	B-X
ATM	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
E2F1	B-X
to	B-X
induce	B-X
the	B-X
phosphorylation	B-X
of	B-X
p53	B-X
and	B-X
apoptosis	B-X
is	B-X
impaired	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
ATM	B-X
status	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
transcriptional	B-X
activation	B-X
of	B-X
target	B-X
genes	B-X
or	B-X
the	B-X
stimulation	B-X
of	B-X
DNA	B-X
synthesis	B-X
by	B-X
E2F1	B-X
.	B-X
Cells	B-X
containing	B-X
mutant	B-X
Nijmegen	B-X
breakage	B-X
syndrome	B-X
protein	B-X
(	B-X
NBS1	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Mre11-Rad50	B-X
DNA	B-X
repair	B-X
complex	B-X
,	B-X
also	B-X
have	B-X
attenuated	B-X
p53	B-X
phosphorylation	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
E2F1	B-X
expression	B-X
.	B-X
Moreover	B-X
,	B-X
E2F1	B-X
induces	B-X
ATM-	B-X
and	B-X
NBS1-dependent	B-X
phosphorylation	B-X
of	B-X
the	B-X
checkpoint	B-X
kinase	B-X
Chk2	B-X
at	B-X
Thr68	B-X
,	B-X
a	B-X
phosphorylation	B-X
site	B-X
that	B-X
stimulates	B-X
Chk2	B-X
activity	B-X
.	B-X
Delayed	B-X
gammaH2AX	B-X
phosphorylation	B-X
and	B-X
absence	B-X
of	B-X
ATM	B-X
autophosphorylation	B-X
at	B-X
Ser1981	B-X
suggest	B-X
that	B-X
E2F1	B-X
stimulates	B-X
ATM	B-X
through	B-X
a	B-X
unique	B-X
mechanism	B-X
that	B-X
is	B-X
distinct	B-X
from	B-X
agents	B-X
that	B-X
cause	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
.	B-X
These	B-X
findings	B-X
identify	B-X
new	B-X
roles	B-X
for	B-X
several	B-X
DNA	B-X
damage	B-X
response	B-X
factors	B-X
by	B-X
demonstrating	B-X
that	B-X
they	B-X
also	B-X
participate	B-X
in	B-X
the	B-X
oncogenic	B-X
stress	B-X
signaling	B-X
pathway	B-X
between	B-X
E2F1	B-X
and	B-X
p53	B-X
.	B-X

In	O
primary	O
human	O
fibroblasts	O
lacking	O
functional	O
ATM	B-Gene_or_gene_product
,	O
the	O
ability	O
of	O
E2F1	B-Gene_or_gene_product
to	O
induce	O
the	O
phosphorylation	O
of	O
p53	B-Gene_or_gene_product
and	O
apoptosis	O
is	O
impaired	O
.	O
<EOS>	B-X
The	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
by	B-X
several	B-X
DNA	B-X
damage-inducible	B-X
kinases	B-X
,	B-X
such	B-X
as	B-X
ATM	B-X
,	B-X
and	B-X
is	B-X
a	B-X
key	B-X
effector	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
promoting	B-X
cell	B-X
cycle	B-X
arrest	B-X
or	B-X
apoptosis	B-X
.	B-X
Deregulation	B-X
of	B-X
the	B-X
Rb-E2F1	B-X
pathway	B-X
also	B-X
results	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
the	B-X
promotion	B-X
of	B-X
apoptosis	B-X
,	B-X
and	B-X
this	B-X
contributes	B-X
to	B-X
the	B-X
suppression	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
novel	B-X
connection	B-X
between	B-X
E2F1	B-X
and	B-X
the	B-X
ATM	B-X
DNA	B-X
damage	B-X
response	B-X
pathway	B-X
.	B-X
In	B-X
primary	B-X
human	B-X
fibroblasts	B-X
lacking	B-X
functional	B-X
ATM	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
E2F1	B-X
to	B-X
induce	B-X
the	B-X
phosphorylation	B-X
of	B-X
p53	B-X
and	B-X
apoptosis	B-X
is	B-X
impaired	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
ATM	B-X
status	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
transcriptional	B-X
activation	B-X
of	B-X
target	B-X
genes	B-X
or	B-X
the	B-X
stimulation	B-X
of	B-X
DNA	B-X
synthesis	B-X
by	B-X
E2F1	B-X
.	B-X
Cells	B-X
containing	B-X
mutant	B-X
Nijmegen	B-X
breakage	B-X
syndrome	B-X
protein	B-X
(	B-X
NBS1	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Mre11-Rad50	B-X
DNA	B-X
repair	B-X
complex	B-X
,	B-X
also	B-X
have	B-X
attenuated	B-X
p53	B-X
phosphorylation	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
E2F1	B-X
expression	B-X
.	B-X
Moreover	B-X
,	B-X
E2F1	B-X
induces	B-X
ATM-	B-X
and	B-X
NBS1-dependent	B-X
phosphorylation	B-X
of	B-X
the	B-X
checkpoint	B-X
kinase	B-X
Chk2	B-X
at	B-X
Thr68	B-X
,	B-X
a	B-X
phosphorylation	B-X
site	B-X
that	B-X
stimulates	B-X
Chk2	B-X
activity	B-X
.	B-X
Delayed	B-X
gammaH2AX	B-X
phosphorylation	B-X
and	B-X
absence	B-X
of	B-X
ATM	B-X
autophosphorylation	B-X
at	B-X
Ser1981	B-X
suggest	B-X
that	B-X
E2F1	B-X
stimulates	B-X
ATM	B-X
through	B-X
a	B-X
unique	B-X
mechanism	B-X
that	B-X
is	B-X
distinct	B-X
from	B-X
agents	B-X
that	B-X
cause	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
.	B-X
These	B-X
findings	B-X
identify	B-X
new	B-X
roles	B-X
for	B-X
several	B-X
DNA	B-X
damage	B-X
response	B-X
factors	B-X
by	B-X
demonstrating	B-X
that	B-X
they	B-X
also	B-X
participate	B-X
in	B-X
the	B-X
oncogenic	B-X
stress	B-X
signaling	B-X
pathway	B-X
between	B-X
E2F1	B-X
and	B-X
p53	B-X
.	B-X

In	O
contrast	O
,	O
ATM	B-Gene_or_gene_product
status	O
has	O
no	O
effect	O
on	O
transcriptional	O
activation	O
of	O
target	O
genes	O
or	O
the	O
stimulation	O
of	O
DNA	O
synthesis	O
by	O
E2F1	B-Gene_or_gene_product
.	O
<EOS>	B-X
E2F	B-X
is	B-X
a	B-X
family	B-X
of	B-X
transcription	B-X
factors	B-X
that	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
a	B-X
wide	B-X
range	B-X
of	B-X
cellular	B-X
processes	B-X
,	B-X
including	B-X
cell-cycle	B-X
progression	B-X
,	B-X
DNA	B-X
replication	B-X
,	B-X
DNA	B-X
repair	B-X
,	B-X
differentiation	B-X
,	B-X
and	B-X
apoptosis	B-X
.	B-X
E2F1	B-X
,	B-X
the	B-X
founding	B-X
member	B-X
of	B-X
the	B-X
family	B-X
,	B-X
undergoes	B-X
posttranslational	B-X
modifications	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
,	B-X
resulting	B-X
in	B-X
E2F1	B-X
stabilization	B-X
.	B-X
In	B-X
some	B-X
cases	B-X
,	B-X
E2F1	B-X
is	B-X
important	B-X
for	B-X
DNA	B-X
damage-induced	B-X
apoptosis	B-X
through	B-X
the	B-X
transcriptional	B-X
activation	B-X
of	B-X
p73	B-X
and	B-X
perhaps	B-X
other	B-X
proapoptotic	B-X
target	B-X
genes	B-X
.	B-X
However	B-X
,	B-X
in	B-X
other	B-X
contexts	B-X
,	B-X
E2F1	B-X
can	B-X
stimulate	B-X
DNA	B-X
repair	B-X
and	B-X
promote	B-X
survival	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
The	B-X
E2F1	B-X
protein	B-X
accumulates	B-X
at	B-X
sites	B-X
of	B-X
both	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
and	B-X
UV	B-X
radiation-induced	B-X
damage	B-X
,	B-X
indicating	B-X
that	B-X
E2F1	B-X
has	B-X
a	B-X
nontranscriptional	B-X
function	B-X
at	B-X
sites	B-X
of	B-X
damage	B-X
.	B-X
This	B-X
review	B-X
summarizes	B-X
recent	B-X
progress	B-X
made	B-X
in	B-X
understanding	B-X
the	B-X
role	B-X
of	B-X
E2F1	B-X
in	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
,	B-X
including	B-X
transcription-independent	B-X
activities	B-X
that	B-X
facilitate	B-X
DNA	B-X
repair	B-X
in	B-X
the	B-X
context	B-X
of	B-X
chromatin	B-X
.	B-X

Cells	O
containing	O
mutant	O
Nijmegen	B-Gene_or_gene_product
breakage	I-Gene_or_gene_product
syndrome	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	O
NBS1	B-Gene_or_gene_product
)	O
,	O
a	O
component	O
of	O
the	O
Mre11	O
-	O
Rad50	O
DNA	O
repair	O
complex	O
,	O
also	O
have	O
attenuated	O
p53	B-Gene_or_gene_product
phosphorylation	O
and	O
apoptosis	O
in	O
response	O
to	O
E2F1	B-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
The	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
by	B-X
several	B-X
DNA	B-X
damage-inducible	B-X
kinases	B-X
,	B-X
such	B-X
as	B-X
ATM	B-X
,	B-X
and	B-X
is	B-X
a	B-X
key	B-X
effector	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
promoting	B-X
cell	B-X
cycle	B-X
arrest	B-X
or	B-X
apoptosis	B-X
.	B-X
Deregulation	B-X
of	B-X
the	B-X
Rb-E2F1	B-X
pathway	B-X
also	B-X
results	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
the	B-X
promotion	B-X
of	B-X
apoptosis	B-X
,	B-X
and	B-X
this	B-X
contributes	B-X
to	B-X
the	B-X
suppression	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
novel	B-X
connection	B-X
between	B-X
E2F1	B-X
and	B-X
the	B-X
ATM	B-X
DNA	B-X
damage	B-X
response	B-X
pathway	B-X
.	B-X
In	B-X
primary	B-X
human	B-X
fibroblasts	B-X
lacking	B-X
functional	B-X
ATM	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
E2F1	B-X
to	B-X
induce	B-X
the	B-X
phosphorylation	B-X
of	B-X
p53	B-X
and	B-X
apoptosis	B-X
is	B-X
impaired	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
ATM	B-X
status	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
transcriptional	B-X
activation	B-X
of	B-X
target	B-X
genes	B-X
or	B-X
the	B-X
stimulation	B-X
of	B-X
DNA	B-X
synthesis	B-X
by	B-X
E2F1	B-X
.	B-X
Cells	B-X
containing	B-X
mutant	B-X
Nijmegen	B-X
breakage	B-X
syndrome	B-X
protein	B-X
(	B-X
NBS1	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Mre11-Rad50	B-X
DNA	B-X
repair	B-X
complex	B-X
,	B-X
also	B-X
have	B-X
attenuated	B-X
p53	B-X
phosphorylation	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
E2F1	B-X
expression	B-X
.	B-X
Moreover	B-X
,	B-X
E2F1	B-X
induces	B-X
ATM-	B-X
and	B-X
NBS1-dependent	B-X
phosphorylation	B-X
of	B-X
the	B-X
checkpoint	B-X
kinase	B-X
Chk2	B-X
at	B-X
Thr68	B-X
,	B-X
a	B-X
phosphorylation	B-X
site	B-X
that	B-X
stimulates	B-X
Chk2	B-X
activity	B-X
.	B-X
Delayed	B-X
gammaH2AX	B-X
phosphorylation	B-X
and	B-X
absence	B-X
of	B-X
ATM	B-X
autophosphorylation	B-X
at	B-X
Ser1981	B-X
suggest	B-X
that	B-X
E2F1	B-X
stimulates	B-X
ATM	B-X
through	B-X
a	B-X
unique	B-X
mechanism	B-X
that	B-X
is	B-X
distinct	B-X
from	B-X
agents	B-X
that	B-X
cause	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
.	B-X
These	B-X
findings	B-X
identify	B-X
new	B-X
roles	B-X
for	B-X
several	B-X
DNA	B-X
damage	B-X
response	B-X
factors	B-X
by	B-X
demonstrating	B-X
that	B-X
they	B-X
also	B-X
participate	B-X
in	B-X
the	B-X
oncogenic	B-X
stress	B-X
signaling	B-X
pathway	B-X
between	B-X
E2F1	B-X
and	B-X
p53	B-X
.	B-X

Moreover	O
,	O
E2F1	B-Gene_or_gene_product
induces	O
ATM	B-Gene_or_gene_product
-	O
and	O
NBS1	B-Gene_or_gene_product
-	O
dependent	O
phosphorylation	O
of	O
the	O
checkpoint	O
kinase	O
Chk2	B-Gene_or_gene_product
at	O
Thr68	O
,	O
a	O
phosphorylation	O
site	O
that	O
stimulates	O
Chk2	B-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
The	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
by	B-X
several	B-X
DNA	B-X
damage-inducible	B-X
kinases	B-X
,	B-X
such	B-X
as	B-X
ATM	B-X
,	B-X
and	B-X
is	B-X
a	B-X
key	B-X
effector	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
promoting	B-X
cell	B-X
cycle	B-X
arrest	B-X
or	B-X
apoptosis	B-X
.	B-X
Deregulation	B-X
of	B-X
the	B-X
Rb-E2F1	B-X
pathway	B-X
also	B-X
results	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
the	B-X
promotion	B-X
of	B-X
apoptosis	B-X
,	B-X
and	B-X
this	B-X
contributes	B-X
to	B-X
the	B-X
suppression	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
novel	B-X
connection	B-X
between	B-X
E2F1	B-X
and	B-X
the	B-X
ATM	B-X
DNA	B-X
damage	B-X
response	B-X
pathway	B-X
.	B-X
In	B-X
primary	B-X
human	B-X
fibroblasts	B-X
lacking	B-X
functional	B-X
ATM	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
E2F1	B-X
to	B-X
induce	B-X
the	B-X
phosphorylation	B-X
of	B-X
p53	B-X
and	B-X
apoptosis	B-X
is	B-X
impaired	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
ATM	B-X
status	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
transcriptional	B-X
activation	B-X
of	B-X
target	B-X
genes	B-X
or	B-X
the	B-X
stimulation	B-X
of	B-X
DNA	B-X
synthesis	B-X
by	B-X
E2F1	B-X
.	B-X
Cells	B-X
containing	B-X
mutant	B-X
Nijmegen	B-X
breakage	B-X
syndrome	B-X
protein	B-X
(	B-X
NBS1	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Mre11-Rad50	B-X
DNA	B-X
repair	B-X
complex	B-X
,	B-X
also	B-X
have	B-X
attenuated	B-X
p53	B-X
phosphorylation	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
E2F1	B-X
expression	B-X
.	B-X
Moreover	B-X
,	B-X
E2F1	B-X
induces	B-X
ATM-	B-X
and	B-X
NBS1-dependent	B-X
phosphorylation	B-X
of	B-X
the	B-X
checkpoint	B-X
kinase	B-X
Chk2	B-X
at	B-X
Thr68	B-X
,	B-X
a	B-X
phosphorylation	B-X
site	B-X
that	B-X
stimulates	B-X
Chk2	B-X
activity	B-X
.	B-X
Delayed	B-X
gammaH2AX	B-X
phosphorylation	B-X
and	B-X
absence	B-X
of	B-X
ATM	B-X
autophosphorylation	B-X
at	B-X
Ser1981	B-X
suggest	B-X
that	B-X
E2F1	B-X
stimulates	B-X
ATM	B-X
through	B-X
a	B-X
unique	B-X
mechanism	B-X
that	B-X
is	B-X
distinct	B-X
from	B-X
agents	B-X
that	B-X
cause	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
.	B-X
These	B-X
findings	B-X
identify	B-X
new	B-X
roles	B-X
for	B-X
several	B-X
DNA	B-X
damage	B-X
response	B-X
factors	B-X
by	B-X
demonstrating	B-X
that	B-X
they	B-X
also	B-X
participate	B-X
in	B-X
the	B-X
oncogenic	B-X
stress	B-X
signaling	B-X
pathway	B-X
between	B-X
E2F1	B-X
and	B-X
p53	B-X
.	B-X

Delayed	O
gammaH2AX	B-Gene_or_gene_product
phosphorylation	O
and	O
absence	O
of	O
ATM	B-Gene_or_gene_product
autophosphorylation	O
at	O
Ser1981	O
suggest	O
that	O
E2F1	B-Gene_or_gene_product
stimulates	O
ATM	B-Gene_or_gene_product
through	O
a	O
unique	O
mechanism	O
that	O
is	O
distinct	O
from	O
agents	O
that	O
cause	O
DNA	O
double	O
-	O
strand	O
breaks	O
.	O
<EOS>	B-X
The	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
by	B-X
several	B-X
DNA	B-X
damage-inducible	B-X
kinases	B-X
,	B-X
such	B-X
as	B-X
ATM	B-X
,	B-X
and	B-X
is	B-X
a	B-X
key	B-X
effector	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
promoting	B-X
cell	B-X
cycle	B-X
arrest	B-X
or	B-X
apoptosis	B-X
.	B-X
Deregulation	B-X
of	B-X
the	B-X
Rb-E2F1	B-X
pathway	B-X
also	B-X
results	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
the	B-X
promotion	B-X
of	B-X
apoptosis	B-X
,	B-X
and	B-X
this	B-X
contributes	B-X
to	B-X
the	B-X
suppression	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
novel	B-X
connection	B-X
between	B-X
E2F1	B-X
and	B-X
the	B-X
ATM	B-X
DNA	B-X
damage	B-X
response	B-X
pathway	B-X
.	B-X
In	B-X
primary	B-X
human	B-X
fibroblasts	B-X
lacking	B-X
functional	B-X
ATM	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
E2F1	B-X
to	B-X
induce	B-X
the	B-X
phosphorylation	B-X
of	B-X
p53	B-X
and	B-X
apoptosis	B-X
is	B-X
impaired	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
ATM	B-X
status	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
transcriptional	B-X
activation	B-X
of	B-X
target	B-X
genes	B-X
or	B-X
the	B-X
stimulation	B-X
of	B-X
DNA	B-X
synthesis	B-X
by	B-X
E2F1	B-X
.	B-X
Cells	B-X
containing	B-X
mutant	B-X
Nijmegen	B-X
breakage	B-X
syndrome	B-X
protein	B-X
(	B-X
NBS1	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Mre11-Rad50	B-X
DNA	B-X
repair	B-X
complex	B-X
,	B-X
also	B-X
have	B-X
attenuated	B-X
p53	B-X
phosphorylation	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
E2F1	B-X
expression	B-X
.	B-X
Moreover	B-X
,	B-X
E2F1	B-X
induces	B-X
ATM-	B-X
and	B-X
NBS1-dependent	B-X
phosphorylation	B-X
of	B-X
the	B-X
checkpoint	B-X
kinase	B-X
Chk2	B-X
at	B-X
Thr68	B-X
,	B-X
a	B-X
phosphorylation	B-X
site	B-X
that	B-X
stimulates	B-X
Chk2	B-X
activity	B-X
.	B-X
Delayed	B-X
gammaH2AX	B-X
phosphorylation	B-X
and	B-X
absence	B-X
of	B-X
ATM	B-X
autophosphorylation	B-X
at	B-X
Ser1981	B-X
suggest	B-X
that	B-X
E2F1	B-X
stimulates	B-X
ATM	B-X
through	B-X
a	B-X
unique	B-X
mechanism	B-X
that	B-X
is	B-X
distinct	B-X
from	B-X
agents	B-X
that	B-X
cause	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
.	B-X
These	B-X
findings	B-X
identify	B-X
new	B-X
roles	B-X
for	B-X
several	B-X
DNA	B-X
damage	B-X
response	B-X
factors	B-X
by	B-X
demonstrating	B-X
that	B-X
they	B-X
also	B-X
participate	B-X
in	B-X
the	B-X
oncogenic	B-X
stress	B-X
signaling	B-X
pathway	B-X
between	B-X
E2F1	B-X
and	B-X
p53	B-X
.	B-X

These	O
findings	O
identify	O
new	O
roles	O
for	O
several	O
DNA	O
damage	O
response	O
factors	O
by	O
demonstrating	O
that	O
they	O
also	O
participate	O
in	O
the	O
oncogenic	O
stress	O
signaling	O
pathway	O
between	O
E2F1	B-Gene_or_gene_product
and	O
p53	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
is	B-X
phosphorylated	B-X
and	B-X
activated	B-X
by	B-X
several	B-X
DNA	B-X
damage-inducible	B-X
kinases	B-X
,	B-X
such	B-X
as	B-X
ATM	B-X
,	B-X
and	B-X
is	B-X
a	B-X
key	B-X
effector	B-X
of	B-X
the	B-X
DNA	B-X
damage	B-X
response	B-X
by	B-X
promoting	B-X
cell	B-X
cycle	B-X
arrest	B-X
or	B-X
apoptosis	B-X
.	B-X
Deregulation	B-X
of	B-X
the	B-X
Rb-E2F1	B-X
pathway	B-X
also	B-X
results	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
p53	B-X
and	B-X
the	B-X
promotion	B-X
of	B-X
apoptosis	B-X
,	B-X
and	B-X
this	B-X
contributes	B-X
to	B-X
the	B-X
suppression	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
a	B-X
novel	B-X
connection	B-X
between	B-X
E2F1	B-X
and	B-X
the	B-X
ATM	B-X
DNA	B-X
damage	B-X
response	B-X
pathway	B-X
.	B-X
In	B-X
primary	B-X
human	B-X
fibroblasts	B-X
lacking	B-X
functional	B-X
ATM	B-X
,	B-X
the	B-X
ability	B-X
of	B-X
E2F1	B-X
to	B-X
induce	B-X
the	B-X
phosphorylation	B-X
of	B-X
p53	B-X
and	B-X
apoptosis	B-X
is	B-X
impaired	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
ATM	B-X
status	B-X
has	B-X
no	B-X
effect	B-X
on	B-X
transcriptional	B-X
activation	B-X
of	B-X
target	B-X
genes	B-X
or	B-X
the	B-X
stimulation	B-X
of	B-X
DNA	B-X
synthesis	B-X
by	B-X
E2F1	B-X
.	B-X
Cells	B-X
containing	B-X
mutant	B-X
Nijmegen	B-X
breakage	B-X
syndrome	B-X
protein	B-X
(	B-X
NBS1	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
Mre11-Rad50	B-X
DNA	B-X
repair	B-X
complex	B-X
,	B-X
also	B-X
have	B-X
attenuated	B-X
p53	B-X
phosphorylation	B-X
and	B-X
apoptosis	B-X
in	B-X
response	B-X
to	B-X
E2F1	B-X
expression	B-X
.	B-X
Moreover	B-X
,	B-X
E2F1	B-X
induces	B-X
ATM-	B-X
and	B-X
NBS1-dependent	B-X
phosphorylation	B-X
of	B-X
the	B-X
checkpoint	B-X
kinase	B-X
Chk2	B-X
at	B-X
Thr68	B-X
,	B-X
a	B-X
phosphorylation	B-X
site	B-X
that	B-X
stimulates	B-X
Chk2	B-X
activity	B-X
.	B-X
Delayed	B-X
gammaH2AX	B-X
phosphorylation	B-X
and	B-X
absence	B-X
of	B-X
ATM	B-X
autophosphorylation	B-X
at	B-X
Ser1981	B-X
suggest	B-X
that	B-X
E2F1	B-X
stimulates	B-X
ATM	B-X
through	B-X
a	B-X
unique	B-X
mechanism	B-X
that	B-X
is	B-X
distinct	B-X
from	B-X
agents	B-X
that	B-X
cause	B-X
DNA	B-X
double-strand	B-X
breaks	B-X
.	B-X
These	B-X
findings	B-X
identify	B-X
new	B-X
roles	B-X
for	B-X
several	B-X
DNA	B-X
damage	B-X
response	B-X
factors	B-X
by	B-X
demonstrating	B-X
that	B-X
they	B-X
also	B-X
participate	B-X
in	B-X
the	B-X
oncogenic	B-X
stress	B-X
signaling	B-X
pathway	B-X
between	B-X
E2F1	B-X
and	B-X
p53	B-X
.	B-X

Expression	O
of	O
MCM10	B-Gene_or_gene_product
and	O
TopBP1	B-Gene_or_gene_product
is	O
regulated	O
by	O
cell	O
proliferation	O
and	O
UV	O
irradiation	O
via	O
the	O
E2F	B-Gene_or_gene_product
transcription	O
factor	O
.	O
<EOS>	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
function	B-X
in	B-X
the	B-X
initiation	B-X
of	B-X
DNA	B-X
replication	B-X
,	B-X
by	B-X
regulating	B-X
the	B-X
chromatin	B-X
binding	B-X
of	B-X
the	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
loading	B-X
factor	B-X
,	B-X
CDC45	B-X
.	B-X
TopBP1	B-X
is	B-X
also	B-X
known	B-X
as	B-X
a	B-X
DNA	B-X
damage	B-X
response	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
the	B-X
transcription	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
is	B-X
activated	B-X
by	B-X
transcription	B-X
factors	B-X
E2F1-3	B-X
,	B-X
but	B-X
not	B-X
by	B-X
factors	B-X
E2F4-7	B-X
.	B-X
Analysis	B-X
of	B-X
various	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoter	B-X
constructs	B-X
showed	B-X
that	B-X
an	B-X
E2F-responsive	B-X
sequence	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
transcription	B-X
initiation	B-X
site	B-X
is	B-X
necessary	B-X
for	B-X
the	B-X
E2F1-induced	B-X
activation	B-X
of	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
gene	B-X
transcription	B-X
,	B-X
which	B-X
is	B-X
further	B-X
suppressed	B-X
by	B-X
pRb	B-X
.	B-X
The	B-X
promoter	B-X
activities	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
were	B-X
demonstrated	B-X
to	B-X
be	B-X
growth	B-X
dependent	B-X
via	B-X
the	B-X
E2F-responsive	B-X
sequence	B-X
.	B-X
Although	B-X
E2F1	B-X
was	B-X
stabilized	B-X
by	B-X
ultraviolet	B-X
(	B-X
UV	B-X
)	B-X
irradiation	B-X
,	B-X
the	B-X
mRNA	B-X
expression	B-X
level	B-X
of	B-X
TopBP1	B-X
was	B-X
suppressed	B-X
in	B-X
HCT116	B-X
human	B-X
diploid	B-X
colon	B-X
cancer	B-X
cells	B-X
.	B-X
We	B-X
showed	B-X
,	B-X
by	B-X
performing	B-X
chromatin	B-X
immunoprecipitation	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
irradiation	B-X
but	B-X
not	B-X
doxorubicin	B-X
treatment	B-X
,	B-X
E2F4	B-X
accumulated	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
a	B-X
model	B-X
in	B-X
which	B-X
UV	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
depends	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
on	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
E2F4	B-X
transcription	B-X
factor	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
,	B-X
which	B-X
results	B-X
in	B-X
suppression	B-X
of	B-X
DNA	B-X
replication	B-X
.	B-X

MCM10	B-Gene_or_gene_product
and	O
TopBP1	B-Gene_or_gene_product
function	O
in	O
the	O
initiation	O
of	O
DNA	O
replication	O
,	O
by	O
regulating	O
the	O
chromatin	O
binding	O
of	O
the	O
DNA	O
polymerase	O
alpha	O
loading	O
factor	O
,	O
CDC45	B-Gene_or_gene_product
.	O
<EOS>	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
function	B-X
in	B-X
the	B-X
initiation	B-X
of	B-X
DNA	B-X
replication	B-X
,	B-X
by	B-X
regulating	B-X
the	B-X
chromatin	B-X
binding	B-X
of	B-X
the	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
loading	B-X
factor	B-X
,	B-X
CDC45	B-X
.	B-X
TopBP1	B-X
is	B-X
also	B-X
known	B-X
as	B-X
a	B-X
DNA	B-X
damage	B-X
response	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
the	B-X
transcription	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
is	B-X
activated	B-X
by	B-X
transcription	B-X
factors	B-X
E2F1-3	B-X
,	B-X
but	B-X
not	B-X
by	B-X
factors	B-X
E2F4-7	B-X
.	B-X
Analysis	B-X
of	B-X
various	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoter	B-X
constructs	B-X
showed	B-X
that	B-X
an	B-X
E2F-responsive	B-X
sequence	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
transcription	B-X
initiation	B-X
site	B-X
is	B-X
necessary	B-X
for	B-X
the	B-X
E2F1-induced	B-X
activation	B-X
of	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
gene	B-X
transcription	B-X
,	B-X
which	B-X
is	B-X
further	B-X
suppressed	B-X
by	B-X
pRb	B-X
.	B-X
The	B-X
promoter	B-X
activities	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
were	B-X
demonstrated	B-X
to	B-X
be	B-X
growth	B-X
dependent	B-X
via	B-X
the	B-X
E2F-responsive	B-X
sequence	B-X
.	B-X
Although	B-X
E2F1	B-X
was	B-X
stabilized	B-X
by	B-X
ultraviolet	B-X
(	B-X
UV	B-X
)	B-X
irradiation	B-X
,	B-X
the	B-X
mRNA	B-X
expression	B-X
level	B-X
of	B-X
TopBP1	B-X
was	B-X
suppressed	B-X
in	B-X
HCT116	B-X
human	B-X
diploid	B-X
colon	B-X
cancer	B-X
cells	B-X
.	B-X
We	B-X
showed	B-X
,	B-X
by	B-X
performing	B-X
chromatin	B-X
immunoprecipitation	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
irradiation	B-X
but	B-X
not	B-X
doxorubicin	B-X
treatment	B-X
,	B-X
E2F4	B-X
accumulated	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
a	B-X
model	B-X
in	B-X
which	B-X
UV	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
depends	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
on	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
E2F4	B-X
transcription	B-X
factor	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
,	B-X
which	B-X
results	B-X
in	B-X
suppression	B-X
of	B-X
DNA	B-X
replication	B-X
.	B-X

TopBP1	B-Gene_or_gene_product
is	O
also	O
known	O
as	O
a	O
DNA	O
damage	O
response	O
protein	O
.	O
<EOS>	B-X
ETAA1	B-X
(	B-X
Ewing	B-X
tumor-associated	B-X
antigen	B-X
1	B-X
)	B-X
,	B-X
also	B-X
known	B-X
as	B-X
ETAA16	B-X
,	B-X
was	B-X
identified	B-X
as	B-X
a	B-X
tumor-specific	B-X
antigen	B-X
in	B-X
the	B-X
Ewing	B-X
family	B-X
of	B-X
tumors	B-X
.	B-X
However	B-X
,	B-X
the	B-X
biological	B-X
function	B-X
of	B-X
this	B-X
protein	B-X
remains	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
the	B-X
identification	B-X
of	B-X
ETAA1	B-X
as	B-X
a	B-X
DNA	B-X
replication	B-X
stress	B-X
response	B-X
protein	B-X
.	B-X
ETAA1	B-X
specifically	B-X
interacts	B-X
with	B-X
RPA	B-X
(	B-X
Replication	B-X
protein	B-X
A	B-X
)	B-X
via	B-X
two	B-X
conserved	B-X
RPA-binding	B-X
domains	B-X
and	B-X
is	B-X
therefore	B-X
recruited	B-X
to	B-X
stalled	B-X
replication	B-X
forks	B-X
.	B-X

In	O
this	O
study	O
,	O
we	O
showed	O
that	O
the	O
transcription	O
of	O
human	O
MCM10	B-Gene_or_gene_product
and	O
TopBP1	B-Gene_or_gene_product
is	O
activated	O
by	O
transcription	O
factors	O
E2F1	B-Gene_or_gene_product
-	O
3	B-Gene_or_gene_product
,	O
but	O
not	O
by	O
factors	O
E2F4	B-Gene_or_gene_product
-	O
7	B-Gene_or_gene_product
.	O

Analysis	O
of	O
various	O
MCM10	B-Gene_or_gene_product
and	O
TopBP1	B-Gene_or_gene_product
promoter	O
constructs	O
showed	O
that	O
an	O
E2F	B-Gene_or_gene_product
-	O
responsive	O
sequence	O
in	O
the	O
vicinity	O
of	O
the	O
transcription	O
initiation	O
site	O
is	O
necessary	O
for	O
the	O
E2F1	B-Gene_or_gene_product
-	O
induced	O
activation	O
of	O
MCM10	B-Gene_or_gene_product
and	O
TopBP1	B-Gene_or_gene_product
gene	O
transcription	O
,	O
which	O
is	O
further	O
suppressed	O
by	O
pRb	B-Gene_or_gene_product
.	O
<EOS>	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
function	B-X
in	B-X
the	B-X
initiation	B-X
of	B-X
DNA	B-X
replication	B-X
,	B-X
by	B-X
regulating	B-X
the	B-X
chromatin	B-X
binding	B-X
of	B-X
the	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
loading	B-X
factor	B-X
,	B-X
CDC45	B-X
.	B-X
TopBP1	B-X
is	B-X
also	B-X
known	B-X
as	B-X
a	B-X
DNA	B-X
damage	B-X
response	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
the	B-X
transcription	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
is	B-X
activated	B-X
by	B-X
transcription	B-X
factors	B-X
E2F1-3	B-X
,	B-X
but	B-X
not	B-X
by	B-X
factors	B-X
E2F4-7	B-X
.	B-X
Analysis	B-X
of	B-X
various	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoter	B-X
constructs	B-X
showed	B-X
that	B-X
an	B-X
E2F-responsive	B-X
sequence	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
transcription	B-X
initiation	B-X
site	B-X
is	B-X
necessary	B-X
for	B-X
the	B-X
E2F1-induced	B-X
activation	B-X
of	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
gene	B-X
transcription	B-X
,	B-X
which	B-X
is	B-X
further	B-X
suppressed	B-X
by	B-X
pRb	B-X
.	B-X
The	B-X
promoter	B-X
activities	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
were	B-X
demonstrated	B-X
to	B-X
be	B-X
growth	B-X
dependent	B-X
via	B-X
the	B-X
E2F-responsive	B-X
sequence	B-X
.	B-X
Although	B-X
E2F1	B-X
was	B-X
stabilized	B-X
by	B-X
ultraviolet	B-X
(	B-X
UV	B-X
)	B-X
irradiation	B-X
,	B-X
the	B-X
mRNA	B-X
expression	B-X
level	B-X
of	B-X
TopBP1	B-X
was	B-X
suppressed	B-X
in	B-X
HCT116	B-X
human	B-X
diploid	B-X
colon	B-X
cancer	B-X
cells	B-X
.	B-X
We	B-X
showed	B-X
,	B-X
by	B-X
performing	B-X
chromatin	B-X
immunoprecipitation	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
irradiation	B-X
but	B-X
not	B-X
doxorubicin	B-X
treatment	B-X
,	B-X
E2F4	B-X
accumulated	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
a	B-X
model	B-X
in	B-X
which	B-X
UV	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
depends	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
on	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
E2F4	B-X
transcription	B-X
factor	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
,	B-X
which	B-X
results	B-X
in	B-X
suppression	B-X
of	B-X
DNA	B-X
replication	B-X
.	B-X

The	O
promoter	O
activities	O
of	O
human	O
MCM10	B-Gene_or_gene_product
and	O
TopBP1	B-Gene_or_gene_product
were	O
demonstrated	O
to	O
be	O
growth	O
dependent	O
via	O
the	O
E2F	B-Gene_or_gene_product
-	O
responsive	O
sequence	O
.	O
<EOS>	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
function	B-X
in	B-X
the	B-X
initiation	B-X
of	B-X
DNA	B-X
replication	B-X
,	B-X
by	B-X
regulating	B-X
the	B-X
chromatin	B-X
binding	B-X
of	B-X
the	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
loading	B-X
factor	B-X
,	B-X
CDC45	B-X
.	B-X
TopBP1	B-X
is	B-X
also	B-X
known	B-X
as	B-X
a	B-X
DNA	B-X
damage	B-X
response	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
the	B-X
transcription	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
is	B-X
activated	B-X
by	B-X
transcription	B-X
factors	B-X
E2F1-3	B-X
,	B-X
but	B-X
not	B-X
by	B-X
factors	B-X
E2F4-7	B-X
.	B-X
Analysis	B-X
of	B-X
various	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoter	B-X
constructs	B-X
showed	B-X
that	B-X
an	B-X
E2F-responsive	B-X
sequence	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
transcription	B-X
initiation	B-X
site	B-X
is	B-X
necessary	B-X
for	B-X
the	B-X
E2F1-induced	B-X
activation	B-X
of	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
gene	B-X
transcription	B-X
,	B-X
which	B-X
is	B-X
further	B-X
suppressed	B-X
by	B-X
pRb	B-X
.	B-X
The	B-X
promoter	B-X
activities	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
were	B-X
demonstrated	B-X
to	B-X
be	B-X
growth	B-X
dependent	B-X
via	B-X
the	B-X
E2F-responsive	B-X
sequence	B-X
.	B-X
Although	B-X
E2F1	B-X
was	B-X
stabilized	B-X
by	B-X
ultraviolet	B-X
(	B-X
UV	B-X
)	B-X
irradiation	B-X
,	B-X
the	B-X
mRNA	B-X
expression	B-X
level	B-X
of	B-X
TopBP1	B-X
was	B-X
suppressed	B-X
in	B-X
HCT116	B-X
human	B-X
diploid	B-X
colon	B-X
cancer	B-X
cells	B-X
.	B-X
We	B-X
showed	B-X
,	B-X
by	B-X
performing	B-X
chromatin	B-X
immunoprecipitation	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
irradiation	B-X
but	B-X
not	B-X
doxorubicin	B-X
treatment	B-X
,	B-X
E2F4	B-X
accumulated	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
a	B-X
model	B-X
in	B-X
which	B-X
UV	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
depends	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
on	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
E2F4	B-X
transcription	B-X
factor	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
,	B-X
which	B-X
results	B-X
in	B-X
suppression	B-X
of	B-X
DNA	B-X
replication	B-X
.	B-X

Although	O
E2F1	B-Gene_or_gene_product
was	O
stabilized	O
by	O
ultraviolet	O
(	O
UV	O
)	O
irradiation	O
,	O
the	O
mRNA	O
expression	O
level	O
of	O
TopBP1	B-Gene_or_gene_product
was	O
suppressed	O
in	O
HCT116	O
human	O
diploid	O
colon	O
cancer	O
cells	O
.	O
<EOS>	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
function	B-X
in	B-X
the	B-X
initiation	B-X
of	B-X
DNA	B-X
replication	B-X
,	B-X
by	B-X
regulating	B-X
the	B-X
chromatin	B-X
binding	B-X
of	B-X
the	B-X
DNA	B-X
polymerase	B-X
alpha	B-X
loading	B-X
factor	B-X
,	B-X
CDC45	B-X
.	B-X
TopBP1	B-X
is	B-X
also	B-X
known	B-X
as	B-X
a	B-X
DNA	B-X
damage	B-X
response	B-X
protein	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
showed	B-X
that	B-X
the	B-X
transcription	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
is	B-X
activated	B-X
by	B-X
transcription	B-X
factors	B-X
E2F1-3	B-X
,	B-X
but	B-X
not	B-X
by	B-X
factors	B-X
E2F4-7	B-X
.	B-X
Analysis	B-X
of	B-X
various	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoter	B-X
constructs	B-X
showed	B-X
that	B-X
an	B-X
E2F-responsive	B-X
sequence	B-X
in	B-X
the	B-X
vicinity	B-X
of	B-X
the	B-X
transcription	B-X
initiation	B-X
site	B-X
is	B-X
necessary	B-X
for	B-X
the	B-X
E2F1-induced	B-X
activation	B-X
of	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
gene	B-X
transcription	B-X
,	B-X
which	B-X
is	B-X
further	B-X
suppressed	B-X
by	B-X
pRb	B-X
.	B-X
The	B-X
promoter	B-X
activities	B-X
of	B-X
human	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
were	B-X
demonstrated	B-X
to	B-X
be	B-X
growth	B-X
dependent	B-X
via	B-X
the	B-X
E2F-responsive	B-X
sequence	B-X
.	B-X
Although	B-X
E2F1	B-X
was	B-X
stabilized	B-X
by	B-X
ultraviolet	B-X
(	B-X
UV	B-X
)	B-X
irradiation	B-X
,	B-X
the	B-X
mRNA	B-X
expression	B-X
level	B-X
of	B-X
TopBP1	B-X
was	B-X
suppressed	B-X
in	B-X
HCT116	B-X
human	B-X
diploid	B-X
colon	B-X
cancer	B-X
cells	B-X
.	B-X
We	B-X
showed	B-X
,	B-X
by	B-X
performing	B-X
chromatin	B-X
immunoprecipitation	B-X
that	B-X
,	B-X
in	B-X
response	B-X
to	B-X
UV	B-X
irradiation	B-X
but	B-X
not	B-X
doxorubicin	B-X
treatment	B-X
,	B-X
E2F4	B-X
accumulated	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
a	B-X
model	B-X
in	B-X
which	B-X
UV	B-X
irradiation-induced	B-X
DNA	B-X
damage	B-X
depends	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
on	B-X
the	B-X
accumulation	B-X
of	B-X
the	B-X
E2F4	B-X
transcription	B-X
factor	B-X
on	B-X
the	B-X
MCM10	B-X
and	B-X
TopBP1	B-X
promoters	B-X
,	B-X
which	B-X
results	B-X
in	B-X
suppression	B-X
of	B-X
DNA	B-X
replication	B-X
.	B-X

We	O
showed	O
,	O
by	O
performing	O
chromatin	O
immunoprecipitation	O
that	O
,	O
in	O
response	O
to	O
UV	O
irradiation	O
but	O
not	O
doxorubicin	O
treatment	O
,	O
E2F4	B-Gene_or_gene_product
accumulated	O
on	O
the	O
MCM10	B-Gene_or_gene_product
and	O
TopBP1	B-Gene_or_gene_product
promoters	O
.	O

Our	O
data	O
suggest	O
a	O
model	O
in	O
which	O
UV	O
irradiation	O
-	O
induced	O
DNA	O
damage	O
depends	O
,	O
at	O
least	O
in	O
part	O
,	O
on	O
the	O
accumulation	O
of	O
the	O
E2F4	B-Gene_or_gene_product
transcription	O
factor	O
on	O
the	O
MCM10	B-Gene_or_gene_product
and	O
TopBP1	B-Gene_or_gene_product
promoters	O
,	O
which	O
results	O
in	O
suppression	O
of	O
DNA	O
replication	O
.	O

Direct	O
binding	O
of	O
apoptosis	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulating	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
to	O
retinoblastoma	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
:	O
novel	O
links	O
between	O
apoptotic	O
signaling	O
and	O
cell	O
cycle	O
machinery	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
protein	B-X
Rb	B-X
has	B-X
antiproliferative	B-X
and	B-X
antiapoptotic	B-X
functions	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
certain	B-X
apoptotic	B-X
signals	B-X
can	B-X
inactivate	B-X
Rb	B-X
via	B-X
the	B-X
p38	B-X
pathway	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rb	B-X
associates	B-X
with	B-X
the	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
ASK1	B-X
in	B-X
response	B-X
to	B-X
specific	B-X
apoptotic	B-X
signals	B-X
.	B-X
An	B-X
LXCXE	B-X
motif	B-X
on	B-X
ASK1	B-X
was	B-X
required	B-X
for	B-X
Rb	B-X
binding	B-X
;	B-X
this	B-X
correlated	B-X
with	B-X
increased	B-X
E2F1	B-X
transcriptional	B-X
activity	B-X
and	B-X
up-regulation	B-X
of	B-X
the	B-X
proapoptotic	B-X
protein	B-X
p73	B-X
.	B-X
Overexpression	B-X
of	B-X
Rb	B-X
inhibited	B-X
ASK1-induced	B-X
apoptosis	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
an	B-X
ASK1	B-X
mutant	B-X
incapable	B-X
of	B-X
binding	B-X
Rb	B-X
could	B-X
not	B-X
induce	B-X
apoptosis	B-X
,	B-X
indicating	B-X
that	B-X
ASK1	B-X
has	B-X
to	B-X
overcome	B-X
the	B-X
antiapoptotic	B-X
properties	B-X
of	B-X
Rb	B-X
to	B-X
kill	B-X
cells	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
in	B-X
asynchronous	B-X
cells	B-X
the	B-X
p73P1	B-X
promoter	B-X
is	B-X
occupied	B-X
predominantly	B-X
by	B-X
E2F3	B-X
;	B-X
upon	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
stimulation	B-X
,	B-X
E2F3	B-X
is	B-X
dissociated	B-X
from	B-X
the	B-X
promoter	B-X
and	B-X
replaced	B-X
by	B-X
E2F1	B-X
.	B-X
At	B-X
the	B-X
same	B-X
time	B-X
,	B-X
TNF-alpha	B-X
stimulation	B-X
causes	B-X
Rb	B-X
to	B-X
dissociate	B-X
from	B-X
the	B-X
p73P1	B-X
promoter	B-X
.	B-X
These	B-X
studies	B-X
suggest	B-X
that	B-X
Rb	B-X
acts	B-X
as	B-X
a	B-X
link	B-X
between	B-X
apoptotic	B-X
and	B-X
proliferative	B-X
pathways	B-X
by	B-X
interacting	B-X
with	B-X
distinct	B-X
kinases	B-X
and	B-X
occupying	B-X
different	B-X
promoters	B-X
.	B-X

The	O
retinoblastoma	B-Gene_or_gene_product
protein	I-Gene_or_gene_product
Rb	B-Gene_or_gene_product
has	O
antiproliferative	O
and	O
antiapoptotic	O
functions	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
protein	B-X
,	B-X
Rb	B-X
,	B-X
suppresses	B-X
tumorigenesis	B-X
by	B-X
inhibiting	B-X
cell	B-X
proliferation	B-X
and	B-X
promoting	B-X
senescence	B-X
and	B-X
differentiation	B-X
.	B-X
Paradoxically	B-X
,	B-X
Rb	B-X
also	B-X
inhibits	B-X
apoptosis	B-X
,	B-X
which	B-X
would	B-X
seem	B-X
to	B-X
oppose	B-X
its	B-X
tumor	B-X
suppressor	B-X
function	B-X
.	B-X
Further	B-X
,	B-X
most	B-X
human	B-X
cancer	B-X
cells	B-X
inactivate	B-X
Rb	B-X
by	B-X
hyperphosphorylation	B-X
and	B-X
demonstrate	B-X
increased	B-X
proliferative	B-X
capacity	B-X
but	B-X
not	B-X
high	B-X
levels	B-X
of	B-X
apoptosis	B-X
.	B-X
As	B-X
a	B-X
potential	B-X
explanation	B-X
for	B-X
these	B-X
findings	B-X
,	B-X
we	B-X
show	B-X
here	B-X
that	B-X
the	B-X
tumor	B-X
suppressor	B-X
and	B-X
antiapoptotic	B-X
functions	B-X
of	B-X
Rb	B-X
are	B-X
regulated	B-X
by	B-X
distinct	B-X
phosphorylation	B-X
events	B-X
.	B-X
However	B-X
,	B-X
high	B-X
cyclin-dependent	B-X
kinase	B-X
activity	B-X
promotes	B-X
phosphorylation	B-X
of	B-X
Ser567	B-X
by	B-X
inducing	B-X
an	B-X
intramolecular	B-X
interaction	B-X
that	B-X
leads	B-X
to	B-X
release	B-X
of	B-X
E2F	B-X
,	B-X
degradation	B-X
of	B-X
Rb	B-X
,	B-X
and	B-X
susceptibility	B-X
to	B-X
apoptosis	B-X
.	B-X
These	B-X
findings	B-X
suggest	B-X
that	B-X
the	B-X
antiproliferative	B-X
and	B-X
antiapoptotic	B-X
activities	B-X
of	B-X
Rb	B-X
may	B-X
represent	B-X
complementary	B-X
functions	B-X
that	B-X
work	B-X
in	B-X
concert	B-X
to	B-X
maintain	B-X
the	B-X
proliferation	B-X
rate	B-X
of	B-X
cells	B-X
within	B-X
certain	B-X
limits	B-X
.	B-X
As	B-X
a	B-X
survival	B-X
strategy	B-X
,	B-X
some	B-X
cancer	B-X
cells	B-X
may	B-X
exploit	B-X
this	B-X
dual	B-X
role	B-X
of	B-X
Rb	B-X
by	B-X
phosphorylating	B-X
sites	B-X
that	B-X
regulate	B-X
tumor	B-X
suppression	B-X
but	B-X
avoiding	B-X
phosphorylation	B-X
of	B-X
Ser567	B-X
and	B-X
consequent	B-X
apoptotic	B-X
stimulus	B-X
.	B-X

Our	O
previous	O
studies	O
have	O
shown	O
that	O
certain	O
apoptotic	O
signals	O
can	O
inactivate	O
Rb	B-Gene_or_gene_product
via	O
the	O
p38	B-Gene_or_gene_product
pathway	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
protein	B-X
Rb	B-X
has	B-X
antiproliferative	B-X
and	B-X
antiapoptotic	B-X
functions	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
certain	B-X
apoptotic	B-X
signals	B-X
can	B-X
inactivate	B-X
Rb	B-X
via	B-X
the	B-X
p38	B-X
pathway	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rb	B-X
associates	B-X
with	B-X
the	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
ASK1	B-X
in	B-X
response	B-X
to	B-X
specific	B-X
apoptotic	B-X
signals	B-X
.	B-X
An	B-X
LXCXE	B-X
motif	B-X
on	B-X
ASK1	B-X
was	B-X
required	B-X
for	B-X
Rb	B-X
binding	B-X
;	B-X
this	B-X
correlated	B-X
with	B-X
increased	B-X
E2F1	B-X
transcriptional	B-X
activity	B-X
and	B-X
up-regulation	B-X
of	B-X
the	B-X
proapoptotic	B-X
protein	B-X
p73	B-X
.	B-X
Overexpression	B-X
of	B-X
Rb	B-X
inhibited	B-X
ASK1-induced	B-X
apoptosis	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
an	B-X
ASK1	B-X
mutant	B-X
incapable	B-X
of	B-X
binding	B-X
Rb	B-X
could	B-X
not	B-X
induce	B-X
apoptosis	B-X
,	B-X
indicating	B-X
that	B-X
ASK1	B-X
has	B-X
to	B-X
overcome	B-X
the	B-X
antiapoptotic	B-X
properties	B-X
of	B-X
Rb	B-X
to	B-X
kill	B-X
cells	B-X
.	B-X
At	B-X
the	B-X
same	B-X
time	B-X
,	B-X
TNF-alpha	B-X
stimulation	B-X
causes	B-X
Rb	B-X
to	B-X
dissociate	B-X
from	B-X
the	B-X
p73P1	B-X
promoter	B-X
.	B-X
These	B-X
are	B-X
promoter-specific	B-X
events	B-X
because	B-X
Rb	B-X
binds	B-X
to	B-X
the	B-X
mitogenic	B-X
cdc25A	B-X
promoter	B-X
upon	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
These	B-X
studies	B-X
suggest	B-X
that	B-X
Rb	B-X
acts	B-X
as	B-X
a	B-X
link	B-X
between	B-X
apoptotic	B-X
and	B-X
proliferative	B-X
pathways	B-X
by	B-X
interacting	B-X
with	B-X
distinct	B-X
kinases	B-X
and	B-X
occupying	B-X
different	B-X
promoters	B-X
.	B-X

Here	O
we	O
show	O
that	O
Rb	B-Gene_or_gene_product
associates	O
with	O
the	O
apoptosis	B-Gene_or_gene_product
signal	I-Gene_or_gene_product
-	I-Gene_or_gene_product
regulating	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
ASK1	B-Gene_or_gene_product
in	O
response	O
to	O
specific	O
apoptotic	O
signals	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
protein	B-X
Rb	B-X
has	B-X
antiproliferative	B-X
and	B-X
antiapoptotic	B-X
functions	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
certain	B-X
apoptotic	B-X
signals	B-X
can	B-X
inactivate	B-X
Rb	B-X
via	B-X
the	B-X
p38	B-X
pathway	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rb	B-X
associates	B-X
with	B-X
the	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
ASK1	B-X
in	B-X
response	B-X
to	B-X
specific	B-X
apoptotic	B-X
signals	B-X
.	B-X
An	B-X
LXCXE	B-X
motif	B-X
on	B-X
ASK1	B-X
was	B-X
required	B-X
for	B-X
Rb	B-X
binding	B-X
;	B-X
this	B-X
correlated	B-X
with	B-X
increased	B-X
E2F1	B-X
transcriptional	B-X
activity	B-X
and	B-X
up-regulation	B-X
of	B-X
the	B-X
proapoptotic	B-X
protein	B-X
p73	B-X
.	B-X
Overexpression	B-X
of	B-X
Rb	B-X
inhibited	B-X
ASK1-induced	B-X
apoptosis	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
an	B-X
ASK1	B-X
mutant	B-X
incapable	B-X
of	B-X
binding	B-X
Rb	B-X
could	B-X
not	B-X
induce	B-X
apoptosis	B-X
,	B-X
indicating	B-X
that	B-X
ASK1	B-X
has	B-X
to	B-X
overcome	B-X
the	B-X
antiapoptotic	B-X
properties	B-X
of	B-X
Rb	B-X
to	B-X
kill	B-X
cells	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
in	B-X
asynchronous	B-X
cells	B-X
the	B-X
p73P1	B-X
promoter	B-X
is	B-X
occupied	B-X
predominantly	B-X
by	B-X
E2F3	B-X
;	B-X
upon	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
stimulation	B-X
,	B-X
E2F3	B-X
is	B-X
dissociated	B-X
from	B-X
the	B-X
promoter	B-X
and	B-X
replaced	B-X
by	B-X
E2F1	B-X
.	B-X
At	B-X
the	B-X
same	B-X
time	B-X
,	B-X
TNF-alpha	B-X
stimulation	B-X
causes	B-X
Rb	B-X
to	B-X
dissociate	B-X
from	B-X
the	B-X
p73P1	B-X
promoter	B-X
.	B-X
These	B-X
are	B-X
promoter-specific	B-X
events	B-X
because	B-X
Rb	B-X
binds	B-X
to	B-X
the	B-X
mitogenic	B-X
cdc25A	B-X
promoter	B-X
upon	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
These	B-X
studies	B-X
suggest	B-X
that	B-X
Rb	B-X
acts	B-X
as	B-X
a	B-X
link	B-X
between	B-X
apoptotic	B-X
and	B-X
proliferative	B-X
pathways	B-X
by	B-X
interacting	B-X
with	B-X
distinct	B-X
kinases	B-X
and	B-X
occupying	B-X
different	B-X
promoters	B-X
.	B-X

An	O
LXCXE	O
motif	O
on	O
ASK1	B-Gene_or_gene_product
was	O
required	O
for	O
Rb	B-Gene_or_gene_product
binding	O
;	O
this	O
correlated	O
with	O
increased	O
E2F1	B-Gene_or_gene_product
transcriptional	O
activity	O
and	O
up	O
-	O
regulation	O
of	O
the	O
proapoptotic	O
protein	O
p73	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
protein	B-X
Rb	B-X
has	B-X
antiproliferative	B-X
and	B-X
antiapoptotic	B-X
functions	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
certain	B-X
apoptotic	B-X
signals	B-X
can	B-X
inactivate	B-X
Rb	B-X
via	B-X
the	B-X
p38	B-X
pathway	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rb	B-X
associates	B-X
with	B-X
the	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
ASK1	B-X
in	B-X
response	B-X
to	B-X
specific	B-X
apoptotic	B-X
signals	B-X
.	B-X
An	B-X
LXCXE	B-X
motif	B-X
on	B-X
ASK1	B-X
was	B-X
required	B-X
for	B-X
Rb	B-X
binding	B-X
;	B-X
this	B-X
correlated	B-X
with	B-X
increased	B-X
E2F1	B-X
transcriptional	B-X
activity	B-X
and	B-X
up-regulation	B-X
of	B-X
the	B-X
proapoptotic	B-X
protein	B-X
p73	B-X
.	B-X
Overexpression	B-X
of	B-X
Rb	B-X
inhibited	B-X
ASK1-induced	B-X
apoptosis	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
an	B-X
ASK1	B-X
mutant	B-X
incapable	B-X
of	B-X
binding	B-X
Rb	B-X
could	B-X
not	B-X
induce	B-X
apoptosis	B-X
,	B-X
indicating	B-X
that	B-X
ASK1	B-X
has	B-X
to	B-X
overcome	B-X
the	B-X
antiapoptotic	B-X
properties	B-X
of	B-X
Rb	B-X
to	B-X
kill	B-X
cells	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
in	B-X
asynchronous	B-X
cells	B-X
the	B-X
p73P1	B-X
promoter	B-X
is	B-X
occupied	B-X
predominantly	B-X
by	B-X
E2F3	B-X
;	B-X
upon	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
stimulation	B-X
,	B-X
E2F3	B-X
is	B-X
dissociated	B-X
from	B-X
the	B-X
promoter	B-X
and	B-X
replaced	B-X
by	B-X
E2F1	B-X
.	B-X
At	B-X
the	B-X
same	B-X
time	B-X
,	B-X
TNF-alpha	B-X
stimulation	B-X
causes	B-X
Rb	B-X
to	B-X
dissociate	B-X
from	B-X
the	B-X
p73P1	B-X
promoter	B-X
.	B-X
These	B-X
are	B-X
promoter-specific	B-X
events	B-X
because	B-X
Rb	B-X
binds	B-X
to	B-X
the	B-X
mitogenic	B-X
cdc25A	B-X
promoter	B-X
upon	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
These	B-X
studies	B-X
suggest	B-X
that	B-X
Rb	B-X
acts	B-X
as	B-X
a	B-X
link	B-X
between	B-X
apoptotic	B-X
and	B-X
proliferative	B-X
pathways	B-X
by	B-X
interacting	B-X
with	B-X
distinct	B-X
kinases	B-X
and	B-X
occupying	B-X
different	B-X
promoters	B-X
.	B-X

Overexpression	O
of	O
Rb	B-Gene_or_gene_product
inhibited	O
ASK1	B-Gene_or_gene_product
-	O
induced	O
apoptosis	O
;	O
in	O
addition	O
,	O
an	O
ASK1	B-Gene_or_gene_product
mutant	O
incapable	O
of	O
binding	O
Rb	B-Gene_or_gene_product
could	O
not	O
induce	O
apoptosis	O
,	O
indicating	O
that	O
ASK1	B-Gene_or_gene_product
has	O
to	O
overcome	O
the	O
antiapoptotic	O
properties	O
of	O
Rb	B-Gene_or_gene_product
to	O
kill	O
cells	O
.	O
<EOS>	B-X
Apoptosis	B-X
signal-regulating	B-X
kinase	B-X
1	B-X
(	B-X
ASK1	B-X
)	B-X
is	B-X
an	B-X
upstream	B-X
MAPK	B-X
involved	B-X
in	B-X
apoptosis	B-X
,	B-X
inflammation	B-X
,	B-X
and	B-X
carcinogenesis	B-X
.	B-X
This	B-X
study	B-X
investigated	B-X
the	B-X
role	B-X
of	B-X
ASK1	B-X
in	B-X
the	B-X
development	B-X
of	B-X
gastric	B-X
cancer	B-X
.	B-X
In	B-X
human	B-X
gastric	B-X
cancer	B-X
specimens	B-X
,	B-X
we	B-X
observed	B-X
increased	B-X
ASK1	B-X
expression	B-X
,	B-X
compared	B-X
to	B-X
nontumor	B-X
epithelium	B-X
.	B-X
Using	B-X
a	B-X
chemically	B-X
induced	B-X
murine	B-X
gastric	B-X
tumorigenesis	B-X
model	B-X
,	B-X
we	B-X
observed	B-X
increased	B-X
tumor	B-X
ASK1	B-X
expression	B-X
,	B-X
and	B-X
ASK1	B-X
knockout	B-X
mice	B-X
had	B-X
both	B-X
fewer	B-X
and	B-X
smaller	B-X
tumors	B-X
than	B-X
wild-type	B-X
(	B-X
WT	B-X
)	B-X
mice	B-X
.	B-X
ASK1	B-X
siRNA	B-X
inhibited	B-X
cell	B-X
proliferation	B-X
through	B-X
the	B-X
accumulation	B-X
of	B-X
cells	B-X
in	B-X
G1	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
,	B-X
and	B-X
reduced	B-X
cyclin	B-X
D1	B-X
expression	B-X
in	B-X
gastric	B-X
cancer	B-X
cells	B-X
,	B-X
whereas	B-X
these	B-X
effects	B-X
were	B-X
uncommon	B-X
in	B-X
other	B-X
cancer	B-X
cells	B-X
.	B-X
ASK1	B-X
overexpression	B-X
induced	B-X
the	B-X
transcription	B-X
of	B-X
cyclin	B-X
D1	B-X
,	B-X
through	B-X
AP-1	B-X
activation	B-X
,	B-X
and	B-X
ASK1	B-X
levels	B-X
were	B-X
regulated	B-X
by	B-X
cyclin	B-X
D1	B-X
,	B-X
via	B-X
the	B-X
Rb-E2F	B-X
pathway	B-X
.	B-X
Exogenous	B-X
ASK1	B-X
induced	B-X
cyclin	B-X
D1	B-X
expression	B-X
,	B-X
followed	B-X
by	B-X
elevated	B-X
expression	B-X
of	B-X
endogenous	B-X
ASK1	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
an	B-X
autoregulatory	B-X
mechanism	B-X
of	B-X
ASK1	B-X
in	B-X
the	B-X
development	B-X
of	B-X
gastric	B-X
cancer	B-X
.	B-X
Targeting	B-X
this	B-X
positive	B-X
feedback	B-X
loop	B-X
,	B-X
ASK1	B-X
may	B-X
present	B-X
a	B-X
potential	B-X
therapeutic	B-X
target	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
advanced	B-X
gastric	B-X
cancer	B-X
.	B-X

Chromatin	O
immunoprecipitation	O
assays	O
show	O
that	O
in	O
asynchronous	O
cells	O
the	O
p73P1	O
promoter	O
is	O
occupied	O
predominantly	O
by	O
E2F3	B-Gene_or_gene_product
;	O
upon	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	I-Gene_or_gene_product
TNF	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulation	O
,	O
E2F3	B-Gene_or_gene_product
is	O
dissociated	O
from	O
the	O
promoter	O
and	O
replaced	O
by	O
E2F1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Our	B-X
previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
certain	B-X
apoptotic	B-X
signals	B-X
can	B-X
inactivate	B-X
Rb	B-X
via	B-X
the	B-X
p38	B-X
pathway	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rb	B-X
associates	B-X
with	B-X
the	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
ASK1	B-X
in	B-X
response	B-X
to	B-X
specific	B-X
apoptotic	B-X
signals	B-X
.	B-X
An	B-X
LXCXE	B-X
motif	B-X
on	B-X
ASK1	B-X
was	B-X
required	B-X
for	B-X
Rb	B-X
binding	B-X
;	B-X
this	B-X
correlated	B-X
with	B-X
increased	B-X
E2F1	B-X
transcriptional	B-X
activity	B-X
and	B-X
up-regulation	B-X
of	B-X
the	B-X
proapoptotic	B-X
protein	B-X
p73	B-X
.	B-X
Overexpression	B-X
of	B-X
Rb	B-X
inhibited	B-X
ASK1-induced	B-X
apoptosis	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
an	B-X
ASK1	B-X
mutant	B-X
incapable	B-X
of	B-X
binding	B-X
Rb	B-X
could	B-X
not	B-X
induce	B-X
apoptosis	B-X
,	B-X
indicating	B-X
that	B-X
ASK1	B-X
has	B-X
to	B-X
overcome	B-X
the	B-X
antiapoptotic	B-X
properties	B-X
of	B-X
Rb	B-X
to	B-X
kill	B-X
cells	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
in	B-X
asynchronous	B-X
cells	B-X
the	B-X
p73P1	B-X
promoter	B-X
is	B-X
occupied	B-X
predominantly	B-X
by	B-X
E2F3	B-X
;	B-X
upon	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
stimulation	B-X
,	B-X
E2F3	B-X
is	B-X
dissociated	B-X
from	B-X
the	B-X
promoter	B-X
and	B-X
replaced	B-X
by	B-X
E2F1	B-X
.	B-X
At	B-X
the	B-X
same	B-X
time	B-X
,	B-X
TNF-alpha	B-X
stimulation	B-X
causes	B-X
Rb	B-X
to	B-X
dissociate	B-X
from	B-X
the	B-X
p73P1	B-X
promoter	B-X
.	B-X
These	B-X
are	B-X
promoter-specific	B-X
events	B-X
because	B-X
Rb	B-X
binds	B-X
to	B-X
the	B-X
mitogenic	B-X
cdc25A	B-X
promoter	B-X
upon	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
These	B-X
studies	B-X
suggest	B-X
that	B-X
Rb	B-X
acts	B-X
as	B-X
a	B-X
link	B-X
between	B-X
apoptotic	B-X
and	B-X
proliferative	B-X
pathways	B-X
by	B-X
interacting	B-X
with	B-X
distinct	B-X
kinases	B-X
and	B-X
occupying	B-X
different	B-X
promoters	B-X
.	B-X

At	O
the	O
same	O
time	O
,	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulation	O
causes	O
Rb	B-Gene_or_gene_product
to	O
dissociate	O
from	O
the	O
p73P1	O
promoter	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
protein	B-X
Rb	B-X
has	B-X
antiproliferative	B-X
and	B-X
antiapoptotic	B-X
functions	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
certain	B-X
apoptotic	B-X
signals	B-X
can	B-X
inactivate	B-X
Rb	B-X
via	B-X
the	B-X
p38	B-X
pathway	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rb	B-X
associates	B-X
with	B-X
the	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
ASK1	B-X
in	B-X
response	B-X
to	B-X
specific	B-X
apoptotic	B-X
signals	B-X
.	B-X
An	B-X
LXCXE	B-X
motif	B-X
on	B-X
ASK1	B-X
was	B-X
required	B-X
for	B-X
Rb	B-X
binding	B-X
;	B-X
this	B-X
correlated	B-X
with	B-X
increased	B-X
E2F1	B-X
transcriptional	B-X
activity	B-X
and	B-X
up-regulation	B-X
of	B-X
the	B-X
proapoptotic	B-X
protein	B-X
p73	B-X
.	B-X
Overexpression	B-X
of	B-X
Rb	B-X
inhibited	B-X
ASK1-induced	B-X
apoptosis	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
an	B-X
ASK1	B-X
mutant	B-X
incapable	B-X
of	B-X
binding	B-X
Rb	B-X
could	B-X
not	B-X
induce	B-X
apoptosis	B-X
,	B-X
indicating	B-X
that	B-X
ASK1	B-X
has	B-X
to	B-X
overcome	B-X
the	B-X
antiapoptotic	B-X
properties	B-X
of	B-X
Rb	B-X
to	B-X
kill	B-X
cells	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
assays	B-X
show	B-X
that	B-X
in	B-X
asynchronous	B-X
cells	B-X
the	B-X
p73P1	B-X
promoter	B-X
is	B-X
occupied	B-X
predominantly	B-X
by	B-X
E2F3	B-X
;	B-X
upon	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
-alpha	B-X
stimulation	B-X
,	B-X
E2F3	B-X
is	B-X
dissociated	B-X
from	B-X
the	B-X
promoter	B-X
and	B-X
replaced	B-X
by	B-X
E2F1	B-X
.	B-X
At	B-X
the	B-X
same	B-X
time	B-X
,	B-X
TNF-alpha	B-X
stimulation	B-X
causes	B-X
Rb	B-X
to	B-X
dissociate	B-X
from	B-X
the	B-X
p73P1	B-X
promoter	B-X
.	B-X
These	B-X
are	B-X
promoter-specific	B-X
events	B-X
because	B-X
Rb	B-X
binds	B-X
to	B-X
the	B-X
mitogenic	B-X
cdc25A	B-X
promoter	B-X
upon	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
These	B-X
studies	B-X
suggest	B-X
that	B-X
Rb	B-X
acts	B-X
as	B-X
a	B-X
link	B-X
between	B-X
apoptotic	B-X
and	B-X
proliferative	B-X
pathways	B-X
by	B-X
interacting	B-X
with	B-X
distinct	B-X
kinases	B-X
and	B-X
occupying	B-X
different	B-X
promoters	B-X
.	B-X

These	O
are	O
promoter	O
-	O
specific	O
events	O
because	O
Rb	B-Gene_or_gene_product
binds	O
to	O
the	O
mitogenic	O
cdc25A	O
promoter	O
upon	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulation	O
.	O

These	O
studies	O
suggest	O
that	O
Rb	B-Gene_or_gene_product
acts	O
as	O
a	O
link	O
between	O
apoptotic	O
and	O
proliferative	O
pathways	O
by	O
interacting	O
with	O
distinct	O
kinases	O
and	O
occupying	O
different	O
promoters	O
.	O
<EOS>	B-X
The	B-X
retinoblastoma	B-X
protein	B-X
Rb	B-X
has	B-X
antiproliferative	B-X
and	B-X
antiapoptotic	B-X
functions	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
have	B-X
shown	B-X
that	B-X
certain	B-X
apoptotic	B-X
signals	B-X
can	B-X
inactivate	B-X
Rb	B-X
via	B-X
the	B-X
p38	B-X
pathway	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Rb	B-X
associates	B-X
with	B-X
the	B-X
apoptosis	B-X
signal-regulating	B-X
kinase	B-X
ASK1	B-X
in	B-X
response	B-X
to	B-X
specific	B-X
apoptotic	B-X
signals	B-X
.	B-X
An	B-X
LXCXE	B-X
motif	B-X
on	B-X
ASK1	B-X
was	B-X
required	B-X
for	B-X
Rb	B-X
binding	B-X
;	B-X
this	B-X
correlated	B-X
with	B-X
increased	B-X
E2F1	B-X
transcriptional	B-X
activity	B-X
and	B-X
up-regulation	B-X
of	B-X
the	B-X
proapoptotic	B-X
protein	B-X
p73	B-X
.	B-X
Overexpression	B-X
of	B-X
Rb	B-X
inhibited	B-X
ASK1-induced	B-X
apoptosis	B-X
;	B-X
in	B-X
addition	B-X
,	B-X
an	B-X
ASK1	B-X
mutant	B-X
incapable	B-X
of	B-X
binding	B-X
Rb	B-X
could	B-X
not	B-X
induce	B-X
apoptosis	B-X
,	B-X
indicating	B-X
that	B-X
ASK1	B-X
has	B-X
to	B-X
overcome	B-X
the	B-X
antiapoptotic	B-X
properties	B-X
of	B-X
Rb	B-X
to	B-X
kill	B-X
cells	B-X
.	B-X
At	B-X
the	B-X
same	B-X
time	B-X
,	B-X
TNF-alpha	B-X
stimulation	B-X
causes	B-X
Rb	B-X
to	B-X
dissociate	B-X
from	B-X
the	B-X
p73P1	B-X
promoter	B-X
.	B-X
These	B-X
are	B-X
promoter-specific	B-X
events	B-X
because	B-X
Rb	B-X
binds	B-X
to	B-X
the	B-X
mitogenic	B-X
cdc25A	B-X
promoter	B-X
upon	B-X
TNF-alpha	B-X
stimulation	B-X
.	B-X
These	B-X
studies	B-X
suggest	B-X
that	B-X
Rb	B-X
acts	B-X
as	B-X
a	B-X
link	B-X
between	B-X
apoptotic	B-X
and	B-X
proliferative	B-X
pathways	B-X
by	B-X
interacting	B-X
with	B-X
distinct	B-X
kinases	B-X
and	B-X
occupying	B-X
different	B-X
promoters	B-X
.	B-X

p105	B-Gene_or_gene_product
,	O
the	O
NF	O
-	O
kappa	O
B	O
p50	B-Gene_or_gene_product
precursor	O
protein	O
,	O
is	O
one	O
of	O
the	O
cellular	O
proteins	O
complexed	O
with	O
the	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
oncoprotein	O
in	O
transformed	O
chicken	O
spleen	O
cells	O
.	O

Active	O
NF	O
-	O
kappa	O
B	O
-	O
like	O
transcription	O
complexes	O
are	O
multimers	O
consisting	O
of	O
one	O
or	O
two	O
members	O
of	O
a	O
family	O
of	O
proteins	O
related	O
to	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
proto	O
-	O
oncoprotein	O
.	O
<EOS>	B-X
Immune	B-X
cells	B-X
activate	B-X
in	B-X
binary	B-X
,	B-X
switch-like	B-X
fashion	B-X
via	B-X
large	B-X
protein	B-X
assemblies	B-X
known	B-X
as	B-X
signalosomes	B-X
,	B-X
but	B-X
the	B-X
molecular	B-X
mechanism	B-X
of	B-X
the	B-X
switch	B-X
is	B-X
not	B-X
yet	B-X
understood	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
employed	B-X
an	B-X
in-cell	B-X
biophysical	B-X
approach	B-X
to	B-X
dissect	B-X
the	B-X
assembly	B-X
mechanism	B-X
of	B-X
the	B-X
CARD-BCL10-MALT1	B-X
(	B-X
CBM	B-X
)	B-X
signalosome	B-X
,	B-X
which	B-X
governs	B-X
nuclear	B-X
transcription	B-X
factor-B	B-X
activation	B-X
in	B-X
both	B-X
innate	B-X
and	B-X
adaptive	B-X
immunity	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
switch	B-X
consists	B-X
of	B-X
a	B-X
sequence-encoded	B-X
and	B-X
deeply	B-X
conserved	B-X
nucleation	B-X
barrier	B-X
to	B-X
ordered	B-X
polymerization	B-X
by	B-X
the	B-X
adaptor	B-X
protein	B-X
BCL10	B-X
.	B-X
The	B-X
particular	B-X
structure	B-X
of	B-X
the	B-X
BCL10	B-X
polymers	B-X
did	B-X
not	B-X
matter	B-X
for	B-X
activity	B-X
.	B-X
Using	B-X
optogenetic	B-X
tools	B-X
and	B-X
single-cell	B-X
transcriptional	B-X
reporters	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
endogenous	B-X
BCL10	B-X
is	B-X
functionally	B-X
supersaturated	B-X
even	B-X
in	B-X
unstimulated	B-X
human	B-X
cells	B-X
,	B-X
and	B-X
this	B-X
results	B-X
in	B-X
a	B-X
predetermined	B-X
response	B-X
to	B-X
stimulation	B-X
upon	B-X
nucleation	B-X
by	B-X
activated	B-X
CARD	B-X
multimers	B-X
.	B-X
Our	B-X
findings	B-X
may	B-X
inform	B-X
on	B-X
the	B-X
progressive	B-X
nature	B-X
of	B-X
age-associated	B-X
inflammation	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
signalosome	B-X
structure	B-X
has	B-X
evolved	B-X
via	B-X
selection	B-X
for	B-X
kinetic	B-X
rather	B-X
than	B-X
equilibrium	B-X
properties	B-X
of	B-X
the	B-X
proteins	B-X
.	B-X

We	O
have	O
isolated	O
a	O
chicken	O
cDNA	O
encoding	O
p105	B-Gene_or_gene_product
,	O
the	O
precursor	O
protein	O
for	O
the	O
p50	B-Gene_or_gene_product
subunit	O
of	O
NF	O
-	O
kappa	O
B	O
.	O
<EOS>	B-X
NF-kappa	B-X
B	B-X
is	B-X
a	B-X
heterodimeric	B-X
transcription	B-X
factor	B-X
consisting	B-X
of	B-X
subunits	B-X
of	B-X
50	B-X
kDa	B-X
(	B-X
p50	B-X
)	B-X
and	B-X
65	B-X
kDa	B-X
(	B-X
p65	B-X
)	B-X
.	B-X
cDNA	B-X
clones	B-X
encoding	B-X
the	B-X
chicken	B-X
NF-kappa	B-X
B	B-X
p65	B-X
subunit	B-X
were	B-X
isolated	B-X
.	B-X
Sequence	B-X
analysis	B-X
showed	B-X
that	B-X
chicken	B-X
p65	B-X
is	B-X
approximately	B-X
55	B-X
%	B-X
identical	B-X
to	B-X
the	B-X
mouse	B-X
and	B-X
human	B-X
p65	B-X
proteins	B-X
,	B-X
and	B-X
contains	B-X
the	B-X
Rel	B-X
homology	B-X
domain	B-X
(	B-X
RHD	B-X
)	B-X
in	B-X
its	B-X
N-terminal	B-X
286	B-X
amino	B-X
acids	B-X
(	B-X
aa	B-X
)	B-X
and	B-X
the	B-X
putative	B-X
transactivation	B-X
domain	B-X
in	B-X
its	B-X
C-terminal	B-X
region	B-X
.	B-X
The	B-X
RHD	B-X
is	B-X
particularly	B-X
highly	B-X
conserved	B-X
between	B-X
the	B-X
chicken	B-X
and	B-X
mammalian	B-X
p65	B-X
proteins	B-X
.	B-X
A	B-X
fusion	B-X
protein	B-X
containing	B-X
the	B-X
RHD	B-X
of	B-X
chicken	B-X
p65	B-X
was	B-X
found	B-X
to	B-X
bind	B-X
to	B-X
a	B-X
consensus	B-X
kappa	B-X
B-site	B-X
in	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
(	B-X
EMSA	B-X
)	B-X
.	B-X
This	B-X
binding	B-X
was	B-X
specifically	B-X
inhibited	B-X
by	B-X
the	B-X
presence	B-X
of	B-X
fusion	B-X
proteins	B-X
containing	B-X
the	B-X
C-terminal	B-X
ankyrin	B-X
repeats	B-X
domain	B-X
(	B-X
ARD	B-X
)	B-X
of	B-X
chicken	B-X
p105	B-X
,	B-X
the	B-X
precursor	B-X
protein	B-X
for	B-X
the	B-X
p50	B-X
subunit	B-X
.	B-X
Immunoprecipitation	B-X
analysis	B-X
showed	B-X
that	B-X
p65	B-X
formed	B-X
a	B-X
complex	B-X
(	B-X
es	B-X
)	B-X
with	B-X
multiple	B-X
cellular	B-X
proteins	B-X
,	B-X
including	B-X
p50	B-X
,	B-X
p105	B-X
and	B-X
c-Rel	B-X
in	B-X
chicken	B-X
spleen	B-X
cells	B-X
.	B-X

Sequence	O
analysis	O
shows	O
that	O
chicken	O
p105	B-Gene_or_gene_product
is	O
approximately	O
70	O
%	O
identical	O
to	O
the	O
mouse	O
and	O
human	O
p105	B-Gene_or_gene_product
proteins	O
,	O
containing	O
the	O
Rel	B-Gene_or_gene_product
homology	O
domain	O
in	O
its	O
N	O
-	O
terminal	O
370	O
amino	O
acids	O
and	O
several	O
ankyrinlike	O
repeats	O
in	O
the	O
C	O
-	O
terminal	O
portion	O
of	O
the	O
protein	O
.	O

The	O
Rel	B-Gene_or_gene_product
homology	O
domain	O
is	O
particularly	O
highly	O
conserved	O
between	O
chicken	O
and	O
mammalian	O
p50	B-Gene_or_gene_product
,	O
and	O
an	O
in	O
vitro	O
-	O
synthesized	O
,	O
truncated	O
chicken	O
p105	B-Gene_or_gene_product
protein	O
,	O
containing	O
sequences	O
that	O
correspond	O
to	O
the	O
predicted	O
p50	B-Gene_or_gene_product
protein	O
,	O
bound	O
to	O
a	O
consensus	O
kappa	O
B	O
site	O
in	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

In	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
-	O
transformed	O
chicken	O
spleen	O
cells	O
,	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
is	O
found	O
in	O
high	O
-	O
molecular	O
-	O
weight	O
complexes	O
which	O
include	O
cellular	O
proteins	O
of	O
approximately	O
124	O
kDa	O
(	O
p124	B-Gene_or_gene_product
)	O
and	O
115	O
kDa	O
(	O
p115	B-Gene_or_gene_product
)	O
.	O

Here	O
we	O
report	O
that	O
in	O
vitro	O
-	O
produced	O
p105	B-Gene_or_gene_product
comigrates	O
with	O
p124	B-Gene_or_gene_product
from	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
-	O
transformed	O
spleen	O
cells	O
and	O
that	O
p105	B-Gene_or_gene_product
and	O
p124	B-Gene_or_gene_product
appear	O
to	O
be	O
identical	O
by	O
partial	O
proteolytic	O
mapping	O
with	O
V8	B-Gene_or_gene_product
protease	O
.	O
<EOS>	B-X
Active	B-X
NF-kappa	B-X
B-like	B-X
transcription	B-X
complexes	B-X
are	B-X
multimers	B-X
consisting	B-X
of	B-X
one	B-X
or	B-X
two	B-X
members	B-X
of	B-X
a	B-X
family	B-X
of	B-X
proteins	B-X
related	B-X
to	B-X
the	B-X
c-Rel	B-X
proto-oncoprotein	B-X
.	B-X
We	B-X
have	B-X
isolated	B-X
a	B-X
chicken	B-X
cDNA	B-X
encoding	B-X
p105	B-X
,	B-X
the	B-X
precursor	B-X
protein	B-X
for	B-X
the	B-X
p50	B-X
subunit	B-X
of	B-X
NF-kappa	B-X
B.	B-X
Sequence	B-X
analysis	B-X
shows	B-X
that	B-X
chicken	B-X
p105	B-X
is	B-X
approximately	B-X
70	B-X
%	B-X
identical	B-X
to	B-X
the	B-X
mouse	B-X
and	B-X
human	B-X
p105	B-X
proteins	B-X
,	B-X
containing	B-X
the	B-X
Rel	B-X
homology	B-X
domain	B-X
in	B-X
its	B-X
N-terminal	B-X
370	B-X
amino	B-X
acids	B-X
and	B-X
several	B-X
ankyrinlike	B-X
repeats	B-X
in	B-X
the	B-X
C-terminal	B-X
portion	B-X
of	B-X
the	B-X
protein	B-X
.	B-X
The	B-X
Rel	B-X
homology	B-X
domain	B-X
is	B-X
particularly	B-X
highly	B-X
conserved	B-X
between	B-X
chicken	B-X
and	B-X
mammalian	B-X
p50	B-X
,	B-X
and	B-X
an	B-X
in	B-X
vitro-synthesized	B-X
,	B-X
truncated	B-X
chicken	B-X
p105	B-X
protein	B-X
,	B-X
containing	B-X
sequences	B-X
that	B-X
correspond	B-X
to	B-X
the	B-X
predicted	B-X
p50	B-X
protein	B-X
,	B-X
bound	B-X
to	B-X
a	B-X
consensus	B-X
kappa	B-X
B	B-X
site	B-X
in	B-X
an	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assay	B-X
.	B-X
In	B-X
v-Rel-transformed	B-X
chicken	B-X
spleen	B-X
cells	B-X
,	B-X
v-Rel	B-X
is	B-X
found	B-X
in	B-X
high-molecular-weight	B-X
complexes	B-X
which	B-X
include	B-X
cellular	B-X
proteins	B-X
of	B-X
approximately	B-X
124	B-X
kDa	B-X
(	B-X
p124	B-X
)	B-X
and	B-X
115	B-X
kDa	B-X
(	B-X
p115	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
in	B-X
vitro-produced	B-X
p105	B-X
comigrates	B-X
with	B-X
p124	B-X
from	B-X
v-Rel-transformed	B-X
spleen	B-X
cells	B-X
and	B-X
that	B-X
p105	B-X
and	B-X
p124	B-X
appear	B-X
to	B-X
be	B-X
identical	B-X
by	B-X
partial	B-X
proteolytic	B-X
mapping	B-X
with	B-X
V8	B-X
protease	B-X
.	B-X
Furthermore	B-X
,	B-X
both	B-X
p105	B-X
and	B-X
p50	B-X
can	B-X
complex	B-X
directly	B-X
with	B-X
v-Rel	B-X
and	B-X
chicken	B-X
c-Rel	B-X
in	B-X
vitro	B-X
.	B-X
However	B-X
,	B-X
in	B-X
vitro	B-X
association	B-X
with	B-X
p105	B-X
by	B-X
v-Rel	B-X
does	B-X
not	B-X
necessarily	B-X
correlate	B-X
with	B-X
transformation	B-X
,	B-X
since	B-X
one	B-X
nontransforming	B-X
v-Rel	B-X
mutant	B-X
can	B-X
associate	B-X
with	B-X
p105	B-X
in	B-X
vitro	B-X
.	B-X

Furthermore	O
,	O
both	O
p105	B-Gene_or_gene_product
and	O
p50	B-Gene_or_gene_product
can	O
complex	O
directly	O
with	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
and	O
chicken	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
in	O
vitro	O
.	O

However	O
,	O
in	O
vitro	O
association	O
with	O
p105	B-Gene_or_gene_product
by	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
does	O
not	O
necessarily	O
correlate	O
with	O
transformation	O
,	O
since	O
one	O
nontransforming	O
v	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Rel	I-Gene_or_gene_product
mutant	O
can	O
associate	O
with	O
p105	B-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
Mutant	B-X
NF-kappaB-deficient	B-X
B	B-X
cells	B-X
from	B-X
knockout	B-X
mice	B-X
lacking	B-X
RelA	B-X
,	B-X
p105/p50	B-X
or	B-X
the	B-X
transactivation	B-X
domain	B-X
of	B-X
c-Rel	B-X
exhibit	B-X
distinct	B-X
and	B-X
selective	B-X
cell-intrinsic	B-X
defects	B-X
in	B-X
their	B-X
ability	B-X
to	B-X
undergo	B-X
class	B-X
switch	B-X
recombination	B-X
(	B-X
CSR	B-X
)	B-X
to	B-X
specific	B-X
Ig	B-X
isotypes	B-X
.	B-X
This	B-X
isotype-specific	B-X
requirement	B-X
for	B-X
particular	B-X
NF-kappaB	B-X
transcription	B-X
factors	B-X
in	B-X
B	B-X
cells	B-X
activated	B-X
to	B-X
undergo	B-X
CSR	B-X
is	B-X
intriguing	B-X
because	B-X
the	B-X
NF-kappaB	B-X
composition	B-X
in	B-X
B	B-X
cells	B-X
is	B-X
also	B-X
highly	B-X
regulated	B-X
and	B-X
can	B-X
vary	B-X
significantly	B-X
depending	B-X
upon	B-X
how	B-X
B	B-X
cells	B-X
are	B-X
activated	B-X
.	B-X
These	B-X
studies	B-X
prompted	B-X
us	B-X
to	B-X
test	B-X
by	B-X
retroviral	B-X
transduction	B-X
of	B-X
normal	B-X
B	B-X
cells	B-X
whether	B-X
changes	B-X
in	B-X
the	B-X
NF-kappaB	B-X
composition	B-X
in	B-X
activated	B-X
B	B-X
cells	B-X
could	B-X
modulate	B-X
cytokine-driven	B-X
CSR	B-X
.	B-X
RelB	B-X
,	B-X
RelA	B-X
,	B-X
c-Rel	B-X
,	B-X
p50	B-X
and	B-X
p52	B-X
were	B-X
first	B-X
expressed	B-X
in	B-X
lipopolysaccharide-activated	B-X
primary	B-X
B	B-X
cells	B-X
and	B-X
then	B-X
induced	B-X
by	B-X
cytokine	B-X
addition	B-X
to	B-X
undergo	B-X
CSR	B-X
to	B-X
IgG1	B-X
,	B-X
IgE	B-X
,	B-X
IgG2a	B-X
,	B-X
IgG2b	B-X
or	B-X
IgA	B-X
.	B-X
Surprisingly	B-X
,	B-X
only	B-X
retroviral	B-X
expression	B-X
of	B-X
RelB	B-X
altered	B-X
CSR	B-X
,	B-X
resulting	B-X
in	B-X
a	B-X
3-fold	B-X
decrease	B-X
in	B-X
CSR	B-X
to	B-X
IgG1	B-X
induced	B-X
by	B-X
IL-4	B-X
.	B-X
This	B-X
effect	B-X
was	B-X
isotype	B-X
specific	B-X
as	B-X
RelB	B-X
expression	B-X
did	B-X
not	B-X
affect	B-X
CSR	B-X
to	B-X
IgE	B-X
within	B-X
the	B-X
same	B-X
culture	B-X
or	B-X
to	B-X
other	B-X
isotypes	B-X
tested	B-X
.	B-X
The	B-X
transactivation	B-X
domain	B-X
of	B-X
RelB	B-X
was	B-X
required	B-X
for	B-X
inhibition	B-X
of	B-X
CSR	B-X
to	B-X
IgG1	B-X
.	B-X
Expression	B-X
of	B-X
p50-RelB	B-X
or	B-X
p52-RelB	B-X
dimers	B-X
joined	B-X
covalently	B-X
by	B-X
a	B-X
flexible	B-X
peptide	B-X
linker	B-X
also	B-X
specifically	B-X
inhibited	B-X
IgG1	B-X
CSR	B-X
.	B-X
RelB-mediated	B-X
inhibition	B-X
of	B-X
IgG1	B-X
CSR	B-X
was	B-X
associated	B-X
with	B-X
a	B-X
decrease	B-X
in	B-X
germline	B-X
gamma1	B-X
transcription	B-X
,	B-X
but	B-X
not	B-X
with	B-X
changes	B-X
in	B-X
proliferation	B-X
as	B-X
assayed	B-X
by	B-X
CFSE	B-X
labeling	B-X
.	B-X
Thus	B-X
,	B-X
RelB	B-X
complexes	B-X
can	B-X
specifically	B-X
inhibit	B-X
CSR	B-X
to	B-X
IgG1	B-X
,	B-X
but	B-X
not	B-X
IgE	B-X
,	B-X
in	B-X
activated	B-X
,	B-X
primary	B-X
B	B-X
cells	B-X
.	B-X

Repression	O
of	O
fibroblast	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
gene	O
expression	O
by	O
E2F4	B-Gene_or_gene_product
in	O
skeletal	O
muscle	O
cells	O
.	O
<EOS>	B-X
Fibroblast	B-X
growth	B-X
factor	B-X
receptor	B-X
1	B-X
(	B-X
FGFR1	B-X
)	B-X
gene	B-X
expression	B-X
is	B-X
positively	B-X
and	B-X
negatively	B-X
regulated	B-X
during	B-X
muscle	B-X
differentiation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
FGFR1	B-X
gene	B-X
expression	B-X
was	B-X
up-regulated	B-X
by	B-X
Sp	B-X
transcription	B-X
factors	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
of	B-X
down-regulation	B-X
of	B-X
this	B-X
gene	B-X
during	B-X
differentiation	B-X
is	B-X
unknown	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
the	B-X
transcription	B-X
factor	B-X
E2F4	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
FGFR1	B-X
gene	B-X
expression	B-X
.	B-X
Immunodetection	B-X
studies	B-X
revealed	B-X
that	B-X
endogenous	B-X
E2F1	B-X
and	B-X
E2F2	B-X
proteins	B-X
were	B-X
cytoplasmic	B-X
in	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
,	B-X
whereas	B-X
E2F4	B-X
was	B-X
abundant	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
both	B-X
.	B-X
Upon	B-X
overexpression	B-X
,	B-X
E2F4	B-X
repressed	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
in	B-X
myoblasts	B-X
and	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
the	B-X
E2F4	B-X
binding	B-X
site	B-X
increased	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
and	B-X
reduced	B-X
E2F4-mediated	B-X
repression	B-X
.	B-X
Gel	B-X
shift	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
a	B-X
synthetic	B-X
FGFR1	B-X
E2F4	B-X
binding	B-X
site	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
the	B-X
endogenous	B-X
FGFR1	B-X
promoter	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
skeletal	B-X
muscle	B-X
cells	B-X
is	B-X
repressed	B-X
by	B-X
E2F4	B-X
.	B-X

Fibroblast	B-Gene_or_gene_product
growth	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
FGFR1	B-Gene_or_gene_product
)	O
gene	O
expression	O
is	O
positively	O
and	O
negatively	O
regulated	O
during	O
muscle	O
differentiation	O
.	O
<EOS>	B-X
Fibroblast	B-X
growth	B-X
factor	B-X
receptor	B-X
1	B-X
(	B-X
FGFR1	B-X
)	B-X
gene	B-X
expression	B-X
is	B-X
positively	B-X
and	B-X
negatively	B-X
regulated	B-X
during	B-X
muscle	B-X
differentiation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
FGFR1	B-X
gene	B-X
expression	B-X
was	B-X
up-regulated	B-X
by	B-X
Sp	B-X
transcription	B-X
factors	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
of	B-X
down-regulation	B-X
of	B-X
this	B-X
gene	B-X
during	B-X
differentiation	B-X
is	B-X
unknown	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
the	B-X
transcription	B-X
factor	B-X
E2F4	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
FGFR1	B-X
gene	B-X
expression	B-X
.	B-X
Immunodetection	B-X
studies	B-X
revealed	B-X
that	B-X
endogenous	B-X
E2F1	B-X
and	B-X
E2F2	B-X
proteins	B-X
were	B-X
cytoplasmic	B-X
in	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
,	B-X
whereas	B-X
E2F4	B-X
was	B-X
abundant	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
both	B-X
.	B-X
Upon	B-X
overexpression	B-X
,	B-X
E2F4	B-X
repressed	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
in	B-X
myoblasts	B-X
and	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
the	B-X
E2F4	B-X
binding	B-X
site	B-X
increased	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
and	B-X
reduced	B-X
E2F4-mediated	B-X
repression	B-X
.	B-X
Gel	B-X
shift	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
a	B-X
synthetic	B-X
FGFR1	B-X
E2F4	B-X
binding	B-X
site	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
the	B-X
endogenous	B-X
FGFR1	B-X
promoter	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
skeletal	B-X
muscle	B-X
cells	B-X
is	B-X
repressed	B-X
by	B-X
E2F4	B-X
.	B-X

We	O
recently	O
reported	O
that	O
FGFR1	B-Gene_or_gene_product
gene	O
expression	O
was	O
up	O
-	O
regulated	O
by	O
Sp	B-Gene_or_gene_product
transcription	O
factors	O
in	O
proliferating	O
myoblasts	O
.	O
<EOS>	B-X
Fibroblast	B-X
growth	B-X
factor	B-X
receptor	B-X
1	B-X
(	B-X
FGFR1	B-X
)	B-X
gene	B-X
expression	B-X
is	B-X
positively	B-X
and	B-X
negatively	B-X
regulated	B-X
during	B-X
muscle	B-X
differentiation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
FGFR1	B-X
gene	B-X
expression	B-X
was	B-X
up-regulated	B-X
by	B-X
Sp	B-X
transcription	B-X
factors	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
of	B-X
down-regulation	B-X
of	B-X
this	B-X
gene	B-X
during	B-X
differentiation	B-X
is	B-X
unknown	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
the	B-X
transcription	B-X
factor	B-X
E2F4	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
FGFR1	B-X
gene	B-X
expression	B-X
.	B-X
Immunodetection	B-X
studies	B-X
revealed	B-X
that	B-X
endogenous	B-X
E2F1	B-X
and	B-X
E2F2	B-X
proteins	B-X
were	B-X
cytoplasmic	B-X
in	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
,	B-X
whereas	B-X
E2F4	B-X
was	B-X
abundant	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
both	B-X
.	B-X
Upon	B-X
overexpression	B-X
,	B-X
E2F4	B-X
repressed	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
in	B-X
myoblasts	B-X
and	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
the	B-X
E2F4	B-X
binding	B-X
site	B-X
increased	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
and	B-X
reduced	B-X
E2F4-mediated	B-X
repression	B-X
.	B-X
Gel	B-X
shift	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
a	B-X
synthetic	B-X
FGFR1	B-X
E2F4	B-X
binding	B-X
site	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
the	B-X
endogenous	B-X
FGFR1	B-X
promoter	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
skeletal	B-X
muscle	B-X
cells	B-X
is	B-X
repressed	B-X
by	B-X
E2F4	B-X
.	B-X

However	O
,	O
the	O
mechanism	O
of	O
down	O
-	O
regulation	O
of	O
this	O
gene	O
during	O
differentiation	O
is	O
unknown	O
.	O
<EOS>	B-X
The	B-X
expression	B-X
profile	B-X
and	B-X
mechanism	B-X
of	B-X
circRNAs	B-X
in	B-X
postmenopausal	B-X
osteoporosis	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Bone	B-X
morphogenetic	B-X
protein	B-X
2	B-X
(	B-X
BMP2	B-X
)	B-X
is	B-X
known	B-X
to	B-X
play	B-X
important	B-X
role	B-X
in	B-X
inducing	B-X
osteogenic	B-X
differentiation	B-X
.	B-X
MiR-98	B-X
was	B-X
reported	B-X
to	B-X
regulate	B-X
osteogenic	B-X
differentiation	B-X
of	B-X
human	B-X
bone	B-X
mesenchymal	B-X
stromal	B-X
cells	B-X
by	B-X
targeting	B-X
BMP2	B-X
.	B-X
Systemic	B-X
sclerosis	B-X
(	B-X
SSc	B-X
)	B-X
is	B-X
an	B-X
autoimmune	B-X
inflammatory	B-X
disease	B-X
with	B-X
unknown	B-X
etiology	B-X
characterized	B-X
by	B-X
microvascular	B-X
injury	B-X
and	B-X
fibrosis	B-X
of	B-X
the	B-X
skin	B-X
and	B-X
internal	B-X
organs	B-X
.	B-X
A	B-X
growing	B-X
body	B-X
of	B-X
evidence	B-X
suggests	B-X
that	B-X
deficiency	B-X
of	B-X
the	B-X
transcription	B-X
factor	B-X
Fli1	B-X
(	B-X
Friend	B-X
leukemia	B-X
integration-1	B-X
)	B-X
has	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
pathogenesis	B-X
of	B-X
SSc	B-X
.	B-X
Fli1	B-X
is	B-X
expressed	B-X
in	B-X
fibroblasts	B-X
,	B-X
endothelial	B-X
cells	B-X
,	B-X
and	B-X
immune	B-X
cells	B-X
,	B-X
and	B-X
has	B-X
important	B-X
roles	B-X
in	B-X
the	B-X
activation	B-X
,	B-X
differentiation	B-X
,	B-X
development	B-X
,	B-X
and	B-X
survival	B-X
of	B-X
these	B-X
cells	B-X
.	B-X
Previous	B-X
studies	B-X
demonstrated	B-X
that	B-X
Fli1	B-X
is	B-X
downregulated	B-X
in	B-X
SSc	B-X
fibroblasts	B-X
by	B-X
an	B-X
epigenetic	B-X
mechanism	B-X
and	B-X
a	B-X
series	B-X
of	B-X
experiments	B-X
with	B-X
Fli1-deficient	B-X
animal	B-X
models	B-X
revealed	B-X
that	B-X
Fli1	B-X
deficiency	B-X
in	B-X
fibroblasts	B-X
and	B-X
endothelial	B-X
cells	B-X
reproduces	B-X
the	B-X
histopathologic	B-X
features	B-X
of	B-X
fibrosis	B-X
and	B-X
vasculopathy	B-X
in	B-X
SSc	B-X
,	B-X
respectively	B-X
.	B-X
In	B-X
this	B-X
article	B-X
,	B-X
we	B-X
review	B-X
the	B-X
impact	B-X
of	B-X
Fli1	B-X
deficiency	B-X
on	B-X
the	B-X
pathogenesis	B-X
of	B-X
SSc	B-X
and	B-X
discuss	B-X
a	B-X
new	B-X
therapeutic	B-X
strategy	B-X
for	B-X
SSc	B-X
by	B-X
targeting	B-X
the	B-X
transcription	B-X
factor	B-X
Fli1	B-X
.	B-X

We	O
have	O
identified	O
the	O
transcription	O
factor	O
E2F4	B-Gene_or_gene_product
as	O
a	O
negative	O
regulator	O
of	O
FGFR1	B-Gene_or_gene_product
gene	O
expression	O
.	O
<EOS>	B-X
Fibroblast	B-X
growth	B-X
factor	B-X
receptor	B-X
1	B-X
(	B-X
FGFR1	B-X
)	B-X
gene	B-X
expression	B-X
is	B-X
positively	B-X
and	B-X
negatively	B-X
regulated	B-X
during	B-X
muscle	B-X
differentiation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
FGFR1	B-X
gene	B-X
expression	B-X
was	B-X
up-regulated	B-X
by	B-X
Sp	B-X
transcription	B-X
factors	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
.	B-X
However	B-X
,	B-X
the	B-X
mechanism	B-X
of	B-X
down-regulation	B-X
of	B-X
this	B-X
gene	B-X
during	B-X
differentiation	B-X
is	B-X
unknown	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
the	B-X
transcription	B-X
factor	B-X
E2F4	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
FGFR1	B-X
gene	B-X
expression	B-X
.	B-X
Immunodetection	B-X
studies	B-X
revealed	B-X
that	B-X
endogenous	B-X
E2F1	B-X
and	B-X
E2F2	B-X
proteins	B-X
were	B-X
cytoplasmic	B-X
in	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
,	B-X
whereas	B-X
E2F4	B-X
was	B-X
abundant	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
both	B-X
.	B-X
Upon	B-X
overexpression	B-X
,	B-X
E2F4	B-X
repressed	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
in	B-X
myoblasts	B-X
and	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
the	B-X
E2F4	B-X
binding	B-X
site	B-X
increased	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
and	B-X
reduced	B-X
E2F4-mediated	B-X
repression	B-X
.	B-X
Gel	B-X
shift	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
a	B-X
synthetic	B-X
FGFR1	B-X
E2F4	B-X
binding	B-X
site	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
the	B-X
endogenous	B-X
FGFR1	B-X
promoter	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
skeletal	B-X
muscle	B-X
cells	B-X
is	B-X
repressed	B-X
by	B-X
E2F4	B-X
.	B-X

Immunodetection	O
studies	O
revealed	O
that	O
endogenous	O
E2F1	B-Gene_or_gene_product
and	O
E2F2	B-Gene_or_gene_product
proteins	O
were	O
cytoplasmic	O
in	O
myoblasts	O
and	O
myotubes	O
,	O
whereas	O
E2F4	B-Gene_or_gene_product
was	O
abundant	O
in	O
the	O
nuclei	O
of	O
both	O
.	O
<EOS>	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
FGFR1	B-X
gene	B-X
expression	B-X
was	B-X
up-regulated	B-X
by	B-X
Sp	B-X
transcription	B-X
factors	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
the	B-X
transcription	B-X
factor	B-X
E2F4	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
FGFR1	B-X
gene	B-X
expression	B-X
.	B-X
Immunodetection	B-X
studies	B-X
revealed	B-X
that	B-X
endogenous	B-X
E2F1	B-X
and	B-X
E2F2	B-X
proteins	B-X
were	B-X
cytoplasmic	B-X
in	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
,	B-X
whereas	B-X
E2F4	B-X
was	B-X
abundant	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
both	B-X
.	B-X
Upon	B-X
overexpression	B-X
,	B-X
E2F4	B-X
repressed	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
in	B-X
myoblasts	B-X
and	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
the	B-X
E2F4	B-X
binding	B-X
site	B-X
increased	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
and	B-X
reduced	B-X
E2F4-mediated	B-X
repression	B-X
.	B-X
Gel	B-X
shift	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
a	B-X
synthetic	B-X
FGFR1	B-X
E2F4	B-X
binding	B-X
site	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
the	B-X
endogenous	B-X
FGFR1	B-X
promoter	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
skeletal	B-X
muscle	B-X
cells	B-X
is	B-X
repressed	B-X
by	B-X
E2F4	B-X
.	B-X

Upon	O
overexpression	O
,	O
E2F4	B-Gene_or_gene_product
repressed	O
FGFR1	B-Gene_or_gene_product
promoter	O
activity	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
in	O
myoblasts	O
and	O
Drosophila	O
SL2	O
cells	O
,	O
and	O
mutation	O
of	O
the	O
E2F4	B-Gene_or_gene_product
binding	O
site	O
increased	O
FGFR1	B-Gene_or_gene_product
promoter	O
activity	O
and	O
reduced	O
E2F4	B-Gene_or_gene_product
-	O
mediated	O
repression	O
.	O

Gel	O
shift	O
assays	O
detected	O
E2F4	B-Gene_or_gene_product
binding	O
to	O
a	O
synthetic	O
FGFR1	B-Gene_or_gene_product
E2F4	B-Gene_or_gene_product
binding	O
site	O
and	O
chromatin	O
immunoprecipitation	O
assays	O
detected	O
E2F4	B-Gene_or_gene_product
binding	O
to	O
the	O
endogenous	O
FGFR1	B-Gene_or_gene_product
promoter	O
in	O
proliferating	O
myoblasts	O
and	O
myotubes	O
.	O

The	O
results	O
indicate	O
that	O
FGFR1	B-Gene_or_gene_product
promoter	O
activity	O
in	O
skeletal	O
muscle	O
cells	O
is	O
repressed	O
by	O
E2F4	B-Gene_or_gene_product
.	O
<EOS>	B-X
Fibroblast	B-X
growth	B-X
factor	B-X
receptor	B-X
1	B-X
(	B-X
FGFR1	B-X
)	B-X
gene	B-X
expression	B-X
is	B-X
positively	B-X
and	B-X
negatively	B-X
regulated	B-X
during	B-X
muscle	B-X
differentiation	B-X
.	B-X
We	B-X
recently	B-X
reported	B-X
that	B-X
FGFR1	B-X
gene	B-X
expression	B-X
was	B-X
up-regulated	B-X
by	B-X
Sp	B-X
transcription	B-X
factors	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
the	B-X
transcription	B-X
factor	B-X
E2F4	B-X
as	B-X
a	B-X
negative	B-X
regulator	B-X
of	B-X
FGFR1	B-X
gene	B-X
expression	B-X
.	B-X
Immunodetection	B-X
studies	B-X
revealed	B-X
that	B-X
endogenous	B-X
E2F1	B-X
and	B-X
E2F2	B-X
proteins	B-X
were	B-X
cytoplasmic	B-X
in	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
,	B-X
whereas	B-X
E2F4	B-X
was	B-X
abundant	B-X
in	B-X
the	B-X
nuclei	B-X
of	B-X
both	B-X
.	B-X
Upon	B-X
overexpression	B-X
,	B-X
E2F4	B-X
repressed	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
in	B-X
myoblasts	B-X
and	B-X
Drosophila	B-X
SL2	B-X
cells	B-X
,	B-X
and	B-X
mutation	B-X
of	B-X
the	B-X
E2F4	B-X
binding	B-X
site	B-X
increased	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
and	B-X
reduced	B-X
E2F4-mediated	B-X
repression	B-X
.	B-X
Gel	B-X
shift	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
a	B-X
synthetic	B-X
FGFR1	B-X
E2F4	B-X
binding	B-X
site	B-X
and	B-X
chromatin	B-X
immunoprecipitation	B-X
assays	B-X
detected	B-X
E2F4	B-X
binding	B-X
to	B-X
the	B-X
endogenous	B-X
FGFR1	B-X
promoter	B-X
in	B-X
proliferating	B-X
myoblasts	B-X
and	B-X
myotubes	B-X
.	B-X
The	B-X
results	B-X
indicate	B-X
that	B-X
FGFR1	B-X
promoter	B-X
activity	B-X
in	B-X
skeletal	B-X
muscle	B-X
cells	B-X
is	B-X
repressed	B-X
by	B-X
E2F4	B-X
.	B-X

TRIP6	B-Gene_or_gene_product
is	O
a	O
RIP2	B-Gene_or_gene_product
-	O
associated	O
common	O
signaling	O
component	O
of	O
multiple	O
NF	O
-	O
kappaB	O
activation	O
pathways	O
.	O
<EOS>	B-X
Receptor-interacting	B-X
protein	B-X
2	B-X
(	B-X
RIP2	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
RIP	B-X
kinase	B-X
family	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
crucially	B-X
involved	B-X
in	B-X
inflammation	B-X
,	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
physiological	B-X
and	B-X
pathological	B-X
roles	B-X
of	B-X
RIP2	B-X
are	B-X
mediated	B-X
through	B-X
its	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
activation	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
triggered	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
,	B-X
interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
,	B-X
Toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
Nod1	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
LIM-domain-containing	B-X
protein	B-X
TRIP6	B-X
as	B-X
a	B-X
RIP2-interacting	B-X
protein	B-X
in	B-X
yeast	B-X
two-hybrid	B-X
screens	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
,	B-X
TRIP6	B-X
interacts	B-X
with	B-X
RIP2	B-X
in	B-X
a	B-X
TNF-	B-X
or	B-X
IL-1-dependent	B-X
manner	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
RIP2-mediated	B-X
NF-kappaB	B-X
activation	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
.	B-X
The	B-X
LIM	B-X
domains	B-X
of	B-X
TRIP6	B-X
are	B-X
responsible	B-X
for	B-X
its	B-X
interaction	B-X
with	B-X
RIP2	B-X
.	B-X
TRIP6	B-X
also	B-X
interacts	B-X
with	B-X
TRAF2	B-X
,	B-X
a	B-X
protein	B-X
that	B-X
is	B-X
crucially	B-X
involved	B-X
in	B-X
TNF	B-X
signaling	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
IL-1	B-X
receptor	B-X
,	B-X
TLR2	B-X
and	B-X
Nod1	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
,	B-X
whereas	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
or	B-X
RNA-interference	B-X
construct	B-X
of	B-X
TRIP6	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
.	B-X
Moreover	B-X
,	B-X
TRIP6	B-X
also	B-X
potentiates	B-X
RIP2-	B-X
and	B-X
Nod1-mediated	B-X
ERK	B-X
activation	B-X
.	B-X
These	B-X
data	B-X
have	B-X
established	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
association	B-X
between	B-X
TRIP6	B-X
and	B-X
RIP2	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
RIP2	B-X
's	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
and	B-X
ERK	B-X
activation	B-X
pathways	B-X
is	B-X
mediated	B-X
through	B-X
TRIP6	B-X
.	B-X

Receptor	B-Gene_or_gene_product
-	I-Gene_or_gene_product
interacting	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
RIP2	B-Gene_or_gene_product
)	O
is	O
a	O
member	O
of	O
the	O
RIP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
family	O
that	O
has	O
been	O
shown	O
to	O
be	O
crucially	O
involved	O
in	O
inflammation	O
,	O
innate	O
and	O
adaptive	O
immune	O
responses	O
.	O
<EOS>	B-X
Receptor-interacting	B-X
protein	B-X
2	B-X
(	B-X
RIP2	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
RIP	B-X
kinase	B-X
family	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
crucially	B-X
involved	B-X
in	B-X
inflammation	B-X
,	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
physiological	B-X
and	B-X
pathological	B-X
roles	B-X
of	B-X
RIP2	B-X
are	B-X
mediated	B-X
through	B-X
its	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
activation	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
triggered	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
,	B-X
interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
,	B-X
Toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
Nod1	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
LIM-domain-containing	B-X
protein	B-X
TRIP6	B-X
as	B-X
a	B-X
RIP2-interacting	B-X
protein	B-X
in	B-X
yeast	B-X
two-hybrid	B-X
screens	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
,	B-X
TRIP6	B-X
interacts	B-X
with	B-X
RIP2	B-X
in	B-X
a	B-X
TNF-	B-X
or	B-X
IL-1-dependent	B-X
manner	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
RIP2-mediated	B-X
NF-kappaB	B-X
activation	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
.	B-X
The	B-X
LIM	B-X
domains	B-X
of	B-X
TRIP6	B-X
are	B-X
responsible	B-X
for	B-X
its	B-X
interaction	B-X
with	B-X
RIP2	B-X
.	B-X
TRIP6	B-X
also	B-X
interacts	B-X
with	B-X
TRAF2	B-X
,	B-X
a	B-X
protein	B-X
that	B-X
is	B-X
crucially	B-X
involved	B-X
in	B-X
TNF	B-X
signaling	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
IL-1	B-X
receptor	B-X
,	B-X
TLR2	B-X
and	B-X
Nod1	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
,	B-X
whereas	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
or	B-X
RNA-interference	B-X
construct	B-X
of	B-X
TRIP6	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
.	B-X
Moreover	B-X
,	B-X
TRIP6	B-X
also	B-X
potentiates	B-X
RIP2-	B-X
and	B-X
Nod1-mediated	B-X
ERK	B-X
activation	B-X
.	B-X
These	B-X
data	B-X
have	B-X
established	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
association	B-X
between	B-X
TRIP6	B-X
and	B-X
RIP2	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
RIP2	B-X
's	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
and	B-X
ERK	B-X
activation	B-X
pathways	B-X
is	B-X
mediated	B-X
through	B-X
TRIP6	B-X
.	B-X

The	O
physiological	O
and	O
pathological	O
roles	O
of	O
RIP2	B-Gene_or_gene_product
are	O
mediated	O
through	O
its	O
involvement	O
in	O
multiple	O
NF	O
-	O
kappaB	O
activation	O
pathways	O
,	O
including	O
those	O
triggered	O
by	O
tumor	B-Gene_or_gene_product
necrosis	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
TNF	B-Gene_or_gene_product
)	O
,	O
interleukin	B-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
,	O
Toll	B-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
TLR2	B-Gene_or_gene_product
)	O
,	O
TLR3	B-Gene_or_gene_product
,	O
TLR4	B-Gene_or_gene_product
and	O
Nod1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Receptor-interacting	B-X
protein	B-X
2	B-X
(	B-X
RIP2	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
RIP	B-X
kinase	B-X
family	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
crucially	B-X
involved	B-X
in	B-X
inflammation	B-X
,	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
physiological	B-X
and	B-X
pathological	B-X
roles	B-X
of	B-X
RIP2	B-X
are	B-X
mediated	B-X
through	B-X
its	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
activation	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
triggered	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
,	B-X
interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
,	B-X
Toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
Nod1	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
LIM-domain-containing	B-X
protein	B-X
TRIP6	B-X
as	B-X
a	B-X
RIP2-interacting	B-X
protein	B-X
in	B-X
yeast	B-X
two-hybrid	B-X
screens	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
,	B-X
TRIP6	B-X
interacts	B-X
with	B-X
RIP2	B-X
in	B-X
a	B-X
TNF-	B-X
or	B-X
IL-1-dependent	B-X
manner	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
RIP2-mediated	B-X
NF-kappaB	B-X
activation	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
.	B-X
The	B-X
LIM	B-X
domains	B-X
of	B-X
TRIP6	B-X
are	B-X
responsible	B-X
for	B-X
its	B-X
interaction	B-X
with	B-X
RIP2	B-X
.	B-X
TRIP6	B-X
also	B-X
interacts	B-X
with	B-X
TRAF2	B-X
,	B-X
a	B-X
protein	B-X
that	B-X
is	B-X
crucially	B-X
involved	B-X
in	B-X
TNF	B-X
signaling	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
IL-1	B-X
receptor	B-X
,	B-X
TLR2	B-X
and	B-X
Nod1	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
,	B-X
whereas	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
or	B-X
RNA-interference	B-X
construct	B-X
of	B-X
TRIP6	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
.	B-X
Moreover	B-X
,	B-X
TRIP6	B-X
also	B-X
potentiates	B-X
RIP2-	B-X
and	B-X
Nod1-mediated	B-X
ERK	B-X
activation	B-X
.	B-X
These	B-X
data	B-X
have	B-X
established	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
association	B-X
between	B-X
TRIP6	B-X
and	B-X
RIP2	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
RIP2	B-X
's	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
and	B-X
ERK	B-X
activation	B-X
pathways	B-X
is	B-X
mediated	B-X
through	B-X
TRIP6	B-X
.	B-X

In	O
this	O
report	O
,	O
we	O
identified	O
the	O
LIM	O
-	O
domain	O
-	O
containing	O
protein	O
TRIP6	B-Gene_or_gene_product
as	O
a	O
RIP2	B-Gene_or_gene_product
-	O
interacting	O
protein	O
in	O
yeast	O
two	O
-	O
hybrid	O
screens	O
.	O
<EOS>	B-X
Receptor-interacting	B-X
protein	B-X
2	B-X
(	B-X
RIP2	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
RIP	B-X
kinase	B-X
family	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
crucially	B-X
involved	B-X
in	B-X
inflammation	B-X
,	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
physiological	B-X
and	B-X
pathological	B-X
roles	B-X
of	B-X
RIP2	B-X
are	B-X
mediated	B-X
through	B-X
its	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
activation	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
triggered	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
,	B-X
interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
,	B-X
Toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
Nod1	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
LIM-domain-containing	B-X
protein	B-X
TRIP6	B-X
as	B-X
a	B-X
RIP2-interacting	B-X
protein	B-X
in	B-X
yeast	B-X
two-hybrid	B-X
screens	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
,	B-X
TRIP6	B-X
interacts	B-X
with	B-X
RIP2	B-X
in	B-X
a	B-X
TNF-	B-X
or	B-X
IL-1-dependent	B-X
manner	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
RIP2-mediated	B-X
NF-kappaB	B-X
activation	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
.	B-X
The	B-X
LIM	B-X
domains	B-X
of	B-X
TRIP6	B-X
are	B-X
responsible	B-X
for	B-X
its	B-X
interaction	B-X
with	B-X
RIP2	B-X
.	B-X
TRIP6	B-X
also	B-X
interacts	B-X
with	B-X
TRAF2	B-X
,	B-X
a	B-X
protein	B-X
that	B-X
is	B-X
crucially	B-X
involved	B-X
in	B-X
TNF	B-X
signaling	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
IL-1	B-X
receptor	B-X
,	B-X
TLR2	B-X
and	B-X
Nod1	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
,	B-X
whereas	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
or	B-X
RNA-interference	B-X
construct	B-X
of	B-X
TRIP6	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
.	B-X
Moreover	B-X
,	B-X
TRIP6	B-X
also	B-X
potentiates	B-X
RIP2-	B-X
and	B-X
Nod1-mediated	B-X
ERK	B-X
activation	B-X
.	B-X
These	B-X
data	B-X
have	B-X
established	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
association	B-X
between	B-X
TRIP6	B-X
and	B-X
RIP2	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
RIP2	B-X
's	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
and	B-X
ERK	B-X
activation	B-X
pathways	B-X
is	B-X
mediated	B-X
through	B-X
TRIP6	B-X
.	B-X

In	O
mammalian	O
cells	O
,	O
TRIP6	B-Gene_or_gene_product
interacts	O
with	O
RIP2	B-Gene_or_gene_product
in	O
a	O
TNF	B-Gene_or_gene_product
-	O
or	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
-	O
dependent	O
manner	O
.	O
<EOS>	B-X
The	B-X
use	B-X
of	B-X
lipid-formulated	B-X
RNA	B-X
vaccines	B-X
for	B-X
cancer	B-X
or	B-X
COVID-19	B-X
is	B-X
associated	B-X
with	B-X
dose-limiting	B-X
systemic	B-X
inflammatory	B-X
responses	B-X
in	B-X
humans	B-X
that	B-X
were	B-X
not	B-X
predicted	B-X
from	B-X
preclinical	B-X
studies	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
the	B-X
'interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
-interleukin	B-X
1	B-X
receptor	B-X
antagonist	B-X
(	B-X
IL-1ra	B-X
)	B-X
'	B-X
axis	B-X
regulates	B-X
vaccine-mediated	B-X
systemic	B-X
inflammation	B-X
in	B-X
a	B-X
host-specific	B-X
manner	B-X
.	B-X
In	B-X
human	B-X
immune	B-X
cells	B-X
,	B-X
RNA	B-X
vaccines	B-X
induce	B-X
production	B-X
of	B-X
IL-1	B-X
cytokines	B-X
,	B-X
predominantly	B-X
IL-1	B-X
,	B-X
which	B-X
is	B-X
dependent	B-X
on	B-X
both	B-X
the	B-X
RNA	B-X
and	B-X
lipid	B-X
formulation	B-X
.	B-X
IL-1	B-X
in	B-X
turn	B-X
triggers	B-X
the	B-X
induction	B-X
of	B-X
the	B-X
broad	B-X
spectrum	B-X
of	B-X
pro-inflammatory	B-X
cytokines	B-X
(	B-X
including	B-X
IL-6	B-X
)	B-X
.	B-X
Unlike	B-X
humans	B-X
,	B-X
murine	B-X
leukocytes	B-X
respond	B-X
to	B-X
RNA	B-X
vaccines	B-X
by	B-X
upregulating	B-X
anti-inflammatory	B-X
IL-1ra	B-X
relative	B-X
to	B-X
IL-1	B-X
(	B-X
predominantly	B-X
IL-1	B-X
)	B-X
,	B-X
protecting	B-X
mice	B-X
from	B-X
cytokine-mediated	B-X
toxicities	B-X
at	B-X
>	B-X
1,000-fold	B-X
higher	B-X
vaccine	B-X
doses	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
IL-1	B-X
pathway	B-X
plays	B-X
a	B-X
key	B-X
role	B-X
in	B-X
triggering	B-X
RNA	B-X
vaccine-associated	B-X
innate	B-X
signaling	B-X
,	B-X
an	B-X
effect	B-X
that	B-X
was	B-X
unexpectedly	B-X
amplified	B-X
by	B-X
certain	B-X
lipids	B-X
used	B-X
in	B-X
vaccine	B-X
formulations	B-X
incorporating	B-X
N1-methyl-pseudouridine-modified	B-X
RNA	B-X
to	B-X
reduce	B-X
activation	B-X
of	B-X
Toll-like	B-X
receptor	B-X
signaling	B-X
.	B-X

Overexpression	O
of	O
TRIP6	B-Gene_or_gene_product
potentiates	O
RIP2	B-Gene_or_gene_product
-	O
mediated	O
NF	O
-	O
kappaB	O
activation	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

The	O
LIM	O
domains	O
of	O
TRIP6	B-Gene_or_gene_product
are	O
responsible	O
for	O
its	O
interaction	O
with	O
RIP2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Receptor-interacting	B-X
protein	B-X
2	B-X
(	B-X
RIP2	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
RIP	B-X
kinase	B-X
family	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
crucially	B-X
involved	B-X
in	B-X
inflammation	B-X
,	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
physiological	B-X
and	B-X
pathological	B-X
roles	B-X
of	B-X
RIP2	B-X
are	B-X
mediated	B-X
through	B-X
its	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
activation	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
triggered	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
,	B-X
interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
,	B-X
Toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
Nod1	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
LIM-domain-containing	B-X
protein	B-X
TRIP6	B-X
as	B-X
a	B-X
RIP2-interacting	B-X
protein	B-X
in	B-X
yeast	B-X
two-hybrid	B-X
screens	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
,	B-X
TRIP6	B-X
interacts	B-X
with	B-X
RIP2	B-X
in	B-X
a	B-X
TNF-	B-X
or	B-X
IL-1-dependent	B-X
manner	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
RIP2-mediated	B-X
NF-kappaB	B-X
activation	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
.	B-X
The	B-X
LIM	B-X
domains	B-X
of	B-X
TRIP6	B-X
are	B-X
responsible	B-X
for	B-X
its	B-X
interaction	B-X
with	B-X
RIP2	B-X
.	B-X
TRIP6	B-X
also	B-X
interacts	B-X
with	B-X
TRAF2	B-X
,	B-X
a	B-X
protein	B-X
that	B-X
is	B-X
crucially	B-X
involved	B-X
in	B-X
TNF	B-X
signaling	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
IL-1	B-X
receptor	B-X
,	B-X
TLR2	B-X
and	B-X
Nod1	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
,	B-X
whereas	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
or	B-X
RNA-interference	B-X
construct	B-X
of	B-X
TRIP6	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
.	B-X
Moreover	B-X
,	B-X
TRIP6	B-X
also	B-X
potentiates	B-X
RIP2-	B-X
and	B-X
Nod1-mediated	B-X
ERK	B-X
activation	B-X
.	B-X
These	B-X
data	B-X
have	B-X
established	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
association	B-X
between	B-X
TRIP6	B-X
and	B-X
RIP2	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
RIP2	B-X
's	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
and	B-X
ERK	B-X
activation	B-X
pathways	B-X
is	B-X
mediated	B-X
through	B-X
TRIP6	B-X
.	B-X

TRIP6	B-Gene_or_gene_product
also	O
interacts	O
with	O
TRAF2	B-Gene_or_gene_product
,	O
a	O
protein	O
that	O
is	O
crucially	O
involved	O
in	O
TNF	B-Gene_or_gene_product
signaling	O
,	O
as	O
well	O
as	O
the	O
IL	O
-	O
1	O
receptor	O
,	O
TLR2	B-Gene_or_gene_product
and	O
Nod1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Receptor-interacting	B-X
protein	B-X
2	B-X
(	B-X
RIP2	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
RIP	B-X
kinase	B-X
family	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
crucially	B-X
involved	B-X
in	B-X
inflammation	B-X
,	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
physiological	B-X
and	B-X
pathological	B-X
roles	B-X
of	B-X
RIP2	B-X
are	B-X
mediated	B-X
through	B-X
its	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
activation	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
triggered	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
,	B-X
interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
,	B-X
Toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
Nod1	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
LIM-domain-containing	B-X
protein	B-X
TRIP6	B-X
as	B-X
a	B-X
RIP2-interacting	B-X
protein	B-X
in	B-X
yeast	B-X
two-hybrid	B-X
screens	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
,	B-X
TRIP6	B-X
interacts	B-X
with	B-X
RIP2	B-X
in	B-X
a	B-X
TNF-	B-X
or	B-X
IL-1-dependent	B-X
manner	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
RIP2-mediated	B-X
NF-kappaB	B-X
activation	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
.	B-X
The	B-X
LIM	B-X
domains	B-X
of	B-X
TRIP6	B-X
are	B-X
responsible	B-X
for	B-X
its	B-X
interaction	B-X
with	B-X
RIP2	B-X
.	B-X
TRIP6	B-X
also	B-X
interacts	B-X
with	B-X
TRAF2	B-X
,	B-X
a	B-X
protein	B-X
that	B-X
is	B-X
crucially	B-X
involved	B-X
in	B-X
TNF	B-X
signaling	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
IL-1	B-X
receptor	B-X
,	B-X
TLR2	B-X
and	B-X
Nod1	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
,	B-X
whereas	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
or	B-X
RNA-interference	B-X
construct	B-X
of	B-X
TRIP6	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
.	B-X
Moreover	B-X
,	B-X
TRIP6	B-X
also	B-X
potentiates	B-X
RIP2-	B-X
and	B-X
Nod1-mediated	B-X
ERK	B-X
activation	B-X
.	B-X
These	B-X
data	B-X
have	B-X
established	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
association	B-X
between	B-X
TRIP6	B-X
and	B-X
RIP2	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
RIP2	B-X
's	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
and	B-X
ERK	B-X
activation	B-X
pathways	B-X
is	B-X
mediated	B-X
through	B-X
TRIP6	B-X
.	B-X

Overexpression	O
of	O
TRIP6	B-Gene_or_gene_product
potentiates	O
NF	O
-	O
kappaB	O
activation	O
by	O
TNF	B-Gene_or_gene_product
,	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
TLR2	B-Gene_or_gene_product
or	O
Nod1	B-Gene_or_gene_product
,	O
whereas	O
a	O
dominant	O
negative	O
mutant	O
or	O
RNA	O
-	O
interference	O
construct	O
of	O
TRIP6	B-Gene_or_gene_product
inhibits	O
NF	O
-	O
kappaB	O
activation	O
by	O
TNF	B-Gene_or_gene_product
,	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
TLR2	B-Gene_or_gene_product
or	O
Nod1	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
nucleotide-binding	B-X
oligomerization	B-X
domain	B-X
(	B-X
NOD	B-X
)	B-X
proteins	B-X
NOD1	B-X
and	B-X
NOD2	B-X
,	B-X
the	B-X
founding	B-X
members	B-X
of	B-X
the	B-X
intracellular	B-X
NOD-like	B-X
receptor	B-X
family	B-X
,	B-X
sense	B-X
conserved	B-X
motifs	B-X
in	B-X
bacterial	B-X
peptidoglycan	B-X
and	B-X
induce	B-X
proinflammatory	B-X
and	B-X
antimicrobial	B-X
responses	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
discuss	B-X
recent	B-X
developments	B-X
about	B-X
the	B-X
mechanisms	B-X
by	B-X
which	B-X
NOD1	B-X
and	B-X
NOD2	B-X
are	B-X
activated	B-X
by	B-X
bacterial	B-X
ligands	B-X
,	B-X
the	B-X
regulation	B-X
of	B-X
their	B-X
signaling	B-X
pathways	B-X
,	B-X
and	B-X
their	B-X
role	B-X
in	B-X
host	B-X
defense	B-X
and	B-X
inflammatory	B-X
disease	B-X
.	B-X
Several	B-X
routes	B-X
for	B-X
the	B-X
entry	B-X
of	B-X
peptidoglycan	B-X
ligands	B-X
to	B-X
the	B-X
host	B-X
cytosol	B-X
to	B-X
trigger	B-X
activation	B-X
of	B-X
NOD1	B-X
and	B-X
NOD2	B-X
have	B-X
been	B-X
elucidated	B-X
.	B-X
Furthermore	B-X
,	B-X
genetic	B-X
screens	B-X
and	B-X
biochemical	B-X
analyses	B-X
have	B-X
revealed	B-X
mechanisms	B-X
that	B-X
regulate	B-X
NOD1	B-X
and	B-X
NOD2	B-X
signaling	B-X
.	B-X
Further	B-X
understanding	B-X
of	B-X
NOD1	B-X
and	B-X
NOD2	B-X
should	B-X
provide	B-X
new	B-X
insight	B-X
into	B-X
the	B-X
pathogenesis	B-X
of	B-X
disease	B-X
and	B-X
the	B-X
development	B-X
of	B-X
new	B-X
strategies	B-X
to	B-X
treat	B-X
inflammatory	B-X
and	B-X
infectious	B-X
disorders	B-X
.	B-X

Moreover	O
,	O
TRIP6	B-Gene_or_gene_product
also	O
potentiates	O
RIP2	B-Gene_or_gene_product
-	O
and	O
Nod1	B-Gene_or_gene_product
-	O
mediated	O
ERK	B-Gene_or_gene_product
activation	O
.	O
<EOS>	B-X
Receptor-interacting	B-X
protein	B-X
2	B-X
(	B-X
RIP2	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
RIP	B-X
kinase	B-X
family	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
crucially	B-X
involved	B-X
in	B-X
inflammation	B-X
,	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
physiological	B-X
and	B-X
pathological	B-X
roles	B-X
of	B-X
RIP2	B-X
are	B-X
mediated	B-X
through	B-X
its	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
activation	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
triggered	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
,	B-X
interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
,	B-X
Toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
Nod1	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
LIM-domain-containing	B-X
protein	B-X
TRIP6	B-X
as	B-X
a	B-X
RIP2-interacting	B-X
protein	B-X
in	B-X
yeast	B-X
two-hybrid	B-X
screens	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
,	B-X
TRIP6	B-X
interacts	B-X
with	B-X
RIP2	B-X
in	B-X
a	B-X
TNF-	B-X
or	B-X
IL-1-dependent	B-X
manner	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
RIP2-mediated	B-X
NF-kappaB	B-X
activation	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
.	B-X
The	B-X
LIM	B-X
domains	B-X
of	B-X
TRIP6	B-X
are	B-X
responsible	B-X
for	B-X
its	B-X
interaction	B-X
with	B-X
RIP2	B-X
.	B-X
TRIP6	B-X
also	B-X
interacts	B-X
with	B-X
TRAF2	B-X
,	B-X
a	B-X
protein	B-X
that	B-X
is	B-X
crucially	B-X
involved	B-X
in	B-X
TNF	B-X
signaling	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
IL-1	B-X
receptor	B-X
,	B-X
TLR2	B-X
and	B-X
Nod1	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
,	B-X
whereas	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
or	B-X
RNA-interference	B-X
construct	B-X
of	B-X
TRIP6	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
.	B-X
Moreover	B-X
,	B-X
TRIP6	B-X
also	B-X
potentiates	B-X
RIP2-	B-X
and	B-X
Nod1-mediated	B-X
ERK	B-X
activation	B-X
.	B-X
These	B-X
data	B-X
have	B-X
established	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
association	B-X
between	B-X
TRIP6	B-X
and	B-X
RIP2	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
RIP2	B-X
's	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
and	B-X
ERK	B-X
activation	B-X
pathways	B-X
is	B-X
mediated	B-X
through	B-X
TRIP6	B-X
.	B-X

These	O
data	O
have	O
established	O
a	O
physical	O
and	O
functional	O
association	O
between	O
TRIP6	B-Gene_or_gene_product
and	O
RIP2	B-Gene_or_gene_product
,	O
and	O
suggest	O
that	O
RIP2	B-Gene_or_gene_product
'	O
s	O
involvement	O
in	O
multiple	O
NF	O
-	O
kappaB	O
and	O
ERK	B-Gene_or_gene_product
activation	O
pathways	O
is	O
mediated	O
through	O
TRIP6	B-Gene_or_gene_product
.	O
<EOS>	B-X
Receptor-interacting	B-X
protein	B-X
2	B-X
(	B-X
RIP2	B-X
)	B-X
is	B-X
a	B-X
member	B-X
of	B-X
the	B-X
RIP	B-X
kinase	B-X
family	B-X
that	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
crucially	B-X
involved	B-X
in	B-X
inflammation	B-X
,	B-X
innate	B-X
and	B-X
adaptive	B-X
immune	B-X
responses	B-X
.	B-X
The	B-X
physiological	B-X
and	B-X
pathological	B-X
roles	B-X
of	B-X
RIP2	B-X
are	B-X
mediated	B-X
through	B-X
its	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
activation	B-X
pathways	B-X
,	B-X
including	B-X
those	B-X
triggered	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
,	B-X
interleukin	B-X
1	B-X
(	B-X
IL-1	B-X
)	B-X
,	B-X
Toll-like	B-X
receptor	B-X
2	B-X
(	B-X
TLR2	B-X
)	B-X
,	B-X
TLR3	B-X
,	B-X
TLR4	B-X
and	B-X
Nod1	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
identified	B-X
the	B-X
LIM-domain-containing	B-X
protein	B-X
TRIP6	B-X
as	B-X
a	B-X
RIP2-interacting	B-X
protein	B-X
in	B-X
yeast	B-X
two-hybrid	B-X
screens	B-X
.	B-X
In	B-X
mammalian	B-X
cells	B-X
,	B-X
TRIP6	B-X
interacts	B-X
with	B-X
RIP2	B-X
in	B-X
a	B-X
TNF-	B-X
or	B-X
IL-1-dependent	B-X
manner	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
RIP2-mediated	B-X
NF-kappaB	B-X
activation	B-X
in	B-X
a	B-X
dose-dependent	B-X
manner	B-X
.	B-X
The	B-X
LIM	B-X
domains	B-X
of	B-X
TRIP6	B-X
are	B-X
responsible	B-X
for	B-X
its	B-X
interaction	B-X
with	B-X
RIP2	B-X
.	B-X
TRIP6	B-X
also	B-X
interacts	B-X
with	B-X
TRAF2	B-X
,	B-X
a	B-X
protein	B-X
that	B-X
is	B-X
crucially	B-X
involved	B-X
in	B-X
TNF	B-X
signaling	B-X
,	B-X
as	B-X
well	B-X
as	B-X
the	B-X
IL-1	B-X
receptor	B-X
,	B-X
TLR2	B-X
and	B-X
Nod1	B-X
.	B-X
Overexpression	B-X
of	B-X
TRIP6	B-X
potentiates	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
,	B-X
whereas	B-X
a	B-X
dominant	B-X
negative	B-X
mutant	B-X
or	B-X
RNA-interference	B-X
construct	B-X
of	B-X
TRIP6	B-X
inhibits	B-X
NF-kappaB	B-X
activation	B-X
by	B-X
TNF	B-X
,	B-X
IL-1	B-X
,	B-X
TLR2	B-X
or	B-X
Nod1	B-X
.	B-X
Moreover	B-X
,	B-X
TRIP6	B-X
also	B-X
potentiates	B-X
RIP2-	B-X
and	B-X
Nod1-mediated	B-X
ERK	B-X
activation	B-X
.	B-X
These	B-X
data	B-X
have	B-X
established	B-X
a	B-X
physical	B-X
and	B-X
functional	B-X
association	B-X
between	B-X
TRIP6	B-X
and	B-X
RIP2	B-X
,	B-X
and	B-X
suggest	B-X
that	B-X
RIP2	B-X
's	B-X
involvement	B-X
in	B-X
multiple	B-X
NF-kappaB	B-X
and	B-X
ERK	B-X
activation	B-X
pathways	B-X
is	B-X
mediated	B-X
through	B-X
TRIP6	B-X
.	B-X

Induction	O
of	O
p21	B-Gene_or_gene_product
by	O
p53	B-Gene_or_gene_product
following	O
DNA	O
damage	O
inhibits	O
both	O
Cdk4	B-Gene_or_gene_product
and	O
Cdk2	B-Gene_or_gene_product
activities	O
.	O
<EOS>	B-X
DNA	B-X
damage	B-X
often	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
and	B-X
causes	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Although	B-X
there	B-X
is	B-X
ample	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
leads	B-X
to	B-X
Cdk2	B-X
inhibition	B-X
,	B-X
it	B-X
is	B-X
unclear	B-X
whether	B-X
this	B-X
checkpoint	B-X
event	B-X
also	B-X
leads	B-X
to	B-X
Cdk4	B-X
inhibition	B-X
.	B-X
Diaminocyclohexane	B-X
(	B-X
trans-diacetato	B-X
)	B-X
(	B-X
dichloro	B-X
)	B-X
platinum	B-X
(	B-X
IV	B-X
)	B-X
(	B-X
DAP	B-X
)	B-X
,	B-X
a	B-X
platinum-based	B-X
coordination	B-X
complex	B-X
,	B-X
is	B-X
a	B-X
DNA-damaging	B-X
agent	B-X
that	B-X
is	B-X
effective	B-X
against	B-X
a	B-X
variety	B-X
of	B-X
tumor	B-X
cells	B-X
resistant	B-X
to	B-X
the	B-X
parental	B-X
drug	B-X
cisplatin	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
established	B-X
that	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
with	B-X
low	B-X
effective	B-X
concentrations	B-X
of	B-X
DAP	B-X
specifically	B-X
activates	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
and	B-X
simultaneously	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
DAP	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
without	B-X
activating	B-X
other	B-X
known	B-X
mechanisms	B-X
that	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
The	B-X
induced	B-X
p21	B-X
binds	B-X
to	B-X
both	B-X
the	B-X
Cdk4/cyclin	B-X
D	B-X
and	B-X
Cdk2/cyclin	B-X
E	B-X
complexes	B-X
and	B-X
inhibits	B-X
both	B-X
of	B-X
their	B-X
kinase	B-X
activities	B-X
.	B-X
Conversely	B-X
,	B-X
inhibition	B-X
of	B-X
p21	B-X
induction	B-X
by	B-X
cycloheximide	B-X
or	B-X
by	B-X
p21	B-X
gene	B-X
deletion	B-X
prevents	B-X
DAP-induced	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Attenuated	B-X
p53	B-X
expression	B-X
and	B-X
p21	B-X
induction	B-X
also	B-X
eliminates	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
and	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
findings	B-X
establish	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
p53-p21	B-X
pathway	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
and	B-X
provide	B-X
the	B-X
first	B-X
solid	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
during	B-X
a	B-X
DNA	B-X
damage-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
inhibits	B-X
both	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X

DNA	O
damage	O
often	O
activates	O
the	O
p53	B-Gene_or_gene_product
-	O
p21	B-Gene_or_gene_product
pathway	O
and	O
causes	O
G	O
(	O
1	O
)	O
-	O
phase	O
arrest	O
in	O
mammalian	O
cells	O
.	O
<EOS>	B-X
Multiple	B-X
pathways	B-X
are	B-X
involved	B-X
in	B-X
maintaining	B-X
the	B-X
genetic	B-X
integrity	B-X
of	B-X
a	B-X
cell	B-X
after	B-X
its	B-X
exposure	B-X
to	B-X
ionizing	B-X
radiation	B-X
.	B-X
Although	B-X
repair	B-X
mechanisms	B-X
such	B-X
as	B-X
homologous	B-X
recombination	B-X
and	B-X
nonhomologous	B-X
end-joining	B-X
are	B-X
important	B-X
mammalian	B-X
responses	B-X
to	B-X
double-strand	B-X
DNA	B-X
damage	B-X
,	B-X
cell	B-X
cycle	B-X
regulation	B-X
is	B-X
perhaps	B-X
the	B-X
most	B-X
important	B-X
determinant	B-X
of	B-X
ionizing	B-X
radiation	B-X
sensitivity	B-X
.	B-X
A	B-X
common	B-X
cellular	B-X
response	B-X
to	B-X
DNA-damaging	B-X
agents	B-X
is	B-X
the	B-X
activation	B-X
of	B-X
cell	B-X
cycle	B-X
checkpoints	B-X
.	B-X
The	B-X
DNA	B-X
damage	B-X
induced	B-X
by	B-X
ionizing	B-X
radiation	B-X
initiates	B-X
signals	B-X
that	B-X
can	B-X
ultimately	B-X
activate	B-X
either	B-X
temporary	B-X
checkpoints	B-X
that	B-X
permit	B-X
time	B-X
for	B-X
genetic	B-X
repair	B-X
or	B-X
irreversible	B-X
growth	B-X
arrest	B-X
that	B-X
results	B-X
in	B-X
cell	B-X
death	B-X
(	B-X
necrosis	B-X
or	B-X
apoptosis	B-X
)	B-X
.	B-X
Such	B-X
checkpoint	B-X
activation	B-X
constitutes	B-X
an	B-X
integrated	B-X
response	B-X
that	B-X
involves	B-X
sensor	B-X
(	B-X
RAD	B-X
,	B-X
BRCA	B-X
,	B-X
NBS1	B-X
)	B-X
,	B-X
transducer	B-X
(	B-X
ATM	B-X
,	B-X
CHK	B-X
)	B-X
,	B-X
and	B-X
effector	B-X
(	B-X
p53	B-X
,	B-X
p21	B-X
,	B-X
CDK	B-X
)	B-X
genes	B-X
.	B-X
One	B-X
of	B-X
the	B-X
key	B-X
proteins	B-X
in	B-X
the	B-X
checkpoint	B-X
pathways	B-X
is	B-X
the	B-X
tumor	B-X
suppressor	B-X
gene	B-X
p53	B-X
,	B-X
which	B-X
coordinates	B-X
DNA	B-X
repair	B-X
with	B-X
cell	B-X
cycle	B-X
progression	B-X
and	B-X
apoptosis	B-X
.	B-X
Specifically	B-X
,	B-X
in	B-X
addition	B-X
to	B-X
other	B-X
mediators	B-X
of	B-X
the	B-X
checkpoint	B-X
response	B-X
(	B-X
CHK	B-X
kinases	B-X
,	B-X
p21	B-X
)	B-X
,	B-X
p53	B-X
mediates	B-X
the	B-X
two	B-X
major	B-X
DNA	B-X
damage-dependent	B-X
cellular	B-X
checkpoints	B-X
,	B-X
one	B-X
at	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-S	B-X
transition	B-X
and	B-X
the	B-X
other	B-X
at	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
-M	B-X
transition	B-X
,	B-X
although	B-X
the	B-X
influence	B-X
on	B-X
the	B-X
former	B-X
process	B-X
is	B-X
more	B-X
direct	B-X
and	B-X
significant	B-X
.	B-X
The	B-X
cell	B-X
cycle	B-X
phase	B-X
also	B-X
determines	B-X
a	B-X
cell	B-X
's	B-X
relative	B-X
radiosensitivity	B-X
,	B-X
with	B-X
cells	B-X
being	B-X
most	B-X
radiosensitive	B-X
in	B-X
the	B-X
G	B-X
(	B-X
2	B-X
)	B-X
-M	B-X
phase	B-X
,	B-X
less	B-X
sensitive	B-X
in	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
,	B-X
and	B-X
least	B-X
sensitive	B-X
during	B-X
the	B-X
latter	B-X
part	B-X
of	B-X
the	B-X
S	B-X
phase	B-X
.	B-X
This	B-X
understanding	B-X
has	B-X
,	B-X
therefore	B-X
,	B-X
led	B-X
to	B-X
the	B-X
realization	B-X
that	B-X
one	B-X
way	B-X
in	B-X
which	B-X
chemotherapy	B-X
and	B-X
fractionated	B-X
radiotherapy	B-X
may	B-X
work	B-X
better	B-X
is	B-X
by	B-X
partial	B-X
synchronization	B-X
of	B-X
cells	B-X
in	B-X
the	B-X
most	B-X
radiosensitive	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
We	B-X
describe	B-X
how	B-X
cell	B-X
cycle	B-X
and	B-X
DNA	B-X
damage	B-X
checkpoint	B-X
control	B-X
relates	B-X
to	B-X
exposure	B-X
to	B-X
ionizing	B-X
radiation	B-X
.	B-X

Although	O
there	O
is	O
ample	O
evidence	O
that	O
p21	B-Gene_or_gene_product
induction	O
by	O
p53	B-Gene_or_gene_product
leads	O
to	O
Cdk2	B-Gene_or_gene_product
inhibition	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
checkpoint	O
event	O
also	O
leads	O
to	O
Cdk4	B-Gene_or_gene_product
inhibition	O
.	O
<EOS>	B-X
DNA	B-X
damage	B-X
often	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
and	B-X
causes	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Although	B-X
there	B-X
is	B-X
ample	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
leads	B-X
to	B-X
Cdk2	B-X
inhibition	B-X
,	B-X
it	B-X
is	B-X
unclear	B-X
whether	B-X
this	B-X
checkpoint	B-X
event	B-X
also	B-X
leads	B-X
to	B-X
Cdk4	B-X
inhibition	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
established	B-X
that	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
with	B-X
low	B-X
effective	B-X
concentrations	B-X
of	B-X
DAP	B-X
specifically	B-X
activates	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
and	B-X
simultaneously	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
DAP	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
without	B-X
activating	B-X
other	B-X
known	B-X
mechanisms	B-X
that	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
The	B-X
induced	B-X
p21	B-X
binds	B-X
to	B-X
both	B-X
the	B-X
Cdk4/cyclin	B-X
D	B-X
and	B-X
Cdk2/cyclin	B-X
E	B-X
complexes	B-X
and	B-X
inhibits	B-X
both	B-X
of	B-X
their	B-X
kinase	B-X
activities	B-X
.	B-X
Conversely	B-X
,	B-X
inhibition	B-X
of	B-X
p21	B-X
induction	B-X
by	B-X
cycloheximide	B-X
or	B-X
by	B-X
p21	B-X
gene	B-X
deletion	B-X
prevents	B-X
DAP-induced	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Attenuated	B-X
p53	B-X
expression	B-X
and	B-X
p21	B-X
induction	B-X
also	B-X
eliminates	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
and	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
findings	B-X
establish	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
p53-p21	B-X
pathway	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
and	B-X
provide	B-X
the	B-X
first	B-X
solid	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
during	B-X
a	B-X
DNA	B-X
damage-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
inhibits	B-X
both	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X

Diaminocyclohexane	O
(	O
trans	O
-	O
diacetato	O
)	O
(	O
dichloro	O
)	O
platinum	O
(	O
IV	O
)	O
(	O
DAP	O
)	O
,	O
a	O
platinum	O
-	O
based	O
coordination	O
complex	O
,	O
is	O
a	O
DNA	O
-	O
damaging	O
agent	O
that	O
is	O
effective	O
against	O
a	O
variety	O
of	O
tumor	O
cells	O
resistant	O
to	O
the	O
parental	O
drug	O
cisplatin	O
.	O

Our	O
previous	O
studies	O
established	O
that	O
treatment	O
of	O
human	O
cancer	O
cells	O
with	O
low	O
effective	O
concentrations	O
of	O
DAP	O
specifically	O
activates	O
the	O
G	O
(	O
1	O
)	O
-	O
phase	O
checkpoint	O
and	O
simultaneously	O
inhibit	O
Cdk4	B-Gene_or_gene_product
and	O
Cdk2	B-Gene_or_gene_product
activities	O
.	O

Here	O
we	O
demonstrate	O
that	O
DAP	O
treatment	O
of	O
human	O
cancer	O
cells	O
activates	O
the	O
p53	B-Gene_or_gene_product
-	O
p21	B-Gene_or_gene_product
pathway	O
without	O
activating	O
other	O
known	O
mechanisms	O
that	O
inhibit	O
Cdk4	B-Gene_or_gene_product
and	O
Cdk2	B-Gene_or_gene_product
activities	O
.	O
<EOS>	B-X
DNA	B-X
damage	B-X
often	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
and	B-X
causes	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Although	B-X
there	B-X
is	B-X
ample	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
leads	B-X
to	B-X
Cdk2	B-X
inhibition	B-X
,	B-X
it	B-X
is	B-X
unclear	B-X
whether	B-X
this	B-X
checkpoint	B-X
event	B-X
also	B-X
leads	B-X
to	B-X
Cdk4	B-X
inhibition	B-X
.	B-X
Diaminocyclohexane	B-X
(	B-X
trans-diacetato	B-X
)	B-X
(	B-X
dichloro	B-X
)	B-X
platinum	B-X
(	B-X
IV	B-X
)	B-X
(	B-X
DAP	B-X
)	B-X
,	B-X
a	B-X
platinum-based	B-X
coordination	B-X
complex	B-X
,	B-X
is	B-X
a	B-X
DNA-damaging	B-X
agent	B-X
that	B-X
is	B-X
effective	B-X
against	B-X
a	B-X
variety	B-X
of	B-X
tumor	B-X
cells	B-X
resistant	B-X
to	B-X
the	B-X
parental	B-X
drug	B-X
cisplatin	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
established	B-X
that	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
with	B-X
low	B-X
effective	B-X
concentrations	B-X
of	B-X
DAP	B-X
specifically	B-X
activates	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
and	B-X
simultaneously	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
DAP	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
without	B-X
activating	B-X
other	B-X
known	B-X
mechanisms	B-X
that	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
The	B-X
induced	B-X
p21	B-X
binds	B-X
to	B-X
both	B-X
the	B-X
Cdk4/cyclin	B-X
D	B-X
and	B-X
Cdk2/cyclin	B-X
E	B-X
complexes	B-X
and	B-X
inhibits	B-X
both	B-X
of	B-X
their	B-X
kinase	B-X
activities	B-X
.	B-X
Conversely	B-X
,	B-X
inhibition	B-X
of	B-X
p21	B-X
induction	B-X
by	B-X
cycloheximide	B-X
or	B-X
by	B-X
p21	B-X
gene	B-X
deletion	B-X
prevents	B-X
DAP-induced	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Attenuated	B-X
p53	B-X
expression	B-X
and	B-X
p21	B-X
induction	B-X
also	B-X
eliminates	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
and	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
findings	B-X
establish	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
p53-p21	B-X
pathway	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
and	B-X
provide	B-X
the	B-X
first	B-X
solid	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
during	B-X
a	B-X
DNA	B-X
damage-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
inhibits	B-X
both	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X

The	O
induced	O
p21	B-Gene_or_gene_product
binds	O
to	O
both	O
the	O
Cdk4	O
/	O
cyclin	O
D	O
and	O
Cdk2	O
/	O
cyclin	O
E	O
complexes	O
and	O
inhibits	O
both	O
of	O
their	O
kinase	O
activities	O
.	O
<EOS>	B-X
DNA	B-X
damage	B-X
often	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
and	B-X
causes	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Although	B-X
there	B-X
is	B-X
ample	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
leads	B-X
to	B-X
Cdk2	B-X
inhibition	B-X
,	B-X
it	B-X
is	B-X
unclear	B-X
whether	B-X
this	B-X
checkpoint	B-X
event	B-X
also	B-X
leads	B-X
to	B-X
Cdk4	B-X
inhibition	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
established	B-X
that	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
with	B-X
low	B-X
effective	B-X
concentrations	B-X
of	B-X
DAP	B-X
specifically	B-X
activates	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
and	B-X
simultaneously	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
DAP	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
without	B-X
activating	B-X
other	B-X
known	B-X
mechanisms	B-X
that	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
The	B-X
induced	B-X
p21	B-X
binds	B-X
to	B-X
both	B-X
the	B-X
Cdk4/cyclin	B-X
D	B-X
and	B-X
Cdk2/cyclin	B-X
E	B-X
complexes	B-X
and	B-X
inhibits	B-X
both	B-X
of	B-X
their	B-X
kinase	B-X
activities	B-X
.	B-X
Conversely	B-X
,	B-X
inhibition	B-X
of	B-X
p21	B-X
induction	B-X
by	B-X
cycloheximide	B-X
or	B-X
by	B-X
p21	B-X
gene	B-X
deletion	B-X
prevents	B-X
DAP-induced	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Attenuated	B-X
p53	B-X
expression	B-X
and	B-X
p21	B-X
induction	B-X
also	B-X
eliminates	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
and	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
findings	B-X
establish	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
p53-p21	B-X
pathway	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
and	B-X
provide	B-X
the	B-X
first	B-X
solid	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
during	B-X
a	B-X
DNA	B-X
damage-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
inhibits	B-X
both	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X

Conversely	O
,	O
inhibition	O
of	O
p21	B-Gene_or_gene_product
induction	O
by	O
cycloheximide	O
or	O
by	O
p21	B-Gene_or_gene_product
gene	O
deletion	O
prevents	O
DAP	O
-	O
induced	O
inhibition	O
of	O
Cdk4	B-Gene_or_gene_product
and	O
Cdk2	B-Gene_or_gene_product
activities	O
.	O
<EOS>	B-X
DNA	B-X
damage	B-X
often	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
and	B-X
causes	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Although	B-X
there	B-X
is	B-X
ample	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
leads	B-X
to	B-X
Cdk2	B-X
inhibition	B-X
,	B-X
it	B-X
is	B-X
unclear	B-X
whether	B-X
this	B-X
checkpoint	B-X
event	B-X
also	B-X
leads	B-X
to	B-X
Cdk4	B-X
inhibition	B-X
.	B-X
Diaminocyclohexane	B-X
(	B-X
trans-diacetato	B-X
)	B-X
(	B-X
dichloro	B-X
)	B-X
platinum	B-X
(	B-X
IV	B-X
)	B-X
(	B-X
DAP	B-X
)	B-X
,	B-X
a	B-X
platinum-based	B-X
coordination	B-X
complex	B-X
,	B-X
is	B-X
a	B-X
DNA-damaging	B-X
agent	B-X
that	B-X
is	B-X
effective	B-X
against	B-X
a	B-X
variety	B-X
of	B-X
tumor	B-X
cells	B-X
resistant	B-X
to	B-X
the	B-X
parental	B-X
drug	B-X
cisplatin	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
established	B-X
that	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
with	B-X
low	B-X
effective	B-X
concentrations	B-X
of	B-X
DAP	B-X
specifically	B-X
activates	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
and	B-X
simultaneously	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
DAP	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
without	B-X
activating	B-X
other	B-X
known	B-X
mechanisms	B-X
that	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
The	B-X
induced	B-X
p21	B-X
binds	B-X
to	B-X
both	B-X
the	B-X
Cdk4/cyclin	B-X
D	B-X
and	B-X
Cdk2/cyclin	B-X
E	B-X
complexes	B-X
and	B-X
inhibits	B-X
both	B-X
of	B-X
their	B-X
kinase	B-X
activities	B-X
.	B-X
Conversely	B-X
,	B-X
inhibition	B-X
of	B-X
p21	B-X
induction	B-X
by	B-X
cycloheximide	B-X
or	B-X
by	B-X
p21	B-X
gene	B-X
deletion	B-X
prevents	B-X
DAP-induced	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Attenuated	B-X
p53	B-X
expression	B-X
and	B-X
p21	B-X
induction	B-X
also	B-X
eliminates	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
and	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
findings	B-X
establish	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
p53-p21	B-X
pathway	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
and	B-X
provide	B-X
the	B-X
first	B-X
solid	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
during	B-X
a	B-X
DNA	B-X
damage-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
inhibits	B-X
both	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X

Attenuated	O
p53	B-Gene_or_gene_product
expression	O
and	O
p21	B-Gene_or_gene_product
induction	O
also	O
eliminates	O
DAP	O
-	O
induced	O
G	O
(	O
1	O
)	O
-	O
phase	O
arrest	O
and	O
inhibition	O
of	O
Cdk4	B-Gene_or_gene_product
and	O
Cdk2	B-Gene_or_gene_product
activities	O
.	O
<EOS>	B-X
DNA	B-X
damage	B-X
often	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
and	B-X
causes	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X
Although	B-X
there	B-X
is	B-X
ample	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
leads	B-X
to	B-X
Cdk2	B-X
inhibition	B-X
,	B-X
it	B-X
is	B-X
unclear	B-X
whether	B-X
this	B-X
checkpoint	B-X
event	B-X
also	B-X
leads	B-X
to	B-X
Cdk4	B-X
inhibition	B-X
.	B-X
Diaminocyclohexane	B-X
(	B-X
trans-diacetato	B-X
)	B-X
(	B-X
dichloro	B-X
)	B-X
platinum	B-X
(	B-X
IV	B-X
)	B-X
(	B-X
DAP	B-X
)	B-X
,	B-X
a	B-X
platinum-based	B-X
coordination	B-X
complex	B-X
,	B-X
is	B-X
a	B-X
DNA-damaging	B-X
agent	B-X
that	B-X
is	B-X
effective	B-X
against	B-X
a	B-X
variety	B-X
of	B-X
tumor	B-X
cells	B-X
resistant	B-X
to	B-X
the	B-X
parental	B-X
drug	B-X
cisplatin	B-X
.	B-X
Our	B-X
previous	B-X
studies	B-X
established	B-X
that	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
with	B-X
low	B-X
effective	B-X
concentrations	B-X
of	B-X
DAP	B-X
specifically	B-X
activates	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
and	B-X
simultaneously	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
DAP	B-X
treatment	B-X
of	B-X
human	B-X
cancer	B-X
cells	B-X
activates	B-X
the	B-X
p53-p21	B-X
pathway	B-X
without	B-X
activating	B-X
other	B-X
known	B-X
mechanisms	B-X
that	B-X
inhibit	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
The	B-X
induced	B-X
p21	B-X
binds	B-X
to	B-X
both	B-X
the	B-X
Cdk4/cyclin	B-X
D	B-X
and	B-X
Cdk2/cyclin	B-X
E	B-X
complexes	B-X
and	B-X
inhibits	B-X
both	B-X
of	B-X
their	B-X
kinase	B-X
activities	B-X
.	B-X
Conversely	B-X
,	B-X
inhibition	B-X
of	B-X
p21	B-X
induction	B-X
by	B-X
cycloheximide	B-X
or	B-X
by	B-X
p21	B-X
gene	B-X
deletion	B-X
prevents	B-X
DAP-induced	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Attenuated	B-X
p53	B-X
expression	B-X
and	B-X
p21	B-X
induction	B-X
also	B-X
eliminates	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
arrest	B-X
and	B-X
inhibition	B-X
of	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
findings	B-X
establish	B-X
that	B-X
activation	B-X
of	B-X
the	B-X
p53-p21	B-X
pathway	B-X
is	B-X
responsible	B-X
for	B-X
the	B-X
DAP-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
and	B-X
provide	B-X
the	B-X
first	B-X
solid	B-X
evidence	B-X
that	B-X
p21	B-X
induction	B-X
by	B-X
p53	B-X
during	B-X
a	B-X
DNA	B-X
damage-induced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
-phase	B-X
checkpoint	B-X
response	B-X
inhibits	B-X
both	B-X
Cdk4	B-X
and	B-X
Cdk2	B-X
activities	B-X
.	B-X

Together	O
,	O
these	O
findings	O
establish	O
that	O
activation	O
of	O
the	O
p53	B-Gene_or_gene_product
-	O
p21	B-Gene_or_gene_product
pathway	O
is	O
responsible	O
for	O
the	O
DAP	O
-	O
induced	O
G	O
(	O
1	O
)	O
-	O
phase	O
checkpoint	O
response	O
and	O
provide	O
the	O
first	O
solid	O
evidence	O
that	O
p21	B-Gene_or_gene_product
induction	O
by	O
p53	B-Gene_or_gene_product
during	O
a	O
DNA	O
damage	O
-	O
induced	O
G	O
(	O
1	O
)	O
-	O
phase	O
checkpoint	O
response	O
inhibits	O
both	O
Cdk4	B-Gene_or_gene_product
and	O
Cdk2	B-Gene_or_gene_product
activities	O
.	O

The	O
sphingoid	O
long	O
chain	O
base	O
phytosphingosine	O
activates	O
AGC	O
-	O
type	O
protein	O
kinases	O
in	O
Saccharomyces	O
cerevisiae	O
including	O
Ypk1	B-Gene_or_gene_product
,	O
Ypk2	B-Gene_or_gene_product
,	O
and	O
Sch9	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Pkh1	B-X
protein	B-X
kinase	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
mammalian	B-X
3-phosphoinositide-dependent	B-X
kinase	B-X
(	B-X
PDK1	B-X
)	B-X
,	B-X
regulates	B-X
downstream	B-X
AGC-type	B-X
protein	B-X
kinases	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Pkc1	B-X
,	B-X
which	B-X
control	B-X
cell	B-X
wall	B-X
integrity	B-X
,	B-X
growth	B-X
,	B-X
and	B-X
other	B-X
processes	B-X
.	B-X
Phytosphingosine	B-X
(	B-X
PHS	B-X
)	B-X
,	B-X
a	B-X
sphingoid	B-X
long	B-X
chain	B-X
base	B-X
,	B-X
is	B-X
hypothesized	B-X
to	B-X
be	B-X
a	B-X
lipid	B-X
activator	B-X
of	B-X
Pkh1	B-X
and	B-X
thereby	B-X
controls	B-X
the	B-X
activity	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
biochemical	B-X
evidence	B-X
supporting	B-X
this	B-X
hypothesis	B-X
,	B-X
and	B-X
in	B-X
addition	B-X
we	B-X
demonstrate	B-X
that	B-X
PHS	B-X
also	B-X
stimulates	B-X
autophosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Greatest	B-X
stimulation	B-X
of	B-X
Ypk1/2	B-X
phosphorylation	B-X
and	B-X
activity	B-X
are	B-X
achieved	B-X
by	B-X
inclusion	B-X
of	B-X
both	B-X
PHS	B-X
and	B-X
Pkh1	B-X
in	B-X
an	B-X
in	B-X
vitro	B-X
kinase	B-X
reaction	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
for	B-X
the	B-X
first	B-X
time	B-X
that	B-X
Pkh1	B-X
phosphorylates	B-X
the	B-X
Sch9	B-X
protein	B-X
kinase	B-X
in	B-X
vitro	B-X
and	B-X
that	B-X
such	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
PHS	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
biochemical	B-X
demonstration	B-X
of	B-X
Sch9	B-X
activators	B-X
,	B-X
and	B-X
the	B-X
results	B-X
further	B-X
support	B-X
roles	B-X
for	B-X
long	B-X
chain	B-X
bases	B-X
in	B-X
heat	B-X
stress	B-X
resistance	B-X
in	B-X
addition	B-X
to	B-X
implying	B-X
roles	B-X
in	B-X
chronological	B-X
aging	B-X
and	B-X
cell	B-X
size	B-X
determination	B-X
,	B-X
since	B-X
Sch9	B-X
functions	B-X
in	B-X
these	B-X
processes	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
data	B-X
support	B-X
a	B-X
model	B-X
in	B-X
which	B-X
PHS	B-X
,	B-X
rather	B-X
than	B-X
simply	B-X
being	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
Pkh1	B-X
,	B-X
also	B-X
activates	B-X
kinases	B-X
that	B-X
are	B-X
downstream	B-X
targets	B-X
of	B-X
Pkh1	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Sch9	B-X
.	B-X

The	O
Pkh1	B-Gene_or_gene_product
protein	O
kinase	O
of	O
Saccharomyces	O
cerevisiae	O
,	O
a	O
homolog	O
of	O
the	O
mammalian	O
3	B-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphoinositide	I-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
PDK1	B-Gene_or_gene_product
)	O
,	O
regulates	O
downstream	O
AGC	O
-	O
type	O
protein	O
kinases	O
including	O
Ypk1	B-Gene_or_gene_product
/	O
2	B-Gene_or_gene_product
and	O
Pkc1	B-Gene_or_gene_product
,	O
which	O
control	O
cell	O
wall	O
integrity	O
,	O
growth	O
,	O
and	O
other	O
processes	O
.	O
<EOS>	B-X
The	B-X
Pkh1	B-X
protein	B-X
kinase	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
mammalian	B-X
3-phosphoinositide-dependent	B-X
kinase	B-X
(	B-X
PDK1	B-X
)	B-X
,	B-X
regulates	B-X
downstream	B-X
AGC-type	B-X
protein	B-X
kinases	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Pkc1	B-X
,	B-X
which	B-X
control	B-X
cell	B-X
wall	B-X
integrity	B-X
,	B-X
growth	B-X
,	B-X
and	B-X
other	B-X
processes	B-X
.	B-X
Phytosphingosine	B-X
(	B-X
PHS	B-X
)	B-X
,	B-X
a	B-X
sphingoid	B-X
long	B-X
chain	B-X
base	B-X
,	B-X
is	B-X
hypothesized	B-X
to	B-X
be	B-X
a	B-X
lipid	B-X
activator	B-X
of	B-X
Pkh1	B-X
and	B-X
thereby	B-X
controls	B-X
the	B-X
activity	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
biochemical	B-X
evidence	B-X
supporting	B-X
this	B-X
hypothesis	B-X
,	B-X
and	B-X
in	B-X
addition	B-X
we	B-X
demonstrate	B-X
that	B-X
PHS	B-X
also	B-X
stimulates	B-X
autophosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Greatest	B-X
stimulation	B-X
of	B-X
Ypk1/2	B-X
phosphorylation	B-X
and	B-X
activity	B-X
are	B-X
achieved	B-X
by	B-X
inclusion	B-X
of	B-X
both	B-X
PHS	B-X
and	B-X
Pkh1	B-X
in	B-X
an	B-X
in	B-X
vitro	B-X
kinase	B-X
reaction	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
for	B-X
the	B-X
first	B-X
time	B-X
that	B-X
Pkh1	B-X
phosphorylates	B-X
the	B-X
Sch9	B-X
protein	B-X
kinase	B-X
in	B-X
vitro	B-X
and	B-X
that	B-X
such	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
PHS	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
biochemical	B-X
demonstration	B-X
of	B-X
Sch9	B-X
activators	B-X
,	B-X
and	B-X
the	B-X
results	B-X
further	B-X
support	B-X
roles	B-X
for	B-X
long	B-X
chain	B-X
bases	B-X
in	B-X
heat	B-X
stress	B-X
resistance	B-X
in	B-X
addition	B-X
to	B-X
implying	B-X
roles	B-X
in	B-X
chronological	B-X
aging	B-X
and	B-X
cell	B-X
size	B-X
determination	B-X
,	B-X
since	B-X
Sch9	B-X
functions	B-X
in	B-X
these	B-X
processes	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
data	B-X
support	B-X
a	B-X
model	B-X
in	B-X
which	B-X
PHS	B-X
,	B-X
rather	B-X
than	B-X
simply	B-X
being	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
Pkh1	B-X
,	B-X
also	B-X
activates	B-X
kinases	B-X
that	B-X
are	B-X
downstream	B-X
targets	B-X
of	B-X
Pkh1	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Sch9	B-X
.	B-X

Phytosphingosine	O
(	O
PHS	O
)	O
,	O
a	O
sphingoid	O
long	O
chain	O
base	O
,	O
is	O
hypothesized	O
to	O
be	O
a	O
lipid	O
activator	O
of	O
Pkh1	B-Gene_or_gene_product
and	O
thereby	O
controls	O
the	O
activity	O
of	O
Ypk1	B-Gene_or_gene_product
/	O
2	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Pkh1	B-X
protein	B-X
kinase	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
mammalian	B-X
3-phosphoinositide-dependent	B-X
kinase	B-X
(	B-X
PDK1	B-X
)	B-X
,	B-X
regulates	B-X
downstream	B-X
AGC-type	B-X
protein	B-X
kinases	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Pkc1	B-X
,	B-X
which	B-X
control	B-X
cell	B-X
wall	B-X
integrity	B-X
,	B-X
growth	B-X
,	B-X
and	B-X
other	B-X
processes	B-X
.	B-X
Phytosphingosine	B-X
(	B-X
PHS	B-X
)	B-X
,	B-X
a	B-X
sphingoid	B-X
long	B-X
chain	B-X
base	B-X
,	B-X
is	B-X
hypothesized	B-X
to	B-X
be	B-X
a	B-X
lipid	B-X
activator	B-X
of	B-X
Pkh1	B-X
and	B-X
thereby	B-X
controls	B-X
the	B-X
activity	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
biochemical	B-X
evidence	B-X
supporting	B-X
this	B-X
hypothesis	B-X
,	B-X
and	B-X
in	B-X
addition	B-X
we	B-X
demonstrate	B-X
that	B-X
PHS	B-X
also	B-X
stimulates	B-X
autophosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Greatest	B-X
stimulation	B-X
of	B-X
Ypk1/2	B-X
phosphorylation	B-X
and	B-X
activity	B-X
are	B-X
achieved	B-X
by	B-X
inclusion	B-X
of	B-X
both	B-X
PHS	B-X
and	B-X
Pkh1	B-X
in	B-X
an	B-X
in	B-X
vitro	B-X
kinase	B-X
reaction	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
for	B-X
the	B-X
first	B-X
time	B-X
that	B-X
Pkh1	B-X
phosphorylates	B-X
the	B-X
Sch9	B-X
protein	B-X
kinase	B-X
in	B-X
vitro	B-X
and	B-X
that	B-X
such	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
PHS	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
biochemical	B-X
demonstration	B-X
of	B-X
Sch9	B-X
activators	B-X
,	B-X
and	B-X
the	B-X
results	B-X
further	B-X
support	B-X
roles	B-X
for	B-X
long	B-X
chain	B-X
bases	B-X
in	B-X
heat	B-X
stress	B-X
resistance	B-X
in	B-X
addition	B-X
to	B-X
implying	B-X
roles	B-X
in	B-X
chronological	B-X
aging	B-X
and	B-X
cell	B-X
size	B-X
determination	B-X
,	B-X
since	B-X
Sch9	B-X
functions	B-X
in	B-X
these	B-X
processes	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
data	B-X
support	B-X
a	B-X
model	B-X
in	B-X
which	B-X
PHS	B-X
,	B-X
rather	B-X
than	B-X
simply	B-X
being	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
Pkh1	B-X
,	B-X
also	B-X
activates	B-X
kinases	B-X
that	B-X
are	B-X
downstream	B-X
targets	B-X
of	B-X
Pkh1	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Sch9	B-X
.	B-X

Here	O
we	O
present	O
biochemical	O
evidence	O
supporting	O
this	O
hypothesis	O
,	O
and	O
in	O
addition	O
we	O
demonstrate	O
that	O
PHS	O
also	O
stimulates	O
autophosphorylation	O
and	O
activation	O
of	O
Ypk1	B-Gene_or_gene_product
/	O
2	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
Pkh1	B-X
protein	B-X
kinase	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
mammalian	B-X
3-phosphoinositide-dependent	B-X
kinase	B-X
(	B-X
PDK1	B-X
)	B-X
,	B-X
regulates	B-X
downstream	B-X
AGC-type	B-X
protein	B-X
kinases	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Pkc1	B-X
,	B-X
which	B-X
control	B-X
cell	B-X
wall	B-X
integrity	B-X
,	B-X
growth	B-X
,	B-X
and	B-X
other	B-X
processes	B-X
.	B-X
Phytosphingosine	B-X
(	B-X
PHS	B-X
)	B-X
,	B-X
a	B-X
sphingoid	B-X
long	B-X
chain	B-X
base	B-X
,	B-X
is	B-X
hypothesized	B-X
to	B-X
be	B-X
a	B-X
lipid	B-X
activator	B-X
of	B-X
Pkh1	B-X
and	B-X
thereby	B-X
controls	B-X
the	B-X
activity	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
biochemical	B-X
evidence	B-X
supporting	B-X
this	B-X
hypothesis	B-X
,	B-X
and	B-X
in	B-X
addition	B-X
we	B-X
demonstrate	B-X
that	B-X
PHS	B-X
also	B-X
stimulates	B-X
autophosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Greatest	B-X
stimulation	B-X
of	B-X
Ypk1/2	B-X
phosphorylation	B-X
and	B-X
activity	B-X
are	B-X
achieved	B-X
by	B-X
inclusion	B-X
of	B-X
both	B-X
PHS	B-X
and	B-X
Pkh1	B-X
in	B-X
an	B-X
in	B-X
vitro	B-X
kinase	B-X
reaction	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
for	B-X
the	B-X
first	B-X
time	B-X
that	B-X
Pkh1	B-X
phosphorylates	B-X
the	B-X
Sch9	B-X
protein	B-X
kinase	B-X
in	B-X
vitro	B-X
and	B-X
that	B-X
such	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
PHS	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
biochemical	B-X
demonstration	B-X
of	B-X
Sch9	B-X
activators	B-X
,	B-X
and	B-X
the	B-X
results	B-X
further	B-X
support	B-X
roles	B-X
for	B-X
long	B-X
chain	B-X
bases	B-X
in	B-X
heat	B-X
stress	B-X
resistance	B-X
in	B-X
addition	B-X
to	B-X
implying	B-X
roles	B-X
in	B-X
chronological	B-X
aging	B-X
and	B-X
cell	B-X
size	B-X
determination	B-X
,	B-X
since	B-X
Sch9	B-X
functions	B-X
in	B-X
these	B-X
processes	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
data	B-X
support	B-X
a	B-X
model	B-X
in	B-X
which	B-X
PHS	B-X
,	B-X
rather	B-X
than	B-X
simply	B-X
being	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
Pkh1	B-X
,	B-X
also	B-X
activates	B-X
kinases	B-X
that	B-X
are	B-X
downstream	B-X
targets	B-X
of	B-X
Pkh1	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Sch9	B-X
.	B-X

Greatest	O
stimulation	O
of	O
Ypk1	B-Gene_or_gene_product
/	O
2	B-Gene_or_gene_product
phosphorylation	O
and	O
activity	O
are	O
achieved	O
by	O
inclusion	O
of	O
both	O
PHS	O
and	O
Pkh1	B-Gene_or_gene_product
in	O
an	O
in	O
vitro	O
kinase	O
reaction	O
.	O

We	O
also	O
demonstrate	O
for	O
the	O
first	O
time	O
that	O
Pkh1	B-Gene_or_gene_product
phosphorylates	O
the	O
Sch9	B-Gene_or_gene_product
protein	O
kinase	O
in	O
vitro	O
and	O
that	O
such	O
phosphorylation	O
is	O
stimulated	O
by	O
PHS	O
.	O
<EOS>	B-X
The	B-X
Pkh1	B-X
protein	B-X
kinase	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
mammalian	B-X
3-phosphoinositide-dependent	B-X
kinase	B-X
(	B-X
PDK1	B-X
)	B-X
,	B-X
regulates	B-X
downstream	B-X
AGC-type	B-X
protein	B-X
kinases	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Pkc1	B-X
,	B-X
which	B-X
control	B-X
cell	B-X
wall	B-X
integrity	B-X
,	B-X
growth	B-X
,	B-X
and	B-X
other	B-X
processes	B-X
.	B-X
Phytosphingosine	B-X
(	B-X
PHS	B-X
)	B-X
,	B-X
a	B-X
sphingoid	B-X
long	B-X
chain	B-X
base	B-X
,	B-X
is	B-X
hypothesized	B-X
to	B-X
be	B-X
a	B-X
lipid	B-X
activator	B-X
of	B-X
Pkh1	B-X
and	B-X
thereby	B-X
controls	B-X
the	B-X
activity	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
biochemical	B-X
evidence	B-X
supporting	B-X
this	B-X
hypothesis	B-X
,	B-X
and	B-X
in	B-X
addition	B-X
we	B-X
demonstrate	B-X
that	B-X
PHS	B-X
also	B-X
stimulates	B-X
autophosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Greatest	B-X
stimulation	B-X
of	B-X
Ypk1/2	B-X
phosphorylation	B-X
and	B-X
activity	B-X
are	B-X
achieved	B-X
by	B-X
inclusion	B-X
of	B-X
both	B-X
PHS	B-X
and	B-X
Pkh1	B-X
in	B-X
an	B-X
in	B-X
vitro	B-X
kinase	B-X
reaction	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
for	B-X
the	B-X
first	B-X
time	B-X
that	B-X
Pkh1	B-X
phosphorylates	B-X
the	B-X
Sch9	B-X
protein	B-X
kinase	B-X
in	B-X
vitro	B-X
and	B-X
that	B-X
such	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
PHS	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
biochemical	B-X
demonstration	B-X
of	B-X
Sch9	B-X
activators	B-X
,	B-X
and	B-X
the	B-X
results	B-X
further	B-X
support	B-X
roles	B-X
for	B-X
long	B-X
chain	B-X
bases	B-X
in	B-X
heat	B-X
stress	B-X
resistance	B-X
in	B-X
addition	B-X
to	B-X
implying	B-X
roles	B-X
in	B-X
chronological	B-X
aging	B-X
and	B-X
cell	B-X
size	B-X
determination	B-X
,	B-X
since	B-X
Sch9	B-X
functions	B-X
in	B-X
these	B-X
processes	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
data	B-X
support	B-X
a	B-X
model	B-X
in	B-X
which	B-X
PHS	B-X
,	B-X
rather	B-X
than	B-X
simply	B-X
being	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
Pkh1	B-X
,	B-X
also	B-X
activates	B-X
kinases	B-X
that	B-X
are	B-X
downstream	B-X
targets	B-X
of	B-X
Pkh1	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Sch9	B-X
.	B-X

This	O
is	O
the	O
first	O
biochemical	O
demonstration	O
of	O
Sch9	B-Gene_or_gene_product
activators	O
,	O
and	O
the	O
results	O
further	O
support	O
roles	O
for	O
long	O
chain	O
bases	O
in	O
heat	O
stress	O
resistance	O
in	O
addition	O
to	O
implying	O
roles	O
in	O
chronological	O
aging	O
and	O
cell	O
size	O
determination	O
,	O
since	O
Sch9	B-Gene_or_gene_product
functions	O
in	O
these	O
processes	O
.	O
<EOS>	B-X
The	B-X
Pkh1	B-X
protein	B-X
kinase	B-X
of	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
a	B-X
homolog	B-X
of	B-X
the	B-X
mammalian	B-X
3-phosphoinositide-dependent	B-X
kinase	B-X
(	B-X
PDK1	B-X
)	B-X
,	B-X
regulates	B-X
downstream	B-X
AGC-type	B-X
protein	B-X
kinases	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Pkc1	B-X
,	B-X
which	B-X
control	B-X
cell	B-X
wall	B-X
integrity	B-X
,	B-X
growth	B-X
,	B-X
and	B-X
other	B-X
processes	B-X
.	B-X
Phytosphingosine	B-X
(	B-X
PHS	B-X
)	B-X
,	B-X
a	B-X
sphingoid	B-X
long	B-X
chain	B-X
base	B-X
,	B-X
is	B-X
hypothesized	B-X
to	B-X
be	B-X
a	B-X
lipid	B-X
activator	B-X
of	B-X
Pkh1	B-X
and	B-X
thereby	B-X
controls	B-X
the	B-X
activity	B-X
of	B-X
Ypk1/2	B-X
.	B-X
Here	B-X
we	B-X
present	B-X
biochemical	B-X
evidence	B-X
supporting	B-X
this	B-X
hypothesis	B-X
,	B-X
and	B-X
in	B-X
addition	B-X
we	B-X
demonstrate	B-X
that	B-X
PHS	B-X
also	B-X
stimulates	B-X
autophosphorylation	B-X
and	B-X
activation	B-X
of	B-X
Ypk1/2	B-X
.	B-X
We	B-X
also	B-X
demonstrate	B-X
for	B-X
the	B-X
first	B-X
time	B-X
that	B-X
Pkh1	B-X
phosphorylates	B-X
the	B-X
Sch9	B-X
protein	B-X
kinase	B-X
in	B-X
vitro	B-X
and	B-X
that	B-X
such	B-X
phosphorylation	B-X
is	B-X
stimulated	B-X
by	B-X
PHS	B-X
.	B-X
This	B-X
is	B-X
the	B-X
first	B-X
biochemical	B-X
demonstration	B-X
of	B-X
Sch9	B-X
activators	B-X
,	B-X
and	B-X
the	B-X
results	B-X
further	B-X
support	B-X
roles	B-X
for	B-X
long	B-X
chain	B-X
bases	B-X
in	B-X
heat	B-X
stress	B-X
resistance	B-X
in	B-X
addition	B-X
to	B-X
implying	B-X
roles	B-X
in	B-X
chronological	B-X
aging	B-X
and	B-X
cell	B-X
size	B-X
determination	B-X
,	B-X
since	B-X
Sch9	B-X
functions	B-X
in	B-X
these	B-X
processes	B-X
.	B-X
Thus	B-X
,	B-X
our	B-X
data	B-X
support	B-X
a	B-X
model	B-X
in	B-X
which	B-X
PHS	B-X
,	B-X
rather	B-X
than	B-X
simply	B-X
being	B-X
an	B-X
upstream	B-X
activator	B-X
of	B-X
Pkh1	B-X
,	B-X
also	B-X
activates	B-X
kinases	B-X
that	B-X
are	B-X
downstream	B-X
targets	B-X
of	B-X
Pkh1	B-X
including	B-X
Ypk1/2	B-X
and	B-X
Sch9	B-X
.	B-X

Thus	O
,	O
our	O
data	O
support	O
a	O
model	O
in	O
which	O
PHS	O
,	O
rather	O
than	O
simply	O
being	O
an	O
upstream	O
activator	O
of	O
Pkh1	B-Gene_or_gene_product
,	O
also	O
activates	O
kinases	O
that	O
are	O
downstream	O
targets	O
of	O
Pkh1	B-Gene_or_gene_product
including	O
Ypk1	B-Gene_or_gene_product
/	O
2	B-Gene_or_gene_product
and	O
Sch9	B-Gene_or_gene_product
.	O

A	O
role	O
for	O
E2F6	B-Gene_or_gene_product
in	O
the	O
restriction	O
of	O
male	O
-	O
germ	O
-	O
cell	O
-	O
specific	O
gene	O
expression	O
.	O
<EOS>	B-X
E2F	B-X
transcription	B-X
factors	B-X
play	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cellular	B-X
proliferation	B-X
and	B-X
can	B-X
be	B-X
subdivided	B-X
into	B-X
activating	B-X
and	B-X
repressing	B-X
family	B-X
members	B-X
[	B-X
1	B-X
]	B-X
.	B-X
Like	B-X
other	B-X
E2Fs	B-X
,	B-X
E2F6	B-X
binds	B-X
to	B-X
E2F	B-X
consensus	B-X
sites	B-X
,	B-X
but	B-X
in	B-X
contrast	B-X
to	B-X
E2F1-5	B-X
,	B-X
it	B-X
lacks	B-X
an	B-X
Rb	B-X
binding	B-X
domain	B-X
and	B-X
functions	B-X
as	B-X
an	B-X
Rb-independent	B-X
transcriptional	B-X
repressor	B-X
[	B-X
2	B-X
,	B-X
3	B-X
,	B-X
4	B-X
and	B-X
5	B-X
]	B-X
.	B-X
Instead	B-X
,	B-X
E2F6	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
complex	B-X
with	B-X
Polycomb	B-X
(	B-X
PcG	B-X
)	B-X
group	B-X
proteins	B-X
[	B-X
6	B-X
and	B-X
7	B-X
]	B-X
,	B-X
which	B-X
have	B-X
a	B-X
well-established	B-X
role	B-X
in	B-X
gene	B-X
silencing	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2F6	B-X
plays	B-X
an	B-X
unexpected	B-X
and	B-X
essential	B-X
role	B-X
in	B-X
the	B-X
tissue	B-X
specificity	B-X
of	B-X
gene	B-X
expression	B-X
.	B-X
E2F6-deficient	B-X
mice	B-X
ubiquitously	B-X
express	B-X
the	B-X
alpha-tubulin	B-X
3	B-X
and	B-X
7	B-X
genes	B-X
,	B-X
which	B-X
are	B-X
expressed	B-X
strictly	B-X
testis-specifically	B-X
in	B-X
control	B-X
mice	B-X
.	B-X
Like	B-X
an	B-X
additional	B-X
E2F6	B-X
target	B-X
gene	B-X
,	B-X
Tex12	B-X
,	B-X
that	B-X
we	B-X
identified	B-X
,	B-X
tubulin	B-X
3	B-X
and	B-X
7	B-X
are	B-X
normally	B-X
expressed	B-X
in	B-X
male	B-X
germ	B-X
cells	B-X
only	B-X
.	B-X
The	B-X
promoters	B-X
of	B-X
the	B-X
alpha-tubulin	B-X
and	B-X
Tex12	B-X
genes	B-X
share	B-X
a	B-X
perfectly	B-X
conserved	B-X
E2F	B-X
site	B-X
,	B-X
which	B-X
E2F6	B-X
binds	B-X
to	B-X
.	B-X
Mechanistically	B-X
,	B-X
E2F6-mediated	B-X
repression	B-X
involves	B-X
CpG	B-X
hypermethylation	B-X
locking	B-X
target	B-X
promoters	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
.	B-X
Thus	B-X
,	B-X
E2F6	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
long-term	B-X
somatic	B-X
silencing	B-X
of	B-X
certain	B-X
male-germ-cell-specific	B-X
genes	B-X
,	B-X
but	B-X
it	B-X
is	B-X
dispensable	B-X
for	B-X
cell-cycle	B-X
regulation	B-X
.	B-X

E2F	B-Gene_or_gene_product
transcription	O
factors	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
regulation	O
of	O
cellular	O
proliferation	O
and	O
can	O
be	O
subdivided	O
into	O
activating	O
and	O
repressing	O
family	O
members	O
[	O
1	O
]	O
.	O
<EOS>	B-X
E2F	B-X
transcription	B-X
factors	B-X
play	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cellular	B-X
proliferation	B-X
and	B-X
can	B-X
be	B-X
subdivided	B-X
into	B-X
activating	B-X
and	B-X
repressing	B-X
family	B-X
members	B-X
[	B-X
1	B-X
]	B-X
.	B-X
Like	B-X
other	B-X
E2Fs	B-X
,	B-X
E2F6	B-X
binds	B-X
to	B-X
E2F	B-X
consensus	B-X
sites	B-X
,	B-X
but	B-X
in	B-X
contrast	B-X
to	B-X
E2F1-5	B-X
,	B-X
it	B-X
lacks	B-X
an	B-X
Rb	B-X
binding	B-X
domain	B-X
and	B-X
functions	B-X
as	B-X
an	B-X
Rb-independent	B-X
transcriptional	B-X
repressor	B-X
[	B-X
2	B-X
,	B-X
3	B-X
,	B-X
4	B-X
and	B-X
5	B-X
]	B-X
.	B-X
Instead	B-X
,	B-X
E2F6	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
complex	B-X
with	B-X
Polycomb	B-X
(	B-X
PcG	B-X
)	B-X
group	B-X
proteins	B-X
[	B-X
6	B-X
and	B-X
7	B-X
]	B-X
,	B-X
which	B-X
have	B-X
a	B-X
well-established	B-X
role	B-X
in	B-X
gene	B-X
silencing	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2F6	B-X
plays	B-X
an	B-X
unexpected	B-X
and	B-X
essential	B-X
role	B-X
in	B-X
the	B-X
tissue	B-X
specificity	B-X
of	B-X
gene	B-X
expression	B-X
.	B-X
E2F6-deficient	B-X
mice	B-X
ubiquitously	B-X
express	B-X
the	B-X
alpha-tubulin	B-X
3	B-X
and	B-X
7	B-X
genes	B-X
,	B-X
which	B-X
are	B-X
expressed	B-X
strictly	B-X
testis-specifically	B-X
in	B-X
control	B-X
mice	B-X
.	B-X
Like	B-X
an	B-X
additional	B-X
E2F6	B-X
target	B-X
gene	B-X
,	B-X
Tex12	B-X
,	B-X
that	B-X
we	B-X
identified	B-X
,	B-X
tubulin	B-X
3	B-X
and	B-X
7	B-X
are	B-X
normally	B-X
expressed	B-X
in	B-X
male	B-X
germ	B-X
cells	B-X
only	B-X
.	B-X
The	B-X
promoters	B-X
of	B-X
the	B-X
alpha-tubulin	B-X
and	B-X
Tex12	B-X
genes	B-X
share	B-X
a	B-X
perfectly	B-X
conserved	B-X
E2F	B-X
site	B-X
,	B-X
which	B-X
E2F6	B-X
binds	B-X
to	B-X
.	B-X
Mechanistically	B-X
,	B-X
E2F6-mediated	B-X
repression	B-X
involves	B-X
CpG	B-X
hypermethylation	B-X
locking	B-X
target	B-X
promoters	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
.	B-X
Thus	B-X
,	B-X
E2F6	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
long-term	B-X
somatic	B-X
silencing	B-X
of	B-X
certain	B-X
male-germ-cell-specific	B-X
genes	B-X
,	B-X
but	B-X
it	B-X
is	B-X
dispensable	B-X
for	B-X
cell-cycle	B-X
regulation	B-X
.	B-X

Like	O
other	O
E2Fs	B-Gene_or_gene_product
,	O
E2F6	B-Gene_or_gene_product
binds	O
to	O
E2F	B-Gene_or_gene_product
consensus	O
sites	O
,	O
but	O
in	O
contrast	O
to	O
E2F1	B-Gene_or_gene_product
-	O
5	B-Gene_or_gene_product
,	O
it	O
lacks	O
an	O
Rb	B-Gene_or_gene_product
binding	O
domain	O
and	O
functions	O
as	O
an	O
Rb	B-Gene_or_gene_product
-	O
independent	O
transcriptional	O
repressor	O
[	O
2	O
,	O
3	O
,	O
4	O
and	O
5	O
]	O
.	O

Instead	O
,	O
E2F6	B-Gene_or_gene_product
has	O
been	O
shown	O
to	O
complex	O
with	O
Polycomb	B-Gene_or_gene_product
(	O
PcG	B-Gene_or_gene_product
)	O
group	O
proteins	O
[	O
6	O
and	O
7	O
]	O
,	O
which	O
have	O
a	O
well	O
-	O
established	O
role	O
in	O
gene	O
silencing	O
.	O
<EOS>	B-X
E2F	B-X
transcription	B-X
factors	B-X
play	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cellular	B-X
proliferation	B-X
and	B-X
can	B-X
be	B-X
subdivided	B-X
into	B-X
activating	B-X
and	B-X
repressing	B-X
family	B-X
members	B-X
[	B-X
1	B-X
]	B-X
.	B-X
Like	B-X
other	B-X
E2Fs	B-X
,	B-X
E2F6	B-X
binds	B-X
to	B-X
E2F	B-X
consensus	B-X
sites	B-X
,	B-X
but	B-X
in	B-X
contrast	B-X
to	B-X
E2F1-5	B-X
,	B-X
it	B-X
lacks	B-X
an	B-X
Rb	B-X
binding	B-X
domain	B-X
and	B-X
functions	B-X
as	B-X
an	B-X
Rb-independent	B-X
transcriptional	B-X
repressor	B-X
[	B-X
2	B-X
,	B-X
3	B-X
,	B-X
4	B-X
and	B-X
5	B-X
]	B-X
.	B-X
Instead	B-X
,	B-X
E2F6	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
complex	B-X
with	B-X
Polycomb	B-X
(	B-X
PcG	B-X
)	B-X
group	B-X
proteins	B-X
[	B-X
6	B-X
and	B-X
7	B-X
]	B-X
,	B-X
which	B-X
have	B-X
a	B-X
well-established	B-X
role	B-X
in	B-X
gene	B-X
silencing	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2F6	B-X
plays	B-X
an	B-X
unexpected	B-X
and	B-X
essential	B-X
role	B-X
in	B-X
the	B-X
tissue	B-X
specificity	B-X
of	B-X
gene	B-X
expression	B-X
.	B-X
E2F6-deficient	B-X
mice	B-X
ubiquitously	B-X
express	B-X
the	B-X
alpha-tubulin	B-X
3	B-X
and	B-X
7	B-X
genes	B-X
,	B-X
which	B-X
are	B-X
expressed	B-X
strictly	B-X
testis-specifically	B-X
in	B-X
control	B-X
mice	B-X
.	B-X
Like	B-X
an	B-X
additional	B-X
E2F6	B-X
target	B-X
gene	B-X
,	B-X
Tex12	B-X
,	B-X
that	B-X
we	B-X
identified	B-X
,	B-X
tubulin	B-X
3	B-X
and	B-X
7	B-X
are	B-X
normally	B-X
expressed	B-X
in	B-X
male	B-X
germ	B-X
cells	B-X
only	B-X
.	B-X
The	B-X
promoters	B-X
of	B-X
the	B-X
alpha-tubulin	B-X
and	B-X
Tex12	B-X
genes	B-X
share	B-X
a	B-X
perfectly	B-X
conserved	B-X
E2F	B-X
site	B-X
,	B-X
which	B-X
E2F6	B-X
binds	B-X
to	B-X
.	B-X
Mechanistically	B-X
,	B-X
E2F6-mediated	B-X
repression	B-X
involves	B-X
CpG	B-X
hypermethylation	B-X
locking	B-X
target	B-X
promoters	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
.	B-X
Thus	B-X
,	B-X
E2F6	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
long-term	B-X
somatic	B-X
silencing	B-X
of	B-X
certain	B-X
male-germ-cell-specific	B-X
genes	B-X
,	B-X
but	B-X
it	B-X
is	B-X
dispensable	B-X
for	B-X
cell-cycle	B-X
regulation	B-X
.	B-X

Here	O
,	O
we	O
show	O
that	O
E2F6	B-Gene_or_gene_product
plays	O
an	O
unexpected	O
and	O
essential	O
role	O
in	O
the	O
tissue	O
specificity	O
of	O
gene	O
expression	O
.	O
<EOS>	B-X
E2F	B-X
transcription	B-X
factors	B-X
play	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
cellular	B-X
proliferation	B-X
and	B-X
can	B-X
be	B-X
subdivided	B-X
into	B-X
activating	B-X
and	B-X
repressing	B-X
family	B-X
members	B-X
[	B-X
1	B-X
]	B-X
.	B-X
Like	B-X
other	B-X
E2Fs	B-X
,	B-X
E2F6	B-X
binds	B-X
to	B-X
E2F	B-X
consensus	B-X
sites	B-X
,	B-X
but	B-X
in	B-X
contrast	B-X
to	B-X
E2F1-5	B-X
,	B-X
it	B-X
lacks	B-X
an	B-X
Rb	B-X
binding	B-X
domain	B-X
and	B-X
functions	B-X
as	B-X
an	B-X
Rb-independent	B-X
transcriptional	B-X
repressor	B-X
[	B-X
2	B-X
,	B-X
3	B-X
,	B-X
4	B-X
and	B-X
5	B-X
]	B-X
.	B-X
Instead	B-X
,	B-X
E2F6	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
complex	B-X
with	B-X
Polycomb	B-X
(	B-X
PcG	B-X
)	B-X
group	B-X
proteins	B-X
[	B-X
6	B-X
and	B-X
7	B-X
]	B-X
,	B-X
which	B-X
have	B-X
a	B-X
well-established	B-X
role	B-X
in	B-X
gene	B-X
silencing	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2F6	B-X
plays	B-X
an	B-X
unexpected	B-X
and	B-X
essential	B-X
role	B-X
in	B-X
the	B-X
tissue	B-X
specificity	B-X
of	B-X
gene	B-X
expression	B-X
.	B-X
E2F6-deficient	B-X
mice	B-X
ubiquitously	B-X
express	B-X
the	B-X
alpha-tubulin	B-X
3	B-X
and	B-X
7	B-X
genes	B-X
,	B-X
which	B-X
are	B-X
expressed	B-X
strictly	B-X
testis-specifically	B-X
in	B-X
control	B-X
mice	B-X
.	B-X
Like	B-X
an	B-X
additional	B-X
E2F6	B-X
target	B-X
gene	B-X
,	B-X
Tex12	B-X
,	B-X
that	B-X
we	B-X
identified	B-X
,	B-X
tubulin	B-X
3	B-X
and	B-X
7	B-X
are	B-X
normally	B-X
expressed	B-X
in	B-X
male	B-X
germ	B-X
cells	B-X
only	B-X
.	B-X
The	B-X
promoters	B-X
of	B-X
the	B-X
alpha-tubulin	B-X
and	B-X
Tex12	B-X
genes	B-X
share	B-X
a	B-X
perfectly	B-X
conserved	B-X
E2F	B-X
site	B-X
,	B-X
which	B-X
E2F6	B-X
binds	B-X
to	B-X
.	B-X
Mechanistically	B-X
,	B-X
E2F6-mediated	B-X
repression	B-X
involves	B-X
CpG	B-X
hypermethylation	B-X
locking	B-X
target	B-X
promoters	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
.	B-X
Thus	B-X
,	B-X
E2F6	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
long-term	B-X
somatic	B-X
silencing	B-X
of	B-X
certain	B-X
male-germ-cell-specific	B-X
genes	B-X
,	B-X
but	B-X
it	B-X
is	B-X
dispensable	B-X
for	B-X
cell-cycle	B-X
regulation	B-X
.	B-X

E2F6	B-Gene_or_gene_product
-	O
deficient	O
mice	O
ubiquitously	O
express	O
the	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
tubulin	I-Gene_or_gene_product
3	I-Gene_or_gene_product
and	O
7	B-Gene_or_gene_product
genes	O
,	O
which	O
are	O
expressed	O
strictly	O
testis	O
-	O
specifically	O
in	O
control	O
mice	O
.	O
<EOS>	B-X
Like	B-X
other	B-X
E2Fs	B-X
,	B-X
E2F6	B-X
binds	B-X
to	B-X
E2F	B-X
consensus	B-X
sites	B-X
,	B-X
but	B-X
in	B-X
contrast	B-X
to	B-X
E2F1-5	B-X
,	B-X
it	B-X
lacks	B-X
an	B-X
Rb	B-X
binding	B-X
domain	B-X
and	B-X
functions	B-X
as	B-X
an	B-X
Rb-independent	B-X
transcriptional	B-X
repressor	B-X
[	B-X
2	B-X
,	B-X
3	B-X
,	B-X
4	B-X
and	B-X
5	B-X
]	B-X
.	B-X
Instead	B-X
,	B-X
E2F6	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
complex	B-X
with	B-X
Polycomb	B-X
(	B-X
PcG	B-X
)	B-X
group	B-X
proteins	B-X
[	B-X
6	B-X
and	B-X
7	B-X
]	B-X
,	B-X
which	B-X
have	B-X
a	B-X
well-established	B-X
role	B-X
in	B-X
gene	B-X
silencing	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
E2F6	B-X
plays	B-X
an	B-X
unexpected	B-X
and	B-X
essential	B-X
role	B-X
in	B-X
the	B-X
tissue	B-X
specificity	B-X
of	B-X
gene	B-X
expression	B-X
.	B-X
E2F6-deficient	B-X
mice	B-X
ubiquitously	B-X
express	B-X
the	B-X
alpha-tubulin	B-X
3	B-X
and	B-X
7	B-X
genes	B-X
,	B-X
which	B-X
are	B-X
expressed	B-X
strictly	B-X
testis-specifically	B-X
in	B-X
control	B-X
mice	B-X
.	B-X
Like	B-X
an	B-X
additional	B-X
E2F6	B-X
target	B-X
gene	B-X
,	B-X
Tex12	B-X
,	B-X
that	B-X
we	B-X
identified	B-X
,	B-X
tubulin	B-X
3	B-X
and	B-X
7	B-X
are	B-X
normally	B-X
expressed	B-X
in	B-X
male	B-X
germ	B-X
cells	B-X
only	B-X
.	B-X
The	B-X
promoters	B-X
of	B-X
the	B-X
alpha-tubulin	B-X
and	B-X
Tex12	B-X
genes	B-X
share	B-X
a	B-X
perfectly	B-X
conserved	B-X
E2F	B-X
site	B-X
,	B-X
which	B-X
E2F6	B-X
binds	B-X
to	B-X
.	B-X
Mechanistically	B-X
,	B-X
E2F6-mediated	B-X
repression	B-X
involves	B-X
CpG	B-X
hypermethylation	B-X
locking	B-X
target	B-X
promoters	B-X
in	B-X
an	B-X
inactive	B-X
state	B-X
.	B-X
Thus	B-X
,	B-X
E2F6	B-X
is	B-X
essential	B-X
for	B-X
the	B-X
long-term	B-X
somatic	B-X
silencing	B-X
of	B-X
certain	B-X
male-germ-cell-specific	B-X
genes	B-X
,	B-X
but	B-X
it	B-X
is	B-X
dispensable	B-X
for	B-X
cell-cycle	B-X
regulation	B-X
.	B-X

Like	O
an	O
additional	O
E2F6	B-Gene_or_gene_product
target	O
gene	O
,	O
Tex12	B-Gene_or_gene_product
,	O
that	O
we	O
identified	O
,	O
tubulin	B-Gene_or_gene_product
3	I-Gene_or_gene_product
and	O
7	B-Gene_or_gene_product
are	O
normally	O
expressed	O
in	O
male	O
germ	O
cells	O
only	O
.	O

The	O
promoters	O
of	O
the	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
tubulin	I-Gene_or_gene_product
and	O
Tex12	B-Gene_or_gene_product
genes	O
share	O
a	O
perfectly	O
conserved	O
E2F	B-Gene_or_gene_product
site	O
,	O
which	O
E2F6	B-Gene_or_gene_product
binds	O
to	O
.	O

Mechanistically	O
,	O
E2F6	B-Gene_or_gene_product
-	O
mediated	O
repression	O
involves	O
CpG	B-Gene_or_gene_product
hypermethylation	O
locking	O
target	O
promoters	O
in	O
an	O
inactive	O
state	O
.	O

Thus	O
,	O
E2F6	B-Gene_or_gene_product
is	O
essential	O
for	O
the	O
long	O
-	O
term	O
somatic	O
silencing	O
of	O
certain	O
male	O
-	O
germ	O
-	O
cell	O
-	O
specific	O
genes	O
,	O
but	O
it	O
is	O
dispensable	O
for	O
cell	O
-	O
cycle	O
regulation	O
.	O

mTOR	B-Gene_or_gene_product
function	O
in	O
skeletal	O
muscle	O
hypertrophy	O
:	O
increased	O
ribosomal	O
RNA	O
via	O
cell	O
cycle	O
regulators	O
.	O
<EOS>	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
the	B-X
potential	B-X
downstream	B-X
functions	B-X
associated	B-X
with	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
during	B-X
myotube	B-X
hypertrophy	B-X
.	B-X
Terminally	B-X
differentiated	B-X
myotubes	B-X
were	B-X
serum	B-X
stimulated	B-X
for	B-X
3	B-X
,	B-X
6	B-X
,	B-X
12	B-X
,	B-X
24	B-X
,	B-X
and	B-X
48	B-X
h.	B-X
This	B-X
treatment	B-X
resulted	B-X
in	B-X
significant	B-X
myotube	B-X
hypertrophy	B-X
(	B-X
protein/DNA	B-X
)	B-X
and	B-X
increased	B-X
RNA	B-X
content	B-X
(	B-X
RNA/DNA	B-X
)	B-X
with	B-X
no	B-X
changes	B-X
in	B-X
DNA	B-X
content	B-X
or	B-X
indices	B-X
of	B-X
cell	B-X
proliferation	B-X
.	B-X
During	B-X
myotube	B-X
hypertrophy	B-X
,	B-X
the	B-X
increase	B-X
in	B-X
RNA	B-X
content	B-X
was	B-X
accompanied	B-X
by	B-X
an	B-X
increase	B-X
in	B-X
tumor	B-X
suppressor	B-X
protein	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
phosphorylation	B-X
and	B-X
a	B-X
corresponding	B-X
increase	B-X
in	B-X
the	B-X
availability	B-X
of	B-X
the	B-X
ribosomal	B-X
DNA	B-X
transcription	B-X
factor	B-X
upstream	B-X
binding	B-X
factor	B-X
(	B-X
UBF	B-X
)	B-X
.	B-X
The	B-X
increases	B-X
in	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
RNA	B-X
content	B-X
were	B-X
blocked	B-X
by	B-X
rapamycin	B-X
treatment	B-X
,	B-X
which	B-X
also	B-X
prevented	B-X
the	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
,	B-X
CDK-4	B-X
activity	B-X
,	B-X
Rb	B-X
phosphorylation	B-X
,	B-X
and	B-X
the	B-X
increase	B-X
in	B-X
UBF	B-X
availability	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
is	B-X
necessary	B-X
for	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
role	B-X
of	B-X
mTOR	B-X
is	B-X
in	B-X
part	B-X
to	B-X
modulate	B-X
cyclin	B-X
D1-dependent	B-X
CDK-4	B-X
activity	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
Rb	B-X
and	B-X
ribosomal	B-X
RNA	B-X
synthesis	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
common	B-X
molecular	B-X
mechanisms	B-X
contribute	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
growth	B-X
during	B-X
the	B-X
G1	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
potential	O
downstream	O
functions	O
associated	O
with	O
mammalian	B-Gene_or_gene_product
target	I-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
(	O
mTOR	B-Gene_or_gene_product
)	O
signaling	O
during	O
myotube	O
hypertrophy	O
.	O
<EOS>	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
the	B-X
potential	B-X
downstream	B-X
functions	B-X
associated	B-X
with	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
during	B-X
myotube	B-X
hypertrophy	B-X
.	B-X
Terminally	B-X
differentiated	B-X
myotubes	B-X
were	B-X
serum	B-X
stimulated	B-X
for	B-X
3	B-X
,	B-X
6	B-X
,	B-X
12	B-X
,	B-X
24	B-X
,	B-X
and	B-X
48	B-X
h.	B-X
This	B-X
treatment	B-X
resulted	B-X
in	B-X
significant	B-X
myotube	B-X
hypertrophy	B-X
(	B-X
protein/DNA	B-X
)	B-X
and	B-X
increased	B-X
RNA	B-X
content	B-X
(	B-X
RNA/DNA	B-X
)	B-X
with	B-X
no	B-X
changes	B-X
in	B-X
DNA	B-X
content	B-X
or	B-X
indices	B-X
of	B-X
cell	B-X
proliferation	B-X
.	B-X
During	B-X
myotube	B-X
hypertrophy	B-X
,	B-X
the	B-X
increase	B-X
in	B-X
RNA	B-X
content	B-X
was	B-X
accompanied	B-X
by	B-X
an	B-X
increase	B-X
in	B-X
tumor	B-X
suppressor	B-X
protein	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
phosphorylation	B-X
and	B-X
a	B-X
corresponding	B-X
increase	B-X
in	B-X
the	B-X
availability	B-X
of	B-X
the	B-X
ribosomal	B-X
DNA	B-X
transcription	B-X
factor	B-X
upstream	B-X
binding	B-X
factor	B-X
(	B-X
UBF	B-X
)	B-X
.	B-X
Serum	B-X
stimulation	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
differentiated	B-X
myotubes	B-X
with	B-X
a	B-X
concomitant	B-X
increase	B-X
in	B-X
cyclin	B-X
D1-dependent	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
-4	B-X
activity	B-X
toward	B-X
Rb	B-X
.	B-X
The	B-X
increases	B-X
in	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
RNA	B-X
content	B-X
were	B-X
blocked	B-X
by	B-X
rapamycin	B-X
treatment	B-X
,	B-X
which	B-X
also	B-X
prevented	B-X
the	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
,	B-X
CDK-4	B-X
activity	B-X
,	B-X
Rb	B-X
phosphorylation	B-X
,	B-X
and	B-X
the	B-X
increase	B-X
in	B-X
UBF	B-X
availability	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
is	B-X
necessary	B-X
for	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
role	B-X
of	B-X
mTOR	B-X
is	B-X
in	B-X
part	B-X
to	B-X
modulate	B-X
cyclin	B-X
D1-dependent	B-X
CDK-4	B-X
activity	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
Rb	B-X
and	B-X
ribosomal	B-X
RNA	B-X
synthesis	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
common	B-X
molecular	B-X
mechanisms	B-X
contribute	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
growth	B-X
during	B-X
the	B-X
G1	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

Terminally	O
differentiated	O
myotubes	O
were	O
serum	O
stimulated	O
for	O
3	O
,	O
6	O
,	O
12	O
,	O
24	O
,	O
and	O
48	O
h	O
.	O
<EOS>	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
the	B-X
potential	B-X
downstream	B-X
functions	B-X
associated	B-X
with	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
during	B-X
myotube	B-X
hypertrophy	B-X
.	B-X
Terminally	B-X
differentiated	B-X
myotubes	B-X
were	B-X
serum	B-X
stimulated	B-X
for	B-X
3	B-X
,	B-X
6	B-X
,	B-X
12	B-X
,	B-X
24	B-X
,	B-X
and	B-X
48	B-X
h.	B-X
This	B-X
treatment	B-X
resulted	B-X
in	B-X
significant	B-X
myotube	B-X
hypertrophy	B-X
(	B-X
protein/DNA	B-X
)	B-X
and	B-X
increased	B-X
RNA	B-X
content	B-X
(	B-X
RNA/DNA	B-X
)	B-X
with	B-X
no	B-X
changes	B-X
in	B-X
DNA	B-X
content	B-X
or	B-X
indices	B-X
of	B-X
cell	B-X
proliferation	B-X
.	B-X
During	B-X
myotube	B-X
hypertrophy	B-X
,	B-X
the	B-X
increase	B-X
in	B-X
RNA	B-X
content	B-X
was	B-X
accompanied	B-X
by	B-X
an	B-X
increase	B-X
in	B-X
tumor	B-X
suppressor	B-X
protein	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
phosphorylation	B-X
and	B-X
a	B-X
corresponding	B-X
increase	B-X
in	B-X
the	B-X
availability	B-X
of	B-X
the	B-X
ribosomal	B-X
DNA	B-X
transcription	B-X
factor	B-X
upstream	B-X
binding	B-X
factor	B-X
(	B-X
UBF	B-X
)	B-X
.	B-X
Serum	B-X
stimulation	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
differentiated	B-X
myotubes	B-X
with	B-X
a	B-X
concomitant	B-X
increase	B-X
in	B-X
cyclin	B-X
D1-dependent	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
-4	B-X
activity	B-X
toward	B-X
Rb	B-X
.	B-X
The	B-X
increases	B-X
in	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
RNA	B-X
content	B-X
were	B-X
blocked	B-X
by	B-X
rapamycin	B-X
treatment	B-X
,	B-X
which	B-X
also	B-X
prevented	B-X
the	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
,	B-X
CDK-4	B-X
activity	B-X
,	B-X
Rb	B-X
phosphorylation	B-X
,	B-X
and	B-X
the	B-X
increase	B-X
in	B-X
UBF	B-X
availability	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
is	B-X
necessary	B-X
for	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
role	B-X
of	B-X
mTOR	B-X
is	B-X
in	B-X
part	B-X
to	B-X
modulate	B-X
cyclin	B-X
D1-dependent	B-X
CDK-4	B-X
activity	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
Rb	B-X
and	B-X
ribosomal	B-X
RNA	B-X
synthesis	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
common	B-X
molecular	B-X
mechanisms	B-X
contribute	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
growth	B-X
during	B-X
the	B-X
G1	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

This	O
treatment	O
resulted	O
in	O
significant	O
myotube	O
hypertrophy	O
(	O
protein	O
/	O
DNA	O
)	O
and	O
increased	O
RNA	O
content	O
(	O
RNA	O
/	O
DNA	O
)	O
with	O
no	O
changes	O
in	O
DNA	O
content	O
or	O
indices	O
of	O
cell	O
proliferation	O
.	O
<EOS>	B-X
This	B-X
chapter	B-X
describes	B-X
selected	B-X
assays	B-X
for	B-X
the	B-X
evaluation	B-X
of	B-X
cellular	B-X
viability	B-X
and	B-X
proliferation	B-X
of	B-X
cell	B-X
cultures	B-X
.	B-X
The	B-X
underlying	B-X
principle	B-X
of	B-X
these	B-X
assays	B-X
is	B-X
the	B-X
measurement	B-X
of	B-X
a	B-X
biochemical	B-X
marker	B-X
to	B-X
evaluate	B-X
the	B-X
cell	B-X
's	B-X
metabolic	B-X
activity	B-X
.	B-X
They	B-X
are	B-X
applicable	B-X
for	B-X
adherent	B-X
or	B-X
suspended	B-X
cell	B-X
lines	B-X
,	B-X
easy	B-X
to	B-X
perform	B-X
,	B-X
and	B-X
comparably	B-X
economical	B-X
.	B-X
This	B-X
cell	B-X
permeable	B-X
PROTAC	B-X
consists	B-X
of	B-X
a	B-X
non-steroidal	B-X
androgen	B-X
receptor	B-X
ligand	B-X
(	B-X
SARM	B-X
)	B-X
and	B-X
the	B-X
MDM2	B-X
ligand	B-X
known	B-X
as	B-X
nutlin	B-X
,	B-X
connected	B-X
by	B-X
a	B-X
PEG-based	B-X
linker	B-X
.	B-X
Upon	B-X
treatment	B-X
of	B-X
HeLa	B-X
cells	B-X
with	B-X
10microM	B-X
PROTAC	B-X
for	B-X
7h	B-X
,	B-X
we	B-X
were	B-X
able	B-X
to	B-X
observe	B-X
a	B-X
decrease	B-X
in	B-X
androgen	B-X
receptor	B-X
levels	B-X
.	B-X
This	B-X
degradation	B-X
is	B-X
proteasome	B-X
dependent	B-X
,	B-X
as	B-X
it	B-X
is	B-X
mitigated	B-X
in	B-X
cells	B-X
pre-treated	B-X
with	B-X
10microM	B-X
epoxomicin	B-X
,	B-X
a	B-X
specific	B-X
proteasome	B-X
inhibitor	B-X
.	B-X
These	B-X
results	B-X
have	B-X
implications	B-X
for	B-X
the	B-X
potential	B-X
study	B-X
and	B-X
treatment	B-X
of	B-X
various	B-X
cancers	B-X
with	B-X
increased	B-X
androgen	B-X
receptor	B-X
levels	B-X
.	B-X

During	O
myotube	O
hypertrophy	O
,	O
the	O
increase	O
in	O
RNA	O
content	O
was	O
accompanied	O
by	O
an	O
increase	O
in	O
tumor	O
suppressor	O
protein	O
retinoblastoma	B-Gene_or_gene_product
(	O
Rb	B-Gene_or_gene_product
)	O
phosphorylation	O
and	O
a	O
corresponding	O
increase	O
in	O
the	O
availability	O
of	O
the	O
ribosomal	O
DNA	O
transcription	O
factor	O
upstream	B-Gene_or_gene_product
binding	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
(	O
UBF	B-Gene_or_gene_product
)	O
.	O

Serum	O
stimulation	O
also	O
induced	O
an	O
increase	O
in	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
protein	O
expression	O
in	O
the	O
differentiated	O
myotubes	O
with	O
a	O
concomitant	O
increase	O
in	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
-	O
dependent	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	I-Gene_or_gene_product
CDK	I-Gene_or_gene_product
)	I-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
activity	O
toward	O
Rb	B-Gene_or_gene_product
.	O
<EOS>	B-X
Terminally	B-X
differentiated	B-X
myotubes	B-X
were	B-X
serum	B-X
stimulated	B-X
for	B-X
3	B-X
,	B-X
6	B-X
,	B-X
12	B-X
,	B-X
24	B-X
,	B-X
and	B-X
48	B-X
h.	B-X
This	B-X
treatment	B-X
resulted	B-X
in	B-X
significant	B-X
myotube	B-X
hypertrophy	B-X
(	B-X
protein/DNA	B-X
)	B-X
and	B-X
increased	B-X
RNA	B-X
content	B-X
(	B-X
RNA/DNA	B-X
)	B-X
with	B-X
no	B-X
changes	B-X
in	B-X
DNA	B-X
content	B-X
or	B-X
indices	B-X
of	B-X
cell	B-X
proliferation	B-X
.	B-X
During	B-X
myotube	B-X
hypertrophy	B-X
,	B-X
the	B-X
increase	B-X
in	B-X
RNA	B-X
content	B-X
was	B-X
accompanied	B-X
by	B-X
an	B-X
increase	B-X
in	B-X
tumor	B-X
suppressor	B-X
protein	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
phosphorylation	B-X
and	B-X
a	B-X
corresponding	B-X
increase	B-X
in	B-X
the	B-X
availability	B-X
of	B-X
the	B-X
ribosomal	B-X
DNA	B-X
transcription	B-X
factor	B-X
upstream	B-X
binding	B-X
factor	B-X
(	B-X
UBF	B-X
)	B-X
.	B-X
Serum	B-X
stimulation	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
differentiated	B-X
myotubes	B-X
with	B-X
a	B-X
concomitant	B-X
increase	B-X
in	B-X
cyclin	B-X
D1-dependent	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
-4	B-X
activity	B-X
toward	B-X
Rb	B-X
.	B-X
The	B-X
increases	B-X
in	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
RNA	B-X
content	B-X
were	B-X
blocked	B-X
by	B-X
rapamycin	B-X
treatment	B-X
,	B-X
which	B-X
also	B-X
prevented	B-X
the	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
,	B-X
CDK-4	B-X
activity	B-X
,	B-X
Rb	B-X
phosphorylation	B-X
,	B-X
and	B-X
the	B-X
increase	B-X
in	B-X
UBF	B-X
availability	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
is	B-X
necessary	B-X
for	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
role	B-X
of	B-X
mTOR	B-X
is	B-X
in	B-X
part	B-X
to	B-X
modulate	B-X
cyclin	B-X
D1-dependent	B-X
CDK-4	B-X
activity	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
Rb	B-X
and	B-X
ribosomal	B-X
RNA	B-X
synthesis	B-X
.	B-X

The	O
increases	O
in	O
myotube	O
hypertrophy	O
and	O
RNA	O
content	O
were	O
blocked	O
by	O
rapamycin	O
treatment	O
,	O
which	O
also	O
prevented	O
the	O
increase	O
in	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
protein	O
expression	O
,	O
CDK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
activity	O
,	O
Rb	B-Gene_or_gene_product
phosphorylation	O
,	O
and	O
the	O
increase	O
in	O
UBF	B-Gene_or_gene_product
availability	O
.	O
<EOS>	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
the	B-X
potential	B-X
downstream	B-X
functions	B-X
associated	B-X
with	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
during	B-X
myotube	B-X
hypertrophy	B-X
.	B-X
Terminally	B-X
differentiated	B-X
myotubes	B-X
were	B-X
serum	B-X
stimulated	B-X
for	B-X
3	B-X
,	B-X
6	B-X
,	B-X
12	B-X
,	B-X
24	B-X
,	B-X
and	B-X
48	B-X
h.	B-X
This	B-X
treatment	B-X
resulted	B-X
in	B-X
significant	B-X
myotube	B-X
hypertrophy	B-X
(	B-X
protein/DNA	B-X
)	B-X
and	B-X
increased	B-X
RNA	B-X
content	B-X
(	B-X
RNA/DNA	B-X
)	B-X
with	B-X
no	B-X
changes	B-X
in	B-X
DNA	B-X
content	B-X
or	B-X
indices	B-X
of	B-X
cell	B-X
proliferation	B-X
.	B-X
During	B-X
myotube	B-X
hypertrophy	B-X
,	B-X
the	B-X
increase	B-X
in	B-X
RNA	B-X
content	B-X
was	B-X
accompanied	B-X
by	B-X
an	B-X
increase	B-X
in	B-X
tumor	B-X
suppressor	B-X
protein	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
phosphorylation	B-X
and	B-X
a	B-X
corresponding	B-X
increase	B-X
in	B-X
the	B-X
availability	B-X
of	B-X
the	B-X
ribosomal	B-X
DNA	B-X
transcription	B-X
factor	B-X
upstream	B-X
binding	B-X
factor	B-X
(	B-X
UBF	B-X
)	B-X
.	B-X
Serum	B-X
stimulation	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
differentiated	B-X
myotubes	B-X
with	B-X
a	B-X
concomitant	B-X
increase	B-X
in	B-X
cyclin	B-X
D1-dependent	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
-4	B-X
activity	B-X
toward	B-X
Rb	B-X
.	B-X
The	B-X
increases	B-X
in	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
RNA	B-X
content	B-X
were	B-X
blocked	B-X
by	B-X
rapamycin	B-X
treatment	B-X
,	B-X
which	B-X
also	B-X
prevented	B-X
the	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
,	B-X
CDK-4	B-X
activity	B-X
,	B-X
Rb	B-X
phosphorylation	B-X
,	B-X
and	B-X
the	B-X
increase	B-X
in	B-X
UBF	B-X
availability	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
is	B-X
necessary	B-X
for	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
role	B-X
of	B-X
mTOR	B-X
is	B-X
in	B-X
part	B-X
to	B-X
modulate	B-X
cyclin	B-X
D1-dependent	B-X
CDK-4	B-X
activity	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
Rb	B-X
and	B-X
ribosomal	B-X
RNA	B-X
synthesis	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
common	B-X
molecular	B-X
mechanisms	B-X
contribute	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
growth	B-X
during	B-X
the	B-X
G1	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

Our	O
findings	O
demonstrate	O
that	O
activation	O
of	O
mTOR	B-Gene_or_gene_product
is	O
necessary	O
for	O
myotube	O
hypertrophy	O
and	O
suggest	O
that	O
the	O
role	O
of	O
mTOR	B-Gene_or_gene_product
is	O
in	O
part	O
to	O
modulate	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
-	O
dependent	O
CDK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
activity	O
in	O
the	O
regulation	O
of	O
Rb	B-Gene_or_gene_product
and	O
ribosomal	O
RNA	O
synthesis	O
.	O
<EOS>	B-X
The	B-X
purpose	B-X
of	B-X
this	B-X
study	B-X
was	B-X
to	B-X
identify	B-X
the	B-X
potential	B-X
downstream	B-X
functions	B-X
associated	B-X
with	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
during	B-X
myotube	B-X
hypertrophy	B-X
.	B-X
Terminally	B-X
differentiated	B-X
myotubes	B-X
were	B-X
serum	B-X
stimulated	B-X
for	B-X
3	B-X
,	B-X
6	B-X
,	B-X
12	B-X
,	B-X
24	B-X
,	B-X
and	B-X
48	B-X
h.	B-X
This	B-X
treatment	B-X
resulted	B-X
in	B-X
significant	B-X
myotube	B-X
hypertrophy	B-X
(	B-X
protein/DNA	B-X
)	B-X
and	B-X
increased	B-X
RNA	B-X
content	B-X
(	B-X
RNA/DNA	B-X
)	B-X
with	B-X
no	B-X
changes	B-X
in	B-X
DNA	B-X
content	B-X
or	B-X
indices	B-X
of	B-X
cell	B-X
proliferation	B-X
.	B-X
During	B-X
myotube	B-X
hypertrophy	B-X
,	B-X
the	B-X
increase	B-X
in	B-X
RNA	B-X
content	B-X
was	B-X
accompanied	B-X
by	B-X
an	B-X
increase	B-X
in	B-X
tumor	B-X
suppressor	B-X
protein	B-X
retinoblastoma	B-X
(	B-X
Rb	B-X
)	B-X
phosphorylation	B-X
and	B-X
a	B-X
corresponding	B-X
increase	B-X
in	B-X
the	B-X
availability	B-X
of	B-X
the	B-X
ribosomal	B-X
DNA	B-X
transcription	B-X
factor	B-X
upstream	B-X
binding	B-X
factor	B-X
(	B-X
UBF	B-X
)	B-X
.	B-X
Serum	B-X
stimulation	B-X
also	B-X
induced	B-X
an	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
in	B-X
the	B-X
differentiated	B-X
myotubes	B-X
with	B-X
a	B-X
concomitant	B-X
increase	B-X
in	B-X
cyclin	B-X
D1-dependent	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
-4	B-X
activity	B-X
toward	B-X
Rb	B-X
.	B-X
The	B-X
increases	B-X
in	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
RNA	B-X
content	B-X
were	B-X
blocked	B-X
by	B-X
rapamycin	B-X
treatment	B-X
,	B-X
which	B-X
also	B-X
prevented	B-X
the	B-X
increase	B-X
in	B-X
cyclin	B-X
D1	B-X
protein	B-X
expression	B-X
,	B-X
CDK-4	B-X
activity	B-X
,	B-X
Rb	B-X
phosphorylation	B-X
,	B-X
and	B-X
the	B-X
increase	B-X
in	B-X
UBF	B-X
availability	B-X
.	B-X
Our	B-X
findings	B-X
demonstrate	B-X
that	B-X
activation	B-X
of	B-X
mTOR	B-X
is	B-X
necessary	B-X
for	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
suggest	B-X
that	B-X
the	B-X
role	B-X
of	B-X
mTOR	B-X
is	B-X
in	B-X
part	B-X
to	B-X
modulate	B-X
cyclin	B-X
D1-dependent	B-X
CDK-4	B-X
activity	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
Rb	B-X
and	B-X
ribosomal	B-X
RNA	B-X
synthesis	B-X
.	B-X
On	B-X
the	B-X
basis	B-X
of	B-X
these	B-X
results	B-X
,	B-X
we	B-X
propose	B-X
that	B-X
common	B-X
molecular	B-X
mechanisms	B-X
contribute	B-X
to	B-X
the	B-X
regulation	B-X
of	B-X
myotube	B-X
hypertrophy	B-X
and	B-X
growth	B-X
during	B-X
the	B-X
G1	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X

On	O
the	O
basis	O
of	O
these	O
results	O
,	O
we	O
propose	O
that	O
common	O
molecular	O
mechanisms	O
contribute	O
to	O
the	O
regulation	O
of	O
myotube	O
hypertrophy	O
and	O
growth	O
during	O
the	O
G1	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

Molecular	O
genetic	O
analysis	O
of	O
the	O
yeast	O
repressor	O
Rfx1	B-Gene_or_gene_product
/	O
Crt1	B-Gene_or_gene_product
reveals	O
a	O
novel	O
two	O
-	O
step	O
regulatory	O
mechanism	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
repressor	B-X
Crt1	B-X
and	B-X
the	B-X
global	B-X
corepressor	B-X
Ssn6-Tup1	B-X
repress	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
ribonucleotide	B-X
reductase	B-X
(	B-X
RNR	B-X
)	B-X
genes	B-X
.	B-X
Initiation	B-X
of	B-X
DNA	B-X
damage	B-X
signals	B-X
causes	B-X
the	B-X
release	B-X
of	B-X
Crt1	B-X
and	B-X
Ssn6-Tup1	B-X
from	B-X
the	B-X
promoter	B-X
,	B-X
coactivator	B-X
recruitment	B-X
,	B-X
and	B-X
derepression	B-X
of	B-X
transcription	B-X
,	B-X
indicating	B-X
that	B-X
Crt1	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
the	B-X
switch	B-X
between	B-X
gene	B-X
repression	B-X
and	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
mapped	B-X
the	B-X
functional	B-X
domains	B-X
of	B-X
Crt1	B-X
and	B-X
identified	B-X
two	B-X
independent	B-X
repression	B-X
domains	B-X
and	B-X
a	B-X
region	B-X
required	B-X
for	B-X
gene	B-X
activation	B-X
.	B-X
The	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
is	B-X
the	B-X
major	B-X
repression	B-X
domain	B-X
,	B-X
it	B-X
directly	B-X
binds	B-X
to	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
,	B-X
and	B-X
its	B-X
repression	B-X
activities	B-X
are	B-X
dependent	B-X
upon	B-X
Ssn6-Tup1	B-X
and	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
bind	B-X
to	B-X
a	B-X
region	B-X
within	B-X
the	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
,	B-X
overlapping	B-X
with	B-X
but	B-X
distinct	B-X
from	B-X
the	B-X
Ssn6-Tup1	B-X
binding	B-X
and	B-X
repression	B-X
domain	B-X
,	B-X
suggesting	B-X
that	B-X
Crt1	B-X
may	B-X
have	B-X
activator	B-X
functions	B-X
.	B-X
Crt1	B-X
mutants	B-X
were	B-X
constructed	B-X
to	B-X
dissect	B-X
its	B-X
activator	B-X
and	B-X
repressor	B-X
functions	B-X
.	B-X
These	B-X
results	B-X
imply	B-X
a	B-X
two-step	B-X
activation	B-X
model	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
and	B-X
that	B-X
Crt1	B-X
functions	B-X
as	B-X
a	B-X
signal-dependent	B-X
dual-transcription	B-X
activator	B-X
and	B-X
repressor	B-X
that	B-X
acts	B-X
in	B-X
a	B-X
transient	B-X
manner	B-X
.	B-X

In	O
Saccharomyces	O
cerevisiae	O
,	O
the	O
repressor	O
Crt1	B-Gene_or_gene_product
and	O
the	O
global	O
corepressor	O
Ssn6	O
-	O
Tup1	O
repress	O
the	O
DNA	O
damage	O
-	O
inducible	O
ribonucleotide	B-Gene_or_gene_product
reductase	I-Gene_or_gene_product
(	O
RNR	B-Gene_or_gene_product
)	O
genes	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
repressor	B-X
Crt1	B-X
and	B-X
the	B-X
global	B-X
corepressor	B-X
Ssn6-Tup1	B-X
repress	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
ribonucleotide	B-X
reductase	B-X
(	B-X
RNR	B-X
)	B-X
genes	B-X
.	B-X
Initiation	B-X
of	B-X
DNA	B-X
damage	B-X
signals	B-X
causes	B-X
the	B-X
release	B-X
of	B-X
Crt1	B-X
and	B-X
Ssn6-Tup1	B-X
from	B-X
the	B-X
promoter	B-X
,	B-X
coactivator	B-X
recruitment	B-X
,	B-X
and	B-X
derepression	B-X
of	B-X
transcription	B-X
,	B-X
indicating	B-X
that	B-X
Crt1	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
the	B-X
switch	B-X
between	B-X
gene	B-X
repression	B-X
and	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
mapped	B-X
the	B-X
functional	B-X
domains	B-X
of	B-X
Crt1	B-X
and	B-X
identified	B-X
two	B-X
independent	B-X
repression	B-X
domains	B-X
and	B-X
a	B-X
region	B-X
required	B-X
for	B-X
gene	B-X
activation	B-X
.	B-X
The	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
is	B-X
the	B-X
major	B-X
repression	B-X
domain	B-X
,	B-X
it	B-X
directly	B-X
binds	B-X
to	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
,	B-X
and	B-X
its	B-X
repression	B-X
activities	B-X
are	B-X
dependent	B-X
upon	B-X
Ssn6-Tup1	B-X
and	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
C-terminal	B-X
repression	B-X
domain	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
Ssn6-Tup1	B-X
and	B-X
HDACs	B-X
and	B-X
functions	B-X
at	B-X
native	B-X
genes	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
bind	B-X
to	B-X
a	B-X
region	B-X
within	B-X
the	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
,	B-X
overlapping	B-X
with	B-X
but	B-X
distinct	B-X
from	B-X
the	B-X
Ssn6-Tup1	B-X
binding	B-X
and	B-X
repression	B-X
domain	B-X
,	B-X
suggesting	B-X
that	B-X
Crt1	B-X
may	B-X
have	B-X
activator	B-X
functions	B-X
.	B-X
Crt1	B-X
mutants	B-X
were	B-X
constructed	B-X
to	B-X
dissect	B-X
its	B-X
activator	B-X
and	B-X
repressor	B-X
functions	B-X
.	B-X
All	B-X
of	B-X
the	B-X
mutants	B-X
were	B-X
competent	B-X
for	B-X
repression	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
,	B-X
but	B-X
a	B-X
majority	B-X
were	B-X
``	B-X
derepression-defective	B-X
''	B-X
mutants	B-X
.	B-X
Further	B-X
characterization	B-X
of	B-X
these	B-X
mutants	B-X
indicated	B-X
that	B-X
they	B-X
are	B-X
capable	B-X
of	B-X
receiving	B-X
DNA	B-X
damage	B-X
signals	B-X
and	B-X
releasing	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
from	B-X
the	B-X
promoter	B-X
but	B-X
are	B-X
selectively	B-X
impaired	B-X
for	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
recruitment	B-X
.	B-X
These	B-X
results	B-X
imply	B-X
a	B-X
two-step	B-X
activation	B-X
model	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
and	B-X
that	B-X
Crt1	B-X
functions	B-X
as	B-X
a	B-X
signal-dependent	B-X
dual-transcription	B-X
activator	B-X
and	B-X
repressor	B-X
that	B-X
acts	B-X
in	B-X
a	B-X
transient	B-X
manner	B-X
.	B-X

Initiation	O
of	O
DNA	O
damage	O
signals	O
causes	O
the	O
release	O
of	O
Crt1	B-Gene_or_gene_product
and	O
Ssn6	O
-	O
Tup1	O
from	O
the	O
promoter	O
,	O
coactivator	O
recruitment	O
,	O
and	O
derepression	O
of	O
transcription	O
,	O
indicating	O
that	O
Crt1	B-Gene_or_gene_product
plays	O
a	O
crucial	O
role	O
in	O
the	O
switch	O
between	O
gene	O
repression	O
and	O
activation	O
.	O

Here	O
we	O
have	O
mapped	O
the	O
functional	O
domains	O
of	O
Crt1	B-Gene_or_gene_product
and	O
identified	O
two	O
independent	O
repression	O
domains	O
and	O
a	O
region	O
required	O
for	O
gene	O
activation	O
.	O

The	O
N	O
terminus	O
of	O
Crt1	B-Gene_or_gene_product
is	O
the	O
major	O
repression	O
domain	O
,	O
it	O
directly	O
binds	O
to	O
the	O
Ssn6	O
-	O
Tup1	O
complex	O
,	O
and	O
its	O
repression	O
activities	O
are	O
dependent	O
upon	O
Ssn6	O
-	O
Tup1	O
and	O
histone	B-Gene_or_gene_product
deacetylases	I-Gene_or_gene_product
(	O
HDACs	B-Gene_or_gene_product
)	O
.	O

In	O
addition	O
,	O
we	O
identified	O
a	O
C	O
-	O
terminal	O
repression	O
domain	O
,	O
which	O
is	O
independent	O
of	O
Ssn6	O
-	O
Tup1	O
and	O
HDACs	B-Gene_or_gene_product
and	O
functions	O
at	O
native	O
genes	O
in	O
vivo	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
TFIID	B-Gene_or_gene_product
and	O
SWI	O
/	O
SNF	O
bind	O
to	O
a	O
region	O
within	O
the	O
N	O
terminus	O
of	O
Crt1	B-Gene_or_gene_product
,	O
overlapping	O
with	O
but	O
distinct	O
from	O
the	O
Ssn6	O
-	O
Tup1	O
binding	O
and	O
repression	O
domain	O
,	O
suggesting	O
that	O
Crt1	B-Gene_or_gene_product
may	O
have	O
activator	O
functions	O
.	O

Crt1	B-Gene_or_gene_product
mutants	O
were	O
constructed	O
to	O
dissect	O
its	O
activator	O
and	O
repressor	O
functions	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
repressor	B-X
Crt1	B-X
and	B-X
the	B-X
global	B-X
corepressor	B-X
Ssn6-Tup1	B-X
repress	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
ribonucleotide	B-X
reductase	B-X
(	B-X
RNR	B-X
)	B-X
genes	B-X
.	B-X
Initiation	B-X
of	B-X
DNA	B-X
damage	B-X
signals	B-X
causes	B-X
the	B-X
release	B-X
of	B-X
Crt1	B-X
and	B-X
Ssn6-Tup1	B-X
from	B-X
the	B-X
promoter	B-X
,	B-X
coactivator	B-X
recruitment	B-X
,	B-X
and	B-X
derepression	B-X
of	B-X
transcription	B-X
,	B-X
indicating	B-X
that	B-X
Crt1	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
the	B-X
switch	B-X
between	B-X
gene	B-X
repression	B-X
and	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
mapped	B-X
the	B-X
functional	B-X
domains	B-X
of	B-X
Crt1	B-X
and	B-X
identified	B-X
two	B-X
independent	B-X
repression	B-X
domains	B-X
and	B-X
a	B-X
region	B-X
required	B-X
for	B-X
gene	B-X
activation	B-X
.	B-X
The	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
is	B-X
the	B-X
major	B-X
repression	B-X
domain	B-X
,	B-X
it	B-X
directly	B-X
binds	B-X
to	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
,	B-X
and	B-X
its	B-X
repression	B-X
activities	B-X
are	B-X
dependent	B-X
upon	B-X
Ssn6-Tup1	B-X
and	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
C-terminal	B-X
repression	B-X
domain	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
Ssn6-Tup1	B-X
and	B-X
HDACs	B-X
and	B-X
functions	B-X
at	B-X
native	B-X
genes	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
bind	B-X
to	B-X
a	B-X
region	B-X
within	B-X
the	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
,	B-X
overlapping	B-X
with	B-X
but	B-X
distinct	B-X
from	B-X
the	B-X
Ssn6-Tup1	B-X
binding	B-X
and	B-X
repression	B-X
domain	B-X
,	B-X
suggesting	B-X
that	B-X
Crt1	B-X
may	B-X
have	B-X
activator	B-X
functions	B-X
.	B-X
Crt1	B-X
mutants	B-X
were	B-X
constructed	B-X
to	B-X
dissect	B-X
its	B-X
activator	B-X
and	B-X
repressor	B-X
functions	B-X
.	B-X
All	B-X
of	B-X
the	B-X
mutants	B-X
were	B-X
competent	B-X
for	B-X
repression	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
,	B-X
but	B-X
a	B-X
majority	B-X
were	B-X
``	B-X
derepression-defective	B-X
''	B-X
mutants	B-X
.	B-X
Further	B-X
characterization	B-X
of	B-X
these	B-X
mutants	B-X
indicated	B-X
that	B-X
they	B-X
are	B-X
capable	B-X
of	B-X
receiving	B-X
DNA	B-X
damage	B-X
signals	B-X
and	B-X
releasing	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
from	B-X
the	B-X
promoter	B-X
but	B-X
are	B-X
selectively	B-X
impaired	B-X
for	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
recruitment	B-X
.	B-X
These	B-X
results	B-X
imply	B-X
a	B-X
two-step	B-X
activation	B-X
model	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
and	B-X
that	B-X
Crt1	B-X
functions	B-X
as	B-X
a	B-X
signal-dependent	B-X
dual-transcription	B-X
activator	B-X
and	B-X
repressor	B-X
that	B-X
acts	B-X
in	B-X
a	B-X
transient	B-X
manner	B-X
.	B-X

All	O
of	O
the	O
mutants	O
were	O
competent	O
for	O
repression	O
of	O
the	O
DNA	O
damage	O
-	O
inducible	O
genes	O
,	O
but	O
a	O
majority	O
were	O
"	O
derepression	O
-	O
defective	O
"	O
mutants	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
repressor	B-X
Crt1	B-X
and	B-X
the	B-X
global	B-X
corepressor	B-X
Ssn6-Tup1	B-X
repress	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
ribonucleotide	B-X
reductase	B-X
(	B-X
RNR	B-X
)	B-X
genes	B-X
.	B-X
Initiation	B-X
of	B-X
DNA	B-X
damage	B-X
signals	B-X
causes	B-X
the	B-X
release	B-X
of	B-X
Crt1	B-X
and	B-X
Ssn6-Tup1	B-X
from	B-X
the	B-X
promoter	B-X
,	B-X
coactivator	B-X
recruitment	B-X
,	B-X
and	B-X
derepression	B-X
of	B-X
transcription	B-X
,	B-X
indicating	B-X
that	B-X
Crt1	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
the	B-X
switch	B-X
between	B-X
gene	B-X
repression	B-X
and	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
have	B-X
mapped	B-X
the	B-X
functional	B-X
domains	B-X
of	B-X
Crt1	B-X
and	B-X
identified	B-X
two	B-X
independent	B-X
repression	B-X
domains	B-X
and	B-X
a	B-X
region	B-X
required	B-X
for	B-X
gene	B-X
activation	B-X
.	B-X
The	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
is	B-X
the	B-X
major	B-X
repression	B-X
domain	B-X
,	B-X
it	B-X
directly	B-X
binds	B-X
to	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
,	B-X
and	B-X
its	B-X
repression	B-X
activities	B-X
are	B-X
dependent	B-X
upon	B-X
Ssn6-Tup1	B-X
and	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
C-terminal	B-X
repression	B-X
domain	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
Ssn6-Tup1	B-X
and	B-X
HDACs	B-X
and	B-X
functions	B-X
at	B-X
native	B-X
genes	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
bind	B-X
to	B-X
a	B-X
region	B-X
within	B-X
the	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
,	B-X
overlapping	B-X
with	B-X
but	B-X
distinct	B-X
from	B-X
the	B-X
Ssn6-Tup1	B-X
binding	B-X
and	B-X
repression	B-X
domain	B-X
,	B-X
suggesting	B-X
that	B-X
Crt1	B-X
may	B-X
have	B-X
activator	B-X
functions	B-X
.	B-X
Crt1	B-X
mutants	B-X
were	B-X
constructed	B-X
to	B-X
dissect	B-X
its	B-X
activator	B-X
and	B-X
repressor	B-X
functions	B-X
.	B-X
All	B-X
of	B-X
the	B-X
mutants	B-X
were	B-X
competent	B-X
for	B-X
repression	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
,	B-X
but	B-X
a	B-X
majority	B-X
were	B-X
``	B-X
derepression-defective	B-X
''	B-X
mutants	B-X
.	B-X
Further	B-X
characterization	B-X
of	B-X
these	B-X
mutants	B-X
indicated	B-X
that	B-X
they	B-X
are	B-X
capable	B-X
of	B-X
receiving	B-X
DNA	B-X
damage	B-X
signals	B-X
and	B-X
releasing	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
from	B-X
the	B-X
promoter	B-X
but	B-X
are	B-X
selectively	B-X
impaired	B-X
for	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
recruitment	B-X
.	B-X
These	B-X
results	B-X
imply	B-X
a	B-X
two-step	B-X
activation	B-X
model	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
and	B-X
that	B-X
Crt1	B-X
functions	B-X
as	B-X
a	B-X
signal-dependent	B-X
dual-transcription	B-X
activator	B-X
and	B-X
repressor	B-X
that	B-X
acts	B-X
in	B-X
a	B-X
transient	B-X
manner	B-X
.	B-X

Further	O
characterization	O
of	O
these	O
mutants	O
indicated	O
that	O
they	O
are	O
capable	O
of	O
receiving	O
DNA	O
damage	O
signals	O
and	O
releasing	O
the	O
Ssn6	O
-	O
Tup1	O
complex	O
from	O
the	O
promoter	O
but	O
are	O
selectively	O
impaired	O
for	O
TFIID	B-Gene_or_gene_product
and	O
SWI	O
/	O
SNF	O
recruitment	O
.	O
<EOS>	B-X
In	B-X
Saccharomyces	B-X
cerevisiae	B-X
,	B-X
the	B-X
repressor	B-X
Crt1	B-X
and	B-X
the	B-X
global	B-X
corepressor	B-X
Ssn6-Tup1	B-X
repress	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
ribonucleotide	B-X
reductase	B-X
(	B-X
RNR	B-X
)	B-X
genes	B-X
.	B-X
Initiation	B-X
of	B-X
DNA	B-X
damage	B-X
signals	B-X
causes	B-X
the	B-X
release	B-X
of	B-X
Crt1	B-X
and	B-X
Ssn6-Tup1	B-X
from	B-X
the	B-X
promoter	B-X
,	B-X
coactivator	B-X
recruitment	B-X
,	B-X
and	B-X
derepression	B-X
of	B-X
transcription	B-X
,	B-X
indicating	B-X
that	B-X
Crt1	B-X
plays	B-X
a	B-X
crucial	B-X
role	B-X
in	B-X
the	B-X
switch	B-X
between	B-X
gene	B-X
repression	B-X
and	B-X
activation	B-X
.	B-X
The	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
is	B-X
the	B-X
major	B-X
repression	B-X
domain	B-X
,	B-X
it	B-X
directly	B-X
binds	B-X
to	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
,	B-X
and	B-X
its	B-X
repression	B-X
activities	B-X
are	B-X
dependent	B-X
upon	B-X
Ssn6-Tup1	B-X
and	B-X
histone	B-X
deacetylases	B-X
(	B-X
HDACs	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
we	B-X
identified	B-X
a	B-X
C-terminal	B-X
repression	B-X
domain	B-X
,	B-X
which	B-X
is	B-X
independent	B-X
of	B-X
Ssn6-Tup1	B-X
and	B-X
HDACs	B-X
and	B-X
functions	B-X
at	B-X
native	B-X
genes	B-X
in	B-X
vivo	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
bind	B-X
to	B-X
a	B-X
region	B-X
within	B-X
the	B-X
N	B-X
terminus	B-X
of	B-X
Crt1	B-X
,	B-X
overlapping	B-X
with	B-X
but	B-X
distinct	B-X
from	B-X
the	B-X
Ssn6-Tup1	B-X
binding	B-X
and	B-X
repression	B-X
domain	B-X
,	B-X
suggesting	B-X
that	B-X
Crt1	B-X
may	B-X
have	B-X
activator	B-X
functions	B-X
.	B-X
Crt1	B-X
mutants	B-X
were	B-X
constructed	B-X
to	B-X
dissect	B-X
its	B-X
activator	B-X
and	B-X
repressor	B-X
functions	B-X
.	B-X
All	B-X
of	B-X
the	B-X
mutants	B-X
were	B-X
competent	B-X
for	B-X
repression	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
,	B-X
but	B-X
a	B-X
majority	B-X
were	B-X
``	B-X
derepression-defective	B-X
''	B-X
mutants	B-X
.	B-X
Further	B-X
characterization	B-X
of	B-X
these	B-X
mutants	B-X
indicated	B-X
that	B-X
they	B-X
are	B-X
capable	B-X
of	B-X
receiving	B-X
DNA	B-X
damage	B-X
signals	B-X
and	B-X
releasing	B-X
the	B-X
Ssn6-Tup1	B-X
complex	B-X
from	B-X
the	B-X
promoter	B-X
but	B-X
are	B-X
selectively	B-X
impaired	B-X
for	B-X
TFIID	B-X
and	B-X
SWI/SNF	B-X
recruitment	B-X
.	B-X
These	B-X
results	B-X
imply	B-X
a	B-X
two-step	B-X
activation	B-X
model	B-X
of	B-X
the	B-X
DNA	B-X
damage-inducible	B-X
genes	B-X
and	B-X
that	B-X
Crt1	B-X
functions	B-X
as	B-X
a	B-X
signal-dependent	B-X
dual-transcription	B-X
activator	B-X
and	B-X
repressor	B-X
that	B-X
acts	B-X
in	B-X
a	B-X
transient	B-X
manner	B-X
.	B-X

These	O
results	O
imply	O
a	O
two	O
-	O
step	O
activation	O
model	O
of	O
the	O
DNA	O
damage	O
-	O
inducible	O
genes	O
and	O
that	O
Crt1	B-Gene_or_gene_product
functions	O
as	O
a	O
signal	O
-	O
dependent	O
dual	O
-	O
transcription	O
activator	O
and	O
repressor	O
that	O
acts	O
in	O
a	O
transient	O
manner	O
.	O

Mechanisms	O
of	O
tumor	O
suppression	O
by	O
the	O
SCF	O
(	O
Fbw7	O
)	O
.	O
<EOS>	B-X
SCF	B-X
ubiquitin	B-X
ligases	B-X
regulate	B-X
the	B-X
degradation	B-X
of	B-X
many	B-X
proteins	B-X
involved	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
division	B-X
and	B-X
growth	B-X
.	B-X
F-box	B-X
proteins	B-X
are	B-X
the	B-X
SCF	B-X
components	B-X
that	B-X
bind	B-X
to	B-X
substrates	B-X
,	B-X
and	B-X
this	B-X
binding	B-X
is	B-X
usually	B-X
signaled	B-X
by	B-X
substrate	B-X
phosphorylation	B-X
.	B-X
The	B-X
Fbw7/hCdc4	B-X
F-box	B-X
protein	B-X
was	B-X
first	B-X
recognized	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
cyclin	B-X
E	B-X
,	B-X
and	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
is	B-X
now	B-X
known	B-X
to	B-X
target	B-X
c-Myc	B-X
,	B-X
c-Jun	B-X
and	B-X
Notch	B-X
for	B-X
degradation	B-X
in	B-X
addition	B-X
to	B-X
its	B-X
role	B-X
in	B-X
cyclin	B-X
E	B-X
proteolysis	B-X
.	B-X
Fbw7	B-X
thus	B-X
negatively	B-X
regulates	B-X
several	B-X
key	B-X
oncoproteins	B-X
.	B-X
Accordingly	B-X
,	B-X
Fbw7	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
human	B-X
cancers	B-X
,	B-X
and	B-X
Fbw7	B-X
functions	B-X
as	B-X
a	B-X
haploin	B-X
sufficient	B-X
tumor	B-X
suppressor	B-X
in	B-X
mice	B-X
.	B-X
Because	B-X
there	B-X
are	B-X
three	B-X
Fbw7	B-X
isoforms	B-X
that	B-X
reside	B-X
in	B-X
different	B-X
subcellular	B-X
compartments	B-X
,	B-X
as	B-X
well	B-X
as	B-X
multiple	B-X
Fbw7	B-X
substrates	B-X
that	B-X
are	B-X
the	B-X
products	B-X
of	B-X
proto-oncogenes	B-X
,	B-X
the	B-X
mechanisms	B-X
of	B-X
tumor	B-X
suppression	B-X
by	B-X
Fbw7	B-X
are	B-X
complex	B-X
and	B-X
incompletely	B-X
understood	B-X
.	B-X
In	B-X
this	B-X
review	B-X
we	B-X
discuss	B-X
the	B-X
activities	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
in	B-X
the	B-X
context	B-X
of	B-X
its	B-X
role	B-X
as	B-X
a	B-X
tumor	B-X
suppressor	B-X
and	B-X
highlight	B-X
recent	B-X
findings	B-X
demonstrating	B-X
that	B-X
dominant	B-X
oncogenes	B-X
disable	B-X
Fbw7	B-X
function	B-X
.	B-X

SCF	O
ubiquitin	B-Gene_or_gene_product
ligases	O
regulate	O
the	O
degradation	O
of	O
many	O
proteins	O
involved	O
in	O
the	O
control	O
of	O
cell	O
division	O
and	O
growth	O
.	O
<EOS>	B-X
Plants	B-X
are	B-X
sessile	B-X
organisms	B-X
that	B-X
have	B-X
to	B-X
adapt	B-X
their	B-X
growth	B-X
to	B-X
the	B-X
surrounding	B-X
environment	B-X
.	B-X
Concomitant	B-X
with	B-X
this	B-X
adaptation	B-X
capability	B-X
,	B-X
they	B-X
have	B-X
adopted	B-X
a	B-X
post-embryonic	B-X
development	B-X
characterized	B-X
by	B-X
continuous	B-X
growth	B-X
and	B-X
differentiation	B-X
abilities	B-X
.	B-X
Constant	B-X
growth	B-X
is	B-X
based	B-X
on	B-X
the	B-X
potential	B-X
of	B-X
stem	B-X
cells	B-X
to	B-X
divide	B-X
almost	B-X
incessantly	B-X
and	B-X
on	B-X
a	B-X
precise	B-X
balance	B-X
between	B-X
cell	B-X
division	B-X
and	B-X
cell	B-X
differentiation	B-X
.	B-X
This	B-X
balance	B-X
is	B-X
influenced	B-X
by	B-X
environmental	B-X
conditions	B-X
and	B-X
by	B-X
the	B-X
genetic	B-X
information	B-X
of	B-X
the	B-X
cell	B-X
.	B-X
Among	B-X
the	B-X
internal	B-X
cues	B-X
,	B-X
the	B-X
cross-talk	B-X
between	B-X
different	B-X
hormonal	B-X
signalling	B-X
pathways	B-X
is	B-X
essential	B-X
to	B-X
control	B-X
this	B-X
division/differentiation	B-X
equilibrium	B-X
.	B-X
Auxin	B-X
,	B-X
one	B-X
of	B-X
the	B-X
most	B-X
important	B-X
plant	B-X
hormones	B-X
,	B-X
regulates	B-X
cell	B-X
division	B-X
and	B-X
differentiation	B-X
,	B-X
among	B-X
many	B-X
other	B-X
processes	B-X
.	B-X
Amazing	B-X
advances	B-X
in	B-X
auxin	B-X
signal	B-X
transduction	B-X
at	B-X
the	B-X
molecular	B-X
level	B-X
have	B-X
been	B-X
reported	B-X
,	B-X
but	B-X
how	B-X
this	B-X
signalling	B-X
is	B-X
connected	B-X
to	B-X
the	B-X
cell	B-X
cycle	B-X
is	B-X
,	B-X
so	B-X
far	B-X
,	B-X
not	B-X
well	B-X
known	B-X
.	B-X
Auxin	B-X
signalling	B-X
involves	B-X
the	B-X
auxin-dependent	B-X
degradation	B-X
of	B-X
transcription	B-X
repressors	B-X
by	B-X
F-box-containing	B-X
E3	B-X
ligases	B-X
of	B-X
ubiquitin	B-X
.	B-X
Recently	B-X
,	B-X
SKP2A	B-X
,	B-X
another	B-X
F-box	B-X
protein	B-X
,	B-X
was	B-X
shown	B-X
to	B-X
bind	B-X
auxin	B-X
and	B-X
to	B-X
target	B-X
cell-cycle	B-X
repressors	B-X
for	B-X
proteolysis	B-X
,	B-X
representing	B-X
a	B-X
novel	B-X
mechanism	B-X
that	B-X
links	B-X
auxin	B-X
to	B-X
cell	B-X
division	B-X
.	B-X
In	B-X
this	B-X
review	B-X
,	B-X
a	B-X
general	B-X
vision	B-X
of	B-X
what	B-X
is	B-X
already	B-X
known	B-X
and	B-X
the	B-X
most	B-X
recent	B-X
advances	B-X
on	B-X
how	B-X
auxin	B-X
signalling	B-X
connects	B-X
to	B-X
cell	B-X
division	B-X
and	B-X
the	B-X
role	B-X
of	B-X
the	B-X
ubiquitin	B-X
pathway	B-X
in	B-X
plant	B-X
cell	B-X
cycle	B-X
will	B-X
be	B-X
covered	B-X
.	B-X

F	O
-	O
box	O
proteins	O
are	O
the	O
SCF	O
components	O
that	O
bind	O
to	O
substrates	O
,	O
and	O
this	O
binding	O
is	O
usually	O
signaled	O
by	O
substrate	O
phosphorylation	O
.	O
<EOS>	B-X
SCF	B-X
ubiquitin	B-X
ligases	B-X
regulate	B-X
the	B-X
degradation	B-X
of	B-X
many	B-X
proteins	B-X
involved	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
division	B-X
and	B-X
growth	B-X
.	B-X
F-box	B-X
proteins	B-X
are	B-X
the	B-X
SCF	B-X
components	B-X
that	B-X
bind	B-X
to	B-X
substrates	B-X
,	B-X
and	B-X
this	B-X
binding	B-X
is	B-X
usually	B-X
signaled	B-X
by	B-X
substrate	B-X
phosphorylation	B-X
.	B-X
The	B-X
Fbw7/hCdc4	B-X
F-box	B-X
protein	B-X
was	B-X
first	B-X
recognized	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
cyclin	B-X
E	B-X
,	B-X
and	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
is	B-X
now	B-X
known	B-X
to	B-X
target	B-X
c-Myc	B-X
,	B-X
c-Jun	B-X
and	B-X
Notch	B-X
for	B-X
degradation	B-X
in	B-X
addition	B-X
to	B-X
its	B-X
role	B-X
in	B-X
cyclin	B-X
E	B-X
proteolysis	B-X
.	B-X
Fbw7	B-X
thus	B-X
negatively	B-X
regulates	B-X
several	B-X
key	B-X
oncoproteins	B-X
.	B-X
Accordingly	B-X
,	B-X
Fbw7	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
human	B-X
cancers	B-X
,	B-X
and	B-X
Fbw7	B-X
functions	B-X
as	B-X
a	B-X
haploin	B-X
sufficient	B-X
tumor	B-X
suppressor	B-X
in	B-X
mice	B-X
.	B-X
Because	B-X
there	B-X
are	B-X
three	B-X
Fbw7	B-X
isoforms	B-X
that	B-X
reside	B-X
in	B-X
different	B-X
subcellular	B-X
compartments	B-X
,	B-X
as	B-X
well	B-X
as	B-X
multiple	B-X
Fbw7	B-X
substrates	B-X
that	B-X
are	B-X
the	B-X
products	B-X
of	B-X
proto-oncogenes	B-X
,	B-X
the	B-X
mechanisms	B-X
of	B-X
tumor	B-X
suppression	B-X
by	B-X
Fbw7	B-X
are	B-X
complex	B-X
and	B-X
incompletely	B-X
understood	B-X
.	B-X
In	B-X
this	B-X
review	B-X
we	B-X
discuss	B-X
the	B-X
activities	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
in	B-X
the	B-X
context	B-X
of	B-X
its	B-X
role	B-X
as	B-X
a	B-X
tumor	B-X
suppressor	B-X
and	B-X
highlight	B-X
recent	B-X
findings	B-X
demonstrating	B-X
that	B-X
dominant	B-X
oncogenes	B-X
disable	B-X
Fbw7	B-X
function	B-X
.	B-X

The	O
Fbw7	B-Gene_or_gene_product
/	O
hCdc4	B-Gene_or_gene_product
F	O
-	O
box	O
protein	O
was	O
first	O
recognized	O
by	O
its	O
ability	O
to	O
bind	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
,	O
and	O
the	O
SCF	O
(	O
Fbw7	O
)	O
is	O
now	O
known	O
to	O
target	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Myc	I-Gene_or_gene_product
,	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
Jun	I-Gene_or_gene_product
and	O
Notch	B-Gene_or_gene_product
for	O
degradation	O
in	O
addition	O
to	O
its	O
role	O
in	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
proteolysis	O
.	O

Fbw7	B-Gene_or_gene_product
thus	O
negatively	O
regulates	O
several	O
key	O
oncoproteins	O
.	O
<EOS>	B-X
The	B-X
Fbw7/hCdc4	B-X
F-box	B-X
protein	B-X
was	B-X
first	B-X
recognized	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
cyclin	B-X
E	B-X
,	B-X
and	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
is	B-X
now	B-X
known	B-X
to	B-X
target	B-X
c-Myc	B-X
,	B-X
c-Jun	B-X
and	B-X
Notch	B-X
for	B-X
degradation	B-X
in	B-X
addition	B-X
to	B-X
its	B-X
role	B-X
in	B-X
cyclin	B-X
E	B-X
proteolysis	B-X
.	B-X
Fbw7	B-X
thus	B-X
negatively	B-X
regulates	B-X
several	B-X
key	B-X
oncoproteins	B-X
.	B-X
Accordingly	B-X
,	B-X
Fbw7	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
human	B-X
cancers	B-X
,	B-X
and	B-X
Fbw7	B-X
functions	B-X
as	B-X
a	B-X
haploin	B-X
sufficient	B-X
tumor	B-X
suppressor	B-X
in	B-X
mice	B-X
.	B-X
Because	B-X
there	B-X
are	B-X
three	B-X
Fbw7	B-X
isoforms	B-X
that	B-X
reside	B-X
in	B-X
different	B-X
subcellular	B-X
compartments	B-X
,	B-X
as	B-X
well	B-X
as	B-X
multiple	B-X
Fbw7	B-X
substrates	B-X
that	B-X
are	B-X
the	B-X
products	B-X
of	B-X
proto-oncogenes	B-X
,	B-X
the	B-X
mechanisms	B-X
of	B-X
tumor	B-X
suppression	B-X
by	B-X
Fbw7	B-X
are	B-X
complex	B-X
and	B-X
incompletely	B-X
understood	B-X
.	B-X
In	B-X
this	B-X
review	B-X
we	B-X
discuss	B-X
the	B-X
activities	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
in	B-X
the	B-X
context	B-X
of	B-X
its	B-X
role	B-X
as	B-X
a	B-X
tumor	B-X
suppressor	B-X
and	B-X
highlight	B-X
recent	B-X
findings	B-X
demonstrating	B-X
that	B-X
dominant	B-X
oncogenes	B-X
disable	B-X
Fbw7	B-X
function	B-X
.	B-X

Accordingly	O
,	O
Fbw7	B-Gene_or_gene_product
is	O
a	O
tumor	O
suppressor	O
that	O
is	O
mutated	O
in	O
a	O
wide	O
spectrum	O
of	O
human	O
cancers	O
,	O
and	O
Fbw7	B-Gene_or_gene_product
functions	O
as	O
a	O
haploin	O
sufficient	O
tumor	O
suppressor	O
in	O
mice	O
.	O

Because	O
there	O
are	O
three	O
Fbw7	B-Gene_or_gene_product
isoforms	O
that	O
reside	O
in	O
different	O
subcellular	O
compartments	O
,	O
as	O
well	O
as	O
multiple	O
Fbw7	B-Gene_or_gene_product
substrates	O
that	O
are	O
the	O
products	O
of	O
proto	O
-	O
oncogenes	O
,	O
the	O
mechanisms	O
of	O
tumor	O
suppression	O
by	O
Fbw7	B-Gene_or_gene_product
are	O
complex	O
and	O
incompletely	O
understood	O
.	O
<EOS>	B-X
F-box	B-X
proteins	B-X
are	B-X
the	B-X
SCF	B-X
components	B-X
that	B-X
bind	B-X
to	B-X
substrates	B-X
,	B-X
and	B-X
this	B-X
binding	B-X
is	B-X
usually	B-X
signaled	B-X
by	B-X
substrate	B-X
phosphorylation	B-X
.	B-X
The	B-X
Fbw7/hCdc4	B-X
F-box	B-X
protein	B-X
was	B-X
first	B-X
recognized	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
cyclin	B-X
E	B-X
,	B-X
and	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
is	B-X
now	B-X
known	B-X
to	B-X
target	B-X
c-Myc	B-X
,	B-X
c-Jun	B-X
and	B-X
Notch	B-X
for	B-X
degradation	B-X
in	B-X
addition	B-X
to	B-X
its	B-X
role	B-X
in	B-X
cyclin	B-X
E	B-X
proteolysis	B-X
.	B-X
Fbw7	B-X
thus	B-X
negatively	B-X
regulates	B-X
several	B-X
key	B-X
oncoproteins	B-X
.	B-X
Accordingly	B-X
,	B-X
Fbw7	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
human	B-X
cancers	B-X
,	B-X
and	B-X
Fbw7	B-X
functions	B-X
as	B-X
a	B-X
haploin	B-X
sufficient	B-X
tumor	B-X
suppressor	B-X
in	B-X
mice	B-X
.	B-X
Because	B-X
there	B-X
are	B-X
three	B-X
Fbw7	B-X
isoforms	B-X
that	B-X
reside	B-X
in	B-X
different	B-X
subcellular	B-X
compartments	B-X
,	B-X
as	B-X
well	B-X
as	B-X
multiple	B-X
Fbw7	B-X
substrates	B-X
that	B-X
are	B-X
the	B-X
products	B-X
of	B-X
proto-oncogenes	B-X
,	B-X
the	B-X
mechanisms	B-X
of	B-X
tumor	B-X
suppression	B-X
by	B-X
Fbw7	B-X
are	B-X
complex	B-X
and	B-X
incompletely	B-X
understood	B-X
.	B-X
In	B-X
this	B-X
review	B-X
we	B-X
discuss	B-X
the	B-X
activities	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
in	B-X
the	B-X
context	B-X
of	B-X
its	B-X
role	B-X
as	B-X
a	B-X
tumor	B-X
suppressor	B-X
and	B-X
highlight	B-X
recent	B-X
findings	B-X
demonstrating	B-X
that	B-X
dominant	B-X
oncogenes	B-X
disable	B-X
Fbw7	B-X
function	B-X
.	B-X

In	O
this	O
review	O
we	O
discuss	O
the	O
activities	O
of	O
the	O
SCF	O
(	O
Fbw7	O
)	O
in	O
the	O
context	O
of	O
its	O
role	O
as	O
a	O
tumor	O
suppressor	O
and	O
highlight	O
recent	O
findings	O
demonstrating	O
that	O
dominant	O
oncogenes	O
disable	O
Fbw7	B-Gene_or_gene_product
function	O
.	O
<EOS>	B-X
SCF	B-X
ubiquitin	B-X
ligases	B-X
regulate	B-X
the	B-X
degradation	B-X
of	B-X
many	B-X
proteins	B-X
involved	B-X
in	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
division	B-X
and	B-X
growth	B-X
.	B-X
F-box	B-X
proteins	B-X
are	B-X
the	B-X
SCF	B-X
components	B-X
that	B-X
bind	B-X
to	B-X
substrates	B-X
,	B-X
and	B-X
this	B-X
binding	B-X
is	B-X
usually	B-X
signaled	B-X
by	B-X
substrate	B-X
phosphorylation	B-X
.	B-X
The	B-X
Fbw7/hCdc4	B-X
F-box	B-X
protein	B-X
was	B-X
first	B-X
recognized	B-X
by	B-X
its	B-X
ability	B-X
to	B-X
bind	B-X
cyclin	B-X
E	B-X
,	B-X
and	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
is	B-X
now	B-X
known	B-X
to	B-X
target	B-X
c-Myc	B-X
,	B-X
c-Jun	B-X
and	B-X
Notch	B-X
for	B-X
degradation	B-X
in	B-X
addition	B-X
to	B-X
its	B-X
role	B-X
in	B-X
cyclin	B-X
E	B-X
proteolysis	B-X
.	B-X
Fbw7	B-X
thus	B-X
negatively	B-X
regulates	B-X
several	B-X
key	B-X
oncoproteins	B-X
.	B-X
Accordingly	B-X
,	B-X
Fbw7	B-X
is	B-X
a	B-X
tumor	B-X
suppressor	B-X
that	B-X
is	B-X
mutated	B-X
in	B-X
a	B-X
wide	B-X
spectrum	B-X
of	B-X
human	B-X
cancers	B-X
,	B-X
and	B-X
Fbw7	B-X
functions	B-X
as	B-X
a	B-X
haploin	B-X
sufficient	B-X
tumor	B-X
suppressor	B-X
in	B-X
mice	B-X
.	B-X
Because	B-X
there	B-X
are	B-X
three	B-X
Fbw7	B-X
isoforms	B-X
that	B-X
reside	B-X
in	B-X
different	B-X
subcellular	B-X
compartments	B-X
,	B-X
as	B-X
well	B-X
as	B-X
multiple	B-X
Fbw7	B-X
substrates	B-X
that	B-X
are	B-X
the	B-X
products	B-X
of	B-X
proto-oncogenes	B-X
,	B-X
the	B-X
mechanisms	B-X
of	B-X
tumor	B-X
suppression	B-X
by	B-X
Fbw7	B-X
are	B-X
complex	B-X
and	B-X
incompletely	B-X
understood	B-X
.	B-X
In	B-X
this	B-X
review	B-X
we	B-X
discuss	B-X
the	B-X
activities	B-X
of	B-X
the	B-X
SCF	B-X
(	B-X
Fbw7	B-X
)	B-X
in	B-X
the	B-X
context	B-X
of	B-X
its	B-X
role	B-X
as	B-X
a	B-X
tumor	B-X
suppressor	B-X
and	B-X
highlight	B-X
recent	B-X
findings	B-X
demonstrating	B-X
that	B-X
dominant	B-X
oncogenes	B-X
disable	B-X
Fbw7	B-X
function	B-X
.	B-X

Identification	O
of	O
an	O
intestinal	O
heme	O
transporter	O
.	O
<EOS>	B-X
Dietary	B-X
heme	B-X
iron	B-X
is	B-X
an	B-X
important	B-X
nutritional	B-X
source	B-X
of	B-X
iron	B-X
in	B-X
carnivores	B-X
and	B-X
omnivores	B-X
that	B-X
is	B-X
more	B-X
readily	B-X
absorbed	B-X
than	B-X
non-heme	B-X
iron	B-X
derived	B-X
from	B-X
vegetables	B-X
and	B-X
grain	B-X
.	B-X
Most	B-X
heme	B-X
is	B-X
absorbed	B-X
in	B-X
the	B-X
proximal	B-X
intestine	B-X
,	B-X
with	B-X
absorptive	B-X
capacity	B-X
decreasing	B-X
distally	B-X
.	B-X
We	B-X
utilized	B-X
a	B-X
subtractive	B-X
hybridization	B-X
approach	B-X
to	B-X
isolate	B-X
a	B-X
heme	B-X
transporter	B-X
from	B-X
duodenum	B-X
by	B-X
taking	B-X
advantage	B-X
of	B-X
the	B-X
intestinal	B-X
gradient	B-X
for	B-X
heme	B-X
absorption	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
a	B-X
membrane	B-X
protein	B-X
named	B-X
HCP	B-X
1	B-X
(	B-X
heme	B-X
carrier	B-X
protein	B-X
1	B-X
)	B-X
,	B-X
with	B-X
homology	B-X
to	B-X
bacterial	B-X
metal-tetracycline	B-X
transporters	B-X
,	B-X
mediates	B-X
heme	B-X
uptake	B-X
by	B-X
cells	B-X
in	B-X
a	B-X
temperature-dependent	B-X
and	B-X
saturable	B-X
manner	B-X
.	B-X
Our	B-X
data	B-X
indicate	B-X
that	B-X
HCP	B-X
1	B-X
is	B-X
the	B-X
long-sought	B-X
intestinal	B-X
heme	B-X
transporter	B-X
.	B-X

Dietary	O
heme	O
iron	O
is	O
an	O
important	O
nutritional	O
source	O
of	O
iron	O
in	O
carnivores	O
and	O
omnivores	O
that	O
is	O
more	O
readily	O
absorbed	O
than	O
non	O
-	O
heme	O
iron	O
derived	O
from	O
vegetables	O
and	O
grain	O
.	O
<EOS>	B-X
Dietary	B-X
heme	B-X
iron	B-X
is	B-X
an	B-X
important	B-X
nutritional	B-X
source	B-X
of	B-X
iron	B-X
in	B-X
carnivores	B-X
and	B-X
omnivores	B-X
that	B-X
is	B-X
more	B-X
readily	B-X
absorbed	B-X
than	B-X
non-heme	B-X
iron	B-X
derived	B-X
from	B-X
vegetables	B-X
and	B-X
grain	B-X
.	B-X
Most	B-X
heme	B-X
is	B-X
absorbed	B-X
in	B-X
the	B-X
proximal	B-X
intestine	B-X
,	B-X
with	B-X
absorptive	B-X
capacity	B-X
decreasing	B-X
distally	B-X
.	B-X
We	B-X
utilized	B-X
a	B-X
subtractive	B-X
hybridization	B-X
approach	B-X
to	B-X
isolate	B-X
a	B-X
heme	B-X
transporter	B-X
from	B-X
duodenum	B-X
by	B-X
taking	B-X
advantage	B-X
of	B-X
the	B-X
intestinal	B-X
gradient	B-X
for	B-X
heme	B-X
absorption	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
a	B-X
membrane	B-X
protein	B-X
named	B-X
HCP	B-X
1	B-X
(	B-X
heme	B-X
carrier	B-X
protein	B-X
1	B-X
)	B-X
,	B-X
with	B-X
homology	B-X
to	B-X
bacterial	B-X
metal-tetracycline	B-X
transporters	B-X
,	B-X
mediates	B-X
heme	B-X
uptake	B-X
by	B-X
cells	B-X
in	B-X
a	B-X
temperature-dependent	B-X
and	B-X
saturable	B-X
manner	B-X
.	B-X
HCP	B-X
1	B-X
protein	B-X
was	B-X
iron	B-X
regulated	B-X
and	B-X
localized	B-X
to	B-X
the	B-X
brush-border	B-X
membrane	B-X
of	B-X
duodenal	B-X
enterocytes	B-X
in	B-X
iron	B-X
deficiency	B-X
.	B-X
Our	B-X
data	B-X
indicate	B-X
that	B-X
HCP	B-X
1	B-X
is	B-X
the	B-X
long-sought	B-X
intestinal	B-X
heme	B-X
transporter	B-X
.	B-X

Most	O
heme	O
is	O
absorbed	O
in	O
the	O
proximal	O
intestine	O
,	O
with	O
absorptive	O
capacity	O
decreasing	O
distally	O
.	O
<EOS>	B-X
Dietary	B-X
heme	B-X
iron	B-X
is	B-X
an	B-X
important	B-X
nutritional	B-X
source	B-X
of	B-X
iron	B-X
in	B-X
carnivores	B-X
and	B-X
omnivores	B-X
that	B-X
is	B-X
more	B-X
readily	B-X
absorbed	B-X
than	B-X
non-heme	B-X
iron	B-X
derived	B-X
from	B-X
vegetables	B-X
and	B-X
grain	B-X
.	B-X
Most	B-X
heme	B-X
is	B-X
absorbed	B-X
in	B-X
the	B-X
proximal	B-X
intestine	B-X
,	B-X
with	B-X
absorptive	B-X
capacity	B-X
decreasing	B-X
distally	B-X
.	B-X
We	B-X
utilized	B-X
a	B-X
subtractive	B-X
hybridization	B-X
approach	B-X
to	B-X
isolate	B-X
a	B-X
heme	B-X
transporter	B-X
from	B-X
duodenum	B-X
by	B-X
taking	B-X
advantage	B-X
of	B-X
the	B-X
intestinal	B-X
gradient	B-X
for	B-X
heme	B-X
absorption	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
a	B-X
membrane	B-X
protein	B-X
named	B-X
HCP	B-X
1	B-X
(	B-X
heme	B-X
carrier	B-X
protein	B-X
1	B-X
)	B-X
,	B-X
with	B-X
homology	B-X
to	B-X
bacterial	B-X
metal-tetracycline	B-X
transporters	B-X
,	B-X
mediates	B-X
heme	B-X
uptake	B-X
by	B-X
cells	B-X
in	B-X
a	B-X
temperature-dependent	B-X
and	B-X
saturable	B-X
manner	B-X
.	B-X
Our	B-X
data	B-X
indicate	B-X
that	B-X
HCP	B-X
1	B-X
is	B-X
the	B-X
long-sought	B-X
intestinal	B-X
heme	B-X
transporter	B-X
.	B-X

We	O
utilized	O
a	O
subtractive	O
hybridization	O
approach	O
to	O
isolate	O
a	O
heme	O
transporter	O
from	O
duodenum	O
by	O
taking	O
advantage	O
of	O
the	O
intestinal	O
gradient	O
for	O
heme	O
absorption	O
.	O
<EOS>	B-X
Dietary	B-X
heme	B-X
iron	B-X
is	B-X
an	B-X
important	B-X
nutritional	B-X
source	B-X
of	B-X
iron	B-X
in	B-X
carnivores	B-X
and	B-X
omnivores	B-X
that	B-X
is	B-X
more	B-X
readily	B-X
absorbed	B-X
than	B-X
non-heme	B-X
iron	B-X
derived	B-X
from	B-X
vegetables	B-X
and	B-X
grain	B-X
.	B-X
Most	B-X
heme	B-X
is	B-X
absorbed	B-X
in	B-X
the	B-X
proximal	B-X
intestine	B-X
,	B-X
with	B-X
absorptive	B-X
capacity	B-X
decreasing	B-X
distally	B-X
.	B-X
We	B-X
utilized	B-X
a	B-X
subtractive	B-X
hybridization	B-X
approach	B-X
to	B-X
isolate	B-X
a	B-X
heme	B-X
transporter	B-X
from	B-X
duodenum	B-X
by	B-X
taking	B-X
advantage	B-X
of	B-X
the	B-X
intestinal	B-X
gradient	B-X
for	B-X
heme	B-X
absorption	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
a	B-X
membrane	B-X
protein	B-X
named	B-X
HCP	B-X
1	B-X
(	B-X
heme	B-X
carrier	B-X
protein	B-X
1	B-X
)	B-X
,	B-X
with	B-X
homology	B-X
to	B-X
bacterial	B-X
metal-tetracycline	B-X
transporters	B-X
,	B-X
mediates	B-X
heme	B-X
uptake	B-X
by	B-X
cells	B-X
in	B-X
a	B-X
temperature-dependent	B-X
and	B-X
saturable	B-X
manner	B-X
.	B-X
HCP	B-X
1	B-X
mRNA	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
duodenum	B-X
and	B-X
regulated	B-X
by	B-X
hypoxia	B-X
.	B-X
Our	B-X
data	B-X
indicate	B-X
that	B-X
HCP	B-X
1	B-X
is	B-X
the	B-X
long-sought	B-X
intestinal	B-X
heme	B-X
transporter	B-X
.	B-X

Here	O
we	O
show	O
a	O
membrane	O
protein	O
named	O
HCP	B-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
heme	B-Gene_or_gene_product
carrier	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
1	I-Gene_or_gene_product
)	O
,	O
with	O
homology	O
to	O
bacterial	O
metal	O
-	O
tetracycline	O
transporters	O
,	O
mediates	O
heme	O
uptake	O
by	O
cells	O
in	O
a	O
temperature	O
-	O
dependent	O
and	O
saturable	O
manner	O
.	O

HCP	B-Gene_or_gene_product
1	I-Gene_or_gene_product
mRNA	O
was	O
highly	O
expressed	O
in	O
duodenum	O
and	O
regulated	O
by	O
hypoxia	O
.	O
<EOS>	B-X
We	B-X
utilized	B-X
a	B-X
subtractive	B-X
hybridization	B-X
approach	B-X
to	B-X
isolate	B-X
a	B-X
heme	B-X
transporter	B-X
from	B-X
duodenum	B-X
by	B-X
taking	B-X
advantage	B-X
of	B-X
the	B-X
intestinal	B-X
gradient	B-X
for	B-X
heme	B-X
absorption	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
a	B-X
membrane	B-X
protein	B-X
named	B-X
HCP	B-X
1	B-X
(	B-X
heme	B-X
carrier	B-X
protein	B-X
1	B-X
)	B-X
,	B-X
with	B-X
homology	B-X
to	B-X
bacterial	B-X
metal-tetracycline	B-X
transporters	B-X
,	B-X
mediates	B-X
heme	B-X
uptake	B-X
by	B-X
cells	B-X
in	B-X
a	B-X
temperature-dependent	B-X
and	B-X
saturable	B-X
manner	B-X
.	B-X
HCP	B-X
1	B-X
mRNA	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
duodenum	B-X
and	B-X
regulated	B-X
by	B-X
hypoxia	B-X
.	B-X
HCP	B-X
1	B-X
protein	B-X
was	B-X
iron	B-X
regulated	B-X
and	B-X
localized	B-X
to	B-X
the	B-X
brush-border	B-X
membrane	B-X
of	B-X
duodenal	B-X
enterocytes	B-X
in	B-X
iron	B-X
deficiency	B-X
.	B-X
Our	B-X
data	B-X
indicate	B-X
that	B-X
HCP	B-X
1	B-X
is	B-X
the	B-X
long-sought	B-X
intestinal	B-X
heme	B-X
transporter	B-X
.	B-X

HCP	B-Gene_or_gene_product
1	I-Gene_or_gene_product
protein	O
was	O
iron	O
regulated	O
and	O
localized	O
to	O
the	O
brush	O
-	O
border	O
membrane	O
of	O
duodenal	O
enterocytes	O
in	O
iron	O
deficiency	O
.	O

Our	O
data	O
indicate	O
that	O
HCP	B-Gene_or_gene_product
1	I-Gene_or_gene_product
is	O
the	O
long	O
-	O
sought	O
intestinal	O
heme	O
transporter	O
.	O

Rapid	O
,	O
Wnt	B-Gene_or_gene_product
-	O
induced	O
changes	O
in	O
GSK3beta	B-Gene_or_gene_product
associations	O
that	O
regulate	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
stabilization	O
are	O
mediated	O
by	O
Galpha	B-Gene_or_gene_product
proteins	O
.	O
<EOS>	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Wnt	B-X
stimulation	B-X
,	B-X
the	B-X
transcriptional	B-X
cofactor	B-X
beta-catenin	B-X
is	B-X
destabilized	B-X
via	B-X
phosphorylation	B-X
by	B-X
protein	B-X
kinase	B-X
GSK3beta	B-X
in	B-X
complex	B-X
with	B-X
Axin	B-X
family	B-X
members	B-X
.	B-X
In	B-X
the	B-X
``	B-X
canonical	B-X
''	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
,	B-X
Disheveled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
required	B-X
to	B-X
functionally	B-X
inhibit	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
GSK3beta/Axin	B-X
complex	B-X
and	B-X
thereby	B-X
stabilize	B-X
beta-catenin	B-X
.	B-X
Yet	B-X
,	B-X
the	B-X
mechanisms	B-X
that	B-X
underlie	B-X
Wnt	B-X
regulation	B-X
of	B-X
GSK3	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
are	B-X
still	B-X
not	B-X
fully	B-X
appreciated	B-X
.	B-X

BACKGROUND	O
:	O
In	O
the	O
absence	O
of	O
Wnt	B-Gene_or_gene_product
stimulation	O
,	O
the	O
transcriptional	O
cofactor	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
is	O
destabilized	O
via	O
phosphorylation	O
by	O
protein	O
kinase	O
GSK3beta	B-Gene_or_gene_product
in	O
complex	O
with	O
Axin	B-Gene_or_gene_product
family	O
members	O
.	O
<EOS>	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Wnt	B-X
stimulation	B-X
,	B-X
the	B-X
transcriptional	B-X
cofactor	B-X
beta-catenin	B-X
is	B-X
destabilized	B-X
via	B-X
phosphorylation	B-X
by	B-X
protein	B-X
kinase	B-X
GSK3beta	B-X
in	B-X
complex	B-X
with	B-X
Axin	B-X
family	B-X
members	B-X
.	B-X
In	B-X
the	B-X
``	B-X
canonical	B-X
''	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
,	B-X
Disheveled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
required	B-X
to	B-X
functionally	B-X
inhibit	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
GSK3beta/Axin	B-X
complex	B-X
and	B-X
thereby	B-X
stabilize	B-X
beta-catenin	B-X
.	B-X
Yet	B-X
,	B-X
the	B-X
mechanisms	B-X
that	B-X
underlie	B-X
Wnt	B-X
regulation	B-X
of	B-X
GSK3	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
are	B-X
still	B-X
not	B-X
fully	B-X
appreciated	B-X
.	B-X

In	O
the	O
"	O
canonical	O
"	O
Wnt	B-Gene_or_gene_product
signaling	O
pathway	O
,	O
Disheveled	B-Gene_or_gene_product
(	O
Dvl	B-Gene_or_gene_product
)	O
is	O
required	O
to	O
functionally	O
inhibit	O
the	O
activity	O
of	O
the	O
GSK3beta	O
/	O
Axin	O
complex	O
and	O
thereby	O
stabilize	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O

Yet	O
,	O
the	O
mechanisms	O
that	O
underlie	O
Wnt	B-Gene_or_gene_product
regulation	O
of	O
GSK3	B-Gene_or_gene_product
and	O
stabilization	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
are	O
still	O
not	O
fully	O
appreciated	O
.	O

RESULTS	O
:	O
Here	O
,	O
we	O
examine	O
time	O
-	O
dependent	O
changes	O
in	O
protein	O
-	O
protein	O
interactions	O
that	O
occur	O
in	O
response	O
to	O
Wnt	B-Gene_or_gene_product
treatment	O
.	O
<EOS>	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Wnt	B-X
stimulation	B-X
,	B-X
the	B-X
transcriptional	B-X
cofactor	B-X
beta-catenin	B-X
is	B-X
destabilized	B-X
via	B-X
phosphorylation	B-X
by	B-X
protein	B-X
kinase	B-X
GSK3beta	B-X
in	B-X
complex	B-X
with	B-X
Axin	B-X
family	B-X
members	B-X
.	B-X
In	B-X
the	B-X
``	B-X
canonical	B-X
''	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
,	B-X
Disheveled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
required	B-X
to	B-X
functionally	B-X
inhibit	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
GSK3beta/Axin	B-X
complex	B-X
and	B-X
thereby	B-X
stabilize	B-X
beta-catenin	B-X
.	B-X
Yet	B-X
,	B-X
the	B-X
mechanisms	B-X
that	B-X
underlie	B-X
Wnt	B-X
regulation	B-X
of	B-X
GSK3	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
are	B-X
still	B-X
not	B-X
fully	B-X
appreciated	B-X
.	B-X

We	O
show	O
that	O
GSK3beta	O
/	O
Axin	O
complexes	O
are	O
rapidly	O
(	O
t1	O
/	O
2	O
<	O
3	O
min	O
)	O
disrupted	O
upon	O
Wnt	B-Gene_or_gene_product
stimulation	O
and	O
that	O
changes	O
in	O
GSK3beta	O
/	O
Axin	O
association	O
substantially	O
precede	O
both	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
stabilization	O
and	O
Axin	B-Gene_or_gene_product
degradation	O
.	O
<EOS>	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Wnt	B-X
stimulation	B-X
,	B-X
the	B-X
transcriptional	B-X
cofactor	B-X
beta-catenin	B-X
is	B-X
destabilized	B-X
via	B-X
phosphorylation	B-X
by	B-X
protein	B-X
kinase	B-X
GSK3beta	B-X
in	B-X
complex	B-X
with	B-X
Axin	B-X
family	B-X
members	B-X
.	B-X
In	B-X
the	B-X
``	B-X
canonical	B-X
''	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
,	B-X
Disheveled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
required	B-X
to	B-X
functionally	B-X
inhibit	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
GSK3beta/Axin	B-X
complex	B-X
and	B-X
thereby	B-X
stabilize	B-X
beta-catenin	B-X
.	B-X
Yet	B-X
,	B-X
the	B-X
mechanisms	B-X
that	B-X
underlie	B-X
Wnt	B-X
regulation	B-X
of	B-X
GSK3	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
are	B-X
still	B-X
not	B-X
fully	B-X
appreciated	B-X
.	B-X

We	O
further	O
demonstrate	O
that	O
depletion	O
of	O
Galpha	B-Gene_or_gene_product
(	I-Gene_or_gene_product
o	I-Gene_or_gene_product
)	I-Gene_or_gene_product
or	O
Galpha	B-Gene_or_gene_product
(	I-Gene_or_gene_product
q	I-Gene_or_gene_product
)	I-Gene_or_gene_product
will	O
inhibit	O
,	O
respectively	O
,	O
the	O
Wnt	B-Gene_or_gene_product
-	O
induced	O
disruption	O
of	O
GSK3beta	O
/	O
Axin2	O
and	O
GSK3beta	O
/	O
Axin	O
complexes	O
and	O
diminish	O
Wnt	B-Gene_or_gene_product
stabilization	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Wnt	B-X
stimulation	B-X
,	B-X
the	B-X
transcriptional	B-X
cofactor	B-X
beta-catenin	B-X
is	B-X
destabilized	B-X
via	B-X
phosphorylation	B-X
by	B-X
protein	B-X
kinase	B-X
GSK3beta	B-X
in	B-X
complex	B-X
with	B-X
Axin	B-X
family	B-X
members	B-X
.	B-X
In	B-X
the	B-X
``	B-X
canonical	B-X
''	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
,	B-X
Disheveled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
required	B-X
to	B-X
functionally	B-X
inhibit	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
GSK3beta/Axin	B-X
complex	B-X
and	B-X
thereby	B-X
stabilize	B-X
beta-catenin	B-X
.	B-X
Yet	B-X
,	B-X
the	B-X
mechanisms	B-X
that	B-X
underlie	B-X
Wnt	B-X
regulation	B-X
of	B-X
GSK3	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
are	B-X
still	B-X
not	B-X
fully	B-X
appreciated	B-X
.	B-X

We	O
also	O
show	O
that	O
direct	O
activation	O
of	O
G	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
in	O
vivo	O
with	O
GTPgammaS	B-Gene_or_gene_product
in	O
the	O
absence	O
of	O
exogenous	O
Wnt	B-Gene_or_gene_product
will	O
disrupt	O
GSK3beta	O
/	O
Axin2	O
complexes	O
and	O
stabilize	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Wnt	B-X
stimulation	B-X
,	B-X
the	B-X
transcriptional	B-X
cofactor	B-X
beta-catenin	B-X
is	B-X
destabilized	B-X
via	B-X
phosphorylation	B-X
by	B-X
protein	B-X
kinase	B-X
GSK3beta	B-X
in	B-X
complex	B-X
with	B-X
Axin	B-X
family	B-X
members	B-X
.	B-X
In	B-X
the	B-X
``	B-X
canonical	B-X
''	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
,	B-X
Disheveled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
required	B-X
to	B-X
functionally	B-X
inhibit	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
GSK3beta/Axin	B-X
complex	B-X
and	B-X
thereby	B-X
stabilize	B-X
beta-catenin	B-X
.	B-X
Yet	B-X
,	B-X
the	B-X
mechanisms	B-X
that	B-X
underlie	B-X
Wnt	B-X
regulation	B-X
of	B-X
GSK3	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
are	B-X
still	B-X
not	B-X
fully	B-X
appreciated	B-X
.	B-X

Finally	O
,	O
we	O
demonstrate	O
an	O
association	O
of	O
Galpha	B-Gene_or_gene_product
(	I-Gene_or_gene_product
o	I-Gene_or_gene_product
)	I-Gene_or_gene_product
with	O
Fz	B-Gene_or_gene_product
that	O
is	O
also	O
very	O
rapidly	O
(	O
t1	O
/	O
2	O
<	O
1	O
min	O
)	O
perturbed	O
upon	O
Wnt	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3a	I-Gene_or_gene_product
stimulation	O
and	O
that	O
the	O
Wnt	B-Gene_or_gene_product
-	O
dependent	O
effects	O
on	O
both	O
GSK3beta	O
/	O
Axin2	O
and	O
Galpha	O
(	O
o	O
)	O
/	O
Fz	O
are	O
pertussis	O
-	O
toxin	O
sensitive	O
.	O
<EOS>	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
Wnt	B-X
stimulation	B-X
,	B-X
the	B-X
transcriptional	B-X
cofactor	B-X
beta-catenin	B-X
is	B-X
destabilized	B-X
via	B-X
phosphorylation	B-X
by	B-X
protein	B-X
kinase	B-X
GSK3beta	B-X
in	B-X
complex	B-X
with	B-X
Axin	B-X
family	B-X
members	B-X
.	B-X
In	B-X
the	B-X
``	B-X
canonical	B-X
''	B-X
Wnt	B-X
signaling	B-X
pathway	B-X
,	B-X
Disheveled	B-X
(	B-X
Dvl	B-X
)	B-X
is	B-X
required	B-X
to	B-X
functionally	B-X
inhibit	B-X
the	B-X
activity	B-X
of	B-X
the	B-X
GSK3beta/Axin	B-X
complex	B-X
and	B-X
thereby	B-X
stabilize	B-X
beta-catenin	B-X
.	B-X
Yet	B-X
,	B-X
the	B-X
mechanisms	B-X
that	B-X
underlie	B-X
Wnt	B-X
regulation	B-X
of	B-X
GSK3	B-X
and	B-X
stabilization	B-X
of	B-X
beta-catenin	B-X
are	B-X
still	B-X
not	B-X
fully	B-X
appreciated	B-X
.	B-X

Collectively	O
,	O
these	O
data	O
implicate	O
a	O
role	O
for	O
G	B-Gene_or_gene_product
proteins	I-Gene_or_gene_product
in	O
the	O
regulation	O
of	O
Wnt	B-Gene_or_gene_product
-	O
mediated	O
protein	O
-	O
protein	O
interactions	O
and	O
signaling	O
to	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O

CONCLUSIONS	O
:	O
We	O
conclude	O
that	O
rapid	O
disruption	O
of	O
GSK3beta	O
/	O
Axin	O
interactions	O
in	O
response	O
to	O
Wnt	B-Gene_or_gene_product
leads	O
to	O
the	O
initial	O
stabilization	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
that	O
Galpha	B-Gene_or_gene_product
(	I-Gene_or_gene_product
o	I-Gene_or_gene_product
)	I-Gene_or_gene_product
and	O
Galpha	B-Gene_or_gene_product
(	I-Gene_or_gene_product
q	I-Gene_or_gene_product
)	I-Gene_or_gene_product
signaling	O
contributes	O
to	O
Wnt	B-Gene_or_gene_product
-	O
mediated	O
GSK3beta	O
/	O
Axin	O
disruption	O
and	O
the	O
ultimate	O
stabilization	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
.	O

Activation	O
of	O
the	O
checkpoint	O
kinase	O
Rad53	B-Gene_or_gene_product
by	O
the	O
phosphatidyl	B-Gene_or_gene_product
inositol	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
Mec1	B-Gene_or_gene_product
.	O
<EOS>	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
,	B-X
the	B-X
ortholog	B-X
of	B-X
mammalian	B-X
Chk2	B-X
,	B-X
is	B-X
an	B-X
essential	B-X
protein	B-X
kinase	B-X
in	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replication	B-X
checkpoint	B-X
pathways	B-X
.	B-X
Consecutive	B-X
phosphatidyl	B-X
inositol	B-X
kinase-like	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
-dependent	B-X
and	B-X
PIKK-independent	B-X
steps	B-X
in	B-X
activation	B-X
of	B-X
Rad53	B-X
are	B-X
key	B-X
steps	B-X
for	B-X
controlling	B-X
and	B-X
transmitting	B-X
diverse	B-X
downstream	B-X
responses	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
enzymatically	B-X
dephosphorylated	B-X
purified	B-X
Rad53	B-X
autoactivates	B-X
in	B-X
vitro	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
.	B-X
Kinetic	B-X
analysis	B-X
demonstrated	B-X
that	B-X
autophosphorylation	B-X
results	B-X
in	B-X
a	B-X
more	B-X
than	B-X
9-fold	B-X
increase	B-X
in	B-X
protein	B-X
kinase	B-X
activity	B-X
.	B-X
Autophosphorylation	B-X
was	B-X
Rad53	B-X
concentration-dependent	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
reaction	B-X
follows	B-X
an	B-X
intermolecular	B-X
mechanism	B-X
.	B-X
DNA	B-X
damage	B-X
induced	B-X
oligomerization	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
Rad53	B-X
molecules	B-X
in	B-X
vivo	B-X
.	B-X
At	B-X
low	B-X
concentrations	B-X
of	B-X
Rad53	B-X
,	B-X
preincubation	B-X
of	B-X
Rad53	B-X
with	B-X
immune	B-X
complexes	B-X
containing	B-X
the	B-X
Mec1/Ddc2	B-X
complex	B-X
can	B-X
activate	B-X
Rad53	B-X
kinase	B-X
activity	B-X
.	B-X
Our	B-X
findings	B-X
showed	B-X
that	B-X
Mec1/Ddc2	B-X
complexes	B-X
can	B-X
directly	B-X
activate	B-X
Rad53	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
,	B-X
and	B-X
more	B-X
generally	B-X
,	B-X
supported	B-X
the	B-X
hypothesis	B-X
that	B-X
PIKKs	B-X
regulate	B-X
Chk2	B-X
orthologs	B-X
through	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
this	B-X
work	B-X
has	B-X
substantiated	B-X
a	B-X
model	B-X
for	B-X
PIKK-independent	B-X
amplification	B-X
of	B-X
Rad53	B-X
activation	B-X
(	B-X
and	B-X
by	B-X
extension	B-X
,	B-X
activation	B-X
of	B-X
other	B-X
Chk2	B-X
orthologs	B-X
)	B-X
mediated	B-X
by	B-X
inter-Rad53	B-X
phosphorylation	B-X
.	B-X

Saccharomyces	O
cerevisiae	O
Rad53	B-Gene_or_gene_product
,	O
the	O
ortholog	O
of	O
mammalian	O
Chk2	B-Gene_or_gene_product
,	O
is	O
an	O
essential	O
protein	O
kinase	O
in	O
DNA	O
damage	O
and	O
DNA	O
replication	O
checkpoint	O
pathways	O
.	O
<EOS>	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
,	B-X
the	B-X
ortholog	B-X
of	B-X
mammalian	B-X
Chk2	B-X
,	B-X
is	B-X
an	B-X
essential	B-X
protein	B-X
kinase	B-X
in	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replication	B-X
checkpoint	B-X
pathways	B-X
.	B-X
Consecutive	B-X
phosphatidyl	B-X
inositol	B-X
kinase-like	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
-dependent	B-X
and	B-X
PIKK-independent	B-X
steps	B-X
in	B-X
activation	B-X
of	B-X
Rad53	B-X
are	B-X
key	B-X
steps	B-X
for	B-X
controlling	B-X
and	B-X
transmitting	B-X
diverse	B-X
downstream	B-X
responses	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
enzymatically	B-X
dephosphorylated	B-X
purified	B-X
Rad53	B-X
autoactivates	B-X
in	B-X
vitro	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
.	B-X
Kinetic	B-X
analysis	B-X
demonstrated	B-X
that	B-X
autophosphorylation	B-X
results	B-X
in	B-X
a	B-X
more	B-X
than	B-X
9-fold	B-X
increase	B-X
in	B-X
protein	B-X
kinase	B-X
activity	B-X
.	B-X
Autophosphorylation	B-X
was	B-X
Rad53	B-X
concentration-dependent	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
reaction	B-X
follows	B-X
an	B-X
intermolecular	B-X
mechanism	B-X
.	B-X
DNA	B-X
damage	B-X
induced	B-X
oligomerization	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
Rad53	B-X
molecules	B-X
in	B-X
vivo	B-X
.	B-X
At	B-X
low	B-X
concentrations	B-X
of	B-X
Rad53	B-X
,	B-X
preincubation	B-X
of	B-X
Rad53	B-X
with	B-X
immune	B-X
complexes	B-X
containing	B-X
the	B-X
Mec1/Ddc2	B-X
complex	B-X
can	B-X
activate	B-X
Rad53	B-X
kinase	B-X
activity	B-X
.	B-X
Our	B-X
findings	B-X
showed	B-X
that	B-X
Mec1/Ddc2	B-X
complexes	B-X
can	B-X
directly	B-X
activate	B-X
Rad53	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
,	B-X
and	B-X
more	B-X
generally	B-X
,	B-X
supported	B-X
the	B-X
hypothesis	B-X
that	B-X
PIKKs	B-X
regulate	B-X
Chk2	B-X
orthologs	B-X
through	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
this	B-X
work	B-X
has	B-X
substantiated	B-X
a	B-X
model	B-X
for	B-X
PIKK-independent	B-X
amplification	B-X
of	B-X
Rad53	B-X
activation	B-X
(	B-X
and	B-X
by	B-X
extension	B-X
,	B-X
activation	B-X
of	B-X
other	B-X
Chk2	B-X
orthologs	B-X
)	B-X
mediated	B-X
by	B-X
inter-Rad53	B-X
phosphorylation	B-X
.	B-X

Consecutive	O
phosphatidyl	B-Gene_or_gene_product
inositol	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
like	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
PIKK	B-Gene_or_gene_product
)	O
-	O
dependent	O
and	O
PIKK	B-Gene_or_gene_product
-	O
independent	O
steps	O
in	O
activation	O
of	O
Rad53	B-Gene_or_gene_product
are	O
key	O
steps	O
for	O
controlling	O
and	O
transmitting	O
diverse	O
downstream	O
responses	O
to	O
DNA	O
damage	O
.	O
<EOS>	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
,	B-X
the	B-X
ortholog	B-X
of	B-X
mammalian	B-X
Chk2	B-X
,	B-X
is	B-X
an	B-X
essential	B-X
protein	B-X
kinase	B-X
in	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replication	B-X
checkpoint	B-X
pathways	B-X
.	B-X
Consecutive	B-X
phosphatidyl	B-X
inositol	B-X
kinase-like	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
-dependent	B-X
and	B-X
PIKK-independent	B-X
steps	B-X
in	B-X
activation	B-X
of	B-X
Rad53	B-X
are	B-X
key	B-X
steps	B-X
for	B-X
controlling	B-X
and	B-X
transmitting	B-X
diverse	B-X
downstream	B-X
responses	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
enzymatically	B-X
dephosphorylated	B-X
purified	B-X
Rad53	B-X
autoactivates	B-X
in	B-X
vitro	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
.	B-X
Kinetic	B-X
analysis	B-X
demonstrated	B-X
that	B-X
autophosphorylation	B-X
results	B-X
in	B-X
a	B-X
more	B-X
than	B-X
9-fold	B-X
increase	B-X
in	B-X
protein	B-X
kinase	B-X
activity	B-X
.	B-X
Autophosphorylation	B-X
was	B-X
Rad53	B-X
concentration-dependent	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
reaction	B-X
follows	B-X
an	B-X
intermolecular	B-X
mechanism	B-X
.	B-X
DNA	B-X
damage	B-X
induced	B-X
oligomerization	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
Rad53	B-X
molecules	B-X
in	B-X
vivo	B-X
.	B-X
At	B-X
low	B-X
concentrations	B-X
of	B-X
Rad53	B-X
,	B-X
preincubation	B-X
of	B-X
Rad53	B-X
with	B-X
immune	B-X
complexes	B-X
containing	B-X
the	B-X
Mec1/Ddc2	B-X
complex	B-X
can	B-X
activate	B-X
Rad53	B-X
kinase	B-X
activity	B-X
.	B-X
Our	B-X
findings	B-X
showed	B-X
that	B-X
Mec1/Ddc2	B-X
complexes	B-X
can	B-X
directly	B-X
activate	B-X
Rad53	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
,	B-X
and	B-X
more	B-X
generally	B-X
,	B-X
supported	B-X
the	B-X
hypothesis	B-X
that	B-X
PIKKs	B-X
regulate	B-X
Chk2	B-X
orthologs	B-X
through	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
this	B-X
work	B-X
has	B-X
substantiated	B-X
a	B-X
model	B-X
for	B-X
PIKK-independent	B-X
amplification	B-X
of	B-X
Rad53	B-X
activation	B-X
(	B-X
and	B-X
by	B-X
extension	B-X
,	B-X
activation	B-X
of	B-X
other	B-X
Chk2	B-X
orthologs	B-X
)	B-X
mediated	B-X
by	B-X
inter-Rad53	B-X
phosphorylation	B-X
.	B-X

However	O
,	O
these	O
activities	O
have	O
not	O
been	O
demonstrated	O
in	O
vitro	O
in	O
defined	O
systems	O
.	O
<EOS>	B-X
However	B-X
,	B-X
despite	B-X
the	B-X
large	B-X
potential	B-X
of	B-X
these	B-X
behaviors	B-X
to	B-X
drive	B-X
brain-wide	B-X
activity	B-X
,	B-X
these	B-X
fidget-like	B-X
behaviors	B-X
are	B-X
rarely	B-X
monitored	B-X
.	B-X
However	B-X
,	B-X
in	B-X
this	B-X
body	B-X
of	B-X
literature	B-X
,	B-X
attention	B-X
has	B-X
not	B-X
been	B-X
paid	B-X
to	B-X
the	B-X
extensive	B-X
documentation	B-X
on	B-X
occupational	B-X
physical	B-X
activity	B-X
imposing	B-X
a	B-X
risk	B-X
of	B-X
impairment	B-X
of	B-X
health	B-X
-	B-X
in	B-X
particular	B-X
musculoskeletal	B-X
health	B-X
in	B-X
terms	B-X
of	B-X
muscle	B-X
pain	B-X
.	B-X
In	B-X
contrast	B-X
during	B-X
physical	B-X
activities	B-X
at	B-X
leisure	B-X
and	B-X
sport	B-X
the	B-X
motor	B-X
recruitment	B-X
patterns	B-X
are	B-X
more	B-X
dynamic	B-X
including	B-X
regularly	B-X
relatively	B-X
high	B-X
muscle	B-X
forces	B-X
-	B-X
also	B-X
activating	B-X
type	B-X
2	B-X
muscles	B-X
fibers	B-X
-	B-X
as	B-X
well	B-X
as	B-X
periods	B-X
of	B-X
full	B-X
relaxation	B-X
even	B-X
of	B-X
the	B-X
type	B-X
1	B-X
muscle	B-X
fibers	B-X
.	B-X
However	B-X
,	B-X
delayed	B-X
muscle	B-X
soreness	B-X
may	B-X
develop	B-X
following	B-X
intensive	B-X
eccentric	B-X
muscle	B-X
activity	B-X
(	B-X
e.g	B-X
.	B-X

Here	O
,	O
we	O
have	O
shown	O
that	O
enzymatically	O
dephosphorylated	O
purified	O
Rad53	B-Gene_or_gene_product
autoactivates	O
in	O
vitro	O
through	O
a	O
phosphorylation	O
-	O
dependent	O
mechanism	O
.	O
<EOS>	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
,	B-X
the	B-X
ortholog	B-X
of	B-X
mammalian	B-X
Chk2	B-X
,	B-X
is	B-X
an	B-X
essential	B-X
protein	B-X
kinase	B-X
in	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replication	B-X
checkpoint	B-X
pathways	B-X
.	B-X
Consecutive	B-X
phosphatidyl	B-X
inositol	B-X
kinase-like	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
-dependent	B-X
and	B-X
PIKK-independent	B-X
steps	B-X
in	B-X
activation	B-X
of	B-X
Rad53	B-X
are	B-X
key	B-X
steps	B-X
for	B-X
controlling	B-X
and	B-X
transmitting	B-X
diverse	B-X
downstream	B-X
responses	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
However	B-X
,	B-X
these	B-X
activities	B-X
have	B-X
not	B-X
been	B-X
demonstrated	B-X
in	B-X
vitro	B-X
in	B-X
defined	B-X
systems	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
enzymatically	B-X
dephosphorylated	B-X
purified	B-X
Rad53	B-X
autoactivates	B-X
in	B-X
vitro	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
.	B-X
Kinetic	B-X
analysis	B-X
demonstrated	B-X
that	B-X
autophosphorylation	B-X
results	B-X
in	B-X
a	B-X
more	B-X
than	B-X
9-fold	B-X
increase	B-X
in	B-X
protein	B-X
kinase	B-X
activity	B-X
.	B-X
Autophosphorylation	B-X
was	B-X
Rad53	B-X
concentration-dependent	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
reaction	B-X
follows	B-X
an	B-X
intermolecular	B-X
mechanism	B-X
.	B-X
DNA	B-X
damage	B-X
induced	B-X
oligomerization	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
Rad53	B-X
molecules	B-X
in	B-X
vivo	B-X
.	B-X
At	B-X
low	B-X
concentrations	B-X
of	B-X
Rad53	B-X
,	B-X
preincubation	B-X
of	B-X
Rad53	B-X
with	B-X
immune	B-X
complexes	B-X
containing	B-X
the	B-X
Mec1/Ddc2	B-X
complex	B-X
can	B-X
activate	B-X
Rad53	B-X
kinase	B-X
activity	B-X
.	B-X
Our	B-X
findings	B-X
showed	B-X
that	B-X
Mec1/Ddc2	B-X
complexes	B-X
can	B-X
directly	B-X
activate	B-X
Rad53	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
,	B-X
and	B-X
more	B-X
generally	B-X
,	B-X
supported	B-X
the	B-X
hypothesis	B-X
that	B-X
PIKKs	B-X
regulate	B-X
Chk2	B-X
orthologs	B-X
through	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
this	B-X
work	B-X
has	B-X
substantiated	B-X
a	B-X
model	B-X
for	B-X
PIKK-independent	B-X
amplification	B-X
of	B-X
Rad53	B-X
activation	B-X
(	B-X
and	B-X
by	B-X
extension	B-X
,	B-X
activation	B-X
of	B-X
other	B-X
Chk2	B-X
orthologs	B-X
)	B-X
mediated	B-X
by	B-X
inter-Rad53	B-X
phosphorylation	B-X
.	B-X

Kinetic	O
analysis	O
demonstrated	O
that	O
autophosphorylation	O
results	O
in	O
a	O
more	O
than	O
9	O
-	O
fold	O
increase	O
in	O
protein	O
kinase	O
activity	O
.	O

Autophosphorylation	O
was	O
Rad53	B-Gene_or_gene_product
concentration	O
-	O
dependent	O
,	O
indicating	O
that	O
the	O
reaction	O
follows	O
an	O
intermolecular	O
mechanism	O
.	O
<EOS>	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
,	B-X
the	B-X
ortholog	B-X
of	B-X
mammalian	B-X
Chk2	B-X
,	B-X
is	B-X
an	B-X
essential	B-X
protein	B-X
kinase	B-X
in	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replication	B-X
checkpoint	B-X
pathways	B-X
.	B-X
Consecutive	B-X
phosphatidyl	B-X
inositol	B-X
kinase-like	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
-dependent	B-X
and	B-X
PIKK-independent	B-X
steps	B-X
in	B-X
activation	B-X
of	B-X
Rad53	B-X
are	B-X
key	B-X
steps	B-X
for	B-X
controlling	B-X
and	B-X
transmitting	B-X
diverse	B-X
downstream	B-X
responses	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
enzymatically	B-X
dephosphorylated	B-X
purified	B-X
Rad53	B-X
autoactivates	B-X
in	B-X
vitro	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
.	B-X
Autophosphorylation	B-X
was	B-X
Rad53	B-X
concentration-dependent	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
reaction	B-X
follows	B-X
an	B-X
intermolecular	B-X
mechanism	B-X
.	B-X
DNA	B-X
damage	B-X
induced	B-X
oligomerization	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
Rad53	B-X
molecules	B-X
in	B-X
vivo	B-X
.	B-X
At	B-X
low	B-X
concentrations	B-X
of	B-X
Rad53	B-X
,	B-X
preincubation	B-X
of	B-X
Rad53	B-X
with	B-X
immune	B-X
complexes	B-X
containing	B-X
the	B-X
Mec1/Ddc2	B-X
complex	B-X
can	B-X
activate	B-X
Rad53	B-X
kinase	B-X
activity	B-X
.	B-X
Our	B-X
findings	B-X
showed	B-X
that	B-X
Mec1/Ddc2	B-X
complexes	B-X
can	B-X
directly	B-X
activate	B-X
Rad53	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
,	B-X
and	B-X
more	B-X
generally	B-X
,	B-X
supported	B-X
the	B-X
hypothesis	B-X
that	B-X
PIKKs	B-X
regulate	B-X
Chk2	B-X
orthologs	B-X
through	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
this	B-X
work	B-X
has	B-X
substantiated	B-X
a	B-X
model	B-X
for	B-X
PIKK-independent	B-X
amplification	B-X
of	B-X
Rad53	B-X
activation	B-X
(	B-X
and	B-X
by	B-X
extension	B-X
,	B-X
activation	B-X
of	B-X
other	B-X
Chk2	B-X
orthologs	B-X
)	B-X
mediated	B-X
by	B-X
inter-Rad53	B-X
phosphorylation	B-X
.	B-X

DNA	O
damage	O
induced	O
oligomerization	O
of	O
a	O
subset	O
of	O
Rad53	B-Gene_or_gene_product
molecules	O
in	O
vivo	O
.	O
<EOS>	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
,	B-X
the	B-X
ortholog	B-X
of	B-X
mammalian	B-X
Chk2	B-X
,	B-X
is	B-X
an	B-X
essential	B-X
protein	B-X
kinase	B-X
in	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replication	B-X
checkpoint	B-X
pathways	B-X
.	B-X
Consecutive	B-X
phosphatidyl	B-X
inositol	B-X
kinase-like	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
-dependent	B-X
and	B-X
PIKK-independent	B-X
steps	B-X
in	B-X
activation	B-X
of	B-X
Rad53	B-X
are	B-X
key	B-X
steps	B-X
for	B-X
controlling	B-X
and	B-X
transmitting	B-X
diverse	B-X
downstream	B-X
responses	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
enzymatically	B-X
dephosphorylated	B-X
purified	B-X
Rad53	B-X
autoactivates	B-X
in	B-X
vitro	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
.	B-X
Autophosphorylation	B-X
was	B-X
Rad53	B-X
concentration-dependent	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
reaction	B-X
follows	B-X
an	B-X
intermolecular	B-X
mechanism	B-X
.	B-X
DNA	B-X
damage	B-X
induced	B-X
oligomerization	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
Rad53	B-X
molecules	B-X
in	B-X
vivo	B-X
.	B-X
At	B-X
low	B-X
concentrations	B-X
of	B-X
Rad53	B-X
,	B-X
preincubation	B-X
of	B-X
Rad53	B-X
with	B-X
immune	B-X
complexes	B-X
containing	B-X
the	B-X
Mec1/Ddc2	B-X
complex	B-X
can	B-X
activate	B-X
Rad53	B-X
kinase	B-X
activity	B-X
.	B-X
Our	B-X
findings	B-X
showed	B-X
that	B-X
Mec1/Ddc2	B-X
complexes	B-X
can	B-X
directly	B-X
activate	B-X
Rad53	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
,	B-X
and	B-X
more	B-X
generally	B-X
,	B-X
supported	B-X
the	B-X
hypothesis	B-X
that	B-X
PIKKs	B-X
regulate	B-X
Chk2	B-X
orthologs	B-X
through	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
this	B-X
work	B-X
has	B-X
substantiated	B-X
a	B-X
model	B-X
for	B-X
PIKK-independent	B-X
amplification	B-X
of	B-X
Rad53	B-X
activation	B-X
(	B-X
and	B-X
by	B-X
extension	B-X
,	B-X
activation	B-X
of	B-X
other	B-X
Chk2	B-X
orthologs	B-X
)	B-X
mediated	B-X
by	B-X
inter-Rad53	B-X
phosphorylation	B-X
.	B-X

At	O
low	O
concentrations	O
of	O
Rad53	B-Gene_or_gene_product
,	O
preincubation	O
of	O
Rad53	B-Gene_or_gene_product
with	O
immune	O
complexes	O
containing	O
the	O
Mec1	O
/	O
Ddc2	O
complex	O
can	O
activate	O
Rad53	B-Gene_or_gene_product
kinase	O
activity	O
.	O
<EOS>	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
,	B-X
the	B-X
ortholog	B-X
of	B-X
mammalian	B-X
Chk2	B-X
,	B-X
is	B-X
an	B-X
essential	B-X
protein	B-X
kinase	B-X
in	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replication	B-X
checkpoint	B-X
pathways	B-X
.	B-X
Consecutive	B-X
phosphatidyl	B-X
inositol	B-X
kinase-like	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
-dependent	B-X
and	B-X
PIKK-independent	B-X
steps	B-X
in	B-X
activation	B-X
of	B-X
Rad53	B-X
are	B-X
key	B-X
steps	B-X
for	B-X
controlling	B-X
and	B-X
transmitting	B-X
diverse	B-X
downstream	B-X
responses	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
enzymatically	B-X
dephosphorylated	B-X
purified	B-X
Rad53	B-X
autoactivates	B-X
in	B-X
vitro	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
.	B-X
Kinetic	B-X
analysis	B-X
demonstrated	B-X
that	B-X
autophosphorylation	B-X
results	B-X
in	B-X
a	B-X
more	B-X
than	B-X
9-fold	B-X
increase	B-X
in	B-X
protein	B-X
kinase	B-X
activity	B-X
.	B-X
Autophosphorylation	B-X
was	B-X
Rad53	B-X
concentration-dependent	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
reaction	B-X
follows	B-X
an	B-X
intermolecular	B-X
mechanism	B-X
.	B-X
DNA	B-X
damage	B-X
induced	B-X
oligomerization	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
Rad53	B-X
molecules	B-X
in	B-X
vivo	B-X
.	B-X
At	B-X
low	B-X
concentrations	B-X
of	B-X
Rad53	B-X
,	B-X
preincubation	B-X
of	B-X
Rad53	B-X
with	B-X
immune	B-X
complexes	B-X
containing	B-X
the	B-X
Mec1/Ddc2	B-X
complex	B-X
can	B-X
activate	B-X
Rad53	B-X
kinase	B-X
activity	B-X
.	B-X
Our	B-X
findings	B-X
showed	B-X
that	B-X
Mec1/Ddc2	B-X
complexes	B-X
can	B-X
directly	B-X
activate	B-X
Rad53	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
,	B-X
and	B-X
more	B-X
generally	B-X
,	B-X
supported	B-X
the	B-X
hypothesis	B-X
that	B-X
PIKKs	B-X
regulate	B-X
Chk2	B-X
orthologs	B-X
through	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
this	B-X
work	B-X
has	B-X
substantiated	B-X
a	B-X
model	B-X
for	B-X
PIKK-independent	B-X
amplification	B-X
of	B-X
Rad53	B-X
activation	B-X
(	B-X
and	B-X
by	B-X
extension	B-X
,	B-X
activation	B-X
of	B-X
other	B-X
Chk2	B-X
orthologs	B-X
)	B-X
mediated	B-X
by	B-X
inter-Rad53	B-X
phosphorylation	B-X
.	B-X

Our	O
findings	O
showed	O
that	O
Mec1	O
/	O
Ddc2	O
complexes	O
can	O
directly	O
activate	O
Rad53	B-Gene_or_gene_product
through	O
a	O
phosphorylation	O
-	O
dependent	O
mechanism	O
,	O
and	O
more	O
generally	O
,	O
supported	O
the	O
hypothesis	O
that	O
PIKKs	B-Gene_or_gene_product
regulate	O
Chk2	B-Gene_or_gene_product
orthologs	O
through	O
phosphorylation	O
.	O
<EOS>	B-X
Saccharomyces	B-X
cerevisiae	B-X
Rad53	B-X
,	B-X
the	B-X
ortholog	B-X
of	B-X
mammalian	B-X
Chk2	B-X
,	B-X
is	B-X
an	B-X
essential	B-X
protein	B-X
kinase	B-X
in	B-X
DNA	B-X
damage	B-X
and	B-X
DNA	B-X
replication	B-X
checkpoint	B-X
pathways	B-X
.	B-X
Consecutive	B-X
phosphatidyl	B-X
inositol	B-X
kinase-like	B-X
kinase	B-X
(	B-X
PIKK	B-X
)	B-X
-dependent	B-X
and	B-X
PIKK-independent	B-X
steps	B-X
in	B-X
activation	B-X
of	B-X
Rad53	B-X
are	B-X
key	B-X
steps	B-X
for	B-X
controlling	B-X
and	B-X
transmitting	B-X
diverse	B-X
downstream	B-X
responses	B-X
to	B-X
DNA	B-X
damage	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
enzymatically	B-X
dephosphorylated	B-X
purified	B-X
Rad53	B-X
autoactivates	B-X
in	B-X
vitro	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
.	B-X
Kinetic	B-X
analysis	B-X
demonstrated	B-X
that	B-X
autophosphorylation	B-X
results	B-X
in	B-X
a	B-X
more	B-X
than	B-X
9-fold	B-X
increase	B-X
in	B-X
protein	B-X
kinase	B-X
activity	B-X
.	B-X
Autophosphorylation	B-X
was	B-X
Rad53	B-X
concentration-dependent	B-X
,	B-X
indicating	B-X
that	B-X
the	B-X
reaction	B-X
follows	B-X
an	B-X
intermolecular	B-X
mechanism	B-X
.	B-X
DNA	B-X
damage	B-X
induced	B-X
oligomerization	B-X
of	B-X
a	B-X
subset	B-X
of	B-X
Rad53	B-X
molecules	B-X
in	B-X
vivo	B-X
.	B-X
At	B-X
low	B-X
concentrations	B-X
of	B-X
Rad53	B-X
,	B-X
preincubation	B-X
of	B-X
Rad53	B-X
with	B-X
immune	B-X
complexes	B-X
containing	B-X
the	B-X
Mec1/Ddc2	B-X
complex	B-X
can	B-X
activate	B-X
Rad53	B-X
kinase	B-X
activity	B-X
.	B-X
Our	B-X
findings	B-X
showed	B-X
that	B-X
Mec1/Ddc2	B-X
complexes	B-X
can	B-X
directly	B-X
activate	B-X
Rad53	B-X
through	B-X
a	B-X
phosphorylation-dependent	B-X
mechanism	B-X
,	B-X
and	B-X
more	B-X
generally	B-X
,	B-X
supported	B-X
the	B-X
hypothesis	B-X
that	B-X
PIKKs	B-X
regulate	B-X
Chk2	B-X
orthologs	B-X
through	B-X
phosphorylation	B-X
.	B-X
Moreover	B-X
,	B-X
this	B-X
work	B-X
has	B-X
substantiated	B-X
a	B-X
model	B-X
for	B-X
PIKK-independent	B-X
amplification	B-X
of	B-X
Rad53	B-X
activation	B-X
(	B-X
and	B-X
by	B-X
extension	B-X
,	B-X
activation	B-X
of	B-X
other	B-X
Chk2	B-X
orthologs	B-X
)	B-X
mediated	B-X
by	B-X
inter-Rad53	B-X
phosphorylation	B-X
.	B-X

Moreover	O
,	O
this	O
work	O
has	O
substantiated	O
a	O
model	O
for	O
PIKK	B-Gene_or_gene_product
-	O
independent	O
amplification	O
of	O
Rad53	B-Gene_or_gene_product
activation	O
(	O
and	O
by	O
extension	O
,	O
activation	O
of	O
other	O
Chk2	B-Gene_or_gene_product
orthologs	O
)	O
mediated	O
by	O
inter	O
-	O
Rad53	B-Gene_or_gene_product
phosphorylation	O
.	O

The	O
mechanisms	O
of	O
regulation	O
of	O
Hdm2	B-Gene_or_gene_product
protein	O
level	O
by	O
serum	O
growth	O
factors	O
.	O
<EOS>	B-X
Cell	B-X
cycle	B-X
progression	B-X
in	B-X
response	B-X
to	B-X
serum	B-X
growth	B-X
factors	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
functional	B-X
Hdm2	B-X
(	B-X
Mdm2	B-X
)	B-X
,	B-X
which	B-X
inhibits	B-X
p53-dependent	B-X
transcription	B-X
of	B-X
anti-proliferative	B-X
genes	B-X
.	B-X
In	B-X
a	B-X
well	B-X
characterised	B-X
non-transformed	B-X
human	B-X
fibroblast	B-X
model	B-X
,	B-X
growth	B-X
factors	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
Hdm2	B-X
with	B-X
rapid	B-X
kinetics	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
previous	B-X
studies	B-X
in	B-X
which	B-X
components	B-X
of	B-X
the	B-X
growth	B-X
factor	B-X
signalling	B-X
pathways	B-X
were	B-X
overexpressed	B-X
,	B-X
hdm2	B-X
mRNA	B-X
expression	B-X
is	B-X
not	B-X
induced	B-X
with	B-X
immediate-early	B-X
kinetics	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
Rather	B-X
,	B-X
the	B-X
elevated	B-X
Hdm2	B-X
protein	B-X
levels	B-X
which	B-X
follow	B-X
growth	B-X
factor	B-X
stimulation	B-X
are	B-X
primarily	B-X
a	B-X
consequence	B-X
of	B-X
phosphatidylinositol-3	B-X
kinase-dependent	B-X
stabilisation	B-X
of	B-X
the	B-X
Hdm2	B-X
protein	B-X
combined	B-X
with	B-X
a	B-X
global	B-X
increase	B-X
in	B-X
protein	B-X
synthesis	B-X
.	B-X

Cell	O
cycle	O
progression	O
in	O
response	O
to	O
serum	O
growth	O
factors	O
is	O
dependent	O
on	O
the	O
expression	O
of	O
functional	O
Hdm2	B-Gene_or_gene_product
(	O
Mdm2	B-Gene_or_gene_product
)	O
,	O
which	O
inhibits	O
p53	B-Gene_or_gene_product
-	O
dependent	O
transcription	O
of	O
anti	O
-	O
proliferative	O
genes	O
.	O
<EOS>	B-X
Cell	B-X
cycle	B-X
progression	B-X
in	B-X
response	B-X
to	B-X
serum	B-X
growth	B-X
factors	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
functional	B-X
Hdm2	B-X
(	B-X
Mdm2	B-X
)	B-X
,	B-X
which	B-X
inhibits	B-X
p53-dependent	B-X
transcription	B-X
of	B-X
anti-proliferative	B-X
genes	B-X
.	B-X
In	B-X
a	B-X
well	B-X
characterised	B-X
non-transformed	B-X
human	B-X
fibroblast	B-X
model	B-X
,	B-X
growth	B-X
factors	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
Hdm2	B-X
with	B-X
rapid	B-X
kinetics	B-X
.	B-X
Here	B-X
we	B-X
dissect	B-X
the	B-X
mechanistic	B-X
basis	B-X
for	B-X
this	B-X
critical	B-X
response	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
previous	B-X
studies	B-X
in	B-X
which	B-X
components	B-X
of	B-X
the	B-X
growth	B-X
factor	B-X
signalling	B-X
pathways	B-X
were	B-X
overexpressed	B-X
,	B-X
hdm2	B-X
mRNA	B-X
expression	B-X
is	B-X
not	B-X
induced	B-X
with	B-X
immediate-early	B-X
kinetics	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
Rather	B-X
,	B-X
the	B-X
elevated	B-X
Hdm2	B-X
protein	B-X
levels	B-X
which	B-X
follow	B-X
growth	B-X
factor	B-X
stimulation	B-X
are	B-X
primarily	B-X
a	B-X
consequence	B-X
of	B-X
phosphatidylinositol-3	B-X
kinase-dependent	B-X
stabilisation	B-X
of	B-X
the	B-X
Hdm2	B-X
protein	B-X
combined	B-X
with	B-X
a	B-X
global	B-X
increase	B-X
in	B-X
protein	B-X
synthesis	B-X
.	B-X

In	O
a	O
well	O
characterised	O
non	O
-	O
transformed	O
human	O
fibroblast	O
model	O
,	O
growth	O
factors	O
induce	O
the	O
expression	O
of	O
Hdm2	B-Gene_or_gene_product
with	O
rapid	O
kinetics	O
.	O

Here	O
we	O
dissect	O
the	O
mechanistic	O
basis	O
for	O
this	O
critical	O
response	O
.	O
<EOS>	B-X
A	B-X
variety	B-X
of	B-X
actions	B-X
are	B-X
tied	B-X
together	B-X
in	B-X
the	B-X
response	B-X
to	B-X
GC	B-X
treatment	B-X
.	B-X
Dissecting	B-X
the	B-X
beneficial	B-X
from	B-X
the	B-X
detrimental	B-X
actions	B-X
in	B-X
GC	B-X
therapy	B-X
is	B-X
a	B-X
major	B-X
challenge	B-X
in	B-X
basic	B-X
research	B-X
,	B-X
raising	B-X
the	B-X
critical	B-X
issue	B-X
of	B-X
whether	B-X
a	B-X
single	B-X
target	B-X
gene	B-X
or	B-X
gene	B-X
family	B-X
might	B-X
eventually	B-X
be	B-X
linked	B-X
to	B-X
a	B-X
specific	B-X
GC	B-X
function	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
GILZ	B-X
interaction	B-X
with	B-X
and	B-X
inhibition	B-X
of	B-X
NF-kappaB	B-X
provided	B-X
a	B-X
first	B-X
molecular	B-X
mechanistic	B-X
basis	B-X
for	B-X
explaining	B-X
GILZ	B-X
effects	B-X
on	B-X
T	B-X
cells	B-X
.	B-X
The	B-X
finding	B-X
that	B-X
GILZ	B-X
silencing	B-X
abrogates	B-X
the	B-X
antiproliferative	B-X
activity	B-X
of	B-X
dexamethasone	B-X
and	B-X
reduces	B-X
GC	B-X
inhibition	B-X
of	B-X
cytokine-induced	B-X
COX-2	B-X
expression	B-X
clearly	B-X
gained	B-X
GILZ	B-X
a	B-X
distinguished	B-X
reputation	B-X
within	B-X
the	B-X
critical	B-X
mediators	B-X
of	B-X
GC	B-X
effects	B-X
.	B-X

In	O
contrast	O
to	O
previous	O
studies	O
in	O
which	O
components	O
of	O
the	O
growth	O
factor	O
signalling	O
pathways	O
were	O
overexpressed	O
,	O
hdm2	B-Gene_or_gene_product
mRNA	O
expression	O
is	O
not	O
induced	O
with	O
immediate	O
-	O
early	O
kinetics	O
in	O
these	O
cells	O
.	O

Rather	O
,	O
the	O
elevated	O
Hdm2	B-Gene_or_gene_product
protein	O
levels	O
which	O
follow	O
growth	O
factor	O
stimulation	O
are	O
primarily	O
a	O
consequence	O
of	O
phosphatidylinositol	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	O
dependent	O
stabilisation	O
of	O
the	O
Hdm2	B-Gene_or_gene_product
protein	O
combined	O
with	O
a	O
global	O
increase	O
in	O
protein	O
synthesis	O
.	O
<EOS>	B-X
Cell	B-X
cycle	B-X
progression	B-X
in	B-X
response	B-X
to	B-X
serum	B-X
growth	B-X
factors	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
functional	B-X
Hdm2	B-X
(	B-X
Mdm2	B-X
)	B-X
,	B-X
which	B-X
inhibits	B-X
p53-dependent	B-X
transcription	B-X
of	B-X
anti-proliferative	B-X
genes	B-X
.	B-X
In	B-X
a	B-X
well	B-X
characterised	B-X
non-transformed	B-X
human	B-X
fibroblast	B-X
model	B-X
,	B-X
growth	B-X
factors	B-X
induce	B-X
the	B-X
expression	B-X
of	B-X
Hdm2	B-X
with	B-X
rapid	B-X
kinetics	B-X
.	B-X
In	B-X
contrast	B-X
to	B-X
previous	B-X
studies	B-X
in	B-X
which	B-X
components	B-X
of	B-X
the	B-X
growth	B-X
factor	B-X
signalling	B-X
pathways	B-X
were	B-X
overexpressed	B-X
,	B-X
hdm2	B-X
mRNA	B-X
expression	B-X
is	B-X
not	B-X
induced	B-X
with	B-X
immediate-early	B-X
kinetics	B-X
in	B-X
these	B-X
cells	B-X
.	B-X
Rather	B-X
,	B-X
the	B-X
elevated	B-X
Hdm2	B-X
protein	B-X
levels	B-X
which	B-X
follow	B-X
growth	B-X
factor	B-X
stimulation	B-X
are	B-X
primarily	B-X
a	B-X
consequence	B-X
of	B-X
phosphatidylinositol-3	B-X
kinase-dependent	B-X
stabilisation	B-X
of	B-X
the	B-X
Hdm2	B-X
protein	B-X
combined	B-X
with	B-X
a	B-X
global	B-X
increase	B-X
in	B-X
protein	B-X
synthesis	B-X
.	B-X

Phosphorylation	O
of	O
the	O
chromosomal	O
passenger	O
protein	O
Bir1	B-Gene_or_gene_product
is	O
required	O
for	O
localization	O
of	O
Ndc10	B-Gene_or_gene_product
to	O
the	O
spindle	O
during	O
anaphase	O
and	O
full	O
spindle	O
elongation	O
.	O

The	O
Saccharomyces	O
cerevisiae	O
inhibitor	B-Gene_or_gene_product
of	I-Gene_or_gene_product
apoptosis	I-Gene_or_gene_product
(	O
IAP	B-Gene_or_gene_product
)	O
repeat	O
protein	O
Bir1	B-Gene_or_gene_product
localizes	O
as	O
a	O
chromosomal	O
passenger	O
.	O
<EOS>	B-X
The	B-X
Saccharomyces	B-X
cerevisiae	B-X
inhibitor	B-X
of	B-X
apoptosis	B-X
(	B-X
IAP	B-X
)	B-X
repeat	B-X
protein	B-X
Bir1	B-X
localizes	B-X
as	B-X
a	B-X
chromosomal	B-X
passenger	B-X
.	B-X
A	B-X
deletion	B-X
analysis	B-X
of	B-X
Bir1	B-X
identified	B-X
two	B-X
regions	B-X
important	B-X
for	B-X
function	B-X
.	B-X
The	B-X
C-terminal	B-X
region	B-X
is	B-X
essential	B-X
for	B-X
growth	B-X
,	B-X
binds	B-X
Sli15	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
and	B-X
sufficient	B-X
for	B-X
the	B-X
localization	B-X
of	B-X
Bir1	B-X
as	B-X
a	B-X
chromosomal	B-X
passenger	B-X
.	B-X
The	B-X
middle	B-X
region	B-X
is	B-X
not	B-X
essential	B-X
but	B-X
is	B-X
required	B-X
to	B-X
localize	B-X
the	B-X
inner	B-X
kinetochore	B-X
protein	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
during	B-X
anaphase	B-X
and	B-X
to	B-X
the	B-X
midzone	B-X
at	B-X
telophase	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
precise	B-X
deletion	B-X
of	B-X
the	B-X
highly	B-X
conserved	B-X
IAP	B-X
repeats	B-X
conferred	B-X
no	B-X
phenotype	B-X
and	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
cell	B-X
cycle	B-X
delay	B-X
caused	B-X
by	B-X
loss	B-X
of	B-X
cohesin	B-X
.	B-X
Bir1	B-X
is	B-X
phosphorylated	B-X
in	B-X
a	B-X
cell	B-X
cycle-dependent	B-X
manner	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
nine	B-X
CDK	B-X
consensus	B-X
sites	B-X
in	B-X
the	B-X
middle	B-X
region	B-X
of	B-X
Bir1	B-X
significantly	B-X
decreased	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
and	B-X
blocked	B-X
localization	B-X
of	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
at	B-X
anaphase	B-X
.	B-X
Moreover	B-X
,	B-X
immunoprecipitation	B-X
of	B-X
Ndc10	B-X
with	B-X
Bir1	B-X
was	B-X
dependent	B-X
on	B-X
phosphorylation	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
phosphorylation	B-X
of	B-X
the	B-X
middle	B-X
region	B-X
of	B-X
Bir1	B-X
is	B-X
required	B-X
to	B-X
bring	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
at	B-X
anaphase	B-X
,	B-X
which	B-X
is	B-X
required	B-X
for	B-X
full	B-X
spindle	B-X
elongation	B-X
.	B-X

A	O
deletion	O
analysis	O
of	O
Bir1	B-Gene_or_gene_product
identified	O
two	O
regions	O
important	O
for	O
function	O
.	O
<EOS>	B-X
The	B-X
Saccharomyces	B-X
cerevisiae	B-X
inhibitor	B-X
of	B-X
apoptosis	B-X
(	B-X
IAP	B-X
)	B-X
repeat	B-X
protein	B-X
Bir1	B-X
localizes	B-X
as	B-X
a	B-X
chromosomal	B-X
passenger	B-X
.	B-X
A	B-X
deletion	B-X
analysis	B-X
of	B-X
Bir1	B-X
identified	B-X
two	B-X
regions	B-X
important	B-X
for	B-X
function	B-X
.	B-X
The	B-X
C-terminal	B-X
region	B-X
is	B-X
essential	B-X
for	B-X
growth	B-X
,	B-X
binds	B-X
Sli15	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
and	B-X
sufficient	B-X
for	B-X
the	B-X
localization	B-X
of	B-X
Bir1	B-X
as	B-X
a	B-X
chromosomal	B-X
passenger	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
precise	B-X
deletion	B-X
of	B-X
the	B-X
highly	B-X
conserved	B-X
IAP	B-X
repeats	B-X
conferred	B-X
no	B-X
phenotype	B-X
and	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
cell	B-X
cycle	B-X
delay	B-X
caused	B-X
by	B-X
loss	B-X
of	B-X
cohesin	B-X
.	B-X
Bir1	B-X
is	B-X
phosphorylated	B-X
in	B-X
a	B-X
cell	B-X
cycle-dependent	B-X
manner	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
nine	B-X
CDK	B-X
consensus	B-X
sites	B-X
in	B-X
the	B-X
middle	B-X
region	B-X
of	B-X
Bir1	B-X
significantly	B-X
decreased	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
and	B-X
blocked	B-X
localization	B-X
of	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
at	B-X
anaphase	B-X
.	B-X
Moreover	B-X
,	B-X
immunoprecipitation	B-X
of	B-X
Ndc10	B-X
with	B-X
Bir1	B-X
was	B-X
dependent	B-X
on	B-X
phosphorylation	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
phosphorylation	B-X
of	B-X
the	B-X
middle	B-X
region	B-X
of	B-X
Bir1	B-X
is	B-X
required	B-X
to	B-X
bring	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
at	B-X
anaphase	B-X
,	B-X
which	B-X
is	B-X
required	B-X
for	B-X
full	B-X
spindle	B-X
elongation	B-X
.	B-X

The	O
C	O
-	O
terminal	O
region	O
is	O
essential	O
for	O
growth	O
,	O
binds	O
Sli15	B-Gene_or_gene_product
,	O
and	O
is	O
necessary	O
and	O
sufficient	O
for	O
the	O
localization	O
of	O
Bir1	B-Gene_or_gene_product
as	O
a	O
chromosomal	O
passenger	O
.	O

The	O
middle	O
region	O
is	O
not	O
essential	O
but	O
is	O
required	O
to	O
localize	O
the	O
inner	O
kinetochore	O
protein	O
Ndc10	B-Gene_or_gene_product
to	O
the	O
spindle	O
during	O
anaphase	O
and	O
to	O
the	O
midzone	O
at	O
telophase	O
.	O
<EOS>	B-X
Thus	B-X
,	B-X
our	B-X
objective	B-X
was	B-X
to	B-X
examine	B-X
ischemic	B-X
stroke	B-X
burden	B-X
at	B-X
the	B-X
global	B-X
,	B-X
regional	B-X
,	B-X
and	B-X
national	B-X
levels	B-X
in	B-X
terms	B-X
of	B-X
sex	B-X
,	B-X
age	B-X
,	B-X
and	B-X
social	B-X
development	B-X
index	B-X
(	B-X
SDI	B-X
)	B-X
.	B-X
The	B-X
burden	B-X
of	B-X
chronic	B-X
obstructive	B-X
pulmonary	B-X
disease	B-X
(	B-X
COPD	B-X
)	B-X
across	B-X
many	B-X
world	B-X
regions	B-X
is	B-X
high	B-X
.	B-X
We	B-X
aim	B-X
to	B-X
estimate	B-X
COPD	B-X
prevalence	B-X
and	B-X
number	B-X
of	B-X
disease	B-X
cases	B-X
for	B-X
the	B-X
years	B-X
1990	B-X
and	B-X
2010	B-X
across	B-X
world	B-X
regions	B-X
based	B-X
on	B-X
the	B-X
best	B-X
available	B-X
evidence	B-X
in	B-X
publicly	B-X
accessible	B-X
scientific	B-X
databases	B-X
.	B-X
Revised	B-X
:	B-X
Nov	B-X
6	B-X
2021The	B-X
shortfalls	B-X
of	B-X
multilateral	B-X
and	B-X
regional	B-X
organizations	B-X
in	B-X
respect	B-X
of	B-X
handling	B-X
the	B-X
COVID-19	B-X
pandemic	B-X
have	B-X
been	B-X
well	B-X
rehearsed	B-X
by	B-X
scholars	B-X
and	B-X
policy	B-X
makers	B-X
in	B-X
multiple	B-X
publications	B-X
and	B-X
statements	B-X
.	B-X
While	B-X
the	B-X
World	B-X
Health	B-X
Organization	B-X
(	B-X
WHO	B-X
)	B-X
and	B-X
its	B-X
regional	B-X
offices	B-X
have	B-X
coordinated	B-X
global	B-X
responses	B-X
,	B-X
regional	B-X
organizations	B-X
,	B-X
like	B-X
the	B-X
European	B-X
Union	B-X
,	B-X
Association	B-X
of	B-X
Southeast	B-X
Asian	B-X
Nations	B-X
,	B-X
or	B-X
African	B-X
Union	B-X
,	B-X
have	B-X
played	B-X
complementary	B-X
roles	B-X
.	B-X
However	B-X
,	B-X
the	B-X
response	B-X
of	B-X
different	B-X
regions	B-X
has	B-X
varied	B-X
,	B-X
revealing	B-X
multiple	B-X
deficits	B-X
in	B-X
the	B-X
structures	B-X
of	B-X
regional	B-X
governance	B-X
.	B-X
The	B-X
Middle	B-X
East	B-X
and	B-X
North	B-X
Africa	B-X
(	B-X
MENA	B-X
)	B-X
is	B-X
a	B-X
region	B-X
affected	B-X
by	B-X
chronic	B-X
ongoing	B-X
conflicts	B-X
and	B-X
serious	B-X
inequalities	B-X
in	B-X
health	B-X
and	B-X
welfare	B-X
provision	B-X
,	B-X
reflected	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
concerted	B-X
responses	B-X
to	B-X
the	B-X
pandemic	B-X
.	B-X
Drawing	B-X
on	B-X
data	B-X
from	B-X
the	B-X
WHO	B-X
,	B-X
United	B-X
Nations	B-X
(	B-X
UN	B-X
)	B-X
,	B-X
regional	B-X
organizations	B-X
,	B-X
media	B-X
and	B-X
secondary	B-X
sources	B-X
,	B-X
it	B-X
first	B-X
discusses	B-X
the	B-X
wider	B-X
global-regional	B-X
context	B-X
;	B-X
second	B-X
,	B-X
reviews	B-X
the	B-X
actions	B-X
of	B-X
regional	B-X
bodies	B-X
,	B-X
like	B-X
the	B-X
League	B-X
of	B-X
Arab	B-X
States	B-X
,	B-X
Gulf	B-X
Cooperation	B-X
Council	B-X
and	B-X
the	B-X
cross-regional	B-X
Organization	B-X
of	B-X
Islamic	B-X
Cooperation	B-X
;	B-X
and	B-X
third	B-X
,	B-X
looks	B-X
at	B-X
some	B-X
country-specific	B-X
situations	B-X
where	B-X
both	B-X
evidence	B-X
of	B-X
good	B-X
practice	B-X
and	B-X
the	B-X
absence	B-X
of	B-X
appropriate	B-X
regional	B-X
level	B-X
provision	B-X
have	B-X
exposed	B-X
deep	B-X
regional	B-X
divides	B-X
.	B-X
It	B-X
concludes	B-X
with	B-X
a	B-X
call	B-X
for	B-X
more	B-X
collaboration	B-X
between	B-X
states	B-X
and	B-X
international	B-X
organizations	B-X
:	B-X
better	B-X
regional	B-X
coordination	B-X
is	B-X
urgently	B-X
needed	B-X
to	B-X
supplement	B-X
existing	B-X
multilateral	B-X
efforts	B-X
.	B-X
A	B-X
collective	B-X
local	B-X
response	B-X
to	B-X
the	B-X
COVID-19	B-X
pandemic	B-X
could	B-X
help	B-X
transcend	B-X
regional	B-X
divides	B-X
and	B-X
spur	B-X
much-needed	B-X
security	B-X
cooperation	B-X
in	B-X
other	B-X
areas	B-X
.	B-X

In	O
contrast	O
,	O
precise	O
deletion	O
of	O
the	O
highly	O
conserved	O
IAP	B-Gene_or_gene_product
repeats	O
conferred	O
no	O
phenotype	O
and	O
did	O
not	O
alter	O
the	O
cell	O
cycle	O
delay	O
caused	O
by	O
loss	O
of	O
cohesin	B-Gene_or_gene_product
.	O

Bir1	B-Gene_or_gene_product
is	O
phosphorylated	O
in	O
a	O
cell	O
cycle	O
-	O
dependent	O
manner	O
.	O

Mutation	O
of	O
all	O
nine	O
CDK	B-Gene_or_gene_product
consensus	O
sites	O
in	O
the	O
middle	O
region	O
of	O
Bir1	B-Gene_or_gene_product
significantly	O
decreased	O
the	O
level	O
of	O
phosphorylation	O
and	O
blocked	O
localization	O
of	O
Ndc10	B-Gene_or_gene_product
to	O
the	O
spindle	O
at	O
anaphase	O
.	O

Moreover	O
,	O
immunoprecipitation	O
of	O
Ndc10	B-Gene_or_gene_product
with	O
Bir1	B-Gene_or_gene_product
was	O
dependent	O
on	O
phosphorylation	O
.	O
<EOS>	B-X
The	B-X
Saccharomyces	B-X
cerevisiae	B-X
inhibitor	B-X
of	B-X
apoptosis	B-X
(	B-X
IAP	B-X
)	B-X
repeat	B-X
protein	B-X
Bir1	B-X
localizes	B-X
as	B-X
a	B-X
chromosomal	B-X
passenger	B-X
.	B-X
A	B-X
deletion	B-X
analysis	B-X
of	B-X
Bir1	B-X
identified	B-X
two	B-X
regions	B-X
important	B-X
for	B-X
function	B-X
.	B-X
The	B-X
C-terminal	B-X
region	B-X
is	B-X
essential	B-X
for	B-X
growth	B-X
,	B-X
binds	B-X
Sli15	B-X
,	B-X
and	B-X
is	B-X
necessary	B-X
and	B-X
sufficient	B-X
for	B-X
the	B-X
localization	B-X
of	B-X
Bir1	B-X
as	B-X
a	B-X
chromosomal	B-X
passenger	B-X
.	B-X
The	B-X
middle	B-X
region	B-X
is	B-X
not	B-X
essential	B-X
but	B-X
is	B-X
required	B-X
to	B-X
localize	B-X
the	B-X
inner	B-X
kinetochore	B-X
protein	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
during	B-X
anaphase	B-X
and	B-X
to	B-X
the	B-X
midzone	B-X
at	B-X
telophase	B-X
.	B-X
Bir1	B-X
is	B-X
phosphorylated	B-X
in	B-X
a	B-X
cell	B-X
cycle-dependent	B-X
manner	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
nine	B-X
CDK	B-X
consensus	B-X
sites	B-X
in	B-X
the	B-X
middle	B-X
region	B-X
of	B-X
Bir1	B-X
significantly	B-X
decreased	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
and	B-X
blocked	B-X
localization	B-X
of	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
at	B-X
anaphase	B-X
.	B-X
Moreover	B-X
,	B-X
immunoprecipitation	B-X
of	B-X
Ndc10	B-X
with	B-X
Bir1	B-X
was	B-X
dependent	B-X
on	B-X
phosphorylation	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
Ndc10	B-X
from	B-X
the	B-X
anaphase	B-X
spindle	B-X
prevented	B-X
elongation	B-X
of	B-X
the	B-X
spindle	B-X
beyond	B-X
7	B-X
microm	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
phosphorylation	B-X
of	B-X
the	B-X
middle	B-X
region	B-X
of	B-X
Bir1	B-X
is	B-X
required	B-X
to	B-X
bring	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
at	B-X
anaphase	B-X
,	B-X
which	B-X
is	B-X
required	B-X
for	B-X
full	B-X
spindle	B-X
elongation	B-X
.	B-X

The	O
loss	O
of	O
Ndc10	B-Gene_or_gene_product
from	O
the	O
anaphase	O
spindle	O
prevented	O
elongation	O
of	O
the	O
spindle	O
beyond	O
7	O
microm	O
.	O
<EOS>	B-X
The	B-X
middle	B-X
region	B-X
is	B-X
not	B-X
essential	B-X
but	B-X
is	B-X
required	B-X
to	B-X
localize	B-X
the	B-X
inner	B-X
kinetochore	B-X
protein	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
during	B-X
anaphase	B-X
and	B-X
to	B-X
the	B-X
midzone	B-X
at	B-X
telophase	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
precise	B-X
deletion	B-X
of	B-X
the	B-X
highly	B-X
conserved	B-X
IAP	B-X
repeats	B-X
conferred	B-X
no	B-X
phenotype	B-X
and	B-X
did	B-X
not	B-X
alter	B-X
the	B-X
cell	B-X
cycle	B-X
delay	B-X
caused	B-X
by	B-X
loss	B-X
of	B-X
cohesin	B-X
.	B-X
Mutation	B-X
of	B-X
all	B-X
nine	B-X
CDK	B-X
consensus	B-X
sites	B-X
in	B-X
the	B-X
middle	B-X
region	B-X
of	B-X
Bir1	B-X
significantly	B-X
decreased	B-X
the	B-X
level	B-X
of	B-X
phosphorylation	B-X
and	B-X
blocked	B-X
localization	B-X
of	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
at	B-X
anaphase	B-X
.	B-X
Moreover	B-X
,	B-X
immunoprecipitation	B-X
of	B-X
Ndc10	B-X
with	B-X
Bir1	B-X
was	B-X
dependent	B-X
on	B-X
phosphorylation	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
Ndc10	B-X
from	B-X
the	B-X
anaphase	B-X
spindle	B-X
prevented	B-X
elongation	B-X
of	B-X
the	B-X
spindle	B-X
beyond	B-X
7	B-X
microm	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
phosphorylation	B-X
of	B-X
the	B-X
middle	B-X
region	B-X
of	B-X
Bir1	B-X
is	B-X
required	B-X
to	B-X
bring	B-X
Ndc10	B-X
to	B-X
the	B-X
spindle	B-X
at	B-X
anaphase	B-X
,	B-X
which	B-X
is	B-X
required	B-X
for	B-X
full	B-X
spindle	B-X
elongation	B-X
.	B-X

We	O
conclude	O
that	O
phosphorylation	O
of	O
the	O
middle	O
region	O
of	O
Bir1	B-Gene_or_gene_product
is	O
required	O
to	O
bring	O
Ndc10	B-Gene_or_gene_product
to	O
the	O
spindle	O
at	O
anaphase	O
,	O
which	O
is	O
required	O
for	O
full	O
spindle	O
elongation	O
.	O

Evidence	O
that	O
the	O
human	O
cytomegalovirus	O
IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
protein	O
binds	O
mdm2	B-Gene_or_gene_product
and	O
facilitates	O
mdm2	B-Gene_or_gene_product
degradation	O
.	O
<EOS>	B-X
Levels	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
increased	B-X
in	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
-infected	B-X
cells	B-X
and	B-X
may	B-X
be	B-X
important	B-X
for	B-X
HCMV	B-X
pathogenesis	B-X
.	B-X
In	B-X
normal	B-X
cells	B-X
p53	B-X
levels	B-X
are	B-X
kept	B-X
low	B-X
due	B-X
to	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
where	B-X
p53	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
mdm2	B-X
and	B-X
mdm2	B-X
binds	B-X
and	B-X
ubiquitinates	B-X
p53	B-X
,	B-X
targeting	B-X
p53	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
uninfected	B-X
cells	B-X
,	B-X
mdm2	B-X
was	B-X
undetectable	B-X
upon	B-X
treatment	B-X
of	B-X
infected	B-X
fibroblasts	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
MG132	B-X
.	B-X
Cellular	B-X
depletion	B-X
of	B-X
mdm2	B-X
was	B-X
reproducible	B-X
in	B-X
p53-null	B-X
cells	B-X
transfected	B-X
with	B-X
the	B-X
HCMV	B-X
IE2-86	B-X
protein	B-X
,	B-X
but	B-X
not	B-X
with	B-X
IE172	B-X
,	B-X
independently	B-X
of	B-X
the	B-X
endogenous	B-X
mdm2	B-X
promoter	B-X
.	B-X
IE2-86	B-X
also	B-X
prevented	B-X
the	B-X
emergence	B-X
of	B-X
presumably	B-X
ubiquitinated	B-X
species	B-X
of	B-X
p53	B-X
.	B-X
The	B-X
regions	B-X
of	B-X
IE2-86	B-X
important	B-X
for	B-X
mdm2	B-X
depletion	B-X
were	B-X
those	B-X
containing	B-X
the	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
putative	B-X
zinc	B-X
finger	B-X
and	B-X
C-terminal	B-X
acidic	B-X
motifs	B-X
.	B-X
mdm2	B-X
and	B-X
IE2-86	B-X
coimmunoprecipitated	B-X
in	B-X
transfected	B-X
and	B-X
infected	B-X
cell	B-X
lysates	B-X
and	B-X
in	B-X
a	B-X
cell-free	B-X
system	B-X
.	B-X
IE2-86	B-X
blocked	B-X
mdm2	B-X
's	B-X
p53-independent	B-X
transactivation	B-X
of	B-X
the	B-X
cyclin	B-X
A	B-X
promoter	B-X
in	B-X
transient-transfection	B-X
experiments	B-X
.	B-X
Pulse-chase	B-X
experiments	B-X
revealed	B-X
that	B-X
IE2-86	B-X
but	B-X
not	B-X
IE1-72	B-X
or	B-X
several	B-X
loss-of-function	B-X
IE2-86	B-X
mutants	B-X
increased	B-X
the	B-X
half-life	B-X
of	B-X
p53	B-X
and	B-X
reduced	B-X
the	B-X
half-life	B-X
of	B-X
mdm2	B-X
.	B-X
Short	B-X
interfering	B-X
RNA-mediated	B-X
depletion	B-X
of	B-X
IE2-86	B-X
restored	B-X
the	B-X
ability	B-X
of	B-X
HCMV-infected	B-X
cells	B-X
to	B-X
accumulate	B-X
mdm2	B-X
in	B-X
response	B-X
to	B-X
proteasome	B-X
inhibition	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
suggest	B-X
that	B-X
specific	B-X
interactions	B-X
between	B-X
IE2-86	B-X
and	B-X
mdm2	B-X
cause	B-X
proteasome-independent	B-X
degradation	B-X
of	B-X
mdm2	B-X
and	B-X
that	B-X
this	B-X
may	B-X
be	B-X
important	B-X
for	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
in	B-X
HCMV-infected	B-X
cells	B-X
.	B-X

Levels	O
of	O
the	O
p53	B-Gene_or_gene_product
tumor	O
suppressor	O
protein	O
are	O
increased	O
in	O
human	O
cytomegalovirus	O
(	O
HCMV	O
)	O
-	O
infected	O
cells	O
and	O
may	O
be	O
important	O
for	O
HCMV	O
pathogenesis	O
.	O
<EOS>	B-X
Levels	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
increased	B-X
in	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
-infected	B-X
cells	B-X
and	B-X
may	B-X
be	B-X
important	B-X
for	B-X
HCMV	B-X
pathogenesis	B-X
.	B-X
In	B-X
normal	B-X
cells	B-X
p53	B-X
levels	B-X
are	B-X
kept	B-X
low	B-X
due	B-X
to	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
where	B-X
p53	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
mdm2	B-X
and	B-X
mdm2	B-X
binds	B-X
and	B-X
ubiquitinates	B-X
p53	B-X
,	B-X
targeting	B-X
p53	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
uninfected	B-X
cells	B-X
,	B-X
mdm2	B-X
was	B-X
undetectable	B-X
upon	B-X
treatment	B-X
of	B-X
infected	B-X
fibroblasts	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
MG132	B-X
.	B-X
Cellular	B-X
depletion	B-X
of	B-X
mdm2	B-X
was	B-X
reproducible	B-X
in	B-X
p53-null	B-X
cells	B-X
transfected	B-X
with	B-X
the	B-X
HCMV	B-X
IE2-86	B-X
protein	B-X
,	B-X
but	B-X
not	B-X
with	B-X
IE172	B-X
,	B-X
independently	B-X
of	B-X
the	B-X
endogenous	B-X
mdm2	B-X
promoter	B-X
.	B-X
IE2-86	B-X
also	B-X
prevented	B-X
the	B-X
emergence	B-X
of	B-X
presumably	B-X
ubiquitinated	B-X
species	B-X
of	B-X
p53	B-X
.	B-X
The	B-X
regions	B-X
of	B-X
IE2-86	B-X
important	B-X
for	B-X
mdm2	B-X
depletion	B-X
were	B-X
those	B-X
containing	B-X
the	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
putative	B-X
zinc	B-X
finger	B-X
and	B-X
C-terminal	B-X
acidic	B-X
motifs	B-X
.	B-X
mdm2	B-X
and	B-X
IE2-86	B-X
coimmunoprecipitated	B-X
in	B-X
transfected	B-X
and	B-X
infected	B-X
cell	B-X
lysates	B-X
and	B-X
in	B-X
a	B-X
cell-free	B-X
system	B-X
.	B-X
IE2-86	B-X
blocked	B-X
mdm2	B-X
's	B-X
p53-independent	B-X
transactivation	B-X
of	B-X
the	B-X
cyclin	B-X
A	B-X
promoter	B-X
in	B-X
transient-transfection	B-X
experiments	B-X
.	B-X
Pulse-chase	B-X
experiments	B-X
revealed	B-X
that	B-X
IE2-86	B-X
but	B-X
not	B-X
IE1-72	B-X
or	B-X
several	B-X
loss-of-function	B-X
IE2-86	B-X
mutants	B-X
increased	B-X
the	B-X
half-life	B-X
of	B-X
p53	B-X
and	B-X
reduced	B-X
the	B-X
half-life	B-X
of	B-X
mdm2	B-X
.	B-X
Short	B-X
interfering	B-X
RNA-mediated	B-X
depletion	B-X
of	B-X
IE2-86	B-X
restored	B-X
the	B-X
ability	B-X
of	B-X
HCMV-infected	B-X
cells	B-X
to	B-X
accumulate	B-X
mdm2	B-X
in	B-X
response	B-X
to	B-X
proteasome	B-X
inhibition	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
suggest	B-X
that	B-X
specific	B-X
interactions	B-X
between	B-X
IE2-86	B-X
and	B-X
mdm2	B-X
cause	B-X
proteasome-independent	B-X
degradation	B-X
of	B-X
mdm2	B-X
and	B-X
that	B-X
this	B-X
may	B-X
be	B-X
important	B-X
for	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
in	B-X
HCMV-infected	B-X
cells	B-X
.	B-X

In	O
normal	O
cells	O
p53	B-Gene_or_gene_product
levels	O
are	O
kept	O
low	O
due	O
to	O
an	O
autoregulatory	O
feedback	O
loop	O
where	O
p53	B-Gene_or_gene_product
activates	O
the	O
transcription	O
of	O
mdm2	B-Gene_or_gene_product
and	O
mdm2	B-Gene_or_gene_product
binds	O
and	O
ubiquitinates	O
p53	B-Gene_or_gene_product
,	O
targeting	O
p53	B-Gene_or_gene_product
for	O
proteasomal	O
degradation	O
.	O

Here	O
we	O
report	O
that	O
,	O
in	O
contrast	O
to	O
uninfected	O
cells	O
,	O
mdm2	B-Gene_or_gene_product
was	O
undetectable	O
upon	O
treatment	O
of	O
infected	O
fibroblasts	O
with	O
the	O
proteasome	O
inhibitor	O
MG132	O
.	O
<EOS>	B-X
Levels	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
increased	B-X
in	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
-infected	B-X
cells	B-X
and	B-X
may	B-X
be	B-X
important	B-X
for	B-X
HCMV	B-X
pathogenesis	B-X
.	B-X
In	B-X
normal	B-X
cells	B-X
p53	B-X
levels	B-X
are	B-X
kept	B-X
low	B-X
due	B-X
to	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
where	B-X
p53	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
mdm2	B-X
and	B-X
mdm2	B-X
binds	B-X
and	B-X
ubiquitinates	B-X
p53	B-X
,	B-X
targeting	B-X
p53	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
uninfected	B-X
cells	B-X
,	B-X
mdm2	B-X
was	B-X
undetectable	B-X
upon	B-X
treatment	B-X
of	B-X
infected	B-X
fibroblasts	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
MG132	B-X
.	B-X
Cellular	B-X
depletion	B-X
of	B-X
mdm2	B-X
was	B-X
reproducible	B-X
in	B-X
p53-null	B-X
cells	B-X
transfected	B-X
with	B-X
the	B-X
HCMV	B-X
IE2-86	B-X
protein	B-X
,	B-X
but	B-X
not	B-X
with	B-X
IE172	B-X
,	B-X
independently	B-X
of	B-X
the	B-X
endogenous	B-X
mdm2	B-X
promoter	B-X
.	B-X
The	B-X
regions	B-X
of	B-X
IE2-86	B-X
important	B-X
for	B-X
mdm2	B-X
depletion	B-X
were	B-X
those	B-X
containing	B-X
the	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
putative	B-X
zinc	B-X
finger	B-X
and	B-X
C-terminal	B-X
acidic	B-X
motifs	B-X
.	B-X
mdm2	B-X
and	B-X
IE2-86	B-X
coimmunoprecipitated	B-X
in	B-X
transfected	B-X
and	B-X
infected	B-X
cell	B-X
lysates	B-X
and	B-X
in	B-X
a	B-X
cell-free	B-X
system	B-X
.	B-X
IE2-86	B-X
blocked	B-X
mdm2	B-X
's	B-X
p53-independent	B-X
transactivation	B-X
of	B-X
the	B-X
cyclin	B-X
A	B-X
promoter	B-X
in	B-X
transient-transfection	B-X
experiments	B-X
.	B-X
Pulse-chase	B-X
experiments	B-X
revealed	B-X
that	B-X
IE2-86	B-X
but	B-X
not	B-X
IE1-72	B-X
or	B-X
several	B-X
loss-of-function	B-X
IE2-86	B-X
mutants	B-X
increased	B-X
the	B-X
half-life	B-X
of	B-X
p53	B-X
and	B-X
reduced	B-X
the	B-X
half-life	B-X
of	B-X
mdm2	B-X
.	B-X
Short	B-X
interfering	B-X
RNA-mediated	B-X
depletion	B-X
of	B-X
IE2-86	B-X
restored	B-X
the	B-X
ability	B-X
of	B-X
HCMV-infected	B-X
cells	B-X
to	B-X
accumulate	B-X
mdm2	B-X
in	B-X
response	B-X
to	B-X
proteasome	B-X
inhibition	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
suggest	B-X
that	B-X
specific	B-X
interactions	B-X
between	B-X
IE2-86	B-X
and	B-X
mdm2	B-X
cause	B-X
proteasome-independent	B-X
degradation	B-X
of	B-X
mdm2	B-X
and	B-X
that	B-X
this	B-X
may	B-X
be	B-X
important	B-X
for	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
in	B-X
HCMV-infected	B-X
cells	B-X
.	B-X

Cellular	O
depletion	O
of	O
mdm2	B-Gene_or_gene_product
was	O
reproducible	O
in	O
p53	B-Gene_or_gene_product
-	O
null	O
cells	O
transfected	O
with	O
the	O
HCMV	O
IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
protein	O
,	O
but	O
not	O
with	O
IE172	B-Gene_or_gene_product
,	O
independently	O
of	O
the	O
endogenous	O
mdm2	B-Gene_or_gene_product
promoter	O
.	O

IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
also	O
prevented	O
the	O
emergence	O
of	O
presumably	O
ubiquitinated	O
species	O
of	O
p53	B-Gene_or_gene_product
.	O
<EOS>	B-X
Levels	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
increased	B-X
in	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
-infected	B-X
cells	B-X
and	B-X
may	B-X
be	B-X
important	B-X
for	B-X
HCMV	B-X
pathogenesis	B-X
.	B-X
In	B-X
normal	B-X
cells	B-X
p53	B-X
levels	B-X
are	B-X
kept	B-X
low	B-X
due	B-X
to	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
where	B-X
p53	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
mdm2	B-X
and	B-X
mdm2	B-X
binds	B-X
and	B-X
ubiquitinates	B-X
p53	B-X
,	B-X
targeting	B-X
p53	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Cellular	B-X
depletion	B-X
of	B-X
mdm2	B-X
was	B-X
reproducible	B-X
in	B-X
p53-null	B-X
cells	B-X
transfected	B-X
with	B-X
the	B-X
HCMV	B-X
IE2-86	B-X
protein	B-X
,	B-X
but	B-X
not	B-X
with	B-X
IE172	B-X
,	B-X
independently	B-X
of	B-X
the	B-X
endogenous	B-X
mdm2	B-X
promoter	B-X
.	B-X
IE2-86	B-X
also	B-X
prevented	B-X
the	B-X
emergence	B-X
of	B-X
presumably	B-X
ubiquitinated	B-X
species	B-X
of	B-X
p53	B-X
.	B-X
The	B-X
regions	B-X
of	B-X
IE2-86	B-X
important	B-X
for	B-X
mdm2	B-X
depletion	B-X
were	B-X
those	B-X
containing	B-X
the	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
putative	B-X
zinc	B-X
finger	B-X
and	B-X
C-terminal	B-X
acidic	B-X
motifs	B-X
.	B-X
mdm2	B-X
and	B-X
IE2-86	B-X
coimmunoprecipitated	B-X
in	B-X
transfected	B-X
and	B-X
infected	B-X
cell	B-X
lysates	B-X
and	B-X
in	B-X
a	B-X
cell-free	B-X
system	B-X
.	B-X
IE2-86	B-X
blocked	B-X
mdm2	B-X
's	B-X
p53-independent	B-X
transactivation	B-X
of	B-X
the	B-X
cyclin	B-X
A	B-X
promoter	B-X
in	B-X
transient-transfection	B-X
experiments	B-X
.	B-X
Pulse-chase	B-X
experiments	B-X
revealed	B-X
that	B-X
IE2-86	B-X
but	B-X
not	B-X
IE1-72	B-X
or	B-X
several	B-X
loss-of-function	B-X
IE2-86	B-X
mutants	B-X
increased	B-X
the	B-X
half-life	B-X
of	B-X
p53	B-X
and	B-X
reduced	B-X
the	B-X
half-life	B-X
of	B-X
mdm2	B-X
.	B-X
Short	B-X
interfering	B-X
RNA-mediated	B-X
depletion	B-X
of	B-X
IE2-86	B-X
restored	B-X
the	B-X
ability	B-X
of	B-X
HCMV-infected	B-X
cells	B-X
to	B-X
accumulate	B-X
mdm2	B-X
in	B-X
response	B-X
to	B-X
proteasome	B-X
inhibition	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
suggest	B-X
that	B-X
specific	B-X
interactions	B-X
between	B-X
IE2-86	B-X
and	B-X
mdm2	B-X
cause	B-X
proteasome-independent	B-X
degradation	B-X
of	B-X
mdm2	B-X
and	B-X
that	B-X
this	B-X
may	B-X
be	B-X
important	B-X
for	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
in	B-X
HCMV-infected	B-X
cells	B-X
.	B-X

The	O
regions	O
of	O
IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
important	O
for	O
mdm2	B-Gene_or_gene_product
depletion	O
were	O
those	O
containing	O
the	O
sequences	O
corresponding	O
to	O
the	O
putative	O
zinc	O
finger	O
and	O
C	O
-	O
terminal	O
acidic	O
motifs	O
.	O

mdm2	B-Gene_or_gene_product
and	O
IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
coimmunoprecipitated	O
in	O
transfected	O
and	O
infected	O
cell	O
lysates	O
and	O
in	O
a	O
cell	O
-	O
free	O
system	O
.	O

IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
blocked	O
mdm2	B-Gene_or_gene_product
'	O
s	O
p53	B-Gene_or_gene_product
-	O
independent	O
transactivation	O
of	O
the	O
cyclin	B-Gene_or_gene_product
A	I-Gene_or_gene_product
promoter	O
in	O
transient	O
-	O
transfection	O
experiments	O
.	O
<EOS>	B-X
Levels	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
increased	B-X
in	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
-infected	B-X
cells	B-X
and	B-X
may	B-X
be	B-X
important	B-X
for	B-X
HCMV	B-X
pathogenesis	B-X
.	B-X
In	B-X
normal	B-X
cells	B-X
p53	B-X
levels	B-X
are	B-X
kept	B-X
low	B-X
due	B-X
to	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
where	B-X
p53	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
mdm2	B-X
and	B-X
mdm2	B-X
binds	B-X
and	B-X
ubiquitinates	B-X
p53	B-X
,	B-X
targeting	B-X
p53	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
uninfected	B-X
cells	B-X
,	B-X
mdm2	B-X
was	B-X
undetectable	B-X
upon	B-X
treatment	B-X
of	B-X
infected	B-X
fibroblasts	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
MG132	B-X
.	B-X
Cellular	B-X
depletion	B-X
of	B-X
mdm2	B-X
was	B-X
reproducible	B-X
in	B-X
p53-null	B-X
cells	B-X
transfected	B-X
with	B-X
the	B-X
HCMV	B-X
IE2-86	B-X
protein	B-X
,	B-X
but	B-X
not	B-X
with	B-X
IE172	B-X
,	B-X
independently	B-X
of	B-X
the	B-X
endogenous	B-X
mdm2	B-X
promoter	B-X
.	B-X
IE2-86	B-X
also	B-X
prevented	B-X
the	B-X
emergence	B-X
of	B-X
presumably	B-X
ubiquitinated	B-X
species	B-X
of	B-X
p53	B-X
.	B-X
The	B-X
regions	B-X
of	B-X
IE2-86	B-X
important	B-X
for	B-X
mdm2	B-X
depletion	B-X
were	B-X
those	B-X
containing	B-X
the	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
putative	B-X
zinc	B-X
finger	B-X
and	B-X
C-terminal	B-X
acidic	B-X
motifs	B-X
.	B-X
mdm2	B-X
and	B-X
IE2-86	B-X
coimmunoprecipitated	B-X
in	B-X
transfected	B-X
and	B-X
infected	B-X
cell	B-X
lysates	B-X
and	B-X
in	B-X
a	B-X
cell-free	B-X
system	B-X
.	B-X
IE2-86	B-X
blocked	B-X
mdm2	B-X
's	B-X
p53-independent	B-X
transactivation	B-X
of	B-X
the	B-X
cyclin	B-X
A	B-X
promoter	B-X
in	B-X
transient-transfection	B-X
experiments	B-X
.	B-X
Pulse-chase	B-X
experiments	B-X
revealed	B-X
that	B-X
IE2-86	B-X
but	B-X
not	B-X
IE1-72	B-X
or	B-X
several	B-X
loss-of-function	B-X
IE2-86	B-X
mutants	B-X
increased	B-X
the	B-X
half-life	B-X
of	B-X
p53	B-X
and	B-X
reduced	B-X
the	B-X
half-life	B-X
of	B-X
mdm2	B-X
.	B-X
Short	B-X
interfering	B-X
RNA-mediated	B-X
depletion	B-X
of	B-X
IE2-86	B-X
restored	B-X
the	B-X
ability	B-X
of	B-X
HCMV-infected	B-X
cells	B-X
to	B-X
accumulate	B-X
mdm2	B-X
in	B-X
response	B-X
to	B-X
proteasome	B-X
inhibition	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
suggest	B-X
that	B-X
specific	B-X
interactions	B-X
between	B-X
IE2-86	B-X
and	B-X
mdm2	B-X
cause	B-X
proteasome-independent	B-X
degradation	B-X
of	B-X
mdm2	B-X
and	B-X
that	B-X
this	B-X
may	B-X
be	B-X
important	B-X
for	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
in	B-X
HCMV-infected	B-X
cells	B-X
.	B-X

Pulse	O
-	O
chase	O
experiments	O
revealed	O
that	O
IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
but	O
not	O
IE1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
72	I-Gene_or_gene_product
or	O
several	O
loss	O
-	O
of	O
-	O
function	O
IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
mutants	O
increased	O
the	O
half	O
-	O
life	O
of	O
p53	B-Gene_or_gene_product
and	O
reduced	O
the	O
half	O
-	O
life	O
of	O
mdm2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Levels	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
increased	B-X
in	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
-infected	B-X
cells	B-X
and	B-X
may	B-X
be	B-X
important	B-X
for	B-X
HCMV	B-X
pathogenesis	B-X
.	B-X
In	B-X
normal	B-X
cells	B-X
p53	B-X
levels	B-X
are	B-X
kept	B-X
low	B-X
due	B-X
to	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
where	B-X
p53	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
mdm2	B-X
and	B-X
mdm2	B-X
binds	B-X
and	B-X
ubiquitinates	B-X
p53	B-X
,	B-X
targeting	B-X
p53	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
uninfected	B-X
cells	B-X
,	B-X
mdm2	B-X
was	B-X
undetectable	B-X
upon	B-X
treatment	B-X
of	B-X
infected	B-X
fibroblasts	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
MG132	B-X
.	B-X
Cellular	B-X
depletion	B-X
of	B-X
mdm2	B-X
was	B-X
reproducible	B-X
in	B-X
p53-null	B-X
cells	B-X
transfected	B-X
with	B-X
the	B-X
HCMV	B-X
IE2-86	B-X
protein	B-X
,	B-X
but	B-X
not	B-X
with	B-X
IE172	B-X
,	B-X
independently	B-X
of	B-X
the	B-X
endogenous	B-X
mdm2	B-X
promoter	B-X
.	B-X
IE2-86	B-X
also	B-X
prevented	B-X
the	B-X
emergence	B-X
of	B-X
presumably	B-X
ubiquitinated	B-X
species	B-X
of	B-X
p53	B-X
.	B-X
The	B-X
regions	B-X
of	B-X
IE2-86	B-X
important	B-X
for	B-X
mdm2	B-X
depletion	B-X
were	B-X
those	B-X
containing	B-X
the	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
putative	B-X
zinc	B-X
finger	B-X
and	B-X
C-terminal	B-X
acidic	B-X
motifs	B-X
.	B-X
mdm2	B-X
and	B-X
IE2-86	B-X
coimmunoprecipitated	B-X
in	B-X
transfected	B-X
and	B-X
infected	B-X
cell	B-X
lysates	B-X
and	B-X
in	B-X
a	B-X
cell-free	B-X
system	B-X
.	B-X
IE2-86	B-X
blocked	B-X
mdm2	B-X
's	B-X
p53-independent	B-X
transactivation	B-X
of	B-X
the	B-X
cyclin	B-X
A	B-X
promoter	B-X
in	B-X
transient-transfection	B-X
experiments	B-X
.	B-X
Pulse-chase	B-X
experiments	B-X
revealed	B-X
that	B-X
IE2-86	B-X
but	B-X
not	B-X
IE1-72	B-X
or	B-X
several	B-X
loss-of-function	B-X
IE2-86	B-X
mutants	B-X
increased	B-X
the	B-X
half-life	B-X
of	B-X
p53	B-X
and	B-X
reduced	B-X
the	B-X
half-life	B-X
of	B-X
mdm2	B-X
.	B-X
Short	B-X
interfering	B-X
RNA-mediated	B-X
depletion	B-X
of	B-X
IE2-86	B-X
restored	B-X
the	B-X
ability	B-X
of	B-X
HCMV-infected	B-X
cells	B-X
to	B-X
accumulate	B-X
mdm2	B-X
in	B-X
response	B-X
to	B-X
proteasome	B-X
inhibition	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
suggest	B-X
that	B-X
specific	B-X
interactions	B-X
between	B-X
IE2-86	B-X
and	B-X
mdm2	B-X
cause	B-X
proteasome-independent	B-X
degradation	B-X
of	B-X
mdm2	B-X
and	B-X
that	B-X
this	B-X
may	B-X
be	B-X
important	B-X
for	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
in	B-X
HCMV-infected	B-X
cells	B-X
.	B-X

Short	O
interfering	O
RNA	O
-	O
mediated	O
depletion	O
of	O
IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
restored	O
the	O
ability	O
of	O
HCMV	O
-	O
infected	O
cells	O
to	O
accumulate	O
mdm2	B-Gene_or_gene_product
in	O
response	O
to	O
proteasome	O
inhibition	O
.	O
<EOS>	B-X
Levels	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
increased	B-X
in	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
-infected	B-X
cells	B-X
and	B-X
may	B-X
be	B-X
important	B-X
for	B-X
HCMV	B-X
pathogenesis	B-X
.	B-X
In	B-X
normal	B-X
cells	B-X
p53	B-X
levels	B-X
are	B-X
kept	B-X
low	B-X
due	B-X
to	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
where	B-X
p53	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
mdm2	B-X
and	B-X
mdm2	B-X
binds	B-X
and	B-X
ubiquitinates	B-X
p53	B-X
,	B-X
targeting	B-X
p53	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
uninfected	B-X
cells	B-X
,	B-X
mdm2	B-X
was	B-X
undetectable	B-X
upon	B-X
treatment	B-X
of	B-X
infected	B-X
fibroblasts	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
MG132	B-X
.	B-X
Cellular	B-X
depletion	B-X
of	B-X
mdm2	B-X
was	B-X
reproducible	B-X
in	B-X
p53-null	B-X
cells	B-X
transfected	B-X
with	B-X
the	B-X
HCMV	B-X
IE2-86	B-X
protein	B-X
,	B-X
but	B-X
not	B-X
with	B-X
IE172	B-X
,	B-X
independently	B-X
of	B-X
the	B-X
endogenous	B-X
mdm2	B-X
promoter	B-X
.	B-X
IE2-86	B-X
also	B-X
prevented	B-X
the	B-X
emergence	B-X
of	B-X
presumably	B-X
ubiquitinated	B-X
species	B-X
of	B-X
p53	B-X
.	B-X
The	B-X
regions	B-X
of	B-X
IE2-86	B-X
important	B-X
for	B-X
mdm2	B-X
depletion	B-X
were	B-X
those	B-X
containing	B-X
the	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
putative	B-X
zinc	B-X
finger	B-X
and	B-X
C-terminal	B-X
acidic	B-X
motifs	B-X
.	B-X
mdm2	B-X
and	B-X
IE2-86	B-X
coimmunoprecipitated	B-X
in	B-X
transfected	B-X
and	B-X
infected	B-X
cell	B-X
lysates	B-X
and	B-X
in	B-X
a	B-X
cell-free	B-X
system	B-X
.	B-X
IE2-86	B-X
blocked	B-X
mdm2	B-X
's	B-X
p53-independent	B-X
transactivation	B-X
of	B-X
the	B-X
cyclin	B-X
A	B-X
promoter	B-X
in	B-X
transient-transfection	B-X
experiments	B-X
.	B-X
Pulse-chase	B-X
experiments	B-X
revealed	B-X
that	B-X
IE2-86	B-X
but	B-X
not	B-X
IE1-72	B-X
or	B-X
several	B-X
loss-of-function	B-X
IE2-86	B-X
mutants	B-X
increased	B-X
the	B-X
half-life	B-X
of	B-X
p53	B-X
and	B-X
reduced	B-X
the	B-X
half-life	B-X
of	B-X
mdm2	B-X
.	B-X
Short	B-X
interfering	B-X
RNA-mediated	B-X
depletion	B-X
of	B-X
IE2-86	B-X
restored	B-X
the	B-X
ability	B-X
of	B-X
HCMV-infected	B-X
cells	B-X
to	B-X
accumulate	B-X
mdm2	B-X
in	B-X
response	B-X
to	B-X
proteasome	B-X
inhibition	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
suggest	B-X
that	B-X
specific	B-X
interactions	B-X
between	B-X
IE2-86	B-X
and	B-X
mdm2	B-X
cause	B-X
proteasome-independent	B-X
degradation	B-X
of	B-X
mdm2	B-X
and	B-X
that	B-X
this	B-X
may	B-X
be	B-X
important	B-X
for	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
in	B-X
HCMV-infected	B-X
cells	B-X
.	B-X

Taken	O
together	O
,	O
the	O
data	O
suggest	O
that	O
specific	O
interactions	O
between	O
IE2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
86	I-Gene_or_gene_product
and	O
mdm2	B-Gene_or_gene_product
cause	O
proteasome	O
-	O
independent	O
degradation	O
of	O
mdm2	B-Gene_or_gene_product
and	O
that	O
this	O
may	O
be	O
important	O
for	O
the	O
accumulation	O
of	O
p53	B-Gene_or_gene_product
in	O
HCMV	O
-	O
infected	O
cells	O
.	O
<EOS>	B-X
Levels	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
increased	B-X
in	B-X
human	B-X
cytomegalovirus	B-X
(	B-X
HCMV	B-X
)	B-X
-infected	B-X
cells	B-X
and	B-X
may	B-X
be	B-X
important	B-X
for	B-X
HCMV	B-X
pathogenesis	B-X
.	B-X
In	B-X
normal	B-X
cells	B-X
p53	B-X
levels	B-X
are	B-X
kept	B-X
low	B-X
due	B-X
to	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
where	B-X
p53	B-X
activates	B-X
the	B-X
transcription	B-X
of	B-X
mdm2	B-X
and	B-X
mdm2	B-X
binds	B-X
and	B-X
ubiquitinates	B-X
p53	B-X
,	B-X
targeting	B-X
p53	B-X
for	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Here	B-X
we	B-X
report	B-X
that	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
uninfected	B-X
cells	B-X
,	B-X
mdm2	B-X
was	B-X
undetectable	B-X
upon	B-X
treatment	B-X
of	B-X
infected	B-X
fibroblasts	B-X
with	B-X
the	B-X
proteasome	B-X
inhibitor	B-X
MG132	B-X
.	B-X
Cellular	B-X
depletion	B-X
of	B-X
mdm2	B-X
was	B-X
reproducible	B-X
in	B-X
p53-null	B-X
cells	B-X
transfected	B-X
with	B-X
the	B-X
HCMV	B-X
IE2-86	B-X
protein	B-X
,	B-X
but	B-X
not	B-X
with	B-X
IE172	B-X
,	B-X
independently	B-X
of	B-X
the	B-X
endogenous	B-X
mdm2	B-X
promoter	B-X
.	B-X
IE2-86	B-X
also	B-X
prevented	B-X
the	B-X
emergence	B-X
of	B-X
presumably	B-X
ubiquitinated	B-X
species	B-X
of	B-X
p53	B-X
.	B-X
The	B-X
regions	B-X
of	B-X
IE2-86	B-X
important	B-X
for	B-X
mdm2	B-X
depletion	B-X
were	B-X
those	B-X
containing	B-X
the	B-X
sequences	B-X
corresponding	B-X
to	B-X
the	B-X
putative	B-X
zinc	B-X
finger	B-X
and	B-X
C-terminal	B-X
acidic	B-X
motifs	B-X
.	B-X
mdm2	B-X
and	B-X
IE2-86	B-X
coimmunoprecipitated	B-X
in	B-X
transfected	B-X
and	B-X
infected	B-X
cell	B-X
lysates	B-X
and	B-X
in	B-X
a	B-X
cell-free	B-X
system	B-X
.	B-X
IE2-86	B-X
blocked	B-X
mdm2	B-X
's	B-X
p53-independent	B-X
transactivation	B-X
of	B-X
the	B-X
cyclin	B-X
A	B-X
promoter	B-X
in	B-X
transient-transfection	B-X
experiments	B-X
.	B-X
Pulse-chase	B-X
experiments	B-X
revealed	B-X
that	B-X
IE2-86	B-X
but	B-X
not	B-X
IE1-72	B-X
or	B-X
several	B-X
loss-of-function	B-X
IE2-86	B-X
mutants	B-X
increased	B-X
the	B-X
half-life	B-X
of	B-X
p53	B-X
and	B-X
reduced	B-X
the	B-X
half-life	B-X
of	B-X
mdm2	B-X
.	B-X
Short	B-X
interfering	B-X
RNA-mediated	B-X
depletion	B-X
of	B-X
IE2-86	B-X
restored	B-X
the	B-X
ability	B-X
of	B-X
HCMV-infected	B-X
cells	B-X
to	B-X
accumulate	B-X
mdm2	B-X
in	B-X
response	B-X
to	B-X
proteasome	B-X
inhibition	B-X
.	B-X
Taken	B-X
together	B-X
,	B-X
the	B-X
data	B-X
suggest	B-X
that	B-X
specific	B-X
interactions	B-X
between	B-X
IE2-86	B-X
and	B-X
mdm2	B-X
cause	B-X
proteasome-independent	B-X
degradation	B-X
of	B-X
mdm2	B-X
and	B-X
that	B-X
this	B-X
may	B-X
be	B-X
important	B-X
for	B-X
the	B-X
accumulation	B-X
of	B-X
p53	B-X
in	B-X
HCMV-infected	B-X
cells	B-X
.	B-X

Activity	O
of	O
TSC2	B-Gene_or_gene_product
is	O
inhibited	O
by	O
AKT	B-Gene_or_gene_product
-	O
mediated	O
phosphorylation	O
and	O
membrane	O
partitioning	O
.	O
<EOS>	B-X
Loss	B-X
of	B-X
tuberin	B-X
,	B-X
the	B-X
product	B-X
of	B-X
TSC2	B-X
gene	B-X
,	B-X
increases	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
,	B-X
promoting	B-X
cell	B-X
growth	B-X
and	B-X
tumor	B-X
development	B-X
.	B-X
We	B-X
show	B-X
that	B-X
hamartin	B-X
colocalizes	B-X
with	B-X
hypophosphorylated	B-X
tuberin	B-X
at	B-X
the	B-X
membrane	B-X
,	B-X
where	B-X
tuberin	B-X
exerts	B-X
its	B-X
GTPase-activating	B-X
protein	B-X
(	B-X
GAP	B-X
)	B-X
activity	B-X
to	B-X
repress	B-X
Rheb	B-X
signaling	B-X
.	B-X
In	B-X
response	B-X
to	B-X
growth	B-X
signals	B-X
,	B-X
tuberin	B-X
is	B-X
phosphorylated	B-X
by	B-X
AKT	B-X
and	B-X
translocates	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
relieving	B-X
Rheb	B-X
repression	B-X
.	B-X
Thus	B-X
,	B-X
tuberin	B-X
bound	B-X
by	B-X
14-3-3	B-X
in	B-X
response	B-X
to	B-X
AKT	B-X
phosphorylation	B-X
is	B-X
sequestered	B-X
away	B-X
from	B-X
its	B-X
membrane-bound	B-X
activation	B-X
partner	B-X
(	B-X
hamartin	B-X
)	B-X
and	B-X
its	B-X
target	B-X
GTPase	B-X
(	B-X
Rheb	B-X
)	B-X
to	B-X
relieve	B-X
the	B-X
growth	B-X
inhibitory	B-X
effects	B-X
of	B-X
this	B-X
tumor	B-X
suppressor	B-X
.	B-X

Loss	O
of	O
tuberin	B-Gene_or_gene_product
,	O
the	O
product	O
of	O
TSC2	B-Gene_or_gene_product
gene	O
,	O
increases	O
mammalian	B-Gene_or_gene_product
target	I-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
(	O
mTOR	B-Gene_or_gene_product
)	O
signaling	O
,	O
promoting	O
cell	O
growth	O
and	O
tumor	O
development	O
.	O
<EOS>	B-X
Loss	B-X
of	B-X
tuberin	B-X
,	B-X
the	B-X
product	B-X
of	B-X
TSC2	B-X
gene	B-X
,	B-X
increases	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
,	B-X
promoting	B-X
cell	B-X
growth	B-X
and	B-X
tumor	B-X
development	B-X
.	B-X
However	B-X
,	B-X
in	B-X
cells	B-X
expressing	B-X
tuberin	B-X
,	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
repression	B-X
of	B-X
mTOR	B-X
signaling	B-X
is	B-X
relieved	B-X
to	B-X
activate	B-X
this	B-X
pathway	B-X
in	B-X
response	B-X
to	B-X
growth	B-X
factors	B-X
and	B-X
how	B-X
hamartin	B-X
participates	B-X
in	B-X
this	B-X
process	B-X
.	B-X
We	B-X
show	B-X
that	B-X
hamartin	B-X
colocalizes	B-X
with	B-X
hypophosphorylated	B-X
tuberin	B-X
at	B-X
the	B-X
membrane	B-X
,	B-X
where	B-X
tuberin	B-X
exerts	B-X
its	B-X
GTPase-activating	B-X
protein	B-X
(	B-X
GAP	B-X
)	B-X
activity	B-X
to	B-X
repress	B-X
Rheb	B-X
signaling	B-X
.	B-X
In	B-X
response	B-X
to	B-X
growth	B-X
signals	B-X
,	B-X
tuberin	B-X
is	B-X
phosphorylated	B-X
by	B-X
AKT	B-X
and	B-X
translocates	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
relieving	B-X
Rheb	B-X
repression	B-X
.	B-X
Phosphorylation	B-X
of	B-X
tuberin	B-X
at	B-X
serines	B-X
939	B-X
and	B-X
981	B-X
does	B-X
not	B-X
alter	B-X
its	B-X
intrinsic	B-X
GAP	B-X
activity	B-X
toward	B-X
Rheb	B-X
but	B-X
partitions	B-X
tuberin	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
where	B-X
it	B-X
is	B-X
bound	B-X
by	B-X
14-3-3	B-X
proteins	B-X
.	B-X
Thus	B-X
,	B-X
tuberin	B-X
bound	B-X
by	B-X
14-3-3	B-X
in	B-X
response	B-X
to	B-X
AKT	B-X
phosphorylation	B-X
is	B-X
sequestered	B-X
away	B-X
from	B-X
its	B-X
membrane-bound	B-X
activation	B-X
partner	B-X
(	B-X
hamartin	B-X
)	B-X
and	B-X
its	B-X
target	B-X
GTPase	B-X
(	B-X
Rheb	B-X
)	B-X
to	B-X
relieve	B-X
the	B-X
growth	B-X
inhibitory	B-X
effects	B-X
of	B-X
this	B-X
tumor	B-X
suppressor	B-X
.	B-X

However	O
,	O
in	O
cells	O
expressing	O
tuberin	B-Gene_or_gene_product
,	O
it	O
is	O
not	O
known	O
how	O
repression	O
of	O
mTOR	B-Gene_or_gene_product
signaling	O
is	O
relieved	O
to	O
activate	O
this	O
pathway	O
in	O
response	O
to	O
growth	O
factors	O
and	O
how	O
hamartin	B-Gene_or_gene_product
participates	O
in	O
this	O
process	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
developmental	B-X
processes	B-X
specific	B-X
to	B-X
humans	B-X
are	B-X
responsible	B-X
for	B-X
malformations	B-X
of	B-X
cortical	B-X
development	B-X
(	B-X
MCDs	B-X
)	B-X
,	B-X
which	B-X
result	B-X
in	B-X
developmental	B-X
delay	B-X
and	B-X
epilepsy	B-X
in	B-X
children	B-X
.	B-X
We	B-X
generated	B-X
a	B-X
human	B-X
cerebral	B-X
organoid	B-X
model	B-X
for	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
(	B-X
TSC	B-X
)	B-X
and	B-X
identified	B-X
a	B-X
specific	B-X
neural	B-X
stem	B-X
cell	B-X
type	B-X
,	B-X
caudal	B-X
late	B-X
interneuron	B-X
progenitor	B-X
(	B-X
CLIP	B-X
)	B-X
cells	B-X
.	B-X
In	B-X
TSC	B-X
,	B-X
CLIP	B-X
cells	B-X
over-proliferate	B-X
,	B-X
generating	B-X
excessive	B-X
interneurons	B-X
,	B-X
brain	B-X
tumors	B-X
,	B-X
and	B-X
cortical	B-X
malformations	B-X
.	B-X
Epidermal	B-X
growth	B-X
factor	B-X
receptor	B-X
inhibition	B-X
reduces	B-X
tumor	B-X
burden	B-X
,	B-X
identifying	B-X
potential	B-X
treatment	B-X
options	B-X
for	B-X
TSC	B-X
and	B-X
related	B-X
disorders	B-X
.	B-X
The	B-X
identification	B-X
of	B-X
CLIP	B-X
cells	B-X
reveals	B-X
the	B-X
extended	B-X
interneuron	B-X
generation	B-X
in	B-X
the	B-X
human	B-X
brain	B-X
as	B-X
a	B-X
vulnerability	B-X
for	B-X
disease	B-X
.	B-X

We	O
show	O
that	O
hamartin	B-Gene_or_gene_product
colocalizes	O
with	O
hypophosphorylated	O
tuberin	B-Gene_or_gene_product
at	O
the	O
membrane	O
,	O
where	O
tuberin	B-Gene_or_gene_product
exerts	O
its	O
GTPase	O
-	O
activating	O
protein	O
(	O
GAP	O
)	O
activity	O
to	O
repress	O
Rheb	B-Gene_or_gene_product
signaling	O
.	O
<EOS>	B-X
Loss	B-X
of	B-X
tuberin	B-X
,	B-X
the	B-X
product	B-X
of	B-X
TSC2	B-X
gene	B-X
,	B-X
increases	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
,	B-X
promoting	B-X
cell	B-X
growth	B-X
and	B-X
tumor	B-X
development	B-X
.	B-X
However	B-X
,	B-X
in	B-X
cells	B-X
expressing	B-X
tuberin	B-X
,	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
repression	B-X
of	B-X
mTOR	B-X
signaling	B-X
is	B-X
relieved	B-X
to	B-X
activate	B-X
this	B-X
pathway	B-X
in	B-X
response	B-X
to	B-X
growth	B-X
factors	B-X
and	B-X
how	B-X
hamartin	B-X
participates	B-X
in	B-X
this	B-X
process	B-X
.	B-X
We	B-X
show	B-X
that	B-X
hamartin	B-X
colocalizes	B-X
with	B-X
hypophosphorylated	B-X
tuberin	B-X
at	B-X
the	B-X
membrane	B-X
,	B-X
where	B-X
tuberin	B-X
exerts	B-X
its	B-X
GTPase-activating	B-X
protein	B-X
(	B-X
GAP	B-X
)	B-X
activity	B-X
to	B-X
repress	B-X
Rheb	B-X
signaling	B-X
.	B-X
In	B-X
response	B-X
to	B-X
growth	B-X
signals	B-X
,	B-X
tuberin	B-X
is	B-X
phosphorylated	B-X
by	B-X
AKT	B-X
and	B-X
translocates	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
relieving	B-X
Rheb	B-X
repression	B-X
.	B-X
Phosphorylation	B-X
of	B-X
tuberin	B-X
at	B-X
serines	B-X
939	B-X
and	B-X
981	B-X
does	B-X
not	B-X
alter	B-X
its	B-X
intrinsic	B-X
GAP	B-X
activity	B-X
toward	B-X
Rheb	B-X
but	B-X
partitions	B-X
tuberin	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
where	B-X
it	B-X
is	B-X
bound	B-X
by	B-X
14-3-3	B-X
proteins	B-X
.	B-X
Thus	B-X
,	B-X
tuberin	B-X
bound	B-X
by	B-X
14-3-3	B-X
in	B-X
response	B-X
to	B-X
AKT	B-X
phosphorylation	B-X
is	B-X
sequestered	B-X
away	B-X
from	B-X
its	B-X
membrane-bound	B-X
activation	B-X
partner	B-X
(	B-X
hamartin	B-X
)	B-X
and	B-X
its	B-X
target	B-X
GTPase	B-X
(	B-X
Rheb	B-X
)	B-X
to	B-X
relieve	B-X
the	B-X
growth	B-X
inhibitory	B-X
effects	B-X
of	B-X
this	B-X
tumor	B-X
suppressor	B-X
.	B-X

In	O
response	O
to	O
growth	O
signals	O
,	O
tuberin	B-Gene_or_gene_product
is	O
phosphorylated	O
by	O
AKT	B-Gene_or_gene_product
and	O
translocates	O
to	O
the	O
cytosol	O
,	O
relieving	O
Rheb	B-Gene_or_gene_product
repression	O
.	O

Phosphorylation	O
of	O
tuberin	B-Gene_or_gene_product
at	O
serines	O
939	O
and	O
981	O
does	O
not	O
alter	O
its	O
intrinsic	O
GAP	O
activity	O
toward	O
Rheb	B-Gene_or_gene_product
but	O
partitions	O
tuberin	B-Gene_or_gene_product
to	O
the	O
cytosol	O
,	O
where	O
it	O
is	O
bound	O
by	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
proteins	O
.	O
<EOS>	B-X
Loss	B-X
of	B-X
tuberin	B-X
,	B-X
the	B-X
product	B-X
of	B-X
TSC2	B-X
gene	B-X
,	B-X
increases	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
,	B-X
promoting	B-X
cell	B-X
growth	B-X
and	B-X
tumor	B-X
development	B-X
.	B-X
However	B-X
,	B-X
in	B-X
cells	B-X
expressing	B-X
tuberin	B-X
,	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
repression	B-X
of	B-X
mTOR	B-X
signaling	B-X
is	B-X
relieved	B-X
to	B-X
activate	B-X
this	B-X
pathway	B-X
in	B-X
response	B-X
to	B-X
growth	B-X
factors	B-X
and	B-X
how	B-X
hamartin	B-X
participates	B-X
in	B-X
this	B-X
process	B-X
.	B-X
We	B-X
show	B-X
that	B-X
hamartin	B-X
colocalizes	B-X
with	B-X
hypophosphorylated	B-X
tuberin	B-X
at	B-X
the	B-X
membrane	B-X
,	B-X
where	B-X
tuberin	B-X
exerts	B-X
its	B-X
GTPase-activating	B-X
protein	B-X
(	B-X
GAP	B-X
)	B-X
activity	B-X
to	B-X
repress	B-X
Rheb	B-X
signaling	B-X
.	B-X
In	B-X
response	B-X
to	B-X
growth	B-X
signals	B-X
,	B-X
tuberin	B-X
is	B-X
phosphorylated	B-X
by	B-X
AKT	B-X
and	B-X
translocates	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
relieving	B-X
Rheb	B-X
repression	B-X
.	B-X
Phosphorylation	B-X
of	B-X
tuberin	B-X
at	B-X
serines	B-X
939	B-X
and	B-X
981	B-X
does	B-X
not	B-X
alter	B-X
its	B-X
intrinsic	B-X
GAP	B-X
activity	B-X
toward	B-X
Rheb	B-X
but	B-X
partitions	B-X
tuberin	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
where	B-X
it	B-X
is	B-X
bound	B-X
by	B-X
14-3-3	B-X
proteins	B-X
.	B-X
Thus	B-X
,	B-X
tuberin	B-X
bound	B-X
by	B-X
14-3-3	B-X
in	B-X
response	B-X
to	B-X
AKT	B-X
phosphorylation	B-X
is	B-X
sequestered	B-X
away	B-X
from	B-X
its	B-X
membrane-bound	B-X
activation	B-X
partner	B-X
(	B-X
hamartin	B-X
)	B-X
and	B-X
its	B-X
target	B-X
GTPase	B-X
(	B-X
Rheb	B-X
)	B-X
to	B-X
relieve	B-X
the	B-X
growth	B-X
inhibitory	B-X
effects	B-X
of	B-X
this	B-X
tumor	B-X
suppressor	B-X
.	B-X

Thus	O
,	O
tuberin	B-Gene_or_gene_product
bound	O
by	O
14	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
in	O
response	O
to	O
AKT	B-Gene_or_gene_product
phosphorylation	O
is	O
sequestered	O
away	O
from	O
its	O
membrane	O
-	O
bound	O
activation	O
partner	O
(	O
hamartin	B-Gene_or_gene_product
)	O
and	O
its	O
target	O
GTPase	O
(	O
Rheb	B-Gene_or_gene_product
)	O
to	O
relieve	O
the	O
growth	O
inhibitory	O
effects	O
of	O
this	O
tumor	O
suppressor	O
.	O
<EOS>	B-X
Loss	B-X
of	B-X
tuberin	B-X
,	B-X
the	B-X
product	B-X
of	B-X
TSC2	B-X
gene	B-X
,	B-X
increases	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
signaling	B-X
,	B-X
promoting	B-X
cell	B-X
growth	B-X
and	B-X
tumor	B-X
development	B-X
.	B-X
However	B-X
,	B-X
in	B-X
cells	B-X
expressing	B-X
tuberin	B-X
,	B-X
it	B-X
is	B-X
not	B-X
known	B-X
how	B-X
repression	B-X
of	B-X
mTOR	B-X
signaling	B-X
is	B-X
relieved	B-X
to	B-X
activate	B-X
this	B-X
pathway	B-X
in	B-X
response	B-X
to	B-X
growth	B-X
factors	B-X
and	B-X
how	B-X
hamartin	B-X
participates	B-X
in	B-X
this	B-X
process	B-X
.	B-X
We	B-X
show	B-X
that	B-X
hamartin	B-X
colocalizes	B-X
with	B-X
hypophosphorylated	B-X
tuberin	B-X
at	B-X
the	B-X
membrane	B-X
,	B-X
where	B-X
tuberin	B-X
exerts	B-X
its	B-X
GTPase-activating	B-X
protein	B-X
(	B-X
GAP	B-X
)	B-X
activity	B-X
to	B-X
repress	B-X
Rheb	B-X
signaling	B-X
.	B-X
In	B-X
response	B-X
to	B-X
growth	B-X
signals	B-X
,	B-X
tuberin	B-X
is	B-X
phosphorylated	B-X
by	B-X
AKT	B-X
and	B-X
translocates	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
relieving	B-X
Rheb	B-X
repression	B-X
.	B-X
Phosphorylation	B-X
of	B-X
tuberin	B-X
at	B-X
serines	B-X
939	B-X
and	B-X
981	B-X
does	B-X
not	B-X
alter	B-X
its	B-X
intrinsic	B-X
GAP	B-X
activity	B-X
toward	B-X
Rheb	B-X
but	B-X
partitions	B-X
tuberin	B-X
to	B-X
the	B-X
cytosol	B-X
,	B-X
where	B-X
it	B-X
is	B-X
bound	B-X
by	B-X
14-3-3	B-X
proteins	B-X
.	B-X
Thus	B-X
,	B-X
tuberin	B-X
bound	B-X
by	B-X
14-3-3	B-X
in	B-X
response	B-X
to	B-X
AKT	B-X
phosphorylation	B-X
is	B-X
sequestered	B-X
away	B-X
from	B-X
its	B-X
membrane-bound	B-X
activation	B-X
partner	B-X
(	B-X
hamartin	B-X
)	B-X
and	B-X
its	B-X
target	B-X
GTPase	B-X
(	B-X
Rheb	B-X
)	B-X
to	B-X
relieve	B-X
the	B-X
growth	B-X
inhibitory	B-X
effects	B-X
of	B-X
this	B-X
tumor	B-X
suppressor	B-X
.	B-X

Adeno	O
-	O
associated	O
virus	O
type	O
2	O
increases	O
proteosome	O
-	O
dependent	O
degradation	O
of	O
p21WAF1	B-Gene_or_gene_product
in	O
a	O
human	O
papillomavirus	O
type	O
31b	O
-	O
positive	O
cervical	O
carcinoma	O
line	O
.	O

Adeno	O
-	O
associated	O
virus	O
type	O
2	O
(	O
AAV2	O
)	O
seropositivity	O
is	O
negatively	O
correlated	O
with	O
the	O
development	O
of	O
human	O
papillomavirus	O
(	O
HPV	O
)	O
-	O
associated	O
cervical	O
cancer	O
.	O
<EOS>	B-X
Adeno-associated	B-X
virus	B-X
type	B-X
2	B-X
(	B-X
AAV2	B-X
)	B-X
seropositivity	B-X
is	B-X
negatively	B-X
correlated	B-X
with	B-X
the	B-X
development	B-X
of	B-X
human	B-X
papillomavirus	B-X
(	B-X
HPV	B-X
)	B-X
-associated	B-X
cervical	B-X
cancer	B-X
.	B-X
We	B-X
have	B-X
begun	B-X
analysis	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
AAV2-mediated	B-X
onco-suppression	B-X
through	B-X
cell	B-X
cycle	B-X
regulation	B-X
in	B-X
HPV-infected	B-X
keratinocytes	B-X
isolated	B-X
from	B-X
a	B-X
low-grade	B-X
cervical	B-X
lesion	B-X
.	B-X
AAV2	B-X
superinfection	B-X
of	B-X
HPV	B-X
type	B-X
31b	B-X
(	B-X
HPV31b	B-X
)	B-X
-positive	B-X
cells	B-X
at	B-X
early	B-X
times	B-X
postinfection	B-X
resulted	B-X
in	B-X
degradation	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
inhibitor	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
protein	B-X
in	B-X
a	B-X
proteosome-dependent	B-X
manner	B-X
.	B-X
Downstream	B-X
consequences	B-X
of	B-X
lowering	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
levels	B-X
included	B-X
a	B-X
proportional	B-X
loss	B-X
of	B-X
cyclin	B-X
E/CDK2	B-X
complexes	B-X
bound	B-X
to	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
stable	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
/cyclin	B-X
E/CDK2	B-X
complexes	B-X
coincided	B-X
with	B-X
an	B-X
increase	B-X
in	B-X
CDK2-associated	B-X
kinase	B-X
activity	B-X
and	B-X
cyclin	B-X
E	B-X
levels	B-X
.	B-X
Both	B-X
events	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
enhance	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
point	B-X
mediated	B-X
by	B-X
active	B-X
cyclin	B-X
E/CDK2	B-X
complexes	B-X
.	B-X
Concurrently	B-X
,	B-X
cyclin	B-X
A	B-X
and	B-X
E2F	B-X
levels	B-X
were	B-X
decreased	B-X
,	B-X
conditions	B-X
reminiscent	B-X
of	B-X
delayed	B-X
entrance	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
infection	B-X
of	B-X
primary	B-X
human	B-X
foreskin	B-X
keratinocytes	B-X
with	B-X
AAV2	B-X
resulted	B-X
in	B-X
upregulation	B-X
of	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
protein	B-X
levels	B-X
,	B-X
reminiscent	B-X
of	B-X
a	B-X
block	B-X
in	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
progression	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
by	B-X
down	B-X
regulating	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
,	B-X
AAV2	B-X
initiates	B-X
cell	B-X
cycle	B-X
activities	B-X
leading	B-X
to	B-X
enhanced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
phase-like	B-X
conditions	B-X
which	B-X
may	B-X
be	B-X
favorable	B-X
for	B-X
AAV2-specific	B-X
functions	B-X
and	B-X
may	B-X
lead	B-X
to	B-X
downstream	B-X
interference	B-X
with	B-X
HPV-associated	B-X
cervical	B-X
cancer	B-X
progression	B-X
.	B-X

We	O
have	O
begun	O
analysis	O
of	O
the	O
molecular	O
mechanisms	O
underlying	O
AAV2	O
-	O
mediated	O
onco	O
-	O
suppression	O
through	O
cell	O
cycle	O
regulation	O
in	O
HPV	O
-	O
infected	O
keratinocytes	O
isolated	O
from	O
a	O
low	O
-	O
grade	O
cervical	O
lesion	O
.	O
<EOS>	B-X
Adeno-associated	B-X
virus	B-X
type	B-X
2	B-X
(	B-X
AAV2	B-X
)	B-X
seropositivity	B-X
is	B-X
negatively	B-X
correlated	B-X
with	B-X
the	B-X
development	B-X
of	B-X
human	B-X
papillomavirus	B-X
(	B-X
HPV	B-X
)	B-X
-associated	B-X
cervical	B-X
cancer	B-X
.	B-X
We	B-X
have	B-X
begun	B-X
analysis	B-X
of	B-X
the	B-X
molecular	B-X
mechanisms	B-X
underlying	B-X
AAV2-mediated	B-X
onco-suppression	B-X
through	B-X
cell	B-X
cycle	B-X
regulation	B-X
in	B-X
HPV-infected	B-X
keratinocytes	B-X
isolated	B-X
from	B-X
a	B-X
low-grade	B-X
cervical	B-X
lesion	B-X
.	B-X
AAV2	B-X
superinfection	B-X
of	B-X
HPV	B-X
type	B-X
31b	B-X
(	B-X
HPV31b	B-X
)	B-X
-positive	B-X
cells	B-X
at	B-X
early	B-X
times	B-X
postinfection	B-X
resulted	B-X
in	B-X
degradation	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
inhibitor	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
protein	B-X
in	B-X
a	B-X
proteosome-dependent	B-X
manner	B-X
.	B-X
Downstream	B-X
consequences	B-X
of	B-X
lowering	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
levels	B-X
included	B-X
a	B-X
proportional	B-X
loss	B-X
of	B-X
cyclin	B-X
E/CDK2	B-X
complexes	B-X
bound	B-X
to	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
.	B-X
Both	B-X
events	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
enhance	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
point	B-X
mediated	B-X
by	B-X
active	B-X
cyclin	B-X
E/CDK2	B-X
complexes	B-X
.	B-X
Concurrently	B-X
,	B-X
cyclin	B-X
A	B-X
and	B-X
E2F	B-X
levels	B-X
were	B-X
decreased	B-X
,	B-X
conditions	B-X
reminiscent	B-X
of	B-X
delayed	B-X
entrance	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
infection	B-X
of	B-X
primary	B-X
human	B-X
foreskin	B-X
keratinocytes	B-X
with	B-X
AAV2	B-X
resulted	B-X
in	B-X
upregulation	B-X
of	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
protein	B-X
levels	B-X
,	B-X
reminiscent	B-X
of	B-X
a	B-X
block	B-X
in	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
progression	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
by	B-X
down	B-X
regulating	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
,	B-X
AAV2	B-X
initiates	B-X
cell	B-X
cycle	B-X
activities	B-X
leading	B-X
to	B-X
enhanced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
phase-like	B-X
conditions	B-X
which	B-X
may	B-X
be	B-X
favorable	B-X
for	B-X
AAV2-specific	B-X
functions	B-X
and	B-X
may	B-X
lead	B-X
to	B-X
downstream	B-X
interference	B-X
with	B-X
HPV-associated	B-X
cervical	B-X
cancer	B-X
progression	B-X
.	B-X

AAV2	O
superinfection	O
of	O
HPV	O
type	O
31b	O
(	O
HPV31b	O
)	O
-	O
positive	O
cells	O
at	O
early	O
times	O
postinfection	O
resulted	O
in	O
degradation	O
of	O
the	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
CDK	B-Gene_or_gene_product
)	O
inhibitor	O
p21	B-Gene_or_gene_product
(	O
WAF1	B-Gene_or_gene_product
)	O
protein	O
in	O
a	O
proteosome	O
-	O
dependent	O
manner	O
.	O

Downstream	O
consequences	O
of	O
lowering	O
p21	B-Gene_or_gene_product
(	O
WAF1	B-Gene_or_gene_product
)	O
levels	O
included	O
a	O
proportional	O
loss	O
of	O
cyclin	O
E	O
/	O
CDK2	O
complexes	O
bound	O
to	O
p21	B-Gene_or_gene_product
(	O
WAF1	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
AAV2	B-X
superinfection	B-X
of	B-X
HPV	B-X
type	B-X
31b	B-X
(	B-X
HPV31b	B-X
)	B-X
-positive	B-X
cells	B-X
at	B-X
early	B-X
times	B-X
postinfection	B-X
resulted	B-X
in	B-X
degradation	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
inhibitor	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
protein	B-X
in	B-X
a	B-X
proteosome-dependent	B-X
manner	B-X
.	B-X
Downstream	B-X
consequences	B-X
of	B-X
lowering	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
levels	B-X
included	B-X
a	B-X
proportional	B-X
loss	B-X
of	B-X
cyclin	B-X
E/CDK2	B-X
complexes	B-X
bound	B-X
to	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
stable	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
/cyclin	B-X
E/CDK2	B-X
complexes	B-X
coincided	B-X
with	B-X
an	B-X
increase	B-X
in	B-X
CDK2-associated	B-X
kinase	B-X
activity	B-X
and	B-X
cyclin	B-X
E	B-X
levels	B-X
.	B-X
Both	B-X
events	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
enhance	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
point	B-X
mediated	B-X
by	B-X
active	B-X
cyclin	B-X
E/CDK2	B-X
complexes	B-X
.	B-X
Concurrently	B-X
,	B-X
cyclin	B-X
A	B-X
and	B-X
E2F	B-X
levels	B-X
were	B-X
decreased	B-X
,	B-X
conditions	B-X
reminiscent	B-X
of	B-X
delayed	B-X
entrance	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
infection	B-X
of	B-X
primary	B-X
human	B-X
foreskin	B-X
keratinocytes	B-X
with	B-X
AAV2	B-X
resulted	B-X
in	B-X
upregulation	B-X
of	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
protein	B-X
levels	B-X
,	B-X
reminiscent	B-X
of	B-X
a	B-X
block	B-X
in	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
progression	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
by	B-X
down	B-X
regulating	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
,	B-X
AAV2	B-X
initiates	B-X
cell	B-X
cycle	B-X
activities	B-X
leading	B-X
to	B-X
enhanced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
phase-like	B-X
conditions	B-X
which	B-X
may	B-X
be	B-X
favorable	B-X
for	B-X
AAV2-specific	B-X
functions	B-X
and	B-X
may	B-X
lead	B-X
to	B-X
downstream	B-X
interference	B-X
with	B-X
HPV-associated	B-X
cervical	B-X
cancer	B-X
progression	B-X
.	B-X

The	O
loss	O
of	O
stable	O
p21	O
(	O
WAF1	O
)	O
/	O
cyclin	O
E	O
/	O
CDK2	O
complexes	O
coincided	O
with	O
an	O
increase	O
in	O
CDK2	B-Gene_or_gene_product
-	I-Gene_or_gene_product
associated	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
activity	O
and	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
levels	O
.	O
<EOS>	B-X
Adeno-associated	B-X
virus	B-X
type	B-X
2	B-X
(	B-X
AAV2	B-X
)	B-X
seropositivity	B-X
is	B-X
negatively	B-X
correlated	B-X
with	B-X
the	B-X
development	B-X
of	B-X
human	B-X
papillomavirus	B-X
(	B-X
HPV	B-X
)	B-X
-associated	B-X
cervical	B-X
cancer	B-X
.	B-X
AAV2	B-X
superinfection	B-X
of	B-X
HPV	B-X
type	B-X
31b	B-X
(	B-X
HPV31b	B-X
)	B-X
-positive	B-X
cells	B-X
at	B-X
early	B-X
times	B-X
postinfection	B-X
resulted	B-X
in	B-X
degradation	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
inhibitor	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
protein	B-X
in	B-X
a	B-X
proteosome-dependent	B-X
manner	B-X
.	B-X
Downstream	B-X
consequences	B-X
of	B-X
lowering	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
levels	B-X
included	B-X
a	B-X
proportional	B-X
loss	B-X
of	B-X
cyclin	B-X
E/CDK2	B-X
complexes	B-X
bound	B-X
to	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
.	B-X
The	B-X
loss	B-X
of	B-X
stable	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
/cyclin	B-X
E/CDK2	B-X
complexes	B-X
coincided	B-X
with	B-X
an	B-X
increase	B-X
in	B-X
CDK2-associated	B-X
kinase	B-X
activity	B-X
and	B-X
cyclin	B-X
E	B-X
levels	B-X
.	B-X
Both	B-X
events	B-X
have	B-X
the	B-X
potential	B-X
to	B-X
enhance	B-X
the	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
transition	B-X
point	B-X
mediated	B-X
by	B-X
active	B-X
cyclin	B-X
E/CDK2	B-X
complexes	B-X
.	B-X
Concurrently	B-X
,	B-X
cyclin	B-X
A	B-X
and	B-X
E2F	B-X
levels	B-X
were	B-X
decreased	B-X
,	B-X
conditions	B-X
reminiscent	B-X
of	B-X
delayed	B-X
entrance	B-X
into	B-X
the	B-X
S	B-X
phase	B-X
of	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
On	B-X
the	B-X
other	B-X
hand	B-X
,	B-X
infection	B-X
of	B-X
primary	B-X
human	B-X
foreskin	B-X
keratinocytes	B-X
with	B-X
AAV2	B-X
resulted	B-X
in	B-X
upregulation	B-X
of	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
protein	B-X
levels	B-X
,	B-X
reminiscent	B-X
of	B-X
a	B-X
block	B-X
in	B-X
G	B-X
(	B-X
1	B-X
)	B-X
phase	B-X
progression	B-X
.	B-X
We	B-X
propose	B-X
that	B-X
by	B-X
down	B-X
regulating	B-X
p21	B-X
(	B-X
WAF1	B-X
)	B-X
,	B-X
AAV2	B-X
initiates	B-X
cell	B-X
cycle	B-X
activities	B-X
leading	B-X
to	B-X
enhanced	B-X
G	B-X
(	B-X
1	B-X
)	B-X
/S	B-X
phase-like	B-X
conditions	B-X
which	B-X
may	B-X
be	B-X
favorable	B-X
for	B-X
AAV2-specific	B-X
functions	B-X
and	B-X
may	B-X
lead	B-X
to	B-X
downstream	B-X
interference	B-X
with	B-X
HPV-associated	B-X
cervical	B-X
cancer	B-X
progression	B-X
.	B-X

Both	O
events	O
have	O
the	O
potential	O
to	O
enhance	O
the	O
G	O
(	O
1	O
)	O
/	O
S	O
transition	O
point	O
mediated	O
by	O
active	O
cyclin	O
E	O
/	O
CDK2	O
complexes	O
.	O

Concurrently	O
,	O
cyclin	B-Gene_or_gene_product
A	I-Gene_or_gene_product
and	O
E2F	B-Gene_or_gene_product
levels	O
were	O
decreased	O
,	O
conditions	O
reminiscent	O
of	O
delayed	O
entrance	O
into	O
the	O
S	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

On	O
the	O
other	O
hand	O
,	O
infection	O
of	O
primary	O
human	O
foreskin	O
keratinocytes	O
with	O
AAV2	O
resulted	O
in	O
upregulation	O
of	O
p21	B-Gene_or_gene_product
(	O
WAF1	B-Gene_or_gene_product
)	O
protein	O
levels	O
,	O
reminiscent	O
of	O
a	O
block	O
in	O
G	O
(	O
1	O
)	O
phase	O
progression	O
.	O

We	O
propose	O
that	O
by	O
down	O
regulating	O
p21	B-Gene_or_gene_product
(	O
WAF1	B-Gene_or_gene_product
)	O
,	O
AAV2	O
initiates	O
cell	O
cycle	O
activities	O
leading	O
to	O
enhanced	O
G	O
(	O
1	O
)	O
/	O
S	O
phase	O
-	O
like	O
conditions	O
which	O
may	O
be	O
favorable	O
for	O
AAV2	O
-	O
specific	O
functions	O
and	O
may	O
lead	O
to	O
downstream	O
interference	O
with	O
HPV	O
-	O
associated	O
cervical	O
cancer	O
progression	O
.	O

Increased	O
p21	B-Gene_or_gene_product
expression	O
and	O
complex	O
formation	O
with	O
cyclin	O
E	O
/	O
CDK2	O
in	O
retinoid	O
-	O
induced	O
pre	O
-	O
B	O
lymphoma	O
cell	O
apoptosis	O
.	O

Cip	B-Gene_or_gene_product
/	O
Kip	B-Gene_or_gene_product
family	O
protein	O
p21	B-Gene_or_gene_product
,	O
a	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
CDK	B-Gene_or_gene_product
)	O
inhibitor	O
,	O
is	O
directly	O
transactivated	O
by	O
retinoic	B-Gene_or_gene_product
acid	I-Gene_or_gene_product
receptor	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
(	O
RARalpha	B-Gene_or_gene_product
)	O
upon	O
retinoic	O
acid	O
(	O
RA	O
)	O
:	O
RARalpha	B-Gene_or_gene_product
binding	O
.	O
<EOS>	B-X
Cip/Kip	B-X
family	B-X
protein	B-X
p21	B-X
,	B-X
a	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
inhibitor	B-X
,	B-X
is	B-X
directly	B-X
transactivated	B-X
by	B-X
retinoic	B-X
acid	B-X
receptor	B-X
alpha	B-X
(	B-X
RARalpha	B-X
)	B-X
upon	B-X
retinoic	B-X
acid	B-X
(	B-X
RA	B-X
)	B-X
:	B-X
RARalpha	B-X
binding	B-X
.	B-X
Yet	B-X
the	B-X
role	B-X
of	B-X
p21	B-X
upregulation	B-X
by	B-X
RA	B-X
in	B-X
lymphoma	B-X
cells	B-X
remains	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
,	B-X
in	B-X
human	B-X
pre-B	B-X
lymphoma	B-X
Nalm6	B-X
cells	B-X
,	B-X
RA-induced	B-X
proliferation	B-X
inhibition	B-X
results	B-X
from	B-X
massive	B-X
cell	B-X
death	B-X
characterized	B-X
by	B-X
apoptosis	B-X
.	B-X
Upregulated	B-X
p21	B-X
by	B-X
RA	B-X
accompanies	B-X
caspase-3	B-X
activation	B-X
and	B-X
precedes	B-X
the	B-X
occurrence	B-X
of	B-X
apoptosis	B-X
.	B-X
p21	B-X
induction	B-X
leads	B-X
to	B-X
increased	B-X
p21	B-X
complex	B-X
formation	B-X
with	B-X
cyclin	B-X
E/CDK2	B-X
,	B-X
which	B-X
occurs	B-X
when	B-X
cyclin	B-X
E	B-X
and	B-X
CDK2	B-X
levels	B-X
remain	B-X
constant	B-X
.	B-X
CDK2	B-X
can	B-X
alternatively	B-X
promote	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
mechanisms	B-X
remain	B-X
unknown	B-X
.	B-X
Data	B-X
presented	B-X
here	B-X
suggest	B-X
a	B-X
novel	B-X
RA-signaling	B-X
,	B-X
by	B-X
which	B-X
RA-induced	B-X
p21	B-X
induction	B-X
and	B-X
complex	B-X
formation	B-X
with	B-X
cyclin	B-X
E/CDK2	B-X
diverts	B-X
CDK2	B-X
function	B-X
from	B-X
normally	B-X
driving	B-X
proliferation	B-X
to	B-X
alternatively	B-X
promoting	B-X
apoptosis	B-X
.	B-X

Yet	O
the	O
role	O
of	O
p21	B-Gene_or_gene_product
upregulation	O
by	O
RA	O
in	O
lymphoma	O
cells	O
remains	O
unknown	O
.	O

Here	O
,	O
we	O
show	O
that	O
,	O
in	O
human	O
pre	O
-	O
B	O
lymphoma	O
Nalm6	O
cells	O
,	O
RA	O
-	O
induced	O
proliferation	O
inhibition	O
results	O
from	O
massive	O
cell	O
death	O
characterized	O
by	O
apoptosis	O
.	O

Upregulated	O
p21	B-Gene_or_gene_product
by	O
RA	O
accompanies	O
caspase	B-Gene_or_gene_product
-	I-Gene_or_gene_product
3	I-Gene_or_gene_product
activation	O
and	O
precedes	O
the	O
occurrence	O
of	O
apoptosis	O
.	O

p21	B-Gene_or_gene_product
induction	O
leads	O
to	O
increased	O
p21	B-Gene_or_gene_product
complex	O
formation	O
with	O
cyclin	O
E	O
/	O
CDK2	O
,	O
which	O
occurs	O
when	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
and	O
CDK2	B-Gene_or_gene_product
levels	O
remain	O
constant	O
.	O
<EOS>	B-X
Cip/Kip	B-X
family	B-X
protein	B-X
p21	B-X
,	B-X
a	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
inhibitor	B-X
,	B-X
is	B-X
directly	B-X
transactivated	B-X
by	B-X
retinoic	B-X
acid	B-X
receptor	B-X
alpha	B-X
(	B-X
RARalpha	B-X
)	B-X
upon	B-X
retinoic	B-X
acid	B-X
(	B-X
RA	B-X
)	B-X
:	B-X
RARalpha	B-X
binding	B-X
.	B-X
Yet	B-X
the	B-X
role	B-X
of	B-X
p21	B-X
upregulation	B-X
by	B-X
RA	B-X
in	B-X
lymphoma	B-X
cells	B-X
remains	B-X
unknown	B-X
.	B-X
Upregulated	B-X
p21	B-X
by	B-X
RA	B-X
accompanies	B-X
caspase-3	B-X
activation	B-X
and	B-X
precedes	B-X
the	B-X
occurrence	B-X
of	B-X
apoptosis	B-X
.	B-X
p21	B-X
induction	B-X
leads	B-X
to	B-X
increased	B-X
p21	B-X
complex	B-X
formation	B-X
with	B-X
cyclin	B-X
E/CDK2	B-X
,	B-X
which	B-X
occurs	B-X
when	B-X
cyclin	B-X
E	B-X
and	B-X
CDK2	B-X
levels	B-X
remain	B-X
constant	B-X
.	B-X
CDK2	B-X
can	B-X
alternatively	B-X
promote	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
mechanisms	B-X
remain	B-X
unknown	B-X
.	B-X
Data	B-X
presented	B-X
here	B-X
suggest	B-X
a	B-X
novel	B-X
RA-signaling	B-X
,	B-X
by	B-X
which	B-X
RA-induced	B-X
p21	B-X
induction	B-X
and	B-X
complex	B-X
formation	B-X
with	B-X
cyclin	B-X
E/CDK2	B-X
diverts	B-X
CDK2	B-X
function	B-X
from	B-X
normally	B-X
driving	B-X
proliferation	B-X
to	B-X
alternatively	B-X
promoting	B-X
apoptosis	B-X
.	B-X

CDK2	B-Gene_or_gene_product
can	O
alternatively	O
promote	O
apoptosis	O
,	O
but	O
the	O
mechanisms	O
remain	O
unknown	O
.	O
<EOS>	B-X
Yet	B-X
the	B-X
role	B-X
of	B-X
p21	B-X
upregulation	B-X
by	B-X
RA	B-X
in	B-X
lymphoma	B-X
cells	B-X
remains	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
,	B-X
in	B-X
human	B-X
pre-B	B-X
lymphoma	B-X
Nalm6	B-X
cells	B-X
,	B-X
RA-induced	B-X
proliferation	B-X
inhibition	B-X
results	B-X
from	B-X
massive	B-X
cell	B-X
death	B-X
characterized	B-X
by	B-X
apoptosis	B-X
.	B-X
Upregulated	B-X
p21	B-X
by	B-X
RA	B-X
accompanies	B-X
caspase-3	B-X
activation	B-X
and	B-X
precedes	B-X
the	B-X
occurrence	B-X
of	B-X
apoptosis	B-X
.	B-X
p21	B-X
induction	B-X
leads	B-X
to	B-X
increased	B-X
p21	B-X
complex	B-X
formation	B-X
with	B-X
cyclin	B-X
E/CDK2	B-X
,	B-X
which	B-X
occurs	B-X
when	B-X
cyclin	B-X
E	B-X
and	B-X
CDK2	B-X
levels	B-X
remain	B-X
constant	B-X
.	B-X
CDK2	B-X
can	B-X
alternatively	B-X
promote	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
mechanisms	B-X
remain	B-X
unknown	B-X
.	B-X
Data	B-X
presented	B-X
here	B-X
suggest	B-X
a	B-X
novel	B-X
RA-signaling	B-X
,	B-X
by	B-X
which	B-X
RA-induced	B-X
p21	B-X
induction	B-X
and	B-X
complex	B-X
formation	B-X
with	B-X
cyclin	B-X
E/CDK2	B-X
diverts	B-X
CDK2	B-X
function	B-X
from	B-X
normally	B-X
driving	B-X
proliferation	B-X
to	B-X
alternatively	B-X
promoting	B-X
apoptosis	B-X
.	B-X

Data	O
presented	O
here	O
suggest	O
a	O
novel	O
RA	O
-	O
signaling	O
,	O
by	O
which	O
RA	O
-	O
induced	O
p21	B-Gene_or_gene_product
induction	O
and	O
complex	O
formation	O
with	O
cyclin	O
E	O
/	O
CDK2	O
diverts	O
CDK2	B-Gene_or_gene_product
function	O
from	O
normally	O
driving	O
proliferation	O
to	O
alternatively	O
promoting	O
apoptosis	O
.	O
<EOS>	B-X
Cip/Kip	B-X
family	B-X
protein	B-X
p21	B-X
,	B-X
a	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
inhibitor	B-X
,	B-X
is	B-X
directly	B-X
transactivated	B-X
by	B-X
retinoic	B-X
acid	B-X
receptor	B-X
alpha	B-X
(	B-X
RARalpha	B-X
)	B-X
upon	B-X
retinoic	B-X
acid	B-X
(	B-X
RA	B-X
)	B-X
:	B-X
RARalpha	B-X
binding	B-X
.	B-X
Yet	B-X
the	B-X
role	B-X
of	B-X
p21	B-X
upregulation	B-X
by	B-X
RA	B-X
in	B-X
lymphoma	B-X
cells	B-X
remains	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
,	B-X
in	B-X
human	B-X
pre-B	B-X
lymphoma	B-X
Nalm6	B-X
cells	B-X
,	B-X
RA-induced	B-X
proliferation	B-X
inhibition	B-X
results	B-X
from	B-X
massive	B-X
cell	B-X
death	B-X
characterized	B-X
by	B-X
apoptosis	B-X
.	B-X
Upregulated	B-X
p21	B-X
by	B-X
RA	B-X
accompanies	B-X
caspase-3	B-X
activation	B-X
and	B-X
precedes	B-X
the	B-X
occurrence	B-X
of	B-X
apoptosis	B-X
.	B-X
p21	B-X
induction	B-X
leads	B-X
to	B-X
increased	B-X
p21	B-X
complex	B-X
formation	B-X
with	B-X
cyclin	B-X
E/CDK2	B-X
,	B-X
which	B-X
occurs	B-X
when	B-X
cyclin	B-X
E	B-X
and	B-X
CDK2	B-X
levels	B-X
remain	B-X
constant	B-X
.	B-X
CDK2	B-X
can	B-X
alternatively	B-X
promote	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
mechanisms	B-X
remain	B-X
unknown	B-X
.	B-X
Data	B-X
presented	B-X
here	B-X
suggest	B-X
a	B-X
novel	B-X
RA-signaling	B-X
,	B-X
by	B-X
which	B-X
RA-induced	B-X
p21	B-X
induction	B-X
and	B-X
complex	B-X
formation	B-X
with	B-X
cyclin	B-X
E/CDK2	B-X
diverts	B-X
CDK2	B-X
function	B-X
from	B-X
normally	B-X
driving	B-X
proliferation	B-X
to	B-X
alternatively	B-X
promoting	B-X
apoptosis	B-X
.	B-X

p53	B-Gene_or_gene_product
transcription	O
-	O
dependent	O
and	O
-	O
independent	O
regulation	O
of	O
cerebellar	O
neural	O
precursor	O
cell	O
apoptosis	O
.	O
<EOS>	B-X
Regulation	B-X
of	B-X
cerebellar	B-X
neural	B-X
precursor	B-X
cell	B-X
(	B-X
NPC	B-X
)	B-X
death	B-X
is	B-X
important	B-X
for	B-X
both	B-X
normal	B-X
brain	B-X
development	B-X
and	B-X
prevention	B-X
of	B-X
brain	B-X
tumor	B-X
formation	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
regulator	B-X
of	B-X
NPC	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
precise	B-X
mechanism	B-X
of	B-X
p53-regulated	B-X
cerebellar	B-X
NPC	B-X
death	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
using	B-X
primary	B-X
cerebellar	B-X
NPCs	B-X
and	B-X
a	B-X
mouse	B-X
cerebellar	B-X
NPC	B-X
line	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
molecular	B-X
regulation	B-X
of	B-X
cerebellar	B-X
NPC	B-X
death	B-X
produced	B-X
by	B-X
staurosporine	B-X
(	B-X
STS	B-X
)	B-X
,	B-X
a	B-X
broad-spectrum	B-X
kinase	B-X
inhibitor	B-X
,	B-X
with	B-X
that	B-X
caused	B-X
by	B-X
genotoxic	B-X
agents	B-X
.	B-X
We	B-X
found	B-X
that	B-X
both	B-X
STS-	B-X
and	B-X
genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
were	B-X
markedly	B-X
inhibited	B-X
by	B-X
p53	B-X
or	B-X
Bax	B-X
deficiency	B-X
.	B-X
Genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
required	B-X
new	B-X
protein	B-X
synthesis	B-X
and	B-X
PUMA	B-X
,	B-X
a	B-X
p53	B-X
transcriptionally	B-X
regulated	B-X
BH3-only	B-X
molecule	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
STS	B-X
caused	B-X
cerebellar	B-X
NPC	B-X
death	B-X
without	B-X
requiring	B-X
new	B-X
protein	B-X
synthesis	B-X
or	B-X
PUMA	B-X
expression	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
genotoxic	B-X
agents	B-X
increased	B-X
nuclear	B-X
p53	B-X
immunoreactivity	B-X
,	B-X
whereas	B-X
STS	B-X
produced	B-X
rapid	B-X
cytoplasmic	B-X
p53	B-X
accumulation	B-X
.	B-X
Interestingly	B-X
,	B-X
STS-induced	B-X
death	B-X
of	B-X
cerebellar	B-X
granule	B-X
neurons	B-X
was	B-X
p53-independent	B-X
,	B-X
indicating	B-X
a	B-X
differentiation-dependent	B-X
feature	B-X
of	B-X
neuronal	B-X
apoptotic	B-X
regulation	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
STS-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
requires	B-X
a	B-X
direct	B-X
effect	B-X
of	B-X
p53	B-X
on	B-X
cytoplasmic	B-X
apoptotic	B-X
mediators	B-X
,	B-X
whereas	B-X
genotoxin-induced	B-X
death	B-X
requires	B-X
p53-dependent	B-X
gene	B-X
transcription	B-X
of	B-X
PUMA	B-X
.	B-X
Thus	B-X
,	B-X
p53	B-X
has	B-X
multiple	B-X
death	B-X
promoting	B-X
mechanisms	B-X
in	B-X
cerebellar	B-X
NPCs	B-X
.	B-X

Regulation	O
of	O
cerebellar	O
neural	O
precursor	O
cell	O
(	O
NPC	O
)	O
death	O
is	O
important	O
for	O
both	O
normal	O
brain	O
development	O
and	O
prevention	O
of	O
brain	O
tumor	O
formation	O
.	O
<EOS>	B-X
Regulation	B-X
of	B-X
cerebellar	B-X
neural	B-X
precursor	B-X
cell	B-X
(	B-X
NPC	B-X
)	B-X
death	B-X
is	B-X
important	B-X
for	B-X
both	B-X
normal	B-X
brain	B-X
development	B-X
and	B-X
prevention	B-X
of	B-X
brain	B-X
tumor	B-X
formation	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
regulator	B-X
of	B-X
NPC	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
precise	B-X
mechanism	B-X
of	B-X
p53-regulated	B-X
cerebellar	B-X
NPC	B-X
death	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
using	B-X
primary	B-X
cerebellar	B-X
NPCs	B-X
and	B-X
a	B-X
mouse	B-X
cerebellar	B-X
NPC	B-X
line	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
molecular	B-X
regulation	B-X
of	B-X
cerebellar	B-X
NPC	B-X
death	B-X
produced	B-X
by	B-X
staurosporine	B-X
(	B-X
STS	B-X
)	B-X
,	B-X
a	B-X
broad-spectrum	B-X
kinase	B-X
inhibitor	B-X
,	B-X
with	B-X
that	B-X
caused	B-X
by	B-X
genotoxic	B-X
agents	B-X
.	B-X
We	B-X
found	B-X
that	B-X
both	B-X
STS-	B-X
and	B-X
genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
were	B-X
markedly	B-X
inhibited	B-X
by	B-X
p53	B-X
or	B-X
Bax	B-X
deficiency	B-X
.	B-X
Genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
required	B-X
new	B-X
protein	B-X
synthesis	B-X
and	B-X
PUMA	B-X
,	B-X
a	B-X
p53	B-X
transcriptionally	B-X
regulated	B-X
BH3-only	B-X
molecule	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
STS	B-X
caused	B-X
cerebellar	B-X
NPC	B-X
death	B-X
without	B-X
requiring	B-X
new	B-X
protein	B-X
synthesis	B-X
or	B-X
PUMA	B-X
expression	B-X
.	B-X
Interestingly	B-X
,	B-X
STS-induced	B-X
death	B-X
of	B-X
cerebellar	B-X
granule	B-X
neurons	B-X
was	B-X
p53-independent	B-X
,	B-X
indicating	B-X
a	B-X
differentiation-dependent	B-X
feature	B-X
of	B-X
neuronal	B-X
apoptotic	B-X
regulation	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
STS-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
requires	B-X
a	B-X
direct	B-X
effect	B-X
of	B-X
p53	B-X
on	B-X
cytoplasmic	B-X
apoptotic	B-X
mediators	B-X
,	B-X
whereas	B-X
genotoxin-induced	B-X
death	B-X
requires	B-X
p53-dependent	B-X
gene	B-X
transcription	B-X
of	B-X
PUMA	B-X
.	B-X
Thus	B-X
,	B-X
p53	B-X
has	B-X
multiple	B-X
death	B-X
promoting	B-X
mechanisms	B-X
in	B-X
cerebellar	B-X
NPCs	B-X
.	B-X

The	O
tumor	O
suppressor	O
p53	B-Gene_or_gene_product
is	O
an	O
important	O
regulator	O
of	O
NPC	O
apoptosis	O
,	O
but	O
the	O
precise	O
mechanism	O
of	O
p53	B-Gene_or_gene_product
-	O
regulated	O
cerebellar	O
NPC	O
death	O
remains	O
largely	O
unknown	O
.	O
<EOS>	B-X
Regulation	B-X
of	B-X
cerebellar	B-X
neural	B-X
precursor	B-X
cell	B-X
(	B-X
NPC	B-X
)	B-X
death	B-X
is	B-X
important	B-X
for	B-X
both	B-X
normal	B-X
brain	B-X
development	B-X
and	B-X
prevention	B-X
of	B-X
brain	B-X
tumor	B-X
formation	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
regulator	B-X
of	B-X
NPC	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
precise	B-X
mechanism	B-X
of	B-X
p53-regulated	B-X
cerebellar	B-X
NPC	B-X
death	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
using	B-X
primary	B-X
cerebellar	B-X
NPCs	B-X
and	B-X
a	B-X
mouse	B-X
cerebellar	B-X
NPC	B-X
line	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
molecular	B-X
regulation	B-X
of	B-X
cerebellar	B-X
NPC	B-X
death	B-X
produced	B-X
by	B-X
staurosporine	B-X
(	B-X
STS	B-X
)	B-X
,	B-X
a	B-X
broad-spectrum	B-X
kinase	B-X
inhibitor	B-X
,	B-X
with	B-X
that	B-X
caused	B-X
by	B-X
genotoxic	B-X
agents	B-X
.	B-X
We	B-X
found	B-X
that	B-X
both	B-X
STS-	B-X
and	B-X
genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
were	B-X
markedly	B-X
inhibited	B-X
by	B-X
p53	B-X
or	B-X
Bax	B-X
deficiency	B-X
.	B-X
Genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
required	B-X
new	B-X
protein	B-X
synthesis	B-X
and	B-X
PUMA	B-X
,	B-X
a	B-X
p53	B-X
transcriptionally	B-X
regulated	B-X
BH3-only	B-X
molecule	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
STS	B-X
caused	B-X
cerebellar	B-X
NPC	B-X
death	B-X
without	B-X
requiring	B-X
new	B-X
protein	B-X
synthesis	B-X
or	B-X
PUMA	B-X
expression	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
genotoxic	B-X
agents	B-X
increased	B-X
nuclear	B-X
p53	B-X
immunoreactivity	B-X
,	B-X
whereas	B-X
STS	B-X
produced	B-X
rapid	B-X
cytoplasmic	B-X
p53	B-X
accumulation	B-X
.	B-X
Interestingly	B-X
,	B-X
STS-induced	B-X
death	B-X
of	B-X
cerebellar	B-X
granule	B-X
neurons	B-X
was	B-X
p53-independent	B-X
,	B-X
indicating	B-X
a	B-X
differentiation-dependent	B-X
feature	B-X
of	B-X
neuronal	B-X
apoptotic	B-X
regulation	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
STS-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
requires	B-X
a	B-X
direct	B-X
effect	B-X
of	B-X
p53	B-X
on	B-X
cytoplasmic	B-X
apoptotic	B-X
mediators	B-X
,	B-X
whereas	B-X
genotoxin-induced	B-X
death	B-X
requires	B-X
p53-dependent	B-X
gene	B-X
transcription	B-X
of	B-X
PUMA	B-X
.	B-X
Thus	B-X
,	B-X
p53	B-X
has	B-X
multiple	B-X
death	B-X
promoting	B-X
mechanisms	B-X
in	B-X
cerebellar	B-X
NPCs	B-X
.	B-X

Here	O
,	O
by	O
using	O
primary	O
cerebellar	O
NPCs	O
and	O
a	O
mouse	O
cerebellar	O
NPC	O
line	O
,	O
we	O
compared	O
the	O
molecular	O
regulation	O
of	O
cerebellar	O
NPC	O
death	O
produced	O
by	O
staurosporine	O
(	O
STS	O
)	O
,	O
a	O
broad	O
-	O
spectrum	O
kinase	O
inhibitor	O
,	O
with	O
that	O
caused	O
by	O
genotoxic	O
agents	O
.	O

We	O
found	O
that	O
both	O
STS	O
-	O
and	O
genotoxin	O
-	O
induced	O
cerebellar	O
NPC	O
death	O
were	O
markedly	O
inhibited	O
by	O
p53	B-Gene_or_gene_product
or	O
Bax	B-Gene_or_gene_product
deficiency	O
.	O
<EOS>	B-X
We	B-X
examined	B-X
the	B-X
effects	B-X
of	B-X
betaine	B-X
,	B-X
an	B-X
endogenous	B-X
and	B-X
dietary	B-X
methyl	B-X
donor	B-X
essential	B-X
for	B-X
the	B-X
methionine-homocysteine	B-X
cycle	B-X
,	B-X
on	B-X
oxidative	B-X
stress	B-X
,	B-X
inflammation	B-X
,	B-X
apoptosis	B-X
,	B-X
and	B-X
autophagy	B-X
in	B-X
methionine-choline	B-X
deficient	B-X
diet	B-X
(	B-X
MCD	B-X
)	B-X
-induced	B-X
non-alcoholic	B-X
fatty	B-X
liver	B-X
disease	B-X
(	B-X
NAFLD	B-X
)	B-X
.	B-X
Betaine	B-X
reduced	B-X
MCD-induced	B-X
increase	B-X
in	B-X
liver	B-X
transaminases	B-X
and	B-X
inflammatory	B-X
infiltration	B-X
,	B-X
as	B-X
well	B-X
as	B-X
hepatosteatosis	B-X
and	B-X
serum	B-X
levels	B-X
of	B-X
low-density	B-X
lipoprotein	B-X
,	B-X
while	B-X
it	B-X
increased	B-X
that	B-X
of	B-X
high-density	B-X
lipoprotein	B-X
.	B-X
MCD-induced	B-X
hepatic	B-X
production	B-X
of	B-X
reactive	B-X
oxygen	B-X
and	B-X
nitrogen	B-X
species	B-X
was	B-X
significantly	B-X
reduced	B-X
by	B-X
betaine	B-X
,	B-X
which	B-X
also	B-X
improved	B-X
liver	B-X
antioxidative	B-X
defense	B-X
by	B-X
increasing	B-X
glutathione	B-X
content	B-X
and	B-X
superoxide-dismutase	B-X
,	B-X
catalase	B-X
,	B-X
glutathione	B-X
peroxidase	B-X
,	B-X
and	B-X
paraoxonase	B-X
activity	B-X
.	B-X
Betaine	B-X
reduced	B-X
the	B-X
liver	B-X
expression	B-X
of	B-X
proinflammatory	B-X
cytokines	B-X
tumor	B-X
necrosis	B-X
factor	B-X
and	B-X
interleukin-6	B-X
,	B-X
as	B-X
well	B-X
as	B-X
that	B-X
of	B-X
proapoptotic	B-X
mediator	B-X
Bax	B-X
,	B-X
while	B-X
increasing	B-X
the	B-X
levels	B-X
of	B-X
anti-inflammatory	B-X
cytokine	B-X
interleukin-10	B-X
and	B-X
antiapoptotic	B-X
Bcl-2	B-X
in	B-X
MCD-fed	B-X
mice	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
the	B-X
beneficial	B-X
effect	B-X
of	B-X
betaine	B-X
in	B-X
MCD-induced	B-X
NAFLD	B-X
is	B-X
associated	B-X
with	B-X
the	B-X
reduction	B-X
of	B-X
liver	B-X
oxidative	B-X
stress	B-X
,	B-X
inflammation	B-X
,	B-X
and	B-X
apoptosis	B-X
,	B-X
and	B-X
the	B-X
increase	B-X
in	B-X
cytoprotective	B-X
Akt/mTOR	B-X
signaling	B-X
and	B-X
autophagy	B-X
.	B-X

Genotoxin	O
-	O
induced	O
cerebellar	O
NPC	O
death	O
required	O
new	O
protein	O
synthesis	O
and	O
PUMA	B-Gene_or_gene_product
,	O
a	O
p53	B-Gene_or_gene_product
transcriptionally	O
regulated	O
BH3	O
-	O
only	O
molecule	O
.	O

In	O
contrast	O
,	O
STS	O
caused	O
cerebellar	O
NPC	O
death	O
without	O
requiring	O
new	O
protein	O
synthesis	O
or	O
PUMA	B-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
Autophagy	B-X
inhibition	B-X
confers	B-X
cell	B-X
sensitivity	B-X
to	B-X
anti-cancer	B-X
agents	B-X
,	B-X
and	B-X
this	B-X
effect	B-X
is	B-X
explained	B-X
by	B-X
the	B-X
ability	B-X
of	B-X
FOXO3	B-X
to	B-X
transactivate	B-X
the	B-X
pro-apoptotic	B-X
gene	B-X
BBC3/PUMA	B-X
.	B-X
Cellular	B-X
stress	B-X
can	B-X
lead	B-X
to	B-X
several	B-X
human	B-X
disease	B-X
pathologies	B-X
due	B-X
to	B-X
aberrant	B-X
cell	B-X
death	B-X
.	B-X
The	B-X
p53	B-X
family	B-X
(	B-X
tp53	B-X
,	B-X
tp63	B-X
,	B-X
and	B-X
tp73	B-X
)	B-X
and	B-X
downstream	B-X
transcriptional	B-X
apoptotic	B-X
target	B-X
genes	B-X
(	B-X
PUMA/BBC3	B-X
and	B-X
NOXA/PMAIP1	B-X
)	B-X
have	B-X
been	B-X
implicated	B-X
as	B-X
mediators	B-X
of	B-X
stress	B-X
signals	B-X
.	B-X
There	B-X
are	B-X
no	B-X
well-established	B-X
,	B-X
gene	B-X
expression	B-X
signatures	B-X
associated	B-X
with	B-X
prognosis	B-X
.	B-X

In	O
addition	O
,	O
genotoxic	O
agents	O
increased	O
nuclear	O
p53	B-Gene_or_gene_product
immunoreactivity	O
,	O
whereas	O
STS	O
produced	O
rapid	O
cytoplasmic	O
p53	B-Gene_or_gene_product
accumulation	O
.	O
<EOS>	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
regulator	B-X
of	B-X
NPC	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
precise	B-X
mechanism	B-X
of	B-X
p53-regulated	B-X
cerebellar	B-X
NPC	B-X
death	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
using	B-X
primary	B-X
cerebellar	B-X
NPCs	B-X
and	B-X
a	B-X
mouse	B-X
cerebellar	B-X
NPC	B-X
line	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
molecular	B-X
regulation	B-X
of	B-X
cerebellar	B-X
NPC	B-X
death	B-X
produced	B-X
by	B-X
staurosporine	B-X
(	B-X
STS	B-X
)	B-X
,	B-X
a	B-X
broad-spectrum	B-X
kinase	B-X
inhibitor	B-X
,	B-X
with	B-X
that	B-X
caused	B-X
by	B-X
genotoxic	B-X
agents	B-X
.	B-X
We	B-X
found	B-X
that	B-X
both	B-X
STS-	B-X
and	B-X
genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
were	B-X
markedly	B-X
inhibited	B-X
by	B-X
p53	B-X
or	B-X
Bax	B-X
deficiency	B-X
.	B-X
Genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
required	B-X
new	B-X
protein	B-X
synthesis	B-X
and	B-X
PUMA	B-X
,	B-X
a	B-X
p53	B-X
transcriptionally	B-X
regulated	B-X
BH3-only	B-X
molecule	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
STS	B-X
caused	B-X
cerebellar	B-X
NPC	B-X
death	B-X
without	B-X
requiring	B-X
new	B-X
protein	B-X
synthesis	B-X
or	B-X
PUMA	B-X
expression	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
genotoxic	B-X
agents	B-X
increased	B-X
nuclear	B-X
p53	B-X
immunoreactivity	B-X
,	B-X
whereas	B-X
STS	B-X
produced	B-X
rapid	B-X
cytoplasmic	B-X
p53	B-X
accumulation	B-X
.	B-X
Interestingly	B-X
,	B-X
STS-induced	B-X
death	B-X
of	B-X
cerebellar	B-X
granule	B-X
neurons	B-X
was	B-X
p53-independent	B-X
,	B-X
indicating	B-X
a	B-X
differentiation-dependent	B-X
feature	B-X
of	B-X
neuronal	B-X
apoptotic	B-X
regulation	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
STS-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
requires	B-X
a	B-X
direct	B-X
effect	B-X
of	B-X
p53	B-X
on	B-X
cytoplasmic	B-X
apoptotic	B-X
mediators	B-X
,	B-X
whereas	B-X
genotoxin-induced	B-X
death	B-X
requires	B-X
p53-dependent	B-X
gene	B-X
transcription	B-X
of	B-X
PUMA	B-X
.	B-X
Thus	B-X
,	B-X
p53	B-X
has	B-X
multiple	B-X
death	B-X
promoting	B-X
mechanisms	B-X
in	B-X
cerebellar	B-X
NPCs	B-X
.	B-X

Interestingly	O
,	O
STS	O
-	O
induced	O
death	O
of	O
cerebellar	O
granule	O
neurons	O
was	O
p53	B-Gene_or_gene_product
-	O
independent	O
,	O
indicating	O
a	O
differentiation	O
-	O
dependent	O
feature	O
of	O
neuronal	O
apoptotic	O
regulation	O
.	O
<EOS>	B-X
Regulation	B-X
of	B-X
cerebellar	B-X
neural	B-X
precursor	B-X
cell	B-X
(	B-X
NPC	B-X
)	B-X
death	B-X
is	B-X
important	B-X
for	B-X
both	B-X
normal	B-X
brain	B-X
development	B-X
and	B-X
prevention	B-X
of	B-X
brain	B-X
tumor	B-X
formation	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
regulator	B-X
of	B-X
NPC	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
precise	B-X
mechanism	B-X
of	B-X
p53-regulated	B-X
cerebellar	B-X
NPC	B-X
death	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
using	B-X
primary	B-X
cerebellar	B-X
NPCs	B-X
and	B-X
a	B-X
mouse	B-X
cerebellar	B-X
NPC	B-X
line	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
molecular	B-X
regulation	B-X
of	B-X
cerebellar	B-X
NPC	B-X
death	B-X
produced	B-X
by	B-X
staurosporine	B-X
(	B-X
STS	B-X
)	B-X
,	B-X
a	B-X
broad-spectrum	B-X
kinase	B-X
inhibitor	B-X
,	B-X
with	B-X
that	B-X
caused	B-X
by	B-X
genotoxic	B-X
agents	B-X
.	B-X
We	B-X
found	B-X
that	B-X
both	B-X
STS-	B-X
and	B-X
genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
were	B-X
markedly	B-X
inhibited	B-X
by	B-X
p53	B-X
or	B-X
Bax	B-X
deficiency	B-X
.	B-X
Genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
required	B-X
new	B-X
protein	B-X
synthesis	B-X
and	B-X
PUMA	B-X
,	B-X
a	B-X
p53	B-X
transcriptionally	B-X
regulated	B-X
BH3-only	B-X
molecule	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
STS	B-X
caused	B-X
cerebellar	B-X
NPC	B-X
death	B-X
without	B-X
requiring	B-X
new	B-X
protein	B-X
synthesis	B-X
or	B-X
PUMA	B-X
expression	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
genotoxic	B-X
agents	B-X
increased	B-X
nuclear	B-X
p53	B-X
immunoreactivity	B-X
,	B-X
whereas	B-X
STS	B-X
produced	B-X
rapid	B-X
cytoplasmic	B-X
p53	B-X
accumulation	B-X
.	B-X
Interestingly	B-X
,	B-X
STS-induced	B-X
death	B-X
of	B-X
cerebellar	B-X
granule	B-X
neurons	B-X
was	B-X
p53-independent	B-X
,	B-X
indicating	B-X
a	B-X
differentiation-dependent	B-X
feature	B-X
of	B-X
neuronal	B-X
apoptotic	B-X
regulation	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
STS-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
requires	B-X
a	B-X
direct	B-X
effect	B-X
of	B-X
p53	B-X
on	B-X
cytoplasmic	B-X
apoptotic	B-X
mediators	B-X
,	B-X
whereas	B-X
genotoxin-induced	B-X
death	B-X
requires	B-X
p53-dependent	B-X
gene	B-X
transcription	B-X
of	B-X
PUMA	B-X
.	B-X
Thus	B-X
,	B-X
p53	B-X
has	B-X
multiple	B-X
death	B-X
promoting	B-X
mechanisms	B-X
in	B-X
cerebellar	B-X
NPCs	B-X
.	B-X

These	O
results	O
suggest	O
that	O
STS	O
-	O
induced	O
cerebellar	O
NPC	O
death	O
requires	O
a	O
direct	O
effect	O
of	O
p53	B-Gene_or_gene_product
on	O
cytoplasmic	O
apoptotic	O
mediators	O
,	O
whereas	O
genotoxin	O
-	O
induced	O
death	O
requires	O
p53	B-Gene_or_gene_product
-	O
dependent	O
gene	O
transcription	O
of	O
PUMA	B-Gene_or_gene_product
.	O
<EOS>	B-X
Regulation	B-X
of	B-X
cerebellar	B-X
neural	B-X
precursor	B-X
cell	B-X
(	B-X
NPC	B-X
)	B-X
death	B-X
is	B-X
important	B-X
for	B-X
both	B-X
normal	B-X
brain	B-X
development	B-X
and	B-X
prevention	B-X
of	B-X
brain	B-X
tumor	B-X
formation	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
regulator	B-X
of	B-X
NPC	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
precise	B-X
mechanism	B-X
of	B-X
p53-regulated	B-X
cerebellar	B-X
NPC	B-X
death	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
using	B-X
primary	B-X
cerebellar	B-X
NPCs	B-X
and	B-X
a	B-X
mouse	B-X
cerebellar	B-X
NPC	B-X
line	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
molecular	B-X
regulation	B-X
of	B-X
cerebellar	B-X
NPC	B-X
death	B-X
produced	B-X
by	B-X
staurosporine	B-X
(	B-X
STS	B-X
)	B-X
,	B-X
a	B-X
broad-spectrum	B-X
kinase	B-X
inhibitor	B-X
,	B-X
with	B-X
that	B-X
caused	B-X
by	B-X
genotoxic	B-X
agents	B-X
.	B-X
We	B-X
found	B-X
that	B-X
both	B-X
STS-	B-X
and	B-X
genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
were	B-X
markedly	B-X
inhibited	B-X
by	B-X
p53	B-X
or	B-X
Bax	B-X
deficiency	B-X
.	B-X
Genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
required	B-X
new	B-X
protein	B-X
synthesis	B-X
and	B-X
PUMA	B-X
,	B-X
a	B-X
p53	B-X
transcriptionally	B-X
regulated	B-X
BH3-only	B-X
molecule	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
STS	B-X
caused	B-X
cerebellar	B-X
NPC	B-X
death	B-X
without	B-X
requiring	B-X
new	B-X
protein	B-X
synthesis	B-X
or	B-X
PUMA	B-X
expression	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
genotoxic	B-X
agents	B-X
increased	B-X
nuclear	B-X
p53	B-X
immunoreactivity	B-X
,	B-X
whereas	B-X
STS	B-X
produced	B-X
rapid	B-X
cytoplasmic	B-X
p53	B-X
accumulation	B-X
.	B-X
Interestingly	B-X
,	B-X
STS-induced	B-X
death	B-X
of	B-X
cerebellar	B-X
granule	B-X
neurons	B-X
was	B-X
p53-independent	B-X
,	B-X
indicating	B-X
a	B-X
differentiation-dependent	B-X
feature	B-X
of	B-X
neuronal	B-X
apoptotic	B-X
regulation	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
STS-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
requires	B-X
a	B-X
direct	B-X
effect	B-X
of	B-X
p53	B-X
on	B-X
cytoplasmic	B-X
apoptotic	B-X
mediators	B-X
,	B-X
whereas	B-X
genotoxin-induced	B-X
death	B-X
requires	B-X
p53-dependent	B-X
gene	B-X
transcription	B-X
of	B-X
PUMA	B-X
.	B-X
Thus	B-X
,	B-X
p53	B-X
has	B-X
multiple	B-X
death	B-X
promoting	B-X
mechanisms	B-X
in	B-X
cerebellar	B-X
NPCs	B-X
.	B-X

Thus	O
,	O
p53	B-Gene_or_gene_product
has	O
multiple	O
death	O
promoting	O
mechanisms	O
in	O
cerebellar	O
NPCs	O
.	O
<EOS>	B-X
Regulation	B-X
of	B-X
cerebellar	B-X
neural	B-X
precursor	B-X
cell	B-X
(	B-X
NPC	B-X
)	B-X
death	B-X
is	B-X
important	B-X
for	B-X
both	B-X
normal	B-X
brain	B-X
development	B-X
and	B-X
prevention	B-X
of	B-X
brain	B-X
tumor	B-X
formation	B-X
.	B-X
The	B-X
tumor	B-X
suppressor	B-X
p53	B-X
is	B-X
an	B-X
important	B-X
regulator	B-X
of	B-X
NPC	B-X
apoptosis	B-X
,	B-X
but	B-X
the	B-X
precise	B-X
mechanism	B-X
of	B-X
p53-regulated	B-X
cerebellar	B-X
NPC	B-X
death	B-X
remains	B-X
largely	B-X
unknown	B-X
.	B-X
Here	B-X
,	B-X
by	B-X
using	B-X
primary	B-X
cerebellar	B-X
NPCs	B-X
and	B-X
a	B-X
mouse	B-X
cerebellar	B-X
NPC	B-X
line	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
molecular	B-X
regulation	B-X
of	B-X
cerebellar	B-X
NPC	B-X
death	B-X
produced	B-X
by	B-X
staurosporine	B-X
(	B-X
STS	B-X
)	B-X
,	B-X
a	B-X
broad-spectrum	B-X
kinase	B-X
inhibitor	B-X
,	B-X
with	B-X
that	B-X
caused	B-X
by	B-X
genotoxic	B-X
agents	B-X
.	B-X
We	B-X
found	B-X
that	B-X
both	B-X
STS-	B-X
and	B-X
genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
were	B-X
markedly	B-X
inhibited	B-X
by	B-X
p53	B-X
or	B-X
Bax	B-X
deficiency	B-X
.	B-X
Genotoxin-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
required	B-X
new	B-X
protein	B-X
synthesis	B-X
and	B-X
PUMA	B-X
,	B-X
a	B-X
p53	B-X
transcriptionally	B-X
regulated	B-X
BH3-only	B-X
molecule	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
STS	B-X
caused	B-X
cerebellar	B-X
NPC	B-X
death	B-X
without	B-X
requiring	B-X
new	B-X
protein	B-X
synthesis	B-X
or	B-X
PUMA	B-X
expression	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
genotoxic	B-X
agents	B-X
increased	B-X
nuclear	B-X
p53	B-X
immunoreactivity	B-X
,	B-X
whereas	B-X
STS	B-X
produced	B-X
rapid	B-X
cytoplasmic	B-X
p53	B-X
accumulation	B-X
.	B-X
Interestingly	B-X
,	B-X
STS-induced	B-X
death	B-X
of	B-X
cerebellar	B-X
granule	B-X
neurons	B-X
was	B-X
p53-independent	B-X
,	B-X
indicating	B-X
a	B-X
differentiation-dependent	B-X
feature	B-X
of	B-X
neuronal	B-X
apoptotic	B-X
regulation	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
STS-induced	B-X
cerebellar	B-X
NPC	B-X
death	B-X
requires	B-X
a	B-X
direct	B-X
effect	B-X
of	B-X
p53	B-X
on	B-X
cytoplasmic	B-X
apoptotic	B-X
mediators	B-X
,	B-X
whereas	B-X
genotoxin-induced	B-X
death	B-X
requires	B-X
p53-dependent	B-X
gene	B-X
transcription	B-X
of	B-X
PUMA	B-X
.	B-X
Thus	B-X
,	B-X
p53	B-X
has	B-X
multiple	B-X
death	B-X
promoting	B-X
mechanisms	B-X
in	B-X
cerebellar	B-X
NPCs	B-X
.	B-X

Cdk	B-Gene_or_gene_product
-	O
inhibitory	O
activity	O
and	O
stability	O
of	O
p27Kip1	B-Gene_or_gene_product
are	O
directly	O
regulated	O
by	O
oncogenic	O
tyrosine	O
kinases	O
.	O
<EOS>	B-X
p27Kip1	B-X
controls	B-X
cell	B-X
proliferation	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
regulating	B-X
the	B-X
activity	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdk	B-X
inhibition	B-X
and	B-X
p27	B-X
stability	B-X
are	B-X
regulated	B-X
through	B-X
direct	B-X
phosphorylation	B-X
by	B-X
tyrosine	B-X
kinases	B-X
.	B-X
A	B-X
conserved	B-X
tyrosine	B-X
residue	B-X
(	B-X
Y88	B-X
)	B-X
in	B-X
the	B-X
Cdk-binding	B-X
domain	B-X
of	B-X
p27	B-X
can	B-X
be	B-X
phosphorylated	B-X
by	B-X
the	B-X
Src-family	B-X
kinase	B-X
Lyn	B-X
and	B-X
the	B-X
oncogene	B-X
product	B-X
BCR-ABL	B-X
.	B-X
Y88	B-X
phosphorylation	B-X
does	B-X
not	B-X
prevent	B-X
p27	B-X
binding	B-X
to	B-X
cyclin	B-X
A/Cdk2	B-X
.	B-X
Instead	B-X
,	B-X
it	B-X
causes	B-X
phosphorylated	B-X
Y88	B-X
and	B-X
the	B-X
entire	B-X
inhibitory	B-X
3	B-X
(	B-X
10	B-X
)	B-X
-helix	B-X
of	B-X
p27	B-X
to	B-X
be	B-X
ejected	B-X
from	B-X
the	B-X
Cdk2	B-X
active	B-X
site	B-X
,	B-X
thus	B-X
restoring	B-X
partial	B-X
Cdk	B-X
activity	B-X
.	B-X
Importantly	B-X
,	B-X
this	B-X
allows	B-X
Y88-phosphorylated	B-X
p27	B-X
to	B-X
be	B-X
efficiently	B-X
phosphorylated	B-X
on	B-X
threonine	B-X
187	B-X
by	B-X
Cdk2	B-X
which	B-X
in	B-X
turn	B-X
promotes	B-X
its	B-X
SCF-Skp2-dependent	B-X
degradation	B-X
.	B-X
This	B-X
direct	B-X
link	B-X
between	B-X
transforming	B-X
tyrosine	B-X
kinases	B-X
and	B-X
p27	B-X
may	B-X
provide	B-X
an	B-X
explanation	B-X
for	B-X
Cdk	B-X
kinase	B-X
activities	B-X
observed	B-X
in	B-X
p27	B-X
complexes	B-X
and	B-X
for	B-X
premature	B-X
p27	B-X
elimination	B-X
in	B-X
cells	B-X
that	B-X
have	B-X
been	B-X
transformed	B-X
by	B-X
activated	B-X
tyrosine	B-X
kinases	B-X
.	B-X

p27Kip1	B-Gene_or_gene_product
controls	O
cell	O
proliferation	O
by	O
binding	O
to	O
and	O
regulating	O
the	O
activity	O
of	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
Cdks	B-Gene_or_gene_product
)	O
.	O
<EOS>	B-X
The	B-X
progression	B-X
through	B-X
the	B-X
phases	B-X
of	B-X
cell	B-X
division	B-X
cycle	B-X
is	B-X
regulated	B-X
by	B-X
different	B-X
cyclins	B-X
and	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
CDKs	B-X
)	B-X
complexes	B-X
.	B-X
Due	B-X
to	B-X
their	B-X
key	B-X
function	B-X
,	B-X
the	B-X
activity	B-X
of	B-X
cyclin/CDK	B-X
complexes	B-X
is	B-X
controlled	B-X
by	B-X
several	B-X
mechanisms	B-X
,	B-X
including	B-X
the	B-X
inhibition	B-X
by	B-X
a	B-X
number	B-X
of	B-X
proteins	B-X
collectively	B-X
defined	B-X
CDK	B-X
inhibitors	B-X
or	B-X
CKIs	B-X
.	B-X
Among	B-X
the	B-X
CKIs	B-X
,	B-X
p27Kip1	B-X
represents	B-X
a	B-X
protein	B-X
of	B-X
central	B-X
activity	B-X
for	B-X
the	B-X
control	B-X
of	B-X
several	B-X
phenotypes	B-X
,	B-X
including	B-X
proliferation	B-X
,	B-X
differentiation	B-X
and	B-X
malignant	B-X
transformation	B-X
.	B-X
p27Kip1	B-X
belongs	B-X
to	B-X
the	B-X
growing	B-X
family	B-X
of	B-X
``	B-X
natively	B-X
unfolded	B-X
,	B-X
''	B-X
``	B-X
intrinsically	B-X
disordered	B-X
''	B-X
or	B-X
``	B-X
intrinsically	B-X
unstructured	B-X
''	B-X
proteins	B-X
.	B-X
The	B-X
disorder	B-X
proteins	B-X
present	B-X
a	B-X
very	B-X
large	B-X
number	B-X
of	B-X
possible	B-X
conformations	B-X
that	B-X
,	B-X
after	B-X
the	B-X
binding	B-X
,	B-X
converge	B-X
to	B-X
a	B-X
well-defined	B-X
structure	B-X
with	B-X
an	B-X
extraordinary	B-X
affinity	B-X
for	B-X
the	B-X
target	B-X
.	B-X
As	B-X
matter	B-X
of	B-X
fact	B-X
,	B-X
the	B-X
absence	B-X
of	B-X
a	B-X
pre-existing	B-X
folding	B-X
strongly	B-X
facilitates	B-X
p27Kip1	B-X
interaction	B-X
with	B-X
a	B-X
number	B-X
of	B-X
targets	B-X
.	B-X
Until	B-X
recently	B-X
,	B-X
p27Kip1	B-X
has	B-X
been	B-X
solely	B-X
viewed	B-X
as	B-X
a	B-X
nuclear	B-X
protein	B-X
with	B-X
the	B-X
function	B-X
of	B-X
modulating	B-X
cyclin-CDK	B-X
activity	B-X
and	B-X
hence	B-X
,	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
However	B-X
,	B-X
exhaustive	B-X
studies	B-X
have	B-X
now	B-X
demonstrated	B-X
that	B-X
the	B-X
protein	B-X
plays	B-X
additional	B-X
roles	B-X
outside	B-X
of	B-X
the	B-X
nucleus	B-X
,	B-X
including	B-X
,	B-X
particularly	B-X
,	B-X
the	B-X
control	B-X
of	B-X
cell	B-X
motility	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
cellular	B-X
localization	B-X
is	B-X
of	B-X
fundamental	B-X
importance	B-X
in	B-X
p27Kip1	B-X
function	B-X
.	B-X
Convincing	B-X
evidences	B-X
have	B-X
demonstrated	B-X
that	B-X
p27Kip1	B-X
is	B-X
a	B-X
phosphoprotein	B-X
showing	B-X
at	B-X
least	B-X
six	B-X
to	B-X
eight	B-X
phosphorylatable	B-X
residues	B-X
.	B-X
However	B-X
,	B-X
the	B-X
precise	B-X
functional	B-X
roles	B-X
of	B-X
the	B-X
phosphorylations	B-X
and	B-X
the	B-X
identification	B-X
of	B-X
the	B-X
kinases	B-X
responsible	B-X
for	B-X
the	B-X
post-synthetic	B-X
modifications	B-X
are	B-X
still	B-X
debated	B-X
.	B-X
In	B-X
this	B-X
brief	B-X
review	B-X
,	B-X
we	B-X
will	B-X
report	B-X
the	B-X
Literature	B-X
data	B-X
that	B-X
connect	B-X
the	B-X
post-synthetic	B-X
modifications	B-X
of	B-X
p27Kip1	B-X
with	B-X
its	B-X
function	B-X
,	B-X
localization	B-X
and	B-X
metabolism	B-X
.	B-X

Here	O
we	O
show	O
that	O
Cdk	B-Gene_or_gene_product
inhibition	O
and	O
p27	B-Gene_or_gene_product
stability	O
are	O
regulated	O
through	O
direct	O
phosphorylation	O
by	O
tyrosine	O
kinases	O
.	O
<EOS>	B-X
p27Kip1	B-X
controls	B-X
cell	B-X
proliferation	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
regulating	B-X
the	B-X
activity	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdk	B-X
inhibition	B-X
and	B-X
p27	B-X
stability	B-X
are	B-X
regulated	B-X
through	B-X
direct	B-X
phosphorylation	B-X
by	B-X
tyrosine	B-X
kinases	B-X
.	B-X
A	B-X
conserved	B-X
tyrosine	B-X
residue	B-X
(	B-X
Y88	B-X
)	B-X
in	B-X
the	B-X
Cdk-binding	B-X
domain	B-X
of	B-X
p27	B-X
can	B-X
be	B-X
phosphorylated	B-X
by	B-X
the	B-X
Src-family	B-X
kinase	B-X
Lyn	B-X
and	B-X
the	B-X
oncogene	B-X
product	B-X
BCR-ABL	B-X
.	B-X
Y88	B-X
phosphorylation	B-X
does	B-X
not	B-X
prevent	B-X
p27	B-X
binding	B-X
to	B-X
cyclin	B-X
A/Cdk2	B-X
.	B-X
Instead	B-X
,	B-X
it	B-X
causes	B-X
phosphorylated	B-X
Y88	B-X
and	B-X
the	B-X
entire	B-X
inhibitory	B-X
3	B-X
(	B-X
10	B-X
)	B-X
-helix	B-X
of	B-X
p27	B-X
to	B-X
be	B-X
ejected	B-X
from	B-X
the	B-X
Cdk2	B-X
active	B-X
site	B-X
,	B-X
thus	B-X
restoring	B-X
partial	B-X
Cdk	B-X
activity	B-X
.	B-X
Importantly	B-X
,	B-X
this	B-X
allows	B-X
Y88-phosphorylated	B-X
p27	B-X
to	B-X
be	B-X
efficiently	B-X
phosphorylated	B-X
on	B-X
threonine	B-X
187	B-X
by	B-X
Cdk2	B-X
which	B-X
in	B-X
turn	B-X
promotes	B-X
its	B-X
SCF-Skp2-dependent	B-X
degradation	B-X
.	B-X
This	B-X
direct	B-X
link	B-X
between	B-X
transforming	B-X
tyrosine	B-X
kinases	B-X
and	B-X
p27	B-X
may	B-X
provide	B-X
an	B-X
explanation	B-X
for	B-X
Cdk	B-X
kinase	B-X
activities	B-X
observed	B-X
in	B-X
p27	B-X
complexes	B-X
and	B-X
for	B-X
premature	B-X
p27	B-X
elimination	B-X
in	B-X
cells	B-X
that	B-X
have	B-X
been	B-X
transformed	B-X
by	B-X
activated	B-X
tyrosine	B-X
kinases	B-X
.	B-X

A	O
conserved	O
tyrosine	O
residue	O
(	O
Y88	O
)	O
in	O
the	O
Cdk	B-Gene_or_gene_product
-	O
binding	O
domain	O
of	O
p27	B-Gene_or_gene_product
can	O
be	O
phosphorylated	O
by	O
the	O
Src	B-Gene_or_gene_product
-	O
family	O
kinase	O
Lyn	B-Gene_or_gene_product
and	O
the	O
oncogene	O
product	O
BCR	B-Gene_or_gene_product
-	I-Gene_or_gene_product
ABL	I-Gene_or_gene_product
.	O
<EOS>	B-X
p27Kip1	B-X
controls	B-X
cell	B-X
proliferation	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
regulating	B-X
the	B-X
activity	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdk	B-X
inhibition	B-X
and	B-X
p27	B-X
stability	B-X
are	B-X
regulated	B-X
through	B-X
direct	B-X
phosphorylation	B-X
by	B-X
tyrosine	B-X
kinases	B-X
.	B-X
A	B-X
conserved	B-X
tyrosine	B-X
residue	B-X
(	B-X
Y88	B-X
)	B-X
in	B-X
the	B-X
Cdk-binding	B-X
domain	B-X
of	B-X
p27	B-X
can	B-X
be	B-X
phosphorylated	B-X
by	B-X
the	B-X
Src-family	B-X
kinase	B-X
Lyn	B-X
and	B-X
the	B-X
oncogene	B-X
product	B-X
BCR-ABL	B-X
.	B-X
Y88	B-X
phosphorylation	B-X
does	B-X
not	B-X
prevent	B-X
p27	B-X
binding	B-X
to	B-X
cyclin	B-X
A/Cdk2	B-X
.	B-X
Instead	B-X
,	B-X
it	B-X
causes	B-X
phosphorylated	B-X
Y88	B-X
and	B-X
the	B-X
entire	B-X
inhibitory	B-X
3	B-X
(	B-X
10	B-X
)	B-X
-helix	B-X
of	B-X
p27	B-X
to	B-X
be	B-X
ejected	B-X
from	B-X
the	B-X
Cdk2	B-X
active	B-X
site	B-X
,	B-X
thus	B-X
restoring	B-X
partial	B-X
Cdk	B-X
activity	B-X
.	B-X
Importantly	B-X
,	B-X
this	B-X
allows	B-X
Y88-phosphorylated	B-X
p27	B-X
to	B-X
be	B-X
efficiently	B-X
phosphorylated	B-X
on	B-X
threonine	B-X
187	B-X
by	B-X
Cdk2	B-X
which	B-X
in	B-X
turn	B-X
promotes	B-X
its	B-X
SCF-Skp2-dependent	B-X
degradation	B-X
.	B-X
This	B-X
direct	B-X
link	B-X
between	B-X
transforming	B-X
tyrosine	B-X
kinases	B-X
and	B-X
p27	B-X
may	B-X
provide	B-X
an	B-X
explanation	B-X
for	B-X
Cdk	B-X
kinase	B-X
activities	B-X
observed	B-X
in	B-X
p27	B-X
complexes	B-X
and	B-X
for	B-X
premature	B-X
p27	B-X
elimination	B-X
in	B-X
cells	B-X
that	B-X
have	B-X
been	B-X
transformed	B-X
by	B-X
activated	B-X
tyrosine	B-X
kinases	B-X
.	B-X

Y88	O
phosphorylation	O
does	O
not	O
prevent	O
p27	B-Gene_or_gene_product
binding	O
to	O
cyclin	O
A	O
/	O
Cdk2	O
.	O
<EOS>	B-X
The	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
CDK	B-X
)	B-X
inhibitor	B-X
p27	B-X
p27	B-X
Extracellular	B-X
mitogen	B-X
signal	B-X
transduction	B-X
is	B-X
initiated	B-X
by	B-X
ligand	B-X
binding	B-X
to	B-X
specific	B-X
receptors	B-X
of	B-X
target	B-X
cells	B-X
.	B-X
Non-receptor	B-X
kinases	B-X
like	B-X
Src	B-X
and	B-X
Lyn	B-X
can	B-X
directly	B-X
phosphorylate	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
protein	B-X
p27	B-X
(	B-X
Kip1	B-X
)	B-X
.	B-X
Tyrosine	B-X
phosphorylation	B-X
can	B-X
cause	B-X
impaired	B-X
Cdk-inhibitory	B-X
activity	B-X
and	B-X
decreased	B-X
stability	B-X
of	B-X
p27	B-X
.	B-X
In	B-X
addition	B-X
to	B-X
these	B-X
non-receptor	B-X
tyrosine	B-X
kinases	B-X
,	B-X
the	B-X
receptor-associated	B-X
tyrosine	B-X
kinase	B-X
Janus	B-X
kinase	B-X
2	B-X
(	B-X
JAK2	B-X
)	B-X
was	B-X
recently	B-X
identified	B-X
to	B-X
phosphorylate	B-X
p27	B-X
.	B-X
JAK2	B-X
becomes	B-X
activated	B-X
through	B-X
binding	B-X
of	B-X
various	B-X
cytokines	B-X
and	B-X
growth	B-X
factors	B-X
to	B-X
their	B-X
corresponding	B-X
receptors	B-X
and	B-X
can	B-X
directly	B-X
bind	B-X
and	B-X
selectively	B-X
phosphorylate	B-X
tyrosine	B-X
residue	B-X
88	B-X
(	B-X
Y88	B-X
)	B-X
of	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
p27	B-X
.	B-X
This	B-X
impairs	B-X
Cdk	B-X
inhibition	B-X
by	B-X
p27	B-X
and	B-X
promotes	B-X
its	B-X
ubiquitin-dependent	B-X
proteasomal	B-X
degradation	B-X
.	B-X
Via	B-X
this	B-X
mechanism	B-X
,	B-X
JAK2	B-X
can	B-X
link	B-X
cytokine	B-X
and	B-X
growth	B-X
factor	B-X
initiated	B-X
signal	B-X
transduction	B-X
to	B-X
p27	B-X
regulation	B-X
,	B-X
whereas	B-X
oncogenes	B-X
like	B-X
JAK2V617F	B-X
or	B-X
BCR-Abl	B-X
can	B-X
use	B-X
this	B-X
mechanism	B-X
to	B-X
inactivate	B-X
the	B-X
Cdk	B-X
inhibitor	B-X
.	B-X

Instead	O
,	O
it	O
causes	O
phosphorylated	O
Y88	O
and	O
the	O
entire	O
inhibitory	O
3	O
(	O
10	O
)	O
-	O
helix	O
of	O
p27	B-Gene_or_gene_product
to	O
be	O
ejected	O
from	O
the	O
Cdk2	B-Gene_or_gene_product
active	O
site	O
,	O
thus	O
restoring	O
partial	O
Cdk	B-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
p27Kip1	B-X
controls	B-X
cell	B-X
proliferation	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
regulating	B-X
the	B-X
activity	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdk	B-X
inhibition	B-X
and	B-X
p27	B-X
stability	B-X
are	B-X
regulated	B-X
through	B-X
direct	B-X
phosphorylation	B-X
by	B-X
tyrosine	B-X
kinases	B-X
.	B-X
A	B-X
conserved	B-X
tyrosine	B-X
residue	B-X
(	B-X
Y88	B-X
)	B-X
in	B-X
the	B-X
Cdk-binding	B-X
domain	B-X
of	B-X
p27	B-X
can	B-X
be	B-X
phosphorylated	B-X
by	B-X
the	B-X
Src-family	B-X
kinase	B-X
Lyn	B-X
and	B-X
the	B-X
oncogene	B-X
product	B-X
BCR-ABL	B-X
.	B-X
Y88	B-X
phosphorylation	B-X
does	B-X
not	B-X
prevent	B-X
p27	B-X
binding	B-X
to	B-X
cyclin	B-X
A/Cdk2	B-X
.	B-X
Instead	B-X
,	B-X
it	B-X
causes	B-X
phosphorylated	B-X
Y88	B-X
and	B-X
the	B-X
entire	B-X
inhibitory	B-X
3	B-X
(	B-X
10	B-X
)	B-X
-helix	B-X
of	B-X
p27	B-X
to	B-X
be	B-X
ejected	B-X
from	B-X
the	B-X
Cdk2	B-X
active	B-X
site	B-X
,	B-X
thus	B-X
restoring	B-X
partial	B-X
Cdk	B-X
activity	B-X
.	B-X
Importantly	B-X
,	B-X
this	B-X
allows	B-X
Y88-phosphorylated	B-X
p27	B-X
to	B-X
be	B-X
efficiently	B-X
phosphorylated	B-X
on	B-X
threonine	B-X
187	B-X
by	B-X
Cdk2	B-X
which	B-X
in	B-X
turn	B-X
promotes	B-X
its	B-X
SCF-Skp2-dependent	B-X
degradation	B-X
.	B-X
This	B-X
direct	B-X
link	B-X
between	B-X
transforming	B-X
tyrosine	B-X
kinases	B-X
and	B-X
p27	B-X
may	B-X
provide	B-X
an	B-X
explanation	B-X
for	B-X
Cdk	B-X
kinase	B-X
activities	B-X
observed	B-X
in	B-X
p27	B-X
complexes	B-X
and	B-X
for	B-X
premature	B-X
p27	B-X
elimination	B-X
in	B-X
cells	B-X
that	B-X
have	B-X
been	B-X
transformed	B-X
by	B-X
activated	B-X
tyrosine	B-X
kinases	B-X
.	B-X

Importantly	O
,	O
this	O
allows	O
Y88	O
-	O
phosphorylated	O
p27	B-Gene_or_gene_product
to	O
be	O
efficiently	O
phosphorylated	O
on	O
threonine	O
187	O
by	O
Cdk2	B-Gene_or_gene_product
which	O
in	O
turn	O
promotes	O
its	O
SCF	O
-	O
Skp2	B-Gene_or_gene_product
-	O
dependent	O
degradation	O
.	O
<EOS>	B-X
p27Kip1	B-X
controls	B-X
cell	B-X
proliferation	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
regulating	B-X
the	B-X
activity	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdk	B-X
inhibition	B-X
and	B-X
p27	B-X
stability	B-X
are	B-X
regulated	B-X
through	B-X
direct	B-X
phosphorylation	B-X
by	B-X
tyrosine	B-X
kinases	B-X
.	B-X
A	B-X
conserved	B-X
tyrosine	B-X
residue	B-X
(	B-X
Y88	B-X
)	B-X
in	B-X
the	B-X
Cdk-binding	B-X
domain	B-X
of	B-X
p27	B-X
can	B-X
be	B-X
phosphorylated	B-X
by	B-X
the	B-X
Src-family	B-X
kinase	B-X
Lyn	B-X
and	B-X
the	B-X
oncogene	B-X
product	B-X
BCR-ABL	B-X
.	B-X
Y88	B-X
phosphorylation	B-X
does	B-X
not	B-X
prevent	B-X
p27	B-X
binding	B-X
to	B-X
cyclin	B-X
A/Cdk2	B-X
.	B-X
Instead	B-X
,	B-X
it	B-X
causes	B-X
phosphorylated	B-X
Y88	B-X
and	B-X
the	B-X
entire	B-X
inhibitory	B-X
3	B-X
(	B-X
10	B-X
)	B-X
-helix	B-X
of	B-X
p27	B-X
to	B-X
be	B-X
ejected	B-X
from	B-X
the	B-X
Cdk2	B-X
active	B-X
site	B-X
,	B-X
thus	B-X
restoring	B-X
partial	B-X
Cdk	B-X
activity	B-X
.	B-X
Importantly	B-X
,	B-X
this	B-X
allows	B-X
Y88-phosphorylated	B-X
p27	B-X
to	B-X
be	B-X
efficiently	B-X
phosphorylated	B-X
on	B-X
threonine	B-X
187	B-X
by	B-X
Cdk2	B-X
which	B-X
in	B-X
turn	B-X
promotes	B-X
its	B-X
SCF-Skp2-dependent	B-X
degradation	B-X
.	B-X
This	B-X
direct	B-X
link	B-X
between	B-X
transforming	B-X
tyrosine	B-X
kinases	B-X
and	B-X
p27	B-X
may	B-X
provide	B-X
an	B-X
explanation	B-X
for	B-X
Cdk	B-X
kinase	B-X
activities	B-X
observed	B-X
in	B-X
p27	B-X
complexes	B-X
and	B-X
for	B-X
premature	B-X
p27	B-X
elimination	B-X
in	B-X
cells	B-X
that	B-X
have	B-X
been	B-X
transformed	B-X
by	B-X
activated	B-X
tyrosine	B-X
kinases	B-X
.	B-X

This	O
direct	O
link	O
between	O
transforming	O
tyrosine	O
kinases	O
and	O
p27	B-Gene_or_gene_product
may	O
provide	O
an	O
explanation	O
for	O
Cdk	B-Gene_or_gene_product
kinase	O
activities	O
observed	O
in	O
p27	B-Gene_or_gene_product
complexes	O
and	O
for	O
premature	O
p27	B-Gene_or_gene_product
elimination	O
in	O
cells	O
that	O
have	O
been	O
transformed	O
by	O
activated	O
tyrosine	O
kinases	O
.	O
<EOS>	B-X
p27Kip1	B-X
controls	B-X
cell	B-X
proliferation	B-X
by	B-X
binding	B-X
to	B-X
and	B-X
regulating	B-X
the	B-X
activity	B-X
of	B-X
cyclin-dependent	B-X
kinases	B-X
(	B-X
Cdks	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
Cdk	B-X
inhibition	B-X
and	B-X
p27	B-X
stability	B-X
are	B-X
regulated	B-X
through	B-X
direct	B-X
phosphorylation	B-X
by	B-X
tyrosine	B-X
kinases	B-X
.	B-X
A	B-X
conserved	B-X
tyrosine	B-X
residue	B-X
(	B-X
Y88	B-X
)	B-X
in	B-X
the	B-X
Cdk-binding	B-X
domain	B-X
of	B-X
p27	B-X
can	B-X
be	B-X
phosphorylated	B-X
by	B-X
the	B-X
Src-family	B-X
kinase	B-X
Lyn	B-X
and	B-X
the	B-X
oncogene	B-X
product	B-X
BCR-ABL	B-X
.	B-X
Y88	B-X
phosphorylation	B-X
does	B-X
not	B-X
prevent	B-X
p27	B-X
binding	B-X
to	B-X
cyclin	B-X
A/Cdk2	B-X
.	B-X
Instead	B-X
,	B-X
it	B-X
causes	B-X
phosphorylated	B-X
Y88	B-X
and	B-X
the	B-X
entire	B-X
inhibitory	B-X
3	B-X
(	B-X
10	B-X
)	B-X
-helix	B-X
of	B-X
p27	B-X
to	B-X
be	B-X
ejected	B-X
from	B-X
the	B-X
Cdk2	B-X
active	B-X
site	B-X
,	B-X
thus	B-X
restoring	B-X
partial	B-X
Cdk	B-X
activity	B-X
.	B-X
Importantly	B-X
,	B-X
this	B-X
allows	B-X
Y88-phosphorylated	B-X
p27	B-X
to	B-X
be	B-X
efficiently	B-X
phosphorylated	B-X
on	B-X
threonine	B-X
187	B-X
by	B-X
Cdk2	B-X
which	B-X
in	B-X
turn	B-X
promotes	B-X
its	B-X
SCF-Skp2-dependent	B-X
degradation	B-X
.	B-X
This	B-X
direct	B-X
link	B-X
between	B-X
transforming	B-X
tyrosine	B-X
kinases	B-X
and	B-X
p27	B-X
may	B-X
provide	B-X
an	B-X
explanation	B-X
for	B-X
Cdk	B-X
kinase	B-X
activities	B-X
observed	B-X
in	B-X
p27	B-X
complexes	B-X
and	B-X
for	B-X
premature	B-X
p27	B-X
elimination	B-X
in	B-X
cells	B-X
that	B-X
have	B-X
been	B-X
transformed	B-X
by	B-X
activated	B-X
tyrosine	B-X
kinases	B-X
.	B-X

A	O
systems	O
-	O
biology	O
analysis	O
of	O
feedback	O
inhibition	O
in	O
the	O
Sho1	B-Gene_or_gene_product
osmotic	O
-	O
stress	O
-	O
response	O
pathway	O
.	O
<EOS>	B-X
A	B-X
common	B-X
property	B-X
of	B-X
signal	B-X
transduction	B-X
systems	B-X
is	B-X
that	B-X
they	B-X
rapidly	B-X
lose	B-X
their	B-X
ability	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
given	B-X
stimulus	B-X
.	B-X
For	B-X
instance	B-X
in	B-X
yeast	B-X
,	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
Hog1	B-X
is	B-X
activated	B-X
and	B-X
inactivated	B-X
within	B-X
minutes	B-X
,	B-X
even	B-X
when	B-X
the	B-X
osmotic-stress	B-X
stimulus	B-X
is	B-X
sustained	B-X
.	B-X

BACKGROUND	O
:	O
A	O
common	O
property	O
of	O
signal	O
transduction	O
systems	O
is	O
that	O
they	O
rapidly	O
lose	O
their	O
ability	O
to	O
respond	O
to	O
a	O
given	O
stimulus	O
.	O
<EOS>	B-X
A	B-X
common	B-X
property	B-X
of	B-X
signal	B-X
transduction	B-X
systems	B-X
is	B-X
that	B-X
they	B-X
rapidly	B-X
lose	B-X
their	B-X
ability	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
given	B-X
stimulus	B-X
.	B-X
For	B-X
instance	B-X
in	B-X
yeast	B-X
,	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
Hog1	B-X
is	B-X
activated	B-X
and	B-X
inactivated	B-X
within	B-X
minutes	B-X
,	B-X
even	B-X
when	B-X
the	B-X
osmotic-stress	B-X
stimulus	B-X
is	B-X
sustained	B-X
.	B-X

For	O
instance	O
in	O
yeast	O
,	O
the	O
mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
Hog1	B-Gene_or_gene_product
is	O
activated	O
and	O
inactivated	O
within	O
minutes	O
,	O
even	O
when	O
the	O
osmotic	O
-	O
stress	O
stimulus	O
is	O
sustained	O
.	O
<EOS>	B-X
A	B-X
common	B-X
property	B-X
of	B-X
signal	B-X
transduction	B-X
systems	B-X
is	B-X
that	B-X
they	B-X
rapidly	B-X
lose	B-X
their	B-X
ability	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
given	B-X
stimulus	B-X
.	B-X
For	B-X
instance	B-X
in	B-X
yeast	B-X
,	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
Hog1	B-X
is	B-X
activated	B-X
and	B-X
inactivated	B-X
within	B-X
minutes	B-X
,	B-X
even	B-X
when	B-X
the	B-X
osmotic-stress	B-X
stimulus	B-X
is	B-X
sustained	B-X
.	B-X

RESULTS	O
:	O
Here	O
,	O
we	O
used	O
a	O
combination	O
of	O
experimental	O
and	O
computational	O
analyses	O
to	O
investigate	O
the	O
dynamic	O
behavior	O
of	O
Hog1	B-Gene_or_gene_product
activation	O
in	O
vivo	O
.	O
<EOS>	B-X
For	B-X
instance	B-X
in	B-X
yeast	B-X
,	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
Hog1	B-X
is	B-X
activated	B-X
and	B-X
inactivated	B-X
within	B-X
minutes	B-X
,	B-X
even	B-X
when	B-X
the	B-X
osmotic-stress	B-X
stimulus	B-X
is	B-X
sustained	B-X
.	B-X

Computational	O
modeling	O
suggested	O
that	O
a	O
negative	O
-	O
feedback	O
loop	O
operates	O
early	O
in	O
the	O
pathway	O
and	O
leads	O
to	O
rapid	O
attenuation	O
of	O
Hog1	B-Gene_or_gene_product
signaling	O
.	O
<EOS>	B-X
A	B-X
common	B-X
property	B-X
of	B-X
signal	B-X
transduction	B-X
systems	B-X
is	B-X
that	B-X
they	B-X
rapidly	B-X
lose	B-X
their	B-X
ability	B-X
to	B-X
respond	B-X
to	B-X
a	B-X
given	B-X
stimulus	B-X
.	B-X
For	B-X
instance	B-X
in	B-X
yeast	B-X
,	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
Hog1	B-X
is	B-X
activated	B-X
and	B-X
inactivated	B-X
within	B-X
minutes	B-X
,	B-X
even	B-X
when	B-X
the	B-X
osmotic-stress	B-X
stimulus	B-X
is	B-X
sustained	B-X
.	B-X

Experimental	O
analysis	O
revealed	O
that	O
the	O
membrane	O
-	O
bound	O
osmosensor	O
Sho1	B-Gene_or_gene_product
is	O
phosphorylated	O
by	O
Hog1	B-Gene_or_gene_product
and	O
that	O
phosphorylation	O
occurs	O
on	O
Ser	O
-	O
166	O
.	O
<EOS>	B-X
For	B-X
instance	B-X
in	B-X
yeast	B-X
,	B-X
the	B-X
mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinase	B-X
Hog1	B-X
is	B-X
activated	B-X
and	B-X
inactivated	B-X
within	B-X
minutes	B-X
,	B-X
even	B-X
when	B-X
the	B-X
osmotic-stress	B-X
stimulus	B-X
is	B-X
sustained	B-X
.	B-X

Moreover	O
,	O
Sho1	B-Gene_or_gene_product
exists	O
in	O
a	O
homo	O
-	O
oligomeric	O
complex	O
,	O
and	O
phosphorylation	O
by	O
Hog1	B-Gene_or_gene_product
promotes	O
a	O
transition	O
from	O
the	O
oligomeric	O
to	O
monomeric	O
state	O
.	O

A	O
phosphorylation	O
-	O
site	O
mutation	O
(	O
Sho1	B-Gene_or_gene_product
(	I-Gene_or_gene_product
S166E	I-Gene_or_gene_product
)	I-Gene_or_gene_product
)	O
diminishes	O
the	O
formation	O
of	O
Sho1	B-Gene_or_gene_product
-	O
oligomers	O
,	O
dampens	O
activation	O
of	O
the	O
Hog1	B-Gene_or_gene_product
kinase	O
,	O
and	O
impairs	O
growth	O
in	O
high	O
-	O
salt	O
or	O
sorbitol	O
conditions	O
.	O
<EOS>	B-X
Our	B-X
pilot	B-X
experiments	B-X
and	B-X
accumulated	B-X
evidences	B-X
showed	B-X
that	B-X
epalrestat	B-X
inhibited	B-X
polyol	B-X
pathway	B-X
and	B-X
reduced	B-X
sorbitol	B-X
production	B-X
,	B-X
and	B-X
suggested	B-X
the	B-X
potential	B-X
renal	B-X
protection	B-X
effects	B-X
of	B-X
epalrestat	B-X
on	B-X
diabetic	B-X
nephropathy	B-X
(	B-X
DN	B-X
)	B-X
.	B-X
We	B-X
observed	B-X
an	B-X
elevation	B-X
of	B-X
sorbitol	B-X
and	B-X
fructose	B-X
,	B-X
and	B-X
a	B-X
decrease	B-X
of	B-X
myo-inositol	B-X
in	B-X
the	B-X
renal	B-X
cortex	B-X
of	B-X
db/db	B-X
mice	B-X
.	B-X
Epalrestat	B-X
reversed	B-X
the	B-X
renal	B-X
accumulation	B-X
of	B-X
the	B-X
polyol	B-X
pathway	B-X
metabolites	B-X
of	B-X
sorbitol	B-X
and	B-X
fructose	B-X
,	B-X
and	B-X
increased	B-X
myo-inositol	B-X
level	B-X
.	B-X
It	B-X
is	B-X
also	B-X
the	B-X
rate-limiting	B-X
enzyme	B-X
of	B-X
the	B-X
polyol	B-X
pathway	B-X
,	B-X
catalyzing	B-X
the	B-X
conversion	B-X
of	B-X
glucose	B-X
to	B-X
sorbitol	B-X
,	B-X
which	B-X
is	B-X
subsequently	B-X
converted	B-X
to	B-X
fructose	B-X
by	B-X
sorbitol	B-X
dehydrogenase	B-X
.	B-X
AR	B-X
is	B-X
highly	B-X
expressed	B-X
by	B-X
Schwann	B-X
cells	B-X
in	B-X
the	B-X
peripheral	B-X
nervous	B-X
system	B-X
(	B-X
PNS	B-X
)	B-X
.	B-X
The	B-X
excess	B-X
glucose	B-X
flux	B-X
through	B-X
AR	B-X
of	B-X
the	B-X
polyol	B-X
pathway	B-X
under	B-X
hyperglycemic	B-X
conditions	B-X
has	B-X
been	B-X
suggested	B-X
to	B-X
play	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
development	B-X
and	B-X
progression	B-X
of	B-X
diabetic	B-X
peripheral	B-X
neuropathy	B-X
(	B-X
DPN	B-X
)	B-X
.	B-X
Despite	B-X
the	B-X
intensive	B-X
basic	B-X
and	B-X
clinical	B-X
studies	B-X
over	B-X
the	B-X
past	B-X
four	B-X
decades	B-X
,	B-X
the	B-X
significance	B-X
of	B-X
AR	B-X
over-activation	B-X
as	B-X
the	B-X
pathogenic	B-X
mechanism	B-X
of	B-X
DPN	B-X
remains	B-X
to	B-X
be	B-X
elucidated	B-X
.	B-X

CONCLUSIONS	O
:	O
These	O
findings	O
reveal	O
a	O
novel	O
phosphorylation	O
-	O
dependent	O
feedback	O
loop	O
leading	O
to	O
diminished	O
cellular	O
responses	O
to	O
an	O
osmotic	O
-	O
stress	O
stimulus	O
.	O

The	O
proline	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rich	I-Gene_or_gene_product
Akt	I-Gene_or_gene_product
substrate	I-Gene_or_gene_product
of	I-Gene_or_gene_product
40	I-Gene_or_gene_product
kDa	I-Gene_or_gene_product
(	O
PRAS40	B-Gene_or_gene_product
)	O
is	O
a	O
physiological	O
substrate	O
of	O
mammalian	B-Gene_or_gene_product
target	I-Gene_or_gene_product
of	I-Gene_or_gene_product
rapamycin	I-Gene_or_gene_product
complex	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
class	B-X
I	B-X
phosphoinositide	B-X
3-kinase	B-X
(	B-X
PI3K	B-X
)	B-X
-mechanistic	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
signaling	B-X
network	B-X
directs	B-X
cellular	B-X
metabolism	B-X
and	B-X
growth	B-X
.	B-X
Activation	B-X
of	B-X
mTORC1	B-X
[	B-X
composed	B-X
of	B-X
mTOR	B-X
,	B-X
regulatory-associated	B-X
protein	B-X
of	B-X
mTOR	B-X
(	B-X
Raptor	B-X
)	B-X
,	B-X
mammalian	B-X
lethal	B-X
with	B-X
SEC13	B-X
protein	B-X
8	B-X
(	B-X
mLST8	B-X
)	B-X
,	B-X
40-kDa	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
(	B-X
PRAS40	B-X
)	B-X
,	B-X
and	B-X
DEP	B-X
domain-containing	B-X
mTOR-interacting	B-X
protein	B-X
(	B-X
DEPTOR	B-X
)	B-X
]	B-X
depends	B-X
on	B-X
the	B-X
Ras-related	B-X
GTPases	B-X
(	B-X
Rags	B-X
)	B-X
and	B-X
Ras	B-X
homolog	B-X
enriched	B-X
in	B-X
brain	B-X
(	B-X
Rheb	B-X
)	B-X
GTPase	B-X
and	B-X
requires	B-X
signals	B-X
from	B-X
amino	B-X
acids	B-X
,	B-X
glucose	B-X
,	B-X
oxygen	B-X
,	B-X
energy	B-X
(	B-X
ATP	B-X
)	B-X
,	B-X
and	B-X
growth	B-X
factors	B-X
(	B-X
including	B-X
cytokines	B-X
and	B-X
hormones	B-X
such	B-X
as	B-X
insulin	B-X
)	B-X
.	B-X
Here	B-X
we	B-X
discuss	B-X
the	B-X
signal	B-X
transduction	B-X
mechanisms	B-X
through	B-X
which	B-X
growth	B-X
factor-responsive	B-X
PI3K	B-X
signaling	B-X
activates	B-X
mTORC1	B-X
.	B-X
We	B-X
focus	B-X
on	B-X
how	B-X
PI3K-dependent	B-X
activation	B-X
of	B-X
Akt	B-X
and	B-X
spatial	B-X
regulation	B-X
of	B-X
the	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
(	B-X
TSC	B-X
)	B-X
complex	B-X
(	B-X
TSC	B-X
complex	B-X
)	B-X
[	B-X
composed	B-X
of	B-X
TSC1	B-X
,	B-X
TSC2	B-X
,	B-X
and	B-X
Tre2-Bub2-Cdc16-1	B-X
domain	B-X
family	B-X
member	B-X
7	B-X
(	B-X
TBC1D7	B-X
)	B-X
]	B-X
switches	B-X
on	B-X
Rheb	B-X
at	B-X
the	B-X
lysosome	B-X
,	B-X
where	B-X
mTORC1	B-X
is	B-X
activated	B-X
.	B-X
Integration	B-X
of	B-X
PI3K-	B-X
and	B-X
amino	B-X
acid-dependent	B-X
signals	B-X
upstream	B-X
of	B-X
mTORC1	B-X
at	B-X
the	B-X
lysosome	B-X
is	B-X
detailed	B-X
in	B-X
a	B-X
working	B-X
model	B-X
.	B-X
A	B-X
coherent	B-X
understanding	B-X
of	B-X
the	B-X
PI3K-mTORC1	B-X
network	B-X
is	B-X
imperative	B-X
as	B-X
its	B-X
dysregulation	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
diverse	B-X
pathologies	B-X
including	B-X
cancer	B-X
,	B-X
diabetes	B-X
,	B-X
autism	B-X
,	B-X
and	B-X
aging	B-X
.	B-X

The	O
proline	B-Gene_or_gene_product
-	I-Gene_or_gene_product
rich	I-Gene_or_gene_product
Akt	I-Gene_or_gene_product
substrate	I-Gene_or_gene_product
of	I-Gene_or_gene_product
40	I-Gene_or_gene_product
kilodaltons	I-Gene_or_gene_product
(	O
PRAS40	B-Gene_or_gene_product
)	O
was	O
identified	O
as	O
a	O
raptor	B-Gene_or_gene_product
-	O
binding	O
protein	O
that	O
is	O
phosphorylated	O
directly	O
by	O
mammalian	O
target	O
of	O
rapamycin	O
(	O
mTOR	O
)	O
complex	O
1	O
(	O
mTORC1	O
)	O
but	O
not	O
mTORC2	O
in	O
vitro	O
,	O
predominantly	O
at	O
PRAS40	B-Gene_or_gene_product
(	O
Ser	O
(	O
183	O
)	O
)	O
.	O

The	O
binding	O
of	O
S6K1	B-Gene_or_gene_product
and	O
4E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
BP1	I-Gene_or_gene_product
to	O
raptor	B-Gene_or_gene_product
requires	O
a	O
TOR	B-Gene_or_gene_product
signaling	O
(	O
TOS	O
)	O
motif	O
,	O
which	O
contains	O
an	O
essential	O
Phe	O
followed	O
by	O
four	O
alternating	O
acidic	O
and	O
small	O
hydrophobic	O
amino	O
acids	O
.	O
<EOS>	B-X
The	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kilodaltons	B-X
(	B-X
PRAS40	B-X
)	B-X
was	B-X
identified	B-X
as	B-X
a	B-X
raptor-binding	B-X
protein	B-X
that	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
but	B-X
not	B-X
mTORC2	B-X
in	B-X
vitro	B-X
,	B-X
predominantly	B-X
at	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
to	B-X
raptor	B-X
requires	B-X
a	B-X
TOR	B-X
signaling	B-X
(	B-X
TOS	B-X
)	B-X
motif	B-X
,	B-X
which	B-X
contains	B-X
an	B-X
essential	B-X
Phe	B-X
followed	B-X
by	B-X
four	B-X
alternating	B-X
acidic	B-X
and	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acids	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
severely	B-X
inhibited	B-X
by	B-X
mutation	B-X
of	B-X
PRAS40	B-X
(	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
to	B-X
Ala	B-X
)	B-X
.	B-X
Immediately	B-X
carboxyl-terminal	B-X
to	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
are	B-X
two	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acid	B-X
followed	B-X
by	B-X
two	B-X
acidic	B-X
residues	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
also	B-X
abolished	B-X
by	B-X
mutation	B-X
of	B-X
the	B-X
major	B-X
mTORC1	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
,	B-X
to	B-X
Asp	B-X
.	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
phosphorylation	B-X
was	B-X
also	B-X
inhibited	B-X
reversibly	B-X
by	B-X
withdrawal	B-X
of	B-X
all	B-X
or	B-X
of	B-X
only	B-X
the	B-X
branched	B-X
chain	B-X
amino	B-X
acids	B-X
;	B-X
this	B-X
inhibition	B-X
was	B-X
reversed	B-X
by	B-X
overexpression	B-X
of	B-X
the	B-X
Rheb	B-X
GTPase	B-X
.	B-X
Overexpressed	B-X
PRAS40	B-X
suppressed	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
at	B-X
their	B-X
rapamycin-sensitive	B-X
phosphorylation	B-X
sites	B-X
,	B-X
and	B-X
reciprocally	B-X
,	B-X
overexpression	B-X
of	B-X
S6K1	B-X
or	B-X
4E-BP1	B-X
suppressed	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
and	B-X
its	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
RNA	B-X
interference-induced	B-X
depletion	B-X
of	B-X
PRAS40	B-X
enhanced	B-X
the	B-X
amino	B-X
acid-stimulated	B-X
phosphorylation	B-X
of	B-X
both	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
.	B-X
These	B-X
results	B-X
establish	B-X
PRAS40	B-X
as	B-X
a	B-X
physiological	B-X
mTORC1	B-X
substrate	B-X
that	B-X
contains	B-X
a	B-X
variant	B-X
TOS	B-X
motif	B-X
.	B-X
Moreover	B-X
,	B-X
they	B-X
indicate	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
raptor	B-X
to	B-X
bind	B-X
endogenous	B-X
substrates	B-X
is	B-X
limiting	B-X
for	B-X
the	B-X
activity	B-X
of	B-X
mTORC1	B-X
in	B-X
vivo	B-X
and	B-X
is	B-X
therefore	B-X
a	B-X
potential	B-X
locus	B-X
of	B-X
regulation	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
binding	O
to	O
raptor	B-Gene_or_gene_product
was	O
severely	O
inhibited	O
by	O
mutation	O
of	O
PRAS40	B-Gene_or_gene_product
(	O
Phe	O
(	O
129	O
)	O
to	O
Ala	O
)	O
.	O

Immediately	O
carboxyl	O
-	O
terminal	O
to	O
Phe	O
(	O
129	O
)	O
are	O
two	O
small	O
hydrophobic	O
amino	O
acid	O
followed	O
by	O
two	O
acidic	O
residues	O
.	O
<EOS>	B-X
The	B-X
binding	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
to	B-X
raptor	B-X
requires	B-X
a	B-X
TOR	B-X
signaling	B-X
(	B-X
TOS	B-X
)	B-X
motif	B-X
,	B-X
which	B-X
contains	B-X
an	B-X
essential	B-X
Phe	B-X
followed	B-X
by	B-X
four	B-X
alternating	B-X
acidic	B-X
and	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acids	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
severely	B-X
inhibited	B-X
by	B-X
mutation	B-X
of	B-X
PRAS40	B-X
(	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
to	B-X
Ala	B-X
)	B-X
.	B-X
Immediately	B-X
carboxyl-terminal	B-X
to	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
are	B-X
two	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acid	B-X
followed	B-X
by	B-X
two	B-X
acidic	B-X
residues	B-X
.	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
phosphorylation	B-X
was	B-X
also	B-X
inhibited	B-X
reversibly	B-X
by	B-X
withdrawal	B-X
of	B-X
all	B-X
or	B-X
of	B-X
only	B-X
the	B-X
branched	B-X
chain	B-X
amino	B-X
acids	B-X
;	B-X
this	B-X
inhibition	B-X
was	B-X
reversed	B-X
by	B-X
overexpression	B-X
of	B-X
the	B-X
Rheb	B-X
GTPase	B-X
.	B-X
RNA	B-X
interference-induced	B-X
depletion	B-X
of	B-X
PRAS40	B-X
enhanced	B-X
the	B-X
amino	B-X
acid-stimulated	B-X
phosphorylation	B-X
of	B-X
both	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
binding	O
to	O
raptor	B-Gene_or_gene_product
was	O
also	O
abolished	O
by	O
mutation	O
of	O
the	O
major	O
mTORC1	O
phosphorylation	O
site	O
,	O
Ser	O
(	O
183	O
)	O
,	O
to	O
Asp	O
.	O
<EOS>	B-X
The	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kilodaltons	B-X
(	B-X
PRAS40	B-X
)	B-X
was	B-X
identified	B-X
as	B-X
a	B-X
raptor-binding	B-X
protein	B-X
that	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
but	B-X
not	B-X
mTORC2	B-X
in	B-X
vitro	B-X
,	B-X
predominantly	B-X
at	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
to	B-X
raptor	B-X
requires	B-X
a	B-X
TOR	B-X
signaling	B-X
(	B-X
TOS	B-X
)	B-X
motif	B-X
,	B-X
which	B-X
contains	B-X
an	B-X
essential	B-X
Phe	B-X
followed	B-X
by	B-X
four	B-X
alternating	B-X
acidic	B-X
and	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acids	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
severely	B-X
inhibited	B-X
by	B-X
mutation	B-X
of	B-X
PRAS40	B-X
(	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
to	B-X
Ala	B-X
)	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
also	B-X
abolished	B-X
by	B-X
mutation	B-X
of	B-X
the	B-X
major	B-X
mTORC1	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
,	B-X
to	B-X
Asp	B-X
.	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
was	B-X
phosphorylated	B-X
in	B-X
intact	B-X
cells	B-X
;	B-X
this	B-X
phosphorylation	B-X
was	B-X
inhibited	B-X
by	B-X
rapamycin	B-X
,	B-X
by	B-X
2-deoxyglucose	B-X
,	B-X
and	B-X
by	B-X
overexpression	B-X
of	B-X
the	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
heterodimer	B-X
.	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
phosphorylation	B-X
was	B-X
also	B-X
inhibited	B-X
reversibly	B-X
by	B-X
withdrawal	B-X
of	B-X
all	B-X
or	B-X
of	B-X
only	B-X
the	B-X
branched	B-X
chain	B-X
amino	B-X
acids	B-X
;	B-X
this	B-X
inhibition	B-X
was	B-X
reversed	B-X
by	B-X
overexpression	B-X
of	B-X
the	B-X
Rheb	B-X
GTPase	B-X
.	B-X
Overexpressed	B-X
PRAS40	B-X
suppressed	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
at	B-X
their	B-X
rapamycin-sensitive	B-X
phosphorylation	B-X
sites	B-X
,	B-X
and	B-X
reciprocally	B-X
,	B-X
overexpression	B-X
of	B-X
S6K1	B-X
or	B-X
4E-BP1	B-X
suppressed	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
and	B-X
its	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
RNA	B-X
interference-induced	B-X
depletion	B-X
of	B-X
PRAS40	B-X
enhanced	B-X
the	B-X
amino	B-X
acid-stimulated	B-X
phosphorylation	B-X
of	B-X
both	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
.	B-X
These	B-X
results	B-X
establish	B-X
PRAS40	B-X
as	B-X
a	B-X
physiological	B-X
mTORC1	B-X
substrate	B-X
that	B-X
contains	B-X
a	B-X
variant	B-X
TOS	B-X
motif	B-X
.	B-X
Moreover	B-X
,	B-X
they	B-X
indicate	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
raptor	B-X
to	B-X
bind	B-X
endogenous	B-X
substrates	B-X
is	B-X
limiting	B-X
for	B-X
the	B-X
activity	B-X
of	B-X
mTORC1	B-X
in	B-X
vivo	B-X
and	B-X
is	B-X
therefore	B-X
a	B-X
potential	B-X
locus	B-X
of	B-X
regulation	B-X
.	B-X

PRAS40	B-Gene_or_gene_product
(	O
Ser	O
(	O
183	O
)	O
)	O
was	O
phosphorylated	O
in	O
intact	O
cells	O
;	O
this	O
phosphorylation	O
was	O
inhibited	O
by	O
rapamycin	O
,	O
by	O
2	O
-	O
deoxyglucose	O
,	O
and	O
by	O
overexpression	O
of	O
the	O
tuberous	O
sclerosis	O
complex	O
heterodimer	O
.	O

PRAS40	B-Gene_or_gene_product
(	O
Ser	O
(	O
183	O
)	O
)	O
phosphorylation	O
was	O
also	O
inhibited	O
reversibly	O
by	O
withdrawal	O
of	O
all	O
or	O
of	O
only	O
the	O
branched	O
chain	O
amino	O
acids	O
;	O
this	O
inhibition	O
was	O
reversed	O
by	O
overexpression	O
of	O
the	O
Rheb	B-Gene_or_gene_product
GTPase	O
.	O
<EOS>	B-X
Branched	B-X
chain	B-X
amino	B-X
acids	B-X
(	B-X
BCAAs	B-X
)	B-X
,	B-X
including	B-X
leucine	B-X
(	B-X
Leu	B-X
)	B-X
,	B-X
isoleucine	B-X
(	B-X
Ile	B-X
)	B-X
,	B-X
and	B-X
valine	B-X
(	B-X
Val	B-X
)	B-X
,	B-X
play	B-X
critical	B-X
roles	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
energy	B-X
homeostasis	B-X
,	B-X
nutrition	B-X
metabolism	B-X
,	B-X
gut	B-X
health	B-X
,	B-X
immunity	B-X
and	B-X
disease	B-X
in	B-X
humans	B-X
and	B-X
animals	B-X
.	B-X
As	B-X
the	B-X
most	B-X
abundant	B-X
of	B-X
essential	B-X
amino	B-X
acids	B-X
(	B-X
EAAs	B-X
)	B-X
,	B-X
BCAAs	B-X
are	B-X
not	B-X
only	B-X
the	B-X
substrates	B-X
for	B-X
synthesis	B-X
of	B-X
nitrogenous	B-X
compounds	B-X
,	B-X
they	B-X
also	B-X
serve	B-X
as	B-X
signaling	B-X
molecules	B-X
regulating	B-X
metabolism	B-X
of	B-X
glucose	B-X
,	B-X
lipid	B-X
,	B-X
and	B-X
protein	B-X
synthesis	B-X
,	B-X
intestinal	B-X
health	B-X
,	B-X
and	B-X
immunity	B-X
via	B-X
special	B-X
signaling	B-X
network	B-X
,	B-X
especially	B-X
phosphoinositide	B-X
3-kinase/protein	B-X
kinase	B-X
B/mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
PI3K/AKT/mTOR	B-X
)	B-X
signal	B-X
pathway	B-X
.	B-X
The	B-X
branched	B-X
chain	B-X
amino	B-X
acids	B-X
(	B-X
BCAAs	B-X
)	B-X
are	B-X
leucine	B-X
,	B-X
valine	B-X
and	B-X
isoleucine	B-X
.	B-X
A	B-X
deficiency	B-X
of	B-X
dietary	B-X
protein	B-X
or	B-X
amino	B-X
acids	B-X
has	B-X
long	B-X
been	B-X
known	B-X
to	B-X
impair	B-X
immune	B-X
function	B-X
and	B-X
increase	B-X
the	B-X
susceptibility	B-X
of	B-X
animals	B-X
and	B-X
humans	B-X
to	B-X
infectious	B-X
disease	B-X
.	B-X
Protein	B-X
malnutrition	B-X
reduces	B-X
concentrations	B-X
of	B-X
most	B-X
amino	B-X
acids	B-X
in	B-X
plasma	B-X
.	B-X
Findings	B-X
from	B-X
recent	B-X
studies	B-X
indicate	B-X
an	B-X
important	B-X
role	B-X
for	B-X
amino	B-X
acids	B-X
in	B-X
immune	B-X
responses	B-X
by	B-X
regulating	B-X
:	B-X
(	B-X
1	B-X
)	B-X
the	B-X
activation	B-X
of	B-X
T	B-X
lymphocytes	B-X
,	B-X
B	B-X
lymphocytes	B-X
,	B-X
natural	B-X
killer	B-X
cells	B-X
and	B-X
macrophages	B-X
;	B-X
(	B-X
2	B-X
)	B-X
cellular	B-X
redox	B-X
state	B-X
,	B-X
gene	B-X
expression	B-X
and	B-X
lymphocyte	B-X
proliferation	B-X
;	B-X
and	B-X
(	B-X
3	B-X
)	B-X
the	B-X
production	B-X
of	B-X
antibodies	B-X
,	B-X
cytokines	B-X
and	B-X
other	B-X
cytotoxic	B-X
substances	B-X
.	B-X
Increasing	B-X
evidence	B-X
shows	B-X
that	B-X
dietary	B-X
supplementation	B-X
of	B-X
specific	B-X
amino	B-X
acids	B-X
to	B-X
animals	B-X
and	B-X
humans	B-X
with	B-X
malnutrition	B-X
and	B-X
infectious	B-X
disease	B-X
enhances	B-X
the	B-X
immune	B-X
status	B-X
,	B-X
thereby	B-X
reducing	B-X
morbidity	B-X
and	B-X
mortality	B-X
.	B-X
Because	B-X
of	B-X
a	B-X
negative	B-X
impact	B-X
of	B-X
imbalance	B-X
and	B-X
antagonism	B-X
among	B-X
amino	B-X
acids	B-X
on	B-X
nutrient	B-X
intake	B-X
and	B-X
utilisation	B-X
,	B-X
care	B-X
should	B-X
be	B-X
exercised	B-X
in	B-X
developing	B-X
effective	B-X
strategies	B-X
of	B-X
enteral	B-X
or	B-X
parenteral	B-X
provision	B-X
for	B-X
maximum	B-X
health	B-X
benefits	B-X
.	B-X
Such	B-X
measures	B-X
should	B-X
be	B-X
based	B-X
on	B-X
knowledge	B-X
about	B-X
the	B-X
biochemistry	B-X
and	B-X
physiology	B-X
of	B-X
amino	B-X
acids	B-X
,	B-X
their	B-X
roles	B-X
in	B-X
immune	B-X
responses	B-X
,	B-X
nutritional	B-X
and	B-X
pathological	B-X
states	B-X
of	B-X
individuals	B-X
and	B-X
expected	B-X
treatment	B-X
outcomes	B-X
.	B-X
New	B-X
knowledge	B-X
about	B-X
the	B-X
metabolism	B-X
of	B-X
amino	B-X
acids	B-X
in	B-X
leucocytes	B-X
is	B-X
critical	B-X
for	B-X
the	B-X
development	B-X
of	B-X
effective	B-X
means	B-X
to	B-X
prevent	B-X
and	B-X
treat	B-X
immunodeficient	B-X
diseases	B-X
.	B-X

Overexpressed	O
PRAS40	B-Gene_or_gene_product
suppressed	O
the	O
phosphorylation	O
of	O
S6K1	B-Gene_or_gene_product
and	O
4E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
BP1	I-Gene_or_gene_product
at	O
their	O
rapamycin	O
-	O
sensitive	O
phosphorylation	O
sites	O
,	O
and	O
reciprocally	O
,	O
overexpression	O
of	O
S6K1	B-Gene_or_gene_product
or	O
4E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
BP1	I-Gene_or_gene_product
suppressed	O
phosphorylation	O
of	O
PRAS40	B-Gene_or_gene_product
(	O
Ser	O
(	O
183	O
)	O
)	O
and	O
its	O
binding	O
to	O
raptor	B-Gene_or_gene_product
.	O

RNA	O
interference	O
-	O
induced	O
depletion	O
of	O
PRAS40	B-Gene_or_gene_product
enhanced	O
the	O
amino	O
acid	O
-	O
stimulated	O
phosphorylation	O
of	O
both	O
S6K1	B-Gene_or_gene_product
and	O
4E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
BP1	I-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kilodaltons	B-X
(	B-X
PRAS40	B-X
)	B-X
was	B-X
identified	B-X
as	B-X
a	B-X
raptor-binding	B-X
protein	B-X
that	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
but	B-X
not	B-X
mTORC2	B-X
in	B-X
vitro	B-X
,	B-X
predominantly	B-X
at	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
to	B-X
raptor	B-X
requires	B-X
a	B-X
TOR	B-X
signaling	B-X
(	B-X
TOS	B-X
)	B-X
motif	B-X
,	B-X
which	B-X
contains	B-X
an	B-X
essential	B-X
Phe	B-X
followed	B-X
by	B-X
four	B-X
alternating	B-X
acidic	B-X
and	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acids	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
severely	B-X
inhibited	B-X
by	B-X
mutation	B-X
of	B-X
PRAS40	B-X
(	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
to	B-X
Ala	B-X
)	B-X
.	B-X
Immediately	B-X
carboxyl-terminal	B-X
to	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
are	B-X
two	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acid	B-X
followed	B-X
by	B-X
two	B-X
acidic	B-X
residues	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
also	B-X
abolished	B-X
by	B-X
mutation	B-X
of	B-X
the	B-X
major	B-X
mTORC1	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
,	B-X
to	B-X
Asp	B-X
.	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
was	B-X
phosphorylated	B-X
in	B-X
intact	B-X
cells	B-X
;	B-X
this	B-X
phosphorylation	B-X
was	B-X
inhibited	B-X
by	B-X
rapamycin	B-X
,	B-X
by	B-X
2-deoxyglucose	B-X
,	B-X
and	B-X
by	B-X
overexpression	B-X
of	B-X
the	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
heterodimer	B-X
.	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
phosphorylation	B-X
was	B-X
also	B-X
inhibited	B-X
reversibly	B-X
by	B-X
withdrawal	B-X
of	B-X
all	B-X
or	B-X
of	B-X
only	B-X
the	B-X
branched	B-X
chain	B-X
amino	B-X
acids	B-X
;	B-X
this	B-X
inhibition	B-X
was	B-X
reversed	B-X
by	B-X
overexpression	B-X
of	B-X
the	B-X
Rheb	B-X
GTPase	B-X
.	B-X
Overexpressed	B-X
PRAS40	B-X
suppressed	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
at	B-X
their	B-X
rapamycin-sensitive	B-X
phosphorylation	B-X
sites	B-X
,	B-X
and	B-X
reciprocally	B-X
,	B-X
overexpression	B-X
of	B-X
S6K1	B-X
or	B-X
4E-BP1	B-X
suppressed	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
and	B-X
its	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
RNA	B-X
interference-induced	B-X
depletion	B-X
of	B-X
PRAS40	B-X
enhanced	B-X
the	B-X
amino	B-X
acid-stimulated	B-X
phosphorylation	B-X
of	B-X
both	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
.	B-X
These	B-X
results	B-X
establish	B-X
PRAS40	B-X
as	B-X
a	B-X
physiological	B-X
mTORC1	B-X
substrate	B-X
that	B-X
contains	B-X
a	B-X
variant	B-X
TOS	B-X
motif	B-X
.	B-X

These	O
results	O
establish	O
PRAS40	B-Gene_or_gene_product
as	O
a	O
physiological	O
mTORC1	O
substrate	O
that	O
contains	O
a	O
variant	O
TOS	O
motif	O
.	O
<EOS>	B-X
The	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kilodaltons	B-X
(	B-X
PRAS40	B-X
)	B-X
was	B-X
identified	B-X
as	B-X
a	B-X
raptor-binding	B-X
protein	B-X
that	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
but	B-X
not	B-X
mTORC2	B-X
in	B-X
vitro	B-X
,	B-X
predominantly	B-X
at	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
to	B-X
raptor	B-X
requires	B-X
a	B-X
TOR	B-X
signaling	B-X
(	B-X
TOS	B-X
)	B-X
motif	B-X
,	B-X
which	B-X
contains	B-X
an	B-X
essential	B-X
Phe	B-X
followed	B-X
by	B-X
four	B-X
alternating	B-X
acidic	B-X
and	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acids	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
severely	B-X
inhibited	B-X
by	B-X
mutation	B-X
of	B-X
PRAS40	B-X
(	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
to	B-X
Ala	B-X
)	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
also	B-X
abolished	B-X
by	B-X
mutation	B-X
of	B-X
the	B-X
major	B-X
mTORC1	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
,	B-X
to	B-X
Asp	B-X
.	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
was	B-X
phosphorylated	B-X
in	B-X
intact	B-X
cells	B-X
;	B-X
this	B-X
phosphorylation	B-X
was	B-X
inhibited	B-X
by	B-X
rapamycin	B-X
,	B-X
by	B-X
2-deoxyglucose	B-X
,	B-X
and	B-X
by	B-X
overexpression	B-X
of	B-X
the	B-X
tuberous	B-X
sclerosis	B-X
complex	B-X
heterodimer	B-X
.	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
phosphorylation	B-X
was	B-X
also	B-X
inhibited	B-X
reversibly	B-X
by	B-X
withdrawal	B-X
of	B-X
all	B-X
or	B-X
of	B-X
only	B-X
the	B-X
branched	B-X
chain	B-X
amino	B-X
acids	B-X
;	B-X
this	B-X
inhibition	B-X
was	B-X
reversed	B-X
by	B-X
overexpression	B-X
of	B-X
the	B-X
Rheb	B-X
GTPase	B-X
.	B-X
Overexpressed	B-X
PRAS40	B-X
suppressed	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
at	B-X
their	B-X
rapamycin-sensitive	B-X
phosphorylation	B-X
sites	B-X
,	B-X
and	B-X
reciprocally	B-X
,	B-X
overexpression	B-X
of	B-X
S6K1	B-X
or	B-X
4E-BP1	B-X
suppressed	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
and	B-X
its	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
RNA	B-X
interference-induced	B-X
depletion	B-X
of	B-X
PRAS40	B-X
enhanced	B-X
the	B-X
amino	B-X
acid-stimulated	B-X
phosphorylation	B-X
of	B-X
both	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
.	B-X
These	B-X
results	B-X
establish	B-X
PRAS40	B-X
as	B-X
a	B-X
physiological	B-X
mTORC1	B-X
substrate	B-X
that	B-X
contains	B-X
a	B-X
variant	B-X
TOS	B-X
motif	B-X
.	B-X
Moreover	B-X
,	B-X
they	B-X
indicate	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
raptor	B-X
to	B-X
bind	B-X
endogenous	B-X
substrates	B-X
is	B-X
limiting	B-X
for	B-X
the	B-X
activity	B-X
of	B-X
mTORC1	B-X
in	B-X
vivo	B-X
and	B-X
is	B-X
therefore	B-X
a	B-X
potential	B-X
locus	B-X
of	B-X
regulation	B-X
.	B-X

Moreover	O
,	O
they	O
indicate	O
that	O
the	O
ability	O
of	O
raptor	B-Gene_or_gene_product
to	O
bind	O
endogenous	O
substrates	O
is	O
limiting	O
for	O
the	O
activity	O
of	O
mTORC1	O
in	O
vivo	O
and	O
is	O
therefore	O
a	O
potential	O
locus	O
of	O
regulation	O
.	O
<EOS>	B-X
The	B-X
proline-rich	B-X
Akt	B-X
substrate	B-X
of	B-X
40	B-X
kilodaltons	B-X
(	B-X
PRAS40	B-X
)	B-X
was	B-X
identified	B-X
as	B-X
a	B-X
raptor-binding	B-X
protein	B-X
that	B-X
is	B-X
phosphorylated	B-X
directly	B-X
by	B-X
mammalian	B-X
target	B-X
of	B-X
rapamycin	B-X
(	B-X
mTOR	B-X
)	B-X
complex	B-X
1	B-X
(	B-X
mTORC1	B-X
)	B-X
but	B-X
not	B-X
mTORC2	B-X
in	B-X
vitro	B-X
,	B-X
predominantly	B-X
at	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
to	B-X
raptor	B-X
requires	B-X
a	B-X
TOR	B-X
signaling	B-X
(	B-X
TOS	B-X
)	B-X
motif	B-X
,	B-X
which	B-X
contains	B-X
an	B-X
essential	B-X
Phe	B-X
followed	B-X
by	B-X
four	B-X
alternating	B-X
acidic	B-X
and	B-X
small	B-X
hydrophobic	B-X
amino	B-X
acids	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
severely	B-X
inhibited	B-X
by	B-X
mutation	B-X
of	B-X
PRAS40	B-X
(	B-X
Phe	B-X
(	B-X
129	B-X
)	B-X
to	B-X
Ala	B-X
)	B-X
.	B-X
PRAS40	B-X
binding	B-X
to	B-X
raptor	B-X
was	B-X
also	B-X
abolished	B-X
by	B-X
mutation	B-X
of	B-X
the	B-X
major	B-X
mTORC1	B-X
phosphorylation	B-X
site	B-X
,	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
,	B-X
to	B-X
Asp	B-X
.	B-X
Overexpressed	B-X
PRAS40	B-X
suppressed	B-X
the	B-X
phosphorylation	B-X
of	B-X
S6K1	B-X
and	B-X
4E-BP1	B-X
at	B-X
their	B-X
rapamycin-sensitive	B-X
phosphorylation	B-X
sites	B-X
,	B-X
and	B-X
reciprocally	B-X
,	B-X
overexpression	B-X
of	B-X
S6K1	B-X
or	B-X
4E-BP1	B-X
suppressed	B-X
phosphorylation	B-X
of	B-X
PRAS40	B-X
(	B-X
Ser	B-X
(	B-X
183	B-X
)	B-X
)	B-X
and	B-X
its	B-X
binding	B-X
to	B-X
raptor	B-X
.	B-X
These	B-X
results	B-X
establish	B-X
PRAS40	B-X
as	B-X
a	B-X
physiological	B-X
mTORC1	B-X
substrate	B-X
that	B-X
contains	B-X
a	B-X
variant	B-X
TOS	B-X
motif	B-X
.	B-X
Moreover	B-X
,	B-X
they	B-X
indicate	B-X
that	B-X
the	B-X
ability	B-X
of	B-X
raptor	B-X
to	B-X
bind	B-X
endogenous	B-X
substrates	B-X
is	B-X
limiting	B-X
for	B-X
the	B-X
activity	B-X
of	B-X
mTORC1	B-X
in	B-X
vivo	B-X
and	B-X
is	B-X
therefore	B-X
a	B-X
potential	B-X
locus	B-X
of	B-X
regulation	B-X
.	B-X

MDM2	B-Gene_or_gene_product
mRNA	O
expression	O
in	O
the	O
p53	B-Gene_or_gene_product
pathway	O
may	O
predict	O
the	O
potential	O
of	O
invasion	O
and	O
liver	O
metastasis	O
in	O
colorectal	O
cancer	O
.	O
<EOS>	B-X
The	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
is	B-X
one	B-X
of	B-X
the	B-X
major	B-X
signaling	B-X
cascades	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
apoptosis	B-X
.	B-X
Although	B-X
many	B-X
tumors	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
show	B-X
disruption	B-X
of	B-X
the	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
examined	B-X
p53	B-X
,	B-X
MDM2	B-X
,	B-X
and	B-X
p14ARF	B-X
simultaneously	B-X
in	B-X
colorectal	B-X
carcinoma	B-X
.	B-X
The	B-X
present	B-X
study	B-X
was	B-X
undertaken	B-X
to	B-X
clarify	B-X
whether	B-X
correlations	B-X
exist	B-X
among	B-X
MDM2	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
p14ARF	B-X
in	B-X
colorectal	B-X
cancer	B-X
.	B-X

PURPOSE	O
:	O
The	O
p53	B-Gene_or_gene_product
/	O
MDM2	B-Gene_or_gene_product
/	O
p14ARF	B-Gene_or_gene_product
pathway	O
is	O
one	O
of	O
the	O
major	O
signaling	O
cascades	O
involved	O
in	O
the	O
regulation	O
of	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
is	B-X
one	B-X
of	B-X
the	B-X
major	B-X
signaling	B-X
cascades	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
apoptosis	B-X
.	B-X
Although	B-X
many	B-X
tumors	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
show	B-X
disruption	B-X
of	B-X
the	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
examined	B-X
p53	B-X
,	B-X
MDM2	B-X
,	B-X
and	B-X
p14ARF	B-X
simultaneously	B-X
in	B-X
colorectal	B-X
carcinoma	B-X
.	B-X
The	B-X
present	B-X
study	B-X
was	B-X
undertaken	B-X
to	B-X
clarify	B-X
whether	B-X
correlations	B-X
exist	B-X
among	B-X
MDM2	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
p14ARF	B-X
in	B-X
colorectal	B-X
cancer	B-X
.	B-X

Although	O
many	O
tumors	O
have	O
been	O
reported	O
to	O
show	O
disruption	O
of	O
the	O
p53	B-Gene_or_gene_product
/	O
MDM2	B-Gene_or_gene_product
/	O
p14ARF	B-Gene_or_gene_product
pathway	O
,	O
few	O
studies	O
have	O
examined	O
p53	B-Gene_or_gene_product
,	O
MDM2	B-Gene_or_gene_product
,	O
and	O
p14ARF	B-Gene_or_gene_product
simultaneously	O
in	O
colorectal	O
carcinoma	O
.	O
<EOS>	B-X
The	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
is	B-X
one	B-X
of	B-X
the	B-X
major	B-X
signaling	B-X
cascades	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
apoptosis	B-X
.	B-X
Although	B-X
many	B-X
tumors	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
show	B-X
disruption	B-X
of	B-X
the	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
examined	B-X
p53	B-X
,	B-X
MDM2	B-X
,	B-X
and	B-X
p14ARF	B-X
simultaneously	B-X
in	B-X
colorectal	B-X
carcinoma	B-X
.	B-X
The	B-X
present	B-X
study	B-X
was	B-X
undertaken	B-X
to	B-X
clarify	B-X
whether	B-X
correlations	B-X
exist	B-X
among	B-X
MDM2	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
p14ARF	B-X
in	B-X
colorectal	B-X
cancer	B-X
.	B-X

The	O
present	O
study	O
was	O
undertaken	O
to	O
clarify	O
whether	O
correlations	O
exist	O
among	O
MDM2	B-Gene_or_gene_product
,	O
p53	B-Gene_or_gene_product
,	O
and	O
p14ARF	B-Gene_or_gene_product
in	O
colorectal	O
cancer	O
.	O
<EOS>	B-X
The	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
is	B-X
one	B-X
of	B-X
the	B-X
major	B-X
signaling	B-X
cascades	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
apoptosis	B-X
.	B-X
Although	B-X
many	B-X
tumors	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
show	B-X
disruption	B-X
of	B-X
the	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
examined	B-X
p53	B-X
,	B-X
MDM2	B-X
,	B-X
and	B-X
p14ARF	B-X
simultaneously	B-X
in	B-X
colorectal	B-X
carcinoma	B-X
.	B-X
The	B-X
present	B-X
study	B-X
was	B-X
undertaken	B-X
to	B-X
clarify	B-X
whether	B-X
correlations	B-X
exist	B-X
among	B-X
MDM2	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
p14ARF	B-X
in	B-X
colorectal	B-X
cancer	B-X
.	B-X

METHODS	O
:	O
We	O
determined	O
the	O
presence	O
of	O
mutations	O
in	O
the	O
p53	B-Gene_or_gene_product
gene	O
,	O
MDM2	B-Gene_or_gene_product
expression	O
,	O
and	O
methylation	O
status	O
of	O
the	O
p14ARF	B-Gene_or_gene_product
in	O
97	O
primary	O
colorectal	O
carcinoma	O
specimens	O
.	O
<EOS>	B-X
The	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
is	B-X
one	B-X
of	B-X
the	B-X
major	B-X
signaling	B-X
cascades	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
apoptosis	B-X
.	B-X
Although	B-X
many	B-X
tumors	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
show	B-X
disruption	B-X
of	B-X
the	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
examined	B-X
p53	B-X
,	B-X
MDM2	B-X
,	B-X
and	B-X
p14ARF	B-X
simultaneously	B-X
in	B-X
colorectal	B-X
carcinoma	B-X
.	B-X
The	B-X
present	B-X
study	B-X
was	B-X
undertaken	B-X
to	B-X
clarify	B-X
whether	B-X
correlations	B-X
exist	B-X
among	B-X
MDM2	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
p14ARF	B-X
in	B-X
colorectal	B-X
cancer	B-X
.	B-X

Associations	O
with	O
survival	O
and	O
clinicopathologic	O
factors	O
were	O
investigated	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
quantify	B-X
the	B-X
effect	B-X
of	B-X
NLR	B-X
on	B-X
survival	B-X
in	B-X
patients	B-X
with	B-X
breast	B-X
cancer	B-X
,	B-X
and	B-X
examine	B-X
the	B-X
effect	B-X
of	B-X
clinicopathologic	B-X
factors	B-X
on	B-X
its	B-X
prognostic	B-X
value	B-X
.	B-X
The	B-X
diagnostic	B-X
and	B-X
prognostic	B-X
significance	B-X
of	B-X
carcinoembryonic	B-X
antigen	B-X
(	B-X
CEA	B-X
)	B-X
,	B-X
carbohydrate	B-X
associated	B-X
antigen	B-X
19-9	B-X
(	B-X
CA19-9	B-X
)	B-X
,	B-X
alpha-fetoprotein	B-X
(	B-X
AFP	B-X
)	B-X
and	B-X
cancer	B-X
antigen	B-X
125	B-X
(	B-X
CA125	B-X
)	B-X
in	B-X
early	B-X
gastric	B-X
cancer	B-X
have	B-X
not	B-X
been	B-X
investigated	B-X
yet	B-X
.	B-X
In	B-X
this	B-X
study	B-X
,	B-X
we	B-X
investigated	B-X
the	B-X
association	B-X
between	B-X
the	B-X
extent	B-X
of	B-X
STAS	B-X
and	B-X
clinicopathological	B-X
characteristics	B-X
and	B-X
patient	B-X
outcomes	B-X
in	B-X
resected	B-X
non-small	B-X
cell	B-X
lung	B-X
cancers	B-X
(	B-X
NSCLCs	B-X
)	B-X
.	B-X
We	B-X
retrospectively	B-X
analyzed	B-X
the	B-X
correlations	B-X
between	B-X
the	B-X
extent	B-X
of	B-X
STAS	B-X
and	B-X
clinicopathologic	B-X
characteristics	B-X
and	B-X
prognostic	B-X
significance	B-X
in	B-X
1869	B-X
resected	B-X
NSCLCs	B-X
.	B-X
In	B-X
ADC	B-X
,	B-X
there	B-X
were	B-X
significant	B-X
differences	B-X
in	B-X
recurrence	B-X
free	B-X
survival	B-X
(	B-X
RFS	B-X
)	B-X
,	B-X
overall	B-X
survival	B-X
(	B-X
OS	B-X
)	B-X
,	B-X
and	B-X
lung	B-X
cancer	B-X
specific	B-X
survival	B-X
(	B-X
LCSS	B-X
)	B-X
according	B-X
to	B-X
the	B-X
extent	B-X
of	B-X
STAS	B-X
.	B-X

RESULTS	O
:	O
At	O
least	O
one	O
abnormality	O
of	O
these	O
three	O
molecules	O
was	O
found	O
in	O
82	O
(	O
84	O
percent	O
)	O
tumors	O
.	O
<EOS>	B-X
The	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
is	B-X
one	B-X
of	B-X
the	B-X
major	B-X
signaling	B-X
cascades	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
apoptosis	B-X
.	B-X
Although	B-X
many	B-X
tumors	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
show	B-X
disruption	B-X
of	B-X
the	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
examined	B-X
p53	B-X
,	B-X
MDM2	B-X
,	B-X
and	B-X
p14ARF	B-X
simultaneously	B-X
in	B-X
colorectal	B-X
carcinoma	B-X
.	B-X

We	O
observed	O
a	O
significant	O
inverse	O
association	O
between	O
MDM2	B-Gene_or_gene_product
expression	O
and	O
tumor	O
invasion	O
(	O
P	O
=	O
0	O
.	O
01	O
)	O
.	O

Furthermore	O
,	O
the	O
presence	O
of	O
liver	O
metastasis	O
was	O
also	O
significantly	O
associated	O
with	O
low	O
MDM2	B-Gene_or_gene_product
expression	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
.	O

CONCLUSIONS	O
:	O
The	O
results	O
suggest	O
that	O
disruption	O
of	O
the	O
p53	B-Gene_or_gene_product
/	O
MDM2	B-Gene_or_gene_product
/	O
p14ARF	B-Gene_or_gene_product
pathway	O
may	O
frequently	O
participate	O
in	O
colonic	O
carcinogenesis	O
and	O
that	O
MDM2	B-Gene_or_gene_product
expression	O
status	O
may	O
be	O
a	O
factor	O
in	O
the	O
prediction	O
of	O
potential	O
invasion	O
and	O
liver	O
metastasis	O
of	O
colorectal	O
carcinomas	O
.	O
<EOS>	B-X
The	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
is	B-X
one	B-X
of	B-X
the	B-X
major	B-X
signaling	B-X
cascades	B-X
involved	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
apoptosis	B-X
.	B-X
Although	B-X
many	B-X
tumors	B-X
have	B-X
been	B-X
reported	B-X
to	B-X
show	B-X
disruption	B-X
of	B-X
the	B-X
p53/MDM2/p14ARF	B-X
pathway	B-X
,	B-X
few	B-X
studies	B-X
have	B-X
examined	B-X
p53	B-X
,	B-X
MDM2	B-X
,	B-X
and	B-X
p14ARF	B-X
simultaneously	B-X
in	B-X
colorectal	B-X
carcinoma	B-X
.	B-X
The	B-X
present	B-X
study	B-X
was	B-X
undertaken	B-X
to	B-X
clarify	B-X
whether	B-X
correlations	B-X
exist	B-X
among	B-X
MDM2	B-X
,	B-X
p53	B-X
,	B-X
and	B-X
p14ARF	B-X
in	B-X
colorectal	B-X
cancer	B-X
.	B-X

Eco1	B-Gene_or_gene_product
-	O
dependent	O
cohesin	O
acetylation	O
during	O
establishment	O
of	O
sister	O
chromatid	O
cohesion	O
.	O
<EOS>	B-X
Replicated	B-X
chromosomes	B-X
are	B-X
held	B-X
together	B-X
by	B-X
the	B-X
chromosomal	B-X
cohesin	B-X
complex	B-X
from	B-X
the	B-X
time	B-X
of	B-X
their	B-X
synthesis	B-X
in	B-X
S	B-X
phase	B-X
onward	B-X
.	B-X
This	B-X
requires	B-X
the	B-X
replication	B-X
fork-associated	B-X
acetyl	B-X
transferase	B-X
Eco1	B-X
,	B-X
but	B-X
Eco1	B-X
's	B-X
mechanism	B-X
of	B-X
action	B-X
is	B-X
not	B-X
known	B-X
.	B-X
An	B-X
acetylation-mimicking	B-X
mutation	B-X
of	B-X
a	B-X
conserved	B-X
lysine	B-X
in	B-X
cohesin	B-X
's	B-X
Smc3	B-X
subunit	B-X
makes	B-X
Eco1	B-X
dispensable	B-X
for	B-X
cell	B-X
growth	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
Smc3	B-X
is	B-X
acetylated	B-X
in	B-X
an	B-X
Eco1-dependent	B-X
manner	B-X
during	B-X
DNA	B-X
replication	B-X
to	B-X
promote	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
.	B-X
A	B-X
second	B-X
set	B-X
of	B-X
eco1-1	B-X
suppressors	B-X
inactivate	B-X
the	B-X
budding	B-X
yeast	B-X
ortholog	B-X
of	B-X
the	B-X
cohesin	B-X
destabilizer	B-X
Wapl	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
Eco1	B-X
modifies	B-X
cohesin	B-X
to	B-X
stabilize	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
in	B-X
parallel	B-X
with	B-X
a	B-X
cohesion	B-X
establishment	B-X
reaction	B-X
that	B-X
is	B-X
in	B-X
principle	B-X
Eco1-independent	B-X
.	B-X

Replicated	O
chromosomes	O
are	O
held	O
together	O
by	O
the	O
chromosomal	O
cohesin	O
complex	O
from	O
the	O
time	O
of	O
their	O
synthesis	O
in	O
S	O
phase	O
onward	O
.	O

This	O
requires	O
the	O
replication	O
fork	O
-	O
associated	O
acetyl	O
transferase	O
Eco1	B-Gene_or_gene_product
,	O
but	O
Eco1	B-Gene_or_gene_product
'	O
s	O
mechanism	O
of	O
action	O
is	O
not	O
known	O
.	O
<EOS>	B-X
Cohesin	B-X
not	B-X
only	B-X
links	B-X
sister	B-X
chromatids	B-X
but	B-X
also	B-X
inhibits	B-X
the	B-X
transcriptional	B-X
machinery	B-X
's	B-X
interaction	B-X
with	B-X
and	B-X
movement	B-X
along	B-X
chromatin	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
replication	B-X
forks	B-X
must	B-X
traverse	B-X
such	B-X
cohesin-associated	B-X
obstructions	B-X
to	B-X
duplicate	B-X
the	B-X
entire	B-X
genome	B-X
in	B-X
S	B-X
phase	B-X
.	B-X
How	B-X
this	B-X
occurs	B-X
is	B-X
unknown	B-X
.	B-X
Through	B-X
single-molecule	B-X
analysis	B-X
,	B-X
we	B-X
demonstrate	B-X
that	B-X
the	B-X
replication	B-X
factor	B-X
C	B-X
(	B-X
RFC	B-X
)	B-X
-CTF18	B-X
clamp	B-X
loader	B-X
(	B-X
RFC	B-X
(	B-X
CTF18	B-X
)	B-X
)	B-X
controls	B-X
the	B-X
velocity	B-X
,	B-X
spacing	B-X
and	B-X
restart	B-X
activity	B-X
of	B-X
replication	B-X
forks	B-X
in	B-X
human	B-X
cells	B-X
and	B-X
is	B-X
required	B-X
for	B-X
robust	B-X
acetylation	B-X
of	B-X
cohesin	B-X
's	B-X
SMC3	B-X
subunit	B-X
and	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
.	B-X
Unexpectedly	B-X
,	B-X
we	B-X
discovered	B-X
that	B-X
cohesin	B-X
acetylation	B-X
itself	B-X
is	B-X
a	B-X
central	B-X
determinant	B-X
of	B-X
fork	B-X
processivity	B-X
,	B-X
as	B-X
slow-moving	B-X
replication	B-X
forks	B-X
were	B-X
found	B-X
in	B-X
cells	B-X
lacking	B-X
the	B-X
Eco1-related	B-X
acetyltransferases	B-X
ESCO1	B-X
or	B-X
ESCO2	B-X
(	B-X
refs	B-X
8-10	B-X
)	B-X
(	B-X
including	B-X
those	B-X
derived	B-X
from	B-X
Roberts	B-X
'	B-X
syndrome	B-X
patients	B-X
,	B-X
in	B-X
whom	B-X
ESCO2	B-X
is	B-X
biallelically	B-X
mutated	B-X
)	B-X
and	B-X
in	B-X
cells	B-X
expressing	B-X
a	B-X
form	B-X
of	B-X
SMC3	B-X
that	B-X
can	B-X
not	B-X
be	B-X
acetylated	B-X
.	B-X
This	B-X
defect	B-X
was	B-X
a	B-X
consequence	B-X
of	B-X
cohesin	B-X
's	B-X
hyperstable	B-X
interaction	B-X
with	B-X
two	B-X
regulatory	B-X
cofactors	B-X
,	B-X
WAPL	B-X
and	B-X
PDS5A	B-X
(	B-X
refs	B-X
12	B-X
,	B-X
13	B-X
)	B-X
;	B-X
removal	B-X
of	B-X
either	B-X
cofactor	B-X
allowed	B-X
forks	B-X
to	B-X
progress	B-X
rapidly	B-X
without	B-X
ESCO1	B-X
,	B-X
ESCO2	B-X
,	B-X
or	B-X
RFC	B-X
(	B-X
CTF18	B-X
)	B-X
.	B-X
Our	B-X
results	B-X
show	B-X
a	B-X
novel	B-X
mechanism	B-X
for	B-X
clamp-loader-dependent	B-X
fork	B-X
progression	B-X
,	B-X
mediated	B-X
by	B-X
the	B-X
post-translational	B-X
modification	B-X
and	B-X
structural	B-X
remodelling	B-X
of	B-X
the	B-X
cohesin	B-X
ring	B-X
.	B-X
Loss	B-X
of	B-X
this	B-X
regulatory	B-X
mechanism	B-X
leads	B-X
to	B-X
the	B-X
spontaneous	B-X
accrual	B-X
of	B-X
DNA	B-X
damage	B-X
and	B-X
may	B-X
contribute	B-X
to	B-X
the	B-X
abnormalities	B-X
of	B-X
the	B-X
Roberts	B-X
'	B-X
syndrome	B-X
cohesinopathy	B-X
.	B-X

We	O
identified	O
spontaneous	O
suppressors	O
of	O
the	O
thermosensitive	O
eco1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
allele	O
in	O
budding	O
yeast	O
.	O
<EOS>	B-X
This	B-X
requires	B-X
the	B-X
replication	B-X
fork-associated	B-X
acetyl	B-X
transferase	B-X
Eco1	B-X
,	B-X
but	B-X
Eco1	B-X
's	B-X
mechanism	B-X
of	B-X
action	B-X
is	B-X
not	B-X
known	B-X
.	B-X
We	B-X
identified	B-X
spontaneous	B-X
suppressors	B-X
of	B-X
the	B-X
thermosensitive	B-X
eco1-1	B-X
allele	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
An	B-X
acetylation-mimicking	B-X
mutation	B-X
of	B-X
a	B-X
conserved	B-X
lysine	B-X
in	B-X
cohesin	B-X
's	B-X
Smc3	B-X
subunit	B-X
makes	B-X
Eco1	B-X
dispensable	B-X
for	B-X
cell	B-X
growth	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
Smc3	B-X
is	B-X
acetylated	B-X
in	B-X
an	B-X
Eco1-dependent	B-X
manner	B-X
during	B-X
DNA	B-X
replication	B-X
to	B-X
promote	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
.	B-X
A	B-X
second	B-X
set	B-X
of	B-X
eco1-1	B-X
suppressors	B-X
inactivate	B-X
the	B-X
budding	B-X
yeast	B-X
ortholog	B-X
of	B-X
the	B-X
cohesin	B-X
destabilizer	B-X
Wapl	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
Eco1	B-X
modifies	B-X
cohesin	B-X
to	B-X
stabilize	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
in	B-X
parallel	B-X
with	B-X
a	B-X
cohesion	B-X
establishment	B-X
reaction	B-X
that	B-X
is	B-X
in	B-X
principle	B-X
Eco1-independent	B-X
.	B-X

An	O
acetylation	O
-	O
mimicking	O
mutation	O
of	O
a	O
conserved	O
lysine	O
in	O
cohesin	O
'	O
s	O
Smc3	B-Gene_or_gene_product
subunit	O
makes	O
Eco1	B-Gene_or_gene_product
dispensable	O
for	O
cell	O
growth	O
,	O
and	O
we	O
show	O
that	O
Smc3	B-Gene_or_gene_product
is	O
acetylated	O
in	O
an	O
Eco1	B-Gene_or_gene_product
-	O
dependent	O
manner	O
during	O
DNA	O
replication	O
to	O
promote	O
sister	O
chromatid	O
cohesion	O
.	O

A	O
second	O
set	O
of	O
eco1	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
suppressors	O
inactivate	O
the	O
budding	O
yeast	O
ortholog	O
of	O
the	O
cohesin	O
destabilizer	O
Wapl	B-Gene_or_gene_product
.	O
<EOS>	B-X
Replicated	B-X
chromosomes	B-X
are	B-X
held	B-X
together	B-X
by	B-X
the	B-X
chromosomal	B-X
cohesin	B-X
complex	B-X
from	B-X
the	B-X
time	B-X
of	B-X
their	B-X
synthesis	B-X
in	B-X
S	B-X
phase	B-X
onward	B-X
.	B-X
This	B-X
requires	B-X
the	B-X
replication	B-X
fork-associated	B-X
acetyl	B-X
transferase	B-X
Eco1	B-X
,	B-X
but	B-X
Eco1	B-X
's	B-X
mechanism	B-X
of	B-X
action	B-X
is	B-X
not	B-X
known	B-X
.	B-X
We	B-X
identified	B-X
spontaneous	B-X
suppressors	B-X
of	B-X
the	B-X
thermosensitive	B-X
eco1-1	B-X
allele	B-X
in	B-X
budding	B-X
yeast	B-X
.	B-X
An	B-X
acetylation-mimicking	B-X
mutation	B-X
of	B-X
a	B-X
conserved	B-X
lysine	B-X
in	B-X
cohesin	B-X
's	B-X
Smc3	B-X
subunit	B-X
makes	B-X
Eco1	B-X
dispensable	B-X
for	B-X
cell	B-X
growth	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
Smc3	B-X
is	B-X
acetylated	B-X
in	B-X
an	B-X
Eco1-dependent	B-X
manner	B-X
during	B-X
DNA	B-X
replication	B-X
to	B-X
promote	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
.	B-X
A	B-X
second	B-X
set	B-X
of	B-X
eco1-1	B-X
suppressors	B-X
inactivate	B-X
the	B-X
budding	B-X
yeast	B-X
ortholog	B-X
of	B-X
the	B-X
cohesin	B-X
destabilizer	B-X
Wapl	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
Eco1	B-X
modifies	B-X
cohesin	B-X
to	B-X
stabilize	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
in	B-X
parallel	B-X
with	B-X
a	B-X
cohesion	B-X
establishment	B-X
reaction	B-X
that	B-X
is	B-X
in	B-X
principle	B-X
Eco1-independent	B-X
.	B-X

Our	O
results	O
indicate	O
that	O
Eco1	B-Gene_or_gene_product
modifies	O
cohesin	O
to	O
stabilize	O
sister	O
chromatid	O
cohesion	O
in	O
parallel	O
with	O
a	O
cohesion	O
establishment	O
reaction	O
that	O
is	O
in	O
principle	O
Eco1	B-Gene_or_gene_product
-	O
independent	O
.	O
<EOS>	B-X
Replicated	B-X
chromosomes	B-X
are	B-X
held	B-X
together	B-X
by	B-X
the	B-X
chromosomal	B-X
cohesin	B-X
complex	B-X
from	B-X
the	B-X
time	B-X
of	B-X
their	B-X
synthesis	B-X
in	B-X
S	B-X
phase	B-X
onward	B-X
.	B-X
This	B-X
requires	B-X
the	B-X
replication	B-X
fork-associated	B-X
acetyl	B-X
transferase	B-X
Eco1	B-X
,	B-X
but	B-X
Eco1	B-X
's	B-X
mechanism	B-X
of	B-X
action	B-X
is	B-X
not	B-X
known	B-X
.	B-X
An	B-X
acetylation-mimicking	B-X
mutation	B-X
of	B-X
a	B-X
conserved	B-X
lysine	B-X
in	B-X
cohesin	B-X
's	B-X
Smc3	B-X
subunit	B-X
makes	B-X
Eco1	B-X
dispensable	B-X
for	B-X
cell	B-X
growth	B-X
,	B-X
and	B-X
we	B-X
show	B-X
that	B-X
Smc3	B-X
is	B-X
acetylated	B-X
in	B-X
an	B-X
Eco1-dependent	B-X
manner	B-X
during	B-X
DNA	B-X
replication	B-X
to	B-X
promote	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
.	B-X
A	B-X
second	B-X
set	B-X
of	B-X
eco1-1	B-X
suppressors	B-X
inactivate	B-X
the	B-X
budding	B-X
yeast	B-X
ortholog	B-X
of	B-X
the	B-X
cohesin	B-X
destabilizer	B-X
Wapl	B-X
.	B-X
Our	B-X
results	B-X
indicate	B-X
that	B-X
Eco1	B-X
modifies	B-X
cohesin	B-X
to	B-X
stabilize	B-X
sister	B-X
chromatid	B-X
cohesion	B-X
in	B-X
parallel	B-X
with	B-X
a	B-X
cohesion	B-X
establishment	B-X
reaction	B-X
that	B-X
is	B-X
in	B-X
principle	B-X
Eco1-independent	B-X
.	B-X

Influence	O
of	O
tetramerisation	O
on	O
site	O
-	O
specific	O
post	O
-	O
translational	O
modifications	O
of	O
p53	B-Gene_or_gene_product
:	O
comparison	O
of	O
human	O
and	O
murine	O
p53	B-Gene_or_gene_product
tumor	O
suppressor	O
protein	O
.	O
<EOS>	B-X
The	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
considered	B-X
the	B-X
``	B-X
Guardian	B-X
of	B-X
the	B-X
Genome	B-X
''	B-X
,	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
and	B-X
mutated	B-X
in	B-X
over	B-X
50	B-X
%	B-X
of	B-X
human	B-X
cancers	B-X
.	B-X
Following	B-X
cellular	B-X
stress	B-X
,	B-X
post-translational	B-X
modifications	B-X
such	B-X
as	B-X
phosphorylation	B-X
and	B-X
acetylation	B-X
stabilise	B-X
and	B-X
activate	B-X
p53	B-X
for	B-X
cell	B-X
cycle	B-X
arrest	B-X
,	B-X
DNA	B-X
repair	B-X
,	B-X
apoptosis	B-X
or	B-X
senescence	B-X
.	B-X
p53	B-X
protein	B-X
functions	B-X
as	B-X
a	B-X
tetramer	B-X
and	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
loss	B-X
of	B-X
tetramerisation	B-X
and	B-X
changes	B-X
at	B-X
the	B-X
N-terminus	B-X
influence	B-X
the	B-X
recovery	B-X
of	B-X
wild	B-X
type	B-X
p53	B-X
'status	B-X
'	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
relationship	B-X
between	B-X
tetramerisation	B-X
and	B-X
post-translational	B-X
modifications	B-X
we	B-X
examined	B-X
a	B-X
range	B-X
of	B-X
site-specific	B-X
modifications	B-X
in	B-X
wild	B-X
type	B-X
and	B-X
dimeric	B-X
mutant	B-X
(	B-X
M340Q/L344R	B-X
)	B-X
murine	B-X
p53	B-X
expressed	B-X
in	B-X
MEFs	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
in	B-X
wild	B-X
type	B-X
,	B-X
monomeric	B-X
(	B-X
L344P	B-X
)	B-X
and	B-X
dimeric	B-X
(	B-X
M340Q/L344R	B-X
)	B-X
human	B-X
p53	B-X
expressed	B-X
in	B-X
HCT116	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
cells	B-X
.	B-X
Using	B-X
site-specific	B-X
antibodies	B-X
we	B-X
demonstrate	B-X
that	B-X
in	B-X
murine	B-X
p53	B-X
,	B-X
S15	B-X
is	B-X
phosphorylated	B-X
in	B-X
a	B-X
tetramerisation-dependent	B-X
manner	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
human	B-X
p53	B-X
S15	B-X
phosphorylation	B-X
is	B-X
not	B-X
tetramerisation-dependent	B-X
.	B-X
Inability	B-X
to	B-X
form	B-X
tetramers	B-X
in	B-X
human	B-X
p53	B-X
proteins	B-X
reduced	B-X
site-specific	B-X
N-terminal	B-X
phosphorylation	B-X
at	B-X
S6	B-X
,	B-X
S9	B-X
and	B-X
S46	B-X
and	B-X
reduced	B-X
C-terminal	B-X
phosphorylation	B-X
and	B-X
acetylation	B-X
at	B-X
S315	B-X
and	B-X
K382	B-X
respectively	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p53	B-X
tetramerisation	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
p21	B-X
and	B-X
hdm2	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
and	B-X
recruitment	B-X
of	B-X
p53	B-X
to	B-X
specific	B-X
promoter	B-X
regions	B-X
of	B-X
p21	B-X
and	B-X
hdm2	B-X
.	B-X

The	O
tumor	O
suppressor	O
protein	O
p53	B-Gene_or_gene_product
is	O
considered	O
the	O
"	O
Guardian	O
of	O
the	O
Genome	O
"	O
,	O
crucial	O
for	O
cell	O
cycle	O
control	O
and	O
mutated	O
in	O
over	O
50	O
%	O
of	O
human	O
cancers	O
.	O
<EOS>	B-X
The	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
considered	B-X
the	B-X
``	B-X
Guardian	B-X
of	B-X
the	B-X
Genome	B-X
''	B-X
,	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
and	B-X
mutated	B-X
in	B-X
over	B-X
50	B-X
%	B-X
of	B-X
human	B-X
cancers	B-X
.	B-X
Following	B-X
cellular	B-X
stress	B-X
,	B-X
post-translational	B-X
modifications	B-X
such	B-X
as	B-X
phosphorylation	B-X
and	B-X
acetylation	B-X
stabilise	B-X
and	B-X
activate	B-X
p53	B-X
for	B-X
cell	B-X
cycle	B-X
arrest	B-X
,	B-X
DNA	B-X
repair	B-X
,	B-X
apoptosis	B-X
or	B-X
senescence	B-X
.	B-X
p53	B-X
protein	B-X
functions	B-X
as	B-X
a	B-X
tetramer	B-X
and	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
loss	B-X
of	B-X
tetramerisation	B-X
and	B-X
changes	B-X
at	B-X
the	B-X
N-terminus	B-X
influence	B-X
the	B-X
recovery	B-X
of	B-X
wild	B-X
type	B-X
p53	B-X
'status	B-X
'	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
relationship	B-X
between	B-X
tetramerisation	B-X
and	B-X
post-translational	B-X
modifications	B-X
we	B-X
examined	B-X
a	B-X
range	B-X
of	B-X
site-specific	B-X
modifications	B-X
in	B-X
wild	B-X
type	B-X
and	B-X
dimeric	B-X
mutant	B-X
(	B-X
M340Q/L344R	B-X
)	B-X
murine	B-X
p53	B-X
expressed	B-X
in	B-X
MEFs	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
in	B-X
wild	B-X
type	B-X
,	B-X
monomeric	B-X
(	B-X
L344P	B-X
)	B-X
and	B-X
dimeric	B-X
(	B-X
M340Q/L344R	B-X
)	B-X
human	B-X
p53	B-X
expressed	B-X
in	B-X
HCT116	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
cells	B-X
.	B-X
Using	B-X
site-specific	B-X
antibodies	B-X
we	B-X
demonstrate	B-X
that	B-X
in	B-X
murine	B-X
p53	B-X
,	B-X
S15	B-X
is	B-X
phosphorylated	B-X
in	B-X
a	B-X
tetramerisation-dependent	B-X
manner	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
human	B-X
p53	B-X
S15	B-X
phosphorylation	B-X
is	B-X
not	B-X
tetramerisation-dependent	B-X
.	B-X
Inability	B-X
to	B-X
form	B-X
tetramers	B-X
in	B-X
human	B-X
p53	B-X
proteins	B-X
reduced	B-X
site-specific	B-X
N-terminal	B-X
phosphorylation	B-X
at	B-X
S6	B-X
,	B-X
S9	B-X
and	B-X
S46	B-X
and	B-X
reduced	B-X
C-terminal	B-X
phosphorylation	B-X
and	B-X
acetylation	B-X
at	B-X
S315	B-X
and	B-X
K382	B-X
respectively	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p53	B-X
tetramerisation	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
p21	B-X
and	B-X
hdm2	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
and	B-X
recruitment	B-X
of	B-X
p53	B-X
to	B-X
specific	B-X
promoter	B-X
regions	B-X
of	B-X
p21	B-X
and	B-X
hdm2	B-X
.	B-X

Following	O
cellular	O
stress	O
,	O
post	O
-	O
translational	O
modifications	O
such	O
as	O
phosphorylation	O
and	O
acetylation	O
stabilise	O
and	O
activate	O
p53	B-Gene_or_gene_product
for	O
cell	O
cycle	O
arrest	O
,	O
DNA	O
repair	O
,	O
apoptosis	O
or	O
senescence	O
.	O
<EOS>	B-X
Cellular	B-X
senescence	B-X
is	B-X
a	B-X
permanent	B-X
state	B-X
of	B-X
cell	B-X
cycle	B-X
arrest	B-X
that	B-X
occurs	B-X
in	B-X
proliferating	B-X
cells	B-X
subjected	B-X
to	B-X
different	B-X
stresses	B-X
.	B-X
Senescence	B-X
is	B-X
,	B-X
therefore	B-X
,	B-X
a	B-X
cellular	B-X
defense	B-X
mechanism	B-X
that	B-X
prevents	B-X
the	B-X
cells	B-X
to	B-X
acquire	B-X
an	B-X
unnecessary	B-X
damage	B-X
.	B-X
The	B-X
senescent	B-X
state	B-X
is	B-X
accompanied	B-X
by	B-X
a	B-X
failure	B-X
to	B-X
re-enter	B-X
the	B-X
cell	B-X
cycle	B-X
in	B-X
response	B-X
to	B-X
mitogenic	B-X
stimuli	B-X
,	B-X
an	B-X
enhanced	B-X
secretory	B-X
phenotype	B-X
and	B-X
resistance	B-X
to	B-X
cell	B-X
death	B-X
.	B-X
Although	B-X
senescence	B-X
is	B-X
one	B-X
of	B-X
the	B-X
causative	B-X
processes	B-X
of	B-X
aging	B-X
and	B-X
it	B-X
is	B-X
responsible	B-X
of	B-X
aging-related	B-X
disorders	B-X
,	B-X
senescent	B-X
cells	B-X
can	B-X
also	B-X
play	B-X
a	B-X
positive	B-X
role	B-X
.	B-X
In	B-X
embryogenesis	B-X
and	B-X
tissue	B-X
remodeling	B-X
,	B-X
senescent	B-X
cells	B-X
are	B-X
required	B-X
for	B-X
the	B-X
proper	B-X
development	B-X
of	B-X
the	B-X
embryo	B-X
and	B-X
tissue	B-X
repair	B-X
.	B-X
In	B-X
cancer	B-X
,	B-X
senescence	B-X
works	B-X
as	B-X
a	B-X
potent	B-X
barrier	B-X
to	B-X
prevent	B-X
tumorigenesis	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
identification	B-X
and	B-X
characterization	B-X
of	B-X
key	B-X
features	B-X
of	B-X
senescence	B-X
,	B-X
the	B-X
induction	B-X
of	B-X
senescence	B-X
in	B-X
cancer	B-X
cells	B-X
,	B-X
or	B-X
the	B-X
elimination	B-X
of	B-X
senescent	B-X
cells	B-X
by	B-X
pharmacological	B-X
interventions	B-X
in	B-X
aging	B-X
tissues	B-X
is	B-X
gaining	B-X
consideration	B-X
in	B-X
several	B-X
fields	B-X
of	B-X
research	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
describe	B-X
the	B-X
known	B-X
key	B-X
features	B-X
of	B-X
senescence	B-X
,	B-X
the	B-X
cell-autonomous	B-X
,	B-X
and	B-X
noncell-autonomous	B-X
regulators	B-X
of	B-X
senescence	B-X
,	B-X
and	B-X
we	B-X
attempt	B-X
to	B-X
discuss	B-X
the	B-X
functional	B-X
role	B-X
of	B-X
this	B-X
fundamental	B-X
process	B-X
in	B-X
different	B-X
contexts	B-X
in	B-X
light	B-X
of	B-X
the	B-X
development	B-X
of	B-X
novel	B-X
therapeutic	B-X
targets	B-X
.	B-X

p53	B-Gene_or_gene_product
protein	O
functions	O
as	O
a	O
tetramer	O
and	O
we	O
have	O
shown	O
that	O
loss	O
of	O
tetramerisation	O
and	O
changes	O
at	O
the	O
N	O
-	O
terminus	O
influence	O
the	O
recovery	O
of	O
wild	O
type	O
p53	B-Gene_or_gene_product
'	O
status	O
'	O
.	O

To	O
investigate	O
the	O
relationship	O
between	O
tetramerisation	O
and	O
post	O
-	O
translational	O
modifications	O
we	O
examined	O
a	O
range	O
of	O
site	O
-	O
specific	O
modifications	O
in	O
wild	O
type	O
and	O
dimeric	O
mutant	O
(	O
M340Q	O
/	O
L344R	O
)	O
murine	O
p53	B-Gene_or_gene_product
expressed	O
in	O
MEFs	O
p53	B-Gene_or_gene_product
(	O
-	O
/	O
-	O
)	O
and	O
in	O
wild	O
type	O
,	O
monomeric	O
(	O
L344P	O
)	O
and	O
dimeric	O
(	O
M340Q	O
/	O
L344R	O
)	O
human	O
p53	B-Gene_or_gene_product
expressed	O
in	O
HCT116	O
p53	B-Gene_or_gene_product
(	O
-	O
/	O
-	O
)	O
cells	O
.	O

Using	O
site	O
-	O
specific	O
antibodies	O
we	O
demonstrate	O
that	O
in	O
murine	O
p53	B-Gene_or_gene_product
,	O
S15	O
is	O
phosphorylated	O
in	O
a	O
tetramerisation	O
-	O
dependent	O
manner	O
.	O

In	O
contrast	O
,	O
human	O
p53	B-Gene_or_gene_product
S15	O
phosphorylation	O
is	O
not	O
tetramerisation	O
-	O
dependent	O
.	O
<EOS>	B-X
The	B-X
tumor	B-X
suppressor	B-X
activity	B-X
of	B-X
p53	B-X
is	B-X
regulated	B-X
by	B-X
interactions	B-X
with	B-X
the	B-X
ubiquitin	B-X
ligase	B-X
HDM2	B-X
and	B-X
the	B-X
general	B-X
transcriptional	B-X
coactivators	B-X
CBP	B-X
and	B-X
p300	B-X
.	B-X
Using	B-X
NMR	B-X
spectroscopy	B-X
and	B-X
isothermal	B-X
titration	B-X
calorimetry	B-X
,	B-X
we	B-X
have	B-X
dissected	B-X
the	B-X
binding	B-X
interactions	B-X
between	B-X
the	B-X
N-terminal	B-X
transactivation	B-X
domain	B-X
(	B-X
TAD	B-X
)	B-X
of	B-X
p53	B-X
,	B-X
the	B-X
TAZ1	B-X
,	B-X
TAZ2	B-X
,	B-X
KIX	B-X
,	B-X
and	B-X
nuclear	B-X
receptor	B-X
coactivator	B-X
binding	B-X
domains	B-X
of	B-X
CBP	B-X
,	B-X
and	B-X
the	B-X
p53-binding	B-X
domain	B-X
of	B-X
HDM2	B-X
.	B-X
The	B-X
p53	B-X
TAD	B-X
contains	B-X
amphipathic	B-X
binding	B-X
motifs	B-X
within	B-X
the	B-X
AD1	B-X
and	B-X
AD2	B-X
regions	B-X
that	B-X
mediate	B-X
interactions	B-X
with	B-X
CBP	B-X
and	B-X
HDM2	B-X
.	B-X
Binding	B-X
of	B-X
the	B-X
p53	B-X
TAD	B-X
to	B-X
CBP	B-X
domains	B-X
is	B-X
dominated	B-X
by	B-X
interactions	B-X
with	B-X
AD2	B-X
,	B-X
although	B-X
the	B-X
affinity	B-X
is	B-X
enhanced	B-X
by	B-X
additional	B-X
interactions	B-X
with	B-X
AD1	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
binding	B-X
of	B-X
p53	B-X
TAD	B-X
to	B-X
HDM2	B-X
is	B-X
mediated	B-X
primarily	B-X
by	B-X
AD1	B-X
.	B-X
The	B-X
p53	B-X
TAD	B-X
can	B-X
bind	B-X
simultaneously	B-X
to	B-X
HDM2	B-X
(	B-X
through	B-X
AD1	B-X
)	B-X
and	B-X
to	B-X
any	B-X
one	B-X
of	B-X
the	B-X
CBP	B-X
domains	B-X
(	B-X
through	B-X
AD2	B-X
)	B-X
to	B-X
form	B-X
a	B-X
ternary	B-X
complex	B-X
.	B-X
Phosphorylation	B-X
of	B-X
p53	B-X
at	B-X
T18	B-X
impairs	B-X
binding	B-X
to	B-X
HDM2	B-X
and	B-X
enhances	B-X
affinity	B-X
for	B-X
the	B-X
CBP	B-X
KIX	B-X
domain	B-X
.	B-X
Multisite	B-X
phosphorylation	B-X
of	B-X
the	B-X
p53	B-X
TAD	B-X
at	B-X
S15	B-X
,	B-X
T18	B-X
,	B-X
and	B-X
S20	B-X
leads	B-X
to	B-X
increased	B-X
affinity	B-X
for	B-X
the	B-X
TAZ1	B-X
and	B-X
KIX	B-X
domains	B-X
of	B-X
CBP	B-X
.	B-X
These	B-X
observations	B-X
suggest	B-X
a	B-X
mechanism	B-X
whereby	B-X
HDM2	B-X
and	B-X
CBP/p300	B-X
function	B-X
synergistically	B-X
to	B-X
regulate	B-X
the	B-X
p53	B-X
response	B-X
.	B-X
In	B-X
unstressed	B-X
cells	B-X
,	B-X
CBP/p300	B-X
,	B-X
HDM2	B-X
and	B-X
p53	B-X
form	B-X
a	B-X
ternary	B-X
complex	B-X
that	B-X
promotes	B-X
polyubiquitination	B-X
and	B-X
degradation	B-X
of	B-X
p53	B-X
.	B-X
After	B-X
cellular	B-X
stress	B-X
and	B-X
DNA	B-X
damage	B-X
,	B-X
p53	B-X
becomes	B-X
phosphorylated	B-X
at	B-X
T18	B-X
and	B-X
other	B-X
residues	B-X
in	B-X
the	B-X
AD1	B-X
region	B-X
,	B-X
releases	B-X
HDM2	B-X
and	B-X
binds	B-X
preferentially	B-X
to	B-X
CBP/p300	B-X
,	B-X
leading	B-X
to	B-X
stabilization	B-X
and	B-X
activation	B-X
of	B-X
p53	B-X
.	B-X

Inability	O
to	O
form	O
tetramers	O
in	O
human	O
p53	B-Gene_or_gene_product
proteins	O
reduced	O
site	O
-	O
specific	O
N	O
-	O
terminal	O
phosphorylation	O
at	O
S6	O
,	O
S9	O
and	O
S46	O
and	O
reduced	O
C	O
-	O
terminal	O
phosphorylation	O
and	O
acetylation	O
at	O
S315	O
and	O
K382	O
respectively	O
.	O
<EOS>	B-X
The	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
considered	B-X
the	B-X
``	B-X
Guardian	B-X
of	B-X
the	B-X
Genome	B-X
''	B-X
,	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
and	B-X
mutated	B-X
in	B-X
over	B-X
50	B-X
%	B-X
of	B-X
human	B-X
cancers	B-X
.	B-X
Following	B-X
cellular	B-X
stress	B-X
,	B-X
post-translational	B-X
modifications	B-X
such	B-X
as	B-X
phosphorylation	B-X
and	B-X
acetylation	B-X
stabilise	B-X
and	B-X
activate	B-X
p53	B-X
for	B-X
cell	B-X
cycle	B-X
arrest	B-X
,	B-X
DNA	B-X
repair	B-X
,	B-X
apoptosis	B-X
or	B-X
senescence	B-X
.	B-X
p53	B-X
protein	B-X
functions	B-X
as	B-X
a	B-X
tetramer	B-X
and	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
loss	B-X
of	B-X
tetramerisation	B-X
and	B-X
changes	B-X
at	B-X
the	B-X
N-terminus	B-X
influence	B-X
the	B-X
recovery	B-X
of	B-X
wild	B-X
type	B-X
p53	B-X
'status	B-X
'	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
relationship	B-X
between	B-X
tetramerisation	B-X
and	B-X
post-translational	B-X
modifications	B-X
we	B-X
examined	B-X
a	B-X
range	B-X
of	B-X
site-specific	B-X
modifications	B-X
in	B-X
wild	B-X
type	B-X
and	B-X
dimeric	B-X
mutant	B-X
(	B-X
M340Q/L344R	B-X
)	B-X
murine	B-X
p53	B-X
expressed	B-X
in	B-X
MEFs	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
in	B-X
wild	B-X
type	B-X
,	B-X
monomeric	B-X
(	B-X
L344P	B-X
)	B-X
and	B-X
dimeric	B-X
(	B-X
M340Q/L344R	B-X
)	B-X
human	B-X
p53	B-X
expressed	B-X
in	B-X
HCT116	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
cells	B-X
.	B-X
Using	B-X
site-specific	B-X
antibodies	B-X
we	B-X
demonstrate	B-X
that	B-X
in	B-X
murine	B-X
p53	B-X
,	B-X
S15	B-X
is	B-X
phosphorylated	B-X
in	B-X
a	B-X
tetramerisation-dependent	B-X
manner	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
human	B-X
p53	B-X
S15	B-X
phosphorylation	B-X
is	B-X
not	B-X
tetramerisation-dependent	B-X
.	B-X
Inability	B-X
to	B-X
form	B-X
tetramers	B-X
in	B-X
human	B-X
p53	B-X
proteins	B-X
reduced	B-X
site-specific	B-X
N-terminal	B-X
phosphorylation	B-X
at	B-X
S6	B-X
,	B-X
S9	B-X
and	B-X
S46	B-X
and	B-X
reduced	B-X
C-terminal	B-X
phosphorylation	B-X
and	B-X
acetylation	B-X
at	B-X
S315	B-X
and	B-X
K382	B-X
respectively	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p53	B-X
tetramerisation	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
p21	B-X
and	B-X
hdm2	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
and	B-X
recruitment	B-X
of	B-X
p53	B-X
to	B-X
specific	B-X
promoter	B-X
regions	B-X
of	B-X
p21	B-X
and	B-X
hdm2	B-X
.	B-X

In	O
addition	O
,	O
p53	B-Gene_or_gene_product
tetramerisation	O
is	O
required	O
for	O
efficient	O
p21	B-Gene_or_gene_product
and	O
hdm2	B-Gene_or_gene_product
transcription	O
and	O
protein	O
expression	O
and	O
recruitment	O
of	O
p53	B-Gene_or_gene_product
to	O
specific	O
promoter	O
regions	O
of	O
p21	B-Gene_or_gene_product
and	O
hdm2	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
considered	B-X
the	B-X
``	B-X
Guardian	B-X
of	B-X
the	B-X
Genome	B-X
''	B-X
,	B-X
crucial	B-X
for	B-X
cell	B-X
cycle	B-X
control	B-X
and	B-X
mutated	B-X
in	B-X
over	B-X
50	B-X
%	B-X
of	B-X
human	B-X
cancers	B-X
.	B-X
Following	B-X
cellular	B-X
stress	B-X
,	B-X
post-translational	B-X
modifications	B-X
such	B-X
as	B-X
phosphorylation	B-X
and	B-X
acetylation	B-X
stabilise	B-X
and	B-X
activate	B-X
p53	B-X
for	B-X
cell	B-X
cycle	B-X
arrest	B-X
,	B-X
DNA	B-X
repair	B-X
,	B-X
apoptosis	B-X
or	B-X
senescence	B-X
.	B-X
p53	B-X
protein	B-X
functions	B-X
as	B-X
a	B-X
tetramer	B-X
and	B-X
we	B-X
have	B-X
shown	B-X
that	B-X
loss	B-X
of	B-X
tetramerisation	B-X
and	B-X
changes	B-X
at	B-X
the	B-X
N-terminus	B-X
influence	B-X
the	B-X
recovery	B-X
of	B-X
wild	B-X
type	B-X
p53	B-X
'status	B-X
'	B-X
.	B-X
To	B-X
investigate	B-X
the	B-X
relationship	B-X
between	B-X
tetramerisation	B-X
and	B-X
post-translational	B-X
modifications	B-X
we	B-X
examined	B-X
a	B-X
range	B-X
of	B-X
site-specific	B-X
modifications	B-X
in	B-X
wild	B-X
type	B-X
and	B-X
dimeric	B-X
mutant	B-X
(	B-X
M340Q/L344R	B-X
)	B-X
murine	B-X
p53	B-X
expressed	B-X
in	B-X
MEFs	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
and	B-X
in	B-X
wild	B-X
type	B-X
,	B-X
monomeric	B-X
(	B-X
L344P	B-X
)	B-X
and	B-X
dimeric	B-X
(	B-X
M340Q/L344R	B-X
)	B-X
human	B-X
p53	B-X
expressed	B-X
in	B-X
HCT116	B-X
p53	B-X
(	B-X
-/-	B-X
)	B-X
cells	B-X
.	B-X
Using	B-X
site-specific	B-X
antibodies	B-X
we	B-X
demonstrate	B-X
that	B-X
in	B-X
murine	B-X
p53	B-X
,	B-X
S15	B-X
is	B-X
phosphorylated	B-X
in	B-X
a	B-X
tetramerisation-dependent	B-X
manner	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
human	B-X
p53	B-X
S15	B-X
phosphorylation	B-X
is	B-X
not	B-X
tetramerisation-dependent	B-X
.	B-X
Inability	B-X
to	B-X
form	B-X
tetramers	B-X
in	B-X
human	B-X
p53	B-X
proteins	B-X
reduced	B-X
site-specific	B-X
N-terminal	B-X
phosphorylation	B-X
at	B-X
S6	B-X
,	B-X
S9	B-X
and	B-X
S46	B-X
and	B-X
reduced	B-X
C-terminal	B-X
phosphorylation	B-X
and	B-X
acetylation	B-X
at	B-X
S315	B-X
and	B-X
K382	B-X
respectively	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
p53	B-X
tetramerisation	B-X
is	B-X
required	B-X
for	B-X
efficient	B-X
p21	B-X
and	B-X
hdm2	B-X
transcription	B-X
and	B-X
protein	B-X
expression	B-X
and	B-X
recruitment	B-X
of	B-X
p53	B-X
to	B-X
specific	B-X
promoter	B-X
regions	B-X
of	B-X
p21	B-X
and	B-X
hdm2	B-X
.	B-X

Analysis	O
of	O
chemical	O
shift	O
changes	O
reveals	O
the	O
binding	O
modes	O
of	O
isoindolinone	O
inhibitors	O
of	O
the	O
MDM2	B-Gene_or_gene_product
-	O
p53	B-Gene_or_gene_product
interaction	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
we	B-X
present	B-X
a	B-X
method	B-X
for	B-X
defining	B-X
the	B-X
binding	B-X
modes	B-X
of	B-X
a	B-X
set	B-X
of	B-X
structurally	B-X
related	B-X
isoindolinone	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
This	B-X
approach	B-X
derives	B-X
the	B-X
location	B-X
and	B-X
orientation	B-X
of	B-X
isoindolinone	B-X
binding	B-X
,	B-X
based	B-X
on	B-X
an	B-X
analysis	B-X
of	B-X
the	B-X
patterns	B-X
of	B-X
magnitude	B-X
and	B-X
direction	B-X
of	B-X
chemical	B-X
shift	B-X
perturbations	B-X
for	B-X
a	B-X
series	B-X
of	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
The	B-X
MDM2-p53	B-X
complex	B-X
is	B-X
an	B-X
attractive	B-X
target	B-X
for	B-X
therapeutic	B-X
intervention	B-X
in	B-X
cancer	B-X
cells	B-X
with	B-X
intact	B-X
tumor	B-X
suppressor	B-X
p53	B-X
,	B-X
as	B-X
it	B-X
offers	B-X
the	B-X
possibility	B-X
of	B-X
releasing	B-X
p53	B-X
by	B-X
blocking	B-X
the	B-X
MDM2-p53	B-X
binding	B-X
site	B-X
with	B-X
a	B-X
small	B-X
molecule	B-X
antagonist	B-X
to	B-X
promote	B-X
apoptosis	B-X
.	B-X
Isoindolinones	B-X
are	B-X
a	B-X
novel	B-X
class	B-X
of	B-X
MDM2-antagonists	B-X
of	B-X
moderate	B-X
affinity	B-X
,	B-X
which	B-X
still	B-X
require	B-X
the	B-X
development	B-X
of	B-X
more	B-X
potent	B-X
candidates	B-X
for	B-X
clinical	B-X
applications	B-X
.	B-X
As	B-X
the	B-X
applicability	B-X
of	B-X
conventional	B-X
structural	B-X
methods	B-X
to	B-X
this	B-X
system	B-X
is	B-X
limited	B-X
by	B-X
a	B-X
number	B-X
of	B-X
fundamental	B-X
factors	B-X
,	B-X
the	B-X
exploitation	B-X
of	B-X
the	B-X
information	B-X
contained	B-X
in	B-X
chemical	B-X
shift	B-X
perturbations	B-X
has	B-X
offered	B-X
a	B-X
useful	B-X
route	B-X
to	B-X
obtaining	B-X
structural	B-X
information	B-X
to	B-X
guide	B-X
the	B-X
development	B-X
of	B-X
more	B-X
potent	B-X
compounds	B-X
.	B-X
For	B-X
a	B-X
set	B-X
of	B-X
12	B-X
structurally	B-X
related	B-X
isoindolinones	B-X
,	B-X
the	B-X
data	B-X
suggests	B-X
4	B-X
different	B-X
orientations	B-X
of	B-X
binding	B-X
,	B-X
caused	B-X
by	B-X
subtle	B-X
changes	B-X
in	B-X
the	B-X
chemical	B-X
structure	B-X
of	B-X
the	B-X
inhibitors	B-X
.	B-X

In	O
this	O
study	O
we	O
present	O
a	O
method	O
for	O
defining	O
the	O
binding	O
modes	O
of	O
a	O
set	O
of	O
structurally	O
related	O
isoindolinone	O
inhibitors	O
of	O
the	O
MDM2	B-Gene_or_gene_product
-	O
p53	B-Gene_or_gene_product
interaction	O
.	O

This	O
approach	O
derives	O
the	O
location	O
and	O
orientation	O
of	O
isoindolinone	O
binding	O
,	O
based	O
on	O
an	O
analysis	O
of	O
the	O
patterns	O
of	O
magnitude	O
and	O
direction	O
of	O
chemical	O
shift	O
perturbations	O
for	O
a	O
series	O
of	O
inhibitors	O
of	O
the	O
MDM2	B-Gene_or_gene_product
-	O
p53	B-Gene_or_gene_product
interaction	O
.	O

The	O
MDM2	O
-	O
p53	O
complex	O
is	O
an	O
attractive	O
target	O
for	O
therapeutic	O
intervention	O
in	O
cancer	O
cells	O
with	O
intact	O
tumor	O
suppressor	O
p53	B-Gene_or_gene_product
,	O
as	O
it	O
offers	O
the	O
possibility	O
of	O
releasing	O
p53	B-Gene_or_gene_product
by	O
blocking	O
the	O
MDM2	B-Gene_or_gene_product
-	O
p53	B-Gene_or_gene_product
binding	O
site	O
with	O
a	O
small	O
molecule	O
antagonist	O
to	O
promote	O
apoptosis	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
we	B-X
present	B-X
a	B-X
method	B-X
for	B-X
defining	B-X
the	B-X
binding	B-X
modes	B-X
of	B-X
a	B-X
set	B-X
of	B-X
structurally	B-X
related	B-X
isoindolinone	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
This	B-X
approach	B-X
derives	B-X
the	B-X
location	B-X
and	B-X
orientation	B-X
of	B-X
isoindolinone	B-X
binding	B-X
,	B-X
based	B-X
on	B-X
an	B-X
analysis	B-X
of	B-X
the	B-X
patterns	B-X
of	B-X
magnitude	B-X
and	B-X
direction	B-X
of	B-X
chemical	B-X
shift	B-X
perturbations	B-X
for	B-X
a	B-X
series	B-X
of	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
The	B-X
MDM2-p53	B-X
complex	B-X
is	B-X
an	B-X
attractive	B-X
target	B-X
for	B-X
therapeutic	B-X
intervention	B-X
in	B-X
cancer	B-X
cells	B-X
with	B-X
intact	B-X
tumor	B-X
suppressor	B-X
p53	B-X
,	B-X
as	B-X
it	B-X
offers	B-X
the	B-X
possibility	B-X
of	B-X
releasing	B-X
p53	B-X
by	B-X
blocking	B-X
the	B-X
MDM2-p53	B-X
binding	B-X
site	B-X
with	B-X
a	B-X
small	B-X
molecule	B-X
antagonist	B-X
to	B-X
promote	B-X
apoptosis	B-X
.	B-X
Isoindolinones	B-X
are	B-X
a	B-X
novel	B-X
class	B-X
of	B-X
MDM2-antagonists	B-X
of	B-X
moderate	B-X
affinity	B-X
,	B-X
which	B-X
still	B-X
require	B-X
the	B-X
development	B-X
of	B-X
more	B-X
potent	B-X
candidates	B-X
for	B-X
clinical	B-X
applications	B-X
.	B-X
For	B-X
a	B-X
set	B-X
of	B-X
12	B-X
structurally	B-X
related	B-X
isoindolinones	B-X
,	B-X
the	B-X
data	B-X
suggests	B-X
4	B-X
different	B-X
orientations	B-X
of	B-X
binding	B-X
,	B-X
caused	B-X
by	B-X
subtle	B-X
changes	B-X
in	B-X
the	B-X
chemical	B-X
structure	B-X
of	B-X
the	B-X
inhibitors	B-X
.	B-X

Isoindolinones	O
are	O
a	O
novel	O
class	O
of	O
MDM2	B-Gene_or_gene_product
-	O
antagonists	O
of	O
moderate	O
affinity	O
,	O
which	O
still	O
require	O
the	O
development	O
of	O
more	O
potent	O
candidates	O
for	O
clinical	O
applications	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
we	B-X
present	B-X
a	B-X
method	B-X
for	B-X
defining	B-X
the	B-X
binding	B-X
modes	B-X
of	B-X
a	B-X
set	B-X
of	B-X
structurally	B-X
related	B-X
isoindolinone	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
This	B-X
approach	B-X
derives	B-X
the	B-X
location	B-X
and	B-X
orientation	B-X
of	B-X
isoindolinone	B-X
binding	B-X
,	B-X
based	B-X
on	B-X
an	B-X
analysis	B-X
of	B-X
the	B-X
patterns	B-X
of	B-X
magnitude	B-X
and	B-X
direction	B-X
of	B-X
chemical	B-X
shift	B-X
perturbations	B-X
for	B-X
a	B-X
series	B-X
of	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
The	B-X
MDM2-p53	B-X
complex	B-X
is	B-X
an	B-X
attractive	B-X
target	B-X
for	B-X
therapeutic	B-X
intervention	B-X
in	B-X
cancer	B-X
cells	B-X
with	B-X
intact	B-X
tumor	B-X
suppressor	B-X
p53	B-X
,	B-X
as	B-X
it	B-X
offers	B-X
the	B-X
possibility	B-X
of	B-X
releasing	B-X
p53	B-X
by	B-X
blocking	B-X
the	B-X
MDM2-p53	B-X
binding	B-X
site	B-X
with	B-X
a	B-X
small	B-X
molecule	B-X
antagonist	B-X
to	B-X
promote	B-X
apoptosis	B-X
.	B-X
Isoindolinones	B-X
are	B-X
a	B-X
novel	B-X
class	B-X
of	B-X
MDM2-antagonists	B-X
of	B-X
moderate	B-X
affinity	B-X
,	B-X
which	B-X
still	B-X
require	B-X
the	B-X
development	B-X
of	B-X
more	B-X
potent	B-X
candidates	B-X
for	B-X
clinical	B-X
applications	B-X
.	B-X
As	B-X
the	B-X
applicability	B-X
of	B-X
conventional	B-X
structural	B-X
methods	B-X
to	B-X
this	B-X
system	B-X
is	B-X
limited	B-X
by	B-X
a	B-X
number	B-X
of	B-X
fundamental	B-X
factors	B-X
,	B-X
the	B-X
exploitation	B-X
of	B-X
the	B-X
information	B-X
contained	B-X
in	B-X
chemical	B-X
shift	B-X
perturbations	B-X
has	B-X
offered	B-X
a	B-X
useful	B-X
route	B-X
to	B-X
obtaining	B-X
structural	B-X
information	B-X
to	B-X
guide	B-X
the	B-X
development	B-X
of	B-X
more	B-X
potent	B-X
compounds	B-X
.	B-X

As	O
the	O
applicability	O
of	O
conventional	O
structural	O
methods	O
to	O
this	O
system	O
is	O
limited	O
by	O
a	O
number	O
of	O
fundamental	O
factors	O
,	O
the	O
exploitation	O
of	O
the	O
information	O
contained	O
in	O
chemical	O
shift	O
perturbations	O
has	O
offered	O
a	O
useful	O
route	O
to	O
obtaining	O
structural	O
information	O
to	O
guide	O
the	O
development	O
of	O
more	O
potent	O
compounds	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
we	B-X
present	B-X
a	B-X
method	B-X
for	B-X
defining	B-X
the	B-X
binding	B-X
modes	B-X
of	B-X
a	B-X
set	B-X
of	B-X
structurally	B-X
related	B-X
isoindolinone	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
This	B-X
approach	B-X
derives	B-X
the	B-X
location	B-X
and	B-X
orientation	B-X
of	B-X
isoindolinone	B-X
binding	B-X
,	B-X
based	B-X
on	B-X
an	B-X
analysis	B-X
of	B-X
the	B-X
patterns	B-X
of	B-X
magnitude	B-X
and	B-X
direction	B-X
of	B-X
chemical	B-X
shift	B-X
perturbations	B-X
for	B-X
a	B-X
series	B-X
of	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
Isoindolinones	B-X
are	B-X
a	B-X
novel	B-X
class	B-X
of	B-X
MDM2-antagonists	B-X
of	B-X
moderate	B-X
affinity	B-X
,	B-X
which	B-X
still	B-X
require	B-X
the	B-X
development	B-X
of	B-X
more	B-X
potent	B-X
candidates	B-X
for	B-X
clinical	B-X
applications	B-X
.	B-X
As	B-X
the	B-X
applicability	B-X
of	B-X
conventional	B-X
structural	B-X
methods	B-X
to	B-X
this	B-X
system	B-X
is	B-X
limited	B-X
by	B-X
a	B-X
number	B-X
of	B-X
fundamental	B-X
factors	B-X
,	B-X
the	B-X
exploitation	B-X
of	B-X
the	B-X
information	B-X
contained	B-X
in	B-X
chemical	B-X
shift	B-X
perturbations	B-X
has	B-X
offered	B-X
a	B-X
useful	B-X
route	B-X
to	B-X
obtaining	B-X
structural	B-X
information	B-X
to	B-X
guide	B-X
the	B-X
development	B-X
of	B-X
more	B-X
potent	B-X
compounds	B-X
.	B-X
For	B-X
a	B-X
set	B-X
of	B-X
12	B-X
structurally	B-X
related	B-X
isoindolinones	B-X
,	B-X
the	B-X
data	B-X
suggests	B-X
4	B-X
different	B-X
orientations	B-X
of	B-X
binding	B-X
,	B-X
caused	B-X
by	B-X
subtle	B-X
changes	B-X
in	B-X
the	B-X
chemical	B-X
structure	B-X
of	B-X
the	B-X
inhibitors	B-X
.	B-X

For	O
a	O
set	O
of	O
12	O
structurally	O
related	O
isoindolinones	O
,	O
the	O
data	O
suggests	O
4	O
different	O
orientations	O
of	O
binding	O
,	O
caused	O
by	O
subtle	O
changes	O
in	O
the	O
chemical	O
structure	O
of	O
the	O
inhibitors	O
.	O
<EOS>	B-X
In	B-X
this	B-X
study	B-X
we	B-X
present	B-X
a	B-X
method	B-X
for	B-X
defining	B-X
the	B-X
binding	B-X
modes	B-X
of	B-X
a	B-X
set	B-X
of	B-X
structurally	B-X
related	B-X
isoindolinone	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
This	B-X
approach	B-X
derives	B-X
the	B-X
location	B-X
and	B-X
orientation	B-X
of	B-X
isoindolinone	B-X
binding	B-X
,	B-X
based	B-X
on	B-X
an	B-X
analysis	B-X
of	B-X
the	B-X
patterns	B-X
of	B-X
magnitude	B-X
and	B-X
direction	B-X
of	B-X
chemical	B-X
shift	B-X
perturbations	B-X
for	B-X
a	B-X
series	B-X
of	B-X
inhibitors	B-X
of	B-X
the	B-X
MDM2-p53	B-X
interaction	B-X
.	B-X
The	B-X
MDM2-p53	B-X
complex	B-X
is	B-X
an	B-X
attractive	B-X
target	B-X
for	B-X
therapeutic	B-X
intervention	B-X
in	B-X
cancer	B-X
cells	B-X
with	B-X
intact	B-X
tumor	B-X
suppressor	B-X
p53	B-X
,	B-X
as	B-X
it	B-X
offers	B-X
the	B-X
possibility	B-X
of	B-X
releasing	B-X
p53	B-X
by	B-X
blocking	B-X
the	B-X
MDM2-p53	B-X
binding	B-X
site	B-X
with	B-X
a	B-X
small	B-X
molecule	B-X
antagonist	B-X
to	B-X
promote	B-X
apoptosis	B-X
.	B-X
As	B-X
the	B-X
applicability	B-X
of	B-X
conventional	B-X
structural	B-X
methods	B-X
to	B-X
this	B-X
system	B-X
is	B-X
limited	B-X
by	B-X
a	B-X
number	B-X
of	B-X
fundamental	B-X
factors	B-X
,	B-X
the	B-X
exploitation	B-X
of	B-X
the	B-X
information	B-X
contained	B-X
in	B-X
chemical	B-X
shift	B-X
perturbations	B-X
has	B-X
offered	B-X
a	B-X
useful	B-X
route	B-X
to	B-X
obtaining	B-X
structural	B-X
information	B-X
to	B-X
guide	B-X
the	B-X
development	B-X
of	B-X
more	B-X
potent	B-X
compounds	B-X
.	B-X
For	B-X
a	B-X
set	B-X
of	B-X
12	B-X
structurally	B-X
related	B-X
isoindolinones	B-X
,	B-X
the	B-X
data	B-X
suggests	B-X
4	B-X
different	B-X
orientations	B-X
of	B-X
binding	B-X
,	B-X
caused	B-X
by	B-X
subtle	B-X
changes	B-X
in	B-X
the	B-X
chemical	B-X
structure	B-X
of	B-X
the	B-X
inhibitors	B-X
.	B-X

SMAR1	B-Gene_or_gene_product
forms	O
a	O
ternary	O
complex	O
with	O
p53	B-Gene_or_gene_product
-	O
MDM2	B-Gene_or_gene_product
and	O
negatively	O
regulates	O
p53	B-Gene_or_gene_product
-	O
mediated	O
transcription	O
.	O
<EOS>	B-X
The	B-X
intra-cellular	B-X
level	B-X
of	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
between	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
negative	B-X
regulator	B-X
MDM2	B-X
.	B-X
The	B-X
role	B-X
of	B-X
MDM2	B-X
in	B-X
down-regulating	B-X
the	B-X
p53	B-X
response	B-X
in	B-X
unstressed	B-X
conditions	B-X
and	B-X
in	B-X
the	B-X
post-stress	B-X
recovery	B-X
phase	B-X
is	B-X
well	B-X
documented	B-X
.	B-X
However	B-X
,	B-X
interplay	B-X
between	B-X
the	B-X
N-terminal	B-X
phosphorylations	B-X
and	B-X
C-terminal	B-X
acetylations	B-X
of	B-X
p53	B-X
in	B-X
this	B-X
context	B-X
remains	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
an	B-X
MAR	B-X
binding	B-X
protein	B-X
SMAR1	B-X
interacts	B-X
with	B-X
MDM2	B-X
and	B-X
the	B-X
Ser15	B-X
phosphorylated	B-X
form	B-X
of	B-X
p53	B-X
,	B-X
forming	B-X
a	B-X
ternary	B-X
complex	B-X
in	B-X
the	B-X
post	B-X
stress-recovery	B-X
phase	B-X
.	B-X
This	B-X
triple	B-X
complex	B-X
formation	B-X
between	B-X
p53	B-X
,	B-X
MDM2	B-X
and	B-X
SMAR1	B-X
results	B-X
in	B-X
recruitment	B-X
of	B-X
HDAC1	B-X
to	B-X
deacetylate	B-X
p53	B-X
.	B-X
The	B-X
deacetylated	B-X
p53	B-X
binds	B-X
poorly	B-X
to	B-X
the	B-X
target	B-X
promoter	B-X
(	B-X
p21	B-X
)	B-X
,	B-X
which	B-X
results	B-X
in	B-X
switching	B-X
off	B-X
the	B-X
p53	B-X
response	B-X
,	B-X
essential	B-X
for	B-X
re-entry	B-X
into	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
knock-down	B-X
of	B-X
SMAR1	B-X
using	B-X
siRNA	B-X
leads	B-X
to	B-X
a	B-X
prolonged	B-X
cell-cycle	B-X
arrest	B-X
in	B-X
the	B-X
post	B-X
stress	B-X
recovery	B-X
phase	B-X
due	B-X
to	B-X
ablation	B-X
of	B-X
p53-MDM2-HDAC1	B-X
interaction	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
highlight	B-X
the	B-X
role	B-X
of	B-X
SMAR1	B-X
in	B-X
masking	B-X
the	B-X
active	B-X
phosphorylation	B-X
site	B-X
of	B-X
p53	B-X
,	B-X
enabling	B-X
the	B-X
deacetylation	B-X
of	B-X
p53	B-X
by	B-X
HDAC1-MDM2	B-X
complex	B-X
,	B-X
thereby	B-X
regulating	B-X
the	B-X
p53	B-X
transcriptional	B-X
response	B-X
during	B-X
stress	B-X
rescue	B-X
.	B-X

The	O
intra	O
-	O
cellular	O
level	O
of	O
tumor	O
suppressor	O
protein	O
p53	B-Gene_or_gene_product
is	O
tightly	O
controlled	O
by	O
an	O
autoregulatory	O
feedback	O
loop	O
between	O
the	O
protein	O
and	O
its	O
negative	O
regulator	O
MDM2	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
intra-cellular	B-X
level	B-X
of	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
between	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
negative	B-X
regulator	B-X
MDM2	B-X
.	B-X
The	B-X
role	B-X
of	B-X
MDM2	B-X
in	B-X
down-regulating	B-X
the	B-X
p53	B-X
response	B-X
in	B-X
unstressed	B-X
conditions	B-X
and	B-X
in	B-X
the	B-X
post-stress	B-X
recovery	B-X
phase	B-X
is	B-X
well	B-X
documented	B-X
.	B-X
However	B-X
,	B-X
interplay	B-X
between	B-X
the	B-X
N-terminal	B-X
phosphorylations	B-X
and	B-X
C-terminal	B-X
acetylations	B-X
of	B-X
p53	B-X
in	B-X
this	B-X
context	B-X
remains	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
an	B-X
MAR	B-X
binding	B-X
protein	B-X
SMAR1	B-X
interacts	B-X
with	B-X
MDM2	B-X
and	B-X
the	B-X
Ser15	B-X
phosphorylated	B-X
form	B-X
of	B-X
p53	B-X
,	B-X
forming	B-X
a	B-X
ternary	B-X
complex	B-X
in	B-X
the	B-X
post	B-X
stress-recovery	B-X
phase	B-X
.	B-X
This	B-X
triple	B-X
complex	B-X
formation	B-X
between	B-X
p53	B-X
,	B-X
MDM2	B-X
and	B-X
SMAR1	B-X
results	B-X
in	B-X
recruitment	B-X
of	B-X
HDAC1	B-X
to	B-X
deacetylate	B-X
p53	B-X
.	B-X
The	B-X
deacetylated	B-X
p53	B-X
binds	B-X
poorly	B-X
to	B-X
the	B-X
target	B-X
promoter	B-X
(	B-X
p21	B-X
)	B-X
,	B-X
which	B-X
results	B-X
in	B-X
switching	B-X
off	B-X
the	B-X
p53	B-X
response	B-X
,	B-X
essential	B-X
for	B-X
re-entry	B-X
into	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
knock-down	B-X
of	B-X
SMAR1	B-X
using	B-X
siRNA	B-X
leads	B-X
to	B-X
a	B-X
prolonged	B-X
cell-cycle	B-X
arrest	B-X
in	B-X
the	B-X
post	B-X
stress	B-X
recovery	B-X
phase	B-X
due	B-X
to	B-X
ablation	B-X
of	B-X
p53-MDM2-HDAC1	B-X
interaction	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
highlight	B-X
the	B-X
role	B-X
of	B-X
SMAR1	B-X
in	B-X
masking	B-X
the	B-X
active	B-X
phosphorylation	B-X
site	B-X
of	B-X
p53	B-X
,	B-X
enabling	B-X
the	B-X
deacetylation	B-X
of	B-X
p53	B-X
by	B-X
HDAC1-MDM2	B-X
complex	B-X
,	B-X
thereby	B-X
regulating	B-X
the	B-X
p53	B-X
transcriptional	B-X
response	B-X
during	B-X
stress	B-X
rescue	B-X
.	B-X

The	O
role	O
of	O
MDM2	B-Gene_or_gene_product
in	O
down	O
-	O
regulating	O
the	O
p53	B-Gene_or_gene_product
response	O
in	O
unstressed	O
conditions	O
and	O
in	O
the	O
post	O
-	O
stress	O
recovery	O
phase	O
is	O
well	O
documented	O
.	O
<EOS>	B-X
The	B-X
intra-cellular	B-X
level	B-X
of	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
between	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
negative	B-X
regulator	B-X
MDM2	B-X
.	B-X
The	B-X
role	B-X
of	B-X
MDM2	B-X
in	B-X
down-regulating	B-X
the	B-X
p53	B-X
response	B-X
in	B-X
unstressed	B-X
conditions	B-X
and	B-X
in	B-X
the	B-X
post-stress	B-X
recovery	B-X
phase	B-X
is	B-X
well	B-X
documented	B-X
.	B-X
However	B-X
,	B-X
interplay	B-X
between	B-X
the	B-X
N-terminal	B-X
phosphorylations	B-X
and	B-X
C-terminal	B-X
acetylations	B-X
of	B-X
p53	B-X
in	B-X
this	B-X
context	B-X
remains	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
an	B-X
MAR	B-X
binding	B-X
protein	B-X
SMAR1	B-X
interacts	B-X
with	B-X
MDM2	B-X
and	B-X
the	B-X
Ser15	B-X
phosphorylated	B-X
form	B-X
of	B-X
p53	B-X
,	B-X
forming	B-X
a	B-X
ternary	B-X
complex	B-X
in	B-X
the	B-X
post	B-X
stress-recovery	B-X
phase	B-X
.	B-X
This	B-X
triple	B-X
complex	B-X
formation	B-X
between	B-X
p53	B-X
,	B-X
MDM2	B-X
and	B-X
SMAR1	B-X
results	B-X
in	B-X
recruitment	B-X
of	B-X
HDAC1	B-X
to	B-X
deacetylate	B-X
p53	B-X
.	B-X
The	B-X
deacetylated	B-X
p53	B-X
binds	B-X
poorly	B-X
to	B-X
the	B-X
target	B-X
promoter	B-X
(	B-X
p21	B-X
)	B-X
,	B-X
which	B-X
results	B-X
in	B-X
switching	B-X
off	B-X
the	B-X
p53	B-X
response	B-X
,	B-X
essential	B-X
for	B-X
re-entry	B-X
into	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
knock-down	B-X
of	B-X
SMAR1	B-X
using	B-X
siRNA	B-X
leads	B-X
to	B-X
a	B-X
prolonged	B-X
cell-cycle	B-X
arrest	B-X
in	B-X
the	B-X
post	B-X
stress	B-X
recovery	B-X
phase	B-X
due	B-X
to	B-X
ablation	B-X
of	B-X
p53-MDM2-HDAC1	B-X
interaction	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
highlight	B-X
the	B-X
role	B-X
of	B-X
SMAR1	B-X
in	B-X
masking	B-X
the	B-X
active	B-X
phosphorylation	B-X
site	B-X
of	B-X
p53	B-X
,	B-X
enabling	B-X
the	B-X
deacetylation	B-X
of	B-X
p53	B-X
by	B-X
HDAC1-MDM2	B-X
complex	B-X
,	B-X
thereby	B-X
regulating	B-X
the	B-X
p53	B-X
transcriptional	B-X
response	B-X
during	B-X
stress	B-X
rescue	B-X
.	B-X

However	O
,	O
interplay	O
between	O
the	O
N	O
-	O
terminal	O
phosphorylations	O
and	O
C	O
-	O
terminal	O
acetylations	O
of	O
p53	B-Gene_or_gene_product
in	O
this	O
context	O
remains	O
unclear	O
.	O

Here	O
,	O
we	O
show	O
that	O
an	O
MAR	B-Gene_or_gene_product
binding	O
protein	O
SMAR1	B-Gene_or_gene_product
interacts	O
with	O
MDM2	B-Gene_or_gene_product
and	O
the	O
Ser15	O
phosphorylated	O
form	O
of	O
p53	B-Gene_or_gene_product
,	O
forming	O
a	O
ternary	O
complex	O
in	O
the	O
post	O
stress	O
-	O
recovery	O
phase	O
.	O
<EOS>	B-X
The	B-X
intra-cellular	B-X
level	B-X
of	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
between	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
negative	B-X
regulator	B-X
MDM2	B-X
.	B-X
The	B-X
role	B-X
of	B-X
MDM2	B-X
in	B-X
down-regulating	B-X
the	B-X
p53	B-X
response	B-X
in	B-X
unstressed	B-X
conditions	B-X
and	B-X
in	B-X
the	B-X
post-stress	B-X
recovery	B-X
phase	B-X
is	B-X
well	B-X
documented	B-X
.	B-X
However	B-X
,	B-X
interplay	B-X
between	B-X
the	B-X
N-terminal	B-X
phosphorylations	B-X
and	B-X
C-terminal	B-X
acetylations	B-X
of	B-X
p53	B-X
in	B-X
this	B-X
context	B-X
remains	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
an	B-X
MAR	B-X
binding	B-X
protein	B-X
SMAR1	B-X
interacts	B-X
with	B-X
MDM2	B-X
and	B-X
the	B-X
Ser15	B-X
phosphorylated	B-X
form	B-X
of	B-X
p53	B-X
,	B-X
forming	B-X
a	B-X
ternary	B-X
complex	B-X
in	B-X
the	B-X
post	B-X
stress-recovery	B-X
phase	B-X
.	B-X
This	B-X
triple	B-X
complex	B-X
formation	B-X
between	B-X
p53	B-X
,	B-X
MDM2	B-X
and	B-X
SMAR1	B-X
results	B-X
in	B-X
recruitment	B-X
of	B-X
HDAC1	B-X
to	B-X
deacetylate	B-X
p53	B-X
.	B-X
The	B-X
deacetylated	B-X
p53	B-X
binds	B-X
poorly	B-X
to	B-X
the	B-X
target	B-X
promoter	B-X
(	B-X
p21	B-X
)	B-X
,	B-X
which	B-X
results	B-X
in	B-X
switching	B-X
off	B-X
the	B-X
p53	B-X
response	B-X
,	B-X
essential	B-X
for	B-X
re-entry	B-X
into	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
knock-down	B-X
of	B-X
SMAR1	B-X
using	B-X
siRNA	B-X
leads	B-X
to	B-X
a	B-X
prolonged	B-X
cell-cycle	B-X
arrest	B-X
in	B-X
the	B-X
post	B-X
stress	B-X
recovery	B-X
phase	B-X
due	B-X
to	B-X
ablation	B-X
of	B-X
p53-MDM2-HDAC1	B-X
interaction	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
highlight	B-X
the	B-X
role	B-X
of	B-X
SMAR1	B-X
in	B-X
masking	B-X
the	B-X
active	B-X
phosphorylation	B-X
site	B-X
of	B-X
p53	B-X
,	B-X
enabling	B-X
the	B-X
deacetylation	B-X
of	B-X
p53	B-X
by	B-X
HDAC1-MDM2	B-X
complex	B-X
,	B-X
thereby	B-X
regulating	B-X
the	B-X
p53	B-X
transcriptional	B-X
response	B-X
during	B-X
stress	B-X
rescue	B-X
.	B-X

This	O
triple	O
complex	O
formation	O
between	O
p53	B-Gene_or_gene_product
,	O
MDM2	B-Gene_or_gene_product
and	O
SMAR1	B-Gene_or_gene_product
results	O
in	O
recruitment	O
of	O
HDAC1	B-Gene_or_gene_product
to	O
deacetylate	O
p53	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
intra-cellular	B-X
level	B-X
of	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
between	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
negative	B-X
regulator	B-X
MDM2	B-X
.	B-X
The	B-X
role	B-X
of	B-X
MDM2	B-X
in	B-X
down-regulating	B-X
the	B-X
p53	B-X
response	B-X
in	B-X
unstressed	B-X
conditions	B-X
and	B-X
in	B-X
the	B-X
post-stress	B-X
recovery	B-X
phase	B-X
is	B-X
well	B-X
documented	B-X
.	B-X
However	B-X
,	B-X
interplay	B-X
between	B-X
the	B-X
N-terminal	B-X
phosphorylations	B-X
and	B-X
C-terminal	B-X
acetylations	B-X
of	B-X
p53	B-X
in	B-X
this	B-X
context	B-X
remains	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
an	B-X
MAR	B-X
binding	B-X
protein	B-X
SMAR1	B-X
interacts	B-X
with	B-X
MDM2	B-X
and	B-X
the	B-X
Ser15	B-X
phosphorylated	B-X
form	B-X
of	B-X
p53	B-X
,	B-X
forming	B-X
a	B-X
ternary	B-X
complex	B-X
in	B-X
the	B-X
post	B-X
stress-recovery	B-X
phase	B-X
.	B-X
This	B-X
triple	B-X
complex	B-X
formation	B-X
between	B-X
p53	B-X
,	B-X
MDM2	B-X
and	B-X
SMAR1	B-X
results	B-X
in	B-X
recruitment	B-X
of	B-X
HDAC1	B-X
to	B-X
deacetylate	B-X
p53	B-X
.	B-X
The	B-X
deacetylated	B-X
p53	B-X
binds	B-X
poorly	B-X
to	B-X
the	B-X
target	B-X
promoter	B-X
(	B-X
p21	B-X
)	B-X
,	B-X
which	B-X
results	B-X
in	B-X
switching	B-X
off	B-X
the	B-X
p53	B-X
response	B-X
,	B-X
essential	B-X
for	B-X
re-entry	B-X
into	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
knock-down	B-X
of	B-X
SMAR1	B-X
using	B-X
siRNA	B-X
leads	B-X
to	B-X
a	B-X
prolonged	B-X
cell-cycle	B-X
arrest	B-X
in	B-X
the	B-X
post	B-X
stress	B-X
recovery	B-X
phase	B-X
due	B-X
to	B-X
ablation	B-X
of	B-X
p53-MDM2-HDAC1	B-X
interaction	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
highlight	B-X
the	B-X
role	B-X
of	B-X
SMAR1	B-X
in	B-X
masking	B-X
the	B-X
active	B-X
phosphorylation	B-X
site	B-X
of	B-X
p53	B-X
,	B-X
enabling	B-X
the	B-X
deacetylation	B-X
of	B-X
p53	B-X
by	B-X
HDAC1-MDM2	B-X
complex	B-X
,	B-X
thereby	B-X
regulating	B-X
the	B-X
p53	B-X
transcriptional	B-X
response	B-X
during	B-X
stress	B-X
rescue	B-X
.	B-X

The	O
deacetylated	O
p53	B-Gene_or_gene_product
binds	O
poorly	O
to	O
the	O
target	O
promoter	O
(	O
p21	B-Gene_or_gene_product
)	O
,	O
which	O
results	O
in	O
switching	O
off	O
the	O
p53	B-Gene_or_gene_product
response	O
,	O
essential	O
for	O
re	O
-	O
entry	O
into	O
the	O
cell	O
cycle	O
.	O

Interestingly	O
,	O
the	O
knock	O
-	O
down	O
of	O
SMAR1	B-Gene_or_gene_product
using	O
siRNA	O
leads	O
to	O
a	O
prolonged	O
cell	O
-	O
cycle	O
arrest	O
in	O
the	O
post	O
stress	O
recovery	O
phase	O
due	O
to	O
ablation	O
of	O
p53	B-Gene_or_gene_product
-	O
MDM2	B-Gene_or_gene_product
-	O
HDAC1	B-Gene_or_gene_product
interaction	O
.	O
<EOS>	B-X
The	B-X
intra-cellular	B-X
level	B-X
of	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
between	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
negative	B-X
regulator	B-X
MDM2	B-X
.	B-X
The	B-X
role	B-X
of	B-X
MDM2	B-X
in	B-X
down-regulating	B-X
the	B-X
p53	B-X
response	B-X
in	B-X
unstressed	B-X
conditions	B-X
and	B-X
in	B-X
the	B-X
post-stress	B-X
recovery	B-X
phase	B-X
is	B-X
well	B-X
documented	B-X
.	B-X
However	B-X
,	B-X
interplay	B-X
between	B-X
the	B-X
N-terminal	B-X
phosphorylations	B-X
and	B-X
C-terminal	B-X
acetylations	B-X
of	B-X
p53	B-X
in	B-X
this	B-X
context	B-X
remains	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
an	B-X
MAR	B-X
binding	B-X
protein	B-X
SMAR1	B-X
interacts	B-X
with	B-X
MDM2	B-X
and	B-X
the	B-X
Ser15	B-X
phosphorylated	B-X
form	B-X
of	B-X
p53	B-X
,	B-X
forming	B-X
a	B-X
ternary	B-X
complex	B-X
in	B-X
the	B-X
post	B-X
stress-recovery	B-X
phase	B-X
.	B-X
This	B-X
triple	B-X
complex	B-X
formation	B-X
between	B-X
p53	B-X
,	B-X
MDM2	B-X
and	B-X
SMAR1	B-X
results	B-X
in	B-X
recruitment	B-X
of	B-X
HDAC1	B-X
to	B-X
deacetylate	B-X
p53	B-X
.	B-X
The	B-X
deacetylated	B-X
p53	B-X
binds	B-X
poorly	B-X
to	B-X
the	B-X
target	B-X
promoter	B-X
(	B-X
p21	B-X
)	B-X
,	B-X
which	B-X
results	B-X
in	B-X
switching	B-X
off	B-X
the	B-X
p53	B-X
response	B-X
,	B-X
essential	B-X
for	B-X
re-entry	B-X
into	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
knock-down	B-X
of	B-X
SMAR1	B-X
using	B-X
siRNA	B-X
leads	B-X
to	B-X
a	B-X
prolonged	B-X
cell-cycle	B-X
arrest	B-X
in	B-X
the	B-X
post	B-X
stress	B-X
recovery	B-X
phase	B-X
due	B-X
to	B-X
ablation	B-X
of	B-X
p53-MDM2-HDAC1	B-X
interaction	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
highlight	B-X
the	B-X
role	B-X
of	B-X
SMAR1	B-X
in	B-X
masking	B-X
the	B-X
active	B-X
phosphorylation	B-X
site	B-X
of	B-X
p53	B-X
,	B-X
enabling	B-X
the	B-X
deacetylation	B-X
of	B-X
p53	B-X
by	B-X
HDAC1-MDM2	B-X
complex	B-X
,	B-X
thereby	B-X
regulating	B-X
the	B-X
p53	B-X
transcriptional	B-X
response	B-X
during	B-X
stress	B-X
rescue	B-X
.	B-X

Thus	O
,	O
the	O
results	O
presented	O
here	O
for	O
the	O
first	O
time	O
highlight	O
the	O
role	O
of	O
SMAR1	B-Gene_or_gene_product
in	O
masking	O
the	O
active	O
phosphorylation	O
site	O
of	O
p53	B-Gene_or_gene_product
,	O
enabling	O
the	O
deacetylation	O
of	O
p53	B-Gene_or_gene_product
by	O
HDAC1	O
-	O
MDM2	O
complex	O
,	O
thereby	O
regulating	O
the	O
p53	B-Gene_or_gene_product
transcriptional	O
response	O
during	O
stress	O
rescue	O
.	O
<EOS>	B-X
The	B-X
intra-cellular	B-X
level	B-X
of	B-X
tumor	B-X
suppressor	B-X
protein	B-X
p53	B-X
is	B-X
tightly	B-X
controlled	B-X
by	B-X
an	B-X
autoregulatory	B-X
feedback	B-X
loop	B-X
between	B-X
the	B-X
protein	B-X
and	B-X
its	B-X
negative	B-X
regulator	B-X
MDM2	B-X
.	B-X
The	B-X
role	B-X
of	B-X
MDM2	B-X
in	B-X
down-regulating	B-X
the	B-X
p53	B-X
response	B-X
in	B-X
unstressed	B-X
conditions	B-X
and	B-X
in	B-X
the	B-X
post-stress	B-X
recovery	B-X
phase	B-X
is	B-X
well	B-X
documented	B-X
.	B-X
However	B-X
,	B-X
interplay	B-X
between	B-X
the	B-X
N-terminal	B-X
phosphorylations	B-X
and	B-X
C-terminal	B-X
acetylations	B-X
of	B-X
p53	B-X
in	B-X
this	B-X
context	B-X
remains	B-X
unclear	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
an	B-X
MAR	B-X
binding	B-X
protein	B-X
SMAR1	B-X
interacts	B-X
with	B-X
MDM2	B-X
and	B-X
the	B-X
Ser15	B-X
phosphorylated	B-X
form	B-X
of	B-X
p53	B-X
,	B-X
forming	B-X
a	B-X
ternary	B-X
complex	B-X
in	B-X
the	B-X
post	B-X
stress-recovery	B-X
phase	B-X
.	B-X
This	B-X
triple	B-X
complex	B-X
formation	B-X
between	B-X
p53	B-X
,	B-X
MDM2	B-X
and	B-X
SMAR1	B-X
results	B-X
in	B-X
recruitment	B-X
of	B-X
HDAC1	B-X
to	B-X
deacetylate	B-X
p53	B-X
.	B-X
The	B-X
deacetylated	B-X
p53	B-X
binds	B-X
poorly	B-X
to	B-X
the	B-X
target	B-X
promoter	B-X
(	B-X
p21	B-X
)	B-X
,	B-X
which	B-X
results	B-X
in	B-X
switching	B-X
off	B-X
the	B-X
p53	B-X
response	B-X
,	B-X
essential	B-X
for	B-X
re-entry	B-X
into	B-X
the	B-X
cell	B-X
cycle	B-X
.	B-X
Interestingly	B-X
,	B-X
the	B-X
knock-down	B-X
of	B-X
SMAR1	B-X
using	B-X
siRNA	B-X
leads	B-X
to	B-X
a	B-X
prolonged	B-X
cell-cycle	B-X
arrest	B-X
in	B-X
the	B-X
post	B-X
stress	B-X
recovery	B-X
phase	B-X
due	B-X
to	B-X
ablation	B-X
of	B-X
p53-MDM2-HDAC1	B-X
interaction	B-X
.	B-X
Thus	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
here	B-X
for	B-X
the	B-X
first	B-X
time	B-X
highlight	B-X
the	B-X
role	B-X
of	B-X
SMAR1	B-X
in	B-X
masking	B-X
the	B-X
active	B-X
phosphorylation	B-X
site	B-X
of	B-X
p53	B-X
,	B-X
enabling	B-X
the	B-X
deacetylation	B-X
of	B-X
p53	B-X
by	B-X
HDAC1-MDM2	B-X
complex	B-X
,	B-X
thereby	B-X
regulating	B-X
the	B-X
p53	B-X
transcriptional	B-X
response	B-X
during	B-X
stress	B-X
rescue	B-X
.	B-X

Modification	O
of	O
cysteine	O
179	O
of	O
IkappaBalpha	B-Gene_or_gene_product
kinase	O
by	O
nimbolide	O
leads	O
to	O
down	O
-	O
regulation	O
of	O
NF	O
-	O
kappaB	O
-	O
regulated	O
cell	O
survival	O
and	O
proliferative	O
proteins	O
and	O
sensitization	O
of	O
tumor	O
cells	O
to	O
chemotherapeutic	O
agents	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
nimbolide	B-X
,	B-X
a	B-X
triterpenoid	B-X
isolated	B-X
from	B-X
Azadirachta	B-X
indica	B-X
,	B-X
enhanced	B-X
the	B-X
apoptosis	B-X
induced	B-X
by	B-X
inflammatory	B-X
cytokines	B-X
and	B-X
chemotherapeutic	B-X
agents	B-X
in	B-X
tumor	B-X
cells	B-X
.	B-X
This	B-X
limonoid	B-X
abrogated	B-X
the	B-X
expression	B-X
of	B-X
proteins	B-X
associated	B-X
with	B-X
cell	B-X
survival	B-X
(	B-X
Bcl-2	B-X
,	B-X
Bcl-xL	B-X
,	B-X
IAP-1	B-X
,	B-X
and	B-X
IAP-2	B-X
)	B-X
,	B-X
proliferation	B-X
(	B-X
cyclin	B-X
D1	B-X
)	B-X
,	B-X
invasion	B-X
(	B-X
MMP-9	B-X
)	B-X
,	B-X
and	B-X
angiogenesis	B-X
(	B-X
VEGF	B-X
)	B-X
,	B-X
all	B-X
regulated	B-X
by	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-B	B-X
.	B-X
Nimbolide	B-X
inhibited	B-X
the	B-X
activation	B-X
of	B-X
NF-B	B-X
induced	B-X
by	B-X
carcinogens	B-X
and	B-X
inflammatory	B-X
stimuli	B-X
.	B-X
Constitutively	B-X
active	B-X
NF-B	B-X
found	B-X
in	B-X
most	B-X
tumor	B-X
cells	B-X
was	B-X
also	B-X
inhibited	B-X
.	B-X
We	B-X
found	B-X
that	B-X
suppression	B-X
of	B-X
NF-B	B-X
activation	B-X
by	B-X
nimbolide	B-X
was	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
IB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
which	B-X
led	B-X
to	B-X
suppression	B-X
of	B-X
IB	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
,	B-X
DNA	B-X
binding	B-X
,	B-X
and	B-X
gene	B-X
transcription	B-X
.	B-X
Reducing	B-X
agent	B-X
reversed	B-X
the	B-X
action	B-X
of	B-X
the	B-X
limonoid	B-X
,	B-X
suggesting	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
cysteine	B-X
residue	B-X
.	B-X
Replacement	B-X
of	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
of	B-X
IKK-	B-X
with	B-X
alanine	B-X
abolished	B-X
the	B-X
effect	B-X
of	B-X
nimbolide	B-X
,	B-X
suggesting	B-X
that	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
inhibiting	B-X
the	B-X
NF-B	B-X
activation	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
nimbolide	B-X
can	B-X
sensitize	B-X
tumor	B-X
cells	B-X
to	B-X
chemotherapeutic	B-X
agents	B-X
through	B-X
interaction	B-X
with	B-X
IKK	B-X
,	B-X
leading	B-X
to	B-X
inhibition	B-X
of	B-X
NF-B-regulated	B-X
proteins	B-X
.	B-X

Reverse	O
pharmacology	O
,	O
also	O
called	O
the	O
"	O
bedside	O
to	O
bench	O
"	O
approach	O
,	O
that	O
deals	O
with	O
new	O
uses	O
for	O
a	O
well	O
known	O
molecular	O
entity	O
has	O
been	O
used	O
extensively	O
in	O
cancer	O
drug	O
development	O
to	O
identify	O
novel	O
compounds	O
and	O
delineate	O
their	O
mechanisms	O
of	O
action	O
.	O
<EOS>	B-X
Reverse	B-X
pharmacology	B-X
,	B-X
also	B-X
called	B-X
the	B-X
``	B-X
bedside	B-X
to	B-X
bench	B-X
''	B-X
approach	B-X
,	B-X
that	B-X
deals	B-X
with	B-X
new	B-X
uses	B-X
for	B-X
a	B-X
well	B-X
known	B-X
molecular	B-X
entity	B-X
has	B-X
been	B-X
used	B-X
extensively	B-X
in	B-X
cancer	B-X
drug	B-X
development	B-X
to	B-X
identify	B-X
novel	B-X
compounds	B-X
and	B-X
delineate	B-X
their	B-X
mechanisms	B-X
of	B-X
action	B-X
.	B-X
Constitutively	B-X
active	B-X
NF-B	B-X
found	B-X
in	B-X
most	B-X
tumor	B-X
cells	B-X
was	B-X
also	B-X
inhibited	B-X
.	B-X
We	B-X
found	B-X
that	B-X
suppression	B-X
of	B-X
NF-B	B-X
activation	B-X
by	B-X
nimbolide	B-X
was	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
IB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
which	B-X
led	B-X
to	B-X
suppression	B-X
of	B-X
IB	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
,	B-X
DNA	B-X
binding	B-X
,	B-X
and	B-X
gene	B-X
transcription	B-X
.	B-X
Reducing	B-X
agent	B-X
reversed	B-X
the	B-X
action	B-X
of	B-X
the	B-X
limonoid	B-X
,	B-X
suggesting	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
cysteine	B-X
residue	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
nimbolide	B-X
can	B-X
sensitize	B-X
tumor	B-X
cells	B-X
to	B-X
chemotherapeutic	B-X
agents	B-X
through	B-X
interaction	B-X
with	B-X
IKK	B-X
,	B-X
leading	B-X
to	B-X
inhibition	B-X
of	B-X
NF-B-regulated	B-X
proteins	B-X
.	B-X

Here	O
,	O
we	O
show	O
that	O
nimbolide	O
,	O
a	O
triterpenoid	O
isolated	O
from	O
Azadirachta	O
indica	O
,	O
enhanced	O
the	O
apoptosis	O
induced	O
by	O
inflammatory	O
cytokines	O
and	O
chemotherapeutic	O
agents	O
in	O
tumor	O
cells	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
nimbolide	B-X
,	B-X
a	B-X
triterpenoid	B-X
isolated	B-X
from	B-X
Azadirachta	B-X
indica	B-X
,	B-X
enhanced	B-X
the	B-X
apoptosis	B-X
induced	B-X
by	B-X
inflammatory	B-X
cytokines	B-X
and	B-X
chemotherapeutic	B-X
agents	B-X
in	B-X
tumor	B-X
cells	B-X
.	B-X
Nimbolide	B-X
inhibited	B-X
the	B-X
activation	B-X
of	B-X
NF-B	B-X
induced	B-X
by	B-X
carcinogens	B-X
and	B-X
inflammatory	B-X
stimuli	B-X
.	B-X
Constitutively	B-X
active	B-X
NF-B	B-X
found	B-X
in	B-X
most	B-X
tumor	B-X
cells	B-X
was	B-X
also	B-X
inhibited	B-X
.	B-X
We	B-X
found	B-X
that	B-X
suppression	B-X
of	B-X
NF-B	B-X
activation	B-X
by	B-X
nimbolide	B-X
was	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
IB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
which	B-X
led	B-X
to	B-X
suppression	B-X
of	B-X
IB	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
,	B-X
DNA	B-X
binding	B-X
,	B-X
and	B-X
gene	B-X
transcription	B-X
.	B-X
Replacement	B-X
of	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
of	B-X
IKK-	B-X
with	B-X
alanine	B-X
abolished	B-X
the	B-X
effect	B-X
of	B-X
nimbolide	B-X
,	B-X
suggesting	B-X
that	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
inhibiting	B-X
the	B-X
NF-B	B-X
activation	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
nimbolide	B-X
can	B-X
sensitize	B-X
tumor	B-X
cells	B-X
to	B-X
chemotherapeutic	B-X
agents	B-X
through	B-X
interaction	B-X
with	B-X
IKK	B-X
,	B-X
leading	B-X
to	B-X
inhibition	B-X
of	B-X
NF-B-regulated	B-X
proteins	B-X
.	B-X

This	O
limonoid	O
abrogated	O
the	O
expression	O
of	O
proteins	O
associated	O
with	O
cell	O
survival	O
(	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
,	O
Bcl	B-Gene_or_gene_product
-	I-Gene_or_gene_product
xL	I-Gene_or_gene_product
,	O
IAP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
,	O
and	O
IAP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
2	I-Gene_or_gene_product
)	O
,	O
proliferation	O
(	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
)	O
,	O
invasion	O
(	O
MMP	B-Gene_or_gene_product
-	I-Gene_or_gene_product
9	I-Gene_or_gene_product
)	O
,	O
and	O
angiogenesis	O
(	O
VEGF	B-Gene_or_gene_product
)	O
,	O
all	O
regulated	O
by	O
nuclear	O
factor	O
(	O
NF	O
)	O
-	O
kappaB	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
nimbolide	B-X
,	B-X
a	B-X
triterpenoid	B-X
isolated	B-X
from	B-X
Azadirachta	B-X
indica	B-X
,	B-X
enhanced	B-X
the	B-X
apoptosis	B-X
induced	B-X
by	B-X
inflammatory	B-X
cytokines	B-X
and	B-X
chemotherapeutic	B-X
agents	B-X
in	B-X
tumor	B-X
cells	B-X
.	B-X
This	B-X
limonoid	B-X
abrogated	B-X
the	B-X
expression	B-X
of	B-X
proteins	B-X
associated	B-X
with	B-X
cell	B-X
survival	B-X
(	B-X
Bcl-2	B-X
,	B-X
Bcl-xL	B-X
,	B-X
IAP-1	B-X
,	B-X
and	B-X
IAP-2	B-X
)	B-X
,	B-X
proliferation	B-X
(	B-X
cyclin	B-X
D1	B-X
)	B-X
,	B-X
invasion	B-X
(	B-X
MMP-9	B-X
)	B-X
,	B-X
and	B-X
angiogenesis	B-X
(	B-X
VEGF	B-X
)	B-X
,	B-X
all	B-X
regulated	B-X
by	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-B	B-X
.	B-X
Nimbolide	B-X
inhibited	B-X
the	B-X
activation	B-X
of	B-X
NF-B	B-X
induced	B-X
by	B-X
carcinogens	B-X
and	B-X
inflammatory	B-X
stimuli	B-X
.	B-X
Constitutively	B-X
active	B-X
NF-B	B-X
found	B-X
in	B-X
most	B-X
tumor	B-X
cells	B-X
was	B-X
also	B-X
inhibited	B-X
.	B-X
We	B-X
found	B-X
that	B-X
suppression	B-X
of	B-X
NF-B	B-X
activation	B-X
by	B-X
nimbolide	B-X
was	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
IB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
which	B-X
led	B-X
to	B-X
suppression	B-X
of	B-X
IB	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
,	B-X
DNA	B-X
binding	B-X
,	B-X
and	B-X
gene	B-X
transcription	B-X
.	B-X
Reducing	B-X
agent	B-X
reversed	B-X
the	B-X
action	B-X
of	B-X
the	B-X
limonoid	B-X
,	B-X
suggesting	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
cysteine	B-X
residue	B-X
.	B-X
Replacement	B-X
of	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
of	B-X
IKK-	B-X
with	B-X
alanine	B-X
abolished	B-X
the	B-X
effect	B-X
of	B-X
nimbolide	B-X
,	B-X
suggesting	B-X
that	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
inhibiting	B-X
the	B-X
NF-B	B-X
activation	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
nimbolide	B-X
can	B-X
sensitize	B-X
tumor	B-X
cells	B-X
to	B-X
chemotherapeutic	B-X
agents	B-X
through	B-X
interaction	B-X
with	B-X
IKK	B-X
,	B-X
leading	B-X
to	B-X
inhibition	B-X
of	B-X
NF-B-regulated	B-X
proteins	B-X
.	B-X

Nimbolide	O
inhibited	O
the	O
activation	O
of	O
NF	O
-	O
kappaB	O
induced	O
by	O
carcinogens	O
and	O
inflammatory	O
stimuli	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
nimbolide	B-X
,	B-X
a	B-X
triterpenoid	B-X
isolated	B-X
from	B-X
Azadirachta	B-X
indica	B-X
,	B-X
enhanced	B-X
the	B-X
apoptosis	B-X
induced	B-X
by	B-X
inflammatory	B-X
cytokines	B-X
and	B-X
chemotherapeutic	B-X
agents	B-X
in	B-X
tumor	B-X
cells	B-X
.	B-X
This	B-X
limonoid	B-X
abrogated	B-X
the	B-X
expression	B-X
of	B-X
proteins	B-X
associated	B-X
with	B-X
cell	B-X
survival	B-X
(	B-X
Bcl-2	B-X
,	B-X
Bcl-xL	B-X
,	B-X
IAP-1	B-X
,	B-X
and	B-X
IAP-2	B-X
)	B-X
,	B-X
proliferation	B-X
(	B-X
cyclin	B-X
D1	B-X
)	B-X
,	B-X
invasion	B-X
(	B-X
MMP-9	B-X
)	B-X
,	B-X
and	B-X
angiogenesis	B-X
(	B-X
VEGF	B-X
)	B-X
,	B-X
all	B-X
regulated	B-X
by	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-B	B-X
.	B-X
Nimbolide	B-X
inhibited	B-X
the	B-X
activation	B-X
of	B-X
NF-B	B-X
induced	B-X
by	B-X
carcinogens	B-X
and	B-X
inflammatory	B-X
stimuli	B-X
.	B-X
Constitutively	B-X
active	B-X
NF-B	B-X
found	B-X
in	B-X
most	B-X
tumor	B-X
cells	B-X
was	B-X
also	B-X
inhibited	B-X
.	B-X
We	B-X
found	B-X
that	B-X
suppression	B-X
of	B-X
NF-B	B-X
activation	B-X
by	B-X
nimbolide	B-X
was	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
IB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
which	B-X
led	B-X
to	B-X
suppression	B-X
of	B-X
IB	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
,	B-X
DNA	B-X
binding	B-X
,	B-X
and	B-X
gene	B-X
transcription	B-X
.	B-X
Replacement	B-X
of	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
of	B-X
IKK-	B-X
with	B-X
alanine	B-X
abolished	B-X
the	B-X
effect	B-X
of	B-X
nimbolide	B-X
,	B-X
suggesting	B-X
that	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
inhibiting	B-X
the	B-X
NF-B	B-X
activation	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
nimbolide	B-X
can	B-X
sensitize	B-X
tumor	B-X
cells	B-X
to	B-X
chemotherapeutic	B-X
agents	B-X
through	B-X
interaction	B-X
with	B-X
IKK	B-X
,	B-X
leading	B-X
to	B-X
inhibition	B-X
of	B-X
NF-B-regulated	B-X
proteins	B-X
.	B-X

Constitutively	O
active	O
NF	O
-	O
kappaB	O
found	O
in	O
most	O
tumor	O
cells	O
was	O
also	O
inhibited	O
.	O
<EOS>	B-X
Hodgkin	B-X
and	B-X
Reed/Sternberg	B-X
(	B-X
HRS	B-X
)	B-X
cells	B-X
in	B-X
classical	B-X
Hodgkin	B-X
lymphoma	B-X
(	B-X
HL	B-X
)	B-X
show	B-X
constitutive	B-X
activity	B-X
of	B-X
both	B-X
the	B-X
canonical	B-X
and	B-X
non-canonical	B-X
NF-B	B-X
signaling	B-X
pathways	B-X
.	B-X
The	B-X
central	B-X
pathogenetic	B-X
role	B-X
of	B-X
this	B-X
activity	B-X
is	B-X
indicated	B-X
from	B-X
studies	B-X
with	B-X
HL	B-X
cell	B-X
lines	B-X
,	B-X
which	B-X
undergo	B-X
apoptosis	B-X
upon	B-X
NF-B	B-X
inhibition	B-X
.	B-X
Multiple	B-X
factors	B-X
contribute	B-X
to	B-X
the	B-X
strong	B-X
NF-B	B-X
activity	B-X
of	B-X
HRS	B-X
cells	B-X
.	B-X
This	B-X
includes	B-X
interaction	B-X
with	B-X
other	B-X
cells	B-X
in	B-X
the	B-X
lymphoma	B-X
microenvironment	B-X
through	B-X
CD30	B-X
,	B-X
CD40	B-X
,	B-X
BCMA	B-X
and	B-X
other	B-X
receptors	B-X
,	B-X
but	B-X
also	B-X
recurrent	B-X
somatic	B-X
genetic	B-X
lesions	B-X
in	B-X
various	B-X
factors	B-X
of	B-X
the	B-X
NF-B	B-X
pathway	B-X
,	B-X
including	B-X
destructive	B-X
mutations	B-X
in	B-X
negative	B-X
regulators	B-X
of	B-X
NF-B	B-X
signaling	B-X
(	B-X
e.g	B-X
.	B-X
TNFAIP3	B-X
,	B-X
NFKBIA	B-X
)	B-X
,	B-X
and	B-X
copy	B-X
number	B-X
gains	B-X
of	B-X
genes	B-X
encoding	B-X
positive	B-X
regulators	B-X
(	B-X
e.g	B-X
.	B-X
In	B-X
Epstein-Barr	B-X
virus-positive	B-X
cases	B-X
of	B-X
classical	B-X
HL	B-X
,	B-X
the	B-X
virus-encoded	B-X
latent	B-X
membrane	B-X
protein	B-X
1	B-X
causes	B-X
NF-B	B-X
activation	B-X
by	B-X
mimicking	B-X
an	B-X
active	B-X
CD40	B-X
receptor	B-X
.	B-X
NF-B	B-X
activity	B-X
is	B-X
also	B-X
seen	B-X
in	B-X
the	B-X
tumor	B-X
cells	B-X
of	B-X
the	B-X
rare	B-X
nodular	B-X
lymphocyte	B-X
predominant	B-X
form	B-X
of	B-X
HL	B-X
,	B-X
but	B-X
the	B-X
causes	B-X
for	B-X
this	B-X
activity	B-X
are	B-X
largely	B-X
unclear	B-X
.	B-X

We	O
found	O
that	O
suppression	O
of	O
NF	O
-	O
kappaB	O
activation	O
by	O
nimbolide	O
was	O
caused	O
by	O
inhibition	O
of	O
IkappaB	O
kinase	O
(	O
IKK	O
)	O
,	O
which	O
led	O
to	O
suppression	O
of	O
IkappaBalpha	B-Gene_or_gene_product
phosphorylation	O
and	O
degradation	O
,	O
nuclear	O
translocation	O
,	O
DNA	O
binding	O
,	O
and	O
gene	O
transcription	O
.	O
<EOS>	B-X
Reverse	B-X
pharmacology	B-X
,	B-X
also	B-X
called	B-X
the	B-X
``	B-X
bedside	B-X
to	B-X
bench	B-X
''	B-X
approach	B-X
,	B-X
that	B-X
deals	B-X
with	B-X
new	B-X
uses	B-X
for	B-X
a	B-X
well	B-X
known	B-X
molecular	B-X
entity	B-X
has	B-X
been	B-X
used	B-X
extensively	B-X
in	B-X
cancer	B-X
drug	B-X
development	B-X
to	B-X
identify	B-X
novel	B-X
compounds	B-X
and	B-X
delineate	B-X
their	B-X
mechanisms	B-X
of	B-X
action	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
nimbolide	B-X
,	B-X
a	B-X
triterpenoid	B-X
isolated	B-X
from	B-X
Azadirachta	B-X
indica	B-X
,	B-X
enhanced	B-X
the	B-X
apoptosis	B-X
induced	B-X
by	B-X
inflammatory	B-X
cytokines	B-X
and	B-X
chemotherapeutic	B-X
agents	B-X
in	B-X
tumor	B-X
cells	B-X
.	B-X
This	B-X
limonoid	B-X
abrogated	B-X
the	B-X
expression	B-X
of	B-X
proteins	B-X
associated	B-X
with	B-X
cell	B-X
survival	B-X
(	B-X
Bcl-2	B-X
,	B-X
Bcl-xL	B-X
,	B-X
IAP-1	B-X
,	B-X
and	B-X
IAP-2	B-X
)	B-X
,	B-X
proliferation	B-X
(	B-X
cyclin	B-X
D1	B-X
)	B-X
,	B-X
invasion	B-X
(	B-X
MMP-9	B-X
)	B-X
,	B-X
and	B-X
angiogenesis	B-X
(	B-X
VEGF	B-X
)	B-X
,	B-X
all	B-X
regulated	B-X
by	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-B	B-X
.	B-X
Nimbolide	B-X
inhibited	B-X
the	B-X
activation	B-X
of	B-X
NF-B	B-X
induced	B-X
by	B-X
carcinogens	B-X
and	B-X
inflammatory	B-X
stimuli	B-X
.	B-X
Constitutively	B-X
active	B-X
NF-B	B-X
found	B-X
in	B-X
most	B-X
tumor	B-X
cells	B-X
was	B-X
also	B-X
inhibited	B-X
.	B-X
We	B-X
found	B-X
that	B-X
suppression	B-X
of	B-X
NF-B	B-X
activation	B-X
by	B-X
nimbolide	B-X
was	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
IB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
which	B-X
led	B-X
to	B-X
suppression	B-X
of	B-X
IB	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
,	B-X
DNA	B-X
binding	B-X
,	B-X
and	B-X
gene	B-X
transcription	B-X
.	B-X
Replacement	B-X
of	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
of	B-X
IKK-	B-X
with	B-X
alanine	B-X
abolished	B-X
the	B-X
effect	B-X
of	B-X
nimbolide	B-X
,	B-X
suggesting	B-X
that	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
inhibiting	B-X
the	B-X
NF-B	B-X
activation	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
nimbolide	B-X
can	B-X
sensitize	B-X
tumor	B-X
cells	B-X
to	B-X
chemotherapeutic	B-X
agents	B-X
through	B-X
interaction	B-X
with	B-X
IKK	B-X
,	B-X
leading	B-X
to	B-X
inhibition	B-X
of	B-X
NF-B-regulated	B-X
proteins	B-X
.	B-X

Reducing	O
agent	O
reversed	O
the	O
action	O
of	O
the	O
limonoid	O
,	O
suggesting	O
the	O
involvement	O
of	O
a	O
cysteine	O
residue	O
.	O
<EOS>	B-X
Reverse	B-X
pharmacology	B-X
,	B-X
also	B-X
called	B-X
the	B-X
``	B-X
bedside	B-X
to	B-X
bench	B-X
''	B-X
approach	B-X
,	B-X
that	B-X
deals	B-X
with	B-X
new	B-X
uses	B-X
for	B-X
a	B-X
well	B-X
known	B-X
molecular	B-X
entity	B-X
has	B-X
been	B-X
used	B-X
extensively	B-X
in	B-X
cancer	B-X
drug	B-X
development	B-X
to	B-X
identify	B-X
novel	B-X
compounds	B-X
and	B-X
delineate	B-X
their	B-X
mechanisms	B-X
of	B-X
action	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
nimbolide	B-X
,	B-X
a	B-X
triterpenoid	B-X
isolated	B-X
from	B-X
Azadirachta	B-X
indica	B-X
,	B-X
enhanced	B-X
the	B-X
apoptosis	B-X
induced	B-X
by	B-X
inflammatory	B-X
cytokines	B-X
and	B-X
chemotherapeutic	B-X
agents	B-X
in	B-X
tumor	B-X
cells	B-X
.	B-X
This	B-X
limonoid	B-X
abrogated	B-X
the	B-X
expression	B-X
of	B-X
proteins	B-X
associated	B-X
with	B-X
cell	B-X
survival	B-X
(	B-X
Bcl-2	B-X
,	B-X
Bcl-xL	B-X
,	B-X
IAP-1	B-X
,	B-X
and	B-X
IAP-2	B-X
)	B-X
,	B-X
proliferation	B-X
(	B-X
cyclin	B-X
D1	B-X
)	B-X
,	B-X
invasion	B-X
(	B-X
MMP-9	B-X
)	B-X
,	B-X
and	B-X
angiogenesis	B-X
(	B-X
VEGF	B-X
)	B-X
,	B-X
all	B-X
regulated	B-X
by	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-B	B-X
.	B-X
Reducing	B-X
agent	B-X
reversed	B-X
the	B-X
action	B-X
of	B-X
the	B-X
limonoid	B-X
,	B-X
suggesting	B-X
the	B-X
involvement	B-X
of	B-X
a	B-X
cysteine	B-X
residue	B-X
.	B-X
Replacement	B-X
of	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
of	B-X
IKK-	B-X
with	B-X
alanine	B-X
abolished	B-X
the	B-X
effect	B-X
of	B-X
nimbolide	B-X
,	B-X
suggesting	B-X
that	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
inhibiting	B-X
the	B-X
NF-B	B-X
activation	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
nimbolide	B-X
can	B-X
sensitize	B-X
tumor	B-X
cells	B-X
to	B-X
chemotherapeutic	B-X
agents	B-X
through	B-X
interaction	B-X
with	B-X
IKK	B-X
,	B-X
leading	B-X
to	B-X
inhibition	B-X
of	B-X
NF-B-regulated	B-X
proteins	B-X
.	B-X

Replacement	O
of	O
Cys	O
(	O
179	O
)	O
of	O
IKK	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta	I-Gene_or_gene_product
with	O
alanine	O
abolished	O
the	O
effect	O
of	O
nimbolide	O
,	O
suggesting	O
that	O
Cys	O
(	O
179	O
)	O
plays	O
a	O
critical	O
role	O
in	O
inhibiting	O
the	O
NF	O
-	O
kappaB	O
activation	O
.	O

Overall	O
,	O
our	O
results	O
indicate	O
that	O
nimbolide	O
can	O
sensitize	O
tumor	O
cells	O
to	O
chemotherapeutic	O
agents	O
through	O
interaction	O
with	O
IKK	O
,	O
leading	O
to	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
-	O
regulated	O
proteins	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
nimbolide	B-X
,	B-X
a	B-X
triterpenoid	B-X
isolated	B-X
from	B-X
Azadirachta	B-X
indica	B-X
,	B-X
enhanced	B-X
the	B-X
apoptosis	B-X
induced	B-X
by	B-X
inflammatory	B-X
cytokines	B-X
and	B-X
chemotherapeutic	B-X
agents	B-X
in	B-X
tumor	B-X
cells	B-X
.	B-X
This	B-X
limonoid	B-X
abrogated	B-X
the	B-X
expression	B-X
of	B-X
proteins	B-X
associated	B-X
with	B-X
cell	B-X
survival	B-X
(	B-X
Bcl-2	B-X
,	B-X
Bcl-xL	B-X
,	B-X
IAP-1	B-X
,	B-X
and	B-X
IAP-2	B-X
)	B-X
,	B-X
proliferation	B-X
(	B-X
cyclin	B-X
D1	B-X
)	B-X
,	B-X
invasion	B-X
(	B-X
MMP-9	B-X
)	B-X
,	B-X
and	B-X
angiogenesis	B-X
(	B-X
VEGF	B-X
)	B-X
,	B-X
all	B-X
regulated	B-X
by	B-X
nuclear	B-X
factor	B-X
(	B-X
NF	B-X
)	B-X
-B	B-X
.	B-X
Nimbolide	B-X
inhibited	B-X
the	B-X
activation	B-X
of	B-X
NF-B	B-X
induced	B-X
by	B-X
carcinogens	B-X
and	B-X
inflammatory	B-X
stimuli	B-X
.	B-X
Constitutively	B-X
active	B-X
NF-B	B-X
found	B-X
in	B-X
most	B-X
tumor	B-X
cells	B-X
was	B-X
also	B-X
inhibited	B-X
.	B-X
We	B-X
found	B-X
that	B-X
suppression	B-X
of	B-X
NF-B	B-X
activation	B-X
by	B-X
nimbolide	B-X
was	B-X
caused	B-X
by	B-X
inhibition	B-X
of	B-X
IB	B-X
kinase	B-X
(	B-X
IKK	B-X
)	B-X
,	B-X
which	B-X
led	B-X
to	B-X
suppression	B-X
of	B-X
IB	B-X
phosphorylation	B-X
and	B-X
degradation	B-X
,	B-X
nuclear	B-X
translocation	B-X
,	B-X
DNA	B-X
binding	B-X
,	B-X
and	B-X
gene	B-X
transcription	B-X
.	B-X
Replacement	B-X
of	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
of	B-X
IKK-	B-X
with	B-X
alanine	B-X
abolished	B-X
the	B-X
effect	B-X
of	B-X
nimbolide	B-X
,	B-X
suggesting	B-X
that	B-X
Cys	B-X
(	B-X
179	B-X
)	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
inhibiting	B-X
the	B-X
NF-B	B-X
activation	B-X
.	B-X
Overall	B-X
,	B-X
our	B-X
results	B-X
indicate	B-X
that	B-X
nimbolide	B-X
can	B-X
sensitize	B-X
tumor	B-X
cells	B-X
to	B-X
chemotherapeutic	B-X
agents	B-X
through	B-X
interaction	B-X
with	B-X
IKK	B-X
,	B-X
leading	B-X
to	B-X
inhibition	B-X
of	B-X
NF-B-regulated	B-X
proteins	B-X
.	B-X

Phosphorylation	O
of	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
at	O
a	O
single	O
serine	O
residue	O
by	O
DNA	O
-	O
dependent	O
protein	O
kinase	O
is	O
critical	O
for	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
upon	O
TNF	B-Gene_or_gene_product
treatment	O
.	O

The	O
DNA	O
binding	O
activity	O
of	O
NF	O
-	O
kappaB	O
is	O
critical	O
for	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
during	O
inflammation	O
.	O
<EOS>	B-X
The	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
NF-B	B-X
is	B-X
critical	B-X
for	B-X
VCAM-1	B-X
expression	B-X
during	B-X
inflammation	B-X
.	B-X
DNA-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
DNA-PK	B-X
)	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
NF-B	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA-PK	B-X
is	B-X
required	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
phosphorylation	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
I-B	B-X
as	B-X
well	B-X
as	B-X
the	B-X
serine	B-X
536	B-X
phosphorylation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
p65	B-X
NF-B	B-X
were	B-X
insufficient	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
requirement	B-X
for	B-X
p50	B-X
NF-B	B-X
in	B-X
TNF-induced	B-X
VCAM-1	B-X
expression	B-X
may	B-X
be	B-X
associated	B-X
with	B-X
its	B-X
interaction	B-X
with	B-X
and	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
be	B-X
dominant	B-X
over	B-X
the	B-X
requirement	B-X
for	B-X
p65	B-X
NF-B	B-X
activation	B-X
.	B-X
p50	B-X
NF-B	B-X
binding	B-X
to	B-X
its	B-X
consensus	B-X
sequence	B-X
increased	B-X
its	B-X
susceptibility	B-X
to	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Additionally	B-X
,	B-X
DNA-PK	B-X
activity	B-X
appeared	B-X
to	B-X
increase	B-X
the	B-X
association	B-X
between	B-X
p50/p50	B-X
and	B-X
p50/p65	B-X
NF-B	B-X
dimers	B-X
upon	B-X
binding	B-X
to	B-X
DNA	B-X
and	B-X
after	B-X
binding	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
the	B-X
VCAM-1	B-X
promoter	B-X
.	B-X
Analyses	B-X
of	B-X
the	B-X
p50	B-X
NF-B	B-X
protein	B-X
sequence	B-X
revealed	B-X
that	B-X
both	B-X
serine	B-X
20	B-X
and	B-X
serine	B-X
227	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
are	B-X
putative	B-X
sites	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Mutation	B-X
of	B-X
serine	B-X
20	B-X
completely	B-X
eliminated	B-X
phosphorylation	B-X
of	B-X
p50	B-X
NF-B	B-X
by	B-X
DNA-PK	B-X
,	B-X
suggesting	B-X
that	B-X
serine	B-X
20	B-X
is	B-X
the	B-X
only	B-X
site	B-X
in	B-X
p50	B-X
NF-B	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Re-establishing	B-X
wild-type	B-X
p50	B-X
NF-B	B-X
,	B-X
but	B-X
not	B-X
its	B-X
serine	B-X
20/alanine	B-X
mutant	B-X
,	B-X
in	B-X
p50	B-X
NF-B	B-X
(	B-X
-/-	B-X
)	B-X
fibroblasts	B-X
reversed	B-X
VCAM-1	B-X
expression	B-X
after	B-X
TNF	B-X
treatment	B-X
,	B-X
demonstrating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
serine	B-X
20	B-X
phosphorylation	B-X
site	B-X
in	B-X
the	B-X
induction	B-X
of	B-X
VCAM-1	B-X
expression	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
elucidate	B-X
a	B-X
novel	B-X
mechanism	B-X
for	B-X
the	B-X
involvement	B-X
of	B-X
DNA-PK	B-X
in	B-X
the	B-X
positive	B-X
regulation	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
drive	B-X
VCAM-1	B-X
expression	B-X
.	B-X

DNA	O
-	O
dependent	O
protein	O
kinase	O
(	O
DNA	O
-	O
PK	O
)	O
is	O
thought	O
to	O
be	O
involved	O
in	O
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
The	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
NF-B	B-X
is	B-X
critical	B-X
for	B-X
VCAM-1	B-X
expression	B-X
during	B-X
inflammation	B-X
.	B-X
DNA-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
DNA-PK	B-X
)	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
NF-B	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA-PK	B-X
is	B-X
required	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
phosphorylation	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
I-B	B-X
as	B-X
well	B-X
as	B-X
the	B-X
serine	B-X
536	B-X
phosphorylation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
p65	B-X
NF-B	B-X
were	B-X
insufficient	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
requirement	B-X
for	B-X
p50	B-X
NF-B	B-X
in	B-X
TNF-induced	B-X
VCAM-1	B-X
expression	B-X
may	B-X
be	B-X
associated	B-X
with	B-X
its	B-X
interaction	B-X
with	B-X
and	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
be	B-X
dominant	B-X
over	B-X
the	B-X
requirement	B-X
for	B-X
p65	B-X
NF-B	B-X
activation	B-X
.	B-X
p50	B-X
NF-B	B-X
binding	B-X
to	B-X
its	B-X
consensus	B-X
sequence	B-X
increased	B-X
its	B-X
susceptibility	B-X
to	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Additionally	B-X
,	B-X
DNA-PK	B-X
activity	B-X
appeared	B-X
to	B-X
increase	B-X
the	B-X
association	B-X
between	B-X
p50/p50	B-X
and	B-X
p50/p65	B-X
NF-B	B-X
dimers	B-X
upon	B-X
binding	B-X
to	B-X
DNA	B-X
and	B-X
after	B-X
binding	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
the	B-X
VCAM-1	B-X
promoter	B-X
.	B-X
Analyses	B-X
of	B-X
the	B-X
p50	B-X
NF-B	B-X
protein	B-X
sequence	B-X
revealed	B-X
that	B-X
both	B-X
serine	B-X
20	B-X
and	B-X
serine	B-X
227	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
are	B-X
putative	B-X
sites	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Mutation	B-X
of	B-X
serine	B-X
20	B-X
completely	B-X
eliminated	B-X
phosphorylation	B-X
of	B-X
p50	B-X
NF-B	B-X
by	B-X
DNA-PK	B-X
,	B-X
suggesting	B-X
that	B-X
serine	B-X
20	B-X
is	B-X
the	B-X
only	B-X
site	B-X
in	B-X
p50	B-X
NF-B	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Re-establishing	B-X
wild-type	B-X
p50	B-X
NF-B	B-X
,	B-X
but	B-X
not	B-X
its	B-X
serine	B-X
20/alanine	B-X
mutant	B-X
,	B-X
in	B-X
p50	B-X
NF-B	B-X
(	B-X
-/-	B-X
)	B-X
fibroblasts	B-X
reversed	B-X
VCAM-1	B-X
expression	B-X
after	B-X
TNF	B-X
treatment	B-X
,	B-X
demonstrating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
serine	B-X
20	B-X
phosphorylation	B-X
site	B-X
in	B-X
the	B-X
induction	B-X
of	B-X
VCAM-1	B-X
expression	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
elucidate	B-X
a	B-X
novel	B-X
mechanism	B-X
for	B-X
the	B-X
involvement	B-X
of	B-X
DNA-PK	B-X
in	B-X
the	B-X
positive	B-X
regulation	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
drive	B-X
VCAM-1	B-X
expression	B-X
.	B-X

Here	O
we	O
show	O
that	O
DNA	O
-	O
PK	O
is	O
required	O
for	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
in	O
response	O
to	O
TNF	B-Gene_or_gene_product
.	O

The	O
phosphorylation	O
and	O
subsequent	O
degradation	O
of	O
I	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaBalpha	I-Gene_or_gene_product
as	O
well	O
as	O
the	O
serine	O
536	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
p65	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
were	O
insufficient	O
for	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
in	O
response	O
to	O
TNF	B-Gene_or_gene_product
.	O

The	O
requirement	O
for	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
in	O
TNF	B-Gene_or_gene_product
-	O
induced	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
may	O
be	O
associated	O
with	O
its	O
interaction	O
with	O
and	O
phosphorylation	O
by	O
DNA	O
-	O
PK	O
,	O
which	O
appears	O
to	O
be	O
dominant	O
over	O
the	O
requirement	O
for	O
p65	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
activation	O
.	O
<EOS>	B-X
The	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
NF-B	B-X
is	B-X
critical	B-X
for	B-X
VCAM-1	B-X
expression	B-X
during	B-X
inflammation	B-X
.	B-X
DNA-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
DNA-PK	B-X
)	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
NF-B	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA-PK	B-X
is	B-X
required	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
phosphorylation	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
I-B	B-X
as	B-X
well	B-X
as	B-X
the	B-X
serine	B-X
536	B-X
phosphorylation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
p65	B-X
NF-B	B-X
were	B-X
insufficient	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
requirement	B-X
for	B-X
p50	B-X
NF-B	B-X
in	B-X
TNF-induced	B-X
VCAM-1	B-X
expression	B-X
may	B-X
be	B-X
associated	B-X
with	B-X
its	B-X
interaction	B-X
with	B-X
and	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
be	B-X
dominant	B-X
over	B-X
the	B-X
requirement	B-X
for	B-X
p65	B-X
NF-B	B-X
activation	B-X
.	B-X
p50	B-X
NF-B	B-X
binding	B-X
to	B-X
its	B-X
consensus	B-X
sequence	B-X
increased	B-X
its	B-X
susceptibility	B-X
to	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Additionally	B-X
,	B-X
DNA-PK	B-X
activity	B-X
appeared	B-X
to	B-X
increase	B-X
the	B-X
association	B-X
between	B-X
p50/p50	B-X
and	B-X
p50/p65	B-X
NF-B	B-X
dimers	B-X
upon	B-X
binding	B-X
to	B-X
DNA	B-X
and	B-X
after	B-X
binding	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
the	B-X
VCAM-1	B-X
promoter	B-X
.	B-X
Analyses	B-X
of	B-X
the	B-X
p50	B-X
NF-B	B-X
protein	B-X
sequence	B-X
revealed	B-X
that	B-X
both	B-X
serine	B-X
20	B-X
and	B-X
serine	B-X
227	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
are	B-X
putative	B-X
sites	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Mutation	B-X
of	B-X
serine	B-X
20	B-X
completely	B-X
eliminated	B-X
phosphorylation	B-X
of	B-X
p50	B-X
NF-B	B-X
by	B-X
DNA-PK	B-X
,	B-X
suggesting	B-X
that	B-X
serine	B-X
20	B-X
is	B-X
the	B-X
only	B-X
site	B-X
in	B-X
p50	B-X
NF-B	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Re-establishing	B-X
wild-type	B-X
p50	B-X
NF-B	B-X
,	B-X
but	B-X
not	B-X
its	B-X
serine	B-X
20/alanine	B-X
mutant	B-X
,	B-X
in	B-X
p50	B-X
NF-B	B-X
(	B-X
-/-	B-X
)	B-X
fibroblasts	B-X
reversed	B-X
VCAM-1	B-X
expression	B-X
after	B-X
TNF	B-X
treatment	B-X
,	B-X
demonstrating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
serine	B-X
20	B-X
phosphorylation	B-X
site	B-X
in	B-X
the	B-X
induction	B-X
of	B-X
VCAM-1	B-X
expression	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
elucidate	B-X
a	B-X
novel	B-X
mechanism	B-X
for	B-X
the	B-X
involvement	B-X
of	B-X
DNA-PK	B-X
in	B-X
the	B-X
positive	B-X
regulation	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
drive	B-X
VCAM-1	B-X
expression	B-X
.	B-X

p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
binding	O
to	O
its	O
consensus	O
sequence	O
increased	O
its	O
susceptibility	O
to	O
phosphorylation	O
by	O
DNA	O
-	O
PK	O
.	O
<EOS>	B-X
The	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
NF-B	B-X
is	B-X
critical	B-X
for	B-X
VCAM-1	B-X
expression	B-X
during	B-X
inflammation	B-X
.	B-X
DNA-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
DNA-PK	B-X
)	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
NF-B	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA-PK	B-X
is	B-X
required	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
phosphorylation	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
I-B	B-X
as	B-X
well	B-X
as	B-X
the	B-X
serine	B-X
536	B-X
phosphorylation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
p65	B-X
NF-B	B-X
were	B-X
insufficient	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
requirement	B-X
for	B-X
p50	B-X
NF-B	B-X
in	B-X
TNF-induced	B-X
VCAM-1	B-X
expression	B-X
may	B-X
be	B-X
associated	B-X
with	B-X
its	B-X
interaction	B-X
with	B-X
and	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
be	B-X
dominant	B-X
over	B-X
the	B-X
requirement	B-X
for	B-X
p65	B-X
NF-B	B-X
activation	B-X
.	B-X
p50	B-X
NF-B	B-X
binding	B-X
to	B-X
its	B-X
consensus	B-X
sequence	B-X
increased	B-X
its	B-X
susceptibility	B-X
to	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Additionally	B-X
,	B-X
DNA-PK	B-X
activity	B-X
appeared	B-X
to	B-X
increase	B-X
the	B-X
association	B-X
between	B-X
p50/p50	B-X
and	B-X
p50/p65	B-X
NF-B	B-X
dimers	B-X
upon	B-X
binding	B-X
to	B-X
DNA	B-X
and	B-X
after	B-X
binding	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
the	B-X
VCAM-1	B-X
promoter	B-X
.	B-X
Analyses	B-X
of	B-X
the	B-X
p50	B-X
NF-B	B-X
protein	B-X
sequence	B-X
revealed	B-X
that	B-X
both	B-X
serine	B-X
20	B-X
and	B-X
serine	B-X
227	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
are	B-X
putative	B-X
sites	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Mutation	B-X
of	B-X
serine	B-X
20	B-X
completely	B-X
eliminated	B-X
phosphorylation	B-X
of	B-X
p50	B-X
NF-B	B-X
by	B-X
DNA-PK	B-X
,	B-X
suggesting	B-X
that	B-X
serine	B-X
20	B-X
is	B-X
the	B-X
only	B-X
site	B-X
in	B-X
p50	B-X
NF-B	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Re-establishing	B-X
wild-type	B-X
p50	B-X
NF-B	B-X
,	B-X
but	B-X
not	B-X
its	B-X
serine	B-X
20/alanine	B-X
mutant	B-X
,	B-X
in	B-X
p50	B-X
NF-B	B-X
(	B-X
-/-	B-X
)	B-X
fibroblasts	B-X
reversed	B-X
VCAM-1	B-X
expression	B-X
after	B-X
TNF	B-X
treatment	B-X
,	B-X
demonstrating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
serine	B-X
20	B-X
phosphorylation	B-X
site	B-X
in	B-X
the	B-X
induction	B-X
of	B-X
VCAM-1	B-X
expression	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
elucidate	B-X
a	B-X
novel	B-X
mechanism	B-X
for	B-X
the	B-X
involvement	B-X
of	B-X
DNA-PK	B-X
in	B-X
the	B-X
positive	B-X
regulation	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
drive	B-X
VCAM-1	B-X
expression	B-X
.	B-X

Additionally	O
,	O
DNA	O
-	O
PK	O
activity	O
appeared	O
to	O
increase	O
the	O
association	O
between	O
p50	B-Gene_or_gene_product
/	O
p50	B-Gene_or_gene_product
and	O
p50	B-Gene_or_gene_product
/	O
p65	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
dimers	O
upon	O
binding	O
to	O
DNA	O
and	O
after	O
binding	O
of	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
to	O
the	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
promoter	O
.	O

Analyses	O
of	O
the	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
protein	O
sequence	O
revealed	O
that	O
both	O
serine	O
20	O
and	O
serine	O
227	O
at	O
the	O
amino	O
terminus	O
of	O
the	O
protein	O
are	O
putative	O
sites	O
for	O
phosphorylation	O
by	O
DNA	O
-	O
PK	O
.	O
<EOS>	B-X
The	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
NF-B	B-X
is	B-X
critical	B-X
for	B-X
VCAM-1	B-X
expression	B-X
during	B-X
inflammation	B-X
.	B-X
DNA-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
DNA-PK	B-X
)	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
NF-B	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA-PK	B-X
is	B-X
required	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
phosphorylation	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
I-B	B-X
as	B-X
well	B-X
as	B-X
the	B-X
serine	B-X
536	B-X
phosphorylation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
p65	B-X
NF-B	B-X
were	B-X
insufficient	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
requirement	B-X
for	B-X
p50	B-X
NF-B	B-X
in	B-X
TNF-induced	B-X
VCAM-1	B-X
expression	B-X
may	B-X
be	B-X
associated	B-X
with	B-X
its	B-X
interaction	B-X
with	B-X
and	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
be	B-X
dominant	B-X
over	B-X
the	B-X
requirement	B-X
for	B-X
p65	B-X
NF-B	B-X
activation	B-X
.	B-X
p50	B-X
NF-B	B-X
binding	B-X
to	B-X
its	B-X
consensus	B-X
sequence	B-X
increased	B-X
its	B-X
susceptibility	B-X
to	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Additionally	B-X
,	B-X
DNA-PK	B-X
activity	B-X
appeared	B-X
to	B-X
increase	B-X
the	B-X
association	B-X
between	B-X
p50/p50	B-X
and	B-X
p50/p65	B-X
NF-B	B-X
dimers	B-X
upon	B-X
binding	B-X
to	B-X
DNA	B-X
and	B-X
after	B-X
binding	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
the	B-X
VCAM-1	B-X
promoter	B-X
.	B-X
Analyses	B-X
of	B-X
the	B-X
p50	B-X
NF-B	B-X
protein	B-X
sequence	B-X
revealed	B-X
that	B-X
both	B-X
serine	B-X
20	B-X
and	B-X
serine	B-X
227	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
are	B-X
putative	B-X
sites	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Mutation	B-X
of	B-X
serine	B-X
20	B-X
completely	B-X
eliminated	B-X
phosphorylation	B-X
of	B-X
p50	B-X
NF-B	B-X
by	B-X
DNA-PK	B-X
,	B-X
suggesting	B-X
that	B-X
serine	B-X
20	B-X
is	B-X
the	B-X
only	B-X
site	B-X
in	B-X
p50	B-X
NF-B	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Re-establishing	B-X
wild-type	B-X
p50	B-X
NF-B	B-X
,	B-X
but	B-X
not	B-X
its	B-X
serine	B-X
20/alanine	B-X
mutant	B-X
,	B-X
in	B-X
p50	B-X
NF-B	B-X
(	B-X
-/-	B-X
)	B-X
fibroblasts	B-X
reversed	B-X
VCAM-1	B-X
expression	B-X
after	B-X
TNF	B-X
treatment	B-X
,	B-X
demonstrating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
serine	B-X
20	B-X
phosphorylation	B-X
site	B-X
in	B-X
the	B-X
induction	B-X
of	B-X
VCAM-1	B-X
expression	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
elucidate	B-X
a	B-X
novel	B-X
mechanism	B-X
for	B-X
the	B-X
involvement	B-X
of	B-X
DNA-PK	B-X
in	B-X
the	B-X
positive	B-X
regulation	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
drive	B-X
VCAM-1	B-X
expression	B-X
.	B-X

Mutation	O
of	O
serine	O
20	O
completely	O
eliminated	O
phosphorylation	O
of	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
by	O
DNA	O
-	O
PK	O
,	O
suggesting	O
that	O
serine	O
20	O
is	O
the	O
only	O
site	O
in	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
for	O
phosphorylation	O
by	O
DNA	O
-	O
PK	O
.	O
<EOS>	B-X
The	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
NF-B	B-X
is	B-X
critical	B-X
for	B-X
VCAM-1	B-X
expression	B-X
during	B-X
inflammation	B-X
.	B-X
DNA-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
DNA-PK	B-X
)	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
NF-B	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA-PK	B-X
is	B-X
required	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
phosphorylation	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
I-B	B-X
as	B-X
well	B-X
as	B-X
the	B-X
serine	B-X
536	B-X
phosphorylation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
p65	B-X
NF-B	B-X
were	B-X
insufficient	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
requirement	B-X
for	B-X
p50	B-X
NF-B	B-X
in	B-X
TNF-induced	B-X
VCAM-1	B-X
expression	B-X
may	B-X
be	B-X
associated	B-X
with	B-X
its	B-X
interaction	B-X
with	B-X
and	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
be	B-X
dominant	B-X
over	B-X
the	B-X
requirement	B-X
for	B-X
p65	B-X
NF-B	B-X
activation	B-X
.	B-X
p50	B-X
NF-B	B-X
binding	B-X
to	B-X
its	B-X
consensus	B-X
sequence	B-X
increased	B-X
its	B-X
susceptibility	B-X
to	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Additionally	B-X
,	B-X
DNA-PK	B-X
activity	B-X
appeared	B-X
to	B-X
increase	B-X
the	B-X
association	B-X
between	B-X
p50/p50	B-X
and	B-X
p50/p65	B-X
NF-B	B-X
dimers	B-X
upon	B-X
binding	B-X
to	B-X
DNA	B-X
and	B-X
after	B-X
binding	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
the	B-X
VCAM-1	B-X
promoter	B-X
.	B-X
Analyses	B-X
of	B-X
the	B-X
p50	B-X
NF-B	B-X
protein	B-X
sequence	B-X
revealed	B-X
that	B-X
both	B-X
serine	B-X
20	B-X
and	B-X
serine	B-X
227	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
are	B-X
putative	B-X
sites	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Mutation	B-X
of	B-X
serine	B-X
20	B-X
completely	B-X
eliminated	B-X
phosphorylation	B-X
of	B-X
p50	B-X
NF-B	B-X
by	B-X
DNA-PK	B-X
,	B-X
suggesting	B-X
that	B-X
serine	B-X
20	B-X
is	B-X
the	B-X
only	B-X
site	B-X
in	B-X
p50	B-X
NF-B	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Re-establishing	B-X
wild-type	B-X
p50	B-X
NF-B	B-X
,	B-X
but	B-X
not	B-X
its	B-X
serine	B-X
20/alanine	B-X
mutant	B-X
,	B-X
in	B-X
p50	B-X
NF-B	B-X
(	B-X
-/-	B-X
)	B-X
fibroblasts	B-X
reversed	B-X
VCAM-1	B-X
expression	B-X
after	B-X
TNF	B-X
treatment	B-X
,	B-X
demonstrating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
serine	B-X
20	B-X
phosphorylation	B-X
site	B-X
in	B-X
the	B-X
induction	B-X
of	B-X
VCAM-1	B-X
expression	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
elucidate	B-X
a	B-X
novel	B-X
mechanism	B-X
for	B-X
the	B-X
involvement	B-X
of	B-X
DNA-PK	B-X
in	B-X
the	B-X
positive	B-X
regulation	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
drive	B-X
VCAM-1	B-X
expression	B-X
.	B-X

Re	O
-	O
establishing	O
wild	O
-	O
type	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
,	O
but	O
not	O
its	O
serine	O
20	O
/	O
alanine	O
mutant	O
,	O
in	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
(	O
-	O
/	O
-	O
)	O
fibroblasts	O
reversed	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
after	O
TNF	B-Gene_or_gene_product
treatment	O
,	O
demonstrating	O
the	O
importance	O
of	O
the	O
serine	O
20	O
phosphorylation	O
site	O
in	O
the	O
induction	O
of	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
The	B-X
RelA	B-X
transcription	B-X
factor	B-X
is	B-X
part	B-X
of	B-X
dimeric	B-X
complexes	B-X
,	B-X
most	B-X
commonly	B-X
either	B-X
p50-RelA	B-X
(	B-X
NF-kappaB	B-X
)	B-X
heterodimers	B-X
or	B-X
RelA	B-X
homodimers	B-X
,	B-X
that	B-X
control	B-X
a	B-X
variety	B-X
of	B-X
cellular	B-X
processes	B-X
.	B-X
Immortalized	B-X
embryonic	B-X
fibroblasts	B-X
established	B-X
from	B-X
rela	B-X
knockout	B-X
mice	B-X
have	B-X
previously	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
more	B-X
sensitive	B-X
to	B-X
apoptosis	B-X
induced	B-X
by	B-X
tumor	B-X
necrosis	B-X
factor	B-X
(	B-X
TNF	B-X
)	B-X
than	B-X
are	B-X
control	B-X
fibroblasts	B-X
.	B-X
In	B-X
this	B-X
report	B-X
,	B-X
we	B-X
show	B-X
that	B-X
one	B-X
line	B-X
of	B-X
rela-/-	B-X
fibroblasts	B-X
has	B-X
additional	B-X
phenotypes	B-X
that	B-X
distinguish	B-X
them	B-X
from	B-X
control	B-X
mouse	B-X
fibroblasts	B-X
.	B-X
As	B-X
compared	B-X
to	B-X
normal	B-X
3T3	B-X
cells	B-X
,	B-X
RelA-deficient	B-X
fibroblasts	B-X
have	B-X
a	B-X
spindled	B-X
morphology	B-X
,	B-X
are	B-X
less	B-X
adherent	B-X
to	B-X
culture	B-X
dishes	B-X
,	B-X
grow	B-X
to	B-X
a	B-X
higher	B-X
saturation	B-X
density	B-X
,	B-X
and	B-X
can	B-X
form	B-X
colonies	B-X
in	B-X
soft	B-X
agar	B-X
.	B-X
These	B-X
properties	B-X
are	B-X
consistent	B-X
with	B-X
a	B-X
weakly	B-X
transformed	B-X
phenotype	B-X
for	B-X
rela-/-	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
RelA-deficient	B-X
fibroblasts	B-X
can	B-X
form	B-X
tumors	B-X
in	B-X
immunodeficient	B-X
mice	B-X
,	B-X
but	B-X
these	B-X
tumors	B-X
regress	B-X
,	B-X
probably	B-X
because	B-X
of	B-X
the	B-X
sensitivity	B-X
of	B-X
these	B-X
cells	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
ability	B-X
of	B-X
rela-/-	B-X
fibroblasts	B-X
to	B-X
form	B-X
colonies	B-X
in	B-X
soft	B-X
agar	B-X
can	B-X
be	B-X
reverted	B-X
by	B-X
re-expression	B-X
of	B-X
wild-type	B-X
mouse	B-X
RelA	B-X
,	B-X
but	B-X
not	B-X
by	B-X
expression	B-X
of	B-X
RelA	B-X
mutants	B-X
that	B-X
can	B-X
not	B-X
form	B-X
homodimers	B-X
.	B-X
There	B-X
is	B-X
no	B-X
clear	B-X
correlation	B-X
between	B-X
the	B-X
absence	B-X
of	B-X
RelA	B-X
and	B-X
the	B-X
levels	B-X
of	B-X
expression	B-X
of	B-X
other	B-X
Rel/NF-kappaB	B-X
family	B-X
members	B-X
or	B-X
adhesion	B-X
proteins	B-X
(	B-X
ICAM-1	B-X
and	B-X
VCAM-1	B-X
)	B-X
whose	B-X
genes	B-X
have	B-X
upstream	B-X
kappaB	B-X
sites	B-X
.	B-X

Together	O
,	O
these	O
results	O
elucidate	O
a	O
novel	O
mechanism	O
for	O
the	O
involvement	O
of	O
DNA	O
-	O
PK	O
in	O
the	O
positive	O
regulation	O
of	O
p50	B-Gene_or_gene_product
NF	O
-	O
kappaB	O
to	O
drive	O
VCAM	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
The	B-X
DNA	B-X
binding	B-X
activity	B-X
of	B-X
NF-B	B-X
is	B-X
critical	B-X
for	B-X
VCAM-1	B-X
expression	B-X
during	B-X
inflammation	B-X
.	B-X
DNA-dependent	B-X
protein	B-X
kinase	B-X
(	B-X
DNA-PK	B-X
)	B-X
is	B-X
thought	B-X
to	B-X
be	B-X
involved	B-X
in	B-X
NF-B	B-X
activation	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
DNA-PK	B-X
is	B-X
required	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
phosphorylation	B-X
and	B-X
subsequent	B-X
degradation	B-X
of	B-X
I-B	B-X
as	B-X
well	B-X
as	B-X
the	B-X
serine	B-X
536	B-X
phosphorylation	B-X
and	B-X
nuclear	B-X
translocation	B-X
of	B-X
p65	B-X
NF-B	B-X
were	B-X
insufficient	B-X
for	B-X
VCAM-1	B-X
expression	B-X
in	B-X
response	B-X
to	B-X
TNF	B-X
.	B-X
The	B-X
requirement	B-X
for	B-X
p50	B-X
NF-B	B-X
in	B-X
TNF-induced	B-X
VCAM-1	B-X
expression	B-X
may	B-X
be	B-X
associated	B-X
with	B-X
its	B-X
interaction	B-X
with	B-X
and	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
be	B-X
dominant	B-X
over	B-X
the	B-X
requirement	B-X
for	B-X
p65	B-X
NF-B	B-X
activation	B-X
.	B-X
p50	B-X
NF-B	B-X
binding	B-X
to	B-X
its	B-X
consensus	B-X
sequence	B-X
increased	B-X
its	B-X
susceptibility	B-X
to	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Additionally	B-X
,	B-X
DNA-PK	B-X
activity	B-X
appeared	B-X
to	B-X
increase	B-X
the	B-X
association	B-X
between	B-X
p50/p50	B-X
and	B-X
p50/p65	B-X
NF-B	B-X
dimers	B-X
upon	B-X
binding	B-X
to	B-X
DNA	B-X
and	B-X
after	B-X
binding	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
the	B-X
VCAM-1	B-X
promoter	B-X
.	B-X
Analyses	B-X
of	B-X
the	B-X
p50	B-X
NF-B	B-X
protein	B-X
sequence	B-X
revealed	B-X
that	B-X
both	B-X
serine	B-X
20	B-X
and	B-X
serine	B-X
227	B-X
at	B-X
the	B-X
amino	B-X
terminus	B-X
of	B-X
the	B-X
protein	B-X
are	B-X
putative	B-X
sites	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Mutation	B-X
of	B-X
serine	B-X
20	B-X
completely	B-X
eliminated	B-X
phosphorylation	B-X
of	B-X
p50	B-X
NF-B	B-X
by	B-X
DNA-PK	B-X
,	B-X
suggesting	B-X
that	B-X
serine	B-X
20	B-X
is	B-X
the	B-X
only	B-X
site	B-X
in	B-X
p50	B-X
NF-B	B-X
for	B-X
phosphorylation	B-X
by	B-X
DNA-PK	B-X
.	B-X
Re-establishing	B-X
wild-type	B-X
p50	B-X
NF-B	B-X
,	B-X
but	B-X
not	B-X
its	B-X
serine	B-X
20/alanine	B-X
mutant	B-X
,	B-X
in	B-X
p50	B-X
NF-B	B-X
(	B-X
-/-	B-X
)	B-X
fibroblasts	B-X
reversed	B-X
VCAM-1	B-X
expression	B-X
after	B-X
TNF	B-X
treatment	B-X
,	B-X
demonstrating	B-X
the	B-X
importance	B-X
of	B-X
the	B-X
serine	B-X
20	B-X
phosphorylation	B-X
site	B-X
in	B-X
the	B-X
induction	B-X
of	B-X
VCAM-1	B-X
expression	B-X
.	B-X
Together	B-X
,	B-X
these	B-X
results	B-X
elucidate	B-X
a	B-X
novel	B-X
mechanism	B-X
for	B-X
the	B-X
involvement	B-X
of	B-X
DNA-PK	B-X
in	B-X
the	B-X
positive	B-X
regulation	B-X
of	B-X
p50	B-X
NF-B	B-X
to	B-X
drive	B-X
VCAM-1	B-X
expression	B-X
.	B-X

NF	O
-	O
kappaB	O
p65	B-Gene_or_gene_product
represses	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
-	O
activated	O
transcription	O
of	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
.	O
<EOS>	B-X
Signaling	B-X
crosstalk	B-X
between	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
pathways	B-X
represents	B-X
a	B-X
functional	B-X
network	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
the	B-X
crosstalk	B-X
also	B-X
occurs	B-X
on	B-X
their	B-X
common	B-X
target	B-X
genes	B-X
,	B-X
the	B-X
cyclin	B-X
D1	B-X
promoter	B-X
was	B-X
used	B-X
as	B-X
a	B-X
model	B-X
because	B-X
it	B-X
contains	B-X
binding	B-X
sites	B-X
for	B-X
both	B-X
proteins	B-X
.	B-X
-catenin	B-X
activated	B-X
transcription	B-X
from	B-X
the	B-X
cyclin	B-X
D1	B-X
promoter	B-X
,	B-X
while	B-X
co-expression	B-X
of	B-X
NF-B	B-X
p65	B-X
reduced	B-X
-catenin-induced	B-X
transcription	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
revealed	B-X
lithium	B-X
chloride-induced	B-X
binding	B-X
of	B-X
-catenin	B-X
on	B-X
one	B-X
of	B-X
the	B-X
T-cell	B-X
activating	B-X
factor	B-X
binding	B-X
sites	B-X
.	B-X
More	B-X
interestingly	B-X
,	B-X
-catenin	B-X
binding	B-X
was	B-X
greatly	B-X
reduced	B-X
by	B-X
NF-B	B-X
p65	B-X
,	B-X
possibly	B-X
by	B-X
the	B-X
protein-protein	B-X
interaction	B-X
between	B-X
the	B-X
two	B-X
proteins	B-X
.	B-X
Such	B-X
a	B-X
dynamic	B-X
and	B-X
complex	B-X
binding	B-X
of	B-X
-catenin	B-X
and	B-X
NF-B	B-X
on	B-X
promoters	B-X
might	B-X
contribute	B-X
to	B-X
the	B-X
regulated	B-X
expression	B-X
of	B-X
their	B-X
target	B-X
genes	B-X
.	B-X

Signaling	O
crosstalk	O
between	O
the	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
pathways	O
represents	O
a	O
functional	O
network	O
.	O
<EOS>	B-X
Signaling	B-X
crosstalk	B-X
between	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
pathways	B-X
represents	B-X
a	B-X
functional	B-X
network	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
the	B-X
crosstalk	B-X
also	B-X
occurs	B-X
on	B-X
their	B-X
common	B-X
target	B-X
genes	B-X
,	B-X
the	B-X
cyclin	B-X
D1	B-X
promoter	B-X
was	B-X
used	B-X
as	B-X
a	B-X
model	B-X
because	B-X
it	B-X
contains	B-X
binding	B-X
sites	B-X
for	B-X
both	B-X
proteins	B-X
.	B-X
-catenin	B-X
activated	B-X
transcription	B-X
from	B-X
the	B-X
cyclin	B-X
D1	B-X
promoter	B-X
,	B-X
while	B-X
co-expression	B-X
of	B-X
NF-B	B-X
p65	B-X
reduced	B-X
-catenin-induced	B-X
transcription	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
revealed	B-X
lithium	B-X
chloride-induced	B-X
binding	B-X
of	B-X
-catenin	B-X
on	B-X
one	B-X
of	B-X
the	B-X
T-cell	B-X
activating	B-X
factor	B-X
binding	B-X
sites	B-X
.	B-X
More	B-X
interestingly	B-X
,	B-X
-catenin	B-X
binding	B-X
was	B-X
greatly	B-X
reduced	B-X
by	B-X
NF-B	B-X
p65	B-X
,	B-X
possibly	B-X
by	B-X
the	B-X
protein-protein	B-X
interaction	B-X
between	B-X
the	B-X
two	B-X
proteins	B-X
.	B-X
Such	B-X
a	B-X
dynamic	B-X
and	B-X
complex	B-X
binding	B-X
of	B-X
-catenin	B-X
and	B-X
NF-B	B-X
on	B-X
promoters	B-X
might	B-X
contribute	B-X
to	B-X
the	B-X
regulated	B-X
expression	B-X
of	B-X
their	B-X
target	B-X
genes	B-X
.	B-X

To	O
test	O
whether	O
the	O
crosstalk	O
also	O
occurs	O
on	O
their	O
common	O
target	O
genes	O
,	O
the	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
promoter	O
was	O
used	O
as	O
a	O
model	O
because	O
it	O
contains	O
binding	O
sites	O
for	O
both	O
proteins	O
.	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
activated	O
transcription	O
from	O
the	O
cyclin	B-Gene_or_gene_product
D1	I-Gene_or_gene_product
promoter	O
,	O
while	O
co	O
-	O
expression	O
of	O
NF	O
-	O
kappaB	O
p65	B-Gene_or_gene_product
reduced	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
-	O
induced	O
transcription	O
.	O

Chromatin	B-Gene_or_gene_product
immunoprecipitation	O
revealed	O
lithium	O
chloride	O
-	O
induced	O
binding	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
on	O
one	O
of	O
the	O
T	B-Gene_or_gene_product
-	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
activating	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
binding	O
sites	O
.	O

More	O
interestingly	O
,	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
binding	O
was	O
greatly	O
reduced	O
by	O
NF	O
-	O
kappaB	O
p65	B-Gene_or_gene_product
,	O
possibly	O
by	O
the	O
protein	O
-	O
protein	O
interaction	O
between	O
the	O
two	O
proteins	O
.	O
<EOS>	B-X
Signaling	B-X
crosstalk	B-X
between	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
pathways	B-X
represents	B-X
a	B-X
functional	B-X
network	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
the	B-X
crosstalk	B-X
also	B-X
occurs	B-X
on	B-X
their	B-X
common	B-X
target	B-X
genes	B-X
,	B-X
the	B-X
cyclin	B-X
D1	B-X
promoter	B-X
was	B-X
used	B-X
as	B-X
a	B-X
model	B-X
because	B-X
it	B-X
contains	B-X
binding	B-X
sites	B-X
for	B-X
both	B-X
proteins	B-X
.	B-X
-catenin	B-X
activated	B-X
transcription	B-X
from	B-X
the	B-X
cyclin	B-X
D1	B-X
promoter	B-X
,	B-X
while	B-X
co-expression	B-X
of	B-X
NF-B	B-X
p65	B-X
reduced	B-X
-catenin-induced	B-X
transcription	B-X
.	B-X
Chromatin	B-X
immunoprecipitation	B-X
revealed	B-X
lithium	B-X
chloride-induced	B-X
binding	B-X
of	B-X
-catenin	B-X
on	B-X
one	B-X
of	B-X
the	B-X
T-cell	B-X
activating	B-X
factor	B-X
binding	B-X
sites	B-X
.	B-X
More	B-X
interestingly	B-X
,	B-X
-catenin	B-X
binding	B-X
was	B-X
greatly	B-X
reduced	B-X
by	B-X
NF-B	B-X
p65	B-X
,	B-X
possibly	B-X
by	B-X
the	B-X
protein-protein	B-X
interaction	B-X
between	B-X
the	B-X
two	B-X
proteins	B-X
.	B-X
Such	B-X
a	B-X
dynamic	B-X
and	B-X
complex	B-X
binding	B-X
of	B-X
-catenin	B-X
and	B-X
NF-B	B-X
on	B-X
promoters	B-X
might	B-X
contribute	B-X
to	B-X
the	B-X
regulated	B-X
expression	B-X
of	B-X
their	B-X
target	B-X
genes	B-X
.	B-X

Such	O
a	O
dynamic	O
and	O
complex	O
binding	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
on	O
promoters	O
might	O
contribute	O
to	O
the	O
regulated	O
expression	O
of	O
their	O
target	O
genes	O
.	O

Zac1	B-Gene_or_gene_product
is	O
a	O
histone	B-Gene_or_gene_product
acetylation	O
-	O
regulated	O
NF	O
-	O
kappaB	O
suppressor	O
that	O
mediates	O
histone	B-Gene_or_gene_product
deacetylase	I-Gene_or_gene_product
inhibitor	I-Gene_or_gene_product
-	O
induced	O
apoptosis	O
.	O
<EOS>	B-X
Histone	B-X
deacetylase	B-X
(	B-X
HDAC	B-X
)	B-X
inhibitors	B-X
are	B-X
a	B-X
class	B-X
of	B-X
promising	B-X
anticancer	B-X
reagents	B-X
.	B-X
They	B-X
are	B-X
able	B-X
to	B-X
induce	B-X
apoptosis	B-X
in	B-X
embryonic	B-X
carcinoma	B-X
(	B-X
EC	B-X
)	B-X
cells	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
increased	B-X
expression	B-X
of	B-X
zinc-finger	B-X
protein	B-X
regulator	B-X
of	B-X
apoptosis	B-X
and	B-X
cell-cycle	B-X
arrest	B-X
(	B-X
Zac1	B-X
)	B-X
is	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-induced	B-X
apoptosis	B-X
in	B-X
F9	B-X
and	B-X
P19	B-X
EC	B-X
cells	B-X
.	B-X
By	B-X
chromatin	B-X
immunoprecipitation	B-X
analysis	B-X
we	B-X
identified	B-X
that	B-X
increased	B-X
Zac1	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
histone	B-X
acetylation	B-X
of	B-X
the	B-X
Zac1	B-X
promoter	B-X
region	B-X
.	B-X
Knockdown	B-X
of	B-X
Zac1	B-X
inhibited	B-X
HDAC	B-X
inhibitor-induced	B-X
cell	B-X
apoptosis	B-X
.	B-X
Moreover	B-X
,	B-X
HDAC	B-X
inhibitors	B-X
repressed	B-X
nuclear	B-X
factor-B	B-X
(	B-X
NF-B	B-X
)	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
effect	B-X
is	B-X
abrogated	B-X
by	B-X
Zac1	B-X
knockdown	B-X
.	B-X
Consistently	B-X
,	B-X
Zac1	B-X
overexpression	B-X
suppressed	B-X
cellular	B-X
NF-B	B-X
activity	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
Zac1	B-X
inhibits	B-X
NF-B	B-X
activity	B-X
by	B-X
interacting	B-X
with	B-X
the	B-X
C-terminus	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
,	B-X
which	B-X
suppresses	B-X
the	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser468	B-X
and	B-X
Ser536	B-X
residues	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
Zac1	B-X
is	B-X
a	B-X
histone	B-X
acetylation-regulated	B-X
suppressor	B-X
of	B-X
NF-B	B-X
,	B-X
which	B-X
is	B-X
induced	B-X
and	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-mediated	B-X
EC	B-X
cell	B-X
apoptosis	B-X
.	B-X

Histone	B-Gene_or_gene_product
deacetylase	I-Gene_or_gene_product
(	I-Gene_or_gene_product
HDAC	I-Gene_or_gene_product
)	I-Gene_or_gene_product
inhibitors	I-Gene_or_gene_product
are	O
a	O
class	O
of	O
promising	O
anticancer	O
reagents	O
.	O
<EOS>	B-X
Although	B-X
histone	B-X
deacetylase	B-X
inhibitors	B-X
(	B-X
HDACi	B-X
)	B-X
have	B-X
shown	B-X
promising	B-X
antitumor	B-X
effects	B-X
in	B-X
specific	B-X
types	B-X
of	B-X
blood	B-X
cancer	B-X
,	B-X
their	B-X
effects	B-X
on	B-X
solid	B-X
tumors	B-X
are	B-X
limited	B-X
.	B-X
Previously	B-X
,	B-X
we	B-X
developed	B-X
LMK235	B-X
(	B-X
5	B-X
)	B-X
,	B-X
a	B-X
class	B-X
I	B-X
and	B-X
class	B-X
IIb	B-X
preferential	B-X
HDACi	B-X
with	B-X
chemosensitizing	B-X
effects	B-X
on	B-X
breast	B-X
cancer	B-X
,	B-X
ovarian	B-X
cancer	B-X
and	B-X
HNSCC	B-X
.	B-X
Based	B-X
on	B-X
its	B-X
promising	B-X
effects	B-X
on	B-X
solid	B-X
tumor	B-X
cells	B-X
,	B-X
we	B-X
modified	B-X
the	B-X
cap	B-X
group	B-X
of	B-X
5	B-X
to	B-X
improve	B-X
its	B-X
anticancer	B-X
activity	B-X
.	B-X
The	B-X
tri-	B-X
and	B-X
dimethoxy-phenyl	B-X
substituted	B-X
compounds	B-X
13a	B-X
and	B-X
13d	B-X
turned	B-X
out	B-X
to	B-X
be	B-X
the	B-X
most	B-X
potent	B-X
HDAC	B-X
inhibitors	B-X
of	B-X
this	B-X
study	B-X
.	B-X
The	B-X
isoform	B-X
profiling	B-X
revealed	B-X
a	B-X
dual	B-X
HDAC2/HDAC6	B-X
inhibition	B-X
profile	B-X
,	B-X
which	B-X
was	B-X
confirmed	B-X
by	B-X
the	B-X
acetylation	B-X
of	B-X
-tubulin	B-X
and	B-X
histone	B-X
H3	B-X
in	B-X
Cal27	B-X
and	B-X
Cal27CisR	B-X
.	B-X

They	O
are	O
able	O
to	O
induce	O
apoptosis	O
in	O
embryonic	O
carcinoma	O
(	O
EC	O
)	O
cells	O
.	O
<EOS>	B-X
Although	B-X
the	B-X
majority	B-X
of	B-X
testicular	B-X
germ	B-X
cell	B-X
tumors	B-X
(	B-X
TGCTs	B-X
)	B-X
are	B-X
curable	B-X
by	B-X
cisplatin-based	B-X
chemotherapy	B-X
,	B-X
in	B-X
a	B-X
few	B-X
cases	B-X
,	B-X
the	B-X
occurrence	B-X
of	B-X
cisplatin	B-X
resistance	B-X
results	B-X
in	B-X
a	B-X
poor	B-X
outcome	B-X
.	B-X
Embryonal	B-X
carcinoma	B-X
(	B-X
EC	B-X
)	B-X
cells	B-X
represent	B-X
the	B-X
presumptive	B-X
tumor	B-X
stem	B-X
cells	B-X
in	B-X
nonseminomatous	B-X
TGCTs	B-X
and	B-X
are	B-X
known	B-X
to	B-X
express	B-X
the	B-X
embryonal	B-X
transcription	B-X
factor	B-X
Oct-3/4	B-X
and	B-X
to	B-X
be	B-X
hypersensitive	B-X
to	B-X
cisplatin	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
a	B-X
lack	B-X
of	B-X
expression	B-X
of	B-X
Oct-3/4	B-X
in	B-X
TGCT	B-X
cells	B-X
is	B-X
associated	B-X
with	B-X
a	B-X
higher	B-X
apoptotic	B-X
threshold	B-X
and	B-X
cisplatin	B-X
resistance	B-X
which	B-X
is	B-X
accompanied	B-X
by	B-X
an	B-X
impaired	B-X
caspase-9	B-X
activation	B-X
,	B-X
reduced	B-X
caspase-3	B-X
activity	B-X
and	B-X
altered	B-X
p53	B-X
accumulation	B-X
.	B-X
We	B-X
were	B-X
able	B-X
to	B-X
induce	B-X
loss	B-X
of	B-X
Oct-3/4	B-X
in	B-X
a	B-X
cisplatin-sensitive	B-X
EC	B-X
cell	B-X
line	B-X
resulting	B-X
in	B-X
a	B-X
secondary	B-X
cisplatin-resistant	B-X
cell	B-X
type	B-X
with	B-X
retained	B-X
EC	B-X
cell	B-X
characteristics	B-X
and	B-X
changes	B-X
in	B-X
apoptotic	B-X
signaling	B-X
identical	B-X
to	B-X
those	B-X
in	B-X
primary	B-X
resistant	B-X
cells	B-X
.	B-X
Furthermore	B-X
,	B-X
we	B-X
show	B-X
that	B-X
EC	B-X
cells	B-X
are	B-X
retained	B-X
in	B-X
their	B-X
undifferentiated	B-X
state	B-X
by	B-X
Oct-3/4	B-X
and	B-X
that	B-X
a	B-X
complete	B-X
and	B-X
ultimate	B-X
loss	B-X
of	B-X
Oct-3/4	B-X
followed	B-X
by	B-X
an	B-X
early	B-X
differentiation	B-X
step	B-X
is	B-X
necessary	B-X
to	B-X
establish	B-X
the	B-X
cisplatin-resistant	B-X
state	B-X
.	B-X
Our	B-X
data	B-X
suggest	B-X
that	B-X
loss	B-X
of	B-X
Oct-3/4	B-X
expression	B-X
leads	B-X
to	B-X
induction	B-X
of	B-X
a	B-X
higher	B-X
apoptotic	B-X
threshold	B-X
and	B-X
to	B-X
cisplatin	B-X
resistance	B-X
in	B-X
EC	B-X
cells	B-X
of	B-X
nonseminomatous	B-X
TGCTs	B-X
.	B-X
We	B-X
hypothesize	B-X
that	B-X
in	B-X
refractory	B-X
TGCTs	B-X
the	B-X
original	B-X
tumor	B-X
stem	B-X
cell	B-X
population	B-X
of	B-X
Oct-3/4-positive	B-X
,	B-X
cisplatin-sensitive	B-X
EC	B-X
cells	B-X
could	B-X
be	B-X
replaced	B-X
by	B-X
an	B-X
Oct-3/4-negative	B-X
,	B-X
resistant	B-X
population	B-X
in	B-X
a	B-X
selection	B-X
process	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
the	B-X
Oct-3/4-positive	B-X
,	B-X
highly	B-X
sensitive	B-X
EC	B-X
cells	B-X
as	B-X
the	B-X
tumor	B-X
stem	B-X
cell	B-X
component	B-X
in	B-X
most	B-X
TGCTs	B-X
could	B-X
explain	B-X
the	B-X
general	B-X
high	B-X
chemosensitivity	B-X
and	B-X
curability	B-X
of	B-X
these	B-X
tumors	B-X
.	B-X

However	O
,	O
the	O
underlying	O
mechanism	O
remains	O
poorly	O
understood	O
.	O
<EOS>	B-X
The	B-X
genetic	B-X
basis	B-X
of	B-X
hEDS	B-X
remains	B-X
however	B-X
unknown	B-X
,	B-X
in	B-X
contrast	B-X
to	B-X
other	B-X
well-described	B-X
EDS	B-X
subtypes	B-X
.	B-X
The	B-X
specific	B-X
underlying	B-X
causes	B-X
and	B-X
mechanisms	B-X
of	B-X
pain	B-X
in	B-X
JHS	B-X
and	B-X
EDS	B-X
remain	B-X
poorly	B-X
understood	B-X
.	B-X
These	B-X
mechanisms	B-X
are	B-X
not	B-X
mutually	B-X
exclusive	B-X
,	B-X
and	B-X
likely	B-X
more	B-X
than	B-X
one	B-X
mechanism	B-X
may	B-X
be	B-X
present	B-X
.	B-X
Yet	B-X
even	B-X
with	B-X
the	B-X
recent	B-X
surge	B-X
in	B-X
studies	B-X
decoding	B-X
the	B-X
mechanisms	B-X
underlying	B-X
these	B-X
diseases	B-X
,	B-X
a	B-X
significant	B-X
proportion	B-X
of	B-X
dyskeratosis	B-X
congenita	B-X
mutations	B-X
remain	B-X
uncharacterized	B-X
or	B-X
poorly	B-X
understood	B-X
.	B-X
This	B-X
review	B-X
connects	B-X
insights	B-X
from	B-X
both	B-X
clinical	B-X
and	B-X
molecular	B-X
studies	B-X
to	B-X
create	B-X
a	B-X
comprehensive	B-X
view	B-X
of	B-X
the	B-X
underlying	B-X
mechanisms	B-X
that	B-X
drive	B-X
these	B-X
diseases	B-X
.	B-X
Through	B-X
this	B-X
,	B-X
we	B-X
emphasize	B-X
recent	B-X
advances	B-X
in	B-X
therapeutics	B-X
and	B-X
pinpoint	B-X
disease-associated	B-X
variants	B-X
that	B-X
remain	B-X
poorly	B-X
defined	B-X
in	B-X
their	B-X
mechanism	B-X
of	B-X
action	B-X
.	B-X

Here	O
we	O
show	O
that	O
increased	O
expression	O
of	O
zinc	B-Gene_or_gene_product
-	I-Gene_or_gene_product
finger	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
regulator	I-Gene_or_gene_product
of	I-Gene_or_gene_product
apoptosis	I-Gene_or_gene_product
and	I-Gene_or_gene_product
cell	I-Gene_or_gene_product
-	I-Gene_or_gene_product
cycle	I-Gene_or_gene_product
arrest	I-Gene_or_gene_product
(	O
Zac1	B-Gene_or_gene_product
)	O
is	O
implicated	O
in	O
HDAC	B-Gene_or_gene_product
inhibitor	I-Gene_or_gene_product
-	O
induced	O
apoptosis	O
in	O
F9	O
and	O
P19	O
EC	O
cells	O
.	O
<EOS>	B-X
Histone	B-X
deacetylase	B-X
(	B-X
HDAC	B-X
)	B-X
inhibitors	B-X
are	B-X
a	B-X
class	B-X
of	B-X
promising	B-X
anticancer	B-X
reagents	B-X
.	B-X
They	B-X
are	B-X
able	B-X
to	B-X
induce	B-X
apoptosis	B-X
in	B-X
embryonic	B-X
carcinoma	B-X
(	B-X
EC	B-X
)	B-X
cells	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
increased	B-X
expression	B-X
of	B-X
zinc-finger	B-X
protein	B-X
regulator	B-X
of	B-X
apoptosis	B-X
and	B-X
cell-cycle	B-X
arrest	B-X
(	B-X
Zac1	B-X
)	B-X
is	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-induced	B-X
apoptosis	B-X
in	B-X
F9	B-X
and	B-X
P19	B-X
EC	B-X
cells	B-X
.	B-X
By	B-X
chromatin	B-X
immunoprecipitation	B-X
analysis	B-X
we	B-X
identified	B-X
that	B-X
increased	B-X
Zac1	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
histone	B-X
acetylation	B-X
of	B-X
the	B-X
Zac1	B-X
promoter	B-X
region	B-X
.	B-X
Knockdown	B-X
of	B-X
Zac1	B-X
inhibited	B-X
HDAC	B-X
inhibitor-induced	B-X
cell	B-X
apoptosis	B-X
.	B-X
Moreover	B-X
,	B-X
HDAC	B-X
inhibitors	B-X
repressed	B-X
nuclear	B-X
factor-B	B-X
(	B-X
NF-B	B-X
)	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
effect	B-X
is	B-X
abrogated	B-X
by	B-X
Zac1	B-X
knockdown	B-X
.	B-X
Consistently	B-X
,	B-X
Zac1	B-X
overexpression	B-X
suppressed	B-X
cellular	B-X
NF-B	B-X
activity	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
Zac1	B-X
inhibits	B-X
NF-B	B-X
activity	B-X
by	B-X
interacting	B-X
with	B-X
the	B-X
C-terminus	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
,	B-X
which	B-X
suppresses	B-X
the	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser468	B-X
and	B-X
Ser536	B-X
residues	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
Zac1	B-X
is	B-X
a	B-X
histone	B-X
acetylation-regulated	B-X
suppressor	B-X
of	B-X
NF-B	B-X
,	B-X
which	B-X
is	B-X
induced	B-X
and	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-mediated	B-X
EC	B-X
cell	B-X
apoptosis	B-X
.	B-X

By	O
chromatin	O
immunoprecipitation	O
analysis	O
we	O
identified	O
that	O
increased	O
Zac1	B-Gene_or_gene_product
expression	O
is	O
mediated	O
by	O
histone	B-Gene_or_gene_product
acetylation	O
of	O
the	O
Zac1	B-Gene_or_gene_product
promoter	O
region	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
increased	B-X
expression	B-X
of	B-X
zinc-finger	B-X
protein	B-X
regulator	B-X
of	B-X
apoptosis	B-X
and	B-X
cell-cycle	B-X
arrest	B-X
(	B-X
Zac1	B-X
)	B-X
is	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-induced	B-X
apoptosis	B-X
in	B-X
F9	B-X
and	B-X
P19	B-X
EC	B-X
cells	B-X
.	B-X
By	B-X
chromatin	B-X
immunoprecipitation	B-X
analysis	B-X
we	B-X
identified	B-X
that	B-X
increased	B-X
Zac1	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
histone	B-X
acetylation	B-X
of	B-X
the	B-X
Zac1	B-X
promoter	B-X
region	B-X
.	B-X
Knockdown	B-X
of	B-X
Zac1	B-X
inhibited	B-X
HDAC	B-X
inhibitor-induced	B-X
cell	B-X
apoptosis	B-X
.	B-X
Moreover	B-X
,	B-X
HDAC	B-X
inhibitors	B-X
repressed	B-X
nuclear	B-X
factor-B	B-X
(	B-X
NF-B	B-X
)	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
effect	B-X
is	B-X
abrogated	B-X
by	B-X
Zac1	B-X
knockdown	B-X
.	B-X
Consistently	B-X
,	B-X
Zac1	B-X
overexpression	B-X
suppressed	B-X
cellular	B-X
NF-B	B-X
activity	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
Zac1	B-X
inhibits	B-X
NF-B	B-X
activity	B-X
by	B-X
interacting	B-X
with	B-X
the	B-X
C-terminus	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
,	B-X
which	B-X
suppresses	B-X
the	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser468	B-X
and	B-X
Ser536	B-X
residues	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
Zac1	B-X
is	B-X
a	B-X
histone	B-X
acetylation-regulated	B-X
suppressor	B-X
of	B-X
NF-B	B-X
,	B-X
which	B-X
is	B-X
induced	B-X
and	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-mediated	B-X
EC	B-X
cell	B-X
apoptosis	B-X
.	B-X

Knockdown	O
of	O
Zac1	B-Gene_or_gene_product
inhibited	O
HDAC	B-Gene_or_gene_product
inhibitor	I-Gene_or_gene_product
-	O
induced	O
cell	O
apoptosis	O
.	O
<EOS>	B-X
Histone	B-X
deacetylase	B-X
(	B-X
HDAC	B-X
)	B-X
inhibitors	B-X
are	B-X
a	B-X
class	B-X
of	B-X
promising	B-X
anticancer	B-X
reagents	B-X
.	B-X
They	B-X
are	B-X
able	B-X
to	B-X
induce	B-X
apoptosis	B-X
in	B-X
embryonic	B-X
carcinoma	B-X
(	B-X
EC	B-X
)	B-X
cells	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
increased	B-X
expression	B-X
of	B-X
zinc-finger	B-X
protein	B-X
regulator	B-X
of	B-X
apoptosis	B-X
and	B-X
cell-cycle	B-X
arrest	B-X
(	B-X
Zac1	B-X
)	B-X
is	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-induced	B-X
apoptosis	B-X
in	B-X
F9	B-X
and	B-X
P19	B-X
EC	B-X
cells	B-X
.	B-X
By	B-X
chromatin	B-X
immunoprecipitation	B-X
analysis	B-X
we	B-X
identified	B-X
that	B-X
increased	B-X
Zac1	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
histone	B-X
acetylation	B-X
of	B-X
the	B-X
Zac1	B-X
promoter	B-X
region	B-X
.	B-X
Knockdown	B-X
of	B-X
Zac1	B-X
inhibited	B-X
HDAC	B-X
inhibitor-induced	B-X
cell	B-X
apoptosis	B-X
.	B-X
Moreover	B-X
,	B-X
HDAC	B-X
inhibitors	B-X
repressed	B-X
nuclear	B-X
factor-B	B-X
(	B-X
NF-B	B-X
)	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
effect	B-X
is	B-X
abrogated	B-X
by	B-X
Zac1	B-X
knockdown	B-X
.	B-X
Consistently	B-X
,	B-X
Zac1	B-X
overexpression	B-X
suppressed	B-X
cellular	B-X
NF-B	B-X
activity	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
Zac1	B-X
inhibits	B-X
NF-B	B-X
activity	B-X
by	B-X
interacting	B-X
with	B-X
the	B-X
C-terminus	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
,	B-X
which	B-X
suppresses	B-X
the	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser468	B-X
and	B-X
Ser536	B-X
residues	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
Zac1	B-X
is	B-X
a	B-X
histone	B-X
acetylation-regulated	B-X
suppressor	B-X
of	B-X
NF-B	B-X
,	B-X
which	B-X
is	B-X
induced	B-X
and	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-mediated	B-X
EC	B-X
cell	B-X
apoptosis	B-X
.	B-X

Moreover	O
,	O
HDAC	B-Gene_or_gene_product
inhibitors	I-Gene_or_gene_product
repressed	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
activity	O
,	O
and	O
this	O
effect	O
is	O
abrogated	O
by	O
Zac1	B-Gene_or_gene_product
knockdown	O
.	O
<EOS>	B-X
Histone	B-X
deacetylase	B-X
(	B-X
HDAC	B-X
)	B-X
inhibitors	B-X
are	B-X
a	B-X
class	B-X
of	B-X
promising	B-X
anticancer	B-X
reagents	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
increased	B-X
expression	B-X
of	B-X
zinc-finger	B-X
protein	B-X
regulator	B-X
of	B-X
apoptosis	B-X
and	B-X
cell-cycle	B-X
arrest	B-X
(	B-X
Zac1	B-X
)	B-X
is	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-induced	B-X
apoptosis	B-X
in	B-X
F9	B-X
and	B-X
P19	B-X
EC	B-X
cells	B-X
.	B-X
By	B-X
chromatin	B-X
immunoprecipitation	B-X
analysis	B-X
we	B-X
identified	B-X
that	B-X
increased	B-X
Zac1	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
histone	B-X
acetylation	B-X
of	B-X
the	B-X
Zac1	B-X
promoter	B-X
region	B-X
.	B-X
Knockdown	B-X
of	B-X
Zac1	B-X
inhibited	B-X
HDAC	B-X
inhibitor-induced	B-X
cell	B-X
apoptosis	B-X
.	B-X
Moreover	B-X
,	B-X
HDAC	B-X
inhibitors	B-X
repressed	B-X
nuclear	B-X
factor-B	B-X
(	B-X
NF-B	B-X
)	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
effect	B-X
is	B-X
abrogated	B-X
by	B-X
Zac1	B-X
knockdown	B-X
.	B-X
Consistently	B-X
,	B-X
Zac1	B-X
overexpression	B-X
suppressed	B-X
cellular	B-X
NF-B	B-X
activity	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
Zac1	B-X
inhibits	B-X
NF-B	B-X
activity	B-X
by	B-X
interacting	B-X
with	B-X
the	B-X
C-terminus	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
,	B-X
which	B-X
suppresses	B-X
the	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser468	B-X
and	B-X
Ser536	B-X
residues	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
Zac1	B-X
is	B-X
a	B-X
histone	B-X
acetylation-regulated	B-X
suppressor	B-X
of	B-X
NF-B	B-X
,	B-X
which	B-X
is	B-X
induced	B-X
and	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-mediated	B-X
EC	B-X
cell	B-X
apoptosis	B-X
.	B-X

Consistently	O
,	O
Zac1	B-Gene_or_gene_product
overexpression	O
suppressed	O
cellular	O
NF	O
-	O
kappaB	O
activity	O
.	O
<EOS>	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
increased	B-X
expression	B-X
of	B-X
zinc-finger	B-X
protein	B-X
regulator	B-X
of	B-X
apoptosis	B-X
and	B-X
cell-cycle	B-X
arrest	B-X
(	B-X
Zac1	B-X
)	B-X
is	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-induced	B-X
apoptosis	B-X
in	B-X
F9	B-X
and	B-X
P19	B-X
EC	B-X
cells	B-X
.	B-X
By	B-X
chromatin	B-X
immunoprecipitation	B-X
analysis	B-X
we	B-X
identified	B-X
that	B-X
increased	B-X
Zac1	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
histone	B-X
acetylation	B-X
of	B-X
the	B-X
Zac1	B-X
promoter	B-X
region	B-X
.	B-X
Knockdown	B-X
of	B-X
Zac1	B-X
inhibited	B-X
HDAC	B-X
inhibitor-induced	B-X
cell	B-X
apoptosis	B-X
.	B-X
Moreover	B-X
,	B-X
HDAC	B-X
inhibitors	B-X
repressed	B-X
nuclear	B-X
factor-B	B-X
(	B-X
NF-B	B-X
)	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
effect	B-X
is	B-X
abrogated	B-X
by	B-X
Zac1	B-X
knockdown	B-X
.	B-X
Consistently	B-X
,	B-X
Zac1	B-X
overexpression	B-X
suppressed	B-X
cellular	B-X
NF-B	B-X
activity	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
Zac1	B-X
inhibits	B-X
NF-B	B-X
activity	B-X
by	B-X
interacting	B-X
with	B-X
the	B-X
C-terminus	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
,	B-X
which	B-X
suppresses	B-X
the	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser468	B-X
and	B-X
Ser536	B-X
residues	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
Zac1	B-X
is	B-X
a	B-X
histone	B-X
acetylation-regulated	B-X
suppressor	B-X
of	B-X
NF-B	B-X
,	B-X
which	B-X
is	B-X
induced	B-X
and	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-mediated	B-X
EC	B-X
cell	B-X
apoptosis	B-X
.	B-X

Further	O
investigation	O
showed	O
that	O
Zac1	B-Gene_or_gene_product
inhibits	O
NF	O
-	O
kappaB	O
activity	O
by	O
interacting	O
with	O
the	O
C	O
-	O
terminus	O
of	O
the	O
p65	B-Gene_or_gene_product
subunit	O
,	O
which	O
suppresses	O
the	O
phosphorylation	O
of	O
p65	B-Gene_or_gene_product
at	O
Ser468	O
and	O
Ser536	O
residues	O
.	O

These	O
results	O
indicate	O
that	O
Zac1	B-Gene_or_gene_product
is	O
a	O
histone	B-Gene_or_gene_product
acetylation	O
-	O
regulated	O
suppressor	O
of	O
NF	O
-	O
kappaB	O
,	O
which	O
is	O
induced	O
and	O
implicated	O
in	O
HDAC	B-Gene_or_gene_product
inhibitor	I-Gene_or_gene_product
-	O
mediated	O
EC	O
cell	O
apoptosis	O
.	O
<EOS>	B-X
Histone	B-X
deacetylase	B-X
(	B-X
HDAC	B-X
)	B-X
inhibitors	B-X
are	B-X
a	B-X
class	B-X
of	B-X
promising	B-X
anticancer	B-X
reagents	B-X
.	B-X
They	B-X
are	B-X
able	B-X
to	B-X
induce	B-X
apoptosis	B-X
in	B-X
embryonic	B-X
carcinoma	B-X
(	B-X
EC	B-X
)	B-X
cells	B-X
.	B-X
Here	B-X
we	B-X
show	B-X
that	B-X
increased	B-X
expression	B-X
of	B-X
zinc-finger	B-X
protein	B-X
regulator	B-X
of	B-X
apoptosis	B-X
and	B-X
cell-cycle	B-X
arrest	B-X
(	B-X
Zac1	B-X
)	B-X
is	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-induced	B-X
apoptosis	B-X
in	B-X
F9	B-X
and	B-X
P19	B-X
EC	B-X
cells	B-X
.	B-X
By	B-X
chromatin	B-X
immunoprecipitation	B-X
analysis	B-X
we	B-X
identified	B-X
that	B-X
increased	B-X
Zac1	B-X
expression	B-X
is	B-X
mediated	B-X
by	B-X
histone	B-X
acetylation	B-X
of	B-X
the	B-X
Zac1	B-X
promoter	B-X
region	B-X
.	B-X
Knockdown	B-X
of	B-X
Zac1	B-X
inhibited	B-X
HDAC	B-X
inhibitor-induced	B-X
cell	B-X
apoptosis	B-X
.	B-X
Moreover	B-X
,	B-X
HDAC	B-X
inhibitors	B-X
repressed	B-X
nuclear	B-X
factor-B	B-X
(	B-X
NF-B	B-X
)	B-X
activity	B-X
,	B-X
and	B-X
this	B-X
effect	B-X
is	B-X
abrogated	B-X
by	B-X
Zac1	B-X
knockdown	B-X
.	B-X
Consistently	B-X
,	B-X
Zac1	B-X
overexpression	B-X
suppressed	B-X
cellular	B-X
NF-B	B-X
activity	B-X
.	B-X
Further	B-X
investigation	B-X
showed	B-X
that	B-X
Zac1	B-X
inhibits	B-X
NF-B	B-X
activity	B-X
by	B-X
interacting	B-X
with	B-X
the	B-X
C-terminus	B-X
of	B-X
the	B-X
p65	B-X
subunit	B-X
,	B-X
which	B-X
suppresses	B-X
the	B-X
phosphorylation	B-X
of	B-X
p65	B-X
at	B-X
Ser468	B-X
and	B-X
Ser536	B-X
residues	B-X
.	B-X
These	B-X
results	B-X
indicate	B-X
that	B-X
Zac1	B-X
is	B-X
a	B-X
histone	B-X
acetylation-regulated	B-X
suppressor	B-X
of	B-X
NF-B	B-X
,	B-X
which	B-X
is	B-X
induced	B-X
and	B-X
implicated	B-X
in	B-X
HDAC	B-X
inhibitor-mediated	B-X
EC	B-X
cell	B-X
apoptosis	B-X
.	B-X

Crosstalk	O
between	O
the	O
canonical	O
NF	O
-	O
kappaB	O
and	O
Notch	B-Gene_or_gene_product
signaling	O
pathways	O
inhibits	O
Ppargamma	B-Gene_or_gene_product
expression	O
and	O
promotes	O
pancreatic	O
cancer	O
progression	O
in	O
mice	O
.	O
<EOS>	B-X
The	B-X
majority	B-X
of	B-X
human	B-X
pancreatic	B-X
cancers	B-X
have	B-X
activating	B-X
mutations	B-X
in	B-X
the	B-X
KRAS	B-X
proto-oncogene	B-X
.	B-X
These	B-X
mutations	B-X
result	B-X
in	B-X
increased	B-X
activity	B-X
of	B-X
the	B-X
NF-B	B-X
pathway	B-X
and	B-X
the	B-X
subsequent	B-X
constitutive	B-X
production	B-X
of	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
inhibitor	B-X
of	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
Ikk2	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
,	B-X
synergizes	B-X
with	B-X
basal	B-X
Notch	B-X
signaling	B-X
to	B-X
upregulate	B-X
transcription	B-X
of	B-X
primary	B-X
Notch	B-X
target	B-X
genes	B-X
,	B-X
resulting	B-X
in	B-X
suppression	B-X
of	B-X
antiinflammatory	B-X
protein	B-X
expression	B-X
and	B-X
promotion	B-X
of	B-X
pancreatic	B-X
carcinogenesis	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
the	B-X
Kras	B-X
(	B-X
G12D	B-X
)	B-X
Pdx1-cre	B-X
mouse	B-X
model	B-X
of	B-X
pancreatic	B-X
cancer	B-X
,	B-X
genetic	B-X
deletion	B-X
of	B-X
Ikk2	B-X
in	B-X
initiated	B-X
pre-malignant	B-X
epithelial	B-X
cells	B-X
substantially	B-X
delayed	B-X
pancreatic	B-X
oncogenesis	B-X
and	B-X
resulted	B-X
in	B-X
downregulation	B-X
of	B-X
the	B-X
classical	B-X
Notch	B-X
target	B-X
genes	B-X
Hes1	B-X
and	B-X
Hey1	B-X
.	B-X
Tnf-	B-X
stimulated	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
and	B-X
,	B-X
in	B-X
collaboration	B-X
with	B-X
basal	B-X
Notch	B-X
signals	B-X
,	B-X
induced	B-X
optimal	B-X
expression	B-X
of	B-X
Notch	B-X
targets	B-X
.	B-X
Hes1	B-X
suppresses	B-X
expression	B-X
of	B-X
Pparg	B-X
,	B-X
which	B-X
encodes	B-X
the	B-X
antiinflammatory	B-X
nuclear	B-X
receptor	B-X
Ppar	B-X
.	B-X
Thus	B-X
,	B-X
crosstalk	B-X
between	B-X
Tnf-/Ikk2	B-X
and	B-X
Notch	B-X
sustains	B-X
the	B-X
intrinsic	B-X
inflammatory	B-X
profile	B-X
of	B-X
transformed	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
reveal	B-X
what	B-X
we	B-X
believe	B-X
to	B-X
be	B-X
a	B-X
novel	B-X
interaction	B-X
between	B-X
oncogenic	B-X
inflammation	B-X
and	B-X
a	B-X
major	B-X
cell	B-X
fate	B-X
pathway	B-X
and	B-X
show	B-X
how	B-X
these	B-X
pathways	B-X
can	B-X
cooperate	B-X
to	B-X
promote	B-X
cancer	B-X
progression	B-X
.	B-X

The	O
majority	O
of	O
human	O
pancreatic	O
cancers	O
have	O
activating	O
mutations	O
in	O
the	O
KRAS	B-Gene_or_gene_product
proto	O
-	O
oncogene	O
.	O
<EOS>	B-X
KRAS	B-X
mutations	B-X
occur	B-X
in	B-X
a	B-X
quarter	B-X
of	B-X
all	B-X
of	B-X
human	B-X
cancers	B-X
,	B-X
yet	B-X
no	B-X
selective	B-X
drug	B-X
has	B-X
been	B-X
approved	B-X
to	B-X
treat	B-X
these	B-X
tumors	B-X
.	B-X
Despite	B-X
the	B-X
recent	B-X
development	B-X
of	B-X
drugs	B-X
that	B-X
block	B-X
KRAS	B-X
A	B-X
hallmark	B-X
of	B-X
pancreatic	B-X
cancer	B-X
is	B-X
the	B-X
prevalence	B-X
of	B-X
oncogenic	B-X
mutation	B-X
in	B-X
the	B-X
KRAS	B-X
gene	B-X
.	B-X
The	B-X
KRAS	B-X
oncogene	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
in	B-X
the	B-X
initiation	B-X
and	B-X
maintenance	B-X
of	B-X
pancreatic	B-X
tumors	B-X
and	B-X
its	B-X
signaling	B-X
network	B-X
represents	B-X
a	B-X
major	B-X
target	B-X
for	B-X
therapeutic	B-X
intervention	B-X
.	B-X
More	B-X
recently	B-X
,	B-X
covalent	B-X
inhibitors	B-X
targeting	B-X
the	B-X
KRAS	B-X

These	O
mutations	O
result	O
in	O
increased	O
activity	O
of	O
the	O
NF	O
-	O
kappaB	O
pathway	O
and	O
the	O
subsequent	O
constitutive	O
production	O
of	O
proinflammatory	O
cytokines	O
.	O
<EOS>	B-X
The	B-X
majority	B-X
of	B-X
human	B-X
pancreatic	B-X
cancers	B-X
have	B-X
activating	B-X
mutations	B-X
in	B-X
the	B-X
KRAS	B-X
proto-oncogene	B-X
.	B-X
These	B-X
mutations	B-X
result	B-X
in	B-X
increased	B-X
activity	B-X
of	B-X
the	B-X
NF-B	B-X
pathway	B-X
and	B-X
the	B-X
subsequent	B-X
constitutive	B-X
production	B-X
of	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
inhibitor	B-X
of	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
Ikk2	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
,	B-X
synergizes	B-X
with	B-X
basal	B-X
Notch	B-X
signaling	B-X
to	B-X
upregulate	B-X
transcription	B-X
of	B-X
primary	B-X
Notch	B-X
target	B-X
genes	B-X
,	B-X
resulting	B-X
in	B-X
suppression	B-X
of	B-X
antiinflammatory	B-X
protein	B-X
expression	B-X
and	B-X
promotion	B-X
of	B-X
pancreatic	B-X
carcinogenesis	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
the	B-X
Kras	B-X
(	B-X
G12D	B-X
)	B-X
Pdx1-cre	B-X
mouse	B-X
model	B-X
of	B-X
pancreatic	B-X
cancer	B-X
,	B-X
genetic	B-X
deletion	B-X
of	B-X
Ikk2	B-X
in	B-X
initiated	B-X
pre-malignant	B-X
epithelial	B-X
cells	B-X
substantially	B-X
delayed	B-X
pancreatic	B-X
oncogenesis	B-X
and	B-X
resulted	B-X
in	B-X
downregulation	B-X
of	B-X
the	B-X
classical	B-X
Notch	B-X
target	B-X
genes	B-X
Hes1	B-X
and	B-X
Hey1	B-X
.	B-X
Tnf-	B-X
stimulated	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
and	B-X
,	B-X
in	B-X
collaboration	B-X
with	B-X
basal	B-X
Notch	B-X
signals	B-X
,	B-X
induced	B-X
optimal	B-X
expression	B-X
of	B-X
Notch	B-X
targets	B-X
.	B-X
Mechanistically	B-X
,	B-X
Tnf-	B-X
stimulation	B-X
resulted	B-X
in	B-X
phosphorylation	B-X
of	B-X
histone	B-X
H3	B-X
at	B-X
the	B-X
Hes1	B-X
promoter	B-X
,	B-X
and	B-X
this	B-X
signal	B-X
was	B-X
lost	B-X
with	B-X
Ikk2	B-X
deletion	B-X
.	B-X
These	B-X
findings	B-X
reveal	B-X
what	B-X
we	B-X
believe	B-X
to	B-X
be	B-X
a	B-X
novel	B-X
interaction	B-X
between	B-X
oncogenic	B-X
inflammation	B-X
and	B-X
a	B-X
major	B-X
cell	B-X
fate	B-X
pathway	B-X
and	B-X
show	B-X
how	B-X
these	B-X
pathways	B-X
can	B-X
cooperate	B-X
to	B-X
promote	B-X
cancer	B-X
progression	B-X
.	B-X

Here	O
,	O
we	O
show	O
that	O
inhibitor	B-Gene_or_gene_product
of	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
2	I-Gene_or_gene_product
(	O
Ikk2	B-Gene_or_gene_product
)	O
,	O
a	O
component	O
of	O
the	O
canonical	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
,	O
synergizes	O
with	O
basal	O
Notch	B-Gene_or_gene_product
signaling	O
to	O
upregulate	O
transcription	O
of	O
primary	O
Notch	B-Gene_or_gene_product
target	O
genes	O
,	O
resulting	O
in	O
suppression	O
of	O
antiinflammatory	O
protein	O
expression	O
and	O
promotion	O
of	O
pancreatic	O
carcinogenesis	O
in	O
mice	O
.	O
<EOS>	B-X
The	B-X
majority	B-X
of	B-X
human	B-X
pancreatic	B-X
cancers	B-X
have	B-X
activating	B-X
mutations	B-X
in	B-X
the	B-X
KRAS	B-X
proto-oncogene	B-X
.	B-X
These	B-X
mutations	B-X
result	B-X
in	B-X
increased	B-X
activity	B-X
of	B-X
the	B-X
NF-B	B-X
pathway	B-X
and	B-X
the	B-X
subsequent	B-X
constitutive	B-X
production	B-X
of	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
inhibitor	B-X
of	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
Ikk2	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
,	B-X
synergizes	B-X
with	B-X
basal	B-X
Notch	B-X
signaling	B-X
to	B-X
upregulate	B-X
transcription	B-X
of	B-X
primary	B-X
Notch	B-X
target	B-X
genes	B-X
,	B-X
resulting	B-X
in	B-X
suppression	B-X
of	B-X
antiinflammatory	B-X
protein	B-X
expression	B-X
and	B-X
promotion	B-X
of	B-X
pancreatic	B-X
carcinogenesis	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
the	B-X
Kras	B-X
(	B-X
G12D	B-X
)	B-X
Pdx1-cre	B-X
mouse	B-X
model	B-X
of	B-X
pancreatic	B-X
cancer	B-X
,	B-X
genetic	B-X
deletion	B-X
of	B-X
Ikk2	B-X
in	B-X
initiated	B-X
pre-malignant	B-X
epithelial	B-X
cells	B-X
substantially	B-X
delayed	B-X
pancreatic	B-X
oncogenesis	B-X
and	B-X
resulted	B-X
in	B-X
downregulation	B-X
of	B-X
the	B-X
classical	B-X
Notch	B-X
target	B-X
genes	B-X
Hes1	B-X
and	B-X
Hey1	B-X
.	B-X
Tnf-	B-X
stimulated	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
and	B-X
,	B-X
in	B-X
collaboration	B-X
with	B-X
basal	B-X
Notch	B-X
signals	B-X
,	B-X
induced	B-X
optimal	B-X
expression	B-X
of	B-X
Notch	B-X
targets	B-X
.	B-X
Mechanistically	B-X
,	B-X
Tnf-	B-X
stimulation	B-X
resulted	B-X
in	B-X
phosphorylation	B-X
of	B-X
histone	B-X
H3	B-X
at	B-X
the	B-X
Hes1	B-X
promoter	B-X
,	B-X
and	B-X
this	B-X
signal	B-X
was	B-X
lost	B-X
with	B-X
Ikk2	B-X
deletion	B-X
.	B-X
Hes1	B-X
suppresses	B-X
expression	B-X
of	B-X
Pparg	B-X
,	B-X
which	B-X
encodes	B-X
the	B-X
antiinflammatory	B-X
nuclear	B-X
receptor	B-X
Ppar	B-X
.	B-X
Thus	B-X
,	B-X
crosstalk	B-X
between	B-X
Tnf-/Ikk2	B-X
and	B-X
Notch	B-X
sustains	B-X
the	B-X
intrinsic	B-X
inflammatory	B-X
profile	B-X
of	B-X
transformed	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
reveal	B-X
what	B-X
we	B-X
believe	B-X
to	B-X
be	B-X
a	B-X
novel	B-X
interaction	B-X
between	B-X
oncogenic	B-X
inflammation	B-X
and	B-X
a	B-X
major	B-X
cell	B-X
fate	B-X
pathway	B-X
and	B-X
show	B-X
how	B-X
these	B-X
pathways	B-X
can	B-X
cooperate	B-X
to	B-X
promote	B-X
cancer	B-X
progression	B-X
.	B-X

We	O
found	O
that	O
in	O
the	O
Kras	B-Gene_or_gene_product
(	O
G12D	O
)	O
Pdx1	B-Gene_or_gene_product
-	O
cre	B-Gene_or_gene_product
mouse	O
model	O
of	O
pancreatic	O
cancer	O
,	O
genetic	O
deletion	O
of	O
Ikk2	B-Gene_or_gene_product
in	O
initiated	O
pre	O
-	O
malignant	O
epithelial	O
cells	O
substantially	O
delayed	O
pancreatic	O
oncogenesis	O
and	O
resulted	O
in	O
downregulation	O
of	O
the	O
classical	O
Notch	B-Gene_or_gene_product
target	O
genes	O
Hes1	B-Gene_or_gene_product
and	O
Hey1	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
majority	B-X
of	B-X
human	B-X
pancreatic	B-X
cancers	B-X
have	B-X
activating	B-X
mutations	B-X
in	B-X
the	B-X
KRAS	B-X
proto-oncogene	B-X
.	B-X
These	B-X
mutations	B-X
result	B-X
in	B-X
increased	B-X
activity	B-X
of	B-X
the	B-X
NF-B	B-X
pathway	B-X
and	B-X
the	B-X
subsequent	B-X
constitutive	B-X
production	B-X
of	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
inhibitor	B-X
of	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
Ikk2	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
,	B-X
synergizes	B-X
with	B-X
basal	B-X
Notch	B-X
signaling	B-X
to	B-X
upregulate	B-X
transcription	B-X
of	B-X
primary	B-X
Notch	B-X
target	B-X
genes	B-X
,	B-X
resulting	B-X
in	B-X
suppression	B-X
of	B-X
antiinflammatory	B-X
protein	B-X
expression	B-X
and	B-X
promotion	B-X
of	B-X
pancreatic	B-X
carcinogenesis	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
the	B-X
Kras	B-X
(	B-X
G12D	B-X
)	B-X
Pdx1-cre	B-X
mouse	B-X
model	B-X
of	B-X
pancreatic	B-X
cancer	B-X
,	B-X
genetic	B-X
deletion	B-X
of	B-X
Ikk2	B-X
in	B-X
initiated	B-X
pre-malignant	B-X
epithelial	B-X
cells	B-X
substantially	B-X
delayed	B-X
pancreatic	B-X
oncogenesis	B-X
and	B-X
resulted	B-X
in	B-X
downregulation	B-X
of	B-X
the	B-X
classical	B-X
Notch	B-X
target	B-X
genes	B-X
Hes1	B-X
and	B-X
Hey1	B-X
.	B-X
Tnf-	B-X
stimulated	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
and	B-X
,	B-X
in	B-X
collaboration	B-X
with	B-X
basal	B-X
Notch	B-X
signals	B-X
,	B-X
induced	B-X
optimal	B-X
expression	B-X
of	B-X
Notch	B-X
targets	B-X
.	B-X
Mechanistically	B-X
,	B-X
Tnf-	B-X
stimulation	B-X
resulted	B-X
in	B-X
phosphorylation	B-X
of	B-X
histone	B-X
H3	B-X
at	B-X
the	B-X
Hes1	B-X
promoter	B-X
,	B-X
and	B-X
this	B-X
signal	B-X
was	B-X
lost	B-X
with	B-X
Ikk2	B-X
deletion	B-X
.	B-X
Hes1	B-X
suppresses	B-X
expression	B-X
of	B-X
Pparg	B-X
,	B-X
which	B-X
encodes	B-X
the	B-X
antiinflammatory	B-X
nuclear	B-X
receptor	B-X
Ppar	B-X
.	B-X
Thus	B-X
,	B-X
crosstalk	B-X
between	B-X
Tnf-/Ikk2	B-X
and	B-X
Notch	B-X
sustains	B-X
the	B-X
intrinsic	B-X
inflammatory	B-X
profile	B-X
of	B-X
transformed	B-X
cells	B-X
.	B-X
These	B-X
findings	B-X
reveal	B-X
what	B-X
we	B-X
believe	B-X
to	B-X
be	B-X
a	B-X
novel	B-X
interaction	B-X
between	B-X
oncogenic	B-X
inflammation	B-X
and	B-X
a	B-X
major	B-X
cell	B-X
fate	B-X
pathway	B-X
and	B-X
show	B-X
how	B-X
these	B-X
pathways	B-X
can	B-X
cooperate	B-X
to	B-X
promote	B-X
cancer	B-X
progression	B-X
.	B-X

Tnf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulated	O
canonical	O
NF	O
-	O
kappaB	O
signaling	O
and	O
,	O
in	O
collaboration	O
with	O
basal	O
Notch	B-Gene_or_gene_product
signals	O
,	O
induced	O
optimal	O
expression	O
of	O
Notch	B-Gene_or_gene_product
targets	O
.	O
<EOS>	B-X
These	B-X
mutations	B-X
result	B-X
in	B-X
increased	B-X
activity	B-X
of	B-X
the	B-X
NF-B	B-X
pathway	B-X
and	B-X
the	B-X
subsequent	B-X
constitutive	B-X
production	B-X
of	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
inhibitor	B-X
of	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
Ikk2	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
,	B-X
synergizes	B-X
with	B-X
basal	B-X
Notch	B-X
signaling	B-X
to	B-X
upregulate	B-X
transcription	B-X
of	B-X
primary	B-X
Notch	B-X
target	B-X
genes	B-X
,	B-X
resulting	B-X
in	B-X
suppression	B-X
of	B-X
antiinflammatory	B-X
protein	B-X
expression	B-X
and	B-X
promotion	B-X
of	B-X
pancreatic	B-X
carcinogenesis	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
the	B-X
Kras	B-X
(	B-X
G12D	B-X
)	B-X
Pdx1-cre	B-X
mouse	B-X
model	B-X
of	B-X
pancreatic	B-X
cancer	B-X
,	B-X
genetic	B-X
deletion	B-X
of	B-X
Ikk2	B-X
in	B-X
initiated	B-X
pre-malignant	B-X
epithelial	B-X
cells	B-X
substantially	B-X
delayed	B-X
pancreatic	B-X
oncogenesis	B-X
and	B-X
resulted	B-X
in	B-X
downregulation	B-X
of	B-X
the	B-X
classical	B-X
Notch	B-X
target	B-X
genes	B-X
Hes1	B-X
and	B-X
Hey1	B-X
.	B-X
Tnf-	B-X
stimulated	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
and	B-X
,	B-X
in	B-X
collaboration	B-X
with	B-X
basal	B-X
Notch	B-X
signals	B-X
,	B-X
induced	B-X
optimal	B-X
expression	B-X
of	B-X
Notch	B-X
targets	B-X
.	B-X
Mechanistically	B-X
,	B-X
Tnf-	B-X
stimulation	B-X
resulted	B-X
in	B-X
phosphorylation	B-X
of	B-X
histone	B-X
H3	B-X
at	B-X
the	B-X
Hes1	B-X
promoter	B-X
,	B-X
and	B-X
this	B-X
signal	B-X
was	B-X
lost	B-X
with	B-X
Ikk2	B-X
deletion	B-X
.	B-X
Hes1	B-X
suppresses	B-X
expression	B-X
of	B-X
Pparg	B-X
,	B-X
which	B-X
encodes	B-X
the	B-X
antiinflammatory	B-X
nuclear	B-X
receptor	B-X
Ppar	B-X
.	B-X
Thus	B-X
,	B-X
crosstalk	B-X
between	B-X
Tnf-/Ikk2	B-X
and	B-X
Notch	B-X
sustains	B-X
the	B-X
intrinsic	B-X
inflammatory	B-X
profile	B-X
of	B-X
transformed	B-X
cells	B-X
.	B-X

Mechanistically	O
,	O
Tnf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulation	O
resulted	O
in	O
phosphorylation	O
of	O
histone	B-Gene_or_gene_product
H3	I-Gene_or_gene_product
at	O
the	O
Hes1	B-Gene_or_gene_product
promoter	O
,	O
and	O
this	O
signal	O
was	O
lost	O
with	O
Ikk2	B-Gene_or_gene_product
deletion	O
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
inhibitor	B-X
of	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
Ikk2	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
,	B-X
synergizes	B-X
with	B-X
basal	B-X
Notch	B-X
signaling	B-X
to	B-X
upregulate	B-X
transcription	B-X
of	B-X
primary	B-X
Notch	B-X
target	B-X
genes	B-X
,	B-X
resulting	B-X
in	B-X
suppression	B-X
of	B-X
antiinflammatory	B-X
protein	B-X
expression	B-X
and	B-X
promotion	B-X
of	B-X
pancreatic	B-X
carcinogenesis	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
the	B-X
Kras	B-X
(	B-X
G12D	B-X
)	B-X
Pdx1-cre	B-X
mouse	B-X
model	B-X
of	B-X
pancreatic	B-X
cancer	B-X
,	B-X
genetic	B-X
deletion	B-X
of	B-X
Ikk2	B-X
in	B-X
initiated	B-X
pre-malignant	B-X
epithelial	B-X
cells	B-X
substantially	B-X
delayed	B-X
pancreatic	B-X
oncogenesis	B-X
and	B-X
resulted	B-X
in	B-X
downregulation	B-X
of	B-X
the	B-X
classical	B-X
Notch	B-X
target	B-X
genes	B-X
Hes1	B-X
and	B-X
Hey1	B-X
.	B-X
Tnf-	B-X
stimulated	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
and	B-X
,	B-X
in	B-X
collaboration	B-X
with	B-X
basal	B-X
Notch	B-X
signals	B-X
,	B-X
induced	B-X
optimal	B-X
expression	B-X
of	B-X
Notch	B-X
targets	B-X
.	B-X
Mechanistically	B-X
,	B-X
Tnf-	B-X
stimulation	B-X
resulted	B-X
in	B-X
phosphorylation	B-X
of	B-X
histone	B-X
H3	B-X
at	B-X
the	B-X
Hes1	B-X
promoter	B-X
,	B-X
and	B-X
this	B-X
signal	B-X
was	B-X
lost	B-X
with	B-X
Ikk2	B-X
deletion	B-X
.	B-X
Hes1	B-X
suppresses	B-X
expression	B-X
of	B-X
Pparg	B-X
,	B-X
which	B-X
encodes	B-X
the	B-X
antiinflammatory	B-X
nuclear	B-X
receptor	B-X
Ppar	B-X
.	B-X
Thus	B-X
,	B-X
crosstalk	B-X
between	B-X
Tnf-/Ikk2	B-X
and	B-X
Notch	B-X
sustains	B-X
the	B-X
intrinsic	B-X
inflammatory	B-X
profile	B-X
of	B-X
transformed	B-X
cells	B-X
.	B-X

Hes1	B-Gene_or_gene_product
suppresses	O
expression	O
of	O
Pparg	B-Gene_or_gene_product
,	O
which	O
encodes	O
the	O
antiinflammatory	O
nuclear	O
receptor	O
Ppargamma	B-Gene_or_gene_product
.	O
<EOS>	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
inhibitor	B-X
of	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
Ikk2	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
,	B-X
synergizes	B-X
with	B-X
basal	B-X
Notch	B-X
signaling	B-X
to	B-X
upregulate	B-X
transcription	B-X
of	B-X
primary	B-X
Notch	B-X
target	B-X
genes	B-X
,	B-X
resulting	B-X
in	B-X
suppression	B-X
of	B-X
antiinflammatory	B-X
protein	B-X
expression	B-X
and	B-X
promotion	B-X
of	B-X
pancreatic	B-X
carcinogenesis	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
the	B-X
Kras	B-X
(	B-X
G12D	B-X
)	B-X
Pdx1-cre	B-X
mouse	B-X
model	B-X
of	B-X
pancreatic	B-X
cancer	B-X
,	B-X
genetic	B-X
deletion	B-X
of	B-X
Ikk2	B-X
in	B-X
initiated	B-X
pre-malignant	B-X
epithelial	B-X
cells	B-X
substantially	B-X
delayed	B-X
pancreatic	B-X
oncogenesis	B-X
and	B-X
resulted	B-X
in	B-X
downregulation	B-X
of	B-X
the	B-X
classical	B-X
Notch	B-X
target	B-X
genes	B-X
Hes1	B-X
and	B-X
Hey1	B-X
.	B-X
Tnf-	B-X
stimulated	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
and	B-X
,	B-X
in	B-X
collaboration	B-X
with	B-X
basal	B-X
Notch	B-X
signals	B-X
,	B-X
induced	B-X
optimal	B-X
expression	B-X
of	B-X
Notch	B-X
targets	B-X
.	B-X
Mechanistically	B-X
,	B-X
Tnf-	B-X
stimulation	B-X
resulted	B-X
in	B-X
phosphorylation	B-X
of	B-X
histone	B-X
H3	B-X
at	B-X
the	B-X
Hes1	B-X
promoter	B-X
,	B-X
and	B-X
this	B-X
signal	B-X
was	B-X
lost	B-X
with	B-X
Ikk2	B-X
deletion	B-X
.	B-X
Hes1	B-X
suppresses	B-X
expression	B-X
of	B-X
Pparg	B-X
,	B-X
which	B-X
encodes	B-X
the	B-X
antiinflammatory	B-X
nuclear	B-X
receptor	B-X
Ppar	B-X
.	B-X

Thus	O
,	O
crosstalk	O
between	O
Tnf	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
/	O
Ikk2	B-Gene_or_gene_product
and	O
Notch	B-Gene_or_gene_product
sustains	O
the	O
intrinsic	O
inflammatory	O
profile	O
of	O
transformed	O
cells	O
.	O
<EOS>	B-X
These	B-X
mutations	B-X
result	B-X
in	B-X
increased	B-X
activity	B-X
of	B-X
the	B-X
NF-B	B-X
pathway	B-X
and	B-X
the	B-X
subsequent	B-X
constitutive	B-X
production	B-X
of	B-X
proinflammatory	B-X
cytokines	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
show	B-X
that	B-X
inhibitor	B-X
of	B-X
B	B-X
kinase	B-X
2	B-X
(	B-X
Ikk2	B-X
)	B-X
,	B-X
a	B-X
component	B-X
of	B-X
the	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
,	B-X
synergizes	B-X
with	B-X
basal	B-X
Notch	B-X
signaling	B-X
to	B-X
upregulate	B-X
transcription	B-X
of	B-X
primary	B-X
Notch	B-X
target	B-X
genes	B-X
,	B-X
resulting	B-X
in	B-X
suppression	B-X
of	B-X
antiinflammatory	B-X
protein	B-X
expression	B-X
and	B-X
promotion	B-X
of	B-X
pancreatic	B-X
carcinogenesis	B-X
in	B-X
mice	B-X
.	B-X
We	B-X
found	B-X
that	B-X
in	B-X
the	B-X
Kras	B-X
(	B-X
G12D	B-X
)	B-X
Pdx1-cre	B-X
mouse	B-X
model	B-X
of	B-X
pancreatic	B-X
cancer	B-X
,	B-X
genetic	B-X
deletion	B-X
of	B-X
Ikk2	B-X
in	B-X
initiated	B-X
pre-malignant	B-X
epithelial	B-X
cells	B-X
substantially	B-X
delayed	B-X
pancreatic	B-X
oncogenesis	B-X
and	B-X
resulted	B-X
in	B-X
downregulation	B-X
of	B-X
the	B-X
classical	B-X
Notch	B-X
target	B-X
genes	B-X
Hes1	B-X
and	B-X
Hey1	B-X
.	B-X
Tnf-	B-X
stimulated	B-X
canonical	B-X
NF-B	B-X
signaling	B-X
and	B-X
,	B-X
in	B-X
collaboration	B-X
with	B-X
basal	B-X
Notch	B-X
signals	B-X
,	B-X
induced	B-X
optimal	B-X
expression	B-X
of	B-X
Notch	B-X
targets	B-X
.	B-X
Mechanistically	B-X
,	B-X
Tnf-	B-X
stimulation	B-X
resulted	B-X
in	B-X
phosphorylation	B-X
of	B-X
histone	B-X
H3	B-X
at	B-X
the	B-X
Hes1	B-X
promoter	B-X
,	B-X
and	B-X
this	B-X
signal	B-X
was	B-X
lost	B-X
with	B-X
Ikk2	B-X
deletion	B-X
.	B-X
Hes1	B-X
suppresses	B-X
expression	B-X
of	B-X
Pparg	B-X
,	B-X
which	B-X
encodes	B-X
the	B-X
antiinflammatory	B-X
nuclear	B-X
receptor	B-X
Ppar	B-X
.	B-X
Thus	B-X
,	B-X
crosstalk	B-X
between	B-X
Tnf-/Ikk2	B-X
and	B-X
Notch	B-X
sustains	B-X
the	B-X
intrinsic	B-X
inflammatory	B-X
profile	B-X
of	B-X
transformed	B-X
cells	B-X
.	B-X

These	O
findings	O
reveal	O
what	O
we	O
believe	O
to	O
be	O
a	O
novel	O
interaction	O
between	O
oncogenic	O
inflammation	O
and	O
a	O
major	O
cell	O
fate	O
pathway	O
and	O
show	O
how	O
these	O
pathways	O
can	O
cooperate	O
to	O
promote	O
cancer	O
progression	O
.	O

Notch1	B-Gene_or_gene_product
promotes	O
glioma	O
cell	O
migration	O
and	O
invasion	O
by	O
stimulating	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
signaling	O
via	O
AKT	B-Gene_or_gene_product
activation	O
.	O
<EOS>	B-X
The	B-X
Notch	B-X
signaling	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
both	B-X
developmental	B-X
processes	B-X
and	B-X
tumorigenesis	B-X
.	B-X
Aberrant	B-X
Notch	B-X
signaling	B-X
has	B-X
been	B-X
repeatedly	B-X
demonstrated	B-X
to	B-X
facilitate	B-X
the	B-X
proliferation	B-X
and	B-X
survival	B-X
of	B-X
glioma	B-X
cells	B-X
by	B-X
regulating	B-X
downstream	B-X
effectors	B-X
or	B-X
other	B-X
signaling	B-X
pathways	B-X
.	B-X
In	B-X
glioblastoma	B-X
multiforme	B-X
specimens	B-X
from	B-X
59	B-X
patients	B-X
,	B-X
Notch1	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
tumor	B-X
tissues	B-X
compared	B-X
with	B-X
normal	B-X
brain	B-X
tissues	B-X
,	B-X
and	B-X
this	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
elevated	B-X
AKT	B-X
phosphorylation	B-X
and	B-X
Snail	B-X
expression	B-X
.	B-X
Increased	B-X
nuclear	B-X
localization	B-X
of	B-X
-catenin	B-X
and	B-X
p50	B-X
as	B-X
well	B-X
as	B-X
enhanced	B-X
IKK/AKT	B-X
interaction	B-X
were	B-X
also	B-X
observed	B-X
in	B-X
glioma	B-X
tissues	B-X
.	B-X
In	B-X
U87MG	B-X
cells	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Notch1	B-X
by	B-X
DLL4	B-X
stimulation	B-X
or	B-X
by	B-X
the	B-X
overexpression	B-X
of	B-X
Notch	B-X
intracellular	B-X
domain	B-X
(	B-X
NICD	B-X
)	B-X
resulted	B-X
in	B-X
AKT	B-X
activation	B-X
and	B-X
thereby	B-X
promoted	B-X
-catenin	B-X
activity	B-X
and	B-X
NF-B	B-X
signaling	B-X
.	B-X
Inhibition	B-X
of	B-X
EGFR	B-X
partially	B-X
blocked	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
stimulated	B-X
by	B-X
Notch1	B-X
activation	B-X
.	B-X
Furthermore	B-X
,	B-X
NICD	B-X
overexpression	B-X
in	B-X
U87MG	B-X
cells	B-X
led	B-X
to	B-X
the	B-X
upregulated	B-X
expression	B-X
of	B-X
several	B-X
metastasis-associated	B-X
molecules	B-X
,	B-X
which	B-X
could	B-X
be	B-X
abrogated	B-X
by	B-X
the	B-X
knockdown	B-X
of	B-X
either	B-X
-catenin	B-X
or	B-X
p50	B-X
.	B-X
In	B-X
U87MG	B-X
and	B-X
U251	B-X
cells	B-X
,	B-X
DLL4-induced	B-X
cellular	B-X
migration	B-X
and	B-X
invasion	B-X
could	B-X
be	B-X
inhibited	B-X
by	B-X
either	B-X
-catenin	B-X
or	B-X
a	B-X
p50	B-X
inhibitor	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
results	B-X
indicate	B-X
that	B-X
Notch	B-X
activation	B-X
could	B-X
stimulate	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
through	B-X
AKT	B-X
activation	B-X
in	B-X
glioma	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
Notch	B-X
activation-stimulated	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
synergistically	B-X
promote	B-X
the	B-X
migratory	B-X
and	B-X
invasive	B-X
properties	B-X
of	B-X
glioma	B-X
cells	B-X
.	B-X

The	O
Notch	B-Gene_or_gene_product
signaling	O
pathway	O
has	O
been	O
implicated	O
in	O
both	O
developmental	O
processes	O
and	O
tumorigenesis	O
.	O
<EOS>	B-X
Glycosylation	B-X
is	B-X
one	B-X
of	B-X
the	B-X
key	B-X
components	B-X
influencing	B-X
several	B-X
signaling	B-X
pathways	B-X
implicated	B-X
in	B-X
cell	B-X
survival	B-X
and	B-X
growth	B-X
.	B-X
The	B-X
Notch	B-X
signaling	B-X
pathway	B-X
plays	B-X
a	B-X
pivotal	B-X
role	B-X
in	B-X
numerous	B-X
cell	B-X
fate	B-X
specifications	B-X
during	B-X
metazoan	B-X
development	B-X
.	B-X
Both	B-X
Notch	B-X
and	B-X
its	B-X
ligands	B-X
are	B-X
repeatedly	B-X
glycosylated	B-X
by	B-X
the	B-X
addition	B-X
of	B-X
sugar	B-X
moieties	B-X
,	B-X
such	B-X
as	B-X
O-fucose	B-X
,	B-X
O-glucose	B-X
,	B-X
or	B-X
O-xylose	B-X
,	B-X
to	B-X
bring	B-X
about	B-X
structural	B-X
and	B-X
functional	B-X
changes	B-X
.	B-X
Disruption	B-X
to	B-X
glycosylation	B-X
processes	B-X
of	B-X
Notch	B-X
proteins	B-X
result	B-X
in	B-X
developmental	B-X
disorders	B-X
and	B-X
disease	B-X
,	B-X
including	B-X
cancer	B-X
.	B-X
This	B-X
review	B-X
summarizes	B-X
the	B-X
importance	B-X
and	B-X
recent	B-X
updates	B-X
on	B-X
the	B-X
role	B-X
of	B-X
glycosylated	B-X
Notch	B-X
proteins	B-X
in	B-X
tumorigenesis	B-X
and	B-X
tumor	B-X
metastasis	B-X
.	B-X

Aberrant	O
Notch	B-Gene_or_gene_product
signaling	O
has	O
been	O
repeatedly	O
demonstrated	O
to	O
facilitate	O
the	O
proliferation	O
and	O
survival	O
of	O
glioma	O
cells	O
by	O
regulating	O
downstream	O
effectors	O
or	O
other	O
signaling	O
pathways	O
.	O
<EOS>	B-X
In	B-X
addition	B-X
to	B-X
the	B-X
three	B-X
best	B-X
characterized	B-X
pathways-apoptosis	B-X
,	B-X
necroptosis	B-X
,	B-X
and	B-X
pyroptosis-other	B-X
forms	B-X
of	B-X
regulated	B-X
cell	B-X
death	B-X
including	B-X
autophagy-dependent	B-X
cell	B-X
death	B-X
(	B-X
ADCD	B-X
)	B-X
,	B-X
mitochondrial	B-X
permeability	B-X
transition	B-X
pore	B-X
(	B-X
MPTP	B-X
)	B-X
-mediated	B-X
necrosis	B-X
,	B-X
parthanatos	B-X
,	B-X
NETosis	B-X
and	B-X
ferroptosis	B-X
,	B-X
and	B-X
their	B-X
relevance	B-X
for	B-X
organismal	B-X
homeostasis	B-X
are	B-X
becoming	B-X
better	B-X
understood	B-X
.	B-X
Importantly	B-X
,	B-X
it	B-X
is	B-X
increasingly	B-X
clear	B-X
that	B-X
none	B-X
of	B-X
these	B-X
pathways	B-X
operate	B-X
alone	B-X
.	B-X
Instead	B-X
,	B-X
a	B-X
more	B-X
complex	B-X
picture	B-X
is	B-X
emerging	B-X
with	B-X
many	B-X
pathways	B-X
sharing	B-X
components	B-X
and	B-X
signaling	B-X
principles	B-X
.	B-X
Therefore	B-X
,	B-X
better	B-X
understanding	B-X
of	B-X
physiological	B-X
and	B-X
mechanistic	B-X
aspects	B-X
of	B-X
cell	B-X
death	B-X
signaling	B-X
should	B-X
yield	B-X
improved	B-X
reagents	B-X
for	B-X
addressing	B-X
unmet	B-X
medical	B-X
needs	B-X
.	B-X

In	O
glioblastoma	O
multiforme	O
specimens	O
from	O
59	O
patients	O
,	O
Notch1	B-Gene_or_gene_product
was	O
highly	O
expressed	O
in	O
tumor	O
tissues	O
compared	O
with	O
normal	O
brain	O
tissues	O
,	O
and	O
this	O
expression	O
was	O
correlated	O
with	O
elevated	O
AKT	B-Gene_or_gene_product
phosphorylation	O
and	O
Snail	B-Gene_or_gene_product
expression	O
.	O
<EOS>	B-X
The	B-X
Notch	B-X
signaling	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
both	B-X
developmental	B-X
processes	B-X
and	B-X
tumorigenesis	B-X
.	B-X
In	B-X
glioblastoma	B-X
multiforme	B-X
specimens	B-X
from	B-X
59	B-X
patients	B-X
,	B-X
Notch1	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
tumor	B-X
tissues	B-X
compared	B-X
with	B-X
normal	B-X
brain	B-X
tissues	B-X
,	B-X
and	B-X
this	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
elevated	B-X
AKT	B-X
phosphorylation	B-X
and	B-X
Snail	B-X
expression	B-X
.	B-X
Increased	B-X
nuclear	B-X
localization	B-X
of	B-X
-catenin	B-X
and	B-X
p50	B-X
as	B-X
well	B-X
as	B-X
enhanced	B-X
IKK/AKT	B-X
interaction	B-X
were	B-X
also	B-X
observed	B-X
in	B-X
glioma	B-X
tissues	B-X
.	B-X
In	B-X
U87MG	B-X
cells	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Notch1	B-X
by	B-X
DLL4	B-X
stimulation	B-X
or	B-X
by	B-X
the	B-X
overexpression	B-X
of	B-X
Notch	B-X
intracellular	B-X
domain	B-X
(	B-X
NICD	B-X
)	B-X
resulted	B-X
in	B-X
AKT	B-X
activation	B-X
and	B-X
thereby	B-X
promoted	B-X
-catenin	B-X
activity	B-X
and	B-X
NF-B	B-X
signaling	B-X
.	B-X
Inhibition	B-X
of	B-X
EGFR	B-X
partially	B-X
blocked	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
stimulated	B-X
by	B-X
Notch1	B-X
activation	B-X
.	B-X
Furthermore	B-X
,	B-X
NICD	B-X
overexpression	B-X
in	B-X
U87MG	B-X
cells	B-X
led	B-X
to	B-X
the	B-X
upregulated	B-X
expression	B-X
of	B-X
several	B-X
metastasis-associated	B-X
molecules	B-X
,	B-X
which	B-X
could	B-X
be	B-X
abrogated	B-X
by	B-X
the	B-X
knockdown	B-X
of	B-X
either	B-X
-catenin	B-X
or	B-X
p50	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
results	B-X
indicate	B-X
that	B-X
Notch	B-X
activation	B-X
could	B-X
stimulate	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
through	B-X
AKT	B-X
activation	B-X
in	B-X
glioma	B-X
cells	B-X
.	B-X

Increased	O
nuclear	O
localization	O
of	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
p50	B-Gene_or_gene_product
as	O
well	O
as	O
enhanced	O
IKKalpha	B-Gene_or_gene_product
/	O
AKT	B-Gene_or_gene_product
interaction	O
were	O
also	O
observed	O
in	O
glioma	O
tissues	O
.	O
<EOS>	B-X
Aberrant	B-X
Notch	B-X
signaling	B-X
has	B-X
been	B-X
repeatedly	B-X
demonstrated	B-X
to	B-X
facilitate	B-X
the	B-X
proliferation	B-X
and	B-X
survival	B-X
of	B-X
glioma	B-X
cells	B-X
by	B-X
regulating	B-X
downstream	B-X
effectors	B-X
or	B-X
other	B-X
signaling	B-X
pathways	B-X
.	B-X
In	B-X
glioblastoma	B-X
multiforme	B-X
specimens	B-X
from	B-X
59	B-X
patients	B-X
,	B-X
Notch1	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
tumor	B-X
tissues	B-X
compared	B-X
with	B-X
normal	B-X
brain	B-X
tissues	B-X
,	B-X
and	B-X
this	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
elevated	B-X
AKT	B-X
phosphorylation	B-X
and	B-X
Snail	B-X
expression	B-X
.	B-X
Increased	B-X
nuclear	B-X
localization	B-X
of	B-X
-catenin	B-X
and	B-X
p50	B-X
as	B-X
well	B-X
as	B-X
enhanced	B-X
IKK/AKT	B-X
interaction	B-X
were	B-X
also	B-X
observed	B-X
in	B-X
glioma	B-X
tissues	B-X
.	B-X
In	B-X
U87MG	B-X
cells	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Notch1	B-X
by	B-X
DLL4	B-X
stimulation	B-X
or	B-X
by	B-X
the	B-X
overexpression	B-X
of	B-X
Notch	B-X
intracellular	B-X
domain	B-X
(	B-X
NICD	B-X
)	B-X
resulted	B-X
in	B-X
AKT	B-X
activation	B-X
and	B-X
thereby	B-X
promoted	B-X
-catenin	B-X
activity	B-X
and	B-X
NF-B	B-X
signaling	B-X
.	B-X
Inhibition	B-X
of	B-X
EGFR	B-X
partially	B-X
blocked	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
stimulated	B-X
by	B-X
Notch1	B-X
activation	B-X
.	B-X
Furthermore	B-X
,	B-X
NICD	B-X
overexpression	B-X
in	B-X
U87MG	B-X
cells	B-X
led	B-X
to	B-X
the	B-X
upregulated	B-X
expression	B-X
of	B-X
several	B-X
metastasis-associated	B-X
molecules	B-X
,	B-X
which	B-X
could	B-X
be	B-X
abrogated	B-X
by	B-X
the	B-X
knockdown	B-X
of	B-X
either	B-X
-catenin	B-X
or	B-X
p50	B-X
.	B-X
In	B-X
U87MG	B-X
and	B-X
U251	B-X
cells	B-X
,	B-X
DLL4-induced	B-X
cellular	B-X
migration	B-X
and	B-X
invasion	B-X
could	B-X
be	B-X
inhibited	B-X
by	B-X
either	B-X
-catenin	B-X
or	B-X
a	B-X
p50	B-X
inhibitor	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
results	B-X
indicate	B-X
that	B-X
Notch	B-X
activation	B-X
could	B-X
stimulate	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
through	B-X
AKT	B-X
activation	B-X
in	B-X
glioma	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
Notch	B-X
activation-stimulated	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
synergistically	B-X
promote	B-X
the	B-X
migratory	B-X
and	B-X
invasive	B-X
properties	B-X
of	B-X
glioma	B-X
cells	B-X
.	B-X

In	O
U87MG	O
cells	O
,	O
the	O
activation	O
of	O
Notch1	B-Gene_or_gene_product
by	O
DLL4	B-Gene_or_gene_product
stimulation	O
or	O
by	O
the	O
overexpression	O
of	O
Notch	B-Gene_or_gene_product
intracellular	O
domain	O
(	O
NICD	O
)	O
resulted	O
in	O
AKT	B-Gene_or_gene_product
activation	O
and	O
thereby	O
promoted	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
activity	O
and	O
NF	O
-	O
kappaB	O
signaling	O
.	O
<EOS>	B-X
The	B-X
Notch	B-X
signaling	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
both	B-X
developmental	B-X
processes	B-X
and	B-X
tumorigenesis	B-X
.	B-X
Aberrant	B-X
Notch	B-X
signaling	B-X
has	B-X
been	B-X
repeatedly	B-X
demonstrated	B-X
to	B-X
facilitate	B-X
the	B-X
proliferation	B-X
and	B-X
survival	B-X
of	B-X
glioma	B-X
cells	B-X
by	B-X
regulating	B-X
downstream	B-X
effectors	B-X
or	B-X
other	B-X
signaling	B-X
pathways	B-X
.	B-X
In	B-X
glioblastoma	B-X
multiforme	B-X
specimens	B-X
from	B-X
59	B-X
patients	B-X
,	B-X
Notch1	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
tumor	B-X
tissues	B-X
compared	B-X
with	B-X
normal	B-X
brain	B-X
tissues	B-X
,	B-X
and	B-X
this	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
elevated	B-X
AKT	B-X
phosphorylation	B-X
and	B-X
Snail	B-X
expression	B-X
.	B-X
Increased	B-X
nuclear	B-X
localization	B-X
of	B-X
-catenin	B-X
and	B-X
p50	B-X
as	B-X
well	B-X
as	B-X
enhanced	B-X
IKK/AKT	B-X
interaction	B-X
were	B-X
also	B-X
observed	B-X
in	B-X
glioma	B-X
tissues	B-X
.	B-X
In	B-X
U87MG	B-X
cells	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Notch1	B-X
by	B-X
DLL4	B-X
stimulation	B-X
or	B-X
by	B-X
the	B-X
overexpression	B-X
of	B-X
Notch	B-X
intracellular	B-X
domain	B-X
(	B-X
NICD	B-X
)	B-X
resulted	B-X
in	B-X
AKT	B-X
activation	B-X
and	B-X
thereby	B-X
promoted	B-X
-catenin	B-X
activity	B-X
and	B-X
NF-B	B-X
signaling	B-X
.	B-X
Inhibition	B-X
of	B-X
EGFR	B-X
partially	B-X
blocked	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
stimulated	B-X
by	B-X
Notch1	B-X
activation	B-X
.	B-X
Furthermore	B-X
,	B-X
NICD	B-X
overexpression	B-X
in	B-X
U87MG	B-X
cells	B-X
led	B-X
to	B-X
the	B-X
upregulated	B-X
expression	B-X
of	B-X
several	B-X
metastasis-associated	B-X
molecules	B-X
,	B-X
which	B-X
could	B-X
be	B-X
abrogated	B-X
by	B-X
the	B-X
knockdown	B-X
of	B-X
either	B-X
-catenin	B-X
or	B-X
p50	B-X
.	B-X
In	B-X
U87MG	B-X
and	B-X
U251	B-X
cells	B-X
,	B-X
DLL4-induced	B-X
cellular	B-X
migration	B-X
and	B-X
invasion	B-X
could	B-X
be	B-X
inhibited	B-X
by	B-X
either	B-X
-catenin	B-X
or	B-X
a	B-X
p50	B-X
inhibitor	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
results	B-X
indicate	B-X
that	B-X
Notch	B-X
activation	B-X
could	B-X
stimulate	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
through	B-X
AKT	B-X
activation	B-X
in	B-X
glioma	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
Notch	B-X
activation-stimulated	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
synergistically	B-X
promote	B-X
the	B-X
migratory	B-X
and	B-X
invasive	B-X
properties	B-X
of	B-X
glioma	B-X
cells	B-X
.	B-X

Inhibition	O
of	O
EGFR	B-Gene_or_gene_product
partially	O
blocked	O
the	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
signaling	O
stimulated	O
by	O
Notch1	B-Gene_or_gene_product
activation	O
.	O
<EOS>	B-X
The	B-X
Notch	B-X
signaling	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
both	B-X
developmental	B-X
processes	B-X
and	B-X
tumorigenesis	B-X
.	B-X
Aberrant	B-X
Notch	B-X
signaling	B-X
has	B-X
been	B-X
repeatedly	B-X
demonstrated	B-X
to	B-X
facilitate	B-X
the	B-X
proliferation	B-X
and	B-X
survival	B-X
of	B-X
glioma	B-X
cells	B-X
by	B-X
regulating	B-X
downstream	B-X
effectors	B-X
or	B-X
other	B-X
signaling	B-X
pathways	B-X
.	B-X
In	B-X
glioblastoma	B-X
multiforme	B-X
specimens	B-X
from	B-X
59	B-X
patients	B-X
,	B-X
Notch1	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
tumor	B-X
tissues	B-X
compared	B-X
with	B-X
normal	B-X
brain	B-X
tissues	B-X
,	B-X
and	B-X
this	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
elevated	B-X
AKT	B-X
phosphorylation	B-X
and	B-X
Snail	B-X
expression	B-X
.	B-X
Increased	B-X
nuclear	B-X
localization	B-X
of	B-X
-catenin	B-X
and	B-X
p50	B-X
as	B-X
well	B-X
as	B-X
enhanced	B-X
IKK/AKT	B-X
interaction	B-X
were	B-X
also	B-X
observed	B-X
in	B-X
glioma	B-X
tissues	B-X
.	B-X
In	B-X
U87MG	B-X
cells	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Notch1	B-X
by	B-X
DLL4	B-X
stimulation	B-X
or	B-X
by	B-X
the	B-X
overexpression	B-X
of	B-X
Notch	B-X
intracellular	B-X
domain	B-X
(	B-X
NICD	B-X
)	B-X
resulted	B-X
in	B-X
AKT	B-X
activation	B-X
and	B-X
thereby	B-X
promoted	B-X
-catenin	B-X
activity	B-X
and	B-X
NF-B	B-X
signaling	B-X
.	B-X
Inhibition	B-X
of	B-X
EGFR	B-X
partially	B-X
blocked	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
stimulated	B-X
by	B-X
Notch1	B-X
activation	B-X
.	B-X
Furthermore	B-X
,	B-X
NICD	B-X
overexpression	B-X
in	B-X
U87MG	B-X
cells	B-X
led	B-X
to	B-X
the	B-X
upregulated	B-X
expression	B-X
of	B-X
several	B-X
metastasis-associated	B-X
molecules	B-X
,	B-X
which	B-X
could	B-X
be	B-X
abrogated	B-X
by	B-X
the	B-X
knockdown	B-X
of	B-X
either	B-X
-catenin	B-X
or	B-X
p50	B-X
.	B-X
In	B-X
U87MG	B-X
and	B-X
U251	B-X
cells	B-X
,	B-X
DLL4-induced	B-X
cellular	B-X
migration	B-X
and	B-X
invasion	B-X
could	B-X
be	B-X
inhibited	B-X
by	B-X
either	B-X
-catenin	B-X
or	B-X
a	B-X
p50	B-X
inhibitor	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
results	B-X
indicate	B-X
that	B-X
Notch	B-X
activation	B-X
could	B-X
stimulate	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
through	B-X
AKT	B-X
activation	B-X
in	B-X
glioma	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
Notch	B-X
activation-stimulated	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
synergistically	B-X
promote	B-X
the	B-X
migratory	B-X
and	B-X
invasive	B-X
properties	B-X
of	B-X
glioma	B-X
cells	B-X
.	B-X

Furthermore	O
,	O
NICD	O
overexpression	O
in	O
U87MG	O
cells	O
led	O
to	O
the	O
upregulated	O
expression	O
of	O
several	O
metastasis	O
-	O
associated	O
molecules	O
,	O
which	O
could	O
be	O
abrogated	O
by	O
the	O
knockdown	O
of	O
either	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
or	O
p50	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
pleiotropic	B-X
consequences	B-X
of	B-X
nuclear	B-X
factor	B-X
of	B-X
kappa	B-X
light	B-X
polypeptide	B-X
gene	B-X
enhancer	B-X
in	B-X
B-cells	B-X
(	B-X
NF-B	B-X
)	B-X
pathway	B-X
activation	B-X
result	B-X
from	B-X
the	B-X
combinatorial	B-X
effects	B-X
of	B-X
the	B-X
five	B-X
subunits	B-X
that	B-X
form	B-X
the	B-X
homo-	B-X
and	B-X
heterodimeric	B-X
NF-B	B-X
complexes	B-X
.	B-X
Here	B-X
we	B-X
discuss	B-X
recent	B-X
results	B-X
that	B-X
reveal	B-X
that	B-X
the	B-X
nuclear	B-X
factor	B-X
of	B-X
kappa	B-X
light	B-X
polypeptide	B-X
gene	B-X
enhancer	B-X
in	B-X
B-cells	B-X
1	B-X
(	B-X
NFKB1	B-X
)	B-X
(	B-X
p105/p50	B-X
)	B-X
subunit	B-X
is	B-X
an	B-X
important	B-X
regulator	B-X
of	B-X
NF-B	B-X
activity	B-X
in	B-X
vivo	B-X
.	B-X
Rather	B-X
p50	B-X
homodimers	B-X
have	B-X
a	B-X
critical	B-X
role	B-X
as	B-X
suppressors	B-X
of	B-X
the	B-X
NF-B	B-X
response	B-X
,	B-X
while	B-X
the	B-X
p105	B-X
precursor	B-X
has	B-X
a	B-X
variety	B-X
of	B-X
NF-B-independent	B-X
functions	B-X
.	B-X
In	B-X
humans	B-X
,	B-X
low	B-X
expression	B-X
of	B-X
Kip1	B-X
ubiquitination-promoting	B-X
complex	B-X
1	B-X
(	B-X
KPC1	B-X
)	B-X
,	B-X
a	B-X
ubiquitin	B-X
ligase	B-X
required	B-X
for	B-X
p105	B-X
to	B-X
p50	B-X
processing	B-X
,	B-X
was	B-X
shown	B-X
to	B-X
correlate	B-X
with	B-X
a	B-X
reduction	B-X
in	B-X
p50	B-X
and	B-X
glioblastoma	B-X
incidence	B-X
.	B-X

In	O
U87MG	O
and	O
U251	O
cells	O
,	O
DLL4	B-Gene_or_gene_product
-	O
induced	O
cellular	O
migration	O
and	O
invasion	O
could	O
be	O
inhibited	O
by	O
either	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
or	O
a	O
p50	B-Gene_or_gene_product
inhibitor	O
.	O
<EOS>	B-X
Biochemical	B-X
and	B-X
genetic	B-X
characterization	B-X
of	B-X
D-type	B-X
cyclins	B-X
,	B-X
their	B-X
cyclin	B-X
D-dependent	B-X
kinases	B-X
(	B-X
CDK4	B-X
and	B-X
CDK6	B-X
)	B-X
,	B-X
and	B-X
the	B-X
polypeptide	B-X
CDK4/6	B-X
inhibitor	B-X
p16	B-X
(	B-X
INK4	B-X
)	B-X
over	B-X
two	B-X
decades	B-X
ago	B-X
revealed	B-X
how	B-X
mammalian	B-X
cells	B-X
regulate	B-X
entry	B-X
into	B-X
the	B-X
DNA	B-X
synthetic	B-X
(	B-X
S	B-X
)	B-X
phase	B-X
of	B-X
the	B-X
cell-division	B-X
cycle	B-X
in	B-X
a	B-X
retinoblastoma	B-X
protein-dependent	B-X
manner	B-X
.	B-X
These	B-X
investigations	B-X
provided	B-X
proof-of-principle	B-X
that	B-X
CDK4/6	B-X
inhibitors	B-X
,	B-X
particularly	B-X
when	B-X
combined	B-X
with	B-X
coinhibition	B-X
of	B-X
allied	B-X
mitogen-dependent	B-X
signal	B-X
transduction	B-X
pathways	B-X
,	B-X
might	B-X
prove	B-X
valuable	B-X
in	B-X
cancer	B-X
therapy	B-X
.	B-X
FDA	B-X
approval	B-X
of	B-X
the	B-X
CDK4/6	B-X
inhibitor	B-X
palbociclib	B-X
used	B-X
with	B-X
the	B-X
aromatase	B-X
inhibitor	B-X
letrozole	B-X
for	B-X
breast	B-X
cancer	B-X
treatment	B-X
highlights	B-X
long-sought	B-X
success	B-X
.	B-X
Poly	B-X
(	B-X
ADP-ribose	B-X
)	B-X
polymerase	B-X
inhibitors	B-X
(	B-X
PARPi	B-X
)	B-X
are	B-X
selectively	B-X
active	B-X
in	B-X
cells	B-X
with	B-X
homologous	B-X
recombination	B-X
(	B-X
HR	B-X
)	B-X
deficiency	B-X
(	B-X
HRD	B-X
)	B-X
caused	B-X
by	B-X
mutations	B-X
in	B-X
BRCA1	B-X
,	B-X
BRCA2	B-X
,	B-X
and	B-X
other	B-X
pathway	B-X
members	B-X
.	B-X
We	B-X
sought	B-X
small	B-X
molecules	B-X
that	B-X
induce	B-X
HRD	B-X
in	B-X
HR-competent	B-X
cells	B-X
to	B-X
induce	B-X
synthetic	B-X
lethality	B-X
with	B-X
PARPi	B-X
and	B-X
extend	B-X
the	B-X
utility	B-X
of	B-X
PARPi	B-X
.	B-X
We	B-X
demonstrated	B-X
that	B-X
inhibition	B-X
of	B-X
bromodomain	B-X
containing	B-X
4	B-X
(	B-X
BRD4	B-X
)	B-X
induced	B-X
HRD	B-X
and	B-X
sensitized	B-X
cells	B-X
across	B-X
multiple	B-X
tumor	B-X
lineages	B-X
to	B-X
PARPi	B-X
regardless	B-X
of	B-X
BRCA1/2	B-X
,	B-X
TP53	B-X
,	B-X
RAS	B-X
,	B-X
or	B-X
BRAF	B-X
mutation	B-X
status	B-X
through	B-X
depletion	B-X
of	B-X
the	B-X
DNA	B-X
double-stand	B-X
break	B-X
resection	B-X
protein	B-X
CtIP	B-X
(	B-X
C-terminal	B-X
binding	B-X
protein	B-X
interacting	B-X
protein	B-X
)	B-X
.	B-X
Importantly	B-X
,	B-X
BRD4	B-X
inhibitor	B-X
(	B-X
BRD4i	B-X
)	B-X
treatment	B-X
reversed	B-X
multiple	B-X
mechanisms	B-X
of	B-X
resistance	B-X
to	B-X
PARPi	B-X
.	B-X

Collectively	O
,	O
these	O
results	O
indicate	O
that	O
Notch	B-Gene_or_gene_product
activation	O
could	O
stimulate	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
signaling	O
through	O
AKT	B-Gene_or_gene_product
activation	O
in	O
glioma	O
cells	O
.	O
<EOS>	B-X
The	B-X
Notch	B-X
signaling	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
both	B-X
developmental	B-X
processes	B-X
and	B-X
tumorigenesis	B-X
.	B-X
Aberrant	B-X
Notch	B-X
signaling	B-X
has	B-X
been	B-X
repeatedly	B-X
demonstrated	B-X
to	B-X
facilitate	B-X
the	B-X
proliferation	B-X
and	B-X
survival	B-X
of	B-X
glioma	B-X
cells	B-X
by	B-X
regulating	B-X
downstream	B-X
effectors	B-X
or	B-X
other	B-X
signaling	B-X
pathways	B-X
.	B-X
In	B-X
glioblastoma	B-X
multiforme	B-X
specimens	B-X
from	B-X
59	B-X
patients	B-X
,	B-X
Notch1	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
tumor	B-X
tissues	B-X
compared	B-X
with	B-X
normal	B-X
brain	B-X
tissues	B-X
,	B-X
and	B-X
this	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
elevated	B-X
AKT	B-X
phosphorylation	B-X
and	B-X
Snail	B-X
expression	B-X
.	B-X
Increased	B-X
nuclear	B-X
localization	B-X
of	B-X
-catenin	B-X
and	B-X
p50	B-X
as	B-X
well	B-X
as	B-X
enhanced	B-X
IKK/AKT	B-X
interaction	B-X
were	B-X
also	B-X
observed	B-X
in	B-X
glioma	B-X
tissues	B-X
.	B-X
In	B-X
U87MG	B-X
cells	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Notch1	B-X
by	B-X
DLL4	B-X
stimulation	B-X
or	B-X
by	B-X
the	B-X
overexpression	B-X
of	B-X
Notch	B-X
intracellular	B-X
domain	B-X
(	B-X
NICD	B-X
)	B-X
resulted	B-X
in	B-X
AKT	B-X
activation	B-X
and	B-X
thereby	B-X
promoted	B-X
-catenin	B-X
activity	B-X
and	B-X
NF-B	B-X
signaling	B-X
.	B-X
Inhibition	B-X
of	B-X
EGFR	B-X
partially	B-X
blocked	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
stimulated	B-X
by	B-X
Notch1	B-X
activation	B-X
.	B-X
Furthermore	B-X
,	B-X
NICD	B-X
overexpression	B-X
in	B-X
U87MG	B-X
cells	B-X
led	B-X
to	B-X
the	B-X
upregulated	B-X
expression	B-X
of	B-X
several	B-X
metastasis-associated	B-X
molecules	B-X
,	B-X
which	B-X
could	B-X
be	B-X
abrogated	B-X
by	B-X
the	B-X
knockdown	B-X
of	B-X
either	B-X
-catenin	B-X
or	B-X
p50	B-X
.	B-X
In	B-X
U87MG	B-X
and	B-X
U251	B-X
cells	B-X
,	B-X
DLL4-induced	B-X
cellular	B-X
migration	B-X
and	B-X
invasion	B-X
could	B-X
be	B-X
inhibited	B-X
by	B-X
either	B-X
-catenin	B-X
or	B-X
a	B-X
p50	B-X
inhibitor	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
results	B-X
indicate	B-X
that	B-X
Notch	B-X
activation	B-X
could	B-X
stimulate	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
through	B-X
AKT	B-X
activation	B-X
in	B-X
glioma	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
Notch	B-X
activation-stimulated	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
synergistically	B-X
promote	B-X
the	B-X
migratory	B-X
and	B-X
invasive	B-X
properties	B-X
of	B-X
glioma	B-X
cells	B-X
.	B-X

Thus	O
,	O
Notch	B-Gene_or_gene_product
activation	O
-	O
stimulated	O
beta	B-Gene_or_gene_product
-	I-Gene_or_gene_product
catenin	I-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
signaling	O
synergistically	O
promote	O
the	O
migratory	O
and	O
invasive	O
properties	O
of	O
glioma	O
cells	O
.	O
<EOS>	B-X
The	B-X
Notch	B-X
signaling	B-X
pathway	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
both	B-X
developmental	B-X
processes	B-X
and	B-X
tumorigenesis	B-X
.	B-X
Aberrant	B-X
Notch	B-X
signaling	B-X
has	B-X
been	B-X
repeatedly	B-X
demonstrated	B-X
to	B-X
facilitate	B-X
the	B-X
proliferation	B-X
and	B-X
survival	B-X
of	B-X
glioma	B-X
cells	B-X
by	B-X
regulating	B-X
downstream	B-X
effectors	B-X
or	B-X
other	B-X
signaling	B-X
pathways	B-X
.	B-X
In	B-X
glioblastoma	B-X
multiforme	B-X
specimens	B-X
from	B-X
59	B-X
patients	B-X
,	B-X
Notch1	B-X
was	B-X
highly	B-X
expressed	B-X
in	B-X
tumor	B-X
tissues	B-X
compared	B-X
with	B-X
normal	B-X
brain	B-X
tissues	B-X
,	B-X
and	B-X
this	B-X
expression	B-X
was	B-X
correlated	B-X
with	B-X
elevated	B-X
AKT	B-X
phosphorylation	B-X
and	B-X
Snail	B-X
expression	B-X
.	B-X
Increased	B-X
nuclear	B-X
localization	B-X
of	B-X
-catenin	B-X
and	B-X
p50	B-X
as	B-X
well	B-X
as	B-X
enhanced	B-X
IKK/AKT	B-X
interaction	B-X
were	B-X
also	B-X
observed	B-X
in	B-X
glioma	B-X
tissues	B-X
.	B-X
In	B-X
U87MG	B-X
cells	B-X
,	B-X
the	B-X
activation	B-X
of	B-X
Notch1	B-X
by	B-X
DLL4	B-X
stimulation	B-X
or	B-X
by	B-X
the	B-X
overexpression	B-X
of	B-X
Notch	B-X
intracellular	B-X
domain	B-X
(	B-X
NICD	B-X
)	B-X
resulted	B-X
in	B-X
AKT	B-X
activation	B-X
and	B-X
thereby	B-X
promoted	B-X
-catenin	B-X
activity	B-X
and	B-X
NF-B	B-X
signaling	B-X
.	B-X
Inhibition	B-X
of	B-X
EGFR	B-X
partially	B-X
blocked	B-X
the	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
stimulated	B-X
by	B-X
Notch1	B-X
activation	B-X
.	B-X
Furthermore	B-X
,	B-X
NICD	B-X
overexpression	B-X
in	B-X
U87MG	B-X
cells	B-X
led	B-X
to	B-X
the	B-X
upregulated	B-X
expression	B-X
of	B-X
several	B-X
metastasis-associated	B-X
molecules	B-X
,	B-X
which	B-X
could	B-X
be	B-X
abrogated	B-X
by	B-X
the	B-X
knockdown	B-X
of	B-X
either	B-X
-catenin	B-X
or	B-X
p50	B-X
.	B-X
In	B-X
U87MG	B-X
and	B-X
U251	B-X
cells	B-X
,	B-X
DLL4-induced	B-X
cellular	B-X
migration	B-X
and	B-X
invasion	B-X
could	B-X
be	B-X
inhibited	B-X
by	B-X
either	B-X
-catenin	B-X
or	B-X
a	B-X
p50	B-X
inhibitor	B-X
.	B-X
Collectively	B-X
,	B-X
these	B-X
results	B-X
indicate	B-X
that	B-X
Notch	B-X
activation	B-X
could	B-X
stimulate	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
through	B-X
AKT	B-X
activation	B-X
in	B-X
glioma	B-X
cells	B-X
.	B-X
Thus	B-X
,	B-X
Notch	B-X
activation-stimulated	B-X
-catenin	B-X
and	B-X
NF-B	B-X
signaling	B-X
synergistically	B-X
promote	B-X
the	B-X
migratory	B-X
and	B-X
invasive	B-X
properties	B-X
of	B-X
glioma	B-X
cells	B-X
.	B-X

The	O
p65	B-Gene_or_gene_product
subunit	O
of	O
NF	O
-	O
kappaB	O
and	O
PARP1	B-Gene_or_gene_product
assist	O
Snail1	B-Gene_or_gene_product
in	O
activating	O
fibronectin	B-Gene_or_gene_product
transcription	O
.	O
<EOS>	B-X
Snail1	B-X
is	B-X
a	B-X
transcriptional	B-X
repressor	B-X
of	B-X
E-cadherin	B-X
that	B-X
triggers	B-X
epithelial-mesenchymal	B-X
transition	B-X
(	B-X
EMT	B-X
)	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
assisted	B-X
Snail1	B-X
interaction	B-X
with	B-X
the	B-X
promoter	B-X
of	B-X
a	B-X
typical	B-X
mesenchymal	B-X
gene	B-X
,	B-X
fibronectin	B-X
(	B-X
FN1	B-X
)	B-X
,	B-X
both	B-X
in	B-X
epithelial	B-X
cells	B-X
undergoing	B-X
EMT	B-X
and	B-X
in	B-X
fibroblasts	B-X
.	B-X
Together	B-X
with	B-X
Snail1	B-X
,	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-B	B-X
and	B-X
PARP1	B-X
bound	B-X
to	B-X
the	B-X
FN1	B-X
promoter	B-X
.	B-X
We	B-X
detected	B-X
nuclear	B-X
interaction	B-X
of	B-X
these	B-X
proteins	B-X
and	B-X
demonstrated	B-X
the	B-X
requirement	B-X
of	B-X
all	B-X
three	B-X
for	B-X
FN1	B-X
transcription	B-X
.	B-X
Moreover	B-X
,	B-X
other	B-X
genes	B-X
involved	B-X
in	B-X
cell	B-X
movement	B-X
mimic	B-X
FN1	B-X
expression	B-X
induced	B-X
by	B-X
Snail1	B-X
or	B-X
TGF-1	B-X
treatment	B-X
and	B-X
recruit	B-X
p65NF-B	B-X
and	B-X
Snail1	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
The	B-X
molecular	B-X
cooperation	B-X
between	B-X
Snail1	B-X
and	B-X
NF-B	B-X
in	B-X
transcription	B-X
activation	B-X
provides	B-X
a	B-X
new	B-X
insight	B-X
into	B-X
how	B-X
Snail1	B-X
can	B-X
modulate	B-X
a	B-X
variety	B-X
of	B-X
cell	B-X
programs	B-X
.	B-X

Snail1	B-Gene_or_gene_product
is	O
a	O
transcriptional	O
repressor	O
of	O
E	B-Gene_or_gene_product
-	I-Gene_or_gene_product
cadherin	I-Gene_or_gene_product
that	O
triggers	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
.	O
<EOS>	B-X
The	B-X
microRNAs	B-X
(	B-X
miRNAs	B-X
)	B-X
are	B-X
a	B-X
class	B-X
of	B-X
small	B-X
,	B-X
20-22	B-X
nucleotides	B-X
in	B-X
length	B-X
,	B-X
endogenously	B-X
expressed	B-X
noncoding	B-X
RNAs	B-X
that	B-X
regulate	B-X
multiple	B-X
targets	B-X
posttranscriptionally	B-X
.	B-X
Interestingly	B-X
,	B-X
miRNAs	B-X
have	B-X
emerged	B-X
as	B-X
regulators	B-X
of	B-X
most	B-X
physiological	B-X
and	B-X
pathological	B-X
processes	B-X
,	B-X
including	B-X
metastatic	B-X
tumor	B-X
progression	B-X
,	B-X
in	B-X
part	B-X
by	B-X
controlling	B-X
a	B-X
reversible	B-X
process	B-X
called	B-X
epithelial-to-mesenchymal	B-X
transition	B-X
(	B-X
EMT	B-X
)	B-X
.	B-X
The	B-X
activation	B-X
of	B-X
EMT	B-X
increases	B-X
the	B-X
migratory	B-X
and	B-X
invasive	B-X
properties	B-X
fundamental	B-X
for	B-X
tumor	B-X
cell	B-X
spread	B-X
while	B-X
activation	B-X
of	B-X
the	B-X
reverse	B-X
mesenchymal-to-epithelial	B-X
transition	B-X
is	B-X
required	B-X
for	B-X
metastasis	B-X
outgrowth	B-X
.	B-X
The	B-X
EMT	B-X
triggering	B-X
leads	B-X
to	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
core	B-X
of	B-X
transcription	B-X
factors	B-X
(	B-X
EMT-TFs	B-X
)	B-X
-	B-X
SNAIL1/SNAIL2	B-X
,	B-X
bHLH	B-X
(	B-X
E47	B-X
,	B-X
E2-2	B-X
,	B-X
and	B-X
TWIST1/TWIST2	B-X
)	B-X
,	B-X
and	B-X
ZEB1/ZEB2	B-X
-	B-X
that	B-X
act	B-X
as	B-X
E-cadherin	B-X
repressors	B-X
and	B-X
,	B-X
ultimately	B-X
,	B-X
coordinate	B-X
EMT	B-X
.	B-X
Recent	B-X
evidence	B-X
indicates	B-X
that	B-X
several	B-X
miRNAs	B-X
regulate	B-X
the	B-X
expression	B-X
of	B-X
EMT-TFs	B-X
or	B-X
EMT-activating	B-X
signaling	B-X
pathways	B-X
.	B-X
Interestingly	B-X
,	B-X
some	B-X
miRNAs	B-X
and	B-X
EMT-TFs	B-X
form	B-X
tightly	B-X
interconnected	B-X
negative	B-X
feedback	B-X
loops	B-X
that	B-X
control	B-X
epithelial	B-X
cell	B-X
plasticity	B-X
,	B-X
providing	B-X
self-reinforcing	B-X
signals	B-X
and	B-X
robustness	B-X
to	B-X
maintain	B-X
the	B-X
epithelial	B-X
or	B-X
mesenchymal	B-X
cell	B-X
status	B-X
.	B-X
Among	B-X
the	B-X
most	B-X
significant	B-X
feedback	B-X
loops	B-X
,	B-X
we	B-X
focus	B-X
on	B-X
the	B-X
ZEB/miR-200	B-X
and	B-X
the	B-X
SNAIL1/miR-34	B-X
networks	B-X
that	B-X
hold	B-X
a	B-X
clear	B-X
impact	B-X
in	B-X
the	B-X
regulation	B-X
of	B-X
the	B-X
epithelial-mesenchymal	B-X
state	B-X
.	B-X
Recent	B-X
insights	B-X
into	B-X
the	B-X
p53	B-X
modulation	B-X
of	B-X
the	B-X
EMT-TF/miRNA	B-X
loops	B-X
and	B-X
epigenetic	B-X
regulatory	B-X
mechanisms	B-X
in	B-X
the	B-X
context	B-X
of	B-X
metastasis	B-X
dissemination	B-X
will	B-X
also	B-X
be	B-X
discussed	B-X
.	B-X
Understanding	B-X
the	B-X
regulation	B-X
of	B-X
EMT	B-X
by	B-X
miRNAs	B-X
opens	B-X
new	B-X
avenues	B-X
for	B-X
the	B-X
diagnosis	B-X
and	B-X
prognosis	B-X
of	B-X
tumors	B-X
and	B-X
identifies	B-X
potential	B-X
therapeutic	B-X
targets	B-X
that	B-X
might	B-X
help	B-X
to	B-X
negatively	B-X
impact	B-X
on	B-X
metastasis	B-X
dissemination	B-X
and	B-X
increasing	B-X
patient	B-X
survival	B-X
.	B-X

Here	O
,	O
we	O
report	O
assisted	O
Snail1	B-Gene_or_gene_product
interaction	O
with	O
the	O
promoter	O
of	O
a	O
typical	O
mesenchymal	O
gene	O
,	O
fibronectin	B-Gene_or_gene_product
(	O
FN1	B-Gene_or_gene_product
)	O
,	O
both	O
in	O
epithelial	O
cells	O
undergoing	O
EMT	O
and	O
in	O
fibroblasts	O
.	O
<EOS>	B-X
Snail1	B-X
is	B-X
a	B-X
transcriptional	B-X
repressor	B-X
of	B-X
E-cadherin	B-X
that	B-X
triggers	B-X
epithelial-mesenchymal	B-X
transition	B-X
(	B-X
EMT	B-X
)	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
assisted	B-X
Snail1	B-X
interaction	B-X
with	B-X
the	B-X
promoter	B-X
of	B-X
a	B-X
typical	B-X
mesenchymal	B-X
gene	B-X
,	B-X
fibronectin	B-X
(	B-X
FN1	B-X
)	B-X
,	B-X
both	B-X
in	B-X
epithelial	B-X
cells	B-X
undergoing	B-X
EMT	B-X
and	B-X
in	B-X
fibroblasts	B-X
.	B-X
Together	B-X
with	B-X
Snail1	B-X
,	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-B	B-X
and	B-X
PARP1	B-X
bound	B-X
to	B-X
the	B-X
FN1	B-X
promoter	B-X
.	B-X
We	B-X
detected	B-X
nuclear	B-X
interaction	B-X
of	B-X
these	B-X
proteins	B-X
and	B-X
demonstrated	B-X
the	B-X
requirement	B-X
of	B-X
all	B-X
three	B-X
for	B-X
FN1	B-X
transcription	B-X
.	B-X
Moreover	B-X
,	B-X
other	B-X
genes	B-X
involved	B-X
in	B-X
cell	B-X
movement	B-X
mimic	B-X
FN1	B-X
expression	B-X
induced	B-X
by	B-X
Snail1	B-X
or	B-X
TGF-1	B-X
treatment	B-X
and	B-X
recruit	B-X
p65NF-B	B-X
and	B-X
Snail1	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
The	B-X
molecular	B-X
cooperation	B-X
between	B-X
Snail1	B-X
and	B-X
NF-B	B-X
in	B-X
transcription	B-X
activation	B-X
provides	B-X
a	B-X
new	B-X
insight	B-X
into	B-X
how	B-X
Snail1	B-X
can	B-X
modulate	B-X
a	B-X
variety	B-X
of	B-X
cell	B-X
programs	B-X
.	B-X

Together	O
with	O
Snail1	B-Gene_or_gene_product
,	O
the	O
p65	B-Gene_or_gene_product
subunit	O
of	O
NF	O
-	O
kappaB	O
and	O
PARP1	B-Gene_or_gene_product
bound	O
to	O
the	O
FN1	B-Gene_or_gene_product
promoter	O
.	O

We	O
detected	O
nuclear	O
interaction	O
of	O
these	O
proteins	O
and	O
demonstrated	O
the	O
requirement	O
of	O
all	O
three	O
for	O
FN1	B-Gene_or_gene_product
transcription	O
.	O
<EOS>	B-X
Snail1	B-X
is	B-X
a	B-X
transcriptional	B-X
repressor	B-X
of	B-X
E-cadherin	B-X
that	B-X
triggers	B-X
epithelial-mesenchymal	B-X
transition	B-X
(	B-X
EMT	B-X
)	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
assisted	B-X
Snail1	B-X
interaction	B-X
with	B-X
the	B-X
promoter	B-X
of	B-X
a	B-X
typical	B-X
mesenchymal	B-X
gene	B-X
,	B-X
fibronectin	B-X
(	B-X
FN1	B-X
)	B-X
,	B-X
both	B-X
in	B-X
epithelial	B-X
cells	B-X
undergoing	B-X
EMT	B-X
and	B-X
in	B-X
fibroblasts	B-X
.	B-X
Together	B-X
with	B-X
Snail1	B-X
,	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-B	B-X
and	B-X
PARP1	B-X
bound	B-X
to	B-X
the	B-X
FN1	B-X
promoter	B-X
.	B-X
We	B-X
detected	B-X
nuclear	B-X
interaction	B-X
of	B-X
these	B-X
proteins	B-X
and	B-X
demonstrated	B-X
the	B-X
requirement	B-X
of	B-X
all	B-X
three	B-X
for	B-X
FN1	B-X
transcription	B-X
.	B-X
Moreover	B-X
,	B-X
other	B-X
genes	B-X
involved	B-X
in	B-X
cell	B-X
movement	B-X
mimic	B-X
FN1	B-X
expression	B-X
induced	B-X
by	B-X
Snail1	B-X
or	B-X
TGF-1	B-X
treatment	B-X
and	B-X
recruit	B-X
p65NF-B	B-X
and	B-X
Snail1	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
The	B-X
molecular	B-X
cooperation	B-X
between	B-X
Snail1	B-X
and	B-X
NF-B	B-X
in	B-X
transcription	B-X
activation	B-X
provides	B-X
a	B-X
new	B-X
insight	B-X
into	B-X
how	B-X
Snail1	B-X
can	B-X
modulate	B-X
a	B-X
variety	B-X
of	B-X
cell	B-X
programs	B-X
.	B-X

Moreover	O
,	O
other	O
genes	O
involved	O
in	O
cell	O
movement	O
mimic	O
FN1	B-Gene_or_gene_product
expression	O
induced	O
by	O
Snail1	B-Gene_or_gene_product
or	O
TGF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
beta1	I-Gene_or_gene_product
treatment	O
and	O
recruit	O
p65NF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
kappaB	I-Gene_or_gene_product
and	O
Snail1	B-Gene_or_gene_product
to	O
their	O
promoters	O
.	O
<EOS>	B-X
Snail1	B-X
is	B-X
a	B-X
transcriptional	B-X
repressor	B-X
of	B-X
E-cadherin	B-X
that	B-X
triggers	B-X
epithelial-mesenchymal	B-X
transition	B-X
(	B-X
EMT	B-X
)	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
assisted	B-X
Snail1	B-X
interaction	B-X
with	B-X
the	B-X
promoter	B-X
of	B-X
a	B-X
typical	B-X
mesenchymal	B-X
gene	B-X
,	B-X
fibronectin	B-X
(	B-X
FN1	B-X
)	B-X
,	B-X
both	B-X
in	B-X
epithelial	B-X
cells	B-X
undergoing	B-X
EMT	B-X
and	B-X
in	B-X
fibroblasts	B-X
.	B-X
Together	B-X
with	B-X
Snail1	B-X
,	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-B	B-X
and	B-X
PARP1	B-X
bound	B-X
to	B-X
the	B-X
FN1	B-X
promoter	B-X
.	B-X
We	B-X
detected	B-X
nuclear	B-X
interaction	B-X
of	B-X
these	B-X
proteins	B-X
and	B-X
demonstrated	B-X
the	B-X
requirement	B-X
of	B-X
all	B-X
three	B-X
for	B-X
FN1	B-X
transcription	B-X
.	B-X
Moreover	B-X
,	B-X
other	B-X
genes	B-X
involved	B-X
in	B-X
cell	B-X
movement	B-X
mimic	B-X
FN1	B-X
expression	B-X
induced	B-X
by	B-X
Snail1	B-X
or	B-X
TGF-1	B-X
treatment	B-X
and	B-X
recruit	B-X
p65NF-B	B-X
and	B-X
Snail1	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
The	B-X
molecular	B-X
cooperation	B-X
between	B-X
Snail1	B-X
and	B-X
NF-B	B-X
in	B-X
transcription	B-X
activation	B-X
provides	B-X
a	B-X
new	B-X
insight	B-X
into	B-X
how	B-X
Snail1	B-X
can	B-X
modulate	B-X
a	B-X
variety	B-X
of	B-X
cell	B-X
programs	B-X
.	B-X

The	O
molecular	O
cooperation	O
between	O
Snail1	B-Gene_or_gene_product
and	O
NF	O
-	O
kappaB	O
in	O
transcription	O
activation	O
provides	O
a	O
new	O
insight	O
into	O
how	O
Snail1	B-Gene_or_gene_product
can	O
modulate	O
a	O
variety	O
of	O
cell	O
programs	O
.	O
<EOS>	B-X
Snail1	B-X
is	B-X
a	B-X
transcriptional	B-X
repressor	B-X
of	B-X
E-cadherin	B-X
that	B-X
triggers	B-X
epithelial-mesenchymal	B-X
transition	B-X
(	B-X
EMT	B-X
)	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
report	B-X
assisted	B-X
Snail1	B-X
interaction	B-X
with	B-X
the	B-X
promoter	B-X
of	B-X
a	B-X
typical	B-X
mesenchymal	B-X
gene	B-X
,	B-X
fibronectin	B-X
(	B-X
FN1	B-X
)	B-X
,	B-X
both	B-X
in	B-X
epithelial	B-X
cells	B-X
undergoing	B-X
EMT	B-X
and	B-X
in	B-X
fibroblasts	B-X
.	B-X
Together	B-X
with	B-X
Snail1	B-X
,	B-X
the	B-X
p65	B-X
subunit	B-X
of	B-X
NF-B	B-X
and	B-X
PARP1	B-X
bound	B-X
to	B-X
the	B-X
FN1	B-X
promoter	B-X
.	B-X
We	B-X
detected	B-X
nuclear	B-X
interaction	B-X
of	B-X
these	B-X
proteins	B-X
and	B-X
demonstrated	B-X
the	B-X
requirement	B-X
of	B-X
all	B-X
three	B-X
for	B-X
FN1	B-X
transcription	B-X
.	B-X
Moreover	B-X
,	B-X
other	B-X
genes	B-X
involved	B-X
in	B-X
cell	B-X
movement	B-X
mimic	B-X
FN1	B-X
expression	B-X
induced	B-X
by	B-X
Snail1	B-X
or	B-X
TGF-1	B-X
treatment	B-X
and	B-X
recruit	B-X
p65NF-B	B-X
and	B-X
Snail1	B-X
to	B-X
their	B-X
promoters	B-X
.	B-X
The	B-X
molecular	B-X
cooperation	B-X
between	B-X
Snail1	B-X
and	B-X
NF-B	B-X
in	B-X
transcription	B-X
activation	B-X
provides	B-X
a	B-X
new	B-X
insight	B-X
into	B-X
how	B-X
Snail1	B-X
can	B-X
modulate	B-X
a	B-X
variety	B-X
of	B-X
cell	B-X
programs	B-X
.	B-X

Double	O
plant	O
homeodomain	O
(	O
PHD	O
)	O
finger	O
proteins	O
DPF3a	B-Gene_or_gene_product
and	O
-	B-Gene_or_gene_product
3b	I-Gene_or_gene_product
are	O
required	O
as	O
transcriptional	O
co	O
-	O
activators	O
in	O
SWI	O
/	O
SNF	O
complex	O
-	O
dependent	O
activation	O
of	O
NF	O
-	O
kappaB	O
RelA	O
/	O
p50	O
heterodimer	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
DPF2	B-X
(	B-X
requiem/REQ	B-X
)	B-X
functions	B-X
as	B-X
a	B-X
linker	B-X
protein	B-X
between	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
and	B-X
RelB/p52	B-X
NF-B	B-X
heterodimer	B-X
and	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
NF-B	B-X
transactivation	B-X
via	B-X
its	B-X
noncanonical	B-X
pathway	B-X
.	B-X
Using	B-X
sensitive	B-X
293FT	B-X
reporter	B-X
cell	B-X
clones	B-X
that	B-X
had	B-X
integrated	B-X
a	B-X
SWI/SNF-dependent	B-X
NF-B	B-X
reporter	B-X
gene	B-X
,	B-X
we	B-X
find	B-X
in	B-X
this	B-X
study	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
DPF1	B-X
,	B-X
DPF2	B-X
,	B-X
DPF3a	B-X
,	B-X
DPF3b	B-X
,	B-X
and	B-X
PHF10	B-X
significantly	B-X
potentiates	B-X
the	B-X
transactivating	B-X
activity	B-X
of	B-X
typical	B-X
NF-B	B-X
dimers	B-X
.	B-X
Knockdown	B-X
analysis	B-X
using	B-X
293FT	B-X
reporter	B-X
cells	B-X
that	B-X
endogenously	B-X
express	B-X
these	B-X
five	B-X
proteins	B-X
at	B-X
low	B-X
levels	B-X
clearly	B-X
showed	B-X
that	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
,	B-X
which	B-X
are	B-X
produced	B-X
from	B-X
the	B-X
DPF3	B-X
gene	B-X
by	B-X
alternative	B-X
splicing	B-X
,	B-X
are	B-X
the	B-X
most	B-X
critical	B-X
for	B-X
the	B-X
RelA/p50	B-X
NF-B	B-X
heterodimer	B-X
transactivation	B-X
induced	B-X
by	B-X
TNF-	B-X
stimulation	B-X
.	B-X
Our	B-X
data	B-X
further	B-X
show	B-X
that	B-X
this	B-X
transactivation	B-X
requires	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
.	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
are	B-X
additionally	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
RelA	B-X
,	B-X
p50	B-X
,	B-X
and	B-X
several	B-X
subunits	B-X
of	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
in	B-X
vitro	B-X
and	B-X
to	B-X
be	B-X
co-immunoprecipitated	B-X
with	B-X
RelA/p50	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
from	B-X
the	B-X
nuclear	B-X
fractions	B-X
of	B-X
cells	B-X
treated	B-X
with	B-X
TNF-	B-X
.	B-X
In	B-X
ChIP	B-X
experiments	B-X
,	B-X
we	B-X
further	B-X
found	B-X
that	B-X
endogenous	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
are	B-X
continuously	B-X
present	B-X
on	B-X
HIV-1	B-X
LTR	B-X
,	B-X
whereas	B-X
the	B-X
kinetics	B-X
of	B-X
RelA/p50	B-X
recruitment	B-X
after	B-X
TNF-	B-X
treatment	B-X
correlate	B-X
well	B-X
with	B-X
the	B-X
viral	B-X
transcriptional	B-X
activation	B-X
levels	B-X
.	B-X
Additionally	B-X
,	B-X
re-ChIP	B-X
experiments	B-X
showed	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
associate	B-X
with	B-X
RelA	B-X
on	B-X
the	B-X
endogenous	B-X
IL-6	B-X
promoter	B-X
after	B-X
TNF-	B-X
treatment	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
present	B-X
data	B-X
indicate	B-X
that	B-X
by	B-X
linking	B-X
RelA/p50	B-X
to	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
,	B-X
DPF3a/b	B-X
induces	B-X
the	B-X
transactivation	B-X
of	B-X
NF-B	B-X
target	B-X
gene	B-X
promoters	B-X
in	B-X
relatively	B-X
inactive	B-X
chromatin	B-X
contexts	B-X
.	B-X

We	O
have	O
previously	O
shown	O
that	O
DPF2	B-Gene_or_gene_product
(	O
requiem	B-Gene_or_gene_product
/	O
REQ	B-Gene_or_gene_product
)	O
functions	O
as	O
a	O
linker	O
protein	O
between	O
the	O
SWI	O
/	O
SNF	O
complex	O
and	O
RelB	O
/	O
p52	O
NF	O
-	O
kappaB	O
heterodimer	O
and	O
plays	O
important	O
roles	O
in	O
NF	O
-	O
kappaB	O
transactivation	O
via	O
its	O
noncanonical	O
pathway	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
DPF2	B-X
(	B-X
requiem/REQ	B-X
)	B-X
functions	B-X
as	B-X
a	B-X
linker	B-X
protein	B-X
between	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
and	B-X
RelB/p52	B-X
NF-B	B-X
heterodimer	B-X
and	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
NF-B	B-X
transactivation	B-X
via	B-X
its	B-X
noncanonical	B-X
pathway	B-X
.	B-X
Using	B-X
sensitive	B-X
293FT	B-X
reporter	B-X
cell	B-X
clones	B-X
that	B-X
had	B-X
integrated	B-X
a	B-X
SWI/SNF-dependent	B-X
NF-B	B-X
reporter	B-X
gene	B-X
,	B-X
we	B-X
find	B-X
in	B-X
this	B-X
study	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
DPF1	B-X
,	B-X
DPF2	B-X
,	B-X
DPF3a	B-X
,	B-X
DPF3b	B-X
,	B-X
and	B-X
PHF10	B-X
significantly	B-X
potentiates	B-X
the	B-X
transactivating	B-X
activity	B-X
of	B-X
typical	B-X
NF-B	B-X
dimers	B-X
.	B-X
Knockdown	B-X
analysis	B-X
using	B-X
293FT	B-X
reporter	B-X
cells	B-X
that	B-X
endogenously	B-X
express	B-X
these	B-X
five	B-X
proteins	B-X
at	B-X
low	B-X
levels	B-X
clearly	B-X
showed	B-X
that	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
,	B-X
which	B-X
are	B-X
produced	B-X
from	B-X
the	B-X
DPF3	B-X
gene	B-X
by	B-X
alternative	B-X
splicing	B-X
,	B-X
are	B-X
the	B-X
most	B-X
critical	B-X
for	B-X
the	B-X
RelA/p50	B-X
NF-B	B-X
heterodimer	B-X
transactivation	B-X
induced	B-X
by	B-X
TNF-	B-X
stimulation	B-X
.	B-X
Our	B-X
data	B-X
further	B-X
show	B-X
that	B-X
this	B-X
transactivation	B-X
requires	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
.	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
are	B-X
additionally	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
RelA	B-X
,	B-X
p50	B-X
,	B-X
and	B-X
several	B-X
subunits	B-X
of	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
in	B-X
vitro	B-X
and	B-X
to	B-X
be	B-X
co-immunoprecipitated	B-X
with	B-X
RelA/p50	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
from	B-X
the	B-X
nuclear	B-X
fractions	B-X
of	B-X
cells	B-X
treated	B-X
with	B-X
TNF-	B-X
.	B-X
In	B-X
ChIP	B-X
experiments	B-X
,	B-X
we	B-X
further	B-X
found	B-X
that	B-X
endogenous	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
are	B-X
continuously	B-X
present	B-X
on	B-X
HIV-1	B-X
LTR	B-X
,	B-X
whereas	B-X
the	B-X
kinetics	B-X
of	B-X
RelA/p50	B-X
recruitment	B-X
after	B-X
TNF-	B-X
treatment	B-X
correlate	B-X
well	B-X
with	B-X
the	B-X
viral	B-X
transcriptional	B-X
activation	B-X
levels	B-X
.	B-X
Additionally	B-X
,	B-X
re-ChIP	B-X
experiments	B-X
showed	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
associate	B-X
with	B-X
RelA	B-X
on	B-X
the	B-X
endogenous	B-X
IL-6	B-X
promoter	B-X
after	B-X
TNF-	B-X
treatment	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
present	B-X
data	B-X
indicate	B-X
that	B-X
by	B-X
linking	B-X
RelA/p50	B-X
to	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
,	B-X
DPF3a/b	B-X
induces	B-X
the	B-X
transactivation	B-X
of	B-X
NF-B	B-X
target	B-X
gene	B-X
promoters	B-X
in	B-X
relatively	B-X
inactive	B-X
chromatin	B-X
contexts	B-X
.	B-X

Using	O
sensitive	O
293FT	O
reporter	O
cell	O
clones	O
that	O
had	O
integrated	O
a	O
SWI	O
/	O
SNF	O
-	O
dependent	O
NF	O
-	O
kappaB	O
reporter	O
gene	O
,	O
we	O
find	O
in	O
this	O
study	O
that	O
the	O
overexpression	O
of	O
DPF1	B-Gene_or_gene_product
,	O
DPF2	B-Gene_or_gene_product
,	O
DPF3a	B-Gene_or_gene_product
,	O
DPF3b	B-Gene_or_gene_product
,	O
and	O
PHF10	B-Gene_or_gene_product
significantly	O
potentiates	O
the	O
transactivating	O
activity	O
of	O
typical	O
NF	O
-	O
kappaB	O
dimers	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
DPF2	B-X
(	B-X
requiem/REQ	B-X
)	B-X
functions	B-X
as	B-X
a	B-X
linker	B-X
protein	B-X
between	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
and	B-X
RelB/p52	B-X
NF-B	B-X
heterodimer	B-X
and	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
NF-B	B-X
transactivation	B-X
via	B-X
its	B-X
noncanonical	B-X
pathway	B-X
.	B-X
Using	B-X
sensitive	B-X
293FT	B-X
reporter	B-X
cell	B-X
clones	B-X
that	B-X
had	B-X
integrated	B-X
a	B-X
SWI/SNF-dependent	B-X
NF-B	B-X
reporter	B-X
gene	B-X
,	B-X
we	B-X
find	B-X
in	B-X
this	B-X
study	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
DPF1	B-X
,	B-X
DPF2	B-X
,	B-X
DPF3a	B-X
,	B-X
DPF3b	B-X
,	B-X
and	B-X
PHF10	B-X
significantly	B-X
potentiates	B-X
the	B-X
transactivating	B-X
activity	B-X
of	B-X
typical	B-X
NF-B	B-X
dimers	B-X
.	B-X
Knockdown	B-X
analysis	B-X
using	B-X
293FT	B-X
reporter	B-X
cells	B-X
that	B-X
endogenously	B-X
express	B-X
these	B-X
five	B-X
proteins	B-X
at	B-X
low	B-X
levels	B-X
clearly	B-X
showed	B-X
that	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
,	B-X
which	B-X
are	B-X
produced	B-X
from	B-X
the	B-X
DPF3	B-X
gene	B-X
by	B-X
alternative	B-X
splicing	B-X
,	B-X
are	B-X
the	B-X
most	B-X
critical	B-X
for	B-X
the	B-X
RelA/p50	B-X
NF-B	B-X
heterodimer	B-X
transactivation	B-X
induced	B-X
by	B-X
TNF-	B-X
stimulation	B-X
.	B-X
Our	B-X
data	B-X
further	B-X
show	B-X
that	B-X
this	B-X
transactivation	B-X
requires	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
.	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
are	B-X
additionally	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
RelA	B-X
,	B-X
p50	B-X
,	B-X
and	B-X
several	B-X
subunits	B-X
of	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
in	B-X
vitro	B-X
and	B-X
to	B-X
be	B-X
co-immunoprecipitated	B-X
with	B-X
RelA/p50	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
from	B-X
the	B-X
nuclear	B-X
fractions	B-X
of	B-X
cells	B-X
treated	B-X
with	B-X
TNF-	B-X
.	B-X
In	B-X
ChIP	B-X
experiments	B-X
,	B-X
we	B-X
further	B-X
found	B-X
that	B-X
endogenous	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
are	B-X
continuously	B-X
present	B-X
on	B-X
HIV-1	B-X
LTR	B-X
,	B-X
whereas	B-X
the	B-X
kinetics	B-X
of	B-X
RelA/p50	B-X
recruitment	B-X
after	B-X
TNF-	B-X
treatment	B-X
correlate	B-X
well	B-X
with	B-X
the	B-X
viral	B-X
transcriptional	B-X
activation	B-X
levels	B-X
.	B-X
Additionally	B-X
,	B-X
re-ChIP	B-X
experiments	B-X
showed	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
associate	B-X
with	B-X
RelA	B-X
on	B-X
the	B-X
endogenous	B-X
IL-6	B-X
promoter	B-X
after	B-X
TNF-	B-X
treatment	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
present	B-X
data	B-X
indicate	B-X
that	B-X
by	B-X
linking	B-X
RelA/p50	B-X
to	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
,	B-X
DPF3a/b	B-X
induces	B-X
the	B-X
transactivation	B-X
of	B-X
NF-B	B-X
target	B-X
gene	B-X
promoters	B-X
in	B-X
relatively	B-X
inactive	B-X
chromatin	B-X
contexts	B-X
.	B-X

Knockdown	O
analysis	O
using	O
293FT	O
reporter	O
cells	O
that	O
endogenously	O
express	O
these	O
five	O
proteins	O
at	O
low	O
levels	O
clearly	O
showed	O
that	O
DPF3a	B-Gene_or_gene_product
and	O
DPF3b	B-Gene_or_gene_product
,	O
which	O
are	O
produced	O
from	O
the	O
DPF3	B-Gene_or_gene_product
gene	O
by	O
alternative	O
splicing	O
,	O
are	O
the	O
most	O
critical	O
for	O
the	O
RelA	O
/	O
p50	O
NF	O
-	O
kappaB	O
heterodimer	O
transactivation	O
induced	O
by	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
stimulation	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
DPF2	B-X
(	B-X
requiem/REQ	B-X
)	B-X
functions	B-X
as	B-X
a	B-X
linker	B-X
protein	B-X
between	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
and	B-X
RelB/p52	B-X
NF-B	B-X
heterodimer	B-X
and	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
NF-B	B-X
transactivation	B-X
via	B-X
its	B-X
noncanonical	B-X
pathway	B-X
.	B-X
Using	B-X
sensitive	B-X
293FT	B-X
reporter	B-X
cell	B-X
clones	B-X
that	B-X
had	B-X
integrated	B-X
a	B-X
SWI/SNF-dependent	B-X
NF-B	B-X
reporter	B-X
gene	B-X
,	B-X
we	B-X
find	B-X
in	B-X
this	B-X
study	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
DPF1	B-X
,	B-X
DPF2	B-X
,	B-X
DPF3a	B-X
,	B-X
DPF3b	B-X
,	B-X
and	B-X
PHF10	B-X
significantly	B-X
potentiates	B-X
the	B-X
transactivating	B-X
activity	B-X
of	B-X
typical	B-X
NF-B	B-X
dimers	B-X
.	B-X
Knockdown	B-X
analysis	B-X
using	B-X
293FT	B-X
reporter	B-X
cells	B-X
that	B-X
endogenously	B-X
express	B-X
these	B-X
five	B-X
proteins	B-X
at	B-X
low	B-X
levels	B-X
clearly	B-X
showed	B-X
that	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
,	B-X
which	B-X
are	B-X
produced	B-X
from	B-X
the	B-X
DPF3	B-X
gene	B-X
by	B-X
alternative	B-X
splicing	B-X
,	B-X
are	B-X
the	B-X
most	B-X
critical	B-X
for	B-X
the	B-X
RelA/p50	B-X
NF-B	B-X
heterodimer	B-X
transactivation	B-X
induced	B-X
by	B-X
TNF-	B-X
stimulation	B-X
.	B-X
Our	B-X
data	B-X
further	B-X
show	B-X
that	B-X
this	B-X
transactivation	B-X
requires	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
.	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
are	B-X
additionally	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
RelA	B-X
,	B-X
p50	B-X
,	B-X
and	B-X
several	B-X
subunits	B-X
of	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
in	B-X
vitro	B-X
and	B-X
to	B-X
be	B-X
co-immunoprecipitated	B-X
with	B-X
RelA/p50	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
from	B-X
the	B-X
nuclear	B-X
fractions	B-X
of	B-X
cells	B-X
treated	B-X
with	B-X
TNF-	B-X
.	B-X
In	B-X
ChIP	B-X
experiments	B-X
,	B-X
we	B-X
further	B-X
found	B-X
that	B-X
endogenous	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
are	B-X
continuously	B-X
present	B-X
on	B-X
HIV-1	B-X
LTR	B-X
,	B-X
whereas	B-X
the	B-X
kinetics	B-X
of	B-X
RelA/p50	B-X
recruitment	B-X
after	B-X
TNF-	B-X
treatment	B-X
correlate	B-X
well	B-X
with	B-X
the	B-X
viral	B-X
transcriptional	B-X
activation	B-X
levels	B-X
.	B-X
Additionally	B-X
,	B-X
re-ChIP	B-X
experiments	B-X
showed	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
associate	B-X
with	B-X
RelA	B-X
on	B-X
the	B-X
endogenous	B-X
IL-6	B-X
promoter	B-X
after	B-X
TNF-	B-X
treatment	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
present	B-X
data	B-X
indicate	B-X
that	B-X
by	B-X
linking	B-X
RelA/p50	B-X
to	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
,	B-X
DPF3a/b	B-X
induces	B-X
the	B-X
transactivation	B-X
of	B-X
NF-B	B-X
target	B-X
gene	B-X
promoters	B-X
in	B-X
relatively	B-X
inactive	B-X
chromatin	B-X
contexts	B-X
.	B-X

Our	O
data	O
further	O
show	O
that	O
this	O
transactivation	O
requires	O
the	O
SWI	O
/	O
SNF	O
complex	O
.	O
<EOS>	B-X
Disruption	B-X
of	B-X
antagonism	B-X
between	B-X
SWI/SNF	B-X
chromatin	B-X
remodelers	B-X
and	B-X
polycomb	B-X
repressor	B-X
complexes	B-X
drives	B-X
the	B-X
formation	B-X
of	B-X
numerous	B-X
cancer	B-X
types	B-X
.	B-X
Recently	B-X
,	B-X
an	B-X
inhibitor	B-X
of	B-X
the	B-X
polycomb	B-X
protein	B-X
EZH2	B-X
was	B-X
approved	B-X
for	B-X
the	B-X
treatment	B-X
of	B-X
a	B-X
sarcoma	B-X
mutant	B-X
in	B-X
the	B-X
SWI/SNF	B-X
subunit	B-X
SMARCB1	B-X
,	B-X
but	B-X
resistance	B-X
occurs	B-X
.	B-X
Here	B-X
,	B-X
we	B-X
performed	B-X
CRISPR	B-X
screens	B-X
in	B-X
SMARCB1-mutant	B-X
rhabdoid	B-X
tumor	B-X
cells	B-X
to	B-X
identify	B-X
genetic	B-X
contributors	B-X
to	B-X
SWI/SNF-polycomb	B-X
antagonism	B-X
and	B-X
potential	B-X
resistance	B-X
mechanisms	B-X
.	B-X
We	B-X
show	B-X
that	B-X
NSD1	B-X
antagonizes	B-X
polycomb	B-X
via	B-X
cooperation	B-X
with	B-X
SWI/SNF	B-X
and	B-X
identify	B-X
co-occurrence	B-X
of	B-X
NSD1	B-X
inactivation	B-X
in	B-X
SWI/SNF-defective	B-X
cancers	B-X
,	B-X
indicating	B-X
in	B-X
vivo	B-X
relevance	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
H3K36me2	B-X
itself	B-X
has	B-X
an	B-X
essential	B-X
role	B-X
in	B-X
the	B-X
activation	B-X
of	B-X
polycomb	B-X
target	B-X
genes	B-X
as	B-X
inhibition	B-X
of	B-X
the	B-X
H3K36me2	B-X
demethylase	B-X
KDM2A	B-X
restores	B-X
the	B-X
efficacy	B-X
of	B-X
EZH2	B-X
inhibition	B-X
in	B-X
SWI/SNF-deficient	B-X
cells	B-X
lacking	B-X
NSD1	B-X
.	B-X
Together	B-X
our	B-X
data	B-X
expand	B-X
the	B-X
mechanistic	B-X
understanding	B-X
of	B-X
SWI/SNF	B-X
and	B-X
polycomb	B-X
interplay	B-X
and	B-X
identify	B-X
NSD1	B-X
as	B-X
the	B-X
key	B-X
for	B-X
coordinating	B-X
this	B-X
transcriptional	B-X
control	B-X
.	B-X

DPF3a	B-Gene_or_gene_product
and	O
DPF3b	B-Gene_or_gene_product
are	O
additionally	O
shown	O
to	O
interact	O
directly	O
with	O
RelA	B-Gene_or_gene_product
,	O
p50	B-Gene_or_gene_product
,	O
and	O
several	O
subunits	O
of	O
the	O
SWI	O
/	O
SNF	O
complex	O
in	O
vitro	O
and	O
to	O
be	O
co	O
-	O
immunoprecipitated	O
with	O
RelA	O
/	O
p50	O
and	O
the	O
SWI	O
/	O
SNF	O
complex	O
from	O
the	O
nuclear	O
fractions	O
of	O
cells	O
treated	O
with	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
DPF2	B-X
(	B-X
requiem/REQ	B-X
)	B-X
functions	B-X
as	B-X
a	B-X
linker	B-X
protein	B-X
between	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
and	B-X
RelB/p52	B-X
NF-B	B-X
heterodimer	B-X
and	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
NF-B	B-X
transactivation	B-X
via	B-X
its	B-X
noncanonical	B-X
pathway	B-X
.	B-X
Using	B-X
sensitive	B-X
293FT	B-X
reporter	B-X
cell	B-X
clones	B-X
that	B-X
had	B-X
integrated	B-X
a	B-X
SWI/SNF-dependent	B-X
NF-B	B-X
reporter	B-X
gene	B-X
,	B-X
we	B-X
find	B-X
in	B-X
this	B-X
study	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
DPF1	B-X
,	B-X
DPF2	B-X
,	B-X
DPF3a	B-X
,	B-X
DPF3b	B-X
,	B-X
and	B-X
PHF10	B-X
significantly	B-X
potentiates	B-X
the	B-X
transactivating	B-X
activity	B-X
of	B-X
typical	B-X
NF-B	B-X
dimers	B-X
.	B-X
Knockdown	B-X
analysis	B-X
using	B-X
293FT	B-X
reporter	B-X
cells	B-X
that	B-X
endogenously	B-X
express	B-X
these	B-X
five	B-X
proteins	B-X
at	B-X
low	B-X
levels	B-X
clearly	B-X
showed	B-X
that	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
,	B-X
which	B-X
are	B-X
produced	B-X
from	B-X
the	B-X
DPF3	B-X
gene	B-X
by	B-X
alternative	B-X
splicing	B-X
,	B-X
are	B-X
the	B-X
most	B-X
critical	B-X
for	B-X
the	B-X
RelA/p50	B-X
NF-B	B-X
heterodimer	B-X
transactivation	B-X
induced	B-X
by	B-X
TNF-	B-X
stimulation	B-X
.	B-X
Our	B-X
data	B-X
further	B-X
show	B-X
that	B-X
this	B-X
transactivation	B-X
requires	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
.	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
are	B-X
additionally	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
RelA	B-X
,	B-X
p50	B-X
,	B-X
and	B-X
several	B-X
subunits	B-X
of	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
in	B-X
vitro	B-X
and	B-X
to	B-X
be	B-X
co-immunoprecipitated	B-X
with	B-X
RelA/p50	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
from	B-X
the	B-X
nuclear	B-X
fractions	B-X
of	B-X
cells	B-X
treated	B-X
with	B-X
TNF-	B-X
.	B-X
In	B-X
ChIP	B-X
experiments	B-X
,	B-X
we	B-X
further	B-X
found	B-X
that	B-X
endogenous	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
are	B-X
continuously	B-X
present	B-X
on	B-X
HIV-1	B-X
LTR	B-X
,	B-X
whereas	B-X
the	B-X
kinetics	B-X
of	B-X
RelA/p50	B-X
recruitment	B-X
after	B-X
TNF-	B-X
treatment	B-X
correlate	B-X
well	B-X
with	B-X
the	B-X
viral	B-X
transcriptional	B-X
activation	B-X
levels	B-X
.	B-X
Additionally	B-X
,	B-X
re-ChIP	B-X
experiments	B-X
showed	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
associate	B-X
with	B-X
RelA	B-X
on	B-X
the	B-X
endogenous	B-X
IL-6	B-X
promoter	B-X
after	B-X
TNF-	B-X
treatment	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
present	B-X
data	B-X
indicate	B-X
that	B-X
by	B-X
linking	B-X
RelA/p50	B-X
to	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
,	B-X
DPF3a/b	B-X
induces	B-X
the	B-X
transactivation	B-X
of	B-X
NF-B	B-X
target	B-X
gene	B-X
promoters	B-X
in	B-X
relatively	B-X
inactive	B-X
chromatin	B-X
contexts	B-X
.	B-X

In	O
ChIP	O
experiments	O
,	O
we	O
further	O
found	O
that	O
endogenous	O
DPF3a	B-Gene_or_gene_product
/	O
b	B-Gene_or_gene_product
and	O
the	O
SWI	O
/	O
SNF	O
complex	O
are	O
continuously	O
present	O
on	O
HIV	O
-	O
1	O
LTR	B-Gene_or_gene_product
,	O
whereas	O
the	O
kinetics	O
of	O
RelA	O
/	O
p50	O
recruitment	O
after	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
treatment	O
correlate	O
well	O
with	O
the	O
viral	O
transcriptional	O
activation	O
levels	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
DPF2	B-X
(	B-X
requiem/REQ	B-X
)	B-X
functions	B-X
as	B-X
a	B-X
linker	B-X
protein	B-X
between	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
and	B-X
RelB/p52	B-X
NF-B	B-X
heterodimer	B-X
and	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
NF-B	B-X
transactivation	B-X
via	B-X
its	B-X
noncanonical	B-X
pathway	B-X
.	B-X
Using	B-X
sensitive	B-X
293FT	B-X
reporter	B-X
cell	B-X
clones	B-X
that	B-X
had	B-X
integrated	B-X
a	B-X
SWI/SNF-dependent	B-X
NF-B	B-X
reporter	B-X
gene	B-X
,	B-X
we	B-X
find	B-X
in	B-X
this	B-X
study	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
DPF1	B-X
,	B-X
DPF2	B-X
,	B-X
DPF3a	B-X
,	B-X
DPF3b	B-X
,	B-X
and	B-X
PHF10	B-X
significantly	B-X
potentiates	B-X
the	B-X
transactivating	B-X
activity	B-X
of	B-X
typical	B-X
NF-B	B-X
dimers	B-X
.	B-X
Knockdown	B-X
analysis	B-X
using	B-X
293FT	B-X
reporter	B-X
cells	B-X
that	B-X
endogenously	B-X
express	B-X
these	B-X
five	B-X
proteins	B-X
at	B-X
low	B-X
levels	B-X
clearly	B-X
showed	B-X
that	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
,	B-X
which	B-X
are	B-X
produced	B-X
from	B-X
the	B-X
DPF3	B-X
gene	B-X
by	B-X
alternative	B-X
splicing	B-X
,	B-X
are	B-X
the	B-X
most	B-X
critical	B-X
for	B-X
the	B-X
RelA/p50	B-X
NF-B	B-X
heterodimer	B-X
transactivation	B-X
induced	B-X
by	B-X
TNF-	B-X
stimulation	B-X
.	B-X
Our	B-X
data	B-X
further	B-X
show	B-X
that	B-X
this	B-X
transactivation	B-X
requires	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
.	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
are	B-X
additionally	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
RelA	B-X
,	B-X
p50	B-X
,	B-X
and	B-X
several	B-X
subunits	B-X
of	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
in	B-X
vitro	B-X
and	B-X
to	B-X
be	B-X
co-immunoprecipitated	B-X
with	B-X
RelA/p50	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
from	B-X
the	B-X
nuclear	B-X
fractions	B-X
of	B-X
cells	B-X
treated	B-X
with	B-X
TNF-	B-X
.	B-X
In	B-X
ChIP	B-X
experiments	B-X
,	B-X
we	B-X
further	B-X
found	B-X
that	B-X
endogenous	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
are	B-X
continuously	B-X
present	B-X
on	B-X
HIV-1	B-X
LTR	B-X
,	B-X
whereas	B-X
the	B-X
kinetics	B-X
of	B-X
RelA/p50	B-X
recruitment	B-X
after	B-X
TNF-	B-X
treatment	B-X
correlate	B-X
well	B-X
with	B-X
the	B-X
viral	B-X
transcriptional	B-X
activation	B-X
levels	B-X
.	B-X
Additionally	B-X
,	B-X
re-ChIP	B-X
experiments	B-X
showed	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
associate	B-X
with	B-X
RelA	B-X
on	B-X
the	B-X
endogenous	B-X
IL-6	B-X
promoter	B-X
after	B-X
TNF-	B-X
treatment	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
present	B-X
data	B-X
indicate	B-X
that	B-X
by	B-X
linking	B-X
RelA/p50	B-X
to	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
,	B-X
DPF3a/b	B-X
induces	B-X
the	B-X
transactivation	B-X
of	B-X
NF-B	B-X
target	B-X
gene	B-X
promoters	B-X
in	B-X
relatively	B-X
inactive	B-X
chromatin	B-X
contexts	B-X
.	B-X

Additionally	O
,	O
re	O
-	O
ChIP	O
experiments	O
showed	O
DPF3a	B-Gene_or_gene_product
/	O
b	B-Gene_or_gene_product
and	O
the	O
SWI	O
/	O
SNF	O
complex	O
associate	O
with	O
RelA	B-Gene_or_gene_product
on	O
the	O
endogenous	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
promoter	O
after	O
TNF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
alpha	I-Gene_or_gene_product
treatment	O
.	O
<EOS>	B-X
We	B-X
have	B-X
previously	B-X
shown	B-X
that	B-X
DPF2	B-X
(	B-X
requiem/REQ	B-X
)	B-X
functions	B-X
as	B-X
a	B-X
linker	B-X
protein	B-X
between	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
and	B-X
RelB/p52	B-X
NF-B	B-X
heterodimer	B-X
and	B-X
plays	B-X
important	B-X
roles	B-X
in	B-X
NF-B	B-X
transactivation	B-X
via	B-X
its	B-X
noncanonical	B-X
pathway	B-X
.	B-X
Using	B-X
sensitive	B-X
293FT	B-X
reporter	B-X
cell	B-X
clones	B-X
that	B-X
had	B-X
integrated	B-X
a	B-X
SWI/SNF-dependent	B-X
NF-B	B-X
reporter	B-X
gene	B-X
,	B-X
we	B-X
find	B-X
in	B-X
this	B-X
study	B-X
that	B-X
the	B-X
overexpression	B-X
of	B-X
DPF1	B-X
,	B-X
DPF2	B-X
,	B-X
DPF3a	B-X
,	B-X
DPF3b	B-X
,	B-X
and	B-X
PHF10	B-X
significantly	B-X
potentiates	B-X
the	B-X
transactivating	B-X
activity	B-X
of	B-X
typical	B-X
NF-B	B-X
dimers	B-X
.	B-X
Knockdown	B-X
analysis	B-X
using	B-X
293FT	B-X
reporter	B-X
cells	B-X
that	B-X
endogenously	B-X
express	B-X
these	B-X
five	B-X
proteins	B-X
at	B-X
low	B-X
levels	B-X
clearly	B-X
showed	B-X
that	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
,	B-X
which	B-X
are	B-X
produced	B-X
from	B-X
the	B-X
DPF3	B-X
gene	B-X
by	B-X
alternative	B-X
splicing	B-X
,	B-X
are	B-X
the	B-X
most	B-X
critical	B-X
for	B-X
the	B-X
RelA/p50	B-X
NF-B	B-X
heterodimer	B-X
transactivation	B-X
induced	B-X
by	B-X
TNF-	B-X
stimulation	B-X
.	B-X
Our	B-X
data	B-X
further	B-X
show	B-X
that	B-X
this	B-X
transactivation	B-X
requires	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
.	B-X
DPF3a	B-X
and	B-X
DPF3b	B-X
are	B-X
additionally	B-X
shown	B-X
to	B-X
interact	B-X
directly	B-X
with	B-X
RelA	B-X
,	B-X
p50	B-X
,	B-X
and	B-X
several	B-X
subunits	B-X
of	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
in	B-X
vitro	B-X
and	B-X
to	B-X
be	B-X
co-immunoprecipitated	B-X
with	B-X
RelA/p50	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
from	B-X
the	B-X
nuclear	B-X
fractions	B-X
of	B-X
cells	B-X
treated	B-X
with	B-X
TNF-	B-X
.	B-X
In	B-X
ChIP	B-X
experiments	B-X
,	B-X
we	B-X
further	B-X
found	B-X
that	B-X
endogenous	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
are	B-X
continuously	B-X
present	B-X
on	B-X
HIV-1	B-X
LTR	B-X
,	B-X
whereas	B-X
the	B-X
kinetics	B-X
of	B-X
RelA/p50	B-X
recruitment	B-X
after	B-X
TNF-	B-X
treatment	B-X
correlate	B-X
well	B-X
with	B-X
the	B-X
viral	B-X
transcriptional	B-X
activation	B-X
levels	B-X
.	B-X
Additionally	B-X
,	B-X
re-ChIP	B-X
experiments	B-X
showed	B-X
DPF3a/b	B-X
and	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
associate	B-X
with	B-X
RelA	B-X
on	B-X
the	B-X
endogenous	B-X
IL-6	B-X
promoter	B-X
after	B-X
TNF-	B-X
treatment	B-X
.	B-X
In	B-X
conclusion	B-X
,	B-X
our	B-X
present	B-X
data	B-X
indicate	B-X
that	B-X
by	B-X
linking	B-X
RelA/p50	B-X
to	B-X
the	B-X
SWI/SNF	B-X
complex	B-X
,	B-X
DPF3a/b	B-X
induces	B-X
the	B-X
transactivation	B-X
of	B-X
NF-B	B-X
target	B-X
gene	B-X
promoters	B-X
in	B-X
relatively	B-X
inactive	B-X
chromatin	B-X
contexts	B-X
.	B-X

In	O
conclusion	O
,	O
our	O
present	O
data	O
indicate	O
that	O
by	O
linking	O
RelA	O
/	O
p50	O
to	O
the	O
SWI	O
/	O
SNF	O
complex	O
,	O
DPF3a	B-Gene_or_gene_product
/	O
b	B-Gene_or_gene_product
induces	O
the	O
transactivation	O
of	O
NF	O
-	O
kappaB	O
target	O
gene	O
promoters	O
in	O
relatively	O
inactive	O
chromatin	O
contexts	O
.	O

Structure	O
-	O
based	O
analysis	O
of	O
the	O
molecular	O
recognitions	O
between	O
HIV	O
-	O
1	O
TAR	B-Gene_or_gene_product
-	O
RNA	O
and	O
transcription	O
factor	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NFkB	O
)	O
.	O
<EOS>	B-X
In	B-X
this	B-X
paper	B-X
we	B-X
applied	B-X
the	B-X
``	B-X
macromolecular	B-X
docking	B-X
''	B-X
procedure	B-X
to	B-X
perform	B-X
molecular	B-X
modeling	B-X
with	B-X
the	B-X
aim	B-X
of	B-X
screening	B-X
transcription	B-X
factor	B-X
sequences	B-X
for	B-X
possible	B-X
interaction	B-X
to	B-X
the	B-X
HIV-1	B-X
TAR-RNA	B-X
,	B-X
employing	B-X
the	B-X
software	B-X
Hex	B-X
version	B-X
4.2	B-X
.	B-X
The	B-X
molecular	B-X
modeling	B-X
data	B-X
were	B-X
compared	B-X
with	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assays	B-X
(	B-X
EMSA	B-X
)	B-X
and	B-X
surface	B-X
plasmon	B-X
resonance	B-X
(	B-X
SPR	B-X
)	B-X
based	B-X
biospecific	B-X
interaction	B-X
analysis	B-X
(	B-X
BIA	B-X
)	B-X
using	B-X
an	B-X
optical	B-X
biosensor	B-X
.	B-X
Finally	B-X
the	B-X
specific	B-X
interactions	B-X
between	B-X
NF-B	B-X
and	B-X
RNA	B-X
have	B-X
been	B-X
calculated	B-X
utilizing	B-X
the	B-X
AMBER-MM	B-X
and	B-X
FMO	B-X
calculations	B-X
.	B-X
The	B-X
results	B-X
obtained	B-X
clearly	B-X
indicate	B-X
that	B-X
(	B-X
a	B-X
)	B-X
NF-kB	B-X
p50	B-X
transcription	B-X
factor	B-X
can	B-X
bind	B-X
TAR-RNA	B-X
;	B-X
(	B-X
b	B-X
)	B-X
this	B-X
binding	B-X
efficiency	B-X
is	B-X
lower	B-X
than	B-X
that	B-X
displayed	B-X
by	B-X
NF-kB	B-X
factor	B-X
in	B-X
respect	B-X
to	B-X
DNA	B-X
sequences	B-X
;	B-X
(	B-X
c	B-X
)	B-X
other	B-X
structured	B-X
RNAs	B-X
used	B-X
as	B-X
controls	B-X
do	B-X
not	B-X
bind	B-X
to	B-X
NF-kB	B-X
;	B-X
(	B-X
d	B-X
)	B-X
TAR-RNA	B-X
is	B-X
capable	B-X
to	B-X
bind	B-X
pre-formed	B-X
NF-kB/DNA	B-X
complexes	B-X
.	B-X
Despite	B-X
the	B-X
fact	B-X
that	B-X
our	B-X
data	B-X
do	B-X
not	B-X
indicate	B-X
whether	B-X
NF-kB/TAR-RNA	B-X
complexes	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
early	B-X
steps	B-X
of	B-X
HIV-1	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
strongly	B-X
indicate	B-X
that	B-X
interactions	B-X
between	B-X
transcription	B-X
factors	B-X
recruited	B-X
at	B-X
the	B-X
level	B-X
of	B-X
HIV-1	B-X
LTR	B-X
might	B-X
interact	B-X
with	B-X
the	B-X
TAR-RNA	B-X
and	B-X
deserve	B-X
further	B-X
studies	B-X
aimed	B-X
to	B-X
determine	B-X
its	B-X
role	B-X
in	B-X
the	B-X
HIV-1	B-X
life	B-X
cycle	B-X
.	B-X

In	O
this	O
paper	O
we	O
applied	O
the	O
"	O
macromolecular	O
docking	O
"	O
procedure	O
to	O
perform	O
molecular	O
modeling	O
with	O
the	O
aim	O
of	O
screening	O
transcription	O
factor	O
sequences	O
for	O
possible	O
interaction	O
to	O
the	O
HIV	O
-	O
1	O
TAR	B-Gene_or_gene_product
-	O
RNA	O
,	O
employing	O
the	O
software	O
Hex	O
version	O
4	O
.	O
2	O
.	O

The	O
molecular	O
modeling	O
data	O
were	O
compared	O
with	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
)	O
and	O
surface	O
plasmon	O
resonance	O
(	O
SPR	O
)	O
based	O
biospecific	O
interaction	O
analysis	O
(	O
BIA	O
)	O
using	O
an	O
optical	O
biosensor	O
.	O
<EOS>	B-X
In	B-X
this	B-X
paper	B-X
we	B-X
applied	B-X
the	B-X
``	B-X
macromolecular	B-X
docking	B-X
''	B-X
procedure	B-X
to	B-X
perform	B-X
molecular	B-X
modeling	B-X
with	B-X
the	B-X
aim	B-X
of	B-X
screening	B-X
transcription	B-X
factor	B-X
sequences	B-X
for	B-X
possible	B-X
interaction	B-X
to	B-X
the	B-X
HIV-1	B-X
TAR-RNA	B-X
,	B-X
employing	B-X
the	B-X
software	B-X
Hex	B-X
version	B-X
4.2	B-X
.	B-X
The	B-X
molecular	B-X
modeling	B-X
data	B-X
were	B-X
compared	B-X
with	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assays	B-X
(	B-X
EMSA	B-X
)	B-X
and	B-X
surface	B-X
plasmon	B-X
resonance	B-X
(	B-X
SPR	B-X
)	B-X
based	B-X
biospecific	B-X
interaction	B-X
analysis	B-X
(	B-X
BIA	B-X
)	B-X
using	B-X
an	B-X
optical	B-X
biosensor	B-X
.	B-X
Finally	B-X
the	B-X
specific	B-X
interactions	B-X
between	B-X
NF-B	B-X
and	B-X
RNA	B-X
have	B-X
been	B-X
calculated	B-X
utilizing	B-X
the	B-X
AMBER-MM	B-X
and	B-X
FMO	B-X
calculations	B-X
.	B-X
Despite	B-X
the	B-X
fact	B-X
that	B-X
our	B-X
data	B-X
do	B-X
not	B-X
indicate	B-X
whether	B-X
NF-kB/TAR-RNA	B-X
complexes	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
early	B-X
steps	B-X
of	B-X
HIV-1	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
strongly	B-X
indicate	B-X
that	B-X
interactions	B-X
between	B-X
transcription	B-X
factors	B-X
recruited	B-X
at	B-X
the	B-X
level	B-X
of	B-X
HIV-1	B-X
LTR	B-X
might	B-X
interact	B-X
with	B-X
the	B-X
TAR-RNA	B-X
and	B-X
deserve	B-X
further	B-X
studies	B-X
aimed	B-X
to	B-X
determine	B-X
its	B-X
role	B-X
in	B-X
the	B-X
HIV-1	B-X
life	B-X
cycle	B-X
.	B-X

Finally	O
the	O
specific	O
interactions	O
between	O
NF	O
-	O
kappaB	O
and	O
RNA	O
have	O
been	O
calculated	O
utilizing	O
the	O
AMBER	O
-	O
MM	O
and	O
FMO	O
calculations	O
.	O
<EOS>	B-X
In	B-X
this	B-X
paper	B-X
we	B-X
applied	B-X
the	B-X
``	B-X
macromolecular	B-X
docking	B-X
''	B-X
procedure	B-X
to	B-X
perform	B-X
molecular	B-X
modeling	B-X
with	B-X
the	B-X
aim	B-X
of	B-X
screening	B-X
transcription	B-X
factor	B-X
sequences	B-X
for	B-X
possible	B-X
interaction	B-X
to	B-X
the	B-X
HIV-1	B-X
TAR-RNA	B-X
,	B-X
employing	B-X
the	B-X
software	B-X
Hex	B-X
version	B-X
4.2	B-X
.	B-X
The	B-X
molecular	B-X
modeling	B-X
data	B-X
were	B-X
compared	B-X
with	B-X
electrophoretic	B-X
mobility	B-X
shift	B-X
assays	B-X
(	B-X
EMSA	B-X
)	B-X
and	B-X
surface	B-X
plasmon	B-X
resonance	B-X
(	B-X
SPR	B-X
)	B-X
based	B-X
biospecific	B-X
interaction	B-X
analysis	B-X
(	B-X
BIA	B-X
)	B-X
using	B-X
an	B-X
optical	B-X
biosensor	B-X
.	B-X
Finally	B-X
the	B-X
specific	B-X
interactions	B-X
between	B-X
NF-B	B-X
and	B-X
RNA	B-X
have	B-X
been	B-X
calculated	B-X
utilizing	B-X
the	B-X
AMBER-MM	B-X
and	B-X
FMO	B-X
calculations	B-X
.	B-X
The	B-X
results	B-X
obtained	B-X
clearly	B-X
indicate	B-X
that	B-X
(	B-X
a	B-X
)	B-X
NF-kB	B-X
p50	B-X
transcription	B-X
factor	B-X
can	B-X
bind	B-X
TAR-RNA	B-X
;	B-X
(	B-X
b	B-X
)	B-X
this	B-X
binding	B-X
efficiency	B-X
is	B-X
lower	B-X
than	B-X
that	B-X
displayed	B-X
by	B-X
NF-kB	B-X
factor	B-X
in	B-X
respect	B-X
to	B-X
DNA	B-X
sequences	B-X
;	B-X
(	B-X
c	B-X
)	B-X
other	B-X
structured	B-X
RNAs	B-X
used	B-X
as	B-X
controls	B-X
do	B-X
not	B-X
bind	B-X
to	B-X
NF-kB	B-X
;	B-X
(	B-X
d	B-X
)	B-X
TAR-RNA	B-X
is	B-X
capable	B-X
to	B-X
bind	B-X
pre-formed	B-X
NF-kB/DNA	B-X
complexes	B-X
.	B-X
Despite	B-X
the	B-X
fact	B-X
that	B-X
our	B-X
data	B-X
do	B-X
not	B-X
indicate	B-X
whether	B-X
NF-kB/TAR-RNA	B-X
complexes	B-X
play	B-X
a	B-X
role	B-X
in	B-X
the	B-X
early	B-X
steps	B-X
of	B-X
HIV-1	B-X
transcriptional	B-X
activation	B-X
,	B-X
the	B-X
results	B-X
presented	B-X
strongly	B-X
indicate	B-X
that	B-X
interactions	B-X
between	B-X
transcription	B-X
factors	B-X
recruited	B-X
at	B-X
the	B-X
level	B-X
of	B-X
HIV-1	B-X
LTR	B-X
might	B-X
interact	B-X
with	B-X
the	B-X
TAR-RNA	B-X
and	B-X
deserve	B-X
further	B-X
studies	B-X
aimed	B-X
to	B-X
determine	B-X
its	B-X
role	B-X
in	B-X
the	B-X
HIV-1	B-X
life	B-X
cycle	B-X
.	B-X

The	O
results	O
obtained	O
clearly	O
indicate	O
that	O
(	O
a	O
)	O
NF	O
-	O
kB	O
p50	B-Gene_or_gene_product
transcription	O
factor	O
can	O
bind	O
TAR	B-Gene_or_gene_product
-	O
RNA	O
;	O
(	O
b	O
)	O
this	O
binding	O
efficiency	O
is	O
lower	O
than	O
that	O
displayed	O
by	O
NF	O
-	O
kB	O
factor	O
in	O
respect	O
to	O
DNA	O
sequences	O
;	O
(	O
c	O
)	O
other	O
structured	O
RNAs	O
used	O
as	O
controls	O
do	O
not	O
bind	O
to	O
NF	O
-	O
kB	O
;	O
(	O
d	O
)	O
TAR	B-Gene_or_gene_product
-	O
RNA	O
is	O
capable	O
to	O
bind	O
pre	O
-	O
formed	O
NF	O
-	O
kB	O
/	O
DNA	O
complexes	O
.	O

Despite	O
the	O
fact	O
that	O
our	O
data	O
do	O
not	O
indicate	O
whether	O
NF	O
-	O
kB	O
/	O
TAR	O
-	O
RNA	O
complexes	O
play	O
a	O
role	O
in	O
the	O
early	O
steps	O
of	O
HIV	O
-	O
1	O
transcriptional	O
activation	O
,	O
the	O
results	O
presented	O
strongly	O
indicate	O
that	O
interactions	O
between	O
transcription	O
factors	O
recruited	O
at	O
the	O
level	O
of	O
HIV	O
-	O
1	O
LTR	O
might	O
interact	O
with	O
the	O
TAR	B-Gene_or_gene_product
-	O
RNA	O
and	O
deserve	O
further	O
studies	O
aimed	O
to	O
determine	O
its	O
role	O
in	O
the	O
HIV	O
-	O
1	O
life	O
cycle	O
.	O
<EOS>	B-X
Despite	B-X
the	B-X
fact	B-X
that	B-X
colchicine	B-X
is	B-X
by	B-X
far	B-X
the	B-X
most	B-X
ancient	B-X
treatment	B-X
for	B-X
gout	B-X
,	B-X
new	B-X
data	B-X
are	B-X
still	B-X
being	B-X
gathered	B-X
.	B-X
In	B-X
gout	B-X
,	B-X
colchicine	B-X
's	B-X
ability	B-X
to	B-X
block	B-X
polymerization	B-X
of	B-X
tubulin	B-X
prevents	B-X
the	B-X
activation	B-X
of	B-X
the	B-X
inflammasome	B-X
.	B-X
Use	B-X
of	B-X
colchicine	B-X
is	B-X
impaired	B-X
by	B-X
the	B-X
impact	B-X
of	B-X
underlying	B-X
comorbid	B-X
conditions	B-X
and	B-X
drug	B-X
interactions	B-X
that	B-X
can	B-X
considerably	B-X
modify	B-X
its	B-X
pharmacokinetics	B-X
and	B-X
pharmacodynamics	B-X
.	B-X
In	B-X
South	B-X
Africa	B-X
,	B-X
from	B-X
the	B-X
mid-19th	B-X
century	B-X
to	B-X
the	B-X
1920s	B-X
,	B-X
practitioners	B-X
prescribed	B-X
it	B-X
for	B-X
a	B-X
multitude	B-X
of	B-X
conditions	B-X
.	B-X
In	B-X
1928	B-X
it	B-X
was	B-X
classified	B-X
as	B-X
a	B-X
Schedule	B-X
I	B-X
substance	B-X
,	B-X
illegal	B-X
,	B-X
and	B-X
without	B-X
medical	B-X
value	B-X
.	B-X
Its	B-X
main	B-X
active	B-X
ingredient	B-X
,	B-X
-9-tetrahydrocannabinol	B-X
(	B-X
THC	B-X
)	B-X
,	B-X
was	B-X
not	B-X
isolated	B-X
until	B-X
1964	B-X
,	B-X
and	B-X
it	B-X
was	B-X
not	B-X
until	B-X
the	B-X
1990s	B-X
that	B-X
the	B-X
far-reaching	B-X
modulatory	B-X
activities	B-X
of	B-X
the	B-X
endocannabinoid	B-X
system	B-X
in	B-X
the	B-X
human	B-X
body	B-X
was	B-X
studied	B-X
.	B-X
Public	B-X
approval	B-X
drives	B-X
medical	B-X
cannabis	B-X
legalisation	B-X
efforts	B-X
without	B-X
the	B-X
scientific	B-X
data	B-X
normally	B-X
required	B-X
to	B-X
justify	B-X
a	B-X
new	B-X
medication	B-X
's	B-X
introduction	B-X
.	B-X
This	B-X
review	B-X
explores	B-X
these	B-X
controversies	B-X
and	B-X
whether	B-X
cannabis	B-X
is	B-X
a	B-X
panacea	B-X
,	B-X
a	B-X
scourge	B-X
,	B-X
or	B-X
both	B-X
.	B-X

Oroxylin	O
A	O
prevents	O
inflammation	O
-	O
related	O
tumor	O
through	O
down	O
-	O
regulation	O
of	O
inflammatory	O
gene	O
expression	O
by	O
inhibiting	O
NF	O
-	O
kappaB	O
signaling	O
.	O
<EOS>	B-X
Increasing	B-X
evidence	B-X
suggests	B-X
that	B-X
inflammatory	B-X
microenvironment	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
at	B-X
different	B-X
stages	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
inflammation	B-X
and	B-X
proliferation	B-X
of	B-X
cancer	B-X
cells	B-X
remain	B-X
poorly	B-X
defined	B-X
.	B-X
Here	B-X
we	B-X
reported	B-X
the	B-X
inhibitory	B-X
effects	B-X
of	B-X
oroxylin	B-X
A	B-X
on	B-X
the	B-X
inflammation-stimulated	B-X
proliferation	B-X
of	B-X
tumor	B-X
cells	B-X
and	B-X
delineated	B-X
the	B-X
mechanism	B-X
of	B-X
its	B-X
action	B-X
.	B-X
The	B-X
results	B-X
indicated	B-X
that	B-X
treatment	B-X
with	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
NF-B	B-X
p65	B-X
nuclear	B-X
translocation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IB	B-X
and	B-X
IKK/	B-X
in	B-X
both	B-X
human	B-X
colon	B-X
tumor	B-X
HCT116	B-X
cells	B-X
and	B-X
human	B-X
monocytes	B-X
THP-1	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
in	B-X
THP-1	B-X
cells	B-X
,	B-X
oroxylin	B-X
A	B-X
significantly	B-X
suppressed	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
secretion	B-X
of	B-X
prototypical	B-X
proinflammatory	B-X
cytokine	B-X
IL-6	B-X
but	B-X
not	B-X
IL-1	B-X
,	B-X
and	B-X
it	B-X
was	B-X
confirmed	B-X
at	B-X
the	B-X
transcription	B-X
level	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
oroxylin	B-X
A	B-X
modulated	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
inflammation-induced	B-X
cancer	B-X
initiation	B-X
and	B-X
progression	B-X
and	B-X
therefore	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
cancer	B-X
chemoprevention	B-X
agent	B-X
for	B-X
inflammation-related	B-X
cancer	B-X
.	B-X

Increasing	O
evidence	O
suggests	O
that	O
inflammatory	O
microenvironment	O
plays	O
a	O
critical	O
role	O
at	O
different	O
stages	O
of	O
tumor	O
development	O
.	O

However	O
,	O
the	O
molecular	O
mechanisms	O
of	O
the	O
interaction	O
between	O
inflammation	O
and	O
proliferation	O
of	O
cancer	O
cells	O
remain	O
poorly	O
defined	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
inflammation	B-X
and	B-X
proliferation	B-X
of	B-X
cancer	B-X
cells	B-X
remain	B-X
poorly	B-X
defined	B-X
.	B-X
Here	B-X
we	B-X
reported	B-X
the	B-X
inhibitory	B-X
effects	B-X
of	B-X
oroxylin	B-X
A	B-X
on	B-X
the	B-X
inflammation-stimulated	B-X
proliferation	B-X
of	B-X
tumor	B-X
cells	B-X
and	B-X
delineated	B-X
the	B-X
mechanism	B-X
of	B-X
its	B-X
action	B-X
.	B-X
The	B-X
results	B-X
indicated	B-X
that	B-X
treatment	B-X
with	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
NF-B	B-X
p65	B-X
nuclear	B-X
translocation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IB	B-X
and	B-X
IKK/	B-X
in	B-X
both	B-X
human	B-X
colon	B-X
tumor	B-X
HCT116	B-X
cells	B-X
and	B-X
human	B-X
monocytes	B-X
THP-1	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
in	B-X
THP-1	B-X
cells	B-X
,	B-X
oroxylin	B-X
A	B-X
significantly	B-X
suppressed	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
secretion	B-X
of	B-X
prototypical	B-X
proinflammatory	B-X
cytokine	B-X
IL-6	B-X
but	B-X
not	B-X
IL-1	B-X
,	B-X
and	B-X
it	B-X
was	B-X
confirmed	B-X
at	B-X
the	B-X
transcription	B-X
level	B-X
.	B-X
Moreover	B-X
,	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
the	B-X
proliferation	B-X
of	B-X
HCT116	B-X
cells	B-X
stimulated	B-X
by	B-X
LPS-induced	B-X
THP-1	B-X
cells	B-X
in	B-X
co-culture	B-X
microenvironment	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
oroxylin	B-X
A	B-X
modulated	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
inflammation-induced	B-X
cancer	B-X
initiation	B-X
and	B-X
progression	B-X
and	B-X
therefore	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
cancer	B-X
chemoprevention	B-X
agent	B-X
for	B-X
inflammation-related	B-X
cancer	B-X
.	B-X

Here	O
we	O
reported	O
the	O
inhibitory	O
effects	O
of	O
oroxylin	O
A	O
on	O
the	O
inflammation	O
-	O
stimulated	O
proliferation	O
of	O
tumor	O
cells	O
and	O
delineated	O
the	O
mechanism	O
of	O
its	O
action	O
.	O
<EOS>	B-X
Increasing	B-X
evidence	B-X
suggests	B-X
that	B-X
inflammatory	B-X
microenvironment	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
at	B-X
different	B-X
stages	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
inflammation	B-X
and	B-X
proliferation	B-X
of	B-X
cancer	B-X
cells	B-X
remain	B-X
poorly	B-X
defined	B-X
.	B-X
Here	B-X
we	B-X
reported	B-X
the	B-X
inhibitory	B-X
effects	B-X
of	B-X
oroxylin	B-X
A	B-X
on	B-X
the	B-X
inflammation-stimulated	B-X
proliferation	B-X
of	B-X
tumor	B-X
cells	B-X
and	B-X
delineated	B-X
the	B-X
mechanism	B-X
of	B-X
its	B-X
action	B-X
.	B-X
The	B-X
results	B-X
indicated	B-X
that	B-X
treatment	B-X
with	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
NF-B	B-X
p65	B-X
nuclear	B-X
translocation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IB	B-X
and	B-X
IKK/	B-X
in	B-X
both	B-X
human	B-X
colon	B-X
tumor	B-X
HCT116	B-X
cells	B-X
and	B-X
human	B-X
monocytes	B-X
THP-1	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
in	B-X
THP-1	B-X
cells	B-X
,	B-X
oroxylin	B-X
A	B-X
significantly	B-X
suppressed	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
secretion	B-X
of	B-X
prototypical	B-X
proinflammatory	B-X
cytokine	B-X
IL-6	B-X
but	B-X
not	B-X
IL-1	B-X
,	B-X
and	B-X
it	B-X
was	B-X
confirmed	B-X
at	B-X
the	B-X
transcription	B-X
level	B-X
.	B-X
Moreover	B-X
,	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
the	B-X
proliferation	B-X
of	B-X
HCT116	B-X
cells	B-X
stimulated	B-X
by	B-X
LPS-induced	B-X
THP-1	B-X
cells	B-X
in	B-X
co-culture	B-X
microenvironment	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
oroxylin	B-X
A	B-X
modulated	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
inflammation-induced	B-X
cancer	B-X
initiation	B-X
and	B-X
progression	B-X
and	B-X
therefore	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
cancer	B-X
chemoprevention	B-X
agent	B-X
for	B-X
inflammation-related	B-X
cancer	B-X
.	B-X

The	O
results	O
indicated	O
that	O
treatment	O
with	O
oroxylin	O
A	O
inhibited	O
NF	O
-	O
kappaB	O
p65	B-Gene_or_gene_product
nuclear	O
translocation	O
and	O
phosphorylation	O
of	O
IkappaBalpha	B-Gene_or_gene_product
and	O
IKKalpha	B-Gene_or_gene_product
/	O
beta	B-Gene_or_gene_product
in	O
both	O
human	O
colon	O
tumor	O
HCT116	O
cells	O
and	O
human	O
monocytes	O
THP	O
-	O
1	O
cells	O
.	O
<EOS>	B-X
Increasing	B-X
evidence	B-X
suggests	B-X
that	B-X
inflammatory	B-X
microenvironment	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
at	B-X
different	B-X
stages	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
inflammation	B-X
and	B-X
proliferation	B-X
of	B-X
cancer	B-X
cells	B-X
remain	B-X
poorly	B-X
defined	B-X
.	B-X
Here	B-X
we	B-X
reported	B-X
the	B-X
inhibitory	B-X
effects	B-X
of	B-X
oroxylin	B-X
A	B-X
on	B-X
the	B-X
inflammation-stimulated	B-X
proliferation	B-X
of	B-X
tumor	B-X
cells	B-X
and	B-X
delineated	B-X
the	B-X
mechanism	B-X
of	B-X
its	B-X
action	B-X
.	B-X
The	B-X
results	B-X
indicated	B-X
that	B-X
treatment	B-X
with	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
NF-B	B-X
p65	B-X
nuclear	B-X
translocation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IB	B-X
and	B-X
IKK/	B-X
in	B-X
both	B-X
human	B-X
colon	B-X
tumor	B-X
HCT116	B-X
cells	B-X
and	B-X
human	B-X
monocytes	B-X
THP-1	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
in	B-X
THP-1	B-X
cells	B-X
,	B-X
oroxylin	B-X
A	B-X
significantly	B-X
suppressed	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
secretion	B-X
of	B-X
prototypical	B-X
proinflammatory	B-X
cytokine	B-X
IL-6	B-X
but	B-X
not	B-X
IL-1	B-X
,	B-X
and	B-X
it	B-X
was	B-X
confirmed	B-X
at	B-X
the	B-X
transcription	B-X
level	B-X
.	B-X
Moreover	B-X
,	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
the	B-X
proliferation	B-X
of	B-X
HCT116	B-X
cells	B-X
stimulated	B-X
by	B-X
LPS-induced	B-X
THP-1	B-X
cells	B-X
in	B-X
co-culture	B-X
microenvironment	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
oroxylin	B-X
A	B-X
modulated	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
inflammation-induced	B-X
cancer	B-X
initiation	B-X
and	B-X
progression	B-X
and	B-X
therefore	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
cancer	B-X
chemoprevention	B-X
agent	B-X
for	B-X
inflammation-related	B-X
cancer	B-X
.	B-X

In	O
addition	O
,	O
in	O
THP	O
-	O
1	O
cells	O
,	O
oroxylin	O
A	O
significantly	O
suppressed	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-	O
induced	O
secretion	O
of	O
prototypical	O
proinflammatory	O
cytokine	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
6	I-Gene_or_gene_product
but	O
not	O
IL	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1beta	I-Gene_or_gene_product
,	O
and	O
it	O
was	O
confirmed	O
at	O
the	O
transcription	O
level	O
.	O

Moreover	O
,	O
oroxylin	O
A	O
inhibited	O
the	O
proliferation	O
of	O
HCT116	O
cells	O
stimulated	O
by	O
LPS	O
-	O
induced	O
THP	O
-	O
1	O
cells	O
in	O
co	O
-	O
culture	O
microenvironment	O
.	O
<EOS>	B-X
Increasing	B-X
evidence	B-X
suggests	B-X
that	B-X
inflammatory	B-X
microenvironment	B-X
plays	B-X
a	B-X
critical	B-X
role	B-X
at	B-X
different	B-X
stages	B-X
of	B-X
tumor	B-X
development	B-X
.	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
inflammation	B-X
and	B-X
proliferation	B-X
of	B-X
cancer	B-X
cells	B-X
remain	B-X
poorly	B-X
defined	B-X
.	B-X
Here	B-X
we	B-X
reported	B-X
the	B-X
inhibitory	B-X
effects	B-X
of	B-X
oroxylin	B-X
A	B-X
on	B-X
the	B-X
inflammation-stimulated	B-X
proliferation	B-X
of	B-X
tumor	B-X
cells	B-X
and	B-X
delineated	B-X
the	B-X
mechanism	B-X
of	B-X
its	B-X
action	B-X
.	B-X
The	B-X
results	B-X
indicated	B-X
that	B-X
treatment	B-X
with	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
NF-B	B-X
p65	B-X
nuclear	B-X
translocation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IB	B-X
and	B-X
IKK/	B-X
in	B-X
both	B-X
human	B-X
colon	B-X
tumor	B-X
HCT116	B-X
cells	B-X
and	B-X
human	B-X
monocytes	B-X
THP-1	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
in	B-X
THP-1	B-X
cells	B-X
,	B-X
oroxylin	B-X
A	B-X
significantly	B-X
suppressed	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
secretion	B-X
of	B-X
prototypical	B-X
proinflammatory	B-X
cytokine	B-X
IL-6	B-X
but	B-X
not	B-X
IL-1	B-X
,	B-X
and	B-X
it	B-X
was	B-X
confirmed	B-X
at	B-X
the	B-X
transcription	B-X
level	B-X
.	B-X
Moreover	B-X
,	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
the	B-X
proliferation	B-X
of	B-X
HCT116	B-X
cells	B-X
stimulated	B-X
by	B-X
LPS-induced	B-X
THP-1	B-X
cells	B-X
in	B-X
co-culture	B-X
microenvironment	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
oroxylin	B-X
A	B-X
modulated	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
inflammation-induced	B-X
cancer	B-X
initiation	B-X
and	B-X
progression	B-X
and	B-X
therefore	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
cancer	B-X
chemoprevention	B-X
agent	B-X
for	B-X
inflammation-related	B-X
cancer	B-X
.	B-X

In	O
summary	O
,	O
oroxylin	O
A	O
modulated	O
NF	O
-	O
kappaB	O
signaling	O
pathway	O
involved	O
in	O
inflammation	O
-	O
induced	O
cancer	O
initiation	O
and	O
progression	O
and	O
therefore	O
could	O
be	O
a	O
potential	O
cancer	O
chemoprevention	O
agent	O
for	O
inflammation	O
-	O
related	O
cancer	O
.	O
<EOS>	B-X
However	B-X
,	B-X
the	B-X
molecular	B-X
mechanisms	B-X
of	B-X
the	B-X
interaction	B-X
between	B-X
inflammation	B-X
and	B-X
proliferation	B-X
of	B-X
cancer	B-X
cells	B-X
remain	B-X
poorly	B-X
defined	B-X
.	B-X
Here	B-X
we	B-X
reported	B-X
the	B-X
inhibitory	B-X
effects	B-X
of	B-X
oroxylin	B-X
A	B-X
on	B-X
the	B-X
inflammation-stimulated	B-X
proliferation	B-X
of	B-X
tumor	B-X
cells	B-X
and	B-X
delineated	B-X
the	B-X
mechanism	B-X
of	B-X
its	B-X
action	B-X
.	B-X
The	B-X
results	B-X
indicated	B-X
that	B-X
treatment	B-X
with	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
NF-B	B-X
p65	B-X
nuclear	B-X
translocation	B-X
and	B-X
phosphorylation	B-X
of	B-X
IB	B-X
and	B-X
IKK/	B-X
in	B-X
both	B-X
human	B-X
colon	B-X
tumor	B-X
HCT116	B-X
cells	B-X
and	B-X
human	B-X
monocytes	B-X
THP-1	B-X
cells	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
in	B-X
THP-1	B-X
cells	B-X
,	B-X
oroxylin	B-X
A	B-X
significantly	B-X
suppressed	B-X
lipopolysaccharide	B-X
(	B-X
LPS	B-X
)	B-X
-induced	B-X
secretion	B-X
of	B-X
prototypical	B-X
proinflammatory	B-X
cytokine	B-X
IL-6	B-X
but	B-X
not	B-X
IL-1	B-X
,	B-X
and	B-X
it	B-X
was	B-X
confirmed	B-X
at	B-X
the	B-X
transcription	B-X
level	B-X
.	B-X
Moreover	B-X
,	B-X
oroxylin	B-X
A	B-X
inhibited	B-X
the	B-X
proliferation	B-X
of	B-X
HCT116	B-X
cells	B-X
stimulated	B-X
by	B-X
LPS-induced	B-X
THP-1	B-X
cells	B-X
in	B-X
co-culture	B-X
microenvironment	B-X
.	B-X
In	B-X
summary	B-X
,	B-X
oroxylin	B-X
A	B-X
modulated	B-X
NF-B	B-X
signaling	B-X
pathway	B-X
involved	B-X
in	B-X
inflammation-induced	B-X
cancer	B-X
initiation	B-X
and	B-X
progression	B-X
and	B-X
therefore	B-X
could	B-X
be	B-X
a	B-X
potential	B-X
cancer	B-X
chemoprevention	B-X
agent	B-X
for	B-X
inflammation-related	B-X
cancer	B-X
.	B-X

(	O
c	O
)	O
2012	O
Wiley	O
Periodicals	O
,	O
Inc	O
.	O
<EOS>	B-X
This	B-X
article	B-X
has	B-X
been	B-X
retracted	B-X
at	B-X
the	B-X
request	B-X
of	B-X
:	B-X
Editor-in-Chief	B-X
and	B-X
Authors	B-X
'Cross-talk	B-X
of	B-X
alpha	B-X
tocopherol-associated	B-X
protein	B-X
and	B-X
JNK	B-X
controls	B-X
the	B-X
oxidative	B-X
stress-induced	B-X
apoptosis	B-X
in	B-X
prostate	B-X
cancer	B-X
cells	B-X
'	B-X
by	B-X
Baoyi	B-X
Zhu	B-X
,	B-X
Xiaojuan	B-X
Li	B-X
,	B-X
Yuying	B-X
Zhang	B-X
,	B-X
Chunwei	B-X
Ye	B-X
,	B-X
Yu	B-X
Wang	B-X
,	B-X
Songwang	B-X
Cai	B-X
,	B-X
Huaiqiu	B-X
Huang	B-X
,	B-X
Yi	B-X
Cai	B-X
,	B-X
Shuyuan	B-X
Yeh	B-X
,	B-X
Zhenhua	B-X
Huang	B-X
,	B-X
Ruihan	B-X
Chen	B-X
,	B-X
Yiran	B-X
Tao	B-X
and	B-X
Xingqiao	B-X
Wen	B-X
The	B-X
above	B-X
article	B-X
,	B-X
published	B-X
online	B-X
on	B-X
28	B-X
November	B-X
2012	B-X
in	B-X
Wiley	B-X
Online	B-X
Library	B-X
(	B-X
wileyonlinelibrary.com	B-X
)	B-X
,	B-X
has	B-X
been	B-X
retracted	B-X
by	B-X
agreement	B-X
between	B-X
the	B-X
authors	B-X
,	B-X
the	B-X
journal	B-X
Editor-in-Chief	B-X
,	B-X
Prof.	B-X
Peter	B-X
Lichter	B-X
,	B-X
and	B-X
Wiley	B-X
Periodicals	B-X
,	B-X
Inc	B-X
.	B-X
The	B-X
Retraction	B-X
has	B-X
been	B-X
agreed	B-X
due	B-X
to	B-X
errors	B-X
that	B-X
were	B-X
detected	B-X
in	B-X
Fig	B-X
.	B-X
Some	B-X
images	B-X
were	B-X
duplicated	B-X
and	B-X
erroneously	B-X
presented	B-X
as	B-X
unique	B-X
.	B-X
Although	B-X
the	B-X
authors	B-X
firmly	B-X
stand	B-X
by	B-X
the	B-X
major	B-X
conclusion	B-X
of	B-X
this	B-X
paper	B-X
,	B-X
they	B-X
believe	B-X
the	B-X
most	B-X
responsible	B-X
course	B-X
of	B-X
action	B-X
is	B-X
to	B-X
retract	B-X
it	B-X
.	B-X
Reference	B-X
Zhu	B-X
,	B-X
B.	B-X
,	B-X
Li	B-X
,	B-X
X.	B-X
,	B-X
Zhang	B-X
,	B-X
Y.	B-X
,	B-X
Ye	B-X
,	B-X
C.	B-X
,	B-X
Wang	B-X
,	B-X
Y.	B-X
,	B-X
Cai	B-X
,	B-X
S.	B-X
,	B-X
Huang	B-X
,	B-X
H.	B-X
,	B-X
Cai	B-X
,	B-X
Y.	B-X
,	B-X
Yeh	B-X
,	B-X
S.	B-X
,	B-X
Huang	B-X
,	B-X
Z.	B-X
,	B-X
Chen	B-X
,	B-X
R.	B-X
,	B-X
Tao	B-X
,	B-X
Y.	B-X
and	B-X
Wen	B-X
,	B-X
X	B-X
.	B-X
(	B-X
2013	B-X
)	B-X
,	B-X
Cross-talk	B-X
of	B-X
alpha	B-X
tocopherol-associated	B-X
protein	B-X
and	B-X
JNK	B-X
controls	B-X
the	B-X
oxidative	B-X
stress-induced	B-X
apoptosis	B-X
in	B-X
prostate	B-X
cancer	B-X
cells	B-X
.	B-X
Cancer	B-X
,	B-X
132	B-X
:	B-X
2270-2282.	B-X
doi	B-X
:	B-X
10.1002/ijc.27927	B-X
.	B-X

Steric	O
and	O
conformational	O
features	O
of	O
the	O
aconitase	B-Gene_or_gene_product
mechanism	O
.	O
<EOS>	B-X
Crystal	B-X
structures	B-X
of	B-X
mitochondrial	B-X
aconitase	B-X
with	B-X
alpha-methylisocitrate	B-X
and	B-X
with	B-X
sulfate	B-X
bound	B-X
have	B-X
been	B-X
solved	B-X
and	B-X
refined	B-X
at	B-X
2.0	B-X
A	B-X
resolution	B-X
with	B-X
R	B-X
factors	B-X
of	B-X
18.2	B-X
and	B-X
16.8	B-X
%	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
steric	B-X
factors	B-X
and	B-X
conformational	B-X
effects	B-X
observed	B-X
in	B-X
both	B-X
new	B-X
structures	B-X
support	B-X
the	B-X
proposed	B-X
mechanism	B-X
for	B-X
the	B-X
overall	B-X
reaction	B-X
catalyzed	B-X
by	B-X
aconitase	B-X
.	B-X
Crystals	B-X
of	B-X
aconitase	B-X
with	B-X
sulfate	B-X
bound	B-X
are	B-X
isomorphous	B-X
to	B-X
those	B-X
with	B-X
isocitrate	B-X
bound	B-X
.	B-X
However	B-X
,	B-X
the	B-X
structure	B-X
displays	B-X
significant	B-X
conformational	B-X
changes	B-X
,	B-X
providing	B-X
a	B-X
model	B-X
for	B-X
the	B-X
substrate-free	B-X
state	B-X
of	B-X
enzyme	B-X
.	B-X
The	B-X
new	B-X
conformation	B-X
of	B-X
Arg-447	B-X
triggers	B-X
a	B-X
concerted	B-X
set	B-X
of	B-X
shifts	B-X
which	B-X
transmits	B-X
conformational	B-X
change	B-X
to	B-X
the	B-X
surface	B-X
of	B-X
the	B-X
protein	B-X
,	B-X
30	B-X
A	B-X
from	B-X
the	B-X
active	B-X
site	B-X
.	B-X

Crystal	O
structures	O
of	O
mitochondrial	O
aconitase	B-Gene_or_gene_product
with	O
alpha	O
-	O
methylisocitrate	O
and	O
with	O
sulfate	O
bound	O
have	O
been	O
solved	O
and	O
refined	O
at	O
2	O
.	O
0	O
A	O
resolution	O
with	O
R	O
factors	O
of	O
18	O
.	O
2	O
and	O
16	O
.	O
8	O
%	O
,	O
respectively	O
.	O

The	O
steric	O
factors	O
and	O
conformational	O
effects	O
observed	O
in	O
both	O
new	O
structures	O
support	O
the	O
proposed	O
mechanism	O
for	O
the	O
overall	O
reaction	O
catalyzed	O
by	O
aconitase	B-Gene_or_gene_product
.	O
<EOS>	B-X
Crystal	B-X
structures	B-X
of	B-X
mitochondrial	B-X
aconitase	B-X
with	B-X
alpha-methylisocitrate	B-X
and	B-X
with	B-X
sulfate	B-X
bound	B-X
have	B-X
been	B-X
solved	B-X
and	B-X
refined	B-X
at	B-X
2.0	B-X
A	B-X
resolution	B-X
with	B-X
R	B-X
factors	B-X
of	B-X
18.2	B-X
and	B-X
16.8	B-X
%	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
steric	B-X
factors	B-X
and	B-X
conformational	B-X
effects	B-X
observed	B-X
in	B-X
both	B-X
new	B-X
structures	B-X
support	B-X
the	B-X
proposed	B-X
mechanism	B-X
for	B-X
the	B-X
overall	B-X
reaction	B-X
catalyzed	B-X
by	B-X
aconitase	B-X
.	B-X
The	B-X
alternate	B-X
substrate	B-X
alpha-methylisocitrate	B-X
is	B-X
derived	B-X
from	B-X
alpha-methyl-cis-aconitate	B-X
during	B-X
crystallization	B-X
and	B-X
is	B-X
observed	B-X
to	B-X
bind	B-X
in	B-X
the	B-X
active	B-X
site	B-X
in	B-X
a	B-X
manner	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
for	B-X
isocitrate	B-X
.	B-X
However	B-X
,	B-X
the	B-X
other	B-X
potential	B-X
hydration	B-X
product	B-X
of	B-X
alpha-methyl-cis-aconitate	B-X
,	B-X
alpha-methylcitrate	B-X
,	B-X
can	B-X
not	B-X
be	B-X
accommodated	B-X
in	B-X
the	B-X
active	B-X
site	B-X
due	B-X
to	B-X
steric	B-X
conflict	B-X
of	B-X
the	B-X
methyl	B-X
group	B-X
with	B-X
Asp-165	B-X
.	B-X
Crystals	B-X
of	B-X
aconitase	B-X
with	B-X
sulfate	B-X
bound	B-X
are	B-X
isomorphous	B-X
to	B-X
those	B-X
with	B-X
isocitrate	B-X
bound	B-X
.	B-X
However	B-X
,	B-X
the	B-X
structure	B-X
displays	B-X
significant	B-X
conformational	B-X
changes	B-X
,	B-X
providing	B-X
a	B-X
model	B-X
for	B-X
the	B-X
substrate-free	B-X
state	B-X
of	B-X
enzyme	B-X
.	B-X
The	B-X
new	B-X
conformation	B-X
of	B-X
Arg-447	B-X
triggers	B-X
a	B-X
concerted	B-X
set	B-X
of	B-X
shifts	B-X
which	B-X
transmits	B-X
conformational	B-X
change	B-X
to	B-X
the	B-X
surface	B-X
of	B-X
the	B-X
protein	B-X
,	B-X
30	B-X
A	B-X
from	B-X
the	B-X
active	B-X
site	B-X
.	B-X

The	O
alternate	O
substrate	O
alpha	O
-	O
methylisocitrate	O
is	O
derived	O
from	O
alpha	O
-	O
methyl	O
-	O
cis	O
-	O
aconitate	O
during	O
crystallization	O
and	O
is	O
observed	O
to	O
bind	O
in	O
the	O
active	O
site	O
in	O
a	O
manner	O
very	O
similar	O
to	O
that	O
observed	O
for	O
isocitrate	O
.	O

The	O
methyl	O
group	O
is	O
accommodated	O
by	O
favorable	O
contact	O
with	O
Ile	O
-	O
425	O
.	O

However	O
,	O
the	O
other	O
potential	O
hydration	O
product	O
of	O
alpha	O
-	O
methyl	O
-	O
cis	O
-	O
aconitate	O
,	O
alpha	O
-	O
methylcitrate	O
,	O
cannot	O
be	O
accommodated	O
in	O
the	O
active	O
site	O
due	O
to	O
steric	O
conflict	O
of	O
the	O
methyl	O
group	O
with	O
Asp	O
-	O
165	O
.	O
<EOS>	B-X
Crystal	B-X
structures	B-X
of	B-X
mitochondrial	B-X
aconitase	B-X
with	B-X
alpha-methylisocitrate	B-X
and	B-X
with	B-X
sulfate	B-X
bound	B-X
have	B-X
been	B-X
solved	B-X
and	B-X
refined	B-X
at	B-X
2.0	B-X
A	B-X
resolution	B-X
with	B-X
R	B-X
factors	B-X
of	B-X
18.2	B-X
and	B-X
16.8	B-X
%	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
steric	B-X
factors	B-X
and	B-X
conformational	B-X
effects	B-X
observed	B-X
in	B-X
both	B-X
new	B-X
structures	B-X
support	B-X
the	B-X
proposed	B-X
mechanism	B-X
for	B-X
the	B-X
overall	B-X
reaction	B-X
catalyzed	B-X
by	B-X
aconitase	B-X
.	B-X
The	B-X
alternate	B-X
substrate	B-X
alpha-methylisocitrate	B-X
is	B-X
derived	B-X
from	B-X
alpha-methyl-cis-aconitate	B-X
during	B-X
crystallization	B-X
and	B-X
is	B-X
observed	B-X
to	B-X
bind	B-X
in	B-X
the	B-X
active	B-X
site	B-X
in	B-X
a	B-X
manner	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
for	B-X
isocitrate	B-X
.	B-X
The	B-X
methyl	B-X
group	B-X
is	B-X
accommodated	B-X
by	B-X
favorable	B-X
contact	B-X
with	B-X
Ile-425	B-X
.	B-X
However	B-X
,	B-X
the	B-X
other	B-X
potential	B-X
hydration	B-X
product	B-X
of	B-X
alpha-methyl-cis-aconitate	B-X
,	B-X
alpha-methylcitrate	B-X
,	B-X
can	B-X
not	B-X
be	B-X
accommodated	B-X
in	B-X
the	B-X
active	B-X
site	B-X
due	B-X
to	B-X
steric	B-X
conflict	B-X
of	B-X
the	B-X
methyl	B-X
group	B-X
with	B-X
Asp-165	B-X
.	B-X
The	B-X
results	B-X
are	B-X
consistent	B-X
with	B-X
the	B-X
requirement	B-X
that	B-X
cis-aconitate	B-X
must	B-X
bind	B-X
in	B-X
two	B-X
ways	B-X
,	B-X
in	B-X
the	B-X
citrate	B-X
mode	B-X
and	B-X
in	B-X
the	B-X
isocitrate	B-X
mode	B-X
.	B-X
However	B-X
,	B-X
the	B-X
structure	B-X
displays	B-X
significant	B-X
conformational	B-X
changes	B-X
,	B-X
providing	B-X
a	B-X
model	B-X
for	B-X
the	B-X
substrate-free	B-X
state	B-X
of	B-X
enzyme	B-X
.	B-X
Three	B-X
water	B-X
molecules	B-X
bind	B-X
in	B-X
place	B-X
of	B-X
the	B-X
C	B-X
alpha-	B-X
and	B-X
C	B-X
beta-hydroxyl	B-X
and	B-X
carboxyl	B-X
groups	B-X
of	B-X
isocitrate	B-X
,	B-X
while	B-X
sulfate	B-X
binds	B-X
in	B-X
place	B-X
of	B-X
the	B-X
C	B-X
gamma-carboxyl	B-X
group	B-X
.	B-X
Side	B-X
chains	B-X
of	B-X
Ser-642	B-X
and	B-X
Arg-447	B-X
in	B-X
the	B-X
active	B-X
site	B-X
rotate	B-X
to	B-X
pair	B-X
with	B-X
other	B-X
side	B-X
chains	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
substrate	B-X
.	B-X
The	B-X
new	B-X
conformation	B-X
of	B-X
Arg-447	B-X
triggers	B-X
a	B-X
concerted	B-X
set	B-X
of	B-X
shifts	B-X
which	B-X
transmits	B-X
conformational	B-X
change	B-X
to	B-X
the	B-X
surface	B-X
of	B-X
the	B-X
protein	B-X
,	B-X
30	B-X
A	B-X
from	B-X
the	B-X
active	B-X
site	B-X
.	B-X

The	O
results	O
are	O
consistent	O
with	O
the	O
requirement	O
that	O
cis	O
-	O
aconitate	O
must	O
bind	O
in	O
two	O
ways	O
,	O
in	O
the	O
citrate	O
mode	O
and	O
in	O
the	O
isocitrate	O
mode	O
.	O
<EOS>	B-X
Crystal	B-X
structures	B-X
of	B-X
mitochondrial	B-X
aconitase	B-X
with	B-X
alpha-methylisocitrate	B-X
and	B-X
with	B-X
sulfate	B-X
bound	B-X
have	B-X
been	B-X
solved	B-X
and	B-X
refined	B-X
at	B-X
2.0	B-X
A	B-X
resolution	B-X
with	B-X
R	B-X
factors	B-X
of	B-X
18.2	B-X
and	B-X
16.8	B-X
%	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
alternate	B-X
substrate	B-X
alpha-methylisocitrate	B-X
is	B-X
derived	B-X
from	B-X
alpha-methyl-cis-aconitate	B-X
during	B-X
crystallization	B-X
and	B-X
is	B-X
observed	B-X
to	B-X
bind	B-X
in	B-X
the	B-X
active	B-X
site	B-X
in	B-X
a	B-X
manner	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
for	B-X
isocitrate	B-X
.	B-X
However	B-X
,	B-X
the	B-X
other	B-X
potential	B-X
hydration	B-X
product	B-X
of	B-X
alpha-methyl-cis-aconitate	B-X
,	B-X
alpha-methylcitrate	B-X
,	B-X
can	B-X
not	B-X
be	B-X
accommodated	B-X
in	B-X
the	B-X
active	B-X
site	B-X
due	B-X
to	B-X
steric	B-X
conflict	B-X
of	B-X
the	B-X
methyl	B-X
group	B-X
with	B-X
Asp-165	B-X
.	B-X
The	B-X
results	B-X
are	B-X
consistent	B-X
with	B-X
the	B-X
requirement	B-X
that	B-X
cis-aconitate	B-X
must	B-X
bind	B-X
in	B-X
two	B-X
ways	B-X
,	B-X
in	B-X
the	B-X
citrate	B-X
mode	B-X
and	B-X
in	B-X
the	B-X
isocitrate	B-X
mode	B-X
.	B-X
Crystals	B-X
of	B-X
aconitase	B-X
with	B-X
sulfate	B-X
bound	B-X
are	B-X
isomorphous	B-X
to	B-X
those	B-X
with	B-X
isocitrate	B-X
bound	B-X
.	B-X
However	B-X
,	B-X
the	B-X
structure	B-X
displays	B-X
significant	B-X
conformational	B-X
changes	B-X
,	B-X
providing	B-X
a	B-X
model	B-X
for	B-X
the	B-X
substrate-free	B-X
state	B-X
of	B-X
enzyme	B-X
.	B-X
Three	B-X
water	B-X
molecules	B-X
bind	B-X
in	B-X
place	B-X
of	B-X
the	B-X
C	B-X
alpha-	B-X
and	B-X
C	B-X
beta-hydroxyl	B-X
and	B-X
carboxyl	B-X
groups	B-X
of	B-X
isocitrate	B-X
,	B-X
while	B-X
sulfate	B-X
binds	B-X
in	B-X
place	B-X
of	B-X
the	B-X
C	B-X
gamma-carboxyl	B-X
group	B-X
.	B-X

Crystals	O
of	O
aconitase	B-Gene_or_gene_product
with	O
sulfate	O
bound	O
are	O
isomorphous	O
to	O
those	O
with	O
isocitrate	O
bound	O
.	O
<EOS>	B-X
Crystal	B-X
structures	B-X
of	B-X
mitochondrial	B-X
aconitase	B-X
with	B-X
alpha-methylisocitrate	B-X
and	B-X
with	B-X
sulfate	B-X
bound	B-X
have	B-X
been	B-X
solved	B-X
and	B-X
refined	B-X
at	B-X
2.0	B-X
A	B-X
resolution	B-X
with	B-X
R	B-X
factors	B-X
of	B-X
18.2	B-X
and	B-X
16.8	B-X
%	B-X
,	B-X
respectively	B-X
.	B-X
The	B-X
steric	B-X
factors	B-X
and	B-X
conformational	B-X
effects	B-X
observed	B-X
in	B-X
both	B-X
new	B-X
structures	B-X
support	B-X
the	B-X
proposed	B-X
mechanism	B-X
for	B-X
the	B-X
overall	B-X
reaction	B-X
catalyzed	B-X
by	B-X
aconitase	B-X
.	B-X
The	B-X
alternate	B-X
substrate	B-X
alpha-methylisocitrate	B-X
is	B-X
derived	B-X
from	B-X
alpha-methyl-cis-aconitate	B-X
during	B-X
crystallization	B-X
and	B-X
is	B-X
observed	B-X
to	B-X
bind	B-X
in	B-X
the	B-X
active	B-X
site	B-X
in	B-X
a	B-X
manner	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
for	B-X
isocitrate	B-X
.	B-X
The	B-X
results	B-X
are	B-X
consistent	B-X
with	B-X
the	B-X
requirement	B-X
that	B-X
cis-aconitate	B-X
must	B-X
bind	B-X
in	B-X
two	B-X
ways	B-X
,	B-X
in	B-X
the	B-X
citrate	B-X
mode	B-X
and	B-X
in	B-X
the	B-X
isocitrate	B-X
mode	B-X
.	B-X
Crystals	B-X
of	B-X
aconitase	B-X
with	B-X
sulfate	B-X
bound	B-X
are	B-X
isomorphous	B-X
to	B-X
those	B-X
with	B-X
isocitrate	B-X
bound	B-X
.	B-X
Three	B-X
water	B-X
molecules	B-X
bind	B-X
in	B-X
place	B-X
of	B-X
the	B-X
C	B-X
alpha-	B-X
and	B-X
C	B-X
beta-hydroxyl	B-X
and	B-X
carboxyl	B-X
groups	B-X
of	B-X
isocitrate	B-X
,	B-X
while	B-X
sulfate	B-X
binds	B-X
in	B-X
place	B-X
of	B-X
the	B-X
C	B-X
gamma-carboxyl	B-X
group	B-X
.	B-X

However	O
,	O
the	O
structure	O
displays	O
significant	O
conformational	O
changes	O
,	O
providing	O
a	O
model	O
for	O
the	O
substrate	O
-	O
free	O
state	O
of	O
enzyme	O
.	O

Three	O
water	O
molecules	O
bind	O
in	O
place	O
of	O
the	O
C	O
alpha	O
-	O
and	O
C	O
beta	O
-	O
hydroxyl	O
and	O
carboxyl	O
groups	O
of	O
isocitrate	O
,	O
while	O
sulfate	O
binds	O
in	O
place	O
of	O
the	O
C	O
gamma	O
-	O
carboxyl	O
group	O
.	O

Side	O
chains	O
of	O
Ser	O
-	O
642	O
and	O
Arg	O
-	O
447	O
in	O
the	O
active	O
site	O
rotate	O
to	O
pair	O
with	O
other	O
side	O
chains	O
in	O
the	O
absence	O
of	O
substrate	O
.	O
<EOS>	B-X
The	B-X
alternate	B-X
substrate	B-X
alpha-methylisocitrate	B-X
is	B-X
derived	B-X
from	B-X
alpha-methyl-cis-aconitate	B-X
during	B-X
crystallization	B-X
and	B-X
is	B-X
observed	B-X
to	B-X
bind	B-X
in	B-X
the	B-X
active	B-X
site	B-X
in	B-X
a	B-X
manner	B-X
very	B-X
similar	B-X
to	B-X
that	B-X
observed	B-X
for	B-X
isocitrate	B-X
.	B-X
However	B-X
,	B-X
the	B-X
other	B-X
potential	B-X
hydration	B-X
product	B-X
of	B-X
alpha-methyl-cis-aconitate	B-X
,	B-X
alpha-methylcitrate	B-X
,	B-X
can	B-X
not	B-X
be	B-X
accommodated	B-X
in	B-X
the	B-X
active	B-X
site	B-X
due	B-X
to	B-X
steric	B-X
conflict	B-X
of	B-X
the	B-X
methyl	B-X
group	B-X
with	B-X
Asp-165	B-X
.	B-X
However	B-X
,	B-X
the	B-X
structure	B-X
displays	B-X
significant	B-X
conformational	B-X
changes	B-X
,	B-X
providing	B-X
a	B-X
model	B-X
for	B-X
the	B-X
substrate-free	B-X
state	B-X
of	B-X
enzyme	B-X
.	B-X
Side	B-X
chains	B-X
of	B-X
Ser-642	B-X
and	B-X
Arg-447	B-X
in	B-X
the	B-X
active	B-X
site	B-X
rotate	B-X
to	B-X
pair	B-X
with	B-X
other	B-X
side	B-X
chains	B-X
in	B-X
the	B-X
absence	B-X
of	B-X
substrate	B-X
.	B-X
The	B-X
new	B-X
conformation	B-X
of	B-X
Arg-447	B-X
triggers	B-X
a	B-X
concerted	B-X
set	B-X
of	B-X
shifts	B-X
which	B-X
transmits	B-X
conformational	B-X
change	B-X
to	B-X
the	B-X
surface	B-X
of	B-X
the	B-X
protein	B-X
,	B-X
30	B-X
A	B-X
from	B-X
the	B-X
active	B-X
site	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
substrate	B-X
,	B-X
a	B-X
chain	B-X
segment	B-X
containing	B-X
the	B-X
[	B-X
4Fe-4S	B-X
]	B-X
ligand	B-X
Cys-358	B-X
also	B-X
shifts	B-X
,	B-X
resulting	B-X
in	B-X
the	B-X
net	B-X
translation	B-X
and	B-X
reorientation	B-X
of	B-X
the	B-X
Fe-S	B-X
cluster	B-X
.	B-X

The	O
new	O
conformation	O
of	O
Arg	O
-	O
447	O
triggers	O
a	O
concerted	O
set	O
of	O
shifts	O
which	O
transmits	O
conformational	O
change	O
to	O
the	O
surface	O
of	O
the	O
protein	O
,	O
30	O
A	O
from	O
the	O
active	O
site	O
.	O

In	O
the	O
absence	O
of	O
substrate	O
,	O
a	O
chain	O
segment	O
containing	O
the	O
[	O
4Fe	O
-	O
4S	O
]	O
ligand	O
Cys	O
-	O
358	O
also	O
shifts	O
,	O
resulting	O
in	O
the	O
net	O
translation	O
and	O
reorientation	O
of	O
the	O
Fe	O
-	O
S	O
cluster	O
.	O

Phosphatidylcholine	B-Gene_or_gene_product
translocase	I-Gene_or_gene_product
:	O
a	O
physiological	O
role	O
for	O
the	O
mdr2	B-Gene_or_gene_product
gene	O
.	O
<EOS>	B-X
P-glycoproteins	B-X
(	B-X
P-gps	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
mouse	B-X
mdr2	B-X
and	B-X
mdr3	B-X
genes	B-X
were	B-X
expressed	B-X
in	B-X
secretory	B-X
vesicles	B-X
(	B-X
SVs	B-X
)	B-X
from	B-X
the	B-X
yeast	B-X
mutant	B-X
sec6-4	B-X
,	B-X
and	B-X
their	B-X
capacity	B-X
to	B-X
function	B-X
as	B-X
a	B-X
lipid	B-X
translocase/flippase	B-X
was	B-X
tested	B-X
.	B-X

P	B-Gene_or_gene_product
-	I-Gene_or_gene_product
glycoproteins	I-Gene_or_gene_product
(	O
P	B-Gene_or_gene_product
-	I-Gene_or_gene_product
gps	I-Gene_or_gene_product
)	O
encoded	O
by	O
the	O
mouse	O
mdr2	B-Gene_or_gene_product
and	O
mdr3	B-Gene_or_gene_product
genes	O
were	O
expressed	O
in	O
secretory	O
vesicles	O
(	O
SVs	O
)	O
from	O
the	O
yeast	O
mutant	O
sec6	O
-	O
4	O
,	O
and	O
their	O
capacity	O
to	O
function	O
as	O
a	O
lipid	B-Gene_or_gene_product
translocase	I-Gene_or_gene_product
/	O
flippase	B-Gene_or_gene_product
was	O
tested	O
.	O
<EOS>	B-X
P-glycoproteins	B-X
(	B-X
P-gps	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
mouse	B-X
mdr2	B-X
and	B-X
mdr3	B-X
genes	B-X
were	B-X
expressed	B-X
in	B-X
secretory	B-X
vesicles	B-X
(	B-X
SVs	B-X
)	B-X
from	B-X
the	B-X
yeast	B-X
mutant	B-X
sec6-4	B-X
,	B-X
and	B-X
their	B-X
capacity	B-X
to	B-X
function	B-X
as	B-X
a	B-X
lipid	B-X
translocase/flippase	B-X
was	B-X
tested	B-X
.	B-X
An	B-X
assay	B-X
that	B-X
uses	B-X
a	B-X
fluorescent	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
analog	B-X
was	B-X
developed	B-X
to	B-X
quantitate	B-X
asymmetric	B-X
lipid	B-X
distribution	B-X
in	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
leaflets	B-X
of	B-X
the	B-X
lipid	B-X
bilayer	B-X
of	B-X
these	B-X
vesicles	B-X
.	B-X
Mdr2	B-X
expression	B-X
in	B-X
SVs	B-X
caused	B-X
a	B-X
time-	B-X
and	B-X
temperature-dependent	B-X
enhancement	B-X
of	B-X
PC	B-X
translocation	B-X
to	B-X
the	B-X
inner	B-X
leaflet	B-X
of	B-X
the	B-X
membrane	B-X
.	B-X
The	B-X
Mdr2-mediated	B-X
effect	B-X
was	B-X
specific	B-X
since	B-X
expression	B-X
of	B-X
Mdr3	B-X
in	B-X
these	B-X
vesicles	B-X
was	B-X
without	B-X
effect	B-X
on	B-X
the	B-X
membrane	B-X
distribution	B-X
of	B-X
PC	B-X
.	B-X
Increased	B-X
Mdr2-mediated	B-X
PC	B-X
translocation	B-X
was	B-X
strictly	B-X
ATP	B-X
and	B-X
Mg2+	B-X
dependent	B-X
,	B-X
was	B-X
abrogated	B-X
by	B-X
the	B-X
ATPase	B-X
inhibitor	B-X
vanadate	B-X
and	B-X
the	B-X
P-gp	B-X
modulator	B-X
verapamil	B-X
,	B-X
but	B-X
was	B-X
insensitive	B-X
to	B-X
the	B-X
presence	B-X
of	B-X
excess	B-X
of	B-X
the	B-X
multidrug	B-X
resistance	B-X
drugs	B-X
colchicine	B-X
and	B-X
vinblastine	B-X
.	B-X

An	O
assay	O
that	O
uses	O
a	O
fluorescent	O
phosphatidylcholine	O
(	O
PC	O
)	O
analog	O
was	O
developed	O
to	O
quantitate	O
asymmetric	O
lipid	O
distribution	O
in	O
the	O
outer	O
and	O
inner	O
leaflets	O
of	O
the	O
lipid	O
bilayer	O
of	O
these	O
vesicles	O
.	O
<EOS>	B-X
P-glycoproteins	B-X
(	B-X
P-gps	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
mouse	B-X
mdr2	B-X
and	B-X
mdr3	B-X
genes	B-X
were	B-X
expressed	B-X
in	B-X
secretory	B-X
vesicles	B-X
(	B-X
SVs	B-X
)	B-X
from	B-X
the	B-X
yeast	B-X
mutant	B-X
sec6-4	B-X
,	B-X
and	B-X
their	B-X
capacity	B-X
to	B-X
function	B-X
as	B-X
a	B-X
lipid	B-X
translocase/flippase	B-X
was	B-X
tested	B-X
.	B-X
An	B-X
assay	B-X
that	B-X
uses	B-X
a	B-X
fluorescent	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
analog	B-X
was	B-X
developed	B-X
to	B-X
quantitate	B-X
asymmetric	B-X
lipid	B-X
distribution	B-X
in	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
leaflets	B-X
of	B-X
the	B-X
lipid	B-X
bilayer	B-X
of	B-X
these	B-X
vesicles	B-X
.	B-X
Mdr2	B-X
expression	B-X
in	B-X
SVs	B-X
caused	B-X
a	B-X
time-	B-X
and	B-X
temperature-dependent	B-X
enhancement	B-X
of	B-X
PC	B-X
translocation	B-X
to	B-X
the	B-X
inner	B-X
leaflet	B-X
of	B-X
the	B-X
membrane	B-X
.	B-X
The	B-X
Mdr2-mediated	B-X
effect	B-X
was	B-X
specific	B-X
since	B-X
expression	B-X
of	B-X
Mdr3	B-X
in	B-X
these	B-X
vesicles	B-X
was	B-X
without	B-X
effect	B-X
on	B-X
the	B-X
membrane	B-X
distribution	B-X
of	B-X
PC	B-X
.	B-X
Increased	B-X
Mdr2-mediated	B-X
PC	B-X
translocation	B-X
was	B-X
strictly	B-X
ATP	B-X
and	B-X
Mg2+	B-X
dependent	B-X
,	B-X
was	B-X
abrogated	B-X
by	B-X
the	B-X
ATPase	B-X
inhibitor	B-X
vanadate	B-X
and	B-X
the	B-X
P-gp	B-X
modulator	B-X
verapamil	B-X
,	B-X
but	B-X
was	B-X
insensitive	B-X
to	B-X
the	B-X
presence	B-X
of	B-X
excess	B-X
of	B-X
the	B-X
multidrug	B-X
resistance	B-X
drugs	B-X
colchicine	B-X
and	B-X
vinblastine	B-X
.	B-X

Mdr2	B-Gene_or_gene_product
expression	O
in	O
SVs	O
caused	O
a	O
time	O
-	O
and	O
temperature	O
-	O
dependent	O
enhancement	O
of	O
PC	O
translocation	O
to	O
the	O
inner	O
leaflet	O
of	O
the	O
membrane	O
.	O

The	O
Mdr2	B-Gene_or_gene_product
-	O
mediated	O
effect	O
was	O
specific	O
since	O
expression	O
of	O
Mdr3	B-Gene_or_gene_product
in	O
these	O
vesicles	O
was	O
without	O
effect	O
on	O
the	O
membrane	O
distribution	O
of	O
PC	O
.	O
<EOS>	B-X
P-glycoproteins	B-X
(	B-X
P-gps	B-X
)	B-X
encoded	B-X
by	B-X
the	B-X
mouse	B-X
mdr2	B-X
and	B-X
mdr3	B-X
genes	B-X
were	B-X
expressed	B-X
in	B-X
secretory	B-X
vesicles	B-X
(	B-X
SVs	B-X
)	B-X
from	B-X
the	B-X
yeast	B-X
mutant	B-X
sec6-4	B-X
,	B-X
and	B-X
their	B-X
capacity	B-X
to	B-X
function	B-X
as	B-X
a	B-X
lipid	B-X
translocase/flippase	B-X
was	B-X
tested	B-X
.	B-X
An	B-X
assay	B-X
that	B-X
uses	B-X
a	B-X
fluorescent	B-X
phosphatidylcholine	B-X
(	B-X
PC	B-X
)	B-X
analog	B-X
was	B-X
developed	B-X
to	B-X
quantitate	B-X
asymmetric	B-X
lipid	B-X
distribution	B-X
in	B-X
the	B-X
outer	B-X
and	B-X
inner	B-X
leaflets	B-X
of	B-X
the	B-X
lipid	B-X
bilayer	B-X
of	B-X
these	B-X
vesicles	B-X
.	B-X
Mdr2	B-X
expression	B-X
in	B-X
SVs	B-X
caused	B-X
a	B-X
time-	B-X
and	B-X
temperature-dependent	B-X
enhancement	B-X
of	B-X
PC	B-X
translocation	B-X
to	B-X
the	B-X
inner	B-X
leaflet	B-X
of	B-X
the	B-X
membrane	B-X
.	B-X
The	B-X
Mdr2-mediated	B-X
effect	B-X
was	B-X
specific	B-X
since	B-X
expression	B-X
of	B-X
Mdr3	B-X
in	B-X
these	B-X
vesicles	B-X
was	B-X
without	B-X
effect	B-X
on	B-X
the	B-X
membrane	B-X
distribution	B-X
of	B-X
PC	B-X
.	B-X
Increased	B-X
Mdr2-mediated	B-X
PC	B-X
translocation	B-X
was	B-X
strictly	B-X
ATP	B-X
and	B-X
Mg2+	B-X
dependent	B-X
,	B-X
was	B-X
abrogated	B-X
by	B-X
the	B-X
ATPase	B-X
inhibitor	B-X
vanadate	B-X
and	B-X
the	B-X
P-gp	B-X
modulator	B-X
verapamil	B-X
,	B-X
but	B-X
was	B-X
insensitive	B-X
to	B-X
the	B-X
presence	B-X
of	B-X
excess	B-X
of	B-X
the	B-X
multidrug	B-X
resistance	B-X
drugs	B-X
colchicine	B-X
and	B-X
vinblastine	B-X
.	B-X

Increased	O
Mdr2	B-Gene_or_gene_product
-	O
mediated	O
PC	O
translocation	O
was	O
strictly	O
ATP	O
and	O
Mg2	O
+	O
dependent	O
,	O
was	O
abrogated	O
by	O
the	O
ATPase	B-Gene_or_gene_product
inhibitor	O
vanadate	O
and	O
the	O
P	B-Gene_or_gene_product
-	I-Gene_or_gene_product
gp	I-Gene_or_gene_product
modulator	O
verapamil	O
,	O
but	O
was	O
insensitive	O
to	O
the	O
presence	O
of	O
excess	O
of	O
the	O
multidrug	O
resistance	O
drugs	O
colchicine	O
and	O
vinblastine	O
.	O

The	O
SRF	B-Gene_or_gene_product
accessory	O
protein	O
Elk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
contains	O
a	O
growth	O
factor	O
-	O
regulated	O
transcriptional	O
activation	O
domain	O
.	O
<EOS>	B-X
The	B-X
Elk-1	B-X
and	B-X
SRF	B-X
transcription	B-X
factors	B-X
form	B-X
a	B-X
ternary	B-X
complex	B-X
at	B-X
the	B-X
c-fos	B-X
serum	B-X
response	B-X
element	B-X
(	B-X
SRE	B-X
)	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
rapidly	B-X
induces	B-X
a	B-X
reversible	B-X
change	B-X
in	B-X
the	B-X
electrophoretic	B-X
mobility	B-X
of	B-X
the	B-X
ternary	B-X
complex	B-X
,	B-X
accompanied	B-X
by	B-X
increased	B-X
phosphorylation	B-X
of	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
and	B-X
by	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
42	B-X
kd	B-X
cellular	B-X
Elk-1	B-X
kinase	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Elk-1	B-X
in	B-X
vitro	B-X
by	B-X
partially	B-X
purified	B-X
p42/p44	B-X
MAP	B-X
kinase	B-X
induces	B-X
a	B-X
similar	B-X
reduction	B-X
in	B-X
ternary	B-X
complex	B-X
mobility	B-X
but	B-X
has	B-X
little	B-X
effect	B-X
on	B-X
the	B-X
efficiency	B-X
of	B-X
its	B-X
formation	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MAP	B-X
kinase	B-X
phosphorylates	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
at	B-X
multiple	B-X
sites	B-X
,	B-X
which	B-X
are	B-X
also	B-X
phosphorylated	B-X
following	B-X
growth	B-X
factor	B-X
stimulation	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
functions	B-X
as	B-X
a	B-X
regulated	B-X
transcriptional	B-X
activation	B-X
domain	B-X
whose	B-X
activity	B-X
in	B-X
vivo	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
integrity	B-X
of	B-X
the	B-X
MAP	B-X
kinase	B-X
sites	B-X
.	B-X
These	B-X
findings	B-X
directly	B-X
link	B-X
transcriptional	B-X
activation	B-X
by	B-X
the	B-X
SRE	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
phosphorylation	B-X
of	B-X
an	B-X
SRE-binding	B-X
protein	B-X
.	B-X

The	O
Elk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
and	O
SRF	B-Gene_or_gene_product
transcription	O
factors	O
form	O
a	O
ternary	O
complex	O
at	O
the	O
c	B-Gene_or_gene_product
-	I-Gene_or_gene_product
fos	I-Gene_or_gene_product
serum	O
response	O
element	O
(	O
SRE	O
)	O
.	O

Growth	O
factor	O
stimulation	O
rapidly	O
induces	O
a	O
reversible	O
change	O
in	O
the	O
electrophoretic	O
mobility	O
of	O
the	O
ternary	O
complex	O
,	O
accompanied	O
by	O
increased	O
phosphorylation	O
of	O
the	O
Elk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
C	O
-	O
terminal	O
region	O
and	O
by	O
the	O
activation	O
of	O
a	O
42	O
kd	O
cellular	O
Elk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
kinase	O
.	O
<EOS>	B-X
The	B-X
Elk-1	B-X
and	B-X
SRF	B-X
transcription	B-X
factors	B-X
form	B-X
a	B-X
ternary	B-X
complex	B-X
at	B-X
the	B-X
c-fos	B-X
serum	B-X
response	B-X
element	B-X
(	B-X
SRE	B-X
)	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
rapidly	B-X
induces	B-X
a	B-X
reversible	B-X
change	B-X
in	B-X
the	B-X
electrophoretic	B-X
mobility	B-X
of	B-X
the	B-X
ternary	B-X
complex	B-X
,	B-X
accompanied	B-X
by	B-X
increased	B-X
phosphorylation	B-X
of	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
and	B-X
by	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
42	B-X
kd	B-X
cellular	B-X
Elk-1	B-X
kinase	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Elk-1	B-X
in	B-X
vitro	B-X
by	B-X
partially	B-X
purified	B-X
p42/p44	B-X
MAP	B-X
kinase	B-X
induces	B-X
a	B-X
similar	B-X
reduction	B-X
in	B-X
ternary	B-X
complex	B-X
mobility	B-X
but	B-X
has	B-X
little	B-X
effect	B-X
on	B-X
the	B-X
efficiency	B-X
of	B-X
its	B-X
formation	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MAP	B-X
kinase	B-X
phosphorylates	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
at	B-X
multiple	B-X
sites	B-X
,	B-X
which	B-X
are	B-X
also	B-X
phosphorylated	B-X
following	B-X
growth	B-X
factor	B-X
stimulation	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
functions	B-X
as	B-X
a	B-X
regulated	B-X
transcriptional	B-X
activation	B-X
domain	B-X
whose	B-X
activity	B-X
in	B-X
vivo	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
integrity	B-X
of	B-X
the	B-X
MAP	B-X
kinase	B-X
sites	B-X
.	B-X
These	B-X
findings	B-X
directly	B-X
link	B-X
transcriptional	B-X
activation	B-X
by	B-X
the	B-X
SRE	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
phosphorylation	B-X
of	B-X
an	B-X
SRE-binding	B-X
protein	B-X
.	B-X

Phosphorylation	O
of	O
Elk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
in	O
vitro	O
by	O
partially	O
purified	O
p42	B-Gene_or_gene_product
/	I-Gene_or_gene_product
p44	I-Gene_or_gene_product
MAP	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
induces	O
a	O
similar	O
reduction	O
in	O
ternary	O
complex	O
mobility	O
but	O
has	O
little	O
effect	O
on	O
the	O
efficiency	O
of	O
its	O
formation	O
.	O
<EOS>	B-X
The	B-X
Elk-1	B-X
and	B-X
SRF	B-X
transcription	B-X
factors	B-X
form	B-X
a	B-X
ternary	B-X
complex	B-X
at	B-X
the	B-X
c-fos	B-X
serum	B-X
response	B-X
element	B-X
(	B-X
SRE	B-X
)	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
rapidly	B-X
induces	B-X
a	B-X
reversible	B-X
change	B-X
in	B-X
the	B-X
electrophoretic	B-X
mobility	B-X
of	B-X
the	B-X
ternary	B-X
complex	B-X
,	B-X
accompanied	B-X
by	B-X
increased	B-X
phosphorylation	B-X
of	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
and	B-X
by	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
42	B-X
kd	B-X
cellular	B-X
Elk-1	B-X
kinase	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Elk-1	B-X
in	B-X
vitro	B-X
by	B-X
partially	B-X
purified	B-X
p42/p44	B-X
MAP	B-X
kinase	B-X
induces	B-X
a	B-X
similar	B-X
reduction	B-X
in	B-X
ternary	B-X
complex	B-X
mobility	B-X
but	B-X
has	B-X
little	B-X
effect	B-X
on	B-X
the	B-X
efficiency	B-X
of	B-X
its	B-X
formation	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MAP	B-X
kinase	B-X
phosphorylates	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
at	B-X
multiple	B-X
sites	B-X
,	B-X
which	B-X
are	B-X
also	B-X
phosphorylated	B-X
following	B-X
growth	B-X
factor	B-X
stimulation	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
functions	B-X
as	B-X
a	B-X
regulated	B-X
transcriptional	B-X
activation	B-X
domain	B-X
whose	B-X
activity	B-X
in	B-X
vivo	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
integrity	B-X
of	B-X
the	B-X
MAP	B-X
kinase	B-X
sites	B-X
.	B-X

In	O
vitro	O
,	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
phosphorylates	O
the	O
Elk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
C	O
-	O
terminal	O
region	O
at	O
multiple	O
sites	O
,	O
which	O
are	O
also	O
phosphorylated	O
following	O
growth	O
factor	O
stimulation	O
in	O
vivo	O
.	O
<EOS>	B-X
The	B-X
Elk-1	B-X
and	B-X
SRF	B-X
transcription	B-X
factors	B-X
form	B-X
a	B-X
ternary	B-X
complex	B-X
at	B-X
the	B-X
c-fos	B-X
serum	B-X
response	B-X
element	B-X
(	B-X
SRE	B-X
)	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
rapidly	B-X
induces	B-X
a	B-X
reversible	B-X
change	B-X
in	B-X
the	B-X
electrophoretic	B-X
mobility	B-X
of	B-X
the	B-X
ternary	B-X
complex	B-X
,	B-X
accompanied	B-X
by	B-X
increased	B-X
phosphorylation	B-X
of	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
and	B-X
by	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
42	B-X
kd	B-X
cellular	B-X
Elk-1	B-X
kinase	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Elk-1	B-X
in	B-X
vitro	B-X
by	B-X
partially	B-X
purified	B-X
p42/p44	B-X
MAP	B-X
kinase	B-X
induces	B-X
a	B-X
similar	B-X
reduction	B-X
in	B-X
ternary	B-X
complex	B-X
mobility	B-X
but	B-X
has	B-X
little	B-X
effect	B-X
on	B-X
the	B-X
efficiency	B-X
of	B-X
its	B-X
formation	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MAP	B-X
kinase	B-X
phosphorylates	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
at	B-X
multiple	B-X
sites	B-X
,	B-X
which	B-X
are	B-X
also	B-X
phosphorylated	B-X
following	B-X
growth	B-X
factor	B-X
stimulation	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
functions	B-X
as	B-X
a	B-X
regulated	B-X
transcriptional	B-X
activation	B-X
domain	B-X
whose	B-X
activity	B-X
in	B-X
vivo	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
integrity	B-X
of	B-X
the	B-X
MAP	B-X
kinase	B-X
sites	B-X
.	B-X
These	B-X
findings	B-X
directly	B-X
link	B-X
transcriptional	B-X
activation	B-X
by	B-X
the	B-X
SRE	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
phosphorylation	B-X
of	B-X
an	B-X
SRE-binding	B-X
protein	B-X
.	B-X

The	O
Elk	B-Gene_or_gene_product
-	I-Gene_or_gene_product
1	I-Gene_or_gene_product
C	O
-	O
terminal	O
region	O
functions	O
as	O
a	O
regulated	O
transcriptional	O
activation	O
domain	O
whose	O
activity	O
in	O
vivo	O
is	O
dependent	O
on	O
the	O
integrity	O
of	O
the	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
sites	O
.	O
<EOS>	B-X
The	B-X
Elk-1	B-X
and	B-X
SRF	B-X
transcription	B-X
factors	B-X
form	B-X
a	B-X
ternary	B-X
complex	B-X
at	B-X
the	B-X
c-fos	B-X
serum	B-X
response	B-X
element	B-X
(	B-X
SRE	B-X
)	B-X
.	B-X
Growth	B-X
factor	B-X
stimulation	B-X
rapidly	B-X
induces	B-X
a	B-X
reversible	B-X
change	B-X
in	B-X
the	B-X
electrophoretic	B-X
mobility	B-X
of	B-X
the	B-X
ternary	B-X
complex	B-X
,	B-X
accompanied	B-X
by	B-X
increased	B-X
phosphorylation	B-X
of	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
and	B-X
by	B-X
the	B-X
activation	B-X
of	B-X
a	B-X
42	B-X
kd	B-X
cellular	B-X
Elk-1	B-X
kinase	B-X
.	B-X
Phosphorylation	B-X
of	B-X
Elk-1	B-X
in	B-X
vitro	B-X
by	B-X
partially	B-X
purified	B-X
p42/p44	B-X
MAP	B-X
kinase	B-X
induces	B-X
a	B-X
similar	B-X
reduction	B-X
in	B-X
ternary	B-X
complex	B-X
mobility	B-X
but	B-X
has	B-X
little	B-X
effect	B-X
on	B-X
the	B-X
efficiency	B-X
of	B-X
its	B-X
formation	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MAP	B-X
kinase	B-X
phosphorylates	B-X
the	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
at	B-X
multiple	B-X
sites	B-X
,	B-X
which	B-X
are	B-X
also	B-X
phosphorylated	B-X
following	B-X
growth	B-X
factor	B-X
stimulation	B-X
in	B-X
vivo	B-X
.	B-X
The	B-X
Elk-1	B-X
C-terminal	B-X
region	B-X
functions	B-X
as	B-X
a	B-X
regulated	B-X
transcriptional	B-X
activation	B-X
domain	B-X
whose	B-X
activity	B-X
in	B-X
vivo	B-X
is	B-X
dependent	B-X
on	B-X
the	B-X
integrity	B-X
of	B-X
the	B-X
MAP	B-X
kinase	B-X
sites	B-X
.	B-X
These	B-X
findings	B-X
directly	B-X
link	B-X
transcriptional	B-X
activation	B-X
by	B-X
the	B-X
SRE	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
phosphorylation	B-X
of	B-X
an	B-X
SRE-binding	B-X
protein	B-X
.	B-X

These	O
findings	O
directly	O
link	O
transcriptional	O
activation	O
by	O
the	O
SRE	O
to	O
the	O
growth	O
factor	O
-	O
regulated	O
phosphorylation	O
of	O
an	O
SRE	O
-	O
binding	O
protein	O
.	O

Physical	O
association	O
of	O
the	O
small	O
GTPase	O
Rho	B-Gene_or_gene_product
with	O
a	O
68	O
-	O
kDa	O
phosphatidylinositol	B-Gene_or_gene_product
4	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphate	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
in	O
Swiss	O
3T3	O
cells	O
.	O
<EOS>	B-X
Our	B-X
previous	B-X
work	B-X
showed	B-X
that	B-X
post-translationally	B-X
modified	B-X
Rho	B-X
in	B-X
its	B-X
GTP-bound	B-X
state	B-X
stimulated	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
activity	B-X
in	B-X
mouse	B-X
fibroblast	B-X
lysates	B-X
.	B-X
To	B-X
investigate	B-X
whether	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
PIP5K	B-X
,	B-X
we	B-X
incubated	B-X
immobilized	B-X
Rho-GST	B-X
with	B-X
Swiss	B-X
3T3	B-X
cell	B-X
lysates	B-X
and	B-X
tested	B-X
for	B-X
retained	B-X
PIP5K	B-X
activity	B-X
.	B-X
Rho-GST	B-X
,	B-X
but	B-X
not	B-X
Ras-GST	B-X
or	B-X
GST	B-X
alone	B-X
,	B-X
bound	B-X
significant	B-X
PIP5K	B-X
activity	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
PIP5K	B-X
was	B-X
independent	B-X
of	B-X
whether	B-X
Rho	B-X
was	B-X
in	B-X
a	B-X
GTP-	B-X
or	B-X
GDP-bound	B-X
state	B-X
.	B-X
An	B-X
antibody	B-X
against	B-X
a	B-X
68-kDa	B-X
human	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
recognized	B-X
a	B-X
single	B-X
68-kDa	B-X
protein	B-X
eluted	B-X
from	B-X
Rho-GST	B-X
column	B-X
.	B-X
The	B-X
Rho-associated	B-X
PIP5K	B-X
responded	B-X
to	B-X
phosphatidic	B-X
acid	B-X
differentially	B-X
from	B-X
the	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
could	B-X
be	B-X
a	B-X
distinct	B-X
isoform	B-X
not	B-X
reported	B-X
previously	B-X
.	B-X
Rho	B-X
co-immunoprecipitated	B-X
with	B-X
the	B-X
68-kDa	B-X
PIP5K	B-X
from	B-X
Swiss	B-X
3T3	B-X
lysates	B-X
,	B-X
demonstrating	B-X
that	B-X
endogenous	B-X
Rho	B-X
also	B-X
interacts	B-X
with	B-X
PIP5K	B-X
.	B-X
ADP-ribosylation	B-X
of	B-X
Rho	B-X
with	B-X
C3	B-X
exoenzyme	B-X
enhanced	B-X
PIP5K	B-X
binding	B-X
by	B-X
approximately	B-X
eightfold	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ADP-ribosylated	B-X
Rho	B-X
functioning	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
a	B-X
68-kDa	B-X
PIP5K	B-X
,	B-X
although	B-X
whether	B-X
the	B-X
association	B-X
is	B-X
direct	B-X
or	B-X
indirect	B-X
is	B-X
unknown	B-X
.	B-X

Our	O
previous	O
work	O
showed	O
that	O
post	O
-	O
translationally	O
modified	O
Rho	B-Gene_or_gene_product
in	O
its	O
GTP	O
-	O
bound	O
state	O
stimulated	O
phosphatidylinositol	B-Gene_or_gene_product
4	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphate	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
PIP5K	B-Gene_or_gene_product
)	O
activity	O
in	O
mouse	O
fibroblast	O
lysates	O
.	O
<EOS>	B-X
Our	B-X
previous	B-X
work	B-X
showed	B-X
that	B-X
post-translationally	B-X
modified	B-X
Rho	B-X
in	B-X
its	B-X
GTP-bound	B-X
state	B-X
stimulated	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
activity	B-X
in	B-X
mouse	B-X
fibroblast	B-X
lysates	B-X
.	B-X
To	B-X
investigate	B-X
whether	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
PIP5K	B-X
,	B-X
we	B-X
incubated	B-X
immobilized	B-X
Rho-GST	B-X
with	B-X
Swiss	B-X
3T3	B-X
cell	B-X
lysates	B-X
and	B-X
tested	B-X
for	B-X
retained	B-X
PIP5K	B-X
activity	B-X
.	B-X
Rho-GST	B-X
,	B-X
but	B-X
not	B-X
Ras-GST	B-X
or	B-X
GST	B-X
alone	B-X
,	B-X
bound	B-X
significant	B-X
PIP5K	B-X
activity	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
PIP5K	B-X
was	B-X
independent	B-X
of	B-X
whether	B-X
Rho	B-X
was	B-X
in	B-X
a	B-X
GTP-	B-X
or	B-X
GDP-bound	B-X
state	B-X
.	B-X
An	B-X
antibody	B-X
against	B-X
a	B-X
68-kDa	B-X
human	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
recognized	B-X
a	B-X
single	B-X
68-kDa	B-X
protein	B-X
eluted	B-X
from	B-X
Rho-GST	B-X
column	B-X
.	B-X
The	B-X
Rho-associated	B-X
PIP5K	B-X
responded	B-X
to	B-X
phosphatidic	B-X
acid	B-X
differentially	B-X
from	B-X
the	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
could	B-X
be	B-X
a	B-X
distinct	B-X
isoform	B-X
not	B-X
reported	B-X
previously	B-X
.	B-X
Rho	B-X
co-immunoprecipitated	B-X
with	B-X
the	B-X
68-kDa	B-X
PIP5K	B-X
from	B-X
Swiss	B-X
3T3	B-X
lysates	B-X
,	B-X
demonstrating	B-X
that	B-X
endogenous	B-X
Rho	B-X
also	B-X
interacts	B-X
with	B-X
PIP5K	B-X
.	B-X
ADP-ribosylation	B-X
of	B-X
Rho	B-X
with	B-X
C3	B-X
exoenzyme	B-X
enhanced	B-X
PIP5K	B-X
binding	B-X
by	B-X
approximately	B-X
eightfold	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ADP-ribosylated	B-X
Rho	B-X
functioning	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
a	B-X
68-kDa	B-X
PIP5K	B-X
,	B-X
although	B-X
whether	B-X
the	B-X
association	B-X
is	B-X
direct	B-X
or	B-X
indirect	B-X
is	B-X
unknown	B-X
.	B-X

To	O
investigate	O
whether	O
Rho	B-Gene_or_gene_product
physically	O
interacts	O
with	O
PIP5K	B-Gene_or_gene_product
,	O
we	O
incubated	O
immobilized	O
Rho	B-Gene_or_gene_product
-	I-Gene_or_gene_product
GST	I-Gene_or_gene_product
with	O
Swiss	O
3T3	O
cell	O
lysates	O
and	O
tested	O
for	O
retained	O
PIP5K	B-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
Our	B-X
previous	B-X
work	B-X
showed	B-X
that	B-X
post-translationally	B-X
modified	B-X
Rho	B-X
in	B-X
its	B-X
GTP-bound	B-X
state	B-X
stimulated	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
activity	B-X
in	B-X
mouse	B-X
fibroblast	B-X
lysates	B-X
.	B-X
To	B-X
investigate	B-X
whether	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
PIP5K	B-X
,	B-X
we	B-X
incubated	B-X
immobilized	B-X
Rho-GST	B-X
with	B-X
Swiss	B-X
3T3	B-X
cell	B-X
lysates	B-X
and	B-X
tested	B-X
for	B-X
retained	B-X
PIP5K	B-X
activity	B-X
.	B-X
Rho-GST	B-X
,	B-X
but	B-X
not	B-X
Ras-GST	B-X
or	B-X
GST	B-X
alone	B-X
,	B-X
bound	B-X
significant	B-X
PIP5K	B-X
activity	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
PIP5K	B-X
was	B-X
independent	B-X
of	B-X
whether	B-X
Rho	B-X
was	B-X
in	B-X
a	B-X
GTP-	B-X
or	B-X
GDP-bound	B-X
state	B-X
.	B-X
An	B-X
antibody	B-X
against	B-X
a	B-X
68-kDa	B-X
human	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
recognized	B-X
a	B-X
single	B-X
68-kDa	B-X
protein	B-X
eluted	B-X
from	B-X
Rho-GST	B-X
column	B-X
.	B-X
The	B-X
Rho-associated	B-X
PIP5K	B-X
responded	B-X
to	B-X
phosphatidic	B-X
acid	B-X
differentially	B-X
from	B-X
the	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
could	B-X
be	B-X
a	B-X
distinct	B-X
isoform	B-X
not	B-X
reported	B-X
previously	B-X
.	B-X
Rho	B-X
co-immunoprecipitated	B-X
with	B-X
the	B-X
68-kDa	B-X
PIP5K	B-X
from	B-X
Swiss	B-X
3T3	B-X
lysates	B-X
,	B-X
demonstrating	B-X
that	B-X
endogenous	B-X
Rho	B-X
also	B-X
interacts	B-X
with	B-X
PIP5K	B-X
.	B-X
ADP-ribosylation	B-X
of	B-X
Rho	B-X
with	B-X
C3	B-X
exoenzyme	B-X
enhanced	B-X
PIP5K	B-X
binding	B-X
by	B-X
approximately	B-X
eightfold	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ADP-ribosylated	B-X
Rho	B-X
functioning	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
a	B-X
68-kDa	B-X
PIP5K	B-X
,	B-X
although	B-X
whether	B-X
the	B-X
association	B-X
is	B-X
direct	B-X
or	B-X
indirect	B-X
is	B-X
unknown	B-X
.	B-X

Rho	B-Gene_or_gene_product
-	I-Gene_or_gene_product
GST	I-Gene_or_gene_product
,	O
but	O
not	O
Ras	B-Gene_or_gene_product
-	I-Gene_or_gene_product
GST	I-Gene_or_gene_product
or	O
GST	B-Gene_or_gene_product
alone	O
,	O
bound	O
significant	O
PIP5K	B-Gene_or_gene_product
activity	O
.	O
<EOS>	B-X
NEK9	B-X
,	B-X
a	B-X
novel	B-X
effector	B-X
of	B-X
IL-6/STAT3	B-X
,	B-X
regulates	B-X
metastasis	B-X
of	B-X
gastric	B-X
cancer	B-X
by	B-X
targeting	B-X
ARHGEF2	B-X
phosphorylation	B-X
.	B-X
Our	B-X
previous	B-X
work	B-X
showed	B-X
that	B-X
post-translationally	B-X
modified	B-X
Rho	B-X
in	B-X
its	B-X
GTP-bound	B-X
state	B-X
stimulated	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
activity	B-X
in	B-X
mouse	B-X
fibroblast	B-X
lysates	B-X
.	B-X
To	B-X
investigate	B-X
whether	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
PIP5K	B-X
,	B-X
we	B-X
incubated	B-X
immobilized	B-X
Rho-GST	B-X
with	B-X
Swiss	B-X
3T3	B-X
cell	B-X
lysates	B-X
and	B-X
tested	B-X
for	B-X
retained	B-X
PIP5K	B-X
activity	B-X
.	B-X
Rho-GST	B-X
,	B-X
but	B-X
not	B-X
Ras-GST	B-X
or	B-X
GST	B-X
alone	B-X
,	B-X
bound	B-X
significant	B-X
PIP5K	B-X
activity	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
PIP5K	B-X
was	B-X
independent	B-X
of	B-X
whether	B-X
Rho	B-X
was	B-X
in	B-X
a	B-X
GTP-	B-X
or	B-X
GDP-bound	B-X
state	B-X
.	B-X
An	B-X
antibody	B-X
against	B-X
a	B-X
68-kDa	B-X
human	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
recognized	B-X
a	B-X
single	B-X
68-kDa	B-X
protein	B-X
eluted	B-X
from	B-X
Rho-GST	B-X
column	B-X
.	B-X
The	B-X
Rho-associated	B-X
PIP5K	B-X
responded	B-X
to	B-X
phosphatidic	B-X
acid	B-X
differentially	B-X
from	B-X
the	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
could	B-X
be	B-X
a	B-X
distinct	B-X
isoform	B-X
not	B-X
reported	B-X
previously	B-X
.	B-X
Rho	B-X
co-immunoprecipitated	B-X
with	B-X
the	B-X
68-kDa	B-X
PIP5K	B-X
from	B-X
Swiss	B-X
3T3	B-X
lysates	B-X
,	B-X
demonstrating	B-X
that	B-X
endogenous	B-X
Rho	B-X
also	B-X
interacts	B-X
with	B-X
PIP5K	B-X
.	B-X
ADP-ribosylation	B-X
of	B-X
Rho	B-X
with	B-X
C3	B-X
exoenzyme	B-X
enhanced	B-X
PIP5K	B-X
binding	B-X
by	B-X
approximately	B-X
eightfold	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ADP-ribosylated	B-X
Rho	B-X
functioning	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
a	B-X
68-kDa	B-X
PIP5K	B-X
,	B-X
although	B-X
whether	B-X
the	B-X
association	B-X
is	B-X
direct	B-X
or	B-X
indirect	B-X
is	B-X
unknown	B-X
.	B-X

The	O
binding	O
of	O
PIP5K	B-Gene_or_gene_product
was	O
independent	O
of	O
whether	O
Rho	B-Gene_or_gene_product
was	O
in	O
a	O
GTP	O
-	O
or	O
GDP	O
-	O
bound	O
state	O
.	O
<EOS>	B-X
Lysosomes	B-X
similarly	B-X
undergo	B-X
constant	B-X
dynamic	B-X
regulation	B-X
by	B-X
the	B-X
RAB7	B-X
GTPase	B-X
,	B-X
which	B-X
cycles	B-X
from	B-X
an	B-X
active	B-X
GTP-bound	B-X
state	B-X
into	B-X
an	B-X
inactive	B-X
GDP-bound	B-X
state	B-X
upon	B-X
GTP	B-X
hydrolysis	B-X
.	B-X
Contact	B-X
formation	B-X
was	B-X
promoted	B-X
by	B-X
active	B-X
GTP-bound	B-X
lysosomal	B-X
RAB7	B-X
,	B-X
and	B-X
contact	B-X
untethering	B-X
was	B-X
mediated	B-X
by	B-X
recruitment	B-X
of	B-X
the	B-X
RAB7	B-X
GTPase-activating	B-X
protein	B-X
TBC1D15	B-X
to	B-X
mitochondria	B-X
by	B-X
FIS1	B-X
to	B-X
drive	B-X
RAB7	B-X
GTP	B-X
hydrolysis	B-X
and	B-X
thereby	B-X
release	B-X
contacts	B-X
.	B-X
Somatic	B-X
mutations	B-X
in	B-X
the	B-X
small	B-X
GTPase	B-X
K-Ras	B-X
are	B-X
the	B-X
most	B-X
common	B-X
activating	B-X
lesions	B-X
found	B-X
in	B-X
human	B-X
cancer	B-X
,	B-X
and	B-X
are	B-X
generally	B-X
associated	B-X
with	B-X
poor	B-X
response	B-X
to	B-X
standard	B-X
therapies	B-X
.	B-X
Efforts	B-X
to	B-X
target	B-X
this	B-X
oncogene	B-X
directly	B-X
have	B-X
faced	B-X
difficulties	B-X
owing	B-X
to	B-X
its	B-X
picomolar	B-X
affinity	B-X
for	B-X
GTP/GDP	B-X
and	B-X
the	B-X
absence	B-X
of	B-X
known	B-X
allosteric	B-X
regulatory	B-X
sites	B-X
.	B-X
Oncogenic	B-X
mutations	B-X
result	B-X
in	B-X
functional	B-X
activation	B-X
of	B-X
Ras	B-X
family	B-X
proteins	B-X
by	B-X
impairing	B-X
GTP	B-X
hydrolysis	B-X
.	B-X
With	B-X
diminished	B-X
regulation	B-X
by	B-X
GTPase	B-X
activity	B-X
,	B-X
the	B-X
nucleotide	B-X
state	B-X
of	B-X
Ras	B-X
becomes	B-X
more	B-X
dependent	B-X
on	B-X
relative	B-X
nucleotide	B-X
affinity	B-X
and	B-X
concentration	B-X
.	B-X
This	B-X
gives	B-X
GTP	B-X
an	B-X
advantage	B-X
over	B-X
GDP	B-X
and	B-X
increases	B-X
the	B-X
proportion	B-X
of	B-X
active	B-X
GTP-bound	B-X
Ras	B-X
.	B-X
These	B-X
compounds	B-X
rely	B-X
on	B-X
the	B-X
mutant	B-X
cysteine	B-X
for	B-X
binding	B-X
and	B-X
therefore	B-X
do	B-X
not	B-X
affect	B-X
the	B-X
wild-type	B-X
protein	B-X
.	B-X
Crystallographic	B-X
studies	B-X
reveal	B-X
the	B-X
formation	B-X
of	B-X
a	B-X
new	B-X
pocket	B-X
that	B-X
is	B-X
not	B-X
apparent	B-X
in	B-X
previous	B-X
structures	B-X
of	B-X
Ras	B-X
,	B-X
beneath	B-X
the	B-X
effector	B-X
binding	B-X
switch-II	B-X
region	B-X
.	B-X
Binding	B-X
of	B-X
these	B-X
inhibitors	B-X
to	B-X
K-Ras	B-X
(	B-X
G12C	B-X
)	B-X
disrupts	B-X
both	B-X
switch-I	B-X
and	B-X
switch-II	B-X
,	B-X
subverting	B-X
the	B-X
native	B-X
nucleotide	B-X
preference	B-X
to	B-X
favour	B-X
GDP	B-X
over	B-X
GTP	B-X
and	B-X
impairing	B-X
binding	B-X
to	B-X
Raf	B-X
.	B-X

An	O
antibody	O
against	O
a	O
68	O
-	O
kDa	O
human	O
erythrocyte	O
type	O
I	O
PIP5K	B-Gene_or_gene_product
recognized	O
a	O
single	O
68	O
-	O
kDa	O
protein	O
eluted	O
from	O
Rho	B-Gene_or_gene_product
-	I-Gene_or_gene_product
GST	I-Gene_or_gene_product
column	O
.	O
<EOS>	B-X
Our	B-X
previous	B-X
work	B-X
showed	B-X
that	B-X
post-translationally	B-X
modified	B-X
Rho	B-X
in	B-X
its	B-X
GTP-bound	B-X
state	B-X
stimulated	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
activity	B-X
in	B-X
mouse	B-X
fibroblast	B-X
lysates	B-X
.	B-X
To	B-X
investigate	B-X
whether	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
PIP5K	B-X
,	B-X
we	B-X
incubated	B-X
immobilized	B-X
Rho-GST	B-X
with	B-X
Swiss	B-X
3T3	B-X
cell	B-X
lysates	B-X
and	B-X
tested	B-X
for	B-X
retained	B-X
PIP5K	B-X
activity	B-X
.	B-X
Rho-GST	B-X
,	B-X
but	B-X
not	B-X
Ras-GST	B-X
or	B-X
GST	B-X
alone	B-X
,	B-X
bound	B-X
significant	B-X
PIP5K	B-X
activity	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
PIP5K	B-X
was	B-X
independent	B-X
of	B-X
whether	B-X
Rho	B-X
was	B-X
in	B-X
a	B-X
GTP-	B-X
or	B-X
GDP-bound	B-X
state	B-X
.	B-X
An	B-X
antibody	B-X
against	B-X
a	B-X
68-kDa	B-X
human	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
recognized	B-X
a	B-X
single	B-X
68-kDa	B-X
protein	B-X
eluted	B-X
from	B-X
Rho-GST	B-X
column	B-X
.	B-X
The	B-X
Rho-associated	B-X
PIP5K	B-X
responded	B-X
to	B-X
phosphatidic	B-X
acid	B-X
differentially	B-X
from	B-X
the	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
could	B-X
be	B-X
a	B-X
distinct	B-X
isoform	B-X
not	B-X
reported	B-X
previously	B-X
.	B-X
Rho	B-X
co-immunoprecipitated	B-X
with	B-X
the	B-X
68-kDa	B-X
PIP5K	B-X
from	B-X
Swiss	B-X
3T3	B-X
lysates	B-X
,	B-X
demonstrating	B-X
that	B-X
endogenous	B-X
Rho	B-X
also	B-X
interacts	B-X
with	B-X
PIP5K	B-X
.	B-X
ADP-ribosylation	B-X
of	B-X
Rho	B-X
with	B-X
C3	B-X
exoenzyme	B-X
enhanced	B-X
PIP5K	B-X
binding	B-X
by	B-X
approximately	B-X
eightfold	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ADP-ribosylated	B-X
Rho	B-X
functioning	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
a	B-X
68-kDa	B-X
PIP5K	B-X
,	B-X
although	B-X
whether	B-X
the	B-X
association	B-X
is	B-X
direct	B-X
or	B-X
indirect	B-X
is	B-X
unknown	B-X
.	B-X

The	O
Rho	B-Gene_or_gene_product
-	O
associated	O
PIP5K	B-Gene_or_gene_product
responded	O
to	O
phosphatidic	O
acid	O
differentially	O
from	O
the	O
erythrocyte	O
type	O
I	O
PIP5K	B-Gene_or_gene_product
,	O
suggesting	O
that	O
it	O
could	O
be	O
a	O
distinct	O
isoform	O
not	O
reported	O
previously	O
.	O

Rho	B-Gene_or_gene_product
co	O
-	O
immunoprecipitated	O
with	O
the	O
68	O
-	O
kDa	O
PIP5K	B-Gene_or_gene_product
from	O
Swiss	O
3T3	O
lysates	O
,	O
demonstrating	O
that	O
endogenous	O
Rho	B-Gene_or_gene_product
also	O
interacts	O
with	O
PIP5K	B-Gene_or_gene_product
.	O
<EOS>	B-X
Our	B-X
previous	B-X
work	B-X
showed	B-X
that	B-X
post-translationally	B-X
modified	B-X
Rho	B-X
in	B-X
its	B-X
GTP-bound	B-X
state	B-X
stimulated	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
activity	B-X
in	B-X
mouse	B-X
fibroblast	B-X
lysates	B-X
.	B-X
To	B-X
investigate	B-X
whether	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
PIP5K	B-X
,	B-X
we	B-X
incubated	B-X
immobilized	B-X
Rho-GST	B-X
with	B-X
Swiss	B-X
3T3	B-X
cell	B-X
lysates	B-X
and	B-X
tested	B-X
for	B-X
retained	B-X
PIP5K	B-X
activity	B-X
.	B-X
Rho-GST	B-X
,	B-X
but	B-X
not	B-X
Ras-GST	B-X
or	B-X
GST	B-X
alone	B-X
,	B-X
bound	B-X
significant	B-X
PIP5K	B-X
activity	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
PIP5K	B-X
was	B-X
independent	B-X
of	B-X
whether	B-X
Rho	B-X
was	B-X
in	B-X
a	B-X
GTP-	B-X
or	B-X
GDP-bound	B-X
state	B-X
.	B-X
An	B-X
antibody	B-X
against	B-X
a	B-X
68-kDa	B-X
human	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
recognized	B-X
a	B-X
single	B-X
68-kDa	B-X
protein	B-X
eluted	B-X
from	B-X
Rho-GST	B-X
column	B-X
.	B-X
The	B-X
Rho-associated	B-X
PIP5K	B-X
responded	B-X
to	B-X
phosphatidic	B-X
acid	B-X
differentially	B-X
from	B-X
the	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
could	B-X
be	B-X
a	B-X
distinct	B-X
isoform	B-X
not	B-X
reported	B-X
previously	B-X
.	B-X
Rho	B-X
co-immunoprecipitated	B-X
with	B-X
the	B-X
68-kDa	B-X
PIP5K	B-X
from	B-X
Swiss	B-X
3T3	B-X
lysates	B-X
,	B-X
demonstrating	B-X
that	B-X
endogenous	B-X
Rho	B-X
also	B-X
interacts	B-X
with	B-X
PIP5K	B-X
.	B-X
ADP-ribosylation	B-X
of	B-X
Rho	B-X
with	B-X
C3	B-X
exoenzyme	B-X
enhanced	B-X
PIP5K	B-X
binding	B-X
by	B-X
approximately	B-X
eightfold	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ADP-ribosylated	B-X
Rho	B-X
functioning	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
a	B-X
68-kDa	B-X
PIP5K	B-X
,	B-X
although	B-X
whether	B-X
the	B-X
association	B-X
is	B-X
direct	B-X
or	B-X
indirect	B-X
is	B-X
unknown	B-X
.	B-X

ADP	O
-	O
ribosylation	O
of	O
Rho	B-Gene_or_gene_product
with	O
C3	B-Gene_or_gene_product
exoenzyme	O
enhanced	O
PIP5K	B-Gene_or_gene_product
binding	O
by	O
approximately	O
eightfold	O
,	O
consistent	O
with	O
the	O
ADP	O
-	O
ribosylated	O
Rho	B-Gene_or_gene_product
functioning	O
as	O
a	O
dominant	O
negative	O
inhibitor	O
.	O
<EOS>	B-X
Our	B-X
previous	B-X
work	B-X
showed	B-X
that	B-X
post-translationally	B-X
modified	B-X
Rho	B-X
in	B-X
its	B-X
GTP-bound	B-X
state	B-X
stimulated	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
5-kinase	B-X
(	B-X
PIP5K	B-X
)	B-X
activity	B-X
in	B-X
mouse	B-X
fibroblast	B-X
lysates	B-X
.	B-X
To	B-X
investigate	B-X
whether	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
PIP5K	B-X
,	B-X
we	B-X
incubated	B-X
immobilized	B-X
Rho-GST	B-X
with	B-X
Swiss	B-X
3T3	B-X
cell	B-X
lysates	B-X
and	B-X
tested	B-X
for	B-X
retained	B-X
PIP5K	B-X
activity	B-X
.	B-X
Rho-GST	B-X
,	B-X
but	B-X
not	B-X
Ras-GST	B-X
or	B-X
GST	B-X
alone	B-X
,	B-X
bound	B-X
significant	B-X
PIP5K	B-X
activity	B-X
.	B-X
The	B-X
binding	B-X
of	B-X
PIP5K	B-X
was	B-X
independent	B-X
of	B-X
whether	B-X
Rho	B-X
was	B-X
in	B-X
a	B-X
GTP-	B-X
or	B-X
GDP-bound	B-X
state	B-X
.	B-X
An	B-X
antibody	B-X
against	B-X
a	B-X
68-kDa	B-X
human	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
recognized	B-X
a	B-X
single	B-X
68-kDa	B-X
protein	B-X
eluted	B-X
from	B-X
Rho-GST	B-X
column	B-X
.	B-X
The	B-X
Rho-associated	B-X
PIP5K	B-X
responded	B-X
to	B-X
phosphatidic	B-X
acid	B-X
differentially	B-X
from	B-X
the	B-X
erythrocyte	B-X
type	B-X
I	B-X
PIP5K	B-X
,	B-X
suggesting	B-X
that	B-X
it	B-X
could	B-X
be	B-X
a	B-X
distinct	B-X
isoform	B-X
not	B-X
reported	B-X
previously	B-X
.	B-X
Rho	B-X
co-immunoprecipitated	B-X
with	B-X
the	B-X
68-kDa	B-X
PIP5K	B-X
from	B-X
Swiss	B-X
3T3	B-X
lysates	B-X
,	B-X
demonstrating	B-X
that	B-X
endogenous	B-X
Rho	B-X
also	B-X
interacts	B-X
with	B-X
PIP5K	B-X
.	B-X
ADP-ribosylation	B-X
of	B-X
Rho	B-X
with	B-X
C3	B-X
exoenzyme	B-X
enhanced	B-X
PIP5K	B-X
binding	B-X
by	B-X
approximately	B-X
eightfold	B-X
,	B-X
consistent	B-X
with	B-X
the	B-X
ADP-ribosylated	B-X
Rho	B-X
functioning	B-X
as	B-X
a	B-X
dominant	B-X
negative	B-X
inhibitor	B-X
.	B-X
These	B-X
results	B-X
demonstrate	B-X
that	B-X
Rho	B-X
physically	B-X
interacts	B-X
with	B-X
a	B-X
68-kDa	B-X
PIP5K	B-X
,	B-X
although	B-X
whether	B-X
the	B-X
association	B-X
is	B-X
direct	B-X
or	B-X
indirect	B-X
is	B-X
unknown	B-X
.	B-X

These	O
results	O
demonstrate	O
that	O
Rho	B-Gene_or_gene_product
physically	O
interacts	O
with	O
a	O
68	O
-	O
kDa	O
PIP5K	B-Gene_or_gene_product
,	O
although	O
whether	O
the	O
association	O
is	O
direct	O
or	O
indirect	O
is	O
unknown	O
.	O
<EOS>	B-X
There	B-X
are	B-X
many	B-X
unknowns	B-X
for	B-X
pregnant	B-X
women	B-X
during	B-X
the	B-X
coronavirus	B-X
disease	B-X
2019	B-X
(	B-X
COVID-19	B-X
)	B-X
pandemic	B-X
.	B-X
Besides	B-X
the	B-X
direct	B-X
impacts	B-X
of	B-X
the	B-X
disease	B-X
,	B-X
a	B-X
plethora	B-X
of	B-X
indirect	B-X
consequences	B-X
of	B-X
the	B-X
pandemic	B-X
adversely	B-X
affect	B-X
maternal	B-X
health	B-X
,	B-X
including	B-X
reduced	B-X
access	B-X
to	B-X
reproductive	B-X
health	B-X
services	B-X
,	B-X
increased	B-X
mental	B-X
health	B-X
strain	B-X
,	B-X
and	B-X
increased	B-X
socioeconomic	B-X
deprivation	B-X
.	B-X
The	B-X
reference	B-X
method	B-X
for	B-X
autoantibody	B-X
testing	B-X
remains	B-X
indirect	B-X
immunofluorescence	B-X
on	B-X
triple	B-X
tissue	B-X
(	B-X
rodent	B-X
liver	B-X
,	B-X
kidney	B-X
and	B-X
stomach	B-X
)	B-X
,	B-X
allowing	B-X
both	B-X
the	B-X
detection	B-X
of	B-X
the	B-X
majority	B-X
of	B-X
liver-relevant	B-X
reactivities	B-X
,	B-X
including	B-X
those	B-X
autoantibodies	B-X
whose	B-X
molecular	B-X
target	B-X
antigens	B-X
are	B-X
unknown	B-X
.	B-X
The	B-X
indirect	B-X
effects	B-X
of	B-X
COVID-19	B-X
may	B-X
therefore	B-X
weigh	B-X
on	B-X
mortality	B-X
from	B-X
measles	B-X
and	B-X
polio	B-X
in	B-X
developing	B-X
countries	B-X
.	B-X
However	B-X
,	B-X
acceptance	B-X
of	B-X
this	B-X
vaccine	B-X
has	B-X
not	B-X
yet	B-X
been	B-X
won	B-X
,	B-X
as	B-X
beyond	B-X
the	B-X
many	B-X
unknowns	B-X
that	B-X
will	B-X
inevitably	B-X
weigh	B-X
around	B-X
such	B-X
rapid	B-X
development	B-X
,	B-X
skepticism	B-X
among	B-X
vaccine	B-X
hesitants	B-X
is	B-X
growing	B-X
.	B-X

Cloning	O
,	O
expression	O
,	O
purification	O
,	O
and	O
characterization	O
of	O
the	O
human	O
broad	O
specificity	O
lysosomal	O
acid	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mannosidase	I-Gene_or_gene_product
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
and	B-X
expressed	B-X
two	B-X
cDNAs	B-X
encoding	B-X
the	B-X
human	B-X
lysosomal	B-X
alpha-mannosidase	B-X
(	B-X
EC	B-X
3.2.1.24	B-X
)	B-X
by	B-X
RT-PCR	B-X
of	B-X
human	B-X
spleen	B-X
mRNA	B-X
.	B-X
The	B-X
shorter	B-X
of	B-X
the	B-X
two	B-X
cDNAs	B-X
(	B-X
3	B-X
kilobases	B-X
(	B-X
kb	B-X
)	B-X
)	B-X
was	B-X
found	B-X
to	B-X
encode	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
of	B-X
2964	B-X
base	B-X
pairs	B-X
and	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Pichia	B-X
pastoris	B-X
,	B-X
was	B-X
found	B-X
to	B-X
encode	B-X
an	B-X
enzyme	B-X
that	B-X
could	B-X
cleave	B-X
high	B-X
mannose	B-X
oligosaccharides	B-X
,	B-X
oligosaccharides	B-X
isolated	B-X
from	B-X
alpha-mannosidosis	B-X
fibroblasts	B-X
,	B-X
and	B-X
p-nitrophenyl-alpha-D-mannopyranoside	B-X
substrates	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Pichia-expressed	B-X
enzyme	B-X
was	B-X
inhibited	B-X
by	B-X
swainsonine	B-X
,	B-X
and	B-X
had	B-X
a	B-X
pH	B-X
optimum	B-X
,	B-X
Km	B-X
,	B-X
and	B-X
Vmax	B-X
characteristic	B-X
of	B-X
the	B-X
enzyme	B-X
purified	B-X
previously	B-X
from	B-X
human	B-X
liver	B-X
.	B-X
No	B-X
alpha-mannosidase	B-X
activity	B-X
could	B-X
be	B-X
detected	B-X
in	B-X
Pichia	B-X
transformants	B-X
containing	B-X
this	B-X
coding	B-X
region	B-X
,	B-X
indicating	B-X
that	B-X
it	B-X
did	B-X
not	B-X
encode	B-X
a	B-X
functional	B-X
enzyme	B-X
.	B-X
Antiserum	B-X
raised	B-X
to	B-X
the	B-X
recombinant	B-X
product	B-X
of	B-X
the	B-X
3-kb	B-X
alpha-mannosidase	B-X
cDNA	B-X
immunoprecipitated	B-X
lysosomal	B-X
alpha-mannosidase	B-X
activity	B-X
from	B-X
human	B-X
fibroblast	B-X
extracts	B-X
.	B-X
Northern	B-X
blots	B-X
identified	B-X
a	B-X
3-kb	B-X
RNA	B-X
transcript	B-X
in	B-X
all	B-X
human	B-X
tissues	B-X
tested	B-X
,	B-X
including	B-X
alpha-mannosidosis	B-X
fibroblasts	B-X
,	B-X
while	B-X
minor	B-X
transcripts	B-X
of	B-X
3.6	B-X
kb	B-X
were	B-X
also	B-X
present	B-X
in	B-X
several	B-X
adult	B-X
tissues	B-X
.	B-X
Human	B-X
chromosome	B-X
mapping	B-X
of	B-X
the	B-X
mannosidase	B-X
gene	B-X
confirmed	B-X
that	B-X
the	B-X
functional	B-X
gene	B-X
maps	B-X
to	B-X
the	B-X
MANB	B-X
locus	B-X
on	B-X
chromosome	B-X
19	B-X
.	B-X
Sequence	B-X
comparisons	B-X
were	B-X
made	B-X
to	B-X
previously	B-X
published	B-X
human	B-X
cDNA	B-X
sequences	B-X
encoding	B-X
a	B-X
putative	B-X
lysosomal	B-X
alpha-mannosidase	B-X
(	B-X
Nebes	B-X
,	B-X
V.	B-X
L.	B-X
,	B-X
and	B-X
Schmidt	B-X
,	B-X
M.	B-X
C.	B-X
(	B-X
1994	B-X
)	B-X
Biochem	B-X
.	B-X
200	B-X
,	B-X
239-245	B-X
)	B-X
and	B-X
several	B-X
differences	B-X
were	B-X
found	B-X
relative	B-X
to	B-X
the	B-X
functional	B-X
lysosomal	B-X
alpha-mannosidase	B-X
encoded	B-X
by	B-X
the	B-X
3-kb	B-X
spleen	B-X
cDNA	B-X
.	B-X

We	O
have	O
cloned	O
and	O
expressed	O
two	O
cDNAs	O
encoding	O
the	O
human	O
lysosomal	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mannosidase	I-Gene_or_gene_product
(	O
EC	B-Gene_or_gene_product
3	I-Gene_or_gene_product
.	I-Gene_or_gene_product
2	I-Gene_or_gene_product
.	I-Gene_or_gene_product
1	I-Gene_or_gene_product
.	I-Gene_or_gene_product
24	I-Gene_or_gene_product
)	O
by	O
RT	O
-	O
PCR	O
of	O
human	O
spleen	O
mRNA	O
.	O

This	O
enzyme	O
is	O
required	O
for	O
the	O
degradation	O
of	O
N	O
-	O
linked	O
carbohydrates	O
during	O
glycoprotein	O
catabolism	O
in	O
eucaryotic	O
cells	O
.	O

The	O
shorter	O
of	O
the	O
two	O
cDNAs	O
(	O
3	O
kilobases	O
(	O
kb	O
)	O
)	O
was	O
found	O
to	O
encode	O
an	O
open	O
reading	O
frame	O
of	O
2964	O
base	O
pairs	O
and	O
,	O
when	O
expressed	O
in	O
Pichia	O
pastoris	O
,	O
was	O
found	O
to	O
encode	O
an	O
enzyme	O
that	O
could	O
cleave	O
high	O
mannose	O
oligosaccharides	O
,	O
oligosaccharides	O
isolated	O
from	O
alpha	O
-	O
mannosidosis	O
fibroblasts	O
,	O
and	O
p	O
-	O
nitrophenyl	O
-	O
alpha	O
-	O
D	O
-	O
mannopyranoside	O
substrates	O
.	O

In	O
addition	O
,	O
the	O
Pichia	O
-	O
expressed	O
enzyme	O
was	O
inhibited	O
by	O
swainsonine	O
,	O
and	O
had	O
a	O
pH	O
optimum	O
,	O
Km	O
,	O
and	O
Vmax	O
characteristic	O
of	O
the	O
enzyme	O
purified	O
previously	O
from	O
human	O
liver	O
.	O

The	O
second	O
,	O
larger	O
RT	O
-	O
PCR	O
product	O
(	O
3	O
.	O
6	O
kb	O
)	O
was	O
found	O
to	O
contain	O
an	O
insertion	O
and	O
a	O
deletion	O
relative	O
to	O
the	O
3	O
-	O
kb	O
spleen	O
amplimer	O
and	O
encoded	O
a	O
truncated	O
coding	O
region	O
,	O
indicating	O
that	O
it	O
resulted	O
from	O
alternate	O
transcript	O
splicing	O
.	O

No	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mannosidase	I-Gene_or_gene_product
activity	O
could	O
be	O
detected	O
in	O
Pichia	O
transformants	O
containing	O
this	O
coding	O
region	O
,	O
indicating	O
that	O
it	O
did	O
not	O
encode	O
a	O
functional	O
enzyme	O
.	O

Antiserum	O
raised	O
to	O
the	O
recombinant	O
product	O
of	O
the	O
3	O
-	O
kb	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mannosidase	I-Gene_or_gene_product
cDNA	O
immunoprecipitated	O
lysosomal	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mannosidase	I-Gene_or_gene_product
activity	O
from	O
human	O
fibroblast	O
extracts	O
.	O

Northern	O
blots	O
identified	O
a	O
3	O
-	O
kb	O
RNA	O
transcript	O
in	O
all	O
human	O
tissues	O
tested	O
,	O
including	O
alpha	O
-	O
mannosidosis	O
fibroblasts	O
,	O
while	O
minor	O
transcripts	O
of	O
3	O
.	O
6	O
kb	O
were	O
also	O
present	O
in	O
several	O
adult	O
tissues	O
.	O
<EOS>	B-X
We	B-X
have	B-X
cloned	B-X
and	B-X
expressed	B-X
two	B-X
cDNAs	B-X
encoding	B-X
the	B-X
human	B-X
lysosomal	B-X
alpha-mannosidase	B-X
(	B-X
EC	B-X
3.2.1.24	B-X
)	B-X
by	B-X
RT-PCR	B-X
of	B-X
human	B-X
spleen	B-X
mRNA	B-X
.	B-X
The	B-X
shorter	B-X
of	B-X
the	B-X
two	B-X
cDNAs	B-X
(	B-X
3	B-X
kilobases	B-X
(	B-X
kb	B-X
)	B-X
)	B-X
was	B-X
found	B-X
to	B-X
encode	B-X
an	B-X
open	B-X
reading	B-X
frame	B-X
of	B-X
2964	B-X
base	B-X
pairs	B-X
and	B-X
,	B-X
when	B-X
expressed	B-X
in	B-X
Pichia	B-X
pastoris	B-X
,	B-X
was	B-X
found	B-X
to	B-X
encode	B-X
an	B-X
enzyme	B-X
that	B-X
could	B-X
cleave	B-X
high	B-X
mannose	B-X
oligosaccharides	B-X
,	B-X
oligosaccharides	B-X
isolated	B-X
from	B-X
alpha-mannosidosis	B-X
fibroblasts	B-X
,	B-X
and	B-X
p-nitrophenyl-alpha-D-mannopyranoside	B-X
substrates	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
Pichia-expressed	B-X
enzyme	B-X
was	B-X
inhibited	B-X
by	B-X
swainsonine	B-X
,	B-X
and	B-X
had	B-X
a	B-X
pH	B-X
optimum	B-X
,	B-X
Km	B-X
,	B-X
and	B-X
Vmax	B-X
characteristic	B-X
of	B-X
the	B-X
enzyme	B-X
purified	B-X
previously	B-X
from	B-X
human	B-X
liver	B-X
.	B-X
The	B-X
second	B-X
,	B-X
larger	B-X
RT-PCR	B-X
product	B-X
(	B-X
3.6	B-X
kb	B-X
)	B-X
was	B-X
found	B-X
to	B-X
contain	B-X
an	B-X
insertion	B-X
and	B-X
a	B-X
deletion	B-X
relative	B-X
to	B-X
the	B-X
3-kb	B-X
spleen	B-X
amplimer	B-X
and	B-X
encoded	B-X
a	B-X
truncated	B-X
coding	B-X
region	B-X
,	B-X
indicating	B-X
that	B-X
it	B-X
resulted	B-X
from	B-X
alternate	B-X
transcript	B-X
splicing	B-X
.	B-X
No	B-X
alpha-mannosidase	B-X
activity	B-X
could	B-X
be	B-X
detected	B-X
in	B-X
Pichia	B-X
transformants	B-X
containing	B-X
this	B-X
coding	B-X
region	B-X
,	B-X
indicating	B-X
that	B-X
it	B-X
did	B-X
not	B-X
encode	B-X
a	B-X
functional	B-X
enzyme	B-X
.	B-X
Antiserum	B-X
raised	B-X
to	B-X
the	B-X
recombinant	B-X
product	B-X
of	B-X
the	B-X
3-kb	B-X
alpha-mannosidase	B-X
cDNA	B-X
immunoprecipitated	B-X
lysosomal	B-X
alpha-mannosidase	B-X
activity	B-X
from	B-X
human	B-X
fibroblast	B-X
extracts	B-X
.	B-X
Northern	B-X
blots	B-X
identified	B-X
a	B-X
3-kb	B-X
RNA	B-X
transcript	B-X
in	B-X
all	B-X
human	B-X
tissues	B-X
tested	B-X
,	B-X
including	B-X
alpha-mannosidosis	B-X
fibroblasts	B-X
,	B-X
while	B-X
minor	B-X
transcripts	B-X
of	B-X
3.6	B-X
kb	B-X
were	B-X
also	B-X
present	B-X
in	B-X
several	B-X
adult	B-X
tissues	B-X
.	B-X
Sequence	B-X
comparisons	B-X
were	B-X
made	B-X
to	B-X
previously	B-X
published	B-X
human	B-X
cDNA	B-X
sequences	B-X
encoding	B-X
a	B-X
putative	B-X
lysosomal	B-X
alpha-mannosidase	B-X
(	B-X
Nebes	B-X
,	B-X
V.	B-X
L.	B-X
,	B-X
and	B-X
Schmidt	B-X
,	B-X
M.	B-X
C.	B-X
(	B-X
1994	B-X
)	B-X
Biochem	B-X
.	B-X
200	B-X
,	B-X
239-245	B-X
)	B-X
and	B-X
several	B-X
differences	B-X
were	B-X
found	B-X
relative	B-X
to	B-X
the	B-X
functional	B-X
lysosomal	B-X
alpha-mannosidase	B-X
encoded	B-X
by	B-X
the	B-X
3-kb	B-X
spleen	B-X
cDNA	B-X
.	B-X

Human	O
chromosome	O
mapping	O
of	O
the	O
mannosidase	B-Gene_or_gene_product
gene	O
confirmed	O
that	O
the	O
functional	O
gene	O
maps	O
to	O
the	O
MANB	O
locus	O
on	O
chromosome	O
19	O
.	O

Sequence	O
comparisons	O
were	O
made	O
to	O
previously	O
published	O
human	O
cDNA	O
sequences	O
encoding	O
a	O
putative	O
lysosomal	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mannosidase	I-Gene_or_gene_product
(	O
Nebes	O
,	O
V	O
.	O
L	O
.	O
,	O
and	O
Schmidt	O
,	O
M	O
.	O
C	O
.	O
(	O
1994	O
)	O
Biochem	O
.	O
Biophys	O
.	O
Res	O
.	O
Commun	O
.	O
200	O
,	O
239	O
-	O
245	O
)	O
and	O
several	O
differences	O
were	O
found	O
relative	O
to	O
the	O
functional	O
lysosomal	O
alpha	B-Gene_or_gene_product
-	I-Gene_or_gene_product
mannosidase	I-Gene_or_gene_product
encoded	O
by	O
the	O
3	O
-	O
kb	O
spleen	O
cDNA	O
.	O

Mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
activate	O
the	O
serine	O
/	O
threonine	O
kinases	O
Mnk1	B-Gene_or_gene_product
and	O
Mnk2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinases	B-X
bind	B-X
tightly	B-X
to	B-X
many	B-X
of	B-X
their	B-X
physiologically	B-X
relevant	B-X
substrates	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
new	B-X
subfamily	B-X
of	B-X
murine	B-X
serine/threonine	B-X
kinases	B-X
,	B-X
whose	B-X
members	B-X
,	B-X
MAP	B-X
kinase-interacting	B-X
kinase	B-X
1	B-X
(	B-X
Mnk1	B-X
)	B-X
and	B-X
Mnk2	B-X
,	B-X
bind	B-X
tightly	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
MAP	B-X
kinases	B-X
,	B-X
Erk1	B-X
and	B-X
Erk2	B-X
.	B-X
MNK1	B-X
,	B-X
but	B-X
not	B-X
Mnk2	B-X
,	B-X
also	B-X
binds	B-X
strongly	B-X
to	B-X
the	B-X
stress-activated	B-X
kinase	B-X
,	B-X
p38	B-X
.	B-X
Erk	B-X
and	B-X
p38	B-X
phosphorylate	B-X
MNK1	B-X
and	B-X
Mnk2	B-X
,	B-X
which	B-X
stimulates	B-X
their	B-X
in	B-X
vitro	B-X
kinase	B-X
activity	B-X
toward	B-X
a	B-X
substrate	B-X
,	B-X
eukaryotic	B-X
initiation	B-X
factor-4E	B-X
(	B-X
eIF-4E	B-X
)	B-X
.	B-X
Initiation	B-X
factor	B-X
eIF-4E	B-X
is	B-X
a	B-X
regulatory	B-X
phosphoprotein	B-X
whose	B-X
phosphorylation	B-X
is	B-X
increased	B-X
by	B-X
insulin	B-X
in	B-X
an	B-X
Erk-dependent	B-X
manner	B-X
.	B-X
In	B-X
cells	B-X
,	B-X
Mnk1	B-X
is	B-X
post-translationally	B-X
modified	B-X
and	B-X
enzymatically	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
treatment	B-X
with	B-X
either	B-X
peptide	B-X
growth	B-X
factors	B-X
,	B-X
phorbol	B-X
esters	B-X
,	B-X
anisomycin	B-X
or	B-X
UV	B-X
.	B-X
Mitogen-	B-X
and	B-X
stress-mediated	B-X
MNK1	B-X
activation	B-X
is	B-X
blocked	B-X
by	B-X
inhibitors	B-X
of	B-X
MAP	B-X
kinase	B-X
kinase	B-X
1	B-X
(	B-X
Mkk1	B-X
)	B-X
and	B-X
p38	B-X
,	B-X
demonstrating	B-X
that	B-X
Mnk1	B-X
is	B-X
downstream	B-X
of	B-X
multiple	B-X
MAP	B-X
kinases	B-X
.	B-X
MNK1	B-X
may	B-X
define	B-X
a	B-X
convergence	B-X
point	B-X
between	B-X
the	B-X
growth	B-X
factor-activated	B-X
and	B-X
one	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
cascades	B-X
and	B-X
is	B-X
a	B-X
candidate	B-X
to	B-X
phosphorylate	B-X
eIF-4E	B-X
in	B-X
cells	B-X
.	B-X

Mitogen	B-Gene_or_gene_product
-	I-Gene_or_gene_product
activated	I-Gene_or_gene_product
protein	I-Gene_or_gene_product
(	I-Gene_or_gene_product
MAP	I-Gene_or_gene_product
)	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
bind	O
tightly	O
to	O
many	O
of	O
their	O
physiologically	O
relevant	O
substrates	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinases	B-X
bind	B-X
tightly	B-X
to	B-X
many	B-X
of	B-X
their	B-X
physiologically	B-X
relevant	B-X
substrates	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
new	B-X
subfamily	B-X
of	B-X
murine	B-X
serine/threonine	B-X
kinases	B-X
,	B-X
whose	B-X
members	B-X
,	B-X
MAP	B-X
kinase-interacting	B-X
kinase	B-X
1	B-X
(	B-X
Mnk1	B-X
)	B-X
and	B-X
Mnk2	B-X
,	B-X
bind	B-X
tightly	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
MAP	B-X
kinases	B-X
,	B-X
Erk1	B-X
and	B-X
Erk2	B-X
.	B-X
MNK1	B-X
,	B-X
but	B-X
not	B-X
Mnk2	B-X
,	B-X
also	B-X
binds	B-X
strongly	B-X
to	B-X
the	B-X
stress-activated	B-X
kinase	B-X
,	B-X
p38	B-X
.	B-X
Initiation	B-X
factor	B-X
eIF-4E	B-X
is	B-X
a	B-X
regulatory	B-X
phosphoprotein	B-X
whose	B-X
phosphorylation	B-X
is	B-X
increased	B-X
by	B-X
insulin	B-X
in	B-X
an	B-X
Erk-dependent	B-X
manner	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MNK1	B-X
rapidly	B-X
phosphorylates	B-X
eIF-4E	B-X
at	B-X
the	B-X
physiologically	B-X
relevant	B-X
site	B-X
,	B-X
Ser209	B-X
.	B-X
In	B-X
cells	B-X
,	B-X
Mnk1	B-X
is	B-X
post-translationally	B-X
modified	B-X
and	B-X
enzymatically	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
treatment	B-X
with	B-X
either	B-X
peptide	B-X
growth	B-X
factors	B-X
,	B-X
phorbol	B-X
esters	B-X
,	B-X
anisomycin	B-X
or	B-X
UV	B-X
.	B-X
Mitogen-	B-X
and	B-X
stress-mediated	B-X
MNK1	B-X
activation	B-X
is	B-X
blocked	B-X
by	B-X
inhibitors	B-X
of	B-X
MAP	B-X
kinase	B-X
kinase	B-X
1	B-X
(	B-X
Mkk1	B-X
)	B-X
and	B-X
p38	B-X
,	B-X
demonstrating	B-X
that	B-X
Mnk1	B-X
is	B-X
downstream	B-X
of	B-X
multiple	B-X
MAP	B-X
kinases	B-X
.	B-X
MNK1	B-X
may	B-X
define	B-X
a	B-X
convergence	B-X
point	B-X
between	B-X
the	B-X
growth	B-X
factor-activated	B-X
and	B-X
one	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
cascades	B-X
and	B-X
is	B-X
a	B-X
candidate	B-X
to	B-X
phosphorylate	B-X
eIF-4E	B-X
in	B-X
cells	B-X
.	B-X

We	O
have	O
identified	O
a	O
new	O
subfamily	O
of	O
murine	O
serine	O
/	O
threonine	O
kinases	O
,	O
whose	O
members	O
,	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
-	I-Gene_or_gene_product
interacting	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
Mnk1	B-Gene_or_gene_product
)	O
and	O
Mnk2	B-Gene_or_gene_product
,	O
bind	O
tightly	O
to	O
the	O
growth	O
factor	O
-	O
regulated	O
MAP	B-Gene_or_gene_product
kinases	I-Gene_or_gene_product
,	O
Erk1	B-Gene_or_gene_product
and	O
Erk2	B-Gene_or_gene_product
.	O

MNK1	B-Gene_or_gene_product
,	O
but	O
not	O
Mnk2	B-Gene_or_gene_product
,	O
also	O
binds	O
strongly	O
to	O
the	O
stress	O
-	O
activated	O
kinase	O
,	O
p38	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
MAPK-interacting	B-X
kinase	B-X
(	B-X
Mnk	B-X
)	B-X
family	B-X
includes	B-X
Mnk1	B-X
and	B-X
Mnk2	B-X
,	B-X
which	B-X
are	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
extracellular	B-X
stimuli	B-X
.	B-X
We	B-X
demonstrate	B-X
that	B-X
Mnk1	B-X
,	B-X
but	B-X
not	B-X
Mnk2	B-X
,	B-X
is	B-X
expressed	B-X
and	B-X
active	B-X
in	B-X
human	B-X
and	B-X
murine	B-X
megakaryocytes	B-X
and	B-X
platelets	B-X
.	B-X
Stimulating	B-X
human	B-X
and	B-X
murine	B-X
megakaryocytes	B-X
and	B-X
platelets	B-X
induced	B-X
Mnk1	B-X
activation	B-X
and	B-X
phosphorylation	B-X
of	B-X
eIF4E	B-X
,	B-X
a	B-X
downstream	B-X
target	B-X
of	B-X
activated	B-X
Mnk1	B-X
that	B-X
triggers	B-X
mRNA	B-X
translation	B-X
.	B-X
Depletion	B-X
of	B-X
Mnk1	B-X
also	B-X
reduced	B-X
megakaryocyte	B-X
ploidy	B-X
and	B-X
proplatelet	B-X
forming	B-X
megakaryocytes	B-X
in	B-X
vitro	B-X
and	B-X
resulted	B-X
in	B-X
thrombocytopenia	B-X
.	B-X

MNK1	B-Gene_or_gene_product
complexes	O
more	O
strongly	O
with	O
inactive	O
than	O
active	O
Erk	B-Gene_or_gene_product
,	O
implying	O
that	O
Mnk	B-Gene_or_gene_product
and	O
Erk	B-Gene_or_gene_product
may	O
dissociate	O
after	O
mitogen	O
stimulation	O
.	O
<EOS>	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
new	B-X
subfamily	B-X
of	B-X
murine	B-X
serine/threonine	B-X
kinases	B-X
,	B-X
whose	B-X
members	B-X
,	B-X
MAP	B-X
kinase-interacting	B-X
kinase	B-X
1	B-X
(	B-X
Mnk1	B-X
)	B-X
and	B-X
Mnk2	B-X
,	B-X
bind	B-X
tightly	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
MAP	B-X
kinases	B-X
,	B-X
Erk1	B-X
and	B-X
Erk2	B-X
.	B-X
MNK1	B-X
,	B-X
but	B-X
not	B-X
Mnk2	B-X
,	B-X
also	B-X
binds	B-X
strongly	B-X
to	B-X
the	B-X
stress-activated	B-X
kinase	B-X
,	B-X
p38	B-X
.	B-X
MNK1	B-X
complexes	B-X
more	B-X
strongly	B-X
with	B-X
inactive	B-X
than	B-X
active	B-X
Erk	B-X
,	B-X
implying	B-X
that	B-X
Mnk	B-X
and	B-X
Erk	B-X
may	B-X
dissociate	B-X
after	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Erk	B-X
and	B-X
p38	B-X
phosphorylate	B-X
MNK1	B-X
and	B-X
Mnk2	B-X
,	B-X
which	B-X
stimulates	B-X
their	B-X
in	B-X
vitro	B-X
kinase	B-X
activity	B-X
toward	B-X
a	B-X
substrate	B-X
,	B-X
eukaryotic	B-X
initiation	B-X
factor-4E	B-X
(	B-X
eIF-4E	B-X
)	B-X
.	B-X
Initiation	B-X
factor	B-X
eIF-4E	B-X
is	B-X
a	B-X
regulatory	B-X
phosphoprotein	B-X
whose	B-X
phosphorylation	B-X
is	B-X
increased	B-X
by	B-X
insulin	B-X
in	B-X
an	B-X
Erk-dependent	B-X
manner	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MNK1	B-X
rapidly	B-X
phosphorylates	B-X
eIF-4E	B-X
at	B-X
the	B-X
physiologically	B-X
relevant	B-X
site	B-X
,	B-X
Ser209	B-X
.	B-X
In	B-X
cells	B-X
,	B-X
Mnk1	B-X
is	B-X
post-translationally	B-X
modified	B-X
and	B-X
enzymatically	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
treatment	B-X
with	B-X
either	B-X
peptide	B-X
growth	B-X
factors	B-X
,	B-X
phorbol	B-X
esters	B-X
,	B-X
anisomycin	B-X
or	B-X
UV	B-X
.	B-X
Mitogen-	B-X
and	B-X
stress-mediated	B-X
MNK1	B-X
activation	B-X
is	B-X
blocked	B-X
by	B-X
inhibitors	B-X
of	B-X
MAP	B-X
kinase	B-X
kinase	B-X
1	B-X
(	B-X
Mkk1	B-X
)	B-X
and	B-X
p38	B-X
,	B-X
demonstrating	B-X
that	B-X
Mnk1	B-X
is	B-X
downstream	B-X
of	B-X
multiple	B-X
MAP	B-X
kinases	B-X
.	B-X
MNK1	B-X
may	B-X
define	B-X
a	B-X
convergence	B-X
point	B-X
between	B-X
the	B-X
growth	B-X
factor-activated	B-X
and	B-X
one	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
cascades	B-X
and	B-X
is	B-X
a	B-X
candidate	B-X
to	B-X
phosphorylate	B-X
eIF-4E	B-X
in	B-X
cells	B-X
.	B-X

Erk	B-Gene_or_gene_product
and	O
p38	B-Gene_or_gene_product
phosphorylate	O
MNK1	B-Gene_or_gene_product
and	O
Mnk2	B-Gene_or_gene_product
,	O
which	O
stimulates	O
their	O
in	O
vitro	O
kinase	O
activity	O
toward	O
a	O
substrate	O
,	O
eukaryotic	B-Gene_or_gene_product
initiation	I-Gene_or_gene_product
factor	I-Gene_or_gene_product
-	I-Gene_or_gene_product
4E	I-Gene_or_gene_product
(	O
eIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4E	I-Gene_or_gene_product
)	O
.	O

Initiation	O
factor	O
eIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4E	I-Gene_or_gene_product
is	O
a	O
regulatory	O
phosphoprotein	O
whose	O
phosphorylation	O
is	O
increased	O
by	O
insulin	B-Gene_or_gene_product
in	O
an	O
Erk	B-Gene_or_gene_product
-	O
dependent	O
manner	O
.	O

In	O
vitro	O
,	O
MNK1	B-Gene_or_gene_product
rapidly	O
phosphorylates	O
eIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4E	I-Gene_or_gene_product
at	O
the	O
physiologically	O
relevant	O
site	O
,	O
Ser209	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinases	B-X
bind	B-X
tightly	B-X
to	B-X
many	B-X
of	B-X
their	B-X
physiologically	B-X
relevant	B-X
substrates	B-X
.	B-X
MNK1	B-X
,	B-X
but	B-X
not	B-X
Mnk2	B-X
,	B-X
also	B-X
binds	B-X
strongly	B-X
to	B-X
the	B-X
stress-activated	B-X
kinase	B-X
,	B-X
p38	B-X
.	B-X
MNK1	B-X
complexes	B-X
more	B-X
strongly	B-X
with	B-X
inactive	B-X
than	B-X
active	B-X
Erk	B-X
,	B-X
implying	B-X
that	B-X
Mnk	B-X
and	B-X
Erk	B-X
may	B-X
dissociate	B-X
after	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Erk	B-X
and	B-X
p38	B-X
phosphorylate	B-X
MNK1	B-X
and	B-X
Mnk2	B-X
,	B-X
which	B-X
stimulates	B-X
their	B-X
in	B-X
vitro	B-X
kinase	B-X
activity	B-X
toward	B-X
a	B-X
substrate	B-X
,	B-X
eukaryotic	B-X
initiation	B-X
factor-4E	B-X
(	B-X
eIF-4E	B-X
)	B-X
.	B-X
Initiation	B-X
factor	B-X
eIF-4E	B-X
is	B-X
a	B-X
regulatory	B-X
phosphoprotein	B-X
whose	B-X
phosphorylation	B-X
is	B-X
increased	B-X
by	B-X
insulin	B-X
in	B-X
an	B-X
Erk-dependent	B-X
manner	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MNK1	B-X
rapidly	B-X
phosphorylates	B-X
eIF-4E	B-X
at	B-X
the	B-X
physiologically	B-X
relevant	B-X
site	B-X
,	B-X
Ser209	B-X
.	B-X
Mitogen-	B-X
and	B-X
stress-mediated	B-X
MNK1	B-X
activation	B-X
is	B-X
blocked	B-X
by	B-X
inhibitors	B-X
of	B-X
MAP	B-X
kinase	B-X
kinase	B-X
1	B-X
(	B-X
Mkk1	B-X
)	B-X
and	B-X
p38	B-X
,	B-X
demonstrating	B-X
that	B-X
Mnk1	B-X
is	B-X
downstream	B-X
of	B-X
multiple	B-X
MAP	B-X
kinases	B-X
.	B-X
MNK1	B-X
may	B-X
define	B-X
a	B-X
convergence	B-X
point	B-X
between	B-X
the	B-X
growth	B-X
factor-activated	B-X
and	B-X
one	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
cascades	B-X
and	B-X
is	B-X
a	B-X
candidate	B-X
to	B-X
phosphorylate	B-X
eIF-4E	B-X
in	B-X
cells	B-X
.	B-X

In	O
cells	O
,	O
Mnk1	B-Gene_or_gene_product
is	O
post	O
-	O
translationally	O
modified	O
and	O
enzymatically	O
activated	O
in	O
response	O
to	O
treatment	O
with	O
either	O
peptide	O
growth	O
factors	O
,	O
phorbol	O
esters	O
,	O
anisomycin	O
or	O
UV	O
.	O
<EOS>	B-X
Ultraviolet	B-X
(	B-X
UV	B-X
)	B-X
radiation	B-X
has	B-X
contributed	B-X
to	B-X
the	B-X
evolution	B-X
of	B-X
organisms	B-X
since	B-X
the	B-X
origins	B-X
of	B-X
life	B-X
.	B-X
Bryophytes	B-X
also	B-X
have	B-X
evolutionary	B-X
importance	B-X
as	B-X
the	B-X
first	B-X
clearly	B-X
identified	B-X
lineage	B-X
of	B-X
land	B-X
plants	B-X
(	B-X
embryophytes	B-X
)	B-X
colonizing	B-X
the	B-X
terrestrial	B-X
environment	B-X
,	B-X
thus	B-X
facing	B-X
high	B-X
UV	B-X
and	B-X
water	B-X
scarcity	B-X
,	B-X
among	B-X
other	B-X
new	B-X
challenges	B-X
.	B-X
Here	B-X
we	B-X
review	B-X
bryophyte	B-X
UV-omics	B-X
,	B-X
the	B-X
discipline	B-X
relating	B-X
bryophytes	B-X
and	B-X
UV	B-X
,	B-X
with	B-X
an	B-X
integrative	B-X
perspective	B-X
from	B-X
genes	B-X
to	B-X
the	B-X
environment	B-X
.	B-X
We	B-X
consider	B-X
species	B-X
and	B-X
habitats	B-X
investigated	B-X
,	B-X
methodology	B-X
,	B-X
response	B-X
variables	B-X
,	B-X
protection	B-X
mechanisms	B-X
,	B-X
environmental	B-X
interactions	B-X
,	B-X
UV	B-X
biomonitoring	B-X
,	B-X
molecular	B-X
and	B-X
evolutionary	B-X
aspects	B-X
,	B-X
and	B-X
applications	B-X
.	B-X
Bryophyte	B-X
UV-omics	B-X
shows	B-X
convergences	B-X
and	B-X
divergences	B-X
with	B-X
the	B-X
UV-omics	B-X
of	B-X
other	B-X
photosynthetic	B-X
organisms	B-X
,	B-X
from	B-X
algae	B-X
to	B-X
tracheophytes	B-X
.	B-X
All	B-X
these	B-X
organisms	B-X
converge	B-X
in	B-X
that	B-X
UV	B-X
damage	B-X
may	B-X
be	B-X
limited	B-X
under	B-X
realistic	B-X
UV	B-X
levels	B-X
,	B-X
due	B-X
to	B-X
structural	B-X
protection	B-X
and/or	B-X
physiological	B-X
acclimation	B-X
capacity	B-X
.	B-X
Nevertheless	B-X
,	B-X
bryophytes	B-X
diverge	B-X
because	B-X
they	B-X
have	B-X
a	B-X
unique	B-X
combination	B-X
of	B-X
vegetative	B-X
and	B-X
reproductive	B-X
characteristics	B-X
to	B-X
cope	B-X
with	B-X
high	B-X
UV	B-X
and	B-X
other	B-X
concomitant	B-X
adverse	B-X
processes	B-X
,	B-X
such	B-X
as	B-X
desiccation	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
UV	B-X
effects	B-X
on	B-X
bryophytes	B-X
depend	B-X
on	B-X
the	B-X
species	B-X
and	B-X
the	B-X
evolutionary	B-X
lineage	B-X
considered	B-X
,	B-X
with	B-X
mosses	B-X
more	B-X
UV-tolerant	B-X
than	B-X
liverworts	B-X
.	B-X
Thus	B-X
,	B-X
bryophytes	B-X
do	B-X
not	B-X
constitute	B-X
a	B-X
homogeneous	B-X
functional	B-X
type	B-X
with	B-X
respect	B-X
to	B-X
their	B-X
UV	B-X
tolerance	B-X
.	B-X

Mitogen	O
-	O
and	O
stress	O
-	O
mediated	O
MNK1	B-Gene_or_gene_product
activation	O
is	O
blocked	O
by	O
inhibitors	O
of	O
MAP	B-Gene_or_gene_product
kinase	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
1	I-Gene_or_gene_product
(	O
Mkk1	B-Gene_or_gene_product
)	O
and	O
p38	B-Gene_or_gene_product
,	O
demonstrating	O
that	O
Mnk1	B-Gene_or_gene_product
is	O
downstream	O
of	O
multiple	O
MAP	B-Gene_or_gene_product
kinases	I-Gene_or_gene_product
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinases	B-X
bind	B-X
tightly	B-X
to	B-X
many	B-X
of	B-X
their	B-X
physiologically	B-X
relevant	B-X
substrates	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
new	B-X
subfamily	B-X
of	B-X
murine	B-X
serine/threonine	B-X
kinases	B-X
,	B-X
whose	B-X
members	B-X
,	B-X
MAP	B-X
kinase-interacting	B-X
kinase	B-X
1	B-X
(	B-X
Mnk1	B-X
)	B-X
and	B-X
Mnk2	B-X
,	B-X
bind	B-X
tightly	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
MAP	B-X
kinases	B-X
,	B-X
Erk1	B-X
and	B-X
Erk2	B-X
.	B-X
MNK1	B-X
,	B-X
but	B-X
not	B-X
Mnk2	B-X
,	B-X
also	B-X
binds	B-X
strongly	B-X
to	B-X
the	B-X
stress-activated	B-X
kinase	B-X
,	B-X
p38	B-X
.	B-X
MNK1	B-X
complexes	B-X
more	B-X
strongly	B-X
with	B-X
inactive	B-X
than	B-X
active	B-X
Erk	B-X
,	B-X
implying	B-X
that	B-X
Mnk	B-X
and	B-X
Erk	B-X
may	B-X
dissociate	B-X
after	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Erk	B-X
and	B-X
p38	B-X
phosphorylate	B-X
MNK1	B-X
and	B-X
Mnk2	B-X
,	B-X
which	B-X
stimulates	B-X
their	B-X
in	B-X
vitro	B-X
kinase	B-X
activity	B-X
toward	B-X
a	B-X
substrate	B-X
,	B-X
eukaryotic	B-X
initiation	B-X
factor-4E	B-X
(	B-X
eIF-4E	B-X
)	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MNK1	B-X
rapidly	B-X
phosphorylates	B-X
eIF-4E	B-X
at	B-X
the	B-X
physiologically	B-X
relevant	B-X
site	B-X
,	B-X
Ser209	B-X
.	B-X
In	B-X
cells	B-X
,	B-X
Mnk1	B-X
is	B-X
post-translationally	B-X
modified	B-X
and	B-X
enzymatically	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
treatment	B-X
with	B-X
either	B-X
peptide	B-X
growth	B-X
factors	B-X
,	B-X
phorbol	B-X
esters	B-X
,	B-X
anisomycin	B-X
or	B-X
UV	B-X
.	B-X
Mitogen-	B-X
and	B-X
stress-mediated	B-X
MNK1	B-X
activation	B-X
is	B-X
blocked	B-X
by	B-X
inhibitors	B-X
of	B-X
MAP	B-X
kinase	B-X
kinase	B-X
1	B-X
(	B-X
Mkk1	B-X
)	B-X
and	B-X
p38	B-X
,	B-X
demonstrating	B-X
that	B-X
Mnk1	B-X
is	B-X
downstream	B-X
of	B-X
multiple	B-X
MAP	B-X
kinases	B-X
.	B-X
MNK1	B-X
may	B-X
define	B-X
a	B-X
convergence	B-X
point	B-X
between	B-X
the	B-X
growth	B-X
factor-activated	B-X
and	B-X
one	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
cascades	B-X
and	B-X
is	B-X
a	B-X
candidate	B-X
to	B-X
phosphorylate	B-X
eIF-4E	B-X
in	B-X
cells	B-X
.	B-X

MNK1	B-Gene_or_gene_product
may	O
define	O
a	O
convergence	O
point	O
between	O
the	O
growth	O
factor	O
-	O
activated	O
and	O
one	O
of	O
the	O
stress	O
-	O
activated	O
protein	O
kinase	O
cascades	O
and	O
is	O
a	O
candidate	O
to	O
phosphorylate	O
eIF	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4E	I-Gene_or_gene_product
in	O
cells	O
.	O
<EOS>	B-X
Mitogen-activated	B-X
protein	B-X
(	B-X
MAP	B-X
)	B-X
kinases	B-X
bind	B-X
tightly	B-X
to	B-X
many	B-X
of	B-X
their	B-X
physiologically	B-X
relevant	B-X
substrates	B-X
.	B-X
We	B-X
have	B-X
identified	B-X
a	B-X
new	B-X
subfamily	B-X
of	B-X
murine	B-X
serine/threonine	B-X
kinases	B-X
,	B-X
whose	B-X
members	B-X
,	B-X
MAP	B-X
kinase-interacting	B-X
kinase	B-X
1	B-X
(	B-X
Mnk1	B-X
)	B-X
and	B-X
Mnk2	B-X
,	B-X
bind	B-X
tightly	B-X
to	B-X
the	B-X
growth	B-X
factor-regulated	B-X
MAP	B-X
kinases	B-X
,	B-X
Erk1	B-X
and	B-X
Erk2	B-X
.	B-X
MNK1	B-X
,	B-X
but	B-X
not	B-X
Mnk2	B-X
,	B-X
also	B-X
binds	B-X
strongly	B-X
to	B-X
the	B-X
stress-activated	B-X
kinase	B-X
,	B-X
p38	B-X
.	B-X
MNK1	B-X
complexes	B-X
more	B-X
strongly	B-X
with	B-X
inactive	B-X
than	B-X
active	B-X
Erk	B-X
,	B-X
implying	B-X
that	B-X
Mnk	B-X
and	B-X
Erk	B-X
may	B-X
dissociate	B-X
after	B-X
mitogen	B-X
stimulation	B-X
.	B-X
Erk	B-X
and	B-X
p38	B-X
phosphorylate	B-X
MNK1	B-X
and	B-X
Mnk2	B-X
,	B-X
which	B-X
stimulates	B-X
their	B-X
in	B-X
vitro	B-X
kinase	B-X
activity	B-X
toward	B-X
a	B-X
substrate	B-X
,	B-X
eukaryotic	B-X
initiation	B-X
factor-4E	B-X
(	B-X
eIF-4E	B-X
)	B-X
.	B-X
Initiation	B-X
factor	B-X
eIF-4E	B-X
is	B-X
a	B-X
regulatory	B-X
phosphoprotein	B-X
whose	B-X
phosphorylation	B-X
is	B-X
increased	B-X
by	B-X
insulin	B-X
in	B-X
an	B-X
Erk-dependent	B-X
manner	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
MNK1	B-X
rapidly	B-X
phosphorylates	B-X
eIF-4E	B-X
at	B-X
the	B-X
physiologically	B-X
relevant	B-X
site	B-X
,	B-X
Ser209	B-X
.	B-X
In	B-X
cells	B-X
,	B-X
Mnk1	B-X
is	B-X
post-translationally	B-X
modified	B-X
and	B-X
enzymatically	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
treatment	B-X
with	B-X
either	B-X
peptide	B-X
growth	B-X
factors	B-X
,	B-X
phorbol	B-X
esters	B-X
,	B-X
anisomycin	B-X
or	B-X
UV	B-X
.	B-X
Mitogen-	B-X
and	B-X
stress-mediated	B-X
MNK1	B-X
activation	B-X
is	B-X
blocked	B-X
by	B-X
inhibitors	B-X
of	B-X
MAP	B-X
kinase	B-X
kinase	B-X
1	B-X
(	B-X
Mkk1	B-X
)	B-X
and	B-X
p38	B-X
,	B-X
demonstrating	B-X
that	B-X
Mnk1	B-X
is	B-X
downstream	B-X
of	B-X
multiple	B-X
MAP	B-X
kinases	B-X
.	B-X
MNK1	B-X
may	B-X
define	B-X
a	B-X
convergence	B-X
point	B-X
between	B-X
the	B-X
growth	B-X
factor-activated	B-X
and	B-X
one	B-X
of	B-X
the	B-X
stress-activated	B-X
protein	B-X
kinase	B-X
cascades	B-X
and	B-X
is	B-X
a	B-X
candidate	B-X
to	B-X
phosphorylate	B-X
eIF-4E	B-X
in	B-X
cells	B-X
.	B-X

Phosphatidylinositol	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphate	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
isozymes	O
catalyze	O
the	O
synthesis	O
of	O
3	O
-	O
phosphate	O
-	O
containing	O
phosphatidylinositol	O
signaling	O
molecules	O
.	O
<EOS>	B-X
Phosphatidylinositol-4-phosphate	B-X
5-kinases	B-X
(	B-X
PIP5Ks	B-X
)	B-X
utilize	B-X
phosphatidylinositols	B-X
containing	B-X
D-3-position	B-X
phosphates	B-X
as	B-X
substrates	B-X
to	B-X
form	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
type	B-X
I	B-X
PIP5Ks	B-X
phosphorylate	B-X
phosphatidylinositol	B-X
3	B-X
,	B-X
4-bisphosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
,	B-X
while	B-X
type	B-X
II	B-X
kinases	B-X
have	B-X
less	B-X
activity	B-X
toward	B-X
this	B-X
substrate	B-X
.	B-X
Remarkably	B-X
,	B-X
these	B-X
kinases	B-X
can	B-X
convert	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
in	B-X
a	B-X
concerted	B-X
reaction	B-X
.	B-X
Kinase	B-X
activities	B-X
toward	B-X
the	B-X
3-position	B-X
phosphoinositides	B-X
are	B-X
comparable	B-X
with	B-X
those	B-X
seen	B-X
with	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
PIP5Ks	B-X
can	B-X
synthesize	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
and	B-X
two	B-X
3-phosphate-containing	B-X
polyphosphoinositides	B-X
.	B-X
These	B-X
unexpected	B-X
activities	B-X
position	B-X
the	B-X
PIP5Ks	B-X
as	B-X
potential	B-X
participants	B-X
in	B-X
the	B-X
generation	B-X
of	B-X
all	B-X
polyphosphoinositide	B-X
signaling	B-X
molecules	B-X
.	B-X

Phosphatidylinositol	B-Gene_or_gene_product
-	I-Gene_or_gene_product
4	I-Gene_or_gene_product
-	I-Gene_or_gene_product
phosphate	I-Gene_or_gene_product
5	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
(	O
PIP5Ks	B-Gene_or_gene_product
)	O
utilize	O
phosphatidylinositols	O
containing	O
D	O
-	O
3	O
-	O
position	O
phosphates	O
as	O
substrates	O
to	O
form	O
phosphatidylinositol	O
3	O
,	O
4	O
-	O
bisphosphate	O
.	O
<EOS>	B-X
Phosphatidylinositol-4-phosphate	B-X
5-kinases	B-X
(	B-X
PIP5Ks	B-X
)	B-X
utilize	B-X
phosphatidylinositols	B-X
containing	B-X
D-3-position	B-X
phosphates	B-X
as	B-X
substrates	B-X
to	B-X
form	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
type	B-X
I	B-X
PIP5Ks	B-X
phosphorylate	B-X
phosphatidylinositol	B-X
3	B-X
,	B-X
4-bisphosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
,	B-X
while	B-X
type	B-X
II	B-X
kinases	B-X
have	B-X
less	B-X
activity	B-X
toward	B-X
this	B-X
substrate	B-X
.	B-X
Remarkably	B-X
,	B-X
these	B-X
kinases	B-X
can	B-X
convert	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
in	B-X
a	B-X
concerted	B-X
reaction	B-X
.	B-X
Kinase	B-X
activities	B-X
toward	B-X
the	B-X
3-position	B-X
phosphoinositides	B-X
are	B-X
comparable	B-X
with	B-X
those	B-X
seen	B-X
with	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
PIP5Ks	B-X
can	B-X
synthesize	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
and	B-X
two	B-X
3-phosphate-containing	B-X
polyphosphoinositides	B-X
.	B-X
These	B-X
unexpected	B-X
activities	B-X
position	B-X
the	B-X
PIP5Ks	B-X
as	B-X
potential	B-X
participants	B-X
in	B-X
the	B-X
generation	B-X
of	B-X
all	B-X
polyphosphoinositide	B-X
signaling	B-X
molecules	B-X
.	B-X

In	O
addition	O
,	O
type	B-Gene_or_gene_product
I	I-Gene_or_gene_product
PIP5Ks	I-Gene_or_gene_product
phosphorylate	O
phosphatidylinositol	O
3	O
,	O
4	O
-	O
bisphosphate	O
to	O
phosphatidylinositol	O
3	O
,	O
4	O
,	O
5	O
-	O
trisphosphate	O
,	O
while	O
type	B-Gene_or_gene_product
II	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
have	O
less	O
activity	O
toward	O
this	O
substrate	O
.	O
<EOS>	B-X
Phosphatidylinositol-4-phosphate	B-X
5-kinases	B-X
(	B-X
PIP5Ks	B-X
)	B-X
utilize	B-X
phosphatidylinositols	B-X
containing	B-X
D-3-position	B-X
phosphates	B-X
as	B-X
substrates	B-X
to	B-X
form	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
type	B-X
I	B-X
PIP5Ks	B-X
phosphorylate	B-X
phosphatidylinositol	B-X
3	B-X
,	B-X
4-bisphosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
,	B-X
while	B-X
type	B-X
II	B-X
kinases	B-X
have	B-X
less	B-X
activity	B-X
toward	B-X
this	B-X
substrate	B-X
.	B-X
Remarkably	B-X
,	B-X
these	B-X
kinases	B-X
can	B-X
convert	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
in	B-X
a	B-X
concerted	B-X
reaction	B-X
.	B-X
Kinase	B-X
activities	B-X
toward	B-X
the	B-X
3-position	B-X
phosphoinositides	B-X
are	B-X
comparable	B-X
with	B-X
those	B-X
seen	B-X
with	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
PIP5Ks	B-X
can	B-X
synthesize	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
and	B-X
two	B-X
3-phosphate-containing	B-X
polyphosphoinositides	B-X
.	B-X
These	B-X
unexpected	B-X
activities	B-X
position	B-X
the	B-X
PIP5Ks	B-X
as	B-X
potential	B-X
participants	B-X
in	B-X
the	B-X
generation	B-X
of	B-X
all	B-X
polyphosphoinositide	B-X
signaling	B-X
molecules	B-X
.	B-X

Remarkably	O
,	O
these	O
kinases	O
can	O
convert	O
phosphatidylinositol	O
3	O
-	O
phosphate	O
to	O
phosphatidylinositol	O
3	O
,	O
4	O
,	O
5	O
-	O
trisphosphate	O
in	O
a	O
concerted	O
reaction	O
.	O

Kinase	O
activities	O
toward	O
the	O
3	O
-	O
position	O
phosphoinositides	O
are	O
comparable	O
with	O
those	O
seen	O
with	O
phosphatidylinositol	O
4	O
-	O
phosphate	O
as	O
the	O
substrate	O
.	O
<EOS>	B-X
Phosphatidylinositol-4-phosphate	B-X
5-kinases	B-X
(	B-X
PIP5Ks	B-X
)	B-X
utilize	B-X
phosphatidylinositols	B-X
containing	B-X
D-3-position	B-X
phosphates	B-X
as	B-X
substrates	B-X
to	B-X
form	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
type	B-X
I	B-X
PIP5Ks	B-X
phosphorylate	B-X
phosphatidylinositol	B-X
3	B-X
,	B-X
4-bisphosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
,	B-X
while	B-X
type	B-X
II	B-X
kinases	B-X
have	B-X
less	B-X
activity	B-X
toward	B-X
this	B-X
substrate	B-X
.	B-X
Remarkably	B-X
,	B-X
these	B-X
kinases	B-X
can	B-X
convert	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
in	B-X
a	B-X
concerted	B-X
reaction	B-X
.	B-X
Kinase	B-X
activities	B-X
toward	B-X
the	B-X
3-position	B-X
phosphoinositides	B-X
are	B-X
comparable	B-X
with	B-X
those	B-X
seen	B-X
with	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
PIP5Ks	B-X
can	B-X
synthesize	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
and	B-X
two	B-X
3-phosphate-containing	B-X
polyphosphoinositides	B-X
.	B-X
These	B-X
unexpected	B-X
activities	B-X
position	B-X
the	B-X
PIP5Ks	B-X
as	B-X
potential	B-X
participants	B-X
in	B-X
the	B-X
generation	B-X
of	B-X
all	B-X
polyphosphoinositide	B-X
signaling	B-X
molecules	B-X
.	B-X

Therefore	O
,	O
the	O
PIP5Ks	B-Gene_or_gene_product
can	O
synthesize	O
phosphatidylinositol	O
4	O
,	O
5	O
-	O
bisphosphate	O
and	O
two	O
3	O
-	O
phosphate	O
-	O
containing	O
polyphosphoinositides	O
.	O
<EOS>	B-X
Phosphatidylinositol-4-phosphate	B-X
5-kinases	B-X
(	B-X
PIP5Ks	B-X
)	B-X
utilize	B-X
phosphatidylinositols	B-X
containing	B-X
D-3-position	B-X
phosphates	B-X
as	B-X
substrates	B-X
to	B-X
form	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
type	B-X
I	B-X
PIP5Ks	B-X
phosphorylate	B-X
phosphatidylinositol	B-X
3	B-X
,	B-X
4-bisphosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
,	B-X
while	B-X
type	B-X
II	B-X
kinases	B-X
have	B-X
less	B-X
activity	B-X
toward	B-X
this	B-X
substrate	B-X
.	B-X
Remarkably	B-X
,	B-X
these	B-X
kinases	B-X
can	B-X
convert	B-X
phosphatidylinositol	B-X
3-phosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
in	B-X
a	B-X
concerted	B-X
reaction	B-X
.	B-X
Kinase	B-X
activities	B-X
toward	B-X
the	B-X
3-position	B-X
phosphoinositides	B-X
are	B-X
comparable	B-X
with	B-X
those	B-X
seen	B-X
with	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
PIP5Ks	B-X
can	B-X
synthesize	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
and	B-X
two	B-X
3-phosphate-containing	B-X
polyphosphoinositides	B-X
.	B-X
These	B-X
unexpected	B-X
activities	B-X
position	B-X
the	B-X
PIP5Ks	B-X
as	B-X
potential	B-X
participants	B-X
in	B-X
the	B-X
generation	B-X
of	B-X
all	B-X
polyphosphoinositide	B-X
signaling	B-X
molecules	B-X
.	B-X

These	O
unexpected	O
activities	O
position	O
the	O
PIP5Ks	B-Gene_or_gene_product
as	O
potential	O
participants	O
in	O
the	O
generation	O
of	O
all	O
polyphosphoinositide	O
signaling	O
molecules	O
.	O
<EOS>	B-X
Phosphatidylinositol-4-phosphate	B-X
5-kinases	B-X
(	B-X
PIP5Ks	B-X
)	B-X
utilize	B-X
phosphatidylinositols	B-X
containing	B-X
D-3-position	B-X
phosphates	B-X
as	B-X
substrates	B-X
to	B-X
form	B-X
phosphatidylinositol	B-X
3,4-bisphosphate	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
type	B-X
I	B-X
PIP5Ks	B-X
phosphorylate	B-X
phosphatidylinositol	B-X
3	B-X
,	B-X
4-bisphosphate	B-X
to	B-X
phosphatidylinositol	B-X
3,4,5-trisphosphate	B-X
,	B-X
while	B-X
type	B-X
II	B-X
kinases	B-X
have	B-X
less	B-X
activity	B-X
toward	B-X
this	B-X
substrate	B-X
.	B-X
Kinase	B-X
activities	B-X
toward	B-X
the	B-X
3-position	B-X
phosphoinositides	B-X
are	B-X
comparable	B-X
with	B-X
those	B-X
seen	B-X
with	B-X
phosphatidylinositol	B-X
4-phosphate	B-X
as	B-X
the	B-X
substrate	B-X
.	B-X
Therefore	B-X
,	B-X
the	B-X
PIP5Ks	B-X
can	B-X
synthesize	B-X
phosphatidylinositol	B-X
4,5-bisphosphate	B-X
and	B-X
two	B-X
3-phosphate-containing	B-X
polyphosphoinositides	B-X
.	B-X
These	B-X
unexpected	B-X
activities	B-X
position	B-X
the	B-X
PIP5Ks	B-X
as	B-X
potential	B-X
participants	B-X
in	B-X
the	B-X
generation	B-X
of	B-X
all	B-X
polyphosphoinositide	B-X
signaling	B-X
molecules	B-X
.	B-X

A	O
novel	O
p53	B-Gene_or_gene_product
-	O
inducible	O
gene	O
,	O
PAG608	B-Gene_or_gene_product
,	O
encodes	O
a	O
nuclear	O
zinc	O
finger	O
protein	O
whose	O
overexpression	O
promotes	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
biological	B-X
effects	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
elicited	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
sequence-specific	B-X
transactivation	B-X
of	B-X
a	B-X
battery	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
The	B-X
differential	B-X
display	B-X
method	B-X
was	B-X
employed	B-X
towards	B-X
identifying	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
with	B-X
emphasis	B-X
on	B-X
genes	B-X
whose	B-X
induction	B-X
may	B-X
contribute	B-X
to	B-X
p53-mediated	B-X
apoptosis	B-X
.	B-X
We	B-X
report	B-X
here	B-X
the	B-X
cloning	B-X
of	B-X
a	B-X
novel	B-X
p53-inducible	B-X
gene	B-X
,	B-X
designated	B-X
PAG608	B-X
.	B-X
PAG608	B-X
transcripts	B-X
are	B-X
induced	B-X
by	B-X
DNA	B-X
damage	B-X
in	B-X
a	B-X
p53-dependent	B-X
manner	B-X
.	B-X
PAG608	B-X
encodes	B-X
a	B-X
nuclear	B-X
zinc	B-X
finger	B-X
protein	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
localize	B-X
preferentially	B-X
to	B-X
nucleoli	B-X
when	B-X
expressed	B-X
at	B-X
moderate	B-X
levels	B-X
in	B-X
transfected	B-X
cells	B-X
.	B-X
Transient	B-X
overexpression	B-X
of	B-X
PAG608	B-X
in	B-X
human	B-X
tumor-derived	B-X
cells	B-X
leads	B-X
to	B-X
distinctive	B-X
changes	B-X
in	B-X
nuclear	B-X
morphology	B-X
,	B-X
and	B-X
can	B-X
promote	B-X
apoptosis	B-X
.	B-X
Together	B-X
with	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
PAG608	B-X
may	B-X
therefore	B-X
play	B-X
a	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
biological	B-X
activities	B-X
of	B-X
p53	B-X
.	B-X

The	O
biological	O
effects	O
of	O
the	O
p53	B-Gene_or_gene_product
tumor	O
suppressor	O
protein	O
are	O
elicited	O
,	O
at	O
least	O
in	O
part	O
,	O
through	O
sequence	O
-	O
specific	O
transactivation	O
of	O
a	O
battery	O
of	O
target	O
genes	O
.	O
<EOS>	B-X
The	B-X
biological	B-X
effects	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
elicited	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
sequence-specific	B-X
transactivation	B-X
of	B-X
a	B-X
battery	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
The	B-X
differential	B-X
display	B-X
method	B-X
was	B-X
employed	B-X
towards	B-X
identifying	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
with	B-X
emphasis	B-X
on	B-X
genes	B-X
whose	B-X
induction	B-X
may	B-X
contribute	B-X
to	B-X
p53-mediated	B-X
apoptosis	B-X
.	B-X
We	B-X
report	B-X
here	B-X
the	B-X
cloning	B-X
of	B-X
a	B-X
novel	B-X
p53-inducible	B-X
gene	B-X
,	B-X
designated	B-X
PAG608	B-X
.	B-X
PAG608	B-X
transcripts	B-X
are	B-X
induced	B-X
by	B-X
DNA	B-X
damage	B-X
in	B-X
a	B-X
p53-dependent	B-X
manner	B-X
.	B-X
PAG608	B-X
encodes	B-X
a	B-X
nuclear	B-X
zinc	B-X
finger	B-X
protein	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
localize	B-X
preferentially	B-X
to	B-X
nucleoli	B-X
when	B-X
expressed	B-X
at	B-X
moderate	B-X
levels	B-X
in	B-X
transfected	B-X
cells	B-X
.	B-X
Transient	B-X
overexpression	B-X
of	B-X
PAG608	B-X
in	B-X
human	B-X
tumor-derived	B-X
cells	B-X
leads	B-X
to	B-X
distinctive	B-X
changes	B-X
in	B-X
nuclear	B-X
morphology	B-X
,	B-X
and	B-X
can	B-X
promote	B-X
apoptosis	B-X
.	B-X
Together	B-X
with	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
PAG608	B-X
may	B-X
therefore	B-X
play	B-X
a	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
biological	B-X
activities	B-X
of	B-X
p53	B-X
.	B-X

The	O
differential	O
display	O
method	O
was	O
employed	O
towards	O
identifying	O
additional	O
p53	B-Gene_or_gene_product
target	O
genes	O
,	O
with	O
emphasis	O
on	O
genes	O
whose	O
induction	O
may	O
contribute	O
to	O
p53	B-Gene_or_gene_product
-	O
mediated	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
biological	B-X
effects	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
elicited	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
sequence-specific	B-X
transactivation	B-X
of	B-X
a	B-X
battery	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
The	B-X
differential	B-X
display	B-X
method	B-X
was	B-X
employed	B-X
towards	B-X
identifying	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
with	B-X
emphasis	B-X
on	B-X
genes	B-X
whose	B-X
induction	B-X
may	B-X
contribute	B-X
to	B-X
p53-mediated	B-X
apoptosis	B-X
.	B-X
We	B-X
report	B-X
here	B-X
the	B-X
cloning	B-X
of	B-X
a	B-X
novel	B-X
p53-inducible	B-X
gene	B-X
,	B-X
designated	B-X
PAG608	B-X
.	B-X
PAG608	B-X
transcripts	B-X
are	B-X
induced	B-X
by	B-X
DNA	B-X
damage	B-X
in	B-X
a	B-X
p53-dependent	B-X
manner	B-X
.	B-X
Transient	B-X
overexpression	B-X
of	B-X
PAG608	B-X
in	B-X
human	B-X
tumor-derived	B-X
cells	B-X
leads	B-X
to	B-X
distinctive	B-X
changes	B-X
in	B-X
nuclear	B-X
morphology	B-X
,	B-X
and	B-X
can	B-X
promote	B-X
apoptosis	B-X
.	B-X
Together	B-X
with	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
PAG608	B-X
may	B-X
therefore	B-X
play	B-X
a	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
biological	B-X
activities	B-X
of	B-X
p53	B-X
.	B-X

We	O
report	O
here	O
the	O
cloning	O
of	O
a	O
novel	O
p53	B-Gene_or_gene_product
-	O
inducible	O
gene	O
,	O
designated	O
PAG608	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
biological	B-X
effects	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
elicited	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
sequence-specific	B-X
transactivation	B-X
of	B-X
a	B-X
battery	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
The	B-X
differential	B-X
display	B-X
method	B-X
was	B-X
employed	B-X
towards	B-X
identifying	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
with	B-X
emphasis	B-X
on	B-X
genes	B-X
whose	B-X
induction	B-X
may	B-X
contribute	B-X
to	B-X
p53-mediated	B-X
apoptosis	B-X
.	B-X
We	B-X
report	B-X
here	B-X
the	B-X
cloning	B-X
of	B-X
a	B-X
novel	B-X
p53-inducible	B-X
gene	B-X
,	B-X
designated	B-X
PAG608	B-X
.	B-X
PAG608	B-X
transcripts	B-X
are	B-X
induced	B-X
by	B-X
DNA	B-X
damage	B-X
in	B-X
a	B-X
p53-dependent	B-X
manner	B-X
.	B-X
PAG608	B-X
encodes	B-X
a	B-X
nuclear	B-X
zinc	B-X
finger	B-X
protein	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
localize	B-X
preferentially	B-X
to	B-X
nucleoli	B-X
when	B-X
expressed	B-X
at	B-X
moderate	B-X
levels	B-X
in	B-X
transfected	B-X
cells	B-X
.	B-X
Transient	B-X
overexpression	B-X
of	B-X
PAG608	B-X
in	B-X
human	B-X
tumor-derived	B-X
cells	B-X
leads	B-X
to	B-X
distinctive	B-X
changes	B-X
in	B-X
nuclear	B-X
morphology	B-X
,	B-X
and	B-X
can	B-X
promote	B-X
apoptosis	B-X
.	B-X
Together	B-X
with	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
PAG608	B-X
may	B-X
therefore	B-X
play	B-X
a	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
biological	B-X
activities	B-X
of	B-X
p53	B-X
.	B-X

PAG608	B-Gene_or_gene_product
transcripts	O
are	O
induced	O
by	O
DNA	O
damage	O
in	O
a	O
p53	B-Gene_or_gene_product
-	O
dependent	O
manner	O
.	O

PAG608	B-Gene_or_gene_product
encodes	O
a	O
nuclear	O
zinc	O
finger	O
protein	O
,	O
which	O
appears	O
to	O
localize	O
preferentially	O
to	O
nucleoli	O
when	O
expressed	O
at	O
moderate	O
levels	O
in	O
transfected	O
cells	O
.	O
<EOS>	B-X
The	B-X
biological	B-X
effects	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
elicited	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
sequence-specific	B-X
transactivation	B-X
of	B-X
a	B-X
battery	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
We	B-X
report	B-X
here	B-X
the	B-X
cloning	B-X
of	B-X
a	B-X
novel	B-X
p53-inducible	B-X
gene	B-X
,	B-X
designated	B-X
PAG608	B-X
.	B-X
PAG608	B-X
transcripts	B-X
are	B-X
induced	B-X
by	B-X
DNA	B-X
damage	B-X
in	B-X
a	B-X
p53-dependent	B-X
manner	B-X
.	B-X
PAG608	B-X
encodes	B-X
a	B-X
nuclear	B-X
zinc	B-X
finger	B-X
protein	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
localize	B-X
preferentially	B-X
to	B-X
nucleoli	B-X
when	B-X
expressed	B-X
at	B-X
moderate	B-X
levels	B-X
in	B-X
transfected	B-X
cells	B-X
.	B-X
Transient	B-X
overexpression	B-X
of	B-X
PAG608	B-X
in	B-X
human	B-X
tumor-derived	B-X
cells	B-X
leads	B-X
to	B-X
distinctive	B-X
changes	B-X
in	B-X
nuclear	B-X
morphology	B-X
,	B-X
and	B-X
can	B-X
promote	B-X
apoptosis	B-X
.	B-X
Together	B-X
with	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
PAG608	B-X
may	B-X
therefore	B-X
play	B-X
a	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
biological	B-X
activities	B-X
of	B-X
p53	B-X
.	B-X

Transient	O
overexpression	O
of	O
PAG608	B-Gene_or_gene_product
in	O
human	O
tumor	O
-	O
derived	O
cells	O
leads	O
to	O
distinctive	O
changes	O
in	O
nuclear	O
morphology	O
,	O
and	O
can	O
promote	O
apoptosis	O
.	O
<EOS>	B-X
The	B-X
biological	B-X
effects	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
elicited	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
sequence-specific	B-X
transactivation	B-X
of	B-X
a	B-X
battery	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
The	B-X
differential	B-X
display	B-X
method	B-X
was	B-X
employed	B-X
towards	B-X
identifying	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
with	B-X
emphasis	B-X
on	B-X
genes	B-X
whose	B-X
induction	B-X
may	B-X
contribute	B-X
to	B-X
p53-mediated	B-X
apoptosis	B-X
.	B-X
We	B-X
report	B-X
here	B-X
the	B-X
cloning	B-X
of	B-X
a	B-X
novel	B-X
p53-inducible	B-X
gene	B-X
,	B-X
designated	B-X
PAG608	B-X
.	B-X
PAG608	B-X
transcripts	B-X
are	B-X
induced	B-X
by	B-X
DNA	B-X
damage	B-X
in	B-X
a	B-X
p53-dependent	B-X
manner	B-X
.	B-X
PAG608	B-X
encodes	B-X
a	B-X
nuclear	B-X
zinc	B-X
finger	B-X
protein	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
localize	B-X
preferentially	B-X
to	B-X
nucleoli	B-X
when	B-X
expressed	B-X
at	B-X
moderate	B-X
levels	B-X
in	B-X
transfected	B-X
cells	B-X
.	B-X
Transient	B-X
overexpression	B-X
of	B-X
PAG608	B-X
in	B-X
human	B-X
tumor-derived	B-X
cells	B-X
leads	B-X
to	B-X
distinctive	B-X
changes	B-X
in	B-X
nuclear	B-X
morphology	B-X
,	B-X
and	B-X
can	B-X
promote	B-X
apoptosis	B-X
.	B-X
Together	B-X
with	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
PAG608	B-X
may	B-X
therefore	B-X
play	B-X
a	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
biological	B-X
activities	B-X
of	B-X
p53	B-X
.	B-X

Together	O
with	O
additional	O
p53	B-Gene_or_gene_product
target	O
genes	O
,	O
PAG608	B-Gene_or_gene_product
may	O
therefore	O
play	O
a	O
role	O
in	O
mediating	O
the	O
biological	O
activities	O
of	O
p53	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
biological	B-X
effects	B-X
of	B-X
the	B-X
p53	B-X
tumor	B-X
suppressor	B-X
protein	B-X
are	B-X
elicited	B-X
,	B-X
at	B-X
least	B-X
in	B-X
part	B-X
,	B-X
through	B-X
sequence-specific	B-X
transactivation	B-X
of	B-X
a	B-X
battery	B-X
of	B-X
target	B-X
genes	B-X
.	B-X
The	B-X
differential	B-X
display	B-X
method	B-X
was	B-X
employed	B-X
towards	B-X
identifying	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
with	B-X
emphasis	B-X
on	B-X
genes	B-X
whose	B-X
induction	B-X
may	B-X
contribute	B-X
to	B-X
p53-mediated	B-X
apoptosis	B-X
.	B-X
We	B-X
report	B-X
here	B-X
the	B-X
cloning	B-X
of	B-X
a	B-X
novel	B-X
p53-inducible	B-X
gene	B-X
,	B-X
designated	B-X
PAG608	B-X
.	B-X
PAG608	B-X
transcripts	B-X
are	B-X
induced	B-X
by	B-X
DNA	B-X
damage	B-X
in	B-X
a	B-X
p53-dependent	B-X
manner	B-X
.	B-X
PAG608	B-X
encodes	B-X
a	B-X
nuclear	B-X
zinc	B-X
finger	B-X
protein	B-X
,	B-X
which	B-X
appears	B-X
to	B-X
localize	B-X
preferentially	B-X
to	B-X
nucleoli	B-X
when	B-X
expressed	B-X
at	B-X
moderate	B-X
levels	B-X
in	B-X
transfected	B-X
cells	B-X
.	B-X
Transient	B-X
overexpression	B-X
of	B-X
PAG608	B-X
in	B-X
human	B-X
tumor-derived	B-X
cells	B-X
leads	B-X
to	B-X
distinctive	B-X
changes	B-X
in	B-X
nuclear	B-X
morphology	B-X
,	B-X
and	B-X
can	B-X
promote	B-X
apoptosis	B-X
.	B-X
Together	B-X
with	B-X
additional	B-X
p53	B-X
target	B-X
genes	B-X
,	B-X
PAG608	B-X
may	B-X
therefore	B-X
play	B-X
a	B-X
role	B-X
in	B-X
mediating	B-X
the	B-X
biological	B-X
activities	B-X
of	B-X
p53	B-X
.	B-X

Organic	B-Gene_or_gene_product
anion	I-Gene_or_gene_product
transporting	I-Gene_or_gene_product
polypeptide	I-Gene_or_gene_product
mediates	O
organic	O
anion	O
/	O
HCO3	O
-	O
exchange	O
.	O
<EOS>	B-X
Organic	B-X
anion	B-X
transporting	B-X
polypeptide	B-X
(	B-X
oatp	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
membrane	B-X
protein	B-X
cloned	B-X
from	B-X
rat	B-X
liver	B-X
that	B-X
mediates	B-X
Na+-independent	B-X
transport	B-X
of	B-X
organic	B-X
anions	B-X
such	B-X
as	B-X
sulfobromophthalein	B-X
and	B-X
taurocholic	B-X
acid	B-X
.	B-X
Previous	B-X
studies	B-X
in	B-X
rat	B-X
hepatocytes	B-X
suggested	B-X
that	B-X
organic	B-X
anion	B-X
uptake	B-X
is	B-X
associated	B-X
with	B-X
base	B-X
exchange	B-X
.	B-X
To	B-X
better	B-X
characterize	B-X
the	B-X
mechanism	B-X
of	B-X
oatp-mediated	B-X
organic	B-X
anion	B-X
uptake	B-X
,	B-X
we	B-X
examined	B-X
transport	B-X
of	B-X
taurocholate	B-X
in	B-X
a	B-X
HeLa	B-X
cell	B-X
line	B-X
stably	B-X
transfected	B-X
with	B-X
oatp	B-X
under	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
zinc-inducible	B-X
promoter	B-X
(	B-X
Shi	B-X
,	B-X
X.	B-X
,	B-X
Bai	B-X
,	B-X
S.	B-X
,	B-X
Ford	B-X
,	B-X
A.	B-X
C.	B-X
,	B-X
Burk	B-X
,	B-X
R.	B-X
D.	B-X
,	B-X
Jacquemin	B-X
,	B-X
E.	B-X
,	B-X
Hagenbuch	B-X
,	B-X
B.	B-X
,	B-X
Meier	B-X
,	B-X
P.	B-X
J.	B-X
,	B-X
and	B-X
Wolkoff	B-X
,	B-X
A.	B-X
W.	B-X
(	B-X
1995	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
organic	B-X
anion	B-X
transport	B-X
is	B-X
coupled	B-X
to	B-X
HCO3-	B-X
extrusion	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
rates	B-X
of	B-X
taurocholate-dependent	B-X
HCO3-	B-X
efflux	B-X
from	B-X
alkali-loaded	B-X
noninduced	B-X
and	B-X
induced	B-X
cells	B-X
.	B-X
Noninduced	B-X
and	B-X
induced	B-X
cells	B-X
were	B-X
alkalinized	B-X
to	B-X
an	B-X
equivalent	B-X
pHi	B-X
(	B-X
approximately	B-X
7.7	B-X
)	B-X
by	B-X
transient	B-X
exposure	B-X
to	B-X
a	B-X
50	B-X
mM	B-X
HCO3-	B-X
,	B-X
Cl	B-X
--	B-X
free	B-X
solution	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
extracellular	B-X
Cl-	B-X
and	B-X
taurocholate	B-X
,	B-X
isohydric	B-X
reduction	B-X
of	B-X
superfusate	B-X
HCO3-	B-X
concentration	B-X
from	B-X
50	B-X
to	B-X
25	B-X
mM	B-X
resulted	B-X
in	B-X
an	B-X
insignificant	B-X
change	B-X
in	B-X
pHi	B-X
over	B-X
time	B-X
(	B-X
dpHi/dt	B-X
)	B-X
in	B-X
both	B-X
groups	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
oatp-mediated	B-X
taurocholate	B-X
transport	B-X
is	B-X
Na+-independent	B-X
,	B-X
saturable	B-X
,	B-X
and	B-X
accompanied	B-X
by	B-X
HCO3-	B-X
exchange	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
organic	B-X
anion/base	B-X
exchange	B-X
is	B-X
an	B-X
important	B-X
,	B-X
potentially	B-X
regulatable	B-X
component	B-X
of	B-X
oatp	B-X
function	B-X
.	B-X

Organic	B-Gene_or_gene_product
anion	I-Gene_or_gene_product
transporting	I-Gene_or_gene_product
polypeptide	I-Gene_or_gene_product
(	O
oatp	B-Gene_or_gene_product
)	O
is	O
an	O
integral	O
membrane	O
protein	O
cloned	O
from	O
rat	O
liver	O
that	O
mediates	O
Na	O
+	O
-	O
independent	O
transport	O
of	O
organic	O
anions	O
such	O
as	O
sulfobromophthalein	O
and	O
taurocholic	O
acid	O
.	O
<EOS>	B-X
Organic	B-X
anion	B-X
transporting	B-X
polypeptide	B-X
(	B-X
oatp	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
membrane	B-X
protein	B-X
cloned	B-X
from	B-X
rat	B-X
liver	B-X
that	B-X
mediates	B-X
Na+-independent	B-X
transport	B-X
of	B-X
organic	B-X
anions	B-X
such	B-X
as	B-X
sulfobromophthalein	B-X
and	B-X
taurocholic	B-X
acid	B-X
.	B-X
Previous	B-X
studies	B-X
in	B-X
rat	B-X
hepatocytes	B-X
suggested	B-X
that	B-X
organic	B-X
anion	B-X
uptake	B-X
is	B-X
associated	B-X
with	B-X
base	B-X
exchange	B-X
.	B-X
To	B-X
better	B-X
characterize	B-X
the	B-X
mechanism	B-X
of	B-X
oatp-mediated	B-X
organic	B-X
anion	B-X
uptake	B-X
,	B-X
we	B-X
examined	B-X
transport	B-X
of	B-X
taurocholate	B-X
in	B-X
a	B-X
HeLa	B-X
cell	B-X
line	B-X
stably	B-X
transfected	B-X
with	B-X
oatp	B-X
under	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
zinc-inducible	B-X
promoter	B-X
(	B-X
Shi	B-X
,	B-X
X.	B-X
,	B-X
Bai	B-X
,	B-X
S.	B-X
,	B-X
Ford	B-X
,	B-X
A.	B-X
C.	B-X
,	B-X
Burk	B-X
,	B-X
R.	B-X
D.	B-X
,	B-X
Jacquemin	B-X
,	B-X
E.	B-X
,	B-X
Hagenbuch	B-X
,	B-X
B.	B-X
,	B-X
Meier	B-X
,	B-X
P.	B-X
J.	B-X
,	B-X
and	B-X
Wolkoff	B-X
,	B-X
A.	B-X
W.	B-X
(	B-X
1995	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
Whereas	B-X
noninduced	B-X
transfected	B-X
cells	B-X
showed	B-X
virtually	B-X
no	B-X
uptake	B-X
of	B-X
[	B-X
3H	B-X
]	B-X
taurocholate	B-X
,	B-X
taurocholate	B-X
uptake	B-X
by	B-X
induced	B-X
cells	B-X
was	B-X
Na+-independent	B-X
and	B-X
saturable	B-X
(	B-X
Km	B-X
=	B-X
19.4	B-X
+/-	B-X
3.3	B-X
microM	B-X
;	B-X
Vmax	B-X
=	B-X
62.2	B-X
+/-	B-X
1.4	B-X
pmol/min/mg	B-X
protein	B-X
;	B-X
n	B-X
=	B-X
3	B-X
)	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
organic	B-X
anion	B-X
transport	B-X
is	B-X
coupled	B-X
to	B-X
HCO3-	B-X
extrusion	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
rates	B-X
of	B-X
taurocholate-dependent	B-X
HCO3-	B-X
efflux	B-X
from	B-X
alkali-loaded	B-X
noninduced	B-X
and	B-X
induced	B-X
cells	B-X
.	B-X
Monolayers	B-X
grown	B-X
on	B-X
glass	B-X
coverslips	B-X
were	B-X
loaded	B-X
with	B-X
the	B-X
pH-sensitive	B-X
dye	B-X
2	B-X
'	B-X
,	B-X
7'-bis	B-X
(	B-X
carboxyethyl	B-X
)	B-X
-5	B-X
(	B-X
6	B-X
)	B-X
-carboxyfluorescein	B-X
;	B-X
intracellular	B-X
pH	B-X
(	B-X
pHi	B-X
)	B-X
was	B-X
measured	B-X
by	B-X
excitation	B-X
ratio	B-X
fluorometry	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
extracellular	B-X
Cl-	B-X
and	B-X
taurocholate	B-X
,	B-X
isohydric	B-X
reduction	B-X
of	B-X
superfusate	B-X
HCO3-	B-X
concentration	B-X
from	B-X
50	B-X
to	B-X
25	B-X
mM	B-X
resulted	B-X
in	B-X
an	B-X
insignificant	B-X
change	B-X
in	B-X
pHi	B-X
over	B-X
time	B-X
(	B-X
dpHi/dt	B-X
)	B-X
in	B-X
both	B-X
groups	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
oatp-mediated	B-X
taurocholate	B-X
transport	B-X
is	B-X
Na+-independent	B-X
,	B-X
saturable	B-X
,	B-X
and	B-X
accompanied	B-X
by	B-X
HCO3-	B-X
exchange	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
organic	B-X
anion/base	B-X
exchange	B-X
is	B-X
an	B-X
important	B-X
,	B-X
potentially	B-X
regulatable	B-X
component	B-X
of	B-X
oatp	B-X
function	B-X
.	B-X

Previous	O
studies	O
in	O
rat	O
hepatocytes	O
suggested	O
that	O
organic	O
anion	O
uptake	O
is	O
associated	O
with	O
base	O
exchange	O
.	O
<EOS>	B-X
Organic	B-X
anion	B-X
transporting	B-X
polypeptide	B-X
(	B-X
oatp	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
membrane	B-X
protein	B-X
cloned	B-X
from	B-X
rat	B-X
liver	B-X
that	B-X
mediates	B-X
Na+-independent	B-X
transport	B-X
of	B-X
organic	B-X
anions	B-X
such	B-X
as	B-X
sulfobromophthalein	B-X
and	B-X
taurocholic	B-X
acid	B-X
.	B-X
Previous	B-X
studies	B-X
in	B-X
rat	B-X
hepatocytes	B-X
suggested	B-X
that	B-X
organic	B-X
anion	B-X
uptake	B-X
is	B-X
associated	B-X
with	B-X
base	B-X
exchange	B-X
.	B-X
To	B-X
better	B-X
characterize	B-X
the	B-X
mechanism	B-X
of	B-X
oatp-mediated	B-X
organic	B-X
anion	B-X
uptake	B-X
,	B-X
we	B-X
examined	B-X
transport	B-X
of	B-X
taurocholate	B-X
in	B-X
a	B-X
HeLa	B-X
cell	B-X
line	B-X
stably	B-X
transfected	B-X
with	B-X
oatp	B-X
under	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
zinc-inducible	B-X
promoter	B-X
(	B-X
Shi	B-X
,	B-X
X.	B-X
,	B-X
Bai	B-X
,	B-X
S.	B-X
,	B-X
Ford	B-X
,	B-X
A.	B-X
C.	B-X
,	B-X
Burk	B-X
,	B-X
R.	B-X
D.	B-X
,	B-X
Jacquemin	B-X
,	B-X
E.	B-X
,	B-X
Hagenbuch	B-X
,	B-X
B.	B-X
,	B-X
Meier	B-X
,	B-X
P.	B-X
J.	B-X
,	B-X
and	B-X
Wolkoff	B-X
,	B-X
A.	B-X
W.	B-X
(	B-X
1995	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
Whereas	B-X
noninduced	B-X
transfected	B-X
cells	B-X
showed	B-X
virtually	B-X
no	B-X
uptake	B-X
of	B-X
[	B-X
3H	B-X
]	B-X
taurocholate	B-X
,	B-X
taurocholate	B-X
uptake	B-X
by	B-X
induced	B-X
cells	B-X
was	B-X
Na+-independent	B-X
and	B-X
saturable	B-X
(	B-X
Km	B-X
=	B-X
19.4	B-X
+/-	B-X
3.3	B-X
microM	B-X
;	B-X
Vmax	B-X
=	B-X
62.2	B-X
+/-	B-X
1.4	B-X
pmol/min/mg	B-X
protein	B-X
;	B-X
n	B-X
=	B-X
3	B-X
)	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
organic	B-X
anion	B-X
transport	B-X
is	B-X
coupled	B-X
to	B-X
HCO3-	B-X
extrusion	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
rates	B-X
of	B-X
taurocholate-dependent	B-X
HCO3-	B-X
efflux	B-X
from	B-X
alkali-loaded	B-X
noninduced	B-X
and	B-X
induced	B-X
cells	B-X
.	B-X
Monolayers	B-X
grown	B-X
on	B-X
glass	B-X
coverslips	B-X
were	B-X
loaded	B-X
with	B-X
the	B-X
pH-sensitive	B-X
dye	B-X
2	B-X
'	B-X
,	B-X
7'-bis	B-X
(	B-X
carboxyethyl	B-X
)	B-X
-5	B-X
(	B-X
6	B-X
)	B-X
-carboxyfluorescein	B-X
;	B-X
intracellular	B-X
pH	B-X
(	B-X
pHi	B-X
)	B-X
was	B-X
measured	B-X
by	B-X
excitation	B-X
ratio	B-X
fluorometry	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
extracellular	B-X
Cl-	B-X
and	B-X
taurocholate	B-X
,	B-X
isohydric	B-X
reduction	B-X
of	B-X
superfusate	B-X
HCO3-	B-X
concentration	B-X
from	B-X
50	B-X
to	B-X
25	B-X
mM	B-X
resulted	B-X
in	B-X
an	B-X
insignificant	B-X
change	B-X
in	B-X
pHi	B-X
over	B-X
time	B-X
(	B-X
dpHi/dt	B-X
)	B-X
in	B-X
both	B-X
groups	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
oatp-mediated	B-X
taurocholate	B-X
transport	B-X
is	B-X
Na+-independent	B-X
,	B-X
saturable	B-X
,	B-X
and	B-X
accompanied	B-X
by	B-X
HCO3-	B-X
exchange	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
organic	B-X
anion/base	B-X
exchange	B-X
is	B-X
an	B-X
important	B-X
,	B-X
potentially	B-X
regulatable	B-X
component	B-X
of	B-X
oatp	B-X
function	B-X
.	B-X

To	O
better	O
characterize	O
the	O
mechanism	O
of	O
oatp	B-Gene_or_gene_product
-	O
mediated	O
organic	O
anion	O
uptake	O
,	O
we	O
examined	O
transport	O
of	O
taurocholate	O
in	O
a	O
HeLa	O
cell	O
line	O
stably	O
transfected	O
with	O
oatp	B-Gene_or_gene_product
under	O
the	O
regulation	O
of	O
a	O
zinc	O
-	O
inducible	O
promoter	O
(	O
Shi	O
,	O
X	O
.	O
,	O
Bai	O
,	O
S	O
.	O
,	O
Ford	O
,	O
A	O
.	O
C	O
.	O
,	O
Burk	O
,	O
R	O
.	O
D	O
.	O
,	O
Jacquemin	O
,	O
E	O
.	O
,	O
Hagenbuch	O
,	O
B	O
.	O
,	O
Meier	O
,	O
P	O
.	O
J	O
.	O
,	O
and	O
Wolkoff	O
,	O
A	O
.	O
W	O
.	O
(	O
1995	O
)	O
J	O
.	O
Biol	O
.	O
Chem	O
.	O
270	O
,	O
25591	O
-	O
25595	O
)	O
.	O

Whereas	O
noninduced	O
transfected	O
cells	O
showed	O
virtually	O
no	O
uptake	O
of	O
[	O
3H	O
]	O
taurocholate	O
,	O
taurocholate	O
uptake	O
by	O
induced	O
cells	O
was	O
Na	O
+	O
-	O
independent	O
and	O
saturable	O
(	O
Km	O
=	O
19	O
.	O
4	O
+	O
/	O
-	O
3	O
.	O
3	O
microM	O
;	O
Vmax	O
=	O
62	O
.	O
2	O
+	O
/	O
-	O
1	O
.	O
4	O
pmol	O
/	O
min	O
/	O
mg	O
protein	O
;	O
n	O
=	O
3	O
)	O
.	O

To	O
test	O
whether	O
organic	O
anion	O
transport	O
is	O
coupled	O
to	O
HCO3	O
-	O
extrusion	O
,	O
we	O
compared	O
the	O
rates	O
of	O
taurocholate	O
-	O
dependent	O
HCO3	O
-	O
efflux	O
from	O
alkali	O
-	O
loaded	O
noninduced	O
and	O
induced	O
cells	O
.	O
<EOS>	B-X
Organic	B-X
anion	B-X
transporting	B-X
polypeptide	B-X
(	B-X
oatp	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
membrane	B-X
protein	B-X
cloned	B-X
from	B-X
rat	B-X
liver	B-X
that	B-X
mediates	B-X
Na+-independent	B-X
transport	B-X
of	B-X
organic	B-X
anions	B-X
such	B-X
as	B-X
sulfobromophthalein	B-X
and	B-X
taurocholic	B-X
acid	B-X
.	B-X
Previous	B-X
studies	B-X
in	B-X
rat	B-X
hepatocytes	B-X
suggested	B-X
that	B-X
organic	B-X
anion	B-X
uptake	B-X
is	B-X
associated	B-X
with	B-X
base	B-X
exchange	B-X
.	B-X
To	B-X
better	B-X
characterize	B-X
the	B-X
mechanism	B-X
of	B-X
oatp-mediated	B-X
organic	B-X
anion	B-X
uptake	B-X
,	B-X
we	B-X
examined	B-X
transport	B-X
of	B-X
taurocholate	B-X
in	B-X
a	B-X
HeLa	B-X
cell	B-X
line	B-X
stably	B-X
transfected	B-X
with	B-X
oatp	B-X
under	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
zinc-inducible	B-X
promoter	B-X
(	B-X
Shi	B-X
,	B-X
X.	B-X
,	B-X
Bai	B-X
,	B-X
S.	B-X
,	B-X
Ford	B-X
,	B-X
A.	B-X
C.	B-X
,	B-X
Burk	B-X
,	B-X
R.	B-X
D.	B-X
,	B-X
Jacquemin	B-X
,	B-X
E.	B-X
,	B-X
Hagenbuch	B-X
,	B-X
B.	B-X
,	B-X
Meier	B-X
,	B-X
P.	B-X
J.	B-X
,	B-X
and	B-X
Wolkoff	B-X
,	B-X
A.	B-X
W.	B-X
(	B-X
1995	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
Whereas	B-X
noninduced	B-X
transfected	B-X
cells	B-X
showed	B-X
virtually	B-X
no	B-X
uptake	B-X
of	B-X
[	B-X
3H	B-X
]	B-X
taurocholate	B-X
,	B-X
taurocholate	B-X
uptake	B-X
by	B-X
induced	B-X
cells	B-X
was	B-X
Na+-independent	B-X
and	B-X
saturable	B-X
(	B-X
Km	B-X
=	B-X
19.4	B-X
+/-	B-X
3.3	B-X
microM	B-X
;	B-X
Vmax	B-X
=	B-X
62.2	B-X
+/-	B-X
1.4	B-X
pmol/min/mg	B-X
protein	B-X
;	B-X
n	B-X
=	B-X
3	B-X
)	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
organic	B-X
anion	B-X
transport	B-X
is	B-X
coupled	B-X
to	B-X
HCO3-	B-X
extrusion	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
rates	B-X
of	B-X
taurocholate-dependent	B-X
HCO3-	B-X
efflux	B-X
from	B-X
alkali-loaded	B-X
noninduced	B-X
and	B-X
induced	B-X
cells	B-X
.	B-X
Monolayers	B-X
grown	B-X
on	B-X
glass	B-X
coverslips	B-X
were	B-X
loaded	B-X
with	B-X
the	B-X
pH-sensitive	B-X
dye	B-X
2	B-X
'	B-X
,	B-X
7'-bis	B-X
(	B-X
carboxyethyl	B-X
)	B-X
-5	B-X
(	B-X
6	B-X
)	B-X
-carboxyfluorescein	B-X
;	B-X
intracellular	B-X
pH	B-X
(	B-X
pHi	B-X
)	B-X
was	B-X
measured	B-X
by	B-X
excitation	B-X
ratio	B-X
fluorometry	B-X
.	B-X
Noninduced	B-X
and	B-X
induced	B-X
cells	B-X
were	B-X
alkalinized	B-X
to	B-X
an	B-X
equivalent	B-X
pHi	B-X
(	B-X
approximately	B-X
7.7	B-X
)	B-X
by	B-X
transient	B-X
exposure	B-X
to	B-X
a	B-X
50	B-X
mM	B-X
HCO3-	B-X
,	B-X
Cl	B-X
--	B-X
free	B-X
solution	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
extracellular	B-X
Cl-	B-X
and	B-X
taurocholate	B-X
,	B-X
isohydric	B-X
reduction	B-X
of	B-X
superfusate	B-X
HCO3-	B-X
concentration	B-X
from	B-X
50	B-X
to	B-X
25	B-X
mM	B-X
resulted	B-X
in	B-X
an	B-X
insignificant	B-X
change	B-X
in	B-X
pHi	B-X
over	B-X
time	B-X
(	B-X
dpHi/dt	B-X
)	B-X
in	B-X
both	B-X
groups	B-X
.	B-X
Addition	B-X
of	B-X
25	B-X
microM	B-X
taurocholate	B-X
to	B-X
the	B-X
superfusate	B-X
led	B-X
to	B-X
a	B-X
rapid	B-X
fall	B-X
in	B-X
pHi	B-X
in	B-X
induced	B-X
(	B-X
-0.037	B-X
+/-	B-X
0.011	B-X
pH	B-X
units/min	B-X
to	B-X
pHi	B-X
of	B-X
7.41	B-X
+/-	B-X
0.14	B-X
)	B-X
but	B-X
not	B-X
in	B-X
noninduced	B-X
(	B-X
0.003	B-X
+/-	B-X
0.006	B-X
pH	B-X
units/min	B-X
to	B-X
pHi	B-X
of	B-X
7.61	B-X
+/-	B-X
0.08	B-X
)	B-X
cells	B-X
(	B-X
p	B-X
<	B-X
0.03	B-X
)	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
oatp-mediated	B-X
taurocholate	B-X
transport	B-X
is	B-X
Na+-independent	B-X
,	B-X
saturable	B-X
,	B-X
and	B-X
accompanied	B-X
by	B-X
HCO3-	B-X
exchange	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
organic	B-X
anion/base	B-X
exchange	B-X
is	B-X
an	B-X
important	B-X
,	B-X
potentially	B-X
regulatable	B-X
component	B-X
of	B-X
oatp	B-X
function	B-X
.	B-X

Monolayers	O
grown	O
on	O
glass	O
coverslips	O
were	O
loaded	O
with	O
the	O
pH	O
-	O
sensitive	O
dye	O
2	O
'	O
,	O
7	O
'	O
-	O
bis	O
(	O
carboxyethyl	O
)	O
-	O
5	O
(	O
6	O
)	O
-	O
carboxyfluorescein	O
;	O
intracellular	O
pH	O
(	O
pHi	O
)	O
was	O
measured	O
by	O
excitation	O
ratio	O
fluorometry	O
.	O

Noninduced	O
and	O
induced	O
cells	O
were	O
alkalinized	O
to	O
an	O
equivalent	O
pHi	O
(	O
approximately	O
7	O
.	O
7	O
)	O
by	O
transient	O
exposure	O
to	O
a	O
50	O
mM	O
HCO3	O
-	O
,	O
Cl	O
-	O
-	O
free	O
solution	O
.	O

In	O
the	O
absence	O
of	O
extracellular	O
Cl	O
-	O
and	O
taurocholate	O
,	O
isohydric	O
reduction	O
of	O
superfusate	O
HCO3	O
-	O
concentration	O
from	O
50	O
to	O
25	O
mM	O
resulted	O
in	O
an	O
insignificant	O
change	O
in	O
pHi	O
over	O
time	O
(	O
dpHi	O
/	O
dt	O
)	O
in	O
both	O
groups	O
.	O

Addition	O
of	O
25	O
microM	O
taurocholate	O
to	O
the	O
superfusate	O
led	O
to	O
a	O
rapid	O
fall	O
in	O
pHi	O
in	O
induced	O
(	O
-	O
0	O
.	O
037	O
+	O
/	O
-	O
0	O
.	O
011	O
pH	O
units	O
/	O
min	O
to	O
pHi	O
of	O
7	O
.	O
41	O
+	O
/	O
-	O
0	O
.	O
14	O
)	O
but	O
not	O
in	O
noninduced	O
(	O
0	O
.	O
003	O
+	O
/	O
-	O
0	O
.	O
006	O
pH	O
units	O
/	O
min	O
to	O
pHi	O
of	O
7	O
.	O
61	O
+	O
/	O
-	O
0	O
.	O
08	O
)	O
cells	O
(	O
p	O
<	O
0	O
.	O
03	O
)	O
.	O

These	O
data	O
indicate	O
that	O
oatp	B-Gene_or_gene_product
-	O
mediated	O
taurocholate	O
transport	O
is	O
Na	O
+	O
-	O
independent	O
,	O
saturable	O
,	O
and	O
accompanied	O
by	O
HCO3	O
-	O
exchange	O
.	O
<EOS>	B-X
Organic	B-X
anion	B-X
transporting	B-X
polypeptide	B-X
(	B-X
oatp	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
membrane	B-X
protein	B-X
cloned	B-X
from	B-X
rat	B-X
liver	B-X
that	B-X
mediates	B-X
Na+-independent	B-X
transport	B-X
of	B-X
organic	B-X
anions	B-X
such	B-X
as	B-X
sulfobromophthalein	B-X
and	B-X
taurocholic	B-X
acid	B-X
.	B-X
Previous	B-X
studies	B-X
in	B-X
rat	B-X
hepatocytes	B-X
suggested	B-X
that	B-X
organic	B-X
anion	B-X
uptake	B-X
is	B-X
associated	B-X
with	B-X
base	B-X
exchange	B-X
.	B-X
To	B-X
better	B-X
characterize	B-X
the	B-X
mechanism	B-X
of	B-X
oatp-mediated	B-X
organic	B-X
anion	B-X
uptake	B-X
,	B-X
we	B-X
examined	B-X
transport	B-X
of	B-X
taurocholate	B-X
in	B-X
a	B-X
HeLa	B-X
cell	B-X
line	B-X
stably	B-X
transfected	B-X
with	B-X
oatp	B-X
under	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
zinc-inducible	B-X
promoter	B-X
(	B-X
Shi	B-X
,	B-X
X.	B-X
,	B-X
Bai	B-X
,	B-X
S.	B-X
,	B-X
Ford	B-X
,	B-X
A.	B-X
C.	B-X
,	B-X
Burk	B-X
,	B-X
R.	B-X
D.	B-X
,	B-X
Jacquemin	B-X
,	B-X
E.	B-X
,	B-X
Hagenbuch	B-X
,	B-X
B.	B-X
,	B-X
Meier	B-X
,	B-X
P.	B-X
J.	B-X
,	B-X
and	B-X
Wolkoff	B-X
,	B-X
A.	B-X
W.	B-X
(	B-X
1995	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
Whereas	B-X
noninduced	B-X
transfected	B-X
cells	B-X
showed	B-X
virtually	B-X
no	B-X
uptake	B-X
of	B-X
[	B-X
3H	B-X
]	B-X
taurocholate	B-X
,	B-X
taurocholate	B-X
uptake	B-X
by	B-X
induced	B-X
cells	B-X
was	B-X
Na+-independent	B-X
and	B-X
saturable	B-X
(	B-X
Km	B-X
=	B-X
19.4	B-X
+/-	B-X
3.3	B-X
microM	B-X
;	B-X
Vmax	B-X
=	B-X
62.2	B-X
+/-	B-X
1.4	B-X
pmol/min/mg	B-X
protein	B-X
;	B-X
n	B-X
=	B-X
3	B-X
)	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
organic	B-X
anion	B-X
transport	B-X
is	B-X
coupled	B-X
to	B-X
HCO3-	B-X
extrusion	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
rates	B-X
of	B-X
taurocholate-dependent	B-X
HCO3-	B-X
efflux	B-X
from	B-X
alkali-loaded	B-X
noninduced	B-X
and	B-X
induced	B-X
cells	B-X
.	B-X
Noninduced	B-X
and	B-X
induced	B-X
cells	B-X
were	B-X
alkalinized	B-X
to	B-X
an	B-X
equivalent	B-X
pHi	B-X
(	B-X
approximately	B-X
7.7	B-X
)	B-X
by	B-X
transient	B-X
exposure	B-X
to	B-X
a	B-X
50	B-X
mM	B-X
HCO3-	B-X
,	B-X
Cl	B-X
--	B-X
free	B-X
solution	B-X
.	B-X
In	B-X
the	B-X
absence	B-X
of	B-X
extracellular	B-X
Cl-	B-X
and	B-X
taurocholate	B-X
,	B-X
isohydric	B-X
reduction	B-X
of	B-X
superfusate	B-X
HCO3-	B-X
concentration	B-X
from	B-X
50	B-X
to	B-X
25	B-X
mM	B-X
resulted	B-X
in	B-X
an	B-X
insignificant	B-X
change	B-X
in	B-X
pHi	B-X
over	B-X
time	B-X
(	B-X
dpHi/dt	B-X
)	B-X
in	B-X
both	B-X
groups	B-X
.	B-X
Addition	B-X
of	B-X
25	B-X
microM	B-X
taurocholate	B-X
to	B-X
the	B-X
superfusate	B-X
led	B-X
to	B-X
a	B-X
rapid	B-X
fall	B-X
in	B-X
pHi	B-X
in	B-X
induced	B-X
(	B-X
-0.037	B-X
+/-	B-X
0.011	B-X
pH	B-X
units/min	B-X
to	B-X
pHi	B-X
of	B-X
7.41	B-X
+/-	B-X
0.14	B-X
)	B-X
but	B-X
not	B-X
in	B-X
noninduced	B-X
(	B-X
0.003	B-X
+/-	B-X
0.006	B-X
pH	B-X
units/min	B-X
to	B-X
pHi	B-X
of	B-X
7.61	B-X
+/-	B-X
0.08	B-X
)	B-X
cells	B-X
(	B-X
p	B-X
<	B-X
0.03	B-X
)	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
oatp-mediated	B-X
taurocholate	B-X
transport	B-X
is	B-X
Na+-independent	B-X
,	B-X
saturable	B-X
,	B-X
and	B-X
accompanied	B-X
by	B-X
HCO3-	B-X
exchange	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
organic	B-X
anion/base	B-X
exchange	B-X
is	B-X
an	B-X
important	B-X
,	B-X
potentially	B-X
regulatable	B-X
component	B-X
of	B-X
oatp	B-X
function	B-X
.	B-X

We	O
conclude	O
that	O
organic	O
anion	O
/	O
base	O
exchange	O
is	O
an	O
important	O
,	O
potentially	O
regulatable	O
component	O
of	O
oatp	B-Gene_or_gene_product
function	O
.	O
<EOS>	B-X
Organic	B-X
anion	B-X
transporting	B-X
polypeptide	B-X
(	B-X
oatp	B-X
)	B-X
is	B-X
an	B-X
integral	B-X
membrane	B-X
protein	B-X
cloned	B-X
from	B-X
rat	B-X
liver	B-X
that	B-X
mediates	B-X
Na+-independent	B-X
transport	B-X
of	B-X
organic	B-X
anions	B-X
such	B-X
as	B-X
sulfobromophthalein	B-X
and	B-X
taurocholic	B-X
acid	B-X
.	B-X
Previous	B-X
studies	B-X
in	B-X
rat	B-X
hepatocytes	B-X
suggested	B-X
that	B-X
organic	B-X
anion	B-X
uptake	B-X
is	B-X
associated	B-X
with	B-X
base	B-X
exchange	B-X
.	B-X
To	B-X
better	B-X
characterize	B-X
the	B-X
mechanism	B-X
of	B-X
oatp-mediated	B-X
organic	B-X
anion	B-X
uptake	B-X
,	B-X
we	B-X
examined	B-X
transport	B-X
of	B-X
taurocholate	B-X
in	B-X
a	B-X
HeLa	B-X
cell	B-X
line	B-X
stably	B-X
transfected	B-X
with	B-X
oatp	B-X
under	B-X
the	B-X
regulation	B-X
of	B-X
a	B-X
zinc-inducible	B-X
promoter	B-X
(	B-X
Shi	B-X
,	B-X
X.	B-X
,	B-X
Bai	B-X
,	B-X
S.	B-X
,	B-X
Ford	B-X
,	B-X
A.	B-X
C.	B-X
,	B-X
Burk	B-X
,	B-X
R.	B-X
D.	B-X
,	B-X
Jacquemin	B-X
,	B-X
E.	B-X
,	B-X
Hagenbuch	B-X
,	B-X
B.	B-X
,	B-X
Meier	B-X
,	B-X
P.	B-X
J.	B-X
,	B-X
and	B-X
Wolkoff	B-X
,	B-X
A.	B-X
W.	B-X
(	B-X
1995	B-X
)	B-X
J.	B-X
Biol	B-X
.	B-X
To	B-X
test	B-X
whether	B-X
organic	B-X
anion	B-X
transport	B-X
is	B-X
coupled	B-X
to	B-X
HCO3-	B-X
extrusion	B-X
,	B-X
we	B-X
compared	B-X
the	B-X
rates	B-X
of	B-X
taurocholate-dependent	B-X
HCO3-	B-X
efflux	B-X
from	B-X
alkali-loaded	B-X
noninduced	B-X
and	B-X
induced	B-X
cells	B-X
.	B-X
These	B-X
data	B-X
indicate	B-X
that	B-X
oatp-mediated	B-X
taurocholate	B-X
transport	B-X
is	B-X
Na+-independent	B-X
,	B-X
saturable	B-X
,	B-X
and	B-X
accompanied	B-X
by	B-X
HCO3-	B-X
exchange	B-X
.	B-X
We	B-X
conclude	B-X
that	B-X
organic	B-X
anion/base	B-X
exchange	B-X
is	B-X
an	B-X
important	B-X
,	B-X
potentially	B-X
regulatable	B-X
component	B-X
of	B-X
oatp	B-X
function	B-X
.	B-X

Cdc53	B-Gene_or_gene_product
is	O
a	O
scaffold	O
protein	O
for	O
multiple	O
Cdc34	O
/	O
Skp1	O
/	O
F	O
-	O
box	O
proteincomplexes	O
that	O
regulate	O
cell	O
division	O
and	O
methionine	O
biosynthesis	O
in	O
yeast	O
.	O
<EOS>	B-X
In	B-X
budding	B-X
yeast	B-X
,	B-X
ubiquitination	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
Sic1	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
E2	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Cdc34	B-X
in	B-X
conjunction	B-X
with	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
composed	B-X
of	B-X
Skp1	B-X
,	B-X
Cdc53	B-X
and	B-X
the	B-X
F-box	B-X
protein	B-X
,	B-X
Cdc4	B-X
(	B-X
the	B-X
SCFCdc4	B-X
complex	B-X
)	B-X
.	B-X
Skp1	B-X
binds	B-X
a	B-X
motif	B-X
called	B-X
the	B-X
F-box	B-X
and	B-X
in	B-X
turn	B-X
F-box	B-X
proteins	B-X
appear	B-X
to	B-X
recruit	B-X
specific	B-X
substrates	B-X
for	B-X
ubiquitination	B-X
.	B-X
We	B-X
find	B-X
that	B-X
Skp1	B-X
interacts	B-X
with	B-X
Cdc53	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
that	B-X
Skp1	B-X
bridges	B-X
Cdc53	B-X
to	B-X
three	B-X
different	B-X
F-box	B-X
proteins	B-X
,	B-X
Cdc4	B-X
,	B-X
Met30	B-X
,	B-X
and	B-X
Grr1	B-X
.	B-X
Cdc53	B-X
contains	B-X
independent	B-X
binding	B-X
sites	B-X
for	B-X
Cdc34	B-X
and	B-X
Skp1	B-X
suggesting	B-X
it	B-X
functions	B-X
as	B-X
a	B-X
scaffold	B-X
protein	B-X
within	B-X
an	B-X
E2/E3	B-X
core	B-X
complex	B-X
.	B-X
F-box	B-X
proteins	B-X
show	B-X
remarkable	B-X
functional	B-X
specificity	B-X
in	B-X
vivo	B-X
:	B-X
Cdc4	B-X
is	B-X
specific	B-X
for	B-X
degradation	B-X
of	B-X
Sic1	B-X
,	B-X
Grr1	B-X
is	B-X
specific	B-X
for	B-X
degradation	B-X
of	B-X
the	B-X
G1	B-X
cyclin	B-X
Cln2	B-X
,	B-X
and	B-X
Met30	B-X
is	B-X
specific	B-X
for	B-X
repression	B-X
of	B-X
methionine	B-X
biosynthesis	B-X
genes	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
Cdc34-Cdc53-Skp1	B-X
E2/E3	B-X
core	B-X
complex	B-X
is	B-X
required	B-X
for	B-X
all	B-X
three	B-X
functions	B-X
.	B-X
Combinatorial	B-X
control	B-X
of	B-X
SCF	B-X
complexes	B-X
may	B-X
provide	B-X
a	B-X
basis	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
diverse	B-X
cellular	B-X
processes	B-X
.	B-X

In	O
budding	O
yeast	O
,	O
ubiquitination	O
of	O
the	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
(	O
Cdk	B-Gene_or_gene_product
)	O
inhibitor	O
Sic1	B-Gene_or_gene_product
is	O
catalyzed	O
by	O
the	O
E2	O
ubiquitin	B-Gene_or_gene_product
conjugating	O
enzyme	O
Cdc34	B-Gene_or_gene_product
in	O
conjunction	O
with	O
an	O
E3	O
ubiquitin	B-Gene_or_gene_product
ligase	O
complex	O
composed	O
of	O
Skp1	B-Gene_or_gene_product
,	O
Cdc53	B-Gene_or_gene_product
and	O
the	O
F	O
-	O
box	O
protein	O
,	O
Cdc4	B-Gene_or_gene_product
(	O
the	O
SCFCdc4	O
complex	O
)	O
.	O

Skp1	B-Gene_or_gene_product
binds	O
a	O
motif	O
called	O
the	O
F	O
-	O
box	O
and	O
in	O
turn	O
F	O
-	O
box	O
proteins	O
appear	O
to	O
recruit	O
specific	O
substrates	O
for	O
ubiquitination	O
.	O

We	O
find	O
that	O
Skp1	B-Gene_or_gene_product
interacts	O
with	O
Cdc53	B-Gene_or_gene_product
in	O
vivo	O
,	O
and	O
that	O
Skp1	B-Gene_or_gene_product
bridges	O
Cdc53	B-Gene_or_gene_product
to	O
three	O
different	O
F	O
-	O
box	O
proteins	O
,	O
Cdc4	B-Gene_or_gene_product
,	O
Met30	B-Gene_or_gene_product
,	O
and	O
Grr1	B-Gene_or_gene_product
.	O
<EOS>	B-X
In	B-X
budding	B-X
yeast	B-X
,	B-X
ubiquitination	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
Sic1	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
E2	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Cdc34	B-X
in	B-X
conjunction	B-X
with	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
composed	B-X
of	B-X
Skp1	B-X
,	B-X
Cdc53	B-X
and	B-X
the	B-X
F-box	B-X
protein	B-X
,	B-X
Cdc4	B-X
(	B-X
the	B-X
SCFCdc4	B-X
complex	B-X
)	B-X
.	B-X
Skp1	B-X
binds	B-X
a	B-X
motif	B-X
called	B-X
the	B-X
F-box	B-X
and	B-X
in	B-X
turn	B-X
F-box	B-X
proteins	B-X
appear	B-X
to	B-X
recruit	B-X
specific	B-X
substrates	B-X
for	B-X
ubiquitination	B-X
.	B-X
We	B-X
find	B-X
that	B-X
Skp1	B-X
interacts	B-X
with	B-X
Cdc53	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
that	B-X
Skp1	B-X
bridges	B-X
Cdc53	B-X
to	B-X
three	B-X
different	B-X
F-box	B-X
proteins	B-X
,	B-X
Cdc4	B-X
,	B-X
Met30	B-X
,	B-X
and	B-X
Grr1	B-X
.	B-X
Cdc53	B-X
contains	B-X
independent	B-X
binding	B-X
sites	B-X
for	B-X
Cdc34	B-X
and	B-X
Skp1	B-X
suggesting	B-X
it	B-X
functions	B-X
as	B-X
a	B-X
scaffold	B-X
protein	B-X
within	B-X
an	B-X
E2/E3	B-X
core	B-X
complex	B-X
.	B-X
F-box	B-X
proteins	B-X
show	B-X
remarkable	B-X
functional	B-X
specificity	B-X
in	B-X
vivo	B-X
:	B-X
Cdc4	B-X
is	B-X
specific	B-X
for	B-X
degradation	B-X
of	B-X
Sic1	B-X
,	B-X
Grr1	B-X
is	B-X
specific	B-X
for	B-X
degradation	B-X
of	B-X
the	B-X
G1	B-X
cyclin	B-X
Cln2	B-X
,	B-X
and	B-X
Met30	B-X
is	B-X
specific	B-X
for	B-X
repression	B-X
of	B-X
methionine	B-X
biosynthesis	B-X
genes	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
Cdc34-Cdc53-Skp1	B-X
E2/E3	B-X
core	B-X
complex	B-X
is	B-X
required	B-X
for	B-X
all	B-X
three	B-X
functions	B-X
.	B-X
Combinatorial	B-X
control	B-X
of	B-X
SCF	B-X
complexes	B-X
may	B-X
provide	B-X
a	B-X
basis	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
diverse	B-X
cellular	B-X
processes	B-X
.	B-X

Cdc53	B-Gene_or_gene_product
contains	O
independent	O
binding	O
sites	O
for	O
Cdc34	B-Gene_or_gene_product
and	O
Skp1	B-Gene_or_gene_product
suggesting	O
it	O
functions	O
as	O
a	O
scaffold	O
protein	O
within	O
an	O
E2	O
/	O
E3	O
core	O
complex	O
.	O
<EOS>	B-X
In	B-X
budding	B-X
yeast	B-X
,	B-X
ubiquitination	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
Sic1	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
E2	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Cdc34	B-X
in	B-X
conjunction	B-X
with	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
composed	B-X
of	B-X
Skp1	B-X
,	B-X
Cdc53	B-X
and	B-X
the	B-X
F-box	B-X
protein	B-X
,	B-X
Cdc4	B-X
(	B-X
the	B-X
SCFCdc4	B-X
complex	B-X
)	B-X
.	B-X
Skp1	B-X
binds	B-X
a	B-X
motif	B-X
called	B-X
the	B-X
F-box	B-X
and	B-X
in	B-X
turn	B-X
F-box	B-X
proteins	B-X
appear	B-X
to	B-X
recruit	B-X
specific	B-X
substrates	B-X
for	B-X
ubiquitination	B-X
.	B-X
We	B-X
find	B-X
that	B-X
Skp1	B-X
interacts	B-X
with	B-X
Cdc53	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
that	B-X
Skp1	B-X
bridges	B-X
Cdc53	B-X
to	B-X
three	B-X
different	B-X
F-box	B-X
proteins	B-X
,	B-X
Cdc4	B-X
,	B-X
Met30	B-X
,	B-X
and	B-X
Grr1	B-X
.	B-X
Cdc53	B-X
contains	B-X
independent	B-X
binding	B-X
sites	B-X
for	B-X
Cdc34	B-X
and	B-X
Skp1	B-X
suggesting	B-X
it	B-X
functions	B-X
as	B-X
a	B-X
scaffold	B-X
protein	B-X
within	B-X
an	B-X
E2/E3	B-X
core	B-X
complex	B-X
.	B-X
F-box	B-X
proteins	B-X
show	B-X
remarkable	B-X
functional	B-X
specificity	B-X
in	B-X
vivo	B-X
:	B-X
Cdc4	B-X
is	B-X
specific	B-X
for	B-X
degradation	B-X
of	B-X
Sic1	B-X
,	B-X
Grr1	B-X
is	B-X
specific	B-X
for	B-X
degradation	B-X
of	B-X
the	B-X
G1	B-X
cyclin	B-X
Cln2	B-X
,	B-X
and	B-X
Met30	B-X
is	B-X
specific	B-X
for	B-X
repression	B-X
of	B-X
methionine	B-X
biosynthesis	B-X
genes	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
Cdc34-Cdc53-Skp1	B-X
E2/E3	B-X
core	B-X
complex	B-X
is	B-X
required	B-X
for	B-X
all	B-X
three	B-X
functions	B-X
.	B-X
Combinatorial	B-X
control	B-X
of	B-X
SCF	B-X
complexes	B-X
may	B-X
provide	B-X
a	B-X
basis	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
diverse	B-X
cellular	B-X
processes	B-X
.	B-X

F	O
-	O
box	O
proteins	O
show	O
remarkable	O
functional	O
specificity	O
in	O
vivo	O
:	O
Cdc4	B-Gene_or_gene_product
is	O
specific	O
for	O
degradation	O
of	O
Sic1	B-Gene_or_gene_product
,	O
Grr1	B-Gene_or_gene_product
is	O
specific	O
for	O
degradation	O
of	O
the	O
G1	B-Gene_or_gene_product
cyclin	I-Gene_or_gene_product
Cln2	B-Gene_or_gene_product
,	O
and	O
Met30	B-Gene_or_gene_product
is	O
specific	O
for	O
repression	O
of	O
methionine	O
biosynthesis	O
genes	O
.	O
<EOS>	B-X
In	B-X
budding	B-X
yeast	B-X
,	B-X
ubiquitination	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
Sic1	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
E2	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Cdc34	B-X
in	B-X
conjunction	B-X
with	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
composed	B-X
of	B-X
Skp1	B-X
,	B-X
Cdc53	B-X
and	B-X
the	B-X
F-box	B-X
protein	B-X
,	B-X
Cdc4	B-X
(	B-X
the	B-X
SCFCdc4	B-X
complex	B-X
)	B-X
.	B-X
Skp1	B-X
binds	B-X
a	B-X
motif	B-X
called	B-X
the	B-X
F-box	B-X
and	B-X
in	B-X
turn	B-X
F-box	B-X
proteins	B-X
appear	B-X
to	B-X
recruit	B-X
specific	B-X
substrates	B-X
for	B-X
ubiquitination	B-X
.	B-X
We	B-X
find	B-X
that	B-X
Skp1	B-X
interacts	B-X
with	B-X
Cdc53	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
that	B-X
Skp1	B-X
bridges	B-X
Cdc53	B-X
to	B-X
three	B-X
different	B-X
F-box	B-X
proteins	B-X
,	B-X
Cdc4	B-X
,	B-X
Met30	B-X
,	B-X
and	B-X
Grr1	B-X
.	B-X
F-box	B-X
proteins	B-X
show	B-X
remarkable	B-X
functional	B-X
specificity	B-X
in	B-X
vivo	B-X
:	B-X
Cdc4	B-X
is	B-X
specific	B-X
for	B-X
degradation	B-X
of	B-X
Sic1	B-X
,	B-X
Grr1	B-X
is	B-X
specific	B-X
for	B-X
degradation	B-X
of	B-X
the	B-X
G1	B-X
cyclin	B-X
Cln2	B-X
,	B-X
and	B-X
Met30	B-X
is	B-X
specific	B-X
for	B-X
repression	B-X
of	B-X
methionine	B-X
biosynthesis	B-X
genes	B-X
.	B-X
Combinatorial	B-X
control	B-X
of	B-X
SCF	B-X
complexes	B-X
may	B-X
provide	B-X
a	B-X
basis	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
diverse	B-X
cellular	B-X
processes	B-X
.	B-X

In	O
contrast	O
,	O
the	O
Cdc34	O
-	O
Cdc53	O
-	O
Skp1	O
E2	O
/	O
E3	O
core	O
complex	O
is	O
required	O
for	O
all	O
three	O
functions	O
.	O
<EOS>	B-X
In	B-X
budding	B-X
yeast	B-X
,	B-X
ubiquitination	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
Sic1	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
E2	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Cdc34	B-X
in	B-X
conjunction	B-X
with	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
composed	B-X
of	B-X
Skp1	B-X
,	B-X
Cdc53	B-X
and	B-X
the	B-X
F-box	B-X
protein	B-X
,	B-X
Cdc4	B-X
(	B-X
the	B-X
SCFCdc4	B-X
complex	B-X
)	B-X
.	B-X
Skp1	B-X
binds	B-X
a	B-X
motif	B-X
called	B-X
the	B-X
F-box	B-X
and	B-X
in	B-X
turn	B-X
F-box	B-X
proteins	B-X
appear	B-X
to	B-X
recruit	B-X
specific	B-X
substrates	B-X
for	B-X
ubiquitination	B-X
.	B-X
We	B-X
find	B-X
that	B-X
Skp1	B-X
interacts	B-X
with	B-X
Cdc53	B-X
in	B-X
vivo	B-X
,	B-X
and	B-X
that	B-X
Skp1	B-X
bridges	B-X
Cdc53	B-X
to	B-X
three	B-X
different	B-X
F-box	B-X
proteins	B-X
,	B-X
Cdc4	B-X
,	B-X
Met30	B-X
,	B-X
and	B-X
Grr1	B-X
.	B-X
Cdc53	B-X
contains	B-X
independent	B-X
binding	B-X
sites	B-X
for	B-X
Cdc34	B-X
and	B-X
Skp1	B-X
suggesting	B-X
it	B-X
functions	B-X
as	B-X
a	B-X
scaffold	B-X
protein	B-X
within	B-X
an	B-X
E2/E3	B-X
core	B-X
complex	B-X
.	B-X
In	B-X
contrast	B-X
,	B-X
the	B-X
Cdc34-Cdc53-Skp1	B-X
E2/E3	B-X
core	B-X
complex	B-X
is	B-X
required	B-X
for	B-X
all	B-X
three	B-X
functions	B-X
.	B-X
Combinatorial	B-X
control	B-X
of	B-X
SCF	B-X
complexes	B-X
may	B-X
provide	B-X
a	B-X
basis	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
diverse	B-X
cellular	B-X
processes	B-X
.	B-X

Combinatorial	O
control	O
of	O
SCF	B-Gene_or_gene_product
complexes	O
may	O
provide	O
a	O
basis	O
for	O
the	O
regulation	O
of	O
diverse	O
cellular	O
processes	O
.	O
<EOS>	B-X
In	B-X
budding	B-X
yeast	B-X
,	B-X
ubiquitination	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
(	B-X
Cdk	B-X
)	B-X
inhibitor	B-X
Sic1	B-X
is	B-X
catalyzed	B-X
by	B-X
the	B-X
E2	B-X
ubiquitin	B-X
conjugating	B-X
enzyme	B-X
Cdc34	B-X
in	B-X
conjunction	B-X
with	B-X
an	B-X
E3	B-X
ubiquitin	B-X
ligase	B-X
complex	B-X
composed	B-X
of	B-X
Skp1	B-X
,	B-X
Cdc53	B-X
and	B-X
the	B-X
F-box	B-X
protein	B-X
,	B-X
Cdc4	B-X
(	B-X
the	B-X
SCFCdc4	B-X
complex	B-X
)	B-X
.	B-X
Combinatorial	B-X
control	B-X
of	B-X
SCF	B-X
complexes	B-X
may	B-X
provide	B-X
a	B-X
basis	B-X
for	B-X
the	B-X
regulation	B-X
of	B-X
diverse	B-X
cellular	B-X
processes	B-X
.	B-X

Rat	O
liver	O
mitochondria	O
can	O
hydrolyse	O
thiamine	O
pyrophosphate	O
to	O
thiamine	O
monophosphate	O
which	O
can	O
cross	O
the	O
mitochondrial	O
membrane	O
in	O
a	O
carrier	O
-	O
mediated	O
process	O
.	O

We	O
show	O
here	O
that	O
TPP	O
-	O
-	O
>	O
TMP	O
conversion	O
can	O
take	O
place	O
in	O
rat	O
liver	O
mitochondria	O
.	O
<EOS>	B-X
We	B-X
show	B-X
here	B-X
that	B-X
TPP	B-X
--	B-X
>	B-X
TMP	B-X
conversion	B-X
can	B-X
take	B-X
place	B-X
in	B-X
rat	B-X
liver	B-X
mitochondria	B-X
.	B-X
This	B-X
occurs	B-X
via	B-X
the	B-X
novel	B-X
,	B-X
putative	B-X
TPP	B-X
pyrophosphatase	B-X
localised	B-X
in	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
,	B-X
as	B-X
shown	B-X
both	B-X
by	B-X
digitonin	B-X
titration	B-X
and	B-X
by	B-X
an	B-X
HPLC	B-X
enzyme	B-X
assay	B-X
carried	B-X
out	B-X
on	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
fraction	B-X
.	B-X
Certain	B-X
features	B-X
of	B-X
the	B-X
reaction	B-X
,	B-X
including	B-X
the	B-X
substrate	B-X
and	B-X
pH	B-X
dependence	B-X
,	B-X
are	B-X
reported	B-X
.	B-X
Additional	B-X
evidence	B-X
is	B-X
given	B-X
that	B-X
externally	B-X
added	B-X
TMP	B-X
can	B-X
cross	B-X
the	B-X
mitochondrial	B-X
membrane	B-X
in	B-X
a	B-X
manner	B-X
consistent	B-X
with	B-X
the	B-X
occurrence	B-X
of	B-X
a	B-X
carrier-mediated	B-X
process	B-X
.	B-X
This	B-X
can	B-X
occur	B-X
both	B-X
via	B-X
the	B-X
TPP	B-X
translocator	B-X
and	B-X
via	B-X
a	B-X
novel	B-X
translocator	B-X
,	B-X
inhibited	B-X
by	B-X
CAT	B-X
but	B-X
different	B-X
from	B-X
the	B-X
ADP/ATP	B-X
carrier	B-X
.	B-X

This	O
occurs	O
via	O
the	O
novel	O
,	O
putative	O
TPP	B-Gene_or_gene_product
pyrophosphatase	I-Gene_or_gene_product
localised	O
in	O
the	O
mitochondrial	O
matrix	O
,	O
as	O
shown	O
both	O
by	O
digitonin	O
titration	O
and	O
by	O
an	O
HPLC	O
enzyme	O
assay	O
carried	O
out	O
on	O
the	O
mitochondrial	O
matrix	O
fraction	O
.	O
<EOS>	B-X
We	B-X
show	B-X
here	B-X
that	B-X
TPP	B-X
--	B-X
>	B-X
TMP	B-X
conversion	B-X
can	B-X
take	B-X
place	B-X
in	B-X
rat	B-X
liver	B-X
mitochondria	B-X
.	B-X
This	B-X
occurs	B-X
via	B-X
the	B-X
novel	B-X
,	B-X
putative	B-X
TPP	B-X
pyrophosphatase	B-X
localised	B-X
in	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
,	B-X
as	B-X
shown	B-X
both	B-X
by	B-X
digitonin	B-X
titration	B-X
and	B-X
by	B-X
an	B-X
HPLC	B-X
enzyme	B-X
assay	B-X
carried	B-X
out	B-X
on	B-X
the	B-X
mitochondrial	B-X
matrix	B-X
fraction	B-X
.	B-X
Additional	B-X
evidence	B-X
is	B-X
given	B-X
that	B-X
externally	B-X
added	B-X
TMP	B-X
can	B-X
cross	B-X
the	B-X
mitochondrial	B-X
membrane	B-X
in	B-X
a	B-X
manner	B-X
consistent	B-X
with	B-X
the	B-X
occurrence	B-X
of	B-X
a	B-X
carrier-mediated	B-X
process	B-X
.	B-X
This	B-X
can	B-X
occur	B-X
both	B-X
via	B-X
the	B-X
TPP	B-X
translocator	B-X
and	B-X
via	B-X
a	B-X
novel	B-X
translocator	B-X
,	B-X
inhibited	B-X
by	B-X
CAT	B-X
but	B-X
different	B-X
from	B-X
the	B-X
ADP/ATP	B-X
carrier	B-X
.	B-X

Certain	O
features	O
of	O
the	O
reaction	O
,	O
including	O
the	O
substrate	O
and	O
pH	O
dependence	O
,	O
are	O
reported	O
.	O
<EOS>	B-X
Comparisons	B-X
of	B-X
the	B-X
catalytic	B-X
domains	B-X
of	B-X
PfACalpha	B-X
and	B-X
a	B-X
second	B-X
putative	B-X
P.	B-X
falciparum	B-X
adenylyl	B-X
cyclase	B-X
(	B-X
PfACbeta	B-X
)	B-X
with	B-X
those	B-X
from	B-X
other	B-X
species	B-X
reveal	B-X
an	B-X
unexpected	B-X
similarity	B-X
with	B-X
adenylyl	B-X
cyclases	B-X
from	B-X
certain	B-X
prokaryotes	B-X
including	B-X
the	B-X
cyanobacteria	B-X
(	B-X
blue	B-X
green	B-X
algae	B-X
)	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
the	B-X
presence	B-X
of	B-X
an	B-X
unusual	B-X
active	B-X
site	B-X
substitution	B-X
in	B-X
a	B-X
position	B-X
that	B-X
determines	B-X
substrate	B-X
specificity	B-X
,	B-X
also	B-X
characteristic	B-X
of	B-X
these	B-X
prokaryotic	B-X
forms	B-X
of	B-X
the	B-X
enzyme	B-X
,	B-X
further	B-X
suggests	B-X
a	B-X
plastid	B-X
origin	B-X
for	B-X
the	B-X
Plasmodium	B-X
cyclases	B-X
.	B-X
Certain	B-X
features	B-X
of	B-X
the	B-X
reaction	B-X
,	B-X
including	B-X
the	B-X
substrate	B-X
and	B-X
pH	B-X
dependence	B-X
,	B-X
are	B-X
reported	B-X
.	B-X

Additional	O
evidence	O
is	O
given	O
that	O
externally	O
added	O
TMP	O
can	O
cross	O
the	O
mitochondrial	O
membrane	O
in	O
a	O
manner	O
consistent	O
with	O
the	O
occurrence	O
of	O
a	O
carrier	O
-	O
mediated	O
process	O
.	O

This	O
can	O
occur	O
both	O
via	O
the	O
TPP	O
translocator	O
and	O
via	O
a	O
novel	O
translocator	O
,	O
inhibited	O
by	O
CAT	O
but	O
different	O
from	O
the	O
ADP	O
/	O
ATP	O
carrier	O
.	O

Maturation	O
of	O
human	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
requires	O
the	O
function	O
of	O
eukaryotic	O
chaperonin	O
CCT	O
.	O
<EOS>	B-X
Cyclin	B-X
E	B-X
,	B-X
a	B-X
partner	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdk2	B-X
,	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
positive	B-X
control	B-X
of	B-X
the	B-X
G1/S	B-X
phase	B-X
transition	B-X
.	B-X
Whereas	B-X
degradation	B-X
of	B-X
cyclin	B-X
E	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
exquisitely	B-X
regulated	B-X
by	B-X
ubiquitination	B-X
and	B-X
proteasomal	B-X
action	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
posttranscriptional	B-X
aspects	B-X
of	B-X
its	B-X
biogenesis	B-X
.	B-X
In	B-X
a	B-X
yeast-based	B-X
screen	B-X
designed	B-X
to	B-X
identify	B-X
human	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
human	B-X
cyclin	B-X
E	B-X
,	B-X
we	B-X
identified	B-X
components	B-X
of	B-X
the	B-X
eukaryotic	B-X
cytosolic	B-X
chaperonin	B-X
CCT	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
CCT	B-X
complex	B-X
in	B-X
yeast	B-X
was	B-X
essential	B-X
for	B-X
the	B-X
maturation	B-X
of	B-X
cyclin	B-X
E	B-X
in	B-X
vivo	B-X
.	B-X
Under	B-X
conditions	B-X
of	B-X
impaired	B-X
CCT	B-X
function	B-X
,	B-X
cyclin	B-X
E	B-X
failed	B-X
to	B-X
accumulate	B-X
.	B-X
Furthermore	B-X
,	B-X
newly	B-X
translated	B-X
cyclin	B-X
E	B-X
,	B-X
both	B-X
in	B-X
vitro	B-X
in	B-X
reticulocyte	B-X
lysate	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
human	B-X
cells	B-X
in	B-X
culture	B-X
,	B-X
is	B-X
efficiently	B-X
bound	B-X
and	B-X
processed	B-X
by	B-X
the	B-X
CCT	B-X
.	B-X
Thus	B-X
,	B-X
both	B-X
the	B-X
acquisition	B-X
of	B-X
the	B-X
native	B-X
state	B-X
and	B-X
turnover	B-X
of	B-X
cyclin	B-X
E	B-X
involve	B-X
ATP-dependent	B-X
processes	B-X
mediated	B-X
by	B-X
large	B-X
oligomeric	B-X
assemblies	B-X
.	B-X

Cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
,	O
a	O
partner	O
of	O
the	O
cyclin	B-Gene_or_gene_product
-	I-Gene_or_gene_product
dependent	I-Gene_or_gene_product
kinase	I-Gene_or_gene_product
Cdk2	I-Gene_or_gene_product
,	O
has	O
been	O
implicated	O
in	O
positive	O
control	O
of	O
the	O
G1	O
/	O
S	O
phase	O
transition	O
.	O
<EOS>	B-X
Cyclin	B-X
E	B-X
,	B-X
a	B-X
partner	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdk2	B-X
,	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
positive	B-X
control	B-X
of	B-X
the	B-X
G1/S	B-X
phase	B-X
transition	B-X
.	B-X
Whereas	B-X
degradation	B-X
of	B-X
cyclin	B-X
E	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
exquisitely	B-X
regulated	B-X
by	B-X
ubiquitination	B-X
and	B-X
proteasomal	B-X
action	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
posttranscriptional	B-X
aspects	B-X
of	B-X
its	B-X
biogenesis	B-X
.	B-X
In	B-X
a	B-X
yeast-based	B-X
screen	B-X
designed	B-X
to	B-X
identify	B-X
human	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
human	B-X
cyclin	B-X
E	B-X
,	B-X
we	B-X
identified	B-X
components	B-X
of	B-X
the	B-X
eukaryotic	B-X
cytosolic	B-X
chaperonin	B-X
CCT	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
CCT	B-X
complex	B-X
in	B-X
yeast	B-X
was	B-X
essential	B-X
for	B-X
the	B-X
maturation	B-X
of	B-X
cyclin	B-X
E	B-X
in	B-X
vivo	B-X
.	B-X
Under	B-X
conditions	B-X
of	B-X
impaired	B-X
CCT	B-X
function	B-X
,	B-X
cyclin	B-X
E	B-X
failed	B-X
to	B-X
accumulate	B-X
.	B-X
Furthermore	B-X
,	B-X
newly	B-X
translated	B-X
cyclin	B-X
E	B-X
,	B-X
both	B-X
in	B-X
vitro	B-X
in	B-X
reticulocyte	B-X
lysate	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
human	B-X
cells	B-X
in	B-X
culture	B-X
,	B-X
is	B-X
efficiently	B-X
bound	B-X
and	B-X
processed	B-X
by	B-X
the	B-X
CCT	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
ATP	B-X
,	B-X
the	B-X
bound	B-X
protein	B-X
is	B-X
folded	B-X
and	B-X
released	B-X
in	B-X
order	B-X
to	B-X
become	B-X
associated	B-X
with	B-X
Cdk2	B-X
.	B-X
Thus	B-X
,	B-X
both	B-X
the	B-X
acquisition	B-X
of	B-X
the	B-X
native	B-X
state	B-X
and	B-X
turnover	B-X
of	B-X
cyclin	B-X
E	B-X
involve	B-X
ATP-dependent	B-X
processes	B-X
mediated	B-X
by	B-X
large	B-X
oligomeric	B-X
assemblies	B-X
.	B-X

Whereas	O
degradation	O
of	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
has	O
been	O
shown	O
to	O
be	O
exquisitely	O
regulated	O
by	O
ubiquitination	O
and	O
proteasomal	O
action	O
,	O
little	O
is	O
known	O
about	O
posttranscriptional	O
aspects	O
of	O
its	O
biogenesis	O
.	O
<EOS>	B-X
Cyclin	B-X
E	B-X
,	B-X
a	B-X
partner	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdk2	B-X
,	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
positive	B-X
control	B-X
of	B-X
the	B-X
G1/S	B-X
phase	B-X
transition	B-X
.	B-X
Whereas	B-X
degradation	B-X
of	B-X
cyclin	B-X
E	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
exquisitely	B-X
regulated	B-X
by	B-X
ubiquitination	B-X
and	B-X
proteasomal	B-X
action	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
posttranscriptional	B-X
aspects	B-X
of	B-X
its	B-X
biogenesis	B-X
.	B-X
In	B-X
a	B-X
yeast-based	B-X
screen	B-X
designed	B-X
to	B-X
identify	B-X
human	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
human	B-X
cyclin	B-X
E	B-X
,	B-X
we	B-X
identified	B-X
components	B-X
of	B-X
the	B-X
eukaryotic	B-X
cytosolic	B-X
chaperonin	B-X
CCT	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
CCT	B-X
complex	B-X
in	B-X
yeast	B-X
was	B-X
essential	B-X
for	B-X
the	B-X
maturation	B-X
of	B-X
cyclin	B-X
E	B-X
in	B-X
vivo	B-X
.	B-X
Under	B-X
conditions	B-X
of	B-X
impaired	B-X
CCT	B-X
function	B-X
,	B-X
cyclin	B-X
E	B-X
failed	B-X
to	B-X
accumulate	B-X
.	B-X
Furthermore	B-X
,	B-X
newly	B-X
translated	B-X
cyclin	B-X
E	B-X
,	B-X
both	B-X
in	B-X
vitro	B-X
in	B-X
reticulocyte	B-X
lysate	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
human	B-X
cells	B-X
in	B-X
culture	B-X
,	B-X
is	B-X
efficiently	B-X
bound	B-X
and	B-X
processed	B-X
by	B-X
the	B-X
CCT	B-X
.	B-X
Thus	B-X
,	B-X
both	B-X
the	B-X
acquisition	B-X
of	B-X
the	B-X
native	B-X
state	B-X
and	B-X
turnover	B-X
of	B-X
cyclin	B-X
E	B-X
involve	B-X
ATP-dependent	B-X
processes	B-X
mediated	B-X
by	B-X
large	B-X
oligomeric	B-X
assemblies	B-X
.	B-X

In	O
a	O
yeast	O
-	O
based	O
screen	O
designed	O
to	O
identify	O
human	O
proteins	O
that	O
interact	O
with	O
human	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
,	O
we	O
identified	O
components	O
of	O
the	O
eukaryotic	O
cytosolic	O
chaperonin	O
CCT	O
.	O

We	O
found	O
that	O
the	O
endogenous	O
CCT	O
complex	O
in	O
yeast	O
was	O
essential	O
for	O
the	O
maturation	O
of	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
in	O
vivo	O
.	O
<EOS>	B-X
Cyclin	B-X
E	B-X
,	B-X
a	B-X
partner	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdk2	B-X
,	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
positive	B-X
control	B-X
of	B-X
the	B-X
G1/S	B-X
phase	B-X
transition	B-X
.	B-X
Whereas	B-X
degradation	B-X
of	B-X
cyclin	B-X
E	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
exquisitely	B-X
regulated	B-X
by	B-X
ubiquitination	B-X
and	B-X
proteasomal	B-X
action	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
posttranscriptional	B-X
aspects	B-X
of	B-X
its	B-X
biogenesis	B-X
.	B-X
In	B-X
a	B-X
yeast-based	B-X
screen	B-X
designed	B-X
to	B-X
identify	B-X
human	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
human	B-X
cyclin	B-X
E	B-X
,	B-X
we	B-X
identified	B-X
components	B-X
of	B-X
the	B-X
eukaryotic	B-X
cytosolic	B-X
chaperonin	B-X
CCT	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
CCT	B-X
complex	B-X
in	B-X
yeast	B-X
was	B-X
essential	B-X
for	B-X
the	B-X
maturation	B-X
of	B-X
cyclin	B-X
E	B-X
in	B-X
vivo	B-X
.	B-X
Under	B-X
conditions	B-X
of	B-X
impaired	B-X
CCT	B-X
function	B-X
,	B-X
cyclin	B-X
E	B-X
failed	B-X
to	B-X
accumulate	B-X
.	B-X
Furthermore	B-X
,	B-X
newly	B-X
translated	B-X
cyclin	B-X
E	B-X
,	B-X
both	B-X
in	B-X
vitro	B-X
in	B-X
reticulocyte	B-X
lysate	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
human	B-X
cells	B-X
in	B-X
culture	B-X
,	B-X
is	B-X
efficiently	B-X
bound	B-X
and	B-X
processed	B-X
by	B-X
the	B-X
CCT	B-X
.	B-X
Thus	B-X
,	B-X
both	B-X
the	B-X
acquisition	B-X
of	B-X
the	B-X
native	B-X
state	B-X
and	B-X
turnover	B-X
of	B-X
cyclin	B-X
E	B-X
involve	B-X
ATP-dependent	B-X
processes	B-X
mediated	B-X
by	B-X
large	B-X
oligomeric	B-X
assemblies	B-X
.	B-X

Under	O
conditions	O
of	O
impaired	O
CCT	O
function	O
,	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
failed	O
to	O
accumulate	O
.	O
<EOS>	B-X
Cyclin	B-X
E	B-X
,	B-X
a	B-X
partner	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdk2	B-X
,	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
positive	B-X
control	B-X
of	B-X
the	B-X
G1/S	B-X
phase	B-X
transition	B-X
.	B-X
Whereas	B-X
degradation	B-X
of	B-X
cyclin	B-X
E	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
exquisitely	B-X
regulated	B-X
by	B-X
ubiquitination	B-X
and	B-X
proteasomal	B-X
action	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
posttranscriptional	B-X
aspects	B-X
of	B-X
its	B-X
biogenesis	B-X
.	B-X
In	B-X
a	B-X
yeast-based	B-X
screen	B-X
designed	B-X
to	B-X
identify	B-X
human	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
human	B-X
cyclin	B-X
E	B-X
,	B-X
we	B-X
identified	B-X
components	B-X
of	B-X
the	B-X
eukaryotic	B-X
cytosolic	B-X
chaperonin	B-X
CCT	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
CCT	B-X
complex	B-X
in	B-X
yeast	B-X
was	B-X
essential	B-X
for	B-X
the	B-X
maturation	B-X
of	B-X
cyclin	B-X
E	B-X
in	B-X
vivo	B-X
.	B-X
Under	B-X
conditions	B-X
of	B-X
impaired	B-X
CCT	B-X
function	B-X
,	B-X
cyclin	B-X
E	B-X
failed	B-X
to	B-X
accumulate	B-X
.	B-X
Furthermore	B-X
,	B-X
newly	B-X
translated	B-X
cyclin	B-X
E	B-X
,	B-X
both	B-X
in	B-X
vitro	B-X
in	B-X
reticulocyte	B-X
lysate	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
human	B-X
cells	B-X
in	B-X
culture	B-X
,	B-X
is	B-X
efficiently	B-X
bound	B-X
and	B-X
processed	B-X
by	B-X
the	B-X
CCT	B-X
.	B-X
Thus	B-X
,	B-X
both	B-X
the	B-X
acquisition	B-X
of	B-X
the	B-X
native	B-X
state	B-X
and	B-X
turnover	B-X
of	B-X
cyclin	B-X
E	B-X
involve	B-X
ATP-dependent	B-X
processes	B-X
mediated	B-X
by	B-X
large	B-X
oligomeric	B-X
assemblies	B-X
.	B-X

Furthermore	O
,	O
newly	O
translated	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
,	O
both	O
in	O
vitro	O
in	O
reticulocyte	O
lysate	O
and	O
in	O
vivo	O
in	O
human	O
cells	O
in	O
culture	O
,	O
is	O
efficiently	O
bound	O
and	O
processed	O
by	O
the	O
CCT	O
.	O
<EOS>	B-X
Cyclin	B-X
E	B-X
,	B-X
a	B-X
partner	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdk2	B-X
,	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
positive	B-X
control	B-X
of	B-X
the	B-X
G1/S	B-X
phase	B-X
transition	B-X
.	B-X
Whereas	B-X
degradation	B-X
of	B-X
cyclin	B-X
E	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
exquisitely	B-X
regulated	B-X
by	B-X
ubiquitination	B-X
and	B-X
proteasomal	B-X
action	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
posttranscriptional	B-X
aspects	B-X
of	B-X
its	B-X
biogenesis	B-X
.	B-X
In	B-X
a	B-X
yeast-based	B-X
screen	B-X
designed	B-X
to	B-X
identify	B-X
human	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
human	B-X
cyclin	B-X
E	B-X
,	B-X
we	B-X
identified	B-X
components	B-X
of	B-X
the	B-X
eukaryotic	B-X
cytosolic	B-X
chaperonin	B-X
CCT	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
CCT	B-X
complex	B-X
in	B-X
yeast	B-X
was	B-X
essential	B-X
for	B-X
the	B-X
maturation	B-X
of	B-X
cyclin	B-X
E	B-X
in	B-X
vivo	B-X
.	B-X
Under	B-X
conditions	B-X
of	B-X
impaired	B-X
CCT	B-X
function	B-X
,	B-X
cyclin	B-X
E	B-X
failed	B-X
to	B-X
accumulate	B-X
.	B-X
Furthermore	B-X
,	B-X
newly	B-X
translated	B-X
cyclin	B-X
E	B-X
,	B-X
both	B-X
in	B-X
vitro	B-X
in	B-X
reticulocyte	B-X
lysate	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
human	B-X
cells	B-X
in	B-X
culture	B-X
,	B-X
is	B-X
efficiently	B-X
bound	B-X
and	B-X
processed	B-X
by	B-X
the	B-X
CCT	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
ATP	B-X
,	B-X
the	B-X
bound	B-X
protein	B-X
is	B-X
folded	B-X
and	B-X
released	B-X
in	B-X
order	B-X
to	B-X
become	B-X
associated	B-X
with	B-X
Cdk2	B-X
.	B-X
Thus	B-X
,	B-X
both	B-X
the	B-X
acquisition	B-X
of	B-X
the	B-X
native	B-X
state	B-X
and	B-X
turnover	B-X
of	B-X
cyclin	B-X
E	B-X
involve	B-X
ATP-dependent	B-X
processes	B-X
mediated	B-X
by	B-X
large	B-X
oligomeric	B-X
assemblies	B-X
.	B-X

In	O
vitro	O
,	O
in	O
the	O
presence	O
of	O
ATP	O
,	O
the	O
bound	O
protein	O
is	O
folded	O
and	O
released	O
in	O
order	O
to	O
become	O
associated	O
with	O
Cdk2	B-Gene_or_gene_product
.	O
<EOS>	B-X
Cyclin	B-X
E	B-X
,	B-X
a	B-X
partner	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdk2	B-X
,	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
positive	B-X
control	B-X
of	B-X
the	B-X
G1/S	B-X
phase	B-X
transition	B-X
.	B-X
In	B-X
a	B-X
yeast-based	B-X
screen	B-X
designed	B-X
to	B-X
identify	B-X
human	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
human	B-X
cyclin	B-X
E	B-X
,	B-X
we	B-X
identified	B-X
components	B-X
of	B-X
the	B-X
eukaryotic	B-X
cytosolic	B-X
chaperonin	B-X
CCT	B-X
.	B-X
Furthermore	B-X
,	B-X
newly	B-X
translated	B-X
cyclin	B-X
E	B-X
,	B-X
both	B-X
in	B-X
vitro	B-X
in	B-X
reticulocyte	B-X
lysate	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
human	B-X
cells	B-X
in	B-X
culture	B-X
,	B-X
is	B-X
efficiently	B-X
bound	B-X
and	B-X
processed	B-X
by	B-X
the	B-X
CCT	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
ATP	B-X
,	B-X
the	B-X
bound	B-X
protein	B-X
is	B-X
folded	B-X
and	B-X
released	B-X
in	B-X
order	B-X
to	B-X
become	B-X
associated	B-X
with	B-X
Cdk2	B-X
.	B-X
Thus	B-X
,	B-X
both	B-X
the	B-X
acquisition	B-X
of	B-X
the	B-X
native	B-X
state	B-X
and	B-X
turnover	B-X
of	B-X
cyclin	B-X
E	B-X
involve	B-X
ATP-dependent	B-X
processes	B-X
mediated	B-X
by	B-X
large	B-X
oligomeric	B-X
assemblies	B-X
.	B-X

Thus	O
,	O
both	O
the	O
acquisition	O
of	O
the	O
native	O
state	O
and	O
turnover	O
of	O
cyclin	B-Gene_or_gene_product
E	I-Gene_or_gene_product
involve	O
ATP	O
-	O
dependent	O
processes	O
mediated	O
by	O
large	O
oligomeric	O
assemblies	O
.	O
<EOS>	B-X
Cyclin	B-X
E	B-X
,	B-X
a	B-X
partner	B-X
of	B-X
the	B-X
cyclin-dependent	B-X
kinase	B-X
Cdk2	B-X
,	B-X
has	B-X
been	B-X
implicated	B-X
in	B-X
positive	B-X
control	B-X
of	B-X
the	B-X
G1/S	B-X
phase	B-X
transition	B-X
.	B-X
Whereas	B-X
degradation	B-X
of	B-X
cyclin	B-X
E	B-X
has	B-X
been	B-X
shown	B-X
to	B-X
be	B-X
exquisitely	B-X
regulated	B-X
by	B-X
ubiquitination	B-X
and	B-X
proteasomal	B-X
action	B-X
,	B-X
little	B-X
is	B-X
known	B-X
about	B-X
posttranscriptional	B-X
aspects	B-X
of	B-X
its	B-X
biogenesis	B-X
.	B-X
In	B-X
a	B-X
yeast-based	B-X
screen	B-X
designed	B-X
to	B-X
identify	B-X
human	B-X
proteins	B-X
that	B-X
interact	B-X
with	B-X
human	B-X
cyclin	B-X
E	B-X
,	B-X
we	B-X
identified	B-X
components	B-X
of	B-X
the	B-X
eukaryotic	B-X
cytosolic	B-X
chaperonin	B-X
CCT	B-X
.	B-X
We	B-X
found	B-X
that	B-X
the	B-X
endogenous	B-X
CCT	B-X
complex	B-X
in	B-X
yeast	B-X
was	B-X
essential	B-X
for	B-X
the	B-X
maturation	B-X
of	B-X
cyclin	B-X
E	B-X
in	B-X
vivo	B-X
.	B-X
Under	B-X
conditions	B-X
of	B-X
impaired	B-X
CCT	B-X
function	B-X
,	B-X
cyclin	B-X
E	B-X
failed	B-X
to	B-X
accumulate	B-X
.	B-X
Furthermore	B-X
,	B-X
newly	B-X
translated	B-X
cyclin	B-X
E	B-X
,	B-X
both	B-X
in	B-X
vitro	B-X
in	B-X
reticulocyte	B-X
lysate	B-X
and	B-X
in	B-X
vivo	B-X
in	B-X
human	B-X
cells	B-X
in	B-X
culture	B-X
,	B-X
is	B-X
efficiently	B-X
bound	B-X
and	B-X
processed	B-X
by	B-X
the	B-X
CCT	B-X
.	B-X
In	B-X
vitro	B-X
,	B-X
in	B-X
the	B-X
presence	B-X
of	B-X
ATP	B-X
,	B-X
the	B-X
bound	B-X
protein	B-X
is	B-X
folded	B-X
and	B-X
released	B-X
in	B-X
order	B-X
to	B-X
become	B-X
associated	B-X
with	B-X
Cdk2	B-X
.	B-X
Thus	B-X
,	B-X
both	B-X
the	B-X
acquisition	B-X
of	B-X
the	B-X
native	B-X
state	B-X
and	B-X
turnover	B-X
of	B-X
cyclin	B-X
E	B-X
involve	B-X
ATP-dependent	B-X
processes	B-X
mediated	B-X
by	B-X
large	B-X
oligomeric	B-X
assemblies	B-X
.	B-X

A	O
human	O
homologue	O
of	O
the	O
checkpoint	O
kinase	O
Cds1	B-Gene_or_gene_product
directly	O
inhibits	O
Cdc25	B-Gene_or_gene_product
phosphatase	O
.	O
<EOS>	B-X
In	B-X
human	B-X
cells	B-X
,	B-X
the	B-X
mitosis-inducing	B-X
kinase	B-X
Cdc2	B-X
is	B-X
inhibited	B-X
by	B-X
phosphorylation	B-X
on	B-X
Thr14	B-X
and	B-X
Tyr15	B-X
.	B-X
Disruption	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
abrogates	B-X
checkpoint-mediated	B-X
regulation	B-X
of	B-X
Cdc2	B-X
and	B-X
renders	B-X
cells	B-X
highly	B-X
sensitive	B-X
to	B-X
agents	B-X
that	B-X
damage	B-X
DNA	B-X
.	B-X
Phosphorylation	B-X
of	B-X
these	B-X
sites	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
Wee1/Myt1	B-X
kinases	B-X
and	B-X
the	B-X
Cdc25	B-X
phosphatase	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
these	B-X
enzymes	B-X
is	B-X
therefore	B-X
likely	B-X
to	B-X
be	B-X
crucial	B-X
for	B-X
the	B-X
operation	B-X
of	B-X
the	B-X
G2-M	B-X
DNA-damage	B-X
checkpoint	B-X
.	B-X

BACKGROUND	O
:	O
In	O
human	O
cells	O
,	O
the	O
mitosis	O
-	O
inducing	O
kinase	O
Cdc2	B-Gene_or_gene_product
is	O
inhibited	O
by	O
phosphorylation	O
on	O
Thr14	O
and	O
Tyr15	O
.	O
<EOS>	B-X
In	B-X
human	B-X
cells	B-X
,	B-X
the	B-X
mitosis-inducing	B-X
kinase	B-X
Cdc2	B-X
is	B-X
inhibited	B-X
by	B-X
phosphorylation	B-X
on	B-X
Thr14	B-X
and	B-X
Tyr15	B-X
.	B-X
Disruption	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
abrogates	B-X
checkpoint-mediated	B-X
regulation	B-X
of	B-X
Cdc2	B-X
and	B-X
renders	B-X
cells	B-X
highly	B-X
sensitive	B-X
to	B-X
agents	B-X
that	B-X
damage	B-X
DNA	B-X
.	B-X
Phosphorylation	B-X
of	B-X
these	B-X
sites	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
Wee1/Myt1	B-X
kinases	B-X
and	B-X
the	B-X
Cdc25	B-X
phosphatase	B-X
.	B-X

Disruption	O
of	O
these	O
phosphorylation	O
sites	O
abrogates	O
checkpoint	O
-	O
mediated	O
regulation	O
of	O
Cdc2	B-Gene_or_gene_product
and	O
renders	O
cells	O
highly	O
sensitive	O
to	O
agents	O
that	O
damage	O
DNA	O
.	O
<EOS>	B-X
In	B-X
human	B-X
cells	B-X
,	B-X
the	B-X
mitosis-inducing	B-X
kinase	B-X
Cdc2	B-X
is	B-X
inhibited	B-X
by	B-X
phosphorylation	B-X
on	B-X
Thr14	B-X
and	B-X
Tyr15	B-X
.	B-X
Disruption	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
abrogates	B-X
checkpoint-mediated	B-X
regulation	B-X
of	B-X
Cdc2	B-X
and	B-X
renders	B-X
cells	B-X
highly	B-X
sensitive	B-X
to	B-X
agents	B-X
that	B-X
damage	B-X
DNA	B-X
.	B-X
Phosphorylation	B-X
of	B-X
these	B-X
sites	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
Wee1/Myt1	B-X
kinases	B-X
and	B-X
the	B-X
Cdc25	B-X
phosphatase	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
these	B-X
enzymes	B-X
is	B-X
therefore	B-X
likely	B-X
to	B-X
be	B-X
crucial	B-X
for	B-X
the	B-X
operation	B-X
of	B-X
the	B-X
G2-M	B-X
DNA-damage	B-X
checkpoint	B-X
.	B-X

Phosphorylation	O
of	O
these	O
sites	O
is	O
controlled	O
by	O
the	O
opposing	O
activities	O
of	O
the	O
Wee1	B-Gene_or_gene_product
/	O
Myt1	B-Gene_or_gene_product
kinases	O
and	O
the	O
Cdc25	B-Gene_or_gene_product
phosphatase	O
.	O
<EOS>	B-X
Disruption	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
abrogates	B-X
checkpoint-mediated	B-X
regulation	B-X
of	B-X
Cdc2	B-X
and	B-X
renders	B-X
cells	B-X
highly	B-X
sensitive	B-X
to	B-X
agents	B-X
that	B-X
damage	B-X
DNA	B-X
.	B-X
Phosphorylation	B-X
of	B-X
these	B-X
sites	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
Wee1/Myt1	B-X
kinases	B-X
and	B-X
the	B-X
Cdc25	B-X
phosphatase	B-X
.	B-X

The	O
regulation	O
of	O
these	O
enzymes	O
is	O
therefore	O
likely	O
to	O
be	O
crucial	O
for	O
the	O
operation	O
of	O
the	O
G2	O
-	O
M	O
DNA	O
-	O
damage	O
checkpoint	O
.	O
<EOS>	B-X
Disruption	B-X
of	B-X
these	B-X
phosphorylation	B-X
sites	B-X
abrogates	B-X
checkpoint-mediated	B-X
regulation	B-X
of	B-X
Cdc2	B-X
and	B-X
renders	B-X
cells	B-X
highly	B-X
sensitive	B-X
to	B-X
agents	B-X
that	B-X
damage	B-X
DNA	B-X
.	B-X
The	B-X
regulation	B-X
of	B-X
these	B-X
enzymes	B-X
is	B-X
therefore	B-X
likely	B-X
to	B-X
be	B-X
crucial	B-X
for	B-X
the	B-X
operation	B-X
of	B-X
the	B-X
G2-M	B-X
DNA-damage	B-X
checkpoint	B-X
.	B-X

RESULTS	O
:	O
Here	O
,	O
we	O
show	O
that	O
the	O
activity	O
of	O
Cdc25	B-Gene_or_gene_product
decreased	O
following	O
exposure	O
to	O
ionizing	O
radiation	O
.	O
<EOS>	B-X
Phosphorylation	B-X
of	B-X
these	B-X
sites	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
Wee1/Myt1	B-X
kinases	B-X
and	B-X
the	B-X
Cdc25	B-X
phosphatase	B-X
.	B-X
The	B-X
cellular	B-X
responses	B-X
to	B-X
ionizing	B-X
radiation	B-X
include	B-X
growth	B-X
arrest	B-X
,	B-X
DNA	B-X
repair	B-X
,	B-X
and	B-X
lethality	B-X
.	B-X
The	B-X
present	B-X
studies	B-X
have	B-X
examined	B-X
the	B-X
effects	B-X
of	B-X
ionizing	B-X
radiation	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
genes	B-X
involved	B-X
in	B-X
cell	B-X
cycle	B-X
control	B-X
.	B-X
The	B-X
results	B-X
demonstrate	B-X
that	B-X
the	B-X
treatment	B-X
of	B-X
asynchronous	B-X
cells	B-X
with	B-X
20	B-X
Gy	B-X
ionizing	B-X
radiation	B-X
is	B-X
associated	B-X
with	B-X
transient	B-X
down-regulation	B-X
of	B-X
the	B-X
cdc2	B-X
,	B-X
cyclin	B-X
A	B-X
,	B-X
cyclin	B-X
B	B-X
,	B-X
and	B-X
cdc25	B-X
genes	B-X
.	B-X
RNA	B-X
stability	B-X
studies	B-X
demonstrate	B-X
that	B-X
the	B-X
down-regulation	B-X
of	B-X
gene	B-X
expression	B-X
following	B-X
ionizing	B-X
radiation	B-X
exposure	B-X
is	B-X
at	B-X
least	B-X
in	B-X
part	B-X
due	B-X
to	B-X
a	B-X
decrease	B-X
in	B-X
transcript	B-X
half-life	B-X
.	B-X
Taken	B-X
together	B-X
with	B-X
clonogenic	B-X
survival	B-X
studies	B-X
,	B-X
these	B-X
findings	B-X
indicate	B-X
that	B-X
down-regulation	B-X
of	B-X
cell	B-X
cycle	B-X
control	B-X
gene	B-X
expression	B-X
is	B-X
associated	B-X
with	B-X
lethality	B-X
,	B-X
whereas	B-X
lower	B-X
doses	B-X
of	B-X
ionizing	B-X
radiation	B-X
have	B-X
little	B-X
,	B-X
if	B-X
any	B-X
,	B-X
effect	B-X
on	B-X
the	B-X
expression	B-X
of	B-X
these	B-X
genes	B-X
.	B-X

The	O
irradiation	O
-	O
induced	O
decrease	O
in	O
Cdc25	B-Gene_or_gene_product
activity	O
was	O
suppressed	O
by	O
wortmannin	O
,	O
an	O
inhibitor	O
of	O
phosphatidylinositol	B-Gene_or_gene_product
(	I-Gene_or_gene_product
PI	I-Gene_or_gene_product
)	I-Gene_or_gene_product
3	I-Gene_or_gene_product
-	I-Gene_or_gene_product
kinases	I-Gene_or_gene_product
,	O
and	O
was	O
dependent	O
on	O
the	O
function	O
of	O
the	O
gene	O
that	O
is	O
mutated	B-Gene_or_gene_product
in	I-Gene_or_gene_product
ataxia	I-Gene_or_gene_product
telangiectasia	I-Gene_or_gene_product
.	O
<EOS>	B-X
Phosphorylation	B-X
of	B-X
these	B-X
sites	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
Wee1/Myt1	B-X
kinases	B-X
and	B-X
the	B-X
Cdc25	B-X
phosphatase	B-X
.	B-X

We	O
also	O
identified	O
two	O
human	O
kinases	O
that	O
phosphorylate	O
and	O
inactivate	O
Cdc25	B-Gene_or_gene_product
in	O
vitro	O
.	O
<EOS>	B-X
In	B-X
human	B-X
cells	B-X
,	B-X
the	B-X
mitosis-inducing	B-X
kinase	B-X
Cdc2	B-X
is	B-X
inhibited	B-X
by	B-X
phosphorylation	B-X
on	B-X
Thr14	B-X
and	B-X
Tyr15	B-X
.	B-X
Phosphorylation	B-X
of	B-X
these	B-X
sites	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
Wee1/Myt1	B-X
kinases	B-X
and	B-X
the	B-X
Cdc25	B-X
phosphatase	B-X
.	B-X

One	O
is	O
the	O
previously	O
characterized	O
Chk1	B-Gene_or_gene_product
kinase	O
.	O
<EOS>	B-X
In	B-X
human	B-X
cells	B-X
,	B-X
the	B-X
mitosis-inducing	B-X
kinase	B-X
Cdc2	B-X
is	B-X
inhibited	B-X
by	B-X
phosphorylation	B-X
on	B-X
Thr14	B-X
and	B-X
Tyr15	B-X
.	B-X
Phosphorylation	B-X
of	B-X
these	B-X
sites	B-X
is	B-X
controlled	B-X
by	B-X
the	B-X
opposing	B-X
activities	B-X
of	B-X
the	B-X
Wee1/Myt1	B-X
kinases	B-X
and	B-X
the	B-X
Cdc25	B-X
phosphatase	B-X
.	B-X
The	B-X
genetic	B-X
syndrome	B-X
Fanconi	B-X
anemia	B-X
(	B-X
FA	B-X
)	B-X
is	B-X
characterized	B-X
by	B-X
aplastic	B-X
anemia	B-X
,	B-X
cancer	B-X
predisposition	B-X
and	B-X
hypersensitivity	B-X
to	B-X
DNA	B-X
interstrand	B-X
crosslinks	B-X
(	B-X
ICLs	B-X
)	B-X
.	B-X
We	B-X
deciphered	B-X
the	B-X
previously	B-X
undefined	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
leading	B-X
to	B-X
the	B-X
ICLs-induced	B-X
S-phase	B-X
checkpoint	B-X
and	B-X
the	B-X
role	B-X
of	B-X
FANCs	B-X
in	B-X
this	B-X
process	B-X
.	B-X
We	B-X
found	B-X
that	B-X
ICLs	B-X
activate	B-X
a	B-X
branched	B-X
pathway	B-X
downstream	B-X
of	B-X
the	B-X
ATR	B-X
kinase	B-X
:	B-X
one	B-X
branch	B-X
depending	B-X
on	B-X
CHK1	B-X
activity	B-X
and	B-X
the	B-X
other	B-X
on	B-X
the	B-X
FANCs-RMN	B-X
complex	B-X
.	B-X
This	B-X
study	B-X
demonstrates	B-X
a	B-X
novel	B-X
relationship	B-X
between	B-X
the	B-X
FA	B-X
pathway	B-X
(	B-X
s	B-X
)	B-X
and	B-X
the	B-X
ATR	B-X
kinase	B-X
.	B-X

The	O
second	O
is	O
novel	O
and	O
is	O
homologous	O
to	O
the	O
Cds1	B-Gene_or_gene_product
/	I-Gene_or_gene_product
Rad53	I-Gene_or_gene_product
family	O
of	O
checkpoint	O
kinases	O
in	O
yeast	O
.	O

Human	O
Cds1	B-Gene_or_gene_product
was	O
found	O
to	O
be	O
activated	O
in	O
response	O
to	O
DNA	O
damage	O
.	O
<EOS>	B-X
In	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
,	B-X
mammalian	B-X
cells	B-X
adopt	B-X
checkpoint	B-X
regulation	B-X
,	B-X
by	B-X
phosphorylation	B-X
and	B-X
stabilization	B-X
of	B-X
p53	B-X
,	B-X
to	B-X
delay	B-X
cell	B-X
cycle	B-X
progression	B-X
.	B-X
Here	B-X
we	B-X
demonstrate	B-X
that	B-X
a	B-X
human	B-X
homolog	B-X
of	B-X
Cds1/Rad53	B-X
kinase	B-X
(	B-X
hCds1	B-X
)	B-X
is	B-X
rapidly	B-X
phosphorylated	B-X
and	B-X
activated	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
not	B-X
only	B-X
in	B-X
normal	B-X
cells	B-X
but	B-X
in	B-X
cancer	B-X
cells	B-X
lacking	B-X
functional	B-X
p53	B-X
.	B-X
A	B-X
survey	B-X
of	B-X
various	B-X
cancer	B-X
cell	B-X
lines	B-X
revealed	B-X
that	B-X
the	B-X
expression	B-X
level	B-X
of	B-X
hCds1	B-X
mRNA	B-X
is	B-X
inversely	B-X
related	B-X
to	B-X
the	B-X
presence	B-X
of	B-X
functional	B-X
p53	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
transfection	B-X
of	B-X
normal	B-X
human	B-X
fibroblasts	B-X
with	B-X
SV40	B-X
T	B-X
antigen	B-X
or	B-X
human	B-X
papilloma	B-X
viruses	B-X
E6	B-X
or	B-X
E7	B-X
causes	B-X
a	B-X
marked	B-X
induction	B-X
of	B-X
hCds1	B-X
mRNA	B-X
,	B-X
and	B-X
the	B-X
introduction	B-X
of	B-X
functional	B-X
p53	B-X
into	B-X
SV40	B-X
T	B-X
antigen-	B-X
and	B-X
E6-	B-X
,	B-X
but	B-X
not	B-X
E7-	B-X
,	B-X
transfected	B-X
cells	B-X
decreases	B-X
the	B-X
hCds1	B-X
level	B-X
,	B-X
suggesting	B-X
that	B-X
p53	B-X
negatively	B-X
regulates	B-X
the	B-X
expression	B-X
of	B-X
hCds1	B-X
.	B-X
In	B-X
cells	B-X
without	B-X
functional	B-X
ataxia	B-X
telangiectasia	B-X
mutated	B-X
(	B-X
ATM	B-X
)	B-X
protein	B-X
,	B-X
phosphorylation	B-X
and	B-X
activation	B-X
of	B-X
hCds1	B-X
were	B-X
observed	B-X
in	B-X
response	B-X
to	B-X
DNA	B-X
damage	B-X
induced	B-X
by	B-X
UV	B-X
but	B-X
not	B-X
by	B-X
ionizing	B-X
irradiation	B-X
.	B-X
These	B-X
results	B-X
suggest	B-X
that	B-X
hCds1	B-X
is	B-X
activated	B-X
through	B-X
an	B-X
ATM-dependent	B-X
as	B-X
well	B-X
as	B-X
-independent	B-X
pathway	B-X
and	B-X
that	B-X
it	B-X
may	B-X
complement	B-X
the	B-X
function	B-X
of	B-X
p53	B-X
in	B-X
DNA	B-X
damage	B-X
checkpoints	B-X
in	B-X
mammalian	B-X
cells	B-X
.	B-X

CONCLUSIONS	O
:	O
These	O
results	O
suggest	O
that	O
,	O
in	O
human	O
cells	O
,	O
the	O
DNA	O
-	O
damage	O
checkpoint	O
involves	O
direct	O
inactivation	O
of	O
Cdc25	B-Gene_or_gene_product
catalyzed	O
by	O
Cds1	B-Gene_or_gene_product
and	O
/	O
or	O
Chk1	B-Gene_or_gene_product
.	O
<EOS>	B-X
The	B-X
cell	B-X
cycle	B-X
checkpoint	B-X
proteins	B-X
ataxia-telangiectasia-mutated-and-Rad3-related	B-X
kinase	B-X
(	B-X
ATR	B-X
)	B-X
and	B-X
its	B-X
major	B-X
downstream	B-X
effector	B-X
checkpoint	B-X
kinase	B-X
1	B-X
(	B-X
CHK1	B-X
)	B-X
prevent	B-X
the	B-X
entry	B-X
of	B-X
cells	B-X
with	B-X
damaged	B-X
or	B-X
incompletely	B-X
replicated	B-X
DNA	B-X
into	B-X
mitosis	B-X
when	B-X
the	B-X
cells	B-X
are	B-X
challenged	B-X
by	B-X
DNA	B-X
damaging	B-X
agents	B-X
,	B-X
such	B-X
as	B-X
radiation	B-X
therapy	B-X
(	B-X
RT	B-X
)	B-X
or	B-X
chemotherapeutic	B-X
drugs	B-X
,	B-X
that	B-X
are	B-X
the	B-X
major	B-X
modalities	B-X
to	B-X
treat	B-X
cancer	B-X
.	B-X
This	B-X
regulation	B-X
is	B-X
particularly	B-X
evident	B-X
in	B-X
cells	B-X
with	B-X
a	B-X
defective	B-X
G1	B-X
checkpoint	B-X
,	B-X
a	B-X
common	B-X
feature	B-X
of	B-X
cancer	B-X
cells	B-X
,	B-X
due	B-X
to	B-X
p53	B-X
mutations	B-X
.	B-X
In	B-X
addition	B-X
,	B-X
ATR	B-X
and/or	B-X
CHK1	B-X
suppress	B-X
replication	B-X
stress	B-X
(	B-X
RS	B-X
)	B-X
by	B-X
inhibiting	B-X
excess	B-X
origin	B-X
firing	B-X
,	B-X
particularly	B-X
in	B-X
cells	B-X
with	B-X
activated	B-X
oncogenes	B-X
.	B-X
We	B-X
also	B-X
discuss	B-X
the	B-X
potential	B-X
mechanisms	B-X
by	B-X
which	B-X
ATR	B-X
and	B-X
CHK1	B-X
inhibition	B-X
induces	B-X
cell	B-X
killing	B-X
in	B-X
the	B-X
presence	B-X
or	B-X
absence	B-X
of	B-X
exogenous	B-X
DNA	B-X
damaging	B-X
agents	B-X
,	B-X
such	B-X
as	B-X
RT	B-X
and	B-X
chemotherapeutic	B-X
agents	B-X
.	B-X
Lastly	B-X
,	B-X
we	B-X
discuss	B-X
synthetic	B-X
lethality	B-X
interactions	B-X
between	B-X
the	B-X
inhibition	B-X
of	B-X
ATR/CHK1	B-X
and	B-X
defects	B-X
in	B-X
other	B-X
DNA	B-X
damage	B-X
response	B-X
(	B-X
DDR	B-X
)	B-X
pathways/genes	B-X
.	B-X

